PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Polato, NR; Voolstra, CR; Schnetzer, J; DeSalvo, MK; Randall, CJ; Szmant, AM; Medina, M; Baums, IB				Polato, Nicholas R.; Voolstra, Christian R.; Schnetzer, Julia; DeSalvo, Michael K.; Randall, Carly J.; Szmant, Alina M.; Medina, Monica; Baums, Iliana B.			Location-Specific Responses to Thermal Stress in Larvae of the Reef-Building Coral Montastraea faveolata	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; GENE-EXPRESSION; ELEVATED-TEMPERATURE; SCLERACTINIAN CORAL; CARIBBEAN CORAL; OXIDATIVE STRESS; ACROPORA-PALMATA; CLIMATE-CHANGE; ELKHORN CORAL; SETTLEMENT	Background: The potential to adapt to a changing climate depends in part upon the standing genetic variation present in wild populations. In corals, the dispersive larval phase is particularly vulnerable to the effects of environmental stress. Larval survival and response to stress during dispersal and settlement will play a key role in the persistence of coral populations. Methodology/Principal Findings: To test the hypothesis that larval transcription profiles reflect location-specific responses to thermal stress, symbiont-free gametes from three to four colonies of the scleractinian coral Montastraea faveolata were collected from Florida and Mexico, fertilized, and raised under mean and elevated (up 1 to 2 degrees C above summer mean) temperatures. These locations have been shown to exchange larvae frequently enough to prevent significant differentiation of neutral loci. Differences among 1,310 unigenes were simultaneously characterized using custom cDNA microarrays, allowing investigation of gene expression patterns among larvae generated from wild populations under stress. Results show both conserved and location-specific variation in key processes including apoptosis, cell structuring, adhesion and development, energy and protein metabolism, and response to stress, in embryos of a reef-building coral. Conclusions/Significance: These results provide first insights into location-specific variation in gene expression in the face of gene flow, and support the hypothesis that coral host genomes may house adaptive potential needed to deal with changing environmental conditions.	[Polato, Nicholas R.; Baums, Iliana B.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Voolstra, Christian R.] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Schnetzer, Julia] Max Planck Inst Marine Microbiol, Bremen, Germany; [DeSalvo, Michael K.; Medina, Monica] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Randall, Carly J.; Szmant, Alina M.] Univ N Carolina, Ctr Marine Sci, Wilmington, NC 28401 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; King Abdullah University of Science & Technology; Max Planck Society; University of California System; University of California Merced; University of North Carolina; University of North Carolina Wilmington	Polato, NR (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	baums@psu.edu	Randall, Carly J./H-4195-2019; Baums, Iliana Brigitta/G-6435-2010; Voolstra, Christian R/H-7158-2014	Randall, Carly J./0000-0001-8112-3552; Baums, Iliana Brigitta/0000-0001-6463-7308; Voolstra, Christian R/0000-0003-4555-3795	National Science Foundation (NSF) [0313708]; NSF Division of Ocean Sciences [0825979]; NSF Division of Intagrative Organismal Systems (IOS) [0644438]; University of California; NOAA; World Bank; University of North Carolina Wilmington Academic Affairs; Division Of Integrative Organismal Systems [1402065] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF Division of Ocean Sciences(National Science Foundation (NSF)); NSF Division of Intagrative Organismal Systems (IOS); University of California(University of California System); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); World Bank(The World Bank India); University of North Carolina Wilmington Academic Affairs; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by a National Science Foundation (NSF) Graduate Research Fellowship Program award to N.R.P.; NSF Division of Ocean Sciences (OCE) grant 0825979 to I.B.B.; NSF Division of Intagrative Organismal Systems (IOS) grant 0644438, NSF OCE grant 0313708, and University of California Mexus grant to M.M.; the NOAA coral reef grant conservation program supporting M. Miller; and the World Bank Coral Reef Targeted Research and University of North Carolina Wilmington Academic Affairs grants to A.M.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Baird A.H., 2006, P 10 INT COR REEF S, P38; Bassim KM, 2003, MAR BIOL, V142, P241, DOI 10.1007/S00227-002-0953-z; Baums IB, 2008, MOL ECOL, V17, P2796, DOI 10.1111/j.1365-294X.2008.03787.x; Bay LK, 2009, MOL ECOL, V18, P3062, DOI 10.1111/j.1365-294X.2009.04257.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berkelmans R, 1999, CORAL REEFS, V18, P219, DOI 10.1007/s003380050186; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; BLACK NA, 1995, BIOL BULL, V188, P234, DOI 10.2307/1542301; BOSCH TCG, 1988, P NATL ACAD SCI USA, V85, P7927, DOI 10.1073/pnas.85.21.7927; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Brown BE, 1997, ADV MAR BIOL, V31, P221, DOI 10.1016/S0065-2881(08)60224-2; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; BUDDEMEIER RW, 2004, ADAPTIVE HYPOTHESIS, P427, DOI DOI 10.1007/978-3-662-06414-6_24; CLAUSEN CD, 1975, MAR BIOL, V33, P93, DOI 10.1007/BF00390713; Coles S.L., 1976, THERMAL TOLERANCE TR; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; DESALVO MK, MOL ECOLOGY IN PRESS; Done TJ, 1999, AM ZOOL, V39, P66; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Dorion S, 2002, J BIOL CHEM, V277, P30792, DOI 10.1074/jbc.M203642200; Downs CA, 2002, FREE RADICAL BIO MED, V33, P533, DOI 10.1016/S0891-5849(02)00907-3; Downs CA, 2000, MAR BIOTECHNOL, V2, P533, DOI 10.1007/s101260000038; DUCKLOW HW, 1979, LIMNOL OCEANOGR, V24, P715, DOI 10.4319/lo.1979.24.4.0715; Edge SE, 2005, MAR POLLUT BULL, V51, P507, DOI 10.1016/j.marpolbul.2005.07.007; Edmunds PJ, 2004, MAR ECOL PROG SER, V269, P111, DOI 10.3354/meps269111; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Fang LS, 1997, CORAL REEFS, V16, P127, DOI 10.1007/s003380050066; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Feldman AL, 2002, BIOTECHNIQUES, V33, P906, DOI 10.2144/02334mt04; Gates RD, 1999, AM ZOOL, V39, P30; GLYNN PW, 1990, CORAL REEFS, V8, P181, DOI 10.1007/BF00265009; GLYNN PW, 1984, ENVIRON CONSERV, V11, P133, DOI 10.1017/S0376892900013825; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; HARRIOTT VJ, 1985, MAR ECOL PROG SER, V21, P81, DOI 10.3354/meps021081; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoover CA, 2008, BIOL BULL-US, V214, P319, DOI 10.2307/25470673; Howe GT, 2003, CAN J BOT, V81, P1247, DOI [10.1139/b03-141, 10.1139/B03-141]; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Jacobs MW, 2006, INTEGR COMP BIOL, V46, P760, DOI 10.1093/icb/icl015; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Kammenga JE, 2007, TRENDS ECOL EVOL, V22, P273, DOI 10.1016/j.tree.2007.01.013; KAUFMANN SHE, 1990, IMMUNOL TODAY, V11, P129, DOI 10.1016/0167-5699(90)90050-J; Knapen D, 2009, TRENDS BIOTECHNOL, V27, P406, DOI 10.1016/j.tibtech.2009.03.007; Krebs RA, 1997, EVOLUTION, V51, P173, DOI 10.1111/j.1558-5646.1997.tb02398.x; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Marsh AG, 2005, J EXP ZOOL PART B, V304B, P238, DOI 10.1002/jez.b.21037; Meyer E, 2009, MAR ECOL PROG SER, V392, P81, DOI 10.3354/meps08208; Miller MW, 2009, MAR ECOL PROG SER, V387, P147, DOI 10.3354/meps08097; Negri AP, 2007, CORAL REEFS, V26, P759, DOI 10.1007/s00338-007-0258-2; Nozawa Y, 2007, MAR BIOL, V152, P1181, DOI 10.1007/s00227-007-0765-2; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Oleksiak MF, 2005, NAT GENET, V37, P67, DOI 10.1038/ng1483; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; PERRET E, 1995, J CELL SCI, V108, P711; Petersen D, 2008, CORAL REEFS, V27, P715, DOI 10.1007/s00338-008-0385-4; R Core Team, 2018, R LANG ENV STAT COMP; Rasanen K, 2007, FUNCT ECOL, V21, P408, DOI 10.1111/j.1365-2435.2007.01246.x; Randall CJ, 2009, CORAL REEFS, V28, P537, DOI 10.1007/s00338-009-0482-z; Randall CJ, 2009, BIOL BULL-US, V217, P269, DOI 10.1086/BBLv217n3p269; Ranz JM, 2006, TRENDS ECOL EVOL, V21, P29, DOI 10.1016/j.tree.2005.09.002; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; RICHMOND RH, 1990, MAR ECOL PROG SER, V60, P185, DOI 10.3354/meps060185; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Schwarz JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-97; Severance EG, 2004, MOL ECOL NOTES, V4, P74, DOI 10.1046/j.1471-8286.2003.00573.x; Severance EG, 2006, MAR BIOL, V150, P57, DOI 10.1007/s00227-006-0332-2; Sharp VA, 1997, J THERM BIOL, V22, P11, DOI 10.1016/S0306-4565(96)00029-0; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sunagawa S, 2008, COMP BIOCHEM PHYS B, V151, P133, DOI 10.1016/j.cbpb.2008.06.007; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; SZMANT AM, 1991, MAR ECOL PROG SER, V74, P13, DOI 10.3354/meps074013; Vermeij MJA, 2006, MAR ECOL PROG SER, V310, P119, DOI 10.3354/meps310119; Voolstra CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-627; Weis VM, 2008, TRENDS ECOL EVOL, V23, P369, DOI 10.1016/j.tree.2008.03.004; WERNER I, 1997, ENV TOXICOLOGY CHEM, V16; Whitehead A, 2006, MOL ECOL, V15, P1197, DOI 10.1111/j.1365-294X.2006.02868.x; Williams EA, 2009, MOL ECOL, V18, P1006, DOI 10.1111/j.1365-294X.2008.04078.x; Wray GA, 2006, INTEGR COMP BIOL, V46, P233, DOI 10.1093/icb/icj030; Yang YH, 2003, INST MATH S, V40, P403	91	82	83	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11221	10.1371/journal.pone.0011221	http://dx.doi.org/10.1371/journal.pone.0011221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585643	Green Accepted, Green Published, gold			2022-12-27	WOS:000279135400010
J	Glauche, I; Herberg, M; Roeder, I				Glauche, Ingmar; Herberg, Maria; Roeder, Ingo			Nanog Variability and Pluripotency Regulation of Embryonic Stem Cells - Insights from a Mathematical Model Analysis	PLOS ONE			English	Article							SELF-RENEWAL; TRANSCRIPTIONAL REGULATION; MOUSE EMBRYOS; ES CELLS; OCT4; DIFFERENTIATION; NETWORKS; STATE; TERATOCARCINOMA; FIBROBLASTS	The expression of the transcription factors Oct4, Sox2, and Nanog is commonly associated with pluripotency of mouse embryonic stem (ES) cells. However, recent observations suggest that ES cell populations are heterogeneous with respect to the expression of Nanog and that individual ES cells reversibly change their Nanog expression level. Furthermore, it has been shown that cells exhibiting a low Nanog level are more likely to undergo differentiation. Applying a novel mathematical transcription factor network model we explore mechanisms and feedback regulations to describe the observed variation of the Nanog levels in mouse ES cells. In particular we show that these variations can occur under different assumptions yielding similar experimental characteristics. Based on model predictions we propose experimental strategies to distinguish between these explanations. Concluding from our results we argue that the heterogeneity with respect to the Nanog concentrations is most likely a functional element to control the differentiation propensity of an ES cell population. Furthermore, we provide a conceptual framework that consistently explains Nanog variability and a potential "gate-keeper'' function of Nanog expression with respect to the control of ES cell differentiation.	[Glauche, Ingmar; Herberg, Maria; Roeder, Ingo] Univ Leipzig, Fac Med, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Glauche, Ingmar; Roeder, Ingo] Tech Univ Dresden, Inst Med Informat & Biometry, Fac Med Carl Gustav Carus, D-8027 Dresden, Germany	Leipzig University; Technische Universitat Dresden	Glauche, I (corresponding author), Univ Leipzig, Fac Med, Inst Med Informat Stat & Epidemiol, Leipzig, Germany.	ingo.roeder@tu-dresden.de			European Commission [200270]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission project EuroSyStem (200270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chen X, 2008, STEM CELLS, V26, P2759, DOI 10.1634/stemcells.2008-0398; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Hoffmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002922; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; MacArthur BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003086; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mullin NP, 2008, BIOCHEM J, V411, P227, DOI 10.1042/BJ20080134; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Shahrezaei V, 2008, CURR OPIN BIOTECH, V19, P369, DOI 10.1016/j.copbio.2008.06.011; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; THOMAS R, 1995, B MATH BIOL, V57, P247, DOI 10.1007/BF02460618; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944	42	69	71	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11238	10.1371/journal.pone.0011238	http://dx.doi.org/10.1371/journal.pone.0011238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574542	Green Submitted, Green Published, gold			2022-12-27	WOS:000279058300022
J	Domitrovic, T; Kozlov, G; Freire, JCG; Masuda, CA; Almeida, MD; Montero-Lomeli, M; Atella, GC; Matta-Camacho, E; Gehring, K; Kurtenbach, E				Domitrovic, Tatiana; Kozlov, Guennadi; Goncalves Freire, Joao Claudio; Masuda, Claudio Akio; Almeida, Marcius da Silva; Montero-Lomeli, Monica; Atella, Georgia Correa; Matta-Camacho, Edna; Gehring, Kalle; Kurtenbach, Eleonora			Structural and Functional Study of Yer067w, a New Protein Involved in Yeast Metabolism Control and Drug Resistance	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; AZOLE RESISTANCE; EVOLUTION; ALIGNMENT; HOMOLOGY; TRANSCRIPTOME; REFINEMENT; GLYCOGEN; HISTORY	The genome of Saccharomyces cerevisiae is arguably the best studied eukaryotic genome, and yet, it contains approximately 1000 genes that are still relatively uncharacterized. As the majority of these ORFs have no homologs with characterized sequence or protein structure, traditional sequence-based approaches cannot be applied to deduce their biological function. Here, we characterize YER067W, a conserved gene of unknown function that is strongly induced in response to many stress conditions and repressed in drug resistant yeast strains. Gene expression patterns of YER067W and its paralog YIL057C suggest an involvement in energy metabolism. We show that yeast lacking YER067W display altered levels of reserve carbohydrates and a growth deficiency in media that requires aerobic metabolism. Impaired mitochondrial function and overall reduction of ergosterol content in the YER067W deleted strain explained the observed 2- and 4-fold increase in resistance to the drugs fluconazole and amphotericin B, respectively. Cell fractionation and immunofluorescence microscopy revealed that Yer067w is associated with cellular membranes despite the absence of a transmembrane domain in the protein. Finally, the 1.7 angstrom resolution crystal structure of Yer067w shows an alpha-beta fold with low similarity to known structures and a putative functional site. YER067W's involvement with aerobic energetic metabolism suggests the assignment of the gene name RGI1, standing for respiratory growth induced 1. Altogether, the results shed light on a previously uncharacterized protein family and provide basis for further studies of its apparent role in energy metabolism control and drug resistance.	[Domitrovic, Tatiana; Goncalves Freire, Joao Claudio; Kurtenbach, Eleonora] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Programa Biol Mol & Estrutural, BR-21941 Rio De Janeiro, Brazil; [Domitrovic, Tatiana; Masuda, Claudio Akio; Almeida, Marcius da Silva; Montero-Lomeli, Monica; Atella, Georgia Correa] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Mol & Biotecnol, BR-21941 Rio De Janeiro, Brazil; [Kozlov, Guennadi; Matta-Camacho, Edna; Gehring, Kalle] McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ, Canada; [Almeida, Marcius da Silva] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl, BR-21941 Rio De Janeiro, Brazil; [Atella, Georgia Correa] Conselho Nacl Desenvolvimento Cient & Tecnolol MC, Inst Nacl Entomol, Rio De Janeiro, Brazil; [Kurtenbach, Eleonora] Conselho Nacl Desenvolvimento Cient & Tecnolol MC, Inst Nacl Pesquisa Translac Saude & Ambiente Regi, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; McGill University; Universidade Federal do Rio de Janeiro	Domitrovic, T (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Programa Biol Mol & Estrutural, BR-21941 Rio De Janeiro, Brazil.	domitrovic@biof.ufrj.br	Gehring, Kalle/N-2945-2019; Domitrovic, Tatiana/AAX-1142-2021; Gehring, Kalle/I-4403-2013; Kurtenbach, Eleonora/L-4148-2016; Masuda, Claudio A/F-7214-2014; Atella, Georgia/AAK-7897-2020; Montero-Lomeli, Monica/D-9885-2013	Gehring, Kalle/0000-0001-6500-1184; Domitrovic, Tatiana/0000-0001-9196-9412; Gehring, Kalle/0000-0001-6500-1184; Kurtenbach, Eleonora/0000-0002-2141-518X; Masuda, Claudio A/0000-0002-0310-7108; almeida, marcius/0000-0003-4921-8185	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Financiadora de Estudos e Projetos (FINEP); Canadian Institutes of Health Research [GSP-48370]; National Science Foundation [DMR 0225180]; National Institutes of Health [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Brazilian grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Financiadora de Estudos e Projetos (FINEP). Operating grant GSP-48370 (to M. Cygler) from the Canadian Institutes of Health Research. K. G is a Chercheur National of the Fonds de la recherche en sante de Quebec (FRSQ). Data acquisition at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron Source (CHESS) was supported by the National Science Foundation award DMR 0225180 and the National Institutes of Health award RR-01646. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson JB, 2009, ANTIMICROB AGENTS CH, V53, P1931, DOI 10.1128/AAC.01315-08; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arthington-Skaggs BA, 1999, J CLIN MICROBIOL, V37, P3332, DOI 10.1128/JCM.37.10.3332-3337.1999; Bammert GF, 2000, ANTIMICROB AGENTS CH, V44, P1255, DOI 10.1128/AAC.44.5.1255-1265.2000; Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Boy-Marcotte E, 1998, J BACTERIOL, V180, P1044, DOI 10.1128/JB.180.5.1044-1052.1998; Brun S, 2004, ANTIMICROB AGENTS CH, V48, P1788, DOI 10.1128/AAC.48.5.1788-1796.2004; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cowen LE, 2008, EUKARYOT CELL, V7, P747, DOI 10.1128/EC.00041-08; Cuff AL, 2009, NUCLEIC ACIDS RES, V37, pD310, DOI 10.1093/nar/gkn877; Domazet-Loso T, 2003, GENOME RES, V13, P2213, DOI 10.1101/gr.1311003; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; Fernandes PMB, 2004, FEBS LETT, V556, P153, DOI 10.1016/S0014-5793(03)01396-6; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Francois J, 2001, FEMS MICROBIOL REV, V25, P125, DOI 10.1016/S0168-6445(00)00059-0; Fribourg S, 2003, EMBO REP, V4, P699, DOI 10.1038/sj.embor.embor883; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gulshan K, 2007, EUKARYOT CELL, V6, P1933, DOI 10.1128/EC.00254-07; Hasek Jiri, 2006, Methods Mol Biol, V313, P85; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hibbs MA, 2007, BIOINFORMATICS, V23, P2692, DOI 10.1093/bioinformatics/btm403; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hong EL, 2008, NUCLEIC ACIDS RES, V36, pD577, DOI 10.1093/nar/gkm909; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Kontoyiannis DP, 2000, J ANTIMICROB CHEMOTH, V46, P191, DOI 10.1093/jac/46.2.191; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lai LC, 2006, EUKARYOT CELL, V5, P1468, DOI 10.1128/EC.00107-06; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Masuda CA, 2000, BIOCHEM CELL BIOL, V78, P51, DOI 10.1139/bcb-78-1-51; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Monteiro PT, 2008, NUCLEIC ACIDS RES, V36, pD132, DOI 10.1093/nar/gkm976; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nishida H, 2006, BIOSCI BIOTECH BIOCH, V70, P2646, DOI 10.1271/bbb.60251; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parrou JL, 1997, ANAL BIOCHEM, V248, P186, DOI 10.1006/abio.1997.2138; Pena-Castillo L, 2007, GENETICS, V176, P7, DOI 10.1534/genetics.107.074468; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Rogers PD, 2003, ANTIMICROB AGENTS CH, V47, P1220, DOI 10.1128/AAC.47.4.1220-1227.2003; Scannell DR, 2007, YEAST, V24, P929, DOI 10.1002/yea.1515; Schneiter Roger, 2006, Methods Mol Biol, V313, P75; Schneiter R, 2007, BIOCHIMIE, V89, P255, DOI 10.1016/j.biochi.2006.07.022; Seo HY, 2008, J MICROBIOL BIOTECHN, V18, P1368; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Siew N, 2004, J MOL BIOL, V342, P369, DOI 10.1016/j.jmb.2004.06.073; Smith JJ, 2002, J CELL BIOL, V158, P259, DOI 10.1083/jcb.200204059; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Wilson WA, 2002, MOL CELL PROTEOMICS, V1, P232, DOI 10.1074/mcp.M100024-MCP200; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200	61	8	11	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11163	10.1371/journal.pone.0011163	http://dx.doi.org/10.1371/journal.pone.0011163			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567505	gold, Green Published			2022-12-27	WOS:000278886300009
J	Matthews, B; Harmon, LJ; M'Gonigle, L; Marchinko, KB; Schaschl, H				Matthews, Blake; Harmon, Luke J.; M'Gonigle, Leithen; Marchinko, Kerry B.; Schaschl, Helmut			Sympatric and Allopatric Divergence of MHC Genes in Threespine Stickleback	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; GASTEROSTEUS-ACULEATUS L.; 3-SPINED STICKLEBACK; ADAPTIVE RADIATION; FRESH-WATER; MATE CHOICE; CLASS-I; ECOLOGICAL IMMUNOLOGY; DISRUPTIVE SELECTION; SEXUAL SELECTION	Parasites can strongly affect the evolution of their hosts, but their effects on host diversification are less clear. In theory, contrasting parasite communities in different foraging habitats could generate divergent selection on hosts and promote ecological speciation. Immune systems are costly to maintain, adaptable, and an important component of individual fitness. As a result, immune system genes, such as those of the Major Histocompatability Complex (MHC), can change rapidly in response to parasite-mediated selection. In threespine stickleback (Gasterosteus aculeatus), as well as in other vertebrates, MHC genes have been linked with female mating preference, suggesting that divergent selection acting on MHC genes might influence speciation. Here, we examined genetic variation at MHC Class II loci of sticklebacks from two lakes with a limnetic and benthic species pair, and two lakes with a single species. In both lakes with species pairs, limnetics and benthics differed in their composition of MHC alleles, and limnetics had fewer MHC alleles per individual than benthics. Similar to the limnetics, the allopatric population with a pelagic phenotype had few MHC alleles per individual, suggesting a correlation between MHC genotype and foraging habitat. Using a simulation model we show that the diversity and composition of MHC alleles in a sympatric species pair depends on the amount of assortative mating and on the strength of parasite-mediated selection in adjacent foraging habitats. Our results indicate parallel divergence in the number of MHC alleles between sympatric stickleback species, possibly resulting from the contrasting parasite communities in littoral and pelagic habitats of lakes.	[Matthews, Blake] Swiss Fed Inst Aquat Sci & Technol EAWAG, Dept Aquat Ecol, Kastanienbaum, Switzerland; [Harmon, Luke J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [M'Gonigle, Leithen] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Marchinko, Kerry B.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Schaschl, Helmut] Univ Vet Med, Res Inst Wildlife Ecol, Vienna, Austria	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Idaho; University of Idaho; University of British Columbia; Fred Hutchinson Cancer Center; University of Veterinary Medicine Vienna	Matthews, B (corresponding author), Swiss Fed Inst Aquat Sci & Technol EAWAG, Dept Aquat Ecol, Kastanienbaum, Switzerland.	blake.matthews@eawag.ch	Matthews, Blake/B-5608-2009; Harmon, Luke/A-8225-2012	Matthews, Blake/0000-0001-9089-704X; Schaschl, Helmut/0000-0003-2826-8773; Harmon, Luke/0000-0002-4985-5750	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) graduate scholarships to BM, KBM, and LM. Financial support was provided by an NSERC Industrial Research Chair (IRC) grant to Asit Mazumder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkhir K, 2002, MOL ECOL NOTES, V2, P611, DOI 10.1046/j.1471-8286.2002.00273.x; Binz T, 2001, J FISH BIOL, V58, P887, DOI 10.1006/jfbi.2000.1485; Blais J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000734; Bolnick DI, 2008, AM NAT, V172, P1, DOI 10.1086/587805; Borghans JAM, 2003, EUR J IMMUNOL, V33, P3353, DOI 10.1002/eji.200324365; Buckling A, 2002, NATURE, V420, P496, DOI 10.1038/nature01164; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Duffy MA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-80; Eizaguirre C, 2009, MOL ECOL, V18, P3316, DOI 10.1111/j.1365-294X.2009.04243.x; Eizaguirre C, 2009, ECOL LETT, V12, P5, DOI 10.1111/j.1461-0248.2008.01247.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frank SA, 2000, J THEOR BIOL, V202, P283, DOI 10.1006/jtbi.1999.1054; Gavrilets S, 2004, FITNESS LANDSCAPES O; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Heckel G, 2002, CONSERV GENET, V3, P79, DOI 10.1023/A:1014255027870; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; Jokela J, 2000, OIKOS, V89, P267, DOI 10.1034/j.1600-0706.2000.890207.x; Kalbe M, 2006, PARASITOLOGY, V132, P105, DOI 10.1017/S0031182005008681; Knudsen R, 2010, J ANIM ECOL, V79, P161, DOI 10.1111/j.1365-2656.2009.01625.x; Koskella B, 2009, EVOLUTION, V63, P2213, DOI 10.1111/j.1558-5646.2009.00711.x; Largiader CR, 1999, MOL ECOL, V8, P342; LAVIN PA, 1986, CAN J FISH AQUAT SCI, V43, P2455, DOI 10.1139/f86-305; MacColl ADC, 2009, ECOGRAPHY, V32, P153, DOI 10.1111/j.1600-0587.2008.05486.x; MacColl ADC, 2009, BIOL J LINN SOC, V96, P425, DOI 10.1111/j.1095-8312.2008.01123.x; Matthews B, 2010, ECOLOGY, V91, P1025, DOI 10.1890/09-0235.1; McKinnon JS, 2004, NATURE, V429, P294, DOI 10.1038/nature02556; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Milinski M, 2005, P NATL ACAD SCI USA, V102, P4414, DOI 10.1073/pnas.0408264102; Milinski M, 2006, ANNU REV ECOL EVOL S, V37, P159, DOI 10.1146/annurev.ecolsys.37.091305.110242; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Nagel L, 1998, EVOLUTION, V52, P209, DOI 10.1111/j.1558-5646.1998.tb05154.x; NOWAK MA, 1992, P NATL ACAD SCI USA, V89, P10896, DOI 10.1073/pnas.89.22.10896; Nuismer SL, 2008, ECOL LETT, V11, P937, DOI 10.1111/j.1461-0248.2008.01207.x; Poulin R, 1999, PARASITOL TODAY, V15, P28, DOI 10.1016/S0169-4758(98)01357-X; *RDEVELOPMENTTEA, 2008, R LANG ENV STAT COMP; Reimchen TE, 2001, BIOL J LINN SOC, V73, P51, DOI 10.1006/bijl.2001.0523; Reimchen TE, 2001, J EVOLUTION BIOL, V14, P632, DOI 10.1046/j.1420-9101.2001.00305.x; Reusch TBH, 2001, NATURE, V414, P300, DOI 10.1038/35104547; Reusch TBH, 2005, J MOL EVOL, V61, P531, DOI 10.1007/s00239-004-0340-0; Reusch TBH, 2004, IMMUNOGENETICS, V56, P427, DOI 10.1007/s00251-004-0704-z; Robinson BW, 2000, BEHAVIOUR, V137, P865, DOI 10.1163/156853900502501; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Sadd BM, 2009, EVOL APPL, V2, P113, DOI 10.1111/j.1752-4571.2008.00057.x; Sato A, 2000, IMMUNOGENETICS, V51, P108, DOI 10.1007/s002510050019; Scharsack JP, 2007, P ROY SOC B-BIOL SCI, V274, P1523, DOI 10.1098/rspb.2007.0210; Schaschl H, 2006, J FISH BIOL, V69, P177, DOI 10.1111/j.1095-8649.2006.01223.x; Schaschl H, 2007, IMMUNOGENETICS, V59, P295, DOI 10.1007/s00251-007-0192-z; SCHLUTER D, 1993, ECOLOGY, V74, P699, DOI 10.2307/1940797; SCHLUTER D, 1995, ECOLOGY, V76, P82, DOI 10.2307/1940633; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schulenburg H, 2009, PHILOS T R SOC B, V364, P3, DOI 10.1098/rstb.2008.0249; Snowberg LK, 2008, AM NAT, V172, P733, DOI 10.1086/591692; Summers K, 2003, BIOL REV, V78, P639, DOI 10.1017/S146479310300616X; Thompson JN, 2009, AM NAT, V173, P125, DOI 10.1086/595752; Traherne JA, 2008, INT J IMMUNOGENET, V35, P179, DOI 10.1111/j.1744-313X.2008.00765.x; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Wegner KM, 2008, J FISH BIOL, V73, P2110, DOI 10.1111/j.1095-8649.2008.02051.x; Wegner KM, 2003, SCIENCE, V301, P1343, DOI 10.1126/science.1088293; Wegner KM, 2003, J EVOLUTION BIOL, V16, P224, DOI 10.1046/j.1420-9101.2003.00519.x; Woelfing B, 2009, PHILOS T R SOC B, V364, P117, DOI 10.1098/rstb.2008.0174	62	41	41	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e10948	10.1371/journal.pone.0010948	http://dx.doi.org/10.1371/journal.pone.0010948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585386	Green Published, Green Submitted, gold			2022-12-27	WOS:000278886100002
J	Amon, LM; Law, W; Fitzgibbon, MP; Gross, JA; O'Briant, K; Peterson, A; Drescher, C; Martin, DB; McIntosh, M				Amon, Lynn M.; Law, Wendy; Fitzgibbon, Matthew P.; Gross, Jennifer A.; O'Briant, Kathy; Peterson, Amelia; Drescher, Charles; Martin, Daniel B.; McIntosh, Martin			Integrative Proteomic Analysis of Serum and Peritoneal Fluids Helps Identify Proteins that Are Up-Regulated in Serum of Women with Ovarian Cancer	PLOS ONE			English	Article							PROSTATE-CANCER; STATISTICAL-MODEL; HUMAN BREAST; BIOMARKER; DIAGNOSIS; MARKERS; VALIDATION; SURFACE; ALGORITHM; PATTERN	Background: We used intensive modern proteomics approaches to identify predictive proteins in ovary cancer. We identify up-regulated proteins in both serum and peritoneal fluid. To evaluate the overall performance of the approach we track the behavior of 20 validated markers across these experiments. Methodology: Mass spectrometry based quantitative proteomics following extensive protein fractionation was used to compare serum of women with serous ovarian cancer to healthy women and women with benign ovarian tumors. Quantitation was achieved by isotopically labeling cysteine amino acids. Label-free mass spectrometry was used to compare peritoneal fluid taken from women with serous ovarian cancer and those with benign tumors. All data were integrated and annotated based on whether the proteins have been previously validated using antibody-based assays. Findings: We selected 54 quantified serum proteins and 358 peritoneal fluid proteins whose case-control differences exceeded a predefined threshold. Seventeen proteins were quantified in both materials and 14 are extracellular. Of 19 validated markers that were identified all were found in cancer peritoneal fluid and a subset of 7 were quantified in serum, with one of these proteins, IGFBP1, newly validated here. Conclusion: Proteome profiling applied to symptomatic ovarian cancer cases identifies a large number of up-regulated serum proteins, many of which are or have been confirmed by immunoassays. The number of currently known validated markers is highest in peritoneal fluid, but they make up a higher percentage of the proteins observed in both serum and peritoneal fluid, suggesting that the 10 additional markers in this group may be high quality candidates.	[Amon, Lynn M.; Law, Wendy; Fitzgibbon, Matthew P.; Gross, Jennifer A.; O'Briant, Kathy; Drescher, Charles; McIntosh, Martin] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Peterson, Amelia; Martin, Daniel B.] Inst Syst Biol, Seattle, WA USA	Fred Hutchinson Cancer Center; Institute for Systems Biology (ISB)	Amon, LM (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	mmcintos@fhcrc.org			National Cancer Institute, National Institutes of Health [U01 CA111273, P50 CA83636, HHSN261200800001E]; Canary Foundation; NATIONAL CANCER INSTITUTE [P50CA083636, U01CA111273] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canary Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in part with Federal funds from the National Cancer Institute, National Institutes of Health, under grant numbers U01 CA111273, P50 CA83636, contract No. HHSN261200800001E, and the Canary Foundation. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam BL, 2002, CANCER RES, V62, P3609; Agarwal R, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.030; ANDERSON G, 2009, JNCI IN PRESS; Baggerly KA, 2004, ENDOCR-RELAT CANCER, V11, P583, DOI 10.1677/erc.1.00868; Baggerly KA, 2005, CANCER INFORM, V1, P9; Baron-Hay S, 2004, CLIN CANCER RES, V10, P1796, DOI 10.1158/1078-0432.CCR-0672-2; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; Brady G, 2007, INT J ORAL MAX SURG, V36, P259, DOI 10.1016/j.ijom.2006.09.009; BROWN P, 2009, PLOS MED IN PRESS; Chechlinska M, NAT REV CANC, V10, P2; Cooper BC, 2002, CLIN CANCER RES, V8, P3193; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Faca V, 2007, J PROTEOME RES, V6, P3558, DOI 10.1021/pr070233q; Faca V, 2006, J PROTEOME RES, V5, P2009, DOI 10.1021/pr060102+; Faca Vitor, 2009, V492, P309, DOI 10.1007/978-1-59745-493-3_19; Faca VM, 2008, PLOS MED, V5, P953, DOI 10.1371/journal.pmed.0050123; FANG Q, 2008, MOL CELL PROTEOMICS; Grizzle WE, 2004, UROL ONCOL-SEMIN ORI, V22, P337, DOI 10.1016/j.urolonc.2004.04.008; Hanas JS, 2008, PANCREAS, V36, P61, DOI 10.1097/mpa.0b013e3180d0a738; Hellstrom I, 2003, CANCER RES, V63, P3695; Hu Jianhua, 2005, Briefings in Functional Genomics & Proteomics, V3, P322, DOI 10.1093/bfgp/3.4.322; Katayama H, 2009, GENOME MED, V1, DOI 10.1186/gm47; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kuk C, 2009, MOL CELL PROTEOMICS, V8, P661, DOI 10.1074/mcp.M800313-MCP200; Maciel CM, 2005, J EXP THER ONCOL, V5, P31; McIntosh M, 2008, CLIN CANCER RES, V14, P7574, DOI 10.1158/1078-0432.CCR-08-0623; McIntosh MW, 2007, CLIN CANCER RES, V13, P4422, DOI 10.1158/1078-0432.CCR-06-2224; McIntosh MW, 2004, GYNECOL ONCOL, V95, P9, DOI 10.1016/j.ygyno.2004.07.039; McIntosh MW, 2002, CANCER EPIDEM BIOMAR, V11, P159; McLerran D, 2008, CLIN CHEM, V54, P53, DOI 10.1373/clinchem.2007.091496; McLerran D, 2008, CLIN CHEM, V54, P44, DOI 10.1373/clinchem.2007.091470; Menon U, 2005, J CLIN ONCOL, V23, P7919, DOI 10.1200/JCO.2005.01.6642; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Palmer C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002633; Pitteri SJ, 2008, J PROTEOME RES, V7, P1481, DOI 10.1021/pr7007994; Pitteri SJ, 2009, GENOME MED, V1, DOI 10.1186/gm121; Rauvala M, 2005, GYNECOL ONCOL, V99, P656, DOI 10.1016/j.ygyno.2005.07.009; REITER L, 2009, MOL CELL PROTEOMICS; Semmes OJ, 2005, CLIN CHEM, V51, P102, DOI 10.1373/clinchem.2004.038950; Simon I, 2006, CANCER RES, V66, P1570, DOI 10.1158/0008-5472.CAN-04-3550; Simon I, 2007, GYNECOL ONCOL, V106, P112, DOI 10.1016/j.ygyno.2007.03.007; Thorpe JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001281; Tsukishiro S, 2005, GYNECOL ONCOL, V96, P516, DOI 10.1016/j.ygyno.2004.10.036; Urban N, 1997, CONTROL CLIN TRIALS, V18, P251, DOI 10.1016/S0197-2456(96)00233-4; URBAN N, 2002, OVARIAN CANC, V6; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xu Y, 1998, JAMA-J AM MED ASSOC, V280, P719, DOI 10.1001/jama.280.8.719; Yousef GM, 2003, CANCER RES, V63, P2223	49	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11137	10.1371/journal.pone.0011137	http://dx.doi.org/10.1371/journal.pone.0011137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559444	gold, Green Submitted, Green Published			2022-12-27	WOS:000278775900025
J	Falcone, T; Fazio, V; Lee, C; Simon, B; Franco, K; Marchi, N; Janigro, D				Falcone, Tatiana; Fazio, Vincent; Lee, Catherine; Simon, Barry; Franco, Kathleen; Marchi, Nicola; Janigro, Damir			Serum S100B: A Potential Biomarker for Suicidality in Adolescents?	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; MINOR HEAD TRAUMA; CHRONIC-SCHIZOPHRENICS; MAJOR DEPRESSION; PERIPHERAL MARKERS; TEMPORAL-LOBES; PROTEIN S100B; CSF BARRIER; DAMAGE; DISRUPTION	Background: Studies have shown that patients suffering from depression or schizophrenia often have immunological alterations that can be detected in the blood. Others reported a possible link between inflammation, a microgliosis and the blood-brain barrier (BBB) in suicidal patients. Serum S100B is a marker of BBB function commonly used to study cerebrovascular wall function. Methods: We measured levels of S100B in serum of 40 adolescents with acute psychosis, 24 adolescents with mood disorders and 20 healthy controls. Patients were diagnosed according to DSM-IV TR criteria. We evaluated suicidal ideation using the suicidality subscale of the Brief Psychiatric Rating Scale for Children (BPRS-C). Results: Serum S100B levels were significantly higher (p<0.05) and correlated to severity of suicidal ideation in patients with psychosis or mood disorders, independent of psychiatric diagnosis. Patients with a BPRS-C suicidality subscores of 1-4 (low suicidality) had mean serum S100B values +/2 SEM of 0.152+/20.020 ng/mL (n = 34) compared to those with BPRS-C suicidality subscores of 5-7 (high suicidality) with a mean of 0.354+/20.044 ng/mL (n = 30). This difference was statistically significant (p<0.05). Conclusion: Our data support the use of S100B as an adjunctive biomarker to assess suicidal risk in patients with mood disorders or schizophrenia.	[Falcone, Tatiana; Fazio, Vincent; Lee, Catherine; Simon, Barry; Franco, Kathleen; Marchi, Nicola; Janigro, Damir] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation	Falcone, T (corresponding author), Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.	janigrd@ccf.org	Marchi, Nicola/J-8607-2016	Marchi, Nicola/0000-0001-9124-0226; Janigro, Damir/0000-0003-2165-5826; Falcone, Tatiana/0000-0002-4431-6782	National Institutes of Health (NIH) [R01]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Damir Janigro is funded by an R01 National Institutes of Health (NIH) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BayardBurfield L, 1996, EUR NEUROPSYCHOPHARM, V6, P195, DOI 10.1016/0924-977X(96)00020-X; Bayer TA, 1999, NEUROSCI LETT, V271, P126, DOI 10.1016/S0304-3940(99)00545-5; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Biberthaler P, 2002, EUR J MED RES, V7, P164; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; FIELDS JH, 1994, AM J PSYCHIAT, V151, P249; Hetzel G, 2005, PSYCHOPHARMACOLOGY, V178, P161, DOI 10.1007/s00213-004-1999-z; Hohoff C, 2010, AM J MED GENET B, V153B, P291, DOI 10.1002/ajmg.b.30950; Hughes CW, 2001, J CHILD ADOL PSYCHOP, V11, P77, DOI 10.1089/104454601750143500; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Kim YK, 2008, PROG NEURO-PSYCHOPH, V32, P356, DOI 10.1016/j.pnpbp.2007.08.041; Kim YK, 2006, PROG NEURO-PSYCHOPH, V30, P1091, DOI 10.1016/j.pnpbp.2006.04.008; Kowalski J, 2001, SCHIZOPHR RES, V50, P169, DOI 10.1016/S0920-9964(00)00156-0; Lindqvist D, 2008, PSYCHONEUROENDOCRINO, V33, P1061, DOI 10.1016/j.psyneuen.2008.05.012; Lindqvist D, 2009, BIOL PSYCHIAT, V66, P287, DOI 10.1016/j.biopsych.2009.01.030; Lo TYM, 2009, J NEUROTRAUM, V26, P1479, DOI 10.1089/neu.2008-0753; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Marchi N, 2003, J NEUROSCI, V23, P1949; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Marchi N, 2009, NEUROBIOL DIS, V33, P171, DOI 10.1016/j.nbd.2008.10.002; Mendlovic S, 1999, IMMUNOL LETT, V67, P105, DOI 10.1016/S0165-2478(98)00145-X; Meyer JM, 2009, BIOL PSYCHIAT, V66, P1013, DOI 10.1016/j.biopsych.2009.06.005; Mora GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005759; Mussack T, 2000, ACT NEUR S, V76, P393; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Radewicz K, 2000, J NEUROPATH EXP NEUR, V59, P137, DOI 10.1093/jnen/59.2.137; Rothermundt M, 2001, MOL PSYCHIATR, V6, P445, DOI 10.1038/sj.mp.4000889; Rothermundt M, 2004, INT REV NEUROBIOL, V59, P445; Schroeter ML, 2009, MOL PSYCHIATR, V14, P235, DOI 10.1038/mp.2008.85; Schroeter ML, 2009, PSYCHIAT RES, V167, P66, DOI 10.1016/j.psychres.2008.01.002; Schroeter ML, 2008, J AFFECT DISORDERS, V111, P271, DOI 10.1016/j.jad.2008.03.005; Sisask M, 2008, NORD J PSYCHIAT, V62, P431, DOI 10.1080/08039480801959273; SMITH RS, 1991, MED HYPOTHESES, V35, P298, DOI 10.1016/0306-9877(91)90272-Z; Somera-Molina KC, 2007, EPILEPSIA, V48, P1785, DOI 10.1111/j.1528-1167.2007.01135.x; Steiner J, 2008, J PSYCHIATR RES, V42, P151, DOI 10.1016/j.jpsychires.2006.10.013; Steiner J, 2006, ACTA NEUROPATHOL, V112, P305, DOI 10.1007/s00401-006-0090-8; Tonelli LH, 2008, ACTA PSYCHIAT SCAND, V117, P198, DOI 10.1111/j.1600-0447.2007.01128.x; TRASKMANBENDZ L, 1992, J CLIN PSYCHOPHARM, V12, pS21; van Heeringen K, 2003, CAN J PSYCHIAT, V48, P292, DOI 10.1177/070674370304800504; Vogelbaum MA, 2005, CANCER-AM CANCER SOC, V104, P817, DOI 10.1002/cncr.21220; WESTLIN S, 2009, NEUROLOGY PSYCHIAT S, V1; Wierzba-Bobrowicz T, 2004, FOLIA NEUROPATHOL, V42, P157; Wierzba-Bobrowicz T, 2005, FOLIA NEUROPATHOL, V43, P81	47	51	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11089	10.1371/journal.pone.0011089	http://dx.doi.org/10.1371/journal.pone.0011089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559426	Green Published, gold			2022-12-27	WOS:000278741100006
J	May, JS; Bennett, NJ; Stevenson, PG				May, Janet S.; Bennett, Neil J.; Stevenson, Philip G.			An In Vitro System for Studying Murid Herpesvirus-4 Latency and Reactivation	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; SARCOMA-ASSOCIATED HERPESVIRUS; PEPTIDE-LOADING COMPLEX; GAMMAHERPESVIRUS 68; GAMMA-HERPESVIRUS; LYTIC CYCLE; CELL LINES; GENE-EXPRESSION; KAPOSI-SARCOMA; INFECTION	The narrow species tropisms of Epstein-Barr Virus (EBV) and the Kaposi's Sarcoma-associated Herpesvirus (KSHV) have made Murid Herpesvirus-4 (MuHV-4) an important tool for understanding how gammaherpesviruses colonize their hosts. However, while MuHV-4 pathogenesis studies can assign a quantitative importance to individual genes, the complexity of in vivo infection can make the underlying mechanisms hard to discern. Furthermore, the lack of good in vitro MuHV-4 latency/reactivation systems with which to dissect mechanisms at the cellular level has made some parallels with EBV and KSHV hard to draw. Here we achieved control of the MuHV-4 lytic/latent switch in vitro by modifying the 59 untranslated region of its major lytic transactivator gene, ORF50. We terminated normal ORF50 transcripts by inserting a polyadenylation signal and transcribed ORF50 instead from a down-stream, doxycycline-inducible promoter. In this way we could establish fibroblast clones that maintained latent MuHV-4 episomes without detectable lytic replication. Productive virus reactivation was then induced with doxycycline. We used this system to show that the MuHV-4 K3 gene plays a significant role in protecting reactivating cells against CD8(+) T cell recognition.	[May, Janet S.; Bennett, Neil J.; Stevenson, Philip G.] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England	University of Cambridge	May, JS (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England.	pgs27@cam.ac.uk	Stevenson, Philip g/F-9688-2014; Stevenson, Philip/F-6651-2011	Stevenson, Philip g/0000-0002-3520-5060; 	Wellcome Trust; U.K. Medical Research Council; Medical Research Council [G9800943, G0701185] Funding Source: researchfish; MRC [G9800943, G0701185] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust and by the U.K. Medical Research Council. PGS is a Wellcome Trust Senior Clinical Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Ahn JW, 2002, J VIROL, V76, P6244, DOI 10.1128/JVI.76.12.6244-6256.2002; Amon W, 2005, REV MED VIROL, V15, P149, DOI 10.1002/rmv.456; Bennett NJ, 2005, PLOS BIOL, V3, P638, DOI 10.1371/journal.pbio.0030120; Boname JM, 2004, IMMUNITY, V20, P305, DOI 10.1016/S1074-7613(04)00047-0; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; Bridgeman A, 2001, J EXP MED, V194, P301, DOI 10.1084/jem.194.3.301; Chen J, 2001, P NATL ACAD SCI USA, V98, P4119, DOI 10.1073/pnas.051004198; Coleman HM, 2003, J VIROL, V77, P13093, DOI 10.1128/JVI.77.24.13093-13105.2003; De Lima BD, 2004, J VIROL, V78, P5103, DOI 10.1128/JVI.78.10.5103-5112.2004; Dutia BM, 1999, J GEN VIROL, V80, P2729, DOI 10.1099/0022-1317-80-10-2729; EFSTATHIOU S, 1990, J GEN VIROL, V71, P1355, DOI 10.1099/0022-1317-71-6-1355; Faulkner GC, 1999, J VIROL, V73, P1555, DOI 10.1128/JVI.73.2.1555-1564.1999; Forrest JC, 2008, J VIROL, V82, P7688, DOI 10.1128/JVI.02689-07; GARDELLA T, 1984, J VIROL, V50, P248, DOI 10.1128/JVI.50.1.248-254.1984; Gill MB, 2006, J GEN VIROL, V87, P1465, DOI 10.1099/vir.0.81760-0; Gillet L, 2009, J GEN VIROL, V90, P602, DOI 10.1099/vir.0.005785-0; Gray KS, 2010, J VIROL, V84, P4946, DOI 10.1128/JVI.00060-10; Grundhoff A, 2004, J CLIN INVEST, V113, P124, DOI 10.1172/JCI200417803; Husain SM, 1999, P NATL ACAD SCI USA, V96, P7508, DOI 10.1073/pnas.96.13.7508; Jarousse N, 2008, J VIROL, V82, P12591, DOI 10.1128/JVI.01167-08; KARTTUNEN J, 1991, P NATL ACAD SCI USA, V88, P3972, DOI 10.1073/pnas.88.9.3972; Laichalk LL, 2005, J VIROL, V79, P1296, DOI 10.1128/JVI.79.2.1296-1307.2005; Liu LZ, 1999, J IMMUNOL, V163, P868; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; May JS, 2004, J GEN VIROL, V85, P137, DOI 10.1099/vir.0.19599-0; Milho R, 2009, J GEN VIROL, V90, P21, DOI 10.1099/vir.0.006569-0; Miller G, 2007, ADV CANCER RES, V97, P81, DOI 10.1016/S0065-230X(06)97004-3; Minarovits J, 2006, CURR TOP MICROBIOL, V310, P61; Pankiewicz R, 2005, J GENE MED, V7, P117, DOI 10.1002/jgm.644; Pantry SN, 2009, SEMIN CANCER BIOL, V19, P153, DOI 10.1016/j.semcancer.2009.02.010; Pavlova LV, 2003, J VIROL, V77, P5731, DOI 10.1128/JVI.77.10.5731-5739.2003; Persons DA, 1998, BLOOD CELL MOL DIS, V24, P167, DOI 10.1006/bcmd.1998.0184; Prince S, 2003, J VIROL, V77, P5000, DOI 10.1128/JVI.77.8.5000-5007.2003; Rice J, 2002, EUR J IMMUNOL, V32, P3481, DOI 10.1002/1521-4141(200212)32:12<3481::AID-IMMU3481>3.0.CO;2-J; Rosa GT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000560; Smit J, 2007, HORM RES, V68, P2; Stevenson PG, 2009, J GEN VIROL, V90, P2317, DOI 10.1099/vir.0.013300-0; Stevenson PG, 2002, NAT IMMUNOL, V3, P733, DOI 10.1038/ni818; Stevenson PG, 1999, J VIROL, V73, P1075, DOI 10.1128/JVI.73.2.1075-1079.1999; Stevenson PG, 1999, EUR J IMMUNOL, V29, P1059, DOI 10.1002/(SICI)1521-4141(199904)29:04<1059::AID-IMMU1059>3.0.CO;2-L; Stewart JP, 1998, J EXP MED, V187, P1941, DOI 10.1084/jem.187.12.1941; Suarez AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000152; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P2347, DOI 10.1099/0022-1317-73-9-2347; SUNILCHANDRA NP, 1993, VIROLOGY, V193, P825, DOI 10.1006/viro.1993.1191; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P3275, DOI 10.1099/0022-1317-73-12-3275; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; Usherwood EJ, 1996, J VIROL, V70, P6516, DOI 10.1128/JVI.70.9.6516-6518.1996; Usherwood EJ, 1996, J GEN VIROL, V77, P2819, DOI 10.1099/0022-1317-77-11-2819; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Weck KE, 1997, NAT MED, V3, P1346, DOI 10.1038/nm1297-1346; Wu TT, 2000, J VIROL, V74, P3659, DOI 10.1128/JVI.74.8.3659-3667.2000; Yang ZS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004556; Yewdell JW, 2002, NAT IMMUNOL, V3, P1019, DOI 10.1038/ni1102-1019	54	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11080	10.1371/journal.pone.0011080	http://dx.doi.org/10.1371/journal.pone.0011080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552028	Green Submitted, gold, Green Published			2022-12-27	WOS:000278662900020
J	Restall, IJ; Lorimer, IAJ				Restall, Ian J.; Lorimer, Ian A. J.			Induction of Premature Senescence by Hsp90 Inhibition in Small Cell Lung Cancer	PLOS ONE			English	Article							SHOCK-PROTEIN 90; MOLECULAR CHAPERONE; PHASE-I; GLIOBLASTOMA CELLS; RESPONSE PATHWAY; STRESS-RESPONSE; CYCLE ARREST; KINASE; TANESPIMYCIN; MACHINERY	Background: The molecular chaperone Hsp90 is a promising new target in cancer therapy and selective Hsp90 inhibitors are currently in clinical trials. Previously these inhibitors have been reported to induce either cell cycle arrest or cell death in cancer cells. Whether the cell cycle arrest is reversible or irreversible has not generally been assessed. Here we have examined in detail the cell cycle arrest and cell death responses of human small cell lung cancer cell lines to Hsp90 inhibition. Methodology/Principal Findings: In MTT assays, small cell lung cancer cells showed a biphasic response to the Hsp90 inhibitors geldanamycin and radicicol, with low concentrations causing proliferation arrest and high concentrations causing cell death. Assessment of Hsp90 intracellular activity using loss of client protein expression showed that geldanamycin concentrations that inhibited Hsp90 correlated closely with those causing proliferation arrest but not cell death. The proliferation arrest induced by low concentrations of geldanamycin was not reversed for a period of over thirty days following drug removal and showed features of senescence. Rare populations of variant small cell lung cancer cells could be isolated that had additional genetic alterations and no longer underwent irreversible proliferation arrest in response to Hsp90 inhibitors. Conclusions/Significance: We conclude that: (1) Hsp90 inhibition primarily induces premature senescence, rather than cell death, in small cell lung cancer cells; (2) small cell lung cancer cells can bypass this senescence through further genetic alterations; (3) Hsp90 inhibitor-induced cell death in small cell lung cancer cells is due to inhibition of a target other than cytosolic Hsp90. These results have implications with regard to how these inhibitors will behave in clinical trials and for the design of future inhibitors in this class.	[Restall, Ian J.; Lorimer, Ian A. J.] Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada; [Restall, Ian J.; Lorimer, Ian A. J.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Lorimer, Ian A. J.] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Restall, IJ (corresponding author), Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada.	ilorimer@ohri.ca	Wang, Weili/D-1546-2011		Canadian Institutes of Health Research [62797]; Canadian Cancer Society [020121]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by grants to IL from the Canadian Institutes of Health Research (grant number62797)(http://www.cihr-irsc.gc.ca/e/193.html) and the Canadian Cancer Society (grant number 020121)(http://www.cancer.ca/canada-wide.aspx?sc_lang=en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagatell R, 2000, CLIN CANCER RES, V6, P3312; Baldwin RM, 2006, ONCOGENE, V25, P2909, DOI 10.1038/sj.onc.1209312; Banerjee S, 2005, ADV MATER, V17, P17, DOI 10.1002/adma.200401340; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chang BD, 1999, CANCER RES, V59, P3761; COOK RM, 1993, CURR PROB CANCER, V17, P71; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Davenport EL, 2007, BLOOD, V110, P2641, DOI 10.1182/blood-2006-11-053728; de Carcer G, 2004, CANCER RES, V64, P5106, DOI 10.1158/0008-5472.CAN-03-2214; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Erlichman C, 2009, EXPERT OPIN INV DRUG, V18, P861, DOI 10.1517/13543780902953699; Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305; Funayama R, 2007, CHROMOSOMA, V116, P431, DOI 10.1007/s00412-007-0115-7; Gaspar N, 2009, CANCER RES, V69, P1966, DOI 10.1158/0008-5472.CAN-08-3131; Gewirtz DA, 2008, BIOCHEM PHARMACOL, V76, P947, DOI 10.1016/j.bcp.2008.06.024; Goetz MP, 2005, J CLIN ONCOL, V23, P1078, DOI 10.1200/JCO.2005.09.119; Grem JL, 2005, J CLIN ONCOL, V23, P1885, DOI 10.1200/JCO.2005.12.085; Guo WC, 2005, CANCER RES, V65, P10006, DOI 10.1158/0008-5472.CAN-05-2029; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kang BH, 2009, J CLIN INVEST, V119, P454, DOI 10.1172/JCI37613; Kelland LR, 1999, J NATL CANCER I, V91, P1940, DOI 10.1093/jnci/91.22.1940; Keppler BR, 2006, J BIOL CHEM, V281, P19840, DOI 10.1074/jbc.M511067200; Kim HR, 1999, IUBMB LIFE, V48, P425, DOI 10.1080/152165499306810; Lavictoire SJ, 2003, J BIOL CHEM, V278, P5292, DOI 10.1074/jbc.M209494200; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Modi S, 2007, J CLIN ONCOL, V25, P5410, DOI 10.1200/JCO.2007.11.7960; Munoz MJ, 1999, MOL GEN GENET, V261, P242, DOI 10.1007/s004380050963; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Oda T, 2007, BLOOD, V109, P5016, DOI 10.1182/blood-2006-08-038638; Ostrovsky O, 2009, MOL BIOL CELL, V20, P1855, DOI 10.1091/mbc.E08-04-0346; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Rodina A, 2007, NAT CHEM BIOL, V3, P498, DOI 10.1038/nchembio.2007.10; Sawai A, 2008, CANCER RES, V68, P589, DOI 10.1158/0008-5472.CAN-07-1570; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Schmitt CA, 2007, BBA-REV CANCER, V1775, P5, DOI 10.1016/j.bbcan.2006.08.005; Schulte TW, 1999, MOL ENDOCRINOL, V13, P1435, DOI 10.1210/me.13.9.1435; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Sher T, 2008, MAYO CLIN PROC, V83, P355, DOI 10.4065/83.3.355; Smith PJ, 1999, INT J RADIAT BIOL, V75, P1137, DOI 10.1080/095530099139610; Soengas MS, 2008, NATURE, V454, P586, DOI 10.1038/454586a; Srethapakdi M, 2000, CANCER RES, V60, P3940; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Taldone T, 2008, CURR OPIN PHARMACOL, V8, P370, DOI 10.1016/j.coph.2008.06.015; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Xu Y, 1999, P NATL ACAD SCI USA, V96, P109, DOI 10.1073/pnas.96.1.109; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; 方岱宁, 1999, [力学与实践, Mechanics in Engineering], V21, P1	52	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11076	10.1371/journal.pone.0011076	http://dx.doi.org/10.1371/journal.pone.0011076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552022	gold, Green Published, Green Submitted			2022-12-27	WOS:000278662900016
J	Ali, SF; Ayub, S; Manzoor, NF; Azim, S; Afif, M; Akhtar, N; Jafery, WA; Tahir, I; Farid-ul-Hasnian, S; Uddin, N				Ali, Syed Faizan; Ayub, Samia; Manzoor, Nauman Fazal; Azim, Sidra; Afif, Muneeza; Akhtar, Nida; Jafery, Wassi Ali; Tahir, Imran; Farid-ul-Hasnian, Syed; Uddin, Najam			Knowledge and Awareness about Cervical Cancer and Its Prevention amongst Interns and Nursing Staff in Tertiary Care Hospitals in Karachi, Pakistan	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; COLLABORATIVE REANALYSIS; CHLAMYDIA-TRACHOMATIS; WOMENS KNOWLEDGE; HPV VACCINATION; INDIVIDUAL DATA; VIRUS HPV; CARCINOMA; ATTITUDES; VACCINES	Background and Objective: Cervical cancer is one of the leading causes of morbidity and mortality amongst the gynecological cancers worldwide, especially in developing countries. It is imperative for at least health professionals in developing countries like Pakistan to have a sound knowledge about the disease. This study was carried out to assess the knowledge and awareness about cervical cancer and its prevention amongst health professionals in tertiary care hospitals in Karachi, Pakistan. Methods and Design: A cross-sectional, interview based survey was conducted in June, 2009. Sample of 400 was divided between the three tertiary care centers. Convenience sampling was applied as no definitive data was available regarding the number of registered interns and nurses at each center. Results: Of all the interviews conducted, 1.8% did not know cervical cancer as a disease. Only 23.3% of the respondents were aware that cervical cancer is the most common cause of gynecological cancers and 26% knew it is second in rank in mortality. Seventy-eight percent were aware that infection is the most common cause of cervical cancer, of these 62% said that virus is the cause and 61% of the respondents knew that the virus is Human Papilloma Virus (HPV). Majority recognized that it is sexually transmitted but only a minority (41%) knew that it can be detected by PCR. Only 26% of the study population was aware of one or more risk factors. Thirty seven percent recognized Pap smear as a screening test. In total only 37 out of 400 respondents were aware of the HPV vaccine. Conclusion: This study serves to highlight that the majority of working health professionals are not adequately equipped with knowledge concerning cervical cancer. Continuing Medical Education program should be started at the hospital level along with conferences to spread knowledge about this disease.	[Ali, Syed Faizan; Farid-ul-Hasnian, Syed] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan	Aga Khan University	Ali, SF (corresponding author), Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan.	fiq200best@hotmail.com						Anttila T, 2001, JAMA-J AM MED ASSOC, V285, P47, DOI 10.1001/jama.285.1.47; Appleby P, 2007, LANCET, V370, P1609, DOI 10.1016/S0140-6736(07)61684-5; Aziz Z, 2003, J Pak Med Assoc, V53, P350; Badar F, 2007, ASIAN PAC J CANCER P, V8, P24; Baykal C, 2008, EUR J GYNAECOL ONCOL, V29, P76; Bhurgri Y, 2007, ASIAN PAC J CANCER P, V8, P357; Bhurgri Yasmin, 2004, Asian Pac J Cancer Prev, V5, P77; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Castle PE, 2002, JNCI-J NATL CANCER I, V94, P1406, DOI 10.1093/jnci/94.18.1406; Das BC, 2008, VACCINE, V26, P2669, DOI 10.1016/j.vaccine.2008.03.056; Donders GGG, 2008, ARCH GYNECOL OBSTET, V277, P291, DOI 10.1007/s00404-007-0487-1; Ferlay J, 2001, CANC INCIDENCE MORTA; Giles M, 2006, AUST NZ J OBSTET GYN, V46, P311, DOI 10.1111/j.1479-828X.2006.00598.x; Goldsmith MR, 2007, J MED SCREEN, V14, P29, DOI 10.1258/096914107780154459; HANISCH R, 2007, INT J GYNECOL CANC; Imam SZ, 2008, ASIAN PAC J CANCER P, V9, P42; KWAN TT, 2008, SEX TRANSM INFECT; Laikangbam P, 2007, INT J GYNECOL CANCER, V17, P107, DOI 10.1111/j.1525-1438.2007.00827.x; Lee PWH, 2007, PREV MED, V45, P130, DOI 10.1016/j.ypmed.2007.07.013; Mosavel M, 2007, J HEALTH COMMUN, V12, P707, DOI 10.1080/10810730701671985; Munoz N, 2002, LANCET, V359, P1093, DOI 10.1016/S0140-6736(02)08151-5; Nganwai P, 2008, ASIAN PAC J CANCER P, V9, P15; Pitts M, 2002, HEALTH EDUC RES, V17, P706, DOI 10.1093/her/17.6.706; Rajkumar T, 2006, INT J CANCER, V118, P1481; Rosenthal D, 2007, WOMEN HEALTH, V45, P59, DOI 10.1300/J013v45n02_04; Sankaranarayanan R, 2006, INT J GYNECOL OBSTET, V95, pS205, DOI 10.1016/S0020-7292(06)60035-0; Sankaranarayanan R, 2006, BEST PRACT RES CL OB, V20, P207, DOI 10.1016/j.bpobgyn.2005.10.007; Shapley M, 2006, BRIT J GEN PRACT, V56, P453; Sherris J, 2005, INT J GYNECOL OBSTET, V89, pS46, DOI 10.1016/j.ijgo.2005.01.010; Stark A, 2008, CANCER DETECT PREV, V32, P15, DOI 10.1016/j.cdp.2008.02.002; TEBEU PM, 2007, INT J GYNECOL CANC; Tiro JA, 2007, CANCER EPIDEM BIOMAR, V16, P288, DOI 10.1158/1055-9965.EPI-06-0756; Vanslyke JG, 2008, QUAL HEALTH RES, V18, P584, DOI 10.1177/1049732308315734; Vrscaj MU, 2008, EUR J GYNAECOL ONCOL, V29, P148; Wallin KL, 2002, INT J CANCER, V101, P371, DOI 10.1002/ijc.10639; Wheeler CM, 2007, NAT CLIN PRACT ONCOL, V4, P224, DOI 10.1038/ncponc0770	36	61	63	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11059	10.1371/journal.pone.0011059	http://dx.doi.org/10.1371/journal.pone.0011059			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608QA	20548787	Green Submitted, Green Published, gold			2022-12-27	WOS:000278599600017
J	Shumay, E; Fowler, JS; Volkow, ND				Shumay, Elena; Fowler, Joanna S.; Volkow, Nora D.			Genomic Features of the Human Dopamine Transporter Gene and Its Potential Epigenetic States: Implications for Phenotypic Diversity	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; TANDEM REPEATS; SEGMENTAL DUPLICATIONS; PROMOTER ARCHITECTURE; TRANSCRIPTION FACTORS; SPLICING REGULATION; ALCOHOL DEPENDENCE; DNA METHYLATION; WIDE ANALYSIS; G-QUADRUPLEX	Human dopamine transporter gene (DAT1 or SLC6A3) has been associated with various brain-related diseases and behavioral traits and, as such, has been investigated intensely in experimental- and clinical-settings. However, the abundance of research data has not clarified the biological mechanism of DAT regulation; similarly, studies of DAT genotype-phenotype associations yielded inconsistent results. Hence, our understanding of the control of the DAT protein product is incomplete; having this knowledge is critical, since DAT plays the major role in the brain's dopaminergic circuitry. Accordingly, we reevaluated the genomic attributes of the SLC6A3 gene that might confer sensitivity to regulation, hypothesizing that its unique genomic characteristics might facilitate highly dynamic, region-specific DAT expression, so enabling multiple regulatory modes. Our comprehensive bioinformatic analyzes revealed very distinctive genomic characteristics of the SLC6A3, including high inter-individual variability of its sequence (897 SNPs, about 90 repeats and several CNVs spell out all abbreviations in abstract) and pronounced sensitivity to regulation by epigenetic mechanisms, as evident from the GC-bias composition (0.55) of the SLC6A3, and numerous intragenic CpG islands (27 CGIs). We propose that this unique combination of the genomic features and the regulatory attributes enables the differential expression of the DAT1 gene and fulfills seemingly contradictory demands to its regulation; that is, robustness of region-specific expression and functional dynamics.	[Shumay, Elena; Fowler, Joanna S.] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA; [Volkow, Nora D.] Natl Inst Drug Abuse, NIH, Bethesda, MD USA	United States Department of Energy (DOE); Brookhaven National Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Shumay, E (corresponding author), Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA.	eshumay@bnl.gov; fowler@bnl.gov; nvolkow@nida.nih.gov			Department of Energy, Office of Biological and Environmental Research; National Institute on Drug Abuse [KO1 DA025280-01A1, K05 DA20001]; NIH; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA020001, K01DA025280] Funding Source: NIH RePORTER	Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was performed at Brookhaven National Laboratory with infrastructure support from the Department of Energy, Office of Biological and Environmental Research and funded by the National Institute on Drug Abuse, grants KO1 DA025280-01A1 (ES), K05 DA20001 (JSF) and NIH Intramural Research Program, NIDA (NDV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELGHANY M, 1989, P NATL ACAD SCI USA, V86, P1761, DOI 10.1073/pnas.86.6.1761; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Andken BB, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-274; Aranda-Abreu GE, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-33; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Bannon MJ, 1997, NEUROLOGY, V48, P969, DOI 10.1212/WNL.48.4.969; Barlati S, 2005, ACTA NEUROCHIR SUPPL, V93, P53; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bock C, 2008, BIOINFORMATICS, V24, P1, DOI 10.1093/bioinformatics/btm546; Boeva V, 2006, BIOINFORMATICS, V22, P676, DOI 10.1093/bioinformatics/btk032; Brodskii L I, 1995, Biokhimiia, V60, P1221; Burt SA, 2008, AGGRESSIVE BEHAV, V34, P437, DOI 10.1002/ab.20251; Carlini DB, 2006, J MOL EVOL, V62, P89, DOI 10.1007/s00239-005-0055-x; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chen JM, 2006, HUM GENET, V120, P301, DOI 10.1007/s00439-006-0218-x; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Chiang CWK, 2008, GENETICS, V180, P2277, DOI 10.1534/genetics.108.096537; Chiaruttini C, 2009, P NATL ACAD SCI USA, V106, P16481, DOI 10.1073/pnas.0902833106; Chinta SJ, 2005, MOL BRAIN RES, V135, P81, DOI 10.1016/j.molbrainres.2004.12.014; Choi JK, 2008, NAT GENET, V40, P141, DOI 10.1038/ng.2007.58; Ciliax BJ, 1999, J COMP NEUROL, V409, P38, DOI 10.1002/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO;2-1; Cirulli F, 2009, NEUROSCI BIOBEHAV R, V33, P573, DOI 10.1016/j.neubiorev.2008.09.001; Colvis CM, 2005, J NEUROSCI, V25, P10379, DOI 10.1523/JNEUROSCI.4119-05.2005; Conrad S, 2009, NATURE, V460, DOI 10.1038/nature08353; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Corral-Debrinski M, 2007, BBA-MOL CELL RES, V1773, P473, DOI 10.1016/j.bbamcr.2006.06.008; Crayton ME, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-16; Cruz-Muros I, 2009, NEUROBIOL AGING, V30, P973, DOI 10.1016/j.neurobiolaging.2007.09.009; Cusack BP, 2005, MOL BIOL EVOL, V22, P2198, DOI 10.1093/molbev/msi218; Dear PH, 2009, TRENDS BIOTECHNOL, V27, P448, DOI 10.1016/j.tibtech.2009.05.003; Denoeud F, 2003, GENOME RES, V13, P856, DOI 10.1101/gr.574403; Didiot MC, 2008, NUCLEIC ACIDS RES, V36, P4902, DOI 10.1093/nar/gkn472; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; Drgon T, 2006, CELL MOL NEUROBIOL, V26, P875, DOI 10.1007/s10571-006-9014-3; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; DURET L, 2009, ANN REV GENOMICS HUM; Finotti A, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-110; Forbes EE, 2009, MOL PSYCHIATR, V14, P60, DOI 10.1038/sj.mp.4002086; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frith MC, 2003, NUCLEIC ACIDS RES, V31, P3666, DOI 10.1093/nar/gkg540; Frohna PA, 1997, SYNAPSE, V25, P293; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Greenwood TA, 2006, MOL PSYCHIATR, V11, P125, DOI 10.1038/sj.mp.4001764; Greenwood TA, 2002, MOL PSYCHIATR, V7, P165, DOI 10.1038/sj.mp.4000958; Guindalini C, 2006, P NATL ACAD SCI USA, V103, P4552, DOI 10.1073/pnas.0504789103; Haddley K, 2008, NEUROCHEM RES, V33, P652, DOI 10.1007/s11064-007-9521-8; Hebert SS, 2007, SCIENCE, V317, P1179, DOI 10.1126/science.1148530; Heinz A, 2000, NEUROPSYCHOPHARMACOL, V22, P133, DOI 10.1016/S0893-133X(99)00099-8; Hurst LD, 2009, NATURE, V457, P543, DOI 10.1038/457543a; Ibanez-Ventoso C, 2006, AGING CELL, V5, P235, DOI 10.1111/j.1474-9726.2006.00210.x; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Jaffee SR, 2007, MOL PSYCHIATR, V12, P432, DOI 10.1038/sj.mp.4001950; Jiang CZ, 2007, MOL BIOL EVOL, V24, P1991, DOI 10.1093/molbev/msm128; Kass SU, 1998, CIBA F SYMP, V214, P22; KASS SU, 1998, NOVART FDN SYMP, V214, P36; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kawase T, 2007, BLOOD, V110, P1055, DOI 10.1182/blood-2007-02-075911; Kikin O, 2008, NUCLEIC ACIDS RES, V36, pD141, DOI 10.1093/nar/gkm982; Kim SR, 2007, DRUG METAB DISPOS, V35, P1865, DOI 10.1124/dmd.107.015339; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Krause J, 2006, WORLD J BIOL PSYCHIA, V7, P152, DOI 10.1080/15622970500518444; Kremerskothen J, 2006, J NEUROCHEM, V96, P1659, DOI 10.1111/j.1471-4159.2006.03679.x; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Kuroyanagi H, 2009, CELL MOL LIFE SCI, V66, P3895, DOI 10.1007/s00018-009-0120-5; Kuyumcu-Martinez NM, 2006, PROG MOLEC, V44, P133; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108; Legendre M, 2007, GENOME RES, V17, P1787, DOI 10.1101/gr.6554007; Levdansky E, 2007, EUKARYOT CELL, V6, P1380, DOI 10.1128/EC.00229-06; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Lim MH, 2006, AM J MED GENET B, V141B, P309, DOI 10.1002/ajmg.b.30282; Lin JC, 2008, J AM CHEM SOC, V130, P14080, DOI 10.1021/ja8063638; Loria PM, 2003, CURR BIOL, V13, P1317, DOI 10.1016/S0960-9822(03)00532-3; Ma QF, 2006, J PHYSIOL-LONDON, V575, P379, DOI 10.1113/jphysiol.2006.113449; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; Martinat C, 2006, P NATL ACAD SCI USA, V103, P2874, DOI 10.1073/pnas.0511153103; McGowan PO, 2008, BRAIN RES, V1237, P12, DOI 10.1016/j.brainres.2008.07.074; Mehler-Wex C, 2006, NEUROTOX RES, V10, P167, DOI 10.1007/BF03033354; Michopoulos I, 2006, WORLD J BIOL PSYCHIA, V7, P265, DOI 10.1080/15622970600671036; Mill J, 2002, AM J MED GENET, V114, P975, DOI 10.1002/ajmg.b.10948; Miller CA, 2008, NEUROBIOL LEARN MEM, V89, P599, DOI 10.1016/j.nlm.2007.07.016; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P1186, DOI 10.1038/nsmb861; Myrick Hugh, 2003, Psychopharmacol Bull, V37 Suppl 2, P89; Nairn AC, 2001, NEURON, V32, P174, DOI 10.1016/S0896-6273(01)00469-X; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Nguyen DQ, 2008, GENOME RES, V18, P1711, DOI 10.1101/gr.077289.108; Ninio J, 2006, BIOCHIMIE, V88, P963, DOI 10.1016/j.biochi.2006.06.002; Nissim-Rafinia M, 2006, PROG MOLEC, V44, P233; O'Dushlaine CT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-175; O'Gara C, 2007, PHARMACOGENET GENOM, V17, P61, DOI 10.1097/01.fpc.0000236328.18928.4c; Okazaki N, 2005, DNA RES, V12, P181, DOI 10.1093/dnares/dsi001; Oki Masaya, 2007, Subcell Biochem, V41, P319; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Ozsarac N, 2002, J NEUROCHEM, V82, P336, DOI 10.1046/j.1471-4159.2002.00964.x; Price RD, 2000, MOL PHARMACOL, V58, P859, DOI 10.1124/mol.58.4.859; PRISTUPA ZB, 1994, MOL PHARMACOL, V45, P125; Radwan A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-186; Rahman L, 2002, GENOMICS, V80, P245, DOI 10.1006/geno.2002.6826; Ralph-Williams RJ, 2003, BIOL PSYCHIAT, V53, P352, DOI 10.1016/S0006-3223(02)01489-0; Reid MS, 2005, ADDICTION, V100, P43, DOI 10.1111/j.1360-0443.2005.00990.x; Ringner M, 2005, PLOS COMPUT BIOL, V1, P585, DOI 10.1371/journal.pcbi.0010072; Robertson G, 2006, NUCLEIC ACIDS RES, V34, pD68, DOI 10.1093/nar/gkj075; Samochowiec J, 2006, NEUROSCI LETT, V410, P1, DOI 10.1016/j.neulet.2006.05.005; Santos-Reboucas CB, 2007, EUR J HUM GENET, V15, P10, DOI 10.1038/sj.ejhg.5201727; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; Sawatzki HK, 2007, HUM MUTAT, V28, P99, DOI 10.1002/humu.20420; Schulz R, 2009, HUM MOL GENET, V18, P118, DOI 10.1093/hmg/ddn322; Semon M, 2006, MOL BIOL EVOL, V23, P1715, DOI 10.1093/molbev/msl034; Sethupathy P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003137; Simmen MW, 2008, GENOMICS, V92, P33, DOI 10.1016/j.ygeno.2008.03.009; Singh M, 2008, MOL CELL BIOCHEM, V312, P131, DOI 10.1007/s11010-008-9728-2; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Stevens SE, 2009, AM J MED GENET B, V150B, P753, DOI 10.1002/ajmg.b.31010; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; THIERRYMIEG D, 2006, GENOME BIOL S1, V7, pS1211; Tzvetkov MV, 2007, GENE, V386, P52, DOI 10.1016/j.gene.2006.08.002; van der Zwaluw CS, 2009, PHARMACOGENOMICS, V10, P853, DOI 10.2217/PGS.09.24; VANDENBERGH DJ, 1992, MOL BRAIN RES, V15, P161, DOI 10.1016/0169-328X(92)90165-8; Vandenbergh DJ, 2000, MOL PSYCHIATR, V5, P283, DOI 10.1038/sj.mp.4000701; VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7; VanNess SH, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-55; Varriale A, 2006, GENE, V385, P111, DOI 10.1016/j.gene.2006.05.031; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Volkow ND, 2005, BIOL PSYCHIAT, V57, P1410, DOI 10.1016/j.biopsych.2004.11.006; Wang E, 2007, AGEING RES REV, V6, P1, DOI 10.1016/j.arr.2007.02.004; Wang GJ, 2004, BRAIN, V127, P2452, DOI 10.1093/brain/awh269; Wang J, 2005, J NEUROCHEM, V93, P474, DOI 10.1111/j.1471-4159.2005.03051.x; Wang J, 2007, EUR J NEUROSCI, V25, P1982, DOI 10.1111/j.1460-9568.2007.05460.x; Wang Y, 2004, BIOINFORMATICS, V20, P1170, DOI 10.1093/bioinformatics/bth059; Wonodi I, 2009, AM J MED GENET B, V150B, P282, DOI 10.1002/ajmg.b.30811; Yang YK, 2008, PROG NEURO-PSYCHOPH, V32, P274, DOI 10.1016/j.pnpbp.2007.08.018; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zahniser NR, 2004, NEUROPHARMACOLOGY, V47, P80, DOI 10.1016/j.neuropharm.2004.07.010; Zelko IN, 2008, AM J RESP CELL MOL, V39, P243, DOI 10.1165/rcmb.2007-0378OC; ZHANG MQ, 2005, CURR PROTOC BIOINFOR, pCH2; Zhang XHF, 2006, P NATL ACAD SCI USA, V103, P13427, DOI 10.1073/pnas.0603042103; Zhou HL, 2007, MOL CELL BIOL, V27, P830, DOI 10.1128/MCB.01015-06; [No title captured]	148	54	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11067	10.1371/journal.pone.0011067	http://dx.doi.org/10.1371/journal.pone.0011067			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548783	gold, Green Published, Green Submitted			2022-12-27	WOS:000278599600023
J	Ferreira, ME; Berndt, KD; Nilsson, J; Wright, APH				Ferreira, Monica E.; Berndt, Kurt D.; Nilsson, Johan; Wright, Anthony P. H.			WD40 Domain Divergence Is Important for Functional Differences between the Fission Yeast Tup11 and Tup12 Co-Repressor Proteins	PLOS ONE			English	Article							COREPRESSOR COMPLEX; TERMINAL DOMAIN; TRANSCRIPTION; GENES; ASSOCIATION; TUP1-SSN6; GROUCHO; BINDING; TARGET; CYC8	We have previously demonstrated that subsets of Ssn6/Tup target genes have distinct requirements for the Schizosaccharomyces pombe homologs of the Tup1/Groucho/TLE co-repressor proteins, Tup11 and Tup12. The very high level of divergence in the histone interacting repression domains of the two proteins suggested that determinants distinguishing Tup11 and Tup12 might be located in this domain. Here we have combined phylogenetic and structural analysis as well as phenotypic characterization, under stress conditions that specifically require Tup12, to identify and characterize the domains involved in Tup12-specific action. The results indicate that divergence in the repression domain is not generally relevant for Tup12-specific function. Instead, we show that the more highly conserved C-terminal WD40 repeat domain of Tup12 is important for Tup12-specific function. Surface amino acid residues specific for the WD40 repeat domain of Tup12 proteins in different fission yeasts are clustered in blade 3 of the propeller-like structure that is characteristic of WD40 repeat domains. The Tup11 and Tup12 proteins in fission yeasts thus provide an excellent model system for studying the functional divergence of WD40 repeat domains.	[Ferreira, Monica E.; Berndt, Kurt D.; Nilsson, Johan; Wright, Anthony P. H.] Sodertorn Univ, Sch Life Sci, Huddinge, Sweden; [Wright, Anthony P. H.] Karolinska Inst, Dept Lab Med, Huddinge, Sweden; [Ferreira, Monica E.; Berndt, Kurt D.; Wright, Anthony P. H.] Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, Huddinge, Sweden	Sodertorn University; Karolinska Institutet; Karolinska Institutet	Ferreira, ME (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Div Canc & Dev Biol, Kansas City, KS 66103 USA.	anthony.wright@sh.se	Berndt, Kurt/J-8574-2015; Wright, Anthony/J-8187-2015	Berndt, Kurt/0000-0002-3049-967X; Wright, Anthony/0000-0003-1029-9969	Swedish Research Council; Swedish Cancer Society; Baltic Sea Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Baltic Sea Foundation	AW is supported by grants from the Swedish Research Council, the Swedish Cancer Society and the Baltic Sea Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bullerwell CE, 2003, NUCLEIC ACIDS RES, V31, P759, DOI 10.1093/nar/gkg134; Dang JJ, 2001, MOL CELL BIOL, V21, P5935, DOI 10.1128/MCB.21.17.5935-5945.2001; Davie JK, 2002, MOL CELL BIOL, V22, P693, DOI 10.1128/MCB.22.3.693-703.2002; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; Fagerstrom-Billai F, 2005, MOL CELL BIOL, V25, P716, DOI 10.1128/MCB.25.2.716-727.2005; Fagerstrom-Billai F, 2007, MOL CELL BIOL, V27, P1069, DOI 10.1128/MCB.01674-06; Green SR, 2005, MOL BIOL CELL, V16, P2605, DOI 10.1091/mbc.e05-02-0126; Jabet C, 2000, J BIOL CHEM, V275, P9011, DOI 10.1074/jbc.275.12.9011; KELEHER CA, 1988, CELL, V53, P927, DOI 10.1016/S0092-8674(88)90449-7; Komachi K, 1997, MOL CELL BIOL, V17, P6023, DOI 10.1128/MCB.17.10.6023; Mennella TA, 2003, EUKARYOT CELL, V2, P1288, DOI 10.1128/EC.2.6.1288-1303.2003; Mukai Y, 1999, MOL CELL BIOL, V19, P8461; Papamichos-Chronakis M, 2000, J BIOL CHEM, V275, P8397, DOI 10.1074/jbc.275.12.8397; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PROFUMO F, 2002, P IEEE INT S IND EL, V1, P1; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Sprague ER, 2000, EMBO J, V19, P3016, DOI 10.1093/emboj/19.12.3016; Swingler TE, 2004, J BIOL CHEM, V279, P34938, DOI 10.1074/jbc.M404488200; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TZAMARIAS D, 1995, GENE DEV, V9, P821, DOI 10.1101/gad.9.7.821; Varanasi US, 1996, MOL CELL BIOL, V16, P6707; Zhang Z, 2005, MOL CELL BIOL, V25, P7399, DOI 10.1128/MCB.25.17.7399-7411.2005; Zhang Z, 2004, J BIOL CHEM, V279, P39240, DOI 10.1074/jbc.M407159200	24	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11009	10.1371/journal.pone.0011009	http://dx.doi.org/10.1371/journal.pone.0011009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544037	Green Published, Green Submitted, gold			2022-12-27	WOS:000278494900021
J	Graveland, H; Wagenaar, JA; Heesterbeek, H; Mevius, D; van Duijkeren, E; Heederik, D				Graveland, Haitske; Wagenaar, Jaap A.; Heesterbeek, Hans; Mevius, Dik; van Duijkeren, Engeline; Heederik, Dick			Methicillin Resistant Staphylococcus aureus ST398 in Veal Calf Farming: Human MRSA Carriage Related with Animal Antimicrobial Usage and Farm Hygiene	PLOS ONE			English	Article							FOOD ANIMALS; HEALTH CONSEQUENCES; PET ANIMALS; TRANSMISSION; HOSPITALS; STRAINS; ORIGIN; AGENTS	Introduction: Recently a specific MRSA sequence type, ST398, emerged in food production animals and farmers. Risk factors for carrying MRSA ST398 in both animals and humans have not been fully evaluated. In this cross-sectional study, we investigated factors associated with MRSA colonization in veal calves and humans working and living on these farms. Methods: A sample of 102 veal calf farms were randomly selected and visited from March 2007-February 2008. Participating farmers were asked to fill in a questionnaire (n = 390) to identify potential risk factors. A nasal swab was taken from each participant. Furthermore, nasal swabs were taken from calves (n = 2151). Swabs were analysed for MRSA by selective enrichment and suspected colonies were confirmed as MRSA by using slide coagulase test and PCR for presence of the mecA-gene. Spa types were identified and a random selection of each spa type was tested with ST398 specific PCR. The Sequence Type of non ST398 strains was determined. Data were analyzed using logistic regression analysis. Results: Human MRSA carriage was strongly associated with intensity of animal contact and with the number of MRSA positive animals on the farm. Calves were more often carrier when treated with antibiotics, while farm hygiene was associated with a lower prevalence of MRSA. Conclusion: This is the first study showing direct associations between animal and human carriage of ST398. The direct associations between animal and human MRSA carriage and the association between MRSA and antimicrobial use in calves implicate prudent use of antibiotics in farm animals.	[Graveland, Haitske; Heederik, Dick] Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands; [Wagenaar, Jaap A.; Mevius, Dik; van Duijkeren, Engeline] Univ Utrecht, Fac Vet Med, Dept Immunol & Infect Dis, Utrecht, Netherlands; [Heesterbeek, Hans] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [Wagenaar, Jaap A.; Mevius, Dik] Cent Vet Inst Wageningen UR, Lelystad, Netherlands; [Heederik, Dick] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University; Wageningen University & Research; Utrecht University; Utrecht University Medical Center	Graveland, H (corresponding author), Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands.	h.graveland@uu.nl		Heederik, Dick/0000-0002-4550-1437; Heesterbeek, Hans/0000-0001-8537-6418	Dutch Ministry of Agriculture, Nature and Food Quality; Product Boards for Livestock, Meat, and Eggs	Dutch Ministry of Agriculture, Nature and Food Quality; Product Boards for Livestock, Meat, and Eggs	This work was supported by the Dutch Ministry of Agriculture, Nature and Food Quality and the Product Boards for Livestock, Meat, and Eggs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AD, 2003, MICROB DRUG RESIST, V9, P373, DOI 10.1089/107662903322762815; Angulo FJ, 2004, J VET MED B, V51, P374, DOI 10.1111/j.1439-0450.2004.00789.x; Dancer SJ, 2008, J ANTIMICROB CHEMOTH, V61, P246, DOI 10.1093/jac/dkm465; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Denis O, 2009, EMERG INFECT DIS, V15, P1098, DOI 10.3201/eid1507.080652; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fessler A, 2010, J ANTIMICROB CHEMOTH, V65, P619, DOI 10.1093/jac/dkq021; Finch R., 2006, J ANTIMICROB CHEMOTH, V58, P3, DOI DOI 10.1093/JAC/DKL373; Fluit AC, 2001, J CLIN MICROBIOL, V39, P3727, DOI 10.1128/JCM.39.10.3727-3732.2001; Graveland H, 2009, VET MICROBIOL, V139, P121, DOI 10.1016/j.vetmic.2009.05.019; Guardabassi L, 2004, J ANTIMICROB CHEMOTH, V54, P321, DOI 10.1093/jac/dkh332; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Juhasz-Kaszanyitzky E, 2007, EMERG INFECT DIS, V13, P630, DOI 10.3201/eid1304.060833; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Lee JH, 2003, APPL ENVIRON MICROB, V69, P6489, DOI 10.1128/AEM.69.11.6489-6494.2003; Lewis HC, 2008, EMERG INFECT DIS, V14, P1383, DOI 10.3201/eid1409.071576; Martineau F, 1998, J CLIN MICROBIOL, V36, P618, DOI 10.1128/JCM.36.3.618-623.1998; Nelson JM, 2007, CLIN INFECT DIS, V44, P977, DOI 10.1086/512369; Simoons-Smit AM, 2000, EUR J CLIN MICROBIOL, V19, P150, DOI 10.1007/s100960050450; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Strommenger B, 2006, J ANTIMICROB CHEMOTH, V57, P461, DOI 10.1093/jac/dki471; SWARTZ MN, 2004, CLIN INFECT DIS, V3, P111; Tiemersma EW, 2004, EMERG INFECT DIS, V10, P1627, DOI 10.3201/eid1009.040069; van den Broek IVF, 2008, EPIDEMIOL INFECT, V24, P1; van Duijkeren E, 2004, VET MICROBIOL, V103, P91, DOI 10.1016/j.vetmic.2004.07.014; van Duijkeren E, 2004, EMERG INFECT DIS, V10, P2235, DOI 10.3201/eid1012.040387; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; van Rijen MML, 2008, CLIN INFECT DIS, V46, P261, DOI 10.1086/524672; van Wamel WJB, 2010, EUR J CLIN MICROBIOL, V29, P119, DOI 10.1007/s10096-009-0816-3; VandenbrouckeGrauls CMJE, 1996, INFECT CONT HOSP EP, V17, P512; Wassenberg M W M, 2008, Ned Tijdschr Geneeskd, V152, P2681; Willems RJL, 1999, ANTIMICROB AGENTS CH, V43, P483, DOI 10.1128/AAC.43.3.483	33	202	203	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e10990	10.1371/journal.pone.0010990	http://dx.doi.org/10.1371/journal.pone.0010990			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544020	gold, Green Published, Green Submitted			2022-12-27	WOS:000278494900009
J	Liu, MY; Schmidt, EE; Halford, WP				Liu, Mingyu; Schmidt, Edward E.; Halford, William P.			ICP0 Dismantles Microtubule Networks in Herpes Simplex Virus-Infected Cells	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; EARLY REGULATORY PROTEIN; GENE-EXPRESSION; UBIQUITIN LIGASE; TYPE-1 INFECTION; NUCLEAR-LOCALIZATION; DELETION MUTANTS; VIRAL-DNA; COMPLEX; PML	Infected-cell protein 0 (ICP0) is a RING finger E3 ligase that regulates herpes simplex virus (HSV) mRNA synthesis, and strongly influences the balance between latency and replication of HSV. For 25 years, the nuclear functions of ICP0 have been the subject of intense scrutiny. To obtain new clues about ICP0's mechanism of action, we constructed HSV-1 viruses that expressed GFP-tagged ICP0. To our surprise, both GFP-tagged and wild-type ICP0 were predominantly observed in the cytoplasm of HSV-infected cells. Although ICP0 is exclusively nuclear during the immediate-early phase of HSV infection, further analysis revealed that ICP0 translocated to the cytoplasm during the early phase where it triggered a previously unrecognized process; ICP0 dismantled the microtubule network of the host cell. A RING finger mutant of ICP0 efficiently bundled microtubules, but failed to disperse microtubule bundles. Synthesis of ICP0 proved to be necessary and sufficient to disrupt microtubule networks in HSV-infected and transfected cells. Plant and animal viruses encode many proteins that reorganize microtubules. However, this is the first report of a viral E3 ligase that regulates microtubule stability. Intriguingly, several cellular E3 ligases orchestrate microtubule disassembly and reassembly during mitosis. Our results suggest that ICP0 serves a dual role in the HSV life cycle, acting first as a nuclear regulator of viral mRNA synthesis and acting later, in the cytoplasm, to dismantle the host cell's microtubule network in preparation for virion synthesis and/or egress.	[Liu, Mingyu; Halford, William P.] So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL USA; [Schmidt, Edward E.] Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA	Southern Illinois University System; Southern Illinois University; Montana State University System; Montana State University Bozeman	Liu, MY (corresponding author), So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL USA.	halford@siumed.edu			Central Research and Excellence in Academic Medicine Committees of the Southern Illinois University School of Medicine; National Institutes of Health [R01 AI51414, R21 AI081072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081072, R01AI051414] Funding Source: NIH RePORTER	Central Research and Excellence in Academic Medicine Committees of the Southern Illinois University School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from the Central Research and Excellence in Academic Medicine Committees of the Southern Illinois University School of Medicine, as well as funds from the National Institutes of Health (R01 AI51414 and R21 AI081072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN M, 1984, J VIROL, V52, P108, DOI 10.1128/JVI.52.1.108-118.1984; Armer H, 2008, J VIROL, V82, P10556, DOI 10.1128/JVI.00907-08; AVITABILE E, 1995, J VIROL, V69, P7472, DOI 10.1128/JVI.69.12.7472-7482.1995; Baker DJ, 2007, CELL MOL LIFE SCI, V64, P589, DOI 10.1007/s00018-007-6443-1; Balliet JW, 2007, VIROLOGY, V361, P372, DOI 10.1016/j.virol.2006.11.022; Blanc S, 1996, P NATL ACAD SCI USA, V93, P15158, DOI 10.1073/pnas.93.26.15158; Boutell C, 2003, J VIROL, V77, P8686, DOI 10.1128/JVI.77.16.8686-8694.2003; Boutell C, 2002, J VIROL, V76, P841, DOI 10.1128/JVI.76.2.841-850.2002; BRINKLEY BR, 1975, ANN NY ACAD SCI, V253, P428, DOI 10.1111/j.1749-6632.1975.tb19218.x; Calistri A, 2007, J VIROL, V81, P11468, DOI 10.1128/JVI.01364-07; Chen XP, 2000, J VIROL, V74, P10132, DOI 10.1128/JVI.74.21.10132-10141.2000; Choi E, 2008, FEBS LETT, V582, P1700, DOI 10.1016/j.febslet.2008.04.028; Cliffe AR, 2008, J VIROL, V82, P12030, DOI 10.1128/JVI.01575-08; Cummings CM, 2009, J BIOL CHEM, V284, P11663, DOI 10.1074/jbc.M809374200; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; Delboy MG, 2010, J VIROL, V84, P1637, DOI 10.1128/JVI.02041-09; DELUCA NA, 1985, J VIROL, V56, P558, DOI 10.1128/JVI.56.2.558-570.1985; DESAI P, 1993, J VIROL, V67, P6125, DOI 10.1128/JVI.67.10.6125-6135.1993; Diefenbach RJ, 2002, J VIROL, V76, P3282, DOI 10.1128/JVI.76.7.3282-3291.2002; Dohner K, 2005, TRENDS MICROBIOL, V13, P320, DOI 10.1016/j.tim.2005.05.010; Douglas MW, 2004, J BIOL CHEM, V279, P28522, DOI 10.1074/jbc.M311671200; Elliott G, 2005, J VIROL, V79, P9735, DOI 10.1128/JVI.79.15.9735-9745.2005; Elliott G, 1999, J VIROL, V73, P4110, DOI 10.1128/JVI.73.5.4110-4119.1999; Elliott G, 1998, J VIROL, V72, P6448, DOI 10.1128/JVI.72.8.6448-6455.1998; EVERETT R, 1995, J VIROL, V69, P7339, DOI 10.1128/JVI.69.11.7339-7344.1995; Everett RD, 2004, J VIROL, V78, P1763, DOI 10.1128/JVI.78.4.1763-1774.2004; EVERETT RD, 1994, EMBO J, V13, P5062, DOI 10.1002/j.1460-2075.1994.tb06835.x; Everett RD, 1998, EMBO J, V17, P7161, DOI 10.1093/emboj/17.24.7161; EVERETT RD, 1989, J GEN VIROL, V70, P1185, DOI 10.1099/0022-1317-70-5-1185; EVERETT RD, 1984, EMBO J, V3, P3135, DOI 10.1002/j.1460-2075.1984.tb02270.x; Everett RD, 1999, EMBO J, V18, P1526, DOI 10.1093/emboj/18.6.1526; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; Everett RD, 2010, J VIROL, V84, P3476, DOI 10.1128/JVI.02544-09; Ferralli J, 2006, J VIROL, V80, P5807, DOI 10.1128/JVI.00254-06; GELMAN IH, 1986, J MOL BIOL, V191, P395, DOI 10.1016/0022-2836(86)90135-X; Halford WP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-44; Halford WP, 2004, J VIROL, V78, P10086, DOI 10.1128/JVI.78.18.10086-10095.2004; Halford WP, 2001, J VIROL, V75, P6143, DOI 10.1128/JVI.75.13.6143-6153.2001; HARMENBERG J, 1982, INTERVIROLOGY, V17, P215, DOI 10.1159/000149291; Hill JM, 1996, ANAL BIOCHEM, V235, P44, DOI 10.1006/abio.1996.0089; Hobbs WE, 1999, J VIROL, V73, P8245, DOI 10.1128/JVI.73.10.8245-8255.1999; HOEBEKE J, 1976, BIOCHEM BIOPH RES CO, V69, P319, DOI 10.1016/0006-291X(76)90524-6; Huh K, 2007, J VIROL, V81, P9737, DOI 10.1128/JVI.00881-07; JOACHIMS M, 1995, VIROLOGY, V211, P451, DOI 10.1006/viro.1995.1427; Kalamvoki M, 2010, J VIROL, V84, P4222, DOI 10.1128/JVI.02585-09; Kannan H, 2009, J VIROL, V83, P6375, DOI 10.1128/JVI.02571-08; KNIPE DM, 1986, MOL CELL BIOL, V6, P2371, DOI 10.1128/MCB.6.7.2371; Kotsakis A, 2001, J VIROL, V75, P8697, DOI 10.1128/JVI.75.18.8697-8711.2001; Leib DA, 1999, J EXP MED, V189, P663, DOI 10.1084/jem.189.4.663; Li H, 2008, VIROLOGY, V375, P13, DOI 10.1016/j.virol.2008.01.038; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; LILLEY CE, 2010, EMBO J; Liu MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008837; Livingston CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000619; Lomonte P, 1999, J VIROL, V73, P9456, DOI 10.1128/JVI.73.11.9456-9467.1999; Lopez P, 2001, J VIROL, V75, P3832, DOI 10.1128/JVI.75.8.3832-3840.2001; Lukashchuk V, 2010, J VIROL, V84, P4026, DOI 10.1128/JVI.02597-09; Man C, 2007, ONCOGENE, V26, P3069, DOI 10.1038/sj.onc.1210106; Maringer K, 2010, J VIROL, V84, P4682, DOI 10.1128/JVI.00126-10; MAUL GG, 1994, J GEN VIROL, V75, P1223, DOI 10.1099/0022-1317-75-6-1223; Maul GG, 1996, VIROLOGY, V217, P67, DOI 10.1006/viro.1996.0094; Morishige N, 2006, J GEN VIROL, V87, P2817, DOI 10.1099/vir.0.82076-0; Moseley GW, 2009, J CELL SCI, V122, P3652, DOI 10.1242/jcs.045542; MULLEN MA, 1995, J VIROL, V69, P476, DOI 10.1128/JVI.69.1.476-491.1995; Nayak R, 2008, J VIROL, V82, P3803, DOI 10.1128/JVI.02532-07; NORRIS DM, 1986, CHEM PLANT PROTECTIO, V1, P97; Pierce AT, 2005, J GEN VIROL, V86, P2421, DOI 10.1099/vir.0.80979-0; Raben N, 2009, METHOD ENZYMOL, V453, P417, DOI 10.1016/S0076-6879(08)04021-4; Randow F, 2009, NAT CELL BIOL, V11, P527, DOI 10.1038/ncb0509-527; REICH E, 1961, SCIENCE, V134, P556, DOI 10.1126/science.134.3478.556; Rodriguez JJ, 2004, VIRAL IMMUNOL, V17, P210, DOI 10.1089/0882824041310568; ROLLMECAK A, 2009, MICROTUBULE SEVERING; SACKS WR, 1987, J VIROL, V61, P829, DOI 10.1128/JVI.61.3.829-839.1987; Samaniego LA, 1998, J VIROL, V72, P3307, DOI 10.1128/JVI.72.4.3307-3320.1998; Sedlackova L, 2008, J VIROL, V82, P268, DOI 10.1128/JVI.01588-07; SMITH KO, 1964, P SOC EXP BIOL MED, V115, P814, DOI 10.3181/00379727-115-29045; Soboleski MR, 2005, FASEB J, V19, P440, DOI 10.1096/fj.04-3180fje; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Sprague ER, 2004, J BIOL CHEM, V279, P14184, DOI 10.1074/jbc.M313281200; Steet R, 2006, MOL BIOL CELL, V17, P2312, DOI 10.1091/mbc.E05-08-0822; Sumara I, 2008, TRENDS CELL BIOL, V18, P84, DOI 10.1016/j.tcb.2007.12.001; SZE P, 1992, VIRUS RES, V26, P141, DOI 10.1016/0168-1702(92)90153-Z; Tei S, 2009, J CELL SCI, V122, P3190, DOI 10.1242/jcs.049627; Terry-Allison T, 2007, J VIROL, V81, P12394, DOI 10.1128/JVI.01068-07; Vossen MTM, 2002, IMMUNOGENETICS, V54, P527, DOI 10.1007/s00251-002-0493-1; Wade RH, 2009, MOL BIOTECHNOL, V43, P177, DOI 10.1007/s12033-009-9193-5; WALKER GM, 1982, J GEN MICROBIOL, V128, P61; Watts NR, 2000, J CELL BIOL, V150, P349, DOI 10.1083/jcb.150.2.349; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; YAO F, 1994, J VIROL, V68, P8158, DOI 10.1128/JVI.68.12.8158-8168.1994; Ye GJ, 2000, J VIROL, V74, P1355, DOI 10.1128/JVI.74.3.1355-1363.2000; Zhu ZM, 1996, J VIROL, V70, P5346, DOI 10.1128/JVI.70.8.5346-5356.1996	92	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e10975	10.1371/journal.pone.0010975	http://dx.doi.org/10.1371/journal.pone.0010975			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544015	Green Submitted, gold, Green Published			2022-12-27	WOS:000278494900004
J	Hilton, BJ; Wolkowicz, R				Hilton, Brett J.; Wolkowicz, Roland			An Assay to Monitor HIV-1 Protease Activity for the Identification of Novel Inhibitors in T-Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RESONANCE ENERGY-TRANSFER; PARTICLE MATURATION; PEPSTATIN-A; PHARMACOKINETICS; PROTEINASE; PRECURSOR; CLEAVAGE; CULTURE; SYSTEM	The emergence of resistant HIV strains, together with the severe side-effects of existing drugs and lack of development of effective anti-HIV vaccines highlight the need for novel antivirals, as well as innovative methods to facilitate their discovery. Here, we have developed an assay in T-cells to monitor the proteolytic activity of the HIV-1 protease (PR). The assay is based on the inducible expression of HIV-1 PR fused within the Gal4 DNA-binding and transactivation domains. The fusion protein binds to the Gal4 responsive element and activates the downstream reporter, enhanced green fluorescent protein (eGFP) gene only in the presence of an effective PR Inhibitor (PI). Thus, in this assay, eGFP acts as a biosensor of PR activity, making it ideal for flow cytometry based screening. Furthermore, the assay was developed using retroviral technology in T-cells, thus providing an ideal environment for the screening of potential novel PIs in a cell-type that represents the natural milieu of HIV infection. Clones with the highest sensitivity, and robust, reliable and reproducible reporter activity, were selected. The assay is easily adaptable to other PR variants, a multiplex platform, as well as to high-throughput plate reader based assays and will greatly facilitate the search for novel peptide and chemical compound based PIs in T-cells.	[Hilton, Brett J.; Wolkowicz, Roland] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	California State University System; San Diego State University	Hilton, BJ (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	roland@sciences.sdsu.edu			California State University	California State University	Funding is from the California State University Program for Education and Research in Biotechnology (CSUPERB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Baxter JD, 2006, J VIROL, V80, P10794, DOI 10.1128/JVI.00712-06; Bolinger C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-8; Cheng TJ, 2004, ANTIMICROB AGENTS CH, V48, P2437, DOI 10.1128/AAC.48.7.2437-2447.2004; Colvin R, 1995, Common Factor, P15; DASMAHAPATRA B, 1992, P NATL ACAD SCI USA, V89, P4159, DOI 10.1073/pnas.89.9.4159; ERICKSON J, 1990, SCIENCE, V249, P527, DOI 10.1126/science.2200122; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Fuse T, 2006, MICROBES INFECT, V8, P1783, DOI 10.1016/j.micinf.2006.02.016; Gong YF, 2000, ANTIMICROB AGENTS CH, V44, P2319, DOI 10.1128/AAC.44.9.2319-2326.2000; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hu K, 2005, J VIROL METHODS, V128, P93, DOI 10.1016/j.jviromet.2005.04.012; Ishima R, 2007, J BIOL CHEM, V282, P17190, DOI 10.1074/jbc.M701304200; JOHNSTON SA, 1986, P NATL ACAD SCI USA, V83, P6553, DOI 10.1073/pnas.83.17.6553; KRAUSSLICH HG, 1989, P NATL ACAD SCI USA, V86, P807, DOI 10.1073/pnas.86.3.807; Lindsten K, 2001, ANTIMICROB AGENTS CH, V45, P2616, DOI 10.1128/AAC.45.9.2616-2622.2001; LOEB DD, 1989, NATURE, V340, P397, DOI 10.1038/340397a0; MATAYOSHI ED, 1990, SCIENCE, V247, P954, DOI 10.1126/science.2106161; Matsuda Zene, 2007, V375, P135; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; Molla A, 1998, VIROLOGY, V250, P255, DOI 10.1006/viro.1998.9383; Mouland AJ, 2002, VIROLOGY, V292, P321, DOI 10.1006/viro.2001.1261; MURRAY MG, 1993, GENE, V134, P123, DOI 10.1016/0378-1119(93)90185-6; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nascimbeni M, 1999, ANTIMICROB AGENTS CH, V43, P2629, DOI 10.1128/AAC.43.11.2629; Pettit SC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-66; Sadler BM, 2002, ANN PHARMACOTHER, V36, P102; SEELMEIER S, 1988, P NATL ACAD SCI USA, V85, P6612, DOI 10.1073/pnas.85.18.6612; Speck RR, 2000, ANTIMICROB AGENTS CH, V44, P1397, DOI 10.1128/AAC.44.5.1397-1403.2000; Stoltzfus CM, 2009, ADV VIRUS RES, V74, P1, DOI 10.1016/S0065-3527(09)74001-1; TOTH MV, 1990, INT J PEPT PROT RES, V36, P544; Vogt VM, 1996, CURR TOP MICROBIOL, V214, P95; Vollenweider F, 1996, BIOCHEM J, V314, P521, DOI 10.1042/bj3140521; VONDERHELM K, 1989, FEBS LETT, V247, P349, DOI 10.1016/0014-5793(89)81368-7; Wiegers K, 1998, J VIROL, V72, P2846, DOI 10.1128/JVI.72.4.2846-2854.1998; Wolkowicz Roland, 2004, Methods Mol Biol, V246, P391	36	13	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10940	10.1371/journal.pone.0010940	http://dx.doi.org/10.1371/journal.pone.0010940			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532177	Green Submitted, gold, Green Published			2022-12-27	WOS:000278318700012
J	Meens, MJPMT; Compeer, MG; Hackeng, TM; van Zandvoort, MA; Janssen, BJA; De Mey, JGR				Meens, Merlijn J. P. M. T.; Compeer, Matthijs G.; Hackeng, Tilman M.; van Zandvoort, Marc A.; Janssen, Ben J. A.; De Mey, Jo G. R.			Stimuli of Sensory-Motor Nerves Terminate Arterial Contractile Effects of Endothelin-1 by CGRP and Dissociation of ET-1/ETA-Receptor Complexes	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; ETA-RECEPTOR; NITRIC-OXIDE; B-RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; CARDIOVASCULAR-DISEASE; LIGAND-BINDING; HIGHLY POTENT; ION-CHANNEL; ANTAGONIST	Background: Endothelin-1 (ET-1), a long-acting paracrine mediator, is implicated in cardiovascular diseases but clinical trials with ET-receptor antagonists were not successful in some areas. We tested whether the quasi-irreversible receptor-binding of ET-1 (i) limits reversing effects of the antagonists and (ii) can be selectively dissociated by an endogenous counterbalancing mechanism. Methodology/Principal findings: In isolated rat mesenteric resistance arteries, ETA-antagonists, endothelium-derived relaxing factors and synthetic vasodilators transiently reduced contractile effects of ET-1 but did not prevent persistent effects of the peptide. Stimuli of peri-vascular vasodilator sensory-motor nerves such as capsaicin not only reduced but also terminated long-lasting effects of ET-1. This was prevented by CGRP-receptor antagonists and was mimicked by exogenous calcitonin gene-related peptide (CGRP). Using 2-photon laser scanning microscopy in vital intact arteries, capsaicin and CGRP, but not ETA-antagonism, were observed to promote dissociation of pre-existing ET-1/ETA-receptor complexes. Conclusions: Irreversible binding and activation of ETA-receptors by ET-1 (i) occur at an antagonist-insensitive site of the receptor and (ii) are selectively terminated by endogenously released CGRP. Hence, natural stimuli of sensory-motor nerves that stimulate release of endogenous CGRP can be considered for therapy of diseases involving ET-1.	[Meens, Merlijn J. P. M. T.; Compeer, Matthijs G.; Janssen, Ben J. A.; De Mey, Jo G. R.] Maastricht Univ, CARIM, Dept Pharmacol & Toxicol, Maastricht, Netherlands; [Hackeng, Tilman M.] Maastricht Univ, CARIM, Dept Biochem, Maastricht, Netherlands; [van Zandvoort, Marc A.] Maastricht Univ, CARIM, Dept Biomed Technol, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Meens, MJPMT (corresponding author), Maastricht Univ, CARIM, Dept Pharmacol & Toxicol, Maastricht, Netherlands.	j.demey@farmaco.unimaas.nl		De Mey, Jo G. R./0000-0001-6274-8071; Hackeng, Tilman/0000-0003-0142-0843	TIPharma (NL) [T2-108-1, T2-301]	TIPharma (NL)	Funding: This study was performed within the framework of TIPharma (NL) projects T2-108-1 (http://www.tipharma.com/projects/project-single/cardiovascular-diseases/metalloproteases-and-endothelial-dysfunction.html) and T2-301 (http://www.tipharma.com/projects/project-single/cardiovascular-diseases/reninangiotensin-system-blockade.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adner M, 2001, BRIT J PHARMACOL, V133, P927, DOI 10.1038/sj.bjp.0704135; Aiyar N, 2000, EUR J PHARMACOL, V403, P1, DOI 10.1016/S0014-2999(00)00419-2; Aumelas A, 1998, BIOCHEMISTRY-US, V37, P5220, DOI 10.1021/bi9723764; Bagnato A, 2008, CAN J PHYSIOL PHARM, V86, P473, DOI 10.1139/Y08-058; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Blandin V, 2000, MOL PHARMACOL, V58, P1461, DOI 10.1124/mol.58.6.1461; BOULANGER C, 1990, J CLIN INVEST, V85, P587, DOI 10.1172/JCI114477; Brain SD, 2004, PHYSIOL REV, V84, P903, DOI 10.1152/physrev.00037.2003; Burnstock G, 2009, ANNU REV PHARMACOL, V49, P1, DOI 10.1146/annurev.pharmtox.052808.102215; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHIBA T, 1989, AM J PHYSIOL, V256, pE331, DOI 10.1152/ajpendo.1989.256.2.E331; CLOZEL M, 1994, J PHARMACOL EXP THER, V270, P228; Conner AC, 2007, BIOCHEM SOC T, V35, P729, DOI 10.1042/BST0350729; Davenport AP, 2002, PHARMACOL REV, V54, P219, DOI 10.1124/pr.54.2.219; De Mey JGR, 2008, J PHARMACOL EXP THER, V324, P930, DOI 10.1124/jpet.107.133660; DEMEY JGR, 2009, MOL CELLULAR PHARM, V5, P246; Deng PY, 2004, J HYPERTENS, V22, P1819, DOI 10.1097/00004872-200409000-00028; Doods H, 2000, BRIT J PHARMACOL, V129, P420, DOI 10.1038/sj.bjp.0703110; Hewage CM, 1999, J PEPT RES, V53, P223, DOI 10.1034/j.1399-3011.1999.00001.x; HilalDandan R, 1997, J PHARMACOL EXP THER, V281, P267; Hilgers RHP, 2009, BRIT J PHARMACOL, V156, P1239, DOI 10.1111/j.1476-5381.2009.00128.x; HIRATA Y, 1993, J CLIN INVEST, V91, P1367, DOI 10.1172/JCI116338; Hynynen Meri M, 2006, Recent Pat Cardiovasc Drug Discov, V1, P95; IHARA M, 1992, LIFE SCI, V50, P247, DOI 10.1016/0024-3205(92)90331-I; IHARA M, 1992, J CARDIOVASC PHARM, V20, pS11, DOI 10.1097/00005344-199204002-00005; ISHIKAWA K, 1994, P NATL ACAD SCI USA, V91, P4892, DOI 10.1073/pnas.91.11.4892; Khodorova A, 2003, NAT MED, V9, P1055, DOI 10.1038/nm885; KIMURA S, 1988, BIOCHEM BIOPH RES CO, V156, P1182, DOI 10.1016/S0006-291X(88)80757-5; Kirkby NS, 2008, BRIT J PHARMACOL, V153, P1105, DOI 10.1038/sj.bjp.0707516; Lattig J, 2009, J PEPT SCI, V15, P479, DOI 10.1002/psc.1146; MAGGI CA, 1989, EUR J PHARMACOL, V166, P121, DOI 10.1016/0014-2999(89)90693-6; Masaki T, 2004, TRENDS PHARMACOL SCI, V25, P219, DOI 10.1016/j.tips.2004.02.008; McMurray JJV, 2007, JAMA-J AM MED ASSOC, V298, P2009, DOI 10.1001/jama.298.17.2009; Meens MJPMT, 2009, J PHARMACOL EXP THER, V331, P87, DOI 10.1124/jpet.109.155143; Megens RTA, 2007, J VASC RES, V44, P87, DOI 10.1159/000098259; Molero MM, 2002, J HYPERTENS, V20, P1799, DOI 10.1097/00004872-200209000-00025; Morris GE, 2010, CARDIOVASC RES, V85, P424, DOI 10.1093/cvr/cvp310; MULVANY MJ, 1990, J HYPERTENS, V8, pS225; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Ohlstein EH, 1998, J PHARMACOL EXP THER, V286, P650; Oksche A, 2000, MOL PHARMACOL, V57, P1104; Peng XM, 2007, J MED CHEM, V50, P2254, DOI 10.1021/jm061327z; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Plant TD, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-35; RANDALL MD, 1989, BRIT J PHARMACOL, V98, P685, DOI 10.1111/j.1476-5381.1989.tb12644.x; Sabaa N, 2008, J CLIN INVEST, V118, P1924, DOI 10.1172/JCI33308; SAEKI T, 1991, BIOCHEM BIOPH RES CO, V179, P286, DOI 10.1016/0006-291X(91)91367-L; SAKAMOTO A, 1993, J BIOL CHEM, V268, P8547; Schneider MP, 2007, ANNU REV PHARMACOL, V47, P731, DOI 10.1146/annurev.pharmtox.47.120505.105134; Stassen FRM, 1998, J PHARMACOL EXP THER, V284, P399; Supowit SC, 1997, HYPERTENSION, V29, P945, DOI 10.1161/01.HYP.29.4.945; Szallasi A, 1999, PHARMACOL REV, V51, P159; TAKAI M, 1992, BIOCHEM BIOPH RES CO, V184, P953, DOI 10.1016/0006-291X(92)90683-C; Talbodec A, 2000, MOL PHARMACOL, V57, P797, DOI 10.1124/mol.57.4.797; TAM JP, 1994, PEPTIDES, V15, P703, DOI 10.1016/0196-9781(94)90099-X; Vanhoutte PM, 2000, J AUTONOM NERV SYST, V81, P271, DOI 10.1016/S0165-1838(00)00126-0; Wang JC, 2004, J NEUROSURG-SPINE, V1, P287, DOI 10.3171/spi.2004.1.3.0287; Xie CQ, 2009, HYPERTENSION, V54, P1298, DOI 10.1161/HYPERTENSIONAHA.109.132167; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Zemanova L, 2004, BIOCHEMISTRY-US, V43, P9021, DOI 10.1021/bi035901+	60	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2010	5	6							e10917	10.1371/journal.pone.0010917	http://dx.doi.org/10.1371/journal.pone.0010917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QF	20532232	Green Published, Green Submitted, gold			2022-12-27	WOS:000278222400012
J	Elliott, KS; Zeggini, E; McCarthy, MI; Gudmundsson, J; Sulem, P; Stacey, SN; Thorlacius, S; Amundadottir, L; Gronberg, H; Xu, JF; Gaborieau, V; Eeles, RA; Neal, DE; Donovan, JL; Hamdy, FC; Muir, K; Hwang, SJ; Spitz, MR; Zanke, B; Carvajal-Carmona, L; Brown, KM; Hayward, NK; Macgregor, S; Tomlinson, IPM; Lemire, M; Amos, CI; Murabito, JM; Isaacs, WB; Easton, DF; Brennan, P; Barkardottir, RB; Gudbjartsson, DF; Rafnar, T; Hunter, DJ; Chanock, SJ; Stefansson, K; Ioannidis, JPA				Elliott, Katherine S.; Zeggini, Eleftheria; McCarthy, Mark I.; Gudmundsson, Julius; Sulem, Patrick; Stacey, Simon N.; Thorlacius, Steinunn; Amundadottir, Laufey; Groenberg, Henrik; Xu, Jianfeng; Gaborieau, Valerie; Eeles, Rosalind A.; Neal, David E.; Donovan, Jenny L.; Hamdy, Freddie C.; Muir, Kenneth; Hwang, Shih-Jen; Spitz, Margaret R.; Zanke, Brent; Carvajal-Carmona, Luis; Brown, Kevin M.; Hayward, Nicholas K.; Macgregor, Stuart; Tomlinson, Ian P. M.; Lemire, Mathieu; Amos, Christopher I.; Murabito, Joanne M.; Isaacs, William B.; Easton, Douglas F.; Brennan, Paul; Barkardottir, Rosa B.; Gudbjartsson, Daniel F.; Rafnar, Thorunn; Hunter, David J.; Chanock, Stephen J.; Stefansson, Kari; Ioannidis, John P. A.		Australian Melanoma Family Study I; PanScan Consortium	Evaluation of Association of HNF1B Variants with Diverse Cancers: Collaborative Analysis of Data from 19 Genome-Wide Association Studies	PLOS ONE			English	Article							PROSTATE-CANCER; DIABETES-MELLITUS; SUSCEPTIBILITY LOCUS; BREAST-CANCER; LUNG-CANCER; RISK LOCI; SEQUENCE VARIANTS; COMMON VARIANTS; GENE; METAANALYSIS	Background: Genome-wide association studies have found type 2 diabetes-associated variants in the HNF1B gene to exhibit reciprocal associations with prostate cancer risk. We aimed to identify whether these variants may have an effect on cancer risk in general versus a specific effect on prostate cancer only. Methodology/Principal Findings: In a collaborative analysis, we collected data from GWAS of cancer phenotypes for the frequently reported variants of HNF1B, rs4430796 and rs7501939, which are in linkage disequilibrium (r(2) = 0.76, HapMap CEU). Overall, the analysis included 16 datasets on rs4430796 with 19,640 cancer cases and 21,929 controls; and 21 datasets on rs7501939 with 26,923 cases and 49,085 controls. Malignancies other than prostate cancer included colorectal, breast, lung and pancreatic cancers, and melanoma. Meta-analysis showed large between-dataset heterogeneity that was driven by different effects in prostate cancer and other cancers. The per-T2D-risk-allele odds ratios (95% confidence intervals) for rs4430796 were 0.79 (0.76, 0.83)] per G allele for prostate cancer (p < 10(-15) for both); and 1.03 (0.99, 1.07) for all other cancers. Similarly for rs7501939 the per-T2D-risk-allele odds ratios (95% confidence intervals) were 0.80 (0.77, 0.83) per T allele for prostate cancer (p < 10(-15) for both); and 1.00 (0.97, 1.04) for all other cancers. No malignancy other than prostate cancer had a nominally statistically significant association. Conclusions/Significance: The examined HNF1B variants have a highly specific effect on prostate cancer risk with no apparent association with any of the other studied cancer types.	[Elliott, Katherine S.; Zeggini, Eleftheria; McCarthy, Mark I.; Carvajal-Carmona, Luis; Tomlinson, Ian P. M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Zeggini, Eleftheria] Univ Cambridge, Wellcome Trust Sanger Inst, Cambridge, England; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Gudmundsson, Julius; Sulem, Patrick; Stacey, Simon N.; Thorlacius, Steinunn; Gudbjartsson, Daniel F.; Rafnar, Thorunn; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Amundadottir, Laufey; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Groenberg, Henrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC USA; [Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Winston Salem, NC USA; [Gaborieau, Valerie] IARC, Genet Epidemiol Grp, Lyon, France; [Eeles, Rosalind A.] Inst Canc Res, Oncogenet Team, Sutton, Surrey, England; [Neal, David E.] Univ Cambridge, Dept Oncol, Cambridge, England; [Donovan, Jenny L.] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Hamdy, Freddie C.] Univ Oxford, Nuffield Dept Surg, Oxford, England; [Muir, Kenneth] Univ Warwick, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Hwang, Shih-Jen] NHLBI, Framingham Study, Bethesda, MD 20892 USA; [Spitz, Margaret R.; Amos, Christopher I.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Zanke, Brent; Lemire, Mathieu] Ontario Inst Canc Res, MaRS Ctr, Toronto, ON, Canada; [Zanke, Brent] Univ Ottawa, Ottawa Hlth Res Inst, Ottawa, ON, Canada; [Brown, Kevin M.] Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ USA; [Hayward, Nicholas K.; Macgregor, Stuart] Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Murabito, Joanne M.] Boston Univ, Sch Med, Gen Internal Med Sect, Boston, MA 02118 USA; [Isaacs, William B.] Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA; [Easton, Douglas F.] Univ Cambridge, Canc Res UK Genet Epidemiol Unit, Cambridge, England; [Barkardottir, Rosa B.] Landspitali Univ Hosp Iceland, Dept Pathol, Reykjavik, Iceland; [Barkardottir, Rosa B.] Univ Iceland, Fac Med, Reykjavik, Iceland; [Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Ioannidis, John P. A.] Fdn Res & Technol Hellas, Biomed Res Inst, Ioannina, Greece; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Ctr Genet Epidemiol & Modelling, Boston, MA 02111 USA	University of Oxford; Wellcome Centre for Human Genetics; University of Cambridge; Wellcome Trust Sanger Institute; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Karolinska Institutet; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; World Health Organization; International Agency for Research on Cancer (IARC); University of London; Institute of Cancer Research - UK; University of Cambridge; University of Bristol; University of Oxford; University of Warwick; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Ottawa; Ottawa Hospital Research Institute; Translational Genomics Research Institute; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; Boston University; Johns Hopkins University; Johns Hopkins Medicine; Cancer Research UK; University of Cambridge; Landspitali National University Hospital; University of Iceland; Harvard University; Harvard T.H. Chan School of Public Health; University of Ioannina; Foundation for Research & Technology - Hellas (FORTH); Tufts University	Elliott, KS (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	jioannid@cc.uoi.gr	Albanes, Demetrius/B-9749-2015; Gallinger, Steven/E-4575-2013; Macgregor, Stuart/C-6442-2009; Wang, Zhaoming/R-5527-2018; Stolzenberg-Solomon, Rachael/Y-9280-2018; hayward, nick/AAV-8802-2020; Krogh, Vittorio/K-2628-2016; Hwang, Shih-Jen/HGU-5826-2022; hayward, nicholas k/C-1367-2015; Tobias, Geoffrey S/M-4135-2016; Aitken, Joanne F/C-5289-2009; Stefansson, Kari/AAE-7187-2019; Ioannidis, John P. A./G-9836-2011; Mann, Graham J/G-4758-2014; Amundadottir, Laufey T/L-7656-2016; Carvajal-Carmona, Luis G/B-3882-2010; McCarthy, Mark/M-3763-2015	Macgregor, Stuart/0000-0001-6731-8142; Wang, Zhaoming/0000-0001-7556-3869; Stolzenberg-Solomon, Rachael/0000-0003-3698-7006; Krogh, Vittorio/0000-0003-0122-8624; hayward, nicholas k/0000-0003-4760-1033; Tobias, Geoffrey S/0000-0002-2878-8253; Mann, Graham J/0000-0003-1301-405X; Amundadottir, Laufey T/0000-0003-1859-8971; Carvajal-Carmona, Luis G/0000-0001-7129-2918; Hamdy, Freddie/0000-0003-2627-2154; Kraft, Peter/0000-0002-4472-8103; Riboli, Elio/0000-0001-6795-6080; Eeles, Rosalind/0000-0002-3698-6241; Jacobs, Kevin/0000-0002-4657-6473; Jenab, Mazda/0000-0002-0573-1852; Murabito, Joanne/0000-0002-0192-7516; Canzian, Federico/0000-0002-4261-4583; McCarthy, Mark/0000-0002-4393-0510; Gudbjartsson, Daniel/0000-0002-5222-9857; Duell, Eric J/0000-0001-5256-0163; Zeggini, Eleftheria/0000-0003-4238-659X; Kefford, Richard/0000-0001-9251-9229; Aitken, Joanne Frances/0000-0001-6859-2186; Neal, David/0000-0002-6033-5086	National Institutes of Health [UL1 RR025752, R01-CA88363, RO1-CA83115]; Wellcome Trust [WT075491/Z/04, WT088885/Z/09/Z]; Australian National Health and Medical Research Council (NHMRC); Swedish Cancer Society (Cancerfonden),; Swedish Research Council; Predication and prevention of breast cancer and prostate cancer; Cancer Research [C5047/A8385, C5047/A7357]; Institute of Cancer Research; Everyman Campaign; Prostate Cancer Research Foundation; NIHR; Royal Marsden NHS Foundation Trust; National Cancer Research Institute (NCRI); Medical Research Council; Cancer Research UK; UK National Institute for Health Research Health Technology Assessment Programme [96/20/06, 96/20/99]; EU [018827]; NHMRC; Cancer Councils of Queensland; NSW; Victoria; National Heart Lung and Blood Institute of the National Institutes of Health; National Heart, Lung and Blood Institute's Framingham Heart Study [N01-HC-25195, N02-HL-6-4278]; Robert Dawson Evans Endowment; MRC [G0900871] Funding Source: UKRI; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA083115, R01CA088363, R01CA097193, R01CA124908] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; Cancer Research UK [10118, 11022] Funding Source: researchfish; Medical Research Council [G0900871] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10242] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Swedish Cancer Society (Cancerfonden),(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Predication and prevention of breast cancer and prostate cancer; Cancer Research; Institute of Cancer Research; Everyman Campaign; Prostate Cancer Research Foundation; NIHR(National Institute for Health Research (NIHR)); Royal Marsden NHS Foundation Trust(Royal Society of New ZealandMarsden Fund (NZ)); National Cancer Research Institute (NCRI); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); UK National Institute for Health Research Health Technology Assessment Programme(National Institute for Health Research (NIHR)); EU(European Commission); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Councils of Queensland(Cancer Council Queensland); NSW; Victoria; National Heart Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Robert Dawson Evans Endowment; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	JPAI is supported by funding for the Tufts Clinical and Translational Science Institute and the Center for Genetic Epidemiology and Modeling is supported by grant UL1 RR025752 from the National Institutes of Health. KSE is supported by the Wellcome Trust (WT075491/Z/04). EZ is supported by the Wellcome Trust (WT088885/Z/09/Z). NH and SM were funded by the Australian National Health and Medical Research Council (NHMRC) and the National Institutes of Health (grant R01-CA88363). HG is supported by Swedish Cancer Society (Cancerfonden), Swedish Research Council, and Linneus grant "Predication and prevention of breast cancer and prostate cancer''. RE and KM are supported by Cancer Research UK Grant C5047/A8385; C5047/A7357, The Institute of Cancer Research and The Everyman Campaign and The Prostate Cancer Research Foundation. The authors acknowledge support from the NIHR to the Biomedical Research Centre at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust. DEN, JLD and FCH would like to acknowledge the support of the National Cancer Research Institute (NCRI) formed by the Department of Health, the Medical Research Council and Cancer Research UK. The Prostate Testing for Cancer and Treatment (ProtecT) study is funded by the UK National Institute for Health Research Health Technology Assessment Programme (projects 96/20/06, 96/20/99). The NCRI provided funding through ProMPT (Prostate Mechanisms of Progression and Treatment) and this support is gratefully acknowledged. The Cambridge prostate biorepository also received funding from the NIHR Comprehensive Biomedical Research Centre Grant. This support is gratefully acknowledged. The views and opinions expressed therein are those of the authors and are not necessarily those of the funding bodies. deCODE acknowledges grant support from the 6th Framework Program of the EU: contract 018827 (Polygene). The Australian Melanoma Family Study (AMFS) was supported by grants from the NHMRC, Cancer Councils of Queensland, NSW and Victoria, and by National Institutes of Health grant RO1-CA83115 to the GenoMEL consortium. The Framingham Heart Study (FHS) The Framingham Heart Study of the National Heart Lung and Blood Institute of the National Institutes of Health and Boston University School of Medicine were supported by the National Heart, Lung and Blood Institute's Framingham Heart Study Contract No. N01-HC-25195 and its contract with Affymetrix, Inc for genotyping services (Contract No. N02-HL-6-4278). Analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. A portion of this research was conducted using the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Brennan P, 2007, HUM MOL GENET, V16, P1794, DOI 10.1093/hmg/ddm127; Brown KM, 2008, NAT GENET, V40, P838, DOI 10.1038/ng.163; Calton BA, 2007, CANCER CAUSE CONTROL, V18, P493, DOI 10.1007/s10552-007-0126-y; Coffinier C, 1999, MECH DEVELOP, V89, P211, DOI 10.1016/S0925-4773(99)00221-X; Cust AE, 2009, AM J EPIDEMIOL, V170, P1541, DOI 10.1093/aje/kwp307; Duggan D, 2007, JNCI-J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Edghill EL, 2006, J MED GENET, V43, P84, DOI 10.1136/jmg.2005.032854; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Gong ZH, 2006, CANCER EPIDEM BIOMAR, V15, P1977, DOI 10.1158/1055-9965.EPI-06-0477; GUDMUNDSSON J, 2008, NAT GENET; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Inoue M, 2006, ARCH INTERN MED, V166, P1871, DOI 10.1001/archinte.166.17.1871; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Kasper JS, 2006, CANCER EPIDEM BIOMAR, V15, P2056, DOI 10.1158/1055-9965.EPI-06-0410; Levin AM, 2008, CANCER RES, V68, P6492, DOI 10.1158/0008-5472.CAN-08-0348; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; PETERSEN GM, NAT GENET; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Reber M, 2001, MECH DEVELOP, V100, P75, DOI 10.1016/S0925-4773(00)00493-7; Rebouissou S, 2005, HUM MOL GENET, V14, P603, DOI 10.1093/hmg/ddi057; Rousseau MC, 2006, INT J CANCER, V118, P2105, DOI 10.1002/ijc.21600; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stattin P, 2007, DIABETES CARE, V30, P561, DOI 10.2337/dc06-0922; Sun J, 2008, NAT GENET, V40, P1153, DOI 10.1038/ng.214; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; THOMAS G, 2008, NAT GENET; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Will JC, 1999, EPIDEMIOLOGY, V10, P313, DOI 10.1097/00001648-199905000-00021; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Yamada H, 2009, JNCI-J NATL CANCER I, V101, P1330, DOI 10.1093/jnci/djp287; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	47	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10858	10.1371/journal.pone.0010858	http://dx.doi.org/10.1371/journal.pone.0010858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526366	Green Published, Green Submitted, gold			2022-12-27	WOS:000278222100002
J	Oliveira, MLS; Miyaji, EN; Ferreira, DM; Moreno, AT; Ferreira, PCD; Lima, FA; Santos, FL; Sakauchi, MA; Takata, CS; Higashi, HG; Raw, I; Kubrusly, FS; Ho, PL				Oliveira, Maria Leonor S.; Miyaji, Eliane N.; Ferreira, Daniela M.; Moreno, Adriana T.; Ferreira, Patricia C. D.; Lima, Fernanda A.; Santos, Fernanda L.; Sakauchi, Maria Aparecida; Takata, Celia S.; Higashi, Hisako G.; Raw, Isaias; Kubrusly, Flavia S.; Ho, Paulo L.			Combination of Pneumococcal Surface Protein A (PspA) with Whole Cell Pertussis Vaccine Increases Protection Against Pneumococcal Challenge in Mice	PLOS ONE			English	Article							ACELLULAR DTP VACCINE; STREPTOCOCCUS-PNEUMONIAE; INTRANASAL IMMUNIZATION; BORDETELLA-PERTUSSIS; COMPLEMENT DEPOSITION; IMMUNE-RESPONSES; WALL POLYSACCHARIDE; CYTOKINE PRODUCTION; ELICIT PROTECTION; CHILDREN YOUNGER	Streptococcus pneumoniae is the leading cause of respiratory acute infections around the world. In Latin America, approximately 20,000 children under 5 years of age die of pneumococcal diseases annually. Pneumococcal surface protein A (PspA) is among the best-characterized pneumococcal antigens that confer protection in animal models of pneumococcal infections and, as such, is a good alternative for the currently available conjugated vaccines. Efficient immune responses directed to PspA in animal models have already been described. Nevertheless, few low cost adjuvants for a subunit pneumococcal vaccine have been proposed to date. Here, we have tested the adjuvant properties of the whole cell Bordetella pertussis vaccine (wP) that is currently part of the DTP (diphtheria-tetanus-pertussis) vaccine administrated to children in several countries, as an adjuvant to PspA. Nasal immunization of BALB/c mice with a combination of PspA5 and wP or wP(low) - a new generation vaccine that contains low levels of B. pertussis LPS - conferred protection against a respiratory lethal challenge with S. pneumoniae. Both PspA5-wP and PspA5-wP(low) vaccines induced high levels of systemic and mucosal antibodies against PspA5, with similar profile, indicating no essential requirement for B. pertussis LPS in the adjuvant properties of wP. Accordingly, nasal immunization of C3H/HeJ mice with PspA5-wP conferred protection against the pneumococcal challenge, thus ruling out a role for TLR4 responses in the adjuvant activity and the protection mechanisms triggered by the vaccines. The high levels of anti-PspA5 antibodies correlated with increased cross-reactivity against PspAs from different clades and also reflected in cross-protection. In addition, passive immunization experiments indicated that antibodies played an important role in protection in this model. Finally, subcutaneous immunization with a combination of PspA5 with DTPlow protected mice against challenge with two different pneumococcal strains, opening the possibility for the development of a combined infant vaccine composed of DTP and PspA.	[Oliveira, Maria Leonor S.; Miyaji, Eliane N.; Ferreira, Daniela M.; Moreno, Adriana T.; Ferreira, Patricia C. D.; Lima, Fernanda A.; Raw, Isaias; Kubrusly, Flavia S.; Ho, Paulo L.] Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil; [Santos, Fernanda L.; Sakauchi, Maria Aparecida; Takata, Celia S.; Higashi, Hisako G.] Inst Butantan, Div Bioind, Sao Paulo, Brazil	Instituto Butantan; Instituto Butantan	Oliveira, MLS (corresponding author), Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil.	mloliveira@butantan.gov.br; hoplee@butantan.gov.br	S macarini, fernanda/V-8252-2017; Ferreira, Daniela M/AFF-4763-2022; SAKAUCHI, MARIA APARECIDA/D-8728-2015; Oliveira, Maria Leonor S/F-4988-2012; Miyaji, Eliane N/D-7642-2012; Ho, Paulo/P-8267-2015; Ferreira, Daniela M/AAE-9881-2022	Ferreira, Daniela M/0000-0002-0594-0902; Miyaji, Eliane N/0000-0003-1689-5366; Ho, Paulo/0000-0003-3652-241X; Oliveira, Maria Leonor/0000-0003-4849-3062; Kubrusly, Flavia/0000-0003-0646-583X	FAPESP; CNPq; Butantan Foundation; PAP-SES	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Butantan Foundation; PAP-SES	The authors gratefully acknowledge support from the folowing Brazilian agencies: FAPESP, CNPq, Butantan Foundation, and PAP-SES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Arulanandam BP, 2001, INFECT IMMUN, V69, P6718, DOI 10.1128/IAI.69.11.6718-6724.2001; Bamberger ES, 2008, EUR J PEDIATR, V167, P133, DOI 10.1007/s00431-007-0548-2; Banus S, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-21; Basset A, 2007, INFECT IMMUN, V75, P5460, DOI 10.1128/IAI.00773-07; Berstad AKH, 2000, VACCINE, V18, P2323, DOI 10.1016/S0264-410X(00)00024-4; Berstad AKH, 2000, VACCINE, V18, P1910, DOI 10.1016/S0264-410X(99)00442-9; BETTINGER JA, 2009, VACCINE; Briles DE, 2000, INFECT IMMUN, V68, P796, DOI 10.1128/IAI.68.2.796-800.2000; Campos IB, 2008, MICROBES INFECT, V10, P481, DOI 10.1016/j.micinf.2008.01.007; Chiba N, 2010, EPIDEMIOL INFECT, V138, P61, DOI 10.1017/S0950268809990239; Dagan R, 2004, INFECT IMMUN, V72, P5383, DOI 10.1128/IAI.72.9.5383-5391.2004; Dagan R, 2009, VACCINE, V27, pC3, DOI 10.1016/j.vaccine.2009.06.002; Dagan R, 2009, VACCINE, V27, pC22, DOI 10.1016/j.vaccine.2009.06.004; Darrieux M, 2007, INFECT IMMUN, V75, P5930, DOI 10.1128/IAI.00940-07; Darrieux M, 2008, J MED MICROBIOL, V57, P273, DOI 10.1099/jmm.0.47661-0; de Quadros CA, 2009, VACCINE, V27, pC29, DOI 10.1016/j.vaccine.2009.06.006; ERREA A, 2010, MED MICROBIOL IMMUNO; Fedele G, 2007, MICROBES INFECT, V9, P855, DOI 10.1016/j.micinf.2007.03.002; Ferreira DM, 2009, CLIN VACCINE IMMUNOL, V16, P636, DOI 10.1128/CVI.00395-08; Ferreira DM, 2008, CLIN VACCINE IMMUNOL, V15, P499, DOI 10.1128/CVI.00400-07; Ferreira DM, 2009, MICROB PATHOGENESIS, V47, P157, DOI 10.1016/j.micpath.2009.05.005; Ferreira DM, 2006, J MED MICROBIOL, V55, P375, DOI 10.1099/jmm.0.46217-0; Franco CM, 2010, PEDIATR INFECT DIS J, V29, P77, DOI 10.1097/INF.0b013e3181af7e90; Fujimoto C, 2006, J IMMUNOL, V177, P6896, DOI 10.4049/jimmunol.177.10.6896; Hale C, 2004, VACCINE, V22, P3595, DOI 10.1016/j.vaccine.2004.03.039; Hanniffy SB, 2007, J INFECT DIS, V195, P185, DOI 10.1086/509807; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; Hollingshead SK, 2006, J MED MICROBIOL, V55, P215, DOI 10.1099/jmm.0.46268-0; HSU KK, 2009, PEDIAT INFECT DIS J; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; Li YH, 2009, P NATL ACAD SCI USA, V106, P593, DOI 10.1073/pnas.0811697106; Locht C, 2008, MICROBES INFECT, V10, P1051, DOI 10.1016/j.micinf.2008.07.008; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Lu YJ, 2009, MICROB PATHOGENESIS, V47, P177, DOI 10.1016/j.micpath.2009.06.008; Lu YJ, 2009, INFECT IMMUN, V77, P2076, DOI 10.1128/IAI.01554-08; Mahon BP, 1996, INFECT IMMUN, V64, P5295, DOI 10.1128/IAI.64.12.5295-5301.1996; Malley R, 2006, INFECT IMMUN, V74, P2187, DOI 10.1128/IAI.74.4.2187-2195.2006; McGuirk P, 2000, INFECT IMMUN, V68, P1383, DOI 10.1128/IAI.68.3.1383-1390.2000; Mielcarek N, 2006, PLOS PATHOG, V2, P662, DOI 10.1371/journal.ppat.0020065; Miyaji EN, 2003, FEMS IMMUNOL MED MIC, V37, P53, DOI 10.1016/S0928-8244(03)00108-1; MORENO AT, 2010, CLIN VACCINE IMMUNOL; Nicol M, 2002, PEDIATR INFECT DIS J, V21, P138, DOI 10.1097/00006454-200202000-00010; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Oliveira MLS, 2006, MICROBES INFECT, V8, P1016, DOI 10.1016/j.micinf.2005.10.020; Oma K, 2009, VACCINE, V27, P3181, DOI 10.1016/j.vaccine.2009.03.055; Orr B, 2007, VACCINE, V25, P64, DOI 10.1016/j.vaccine.2006.07.019; *PAHO, 2007, IMM NEWSL, P1; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Pimenta FC, 2006, J CLIN MICROBIOL, V44, P2838, DOI 10.1128/JCM.00156-06; Prikazsky V, 2001, INT J CLIN PRACT, V55, P156; Quintilio W, 2009, VACCINE, V27, P4219, DOI 10.1016/j.vaccine.2009.04.047; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Reinert P, 2003, ARCH PEDIATRIE, V10, P1048, DOI 10.1016/j.arcped.2003.09.039; Ren B, 2004, INFECT IMMUN, V72, P114, DOI 10.1128/IAI.72.1.114-122.2004; Ren B, 2003, INFECT IMMUN, V71, P75, DOI 10.1128/IAI.71.1.75-85.2003; Shaper M, 2004, INFECT IMMUN, V72, P5031, DOI 10.1128/IAI.72.9.5031-5040.2004; Shouval DS, 2009, PEDIATR INFECT DIS J, V28, P277, DOI 10.1097/INF.0b013e31818e0e2e; Tai SS, 2006, CRIT REV MICROBIOL, V32, P139, DOI 10.1080/10408410600822942; Tamizifar H, 1997, J MED MICROBIOL, V46, P61, DOI 10.1099/00222615-46-1-61; TAMIZIFAR H, 1995, VACCINE, V13, P1539, DOI 10.1016/0264-410X(95)00092-F; TECHASAENSIRI C, 2009, PEDIAT INFECT DIS J; Tonon S, 2006, EUR J IMMUNOL, V36, P1794, DOI 10.1002/eji.200535697; Tu AHT, 1999, INFECT IMMUN, V67, P4720, DOI 10.1128/IAI.67.9.4720-4724.1999; Xin W, 2009, INFECT IMMUN, V77, P4518, DOI 10.1128/IAI.00486-09; Yano A, 2007, MICROBIOL IMMUNOL, V51, P685, DOI 10.1111/j.1348-0421.2007.tb03957.x; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731; Zorzeto TQ, 2009, CLIN VACCINE IMMUNOL, V16, P544, DOI 10.1128/CVI.00339-08	69	37	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10863	10.1371/journal.pone.0010863	http://dx.doi.org/10.1371/journal.pone.0010863			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523738	Green Published, gold, Green Submitted			2022-12-27	WOS:000278221900013
J	Brodeur, MB; Dionne-Dostie, E; Montreuil, T; Lepage, M				Brodeur, Mathieu B.; Dionne-Dostie, Emmanuelle; Montreuil, Tina; Lepage, Martin			The Bank of Standardized Stimuli (BOSS), a New Set of 480 Normative Photos of Objects to Be Used as Visual Stimuli in Cognitive Research	PLOS ONE			English	Article							PICTURE-NAMING NORMS; AGE-OF-ACQUISITION; NAME AGREEMENT; IMAGE AGREEMENT; VANDERWART PICTURES; PSYCHOLINGUISTIC NORMS; EVERYDAY OBJECTS; SURFACE DETAIL; WORD-FREQUENCY; FAMILIARITY	There are currently stimuli with published norms available to study several psychological aspects of language and visual cognitions. Norms represent valuable information that can be used as experimental variables or systematically controlled to limit their potential influence on another experimental manipulation. The present work proposes 480 photo stimuli that have been normalized for name, category, familiarity, visual complexity, object agreement, viewpoint agreement, and manipulability. Stimuli are also available in grayscale, blurred, scrambled, and line-drawn version. This set of objects, the Bank Of Standardized Stimuli (BOSS), was created specifically to meet the needs of scientists in cognition, vision and psycholinguistics who work with photo stimuli.	[Brodeur, Mathieu B.; Montreuil, Tina; Lepage, Martin] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Brodeur, Mathieu B.; Montreuil, Tina; Lepage, Martin] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Dionne-Dostie, Emmanuelle] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Montreuil, Tina] Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada	McGill University; McGill University; Universite de Montreal; University of Quebec; University of Quebec Montreal	Brodeur, MB (corresponding author), McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	mathieu.brodeur@douglas.mcgill.ca			Natural Sciences and Engineering Research Council of Canada [238617]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding: This study was supported by an operating grant from the Natural Sciences and Engineering Research Council of Canada (grant #238617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBATE MS, 1984, PICTURES PLEASE LA S; ADLINGTON RL, 2008, J CLIN EXPT NEUROPSY, DOI DOI 10.1080/13803390802488103:1-23; Alario FX, 1999, BEHAV RES METH INS C, V31, P531, DOI 10.3758/BF03200732; Alario FX, 2004, BEHAV RES METH INS C, V36, P140, DOI 10.3758/BF03195559; Alvarez B, 2007, BEHAV RES METHODS, V39, P377, DOI 10.3758/BF03193006; Barbarotto R, 2002, NEUROPSYCHOLOGIA, V40, P1637, DOI 10.1016/S0028-3932(02)00029-5; Barry C, 1997, Q J EXP PSYCHOL-A, V50, P560, DOI 10.1080/783663595; Bates E, 2003, PSYCHON B REV, V10, P344, DOI 10.3758/BF03196494; Bates E, 2001, MEM COGNITION, V29, P986, DOI 10.3758/BF03195761; BERMAN S, 1989, BEHAV RES METH INSTR, V21, P371, DOI 10.3758/BF03202800; BIEDERMAN I, 1988, COGNITIVE PSYCHOL, V20, P38, DOI 10.1016/0010-0285(88)90024-2; Bonin P, 2004, BEHAV RES METH INS C, V36, P127, DOI 10.3758/BF03195558; Bonin P, 2003, BEHAV RES METH INS C, V35, P158, DOI 10.3758/BF03195507; Bonin P, 2008, BEHAV RES METHODS, V40, P137, DOI 10.3758/BRM.40.1.137; Boutsen L, 1998, PERCEPT PSYCHOPHYS, V60, P900, DOI 10.3758/BF03206072; BRODIE EE, 1991, AM J PSYCHOL, V104, P517, DOI 10.2307/1422939; Bulthoff I, 2006, PROG BRAIN RES, V154, P315, DOI 10.1016/S0079-6123(06)54017-8; Cannard C, 2005, BEHAV RES METHODS, V37, P417, DOI 10.3758/BF03192710; CANO ME, 2008, INT J PSYCHOPHYSIOLO; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; COLTHEART M, 1981, Q J EXP PSYCHOL-A, V33, P497, DOI 10.1080/14640748108400805; Cuetos F, 1999, BEHAV RES METH INS C, V31, P650, DOI 10.3758/BF03200741; Cuetos F, 2003, BEHAV RES METH INS C, V35, P168, DOI 10.3758/BF03195508; Cycowicz YM, 1997, J EXP CHILD PSYCHOL, V65, P171, DOI 10.1006/jecp.1996.2356; D'Amico S, 2001, J COGN DEV, V2, P71, DOI 10.1207/S15327647JCD0201_4; DAVIDOFF JB, 1988, Q J EXP PSYCHOL-A, V40, P533, DOI 10.1080/02724988843000069; De Winter J, 2004, BEHAV RES METH INS C, V36, P604, DOI 10.3758/BF03206541; DEGROOT AMB, 1989, J EXP PSYCHOL LEARN, V15, P824, DOI 10.1037/0278-7393.15.5.824; Dell'acqua R, 2000, BEHAV RES METH INS C, V32, P588, DOI 10.3758/BF03200832; DUNN L, 1981, CIRCLE PINES; Ekman P., 1976, PICTURES FACIAL AFFE; Ellis AW, 1998, J EXP PSYCHOL LEARN, V24, P515, DOI 10.1037/0278-7393.24.2.515; Fiez JA, 1997, MEM COGNITION, V25, P543, DOI 10.3758/BF03201129; Filliter JH, 2005, BRAIN COGNITION, V57, P61, DOI 10.1016/j.bandc.2004.08.022; GILHOOLY KJ, 1980, BEHAV RES METH INSTR, V12, P395, DOI 10.3758/BF03201693; Gomez P, 2008, PSYCHON B REV, V15, P940, DOI 10.3758/PBR.15.5.940; Goodale MA, 2004, CURR OPIN NEUROBIOL, V14, P203, DOI 10.1016/j.conb.2004.03.002; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Himmanen SA, 2003, J CLIN EXP NEUROPSYC, V25, P1178, DOI 10.1076/jcen.25.8.1178.16729; Ishai A, 2000, J COGNITIVE NEUROSCI, V12, P35, DOI 10.1162/089892900564055; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; James TW, 2002, NEURON, V35, P793, DOI 10.1016/S0896-6273(02)00803-6; KOSSLYN SM, 1994, BRAIN, V117, P1055, DOI 10.1093/brain/117.5.1055; Kremin H, 2003, BRAIN COGNITION, V53, P243, DOI 10.1016/S0278-2626(03)00119-2; LANG PJ, 2005, A6 U FL; Laws KR, 1999, NEUROPSYCHOLOGIA, V37, P1263, DOI 10.1016/S0028-3932(99)00018-4; Lundqvist D., 1998, KAROLINSKA DIRECTED; Magnie MN, 2003, J CLIN EXP NEUROPSYC, V25, P521, DOI 10.1076/jcen.25.4.521.13873; Masterson J, 1998, J NEUROLINGUIST, V11, P331, DOI 10.1016/S0911-6044(98)00023-2; Masterson J, 2008, J CHILD LANG, V35, P373, DOI 10.1017/S0305000907008549; McMullen PA, 2006, BRAIN COGNITION, V62, P228, DOI 10.1016/j.bandc.2006.06.002; Miranda Mnica Carolina, 2004, Revista Brasileira de Psiquiatria, V26, P226; Nishimoto T, 2005, BEHAV RES METHODS, V37, P398, DOI 10.3758/BF03192709; Op de Beeck H, 2001, PERCEPTION, V30, P1337; OSTERGAARD AL, 1985, J EXP PSYCHOL LEARN, V11, P579, DOI 10.1037/0278-7393.11.3.579; Panis S, 2008, PERCEPTION, V37, P271, DOI 10.1068/p5516; Pind J, 2000, SCAND J PSYCHOL, V41, P41, DOI 10.1111/1467-9450.00169; Pompeia S, 2003, ARQ NEURO-PSIQUIAT, V61, P916, DOI 10.1590/S0004-282X2003000600005; Pompeia S, 2001, ARQ NEURO-PSIQUIAT, V59, P330, DOI 10.1590/S0004-282X2001000300004; PRICE CJ, 1989, Q J EXP PSYCHOL-A, V41, P797, DOI 10.1080/14640748908402394; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Sanfeliu MC, 1996, BEHAV RES METH INSTR, V28, P537, DOI 10.3758/BF03200541; SCHIANO DJ, 1981, MEM COGNITION, V9, P110, DOI 10.3758/BF03196956; Schwier V, 2004, BEHAV RES METH INS C, V36, P564, DOI 10.3758/BF03195603; Severens E, 2005, ACTA PSYCHOL, V119, P159, DOI 10.1016/j.actpsy.2005.01.002; Sim EJ, 2005, COGNITIVE BRAIN RES, V24, P260, DOI 10.1016/j.cogbrainres.2005.02.006; Sirois M, 2006, BEHAV RES METHODS, V38, P300, DOI 10.3758/BF03192781; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; SNODGRASS JG, 1988, PERCEPT MOTOR SKILL, V67, P3, DOI 10.2466/pms.1988.67.1.3; STEWART F, 1992, Q J EXP PSYCHOL-A, V44, P261, DOI 10.1080/02724989243000037; Szekely A, 2003, BEHAV RES METH INS C, V35, P621, DOI 10.3758/BF03195542; Van Schagen I., 1983, NEDERLANDS TIJDSCHRI, V38, P236; VERFAILLIE K, 1995, PERCEPT PSYCHOPHYS, V57, P925, DOI 10.3758/BF03205454; Viggiano MP, 2004, CORTEX, V40, P491, DOI 10.1016/S0010-9452(08)70142-4; VITKOVITCH M, 1995, Q J EXP PSYCHOL-A, V48, P822, DOI 10.1080/14640749508401419; Wagemans J, 2008, PERCEPTION, V37, P207, DOI 10.1068/p5825; Weekes BS, 2007, BEHAV RES METHODS, V39, P335, DOI 10.3758/BF03193165; WURM LH, 1993, J EXP PSYCHOL HUMAN, V19, P899, DOI 10.1037/0096-1523.19.4.899; Yoon C, 2004, BEHAV RES METH INS C, V36, P639, DOI 10.3758/BF03206545	79	351	354	6	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10773	10.1371/journal.pone.0010773	http://dx.doi.org/10.1371/journal.pone.0010773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	601CC	20532245	Green Submitted, Green Published, gold			2022-12-27	WOS:000278034600007
J	Ahmed, S; Creanga, AA; Gillespie, DG; Tsui, AO				Ahmed, Saifuddin; Creanga, Andreea A.; Gillespie, Duff G.; Tsui, Amy O.			Economic Status, Education and Empowerment: Implications for Maternal Health Service Utilization in Developing Countries	PLOS ONE			English	Article							OBSTETRIC CARE; MORTALITY; EQUITY; POOR; DETERMINANTS; RESOURCES; SEEKING	Background: Relative to the attention given to improving the quality of and access to maternal health services, the influence of women's socio-economic situation on maternal health care use has received scant attention. The objective of this paper is to examine the relationship between women's economic, educational and empowerment status, introduced as the 3Es, and maternal health service utilization in developing countries. Methods/Principal Findings: The analysis uses data from the most recent Demographic and Health Surveys conducted in 31 countries for which data on all the 3Es are available. Separate logistic regression models are fitted for modern contraceptive use, antenatal care and skilled birth attendance in relation to the three covariates of interest: economic, education and empowerment status, additionally controlling for women's age and residence. We use meta-analysis techniques to combine and summarize results from multiple countries. The 3Es are significantly associated with utilization of maternal health services. The odds of having a skilled attendant at delivery for women in the poorest wealth quintile are 94% lower than that for women in the highest wealth quintile and almost 5 times higher for women with complete primary education relative to those less educated. The likelihood of using modern contraception and attending four or more antenatal care visits are 2.01 and 2.89 times, respectively, higher for women with complete primary education than for those less educated. Women with the highest empowerment score are between 1.31 and 1.82 times more likely than those with a null empowerment score to use modern contraception, attend four or more antenatal care visits and have a skilled attendant at birth. Conclusions/Significance: Efforts to expand maternal health service utilization can be accelerated by parallel investments in programs aimed at poverty eradication (MDG 1), universal primary education (MDG 2), and women's empowerment (MDG 3).	[Ahmed, Saifuddin; Creanga, Andreea A.; Gillespie, Duff G.; Tsui, Amy O.] Johns Hopkins Bloomberg Sch Publ Hlth, Populat Family & Reprod Hlth Dept, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Ahmed, S (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Populat Family & Reprod Hlth Dept, Baltimore, MD USA.	acreanga@jhsph.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER; NICHD NIH HHS [R24 HD042854] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abou-Zahr CL, 2003, ANTENATAL CARE DEV C; Al Riyami Asya, 2004, Reprod Health Matters, V12, P144, DOI 10.1016/S0968-8080(04)23113-5; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Basu AM, 2005, SOC SCI MED, V60, P2011, DOI 10.1016/j.socscimed.2004.08.057; Bhandari B, 1989, Indian Pediatr, V26, P228; Bloom SS, 2001, DEMOGRAPHY, V38, P67, DOI 10.1353/dem.2001.0001; Borghi J, 2006, LANCET, V368, P1457, DOI 10.1016/S0140-6736(06)69383-5; CALDWELL JC, 1993, SOC SCI MED, V36, P125, DOI 10.1016/0277-9536(93)90204-H; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; CHOWDHURY M, 2000, WHO GETS VACCINATED; Chowdhury ME, 2006, LANCET, V367, P327, DOI 10.1016/S0140-6736(06)68070-7; *DEP REP HLTH RES, 2007, MAT MORT 2005 EST DE; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Fotso Jean-Christophe, 2009, Reprod Health, V6, P9, DOI 10.1186/1742-4755-6-9; Gillespie D, 2007, B WORLD HEALTH ORGAN, V85, P100, DOI 10.2471/BLT.06.033829; Gwatkin DR, 2005, LANCET, V365, P813, DOI 10.1016/S0140-6736(05)17992-6; Gwatkin DR, 2004, LANCET, V364, P1273, DOI 10.1016/S0140-6736(04)17145-6; Gwatkin DR., 2003, INITIAL COUNTRY LEVE; Habicht J, 2005, SOC SCI MED, V60, P777, DOI 10.1016/j.socscimed.2004.06.026; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; KLOOS H, 1990, SOC SCI MED, V31, P101, DOI 10.1016/0277-9536(90)90052-T; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Kruk ME, 2008, AM J PUBLIC HEALTH, V98, P142, DOI 10.2105/AJPH.2006.104265; Onwujekwe O, 2005, SOC SCI MED, V61, P455, DOI 10.1016/j.socscimed.2004.11.066; *ORC MACR, DEM HLTH SURV; Rahman MH, 2008, J BIOSOC SCI, V40, P19, DOI 10.1017/S0021932007002258; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Rosenfield A, 2007, NEW ENGL J MED, V356, P1395, DOI 10.1056/NEJMp078026; Sarin AR, 1997, WORLD HEALTH FORUM, V18, P67; SUBBARAO K, 1995, ECON DEV CULT CHANGE, V44, P105, DOI 10.1086/452202; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Wilder-Smith A, 2003, TROP DOCT, V33, P135, DOI 10.1177/004947550303300305; WOLTER KM, 2003, INTRO VARIANCE ESTIM; *WORLD BANK, 2004, QUANT TECHN HLTH EQ	36	395	396	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11190	10.1371/journal.pone.0011190	http://dx.doi.org/10.1371/journal.pone.0011190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	615KY	20585646	Green Published, Green Submitted, gold			2022-12-27	WOS:000279135400006
J	Guo, R; Scott, GI; Ren, J				Guo, Rui; Scott, Glenda I.; Ren, Jun			Involvement of AMPK in Alcohol Dehydrogenase Accentuated Myocardial Dysfunction Following Acute Ethanol Challenge in Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CARDIAC CONTRACTILE DYSFUNCTION; ENERGY-METABOLISM; OXIDATIVE STRESS; ISCHEMIC-HEART; FATTY-ACID; OVEREXPRESSION; INSULIN; PHOSPHORYLATION; ACETALDEHYDE	Objectives: Binge alcohol drinking often triggers myocardial contractile dysfunction although the underlying mechanism is not fully clear. This study was designed to examine the impact of cardiac-specific overexpression of alcohol dehydrogenase (ADH) on ethanol-induced change in cardiac contractile function, intracellular Ca(2+) homeostasis, insulin and AMP-dependent kinase (AMPK) signaling. Methods: ADH transgenic and wild-type FVB mice were acutely challenged with ethanol (3 g/kg/d, i.p.) for 3 days. Oral glucose tolerance test, cardiac AMP/ATP levels, cardiac contractile function, intracellular Ca(2+) handling and AMPK signaling (including ACC and LKB1) were examined. Results: Ethanol exposure led to glucose intolerance, elevated plasma insulin, compromised cardiac contractile and intracellular Ca(2+) properties, downregulated protein phosphatase PP2A subunit and PPAR-gamma, as well as phosphorylation of AMPK, ACC and LKB1, all of which except plasma insulin were overtly accentuated by ADH transgene. Interestingly, myocardium from ethanol-treated FVB mice displayed enhanced expression of PP2C alpha and PGC-1 alpha, decreased insulin receptor expression as well as unchanged expression of Glut4, the response of which was unaffected by ADH. Cardiac AMP-to-ATP ratio was significantly enhanced by ethanol exposure with a more pronounced increase in ADH mice. In addition, the AMPK inhibitor compound C (10 mu M) abrogated acute ethanol exposure-elicited cardiomyocyte mechanical dysfunction. Conclusions: In summary, these data suggest that the ADH transgene exacerbated acute ethanol toxicity-induced myocardial contractile dysfunction, intracellular Ca(2+) mishandling and glucose intolerance, indicating a role of ADH in acute ethanol toxicity-induced cardiac dysfunction possibly related to altered cellular fuel AMPK signaling cascade.	[Guo, Rui; Scott, Glenda I.; Ren, Jun] Univ Wyoming, Coll Hlth Sci, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA	University of Wyoming	Guo, R (corresponding author), Univ Wyoming, Coll Hlth Sci, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA.	jren@uwyo.edu	Guo, Rui/ACH-5568-2022; Ren, Jun/ACG-5366-2022	Ren, Jun/0000-0002-0275-0783	National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism [1R01 AA013412]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013412] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism 1R01 AA013412. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergheim I, 2006, GASTROENTEROLOGY, V130, P2099, DOI 10.1053/j.gastro.2006.03.020; Bertrand L, 2008, CARDIOVASC RES, V79, P238, DOI 10.1093/cvr/cvn093; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Ceylan-Isik AF, 2010, J MOL CELL CARDIOL, V48, P367, DOI 10.1016/j.yjmcc.2009.11.003; Doser TA, 2009, CIRCULATION, V119, P1941, DOI 10.1161/CIRCULATIONAHA.108.823799; Duan JH, 2002, AM J PHYSIOL-HEART C, V282, pH1216, DOI 10.1152/ajpheart.00780.2001; FENG L, 2004, ACTA PHARMACOL SIN, V31, P329; Seiva FRF, 2009, ALCOHOL, V43, P649, DOI 10.1016/j.alcohol.2009.09.028; Gaidhu MP, 2006, J BIOL CHEM, V281, P25956, DOI 10.1074/jbc.M602992200; Guo R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008757; Hintz KK, 2003, ALCOHOL CLIN EXP RES, V27, P1090, DOI 10.1097/01.ALC.0000075823.73536.DD; Hong-Brown LQ, 2007, J BIOL CHEM, V282, P3702, DOI 10.1074/jbc.M606593200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim AS, 2009, ACTA PHYSIOL, V196, P37, DOI 10.1111/j.1748-1716.2009.01978.x; KOPIC S, CELL PHYSL BIOCH, V25, P195; Lamberts RR, 2009, CIRCULATION, V120, pS10, DOI 10.1161/CIRCULATIONAHA.108.828426; Li SY, 2008, J MOL CELL CARDIOL, V44, P992, DOI 10.1016/j.yjmcc.2008.02.276; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Liangpunsakul S, 2008, AM J PHYSIOL-GASTR L, V295, pG1173, DOI 10.1152/ajpgi.90349.2008; Ma H, 2009, J AM COLL CARDIOL, V54, P2187, DOI 10.1016/j.jacc.2009.04.100; O'Keefe JH, 2007, J AM COLL CARDIOL, V50, P1009, DOI 10.1016/j.jacc.2007.04.089; Pan JS, 2008, WORLD J GASTROENTERO, V14, P5857, DOI 10.3748/wjg.14.5857; Patel VB, 1997, ADVERSE DRUG REACT T, V16, P15; RAMNANAN CJ, MOL CELL BIOCH, V335, P91; RAMNANAN CJ, 2009, MOL CELL BIOCH; Ren J, 1997, CELL MOL BIOL, V43, P825; Ren J, 2002, PHARMACOL RES, V45, P195, DOI 10.1006/phrs.2002.0947; Ren Jun, 2008, Ther Adv Cardiovasc Dis, V2, P497, DOI 10.1177/1753944708095137; Rodriguez A, 2008, LIFE SCI, V83, P540, DOI 10.1016/j.lfs.2008.07.022; Ryu JH, 2008, BIOCHEM BIOPH RES CO, V366, P438, DOI 10.1016/j.bbrc.2007.11.134; SALASPURO MP, 1977, EUR J CLIN INVEST, V7, P487, DOI 10.1111/j.1365-2362.1977.tb01640.x; Sambandam N, 2003, PROG LIPID RES, V42, P238, DOI 10.1016/S0163-7827(02)00065-6; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; SARDESAI VM, 1978, J NUTR, V108, P1907, DOI 10.1093/jn/108.12.1907; Stolle M, 2009, DTSCH ARZTEBL INT, V106, P323, DOI 10.3238/arztebl.2009.0323; Tian R, 2006, CIRC RES, V99, P3, DOI 10.1161/01.RES.0000233142.26369.f6; Verma SK, 2005, BASIC CLIN PHARMACOL, V96, P475, DOI 10.1111/j.1742-7843.2005.pto_96611.x; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Zhang XC, 2004, ALCOHOL, V32, P175, DOI 10.1016/j.alcohol.2004.01.005	39	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11268	10.1371/journal.pone.0011268	http://dx.doi.org/10.1371/journal.pone.0011268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585647	Green Published, gold, Green Submitted			2022-12-27	WOS:000279135400014
J	Henaux, V; Samuel, MD; Bunck, CM				Henaux, Viviane; Samuel, Michael D.; Bunck, Christine M.			Model-Based Evaluation of Highly and Low Pathogenic Avian Influenza Dynamics in Wild Birds	PLOS ONE			English	Article							A VIRUS; NORTH-AMERICA; MIGRATORY BIRDS; SOUTH-KOREA; HONG-KONG; DUCKS; H5N1; WATERFOWL; SUSCEPTIBILITY; TRANSMISSION	There is growing interest in avian influenza (AI) epidemiology to predict disease risk in wild and domestic birds, and prevent transmission to humans. However, understanding the epidemic dynamics of highly pathogenic (HPAI) viruses remains challenging because they have rarely been detected in wild birds. We used modeling to integrate available scientific information from laboratory and field studies, evaluate AI dynamics in individual hosts and waterfowl populations, and identify key areas for future research. We developed a Susceptible-Exposed-Infectious-Recovered (SEIR) model and used published laboratory challenge studies to estimate epidemiological parameters (rate of infection, latency period, recovery and mortality rates), considering the importance of age classes, and virus pathogenicity. Infectious contact leads to infection and virus shedding within 1-2 days, followed by relatively slower period for recovery or mortality. We found a shorter infectious period for HPAI than low pathogenic (LP) AI, which may explain that HPAI has been much harder to detect than LPAI during surveillance programs. Our model predicted a rapid LPAI epidemic curve, with a median duration of infection of 50-60 days and no fatalities. In contrast, HPAI dynamics had lower prevalence and higher mortality, especially in young birds. Based on field data from LPAI studies, our model suggests to increase surveillance for HPAI in post-breeding areas, because the presence of immunologically naive young birds is predicted to cause higher HPAI prevalence and bird losses during this season. Our results indicate a better understanding of the transmission, infection, and immunity-related processes is required to refine predictions of AI risk and spread, improve surveillance for HPAI in wild birds, and develop disease control strategies to reduce potential transmission to domestic birds and/or humans.	[Henaux, Viviane] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA; [Samuel, Michael D.] US Geol Survey, Wisconsin Cooperat Wildlife Res Unit, Madison, WI USA; [Bunck, Christine M.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Henaux, V (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA.	henaux@wisc.edu			United States Geological Survey (USGS) [MSN105937, 1434-03HQRU1511/105]	United States Geological Survey (USGS)(United States Geological Survey)	This work was funded by the United States Geological Survey (USGS) to University of Wisconsin - Madison, under grant ID: MSN105937, number: 1434-03HQRU1511/105. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron J, 1982, POPULATION DYNAMICS, P139; Bellrose F, 1980, DUCKS GEESE SWANS N; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Brown JD, 2007, J WILDLIFE DIS, V43, P660, DOI 10.7589/0090-3558-43.4.660; Brown JD, 2006, EMERG INFECT DIS, V12, P1663, DOI 10.3201/eid1211.060652; Burnham K. P., 1998, MODEL SELECTION INFE; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; De Marco MA, 2003, AVIAN DIS, V47, P861, DOI 10.1637/0005-2086-47.s3.861; Feare CJ, 2007, AVIAN DIS, V51, P440, DOI 10.1637/7575-040106R1.1; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Gaidet N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000127; Grenfell B. T., 1995, P362, DOI 10.1017/CBO9780511629396.014; Gronnesby J K, 1996, Lifetime Data Anal, V2, P315, DOI 10.1007/BF00127305; Guberti V, 2007, AVIAN DIS, V51, P275, DOI 10.1637/7633-042806R1.1; HIGGINS DA, 1987, IMMUNOLOGY, V62, P499; HINSHAW VS, 1980, CAN J MICROBIOL, V26, P622, DOI 10.1139/m80-108; HINSHAW VS, 1985, B WORLD HEALTH ORGAN, V63, P711; HINSHAW VS, 1978, J GEN VIROL, V41, P115, DOI 10.1099/0022-1317-41-1-115; Hosmer DW, 2008, APPL SURVIVAL ANAL R, V2nd; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Ip HS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-71; Jilbert AR, 1998, VIROLOGY, V244, P273, DOI 10.1006/viro.1998.9095; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1267, DOI 10.3201/eid1408.080078; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; KIDA H, 1980, INFECT IMMUN, V30, P547; Lee CW, 2005, J VIROL, V79, P3692, DOI 10.1128/JVI.79.6.3692-3702.2005; Lee YJ, 2008, EMERG INFECT DIS, V14, P487, DOI 10.3201/eid1403.070767; Manache G, 2004, J WATER RES PL-ASCE, V130, P232, DOI 10.1061/(ASCE)0733-9496(2004)130:3(232); MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pantin-Jackwood MJ, 2007, VIRUS RES, V130, P151, DOI 10.1016/j.virusres.2007.06.006; Pantin-Jackwood MJ, 2007, AVIAN DIS, V51, P250, DOI 10.1637/7710-090606R.1; Parmley EJ, 2008, EMERG INFECT DIS, V14, P84, DOI 10.3201/eid1401.061562; Pasick J, 2007, EMERG INFECT DIS, V13, P1821, DOI 10.3201/eid1312.070502; Perdue ML, 2000, AVIAN POULT BIOL REV, V11, P1; Pillai SPS, 2008, VET MICROBIOL, V129, P48, DOI 10.1016/j.vetmic.2007.11.003; Pinheiro J. C., 2005, NLME LINEAR NONLINEA; R Development Core Team, 2005, R LANG ENV STAT COMP; Rappole JH, 2006, EMERG INFECT DIS, V12, P1486, DOI 10.3201/eid1210.051577; SHARP GB, 1993, EPIDEMIOL INFECT, V110, P161, DOI 10.1017/S0950268800050780; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; Spackman E, 2007, J VIROL, V81, P11612, DOI 10.1128/JVI.01368-07; Stallknecht DE, 2009, REV SCI TECH OIE, V28, P59; Stallknecht D. E., 2008, AVIAN INFLUENZA, V1, P43, DOI DOI 10.1002/9780813818634.ch3; STALLKNECHT DE, 1990, AVIAN DIS, V34, P398, DOI 10.2307/1591427; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Sturm-Ramirez KM, 2004, J VIROL, V78, P4892, DOI 10.1128/JVI.78.9.4892-4901.2004; Swayne D. E., 2008, AVIAN INFLUENZA, P287; THERNEAU T, 2007, SURVIVAL SURVIVAL AN; Tian GB, 2005, VIROLOGY, V341, P153, DOI 10.1016/j.virol.2005.07.011; Tumpey TM, 2002, J VIROL, V76, P6344, DOI 10.1128/JVI.76.12.6344-6355.2002; van der Goot JA, 2005, P NATL ACAD SCI USA, V102, P18141, DOI 10.1073/pnas.0505098102; van der Goot JA, 2007, VACCINE, V25, P8318, DOI 10.1016/j.vaccine.2007.09.048; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; Webster RG, 2002, J VIROL, V76, P118, DOI 10.1128/JVI.76.1.118-126.2002; WESTBURY HA, 1979, VET MICROBIOL, V4, P223, DOI 10.1016/0378-1135(79)90058-0	59	23	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e10997	10.1371/journal.pone.0010997	http://dx.doi.org/10.1371/journal.pone.0010997			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585637	Green Published, gold			2022-12-27	WOS:000279135400001
J	Zhang, WD; Savelieva, KV; Suwanichkul, A; Small, DL; Kirkpatrick, LL; Xu, NH; Lanthorn, TH; Ye, GL				Zhang, Wandong; Savelieva, Katerina V.; Suwanichkul, Adisak; Small, Daniel L.; Kirkpatrick, Laura L.; Xu, Nianhua; Lanthorn, Thomas H.; Ye, Gui-Lan			Transmembrane and Ubiquitin-Like Domain Containing 1 (Tmub1) Regulates Locomotor Activity and Wakefulness in Mice and Interacts with CAMLG	PLOS ONE			English	Article							MODULATING CYCLOPHILIN LIGAND; GABA(A) RECEPTORS; GENE-EXPRESSION; PROTEIN; MEMBRANE; BINDING; SLEEP; BRAIN; CELLS; IDENTIFICATION	Tmub1 (C7orf21/HOPS) encodes a protein containing a ubiquitin-like domain. Tmub1 is highly expressed in the nervous system. To study its physiological function, we generated mice with Tmub1 deleted by homologous recombination. The knockout mice were grossly normal and viable. In a comprehensive behavioral testing battery, the only knockout phenotype displayed was a strong increase in home cage locomotor activity during the dark phase (subjective day) of the light;dark (L;D) cycle. There were no changes in activity during the light period. There were no changes in locomotor activity observed in other assays, e. g. novel open-field. The increase in dark phase locomotor activity persisted during a seven day D;D (complete darkness) challenge, and remained largely confined to the normally dark period. Telemetric recording in freely moving subjects for one 24 hr L;D cycle, revealed the same increase in locomotor activity in the dark phase. In addition, EEG analysis showed that the knockout mice exhibited increased waking and decreased NREM & REM times during the dark phase, but the EEG was otherwise normal. Using lacZ as a reporter we found Tmub1 expression prominent in a few brain structures including the thalamus, a region known to drive wakefulness and arousal via its projections to the cortex. We identified calcium modulating cyclophilin ligand CAMLG/CAML as a binding partner by a yeast two-hybrid screen of a brain library. The interaction of Tmub1 and CAMLG was confirmed by co-immunoprecipitation assays in HEK cells. The two proteins were also found to be co-localized to the cytoplasm when expressed in HEK cells. Both Tmub1 and CAMLG have been recently described in the regulation of membrane trafficking of specific receptors. Taken together our results implicate Tmub1 in the regulation of locomotor activity and wakefulness and suggest that Tmub1 binds to and functions together with CAMLG.	[Zhang, Wandong; Savelieva, Katerina V.; Suwanichkul, Adisak; Small, Daniel L.; Kirkpatrick, Laura L.; Xu, Nianhua; Lanthorn, Thomas H.; Ye, Gui-Lan] Lexicon Pharmaceut Inc, Neurosci Res, The Woodlands, TX USA	Lexicon Pharmaceuticals	Zhang, WD (corresponding author), Lexicon Pharmaceut Inc, Neurosci Res, The Woodlands, TX USA.	gye@lexpharma.com			Lexicon Pharmaceuticals	Lexicon Pharmaceuticals	The study was conducted at and financially supported by Lexicon Pharmaceuticals. All authors were employees of Lexicon Pharmaceuticals when conducting the research of this manuscript. Authors designed the study, conducted data collection and analysis, and prepared the manuscript. Lexicon Pharmaceuticals approved the decision to publish this manuscript.	Abuin A, 2002, TRENDS BIOTECHNOL, V20, P36, DOI 10.1016/S0167-7799(01)01843-1; Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; BRAM RJ, 1994, NATURE, V371, P355, DOI 10.1038/371355a0; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Coyle JE, 2002, NEURON, V33, P63, DOI 10.1016/S0896-6273(01)00558-X; Della Fazia MA, 2005, J CELL SCI, V118, P3185, DOI 10.1242/jcs.02452; Feng PH, 2002, J VIROL, V76, P11491, DOI 10.1128/JVI.76.22.11491-11504.2002; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guang W, 2009, INT J BIOCHEM CELL B, V41, P1354, DOI 10.1016/j.biocel.2008.12.004; Guo SD, 2005, J BIOL CHEM, V280, P12536, DOI 10.1074/jbc.M500296200; Hartmann-Petersen R, 2004, SEMIN CELL DEV BIOL, V15, P247, DOI 10.1016/j.semcdb.2003.12.006; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim JY, 2008, KOREAN J PARASITOL, V46, P209, DOI 10.3347/kjp.2008.46.4.209; Leil TA, 2004, J NEUROSCI, V24, P11429, DOI 10.1523/JNEUROSCI.3355-04.2004; Liu GY, 2009, CELL MOL IMMUNOL, V6, P27, DOI 10.1038/cmi.2009.4; Madsen L, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S1; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Nagano J, 2005, BIOCHEM BIOPH RES CO, V338, P880, DOI 10.1016/j.bbrc.2005.10.022; Pieroni S, 2008, CELL CYCLE, V7, P1462, DOI 10.4161/cc.7.10.5882; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; TINUPER P, 1989, ELECTROEN CLIN NEURO, V73, P117, DOI 10.1016/0013-4694(89)90190-9; Tran DD, 2003, DEV CELL, V5, P245, DOI 10.1016/S1534-5807(03)00207-7; Varthakavi V, 2008, NAT MED, V14, P641, DOI 10.1038/nm1778; Villablanca JR, 2004, J SLEEP RES, V13, P179, DOI 10.1111/j.1365-2869.2004.00412.x; Vogel P, 2008, VET PATHOL, V45, P264, DOI 10.1354/vp.45-2-264; Wattler S, 1999, BIOTECHNIQUES, V26, P1150, DOI 10.2144/99266rr02; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Yang HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002809; Yuan X, 2008, MOL CELL NEUROSCI, V38, P277, DOI 10.1016/j.mcn.2008.03.002	32	10	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11261	10.1371/journal.pone.0011261	http://dx.doi.org/10.1371/journal.pone.0011261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582322	Green Submitted, Green Published, gold			2022-12-27	WOS:000279058500013
J	Bull, JJ; Jessop, TS; Whiteley, M				Bull, J. J.; Jessop, Tim S.; Whiteley, Marvin			Deathly Drool: Evolutionary and Ecological Basis of Septic Bacteria in Komodo Dragon Mouths	PLOS ONE			English	Article							FLORA; POPULATIONS; BITES; VENOM; SIZE	Komodo dragons, the world's largest lizard, dispatch their large ungulate prey by biting and tearing flesh. If a prey escapes, oral bacteria inoculated into the wound reputedly induce a sepsis that augments later prey capture by the same or other lizards. However, the ecological and evolutionary basis of sepsis in Komodo prey acquisition is controversial. Two models have been proposed. The "bacteria as venom'' model postulates that the oral flora directly benefits the lizard in prey capture irrespective of any benefit to the bacteria. The "passive acquisition'' model is that the oral flora of lizards reflects the bacteria found in carrion and sick prey, with no relevance to the ability to induce sepsis in subsequent prey. A third model is proposed and analyzed here, the "lizard-lizard epidemic'' model. In this model, bacteria are spread indirectly from one lizard mouth to another. Prey escaping an initial attack act as vectors in infecting new lizards. This model requires specific life history characteristics and ways to refute the model based on these characteristics are proposed and tested. Dragon life histories (some details of which are reported here) prove remarkably consistent with the model, especially that multiple, unrelated lizards feed communally on large carcasses and that escaping, wounded prey are ultimately fed on by other lizards. The identities and evolutionary histories of bacteria in the oral flora may yield the most useful additional insights for further testing the epidemic model and can now be obtained with new technologies.	[Bull, J. J.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Whiteley, Marvin] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Bull, J. J.; Whiteley, Marvin] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Bull, J. J.] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Jessop, Tim S.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Melbourne	Bull, JJ (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	bull@mail.utexas.edu	Jessop, Tim/I-6647-2012; Jessop, Tim/Q-2473-2019	Jessop, Tim S./0000-0002-7712-4373	National Institutes of Health (NIH) [GM57756, AI075068]; University of Texas; Zoological Society of San Diego; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057756] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas; Zoological Society of San Diego; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health (NIH) GM57756 and the University of Texas Miescher Regents Professorship to JJB and NIH AI075068 to MW. TSJ was supported by a Conservation Research Fellowship from the Zoological Society of San Diego. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUFFENBERG W, 1981, BEHAV ECOLOGY KOMODO, V10, P40; BAILIE WE, 1978, J CLIN MICROBIOL, V7, P223; Barer MR, 1999, ADV MICROB PHYSIOL, V41, P93, DOI 10.1016/S0065-2911(08)60166-6; BREDY JP, 1989, J WILDLIFE DIS, V25, P232, DOI 10.7589/0090-3558-25.2.232; Fry BG, 2009, P NATL ACAD SCI USA, V106, P8969, DOI 10.1073/pnas.0810883106; GOLDSTEIN EJC, 1981, J CLIN MICROBIOL, V13, P954, DOI 10.1128/JCM.13.5.954-956.1981; GOLDSTEIN EJC, 1979, J INFECT DIS, V140, P818, DOI 10.1093/infdis/140.5.818; HUBBERT WT, 1970, AM J PUBLIC HEALTH N, V60, P1103, DOI 10.2105/AJPH.60.6.1103; Jessop TS, 2007, BIOL CONSERV, V135, P247, DOI 10.1016/j.biocon.2006.10.025; Jessop TS, 2006, OIKOS, V112, P422, DOI 10.1111/j.0030-1299.2006.14371.x; LENNETTE EH, 1985, MANUAL CLIN MICROBIO, V16, P1149; Montgomery JM, 2002, J WILDLIFE DIS, V38, P545, DOI 10.7589/0090-3558-38.3.545; OWEN C R, 1968, Rocky Mountain Medical Journal, V65, P45; PURWANDANA D, 2007, THESIS U KEBANGSAAN; RAFFI F, 1987, SCAND J INFECT DIS, V19, P385, DOI 10.3109/00365548709021670; Rosen M. N., 1969, Bulletin of the Wildlife Disease Association, V5, P195; SAPHIR DA, 1976, J CLIN MICROBIOL, V3, P344; Shine R., 1988, BIOL REPTILIA, P275; SMITH J. E., 1958, JOUR COMP PATH AND THERAP, V68, P315, DOI 10.1016/S0368-1742(58)80033-8; TITCHE AR, 1979, CALIFORNIA DEP FISH, V79, P49	20	25	26	2	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11097	10.1371/journal.pone.0011097	http://dx.doi.org/10.1371/journal.pone.0011097			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574514	Green Published, gold			2022-12-27	WOS:000279058300003
J	Kozak, LP; Newman, S; Chao, PM; Mendoza, T; Koza, RA				Kozak, Leslie P.; Newman, Susan; Chao, Pei-Min; Mendoza, Tamra; Koza, Robert A.			The Early Nutritional Environment of Mice Determines the Capacity for Adipose Tissue Expansion by Modulating Genes of Caveolae Structure	PLOS ONE			English	Article							DIET-INDUCED OBESITY; WHITE FAT; REGULATES CAVEOLIN-1; GLUCOSE-INTOLERANCE; DIABETES-MELLITUS; 3T3-L1 ADIPOCYTES; ENERGY-BALANCE; LEPTIN SURGE; ANNEXIN-II; IN-UTERO	While the phenomenon linking the early nutritional environment to disease susceptibility exists in many mammalian species, the underlying mechanisms are unknown. We hypothesized that nutritional programming is a variable quantitative state of gene expression, fixed by the state of energy balance in the neonate, that waxes and wanes in the adult animal in response to changes in energy balance. We tested this hypothesis with an experiment, based upon global gene expression, to identify networks of genes in which expression patterns in inguinal fat of mice have been altered by the nutritional environment during early post-natal development. The effects of over-and under-nutrition on adiposity and gene expression phenotypes were assessed at 5, 10, 21 days of age and in adult C57Bl/6J mice fed chow followed by high fat diet for 8 weeks. Under-nutrition severely suppressed plasma insulin and leptin during lactation and diet-induced obesity in adult mice, whereas over-nourished mice were phenotypically indistinguishable from those on a control diet. Food intake was not affected by under-or over-nutrition. Microarray gene expression data revealed a major class of genes encoding proteins of the caveolae and cytoskeleton, including Cav1, Cav2, Ptrf (Cavin1), Ldlr, Vldlr and Mest, that were highly associated with adipose tissue expansion in 10 day-old mice during the dynamic phase of inguinal fat development and in adult animals exposed to an obesogenic environment. In conclusion gene expression profiles, fat mass and adipocyte size in 10 day old mice predicted similar phenotypes in adult mice with variable diet-induced obesity. These results are supported by phenotypes of KO mice and suggest that when an animal enters a state of positive energy balance adipose tissue expansion is initiated by coordinate changes in mRNA levels for proteins required for modulating the structure of the caveolae to maximize the capacity of the adipocyte for lipid storage.	[Kozak, Leslie P.; Newman, Susan; Mendoza, Tamra; Koza, Robert A.] Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Chao, Pei-Min] China Med Univ, Dept Nutr, Taichung, Taiwan	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; China Medical University Taiwan	Kozak, LP (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA USA.	Kozaklp@pbrc.edu	Chao, Pei-Min/L-8157-2013; chao, P/GSD-8001-2022	Chao, Pei-Min/0000-0002-4846-3245; 	Center of Biomedical Research Excellence COBRE (National Institutes of Health (NIH)) [P20-RR021945]; Clinical Nutrition Research Unit CNRU [NIH 1P30-DK072476]; Health Excellent Fund of the State of Louisiana; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	Center of Biomedical Research Excellence COBRE (National Institutes of Health (NIH))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Nutrition Research Unit CNRU; Health Excellent Fund of the State of Louisiana; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research was supported by grants from Center of Biomedical Research Excellence COBRE (National Institutes of Health (NIH) P20-RR021945), Clinical Nutrition Research Unit CNRU (NIH 1P30-DK072476) and the Health Excellent Fund of the State of Louisiana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Allison DB, 1996, INT J OBESITY, V20, P501; Barker DJP, 2006, NAT CLIN PRACT NEPHR, V2, P700, DOI 10.1038/ncpneph0344; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1986, LANCET, V1, P1077; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Boullu-Ciocca S, 2008, DIABETES, V57, P669, DOI 10.2337/db07-1316; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Burgermeister E, 2003, ONCOGENE, V22, P3888, DOI 10.1038/sj.onc.1206625; Cohen AW, 2003, AM J PHYSIOL-ENDOC M, V285, pE1151, DOI 10.1152/ajpendo.00324.2003; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; Drake AJ, 2007, CLIN SCI, V113, P219, DOI 10.1042/CS20070107; Engelman JA, 1999, J BIOL CHEM, V274, P32333, DOI 10.1074/jbc.274.45.32333; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gnanalingham MG, 2005, AM J PHYSIOL-REG I, V289, pR1407, DOI 10.1152/ajpregu.00375.2005; Goudriaan JR, 2001, ARTERIOSCL THROM VAS, V21, P1488, DOI 10.1161/hq0901.095147; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Guilherme A, 2000, J BIOL CHEM, V275, P38151, DOI 10.1074/jbc.M003432200; Guo KY, 2004, AM J PHYSIOL-REG I, V287, pR112, DOI 10.1152/ajpregu.00028.2004; Hales CN, 2003, DIABETOLOGIA, V46, P1013, DOI 10.1007/s00125-003-1131-7; Hayes M, 2005, INT J OBESITY, V29, P151, DOI 10.1038/sj.ijo.0802842; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Hosooka T, 2008, NAT MED, V14, P188, DOI 10.1038/nm1706; Huang J, 2004, ENDOCRINOLOGY, V145, P1579, DOI 10.1210/en.2003-1197; Jimenez-Chillaron JC, 2006, DIABETOLOGIA, V49, P1974, DOI 10.1007/s00125-006-0311-7; Koza RA, 2000, J BIOL CHEM, V275, P34486, DOI 10.1074/jbc.M002136200; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Levine JA, 1999, SCIENCE, V283, P212, DOI 10.1126/science.283.5399.212; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; MCCANCE RA, 1962, LANCET, V2, P671; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; Nikonova L, 2008, FASEB J, V22, P3925, DOI 10.1096/fj.08-108266; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Patel MS, 2002, J BIOL CHEM, V277, P1629, DOI 10.1074/jbc.R100017200; Plagemann A, 2006, HORM RES, V65, P83, DOI 10.1159/000091511; Poussin C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003385; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Razani B, 2002, MOL CELL BIOL, V22, P2329, DOI 10.1128/MCB.22.7.2329-2344.2002; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Riachi M, 2004, CAN J PHYSIOL PHARM, V82, P1075, DOI [10.1139/y04-117, 10.1139/Y04-117]; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Sakai T, 2007, J BIOL CHEM, V282, P2038, DOI 10.1074/jbc.M608144200; SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Srinivasan M, 2003, EXP BIOL MED, V228, P15, DOI 10.1177/153537020322800102; Takahashi M, 2005, AM J PHYSIOL-ENDOC M, V288, pE117, DOI 10.1152/ajpendo.00244.2004; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; TeichertKuliszewska K, 1996, INT J OBESITY, V20, pS108; Uittenbogaard A, 2002, J BIOL CHEM, V277, P4925, DOI 10.1074/jbc.M109278200; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005; Zhang YY, 2002, AM J PHYSIOL-REG I, V282, pR226, DOI 10.1152/ajpregu.00392.2001	62	52	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11015	10.1371/journal.pone.0011015	http://dx.doi.org/10.1371/journal.pone.0011015			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574519	gold, Green Published, Green Submitted			2022-12-27	WOS:000279058300002
J	Nachman, J; Gish, G; Virag, C; Pawson, T; Pomes, R; Pai, E				Nachman, Joseph; Gish, Gerry; Virag, Cristina; Pawson, Tony; Pomes, Regis; Pai, Emil			Conformational Determinants of Phosphotyrosine Peptides Complexed with the Src SH2 Domain	PLOS ONE			English	Article							SECONDARY STRUCTURE; STRUCTURAL BASIS; BINDING; SPECIFICITY; INHIBITORS; PP60(C-SRC); MODEL	The inhibition of specific SH2 domain mediated protein-protein interactions as an effective chemotherapeutic approach in the treatment of diseases remains a challenge. That different conformations of peptide-ligands are preferred by different SH2 domains is an underappreciated observation from the structural analysis of phosphotyrosine peptide binding to SH2 domains that may aid in future drug design. To explore the nature of ligand binding, we use simulated annealing (SA) to sample the conformational space of phosphotyrosine-containing peptides complexed with the Src SH2 domain. While in good agreement with the crystallographic and NMR studies of high-affinity phosphopeptide-SH2 domain complexes, the results suggest that the structural basis for phopsphopeptide-Src SH2 interactions is more complex than the "two-pronged plug two-hole socket'' model. A systematic study of peptides of type pYEEX, where pY is phosphotyrosine and X is a hydrophobic residue, indicates that these peptides can assume two conformations, one extended and one helical, representing the balance between the interaction of residue X with the hydrophobic hole on the surface of the Src SH2 domain, and its contribution to the inherent tendency of the two glutamic acids to form an a-helix. In contrast, a beta-turn conformation, almost identical to that observed in the crystal structure of pYVNV bound to the Grb2 SH2 domain, predominates for pYXNX peptides, even in the presence of isoleucine at the third position. While peptide binding affinities, as measured by fluorescence polarization, correlate with the relative proportion of extended peptide conformation, these results suggest a model where all three residues C-terminal to the phosphotyrosine determine the conformation of the bound phosphopeptide. The information obtained in this work can be used in the design of specific SH2 domain inhibitors.	[Nachman, Joseph; Pomes, Regis; Pai, Emil] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Gish, Gerry; Virag, Cristina; Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Div Mol & Dev Biol, Toronto, ON M5G 1X5, Canada; [Pomes, Regis] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Pai, Emil] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Pai, Emil] Univ Toronto, Dept Mol Biol, Toronto, ON, Canada; [Pai, Emil] Ontario Canc Inst, Div Genom & Prote, Toronto, ON M4X 1K9, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Nachman, J (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	nachman@hera.med.utoronto.ca	Pawson, Tony J/E-4578-2013; Pai, Emil/R-8908-2019; Gish, Gerald D/C-7228-2017; Pai, Emil F/D-2526-2013	Pai, Emil/0000-0002-1162-7242; 	PrioNet, National Centre of Excellence, Canada; Canada Research Chairs Program	PrioNet, National Centre of Excellence, Canada; Canada Research Chairs Program(Canada Research Chairs)	This research was supported by a grant from PrioNet, National Centre of Excellence, Canada, and the Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO G, 1995, J BIOL CHEM, V270, P9840, DOI 10.1074/jbc.270.17.9840; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Bradshaw JM, 1998, BIOCHEMISTRY-US, V37, P9083, DOI 10.1021/bi973147k; CASE DA, 1999, AMBER6; CHOU KC, 1991, PROTEIN ENG, V4, P661, DOI 10.1093/protein/4.6.661; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; Coleman DR, 2005, J MED CHEM, V48, P6661, DOI 10.1021/jm050513m; Davidson JP, 2002, J AM CHEM SOC, V124, P205, DOI 10.1021/ja011746f; FRISCH MJ, 1995, GAUSSIAN 94; Gay B, 1997, BIOCHEMISTRY-US, V36, P5712, DOI 10.1021/bi962642y; GILMER T, 1994, J BIOL CHEM, V269, P31711; GUARNIERI F, 1995, J COMPUT CHEM, V16, P648, DOI 10.1002/jcc.540160512; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; Hassan SA, 2001, INT J QUANTUM CHEM, V83, P193, DOI 10.1002/qua.1210; Jojart B, 2006, J MOL MODEL, V12, P823, DOI 10.1007/s00894-006-0104-4; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; Kimber MS, 2000, MOL CELL, V5, P1043, DOI 10.1016/S1097-2765(00)80269-5; LUTTRELL DK, 1994, P NATL ACAD SCI USA, V91, P83, DOI 10.1073/pnas.91.1.83; Lynch BA, 1997, ANAL BIOCHEM, V247, P77, DOI 10.1006/abio.1997.2042; Malkov SN, 2008, J MOL MODEL, V14, P769, DOI 10.1007/s00894-008-0313-0; MARENGERE LEM, 1994, NATURE, V369, P502, DOI 10.1038/369502a0; Nam NH, 2004, J MED CHEM, V47, P3131, DOI 10.1021/jm040008+; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Rahuel J, 1996, NAT STRUCT BIOL, V3, P586, DOI 10.1038/nsb0796-586; Schaefer M, 1999, THEOR CHEM ACC, V101, P194, DOI 10.1007/s002140050429; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Steinbach PJ, 2004, PROTEINS, V57, P665, DOI 10.1002/prot.20247; Verkhivker GM, 2002, J MED CHEM, V45, P72, DOI 10.1021/jm0101141; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; XU RX, 1995, BIOCHEMISTRY-US, V34, P2107, DOI 10.1021/bi00007a003; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	34	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11215	10.1371/journal.pone.0011215	http://dx.doi.org/10.1371/journal.pone.0011215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574521	Green Published, gold, Green Submitted			2022-12-27	WOS:000279058300010
J	Venkataraman, S; Alimova, I; Fan, R; Harris, P; Foreman, N; Vibhakar, R				Venkataraman, Sujatha; Alimova, Irina; Fan, Rong; Harris, Peter; Foreman, Nicholas; Vibhakar, Rajeev			MicroRNA 128a Increases Intracellular ROS Level by Targeting Bmi-1 and Inhibits Medulloblastoma Cancer Cell Growth by Promoting Senescence	PLOS ONE			English	Article							SELF-RENEWAL; STEM-CELLS; DEVELOPMENTAL BIOLOGY; PROLIFERATION; EXPRESSION; DIFFERENTIATION; POLYCISTRON; ONCOGENE; PROFILES; PATHWAY	Background: MicroRNAs (miRNAs) are a class of short non-coding RNAs that regulate cell homeostasis by inhibiting translation or degrading mRNA of target genes, and thereby can act as tumor suppressor genes or oncogenes. The role of microRNAs in medulloblastoma has only recently been addressed. We hypothesized that microRNAs differentially expressed during normal CNS development might be abnormally regulated in medulloblastoma and are functionally important for medulloblastoma cell growth. Methodology and Principal Findings: We examined the expression of microRNAs in medulloblastoma and then investigated the functional role of one specific one, miR-128a, in regulating medulloblastoma cell growth. We found that many microRNAs associated with normal neuronal differentiation are significantly down regulated in medulloblastoma. One of these, miR-128a, inhibits growth of medulloblastoma cells by targeting the Bmi-1 oncogene. In addition, miR-128a alters the intracellular redox state of the tumor cells and promotes cellular senescence. Conclusions and Significance: Here we report the novel regulation of reactive oxygen species (ROS) by microRNA 128a via the specific inhibition of the Bmi-1 oncogene. We demonstrate that miR-128a has growth suppressive activity in medulloblastoma and that this activity is partially mediated by targeting Bmi-1. This data has implications for the modulation of redox states in cancer stem cells, which are thought to be resistant to therapy due to their low ROS states.	[Venkataraman, Sujatha; Alimova, Irina; Harris, Peter; Foreman, Nicholas; Vibhakar, Rajeev] Univ Colorado, Dept Pediat, Denver, CO 80202 USA; [Foreman, Nicholas; Vibhakar, Rajeev] Childrens Hosp, Aurora, CO USA; [Fan, Rong; Vibhakar, Rajeev] Univ Iowa, Dept Pediat, Childrens Hosp, Iowa City, IA 52242 USA	University of Colorado System; University of Colorado Denver; Children's Hospital Colorado; University of Iowa	Venkataraman, S (corresponding author), Univ Colorado, Dept Pediat, Denver, CO 80202 USA.	Rajeev.Vibhakar@ucdenver.edu		Foreman, Nicholas/0000-0003-4848-4801	Pediatric Brain Tumor Foundation; Bear Necessities Pediatric Cancer Foundation; National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS) [K08NS059790]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS059790] Funding Source: NIH RePORTER	Pediatric Brain Tumor Foundation; Bear Necessities Pediatric Cancer Foundation; National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Pediatric Brain Tumor Foundation (http://www.pbtfus.org/), the Bear Necessities Pediatric Cancer Foundation (http://www.bearnecessities.org), and National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS) grant K08NS059790. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Ferretti E, 2009, INT J CANCER, V124, P568, DOI 10.1002/ijc.23948; Finkel T, 1999, J LEUKOCYTE BIOL, V65, P337, DOI 10.1002/jlb.65.3.337; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hara E, 1996, MOL CELL BIOL, V16, P859; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011; Marino S, 2005, TRENDS MOL MED, V11, P17, DOI 10.1016/j.molmed.2004.11.008; Mihic-Probst D, 2007, INT J CANCER, V121, P1764, DOI 10.1002/ijc.22891; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Mulhern RK, 2005, J CLIN ONCOL, V23, P5511, DOI 10.1200/JCO.2005.00.703; Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710; Pierson J, 2008, J NEURO-ONCOL, V90, P1, DOI 10.1007/s11060-008-9624-3; ROSEN GM, 1984, P NATL ACAD SCI-BIOL, V81, P7269, DOI 10.1073/pnas.81.23.7269; Rubin JB, 2002, CANCER CELL, V2, P7, DOI 10.1016/S1535-6108(02)00090-9; Rutka James T, 2004, Expert Rev Neurother, V4, P879, DOI 10.1586/14737175.4.5.879; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Song YS, 2005, MECH AGEING DEV, V126, P580, DOI 10.1016/j.mad.2004.11.008; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Uziel T, 2009, P NATL ACAD SCI USA, V106, P2812, DOI 10.1073/pnas.0809579106; Vibhakar R, 2007, NEURO-ONCOLOGY, V9, P135, DOI 10.1215/15228517-2006-038; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385	38	137	142	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e10748	10.1371/journal.pone.0010748	http://dx.doi.org/10.1371/journal.pone.0010748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574517	gold, Green Published, Green Submitted			2022-12-27	WOS:000279058300001
J	Nakamura, S; Kinoshita, S; Yokoi, N; Ogawa, Y; Shibuya, M; Nakashima, H; Hisamura, R; Imada, T; Imagawa, T; Uehara, M; Shibuya, I; Dogru, M; Ward, S; Tsubota, K				Nakamura, Shigeru; Kinoshita, Shigeru; Yokoi, Norihiko; Ogawa, Yoko; Shibuya, Michiko; Nakashima, Hideo; Hisamura, Ryuji; Imada, Toshihiro; Imagawa, Tomohiro; Uehara, Masato; Shibuya, Izumi; Dogru, Murat; Ward, Samantha; Tsubota, Kazuo			Lacrimal Hypofunction as a New Mechanism of Dry Eye in Visual Display Terminal Users	PLOS ONE			English	Article							TEAR DYNAMICS; EXOCYTOSIS; GLAND; BLINKING; PILOCARPINE; DISORDERS; SECRETION; SYMPTOMS; DISEASE; CELLS	Background: Dry eye has shown a marked increase due to visual display terminal (VDT) use. It remains unclear whether reduced blinking while focusing can have a direct deleterious impact on the lacrimal gland function. To address this issue that potentially affects the life quality, we conducted a large-scale epidemiological study of VDT users and an animal study. Methodology/Principal Findings: Cross sectional survey carried out in Japan. A total of 1025 office workers who use VDT were enrolled. The association between VDT work duration and changes in tear film status, precorneal tear stability, lipid layer status and tear secretion were analyzed. For the animal model study, the rat VDT user model, placing rats onto a balance swing in combination with exposure to an evaporative environment was used to analyze lacrimal gland function. There was no positive relationship between VDT working duration and change in tear film stability and lipid layer status. The odds ratio for decrease in Schirmer score, index of tear secretion, were significantly increased with VDT working year (P = 0.012) and time (P = 0.005). The rat VDT user model, showed chronic reduction of tear secretion and was accompanied by an impairment of the lacrimal gland function and morphology. This dysfunction was recovered when rats were moved to resting conditions without the swing. Conclusions/Significance: These data suggest that lacrimal gland hypofunction is associated with VDT use and may be a critical mechanism for VDT-associated dry eye. We believe this to be the first mechanistic link to the pathogenesis of dry eye in office workers.	[Nakamura, Shigeru; Ogawa, Yoko; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Nakamura, Shigeru; Shibuya, Michiko; Nakashima, Hideo; Hisamura, Ryuji; Imada, Toshihiro] Ophtecs Corp, Res Ctr, Toyooka, Japan; [Kinoshita, Shigeru; Yokoi, Norihiko] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Nakashima, Hideo; Imagawa, Tomohiro; Uehara, Masato] Tottori Univ, Fac Agr, Dept Vet Anat, Tottori 680, Japan; [Shibuya, Izumi] Tottori Univ, Fac Agr, Dept Vet Physiol, Tottori 680, Japan; [Dogru, Murat; Ward, Samantha] Keio Univ, Sch Med, Johnson & Johnson Ocular Surface Visual Opt Dept, Tokyo, Japan	Keio University; Kyoto Prefectural University of Medicine; Tottori University; Tottori University; Keio University	Nakamura, S (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	tsubota@sc.itc.keio.ac.jp	Ogawa, Yoko/AAV-1932-2021	Ogawa, Yoko/0000-0002-2906-9621; Shibuya, Izumi/0000-0003-4137-5856	Japanese Ministry of Health, Labour and Welfare	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	Grant funding was received from the Japanese Ministry of Health, Labour and Welfare. 1) Principal investigator: Kazuo Tsubota, "Establishment of a world consensus of dry eye diagnostic criteria and implementation into Japanese dry eye diagnostic criteria''. 2) Principal investigator: Kazuo Tsubota, "Development of new treatment methods for lacrimal gland destruction resulting from treatment-refractory disorders''. 3) Principal investigator: Shigeru Kinoshita, "Preparation method of GNP-based cultivated epithelia sheet for transplantation''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson MB, 2002, ADV EXP MED BIOL, V506, P1121; Acosta MC, 1999, EXP EYE RES, V68, P663, DOI 10.1006/exer.1998.0656; EDWARDS AS, 1946, J EXP PSYCHOL, V36, P526, DOI 10.1037/h0059909; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; HALL HD, 1964, P SOC EXP BIOL MED, V117, P789, DOI 10.3181/00379727-117-29699; Hodges RR, 2003, INT REV CYTOL, V231, P129, DOI 10.1016/S0074-7696(03)31004-6; HOLLY FJ, 1977, SURV OPHTHALMOL, V22, P69, DOI 10.1016/0039-6257(77)90087-X; *INT CORP, PERS COMP TURNS 25 N; JORDAN A, 1980, OPHTHALMOLOGY, V87, P920; Kaido M, 2007, CORNEA, V26, pS29, DOI 10.1097/ICO.0b013e31812f6913; Koh S, 2008, INVEST OPHTH VIS SCI, V49, P133, DOI 10.1167/iovs.07-0762; Lemp MA, 2008, AM J OPHTHALMOL, V146, P350, DOI 10.1016/j.ajo.2008.05.016; Lemp Michael A., 1995, CLAO Journal, V21, P221; Matsumoto M, 2004, P NATL ACAD SCI USA, V101, P8313, DOI 10.1073/pnas.0306709101; *MIN LAB JAP, 1985, GUID OCC HLTH VDT WO; Nakamura S, 2005, INVEST OPHTH VIS SCI, V46, P2379, DOI 10.1167/iovs.04-1344; Nakamura S, 2007, INVEST OPHTH VIS SCI, V48, P1552, DOI 10.1167/iovs.06-1027; Nguyen DH, 2004, PHYSIOL GENOMICS, V18, P108, DOI 10.1152/physiolgenomics.00011.2004; OBATA H, 1995, OPHTHALMOLOGY, V102, P678, DOI 10.1016/S0161-6420(95)30971-2; Papas AS, 2004, JCR-J CLIN RHEUMATOL, V10, P169, DOI 10.1097/01.rhu.0000135553.08057.21; Pflugfelder SC, 1998, CORNEA, V17, P38, DOI 10.1097/00003226-199801000-00007; Riedel D, 2002, MOL CELL BIOL, V22, P6487, DOI 10.1128/MCB.22.18.6487-6497.2002; SAKAMOTO R, 1993, INVEST OPHTH VIS SCI, V34, P3510; SCOTT J, 1994, J DENT RES, V73, P1180, DOI 10.1177/00220345940730060901; Toshida H, 2007, INVEST OPHTH VIS SCI, V48, P4468, DOI 10.1167/iovs.06-1486; Tsubota K, 1998, PROG RETIN EYE RES, V17, P565, DOI 10.1016/S1350-9462(98)00004-4; Tsubota K, 1996, LANCET, V347, P768, DOI 10.1016/S0140-6736(96)90122-1; TSUBOTA K, 1995, ARCH OPHTHALMOL-CHIC, V113, P155, DOI 10.1001/archopht.1995.01100020037025; TSUBOTA K, 1993, NEW ENGL J MED, V328, P584, DOI 10.1056/NEJM199302253280817; Uchino M, 2008, OPHTHALMOLOGY, V115, P1982, DOI 10.1016/j.ophtha.2008.06.022; Vivino FB, 1999, ARCH INTERN MED, V159, P174, DOI 10.1001/archinte.159.2.174; Wang CC, 2007, MOL BIOL CELL, V18, P1056, DOI 10.1091/mbc.E06-10-0974; *WHO, 1987, OFFS PUBL WHO, V99; Wolkoff P, 2005, OCCUP ENVIRON MED, V62, P4, DOI 10.1136/oem.2004.016030; Wu KJ, 2006, EXP EYE RES, V83, P84, DOI 10.1016/j.exer.2005.11.009; Yokoi N, 1996, AM J OPHTHALMOL, V122, P818, DOI 10.1016/S0002-9394(14)70378-2	36	84	87	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11119	10.1371/journal.pone.0011119	http://dx.doi.org/10.1371/journal.pone.0011119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559543	Green Published, gold, Green Submitted			2022-12-27	WOS:000278775900010
J	Heinisch, JJ; Dupres, V; Wilk, S; Jendretzki, A; Dufrene, YF				Heinisch, Juergen J.; Dupres, Vincent; Wilk, Sabrina; Jendretzki, Arne; Dufrene, Yves F.			Single-Molecule Atomic Force Microscopy Reveals Clustering of the Yeast Plasma-Membrane Sensor Wsc1	PLOS ONE			English	Article							CELL-WALL INTEGRITY; SACCHAROMYCES-CEREVISIAE; LIPID RAFTS; ESCHERICHIA-COLI; STRESS-RESPONSE; RECEPTOR; MAINTENANCE; ACTIVATION; MECHANISMS; PROTEINS	Signalling is a key feature of living cells which frequently involves the local clustering of specific proteins in the plasma membrane. How such protein clustering is achieved within membrane microdomains ("rafts'') is an important, yet largely unsolved problem in cell biology. The plasma membrane of yeast cells represents a good model to address this issue, since it features protein domains that are sufficiently large and stable to be observed by fluorescence microscopy. Here, we demonstrate the ability of single-molecule atomic force microscopy to resolve lateral clustering of the cell integrity sensor Wsc1 in living Saccharomyces cerevisiae cells. We first localize individual wild-type sensors on the cell surface, revealing that they form clusters of similar to 200 nm size. Analyses of three different mutants indicate that the cysteine-rich domain of Wsc1 has a crucial, not yet anticipated function in sensor clustering and signalling. Clustering of Wsc1 is strongly enhanced in deionized water or at elevated temperature, suggesting its relevance in proper stress response. Using in vivo GFP-localization, we also find that non-clustering mutant sensors accumulate in the vacuole, indicating that clustering may prevent endocytosis and sensor turnover. This study represents the first in vivo single-molecule demonstration for clustering of a transmembrane protein in S. cerevisiae. Our findings indicate that in yeast, like in higher eukaryotes, signalling is coupled to the localized enrichment of sensors and receptors within membrane patches.	[Heinisch, Juergen J.; Wilk, Sabrina; Jendretzki, Arne] Univ Osnabruck, Fachbereich Biol Chem AG Genet, Osnabruck, Germany; [Dupres, Vincent; Dufrene, Yves F.] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain, Belgium	University Osnabruck; Universite Catholique Louvain	Heinisch, JJ (corresponding author), Univ Osnabruck, Fachbereich Biol Chem AG Genet, Osnabruck, Germany.	Juergen.Heinisch@Biologie.Uni-Osnabrueck.DE; Yves.Dufrene@uclouvain.be	Heinisch, Juergen J./G-3801-2017; Dupres, Vincent/GLQ-5321-2022	Dupres, Vincent/0000-0002-1970-3633; Dufrene, Yves/0000-0002-7289-4248	National Foundation for Scientific Research (FNRS); Universite Catholique de Louvain (Fonds Speciaux de Recherche); Region Wallonne; Federal Office for Scientific, Technical and Cultural Affairs; Research Department of the Communaute Francaise de Belgique; Deutsche Forschungsgemeinschaft (DFG) [SFB431]	National Foundation for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Universite Catholique de Louvain (Fonds Speciaux de Recherche); Region Wallonne; Federal Office for Scientific, Technical and Cultural Affairs; Research Department of the Communaute Francaise de Belgique; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the National Foundation for Scientific Research (FNRS), the Universite Catholique de Louvain (Fonds Speciaux de Recherche), the Region Wallonne, the Federal Office for Scientific, Technical and Cultural Affairs (Interuniversity Poles of Attraction Programme), the Research Department of the Communaute Francaise de Belgique (Concerted Research Action) and the Deutsche Forschungsgemeinschaft (DFG) within the framework of the SFB431. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahimou FO, 2003, YEAST, V20, P25, DOI 10.1002/yea.923; Alonso MA, 2001, J CELL SCI, V114, P3957; ARVANITIDIS A, 1994, J BIOL CHEM, V269, P8911; Besschetnova TY, 2008, P NATL ACAD SCI USA, V105, P12289, DOI 10.1073/pnas.0802868105; Dupres V, 2009, NAT CHEM BIOL, V5, P857, DOI 10.1038/nchembio.220; Gestwicki JE, 2002, NATURE, V415, P81, DOI 10.1038/415081a; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Grossmann G, 2007, EMBO J, V26, P1, DOI 10.1038/sj.emboj.7601466; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; HEINISCH JJ, 1993, YEAST, V9, P1103, DOI 10.1002/yea.320091010; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; Heinisch JJ, 2010, NAT PROTOC, V5, P670, DOI 10.1038/nprot.2010.19; Huk KH, 2002, MOL NEUROBIOL, V25, P79; Jacobson K, 1999, TRENDS CELL BIOL, V9, P87, DOI 10.1016/S0962-8924(98)01495-0; Kenworthy AK, 2008, EMBO REP, V9, P531, DOI 10.1038/embor.2008.92; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P1786, DOI 10.1073/pnas.0507438103; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Lagerholm BC, 2005, ANNU REV PHYS CHEM, V56, P309, DOI 10.1146/annurev.physchem.56.092503.141211; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Linggi B, 2006, TRENDS CELL BIOL, V16, P649, DOI 10.1016/j.tcb.2006.10.008; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lodder AL, 1999, GENETICS, V152, P1487; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Michel V, 2007, BIOL CELL, V99, P129, DOI 10.1042/BC20060051; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Ponting CP, 1999, CURR BIOL, V9, pR585, DOI 10.1016/S0960-9822(99)80379-0; Puchner EM, 2009, CURR OPIN STRUC BIOL, V19, P605, DOI 10.1016/j.sbi.2009.09.005; Qian F, 2005, J BIOL CHEM, V280, P40723, DOI 10.1074/jbc.M509650200; Rajavel M, 1999, MOL CELL BIOL, V19, P3969; Rodicio R, 2008, FUNGAL GENET BIOL, V45, P422, DOI 10.1016/j.fgb.2007.07.009; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stradalova V, 2009, J CELL SCI, V122, P2887, DOI 10.1242/jcs.051227; Straede A, 2007, YEAST, V24, P321, DOI 10.1002/yea.1478; Straede A, 2007, FEBS LETT, V581, P4495, DOI 10.1016/j.febslet.2007.08.027; Vay HA, 2004, MICROBIOL-SGM, V150, P3281, DOI 10.1099/mic.0.27264-0; Verbelen C, 2007, J MOL RECOGNIT, V20, P490, DOI 10.1002/jmr.833; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	42	71	74	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11104	10.1371/journal.pone.0011104	http://dx.doi.org/10.1371/journal.pone.0011104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559440	gold, Green Published, Green Submitted			2022-12-27	WOS:000278741100017
J	Perrot, P; Rousseau, J; Bouffaut, AL; Redini, F; Cassagnau, E; Deschaseaux, F; Heymann, MF; Heymann, D; Duteille, F; Trichet, V; Gouin, F				Perrot, Pierre; Rousseau, Julie; Bouffaut, Anne-Laure; Redini, Francoise; Cassagnau, Elisabeth; Deschaseaux, Frederic; Heymann, Marie-Francoise; Heymann, Dominique; Duteille, Franck; Trichet, Valerie; Gouin, Francois			Safety Concern between Autologous Fat Graft, Mesenchymal Stem Cell and Osteosarcoma Recurrence	PLOS ONE			English	Article							SOLUBLE RECEPTOR ACTIVATOR; OSTEOLYTIC BONE-DISEASE; BREAST-CANCER; NONMETASTATIC OSTEOSARCOMA; CONSERVATIVE TREATMENT; PULMONARY METASTASIS; PROGNOSTIC-FACTORS; MULTIPLE-MYELOMA; TUMOR DORMANCY; STROMAL CELLS	Background: Osteosarcoma is the most common malignant primary bone tumour in young adult treated by neo adjuvant chemotherapy, surgical tumor removal and adjuvant multidrug chemotherapy. For correction of soft tissue defect consecutive to surgery and/or tumor treatment, autologous fat graft has been proposed in plastic and reconstructive surgery. Principal Findings: We report here a case of a late local recurrence of osteosarcoma which occurred 13 years after the initial pathology and 18 months after a lipofilling procedure. Because such recurrence was highly unexpected, we investigated the possible relationship of tumor growth with fat injections and with mesenchymal stem/stromal cell like cells which are largely found in fatty tissue. Results obtained in osteosarcoma pre-clinical models show that fat grafts or progenitor cells promoted tumor growth. Significance: These observations and results raise the question of whether autologous fat grafting is a safe reconstructive procedure in a known post neoplasic context.	[Perrot, Pierre; Rousseau, Julie; Bouffaut, Anne-Laure; Redini, Francoise; Heymann, Marie-Francoise; Heymann, Dominique; Duteille, Franck; Trichet, Valerie; Gouin, Francois] INSERM, U957, Nantes, France; [Perrot, Pierre; Rousseau, Julie; Bouffaut, Anne-Laure; Redini, Francoise; Heymann, Marie-Francoise; Heymann, Dominique; Duteille, Franck; Trichet, Valerie; Gouin, Francois] Univ Nantes, Nantes Atlantique Univ, Lab Physiopathol Resorpt Osseuse & Therapie Tumeu, EA3822, Nantes, France; [Perrot, Pierre; Bouffaut, Anne-Laure; Duteille, Franck] Ctr Hosp Univ, Serv Chirurg Plast & Brules, Nantes, France; [Cassagnau, Elisabeth; Heymann, Marie-Francoise] Ctr Hosp Univ, Serv Anat Pathol, Nantes, France; [Deschaseaux, Frederic] Etab Francais du Sang Ctr Atlantique, EA3855, Tours, France; [Gouin, Francois] Ctr Hosp Univ, Serv Orthopedie Traumatol, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Perrot, P (corresponding author), INSERM, U957, Nantes, France.	francois.gouin@chu-nantes.fr	Trichet, Valérie/L-1553-2015; gouin, francois/L-1478-2015; REDINI, Francoise/K-7981-2015; Heymann, Dominique/AAC-6014-2019	Trichet, Valérie/0000-0003-4183-9032; Heymann, Dominique/0000-0001-7777-0669; Rousseau, Julie/0000-0002-8720-7877; Heymann, Marie-Francoise/0000-0002-5585-8261	Fondation pour l'Avenir de la Recherche Medicale Appliquee [ET 8-486]; Ligue contre le cancer/Canceropole Grand Ouest/Regions Bretagne, Centre, Pays de la Loire, Poitou-Charentes [DAFCG/7506]	Fondation pour l'Avenir de la Recherche Medicale Appliquee; Ligue contre le cancer/Canceropole Grand Ouest/Regions Bretagne, Centre, Pays de la Loire, Poitou-Charentes	This work was supported by Fondation pour l'Avenir de la Recherche Medicale Appliquee (study ET 8-486, Paris, France), Ligue contre le cancer/Canceropole Grand Ouest/Regions Bretagne, Centre, Pays de la Loire, Poitou-Charentes (convention DAFCG/7506, Nantes, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacci G, 2000, J CLIN ONCOL, V18, P4016, DOI 10.1200/JCO.2000.18.24.4016; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; BILLS CE, 1971, JOHNS HOPKINS MED J, V128, P194; Carriere A, 2009, ARTERIOSCL THROM VAS, V29, P1093, DOI 10.1161/ATVBAHA.109.188318; Chan CW, 2008, J PLAST RECONSTR AES, V61, P1438, DOI 10.1016/j.bjps.2008.08.006; Coleman SR, 1997, CLIN PLAST SURG, V24, P347; Coleman SR, 2007, PLAST RECONSTR SURG, V119, P775, DOI 10.1097/01.prs.0000252001.59162.c9; Croucher PI, 2001, BLOOD, V98, P3534, DOI 10.1182/blood.V98.13.3534; Damiens C, 2000, CYTOKINE, V12, P539, DOI 10.1006/cyto.1999.0593; Delay E, 2008, ANN CHIR PLAST ESTH, V53, P153, DOI 10.1016/j.anplas.2007.09.005; Demicheli R, 2007, NAT CLIN PRACT ONCOL, V4, P699, DOI 10.1038/ncponc0999; Dennis JE, 2002, STEM CELLS, V20, P205, DOI 10.1634/stemcells.20-3-205; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Djouad F, 2006, TRANSPLANTATION, V82, P1060, DOI 10.1097/01.tp.0000236098.13804.0b; Ferrari S, 1997, ANN ONCOL, V8, P765, DOI 10.1023/A:1008221713505; Ferrari S, 2006, J PEDIAT HEMATOL ONC, V28, P418, DOI 10.1097/01.mph.0000212944.82361.1d; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Georges S, 2009, CYTOKINE GROWTH F R, V20, P29, DOI 10.1016/j.cytogfr.2008.11.005; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Gimble JM, 2004, ENDOCRINE, V23, P183, DOI 10.1385/ENDO:23:2-3:183; Gosset J, 2008, ANN CHIR PLAST ESTH, V53, P190, DOI 10.1016/j.anplas.2007.09.001; Heath DJ, 2007, CANCER RES, V67, P202, DOI 10.1158/0008-5472.CAN-06-1287; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Kaya M, 2000, CLIN CANCER RES, V6, P572; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Kim MS, 2007, CLIN ORTHOP RELAT R, P157, DOI 10.1097/BLO.0b013e318142b27d; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; Koksal Y, 2008, PEDIATR HEMAT ONCOL, V25, P83, DOI 10.1080/08880010701621010; Lamoureux F, 2008, MOL CANCER THER, V7, P3389, DOI 10.1158/1535-7163.MCT-08-0497; Lamoureux F, 2007, CANCER RES, V67, P7308, DOI 10.1158/0008-5472.CAN-06-4130; Lamoureux F, 2009, CANCER RES, V69, P526, DOI 10.1158/0008-5472.CAN-08-2648; Lazennec G, 2008, STEM CELLS, V26, P1387, DOI 10.1634/stemcells.2007-1006; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Luo XH, 2006, J BONE MINER RES, V21, P1648, DOI 10.1359/JBMR.060707; MEYERS PA, 1992, J CLIN ONCOL, V10, P5, DOI 10.1200/JCO.1992.10.1.5; Mishra PJ, 2009, CANCER RES, V69, P1255, DOI 10.1158/0008-5472.CAN-08-3562; Missana MC, 2007, EJSO-EUR J SURG ONC, V33, P685, DOI 10.1016/j.ejso.2006.12.002; Mojallal A, 2009, J PLAST RECONSTR AES, V62, P708, DOI 10.1016/j.bjps.2009.01.037; Morony S, 2001, CANCER RES, V61, P4432; MOTRESCU ER, 2008, BIOL CHEM; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Naumov GN, 2006, JNCI-J NATL CANCER I, V98, P316, DOI 10.1093/jnci/djj068; Nishimura T, 2000, LARYNGOSCOPE, V110, P1333, DOI 10.1097/00005537-200008000-00021; Ory B, 2005, CANCER-AM CANCER SOC, V104, P2522, DOI 10.1002/cncr.21530; Pearse RN, 2001, P NATL ACAD SCI USA, V98, P11581, DOI 10.1073/pnas.201394498; PINNEY DF, 1989, ENVIRON HEALTH PERSP, V80, P221, DOI 10.2307/3430747; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; SALGARELLO M, 2009, AESTHETIC PLAST SURG; Schwarz EM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2171; Spear SL, 2008, PLAST RECONSTR SURG, V122, P983, DOI 10.1097/PRS.0b013e31818237cf; Uesugi M, 2000, CANCER LETT, V155, P169, DOI 10.1016/S0304-3835(00)00424-9; VARANI J, 1981, J SURG ONCOL, V17, P9, DOI 10.1002/jso.2930170103; Vona-Davis L, 2009, CYTOKINE GROWTH F R, V20, P193, DOI 10.1016/j.cytogfr.2009.05.007; WALTER M, 2009, ONCOGENE; Wilson H, 2008, VET J, V175, P69, DOI 10.1016/j.tvjl.2007.07.025; Xu WT, 2009, CANCER LETT, V281, P32, DOI 10.1016/j.canlet.2009.02.022; Yoshimura K, 2008, AESTHET PLAST SURG, V32, P48, DOI 10.1007/s00266-007-9019-4; Zhang J, 2003, CANCER RES, V63, P7883	58	84	89	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e10999	10.1371/journal.pone.0010999	http://dx.doi.org/10.1371/journal.pone.0010999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544017	Green Published, gold, Green Accepted			2022-12-27	WOS:000278494900011
J	Gui, JH; Wang, T; Jones, RPO; Trump, D; Zimmer, T; Lei, M				Gui, Junhong; Wang, Tao; Jones, Richard P. O.; Trump, Dorothy; Zimmer, Thomas; Lei, Ming			Multiple Loss-of-Function Mechanisms Contribute to SCN5A-Related Familial Sick Sinus Syndrome	PLOS ONE			English	Article							CARDIAC CONDUCTION DEFECT; SODIUM-CHANNEL MUTATIONS; LONG-QT SYNDROME; X-LINKED RETINOSCHISIS; ST-SEGMENT ELEVATION; BUNDLE-BRANCH BLOCK; SCN5A MUTATION; BRUGADA-SYNDROME; ATRIAL STANDSTILL; NODE DYSFUNCTION	Background: To identify molecular mechanisms underlying SCN5A-related sick sinus syndrome (SSS), a rare type of SSS, in parallel experiments we elucidated the electrophysiological properties and the cell surface localization of thirteen human Na(v)1.5 (hNa(v)1.5) mutant channels previously linked to this disease. Methodology/Principal Findings: Mutant hNa(v)1.5 channels expressed by HEK293 cells and Xenopus oocytes were investigated by whole-cell patch clamp and two-microelectrode voltage clamp, respectively. HEK293 cell surface biotinylation experiments quantified the fraction of correctly targeted channel proteins. Our data suggested three distinct mutant channel subtypes: Group 1 mutants (L212P, P1298L, DelF1617, R1632H) gave peak current densities and cell surface targeting indistinguishable from wild-type hNa(v)1.5. Loss-of-function of these mutants resulted from altered channel kinetics, including a negative shift of steady-state inactivation and a reduced voltage dependency of open-state inactivation. Group 2 mutants (E161K, T220I, D1275N) gave significantly reduced whole-cell currents due to impaired cell surface localization (D1275N), altered channel properties at unchanged cell surface localization (T220I), or a combination of both (E161K). Group 3 mutant channels were non-functional, due to an almost complete lack of protein at the plasma membrane (T187I, W1421X, K1578fs/52, R1623X) or a probable gating/permeation defect with normal surface localisation (R878C, G1408R). Conclusions/Significance: This study indicates that multiple molecular mechanisms, including gating abnormalities, trafficking defects, or a combination of both, are responsible for SCN5A-related familial SSS.	[Gui, Junhong; Wang, Tao; Jones, Richard P. O.; Trump, Dorothy; Lei, Ming] Univ Manchester, Cardiovasc & Genet Med Res Grp, Sch Biomed, Manchester, Lancs, England; [Zimmer, Thomas] Univ Jena, Inst Physiol 2, Jena, Germany	University of Manchester; Friedrich Schiller University of Jena	Gui, JH (corresponding author), Univ Manchester, Cardiovasc & Genet Med Res Grp, Sch Biomed, Manchester, Lancs, England.	thomas.zimmer@mti.uni-jena.de; ming.lei@manchester.ac.uk	Lei, Ming/G-3686-2011; Lei, Ming/S-7209-2016	Lei, Ming/0000-0002-0928-341X	Wellcome Trust [081809, 081283]; British Heart Foundation [pG/08/006/24399]; Friedrich Schiller University of Jena [923409]; Dorothy Hodgkin Postgraduate Award	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); Friedrich Schiller University of Jena; Dorothy Hodgkin Postgraduate Award	This work was supported by The Wellcome Trust (ML, grant numbers 081809 and 081283), and The British Heart Foundation (ML, pG/08/006/24399) and the Friedrich Schiller University of Jena (TZ, budget account No. 923409), JG is supported by a Dorothy Hodgkin Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriel H, 2010, J MOL CELL CARDIOL, V48, P2, DOI 10.1016/j.yjmcc.2009.08.025; Baroudi G, 2000, FEBS LETT, V467, P12, DOI 10.1016/S0014-5793(00)01099-1; Benson DW, 2003, J CLIN INVEST, V112, P1019, DOI 10.1172/JCI200318062; Blechschmidt S, 2008, PROG BIOPHYS MOL BIO, V98, P309, DOI 10.1016/j.pbiomolbio.2009.01.009; Brugada J, 1997, J CARDIOVASC ELECTR, V8, P325, DOI 10.1111/j.1540-8167.1997.tb00796.x; Brugada J, 1998, CIRCULATION, V97, P457; Chandler NJ, 2009, CIRCULATION, V119, P1562, DOI 10.1161/CIRCULATIONAHA.108.804369; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Chen TH, 2005, AM J PHYSIOL-HEART C, V288, pH2666, DOI 10.1152/ajpheart.00521.2004; DEMARNEFFE M, 1993, EUR HEART J, V14, P649, DOI 10.1093/eurheartj/14.5.649; FREEDMAN RA, 2001, CARDIAC ELECTROPHYSI, V5, P45; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; Groenewegen WA, 2003, CIRC RES, V92, P14, DOI 10.1161/01.RES.0000050585.07097.D7; GUI J, 2010, J CARDIOVAS IN PRESS; Kyndt F, 2001, CIRCULATION, V104, P3081, DOI 10.1161/hc5001.100834; Laitinen-Forsblom PJ, 2006, J CARDIOVASC ELECTR, V17, P480, DOI 10.1111/j.1540-8167.2006.00411.x; Lei M, 2005, J PHYSIOL-LONDON, V567, P387, DOI 10.1113/jphysiol.2005.083188; Lei M, 2007, CARDIOVASC RES, V74, P356, DOI 10.1016/j.cardiores.2007.01.009; Lei M, 2008, PROG BIOPHYS MOL BIO, V98, P171, DOI 10.1016/j.pbiomolbio.2008.10.003; LOWN B, 1967, BRIT HEART J, V29, P469; Makita N, 2005, HEART RHYTHM, V2, P1128, DOI 10.1016/j.hrthm.2005.06.032; Makiyama T, 2005, J AM COLL CARDIOL, V46, P2100, DOI 10.1016/j.jacc.2005.08.043; McNair WP, 2004, CIRCULATION, V110, P2163, DOI 10.1161/01.CIR.0000144458.58660.BB; *NIH, NIH PUBL, V8523; Niu DM, 2006, J MED GENET, V43, P817, DOI 10.1136/jmg.2006.042192; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Otagiri T, 2008, PEDIATR RES, V64, P482, DOI 10.1203/PDR.0b013e3181841eca; RODRIGUEZ RD, 1990, GERIATRICS, V45, P26; Ruan YF, 2009, NAT REV CARDIOL, V6, P337, DOI 10.1038/nrcardio.2009.44; Schott JJ, 1999, NAT GENET, V23, P20, DOI 10.1038/12618; Schulze-Bahr Eric, 2003, Hum Mutat, V21, P651, DOI 10.1002/humu.9144; Smits JPP, 2005, J MOL CELL CARDIOL, V38, P969, DOI 10.1016/j.yjmcc.2005.02.024; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Veldkamp MW, 2003, CIRC RES, V92, P976, DOI 10.1161/01.RES.0000069689.09869.A8; Verkerk AO, 2009, INT J BIOL SCI, V5, P201; Wang Q, 1997, CURR OPIN CARDIOL, V12, P310, DOI 10.1097/00001573-199705000-00013; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang T, 2006, BRIT J OPHTHALMOL, V90, P81, DOI 10.1136/bjo.2005.078048; Wang T, 2002, HUM MOL GENET, V11, P3097, DOI 10.1093/hmg/11.24.3097; Zhang Y, 2008, ACTA PHYSIOL, V194, P311, DOI 10.1111/j.1748-1716.2008.01883.x; Zimmer T, 2002, J GEN PHYSIOL, V120, P887, DOI 10.1085/jgp.20028703; Zimmer T, 2008, PROG BIOPHYS MOL BIO, V98, P120, DOI 10.1016/j.pbiomolbio.2008.10.005	42	55	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10985	10.1371/journal.pone.0010985	http://dx.doi.org/10.1371/journal.pone.0010985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539757	Green Submitted, Green Published, gold			2022-12-27	WOS:000278465900006
J	Becerril, S; Rodriguez, A; Catalan, V; Sainz, N; Ramirez, B; Collantes, M; Penuelas, I; Gomez-Ambrosi, J; Fruhbeck, G				Becerril, Sara; Rodriguez, Amaia; Catalan, Victoria; Sainz, Neira; Ramirez, Beatriz; Collantes, Maria; Penuelas, Ivan; Gomez-Ambrosi, Javier; Fruhbeck, Gema			Deletion of Inducible Nitric-Oxide Synthase in Leptin-Deficient Mice Improves Brown Adipose Tissue Function	PLOS ONE			English	Article							II-INDUCED VASOCONSTRICTION; GENE-EXPRESSION; TRANSCRIPTIONAL COACTIVATOR; MITOCHONDRIAL RESPIRATION; UNCOUPLING PROTEIN-1; METABOLIC REGULATOR; DEPENDENT MECHANISM; ENERGY-EXPENDITURE; INSULIN-RESISTANCE; HYPERTENSIVE-RATS	Background: Leptin and nitric oxide (NO) on their own participate in the control of non-shivering thermogenesis. However, the functional interplay between both factors in this process has not been explored so far. Therefore, the aim of the present study was to analyze the impact of the absence of the inducible NO synthase (iNOS) gene in the regulation of energy balance in ob/ob mice. Methods and Findings: Double knockout (DBKO) mice simultaneously lacking the ob and iNOS genes were generated, and the expression of molecules involved in the control of brown fat cell function was analyzed by real-time PCR, western-blot and immunohistochemistry. Twelve week-old DBKO mice exhibited reduced body weight (p < 0.05), decreased amounts of total fat pads (p < 0.05), lower food efficiency rates (p < 0.05) and higher rectal temperature (p, 0.05) than ob/ob mice. Ablation of iNOS also improved the carbohydrate and lipid metabolism of ob/ob mice. DBKO showed a marked reduction in the size of brown adipocytes compared to ob/ob mutants. In this sense, in comparison to ob/ob mice, DBKO rodents showed an increase in the expression of PR domain containing 16 (Prdm16), a transcriptional regulator of brown adipogenesis. Moreover, iNOS deletion enhanced the expression of mitochondria-related proteins, such as peroxisome proliferator-activated receptor gamma coactivator-1 alpha (Pgc-1 alpha), sirtuin-1 (Sirt-1) and sirtuin-3 (Sirt-3). Accordingly, mitochondrial uncoupling proteins 1 and 3 (Ucp-1 and Ucp-3) were upregulated in brown adipose tissue (BAT) of DBKO mice as compared to ob/ob rodents. Conclusion: Ablation of iNOS improved the energy balance of ob/ob mice by decreasing food efficiency through an increase in thermogenesis. These effects may be mediated, in part, through the recovery of the BAT phenotype and brown fat cell function improvement.	[Becerril, Sara; Rodriguez, Amaia; Catalan, Victoria; Sainz, Neira; Ramirez, Beatriz; Gomez-Ambrosi, Javier; Fruhbeck, Gema] Univ Navarra Clin, Metab Res Lab, Pamplona, Spain; [Fruhbeck, Gema] Univ Navarra Clin, Dept Endocrinol, Pamplona, Spain; [Becerril, Sara; Rodriguez, Amaia; Catalan, Victoria; Sainz, Neira; Ramirez, Beatriz; Gomez-Ambrosi, Javier; Fruhbeck, Gema] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Madrid, Spain; [Collantes, Maria; Penuelas, Ivan] Univ Navarra Clin, MicroPET Res Unit CIMA CUN, Pamplona, Spain	University of Navarra; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Navarra	Becerril, S (corresponding author), Univ Navarra Clin, Metab Res Lab, Pamplona, Spain.	gfruhbeck@unav.es	Penuelas, Ivan/I-6292-2013; Catalan, Victoria/H-3566-2017; Ramírez, Beatriz/I-1922-2017; Sáinz, Neira/AAA-4624-2019; Gómez-Ambrosi, Javier/D-2984-2017; Collantes, María/A-4641-2015; Rodriguez, Amaia/D-3044-2019	Penuelas, Ivan/0000-0001-8008-976X; Catalan, Victoria/0000-0002-7513-7509; Ramírez, Beatriz/0000-0003-3381-7220; Gómez-Ambrosi, Javier/0000-0001-5601-1604; Collantes, María/0000-0003-1162-1470; Rodriguez, Amaia/0000-0002-2180-461X; Becerril, Sara/0000-0002-3441-1970	Departments of Industry and Education of the Gobierno de Navarra; Instituto de Salud Carlos III; Fondo de Investigacion Sanitaria (FIS) del Ministerio de Sanidad y Consumo; Ministerio de Ciencia y Tecnologi-a; PIUNA foundation	Departments of Industry and Education of the Gobierno de Navarra; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo de Investigacion Sanitaria (FIS) del Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Ministerio de Ciencia y Tecnologi-a(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); PIUNA foundation	SB was recipient of doctoral training grants from the Departments of Industry and Education of the Gobierno de Navarra. This work was supported by grants from the Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (FIS) del Ministerio de Sanidad y Consumo to G.F. and J.G.A; from the Ministerio de Ciencia y Tecnologi-a to G.F.; from the Department of Health of the Gobierno de Navarra to G.F. and J.G.A.; and from PIUNA foundation to G.F. CIBER de Fisiopatologia de la Obesidad y Nutricion (CIBEROBN) is an initiative of the Instituto de Salud Carlos III, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Brown GC, 2002, FREE RADICAL BIO MED, V33, P1440, DOI 10.1016/S0891-5849(02)01112-7; Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Catalan V, 2007, HORM METAB RES, V39, P495, DOI 10.1055/s-2007-982502; Catalan V, 2009, OBES SURG, V19, P771, DOI 10.1007/s11695-009-9834-6; Chehab FF, 1997, SCIENCE, V275, P88, DOI 10.1126/science.275.5296.88; Chen W, 2009, MOL CELL, V35, P755, DOI 10.1016/j.molcel.2009.09.015; Christian M, 2005, MOL CELL BIOL, V25, P9383, DOI 10.1128/MCB.25.21.9383-9391.2005; Commins SP, 1999, ENDOCRINOLOGY, V140, P292, DOI 10.1210/en.140.1.292; Debevec D, 2007, MOL ENDOCRINOL, V21, P1581, DOI 10.1210/me.2007-0103; Densmore VS, 2006, ENDOCRINOLOGY, V147, P4486, DOI 10.1210/en.2006-0106; Dixit VD, 2003, ENDOCRINOLOGY, V144, P5595, DOI 10.1210/en.2003-0600; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Finocchietto PV, 2009, EXP BIOL MED, V234, P1020, DOI 10.3181/0902-MR-81; Fortuno A, 2002, ENDOCRINOLOGY, V143, P3555, DOI 10.1210/en.2002-220075; Fruhbeck G, 2009, TRENDS PHARMACOL SCI, V30, P387, DOI 10.1016/j.tips.2009.05.003; Fruhbeck G, 2001, CELL SIGNAL, V13, P827, DOI 10.1016/S0898-6568(01)00211-X; Fruhbeck G, 1999, DIABETES, V48, P903, DOI 10.2337/diabetes.48.4.903; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Fruhbeck G, 2005, LANCET, V366, P615, DOI 10.1016/S0140-6736(05); Fruhbeck G, 2009, TRENDS CELL BIOL, V19, P141, DOI 10.1016/j.tcb.2009.01.007; Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340; Galgani J, 2008, INT J OBESITY, V32, pS109, DOI 10.1038/ijo.2008.246; Giordano A, 2002, FEBS LETT, V514, P135, DOI 10.1016/S0014-5793(02)02245-7; Gomez-Ambrosi J, 2004, FEBS LETT, V577, P351, DOI 10.1016/j.febslet.2004.10.028; Gomez-Ambrosi J, 2001, MOL CELL ENDOCRINOL, V176, P85, DOI 10.1016/S0303-7207(01)00451-8; Gomez-Ambrosi J, 2007, J CLIN ENDOCR METAB, V92, P3719, DOI 10.1210/jc.2007-0349; Gullicksen PS, 2002, PHYSIOL BEHAV, V75, P473, DOI 10.1016/S0031-9384(02)00652-2; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kakuma T, 2000, ENDOCRINOLOGY, V141, P4576, DOI 10.1210/en.141.12.4576; KLINGENBERG M, 1990, TRENDS BIOCHEM SCI, V15, P108, DOI 10.1016/0968-0004(90)90194-G; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; MacLean A, 1998, J GEN VIROL, V79, P825, DOI 10.1099/0022-1317-79-4-825; Mazo M, 2008, EUR J HEART FAIL, V10, P454, DOI 10.1016/j.ejheart.2008.03.017; Merial C, 2000, AM J PHYSIOL-CELL PH, V279, pC1100, DOI 10.1152/ajpcell.2000.279.4.C1100; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; Nau K, 2008, J COMP PHYSIOL B, V178, P269, DOI 10.1007/s00360-007-0219-7; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Nisoli E, 1997, ENDOCRINOLOGY, V138, P676, DOI 10.1210/en.138.2.676; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Raso GM, 2002, BRIT J PHARMACOL, V137, P799, DOI 10.1038/sj.bjp.0704903; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rodriguez A, 2008, LIFE SCI, V83, P540, DOI 10.1016/j.lfs.2008.07.022; Rodriguez A, 2006, J HYPERTENS, V24, P1589, DOI 10.1097/01.hjh.0000239295.17636.6e; Rodriguez A, 2007, ENDOCRINOLOGY, V148, P324, DOI 10.1210/en.2006-0940; Sahu A, 2004, ENDOCRINOLOGY, V145, P2613, DOI 10.1210/en.2004-0032; Scarpace PJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE259, DOI 10.1152/ajpendo.1998.275.2.E259; SCARPACE PJ, 1997, AM J PHYSIOL, V273, P226; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Shiuchi T, 2001, ENDOCRINOLOGY, V142, P608, DOI 10.1210/en.142.2.608; Soszynski D, 2007, J PHYSIOL PHARMACOL, V58, P657; Sugita H, 2005, J BIOL CHEM, V280, P14203, DOI 10.1074/jbc.M411226200; Sugita H, 2002, AM J PHYSIOL-ENDOC M, V282, pE386, DOI 10.1152/ajpendo.00087.2001; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Ueno N, 1998, MECH AGEING DEV, V100, P67, DOI 10.1016/S0047-6374(97)00123-1; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Villarroya F, 2001, BIOCHEM SOC T, V29, P76; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Webber J, 2003, P NUTR SOC, V62, P539, DOI 10.1079/PNS2003256; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; White R, 2008, FEBS LETT, V582, P39, DOI 10.1016/j.febslet.2007.11.017; White V, 2007, DIABETES-METAB RES, V23, P580, DOI 10.1002/dmrr.750; Zarrindast MR, 2003, EUR J PHARMACOL, V482, P205, DOI 10.1016/j.ejphar.2003.10.006; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	70	41	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10962	10.1371/journal.pone.0010962	http://dx.doi.org/10.1371/journal.pone.0010962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532036	Green Published, Green Submitted, gold			2022-12-27	WOS:000278380500008
J	Panchanathan, R; Shen, H; Zhang, X; Ho, SM; Choubey, D				Panchanathan, Ravichandran; Shen, Hui; Zhang, Xiang; Ho, Shuk-mei; Choubey, Divaker			Mutually Positive Regulatory Feedback Loop between Interferons and Estrogen Receptor-alpha in Mice: Implications for Sex Bias in Autoimmunity	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; SUBTYPE-SELECTIVE AGONISTS; I-INTERFERON; IFN-GAMMA; GENE; EXPRESSION; DISEASE; GLOMERULONEPHRITIS; INDUCTION; PROMOTER	Background: Systemic lupus erythematosus (SLE), an autoimmune disease, predominantly affects women of childbearing age. Moreover, increased serum levels of interferon-alpha (IFN-alpha) are associated with the disease. Although, the female sex hormone estrogen (E2) is implicated in sex bias in SLE through up-regulation of IFN-gamma expression, the molecular mechanisms remain unknown. Here we report that activation of IFN (alpha or gamma)-signaling in immune cells up-regulates expression of estrogen receptor-alpha (ER alpha; encoded by the Esr1 gene) and stimulates expression of target genes. Methodology/Principal Findings: We found that treatment of mouse splenic cells and mouse cell lines with IFN (alpha or gamma) increased steady-state levels of ER alpha mRNA and protein. The increase in the ERa mRNA levels was primarily due to the transcriptional mechanisms and it was dependent upon the activation of signal transducer and activator of transcription-1 (STAT1) factor by IFN. Moreover, the IFN-treatment of cells also stimulated transcription of a reporter gene, expression of which was driven by the promoter region of the murine Esr1 gene. Notably, splenic cells from pre-autoimmune lupus-prone (NZB x NZW)F-1 female mice had relatively higher steady-state levels of mRNAs encoded by the IFN and ER alpha-responsive genes as compared to the age-matched males. Conclusions/Significance: Our observations identify a novel mutually positive regulatory feedback loop between IFNs and ERa in immune cells in mice and support the idea that activation of this regulatory loop contributes to sex bias in SLE.	[Panchanathan, Ravichandran; Shen, Hui; Zhang, Xiang; Ho, Shuk-mei; Choubey, Divaker] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45221 USA; [Panchanathan, Ravichandran; Shen, Hui; Choubey, Divaker] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Choubey, D (corresponding author), Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45221 USA.	Divaker.choubey@uc.edu	Choubey, Divaker/A-4771-2008; Panchanathan, Ravichandran/E-1801-2015; Zhang, Xiang/D-3632-2009		National Institutes of Health [AI066261]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Work was supported by a grant (AI066261) from the National Institutes of Health to D. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Berghofer B, 2006, J IMMUNOL, V177, P2088, DOI 10.4049/jimmunol.177.4.2088; Bernier MO, 2009, ARTHRIT RHEUM-ARTHR, V61, P476, DOI 10.1002/art.24398; Bynote KK, 2008, GENES IMMUN, V9, P137, DOI 10.1038/sj.gene.6364458; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; CICATIELLO L, 1995, MOL ENDOCRINOL, V9, P1077, DOI 10.1210/me.9.8.1077; CLAYMAN CH, 1977, J VIROL, V23, P209, DOI 10.1128/JVI.23.1.209-212.1977; Cohen-Solal JFG, 2006, CURR TOP MICROBIOL, V305, P67, DOI 10.1007/3-540-29714-6_4; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; Dai RJ, 2009, J IMMUNOL, V183, P6998, DOI 10.4049/jimmunol.0901737; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Erlandsson MC, 2001, IMMUNOLOGY, V103, P17, DOI 10.1046/j.1365-2567.2001.01212.x; Feng F, 2010, CLIN IMMUNOL, V134, P226, DOI 10.1016/j.clim.2009.10.004; Gourdy P, 2005, BLOOD, V105, P2415, DOI 10.1182/blood-2004-07-2819; Haas C, 1998, J IMMUNOL, V160, P3713; Harigai M, 2008, J IMMUNOL, V181, P2211, DOI 10.4049/jimmunol.181.3.2211; Inui A, 2007, CLIN RHEUMATOL, V26, P1675, DOI 10.1007/s10067-007-0568-3; Ishibashi O, 2001, BBA-GENE STRUCT EXPR, V1519, P223, DOI 10.1016/S0167-4781(01)00232-9; Johnston JB, 2000, J VIROL, V74, P7211, DOI 10.1128/JVI.74.16.7211-7220.2000; Kipp JJL, 2007, J BIOL CHEM, V282, P36755, DOI 10.1074/jbc.M705143200; Kotzin BL, 1996, CELL, V85, P303, DOI 10.1016/S0092-8674(00)81108-3; Li J, 2007, CLIN IMMUNOL, V123, P219, DOI 10.1016/j.clim.2007.01.008; Li J, 2006, INT IMMUNOPHARMACOL, V6, P1413, DOI 10.1016/j.intimp.2006.04.019; Lu Q, 2007, GENES IMMUN, V8, P590, DOI 10.1038/sj.gene.6364421; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Nakaya M, 2006, BIOSCI BIOTECH BIOCH, V70, P47, DOI 10.1271/bbb.70.47; Niewold TB, 2008, ARTHRITIS RHEUM-US, V58, P2113, DOI 10.1002/art.23619; Panchanathan R, 2009, J IMMUNOL, V183, P7031, DOI 10.4049/jimmunol.0802665; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rider V, 2001, INT IMMUNOPHARMACOL, V1, P1009, DOI 10.1016/S1567-5769(01)00046-7; ROUBINIAN JR, 1977, J CLIN INVEST, V59, P1066, DOI 10.1172/JCI108729; ROUBINIAN JR, 1978, J EXP MED, V147, P1568, DOI 10.1084/jem.147.6.1568; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Siracusa MC, 2008, J IMMUNOL, V180, P1423, DOI 10.4049/jimmunol.180.3.1423; Smith-Bouvier DL, 2008, J EXP MED, V205, P1099, DOI 10.1084/jem.20070850; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Theofilopoulos AN, 2001, ARTHRITIS RES, V3, P136, DOI 10.1186/ar290; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Zandman-Goddard G, 2007, AUTOIMMUN REV, V6, P366, DOI 10.1016/j.autrev.2006.10.001	41	49	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10868	10.1371/journal.pone.0010868	http://dx.doi.org/10.1371/journal.pone.0010868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526365	gold, Green Submitted, Green Published			2022-12-27	WOS:000278222100004
J	Sharp, KH; Ritchie, KB; Schupp, PJ; Ritson-Williams, R; Paul, VJ				Sharp, Koty H.; Ritchie, Kim B.; Schupp, Peter J.; Ritson-Williams, Raphael; Paul, Valerie J.			Bacterial Acquisition in Juveniles of Several Broadcast Spawning Coral Species	PLOS ONE			English	Article							BLACK BAND DISEASE; VERTICAL TRANSMISSION; REPRODUCTIVE ISOLATION; MONTASTREA-ANNULARIS; SYMBIONTS; CYANOBACTERIA; POPULATIONS; DIVERSITY; PATHOGEN; BIVALVIA	Coral animals harbor diverse microorganisms in their tissues, including archaea, bacteria, viruses, and zooxanthellae. The extent to which coral-bacterial associations are specific and the mechanisms for their maintenance across generations in the environment are unknown. The high diversity of bacteria in adult coral colonies has made it challenging to identify species-specific patterns. Localization of bacteria in gametes and larvae of corals presents an opportunity for determining when bacterial-coral associations are initiated and whether they are dynamic throughout early development. This study focuses on the early onset of bacterial associations in the mass spawning corals Montastraea annularis, M. franksi, M. faveolata, Acropora palmata, A. cervicornis, Diploria strigosa, and A. humilis. The presence of bacteria and timing of bacterial colonization was evaluated in gametes, swimming planulae, and newly settled polyps by fluorescence in situ hybridization (FISH) using general eubacterial probes and laser-scanning confocal microscopy. The coral species investigated in this study do not appear to transmit bacteria via their gametes, and bacteria are not detectable in or on the corals until after settlement and metamorphosis. This study suggests that mass-spawning corals do not acquire, or are not colonized by, detectable numbers of bacteria until after larval settlement and development of the juvenile polyp. This timing lays the groundwork for developing and testing new hypotheses regarding general regulatory mechanisms that control bacterial colonization and infection of corals, and how interactions among bacteria and juvenile polyps influence the structure of bacterial assemblages in corals.	[Sharp, Koty H.; Ritson-Williams, Raphael; Paul, Valerie J.] Smithsonian Marine Stn Ft Pierce, Ft Pierce, FL USA; [Ritchie, Kim B.] Mote Marine Lab, Sarasota, FL 34236 USA; [Schupp, Peter J.] Univ Guam, Univ Guam Stn, Mangilao, GU USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Mote Marine Laboratory & Aquarium; University of Guam	Sharp, KH (corresponding author), Ocean Genome Legacy, Ipswich, MA USA.	kotysharp@gmail.com	Schupp, Peter j/D-3296-2015	Schupp, Peter Josef/0000-0003-4831-2751	Mote Marine Laboratory; Smithsonian Marine Science Network; NIH MBRS SCORE [S06-GM-44796]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM044796] Funding Source: NIH RePORTER	Mote Marine Laboratory; Smithsonian Marine Science Network(Smithsonian InstitutionSmithsonian Tennenbaum Marine Observatories Network); NIH MBRS SCORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded primarily by the Mote Marine Laboratory "Protect Our Reefs'' License Plate Research Grant. K. S. was supported by the Smithsonian Marine Science Network Postdoctoral Fellowship. P.J.S. acknowledges partial support by NIH MBRS SCORE grant S06-GM-44796. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apprill A, 2009, ISME J, V3, P685, DOI 10.1038/ismej.2009.3; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; BABCOCK RC, 1986, CORAL REEFS, V5, P111, DOI 10.1007/BF00298178; Banin E, 2001, FEMS MICROBIOL LETT, V199, P33; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Benkendorff K, 2001, J INVERTEBR PATHOL, V78, P109, DOI 10.1006/jipa.2001.5047; CARY SC, 1994, EOS, V75, P60; Enticknap JJ, 2006, APPL ENVIRON MICROB, V72, P3724, DOI 10.1128/AEM.72.5.3724-3732.2006; Fiala-Medioni A, 2002, MAR BIOL, V141, P1035, DOI 10.1007/s00227-002-0903-9; Frias-Lopez J, 2003, APPL ENVIRON MICROB, V69, P2409, DOI 10.1128/AEM.69.4.2409-2413.2003; Frias-Lopez J, 2004, APPL ENVIRON MICROB, V70, P5955, DOI 10.1128/AEM.70.10.5955-5962.2004; Gros O, 1999, INVERTEBR REPROD DEV, V36, P93, DOI 10.1080/07924259.1999.9652683; Haygood MG, 1997, APPL ENVIRON MICROB, V63, P4612, DOI 10.1128/AEM.63.11.4612-4616.1997; Hirose E, 2000, ZOOL SCI, V17, P233, DOI 10.2108/zsj.17.233; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Knowlton N, 2003, AM NAT, V162, pS51, DOI 10.1086/378684; Knowlton N, 1997, MAR BIOL, V127, P705, DOI 10.1007/s002270050061; Krueger DM, 1996, BIOL BULL, V190, P195, DOI 10.2307/1542539; Kushmaro A, 1997, MAR ECOL PROG SER, V147, P159, DOI 10.3354/meps147159; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; Levitan DR, 2004, EVOLUTION, V58, P308, DOI 10.1111/j.0014-3820.2004.tb01647.x; Loy A, 2003, NUCLEIC ACIDS RES, V31, P514, DOI 10.1093/nar/gkg016; Marquis CP, 2005, CORAL REEFS, V24, P248, DOI 10.1007/s00338-005-0473-7; Negri AP, 2001, MAR ECOL PROG SER, V223, P121, DOI 10.3354/meps223121; Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957; Olson ND, 2009, J EXP MAR BIOL ECOL, V371, P140, DOI 10.1016/j.jembe.2009.01.012; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; PAWLIK JR, 1988, J EXP MAR BIOL ECOL, V119, P99, DOI 10.1016/0022-0981(88)90225-0; Peek AS, 1998, P NATL ACAD SCI USA, V95, P9962, DOI 10.1073/pnas.95.17.9962; Ritchie KB, 1995, MOL MAR BIOL BIOTECH, V4, P345; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Ritson-Williams Raphael, 2009, Smithsonian Contributions to the Marine Sciences, P437; Rohwer F, 2001, CORAL REEFS, V20, P85; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Schmitt S, 2007, APPL ENVIRON MICROB, V73, P2067, DOI 10.1128/AEM.01944-06; Sharp KH, 2007, APPL ENVIRON MICROB, V73, P622, DOI 10.1128/AEM.01493-06; SZMANT AM, 1991, MAR ECOL PROG SER, V74, P13, DOI 10.3354/meps074013; VANVEGHEL MLJ, 1994, MAR ECOL PROG SER, V109, P209, DOI 10.3354/meps109209; Wood-Charlson EM, 2006, CELL MICROBIOL, V8, P1985, DOI 10.1111/j.1462-5822.2006.00765.x	43	61	62	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10898	10.1371/journal.pone.0010898	http://dx.doi.org/10.1371/journal.pone.0010898			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526374	Green Published, Green Submitted, gold			2022-12-27	WOS:000278222100027
J	Goncalves, JT; Stuhmer, W				Goncalves, J. Tiago; Stuehmer, Walter			Calmodulin Interaction with hEAG1 Visualized by FRET Microscopy	PLOS ONE			English	Article							A-GO-GO; POTASSIUM CHANNELS; HUMAN ETHER; BINDING-SITE; BETA-SUBUNIT; K+ CHANNELS; N-TERMINUS; EAG; INHIBITION; DROSOPHILA	Background: Ca2+-mediated regulation of ion channels provides a link between intracellular signaling pathways and membrane electrical activity. Intracellular Ca2+ inhibits the voltage-gated potassium channel EAG1 through the direct binding of calmodulin (CaM). Three CaM binding sites (BD-C1: 674-683, BD-C2: 711-721, BD-N: 151-165) have been identified in a peptide screen and were proposed to mediate binding. The participation of the three sites in CaM binding to the native channel, however, remains unclear. Methodology/Principal Findings: Here we studied the binding of Ca2+/CaM to the EAG channel by visualizing the interaction between YFP-labeled CaM and Cerulean-labeled hEAG1 in mammalian cells by FRET. The results of our cellular approach substantiate that two CaM binding sites are predominantly involved; the high-affinity 1-8-14 based CaM binding domain in the N-terminus and the second C-terminal binding domain BD-C2. Mutations at these sites completely abolished CaM binding to hEAG1. Conclusions/Significance: We demonstrated that the BD-N and BD-C2 binding domains are sufficient for CaM binding to the native channel, and, therefore, that BD-C1 is unable to bind CaM independently.	[Goncalves, J. Tiago; Stuehmer, Walter] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Stuehmer, Walter] DFG Res Ctr Mol Physiol Brain, Gottingen, Germany	Max Planck Society; German Research Foundation (DFG)	Goncalves, JT (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	goncalves@ucla.edu	Stuehmer, Walter/A-2176-2009	Stuehmer, Walter/0000-0002-0642-7764; Goncalves, J. Tiago/0000-0003-2303-1822	Deutsche Forschungsgemeinschaft [406, 723]; Center for Molecular Physiology of the Brain	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Molecular Physiology of the Brain	This work was supported by the Deutsche Forschungsgemeinschaft (www.dfg.de) through the following funding programs: Sonderforschungsbereich 406, Graduiertenkolleg 723 and Center for Molecular Physiology of the Brain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Bradley J, 2004, NAT NEUROSCI, V7, P705, DOI 10.1038/nn1266; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Brueggemann Andrea, 1993, Nature (London), V365, P445; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Ganetzky B, 1983, J NEUROGENET, V1, P17, DOI 10.3109/01677068309107069; Grunwald ME, 1998, J BIOL CHEM, V273, P9148, DOI 10.1074/jbc.273.15.9148; Jenke M, 2003, EMBO J, V22, P395, DOI 10.1093/emboj/cdg035; KAPLAN WD, 1969, GENETICS, V61, P399; Ludwig J, 1997, EMBO J, V16, P6337, DOI 10.1093/emboj/16.21.6337; Meyer R, 1999, J MEMBRANE BIOL, V171, P107, DOI 10.1007/s002329900563; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Occhiodoro T, 1998, FEBS LETT, V434, P177, DOI 10.1016/S0014-5793(98)00973-9; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Robertson GA, 1996, NEUROPHARMACOLOGY, V35, P841, DOI 10.1016/0028-3908(96)00113-X; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Schonherr R, 2000, EMBO J, V19, P3263, DOI 10.1093/emboj/19.13.3263; Schonherr R, 2002, FEBS LETT, V514, P204, DOI 10.1016/S0014-5793(02)02365-7; Stansfeld CE, 1996, P NATL ACAD SCI USA, V93, P9910, DOI 10.1073/pnas.93.18.9910; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Takanishi CL, 2006, BRAIN RES, V1091, P132, DOI 10.1016/j.brainres.2006.01.119; Terlau H, 1997, J PHYSIOL-LONDON, V502, P537, DOI 10.1111/j.1469-7793.1997.537bj.x; Trudeau MC, 2002, P NATL ACAD SCI USA, V99, P8424, DOI 10.1073/pnas.122015999; Valentin G, 2005, NAT METHODS, V2, P801, DOI 10.1038/nmeth1105-801; WARMKE J, 1991, SCIENCE, V252, P1560, DOI 10.1126/science.1840699; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Weitz D, 1998, EMBO J, V17, P2273, DOI 10.1093/emboj/17.8.2273; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200; Ziechner U, 2006, FEBS J, V273, P1074, DOI 10.1111/j.1742-4658.2006.05134.x	32	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10873	10.1371/journal.pone.0010873	http://dx.doi.org/10.1371/journal.pone.0010873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523736	Green Submitted, Green Published, gold			2022-12-27	WOS:000278221900019
J	Gawlik, K; Remacle, AG; Shiryaev, SA; Golubkov, VS; Ouyang, MX; Wang, YX; Strongin, AY				Gawlik, Katarzyna; Remacle, Albert G.; Shiryaev, Sergey A.; Golubkov, Vladislav S.; Ouyang, Mingxing; Wang, Yingxiao; Strongin, Alex Y.			RETRACTED: A Femtomol Range FRET Biosensor Reports Exceedingly Low Levels of Cell Surface Furin: Implications for the Processing of Anthrax Protective Antigen (Retracted article. See vol. 17, 2022)	PLOS ONE			English	Article; Retracted Publication							PROPROTEIN CONVERTASES; MATRIX METALLOPROTEINASES; HUMAN HEAD; INHIBITION; RECEPTOR; CLEAVAGE; TOXIN; SPECIFICITY; ACTIVATION; BINDING	Furin, a specialized endoproteinase, transforms proproteins into biologically active proteins. Furin function is important for normal cells and also in multiple pathologies including malignancy and anthrax. Furin is believed to cycle between the Golgi compartment and the cell surface. Processing of anthrax protective antigen-83 (PA83) by the cells is considered thus far as evidence for the presence of substantial levels of cell-surface furin. To monitor furin, we designed a cleavage-activated FRET biosensor in which the Enhanced Cyan and Yellow Fluorescent Proteins were linked by the peptide sequence SNSRKKR down arrow STSAGP derived from anthrax PA83. Both because of the sensitivity and selectivity of the anthrax sequence to furin proteolysis and the FRET-based detection, the biosensor recorded the femtomolar levels of furin in the in vitro reactions and cell-based assays. Using the biosensor that was cell-impermeable because of its size and also by other relevant methods, we determined that exceedingly low levels, if any, of cell-surface furin are present in the intact cells and in the cells with the enforced furin overexpression. This observation was in a sharp contrast with the existing concepts about the furin presentation on cell surfaces and anthrax disease mechanism. We next demonstrated using cell-based tests that PA83, in fact, was processed by furin in the extracellular milieu and that only then the resulting PA63 bound the anthrax toxin cell-surface receptors. We also determined that the biosensor, but not the conventional peptide substrates, allowed continuous monitoring of furin activity in cancer cell extracts. Our results suggest that there are no physiologically-relevant levels of cell-surface furin and, accordingly, that the mechanisms of anthrax should be re-investigated. In addition, the availability of the biosensor is a foundation for non-invasive monitoring of furin activity in cancer cells. Conceptually, the biosensor we developed may serve as a prototype for other proteinase-activated biosensors.	[Gawlik, Katarzyna; Remacle, Albert G.; Shiryaev, Sergey A.; Golubkov, Vladislav S.; Strongin, Alex Y.] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA USA; [Ouyang, Mingxing; Wang, Yingxiao] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Ouyang, Mingxing; Wang, Yingxiao] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA	Sanford Burnham Prebys Medical Discovery Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Gawlik, K (corresponding author), Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA USA.	strongin@burnham.org	Strongin, Alex/R-6609-2019; Ouyang, Mingxing/AAF-5896-2019; Golubkov, Vladislav/L-6828-2017; Ouyang, Mingxing/C-9130-2011; Ouyang, Mingxing/F-8907-2019; Ouyang, Mingxing/J-4529-2013	Strongin, Alex/0000-0003-3765-3016; Ouyang, Mingxing/0000-0002-2910-0713; 	National Institutes of Health [CA83017, CA77470, CA139272]; NATIONAL CANCER INSTITUTE [R01CA077470, R01CA083017, R21CA139272] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work reported here was supported by National Institutes of Health Grants CA83017 and CA77470 (to AYS), and CA139272 (to YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207; Angres B, 2009, CYTOM PART A, V75A, P420, DOI 10.1002/cyto.a.20698; Bassi DE, 2003, AM J PATHOL, V162, P439, DOI 10.1016/S0002-9440(10)63838-2; Bassi DE, 2001, P NATL ACAD SCI USA, V98, P10326, DOI 10.1073/pnas.191199198; Bassi DE, 2001, MOL CARCINOGEN, V31, P224, DOI 10.1002/mc.1057; Chauhan V, 2002, INFECT IMMUN, V70, P4477, DOI 10.1128/IAI.70.8.4477-4484.2002; Chekanov AV, 2006, ARCH BIOCHEM BIOPHYS, V446, P52, DOI 10.1016/j.abb.2005.11.013; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fugere M, 2005, TRENDS PHARMACOL SCI, V26, P294, DOI 10.1016/j.tips.2005.04.006; Fugere M, 2002, J BIOL CHEM, V277, P7648, DOI 10.1074/jbc.M107467200; Gawlik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005031; Golubkov VS, 2005, J BIOL CHEM, V280, P25079, DOI 10.1074/jbc.M502779200; Hsu YY, 2007, BIOCHEM BIOPH RES CO, V353, P939, DOI 10.1016/j.bbrc.2006.12.145; Izidoro MA, 2009, ARCH BIOCHEM BIOPHYS, V487, P105, DOI 10.1016/j.abb.2009.05.013; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Jones J, 2000, J BIOMOL SCREEN, V5, P307, DOI 10.1177/108705710000500502; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; Kiyokawa E, 2006, CANCER SCI, V97, P8, DOI 10.1111/j.1349-7006.2006.00141.x; Komiyama T, 2009, J BIOL CHEM, V284, P15729, DOI 10.1074/jbc.M901540200; LEDUC R, 1992, J BIOL CHEM, V267, P14304; Li Isaac T, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P531; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Ouyang MX, 2008, P NATL ACAD SCI USA, V105, P14353, DOI 10.1073/pnas.0807537105; Ouyang MX, 2008, J BIOL CHEM, V283, P17740, DOI 10.1074/jbc.M709872200; Ouyang MX, 2010, CANCER RES, V70, P2204, DOI 10.1158/0008-5472.CAN-09-3698; Page RE, 2007, CELL ONCOL, V29, P289; REMACLE AG, 2010, INT J BIOCH CELL BIO; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; Rozanov DV, 2005, INT J BIOCHEM CELL B, V37, P142, DOI 10.1016/j.biocel.2004.06.005; Scamuffa N, 2008, J CLIN INVEST, V118, P352, DOI 10.1172/JCI32040; Schapiro FB, 2004, MOL BIOL CELL, V15, P2884, DOI 10.1091/mbc.E03-09-0653; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah Nabil G, 2006, Biochem J, V393, pe1; SEIDAH NG, 1993, ANN NY ACAD SCI, V680, P135, DOI 10.1111/j.1749-6632.1993.tb19680.x; SEIDAH NG, 1993, BIOCHEM SOC T, V21, P685, DOI 10.1042/bst0210685; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shiryaev SA, 2006, BIOCHEM J, V393, P503, DOI 10.1042/BJ20051374; Shiryaev SA, 2007, J BIOL CHEM, V282, P20847, DOI 10.1074/jbc.M703847200; Shiryaev SA, 2007, J VIROL, V81, P4501, DOI 10.1128/JVI.02719-06; Singh Y, 1999, INFECT IMMUN, V67, P1853; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; STOPPELLI MP, 1986, CELL, V45, P675, DOI 10.1016/0092-8674(86)90782-8; Suzuki M, 2008, J AM CHEM SOC, V130, P5720, DOI 10.1021/ja710870e; TAKAHASHI S, 1995, J BIOL CHEM, V270, P26565, DOI 10.1074/jbc.270.44.26565; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tian H, 2007, BRIT J PHARMACOL, V150, P321, DOI 10.1038/sj.bjp.0706988; Wang YT, 2008, J COMMUN NETW-S KOR, V10, P38, DOI 10.1109/JCN.2008.6388326; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zucker S, 2003, CURR TOP DEV BIOL, V54, P1, DOI 10.1016/S0070-2153(03)54004-2	53	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11305	10.1371/journal.pone.0011305	http://dx.doi.org/10.1371/journal.pone.0011305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585585	Green Published, gold, Green Submitted			2022-12-27	WOS:000279135800014
J	Xue, Y; Liu, ZX; Gao, XJ; Jin, CJ; Wen, LP; Yao, XB; Ren, JA				Xue, Yu; Liu, Zexian; Gao, Xinjiao; Jin, Changjiang; Wen, Longping; Yao, Xuebiao; Ren, Jian			GPS-SNO: Computational Prediction of Protein S-Nitrosylation Sites with a Modified GPS Algorithm	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; IDENTIFICATION; DENITROSYLATION	As one of the most important and ubiquitous post-translational modifications (PTMs) of proteins, S-nitrosylation plays important roles in a variety of biological processes, including the regulation of cellular dynamics and plasticity. Identification of S-nitrosylated substrates with their exact sites is crucial for understanding the molecular mechanisms of S-nitrosylation. In contrast with labor-intensive and time-consuming experimental approaches, prediction of S-nitrosylation sites using computational methods could provide convenience and increased speed. In this work, we developed a novel software of GPS-SNO 1.0 for the prediction of S-nitrosylation sites. We greatly improved our previously developed algorithm and released the GPS 3.0 algorithm for GPS-SNO. By comparison, the prediction performance of GPS 3.0 algorithm was better than other methods, with an accuracy of 75.80%, a sensitivity of 53.57% and a specificity of 80.14%. As an application of GPS-SNO 1.0, we predicted putative S-nitrosylation sites for hundreds of potentially S-nitrosylated substrates for which the exact S-nitrosylation sites had not been experimentally determined. In this regard, GPS-SNO 1.0 should prove to be a useful tool for experimentalists. The online service and local packages of GPS-SNO were implemented in JAVA and are freely available at: http://sno.biocuckoo.org/.	[Xue, Yu] Huazhong Univ Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Dept Syst Biol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Liu, Zexian; Gao, Xinjiao; Jin, Changjiang; Wen, Longping; Yao, Xuebiao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Liu, Zexian; Gao, Xinjiao; Jin, Changjiang; Wen, Longping; Yao, Xuebiao] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Ren, Jian] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Sun Yat Sen University	Xue, Y (corresponding author), Huazhong Univ Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Dept Syst Biol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	xueyu@mail.hust.edu.cn; renjian.sysu@gmail.com	Liu, Zexian/D-1153-2011; Xue, Yu/G-5929-2011; Ren, Jian/D-3270-2011; Yao, Xuebiao/P-5771-2014	Liu, Zexian/0000-0001-9698-0610; Xue, Yu/0000-0002-9403-6869; Ren, Jian/0000-0002-4161-1292; Wen, Longping/0000-0003-0384-4578	National Basic Research Program [2006CB933300, 2007CB947401, 2007CB914503, 2010CB945400]; National Natural Science Foundation of China [90919001, 30700138, 30900835, 30830036, 30721002]; Chinese Academy of Sciences [KSCX2-YW-R-139, INFO-115-C01-SDB4-36]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National Basic Research Program (973 project) (2006CB933300, 2007CB947401, 2007CB914503, 2010CB945400), National Natural Science Foundation of China (90919001, 30700138, 30900835, 30830036, 30721002), and Chinese Academy of Sciences (KSCX2-YW-R-139, INFO-115-C01-SDB4-36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Derakhshan B, 2007, NAT PROTOC, V2, P1685, DOI 10.1038/nprot.2007.210; DHAWAN AP, 1991, IEEE ENG MED BIOL, V10, P30, DOI 10.1109/51.107166; Filzmoser P, 1999, MAGN RESON IMAGING, V17, P817, DOI 10.1016/S0730-725X(99)00014-4; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Han P, 2008, RAPID COMMUN MASS SP, V22, P1137, DOI 10.1002/rcm.3476; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Hernlund E, 2009, FREE RADICAL BIO MED, V46, P1607, DOI 10.1016/j.freeradbiomed.2009.03.015; Herwig R, 1999, GENOME RES, V9, P1093, DOI 10.1101/gr.9.11.1093; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hess DT, 2001, NAT CELL BIOL, V3, pE46, DOI 10.1038/35055152; Huang B, 2009, CARDIOVASC RES, V83, P536, DOI 10.1093/cvr/cvp154; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kuncewicz T, 2003, MOL CELL PROTEOMICS, V2, P156, DOI 10.1074/mcp.M300003-MCP200; Lai TS, 2001, BIOCHEMISTRY-US, V40, P4904, DOI 10.1021/bi002321t; Lefievre L, 2007, PROTEOMICS, V7, P3066, DOI 10.1002/pmic.200700254; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Li H, 2009, MOL CELL PROTEOMICS, V8, P1839, DOI 10.1074/mcp.M900030-MCP200; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; Murphy JP, 2010, PROTEOMICS, V10, P1847, DOI 10.1002/pmic.200900711; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Ozawa K, 2008, MOL CELL, V31, P395, DOI 10.1016/j.molcel.2008.05.024; Paige JS, 2008, CHEM BIOL, V15, P1307, DOI 10.1016/j.chembiol.2008.10.013; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Soukas A, 2000, GENE DEV, V14, P963; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Tannenbaum SR, 2006, ACS CHEM BIOL, V1, P615, DOI 10.1021/cb600439h; Tsang AHK, 2009, P NATL ACAD SCI USA, V106, P4900, DOI 10.1073/pnas.0810595106; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yoon S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S10; Zhou FF, 2004, BIOCHEM BIOPH RES CO, V325, P1443, DOI 10.1016/j.bbrc.2004.11.001	41	174	177	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11290	10.1371/journal.pone.0011290	http://dx.doi.org/10.1371/journal.pone.0011290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585580	Green Submitted, gold, Green Published			2022-12-27	WOS:000279135800004
J	Hatano, E; Kunert, G; Weisser, WW				Hatano, Eduardo; Kunert, Grit; Weisser, Wolfgang W.			Aphid Wing Induction and Ecological Costs of Alarm Pheromone Emission under Field Conditions	PLOS ONE			English	Article							GREEN PEACH APHID; ACYRTHOSIPHON-PISUM; 2 STRAINS; (E)-BETA-FARNESENE; BEHAVIOR; PREDATORS; RESPONSES; LADYBIRD; FORMS	The pea aphid, Acyrthosiphon pisum Harris, (Homoptera: Aphididae) releases the volatile sesquiterpene (E)-beta-farnesene (EBF) when attacked by a predator, triggering escape responses in the aphid colony. Recently, it was shown that this alarm pheromone also mediates the production of the winged dispersal morph under laboratory conditions. The present work tested the wing-inducing effect of EBF under field conditions. Aphid colonies were exposed to two treatments (control and EBF) and tested in two different environmental conditions (field and laboratory). As in previous experiments aphids produced higher proportion of winged morphs among their offspring when exposed to EBF in the laboratory but even under field conditions the proportion of winged offspring was higher after EBF application (6.84 +/- 0.98%) compared to the hexane control (1.54 +/- 0.25%). In the field, the proportion of adult aphids found on the plant at the end of the experiment was lower in the EBF treatment (58.1 +/- 5.5%) than in the control (66.9 +/- 4.6%), in contrast to the climate chamber test where the numbers of adult aphids found on the plant at the end of the experiment were, in both treatments, similar to the numbers put on the plant initially. Our results show that the role of EBF in aphid wing induction is also apparent under field conditions and they may indicate a potential cost of EBF emission. They also emphasize the importance of investigating the ecological role of induced defences under field conditions.	[Hatano, Eduardo; Weisser, Wolfgang W.] Univ Jena, Inst Ecol, Jena, Germany; [Hatano, Eduardo; Kunert, Grit] Max Planck Inst Chem Ecol, Jena, Germany	Friedrich Schiller University of Jena; Max Planck Society	Hatano, E (corresponding author), Univ Jena, Inst Ecol, Jena, Germany.	wolfgang.weisser@uni-jena.de	Hatano, Eduardo/AAK-1381-2020; Kunert, Grit/H-4271-2014; Hatano, Eduardo/AAE-3430-2020; Weisser, Wolfgang W/B-9718-2014	Hatano, Eduardo/0000-0002-2575-244X; Kunert, Grit/0000-0002-9969-8044; Weisser, Wolfgang W/0000-0002-2757-8959	Deutsche Forschungsgemeinschaft (DFG); International Max Planck Research School (IMPRS)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); International Max Planck Research School (IMPRS)	This study was supported by the Deutsche Forschungsgemeinschaft (DFG) and the International Max Planck Research School (IMPRS) for the "Exploration of Ecological Interactions with Molecular and Chemical Techniques''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar EB, 2001, CAN ENTOMOL, V133, P389, DOI 10.4039/Ent133389-3; Al Abassi S, 2000, J CHEM ECOL, V26, P1765, DOI 10.1023/A:1005555300476; Beale MH, 2006, P NATL ACAD SCI USA, V103, P10509, DOI 10.1073/pnas.0603998103; Boo KS, 1998, J CHEM ECOL, V24, P631, DOI 10.1023/A:1022386001722; BOWERS WS, 1972, SCIENCE, V177, P1121, DOI 10.1126/science.177.4054.1121; Bruce TJA, 2005, PEST MANAG SCI, V61, P1115, DOI 10.1002/ps.1102; Crawley M.J., 2007, J CHEM INF MODEL, DOI DOI 10.1002/9780470515075; Crawley M. J., 2007, R BOOK, DOI [10.1002/9780470515075, DOI 10.1002/9780470515075]; CRAWLEY MJ, 2002, STAT COMPUTING; DILL LM, 1990, OECOLOGIA, V83, P473, DOI 10.1007/BF00317197; DIXON A. F. G., 1958, TRANS ROY ENTOMOL SOC LONDON, V110, P319; Dixon AF G, 1998, APHID ECOLOGY; Dixon AFG, 1999, P ROY SOC B-BIOL SCI, V266, P1549, DOI 10.1098/rspb.1999.0814; EDWARDS LJ, 1973, NATURE, V241, P126, DOI 10.1038/241126b0; FOLDIHOPE C, 1990, INT J INSECT MORPHOL, V19, P25, DOI 10.1016/0020-7322(90)90028-N; Francis FD, 2005, EUR J ENTOMOL, V102, P431, DOI 10.14411/eje.2005.061; Hatano E, 2008, J CHEM ECOL, V34, P1149, DOI 10.1007/s10886-008-9527-y; Katis NI, 2007, APHIDS AS CROP PESTS, P353, DOI 10.1079/9780851998190.0353; KISLOW CJ, 1972, NATURE, V235, P108, DOI 10.1038/235108a0; Kunert G, 2005, ECOL LETT, V8, P596, DOI 10.1111/j.1461-0248.2005.00754.x; Kunert G, 2003, OECOLOGIA, V135, P304, DOI 10.1007/s00442-003-1185-8; Kunert G, 2007, EUR J ENTOMOL, V104, P47, DOI 10.14411/eje.2007.007; LEES AD, 1966, NATURE, V210, P986, DOI 10.1038/210986a0; Losey JE, 1998, ECOL ENTOMOL, V23, P53, DOI 10.1046/j.1365-2311.1998.00102.x; Micha SG, 1996, CHEMOECOLOGY, V7, P132, DOI 10.1007/BF01245965; Mondor EB, 2007, BIOL INVASIONS, V9, P623, DOI 10.1007/s10530-006-9062-0; MONTGOMERY ME, 1977, ENTOMOL EXP APPL, V22, P236, DOI 10.1007/BF00302860; Muller CB, 2001, ECOL ENTOMOL, V26, P330, DOI 10.1046/j.1365-2311.2001.00321.x; NAULT L R, 1973, Environmental Entomology, V2, P101, DOI 10.1093/ee/2.1.101; NAULT LR, 1976, SCIENCE, V192, P1349, DOI 10.1126/science.1273595; PICKETT JA, 1980, J CHEM ECOL, V6, P349, DOI 10.1007/BF01402913; Podjasek JO, 2005, CAN J ZOOL, V83, P1138, DOI [10.1139/Z05-108, 10.1139/z05-108]; Quisenberry SS, 2007, APHIDS AS CROP PESTS, P331, DOI 10.1079/9780851998190.0331; ROITBERG BD, 1979, J ANIM ECOL, V48, P111, DOI 10.2307/4104; ROITBERG BD, 1978, CAN J ZOOL, V56, P103, DOI 10.1139/z78-014; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Schwartzberg EG, 2008, J CHEM ECOL, V34, P76, DOI 10.1007/s10886-007-9397-8; Sloggett JJ, 2004, SCI UPDATE, P79; Sloggett JJ, 2002, OIKOS, V98, P323, DOI 10.1034/j.1600-0706.2002.980213.x; SUTHERLA.OR, 1967, NATURE, V216, P387, DOI 10.1038/216387a0; SUTHERLAND OR, 1969, J INSECT PHYSIOL, V15, P1385, DOI 10.1016/0022-1910(69)90199-1; SUTHERLAND OR, 1970, J INSECT PHYSIOL, V16, P1349, DOI 10.1016/0022-1910(70)90134-4; Verheggen FJ, 2009, BEHAV ECOL, V20, P283, DOI 10.1093/beheco/arp009; Weisser WW, 1999, P ROY SOC B-BIOL SCI, V266, P1175, DOI 10.1098/rspb.1999.0760; WOHLERS P, 1980, ENTOMOL EXP APPL, V27, P156, DOI 10.1007/BF00573890; WOHLERS P, 1981, ENTOMOL EXP APPL, V29, P117, DOI 10.1007/BF00300757; Xiangyu JG, 2002, PHYSIOL ENTOMOL, V27, P307, DOI 10.1046/j.1365-3032.2002.00302.x	47	33	35	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11188	10.1371/journal.pone.0011188	http://dx.doi.org/10.1371/journal.pone.0011188			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585639	Green Submitted, gold, Green Published			2022-12-27	WOS:000279135400005
J	Wu, CH; Sercu, B; Van de Werfhorst, LC; Wong, J; DeSantis, TZ; Brodie, EL; Hazen, TC; Holden, PA; Andersen, GL				Wu, Cindy H.; Sercu, Bram; Van de Werfhorst, Laurie C.; Wong, Jakk; DeSantis, Todd Z.; Brodie, Eoin L.; Hazen, Terry C.; Holden, Patricia A.; Andersen, Gary L.			Characterization of Coastal Urban Watershed Bacterial Communities Leads to Alternative Community-Based Indicators	PLOS ONE			English	Article							MICROBIAL COMMUNITY; PHYLOGENETIC DIVERSITY; MICROARRAY ANALYSIS; ESCHERICHIA-COLI; FECAL POLLUTION; GENETIC-MARKERS; TREATMENT-PLANT; CLONE LIBRARY; LAKE; SLUDGE	Background: Microbial communities in aquatic environments are spatially and temporally dynamic due to environmental fluctuations and varied external input sources. A large percentage of the urban watersheds in the United States are affected by fecal pollution, including human pathogens, thus warranting comprehensive monitoring. Methodology/Principal Findings: Using a high-density microarray (PhyloChip), we examined water column bacterial community DNA extracted from two connecting urban watersheds, elucidating variable and stable bacterial subpopulations over a 3-day period and community composition profiles that were distinct to fecal and non-fecal sources. Two approaches were used for indication of fecal influence. The first approach utilized similarity of 503 operational taxonomic units (OTUs) common to all fecal samples analyzed in this study with the watershed samples as an index of fecal pollution. A majority of the 503 OTUs were found in the phyla Firmicutes, Proteobacteria, Bacteroidetes, and Actinobacteria. The second approach incorporated relative richness of 4 bacterial classes (Bacilli, Bacteroidetes, Clostridia and alpha-proteobacteria) found to have the highest variance in fecal and non-fecal samples. The ratio of these 4 classes (BBC: A) from the watershed samples demonstrated a trend where bacterial communities from gut and sewage sources had higher ratios than from sources not impacted by fecal material. This trend was also observed in the 124 bacterial communities from previously published and unpublished sequencing or PhyloChip-analyzed studies. Conclusions/Significance: This study provided a detailed characterization of bacterial community variability during dry weather across a 3-day period in two urban watersheds. The comparative analysis of watershed community composition resulted in alternative community-based indicators that could be useful for assessing ecosystem health.	[Wu, Cindy H.; Wong, Jakk; DeSantis, Todd Z.; Brodie, Eoin L.; Hazen, Terry C.; Andersen, Gary L.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Dept Ecol, Berkeley, CA 94720 USA; [Sercu, Bram; Van de Werfhorst, Laurie C.; Holden, Patricia A.] Univ Calif Santa Barbara, Donald Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Santa Barbara	Wu, CH (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Dept Ecol, Berkeley, CA 94720 USA.	GLAndersen@lbl.gov	Hazen, Terry C/C-1076-2012; Brodie, Eoin L/A-7853-2008; Andersen, Gary/G-2792-2015	Hazen, Terry C/0000-0002-2536-9993; Brodie, Eoin L/0000-0002-8453-8435; Andersen, Gary/0000-0002-1618-9827	Department of Energy [DE-AC02-05CH11231]; Rathmann Family Foundation; California State Water Resources Control Board; Department of Public Health, Marin County California; City of Santa Barbara; Switzer Foundation; NSF [OCE 9982105, OCE 0620276]	Department of Energy(United States Department of Energy (DOE)); Rathmann Family Foundation; California State Water Resources Control Board; Department of Public Health, Marin County California; City of Santa Barbara; Switzer Foundation; NSF(National Science Foundation (NSF))	Part of this work was performed at Lawrence Berkeley National Laboratory under Department of Energy contract number DE-AC02-05CH11231 and funded by the Rathmann Family Foundation and the California State Water Resources Control Board Prop. 50 Clean Beaches Initiative grant with additional assistance by the Department of Public Health, Marin County California (CHW, JW, TZD, ELB, TCH, GLA). Additional funding was provided by the City of Santa Barbara through Measure B funding, the California State Water Resources Control Board Prop. 50 Clean Beaches Initiative grant and by the Switzer Foundation through a Leadership Grant. Flow data were provided through the NSF-funded Santa Barbara Long Term Ecological Research project, NSF OCE 9982105 and OCE 0620276 (BS, LCVDW, PAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Andersen GL, 2010, ENVIRONMENTAL MOLECULAR MICROBIOLOGY, P87; Benlloch S, 1995, FEMS MICROBIOL ECOL, V18, P267; Black LE, 2007, APPL ENVIRON MICROB, V73, P3965, DOI 10.1128/AEM.02780-06; Bodtker G, 2008, J IND MICROBIOL BIOT, V35, P1625, DOI 10.1007/s10295-008-0406-x; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; Cardenas E, 2008, CURR OPIN BIOTECH, V19, P544, DOI 10.1016/j.copbio.2008.10.010; Chauhan A, 2009, P NATL ACAD SCI USA, V106, P4301, DOI 10.1073/pnas.0809671106; Chouari R, 2005, ENVIRON MICROBIOL, V7, P1104, DOI 10.1111/j.1462-2920.2005.00795.x; Chouari R, 2005, APPL ENVIRON MICROB, V71, P2145, DOI 10.1128/AEM.71.4.2145-2153.2005; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Crump BC, 2004, APPL ENVIRON MICROB, V70, P1494, DOI 10.1128/AEM.70.3.1494-1505.2004; Cruz-Martinez K, 2009, ISME J, V3, P738, DOI 10.1038/ismej.2009.16; Daffonchio D, 2006, NATURE, V440, P203, DOI 10.1038/nature04418; Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07; DeAngelis KM, 2009, ISME J, V3, P168, DOI 10.1038/ismej.2008.103; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; DOWD SE, 2008, BMC MICROBIOL, V8; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Evans J, 2006, J MOL EVOL, V62, P785, DOI 10.1007/s00239-005-0176-2; Field KG, 2003, ENVIRON MONIT ASSESS, V81, P313, DOI 10.1023/A:1021349629950; Flanagan JL, 2007, J CLIN MICROBIOL, V45, P1954, DOI 10.1128/JCM.02187-06; Fogarty LR, 2005, APPL ENVIRON MICROB, V71, P5999, DOI 10.1128/AEM.71.10.5999-6007.2005; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Franklin MP, 2005, ENVIRON MICROBIOL, V7, P723, DOI 10.1111/j.1462-2920.2004.00736.x; FUHRMAN JA, 1993, APPL ENVIRON MICROB, V59, P1294, DOI 10.1128/AEM.59.5.1294-1302.1993; GELDREICH EE, 1976, CRIT REV ENV CONTR, V6, P349, DOI 10.1080/10643387609381645; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Graneli E, 2008, HARMFUL ALGAE, V8, P94, DOI 10.1016/j.hal.2008.08.011; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hartman WH, 2008, P NATL ACAD SCI USA, V105, P17842, DOI 10.1073/pnas.0808254105; Harwood VJ, 2005, APPL ENVIRON MICROB, V71, P3163, DOI 10.1128/AEM.71.6.3163-3170.2005; Hirayama H, 2005, EXTREMOPHILES, V9, P169, DOI 10.1007/s00792-005-0433-8; Humayoun SB, 2003, APPL ENVIRON MICROB, V69, P1030, DOI 10.1128/AEM.69.2.1030-1042.2003; Ishii S, 2006, APPL ENVIRON MICROB, V72, P612, DOI 10.1128/AEM.72.1.612-621.2006; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Juretschko S, 2002, SYST APPL MICROBIOL, V25, P84, DOI 10.1078/0723-2020-00093; Juteau P, 2004, APPL MICROBIOL BIOT, V66, P115, DOI 10.1007/s00253-004-1692-5; Kaartokallio H, 2005, APPL ENVIRON MICROB, V71, P4364, DOI 10.1128/AEM.71.8.4364-4371.2005; La Duc MT, 2007, APPL ENVIRON MICROB, V73, P2600, DOI 10.1128/AEM.03007-06; LaPara TM, 2000, APPL ENVIRON MICROB, V66, P3951, DOI 10.1128/AEM.66.9.3951-3959.2000; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Lu JR, 2007, WATER RES, V41, P3561, DOI 10.1016/j.watres.2007.05.033; Madrid VM, 2001, APPL ENVIRON MICROB, V67, P1663, DOI 10.1128/AEM.67.4.1663-1674.2001; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Masuda N, 2002, J BACTERIOL, V184, P6225, DOI 10.1128/JB.184.22.6225-6234.2002; McCune B., 2006, PC ORD MULTIVARIATE; Mei R, 2003, P NATL ACAD SCI USA, V100, P11237, DOI 10.1073/pnas.1534744100; MIELKE PW, 1994, J EDUC BEHAV STAT, V19, P217, DOI 10.2307/1165295; Mosier AC, 2007, FEMS MICROBIOL ECOL, V59, P274, DOI 10.1111/j.1574-6941.2006.00220.x; Moustafa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005758; Nelson CE, 2009, ISME J, V3, P13, DOI 10.1038/ismej.2008.81; Nelson KE, 2010, ENVIRONMENTAL MOLECULAR MICROBIOLOGY, P21; Paerl HW, 2003, FEMS MICROBIOL ECOL, V46, P233, DOI 10.1016/S0168-6496(03)00200-9; Petersen TM, 2005, J ENVIRON ENG, V131, P1414, DOI 10.1061/(ASCE)0733-9372(2005)131:10(1414); Platt RH, 2006, ENVIRONMENT, V48, P38; Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Roest K, 2005, SYST APPL MICROBIOL, V28, P175, DOI 10.1016/j.syapm.2004.10.006; Sagaram US, 2009, APPL ENVIRON MICROB, V75, P1566, DOI 10.1128/AEM.02404-08; Savichtcheva O, 2007, WATER RES, V41, P3615, DOI 10.1016/j.watres.2007.03.028; Savichtcheva O, 2006, WATER RES, V40, P2463, DOI 10.1016/j.watres.2006.04.040; Scupham AJ, 2008, MICROB ECOL, V56, P322, DOI 10.1007/s00248-007-9349-4; Sercu B, 2009, ENVIRON SCI TECHNOL, V43, P293, DOI 10.1021/es801505p; Shibata T, 2004, WATER RES, V38, P3119, DOI 10.1016/j.watres.2004.04.044; Smit E, 2001, APPL ENVIRON MICROB, V67, P2284, DOI 10.1128/AEM.67.5.2284-2291.2001; Sun HY, 2004, APPL ENVIRON MICROB, V70, P5868, DOI 10.1128/AEM.70.10.5868-5874.2004; Troussellier M, 2002, AQUAT MICROB ECOL, V28, P13, DOI 10.3354/ame028013; Urbach E, 2001, LIMNOL OCEANOGR, V46, P557, DOI 10.4319/lo.2001.46.3.0557; van der Wielen PWJJ, 2005, SCIENCE, V307, P121, DOI 10.1126/science.1103569; WASSEL RA, 1983, MICROB ECOL, V9, P155, DOI 10.1007/BF02015128; Wery N, 2008, WATER RES, V42, P53, DOI 10.1016/j.watres.2007.06.048; West NJ, 2008, ENVIRON MICROBIOL, V10, P738, DOI 10.1111/j.1462-2920.2007.01497.x; Williams MM, 2004, J APPL MICROBIOL, V96, P954, DOI 10.1111/j.1365-2672.2004.02229.x; WILSON KH, 1990, J CLIN MICROBIOL, V28, P1942, DOI 10.1128/JCM.28.9.1942-1946.1990; Woebken D, 2007, APPL ENVIRON MICROB, V73, P4648, DOI 10.1128/AEM.02774-06; Wrighton KC, 2008, ISME J, V2, P1146, DOI 10.1038/ismej.2008.48; Zaballos M, 2006, FEMS MICROBIOL ECOL, V56, P389, DOI 10.1111/j.1574-6941.2006.00060.x; Zrafi-Nouira I, 2009, BIODEGRADATION, V20, P467, DOI 10.1007/s10532-008-9235-x; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	94	56	60	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11285	10.1371/journal.pone.0011285	http://dx.doi.org/10.1371/journal.pone.0011285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585654	gold, Green Submitted, Green Published			2022-12-27	WOS:000279135400027
J	Gertsenstein, M; Nutter, LMJ; Reid, T; Pereira, M; Stanford, WL; Rossant, J; Nagy, A				Gertsenstein, Marina; Nutter, Lauryl M. J.; Reid, Tammy; Pereira, Monica; Stanford, William L.; Rossant, Janet; Nagy, Andras			Efficient Generation of Germ Line Transmitting Chimeras from C57BL/6N ES Cells by Aggregation with Outbred Host Embryos	PLOS ONE			English	Article							INBRED MOUSE STRAINS; STEM-CELLS; BALB/C BLASTOCYSTS; RAT BLASTOCYSTS; SELF-RENEWAL; MICE; GENE; ESTABLISHMENT; KNOCKOUT; DERIVATION	Genetically modified mouse strains derived from embryonic stem (ES) cells have become essential tools for functional genomics and biomedical research. Large scale mutagenesis projects are producing libraries of mutant C57BL/6 (B6) ES cells to enable the functional annotation of every gene of the mouse genome. To realize the utility of these resources, efficient and accessible methods of generating mutant mice from these ES cells are necessary. Here, we describe a combination of ICR morula aggregation and a chemically-defined culture medium with widely available and accessible components for the high efficiency generation of germline transmitting chimeras from C57BL/6N ES cells. Together these methods will ease the access of the broader biomedical research community to the publicly available B6 ES cell resources.	[Gertsenstein, Marina; Pereira, Monica; Nagy, Andras] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Gertsenstein, Marina; Pereira, Monica] Toronto Ctr Phenogen, Toronto, ON, Canada; [Nutter, Lauryl M. J.; Rossant, Janet] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Reid, Tammy; Stanford, William L.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Rossant, Janet; Nagy, Andras] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Rossant, Janet] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Gertsenstein, M (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	nagy@mshri.on.ca	Nagy, Andras/G-6465-2013	Nagy, Andras/0000-0003-4311-0413; Nutter, Lauryl/0000-0001-9619-146X; Stanford, William/0000-0002-5813-8016	Genome Prairie; Genome Canada; National Institutes of Health [1U01DA23284, 5U01DA023284-2]; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA023284] Funding Source: NIH RePORTER	Genome Prairie; Genome Canada(Genome Canada); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported with NorCOMM grant funding provided by Genome Prairie (http://www.genomeprairie.ca/) and Genome Canada (http://www.genomecanada.ca/) to WS, JR, and AN; and National Institutes of Health KOMP funding (grant 1U01DA23284 and 5U01DA023284-2; http://www.nih.gov/science/models/mouse/knockout/) to AN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Batlle-Morera L, 2008, GENESIS, V46, P758, DOI 10.1002/dvg.20442; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Chen SB, 2006, MOL BIOSYST, V2, P18, DOI 10.1039/b512000b; Cheng J, 2004, GENESIS, V39, P100, DOI 10.1002/gene.20031; Collins FS, 2007, CELL, V129, P235, DOI 10.1016/j.cell.2007.04.007; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Hansen GM, 2008, GENOME RES, V18, P1670, DOI 10.1101/gr.078352.108; Huang JJ, 2008, STEM CELLS, V26, P1883, DOI 10.1634/stemcells.2008-0164; Hughes ED, 2007, MAMM GENOME, V18, P549, DOI 10.1007/s00335-007-9054-0; KAWASE E, 1994, INT J DEV BIOL, V38, P385; KIYONARI H, 2010, GENESIS; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; LALLEMAND Y, 1990, DEVELOPMENT, V110, P1241; LEDERMANN B, 1991, EXP CELL RES, V197, P254, DOI 10.1016/0014-4827(91)90430-3; Lemckert FA, 1997, NUCLEIC ACIDS RES, V25, P917, DOI 10.1093/nar/25.4.917; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; McVicar DW, 2002, J IMMUNOL, V169, P1721, DOI 10.4049/jimmunol.169.4.1721; MEREAU A, 1993, J CELL BIOL, V122, P713, DOI 10.1083/jcb.122.3.713; NAGY A, 1990, DEVELOPMENT, V110, P815; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NAGY A, 2003, MANIPULATING MOUSE E, pR10; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Pacholczyk G, 2008, BIOTECHNIQUES, V44, P413, DOI 10.2144/000112706; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Poueymirou WT, 2007, NAT BIOTECHNOL, V25, P91, DOI 10.1038/nbt1263; Sato H, 2009, GENESIS, V47, P414, DOI 10.1002/dvg.20514; Schoonjans L, 2003, STEM CELLS, V21, P90, DOI 10.1634/stemcells.21-1-90; Schuster-Gossler K, 2001, BIOTECHNIQUES, V31, P1022, DOI 10.2144/01315st01; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; Seong E, 2004, TRENDS GENET, V20, P59, DOI 10.1016/j.tig.2003.12.006; Sharova LV, 2007, DEV BIOL, V307, P446, DOI 10.1016/j.ydbio.2007.05.004; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; STEWART CL, 1993, METHOD ENZYMOL, V225, P823; Tajbakhsh S, 1996, DEV DYNAM, V206, P291, DOI 10.1002/(SICI)1097-0177(199607)206:3<291::AID-AJA6>3.0.CO;2-D; TOKUNAGA T, 1992, DEV GROWTH DIFFER, V34, P561; Ward CM, 2004, EXP CELL RES, V293, P229, DOI 10.1016/j.yexcr.2003.10.017; Ware CB, 2003, TRANSGENIC RES, V12, P743, DOI 10.1023/B:TRAG.0000005246.35812.c8; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	46	78	83	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11260	10.1371/journal.pone.0011260	http://dx.doi.org/10.1371/journal.pone.0011260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582321	Green Published, Green Submitted, gold			2022-12-27	WOS:000279058500012
J	Evangelista, AM; Rao, VS; Filo, AR; Marozkina, NV; Doctor, A; Jones, DR; Gaston, B; Guilford, WH				Evangelista, Alicia M.; Rao, Vijay S.; Filo, Ashley R.; Marozkina, Nadzeya V.; Doctor, Allan; Jones, David R.; Gaston, Benjamin; Guilford, William H.			Direct Regulation of Striated Muscle Myosins by Nitric Oxide and Endogenous Nitrosothiols	PLOS ONE			English	Article							SKELETAL-MUSCLE; IN-VITRO; ACTIN-FILAMENTS; FORCE; MOTILITY; PURIFICATION; PROTEINS; ASSAY	Background: Nitric oxide (NO) has long been recognized to affect muscle contraction [1], both through activation of guanylyl cyclase and through modification of cysteines in proteins to yield S-nitrosothiols. While NO affects the contractile apparatus directly, the identities of the target myofibrillar proteins remain unknown. Here we report that nitrogen oxides directly regulate striated muscle myosins. Principal Findings: Exposure of skeletal and cardiac myosins to physiological concentrations of nitrogen oxides, including the endogenous nitrosothiol S-nitroso-L-cysteine, reduced the velocity of actin filaments over myosin in a dose-dependent and oxygen-dependent manner, caused a doubling of force as measured in a laser trap transducer, and caused S-nitrosylation of cysteines in the myosin heavy chain. These biomechanical effects were not observed in response to S-nitroso-D-cysteine, demonstrating specificity for the naturally occurring isomer. Both myosin heavy chain isoforms in rats and cardiac myosin heavy chain from human were S-nitrosylated in vivo. Significance: These data show that nitrosylation signaling acts as a molecular "gear shift'' for myosin-an altogether novel mechanism by which striated muscle and cellular biomechanics may be regulated.	[Evangelista, Alicia M.; Rao, Vijay S.; Filo, Ashley R.; Guilford, William H.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA; [Marozkina, Nadzeya V.; Gaston, Benjamin] Univ Virginia, Dept Pediat, Charlottesville, VA USA; [Doctor, Allan] Washington Univ, Dept Pediat, St Louis, MO 63130 USA	University of Virginia; University of Virginia; Washington University (WUSTL)	Evangelista, AM (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA.	guilford@virginia.edu		Guilford, William/0000-0002-6543-5713; Doctor, Allan/0000-0002-6096-6400	National Institutes of Health [EB002185, CA136705, HL059337]; National Science Foundation [MCB0718430]; NATIONAL CANCER INSTITUTE [R01CA136705] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL059337, R01HL059337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by grants from the National Institutes of Health (EB002185 to WHG, CA136705 to DRJ, and HL059337 to BMG) and the National Science Foundation (MCB0718430 to WHG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allersma MW, 1998, BIOPHYS J, V74, P1074, DOI 10.1016/S0006-3495(98)74031-7; Andrade FH, 1998, J PHYSIOL-LONDON, V509, P577, DOI 10.1111/j.1469-7793.1998.577bn.x; Brunori M, 2001, TRENDS BIOCHEM SCI, V26, P21, DOI 10.1016/S0968-0004(00)01698-4; Cuda G, 1997, BIOPHYS J, V72, P1767, DOI 10.1016/S0006-3495(97)78823-4; Galler S, 1997, PFLUG ARCH EUR J PHY, V434, P242, DOI 10.1007/s004240050391; Gow A, 2007, J CHROMATOGR B, V851, P140, DOI 10.1016/j.jchromb.2007.01.052; GRUETTER CA, 1979, J CYCLIC NUCL PROT, V5, P211; Guilford WH, 2004, ANAL BIOCHEM, V326, P153, DOI 10.1016/j.ab.2003.11.025; Guo B, 2004, CELL MOTIL CYTOSKEL, V59, P264, DOI 10.1002/cm.20040; Han PW, 2008, ANAL BIOCHEM, V377, P150, DOI 10.1016/j.ab.2008.03.023; HARADA Y, 1987, NATURE, V326, P805, DOI 10.1038/326805a0; HARRIS DE, 1991, AM J PHYSIOL, V260, pC1104; HARRIS DE, 1994, J MUSCLE RES CELL M, V15, P11, DOI 10.1007/BF00123828; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kanai AJ, 1997, AM J PHYSIOL-CELL PH, V273, pC1371, DOI 10.1152/ajpcell.1997.273.4.C1371; KIELLEY WW, 1961, BIOCHIM BIOPHYS ACTA, V51, P591; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; MALAVIA NK, 2007, AM J RESP CRIT CARE, V175, pA522; Marechal G, 1999, CELL MOL LIFE SCI, V55, P1088, DOI 10.1007/s000180050359; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MARINO SM, 2009, J MOL BIOL; Nogueira L, 2009, BIOCHEM J, V424, P221, DOI 10.1042/BJ20091144; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pearce LL, 2002, J BIOL CHEM, V277, P13556, DOI 10.1074/jbc.M109838200; Perkins WJ, 1997, J APPL PHYSIOL, V83, P1326, DOI 10.1152/jappl.1997.83.4.1326; Peterson J, 2004, AM J PHYSIOL-HEART C, V286, pH55, DOI 10.1152/ajpheart.00744.2003; Pinsky DJ, 1997, CIRC RES, V81, P372, DOI 10.1161/01.RES.81.3.372; Rao VS, 2009, CELL MOTIL CYTOSKEL, V66, P10, DOI 10.1002/cm.20321; Roberts CK, 1999, AM J PHYSIOL-ENDOC M, V277, pE390, DOI 10.1152/ajpendo.1999.277.2.E390; Rodriguez J, 2003, P NATL ACAD SCI USA, V100, P336, DOI 10.1073/pnas.0234600100; SHIVERICK KT, 1975, BIOCHIM BIOPHYS ACTA, V393, P124, DOI 10.1016/0005-2795(75)90222-6; Snook JH, 2008, FREE RADICAL BIO MED, V44, P14, DOI 10.1016/j.freeradbiomed.2007.09.004; Takahashi S, 1999, FREE RADICAL BIO MED, V27, pS87, DOI 10.1016/S0891-5849(99)90801-8; Umar S, 2010, MOL CELL BIOCHEM, V333, P191, DOI 10.1007/s11010-009-0219-x	35	53	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11209	10.1371/journal.pone.0011209	http://dx.doi.org/10.1371/journal.pone.0011209			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585450	Green Submitted, Green Published, gold			2022-12-27	WOS:000278977200012
J	Hsieh, STT				Hsieh, Shi-Tong Tonia			A Locomotor Innovation Enables Water-Land Transition in a Marine Fish	PLOS ONE			English	Article							EEL ANGUILLA-ROSTRATA; EVOLUTIONARY INNOVATIONS; ALTICUS-MONOCHRUS; ESCAPE RESPONSES; MUSCLE-ACTIVITY; INDIAN-OCEAN; PECTORAL FIN; ORIGIN; KINEMATICS; MACROEVOLUTION	Background: Morphological innovations that significantly enhance performance capacity may enable exploitation of new resources and invasion of new ecological niches. The invasion of land from the aquatic realm requires dramatic structural and physiological modifications to permit survival in a gravity-dominated, aerial environment. Most fishes are obligatorily aquatic, with amphibious fishes typically making slow-moving and short forays on to land. Methodology/Principal Findings: Here I describe the behaviors and movements of a little known marine fish that moves extraordinarily rapidly on land. I found that the Pacific leaping blenny, Alticus arnoldorum, employs a tail-twisting movement on land, previously unreported in fishes. Focal point behavioral observations of Alticus show that they have largely abandoned the marine realm, feed and reproduce on land, and even defend terrestrial territories. Comparisons of these blennies' terrestrial kinematic and kinetic (i.e., force) measurements with those of less terrestrial sister genera show A. arnoldorum move with greater stability and locomotor control, and can move away more rapidly from impending threats. Conclusions/Significance: My results demonstrate that axial tail twisting serves as a key innovation enabling invasion of a novel marine niche. This paper highlights the potential of using this system to address general evolutionary questions about water-land transitions and niche invasions.	[Hsieh, Shi-Tong Tonia] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Hsieh, STT (corresponding author), Temple Univ, Dept Biol, Philadelphia, PA 19122 USA.	sthsieh@temple.edu		Hsieh, Shi-Tong/0000-0003-2233-3327	National Geographic Society; Society of Integrative and Comparative Biology; Museum of Comparative Zoology at Harvard University	National Geographic Society(National Geographic Society); Society of Integrative and Comparative Biology; Museum of Comparative Zoology at Harvard University	This study was funded by the National Geographic Society Research and Exploration Grant (http://www.nationalgeographic.com/field/grants-programs/cre.html), a Student Travel Fellowship from the Society of Integrative and Comparative Biology (http://www.sicb.org/grants/fgst/), and the Putnam Expedition Fund from the Museum of Comparative Zoology at Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1990, PHILOS T ROY SOC B, V329, P3, DOI 10.1098/rstb.1990.0144; Anker A, 2006, EVOLUTION, V60, P2507, DOI 10.1111/j.0014-3820.2006.tb01886.x; Aubret F, 2008, FUNCT ECOL, V22, P317, DOI 10.1111/j.1365-2435.2007.01359.x; Bhikajee M, 2006, AFR ZOOL, V41, P1, DOI 10.3377/1562-7020(2006)41[1:LHCOAM]2.0.CO;2; Bhikajee M, 2002, AFR ZOOL, V37, P221; BROWN CR, 1992, COPEIA, P1007; BURKE AC, 1989, J MORPHOL, V199, P363, DOI 10.1002/jmor.1051990310; CARSTENS T, 1968, Sarsia, V34, P37; COATES MI, 1994, DEVELOPMENT, P169; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Deluzio KJ, 2007, GAIT POSTURE, V25, P86, DOI 10.1016/j.gaitpost.2006.01.007; DENNY MW, 1985, LIMNOL OCEANOGR, V30, P1171, DOI 10.4319/lo.1985.30.6.1171; Domenici P, 1997, J EXP BIOL, V200, P1165; Eckhart L, 2008, P NATL ACAD SCI USA, V105, P18419, DOI 10.1073/pnas.0805154105; Gilbert SF, 2001, EVOL DEV, V3, P47, DOI 10.1046/j.1525-142x.2001.003002047.x; Gillis GB, 2000, J EXP BIOL, V203, P471; Gillis GB, 1998, J EXP BIOL, V201, P949; Graham JB, 1997, AIR BREATHING FISHES, DOI DOI 10.1016/B978-012294860-2/50006-4; Hale ME, 2002, J EXP BIOL, V205, P2005; HARRIS VERNON A., 1960, PROC ZOOL SOC LONDON, V134, P107; Hoso M, 2007, BIOL LETTERS, V3, P169, DOI 10.1098/rsbl.2006.0600; Hsieh ST, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2202910; Huberty CJ, 2003, J EXP EDUC, V71, P177, DOI 10.1080/00220970309602062; Hunter JP, 1998, TRENDS ECOL EVOL, V13, P31, DOI 10.1016/S0169-5347(97)01273-1; JENSSEN TA, 1977, AM ZOOL, V17, P203; Jindrich DL, 2002, J EXP BIOL, V205, P2803; Lee M, 2009, HUM MOVEMENT SCI, V28, P226, DOI 10.1016/j.humov.2008.10.008; LIEM KF, 1973, SYST ZOOL, V22, P425, DOI 10.2307/2412950; Love AC, 2003, BIOL PHILOS, V18, P309, DOI 10.1023/A:1023940220348; MARSH RL, 1994, J EXP BIOL, V188, P131; MARTIN KLM, 1989, COPEIA, P723; Miller A.H., 1949, ORNITHOLOGIE ALS BIO, V28, P84; Nelson JS., 2016, FISHES WORLD, DOI DOI 10.1002/9781119174844.FMATTER; Pace CM, 2009, J EXP BIOL, V212, P2279, DOI 10.1242/jeb.029041; Prum RO, 1999, J EXP ZOOL, V285, P291; Prum RO, 1997, AM NAT, V149, P668, DOI 10.1086/286014; Rao H. S., 1938, Records of the Indian Museum, V40, P377; RITTER D, 1995, J EXP BIOL, V198, P2477; Sazima Ivan, 2003, Ichthyological Exploration of Freshwaters, V14, P175; Schmitt J, 2000, BIOL CYBERN, V83, P501, DOI 10.1007/s004220000181; Schoenfuss HL, 2003, J ZOOL, V261, P191, DOI 10.1017/S0952836903004102; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; Springer V. G., 1994, INDOWEST PACIFIC BLE; Swanson BO, 2004, J EXP BIOL, V207, P4037, DOI 10.1242/jeb.01237; Tytell ED, 2002, J EXP BIOL, V205, P2591; Vermeij GJ, 2006, P NATL ACAD SCI USA, V103, P1804, DOI 10.1073/pnas.0508724103; Wainwright PC, 2007, ANNU REV ECOL EVOL S, V38, P381, DOI 10.1146/annurev.ecolsys.38.091206.095706	47	51	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11197	10.1371/journal.pone.0011197	http://dx.doi.org/10.1371/journal.pone.0011197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585564	Green Published, Green Submitted, gold			2022-12-27	WOS:000278977200004
J	Fischer, AJ; Zelinka, C; Scott, MA				Fischer, Andy J.; Zelinka, Christopher; Scott, Melissa A.			Heterogeneity of Glia in the Retina and Optic Nerve of Birds and Mammals	PLOS ONE			English	Article							TRANSFERRIN-BINDING PROTEIN; CHOLINERGIC AMACRINE CELLS; FIBRILLARY ACIDIC PROTEIN; MULLER GLIA; CHICKEN RETINA; PROGENITOR CELLS; PRIMATE RETINA; GANGLION-CELLS; OLIGODENDROCYTE DIFFERENTIATION; INTERMEDIATE-FILAMENT	We have recently described a novel type of glial cell that is scattered across the inner layers of the avian retina [1]. These cells are stimulated by insulin-like growth factor 1 (IGF1) to proliferate, migrate distally into the retina, and up-regulate the nestin-related intermediate filament transitin. These changes in glial activity correspond with increased susceptibility of neurons to excitotoxic damage. This novel cell-type has been termed the Non-astrocytic Inner Retinal Glia-like (NIRG) cells. The purpose of the study was to investigate whether the retinas of non-avian species contain cells that resemble NIRG cells. We assayed for NIRG cells by probing for the expression of Sox2, Sox9, Nkx2.2, vimentin and nestin. NIRG cells were distinguished from astrocytes by a lack of expression for Glial Fibrilliary Acidic Protein (GFAP). We examined the retinas of adult mice, guinea pigs, dogs and monkeys (Macaca fasicularis). In the mouse retina and optic nerve head, we identified numerous astrocytes that expressed GFAP, S100 beta, Sox2 and Sox9; however, we found no evidence for NIRG-like cells that were positive for Nkx2.2, nestin, and negative for GFAP. In the guinea pig retina, we did not find astrocytes or NIRG cells in the retina, whereas we identified astrocytes in the optic nerve. In the eyes of dogs and monkeys, we found astrocytes and NIRG-like cells scattered across inner layers of the retina and within the optic nerve. We conclude that NIRG-like cells are present in the retinas of canines and non-human primates, whereas the retinas of mice and guinea pigs do not contain NIRG cells.	[Fischer, Andy J.; Zelinka, Christopher; Scott, Melissa A.] Ohio State Univ, Coll Med, Dept Neurosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Fischer, AJ (corresponding author), Ohio State Univ, Coll Med, Dept Neurosci, Columbus, OH 43210 USA.	fischer.412@osu.edu	Fischer, Andy J./AFF-1827-2022; Fischer, Andrew J/E-3061-2011; Fischer, Andy J./AAE-9817-2022	Fischer, Andy J./0000-0001-6123-7405; Fischer, Andy J./0000-0001-6123-7405	National Institutes of Health, National Eye Institute [RO1 EY016043-04]; NICHD; NATIONAL EYE INSTITUTE [R01EY016043] Funding Source: NIH RePORTER	National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health, National Eye Institute RO1 EY016043-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. John Buford (the Ohio State University) for providing primate tissues, Dr. Simon Petersen-Jones (Michigan State University) for providing canine tissues, Dr. Karl Obrietan (the Ohio State University) for providing murine tissues, and Dr. Jackie Wood (the Ohio State University) for providing guinea pig tissues. We thank Drs. P. Henion and J.J. Lucas for providing antibodies to transitin and transferrin binding protein, respectively. Confocal microscopy was performed at the Hunt-Curtis Imaging Facility at the Department of Neuroscience of The Ohio State University. The Islet1, Nkx2.2 (developed by Dr. T. M Jessell) and vimentin (developed by Dr. A. Alvarez-Buylla) antibodies were obtained from the Developmental Studies Hybridoma Bank developed under auspices of the NICHD and maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA 52242.	ALVAREZBUYLLA A, 1987, J COMP NEUROL, V264, P159, DOI 10.1002/cne.902640203; Bhat RV, 1996, GLIA, V17, P169; Cai J, 2010, GLIA, V58, P458, DOI 10.1002/glia.20937; Cho SS, 1999, BRAIN RES, V816, P229, DOI 10.1016/S0006-8993(98)01117-2; CHO SS, 1995, BRAIN RES, V674, P15, DOI 10.1016/0006-8993(94)01398-2; Cho SS, 1997, J COMP NEUROL, V382, P260; Close JL, 2005, DEVELOPMENT, V132, P3015, DOI 10.1242/dev.01882; CLOSE JL, 2000, SOC NEUR ABSTR, V26, P1603; Dacey DM, 2003, CURR OPIN NEUROBIOL, V13, P421, DOI 10.1016/S0959-4388(03)00103-X; Dacey DM, 1999, PROG RETIN EYE RES, V18, P737, DOI 10.1016/S1350-9462(98)00013-5; Dacey DM, 1996, P NATL ACAD SCI USA, V93, P582, DOI 10.1073/pnas.93.2.582; Dakubo GD, 2003, DEVELOPMENT, V130, P2967, DOI 10.1242/dev.00515; Dorrell MI, 2006, PROG RETIN EYE RES, V25, P277, DOI 10.1016/j.preteyeres.2006.01.001; Elshatory Y, 2007, J NEUROSCI, V27, P12707, DOI 10.1523/JNEUROSCI.3951-07.2007; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Fischer AJ, 2005, J COMP NEUROL, V484, P1, DOI 10.1002/cne.20406; Fischer AJ, 2001, INVEST OPHTH VIS SCI, V42, P3256; Fischer AJ, 2004, MOL CELL NEUROSCI, V27, P531, DOI 10.1016/j.mcn.2004.08.007; FISCHER AJ, 2010, MULLER GLIA GLIA, V58, P633; Fischer AJ, 2008, J COMP NEUROL, V506, P584, DOI 10.1002/cne.21578; Fischer AJ, 2009, GLIA, V57, P1538, DOI 10.1002/glia.20868; Fischer AJ, 2009, GLIA, V57, P166, DOI 10.1002/glia.20743; Friedlander Martin, 2007, Angiogenesis, V10, P89, DOI 10.1007/s10456-007-9070-4; Fu H, 2001, DEV BRAIN RES, V129, P115, DOI 10.1016/S0165-3806(01)00178-X; GalliResta L, 1997, J NEUROSCI, V17, P7831; Gao LM, 2006, J NEUROSCI, V26, P7619, DOI 10.1523/JNEUROSCI.0855-06.2006; Gao LM, 2006, DEV BIOL, V290, P277, DOI 10.1016/j.ydbio.2005.11.007; Ghai K, 2010, J NEUROSCI, V30, P3101, DOI 10.1523/JNEUROSCI.4919-09.2010; KOHSAKA S, 1980, J NEUROCHEM, V34, P662, DOI 10.1111/j.1471-4159.1980.tb11195.x; Kuhlmann T, 2007, J NEUROPATH EXP NEUR, V66, P238, DOI 10.1097/01.jnen.0000248559.83573.71; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; Marquardt T, 2003, PROG RETIN EYE RES, V22, P567, DOI 10.1016/S1350-9462(03)00036-3; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; MARSHAK DR, 1990, PROG BRAIN RES, V86, P169; Messam CA, 2000, EXP NEUROL, V161, P585, DOI 10.1006/exnr.1999.7319; Messam CA, 2002, DEV BRAIN RES, V134, P87, DOI 10.1016/S0165-3806(01)00325-X; Moshiri A, 2008, DEV BIOL, V316, P214, DOI 10.1016/j.ydbio.2008.01.015; NARANG HK, 1977, NATURE, V266, P858, DOI 10.1038/266855a0; Poche RA, 2008, J COMP NEUROL, V510, P237, DOI 10.1002/cne.21746; POOLA I, 1988, J BIOL CHEM, V263, P19137; Qi YC, 2001, DEVELOPMENT, V128, P2723; Raff MC, 1987, PROG BRAIN RES <D>, V71, P435; Rompani SB, 2010, J NEUROSCI, V30, P4970, DOI 10.1523/JNEUROSCI.3456-09.2010; SCHNITZER J, 1988, GLIA, V1, P74, DOI 10.1002/glia.440010109; SELINFREUND RH, 1991, P NATL ACAD SCI USA, V88, P3554, DOI 10.1073/pnas.88.9.3554; SELINFREUND RH, 1990, J CELL BIOL, V111, P2021, DOI 10.1083/jcb.111.5.2021; SHAW G, 1984, EUR J CELL BIOL, V33, P95; Soula C, 2001, DEVELOPMENT, V128, P1369; Stanke J, 2010, J COMP NEUROL, V518, P2316, DOI 10.1002/cne.22335; Stanke JJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-13; STONE J, 1987, J COMP NEUROL, V255, P35, DOI 10.1002/cne.902550104; Tsai HH, 2002, TRENDS NEUROSCI, V25, P173, DOI 10.1016/S0166-2236(00)02096-8; VANELDIK LJ, 1994, BBA-MOL CELL RES, V1223, P398, DOI 10.1016/0167-4889(94)90101-5; Wang YP, 2002, NAT NEUROSCI, V5, P831, DOI 10.1038/nn911; WATANABE T, 1988, NATURE, V332, P834, DOI 10.1038/332834a0; West H, 2005, DEVELOPMENT, V132, P1855, DOI 10.1242/dev.01732; Won MH, 2000, MICROSC RES TECHNIQ, V50, P151, DOI 10.1002/1097-0029(20000715)50:2<151::AID-JEMT7>3.0.CO;2-5; WYSE JPH, 1981, ACTA NEUROPATHOL, V54, P203, DOI 10.1007/BF00687743; Xiang MQ, 1996, P NATL ACAD SCI USA, V93, P11950, DOI 10.1073/pnas.93.21.11950; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7	62	40	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e10774	10.1371/journal.pone.0010774	http://dx.doi.org/10.1371/journal.pone.0010774			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567503	Green Published, Green Submitted, gold			2022-12-27	WOS:000278886300001
J	King, J; Keim, M; Teo, R; Weening, KE; Kapur, M; McQuillan, K; Ryves, J; Rogers, B; Dalton, E; Williams, RSB; Harwood, AJ				King, Jason; Keim, Melanie; Teo, Regina; Weening, Karin E.; Kapur, Mridu; McQuillan, Karina; Ryves, Jonathan; Rogers, Ben; Dalton, Emma; Williams, Robin S. B.; Harwood, Adrian J.			Genetic Control of Lithium Sensitivity and Regulation of Inositol Biosynthetic Genes	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; MANIC-DEPRESSIVE PATIENTS; DIPEPTIDYL PEPTIDASE-IV; BIPOLAR DISORDER; DICTYOSTELIUM-DISCOIDEUM; PROLYL ENDOPEPTIDASE; ANTIPSYCHOTIC-DRUGS; MONOPHOSPHATASE; POLYPHOSPHATES; CELLS	Lithium (Li+) is a common treatment for bipolar mood disorder, a major psychiatric illness with a lifetime prevalence of more than 1%. Risk of bipolar disorder is heavily influenced by genetic predisposition, but is a complex genetic trait and, to date, genetic studies have provided little insight into its molecular origins. An alternative approach is to investigate the genetics of Li+ sensitivity. Using the social amoeba Dictyostelium, we previously identified prolyl oligopeptidase (PO) as a modulator of Li+ sensitivity. In a link to the clinic, PO enzyme activity is altered in bipolar disorder patients. Further studies demonstrated that PO is a negative regulator of inositol(1,4,5) trisphosphate (IP3) synthesis, a Li+ sensitive intracellular signal. However, it was unclear how PO could influence either Li+ sensitivity or risk of bipolar disorder. Here we show that in both Dictyostelium and cultured human cells PO acts via Multiple Inositol Polyphosphate Phosphatase (Mipp1) to control gene expression. This reveals a novel, gene regulatory network that modulates inositol metabolism and Li+ sensitivity. Among its targets is the inositol monophosphatase gene IMPA2, which has also been associated with risk of bipolar disorder in some family studies, and our observations offer a cellular signalling pathway in which PO activity and IMPA2 gene expression converge.	[King, Jason; Keim, Melanie; Teo, Regina; Weening, Karin E.; Kapur, Mridu; McQuillan, Karina; Ryves, Jonathan; Rogers, Ben; Dalton, Emma; Harwood, Adrian J.] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [Williams, Robin S. B.] Univ London, Sch Biol Sci, Egham, Surrey, England	Cardiff University; University of London; Royal Holloway University London	Harwood, AJ (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.	harwoodaj@cf.ac.uk	Harwood, Adrian/A-4350-2010; Williams, Robin/G-6807-2011; Kapur, Mridu/M-2669-2019; King, Jason/D-6228-2011	Kapur, Mridu/0000-0002-3313-5038; King, Jason/0000-0003-0596-4506; Dalton, Emma/0000-0002-3517-0742; Harwood, Adrian/0000-0003-3124-5169	Wellcome Trust [74540]; BBSRC	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Wellcome Trust Programme Grant to AJH (74540) and a BBSRC committee studentship to JSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agam G, 2003, J PSYCHIAT RES, V37, P433, DOI 10.1016/S0022-3956(03)00044-X; Alloy LB, 2005, CLIN PSYCHOL REV, V25, P1043, DOI 10.1016/j.cpr.2005.06.006; ATACK JR, 1995, FEBS LETT, V361, P1, DOI 10.1016/0014-5793(95)00063-F; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; Breen G, 2004, BIPOLAR DISORD, V6, P156, DOI 10.1111/j.1399-5618.2004.00100.x; Burgess S.S.A., 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003013, DOI 10.1002/14651858.CD003013]; Casals I, 2002, ANAL BIOCHEM, V300, P69, DOI 10.1006/abio.2001.5449; Cho J, 2008, P NATL ACAD SCI USA, V105, P5998, DOI 10.1073/pnas.0710980105; Craddock N, 2009, TRENDS GENET, V25, P99, DOI 10.1016/j.tig.2008.12.002; Eickholt BJ, 2005, MOL PHARMACOL, V67, P1426, DOI 10.1124/mol.104.009308; Fischbach A, 2006, BIOCHEM J, V397, P509, DOI 10.1042/BJ20060277; Fornai F, 2008, P NATL ACAD SCI USA, V105, P2052, DOI 10.1073/pnas.0708022105; Gao Y, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702106200; GEE NS, 1988, BIOCHEM J, V253, P777, DOI 10.1042/bj2530777; GUSE AH, 1995, J CHROMATOGR B, V672, P189, DOI 10.1016/0378-4347(95)00219-9; INHORN RC, 1988, J BIOL CHEM, V263, P14559; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; King JS, 2009, DIS MODEL MECH, V2, P306, DOI 10.1242/dmm.001271; LAX AJ, 1979, J CELL SCI, V36, P311; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loovers HM, 2003, J BIOL CHEM, V278, P5652, DOI 10.1074/jbc.M208396200; Maes M, 1996, ACTA PSYCHIAT SCAND, V93, P1, DOI 10.1111/j.1600-0447.1996.tb10612.x; MAES M, 1995, PSYCHIAT RES, V58, P217, DOI 10.1016/0165-1781(95)02698-V; Mamdani F, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-9; MAYR GW, 1988, BIOCHEM J, V254, P585, DOI 10.1042/bj2540585; Nalaskowski MM, 2002, BIOCHEM J, V366, P549, DOI 10.1042/BJ20020327; Ohnishi T, 2007, NEUROPSYCHOPHARMACOL, V32, P1727, DOI 10.1038/sj.npp.1301307; Otto JC, 2007, P NATL ACAD SCI USA, V104, P15653, DOI 10.1073/pnas.0705729104; Padmos RC, 2008, ARCH GEN PSYCHIAT, V65, P395, DOI 10.1001/archpsyc.65.4.395; Padmos RC, 2009, ARCH GEN PSYCHIAT, V66, P957, DOI 10.1001/archgenpsychiatry.2009.116; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Schulz I, 2002, EUR J BIOCHEM, V269, P5813, DOI 10.1046/j.1432-1033.2002.03297.x; Shaltiel G, 2001, World J Biol Psychiatry, V2, P95; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Sjoholt G, 2004, MOL PSYCHIATR, V9, P621, DOI 10.1038/sj.mp.4001460; Sjoholt G, 2000, MOL PSYCHIATR, V5, P172, DOI 10.1038/sj.mp.4000681; Soll DR, 2001, METH MOL B, V161, P45; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Taylor Levi, 2002, Curr Psychiatry Rep, V4, P130, DOI 10.1007/s11920-002-0046-1; Van Gool AR, 2004, J INTERF CYTOK RES, V24, P411, DOI 10.1089/1079990041535629; VANDIJKEN P, 1995, J BIOL CHEM, V270, P29724; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; Williams RSB, 1999, EMBO J, V18, P2734, DOI 10.1093/emboj/18.10.2734; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; Wilson MP, 1996, J BIOL CHEM, V271, P11904, DOI 10.1074/jbc.271.20.11904; Yang XN, 2000, BIOCHEM J, V351, P551, DOI 10.1042/0264-6021:3510551; ZIGMOND SH, 1988, METHOD ENZYMOL, V162, P65	47	18	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11151	10.1371/journal.pone.0011151	http://dx.doi.org/10.1371/journal.pone.0011151			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567601	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000278886300005
J	Prescott, J; Hall, P; Acuna-Retamar, M; Ye, CY; Wathelet, MG; Ebihara, H; Feldmann, H; Hjelle, B				Prescott, Joseph; Hall, Pamela; Acuna-Retamar, Mariana; Ye, Chunyan; Wathelet, Marc G.; Ebihara, Hideki; Feldmann, Heinz; Hjelle, Brian			New World Hantaviruses Activate IFN lambda Production in Type I IFN-Deficient Vero E6 Cells	PLOS ONE			English	Article							SIN-NOMBRE HANTAVIRUS; MOUSE PEROMYSCUS-MANICULATUS; INNATE IMMUNE-RESPONSES; PULMONARY SYNDROME; INTERFERON ANTAGONIST; VIRUS-INFECTION; UNITED-STATES; T-CELLS; REPLICATION; EXPRESSION	Background: Hantaviruses indigenous to the New World are the etiologic agents of hantavirus cardiopulmonary syndrome (HCPS). These viruses induce a strong interferon-stimulated gene (ISG) response in human endothelial cells. African green monkey-derived Vero E6 cells are used to propagate hantaviruses as well as many other viruses. The utility of the Vero E6 cell line for virus production is thought to owe to their lack of genes encoding type I interferons (IFN), rendering them unable to mount an efficient innate immune response to virus infection. Interferon lambda, a more recently characterized type III IFN, is transcriptionally controlled much like the type I IFNs, and activates the innate immune system in a similar manner. Methodology/Principal Findings: We show that Vero E6 cells respond to hantavirus infection by secreting abundant IFN lambda. Three New World hantaviruses were similarly able to induce IFN lambda expression in this cell line. The IFN lambda contained within virus preparations generated with Vero E6 cells independently activates ISGs when used to infect several non-endothelial cell lines, whereas innate immune responses by endothelial cells are specifically due to viral infection. We show further that Sin Nombre virus replicates to high titer in human hepatoma cells (Huh7) without inducing ISGs. Conclusions/Significance: Herein we report that Vero E6 cells respond to viral infection with a highly active antiviral response, including secretion of abundant IFN lambda. This cytokine is biologically active, and when contained within viral preparations and presented to human epithelioid cell lines, results in the robust activation of innate immune responses. We also show that both Huh7 and A549 cell lines do not respond to hantavirus infection, confirming that the cytoplasmic RNA helicase pathways possessed by these cells are not involved in hantavirus recognition. We demonstrate that Vero E6 actively respond to virus infection and inhibiting IFN lambda production in these cells might increase their utility for virus propagation.	[Prescott, Joseph; Ebihara, Hideki; Feldmann, Heinz] NIAID, Virol Lab, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT USA; [Hall, Pamela] New Mexico Vet Affairs Hlth Care Syst, Res Serv 151, Albuquerque, NM USA; [Acuna-Retamar, Mariana; Ye, Chunyan; Wathelet, Marc G.; Hjelle, Brian] Univ New Mexico, Sch Med, Dept Pathol, Ctr Infect Dis & Immun, Albuquerque, NM 87131 USA; [Hjelle, Brian] Univ New Mexico, Dept Biol, Sch Med, Ctr Infect Dis & Immun, Albuquerque, NM 87131 USA; [Hjelle, Brian] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Ctr Infect Dis & Immun, Albuquerque, NM 87131 USA; [Wathelet, Marc G.] Lovelace Resp Res Inst, Program Infect Dis, Albuquerque, NM USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of New Mexico; University of New Mexico; University of New Mexico; Lovelace Respiratory Research Institute	Feldmann, H (corresponding author), NIAID, Virol Lab, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT USA.	feldmannh@niaid.nih.gov	Hall, Pamela/O-5402-2016	Hall, Pamela/0000-0003-2367-3382; Prescott, Joseph/0000-0001-5718-5155; Ebihara, Hideki/0000-0002-2576-9735	U.S Public Services [U01 AI56618]; Division of Intramural Research (DIR) of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI074246, U01AI056618, ZIAAI001089] Funding Source: NIH RePORTER	U.S Public Services; Division of Intramural Research (DIR) of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U.S Public Services grants U01 AI56618 (BH) and Division of Intramural Research (DIR) of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alff PJ, 2008, J VIROL, V82, P9115, DOI 10.1128/JVI.00290-08; Alff PJ, 2006, J VIROL, V80, P9676, DOI 10.1128/JVI.00508-06; Ank N, 2009, BIOFACTORS, V35, P82, DOI 10.1002/biof.19; Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Botten J, 2000, P NATL ACAD SCI USA, V97, P10578, DOI 10.1073/pnas.180197197; Botten J, 2003, J VIROL, V77, P1540, DOI 10.1128/JVI.77.2.1540-1550.2002; CHANG KC, 1991, ARCH VIROL, V117, P1, DOI 10.1007/BF01310488; Chew T, 2009, MOL IMMUNOL, V46, P393, DOI 10.1016/j.molimm.2008.10.010; CHILDS JE, 1994, J INFECT DIS, V169, P1271, DOI 10.1093/infdis/169.6.1271; ELLIOTT LH, 1994, AM J TROP MED HYG, V51, P102, DOI 10.4269/ajtmh.1994.51.102; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; Gavrilovskaya I, 1999, J CLIN MICROBIOL, V37, P122, DOI 10.1128/JCM.37.1.122-126.1999; Geimonen E, 2002, P NATL ACAD SCI USA, V99, P13837, DOI 10.1073/pnas.192298899; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Handke W, 2009, J IMMUNOL, V182, P2849, DOI 10.4049/jimmunol.0802893; Hartman AL, 2008, J VIROL, V82, P2699, DOI 10.1128/JVI.02344-07; Huang ZH, 2003, J VIROL, V77, P8676, DOI 10.1128/JVI.77.16.8676-8685.2003; KITAMURA T, 1983, JPN J MED SCI BIOL, V36, P17, DOI 10.7883/yoken1952.36.17; Kotenko SV, 2002, CYTOKINE GROWTH F R, V13, P223, DOI 10.1016/S1359-6101(02)00012-6; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Li Z D, 1983, Zhonghua Liu Xing Bing Xue Za Zhi, V4, P198; Mennechet FJD, 2006, BLOOD, V107, P4417, DOI 10.1182/blood-2005-10-4129; Mertz GJ, 1997, ADV INTERNAL MED, V42, P369; Mori M, 1999, J INFECT DIS, V179, P295, DOI 10.1086/314597; Nam JH, 2003, VIRUS GENES, V26, P31, DOI 10.1023/A:1022373904357; NOLTE KB, 1995, HUM PATHOL, V26, P110, DOI 10.1016/0046-8177(95)90123-X; Oelschlegel R, 2007, VIRUS RES, V127, P100, DOI 10.1016/j.virusres.2007.03.027; Perrone LA, 2007, J VIROL, V81, P884, DOI 10.1128/JVI.01074-06; Pober JS, 2001, ANN NY ACAD SCI, V941, P12; Prescott J, 2005, J VIROL, V79, P15007, DOI 10.1128/JVI.79.24.15007-15015.2005; Prescott JB, 2007, J IMMUNOL, V179, P1796, DOI 10.4049/jimmunol.179.3.1796; PUTHAVATHANA P, 1992, VIRUS RES, V26, P1, DOI 10.1016/0168-1702(92)90142-V; Ronni T, 1998, J INTERF CYTOK RES, V18, P773, DOI 10.1089/jir.1998.18.773; Schountz T, 2007, P NATL ACAD SCI USA, V104, P15496, DOI 10.1073/pnas.0707454104; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Song JW, 2009, J VIROL, V83, P6184, DOI 10.1128/JVI.00371-09; Song JW, 1996, VIRUS GENES, V12, P249; Spiropoulou CF, 2007, J VIROL, V81, P2769, DOI 10.1128/JVI.02402-06; Stoltz M, 2007, J VIROL, V81, P8685, DOI 10.1128/JVI.00415-07; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; ZAKI SR, 1995, AM J PATHOL, V146, P552; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	43	39	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11159	10.1371/journal.pone.0011159	http://dx.doi.org/10.1371/journal.pone.0011159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567522	Green Published, Green Submitted, gold			2022-12-27	WOS:000278886300006
J	Squeri, V; Masia, L; Casadio, M; Morasso, P; Vergaro, E				Squeri, Valentina; Masia, Lorenzo; Casadio, Maura; Morasso, Pietro; Vergaro, Elena			Force-Field Compensation in a Manual Tracking Task	PLOS ONE			English	Article							NERVOUS-SYSTEM; TRAJECTORY FORMATION; STEADY POSTURE; NEURAL-CONTROL; DYNAMICS; MOVEMENTS; REPRESENTATION; INTERMITTENCY; MAINTENANCE; IMPEDANCE	This study addresses force/movement control in a dynamic "hybrid'' task: the master sub-task is continuous manual tracking of a target moving along an eight-shaped Lissajous figure, with the tracking error as the primary performance index; the slave sub-task is compensation of a disturbing curl viscous field, compatibly with the primary performance index. The two sub-tasks are correlated because the lateral force the subject must exert on the eight-shape must be proportional to the longitudinal movement speed in order to perform a good tracking. The results confirm that visuo-manual tracking is characterized by an intermittent control mechanism, in agreement with previous work; the novel finding is that the overall control patterns are not altered by the presence of a large deviating force field, if compared with the undisturbed condition. It is also found that the control of interaction-forces is achieved by a combination of arm stiffness properties and direct force control, as suggested by the systematic lateral deviation of the trajectories from the nominal path and the comparison between perturbed trials and catch trials. The coordination of the two sub-tasks is quickly learnt after the activation of the deviating force field and is achieved by a combination of force and the stiffness components (about 80% vs. 20%), which is a function of the implicit accuracy of the tracking task.	[Squeri, Valentina; Masia, Lorenzo; Casadio, Maura; Morasso, Pietro] Italian Inst Technol, RBCS Dept, Genoa, Italy; [Casadio, Maura] Northwestern Univ, Chicago, IL 60611 USA; [Casadio, Maura; Morasso, Pietro; Vergaro, Elena] Univ Genoa, DIST Dept, Genoa, Italy	Istituto Italiano di Tecnologia - IIT; Northwestern University; University of Genoa	Squeri, V (corresponding author), Italian Inst Technol, RBCS Dept, Genoa, Italy.	valentina.squeri@iit.it	MASIA, LORENZO/D-9385-2014; Casadio, Maura/AAH-2861-2022; Casadio, Maura/AFM-0496-2022		RBCS dept. of the Italian Institute of Technology; EU [FP7]	RBCS dept. of the Italian Institute of Technology; EU(European Commission)	This work was partly supported by the RBCS dept. of the Italian Institute of Technology and the EU-funded FP7 project HUMOUR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL RW, 1972, J EXP PSYCHOL, V96, P92, DOI 10.1037/h0033457; BIZZI E, 1976, J NEUROPHYSIOL, V39, P435, DOI 10.1152/jn.1976.39.2.435; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Casadio Maura, 2006, Technol Health Care, V14, P123; Chib VS, 2009, J NEUROSCI, V29, P3939, DOI 10.1523/JNEUROSCI.5856-08.2009; Conditt MA, 1999, P NATL ACAD SCI USA, V96, P11625, DOI 10.1073/pnas.96.20.11625; FAVILLA M, 1989, EXP BRAIN RES, V75, P280; FELDMAN AG, 1966, BIOPHYS-USSR, V11, P766; FELDMAN AG, 1966, BIOPHYS-USSR, V11, P565; Hanneton S, 1997, BIOL CYBERN, V77, P381, DOI 10.1007/s004220050398; Hayhoe MM, 2003, J VISION, V3, P49, DOI 10.1167/3.1.6; Hogan N., 1985, ASME, V107, P1, DOI DOI 10.1115/1.3140702; KEARNEY RE, 1982, J BIOMECH, V15, P753, DOI 10.1016/0021-9290(82)90090-2; MCINTYRE J, 1995, J NEUROPHYSIOL, V73, P1201, DOI 10.1152/jn.1995.73.3.1201; MIALL RC, 1993, J MOTOR BEHAV, V25, P53, DOI 10.1080/00222895.1993.9941639; MORASSO P, 1981, EXP BRAIN RES, V42, P223; MORASSO P, 1982, BIOL CYBERN, V45, P131, DOI 10.1007/BF00335240; Mugge W, 2010, EXP BRAIN RES, V200, P325, DOI 10.1007/s00221-009-1985-0; Mugge W, 2009, J NEUROSCI, V29, P5476, DOI 10.1523/JNEUROSCI.0116-09.2009; NAVAS F, 1968, BIOPHYS J, V8, P252, DOI 10.1016/S0006-3495(68)86488-4; Nisky I, 2008, IEEE T HAPTICS, V1, P73, DOI [10.1109/TOH.2008.17, 10.1109/ToH.2008.17]; Ohta K, 2004, BIOL CYBERN, V91, P23, DOI 10.1007/s00422-004-0491-5; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pasalar S, 2005, EXP BRAIN RES, V163, P214, DOI 10.1007/s00221-004-2169-6; Poulton EC., 1974, TRACKING SKILL MANUA; RAIBERT MH, 1981, T ASME, V102, P126; Roitman AV, 2004, J NEUROPHYSIOL, V91, P901, DOI 10.1152/jn.00261.2003; RUSSELL D, 1989, P IEEE ENG MED BIOL, P892; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; STEINBACH MJ, 1969, J EXP PSYCHOL, V82, P366, DOI 10.1037/h0028115; TSUJI T, 1995, BIOL CYBERN, V72, P475, DOI 10.1007/BF00199890; Venkadesan M, 2008, J NEUROSCI, V28, P1366, DOI 10.1523/JNEUROSCI.4993-07.2008; VIVIANI P, 1982, NEUROSCIENCE, V7, P431, DOI 10.1016/0306-4522(82)90277-9; WOLPERT DM, 1992, J MOTOR BEHAV, V24, P299, DOI 10.1080/00222895.1992.9941626	34	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11189	10.1371/journal.pone.0011189	http://dx.doi.org/10.1371/journal.pone.0011189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567516	Green Submitted, Green Published, gold			2022-12-27	WOS:000278886300029
J	Stevens, VM; Pavoine, S; Baguette, M				Stevens, Virginie M.; Pavoine, Sandrine; Baguette, Michel			Variation within and between Closely Related Species Uncovers High Intra-Specific Variability in Dispersal	PLOS ONE			English	Article							DENSITY-DEPENDENT DISPERSAL; HABITAT FRAGMENTATION; CLIMATE-CHANGE; QUADRATIC ENTROPY; PARARGE-AEGERIA; WOLF SPIDER; DYNAMICS; LEPIDOPTERA; SELECTION; BEHAVIOR	Mounting evidence shows that contrasting selection pressures generate variability in dispersal patterns among individuals or populations of the same species, with potential impacts on both species dynamics and evolution. However, this variability is hardly considered in empirical works, where a single dispersal function is considered to adequately reflect the species-specific dispersal ability, suggesting thereby that within-species variation is negligible as regard to inter-specific differences in dispersal abilities. We propose here an original method to make the comparison of intra- and inter-specific variability in dispersal, by decomposing the diversity of that trait along a phylogeny of closely related species. We used as test group European butterflies that are classic study organisms in spatial ecology. We apply the analysis separately to eight metrics that reflect the dispersal propensity, the dispersal ability or the dispersal efficiency of populations and species. At the inter-specific level, only the dispersal ability showed the signature of a phylogenetic signal while neither the dispersal propensity nor the dispersal efficiency did. At the within-species level, the partitioning of dispersal diversity showed that dispersal was variable or highly variable among populations: intra- specific variability represented from 11% to 133% of inter-specific variability in dispersal metrics. This finding shows that dispersal variation is far from negligible in the wild. Understanding the processes behind this high within-species variation should allow us to properly account for dispersal in demographic models. Accordingly, to encompass the within species variability in life histories the use of more than one value per trait per species should be encouraged in the construction of databases aiming at being sources for modelling purposes.	[Stevens, Virginie M.] FRS FNRS, Liege, Belgium; [Stevens, Virginie M.] Univ Liege, Unite Biol Comportement, Liege, Belgium; [Stevens, Virginie M.; Baguette, Michel] Museum Natl Hist Nat, UMR CNRS MNHN 7179, Brunoy, France; [Pavoine, Sandrine] Museum Natl Hist Nat, UMR CNRS MNHN 7204, Dept Ecol & Gest Biodivers Paris, F-75231 Paris, France; [Baguette, Michel] CNRS Moulis, USR CNRS Stn Ecol Expt 2936, St Girons, France	Fonds de la Recherche Scientifique - FNRS; University of Liege; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS)	Stevens, VM (corresponding author), FRS FNRS, Liege, Belgium.	stevens@mnhn.fr	Baguette, Michel/HHZ-3609-2022; Baguette, Michel/E-4754-2011		CNRS-MNHN [7179]; EU [226852]	CNRS-MNHN(Centre National de la Recherche Scientifique (CNRS)); EU(European Commission)	This study was funded by the mixed CNRS-MNHN research unit 7179. MB was partly funded by the EU FP7 SCALES project (Securing the conservations of biodiversity across Administrative levels and spatial, temporal and Ecological Scales; project #226852). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 1999, EVOL ECOL RES, V1, P895; Anderson BJ, 2009, P ROY SOC B-BIOL SCI, V276, P1415, DOI 10.1098/rspb.2008.1681; [Anonymous], 2004, WINGS CHECKERSPOTS M, DOI DOI 10.1086/431079; Berwaerts K, 2002, FUNCT ECOL, V16, P484, DOI 10.1046/j.1365-2435.2002.00650.x; Bonte D, 2007, BEHAV ECOL, V18, P438, DOI 10.1093/beheco/arl103; Bonte D, 2006, ANIM BEHAV, V72, P655, DOI 10.1016/j.anbehav.2005.11.026; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Bowler DE, 2009, J ANIM ECOL, V78, P1234, DOI 10.1111/j.1365-2656.2009.01580.x; Cizek L, 2006, ECOL ENTOMOL, V31, P337, DOI 10.1111/j.1365-2311.2006.00783.x; Clarke AL, 1997, OIKOS, V79, P429, DOI 10.2307/3546885; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Dytham C, 2006, OIKOS, V113, P530, DOI 10.1111/j.2006.0030-1299.14395.x; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; GOULSON D, 1993, HEREDITY, V71, P386, DOI 10.1038/hdy.1993.153; Haag CR, 2005, P ROY SOC B-BIOL SCI, V272, P2449, DOI 10.1098/rspb.2005.3235; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hanski I., 1999, METAPOPULATION ECOLO; Hanski Ilkka, 1995, P149, DOI 10.1016/B978-012159270-7/50009-9; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hovestadt Thomas, 2009, P97; Hughes CL, 2003, P ROY SOC B-BIOL SCI, V270, pS147, DOI 10.1098/rsbl.2003.0049; Ims Rolf A., 1997, P247, DOI 10.1016/B978-012323445-2/50015-8; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; Merckx T, 2007, ANIM BEHAV, V74, P1029, DOI 10.1016/j.anbehav.2006.12.020; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; Neve G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-84; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pavoine S, 2005, ENVIRON ECOL STAT, V12, P125, DOI 10.1007/s10651-005-1037-2; PAVOINE S, 2010, ECOLOGICAL IN PRESS; Plaistow SJ, 2009, PHILOS T R SOC B, V364, P1049, DOI 10.1098/rstb.2008.0251; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; R Core Team, 2020, R LANG ENV STAT COMP; Rao C. R., 1986, ENCY STAT SCI, V7, P614; Roff Derek A., 2001, P191; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Schtickzelle N, 2006, ECOLOGY, V87, P1057, DOI 10.1890/0012-9658(2006)87[1057:DDWHFI]2.0.CO;2; STEVENS VM, 2010, BIOL REV IN PRESS, DOI DOI 10.1111/J.1469-185X.2009.00119.X; Stirling DG, 2002, J EVOLUTION BIOL, V15, P277, DOI 10.1046/j.1420-9101.2002.00389.x; Trakhtenbrot A, 2005, DIVERS DISTRIB, V11, P173, DOI 10.1111/j.1366-9516.2005.00156.x; Travis JMJ, 2009, J THEOR BIOL, V259, P151, DOI 10.1016/j.jtbi.2009.03.008; Watt WB, 1996, MOL BIOL EVOL, V13, P699, DOI 10.1093/oxfordjournals.molbev.a025631	43	69	71	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11123	10.1371/journal.pone.0011123	http://dx.doi.org/10.1371/journal.pone.0011123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559551	Green Published, gold, Green Submitted			2022-12-27	WOS:000278775900013
J	Xu, FL; Proft, J; Gibbs, S; Winkfein, B; Johnson, JN; Syed, N; Braun, JEA				Xu, Fenglian; Proft, Juliane; Gibbs, Sarah; Winkfein, Bob; Johnson, Jadah N.; Syed, Naweed; Braun, Janice E. A.			Quercetin Targets Cysteine String Protein (CSP alpha) and Impairs Synaptic Transmission	PLOS ONE			English	Article							CALCIUM CURRENT; DROSOPHILA; CA2+; VESICLES; COMPLEX; NEUROTRANSMITTER; SYNAPTOGENESIS; MODULATION; EXPRESSION; SECRETION	Background: Cysteine string protein (CSP alpha) is a synaptic vesicle protein that displays unique anti-neurodegenerative properties. CSP alpha is a member of the conserved J protein family, also called the Hsp40 (heat shock protein of 40 kDa) protein family, whose importance in protein folding has been recognized for many years. Deletion of the CSP alpha in mice results in knockout mice that are normal for the first 2-3 weeks of life followed by an unexplained presynaptic neurodegeneration and premature death. How CSP alpha prevents neurodegeneration is currently not known. As a neuroprotective synaptic vesicle protein, CSP alpha represents a promising therapeutic target for the prevention of neurodegenerative disorders. Methodology/Principal Findings: Here, we demonstrate that the flavonoid quercetin promotes formation of stable CSP alpha-CSP alpha dimers and that quercetin-induced dimerization is dependent on the unique cysteine string region. Furthermore, in primary cultures of Lymnaea neurons, quercetin induction of CSP alpha dimers correlates with an inhibition of synapse formation and synaptic transmission suggesting that quercetin interfers with CSP alpha function. Quercetin's action on CSP alpha is concentration dependent and does not promote dimerization of other synaptic proteins or other J protein family members and reduces the assembly of CSP alpha:Hsc70 units (70kDa heat shock cognate protein). Conclusions/Significance: Quercetin is a plant derived flavonoid and popular nutritional supplement proposed to prevent memory loss and altitude sickness among other ailments, although its precise mechanism(s) of action has been unclear. In view of the therapeutic promise of upregulation of CSP alpha and the undesired consequences of CSP alpha dysfunction, our data establish an essential proof of principle that pharmaceutical agents can selectively target the neuroprotective J protein CSP alpha.	[Xu, Fenglian; Syed, Naweed] Univ Calgary, Dept Anat & Cell Biol, Calgary, AB, Canada; [Proft, Juliane; Gibbs, Sarah; Winkfein, Bob; Johnson, Jadah N.; Braun, Janice E. A.] Univ Calgary, Dept Physiol & Pharmacol, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary; University of Calgary	Xu, FL (corresponding author), Univ Calgary, Dept Anat & Cell Biol, Calgary, AB, Canada.	braunj@ucalgary.ca	Proft, Juliane/H-6549-2014; Xu, Fenglian/B-3961-2016	Proft, Juliane/0000-0003-0980-8930; 	CIHR [MOP-49476(JEAB) FRN-49600(NIS)]	CIHR(Canadian Institutes of Health Research (CIHR))	This work was funded by CIHR MOP-49476(JEAB) FRN-49600(NIS). JEAB is an AHFMR senior scholar. FX is an AHFMR and HBI Postdoctoral Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold C, 2004, J EXP BIOL, V207, P1323, DOI 10.1242/jeb.00898; Bai LP, 2007, BIOCHEM BIOPH RES CO, V352, P123, DOI 10.1016/j.bbrc.2006.10.178; BARZILAI A, 1983, BIOCHIM BIOPHYS ACTA, V730, P245, DOI 10.1016/0005-2736(83)90340-1; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; BRAUN JEA, 1995, NEUROPHARMACOLOGY, V34, P1361, DOI 10.1016/0028-3908(95)00114-L; Braun JEA, 1996, J BIOL CHEM, V271, P25989, DOI 10.1074/jbc.271.42.25989; Bronk P, 2005, J NEUROSCI, V25, P2204, DOI 10.1523/JNEUROSCI.3610-04.2005; Chamberlain LH, 1998, BIOCHEM J, V335, P205, DOI 10.1042/bj3350205; Chamberlain LH, 1997, BIOCHEM J, V322, P853, DOI 10.1042/bj3220853; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chen S, 2002, J PHYSIOL-LONDON, V538, P383, DOI 10.1113/jphysiol.2001.013397; Cogolludo A, 2007, CARDIOVASC RES, V73, P424, DOI 10.1016/j.cardiores.2006.09.008; Dawson-Scully K, 2000, J NEUROSCI, V20, P6039, DOI 10.1523/JNEUROSCI.20-16-06039.2000; Dawson-Scully K, 2007, SYNAPSE, V61, P1, DOI 10.1002/syn.20335; Do T, 2007, J NEUROCHEM, V101, P619, DOI 10.1111/j.1471-4159.2006.04388.x; Feng ZP, 1997, J NEUROSCI, V17, P7839; Feng ZP, 2000, J NEUROBIOL, V42, P357, DOI 10.1002/(SICI)1097-4695(20000215)42:3<357::AID-NEU7>3.0.CO;2-F; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Gibbs SJ, 2008, NEUROBIOL DIS, V32, P196, DOI 10.1016/j.nbd.2008.07.016; Gibbs SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004595; GUNDERSEN CB, 1992, NEURON, V9, P527, DOI 10.1016/0896-6273(92)90190-O; GUNDERSEN CB, 1994, J BIOL CHEM, V269, P19197; Hamakawa T, 1999, J NEUROSCI, V19, P9306; Johnson JN, 2010, BIOCHEM CELL BIOL, V88, P157, DOI [10.1139/O09-124, 10.1139/o09-124]; KAO JPY, 1994, METHOD CELL BIOL, V40, P155; Leveque C, 1998, J BIOL CHEM, V273, P13488, DOI 10.1074/jbc.273.22.13488; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; MASTROGIACOMO A, 1994, SCIENCE, V263, P981, DOI 10.1126/science.7906056; Miller LC, 2003, J CELL SCI, V116, P2967, DOI 10.1242/jcs.00595; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; Nie ZP, 1999, J NEUROSCI, V19, P10270; PATTNAIK BR, 2009, AM J PHYSL CELL PHYS; Ranjan R, 1998, J NEUROSCI, V18, P956; Rosales-Hernandez A, 2009, CELL STRESS CHAPERON, V14, P71, DOI 10.1007/s12192-008-0056-y; Saponara S, 2002, BRIT J PHARMACOL, V135, P1819, DOI 10.1038/sj.bjp.0704631; Saponara S, 2008, EUR J PHARMACOL, V598, P75, DOI 10.1016/j.ejphar.2008.08.016; Schmitz F, 2006, P NATL ACAD SCI USA, V103, P2926, DOI 10.1073/pnas.0510060103; SHOSHAN V, 1981, J BIOL CHEM, V256, P887; Stahl B, 1999, EUR J CELL BIOL, V78, P375, DOI 10.1016/S0171-9335(99)80079-X; Swayne LA, 2003, BIOCHEM BIOPH RES CO, V300, P921, DOI 10.1016/S0006-291X(02)02964-9; Swayne LA, 2006, BIOCHEM BIOPH RES CO, V348, P83, DOI 10.1016/j.bbrc.2006.07.033; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; Umbach JA, 1998, J NEUROSCI, V18, P3233; UMBACH JA, 1994, NEURON, V13, P899, DOI 10.1016/0896-6273(94)90255-0; Umbach JA, 1997, J NEUROSCI, V17, P7203; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Woodin MA, 1999, LEARN MEMORY, V6, P307; Wu SN, 2003, J CELL PHYSIOL, V195, P298, DOI 10.1002/jcp.10244; Xu FL, 2009, J NEUROSCI, V29, P2167, DOI 10.1523/JNEUROSCI.4682-08.2009; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhao X, 2008, CELL MOL LIFE SCI, V65, P2385, DOI 10.1007/s00018-008-8089-z; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; [No title captured]	53	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11045	10.1371/journal.pone.0011045	http://dx.doi.org/10.1371/journal.pone.0011045			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548785	Green Submitted, Green Published, gold			2022-12-27	WOS:000278599600006
J	Demetriou, VL; van de Vijver, DAMC; Kousiappa, I; Balotta, C; Clotet, B; Grossman, Z; Jorgensen, LB; Lepej, SZ; Levy, I; Nielsen, C; Paraskevis, D; Poljak, M; Roman, F; Ruiz, L; Schmidt, JC; Vandamme, AM; Van Laethem, K; Vercauteren, J; Kostrikis, LG				Demetriou, Victoria L.; van de Vijver, David A. M. C.; Kousiappa, Ioanna; Balotta, Claudia; Clotet, Bonaventura; Grossman, Zehava; Jorgensen, Louise B.; Lepej, Snjezana Z.; Levy, Itzchak; Nielsen, Claus; Paraskevis, Dimitrios; Poljak, Mario; Roman, Francois; Ruiz, Lidia; Schmidt, Jean-Claude; Vandamme, Anne-Mieke; Van Laethem, Kristel; Vercauteren, Jurgen; Kostrikis, Leondios G.			Cellular HIV-1 DNA Levels in Drug Sensitive Strains Are Equivalent to Those in Drug Resistant Strains in Newly-Diagnosed Patients in Europe	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; DISEASE PROGRESSION; PERIPHERAL-BLOOD; VIRAL LOAD; TYPE-1 DNA; ANTIRETROVIRAL THERAPY; PRIMARY INFECTION; CORECEPTOR USAGE; FOLLOW-UP; RESERVOIR	Background: HIV-1 genotypic drug resistance is an important threat to the success of antiretroviral therapy and transmitted resistance has reached 9% prevalence in Europe. Studies have demonstrated that HIV-1 DNA load in peripheral blood mononuclear cells (PBMC) have a predictive value for disease progression, independently of CD4 counts and plasma viral load. Methodology/Principal Findings: Molecular-beacon-based real-time PCR was used to measure HIV-1 second template switch (STS) DNA in PBMC in newly-diagnosed HIV-1 patients across Europe. These patients were representative for the HIV-1 epidemic in the participating countries and were carrying either drug-resistant or sensitive viral strains. The assay design was improved from a previous version to specifically detect M-group HIV-1 and human CCR5 alleles. The findings resulted in a median of 3.32 log(10) HIV-1 copies/10(6) PBMC and demonstrated for the first time no correlation between cellular HIV-1 DNA load and transmitted drug-resistance. A weak association between cellular HIV-1 DNA levels with plasma viral RNA load and CD4(+) T-cell counts was also reconfirmed. Co-receptor tropism for 91% of samples, whether or not they conferred resistance, was CCR5. A comparison of pol sequences derived from RNA and DNA, resulted in a high similarity between the two. Conclusions/Significance: An improved molecular-beacon-based real-time PCR assay is reported for the measurement of HIV-1 DNA in PBMC and has investigated the association between cellular HIV-1 DNA levels and transmitted resistance to antiretroviral therapy in newly-diagnosed patients from across Europe. The findings show no correlation between these two parameters, suggesting that transmitted resistance does not impact disease progression in HIV-1 infected individuals. The CCR5 co-receptor tropism predominance implies that both resistant and non-resistant strains behave similarly in early infection. Furthermore, a correlation found between RNA-and DNA-derived sequences in the pol region suggests that genotypic drug-resistance testing could be carried out on either template.	[Demetriou, Victoria L.; Kousiappa, Ioanna; Kostrikis, Leondios G.] Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus; [van de Vijver, David A. M. C.] Univ Med Ctr, Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Balotta, Claudia] Univ Milan, Inst Infect & Trop Dis, Milan, Italy; [Clotet, Bonaventura; Ruiz, Lidia] Hosp Badalona Germans Trias & Pujol, IrsiCaixa Fdn, Barcelona, Spain; [Grossman, Zehava] Chaim Sheba Med Ctr, Natl HIV Reference Lab, Publ Hlth Labs, MOH Cent Virol, Ramat Gan, Israel; [Jorgensen, Louise B.; Nielsen, Claus] Statens Serum Inst, Retrovirus Lab, Div Diagnost Microbiol, Dept Virol, DK-2300 Copenhagen, Denmark; [Lepej, Snjezana Z.] Univ Zagreb, Univ Hosp Infect Dis, Zagreb, Croatia; [Levy, Itzchak] Chaim Sheba Med Ctr, Infect Dis Unit, Ramat Gan, Israel; [Paraskevis, Dimitrios] Univ Athens, Sch Med, Natl Retrovirus Reference Ctr, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece; [Poljak, Mario] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia; [Roman, Francois; Schmidt, Jean-Claude] Ctr Hosp Luxembourg, Retrovirol Lab, Natl Serv Infect Dis, Luxembourg, Luxembourg; [Vandamme, Anne-Mieke; Van Laethem, Kristel; Vercauteren, Jurgen] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium	University of Cyprus; Erasmus University Rotterdam; Erasmus MC; University of Milan; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Chaim Sheba Medical Center; Statens Serum Institut; University of Zagreb; Chaim Sheba Medical Center; Athens Medical School; National & Kapodistrian University of Athens; University of Ljubljana; Luxembourg Hospital Center; KU Leuven	Demetriou, VL (corresponding author), Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus.	lkostrik@ucy.ac.cy	KOSTRIKIS, LEONDIOS G/A-5330-2016; Paraskevis, Dimitrios/H-5835-2019; Ruiz, Lidia/ABF-9720-2021; Vercauteren, Jurgen/P-7676-2019; Vandamme, Anne-Mieke/I-4127-2012; Van Laethem, Kristel/R-6282-2016; Balotta, Claudia/L-7295-2017	KOSTRIKIS, LEONDIOS G/0000-0002-5340-7109; Paraskevis, Dimitrios/0000-0001-6167-7152; Vercauteren, Jurgen/0000-0003-0698-4736; Vandamme, Anne-Mieke/0000-0002-6594-2766; Van Laethem, Kristel/0000-0001-6036-2271; Balotta, Claudia/0000-0002-1107-9119; Kousiappa, Ioanna/0000-0002-7491-5946; van de Vijver, David/0000-0001-5877-8526	University of Cyprus; Cyprus Research Promotion [PENEK/ENISX/0308/15]; European Commission [LSHP-CT-2006-518211]; Cyprus Research Promotion Foundation [KY-IT/0906/04]; Belgian Fonds voor Wetenschappelijk Onderzoek [G.0611.09]; Interuniversitaire Attractiepolen [P6/41]	University of Cyprus; Cyprus Research Promotion; European Commission(European CommissionEuropean Commission Joint Research Centre); Cyprus Research Promotion Foundation; Belgian Fonds voor Wetenschappelijk Onderzoek; Interuniversitaire Attractiepolen	The project was funded by the University of Cyprus. IK was funded by grants PENEK/ENISX/0308/15 from the Cyprus Research Promotion. Coordination aspects have been funded by the EuropeHIVResistance grant LSHP-CT-2006-518211 from the European Commission. Additional support was provided by grant KY-IT/0906/04 from the Cyprus Research Promotion Foundation, and for Belgium grants G.0611.09 (Belgian Fonds voor Wetenschappelijk Onderzoek) and P6/41 (Interuniversitaire Attractiepolen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; Avettand-Fenoel V, 2008, J CLIN VIROL, V42, P399, DOI 10.1016/j.jcv.2008.03.013; Beloukas A, 2009, CURR HIV RES, V7, P255, DOI 10.2174/157016209788348001; Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; Brown AJL, 2003, J INFECT DIS, V187, P683, DOI 10.1086/367989; Carr JM, 2007, J CLIN MICROBIOL, V45, P1288, DOI 10.1128/JCM.01926-06; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Descamps D, 2005, JAIDS-J ACQ IMM DEF, V38, P545, DOI 10.1097/01.qai.0000155201.51232.2e; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FERRE F, 1995, J ACQ IMMUN DEF SYND, V10, pS51; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Goujard C, 2006, CLIN INFECT DIS, V42, P709, DOI 10.1086/500213; Hatzakis A, 2000, LANCET, V355, P599, DOI 10.1016/S0140-6736(99)10311-8; Hatzakis AE, 2004, AIDS, V18, P2261, DOI 10.1097/00002030-200411190-00006; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Jensen MA, 2006, J VIROL, V80, P4698, DOI 10.1128/JVI.80.10.4698-4704.2006; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Johnson Victoria A, 2008, Top HIV Med, V16, P138; Kabamba-Mukadi B, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-15; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kostrikis LG, 2002, J VIROL, V76, P10099, DOI 10.1128/JVI.76.20.10099-10108.2002; Kousiappa I, 2009, AIDS RES HUM RETROV, V25, P23, DOI 10.1089/aid.2008.0168; Kozal MJ, 2004, AIDS, V18, P2185, DOI 10.1097/00002030-200411050-00011; Minga AK, 2008, JAIDS-J ACQ IMM DEF, V48, P350, DOI 10.1097/QAI.0b013e3181775e55; Ngo-Giang-Huong N, 2001, AIDS, V15, P665, DOI 10.1097/00002030-200104130-00001; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Re MC, 2006, NEW MICROBIOL, V29, P81; RE MC, 2009, CLIN MICROBIOL INFEC; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Rouzioux C, 2005, J INFECT DIS, V192, P46, DOI 10.1086/430610; Ruitenberg JJ, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-11; Russell RR, 2001, VIRAL IMMUNOL, V14, P379, DOI 10.1089/08828240152716628; Saitoh A, 2002, J INFECT DIS, V185, P1409, DOI 10.1086/340614; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sedaghat AR, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-2; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Sing T, 2007, ANTIVIR THER, V12, P1097; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; Strain MC, 2005, J INFECT DIS, V191, P1410, DOI 10.1086/428777; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tierney C, 2003, J INFECT DIS, V187, P144, DOI 10.1086/345870; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; VANDEVIJVER D, 2007, THEORETICAL BIOL BIO, P17; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; VERHOFSTEDE C, 1994, AIDS, V8, P1421, DOI 10.1097/00002030-199410000-00008; Viard JP, 2004, AIDS, V18, P45, DOI 10.1097/00002030-200401020-00005; Weinstock HS, 2004, J INFECT DIS, V189, P2174, DOI 10.1086/420789; Wensing AMJ, 2008, AIDS, V22, P625, DOI 10.1097/QAD.0b013e3282f5e062; Yerly S, 2001, AIDS, V15, P2287, DOI 10.1097/00002030-200111230-00010; 2009, STANFORD HIV RESISTA	54	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e10976	10.1371/journal.pone.0010976	http://dx.doi.org/10.1371/journal.pone.0010976			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544014	Green Published, gold			2022-12-27	WOS:000278494900005
J	Song, CNA; Fang, JG; Wang, C; Guo, L; Nicholas, KK; Ma, ZQ				Song, Changnian; Fang, Jinggui; Wang, Chen; Guo, Lei; Nicholas, Kibet Korir; Ma, Zhengqiang			MiR-RACE, a New Efficient Approach to Determine the Precise Sequences of Computationally Identified Trifoliate Orange (Poncirus trifoliata) MicroRNAs	PLOS ONE			English	Article							REGULATORY ROLES; SMALL RNAS; PCR; TARGETS	Background: Among the hundreds of genes encoding miRNAs in plants reported, much more were predicted by numerous computational methods. However, unlike protein-coding genes defined by start and stop codons, the ends of miRNA molecules do not have characteristics that can be used to define the mature miRNAs exactly, which made computational miRNA prediction methods often cannot predict the accurate location of the mature miRNA in a precursor with nucleotide-level precision. To our knowledge, there haven't been reports about comprehensive strategies determining the precise sequences, especially two termini, of these miRNAs. Methods: In this study, we report an efficient method to determine the precise sequences of computationally predicted microRNAs (miRNAs) that combines miRNA-enriched library preparation, two specific 5' and 3' miRNA RACE (miR-RACE) PCR reactions, and sequence-directed cloning, in which the most challenging step is the two specific gene specific primers designed for the two RACE reactions. miRNA-mediated mRNA cleavage by RLM-5' RACE and sequencing were carried out to validate the miRNAs detected. Real-time PCR was used to analyze the expression of each miRNA. Results: The efficiency of this newly developed method was validated using nine trifoliate orange (Poncirus trifoliata) miRNAs predicted computationally. The miRNAs computationally identified were validated by miR-RACE and sequencing. Quantitative analysis showed that they have variable expression. Eight target genes have been experimentally verified by detection of the miRNA-mediated mRNA cleavage in Poncirus trifoliate. Conclusion: The efficient and powerful approach developed herein can be successfully used to validate the sequences of miRNAs, especially the termini, which depict the complete miRNA sequence in the computationally predicted precursor.	[Song, Changnian; Fang, Jinggui; Wang, Chen; Guo, Lei; Nicholas, Kibet Korir] Nanjing Agr Univ, Coll Hort, Nanjing, Peoples R China; [Ma, Zhengqiang] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Fang, JG (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Peoples R China.	fanggg@njau.edu.cn	Ma, Zhengqiang/AAQ-9160-2021; Ma, Zhengqiang/AAI-9876-2020	Ma, Zhengqiang/0000-0003-4950-5387; Fang, Jinggui/0000-0003-1975-2715	NCET Program of China [NCET-08-0796]; China Ministry of Education [109084]	NCET Program of China(Program for New Century Excellent Talents in University (NCET)); China Ministry of Education(Ministry of Education, China)	This work was supported by the NCET Program of China (grant no. NCET-08-0796) and the Science and Technology Key Project of the China Ministry of Education (grant no. 109084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adai A, 2005, GENOME RES, V15, P78, DOI 10.1101/gr.2908205; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; CARTER P, 1986, BIOCHEM J, V237, P1; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Dsouza M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4; Elbashir S.M., 2001, GENE DEV, V16, P1616; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; HUTCHISON CA, 1978, J BIOL CHEM, V253, P6551; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; KOVALIC D, 1991, NUCLEIC ACIDS RES, V19, P4560, DOI 10.1093/nar/19.16.4560; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mallory AC, 2008, TRENDS PLANT SCI, V13, P359, DOI 10.1016/j.tplants.2008.03.007; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Peng RH, 2006, APPL MICROBIOL BIOT, V73, P234, DOI 10.1007/s00253-006-0583-3; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ruvkun Gary, 2004, Cell, VS116, pS93, DOI 10.1016/S0092-8674(04)00034-0; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Song CN, 2009, PLANTA, V230, P671, DOI 10.1007/s00425-009-0971-x; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Sunkar Ramanjulu, 2008, BMC Plant Biol, V8, P25, DOI 10.1186/1471-2229-8-25; Wang JF, 2004, NUCLEIC ACIDS RES, V32, P1688, DOI 10.1093/nar/gkh332; Zhang BH, 2006, COMPUT BIOL CHEM, V30, P395, DOI 10.1016/j.compbiolchem.2006.08.006; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	40	45	49	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10861	10.1371/journal.pone.0010861	http://dx.doi.org/10.1371/journal.pone.0010861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539756	Green Submitted, gold, Green Published			2022-12-27	WOS:000278465900001
J	Becker, MH; Harris, RN				Becker, Matthew H.; Harris, Reid N.			Cutaneous Bacteria of the Redback Salamander Prevent Morbidity Associated with a Lethal Disease	PLOS ONE			English	Article							CHYTRID BATRACHOCHYTRIUM-DENDROBATIDIS; SKIN PEPTIDE DEFENSES; YELLOW-LEGGED FROG; HYDROGEN-PEROXIDE; POPULATION DECLINES; INFECTIOUS-DISEASES; AMPHIBIAN PATHOGEN; PLETHODON-CINEREUS; CENTRAL-AMERICA; RANA-MUSCOSA	Chytridiomycosis, caused by the fungal pathogen Batrachochytrium dendrobatidis (Bd), is an infectious disease that causes population declines of many amphibians. Cutaneous bacteria isolated from redback salamanders, Plethodon cinereus, and mountain yellow-legged frogs, Rana muscosa, inhibit the growth of Bd in vitro. In this study, the bacterial community present on the skin of P. cinereus individuals was investigated to determine if it provides protection to salamanders from the lethal and sub-lethal effects of chytridiomycosis. When the cutaneous bacterial community was reduced prior to Bd exposure, salamanders experienced a significantly greater decrease in body mass, which is a symptom of the disease, when compared to infected individuals with a normal bacterial community. In addition, a greater proportion of infected individuals with a reduced bacterial community experienced limb-lifting, a behavior seen only in infected individuals. Overall, these results demonstrate that the cutaneous bacterial community of P. cinereus provides protection to the salamander from Bd and that alteration of this community can change disease resistance. Therefore, symbiotic microbes associated with this species appear to be an important component of its innate skin defenses.	[Becker, Matthew H.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Harris, Reid N.] James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA	Virginia Polytechnic Institute & State University; James Madison University	Becker, MH (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	mhbecker3@gmail.com			National Science Foundation [0640373]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (grant 0640373 to RNH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2009, AQUAT BIOL, V4, P289, DOI 10.3354/ab00102; Andre SE, 2008, J WILDLIFE DIS, V44, P716, DOI 10.7589/0090-3558-44.3.716; Austin RM, 2000, BIOLOGY OF PLETHODONTID SALAMANDERS, P451; Becker MH, 2009, APPL ENVIRON MICROB, V75, P6635, DOI 10.1128/AEM.01294-09; Belden LK, 2007, FRONT ECOL ENVIRON, V5, P533; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Blaustein AR, 2009, ECOHEALTH, V6, P373, DOI 10.1007/s10393-009-0266-5; Boskey ER, 1999, INFECT IMMUN, V67, P5170, DOI 10.1128/IAI.67.10.5170-5175.1999; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brook I, 1999, CRIT REV MICROBIOL, V25, P155, DOI 10.1080/10408419991299211; Brucker RM, 2008, J CHEM ECOL, V34, P1422, DOI 10.1007/s10886-008-9555-7; Brucker RM, 2008, J CHEM ECOL, V34, P39, DOI 10.1007/s10886-007-9352-8; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; CHAN RCY, 1985, INFECT IMMUN, V47, P84, DOI 10.1128/IAI.47.1.84-89.1985; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davidson EW, 2003, COPEIA, P601, DOI 10.1643/CP-02-120R1; GILTURNES MS, 1992, BIOL BULL, V182, P105, DOI 10.2307/1542184; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Harris RN, 2009, DIS AQUAT ORGAN, V83, P11, DOI 10.3354/dao02004; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; KENNEDY MJ, 1985, INFECT IMMUN, V49, P654, DOI 10.1128/IAI.49.3.654-663.1985; Lauer A, 2007, COPEIA, P630, DOI 10.1643/0045-8511(2007)2007[630:CCBFTE]2.0.CO;2; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Lumsden JS, 1998, J AQUAT ANIM HEALTH, V10, P230, DOI 10.1577/1548-8667(1998)010&lt;0230:UOHPTT&gt;2.0.CO;2; Matousek JL, 2002, VET DERMATOL, V13, P293, DOI 10.1046/j.1365-3164.2002.00312.x; Murphy PJ, 2009, ECOHEALTH, V6, P109, DOI 10.1007/s10393-009-0230-4; Pessier AP, 2002, SEMIN AVIAN EXOT PET, V11, P162, DOI 10.1053/saep.2002.123980; Rach JJ, 2003, N AM J AQUACULT, V65, P300, DOI 10.1577/C03-005; Retallick RWR, 2007, DIS AQUAT ORGAN, V75, P201, DOI 10.3354/dao075201; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Rollins-Smith LA, 2005, DEV COMP IMMUNOL, V29, P589, DOI 10.1016/j.dci.2004.11.004; Rollins-Smith LA, 2002, DEV COMP IMMUNOL, V26, P471, DOI 10.1016/S0145-305X(01)00088-X; Russo R, 2007, J AQUAT ANIM HEALTH, V19, P121, DOI 10.1577/H05-024.1; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Sokal R.R., 2012, BIOMETRY; Webster NS, 2008, ISME J, V2, P830, DOI 10.1038/ismej.2008.42; Wilson, 2005, MICROBIAL INHABITANT, P375; Woodhams DC, 2006, OECOLOGIA, V146, P531, DOI 10.1007/s00442-005-0228-8; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1; Woodhams DC, 2007, BIOL CONSERV, V138, P390, DOI 10.1016/j.biocon.2007.05.004; Woodhams DC, 2006, J WILDLIFE DIS, V42, P207, DOI 10.7589/0090-3558-42.2.207; Wyngaard G.A., 1982, P485	51	130	135	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10957	10.1371/journal.pone.0010957	http://dx.doi.org/10.1371/journal.pone.0010957			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532032	gold, Green Published, Green Submitted			2022-12-27	WOS:000278380500003
J	Martinez-Forero, I; Pelaez-Lopez, A; Villoslada, P				Martinez-Forero, Ivan; Pelaez-Lopez, Antonio; Villoslada, Pablo			Steady State Detection of Chemical Reaction Networks Using a Simplified Analytical Method	PLOS ONE			English	Article							MULTIPLE EQUILIBRIA; MULTISITE PHOSPHORYLATION; CELL-DEATH; BISTABILITY; SURVIVAL; SYSTEMS; GRAPH	Chemical reaction networks (CRNs) are susceptible to mathematical modelling. The dynamic behavior of CRNs can be investigated by solving the polynomial equations derived from its structure. However, simple CRN give rise to non-linear polynomials that are difficult to resolve. Here we propose a procedure to locate the steady states of CRNs from a formula derived through algebraic geometry methods. We have applied this procedure to define the steady states of a classic CRN that exhibits instability, and to a model of programmed cell death.	[Martinez-Forero, Ivan; Pelaez-Lopez, Antonio] Univ Navarra, Dept Appl Math & Phys, E-31080 Pamplona, Spain; [Villoslada, Pablo] Hosp Clin Barcelona, Inst Biomed Res August Pi Sunyer IDIBAPS, Barcelona, Spain	University of Navarra; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Martinez-Forero, I (corresponding author), Univ Navarra, Dept Appl Math & Phys, E-31080 Pamplona, Spain.	pvilloslada@clinic.ub.es	Villoslada, Pablo/AAF-9547-2019	Villoslada, Pablo/0000-0002-8735-6119				Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Bagci EZ, 2006, BIOPHYS J, V90, P1546, DOI 10.1529/biophysj.105.068122; Bailey JE, 2001, NAT BIOTECHNOL, V19, P503, DOI 10.1038/89204; CLARKE BL, 1988, CELL BIOPHYS, V12, P237, DOI 10.1007/BF02918360; CLARKE BL, 1980, ADV CHEM PHYS, V43, P1; Conradi C, 2005, IEE P SYST BIOL, V152, P243, DOI 10.1049/ip-syb:20050045; Conradi C, 2008, MATH BIOSCI, V211, P105, DOI 10.1016/j.mbs.2007.10.004; Conradi C, 2007, P NATL ACAD SCI USA, V104, P19175, DOI 10.1073/pnas.0705731104; Cox D. A., 2007, IDEALS VARIETIES ALG; Craciun G, 2006, IEE P SYST BIOL, V153, P179, DOI 10.1049/ip-syb:20050093; Craciun G, 2005, SIAM J APPL MATH, V65, P1526, DOI 10.1137/S0036139904440278; Craciun G, 2006, SIAM J APPL MATH, V66, P1321, DOI 10.1137/050634177; Craciun G, 2006, P NATL ACAD SCI USA, V103, P8697, DOI 10.1073/pnas.0602767103; Craciun G, 2009, J SYMB COMPUT, V44, P1551, DOI 10.1016/j.jsc.2008.08.006; EDELSTEIN BB, 1970, J THEOR BIOL, V29, P57, DOI 10.1016/0022-5193(70)90118-9; Feinberg M, 1979, MATH RES CTR U WISC; Gatermann K, 2005, J SYMB COMPUT, V40, P1361, DOI 10.1016/j.jsc.2005.07.002; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Lavrik IN, 2007, J BIOL CHEM, V282, P13664, DOI 10.1074/jbc.M700434200; Manrai AK, 2008, BIOPHYS J, V95, P5533, DOI 10.1529/biophysj.108.140632; Sabouri-Ghomi M, 2008, J THEOR BIOL, V250, P209, DOI 10.1016/j.jtbi.2007.09.001; Shinar G, 2010, SCIENCE, V327, P1389, DOI 10.1126/science.1183372; Thomson M, 2009, J THEOR BIOL, V261, P626, DOI 10.1016/j.jtbi.2009.09.003; Thomson M, 2009, NATURE, V460, P274, DOI 10.1038/nature08102; Wee KB, 2006, BIOPHYS J, V91, P857, DOI 10.1529/biophysj.105.077693	26	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10823	10.1371/journal.pone.0010823	http://dx.doi.org/10.1371/journal.pone.0010823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532219	gold, Green Published, Green Submitted			2022-12-27	WOS:000278318700001
J	Mizoro, Y; Yamaguchi, Y; Kitazawa, R; Yamada, H; Matsuo, M; Fustin, JM; Doi, M; Okamura, H				Mizoro, Yasutaka; Yamaguchi, Yoshiaki; Kitazawa, Rena; Yamada, Hiroyuki; Matsuo, Masahiro; Fustin, Jean-Michel; Doi, Masao; Okamura, Hitoshi			Activation of AMPA Receptors in the Suprachiasmatic Nucleus Phase-Shifts the Mouse Circadian Clock In Vivo and In Vitro	PLOS ONE			English	Article							BIOLOGICAL CLOCK; MESSENGER-RNA; GLUTAMATE; LIGHT; RAT; NMDA; MPER1; ASPARTATE; CHANNELS; RHYTHMS	The glutamatergic neurotransmission in the suprachiasmatic nucleus (SCN) plays a central role in the entrainment of the circadian rhythms to environmental light-dark cycles. Although the glutamatergic effect operating via NMDAR (N-methyl D-aspartate receptor) is well elucidated, much less is known about a role of AMPAR (alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor) in circadian entrainment. Here we show that, in the mouse SCN, GluR2 and GluR4 AMPAR subtypes are abundantly expressed in the retinorecipient area. In vivo microinjection of AMPA in the SCN during the early subjective night phase-delays the behavioral rhythm. In the organotypic SCN slice culture, AMPA application induces phase-dependent phase-shifts of core-clock gene transcription rhythms. These data demonstrate that activation of AMPAR is capable of phase-shifting the circadian clock both in vivo and in vitro, and are consistent with the hypothesis that activation of AMPA receptors is a critical step in the transmission of photic information to the SCN.	[Mizoro, Yasutaka; Yamaguchi, Yoshiaki; Yamada, Hiroyuki; Matsuo, Masahiro; Fustin, Jean-Michel; Doi, Masao; Okamura, Hitoshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Syst Biol, Kyoto, Japan; [Kitazawa, Rena; Okamura, Hitoshi] Kobe Univ, Grad Sch Med, Div Mol Brain Sci, Kobe, Hyogo 657, Japan	Kyoto University; Kobe University	Mizoro, Y (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Syst Biol, Kyoto, Japan.	okamurah@pharm.kyoto-u.ac.jp	Fustin, Jean-Michel/R-6621-2019; Yamaguchi, Yoshiaki/K-9418-2013; Doi, Masao/J-9267-2019; Matsuo, Masahiro/L-9692-2013	Fustin, Jean-Michel/0000-0002-6200-6075; Yamaguchi, Yoshiaki/0000-0003-4126-542X; Doi, Masao/0000-0001-6264-9217; Matsuo, Masahiro/0000-0003-3283-3413; Mizoro, Yasutaka/0000-0002-5081-4884	Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government (MECSSTJG); SRF; Kanae Foundation for the Promotion of Medical Science [MECSSTJG21790073]	Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government (MECSSTJG)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); SRF; Kanae Foundation for the Promotion of Medical Science	This work was supported by research grants to H.O. from Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government (MECSSTJG) and from SRF, and to Y.Y. from MECSSTJG21790073 and from Kanae Foundation for the Promotion of Medical Science (http://www.kanae-zaidan.com/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Akiyama M, 1999, J NEUROSCI, V19, P1115; Anderson CM, 2000, GLIA, V32, P1; Asai M, 2001, CURR BIOL, V11, P1524, DOI 10.1016/S0960-9822(01)00445-6; CAGAMPANG FRA, 1994, BRAIN RES, V639, P175, DOI 10.1016/0006-8993(94)91780-9; CLINE HT, 1991, NEURON, V6, P259, DOI 10.1016/0896-6273(91)90361-3; COLWELL CS, 1991, BRAIN RES, V554, P105, DOI 10.1016/0006-8993(91)90177-W; COLWELL CS, 1992, J BIOL RHYTHM, V7, P125, DOI 10.1177/074873049200700204; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; DEVRIES MJ, 1993, BRAIN RES, V612, P231, DOI 10.1016/0006-8993(93)91665-F; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; GANNON RL, 1994, MOL BRAIN RES, V23, P338, DOI 10.1016/0169-328X(94)90244-5; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Lee HS, 2003, J BIOL RHYTHM, V18, P435, DOI 10.1177/0748730403259106; Leone MJ, 2006, J NEUROSCI RES, V84, P1521, DOI 10.1002/jnr.21042; LIOU SY, 1986, BRAIN RES BULL, V16, P527, DOI 10.1016/0361-9230(86)90182-6; Masubuchi S, 2005, J NEUROSCI, V25, P4719, DOI 10.1523/JNEUROSCI.4761-04.2005; Mintz EM, 1999, J NEUROSCI, V19, P5124; MOORE RY, 1972, J COMP NEUROL, V146, P1, DOI 10.1002/cne.901460102; Moriya T, 2003, J NEUROCHEM, V85, P978, DOI 10.1046/j.1471-4159.2003.01758.x; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Paul KN, 2003, NEUROSCIENCE, V119, P137, DOI 10.1016/S0306-4522(03)00098-8; Pickard GE, 1996, J NEUROSCI, V16, P8208; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; SCHWARTZ WJ, 1990, J NEUROSCI, V10, P3685; SHIBATA S, 1994, AM J PHYSIOL, V267, pR360, DOI 10.1152/ajpregu.1994.267.2.R360; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; TOMINAGA K, 1994, NEUROSCIENCE, V59, P1025, DOI 10.1016/0306-4522(94)90303-4; VANDENPOL AN, 1991, J NEUROSCI, V11, P2087; Wakamatsu H, 2001, NEUROREPORT, V12, P127, DOI 10.1097/00001756-200101220-00033; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682	34	24	24	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10951	10.1371/journal.pone.0010951	http://dx.doi.org/10.1371/journal.pone.0010951			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532181	gold, Green Published, Green Submitted			2022-12-27	WOS:000278318700019
J	Reid, AJ; Ranea, JAG; Clegg, AB; Orengo, CA				Reid, Adam J.; Ranea, Juan A. G.; Clegg, Andrew B.; Orengo, Christine A.			CODA: Accurate Detection of Functional Associations between Proteins in Eukaryotic Genomes Using Domain Fusion	PLOS ONE			English	Article							GENE FUSION; SEMANTIC SIMILARITY; SEQUENCE; DATABASE	Background: In order to understand how biological systems function it is necessary to determine the interactions and associations between proteins. Gene fusion prediction is one approach to detection of such functional relationships. Its use is however known to be problematic in higher eukaryotic genomes due to the presence of large homologous domain families. Here we introduce CODA (Co-Occurrence of Domains Analysis), a method to predict functional associations based on the gene fusion idiom. Methodology/Principal Findings: We apply a novel scoring scheme which takes account of the genome-specific size of homologous domain families involved in fusion to improve accuracy in predicting functional associations. We show that CODA is able to accurately predict functional similarities in human with comparison to state-of-the-art methods and show that different methods can be complementary. CODA is used to produce evidence that a currently uncharacterised human protein may be involved in pathways related to depression and that another is involved in DNA replication. Conclusions/Significance: The relative performance of different gene fusion methodologies has not previously been explored. We find that they are largely complementary, with different methods being more or less appropriate in different genomes. Our method is the only one currently available for download and can be run on an arbitrary dataset by the user. The CODA software and datasets are freely available from ftp://ftp.biochem.ucl.ac.uk/pub/gene3d_data/v6.1.0/CODA/. Predictions are also available via web services from http://funcnet.eu/.	[Reid, Adam J.] Wellcome Trust Sanger Inst, Cambridge, England; [Ranea, Juan A. G.; Clegg, Andrew B.; Orengo, Christine A.] UCL, Res Dept Struct & Mol Biol, London, England; [Ranea, Juan A. G.] Univ Malaga, Dept Mol Biol & Biochem, E-29071 Malaga, Spain	Wellcome Trust Sanger Institute; University of London; University College London; Universidad de Malaga	Reid, AJ (corresponding author), Wellcome Trust Sanger Inst, Cambridge, England.	ar11@sanger.ac.uk		Reid, Adam/0000-0002-5926-7768; Garcia Ranea, Juan Antonio/0000-0003-0327-1837	Biotechnology and Biological Sciences Research Council; Spanish Education and Science Ministry [RYC-2007-01649]; MED [SAF-09839]; European Union [LSHG-CT-2005-518254, LHSG-CT-2004-512092]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Spanish Education and Science Ministry(Spanish Government); MED; European Union(European Commission)	Funding: AJR acknowledges financial support from the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/). JAGR acknowledges financial support from the Spanish Education and Science Ministry through the Ramon y Cajal program (RYC-2007-01649) (http://ciencia.micinn.fecyt.es/ciencia/jsp/plantilla.jsp?area=cajal&id=11), the Plan Nacional project (SAF-09839 Subprograma MED) (http://www.plannacionalidi.es/), and the European Union's ENFIN Network of Excellence (Experimental Network for Functional Integration, LSHG-CT-2005-518254) (http://www.enfin.org/). ABC acknowledges support from the European Union's EMBRACE Network of Excellence (European Model for Bioinformatics Research And Community Education, LHSG-CT-2004-512092) (http://www.embracegrid.info/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apic G, 2001, Bioinformatics, V17 Suppl 1, pS83; BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Bellivier F, 2004, AM J MED GENET B, V124B, P87, DOI 10.1002/ajmg.b.20015; Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Enright AJ, 2001, GENOME BIOL, V2; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; HOFFMAN S, 1983, P NATL ACAD SCI-BIOL, V80, P5762, DOI 10.1073/pnas.80.18.5762; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Kummerfeld SK, 2005, TRENDS GENET, V21, P25, DOI 10.1016/j.tig.2004.11.007; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Marcotte Cynthia J Verjovsky, 2002, Appl Bioinformatics, V1, P93; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Snel B, 2000, TRENDS GENET, V16, P9, DOI 10.1016/S0168-9525(99)01924-1; Truong K, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-16; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Yanai I, 2001, P NATL ACAD SCI USA, V98, P7940, DOI 10.1073/pnas.141236298; Yeats C, 2008, NUCLEIC ACIDS RES, V36, pD414, DOI 10.1093/nar/gkm1019	22	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2010	5	6							e10908	10.1371/journal.pone.0010908	http://dx.doi.org/10.1371/journal.pone.0010908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QF	20532224	Green Published, Green Submitted, gold			2022-12-27	WOS:000278222400005
J	Teo, SLH; Block, BA				Teo, Steven L. H.; Block, Barbara A.			Comparative Influence of Ocean Conditions on Yellowfin and Atlantic Bluefin Tuna Catch from Longlines in the Gulf of Mexico	PLOS ONE			English	Article							BINOMIAL REGRESSION-MODEL; POPULATION-STRUCTURE; SHARK BYCATCH; SEA-TURTLES; BY-CATCH; HABITAT; TEMPERATURE; CRUSTACEA; SUMMER; RATES	Directed fishing effort for Atlantic bluefin tuna in the Gulf of Mexico (GOM), their primary spawning grounds in the western Atlantic, has been prohibited since the 1980s due to a precipitous decline of the spawning stock biomass. However, pelagic longlines targeted at other species, primarily yellowfin tuna and swordfish, continue to catch Atlantic bluefin tuna in the GOM as bycatch. Spatial and temporal management measures minimizing bluefin tuna bycatch in the GOM will likely become important in rebuilding the western Atlantic bluefin stock. In order to help inform management policy and understand the relative distribution of target and bycatch species in the GOM, we compared the spatiotemporal variability and environmental influences on the catch per unit effort (CPUE) of yellowfin (target) and bluefin tuna (bycatch). Catch and effort data from pelagic longline fisheries observers (1993-2005) and scientific tagging cruises (1998-2002) were coupled with environmental and biological data. Negative binomial models were used to fit the data for both species and Akaike's Information Criterion (corrected for small sample size) was used to determine the best model. Our results indicate that bluefin CPUE had higher spatiotemporal variability as compared to yellowfin CPUE. Bluefin CPUE increased substantially during the breeding months (March-June) and peaked in April and May, while yellowfin CPUE remained relatively high throughout the year. In addition, bluefin CPUE was significantly higher in areas with negative sea surface height anomalies and cooler sea surface temperatures, which are characteristic of mesoscale cyclonic eddies. In contrast, yellowfin CPUE was less sensitive to environmental variability. These differences in seasonal variability and sensitivity to environmental influences suggest that bluefin tuna bycatch in the GOM can be reduced substantially by managing the spatial and temporal distribution of the pelagic longline effort without substantially impacting yellowfin tuna catches.	[Teo, Steven L. H.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Block, Barbara A.] Stanford Univ, Hopkins Marine Stn, Tuna Res & Conservat Ctr, Pacific Grove, CA 93950 USA	University of California System; University of California Davis; Stanford University	Teo, SLH (corresponding author), Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA.	slhteo@gmail.com	Fennell, Hannah/AAI-1408-2019		Lenfest Foundation; National Oceanic and Atmospheric Administration; Disney Conservation Fund; Packard, Pew, and Monterey Bay Aquarium Foundations	Lenfest Foundation; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Disney Conservation Fund; Packard, Pew, and Monterey Bay Aquarium Foundations	Funding for this study was provided by the Lenfest Foundation, National Oceanic and Atmospheric Administration, Disney Conservation Fund, and the Packard, Pew, and Monterey Bay Aquarium Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armsworth PR, 2010, J APPL ECOL, V47, P36, DOI 10.1111/j.1365-2664.2009.01738.x; Bakun A., 1996, OCEAN PROCESSES MARI; Baumgartner MF, 2005, CAN J FISH AQUAT SCI, V62, P527, DOI 10.1139/F04-238; BEERKIRCHER L, 2009, NMFSSEFSC588 NOAA; Beerkircher L. R, 2002, NMFSSEFSC486 NOAA; BERRIGAN D, 1994, OIKOS, V70, P474, DOI 10.2307/3545787; Bigelow KA, 1999, FISH OCEANOGR, V8, P178, DOI 10.1046/j.1365-2419.1999.00105.x; Blank JM, 2002, J EXP BIOL, V205, P1881; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Boustany AM, 2008, MAR BIOL, V156, P13, DOI 10.1007/s00227-008-1058-0; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carlsson J, 2007, J HERED, V98, P23, DOI 10.1093/jhered/esl046; Dickhut RM, 2009, ENVIRON SCI TECHNOL, V43, P8522, DOI 10.1021/es901810e; DIETRICH DE, 1994, J GEOPHYS RES-OCEANS, V99, P7599, DOI 10.1029/93JC03572; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Gardner Beth, 2008, Endangered Species Research, V5, P279, DOI 10.3354/esr00105; Gasca R, 2003, HYDROBIOLOGIA, V510, P115, DOI 10.1023/B:HYDR.0000008637.16933.6f; Gasca R, 2001, B MAR SCI, V68, P397; Gilman E, 2005, FISH FISH, V6, P35, DOI 10.1111/j.1467-2679.2005.00175.x; Hall SJ, 2005, FISH FISH, V6, P134, DOI 10.1111/j.1467-2979.2005.00183.x; Hilbe JM, 2007, NEGATIVE BINOMIAL RE; Hobday AJ, 2006, FISHERIES MANAG ECOL, V13, P365, DOI 10.1111/j.1365-2400.2006.00515.x; *ICCAT, 2007, REP STAND COMM RES S, P81; Lewison RL, 2007, CONSERV BIOL, V21, P79, DOI 10.1111/j.1523-1739.2006.00592.x; Magnuson J. J., 1994, ASSESSMENT ATLANTIC; Mandelman JW, 2008, REV FISH BIOL FISHER, V18, P427, DOI 10.1007/s11160-008-9084-z; Mather FJ, 1995, NMFSSEFSC370 NOAA; Minami M, 2007, FISH RES, V84, P210, DOI 10.1016/j.fishres.2006.10.019; OLSON DB, 1991, ANNU REV EARTH PL SC, V19, P283, DOI 10.1146/annurev.ea.19.050191.001435; Pascual A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024633; PERRY RI, 1994, CAN J FISH AQUAT SCI, V51, P589, DOI 10.1139/f94-061; Pradhan NC, 2006, FISH RES, V78, P309, DOI 10.1016/j.fishres.2005.12.013; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Russ J. C., 2002, IMAGE PROCESSING HDB, V4th, DOI DOI 10.1201/9781420040760; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; SONU SC, 2008, BLUEFIN TUNA SUPPLY; Stammer D, 1998, J PHYS OCEANOGR, V28, P727, DOI 10.1175/1520-0485(1998)028<0727:OECETA>2.0.CO;2; Teo SLH, 2007, MAR BIOL, V152, P1105, DOI 10.1007/s00227-007-0758-1; Teo SLH, 2007, MAR BIOL, V151, P1, DOI 10.1007/s00227-006-0447-5; Venables WN., 2002, MODERN APPL STAT S 4; Ward P, 2007, REV FISH BIOL FISHER, V17, P501, DOI 10.1007/s11160-007-9051-0; Ward P, 2009, FISH RES, V97, P253, DOI 10.1016/j.fishres.2009.02.009; Waugh DW, 2006, J PHYS OCEANOGR, V36, P526, DOI 10.1175/JPO2865.1; Weng KC, 2009, J FISH BIOL, V74, P1434, DOI 10.1111/j.1095-8649.2009.02209.x; Wormuth John H., 2000, Gulf of Mexico Science, V18, P23; 2000, US FED REG, P47214	47	53	53	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10756	10.1371/journal.pone.0010756	http://dx.doi.org/10.1371/journal.pone.0010756			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526356	gold, Green Published, Green Submitted			2022-12-27	WOS:000278222100001
J	van't Hof, AE; Saccheri, IJ				van't Hof, Arjen E.; Saccheri, Ilik J.			Industrial Melanism in the Peppered Moth Is Not Associated with Genetic Variation in Canonical Melanisation Gene Candidates	PLOS ONE			English	Article							PROPHENOLOXIDASE-ACTIVATING PROTEINASE-1; MANDUCA-SEXTA HEMOLYMPH; BLACK-AND-WHITE; DROSOPHILA-MELANOGASTER; CUTICULAR MELANIZATION; ADAPTIVE PIGMENTATION; TOBACCO HORNWORM; PAPILIO-XUTHUS; BOMBYX-MORI; EVOLUTION	Industrial melanism in the peppered moth (Biston betularia) is an iconic case study of ecological genetics but the molecular identity of the gene determining the difference between the typical and melanic (carbonaria) morphs is entirely unknown. We applied the candidate gene approach to look for associations between genetic polymorphisms within sixteen a priori melanisation gene candidates and the carbonaria morph. The genes were isolated and sequence characterised in B. betularia using degenerate PCR and from whole-transcriptome sequence. The list of candidates contains all the genes previously implicated in melanisation pattern differences in other insects, including aaNAT, DOPA-decarboxylase, ebony, tan, tyrosine hydroxylase, yellow and yellow2 (yellow-fa). Co-segregation of candidate gene alleles and carbonaria morph was tested in 73 offspring of a carbonaria male-typical female backcross. Surprisingly, none of the sixteen candidate genes was in close linkage with the locus controlling the carbonaria-typical polymorphism. Our study demonstrates that the 'carbonaria gene' is not a structural variant of a canonical melanisation pathway gene, neither is it a cis-regulatory element of these enzyme-coding genes. The implication is either that we have failed to characterize an unknown enzyme-coding gene in the melanisation pathway, or more likely, that the 'carbonaria gene' is a higher level trans-acting factor which regulates the spatial expression of one or more of the melanisation candidates in this study to alter the pattern of melanin production.	[van't Hof, Arjen E.; Saccheri, Ilik J.] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England	University of Liverpool	van't Hof, AE (corresponding author), Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England.	saccheri@liv.ac.uk	Van 't Hof, Arjen/AAE-8044-2022		Natural Environment Research Council [NE/C003101/1]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Natural Environment Research Council (NE/C003101/1), http://www.nerc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An CJ, 2009, J BIOL CHEM, V284, P19716, DOI 10.1074/jbc.M109.007112; Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; BARRETT AJ, 1995, ARCH BIOCHEM BIOPHYS, V318, P247, DOI 10.1006/abbi.1995.1227; BIESSMANN H, 1985, P NATL ACAD SCI USA, V82, P7369, DOI 10.1073/pnas.82.21.7369; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cook Laurence M., 2003, Entomologist's Gazette, V54, P211; Cook LM, 2003, Q REV BIOL, V78, P399, DOI 10.1086/378925; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Futahashi R, 2006, INSECT BIOCHEM MOLEC, V36, P63, DOI 10.1016/j.ibmb.2005.11.002; Futahashi R, 2005, DEV GENES EVOL, V215, P519, DOI 10.1007/s00427-005-0014-y; Futahashi R, 2008, GENETICS, V180, P1995, DOI 10.1534/genetics.108.096388; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Gorman MJ, 2007, J BIOL CHEM, V282, P11742, DOI 10.1074/jbc.M611243200; Gratten J, 2007, P ROY SOC B-BIOL SCI, V274, P619, DOI 10.1098/rspb.2006.3762; Gupta S, 2005, INSECT BIOCHEM MOLEC, V35, P241, DOI 10.1016/j.ibmb.2004.12.003; Hartzer KL, 2005, ARCH INSECT BIOCHEM, V59, P67, DOI 10.1002/arch.20056; HIRUMA K, 1988, DEV BIOL, V130, P87, DOI 10.1016/0012-1606(88)90416-2; Hiruma K, 2009, INSECT BIOCHEM MOLEC, V39, P245, DOI 10.1016/j.ibmb.2009.01.008; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; HORI M, 1984, INSECT BIOCHEM, V14, P267, DOI 10.1016/0020-1790(84)90059-3; HULTMARK D, 1993, TRENDS GENET, V9, P178, DOI 10.1016/0168-9525(93)90165-E; Jiang HB, 2003, INSECT BIOCHEM MOLEC, V33, P1049, DOI 10.1016/S0965-1748(03)00123-1; Kingsley EP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006435; Koch PB, 2000, CURR BIOL, V10, P591, DOI 10.1016/S0960-9822(00)00494-2; Koch PB, 1998, DEVELOPMENT, V125, P2303; Lee SY, 1998, EUR J BIOCHEM, V254, P50, DOI 10.1046/j.1432-1327.1998.2540050.x; Llopart A, 2002, EVOLUTION, V56, P2262; Lu Z, 2008, J BIOL CHEM, V283, P21325, DOI 10.1074/jbc.M801593200; Majerus MEN, 2003, TRENDS GENET, V19, P585, DOI 10.1016/j.tig.2003.09.003; Mitchell A, 2000, SYST BIOL, V49, P202, DOI 10.1093/sysbio/49.2.202; Pool JE, 2007, MOL ECOL, V16, P2844, DOI 10.1111/j.1365-294X.2007.03324.x; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; RYCHLIK W, 2000, OLIGO PRIMER ANAL SO; SACCHERI IJ, 1993, J HERED, V84, P195, DOI 10.1093/oxfordjournals.jhered.a111316; Saccheri IJ, 2008, P NATL ACAD SCI USA, V105, P16212, DOI 10.1073/pnas.0803785105; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Srinivasan A, 2006, CELL MOL BIOL LETT, V11, P132, DOI 10.2478/s11658-006-0012-8; Sugumaran M, 2009, PIGM CELL MELANOMA R, V22, P523, DOI 10.1111/j.1755-148X.2009.00608.x; Takahashi A, 2007, GENETICS, V177, P1233, DOI 10.1534/genetics.107.075283; Talloen W, 2004, EVOLUTION, V58, P360, DOI 10.1111/j.0014-3820.2004.tb01651.x; Tong YR, 2005, J BIOL CHEM, V280, P14932, DOI 10.1074/jbc.M500532200; True JR, 2005, PLOS GENET, V1, P551, DOI 10.1371/journal.pgen.0010063; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; Wang RG, 2001, EUR J BIOCHEM, V268, P895, DOI 10.1046/j.1432-1327.2001.01945.x; WIERNASZ DC, 1989, EVOLUTION, V43, P1672, DOI 10.1111/j.1558-5646.1989.tb02617.x; Wittkopp PJ, 2009, SCIENCE, V326, P540, DOI 10.1126/science.1176980; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Wittkopp PJ, 2003, P NATL ACAD SCI USA, V100, P1808, DOI 10.1073/pnas.0336368100; Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2; Xia AH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-195; Zou Z, 2005, INSECT BIOCHEM MOLEC, V35, P627, DOI 10.1016/j.ibmb.2005.02.004	52	23	24	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10889	10.1371/journal.pone.0010889	http://dx.doi.org/10.1371/journal.pone.0010889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526362	Green Published, gold, Green Submitted			2022-12-27	WOS:000278222100018
J	Hall, GBC; Doyle, KAR; Goldberg, J; West, D; Szatmari, P				Hall, Geoffrey B. C.; Doyle, Krissy A. R.; Goldberg, Jeremy; West, Dianne; Szatmari, Peter			Amygdala Engagement in Response to Subthreshold Presentations of Anxious Face Stimuli in Adults with Autism Spectrum Disorders: Preliminary Insights	PLOS ONE			English	Article							EMOTIONAL FACIAL EXPRESSIONS; PERVASIVE DEVELOPMENTAL DISORDERS; NEURAL RESPONSES; FUNCTIONAL NEUROANATOMY; GAZE-FIXATION; BRAIN; FEAR; INDIVIDUALS; MONKEY; INFORMATION	Current theoretical models of autism spectrum disorders (ASD) have proposed that impairments in the processing of social/emotional information may be linked to amygdala dysfunction. However, the extent to which amygdala functions are compromised in ASD has become a topic of debate in recent years. In a jittered functional magnetic resonance imaging study, sub-threshold presentations of anxious faces permitted an examination of amygdala recruitment in 12 high functioning adult males with ASD and 12 matched controls. We found heightened neural activation of the amygdala in both high functioning adults with ASD and matched controls. Neither the intensity nor the time-course of amygdala activation differed between the groups. However, the adults with ASD showed significantly lower levels of fusiform activation during the trials compared to controls. Our findings suggest that in ASD, the transmission of socially salient information along subcortical pathways is intact: and yet the signaling of this information to structures downstream may be impoverished, and the pathways that facilitate subsequent processing deficient.	[Hall, Geoffrey B. C.; Doyle, Krissy A. R.; Goldberg, Jeremy; West, Dianne; Szatmari, Peter] McMaster Univ, Fac Hlth Sci, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Hall, Geoffrey B. C.] St Josephs Healthcare, Brain Body Inst, Hamilton, ON, Canada; [Hall, Geoffrey B. C.; Szatmari, Peter] McMaster Univ, Offord Ctr Child Studies, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Hall, GBC (corresponding author), McMaster Univ, Fac Hlth Sci, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada.	hallg@mcmaster.ca		/0000-0002-3398-6692				Adolphs R, 2001, J COGNITIVE NEUROSCI, V13, P232, DOI 10.1162/089892901564289; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Amaral DG, 2003, GENES BRAIN BEHAV, V2, P295, DOI 10.1034/j.1601-183X.2003.00043.x; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Bailey A, 1996, J CHILD PSYCHOL PSYC, V37, P89, DOI 10.1111/j.1469-7610.1996.tb01381.x; BARBUR JL, 1980, BRAIN, V103, P905, DOI 10.1093/brain/103.4.905; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; BAUMAN M, 1985, NEUROLOGY, V35, P866, DOI 10.1212/WNL.35.6.866; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; BENEVENTO LA, 1975, J COMP NEUROL, V160, P339, DOI 10.1002/cne.901600306; Bernier R, 2005, J AUTISM DEV DISORD, V35, P575, DOI 10.1007/s10803-005-0002-0; Bertone A, 2005, BRAIN, V128, P2430, DOI 10.1093/brain/awh561; Blair K, 2008, AM J PSYCHIAT, V165, P1193, DOI 10.1176/appi.ajp.2008.07071060; Brambilla P, 2003, BRAIN RES BULL, V61, P557, DOI 10.1016/j.brainresbull.2003.06.001; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Courchesne E, 1999, NEUROLOGY, V52, P1057, DOI 10.1212/WNL.52.5.1057; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; Dalton KM, 2007, BIOL PSYCHIAT, V61, P512, DOI 10.1016/j.biopsych.2006.05.019; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Deeley Q, 2006, BRIT J PSYCHIAT, V189, P533, DOI 10.1192/bjp.bp.106.021410; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Ekman P., 1976, PICTURES FACIAL AFFE; GALLAGHER M, 1994, P NATL ACAD SCI USA, V91, P11771, DOI 10.1073/pnas.91.25.11771; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Grelotti DJ, 2002, DEV PSYCHOBIOL, V40, P213, DOI 10.1002/dev.10028; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Howard MA, 2000, NEUROREPORT, V11, P2931, DOI 10.1097/00001756-200009110-00020; Hubl D, 2003, NEUROLOGY, V61, P1232, DOI 10.1212/01.WNL.0000091862.22033.1A; JONES EG, 1976, BRAIN RES, V104, P142, DOI 10.1016/0006-8993(76)90654-5; LeDoux J, 1996, PROG BRAIN RES, V107, P437; LeDoux J. E., 1996, EMOTIONAL BRAIN; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lundqvist D., 1998, KAROLINSKA DIRECTED; MILLER M, 1980, J NEUROPHYSIOL, V43, P1510, DOI 10.1152/jn.1980.43.6.1510; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Morris JS, 2001, NEUROIMAGE, V13, P1044, DOI 10.1006/nimg.2000.0721; Morris JS, 2002, NEUROIMAGE, V17, P214, DOI 10.1006/nimg.2002.1220; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Morris JS, 1997, P ROY SOC B-BIOL SCI, V264, P769, DOI 10.1098/rspb.1997.0109; Muller RA, 2007, MENT RETARD DEV D R, V13, P85, DOI 10.1002/mrdd.20141; Palmen SJMC, 2006, PSYCHOL MED, V36, P827, DOI 10.1017/S0033291706007215; Palmen SJMC, 2004, J NEURAL TRANSM, V111, P903, DOI 10.1007/s00702-003-0068-9; Pasley BN, 2004, NEURON, V42, P163, DOI 10.1016/S0896-6273(04)00155-2; Pellicano E, 2005, NEUROPSYCHOLOGIA, V43, P1044, DOI 10.1016/j.neuropsychologia.2004.10.003; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Pierce K, 2004, BRAIN, V127, P2703, DOI 10.1093/brain/awh289; Piggot J, 2004, J AM ACAD CHILD PSY, V43, P473, DOI 10.1097/00004583-200404000-00014; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Schumann CM, 2006, J NEUROSCI, V26, P7674, DOI 10.1523/JNEUROSCI.1285-06.2006; Silvert L, 2007, NEUROIMAGE, V38, P357, DOI 10.1016/j.neuroimage.2007.07.023; Talairach J., 1988, COPLANAR STEREOTAXIC; Van Amelsvoort T, 2006, BRIT J PSYCHIAT, V189, P560, DOI 10.1192/bjp.bp.105.019876; van Kooten IAJ, 2008, BRAIN, V131, P987, DOI 10.1093/brain/awn033; Volkmar FR, 2004, J CHILD PSYCHOL PSYC, V45, P135, DOI 10.1046/j.0021-9630.2003.00317.x; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wickelgren A, 2005, SCIENCE, V308, P1856, DOI 10.1126/science.308.5730.1856; Williams MA, 2004, EXP BRAIN RES, V154, P403, DOI 10.1007/s00221-003-1740-x; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	65	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10804	10.1371/journal.pone.0010804	http://dx.doi.org/10.1371/journal.pone.0010804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	601CE	20520836	Green Published, gold, Green Submitted			2022-12-27	WOS:000278034800004
J	Wu, DC; Paulson, RF				Wu, Dai-Chen; Paulson, Robert F.			Hypoxia Regulates BMP4 Expression in the Murine Spleen during the Recovery from Acute Anemia	PLOS ONE			English	Article							INDUCIBLE FACTOR; CHUVASH POLYCYTHEMIA; TRANSCRIPTIONAL ACTIVITY; STRESS ERYTHROPOIESIS; PROLINE HYDROXYLATION; ERYTHROID PROGENITORS; OXYGEN HOMEOSTASIS; STEM-CELLS; HIF2A GENE; PROTEIN	Background: Bone marrow erythropoiesis is primarily homeostatic, producing new erythrocytes at a constant rate. However at times of acute anemia, new erythrocytes must be rapidly produced much faster than bone marrow steady state erythropoiesis. At these times stress erythropoiesis predominates. Stress erythropoiesis occurs in the fetal liver during embryogenesis and in the adult spleen and liver. In adult mice, stress erythropoiesis utilizes a specialized population of stress erythroid progenitors that are resident in the spleen. In response to acute anemia, these progenitors rapidly expand and differentiate in response to three signals, BMP4, SCF and hypoxia. In absence of acute anemic stress, two of these signals, BMP4 and hypoxia, are not present and the pathway is not active. The initiating event in the activation of this pathway is the up-regulation of BMP4 expression in the spleen. Methodology/Principal Findings: In this paper we analyze the regulation of BMP4 expression in the spleen by hypoxia. Using stromal cell lines, we establish a role for hypoxia transcription factor HIFs (Hypoxia Inducible Factors) in the transcription of BMP4. We identified putative Hypoxia Responsive Elements (HREs) in the BMP4 gene using bioinformatics. Analysis of these elements showed that in vivo, Hif2 alpha binds two cis regulatory sites in the BMP4 gene, which regulate BMP4 expression during the recovery from acute anemia. Conclusions and Significance: These data show that hypoxia plays a key role in initiating the BMP4 dependent stress erythropoiesis pathway by regulating BMP4 expression.	[Wu, Dai-Chen; Paulson, Robert F.] Penn State Univ, Grad Program Biochem Microbiol & Mol Biol, University Pk, PA 16802 USA; [Wu, Dai-Chen] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Paulson, Robert F.] Penn State Univ, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Paulson, Robert F.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wu, DC (corresponding author), Penn State Univ, Grad Program Biochem Microbiol & Mol Biol, University Pk, PA 16802 USA.	rfp5@psu.edu			National Institutes of Health [RO1DK080040-01]; Paulson Lab; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paulson Lab; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a National Institutes of Health grant, RO1DK080040-01 (RFP). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Zhiqiang Zhang for helpful suggestion on ChIP assay, Dr. Ross Hardison for providing the pMCSgLuc plasmid, and members of Paulson Lab for their support during this work.	Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Binnerts ME, 2004, BIOCHEM BIOPH RES CO, V315, P272, DOI 10.1016/j.bbrc.2004.01.048; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gordeuk VR, 2004, BLOOD, V103, P3924, DOI 10.1182/blood-2003-07-2535; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hegde S, 2007, MAMM GENOME, V18, P852, DOI 10.1007/s00335-007-9074-9; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hickey MM, 2007, J CLIN INVEST, V117, P3879, DOI 10.1172/JCI32614; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Kolbe D, 2004, GENOME RES, V14, P700, DOI 10.1101/gr.1976004; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lenox LE, 2009, EXP HEMATOL, V37, P549, DOI 10.1016/j.exphem.2009.01.004; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Maegdefrau U, 2009, J PATHOL, V218, P520, DOI 10.1002/path.2563; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Moore KA, 1997, BLOOD, V89, P4337, DOI 10.1182/blood.V89.12.4337; Nakayama K, 2009, J BIOCHEM, V146, P757, DOI 10.1093/jb/mvp167; Percy MJ, 2008, BLOOD, V111, P5400, DOI 10.1182/blood-2008-02-137703; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; PERRY JM, 2008, BLOOD; Perry JM, 2007, BLOOD, V109, P4494, DOI 10.1182/blood-2006-04-016154; Porayette P, 2008, DEV BIOL, V317, P24, DOI 10.1016/j.ydbio.2008.01.047; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; Scortegagna M, 2003, BLOOD, V102, P1634, DOI 10.1182/blood-2003-02-0448; Semenza GL, 2009, BLOOD, V114, P2015, DOI 10.1182/blood-2009-05-189985; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; Taylor J, 2006, GENOME RES, V16, P1596, DOI 10.1101/gr.4537706; VANWIJK R, 2009, HAEMATOLOGICA; Wang H, 2006, GENOME RES, V16, P1480, DOI 10.1101/gr.5353806; YANAI N, 1989, BLOOD, V74, P2391; Yoon D, 2006, J BIOL CHEM, V281, P25703, DOI 10.1074/jbc.M602329200	43	35	36	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11303	10.1371/journal.pone.0011303	http://dx.doi.org/10.1371/journal.pone.0011303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585586	Green Published, Green Submitted, gold			2022-12-27	WOS:000279135800012
J	Badaut, C; Bertin, G; Rustico, T; Fievet, N; Massougbodji, A; Gaye, A; Deloron, P				Badaut, Cyril; Bertin, Gwladys; Rustico, Tatiana; Fievet, Nadine; Massougbodji, Achille; Gaye, Alioune; Deloron, Philippe			Towards the Rational Design of a Candidate Vaccine against Pregnancy Associated Malaria: Conserved Sequences of the DBL6 epsilon Domain of VAR2CSA	PLOS ONE			English	Article							CHONDROITIN SULFATE-A; FALCIPARUM-INFECTED ERYTHROCYTES; PLASMODIUM-FALCIPARUM; VAR GENES; ANTIGENIC VARIATION; PARASITE ADHESION; VARIANT ANTIGENS; ANTIBODIES; WOMEN; SURFACE	Background: Placental malaria is a disease linked to the sequestration of Plasmodium falciparum infected red blood cells (IRBC) in the placenta, leading to reduced materno-fetal exchanges and to local inflammation. One of the virulence factors of P. falciparum involved in cytoadherence to chondroitin sulfate A, its placental receptor, is the adhesive protein VAR2CSA. Its localisation on the surface of IRBC makes it accessible to the immune system. VAR2CSA contains six DBL domains. The DBL6 epsilon domain is the most variable. High variability constitutes a means for the parasite to evade the host immune response. The DBL6 epsilon domain could constitute a very attractive basis for a vaccine candidate but its reported variability necessitates, for antigenic characterisations, identifying and classifying commonalities across isolates. Methodology/Principal Findings: Local alignment analysis of the DBL6 epsilon domain had revealed that it is not as variable as previously described. Variability is concentrated in seven regions present on the surface of the DBL6 epsilon domain. The main goal of our work is to classify and group variable sequences that will simplify further research to determine dominant epitopes. Firstly, variable sequences were grouped following their average percent pairwise identity (APPI). Groups comprising many variable sequences sharing low variability were found. Secondly, ELISA experiments following the IgG recognition of a recombinant DBL6 epsilon domain, and of peptides mimicking its seven variable blocks, allowed to determine an APPI cut-off and to isolate groups represented by a single consensus sequence. Conclusions/Significance: A new sequence approach is used to compare variable regions in sequences that have extensive segmental gene relationship. Using this approach, the VAR2CSA DBL6 domain is composed of 7 variable blocks with limited polymorphism. Each variable block is composed of a limited number of consensus types. Based on peptide based ELISA, variable blocks with 85% or greater sequence identity are expected to be recognized equally well by antibody and can be considered the same consensus type. Therefore, the analysis of the antibody response against the classified small number of sequences should be helpful to determine epitopes.	[Badaut, Cyril; Bertin, Gwladys; Rustico, Tatiana; Fievet, Nadine; Deloron, Philippe] Inst Rech Dev, Mother & Child Faced Trop Infect Res Unit, UMR216, Paris, France; [Badaut, Cyril; Bertin, Gwladys; Deloron, Philippe] Univ Paris 05, Paris, France; [Massougbodji, Achille] Univ Abomey Calavi, Dept Zool & Genet, Fac Sci & Tech, Cotonou, Benin; [Gaye, Alioune] Ctr Sante Roi Baudoin Guediawaye, Dakar, Senegal	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Abomey Calavi	Badaut, C (corresponding author), Inst Rech Dev, Mother & Child Faced Trop Infect Res Unit, UMR216, Paris, France.	cbadaut@gmail.com; Philippe.Deloron@ird.fr	Deloron, Philippe/G-6305-2010	Deloron, Philippe/0000-0003-4705-2484; Bertin, Gwladys/0000-0002-2218-9591; Fievet, Nadine/0000-0003-2272-9794; Badaut, Cyril/0000-0002-0064-6384	Institut de Medecine et d'Epidemiologie Appliquee [IMEA-0801]; European Commission [200889]; French National Agency [ANR-05-MIME-009-01]; National Agency of Research (ANR); Institute of Research for Development (IRD)	Institut de Medecine et d'Epidemiologie Appliquee; European Commission(European CommissionEuropean Commission Joint Research Centre); French National Agency(French National Research Agency (ANR)); National Agency of Research (ANR)(French National Research Agency (ANR)); Institute of Research for Development (IRD)	This study received financial support from the Institut de Medecine et d'Epidemiologie Appliquee (grant IMEA-0801), from the European Commission, FP7 program (grant 200889), and from the French National Agency for Research (grant ANR-05-MIME-009-01). C. Badaut was supported by the National Agency of Research (ANR) and by the Institute of Research for Development (IRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Briand V, 2008, J INFECT DIS, V198, P594, DOI 10.1086/590114; Bull PC, 2008, MOL MICROBIOL, V68, P1519, DOI 10.1111/j.1365-2958.2008.06248.x; Bull PC, 2007, MOL BIOCHEM PARASIT, V154, P98, DOI 10.1016/j.molbiopara.2007.03.011; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; Duffy MF, 2006, INFECT IMMUN, V74, P4875, DOI 10.1128/IAI.01978-05; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Fernandez P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-170; Fievet N, 2006, INFECT GENET EVOL, V6, P459, DOI 10.1016/j.meegid.2006.02.006; Fried M, 1998, J MOL MED-JMM, V76, P162, DOI 10.1007/s001090050205; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; GOUDSMIT J, 1991, FASEB J, V5, P2427, DOI 10.1096/fasebj.5.10.2065891; KHUNRAE P, 2009, J MOL BIOL; Kraemer SM, 2003, MOL MICROBIOL, V50, P1527, DOI 10.1046/j.1365-2958.2003.03814.x; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Maubert B, 1999, INFECT IMMUN, V67, P5367, DOI 10.1128/IAI.67.10.5367-5371.1999; Ndam NGT, 2006, J INFECT DIS, V193, P713, DOI 10.1086/500146; Ndam NGT, 2005, J INFECT DIS, V192, P331, DOI 10.1086/430933; Ndam NGT, 2004, J INFECT DIS, V190, P2001, DOI 10.1086/425521; O'Neil-Dunne I, 2001, INFECT IMMUN, V69, P7487, DOI 10.1128/IAI.69.12.7487-7492.2001; Oleinikov AV, 2007, J INFECT DIS, V196, P155, DOI 10.1086/518513; Pasternak ND, 2009, INT J BIOCHEM CELL B, V41, P1463, DOI 10.1016/j.biocel.2008.12.012; Ralph SA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r93; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Sander AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006667; Smith JD, 2000, MOL BIOCHEM PARASIT, V110, P293, DOI 10.1016/S0166-6851(00)00279-6; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; Staalsoe T, 2001, J INFECT DIS, V184, P618, DOI 10.1086/322809; Taylor HM, 2000, MOL BIOCHEM PARASIT, V110, P391, DOI 10.1016/S0166-6851(00)00286-3; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466	35	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11276	10.1371/journal.pone.0011276	http://dx.doi.org/10.1371/journal.pone.0011276			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585655	Green Published, Green Submitted, gold			2022-12-27	WOS:000279135400021
J	Napolitano, G; Amente, S; Castiglia, V; Gargano, B; Ruda, V; Darzacq, X; Bensaude, O; Majello, B; Lania, L				Napolitano, Giuliana; Amente, Stefano; Castiglia, Virginia; Gargano, Barbara; Ruda, Vera; Darzacq, Xavier; Bensaude, Olivier; Majello, Barbara; Lania, Luigi			Caffeine Prevents Transcription Inhibition and P-TEFb/7SK Dissociation Following UV-Induced DNA Damage	PLOS ONE			English	Article							P-TEFB; 7SK SNRNP; CELL-CYCLE; CDK9/CYCLIN T1; PHOSPHORYLATION; ELONGATION; PROTEIN; KINASE; HEXIM1; FLAVOPIRIDOL	Background: The mechanisms by which DNA damage triggers suppression of transcription of a large number of genes are poorly understood. DNA damage rapidly induces a release of the positive transcription elongation factor b (P-TEFb) from the large inactive multisubunit 7SK snRNP complex. P-TEFb is required for transcription of most class II genes through stimulation of RNA polymerase II elongation and cotranscriptional pre-mRNA processing. Methodology/Principal Findings: We show here that caffeine prevents UV-induced dissociation of P-TEFb as well as transcription inhibition. The caffeine-effect does not involve PI3-kinase-related protein kinases, because inhibition of phosphatidylinositol 3-kinase family members (ATM, ATR and DNA-PK) neither prevents P-TEFb dissociation nor transcription inhibition. Finally, caffeine prevention of transcription inhibition is independent from DNA damage. Conclusion/Significance: Pharmacological prevention of P-TEFb/7SK snRNP dissociation and transcription inhibition following UV-induced DNA damage is correlated.	[Napolitano, Giuliana; Amente, Stefano; Castiglia, Virginia; Gargano, Barbara; Majello, Barbara; Lania, Luigi] Univ Naples Federico II, Dept Struct & Funct Biol, Naples, Italy; [Amente, Stefano; Lania, Luigi] Naples Oncogenom Ctr NOGEC, Naples, Italy; [Ruda, Vera; Darzacq, Xavier; Bensaude, Olivier] CNRS, UMR 8197, Inst Biol, Ecole Normale Super, Paris, France	University of Naples Federico II; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Napolitano, G (corresponding author), Univ Naples Federico II, Dept Struct & Funct Biol, Naples, Italy.	majello@unina.it; lania@unina.it	Amente, Stefano/AAU-7605-2020	Amente, Stefano/0000-0003-0612-6096; Majello, Barbara/0000-0003-2789-3585; Bensaude, Olivier/0000-0002-0259-6608; Napolitano, Giuliana/0000-0002-1637-6016; Darzacq, Xavier/0000-0003-2537-8395	Associazione Italiana Ricerca sul Cancro [5366]; University of Naples (Polo delle Scienze e delle Tecnologie)	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); University of Naples (Polo delle Scienze e delle Tecnologie)	This work was supported by funds from Associazione Italiana Ricerca sul Cancro, Investigator Grant (IG) 5366 (LL) and by the University of Naples (Polo delle Scienze e delle Tecnologie) for a travel fellowship to GN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amente S, 2009, CELL CYCLE, V8, P1249, DOI 10.4161/cc.8.8.8286; Barboric M, 2009, P NATL ACAD SCI USA, V106, P7798, DOI 10.1073/pnas.0903188106; Barrandon C, 2007, MOL CELL BIOL, V27, P6996, DOI 10.1128/MCB.00975-07; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Biglione S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-47; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Chen B, 2008, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2008/01/007; Cho SY, 2009, EMBO J, V28, P1407, DOI 10.1038/emboj.2009.99; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Darzacq X, 2006, J CELL BIOL, V173, P207, DOI 10.1083/jcb.200601105; Espinoza-Derout J, 2007, CARDIOVASC RES, V75, P129, DOI 10.1016/j.cardiores.2007.03.019; Gargano B, 2007, CELL CYCLE, V6, P2031, DOI 10.4161/cc.6.16.4554; Gentile M, 2003, NUCLEIC ACIDS RES, V31, P4779, DOI 10.1093/nar/gkg675; He N, 2008, MOL CELL, V29, P588, DOI 10.1016/j.molcel.2008.01.003; He NH, 2006, MOL CELL BIOL, V26, P7068, DOI 10.1128/MCB.00778-06; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Kohoutek J, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-19; Krueger BJ, 2008, NUCLEIC ACIDS RES, V36, P2219, DOI 10.1093/nar/gkn061; Luo ZH, 2001, MUTAT RES-DNA REPAIR, V486, P259, DOI 10.1016/S0921-8777(01)00097-0; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Michels Annemieke A., 2008, Biotechnology Journal, V3, P1022, DOI 10.1002/biot.200800104; Munoz MJ, 2009, CELL, V137, P708, DOI 10.1016/j.cell.2009.03.010; Napolitano G, 2007, CELL CYCLE, V6, P1126, DOI 10.4161/cc.6.9.4137; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Pirngruber J, 2009, EMBO REP, V10, P894, DOI 10.1038/embor.2009.108; Proietti-De-Santis L, 2006, EMBO J, V25, P1915, DOI 10.1038/sj.emboj.7601071; Rockx DAP, 2000, P NATL ACAD SCI USA, V97, P10503, DOI 10.1073/pnas.180169797; Santella L, 2005, CELL MOL LIFE SCI, V62, P2405, DOI 10.1007/s00018-005-5083-6; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Van Herreweghe E, 2007, EMBO J, V26, P3570, DOI 10.1038/sj.emboj.7601783; Wang Y, 2008, J BIOL CHEM, V283, P33578, DOI 10.1074/jbc.M807495200; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575	36	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11245	10.1371/journal.pone.0011245	http://dx.doi.org/10.1371/journal.pone.0011245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574533	Green Published, Green Submitted, gold			2022-12-27	WOS:000279058300028
J	Proverbio, AM; Riva, F; Martin, E; Zani, A				Proverbio, Alice Mado; Riva, Federica; Martin, Eleonora; Zani, Alberto			Face Coding Is Bilateral in the Female Brain	PLOS ONE			English	Article							GENDER-DIFFERENCES; SEX-DIFFERENCES; RECOGNITION; PERCEPTION; SYSTEM; LATERALIZATION; SELECTIVITY; ASYMMETRY; EMOTION; DOMAIN	Background: It is currently believed that face processing predominantly activates the right hemisphere in humans, but available literature is very inconsistent. Methodology/Principal Findings: In this study, ERPs were recorded in 50 right-handed women and men in response to 390 faces (of different age and sex), and 130 technological objects. Results showed no sex difference in the amplitude of N170 to objects; a much larger face-specific response over the right hemisphere in men, and a bilateral response in women; a lack of face-age coding effect over the left hemisphere in men, with no differences in N170 to faces as a function of age; a significant bilateral face-age coding effect in women. Conclusions/Significance: LORETA reconstruction showed a significant left and right asymmetry in the activation of the fusiform gyrus (BA19), in women and men, respectively. The present data reveal a lesser degree of lateralization of brain functions related to face coding in women than men. In this light, they may provide an explanation of the inconsistencies in the available literature concerning the asymmetric activity of left and right occipito-temporal cortices devoted to face perception during processing of face identity, structure, familiarity or affective content.	[Proverbio, Alice Mado; Riva, Federica; Martin, Eleonora] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Zani, Alberto] CNR, Natl Res Council, Inst Bioimaging & Mol Physiol, I-20133 Milan, Italy	University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR)	Proverbio, AM (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	mado.proverbio@unimib.it	Zani, Alberto/ABI-3498-2020; Zani, Alberto/ABG-8894-2020	Zani, Alberto/0000-0002-3906-7988; Proverbio, Alice Mado/0000-0002-5138-1523	University of Milano-Bicocca [2008/2009]; Institute of Bioimaging and Molecular Physiology of National Research Council (IBFM-CNR)	University of Milano-Bicocca; Institute of Bioimaging and Molecular Physiology of National Research Council (IBFM-CNR)	Supported by University of Milano-Bicocca 2008/2009 FAR grants to AMP and grants from the Institute of Bioimaging and Molecular Physiology of National Research Council (IBFM-CNR) to AZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourne VJ, 2005, NEUROPSYCHOLOGIA, V43, P953, DOI 10.1016/j.neuropsychologia.2004.08.007; DOMES G, 2009, HUMAN BRAIN IN PRESS; Ewbank MP, 2008, NEUROIMAGE, V40, P1857, DOI 10.1016/j.neuroimage.2008.01.049; Glocker ML, 2009, P NATL ACAD SCI USA, V106, P9115, DOI 10.1073/pnas.0811620106; Harris AM, 2005, NEUROPSYCHOLOGIA, V43, P2125, DOI 10.1016/j.neuropsychologia.2005.03.017; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Henson RN, 2003, CEREB CORTEX, V13, P793, DOI 10.1093/cercor/13.7.793; Itier RJ, 2004, NEUROREPORT, V15, P1261, DOI 10.1097/01.wnr.0000127827.73576.d8; Jemel B, 2005, NEUROPSYCHOLOGIA, V43, P2024, DOI 10.1016/j.neuropsychologia.2005.03.016; Jiang Y, 2009, NEUROIMAGE, V44, P1171, DOI 10.1016/j.neuroimage.2008.09.038; Johnson BW, 2002, NEUROREPORT, V13, P1929, DOI 10.1097/00001756-200210280-00020; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kemp AH, 2004, NEUROIMAGE, V21, P632, DOI 10.1016/j.neuroimage.2003.09.055; Killgore WDS, 2001, NEUROREPORT, V12, P427, DOI 10.1097/00001756-200102120-00047; Lee TMC, 2002, NEUROSCI LETT, V333, P13, DOI 10.1016/S0304-3940(02)00965-5; Liu J, 2000, NEUROREPORT, V11, P337, DOI 10.1097/00001756-200002070-00023; LIU J, 2009, J COGN NEUROSCI 0320; MCKELVIE SJ, 1993, J SOC BEHAV PERS, V8, P297; Meeren HKM, 2005, P NATL ACAD SCI USA, V102, P16518, DOI 10.1073/pnas.0507650102; Palmero-Soler E, 2007, PHYS MED BIOL, V52, P1783, DOI 10.1088/0031-9155/52/7/002; Pizzagalli DA, 2002, NEUROIMAGE, V16, P663, DOI 10.1006/nimg.2002.1126; Pourtois G, 2005, J COGNITIVE NEUROSCI, V17, P1043, DOI 10.1162/0898929054475181; Proverbio AM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-44; Proverbio AM, 2006, NEUROPSYCHOLOGIA, V44, P2987, DOI 10.1016/j.neuropsychologia.2006.06.015; Rhodes G, 2004, J COGNITIVE NEUROSCI, V16, P189, DOI 10.1162/089892904322984508; Righart R, 2006, CEREB CORTEX, V16, P1249, DOI 10.1093/cercor/bhj066; Rilea SL, 2004, BRAIN COGNITION, V56, P332, DOI 10.1016/j.bandc.2004.09.002; Rossion B, 2000, J COGNITIVE NEUROSCI, V12, P793, DOI 10.1162/089892900562606; SHAYWITZ BA, 1995, NATURE, V373, P607, DOI 10.1038/373607a0; Valkonen-Korhonen M, 2005, COGNITIVE BRAIN RES, V23, P277, DOI 10.1016/j.cogbrainres.2004.10.019; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Werheid K, 2007, BIOL PSYCHOL, V76, P100, DOI 10.1016/j.biopsycho.2007.06.008; WILLEMS RM, 2009, CEREB CORTE IN PRESS; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7; Zanow F, 2004, BRAIN TOPOGR, V16, P287	38	52	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11242	10.1371/journal.pone.0011242	http://dx.doi.org/10.1371/journal.pone.0011242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	614KV	20574528	Green Submitted, Green Published, gold			2022-12-27	WOS:000279058300026
J	Kawaguchi, H; Hirakawa, K; Miyauchi, K; Koike, K; Ohno, Y; Sakamoto, A				Kawaguchi, Hiroshi; Hirakawa, Keiko; Miyauchi, Kensuke; Koike, Kaoru; Ohno, Youkichi; Sakamoto, Atsuhiro			Pattern Recognition Analysis of Proton Nuclear Magnetic Resonance Spectra of Brain Tissue Extracts from Rats Anesthetized with Propofol or Isoflurane	PLOS ONE			English	Article							CEREBRAL GLUCOSE-UTILIZATION; POSITRON EMISSION TOMOGRAPHY; BLOOD-FLOW; SEVOFLURANE ANESTHESIA; GENE-EXPRESSION; METABOLIC-RATE; IN-VIVO; HUMANS; ELECTROENCEPHALOGRAM; METABONOMICS	Background: General anesthesia is routinely used as a surgical procedure and its safety has been endorsed by clinical outcomes; however, its effects at the molecular level have not been elucidated. General anesthetics influence glucose metabolism in the brain. However, the effects of anesthetics on brain metabolites other than those related to glucose have not been well characterized. We used a pattern recognition analysis of proton nuclear magnetic resonance spectra to visualize the changes in holistic brain metabolic phenotypes in response to the widely used intravenous anesthetic propofol and the volatile anesthetic isoflurane. Methodology/Principal Findings: Rats were randomized into five groups (n = 7 each group). Propofol and isoflurane were administered to two groups each, for 2 or 6 h. The control group received no anesthesia. Brains were removed directly after anesthesia. Hydrophilic compounds were extracted from excised whole brains and measured by proton nuclear magnetic resonance spectroscopy. All spectral data were processed and analyzed by principal component analysis for comparison of the metabolite profiles. Data were visualized by plotting principal component (PC) scores. In the plots, each point represents an individual sample. The propofol and isoflurane groups were clustered separately on the plots, and this separation was especially pronounced when comparing the 6-h groups. The PC scores of the propofol group were clearly distinct from those of the control group, particularly in the 6-h group, whereas the difference in PC scores was more subtle in the isoflurane group and control groups. Conclusions/Significance: The results of the present study showed that propofol and isoflurane exerted differential effects on holistic brain metabolism under anesthesia.	[Kawaguchi, Hiroshi; Miyauchi, Kensuke; Sakamoto, Atsuhiro] Nippon Med Sch, Dept Anesthesiol, Bunkyo Ku, Tokyo 113, Japan; [Hirakawa, Keiko; Ohno, Youkichi] Nippon Med Sch, NMR Lab, Bunkyo Ku, Tokyo 113, Japan; [Hirakawa, Keiko; Ohno, Youkichi] Nippon Med Sch, Dept Legal Med, Bunkyo Ku, Tokyo 113, Japan; [Koike, Kaoru] Kyoto Univ, Grad Sch Med, Dept Primary Care & Emergency Med, Kyoto, Japan	Nippon Medical School; Nippon Medical School; Nippon Medical School; Kyoto University	Kawaguchi, H (corresponding author), Nippon Med Sch, Dept Anesthesiol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 113, Japan.	hiro-kawaguchi@nms.ac.jp			Promotion and Mutual Aid Corporation for Private Schools of Japan; Science Research Promotion Fund; Department of Neurosurgery, Nippon Medical School; Fujitsu Limited	Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); Science Research Promotion Fund; Department of Neurosurgery, Nippon Medical School; Fujitsu Limited	This work was supported by the Promotion and Mutual Aid Corporation for Private Schools of Japan and the Science Research Promotion Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Mr. Takayuki Asakura, Department of Neurosurgery, Nippon Medical School, and Mr. Kohtaro Yuta, Fujitsu Limited for supporting this research.	Alkire MT, 1998, ANESTHESIOLOGY, V89, P323, DOI 10.1097/00000542-199808000-00007; Alkire MT, 1997, ANESTHESIOLOGY, V86, P549, DOI 10.1097/00000542-199703000-00006; ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; ARTRU AA, 1992, J NEUROSURG ANESTH, V4, P99, DOI 10.1097/00008506-199204000-00005; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; Brulatout S, 1996, J NEUROCHEM, V66, P2491; CARMICHAEL FJ, 1991, J PHARMACOL EXP THER, V259, P403; CROSBY G, 1982, ANESTHESIOLOGY, V56, P437, DOI 10.1097/00000542-198206000-00005; DAM M, 1990, ANESTHESIOLOGY, V73, P499, DOI 10.1097/00000542-199009000-00021; DOLIN SJ, 1992, BRIT J ANAESTH, V68, P523, DOI 10.1093/bja/68.5.523; Eilers H, 1999, ANESTH ANALG, V88, P1168, DOI 10.1097/00000539-199905000-00037; FOLCH J, 1956, CAN J BIOCHEM PHYS, V34, P305; GODOY MM, J VIRAL HEPAT; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Kalenka A, 2007, ANESTH ANALG, V104, P1129, DOI 10.1213/01.ane.0000260799.37107.e6; Kobayashi K, 2007, BRAIN RES, V1185, P1, DOI 10.1016/j.brainres.2007.09.011; Lenz C, 1998, ANESTHESIOLOGY, V89, P1480, DOI 10.1097/00000542-199812000-00026; Lindon JC, 2006, PHARM RES, V23, P1075, DOI 10.1007/s11095-006-0025-z; Lowes DA, 2005, ANESTH ANALG, V101, P697, DOI 10.1213/01.ANE.0000160587.72827.B4; Ludbrook GL, 2002, ANESTHESIOLOGY, V97, P1363, DOI 10.1097/00000542-200212000-00006; MAEKAWA T, 1986, ANESTHESIOLOGY, V65, P144, DOI 10.1097/00000542-198608000-00003; Matta BF, 1999, ANESTHESIOLOGY, V91, P677, DOI 10.1097/00000542-199909000-00019; MATTA BF, 1995, ANESTHESIOLOGY, V83, P980, DOI 10.1097/00000542-199511000-00011; McCulloch TJ, 2007, ANESTHESIOLOGY, V106, P56, DOI 10.1097/00000542-200701000-00012; Nguyen HT, 2009, ANESTHESIOLOGY, V110, P326, DOI 10.1097/ALN.0b013e3181942b5b; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; ORI C, 1986, ANESTHESIOLOGY, V65, P152, DOI 10.1097/00000542-198608000-00004; Oshima T, 2002, ACTA ANAESTH SCAND, V46, P831, DOI 10.1034/j.1399-6576.2002.460713.x; Patel AB, 2005, P NATL ACAD SCI USA, V102, P5588, DOI 10.1073/pnas.0501703102; Pears MR, 2007, METABOLOMICS, V3, P121, DOI 10.1007/s11306-007-0051-9; Philippeos C, 2009, J BIOMOL NMR, V44, P127, DOI 10.1007/s10858-009-9329-8; Sakamoto A, 2005, GENE, V356, P39, DOI 10.1016/j.gene.2005.03.022; Serkova NJ, 2008, AM J PHYSIOL-LUNG C, V295, pL152, DOI 10.1152/ajplung.00515.2007; TSAI GC, 1995, PROG NEUROBIOL, V46, P531, DOI 10.1016/0301-0082(95)00014-M; WESTERGAARD N, 1995, DEV NEUROSCI-BASEL, V17, P203, DOI 10.1159/000111288; YOSHIKAWA C, 2002, E-POLYMERS, V13, P1	36	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11172	10.1371/journal.pone.0011172	http://dx.doi.org/10.1371/journal.pone.0011172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567596	gold, Green Published, Green Submitted			2022-12-27	WOS:000278886300016
J	Chiavolini, D; Rangel-Moreno, J; Berg, G; Christian, K; Oliveira-Nascimento, L; Weir, S; Alroy, J; Randall, TD; Wetzler, LM				Chiavolini, Damiana; Rangel-Moreno, Javier; Berg, Gretchen; Christian, Kate; Oliveira-Nascimento, Laura; Weir, Susan; Alroy, Joseph; Randall, Troy D.; Wetzler, Lee M.			Bronchus-Associated Lymphoid Tissue (BALT) and Survival in a Vaccine Mouse Model of Tularemia	PLOS ONE			English	Article							CHOLERA-TOXIN-B; VIRULENT TYPE-A; FRANCISELLA-TULARENSIS; PROTECTIVE IMMUNITY; INTRANASAL VACCINATION; RESPIRATORY TULAREMIA; AEROSOL CHALLENGE; GAMMA-INTERFERON; DENDRITIC CELLS; VARYING DEGREES	Background: Francisella tularensis causes severe pulmonary disease, and nasal vaccination could be the ideal measure to effectively prevent it. Nevertheless, the efficacy of this type of vaccine is influenced by the lack of an effective mucosal adjuvant. Methodology/Principal Findings: Mice were immunized via the nasal route with lipopolysaccharide isolated from F. tularensis and neisserial recombinant PorB as an adjuvant candidate. Then, mice were challenged via the same route with the F. tularensis attenuated live vaccine strain (LVS). Mouse survival and analysis of a number of immune parameters were conducted following intranasal challenge. Vaccination induced a systemic antibody response and 70% of mice were protected from challenge as showed by their improved survival and weight regain. Lungs from mice recovering from infection presented prominent lymphoid aggregates in peribronchial and perivascular areas, consistent with the location of bronchus-associated lymphoid tissue (BALT). BALT areas contained proliferating B and T cells, germinal centers, T cell infiltrates, dendritic cells (DCs). We also observed local production of antibody generating cells and homeostatic chemokines in BALT areas. Conclusions: These data indicate that PorB might be an optimal adjuvant candidate for improving the protective effect of F. tularensis antigens. The presence of BALT induced after intranasal challenge in vaccinated mice might play a role in regulation of local immunity and long-term protection, but more work is needed to elucidate mechanisms that lead to its formation.	[Chiavolini, Damiana; Berg, Gretchen; Christian, Kate; Oliveira-Nascimento, Laura; Weir, Susan; Wetzler, Lee M.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Rangel-Moreno, Javier; Randall, Troy D.] Univ Rochester, Sch Med, Div Allergy Immunol & Rheumatol, Rochester, NY USA; [Oliveira-Nascimento, Laura] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil; [Alroy, Joseph] Tufts Univ, Sch Med, Dept Pathol, Cummings Sch Vet Med, Boston, MA 02111 USA; [Alroy, Joseph] Tufts Med Ctr, Boston, MA USA	Boston University; University of Rochester; Universidade de Sao Paulo; Tufts University; Tufts Medical Center	Chiavolini, D (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	lwetzler@bu.edu	Oliveira-Nascimento, Laura/I-4859-2012	de Oliveira Nascimento, Laura/0000-0002-4741-8493; Rangel-Moreno, Javier/0000-0002-9738-1182; Weir, Susan/0000-0001-5570-0221; Wetzler, Lee/0000-0002-6596-2986	National Institutes of Health/National Institute of Allergy and Infectious Diseases [U19 AI056543]; CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056543] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases grant U19 AI056543. Laura de Oliveira Nascimento had financial support from CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakshi CS, 2008, VACCINE, V26, P5276, DOI 10.1016/j.vaccine.2008.07.051; BIENENSTOCK J, 1973, LAB INVEST, V28, P693; Bienenstock J, 2005, IMMUNOL REV, V206, P22, DOI 10.1111/j.0105-2896.2005.00299.x; BIENENSTOCK J, 1973, LAB INVEST, V28, P686; Bitsaktsis C, 2009, J IMMUNOL, V182, P4899, DOI 10.4049/jimmunol.0803242; Chen HD, 2003, AM J PATHOL, V163, P1341, DOI 10.1016/S0002-9440(10)63493-1; Chen HM, 2000, J CONTROL RELEASE, V67, P117, DOI 10.1016/S0168-3659(00)00199-1; Chiavolini D, 2008, CLIN VACCINE IMMUNOL, V15, P1322, DOI 10.1128/CVI.00125-08; Chiavolini D, 2008, INFECT IMMUN, V76, P486, DOI 10.1128/IAI.00862-07; Ciabattini A, 2008, VACCINE, V26, P4244, DOI 10.1016/j.vaccine.2008.05.049; Cole LE, 2009, P NATL ACAD SCI USA, V106, P4343, DOI 10.1073/pnas.0813411106; Conlan JW, 2005, VACCINE, V23, P2477, DOI 10.1016/j.vaccine.2004.10.034; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P39, DOI 10.1016/S0882-4010(02)00194-8; Conlan JW, 2002, VACCINE, V20, P3465, DOI 10.1016/S0264-410X(02)00345-6; Csaba N, 2009, ADV DRUG DELIVER REV, V61, P140, DOI 10.1016/j.addr.2008.09.005; DiTommaso A, 1996, INFECT IMMUN, V64, P974, DOI 10.1128/IAI.64.3.974-979.1996; Dreisbach VC, 2000, INFECT IMMUN, V68, P1988, DOI 10.1128/IAI.68.4.1988-1996.2000; FULOP M, 1995, VACCINE, V13, P1220, DOI 10.1016/0264-410X(95)00062-6; Fulop M, 2001, VACCINE, V19, P4465, DOI 10.1016/S0264-410X(01)00189-X; GeurtsvanKessel CH, 2009, J EXP MED, V206, P2339, DOI 10.1084/jem.20090410; GOLOVLIOV I, 1995, VACCINE, V13, P261, DOI 10.1016/0264-410X(95)93311-V; Gregory SH, 2010, VACCINE, V28, P2908, DOI 10.1016/j.vaccine.2010.01.067; Hartley MG, 2004, INFECT IMMUN, V72, P4109, DOI 10.1128/IAI.72.7.4109-4113.2004; HIRABAYASHI Y, 1990, VACCINE, V8, P243, DOI 10.1016/0264-410X(90)90053-O; Huntley JF, 2008, INFECT IMMUN, V76, P3664, DOI 10.1128/IAI.00374-08; IWATA M, 1991, INFECT IMMUN, V59, P1514, DOI 10.1128/IAI.59.4.1514-1520.1991; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; Kahnert A, 2007, J INFECT DIS, V195, P46, DOI 10.1086/508894; Massari P, 2005, PROTEIN EXPRES PURIF, V44, P136, DOI 10.1016/j.pep.2005.04.021; Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Moyron-Quiroz JE, 2006, IMMUNITY, V25, P643, DOI 10.1016/j.immuni.2006.08.022; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Oyston PCF, 2005, ANTON LEEUW INT J G, V87, P277, DOI 10.1007/s10482-004-6251-7; Pabst R, 2007, IMMUNOL LETT, V112, P1, DOI 10.1016/j.imlet.2007.06.009; Pammit MA, 2006, INFECT IMMUN, V74, P2063, DOI 10.1128/IAI.74.4.2063-2071.2006; Pechous RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002487; QI HL, 1994, INFECT IMMUN, V62, P2432, DOI 10.1128/IAI.62.6.2432-2439.1994; Randall TD, 2010, J EXP MED, V207, P451, DOI 10.1084/jem.20100059; Rangel-Moreno J, 2007, P NATL ACAD SCI USA, V104, P10577, DOI 10.1073/pnas.0700591104; Rangel-Moreno J, 2006, J CLIN INVEST, V116, P3183, DOI 10.1172/JCI28756; Rangel-Moreno Javier, 2007, Inmunologia, V26, P13; Rodriguez F, 2001, J VET MED B, V48, P259, DOI 10.1046/j.1439-0450.2001.00434.x; SATO A, 1992, AM REV RESPIR DIS, V146, P473, DOI 10.1164/ajrccm/146.2.473; Suda T, 1999, CHEST, V115, P357, DOI 10.1378/chest.115.2.357; Tschernig T, 2000, PATHOBIOLOGY, V68, P1, DOI 10.1159/000028109; Tschernig Thomas, 2009, BMC Pulm Med, V9, P39, DOI 10.1186/1471-2466-9-39; Turner DL, 2007, J VIROL, V81, P2039, DOI 10.1128/JVI.02167-06; Ulrichs T, 2004, J PATHOL, V204, P217, DOI 10.1002/path.1628; WU HY, 1993, INFECT IMMUN, V61, P314, DOI 10.1128/IAI.61.1.314-322.1993; Wu TH, 2005, INFECT IMMUN, V73, P2644, DOI 10.1128/IAI.73.5.2644-2654.2005	51	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11156	10.1371/journal.pone.0011156	http://dx.doi.org/10.1371/journal.pone.0011156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585390	Green Published, gold			2022-12-27	WOS:000278886100019
J	Cohen, I; Maoz, M; Turm, H; Grisaru-Granovsky, S; Maly, B; Uziely, B; Weiss, E; Abramovitch, R; Gross, E; Barzilay, O; Qiu, Y; Bar-Shavit, R				Cohen, Irit; Maoz, Myriam; Turm, Hagit; Grisaru-Granovsky, Sorina; Maly, Bella; Uziely, Beatrice; Weiss, Einat; Abramovitch, Rinat; Gross, Eithan; Barzilay, Oded; Qiu, Yun; Bar-Shavit, Rachel			Etk/Bmx Regulates Proteinase-Activated-Receptor1 (PAR(1)) in Breast Cancer Invasion: Signaling Partners, Hierarchy and Physiological Significance	PLOS ONE			English	Article							PROTEASE-ACTIVATED RECEPTOR-1; NONRECEPTOR TYROSINE KINASES; PLECKSTRIN-HOMOLOGY DOMAIN; CARCINOMA CELL INVASION; FOCAL ADHESION KINASE; THROMBIN RECEPTOR; TUMOR PROGRESSION; SH2 DOMAIN; EXPRESSION; TRAFFICKING	Background: While protease-activated-receptor 1 (PAR1) plays a central role in tumor progression, little is known about the cell signaling involved. Methodology/Principal Findings: We show here the impact of PAR1 cellular activities using both an orthotopic mouse mammary xenograft and a colorectal-liver metastasis model in vivo, with biochemical analyses in vitro. Large and highly vascularized tumors were generated by cells over-expressing wt hPar1, Y397Z hPar1, with persistent signaling, or Y381A hPar1 mutant constructs. In contrast, cells over-expressing the truncated form of hPar1, which lacks the cytoplasmic tail, developed small or no tumors, similar to cells expressing empty vector or control untreated cells. Antibody array membranes revealed essential hPar1 partners including Etk/Bmx and Shc. PAR(1) activation induces Etk/Bmx and Shc binding to the receptor C-tail to form a complex. Y/A mutations in the PAR1 C-tail did not prevent Shc-PAR(1) association, but enhanced the number of liver metastases compared with the already increased metastases obtained with wt hPar1. We found that Etk/Bmx first binds via the PH domain to a region of seven residues, located between C378-S384 in PAR(1) C-tail, enabling subsequent Shc association. Importantly, expression of the hPar1-7A mutant form (substituted A, residues 378384), which is incapable of binding Etk/Bmx, resulted in inhibition of invasion through Matrigel-coated membranes. Similarly, knocking down Etk/Bmx inhibited PAR1-induced MDA-MB-435 cell migration. In addition, intact spheroid morphogenesis of MCF10A cells is markedly disrupted by the ectopic expression of wt hPar1. In contrast, the forced expression of the hPar1-7A mutant results in normal ball-shaped spheroids. Thus, by preventing binding of Etk/Bmx to PAR(1) -C-tail, hPar1 oncogenic properties are abrogated. Conclusions/Significance: This is the first demonstration that a cytoplasmic portion of the PAR(1) C-tail functions as a scaffold site. We identify here essential signaling partners, determine the hierarchy of binding and provide a platform for therapeutic vehicles via definition of the critical PAR(1)-associating region in the breast cancer signaling niche.	[Cohen, Irit; Maoz, Myriam; Turm, Hagit; Grisaru-Granovsky, Sorina; Uziely, Beatrice; Weiss, Einat; Barzilay, Oded; Bar-Shavit, Rachel] Hadassah Univ Hosp, Dept Oncol, IL-91120 Jerusalem, Israel; [Maly, Bella] Hadassah Univ Hosp, Dept Pathol, IL-91120 Jerusalem, Israel; [Abramovitch, Rinat] Hadassah Univ Hosp, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel; [Gross, Eithan] Hadassah Univ Hosp, Dept Pediat Surg, IL-91120 Jerusalem, Israel; [Qiu, Yun] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University System of Maryland; University of Maryland Baltimore	Cohen, I (corresponding author), Hadassah Univ Hosp, Dept Oncol, IL-91120 Jerusalem, Israel.	rachel.bar-shavit@ekmd.huji.ac.il			Israel Scientific Foundation (ISF); Israel Cancer Research Fund ( ICRF); Fritz Thyssen Foundation	Israel Scientific Foundation (ISF)(Israel Science Foundation); Israel Cancer Research Fund ( ICRF); Fritz Thyssen Foundation	This research was supported by funds from the Israel Scientific Foundation (ISF), the Israel Cancer Research Fund (ICRF), and the Fritz Thyssen Foundation (to RB). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abassi YA, 2003, J BIOL CHEM, V278, P35636, DOI 10.1074/jbc.M306438200; ALBINI A, 1987, CANCER RES, V47, P3239; Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; Bagheri-Yarmand R, 2001, J BIOL CHEM, V276, P29403, DOI 10.1074/jbc.M103129200; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Booden MA, 2004, MOL CELL BIOL, V24, P1990, DOI 10.1128/MCB.24.5.1990-1999.2004; Camerer E, 2004, BLOOD, V103, P152, DOI 10.1182/blood-2003-08-2707; Chen RY, 2001, NAT CELL BIOL, V3, P439, DOI 10.1038/35074500; Collins LR, 1997, ONCOGENE, V15, P595, DOI 10.1038/sj.onc.1201220; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Even-Ram SC, 2003, J PATHOL, V200, P47, DOI 10.1002/path.1338; Even-Ram SC, 2001, J BIOL CHEM, V276, P10952, DOI 10.1074/jbc.M007027200; Griffin CT, 2001, SCIENCE, V293, P1666, DOI 10.1126/science.1061259; Grisaru-Granovsky S, 2005, INT J CANCER, V113, P372, DOI 10.1002/ijc.20607; Groeger AM, 2004, HISTOPATHOLOGY, V44, P54, DOI 10.1111/j.1365-2559.2004.01750.x; Hammes SR, 1999, BIOCHEMISTRY-US, V38, P2486, DOI 10.1021/bi982527i; HEIN L, 1994, J BIOL CHEM, V269, P27719; Jiang Y, 1998, NATURE, V395, P808, DOI 10.1038/27454; Kim O, 2002, J BIOL CHEM, V277, P30066, DOI 10.1074/jbc.M201713200; Kuruppu D, 2002, J SURG RES, V103, P47, DOI 10.1006/jsre.2001.6299; Lee LF, 2001, MOL CELL BIOL, V21, P8385, DOI 10.1128/MCB.21.24.8385-8397.2001; Ma YC, 1998, P NATL ACAD SCI USA, V95, P12197, DOI 10.1073/pnas.95.21.12197; Mao JH, 1998, EMBO J, V17, P5638, DOI 10.1093/emboj/17.19.5638; NAKAZATO Y, CANCER, V116, P2011; Obreztchikova M, 2006, J BIOL CHEM, V281, P20197, DOI 10.1074/jbc.M601859200; Paavonen K, 2004, MOL BIOL CELL, V15, P4226, DOI 10.1091/mbc.E04-03-0241; Palumbo JS, 2000, BLOOD, V96, P3302, DOI 10.1182/blood.V96.10.3302; Pan S, 2002, MOL CELL BIOL, V22, P7512, DOI 10.1128/MCB.22.21.7512-7523.2002; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; PRONK GJ, 1993, J BIOL CHEM, V268, P5748; Qiu Y, 1998, P NATL ACAD SCI USA, V95, P3644, DOI 10.1073/pnas.95.7.3644; Qiu Y, 2000, ONCOGENE, V19, P5651, DOI 10.1038/sj.onc.1203958; RICKLES FR, 1983, BLOOD, V62, P14; Salah Z, 2007, MOL CANCER RES, V5, P229, DOI 10.1158/1541-7786.MCR-06-0261; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Swift S, 2006, J BIOL CHEM, V281, P4109, DOI 10.1074/jbc.M509525200; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Tsai YT, 2000, MOL CELL BIOL, V20, P2043, DOI 10.1128/MCB.20.6.2043-2054.2000; Yin YJ, 2003, ARTERIOSCL THROM VAS, V23, P940, DOI 10.1161/01.ATV.0000066878.27340.22	43	25	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11135	10.1371/journal.pone.0011135	http://dx.doi.org/10.1371/journal.pone.0011135			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559570	Green Published, Green Submitted, gold			2022-12-27	WOS:000278775900024
J	Lehmann, C; Lafferty, M; Garzino-Demo, A; Jung, N; Hartmann, P; Fatkenheuer, G; Wolf, JS; van Lunzen, J; Romerio, F				Lehmann, Clara; Lafferty, Mark; Garzino-Demo, Alfredo; Jung, Norma; Hartmann, Pia; Faetkenheuer, Gerd; Wolf, Jeffrey S.; van Lunzen, Jan; Romerio, Fabio			Plasmacytoid Dendritic Cells Accumulate and Secrete Interferon Alpha in Lymph Nodes of HIV-1 Patients	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE-ANTIRETROVIRAL-THERAPY; BLOOD MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; T-CELLS; I INTERFERON; HIV-1-INFECTED PATIENTS; IMMUNE ACTIVATION; PROGNOSTIC VALUE; RNA LEVELS	Circulating plasmacytoid dendritic cells (pDC) decline during HIV-1 infection, but at the same time they express markedly higher levels of interferon alpha (IFN alpha), which is associated with HIV-1 disease progression. Here we show an accumulation of pDC in lymph nodes (LN) of treatment-naive HIV-1 patients. This phenomenon was associated with elevated expression of the LN homing marker, CCR7, on pDC in peripheral blood of HIV-1 patients, which conferred increased migratory capacity in response to CCR7 ligands in ex vivo functional assays. LN-homed pDC of HIV-1 patients presented higher CD40 and lower BDCA2 levels, but unchanged CD83 and CD86 expression. In addition, these cells expressed markedly higher amounts of IFN alpha compared to uninfected individuals, and were undergoing faster rates of cell death. These results demonstrate for the first time that in asymptomatic, untreated HIV-1 patients circulating pDC up-regulate CCR7 expression, accumulate in lymph nodes, and express high amounts of IFN alpha before undergoing cell death. Since IFN alpha inhibits cell proliferation and modulates immune responses, chronically high levels of this cytokine in LN of HIV-1 patients may impair differentiation and immune function of bystander CD4(+) T cells, thus playing into the mechanisms of AIDS immunopathogenesis.	[Lehmann, Clara; Lafferty, Mark; Garzino-Demo, Alfredo; Romerio, Fabio] Univ Maryland, Inst Human Virol, Baltimore, MD 21201 USA; [Lehmann, Clara; Romerio, Fabio] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Lehmann, Clara; Jung, Norma; Faetkenheuer, Gerd] Univ Cologne, Dept Internal Med 1, Cologne, Germany; [Lafferty, Mark; Garzino-Demo, Alfredo] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Wolf, Jeffrey S.] Univ Maryland, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Baltimore, MD 21201 USA; [van Lunzen, Jan] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [van Lunzen, Jan] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-2000 Hamburg, Germany	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Cologne; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; University of Hamburg	Lehmann, C (corresponding author), Univ Maryland, Inst Human Virol, Baltimore, MD 21201 USA.	fromerio@ihv.umaryland.edu	Serei, Virian D/B-4616-2015; Lehmann, Clara/F-9671-2016	Lehmann, Clara/0000-0002-7042-1578; Garzino-Demo, Alfredo/0000-0002-4095-6950	National Institute of Neurological Disorders and Stroke (NINDS) [R01NS066842]; National Institute of Dental and Craniofacial Research [1R21DE15508-01]; German Federal Ministry of Research and Education (BMBF) [01KI0771]; National Institute of Allergy and Infectious Diseases (NIAID) [T32AI007540]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE015508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066842] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); German Federal Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work described was supported by awards R01NS066842 from the National Institute of Neurological Disorders and Stroke (NINDS) and 1R21DE15508-01 from the National Institute of Dental and Craniofacial Research (A.G.-D.). C. L. and N.J. were supported by the German Federal Ministry of Research and Education (BMBF grant 01KI0771). M. K. L. was a trainee under Institutional Training Grant T32AI007540 from the National Institute of Allergy and Infectious Diseases (NIAID). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID, NINDS or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2002, J VIROL, V76, P8433, DOI 10.1128/JVI.76.16.8433-8445.2002; Almeida M, 2005, AIDS, V19, P261; Barron MA, 2003, J INFECT DIS, V187, P26, DOI 10.1086/345957; Biron CA, 1998, ADV EXP MED BIOL, V452, P143; Boasso A, 2008, CLIN IMMUNOL, V126, P235, DOI 10.1016/j.clim.2007.08.015; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brown KN, 2007, J IMMUNOL, V178, P6958, DOI 10.4049/jimmunol.178.11.6958; Brown KN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000413; Chehimi J, 2002, J IMMUNOL, V168, P4796, DOI 10.4049/jimmunol.168.9.4796; de la Rosa G, 2003, J LEUKOCYTE BIOL, V73, P639, DOI 10.1189/jlb.1002516; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Desai S, 2007, JAIDS-J ACQ IMM DEF, V45, P501, DOI 10.1097/QAI.0b013e3180654811; Dillon SM, 2008, JAIDS-J ACQ IMM DEF, V48, P1, DOI 10.1097/QAI.0b013e3181664b60; Diop OM, 2008, J VIROL, V82, P5145, DOI 10.1128/JVI.02433-07; Donaghy H, 2001, BLOOD, V98, P2574, DOI 10.1182/blood.V98.8.2574; Donaghy H, 2003, BLOOD, V101, P4505, DOI 10.1182/blood-2002-10-3189; Durbin JE, 2000, J IMMUNOL, V164, P4220, DOI 10.4049/jimmunol.164.8.4220; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; FAHEY JL, 1990, NEW ENGL J MED, V322, P166, DOI 10.1056/NEJM199001183220305; Feldman S, 2001, CLIN IMMUNOL, V101, P201, DOI 10.1006/clim.2001.5111; Fonteneau JF, 2004, J VIROL, V78, P5223, DOI 10.1128/JVI.78.10.5223-5232.2004; Foussat A, 2001, BLOOD, V98, P1678, DOI 10.1182/blood.V98.6.1678; FRANCIS ML, 1992, AIDS RES HUM RETROV, V8, P199, DOI 10.1089/aid.1992.8.199; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Graham LM, 2009, CYTOKINE, V48, P148, DOI 10.1016/j.cyto.2009.07.010; Herbeuval JP, 2007, CLIN IMMUNOL, V123, P121, DOI 10.1016/j.clim.2006.09.016; Herbeuval JP, 2006, P NATL ACAD SCI USA, V103, P7000, DOI 10.1073/pnas.0600363103; Herbeuval JP, 2005, BLOOD, V106, P3524, DOI 10.1182/blood-2005-03-1243; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kleeberger CA, 1999, CLIN DIAGN LAB IMMUN, V6, P14, DOI 10.1128/CDLI.6.1.14-19.1999; Krathwohl MD, 2006, J INFECT DIS, V193, P494, DOI 10.1086/499597; Lehmann C, 2009, AIDS RES HUM RETROV, V25, P577, DOI 10.1089/aid.2008.0238; Lehmann C, 2008, JAIDS-J ACQ IMM DEF, V48, P522, DOI 10.1097/QAI.0b013e31817f97cf; Lore K, 2002, AIDS, V16, P683, DOI 10.1097/00002030-200203290-00003; Malleret B, 2008, IMMUNOLOGY, V124, P223, DOI 10.1111/j.1365-2567.2007.02758.x; Malleret B, 2008, BLOOD, V112, P4598, DOI 10.1182/blood-2008-06-162651; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Pacanowski J, 2001, BLOOD, V98, P3016, DOI 10.1182/blood.V98.10.3016; Pacanowski M, 2004, J INFECT DIS, V190, P1889, DOI 10.1086/425020; Panda A, 2010, J IMMUNOL, V184, P2518, DOI 10.4049/jimmunol.0901022; Pandrea IV, 2007, J IMMUNOL, V179, P3035, DOI 10.4049/jimmunol.179.5.3035; Popovic M, 2005, P NATL ACAD SCI USA, V102, P14807, DOI 10.1073/pnas.0506857102; Reimann KA, 2000, CLIN DIAGN LAB IMMUN, V7, P352, DOI 10.1128/CDLI.7.3.352-359.2000; Schmidt B, 2005, VIROLOGY, V343, P256, DOI 10.1016/j.virol.2005.09.059; Sedaghat AR, 2008, J VIROL, V82, P1870, DOI 10.1128/JVI.02228-07; SEN GC, 1993, ADV VIRUS RES, V42, P57, DOI 10.1016/S0065-3527(08)60083-4; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Siegal Frederick, 2003, Res Initiat Treat Action, V8, P10; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; SIMON A, 1991, J VIROL, V65, P968, DOI 10.1128/JVI.65.2.968-971.1991; Soumelis V, 2001, BLOOD, V98, P906, DOI 10.1182/blood.V98.4.906; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Tilton JC, 2008, J VIROL, V82, P3997, DOI 10.1128/JVI.01545-07; VONWUSSOW P, 1990, AIDS, V4, P119, DOI 10.1097/00002030-199002000-00004; Weinberg A, 2000, CLIN DIAGN LAB IMMUN, V7, P714, DOI 10.1128/CDLI.7.4.714-716.2000; Weinberg A, 2007, CLIN VACCINE IMMUNOL, V14, P1242, DOI 10.1128/CVI.00187-07; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; Wu PP, 2008, CLIN IMMUNOL, V129, P40, DOI 10.1016/j.clim.2008.06.004; Yonezawa A, 2003, J VIROL, V77, P3777, DOI 10.1128/JVI.77.6.3777-3784.2003; Zagury D, 1998, P NATL ACAD SCI USA, V95, P3851, DOI 10.1073/pnas.95.7.3851	67	63	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11110	10.1371/journal.pone.0011110	http://dx.doi.org/10.1371/journal.pone.0011110			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559432	Green Published, gold, Green Submitted			2022-12-27	WOS:000278741100022
J	Akimana, C; Al-Khodor, S; Abu Kwaik, Y				Akimana, Christine; Al-Khodor, Souhaila; Abu Kwaik, Yousef			Host Factors Required for Modulation of Phagosome Biogenesis and Proliferation of Francisella tularensis within the Cytosol	PLOS ONE			English	Article							LIVE VACCINE STRAIN; HUMAN MACROPHAGES; DROSOPHILA CELLS; RNAI SCREEN; INTRACELLULAR FATE; INFECTION; GROWTH; PATHOGENICITY; ESCAPE; SURVIVAL	Francisella tularensis is a highly infectious facultative intracellular bacterium that can be transmitted between mammals by arthropod vectors. Similar to many other intracellular bacteria that replicate within the cytosol, such as Listeria, Shigella, Burkholderia, and Rickettsia, the virulence of F. tularensis depends on its ability to modulate biogenesis of its phagosome and to escape into the host cell cytosol where it proliferates. Recent studies have identified the F. tularensis genes required for modulation of phagosome biogenesis and escape into the host cell cytosol within human and arthropod-derived cells. However, the arthropod and mammalian host factors required for intracellular proliferation of F. tularensis are not known. We have utilized a forward genetic approach employing genome-wide RNAi screen in Drosophila melanogaster-derived cells. Screening a library of similar to 21,300 RNAi, we have identified at least 186 host factors required for intracellular bacterial proliferation. We silenced twelve mammalian homologues by RNAi in HEK293T cells and identified three conserved factors, the PI4 kinase PI4KCA, the ubiquitin hydrolase USP22, and the ubiquitin ligase CDC27, which are also required for replication in human cells. The PI4KCA and USP22 mammalian factors are not required for modulation of phagosome biogenesis or phagosomal escape but are required for proliferation within the cytosol. In contrast, the CDC27 ubiquitin ligase is required for evading lysosomal fusion and for phagosomal escape into the cytosol. Although F. tularensis interacts with the autophagy pathway during late stages of proliferation in mouse macrophages, this does not occur in human cells. Our data suggest that F. tularensis utilizes host ubiquitin turnover in distinct mechanisms during the phagosomal and cytosolic phases and phosphoinositide metabolism is essential for cytosolic proliferation of F. tularensis. Our data will facilitate deciphering molecular ecology, patho-adaptation of F. tularensis to the arthropod vector and its role in bacterial ecology and patho-evolution to infect mammals.	[Akimana, Christine; Al-Khodor, Souhaila; Abu Kwaik, Yousef] Univ Louisville, Coll Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Abu Kwaik, Yousef] Univ Louisville, Dept Biol, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Akimana, C (corresponding author), Univ Louisville, Coll Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA.	abukwaik@louisville.edu	Khodor, Souhaila Al/AAQ-6938-2020; Abu Kwaik, Yousef/A-2802-2012	Abu Kwaik, Yousef/0000-0002-2119-2078; Al Khodor, Souhaila/0000-0003-4858-7130	National Institute of Allergy and Infectious Diseases (NIAID) [R01AI43965, R01AI069321]; Commonwealth of Kentucky Research Challenge Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069321, R01AI043965] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Commonwealth of Kentucky Research Challenge Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	YA is supported by Public Health Service Awards R01AI43965 and R01AI069321 from National Institute of Allergy and Infectious Diseases (NIAID) and by the Commonwealth of Kentucky Research Challenge Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd H, 2003, APPL ENVIRON MICROB, V69, P600, DOI 10.1128/AEM.69.1.600-606.2003; Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Aperis G, 2007, MICROBES INFECT, V9, P729, DOI 10.1016/j.micinf.2007.02.016; ASARE R, 2010, ENV MICROBI IN PRESS; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Champion MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000459; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Cheng LW, 2005, P NATL ACAD SCI USA, V102, P13646, DOI 10.1073/pnas.0506461102; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Clemens DL, 2007, ANN NY ACAD SCI, V1105, P160, DOI 10.1196/annals.1409.001; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Deng K, 2006, INFECT IMMUN, V74, P4224, DOI 10.1128/IAI.01975-05; Derre I, 2007, PLOS PATHOG, V3, P1446, DOI 10.1371/journal.ppat.0030155; Dorer MS, 2006, PLOS PATHOG, V2, P315, DOI 10.1371/journal.ppat.0020034; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; FORTIER AH, 1995, INFECT IMMUN, V63, P1478, DOI 10.1128/IAI.63.4.1478-1483.1995; FRANCIS E., 1927, Public Health Reports, V42, P2763, DOI 10.2307/4578567; Horzempa J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-172; Hrstka R, 2005, MICROBES INFECT, V7, P619, DOI 10.1016/j.micinf.2004.12.020; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; Koo IC, 2008, P NATL ACAD SCI USA, V105, P710, DOI 10.1073/pnas.0708110105; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Lee HJ, 2006, GENE EXPR PATTERNS, V6, P277, DOI 10.1016/j.modgep.2005.07.007; Lindemann SR, 2007, INFECT IMMUN, V75, P3178, DOI 10.1128/IAI.01811-06; Milne TS, 2007, J MED MICROBIOL, V56, P1268, DOI 10.1099/jmm.0.47190-0; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Parsa KVL, 2008, MOL IMMUNOL, V45, P3012, DOI 10.1016/j.molimm.2008.01.011; Petersen JM, 2009, VET RES, V40, DOI 10.1051/vetres:2008045; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Philips JA, 2008, P NATL ACAD SCI USA, V105, P3070, DOI 10.1073/pnas.0707206105; Pizarro-Cerda J, 2007, CELL MICROBIOL, V9, P2381, DOI 10.1111/j.1462-5822.2007.00967.x; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Read A, 2008, J MED ENTOMOL, V45, P1108, DOI 10.1603/0022-2585(2008)45[1108:FGRFRI]2.0.CO;2; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Santic M, 2005, CELL MICROBIOL, V7, P957, DOI 10.1111/j.1462-5822.2005.00529.x; Santic M, 2006, TRENDS MICROBIOL, V14, P37, DOI 10.1016/j.tim.2005.11.008; Santic M, 2008, INFECT IMMUN, V76, P2671, DOI 10.1128/IAI.00185-08; Santic M, 2009, ENVIRON MICROBIOL, V11, P1473, DOI 10.1111/j.1462-2920.2009.01875.x; Sjostedt A, 2006, MICROBES INFECT, V8, P561, DOI 10.1016/j.micinf.2005.08.001; Titball RW, 2003, ASM NEWS, V69, P558; Vaillancourt FH, 2009, VIROLOGY, V387, P5, DOI 10.1016/j.virol.2009.02.039; Vogler AJ, 2009, J BACTERIOL, V191, P2474, DOI 10.1128/JB.01786-08; Vonkavaara M, 2008, CELL MICROBIOL, V10, P1327, DOI 10.1111/j.1462-5822.2008.01129.x; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015	48	49	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11025	10.1371/journal.pone.0011025	http://dx.doi.org/10.1371/journal.pone.0011025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552012	Green Published, Green Submitted, gold			2022-12-27	WOS:000278662900008
J	Farnsworth, A; Flaman, AS; Prasad, SS; Gravel, C; Williams, A; Yauk, CL; Li, XG				Farnsworth, Aaron; Flaman, Anathea S.; Prasad, Shiv S.; Gravel, Caroline; Williams, Andrew; Yauk, Carole L.; Li, Xuguang			Acetaminophen Modulates the Transcriptional Response to Recombinant Interferon-beta	PLOS ONE			English	Article							NF-KAPPA-B; C-MYC EXPRESSION; GENE-EXPRESSION; LIVER-INJURY; ALPHA; ACTIVATION; INHIBITION; ASPIRIN; HEPATOTOXICITY; PARACETAMOL	Background: Recombinant interferon treatment can result in several common side effects including fever and injection-site pain. Patients are often advised to use acetaminophen or other over-the-counter pain medications as needed. Little is known regarding the transcriptional changes induced by such co-administration. Methodology/Principal Findings: We tested whether the administration of acetaminophen causes a change in the response normally induced by interferon-beta treatment. CD-1 mice were administered acetaminophen (APAP), interferon-beta (IFN-beta) or a combination of IFN-beta+APAP and liver and serum samples were collected for analysis. Differential gene expression was determined using an Agilent 22 k whole mouse genome microarray. Data were analyzed by several methods including Gene Ontology term clustering and Gene Set Enrichment Analysis. We observed a significant change in the transcription profile of hepatic cells when APAP was co-administered with IFN-beta. These transcriptional changes included a marked up-regulation of genes involved in signal transduction and cell differentiation and down-regulation of genes involved in cellular metabolism, trafficking and the I kappa BK/NF-kappa B cascade. Additionally, we observed a large decrease in the expression of several IFN-induced genes including Ifit-3, Isg-15, Oasl1, Zbp1 and predicted gene EG634650 at both early and late time points. Conclusions/Significance: A significant change in the transcriptional response was observed following co-administration of IFN-beta+APAP relative to IFN-beta treatment alone. These results suggest that administration of acetaminophen has the potential to modify the efficacy of IFN-beta treatment.	[Farnsworth, Aaron; Flaman, Anathea S.; Prasad, Shiv S.; Gravel, Caroline; Li, Xuguang] Hlth Canada, Ctr Vaccine Evaluat, Biol & Genet Therapies Directorate, Ottawa, ON K1A 0L2, Canada; [Williams, Andrew; Yauk, Carole L.] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada	Health Canada; Health Canada	Farnsworth, A (corresponding author), Hlth Canada, Ctr Vaccine Evaluat, Biol & Genet Therapies Directorate, Ottawa, ON K1A 0L2, Canada.	Aaron_Farnsworth@hc-sc.gc.ca		Williams, Andrew/0000-0002-7637-7686; Yauk, Carole/0000-0002-6725-3454; Yauk, Carole/0000-0003-4919-876X	Health Canada (Canadian Regulatory Strategy for Biotechnology)	Health Canada (Canadian Regulatory Strategy for Biotechnology)	This work was funded by Health Canada (www.hc-sc.gc.ca/) (Canadian Regulatory Strategy for Biotechnology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SL, 1999, J INTERF CYTOK RES, V19, P487, DOI 10.1089/107999099313938; Aronoff DM, 2006, CLIN PHARMACOL THER, V79, P9, DOI 10.1016/j.clpt.2005.09.009; BEIERSCHMITT WP, 1989, TOXICOL APPL PHARM, V98, P517, DOI 10.1016/0041-008X(89)90180-4; Bekisz J, 2004, GROWTH FACTORS, V22, P243, DOI 10.1080/08977190400000833; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boulares HA, 1999, TOXICOL SCI, V48, P264, DOI 10.1093/toxsci/48.2.264; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chernesky M, 1993, Clin Diagn Virol, V1, P129, DOI 10.1016/0928-0197(93)90021-V; Crocker JFS, 1998, CLIN INVEST MED, V21, P192; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; EVANS LM, 1991, J IMMUNOTHER, V10, P39, DOI 10.1097/00002371-199102000-00006; Girouard Nathalie, 2008, Can J Neurosci Nurs, V30, P18; GRAHAM NMH, 1990, J INFECT DIS, V162, P1277, DOI 10.1093/infdis/162.6.1277; HENDRIX CW, 1995, ANTIVIR RES, V28, P121, DOI 10.1016/0166-3542(95)00043-L; Hiscott J, 2003, ANN NY ACAD SCI, V1010, P237, DOI 10.1196/annals.1299.042; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaiser WJ, 2008, J IMMUNOL, V181, P6427, DOI 10.4049/jimmunol.181.9.6427; KALABIS GM, 1990, J PHARMACOL EXP THER, V255, P1408; Kauffman MA, 2009, INT J CLIN PHARM TH, V47, P328; KELLOKUMPULEHTINEN P, 1989, LANCET, V1, P1143; Kerr MK, 2003, BIOMETRICS, V59, P822; Kerr MK, 2001, GENET RES, V77, P123; Liang YL, 2005, BIOINFORMATICS, V21, P3009, DOI 10.1093/bioinformatics/bti465; Lou YJ, 2009, CANCER RES, V69, P3673, DOI 10.1158/0008-5472.CAN-08-4922; Marques J, 2008, J GEN VIROL, V89, P2767, DOI 10.1099/vir.0.2008/003558-0; Martin-Saavedra FM, 2008, MOL IMMUNOL, V45, P4008, DOI 10.1016/j.molimm.2008.06.006; MILANESE C, 1990, J NEUROL NEUROSUR PS, V53, P554, DOI 10.1136/jnnp.53.7.554; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakagawa H, 2008, GASTROENTEROLOGY, V135, P1311, DOI 10.1053/j.gastro.2008.07.006; OZAKI Y, 1987, BIOCHEM BIOPH RES CO, V144, P1147, DOI 10.1016/0006-291X(87)91431-8; Pappas DJ, 2009, PHYSIOL GENOMICS, V38, P362, DOI 10.1152/physiolgenomics.00058.2009; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Prymula R, 2009, LANCET, V374, P1339, DOI 10.1016/S0140-6736(09)61208-3; Raming K, 1998, RECEPTOR CHANNEL, V6, P141; ROMERIL KR, 1989, NEW ZEAL MED J, V102, P186; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Schlee M, 2007, INT J CANCER, V120, P1387, DOI 10.1002/ijc.22372; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TAKAOKI M, 1988, J INTERFERON RES, V8, P727, DOI 10.1089/jir.1988.8.727; Team RDC, 2005, R LANG ENV STAT COMP; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Tulley PN, 2004, BRIT J OPHTHALMOL, V88, P1563, DOI 10.1136/bjo.2003.033498; VISCO G, 1991, LANCET, V337, P741, DOI 10.1016/0140-6736(91)90333-K; Wang RP, 2008, MOL IMMUNOL, V45, P1926, DOI 10.1016/j.molimm.2007.10.034; Williams DP, 2004, CHEM RES TOXICOL, V17, P1551, DOI 10.1021/tx049846x; WITTER FR, 1988, CLIN PHARMACOL THER, V44, P239, DOI 10.1038/clpt.1988.143; Wu CF, 2003, BIOSENS BIOELECTRON, V19, P1, DOI 10.1016/S0956-5663(03)00118-0; Xiao S, 2006, P NATL ACAD SCI USA, V103, P16448, DOI 10.1073/pnas.0607830103; Yamaura K, 2002, BIOL PHARM BULL, V25, P201, DOI 10.1248/bpb.25.201; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yuan TTT, 2001, GENE, V278, P41, DOI 10.1016/S0378-1119(01)00709-0; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102	55	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e11031	10.1371/journal.pone.0011031	http://dx.doi.org/10.1371/journal.pone.0011031			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20544007	Green Published, gold, Green Submitted			2022-12-27	WOS:000278557600010
J	Huang, T; Shi, XH; Wang, P; He, ZS; Feng, KY; Hu, LL; Kong, XY; Li, YX; Cai, YD; Chou, KC				Huang, Tao; shi, Xiao-He; Wang, Ping; He, Zhisong; Feng, Kai-Yan; Hu, Lele; Kong, Xiangyin; Li, Yi-Xue; Cai, Yu-Dong; Chou, Kuo-Chen			Analysis and Prediction of the Metabolic Stability of Proteins Based on Their Sequential Features, Subcellular Locations and Interaction Networks	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; INFLUENZA-A VIRUS; FREQUENCY VIBRATIONS PHONONS; M2 PROTON CHANNEL; BIOLOGICAL FUNCTIONS; STRUCTURAL CLASSES; ALLOSTERIC TRANSITION; SECONDARY STRUCTURE; COLLECTIVE MOTION; BINDING MECHANISM	The metabolic stability is a very important idiosyncracy of proteins that is related to their global flexibility, intramolecular fluctuations, various internal dynamic processes, as well as many marvelous biological functions. Determination of protein's metabolic stability would provide us with useful information for in-depth understanding of the dynamic action mechanisms of proteins. Although several experimental methods have been developed to measure protein's metabolic stability, they are time-consuming and more expensive. Reported in this paper is a computational method, which is featured by (1) integrating various properties of proteins, such as biochemical and physicochemical properties, subcellular locations, network properties and protein complex property, (2) using the mRMR (Maximum Relevance & Minimum Redundancy) principle and the IFS (Incremental Feature Selection) procedure to optimize the prediction engine, and (3) being able to identify proteins among the four types: "short'', "medium'', "long'', and "extra-long'' half-life spans. It was revealed through our analysis that the following seven characters played major roles in determining the stability of proteins: (1) KEGG enrichment scores of the protein and its neighbors in network, (2) subcellular locations, (3) polarity, (4) amino acids composition, (5) hydrophobicity, (6) secondary structure propensity, and (7) the number of protein complexes the protein involved. It was observed that there was an intriguing correlation between the predicted metabolic stability of some proteins and the real half-life of the drugs designed to target them. These findings might provide useful insights for designing protein-stability-relevant drugs. The computational method can also be used as a large-scale tool for annotating the metabolic stability for the avalanche of protein sequences generated in the post-genomic age.	[Huang, Tao; Li, Yi-Xue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao; Feng, Kai-Yan; Li, Yi-Xue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Hu, Lele; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [shi, Xiao-He; Wang, Ping; Kong, Xiangyin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [shi, Xiao-He; Wang, Ping; Kong, Xiangyin] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [He, Zhisong] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China; [Kong, Xiangyin] Shanghai Jiao Tong Univ, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Cai, Yu-Dong; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; Shanghai Jiao Tong University; Fudan University	Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China.	xykong@sibs.ac.cn; yxli@sibs.ac.cn; cai_yud@yahoo.com.cn; kcchou@gordonlifescience.org	Chou, Kuo-Chen/A-8340-2009	cai, yudong/0000-0001-5664-7979	National High Technology Research and Development Program of China [2006AA02A301]; National Basic Research Program of China [2007CB512202]; Chinese Academy of Sciences [KSCX1-YW-R-74, KSCX2-YW-R-112]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National High Technology Research and Development Program of China (2006AA02A301), the National Basic Research Program of China (No. 2007CB512202), the Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No. KSCX1-YW-R-74) and Key Research Program (CAS) (KSCX2-YW-R-112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; CHOTHIA C, 1990, ANNU REV BIOCHEM, V59, P1007, DOI 10.1146/annurev.bi.59.070190.005043; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; CHOU KC, 1984, BIOPHYS CHEM, V20, P61, DOI 10.1016/0301-4622(84)80005-8; CHOU KC, 1987, BIOPOLYMERS, V26, P285, DOI 10.1002/bip.360260209; CHOU KC, 1992, EUR J BIOCHEM, V207, P429, DOI 10.1111/j.1432-1033.1992.tb17067.x; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; CHOU KC, 1989, TRENDS BIOCHEM SCI, V14, P212, DOI 10.1016/0968-0004(89)90026-1; Chou KC, 2003, BIOCHEM BIOPH RES CO, V311, P743, DOI 10.1016/j.bbrc.2003.10.062; CHOU KC, 1992, PROTEIN SCI, V1, P810, DOI 10.1002/pro.5560010613; CHOU KC, 1988, BIOPOLYMERS, V27, P1795, DOI 10.1002/bip.360271109; CHOU KC, 1988, BIOPHYS CHEM, V30, P3, DOI 10.1016/0301-4622(88)85002-6; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; CHOU KC, 1994, J BIOL CHEM, V269, P22014; CHOU KC, 1977, SCI SINICA, V20, P447; CHOU KC, 1994, BIOPOLYMERS, V34, P143, DOI 10.1002/bip.360340114; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; CHOU KC, 1991, PROTEINS, V9, P280, DOI 10.1002/prot.340090406; CHOU KC, 2009, NAT SCI, V2, P63, DOI DOI 10.4236/NS.2009.12011; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; Cristian L, 2003, PROTEIN SCI, V12, P1732, DOI 10.1110/ps.0378603; Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045; Du QS, 2009, J THEOR BIOL, V259, P159, DOI 10.1016/j.jtbi.2009.03.003; Dubchak I, 1999, PROTEINS, V35, P401, DOI 10.1002/(SICI)1097-0134(19990601)35:4<401::AID-PROT3>3.0.CO;2-K; FAUCHERE JL, 1988, INT J PEPT PROT RES, V32, P269; Fields PA, 2001, COMP BIOCHEM PHYS A, V129, P417, DOI 10.1016/S1095-6433(00)00359-7; Gong K, 2009, MED CHEM, V5, P242, DOI 10.2174/157340609788185936; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Gromiha MM, 2004, PROG BIOPHYS MOL BIO, V86, P235, DOI 10.1016/j.pbiomolbio.2003.09.003; Huang RB, 2008, BIOCHEM BIOPH RES CO, V377, P1243, DOI 10.1016/j.bbrc.2008.10.148; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kamerzell TJ, 2008, J PHARM SCI-US, V97, P3494, DOI 10.1002/jps.21269; Li FM, 2008, PROTEIN PEPTIDE LETT, V15, P612, DOI 10.2174/092986608784966930; Li L, 2007, BIOCHEM BIOPH RES CO, V358, P1102, DOI 10.1016/j.bbrc.2007.05.053; Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681; Lin H, 2008, J THEOR BIOL, V252, P350, DOI 10.1016/j.jtbi.2008.02.004; Lumry R, 2002, BIOPHYS CHEM, V101, P81, DOI 10.1016/S0301-4622(02)00156-4; Madkan A., 2009, NAT SCI, V1, P157, DOI [10.4236/ns.2009.13020, DOI 10.4236/NS.2009.13020]; MARTEL P, 1992, PROG BIOPHYS MOL BIO, V57, P129, DOI 10.1016/0079-6107(92)90023-Y; Minetti CASA, 2006, ARCH BIOCHEM BIOPHYS, V453, P32, DOI 10.1016/j.abb.2006.03.023; Niu B, 2009, MOL DIVERS, V13, P313, DOI 10.1007/s11030-009-9116-1; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pielak RM, 2009, P NATL ACAD SCI USA, V106, P7379, DOI 10.1073/pnas.0902548106; Pollastri G, 2002, PROTEINS, V47, P142, DOI 10.1002/prot.10069; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Qian ZL, 2006, BIOCHEM BIOPH RES CO, V348, P1034, DOI 10.1016/j.bbrc.2006.07.149; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Shen H.-B., 2009, J BIOMED SCI ENG, V2, DOI DOI 10.4236/JBISE.2009.23024; Shen H.B., 2009, OPEN BIOINFORM J, V3, P31, DOI DOI 10.2174/1875036200903010031; Shen HB, 2009, J THEOR BIOL, V256, P441, DOI 10.1016/j.jtbi.2008.10.007; Wang JF, 2009, BIOCHEM BIOPH RES CO, V390, P608, DOI 10.1016/j.bbrc.2009.10.014; Wang JF, 2009, MED CHEM, V5, P263, DOI 10.2174/157340609788185954; Wang JF, 2009, PROTEIN ENG DES SEL, V22, P349, DOI 10.1093/protein/gzp012; Wang JF, 2009, CURR MED CHEM, V16, P232, DOI 10.2174/092986709787002727; Wang JF, 2009, NAT STRUCT MOL BIOL, V16, P1267, DOI 10.1038/nsmb.1707; Wei H, 2009, MED CHEM, V5, P305, DOI 10.2174/157340609788681430; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Xiao X, 2007, PROTEIN PEPTIDE LETT, V14, P871, DOI 10.2174/092986607782110293; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhang TL, 2008, J THEOR BIOL, V250, P186, DOI 10.1016/j.jtbi.2007.09.014	72	158	161	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10972	10.1371/journal.pone.0010972	http://dx.doi.org/10.1371/journal.pone.0010972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532046	Green Published, gold			2022-12-27	WOS:000278380500016
J	Lucas, DM; Alinari, L; West, DA; Davis, ME; Edwards, RB; Johnson, AJ; Blum, KA; Hofmeister, CC; Freitas, MA; Parthun, MR; Wang, DS; Lehman, A; Zhang, XL; Jarjoura, D; Kulp, SK; Croce, CM; Grever, MR; Chen, CS; Baiocchi, RA; Byrd, JC				Lucas, David M.; Alinari, Lapo; West, Derek A.; Davis, Melanie E.; Edwards, Ryan B.; Johnson, Amy J.; Blum, Kristie A.; Hofmeister, Craig C.; Freitas, Michael A.; Parthun, Mark R.; Wang, Dasheng; Lehman, Amy; Zhang, Xiaoli; Jarjoura, David; Kulp, Samuel K.; Croce, Carlo M.; Grever, Michael R.; Chen, Ching-Shih; Baiocchi, Robert A.; Byrd, John C.			The Novel Deacetylase Inhibitor AR-42 Demonstrates Pre-Clinical Activity in B-Cell Malignancies In Vitro and In Vivo	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; SUBEROYLANILIDE HYDROXAMIC ACID; HISTONE DEACETYLASE; DEPSIPEPTIDE FR901228; APOPTOSIS; MOUSE; ACTIVATION; LYMPHOMA; SURVIVAL; LINES	Background: While deacetylase (DAC) inhibitors show promise for the treatment of B-cell malignancies, those introduced to date are weak inhibitors of class I and II DACs or potent inhibitors of class I DAC only, and have shown suboptimal activity or unacceptable toxicities. We therefore investigated the novel DAC inhibitor AR-42 to determine its efficacy in B-cell malignancies. Principal Findings: In mantle cell lymphoma (JeKo-1), Burkitt's lymphoma (Raji), and acute lymphoblastic leukemia (697) cell lines, the 48-hr IC50 (50% growth inhibitory concentration) of AR-42 is 0.61 mu M or less. In chronic lymphocytic leukemia (CLL) patient cells, the 48-hr LC50 (concentration lethal to 50%) of AR-42 is 0.76 mu M. AR-42 produces dose-and time-dependent acetylation both of histones and tubulin, and induces caspase-dependent apoptosis that is not reduced in the presence of stromal cells. AR-42 also sensitizes CLL cells to TNF-Related Apoptosis Inducing Ligand (TRAIL), potentially through reduction of c-FLIP. AR-42 significantly reduced leukocyte counts and/or prolonged survival in three separate mouse models of B-cell malignancy without evidence of toxicity. Conclusions/Significance: Together, these data demonstrate that AR-42 has in vitro and in vivo efficacy at tolerable doses. These results strongly support upcoming phase I testing of AR-42 in B-cell malignancies.	[Lucas, David M.; Alinari, Lapo; West, Derek A.; Davis, Melanie E.; Edwards, Ryan B.; Johnson, Amy J.; Blum, Kristie A.; Hofmeister, Craig C.; Grever, Michael R.; Baiocchi, Robert A.; Byrd, John C.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Freitas, Michael A.; Croce, Carlo M.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Parthun, Mark R.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Lucas, David M.; Wang, Dasheng; Kulp, Samuel K.; Grever, Michael R.; Chen, Ching-Shih; Byrd, John C.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Lehman, Amy; Zhang, Xiaoli; Jarjoura, David] Ohio State Univ, Ctr Biostat, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Lucas, DM (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	john.byrd@osumc.edu	Young, Richard A/F-6495-2012; Johnson, Amy/A-5662-2009; Hofmeister, Craig/E-3256-2011; Freitas, Michael/C-8953-2009; Blum, Kristie/E-2768-2011; Lucas, David M/E-3555-2011; Hofmeister, Craig/O-4988-2019	Young, Richard A/0000-0001-8855-8647; Hofmeister, Craig/0000-0003-4816-1607; Freitas, Michael/0000-0002-3103-8410; Hofmeister, Craig/0000-0003-4816-1607	National Cancer Institute [P01 CA101956, P01 CA081534, P50 CA140158]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [P50CA140158, P01CA101956, R01CA107106, P01CA081534] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded by the National Cancer Institute (P01 CA101956, P01 CA081534 and P50 CA140158) and a Specialized Center of Research grant from the Leukemia and Lymphoma Society (www.lls.org). Laboratory support was also provided by the V Foundation (www.jimmyv.org), the D. Warren Brown Foundation, and the Lymphoma Research Foundation (Mantle Cell Lymphoma Initiative) (www.lymphoma.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin HM, 2003, ARCH PATHOL LAB MED, V127, P424; Aron JL, 2003, BLOOD, V102, P652, DOI 10.1182/blood-2002-12-3794; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; BLUM KA, 2009, BR J HAEMATOL; Blum KA, 2009, BRIT J HAEMATOL, V147, P507, DOI 10.1111/j.1365-2141.2009.07881.x; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Byrd JC, 2005, BLOOD, V105, P959, DOI 10.1182/blood-2004-05-1693; Byrd JC, 1999, BLOOD, V94, P1401, DOI 10.1182/blood.V94.4.1401.416k30_1401_1408; Byrd JC, 2007, BLOOD, V109, P399, DOI 10.1182/blood-2006-05-020735; CATTAN AR, 1994, LEUKEMIA RES, V18, P513, DOI 10.1016/0145-2126(94)90089-2; Dickinson M, 2009, BRIT J HAEMATOL, V147, P97, DOI 10.1111/j.1365-2141.2009.07837.x; Garcia-Manero G, 2008, BLOOD, V111, P1060, DOI 10.1182/blood-2007-06-098061; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hernandez A, 2001, SURGERY, V130, P265, DOI 10.1067/msy.2001.115897; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Inoue H, 2002, INT J MOL MED, V9, P521; Inoue S, 2004, CELL DEATH DIFFER, V11, pS193, DOI 10.1038/sj.cdd.4401535; Inoue S, 2006, CANCER RES, V66, P6785, DOI 10.1158/0008-5472.CAN-05-4563; Jeon HJ, 1998, BRIT J HAEMATOL, V102, P1323, DOI 10.1046/j.1365-2141.1998.00911.x; Johnson AJ, 2006, BLOOD, V108, P1334, DOI 10.1182/blood-2005-12-011213; Kawada J, 2009, J BIOL CHEM, V284, P17102, DOI 10.1074/jbc.M809090200; KIRSCHBAUM M, 2008, BLOOD, V112, pA1564; Kisseberth WC, 2008, AM J VET RES, V69, P938, DOI 10.2460/ajvr.69.7.938; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kulp SK, 2006, CLIN CANCER RES, V12, P5199, DOI 10.1158/1078-0432.CCR-06-0429; Kummar S, 2007, CLIN CANCER RES, V13, P5411, DOI 10.1158/1078-0432.CCR-07-0791; Kurtova AV, 2009, BLOOD, V114, P4441, DOI 10.1182/blood-2009-07-233718; Lagneaux L, 2007, EXP HEMATOL, V35, P1527, DOI 10.1016/j.exphem.2007.06.014; Lee MJ, 2008, CURR OPIN ONCOL, V20, P639, DOI 10.1097/CCO.0b013e3283127095; LIN TY, BLOOD; LIU Q, 2010, CLIN CANC R IN PRESS; Lu Q, 2005, J MED CHEM, V48, P5530, DOI 10.1021/jm0503749; Lu Q, 2004, J MED CHEM, V47, P467, DOI 10.1021/jm0303655; Lu YS, 2007, HEPATOLOGY, V46, P1119, DOI 10.1002/hep.21804; Lucas DM, 2009, BLOOD, V113, P4656, DOI 10.1182/blood-2008-09-175430; Lucas DM, 2004, LEUKEMIA, V18, P1207, DOI 10.1038/sj.leu.2403388; MacFarlane M, 2002, ONCOGENE, V21, P6809, DOI 10.1038/sj.onc.1205853; Medina V, 1997, CANCER RES, V57, P3697; Mitsiades N, 2003, BLOOD, V101, P4055, DOI 10.1182/blood-2002-11-3514; Mudry RE, 2000, BLOOD, V96, P1926, DOI 10.1182/blood.V96.5.1926.h8001926_1926_1932; Nishio M, 2005, BLOOD, V106, P1012, DOI 10.1182/blood-2004-03-0889; O'Connor OA, 2006, J CLIN ONCOL, V24, P166, DOI 10.1200/JCO.2005.01.9679; Olsen EA, 2007, J CLIN ONCOL, V25, P3109, DOI 10.1200/JCO.2006.10.2434; Panayiotidis P, 1996, BRIT J HAEMATOL, V92, P97, DOI 10.1046/j.1365-2141.1996.00305.x; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; ROECKLEIN BA, 1995, BLOOD, V85, P997, DOI 10.1182/blood.V85.4.997.bloodjournal854997; Rosato RR, 2003, MOL CANCER THER, V2, P1273; Sargeant AM, 2008, CANCER RES, V68, P3999, DOI 10.1158/0008-5472.CAN-08-0203; Stimson L, 2009, ANN ONCOL, V20, P1293, DOI 10.1093/annonc/mdn792; TANAKA T, 1993, J EXP MED, V178, P1103, DOI 10.1084/jem.178.3.1103; Wu QL, 2009, J IMMUNOL, V182, P6771, DOI 10.4049/jimmunol.0801847; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; YOUNES A, 2007, BLOOD, V118, pA2571; Younes A, 2007, BLOOD, V110, p756A; Zelenetz AD, 2006, ANN ONCOL, V17, P12, DOI 10.1093/annonc/mdj992	58	46	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10941	10.1371/journal.pone.0010941	http://dx.doi.org/10.1371/journal.pone.0010941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532179	gold, Green Submitted, Green Published			2022-12-27	WOS:000278318700013
J	Mancini, G; D'Annessa, I; Coletta, A; Sanna, N; Chillemi, G; Desideri, A				Mancini, Giordano; D'Annessa, Ilda; Coletta, Andrea; Sanna, Nico; Chillemi, Giovanni; Desideri, Alessandro			Structural and Dynamical Effects Induced by the Anticancer Drug Topotecan on the Human Topoisomerase I - DNA Complex	PLOS ONE			English	Article							DOMAIN	Background: Human topoisomerase I catalyzes the relaxation of DNA supercoils in fundamental cell processes like transcription, replication and chromosomal segregation. It is the only target of the camptothecin family of anticancer drugs. Among these, topotecan has been used to treat lung and ovarian carcinoma for several years. Camptothecins reversibly binds to the covalent intermediate DNA-enzyme, stabilizing the cleavable complex and reducing the religation rate. The stalled complex then collides with the progression of the replication fork, producing lethal double strand DNA breaks and eventually cell death. Methodology/Principal Findings: Long lasting molecular dynamics simulations of the DNA-topoisomerase I binary complex and of the DNA-topoisomerase-topotecan ternary complex have been performed and compared. The conformational space sampled by the binary complex is reduced by the presence of the drug, as observed by principal component and cluster analyses. This conformational restraint is mainly due to the reduced flexibility of residues 633-643 (the region connecting the linker to the core domain) that causes an overall mobility loss in the ternary complex linker domain. During the simulation, DNA/drug stacking interactions are fully maintained, and hydrogen bonds are maintained with the enzyme. Topotecan keeps the catalytic residue Lys532 far from the DNA, making it unable to participate to the religation reaction. Arg364 is observed to interact with both the B and E rings of topotecan with two stable direct hydrogen bonds. An interesting constrain exerted by the protein on the geometrical arrangement of topotecan is also observed. Conclusions/Significance: Atomistic-scale understanding of topotecan interactions with the DNA-enzyme complex is fundamental to the explaining of its poisonous effect and of the drug resistance observed in several single residue topoisomerase mutants. We observed significant alterations due to topotecan in both short-range interactions and long-range protein domain communications.	[Mancini, Giordano; D'Annessa, Ilda; Sanna, Nico; Chillemi, Giovanni] CASPUR Interuniv Consortium Applicat Super Comp U, Rome, Italy; [D'Annessa, Ilda; Coletta, Andrea; Desideri, Alessandro] Univ Roma Tor Vergata, Dept Biol, Rome, Italy; [D'Annessa, Ilda; Coletta, Andrea; Desideri, Alessandro] Univ Roma Tor Vergata, Ctr Bioinformat & Biostat, Rome, Italy	CINECA, Italy; University of Rome Tor Vergata; University of Rome Tor Vergata	Mancini, G (corresponding author), CASPUR Interuniv Consortium Applicat Super Comp U, Rome, Italy.	g.chillemi@caspur.it; desideri@uniroma2.it	Chillemi, Giovanni/E-5201-2010; Chillemi, Giovanni/O-2825-2019; Sanna, Nico/AAB-7170-2020; SANNA, Nico/R-8799-2016; Coletta, Andrea/GXF-2972-2022; Coletta, Andrea/H-9856-2012	Chillemi, Giovanni/0000-0003-3901-6926; Chillemi, Giovanni/0000-0003-3901-6926; Sanna, Nico/0000-0002-1947-7939; SANNA, Nico/0000-0002-1947-7939; Coletta, Andrea/0000-0003-4032-394X; D'Annessa, Ilda/0000-0002-6174-6899; desideri, alessandro/0000-0003-1541-4217	AIRC (Associazione Italiana Ricerca Cancro); CASPUR Supercomputing Consortium	AIRC (Associazione Italiana Ricerca Cancro)(Fondazione AIRC per la ricerca sul cancro); CASPUR Supercomputing Consortium	This work was partly supported by the grant to AD from AIRC (Associazione Italiana Ricerca Cancro) "Characterization of human topoisomerase mutants resistant to camptothecin and its derivatives". The authors acknowledge CASPUR Supercomputing Consortium for computational resources (Standard HPC grant 2009 "Studio dell'interazione topoisomerasi I-droghe antitumorali attraverso dinamica molecolare classica e calcoli ab-initio") and for financing a PhD grant to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; BENEDETTI P, 1993, CANCER RES, V53, P4343; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; CHEN AY, 1994, ANNU REV PHARMACOL, V34, P191, DOI 10.1146/annurev.pa.34.040194.001203; Chillemi G, 2005, NUCLEIC ACIDS RES, V33, P3339, DOI 10.1093/nar/gki642; Chillemi G, 2004, BIOPHYS J, V87, P4087, DOI 10.1529/biophysj.104.044925; CHILLEMI G, 2009, THEOR CHEM IN PRESS; Chillemi G, 2008, NUCLEIC ACIDS RES, V36, P5645, DOI 10.1093/nar/gkn558; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Fiorani P, 1999, MOL PHARMACOL, V56, P1105, DOI 10.1124/mol.56.6.1105; Fiorani P, 2003, J BIOL CHEM, V278, P43268, DOI 10.1074/jbc.M303899200; Fiorani P, 2009, NUCLEIC ACIDS RES, V37, P6849, DOI 10.1093/nar/gkp669; GARCIA AE, 1992, PHYS REV LETT, V68, P2696, DOI 10.1103/PhysRevLett.68.2696; Hess B, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031910; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HSIANG YH, 1988, CANCER RES, V48, P1722; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Interthal H, 2004, J BIOL CHEM, V279, P2984, DOI 10.1074/jbc.M309959200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Krogh BO, 2000, MOL CELL, V5, P1035, DOI 10.1016/S1097-2765(00)80268-3; Krogh BO, 2002, J BIOL CHEM, V277, P5711, DOI 10.1074/jbc.C100681200; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POMMIER Y, 1998, BIOCH BIOPHYS ACTA G, V1, P83; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Redinbo MR, 2000, BIOCHEMISTRY-US, V39, P6832, DOI 10.1021/bi992690t; Sanna N, 2005, J AM CHEM SOC, V127, P15429, DOI 10.1021/ja052637u; Sanna N, 2009, J PHYS CHEM B, V113, P5369, DOI 10.1021/jp809801y; Siu FM, 2008, J AM CHEM SOC, V130, P17928, DOI 10.1021/ja806934y; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stewart L, 1997, J MOL BIOL, V269, P355, DOI 10.1006/jmbi.1997.1056; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Stewart L, 1996, J BIOL CHEM, V271, P7602, DOI 10.1074/jbc.271.13.7602; Szklarczyk O, 2009, PROTEINS, V77, P420, DOI 10.1002/prot.22450; WALL ME, 1966, J AM CHEM SOC, V88, P3888, DOI 10.1021/ja00968a057; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; GRACE	45	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10934	10.1371/journal.pone.0010934	http://dx.doi.org/10.1371/journal.pone.0010934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532182	Green Published, Green Submitted, gold			2022-12-27	WOS:000278318700008
J	Wildschut, ED; de Hoog, M; Ahsman, MJ; Tibboel, D; Osterhaus, ADME; Fraaij, PLA				Wildschut, Enno D.; de Hoog, Matthijs; Ahsman, Maurice J.; Tibboel, Dick; Osterhaus, Albert D. M. E.; Fraaij, Pieter L. A.			Plasma Concentrations of Oseltamivir and Oseltamivir Carboxylate in Critically Ill Children on Extracorporeal Membrane Oxygenation Support	PLOS ONE			English	Article							2009 INFLUENZA A(H1N1); PRODRUG OSELTAMIVIR; A H1N1; PHARMACOKINETICS	Introduction: To evaluate the effect of extracorporeal membrane oxygenation (ECMO) support on pharmacokinetics of oseltamivir and oseltamivir carboxylate (OC) in children. Methodology: Steady state 0-12 hour pharmacokinetic sampling was performed in new influenza A (H1N1) infected children treated with oseltamivir while on ECMO support. Cmax, Cmin and AUC(0-12) (h) were calculated. The age-specific oseltamivir dosage was doubled to counter expected decreased plasma drug concentrations due to increased volume of distribution on ECMO support. Principal Findings: Three patients were enrolled aged 15, 6 and 14 years in this pharmacokinetic case series. For two children the OC plasma concentrations were higher than those found in children and adults not on ECMO. These increased plasma concentrations related to the increased oseltamivir dosage and decreased kidney function. In one patient suboptimal plasma concentrations coincided with a decreased gastric motility. Conclusion: Oseltamivir pharmacokinetics do not appear to be significantly influenced by ECMO support. Caution is required in case of nasogastric administration and decreased gastric motility. Due to the limited number of (paediatric) patients available further multicenter studies are warranted.	[Wildschut, Enno D.; de Hoog, Matthijs; Tibboel, Dick; Fraaij, Pieter L. A.] Erasmus MC Sophia Childrens Hosp, Dept Paediat Surg, Rotterdam, Netherlands; [de Hoog, Matthijs] Erasmus MC Sophia Childrens Hosp, Dept Paediat, Rotterdam, Netherlands; [Ahsman, Maurice J.] Erasmus MC, Dept Hosp Pharm, Clin Pharmacol Unit, Rotterdam, Netherlands; [Osterhaus, Albert D. M. E.; Fraaij, Pieter L. A.] Erasmus MC, Dept Virol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Wildschut, ED (corresponding author), Erasmus MC Sophia Childrens Hosp, Dept Paediat Surg, Rotterdam, Netherlands.	p.fraaij@erasmusmc.nl	Fraaij, Pieter/AAU-9783-2021; de Hoog, Matthijs/A-3882-2013	Osterhaus, Albert/0000-0002-6074-1172; Ahsman, Maurice/0000-0002-6084-2571	Viroclinics Biosciences BV	Viroclinics Biosciences BV	The study was funded by Viroclinics Biosciences BV through partime employment of Ab Osterhaus. Viroclinics Biosciences BV allows the manuscript, upon publication, as well as any accompanying materials, to be freely distributed, subject only to the condition of appropriate citation in any copies or derivative works. Ab Osterhaus (employed by Viroclinics Biosciences BV) was involved in manuscript preparation.	[Anonymous], 2009, PAND H1N1 2009 UPD 7; Ariano RE, 2010, CAN MED ASSOC J, V182, P357, DOI 10.1503/cmaj.092127; Buck ML, 2003, CLIN PHARMACOKINET, V42, P403, DOI 10.2165/00003088-200342050-00001; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; He G, 1999, CLIN PHARMACOKINET, V37, P471, DOI 10.2165/00003088-199937060-00003; Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673; Oo C, 2003, EUR J CLIN PHARMACOL, V59, P411, DOI 10.1007/s00228-003-0639-6; Oo C, 2001, Paediatr Drugs, V3, P229, DOI 10.2165/00128072-200103030-00005; Taylor WRJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003410; 2009, MMWR MORB MORTAL WKL, V58, P969	11	31	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10938	10.1371/journal.pone.0010938	http://dx.doi.org/10.1371/journal.pone.0010938			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532176	Green Published, Green Submitted, gold			2022-12-27	WOS:000278318700011
J	Unal, EB; Gursoy, A; Erman, B				Unal, E. Besray; Gursoy, Attila; Erman, Burak			VitAL: Viterbi Algorithm for de novo Peptide Design	PLOS ONE			English	Article							NETWORK-BASED PREDICTION; HIDDEN MARKOV-MODELS; GENETIC ALGORITHM; BINDING PEPTIDES; LIGAND; IDENTIFICATION; MOLECULES; DOCKING; COMPLEX; INTERACT	Background: Drug design against proteins to cure various diseases has been studied for several years. Numerous design techniques were discovered for small organic molecules for specific protein targets. The specificity, toxicity and selectivity of small molecules are hard problems to solve. The use of peptide drugs enables a partial solution to the toxicity problem. There has been a wide interest in peptide design, but the design techniques of a specific and selective peptide inhibitor against a protein target have not yet been established. Methodology/Principal Findings: A novel de novo peptide design approach is developed to block activities of disease related protein targets. No prior training, based on known peptides, is necessary. The method sequentially generates the peptide by docking its residues pair by pair along a chosen path on a protein. The binding site on the protein is determined via the coarse grained Gaussian Network Model. A binding path is determined. The best fitting peptide is constructed by generating all possible peptide pairs at each point along the path and determining the binding energies between these pairs and the specific location on the protein using AutoDock. The Markov based partition function for all possible choices of the peptides along the path is generated by a matrix multiplication scheme. The best fitting peptide for the given surface is obtained by a Hidden Markov model using Viterbi decoding. The suitability of the conformations of the peptides that result upon binding on the surface are included in the algorithm by considering the intrinsic Ramachandran potentials. Conclusions/Significance: The model is tested on known protein-peptide inhibitor complexes. The present algorithm predicts peptides that have better binding energies than those of the existing ones. Finally, a heptapeptide is designed for a protein that has excellent binding affinity according to AutoDock results.	[Unal, E. Besray; Gursoy, Attila; Erman, Burak] Koc Univ, Ctr Computat Biol & Bioinformat, Istanbul, Turkey	Koc University	Unal, EB (corresponding author), Koc Univ, Ctr Computat Biol & Bioinformat, Istanbul, Turkey.	berman@ku.edu.tr	Gursoy, Attila/E-9565-2015; erman, burak/F-5900-2015; Gursoy, Attila/Z-4394-2019	Gursoy, Attila/0000-0002-2297-2113; erman, burak/0000-0002-2496-6059; Gursoy, Attila/0000-0002-2297-2113				Abe K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-451; *ACC INC, DS MOD 2 5; Ajay, 1998, J MED CHEM, V41, P3314, DOI 10.1021/jm970666c; [Anonymous], HYPERCHEM TM PROF 7; Belda I, 2005, J COMPUT AID MOL DES, V19, P585, DOI 10.1007/s10822-005-9015-1; Brusic V, 1998, BIOINFORMATICS, V14, P121, DOI 10.1093/bioinformatics/14.2.121; Budin N, 2001, COMB CHEM HIGH T SCR, V4, P661; Budin N, 2001, J COMPUT CHEM, V22, P1956, DOI 10.1002/jcc.1145; Budin N, 2001, BIOL CHEM, V382, P1365, DOI 10.1515/BC.2001.168; Bystroff Christopher, 2008, V413, P173; CHANDLER BE, 1995, SCH SYSTEM SPECIAL I, V2, P2; Ewens W.J., 2001, STAT METHODS BIOINFO; Fariselli P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S12; Fiorillo MT, 2005, J BIOL CHEM, V280, P2962, DOI 10.1074/jbc.M410807200; Fitzkee NC, 2005, PROTEINS, V58, P852, DOI 10.1002/prot.20394; Flory P. J., 1969, STAT MECH CHAIN MOL, V8, P699, DOI [10.1002/bip.1969.360080514, DOI 10.1002/BIP.1969.360080514]; FORNEY GD, 1973, P IEEE, V61, P268, DOI 10.1109/PROC.1973.9030; FRENKEL D, 1995, J COMPUT AID MOL DES, V9, P213, DOI 10.1007/BF00124453; Fujinaga M, 2004, P NATL ACAD SCI USA, V101, P3364, DOI 10.1073/pnas.0400246101; Haack T, 1997, LETT PEPT SCI, V4, P377, DOI 10.1023/A:1008825727500; HALILOGLU T, 2010, PLOS COMPUTATI UNPUB; Haliloglu T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.088103; Haliloglu T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.228102; HAMMER J, 1995, J EXP MED, V181, P1847, DOI 10.1084/jem.181.5.1847; HAMMER J, 1994, J EXP MED, V180, P2353, DOI 10.1084/jem.180.6.2353; HANAI T, 2000, GENOME INFORM, V11, P394; HARRISON LC, 1993, J LEUKOCYTE BIOL, P105; Hetenyi C, 2002, PROTEIN SCI, V11, P1729, DOI 10.1110/ps.0202302; Honeyman MC, 1998, NAT BIOTECHNOL, V16, P966, DOI 10.1038/nbt1098-966; Hulsmeyer M, 2004, J EXP MED, V199, P271, DOI 10.1084/jem.20031690; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Juretic D, 2009, J CHEM INF MODEL, V49, P2873, DOI 10.1021/ci900327a; Kamphausen S, 2002, J COMPUT AID MOL DES, V16, P551, DOI 10.1023/A:1021928016359; Karplus PA, 1996, PROTEIN SCI, V5, P1406, DOI 10.1002/pro.5560050719; Kato R, 2003, ENZYME MICROB TECH, V33, P472, DOI 10.1016/S0141-0229(03)00150-9; Keskin O, 2004, PROTEINS, V55, P992, DOI 10.1002/prot.20100; Klepeis JL, 2004, IND ENG CHEM RES, V43, P3817, DOI 10.1021/ie0340995; KUMAR J, 2009, CRYSTAL STRUCTURE CO; Lin-Su Karen, 2002, Rev Endocr Metab Disord, V3, P313, DOI 10.1023/A:1020949507265; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; Louis JM, 1998, BIOCHEMISTRY-US, V37, P2105, DOI 10.1021/bi972059x; Mayrose I, 2007, BIOINFORMATICS, V23, P3244, DOI 10.1093/bioinformatics/btm493; Mirabeau O, 2007, GENOME RES, V17, P320, DOI 10.1101/gr.5755407; Moreau V, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-71; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nam KH, 2009, BIOCHEM BIOPH RES CO, V381, P630, DOI 10.1016/j.bbrc.2009.02.113; Noguchi H, 2002, J BIOSCI BIOENG, V94, P264, DOI 10.1263/jbb.94.264; Noguchi H, 2001, J BIOSCI BIOENG, V92, P227, DOI 10.1263/jbb.92.227; OLDENBURG KR, 1992, P NATL ACAD SCI USA, V89, P5393, DOI 10.1073/pnas.89.12.5393; Pegg SCH, 2001, J COMPUT AID MOL DES, V15, P911, DOI 10.1023/A:1014389729000; Petsalaki E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000335; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Riester D, 2005, P NATL ACAD SCI USA, V102, P8597, DOI 10.1073/pnas.0501983102; Ruckert C, 2006, J BIOL CHEM, V281, P2306, DOI 10.1074/jbc.M508528200; Singh J, 1996, J AM CHEM SOC, V118, P1669, DOI 10.1021/ja953172i; Sonmez K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000258; SRAMEK R, 2009, LECT NOTES COMPUTER; Stein A, 2008, FEBS LETT, V582, P1245, DOI 10.1016/j.febslet.2008.02.020; Tuncbag N, 2009, MOL BIOSYST, V5, P1770, DOI [10.1039/b905661k, 10.1039/B905661K]; Tuncbag N, 2009, BIOINFORMATICS, V25, P1513, DOI 10.1093/bioinformatics/btp240; Unal EB, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036014; UNAL EB, 2010, 5 INT S HLTH INF BIO; Vanhee P, 2009, STRUCTURE, V17, P1128, DOI 10.1016/j.str.2009.06.013; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Zhang HF, 2001, J SUPERCRIT FLUID, V20, P65, DOI 10.1016/S0896-8446(01)00053-5	66	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2010	5	6							e10926	10.1371/journal.pone.0010926	http://dx.doi.org/10.1371/journal.pone.0010926			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604NC	20532195	Green Published, gold			2022-12-27	WOS:000278284700009
J	Bonilla, DL; Ly, LH; Fan, YY; Chapkin, RS; McMurray, DN				Bonilla, Diana L.; Ly, Lan H.; Fan, Yang-Yi; Chapkin, Robert S.; McMurray, David N.			Incorporation of a Dietary Omega 3 Fatty Acid Impairs Murine Macrophage Responses to Mycobacterium tuberculosis	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE PRODUCTION; CD4(+) T-CELLS; DOCOSAHEXAENOIC ACID; FISH-OIL; PHAGOSOME MATURATION; LISTERIA-MONOCYTOGENES; PULMONARY TUBERCULOSIS; EICOSAPENTAENOIC ACID	Background: Beside their health benefits, dietary omega 3 polyunsaturated fatty acids (n-3 PUFA) might impair host resistance to Mycobacterium tuberculosis (Mtb) by creating an immunosuppressive environment. We hypothesized that incorporation of n-3 PUFA suppresses activation of macrophage antimycobacterial responses and favors bacterial growth, in part, by modulating the IFN gamma-mediated signaling pathway. Methodology/Principal Findings: Murine macrophage-like J774A.1 cells were incubated with bovine serum albumin (BSA)-conjugated docosahexaenoic acid (DHA; 22:6n-3) or BSA alone, activated with recombinant IFN gamma, and infected with a virulent strain (H37Rv) of M. tuberculosis. The fatty acid composition of macrophage membranes was modified significantly by DHA treatment. DHA-treated macrophages were less effective in controlling intracellular mycobacteria and showed impaired oxidative metabolism and reduced phagolysosome maturation. Incorporation of DHA resulted in defective macrophage activation, as characterized by reduced production of pro-inflammatory cytokines (TNF alpha, IL-6 and MCP-1), and lower expression of co-stimulatory molecules (CD40 and CD86). DHA treatment impaired STAT1 phosphorylation and colocalization of the IFN gamma receptor with lipid rafts, without affecting surface expression of IFN gamma receptor. Conclusions/Significance: We conclude that DHA reduces the ability of J774A.1 cells to control M. tuberculosis in response to activation by IFN gamma, by modulation of IFN gamma receptor signaling and function, suggesting that n-3 PUFA-enriched diets may have a detrimental effect on host immunity to tuberculosis.	[Bonilla, Diana L.; Ly, Lan H.; McMurray, David N.] Texas A&M Hlth Sci Ctr, Dept Microbial & Mol Pathogenesis, Coll Med, College Stn, TX USA; [Fan, Yang-Yi; Chapkin, Robert S.] Texas A&M Univ, Program Integrat Nutr & Complex Dis, College Stn, TX USA; [Fan, Yang-Yi; Chapkin, Robert S.; McMurray, David N.] Texas A&M Univ, Fac Nutr, College Stn, TX USA; [Chapkin, Robert S.; McMurray, David N.] Texas A&M Univ, Ctr Environm & Rural Hlth, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Bonilla, DL (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	bonilla@bcm.edu		Chapkin, Robert/0000-0002-6515-3898	National Institutes of Health [AI-15495, CA-129444, DK-071707, P30-ES09106]; NATIONAL CANCER INSTITUTE [R01CA129444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by U.S. Public Health Service Grant # AI-15495, CA-129444, DK-071707 and P30-ES09106 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anes E, 2003, NAT CELL BIOL, V5, P793, DOI 10.1038/ncb1036; Arrington JL, 2001, J NUTR, V131, P1147, DOI 10.1093/jn/131.4.1147; Bagga D, 2003, P NATL ACAD SCI USA, V100, P1751, DOI 10.1073/pnas.0334211100; CALDER PC, 1990, BIOCHEM J, V269, P807, DOI 10.1042/bj2690807; Calder PC, 2001, LIPIDS, V36, P1007, DOI 10.1007/s11745-001-0812-7; CARTER WO, 1994, J LEUKOCYTE BIOL, V55, P253; Changsen C, 2003, ANTIMICROB AGENTS CH, V47, P3682, DOI 10.1128/AAC.47.12.3682-3687.2003; Chapkin RS, 2008, CHEM PHYS LIPIDS, V153, P14, DOI 10.1016/j.chemphyslip.2008.02.011; Chapkin RS, 2008, BBA-BIOMEMBRANES, V1778, P466, DOI 10.1016/j.bbamem.2007.11.003; Chapkin RS, 2007, J NUTR, V137, p200S, DOI 10.1093/jn/137.1.200S; CHAPKIN RS, 1992, J NUTR BIOCHEM, V3, P599, DOI 10.1016/0955-2863(92)90054-M; CHAPKIN RS, 1991, J LIPID RES, V32, P1205; CHICUREL M, 1988, INFECT IMMUN, V56, P479, DOI 10.1128/IAI.56.2.479-483.1988; CINCO M, 1994, FEMS MICROBIOL LETT, V122, P187, DOI 10.1111/j.1574-6968.1994.tb07163.x; Cleland LG, 2003, DRUGS, V63, P845, DOI 10.2165/00003495-200363090-00001; CLOUVAMOLYVDAS P, 1992, JPEN-PARENTER ENTER, V16, P343, DOI 10.1177/0148607192016004343; Conquer JA, 1998, J LIPID RES, V39, P286; Courreges MC, 2001, NUTR RES, V21, P229, DOI 10.1016/S0271-5317(00)00260-8; Deretic V, 1997, ELECTROPHORESIS, V18, P2542, DOI 10.1002/elps.1150181409; Dewey A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004597.pub2; DIANA L, 2009, J INFECT DI IN PRESS; ELSINGHORST EA, 1994, METHOD ENZYMOL, V236, P405; ENDRES S, 1989, NEW ENGL J MED, V320, P265, DOI 10.1056/NEJM198902023200501; Fan YY, 2003, CARCINOGENESIS, V24, P1541, DOI 10.1093/carcin/bgg110; Fan YY, 2004, J IMMUNOL, V173, P6151, DOI 10.4049/jimmunol.173.10.6151; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; FOLCH J, 1957, J BIOL CHEM, V226, P497; FOWLER KH, 1993, J IMMUNOL, V151, P5186; Fritsche KL, 1997, CLIN SCI, V92, P95, DOI 10.1042/cs0920095; FUKUDA M, 1990, SEIKAGAKU, V62, P1225; GROVER AA, 1967, J BACTERIOL, V94, P832, DOI 10.1128/JB.94.4.832-835.1967; Hughes DA, 1997, CLIN EXP IMMUNOL, V110, P516, DOI 10.1046/j.1365-2249.1997.4351455.x; Irons R, 2005, J INFECT DIS, V191, P481, DOI 10.1086/427264; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; JORDAO L, 2008, MICROBES INFECT; KAPLAN GJ, 1972, AM REV RESPIR DIS, V105, P920; KhairElDin TA, 1996, AM J REPROD IMMUNOL, V36, P1; Kim W, 2008, J IMMUNOL, V181, P6236, DOI 10.4049/jimmunol.181.9.6236; Lasco TM, 2005, TUBERCULOSIS, V85, P245, DOI 10.1016/j.tube.2005.01.001; LESLIE CA, 1985, J EXP MED, V162, P1336, DOI 10.1084/jem.162.4.1336; Lu CY, 1998, J REPROD IMMUNOL, V38, P31, DOI 10.1016/S0165-0378(98)00005-9; Ly LH, 2005, CLIN EXP IMMUNOL, V139, P202, DOI 10.1111/j.1365-2249.2004.02685.x; Martens GW, 2008, INFECT IMMUN, V76, P3464, DOI 10.1128/IAI.00037-08; MAYATEPEK E, 1994, INFECTION, V22, P106, DOI 10.1007/BF01739016; Farland CT, 2008, J NUTR, V138, P2123, DOI 10.3945/jn.108.093740; McMurray DN, 2001, TRENDS MOL MED, V7, P135, DOI 10.1016/S1471-4914(00)01901-8; MCMURRAY DN, 1989, INFECT IMMUN, V57, P1746, DOI 10.1128/IAI.57.6.1746-1749.1989; Mehta PK, 1996, INFECT IMMUN, V64, P2673, DOI 10.1128/IAI.64.7.2673-2679.1996; Ng Y, 2005, CARCINOGENESIS, V26, P1914, DOI 10.1093/carcin/bgi163; Oarada M, 2003, BBA-GEN SUBJECTS, V1622, P151, DOI 10.1016/S0304-4165(03)00136-3; Paul KP, 1997, METABOLISM, V46, P619, DOI 10.1016/S0026-0495(97)90003-2; Peres CM, 2007, MICROBES INFECT, V9, P483, DOI 10.1016/j.micinf.2007.01.006; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Raza Shaikh S., 2007, Journal of Lipid Research, V48, P127, DOI 10.1194/jlr.M600365-JLR200; Russell DG, 2003, NAT CELL BIOL, V5, P776, DOI 10.1038/ncb0903-776; Sawant KV, 2007, INFECT IMMUN, V75, P1870, DOI 10.1128/IAI.00858-06; SCHMIDT EB, 1992, SCAND J CLIN LAB INV, V52, P229, DOI 10.3109/00365519209088790; SHICHIRI G, 1993, ARCH BIOCHEM BIOPHYS, V303, P231, DOI 10.1006/abbi.1993.1277; Stillwell W, 2003, CHEM PHYS LIPIDS, V126, P1, DOI 10.1016/S0009-3084(03)00101-4; Switzer KC, 2004, J LIPID RES, V45, P1482, DOI 10.1194/jlr.M400028-JLR200; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Via LE, 1998, J CELL SCI, V111, P897; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Weldon SM, 2007, J NUTR BIOCHEM, V18, P250, DOI 10.1016/j.jnutbio.2006.04.003; Wiesenfeld PW, 2001, COMP BIOCHEM PHYS B, V128, P123, DOI 10.1016/S1096-4959(00)00305-5	65	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10878	10.1371/journal.pone.0010878	http://dx.doi.org/10.1371/journal.pone.0010878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526363	Green Published, gold, Green Submitted			2022-12-27	WOS:000278222100009
J	Fogal, B; McClaskey, C; Yan, S; Yan, HL; Rivkees, SA				Fogal, Birgit; McClaskey, Carolyn; Yan, Sha; Yan, Henglin; Rivkees, Scott A.			Diazoxide Promotes Oligodendrocyte Precursor Cell Proliferation and Myelination	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; WHITE-MATTER; ADENOSINE RECEPTORS; CHANNEL EXPRESSION; PROGENITOR; HYPOXIA; INFANTS; P27; MODULATION; REDUCTION	Background: Several clinical conditions are associated with white matter injury, including periventricular white matter injury (PWMI), which is a form of brain injury sustained by preterm infants. It has been suggested that white matter injury in this condition is due to altered oligodendrocyte (OL) development or death, resulting in OL loss and hypomyelination. At present drugs are not available that stimulate OL proliferation and promote myelination. Evidence suggests that depolarizing stimuli reduces OL proliferation and differentiation, whereas agents that hyperpolarize OLs stimulate OL proliferation and differentiation. Considering that the drug diazoxide activates K-ATP channels to hyperpolarize cells, we tested if this compound could influence OL proliferation and myelination. Methodology/Findings: Studies were performed using rat oligodendrocyte precursor cell (OPC) cultures, cerebellar slice cultures, and an in vivo model of PWMI in which newborn mice were exposed to chronic sublethal hypoxia (10% O-2). We found that K-ATP channel components Kir 6.1 and 6.2 and SUR2 were expressed in oligodendrocytes. Additionally, diazoxide potently stimulated OPC proliferation, as did other K-ATP activators. Diazoxide also stimulated myelination in cerebellar slice cultures. We also found that diazoxide prevented hypomyelination and ventriculomegaly following chronic sublethal hypoxia. Conclusions: These results identify KATP channel components in OLs and show that diazoxide can stimulate OL proliferation in vitro. Importantly we find that diazoxide can promote myelination in vivo and prevent hypoxia-induced PWMI.	[Fogal, Birgit; McClaskey, Carolyn; Yan, Sha; Yan, Henglin; Rivkees, Scott A.] Yale Univ, Sch Med, Dept Pediat, Sect Dev Biol & Endocrinol,Yale Child Hlth Res Ct, New Haven, CT 06510 USA	Yale University	Fogal, B (corresponding author), Yale Univ, Sch Med, Dept Pediat, Sect Dev Biol & Endocrinol,Yale Child Hlth Res Ct, New Haven, CT 06510 USA.	scott.rivkees@yale.edu	Messier, Claude/A-2322-2008; McClaskey, Carolyn/AGH-4517-2022; McClaskey, Carolyn/ABE-8223-2021	Messier, Claude/0000-0002-4791-1763; McClaskey, Carolyn/0000-0002-0942-6281; McClaskey, Carolyn/0000-0002-0942-6281; Fogal, Birgit/0000-0002-1682-7729	Cerebral Palsy International Research Foundation; National Institutes of Health [1R43NS060188-01, 1R01NS068039]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R43NS060188, R01NS068039] Funding Source: NIH RePORTER	Cerebral Palsy International Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a generous gift from Tony and Cynthia Petrello, the Cerebral Palsy International Research Foundation, and National Institutes of Health grants 1R43NS060188-01 and 1R01NS068039. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebiyi A, 2008, MOL PHARMACOL, V74, P736, DOI 10.1124/mol.108.048165; Akundi RS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004739; ATWAL KS, 1994, J CARDIOVASC PHARM, V24, pS12, DOI 10.1097/00005344-199424014-00003; Babenko AP, 1998, ANNU REV PHYSIOL, V60, P667, DOI 10.1146/annurev.physiol.60.1.667; Babenko AP, 2000, J BIOL CHEM, V275, P717, DOI 10.1074/jbc.275.2.717; Back SA, 2006, ANN NEUROL, V60, P696, DOI 10.1002/ana.21008; Back SA, 2006, MENT RETARD DEV D R, V12, P129, DOI 10.1002/mrdd.20107; BARRES BA, 1990, NEURON, V4, P507, DOI 10.1016/0896-6273(90)90109-S; Blain SW, 2003, CANCER CELL, V3, P111, DOI 10.1016/S1535-6108(03)00026-6; Bodensteiner JB, 2006, J CHILD NEUROL, V21, P743, DOI 10.1177/08830738060210091101; Bolton S, 2006, EXP NEUROL, V202, P36, DOI 10.1016/j.expneurol.2006.05.009; Bouslama-Oueghlani L, 2003, J NEUROSCI, V23, P8318; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Craig A, 2003, EXP NEUROL, V181, P231, DOI 10.1016/S0014-4886(03)00032-3; Desdouets C, 2000, PATHOL BIOL, V48, P203; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Gallo V, 1996, J NEUROSCI, V16, P2659, DOI 10.1523/jneurosci.16-08-02659.1996; Gipson K, 2002, J MEMBRANE BIOL, V189, P201, DOI 10.1007/s00232-002-1014-8; Gribble FM, 2002, BIOCHEM SOC T, V30, P333, DOI 10.1042/bst0300333; Groenendaal F, 1997, DEV MED CHILD NEUROL, V39, P373; Jones LJ, 2001, J IMMUNOL METHODS, V254, P85, DOI 10.1016/S0022-1759(01)00404-5; Kalsi AS, 2004, J ANAT, V204, P475, DOI 10.1111/j.0021-8782.2004.00288.x; KARSCHIN A, 1995, NEUROSCI LETT, V183, P135, DOI 10.1016/0304-3940(94)11133-4; Kinney H C, 1998, Semin Pediatr Neurol, V5, P180, DOI 10.1016/S1071-9091(98)80033-8; Kinney HC, 2005, J NEUROL SCI, V228, P190, DOI 10.1016/j.jns.2004.10.006; Knutson P, 1997, J NEUROSCI, V17, P2669, DOI 10.1523/jneurosci.17-08-02669.1997; Liu YG, 2001, MOL PHARMACOL, V59, P225, DOI 10.1124/mol.59.2.225; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Maysami S, 2006, NEUROREPORT, V17, P1187, DOI 10.1097/01.wnr.0000227985.92551.9a; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; MCLAURIN J, 1995, NEUROL CLIN, V13, P23, DOI 10.1016/S0733-8619(18)30060-4; Ment LR, 1998, DEV BRAIN RES, V111, P197, DOI 10.1016/S0165-3806(98)00139-4; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Neusch C, 2001, J NEUROSCI, V21, P5429, DOI 10.1523/JNEUROSCI.21-15-05429.2001; Othman T, 2003, GLIA, V44, P166, DOI 10.1002/glia.10281; Pagano M, 2004, MOL CELL, V14, P414, DOI 10.1016/S1097-2765(04)00268-0; PAPPAS CA, 1994, NEUROREPORT, V6, P193, DOI 10.1097/00001756-199412300-00049; Pinney SE, 2008, J CLIN INVEST, V118, P2877, DOI 10.1172/JCI35414; Porter GA, 2002, J BIOL CHEM, V277, P28942, DOI 10.1074/jbc.M203961200; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Rushing S, 2004, SEMIN PERINATOL, V28, P444, DOI 10.1053/j.semperi.2004.10.007; Simpson PB, 1998, J PHYSIOL-LONDON, V508, P413, DOI 10.1111/j.1469-7793.1998.413bq.x; Stange KC, 2006, ANN FAM MED, V4, P81, DOI 10.1370/afm.510; Tai KK, 2003, J NEUROCHEM, V84, P1193, DOI 10.1046/j.1471-4159.2003.01625.x; Turner CP, 2003, P NATL ACAD SCI USA, V100, P11718, DOI 10.1073/pnas.1931975100; *US FDA, 2010, DIAZ; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Williamson AV, 1997, EUR J NEUROSCI, V9, P706, DOI 10.1111/j.1460-9568.1997.tb01419.x; Wilson-Costello D, 2005, PEDIATRICS, V115, P997, DOI 10.1542/peds.2004-0221; Yan HL, 2006, NEUROREPORT, V17, P55, DOI 10.1097/01.wnr.0000192733.00535.b6; Yan HL, 2002, J NEUROSCI RES, V69, P597, DOI 10.1002/jnr.10323; Ye P, 2002, J NEUROSCI, V22, P6041	54	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10906	10.1371/journal.pone.0010906	http://dx.doi.org/10.1371/journal.pone.0010906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531945	Green Submitted, gold, Green Published			2022-12-27	WOS:000278222100033
J	Markel, G; Bar-Haim, E; Zahavy, E; Cohen, H; Cohen, O; Shafferman, A; Velan, B				Markel, Gal; Bar-Haim, Erez; Zahavy, Eran; Cohen, Hila; Cohen, Ofer; Shafferman, Avigdor; Velan, Baruch			The Involvement of IL-17A in the Murine Response to Sub-Lethal Inhalational Infection with Francisella tularensis	PLOS ONE			English	Article							T-CELLS; INTRACELLULAR BACTERIUM; IMMUNE-RESPONSE; HOST-DEFENSE; TULAREMIA; LVS; ACTIVATION; RESISTANCE; GROWTH; MACROPHAGES	Background: Francisella tularensis is an intercellular bacterium often causing fatal disease when inhaled. Previous reports have underlined the role of cell-mediated immunity and IFN gamma in the host response to Francisella tularensis infection. Methodology/Principal Findings: Here we provide evidence for the involvement of IL-17A in host defense to inhalational tularemia, using a mouse model of intranasal infection with the Live Vaccine Strain (LVS). We demonstrate the kinetics of IL-17A production in lavage fluids of infected lungs and identify the IL-17A-producing lymphocytes as pulmonary gamma delta and Th17 cells. The peak of IL-17A production appears early during sub-lethal infection, it precedes the peak of immune activation and the nadir of the disease, and then subsides subsequently. Exogenous airway administration of IL-17A or of IL-23 had a limited yet consistent effect of delaying the onset of death from a lethal dose of LVS, implying that IL-17A may be involved in restraining the infection. The protective role for IL-17A was directly demonstrated by in vivo neutralization of IL-17A. Administration of anti IL-17A antibodies concomitantly to a sub-lethal airway infection with 0.1 x LD50 resulted in a fatal disease. Conclusion: In summary, these data characterize the involvement and underline the protective key role of the IL-17A axis in the lungs from inhalational tularemia.	[Markel, Gal; Bar-Haim, Erez; Cohen, Hila; Cohen, Ofer; Shafferman, Avigdor; Velan, Baruch] Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel; [Zahavy, Eran] Israel Inst Biol Res, Dept Infect Dis, IL-70450 Ness Ziona, Israel		Markel, G (corresponding author), Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel.	baruchv@iibr.gov.il	Bar-Haim, Erez/AAA-6444-2020	Bar-Haim, Erez/0000-0003-3435-8599	IIBR Research Funds	IIBR Research Funds	The study was funded by the IIBR Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Haim E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000211; Baron SD, 2007, INFECT IMMUN, V75, P2152, DOI 10.1128/IAI.01606-06; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Butchar JP, 2007, J IMMUNOL, V178, P4445, DOI 10.4049/jimmunol.178.7.4445; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Chen WX, 2004, MICROB PATHOGENESIS, V36, P311, DOI 10.1016/j.micpath.2004.02.003; Collazo CM, 2009, INFECT IMMUN, V77, P2010, DOI 10.1128/IAI.01322-08; CONLAN JW, 1994, INFECT IMMUN, V62, P5603, DOI 10.1128/IAI.62.12.5603-5607.1994; Cowley SC, 1996, MOL MICROBIOL, V20, P867, DOI 10.1111/j.1365-2958.1996.tb02524.x; Cowley SC, 2005, J EXP MED, V202, P309, DOI 10.1084/jem.20050569; Cowley SC, 2003, J EXP MED, V198, P379, DOI 10.1084/jem.20030687; COWLEY SC, 2010, J IMMUNOL       0414; Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Duckett NS, 2005, INFECT IMMUN, V73, P2306, DOI 10.1128/IAI.73.4.2306-2311.2005; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; Elkins KL, 2002, INFECT IMMUN, V70, P1936, DOI 10.1128/IAI.70.4.1936-1948.2002; Elkins KL, 2003, MICROBES INFECT, V5, P135, DOI 10.1016/S1286-4579(02)00084-9; ELKINS KL, 1993, INFECT IMMUN, V61, P823, DOI 10.1128/IAI.61.3.823-829.1993; Elkins KL, 1996, INFECT IMMUN, V64, P3288, DOI 10.1128/IAI.64.8.3288-3293.1996; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; FORTIER AH, 1992, INFECT IMMUN, V60, P817, DOI 10.1128/IAI.60.3.817-825.1992; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; IAWKURA Y, 2008, IMMUNOL REV, V26, P57; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; KOLLOCH RE, 2004, PERFUSION-GERMANY, V17, P467; Kroca M, 2000, CLIN EXP IMMUNOL, V120, P280, DOI 10.1046/j.1365-2249.2000.01215.x; LEIBY DA, 1992, INFECT IMMUN, V60, P84, DOI 10.1128/IAI.60.1.84-89.1992; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Lopez MC, 2004, CELL IMMUNOL, V232, P75, DOI 10.1016/j.cellimm.2005.02.001; Lyons CR, 2007, ANN NY ACAD SCI, V1105, P238, DOI 10.1196/annals.1409.003; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nembrini C, 2009, J ALLERGY CLIN IMMUN, V123, P986, DOI 10.1016/j.jaci.2009.03.033; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Overbergh L, 2003, J Biomol Tech, V14, P33; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Poquet Y, 1998, INFECT IMMUN, V66, P2107, DOI 10.1128/IAI.66.5.2107-2114.1998; Pulendran B, 2004, IMMUNOL RES, V29, P187, DOI 10.1385/IR:29:1-3:187; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; SJOSTEDT A, 2007, ANN NY ACAD SCI, V1005, P1; TARVNIK A, 1989, REV INFECT DIS, V11, P440; Taylor GA, 2007, MICROBES INFECT, V9, P1644, DOI 10.1016/j.micinf.2007.09.004; Woolard MD, 2008, INFECT IMMUN, V76, P2651, DOI 10.1128/IAI.01412-07; Woolard MD, 2007, J IMMUNOL, V178, P2065, DOI 10.4049/jimmunol.178.4.2065; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yee D, 1996, J IMMUNOL, V157, P5042	48	36	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11176	10.1371/journal.pone.0011176	http://dx.doi.org/10.1371/journal.pone.0011176			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585449	Green Published, gold, Green Submitted			2022-12-27	WOS:000278977200003
J	Stich, M; Manrubia, SC; Lazaro, E				Stich, Michael; Manrubia, Susanna C.; Lazaro, Ester			Variable Mutation Rates as an Adaptive Strategy in Replicator Populations	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; DEPENDENT RNA-POLYMERASE; ESCHERICHIA-COLI; EVOLUTION; ADAPTATION; MUTATORS; RESISTANCE; DYNAMICS; FIDELITY; FITNESS	For evolving populations of replicators, there is much evidence that the effect of mutations on fitness depends on the degree of adaptation to the selective pressures at play. In optimized populations, most mutations have deleterious effects, such that low mutation rates are favoured. In contrast to this, in populations thriving in changing environments a larger fraction of mutations have beneficial effects, providing the diversity necessary to adapt to new conditions. What is more, non-adapted populations occasionally benefit from an increase in the mutation rate. Therefore, there is no optimal universal value of the mutation rate and species attempt to adjust it to their momentary adaptive needs. In this work we have used stationary populations of RNA molecules evolving in silico to investigate the relationship between the degree of adaptation of an optimized population and the value of the mutation rate promoting maximal adaptation in a short time to a new selective pressure. Our results show that this value can significantly differ from the optimal value at mutation-selection equilibrium, being strongly influenced by the structure of the population when the adaptive process begins. In the short-term, highly optimized populations containing little variability respond better to environmental changes upon an increase of the mutation rate, whereas populations with a lower degree of optimization but higher variability benefit from reducing the mutation rate to adapt rapidly. These findings show a good agreement with the behaviour exhibited by actual organisms that replicate their genomes under broadly different mutation rates.	[Stich, Michael; Manrubia, Susanna C.; Lazaro, Ester] Ctr Astrobiol CSIC INTA, Dept Mol Evolut, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA)	Stich, M (corresponding author), Ctr Astrobiol CSIC INTA, Dept Mol Evolut, Madrid, Spain.	lazarolm@inta.es	Lázaro, Ester/L-3398-2017; Manrubia, Susanna/K-4501-2014	Lázaro, Ester/0000-0001-7477-7822; Manrubia, Susanna/0000-0003-0134-2785	Spanish MICINN [FIS2008-05273]; Comunidad Autonoma de Madrid [MODELICO-CM/S2009ESP-1691]	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid)	This work was financially supported by Spanish MICINN (www.micinn.es) through research project FIS2008-05273 and by Comunidad Autonoma de Madrid through project MODELICO-CM/S2009ESP-1691. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias A, 2008, J VIROL, V82, P12346, DOI 10.1128/JVI.01297-08; Biebricher CK, 2005, VIRUS RES, V107, P117, DOI 10.1016/j.virusres.2004.11.002; Cases-Gonzalez C, 2008, J MOL BIOL, V384, P1120, DOI 10.1016/j.jmb.2008.10.014; Clune J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000187; Couce A, 2009, FEMS MICROBIOL REV, V33, P531, DOI 10.1111/j.1574-6976.2009.00165.x; De Visser JAGM, 2005, J EVOLUTION BIOL, V18, P779, DOI 10.1111/j.1420-9101.2005.00879.x; de Visser JAGM, 2002, MICROBIOL-SGM, V148, P1247, DOI 10.1099/00221287-148-5-1247; Denamur E, 2006, MOL MICROBIOL, V60, P820, DOI 10.1111/j.1365-2958.2006.05150.x; Domingo E, 2008, EXPERT OPIN BIOL TH, V8, P1455, DOI 10.1517/14712598.8.10.1455 ; Drake JW, 1999, ANN NY ACAD SCI, V870, P100, DOI 10.1111/j.1749-6632.1999.tb08870.x; Drake JW, 1998, GENETICS, V148, P1667; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Earl DJ, 2004, P NATL ACAD SCI USA, V101, P11531, DOI 10.1073/pnas.0404656101; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Elena SF, 1999, J EVOLUTION BIOL, V12, P1078, DOI 10.1046/j.1420-9101.1999.00110.x; Fisher RA, 1930, GENETICAL THEORY NAT; FONTANA W, 1987, BIOPHYS CHEM, V26, P123, DOI 10.1016/0301-4622(87)80017-0; Furio V, 2005, P NATL ACAD SCI USA, V102, P10233, DOI 10.1073/pnas.0501062102; GILLESPIE JH, 1981, EVOLUTION, V35, P468, DOI [10.2307/2408195, 10.1111/j.1558-5646.1981.tb04910.x]; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; HOLLAND JJ, 1990, J VIROL, V64, P3960, DOI 10.1128/JVI.64.8.3960-3962.1990; HUYNEN MA, 1993, J THEOR BIOL, V165, P251, DOI 10.1006/jtbi.1993.1188; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; Kibota TT, 1996, NATURE, V381, P694, DOI 10.1038/381694a0; KIMURA M, 1967, GENET RES, V9, P23, DOI 10.1017/S0016672300010284; Lazaro E, 2003, P NATL ACAD SCI USA, V100, P10830, DOI 10.1073/pnas.1332668100; LeClerc JE, 1998, MUTAT RES-FUND MOL M, V400, P89; LEIGH EG, 1970, AM NAT, V104, P301, DOI 10.1086/282663; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Loeb LA, 1999, P NATL ACAD SCI USA, V96, P1492, DOI 10.1073/pnas.96.4.1492; Mansky LM, 2000, TRENDS GENET, V16, P512, DOI 10.1016/S0168-9525(00)02125-9; Mao EF, 1997, J BACTERIOL, V179, P417, DOI 10.1128/jb.179.2.417-422.1997; Martinez JL, 2007, NAT REV MICROBIOL, V5, P958, DOI 10.1038/nrmicro1796; Matic I, 1997, SCIENCE, V277, P1833, DOI 10.1126/science.277.5333.1833; Orr HA, 2000, GENETICS, V155, P961; Pal C, 2007, NATURE, V450, P1079, DOI 10.1038/nature06350; Perales C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000658; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Pfeiffer JK, 2005, PLOS PATHOG, V1, P102, DOI 10.1371/journal.ppat.0010011; QUINONES A, 1985, MOL GEN GENET, V201, P315, DOI 10.1007/BF00425677; Richardson AR, 2002, P NATL ACAD SCI USA, V99, P6103, DOI 10.1073/pnas.092568699; Schaaper RM, 1998, GENETICS, V148, P1579; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Silander OK, 2007, PLOS BIOL, V5, P922, DOI 10.1371/journal.pbio.0050094; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Stich M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-110; Stich M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-46; Travis JMJ, 2002, P ROY SOC B-BIOL SCI, V269, P591, DOI 10.1098/rspb.2001.1902; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; WRIGHT S, 1932, P 6 INT C GEN, V1, P355	54	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11186	10.1371/journal.pone.0011186	http://dx.doi.org/10.1371/journal.pone.0011186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567506	Green Published, Green Accepted, gold			2022-12-27	WOS:000278886300028
J	Henkel, M; Mitzner, D; Henklein, P; Meyer-Almes, FJ; Moroni, A; DiFrancesco, ML; Henkes, LM; Kreim, M; Kast, SM; Schubert, U; Thiel, G				Henkel, Michael; Mitzner, David; Henklein, Peter; Meyer-Almes, Franz-Josef; Moroni, Anna; DiFrancesco, Mattia L.; Henkes, Leonhard M.; Kreim, Michael; Kast, Stefan M.; Schubert, Ulrich; Thiel, Gerhard			The Proapoptotic Influenza A Virus Protein PB1-F2 Forms a Nonselective Ion Channel	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; LIPID-MEMBRANES; MITOCHONDRIAL PROTEIN; CONSTANT-PRESSURE; PORE FORMATION; CELL-DEATH; TRANSLOCATION; VIROPORINS; MECHANISMS; APOPTOSIS	Background: PB1-F2 is a proapoptotic influenza A virus protein of approximately 90 amino acids in length that is located in the nucleus, cytosol and in the mitochondria membrane of infected cells. Previous studies indicated that the molecule destabilizes planar lipid bilayers and has a strong inherent tendency for multimerization. This may be correlate with its capacity to induce mitochondrial membrane depolarization. Methodology/Principal Findings: Here, we investigated whether PB1-F2 is able to form ion channels within planar lipid bilayers and microsomes. For that purpose, a set of biologically active synthetic versions of PB1-F2 (sPB1-F2) derived from the IAV isolates A/Puerto Rico/8/34(H1N1)( IAV(PR8)), from A/Brevig Mission/1/1918( H1N1) (IAV(SF2)) or the H5N1 consensus sequence (IAV(BF2)) were used. Electrical and fluorimetric measurements show that all three peptides generate in planar lipid bilayers or in liposomes, respectively, a barely selective conductance that is associated with stochastic channel type fluctuations between a closed state and at least two defined open states. Unitary channel fluctuations were also generated when a truncated protein comprising only the 37 c-terminal amino acids of sPB1-F2 was reconstituted in bilayers. Experiments were complemented by extensive molecular dynamics simulations of the truncated fragment in a lipid bilayer. The results indicate that the c-terminal region exhibits a slightly bent helical fold, which is stable and remains embedded in the bilayer for over 180 ns. Conclusion/Significance: The data support the idea that PB1-F2 is able to form protein channel pores with no appreciable selectivity in membranes and that the c-terminus is important for this function. This information could be important for drug development.	[Henkel, Michael; Henkes, Leonhard M.; Kreim, Michael; Thiel, Gerhard] Tech Univ Darmstadt, Dept Bot, Darmstadt, Germany; [Mitzner, David; Schubert, Ulrich] ViroLogik GmbH, Innovat Ctr Med Technol & Pharmaceut IZMP, Erlangen, Germany; [Henklein, Peter] Humboldt Univ, Inst Biochem, Berlin, Germany; [Meyer-Almes, Franz-Josef] Hsch Darmstadt, Dept Chem & Biotechnol, Darmstadt, Germany; [Moroni, Anna; DiFrancesco, Mattia L.] Univ Milan, CNR, IBF, Milan, Italy; [Moroni, Anna; DiFrancesco, Mattia L.] Univ Milan, Dipartimento Biol, Milan, Italy; [Kast, Stefan M.] Tech Univ Dortmund, Dortmund, Germany; [Schubert, Ulrich] Univ Erlangen Nurnberg, Erlangen, Germany	Technical University of Darmstadt; Humboldt University of Berlin; Hochschule Darmstadt; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan; University of Milan; Dortmund University of Technology; University of Erlangen Nuremberg	Henkel, M (corresponding author), Tech Univ Darmstadt, Dept Bot, Darmstadt, Germany.	thiel@bio.tu-darmstadt.de	Meyer-Almes, Franz-Josef/D-9219-2017; moroni, anna/H-2097-2014; DiFrancesco, Mattia Lorenzo/AAC-1029-2022	Meyer-Almes, Franz-Josef/0000-0002-1001-3249; moroni, anna/0000-0002-1860-406X; DiFrancesco, Mattia Lorenzo/0000-0002-7511-4438; Thiel, Gerhard/0000-0002-2335-1351; Tripp, Ralph/0000-0002-2924-9956	Deutsche Forschungsgemeinschaft; Adolf-Messer-Stiftung; Fonds der Chemischen Industrie; European Drug Initiative on Channels and Transporters (EDICT)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Adolf-Messer-Stiftung; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); European Drug Initiative on Channels and Transporters (EDICT)(European Commission)	GT received funding from Deutsche Forschungsgemeinschaft, SMK from Adolf-Messer-Stiftung and the Fonds der Chemischen Industrie, and AM from European Drug Initiative on Channels and Transporters (EDICT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binder H, 2003, BIOPHYS J, V85, P982, DOI 10.1016/S0006-3495(03)74537-8; Bruns K, 2007, J BIOL CHEM, V282, P353, DOI 10.1074/jbc.M606494200; Chanturiya AN, 2004, J VIROL, V78, P6304, DOI 10.1128/JVI.78.12.6304-6312.2004; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; CHEVALIER C, 2010, J BIOL CHEM IN PRESS; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Duclohier H, 2001, J MEMBRANE BIOL, V184, P1, DOI 10.1007/s00232-001-0077-2; EISENBERG M, 1973, J MEMBRANE BIOL, V14, P143, DOI 10.1007/BF01868075; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fischman Robert L., 2002, COLUM J ENV L, V27, P45; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gibbs JS, 2003, J VIROL, V77, P7214, DOI 10.1128/JVI.77.13.7214-7224.2003; Gonzalez ME, 2003, FEBS LETT, V552, P28, DOI 10.1016/S0014-5793(03)00780-4; Henklein P, 2005, J PEPT SCI, V11, P481, DOI 10.1002/psc.641; Herce HD, 2009, BIOPHYS J, V97, P1917, DOI 10.1016/j.bpj.2009.05.066; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; KOVACS RJ, 1988, J BIOL CHEM, V263, P18364; Lamb RA, 2001, NAT MED, V7, P1286, DOI 10.1038/nm1201-1286; Lowy RJ, 2003, INT REV IMMUNOL, V22, P425, DOI 10.1080/08830180305216; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Madan V, 2008, CELL MICROBIOL, V10, P437, DOI 10.1111/j.1462-5822.2007.01057.x; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; Mitzner D, 2009, CELL MICROBIOL, V11, P1502, DOI 10.1111/j.1462-5822.2009.01343.x; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Nieva JL, 2003, FEBS LETT, V552, P68, DOI 10.1016/S0014-5793(03)00852-4; Roder R, 2008, J PEPT SCI, V14, P954, DOI 10.1002/psc.1031; Schlenkrich Michael, 1996, P31; Schnitzler SU, 2009, VIRUS GENES, V39, P279, DOI 10.1007/s11262-009-0404-8; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; Tu K, 1995, BIOPHYS J, V69, P2558, DOI 10.1016/S0006-3495(95)80126-8; Webby RJ, 2001, PHILOS T R SOC B, V356, P1817, DOI 10.1098/rstb.2001.0997; Yewdell J, 2002, CURR OPIN MICROBIOL, V5, P414, DOI 10.1016/S1369-5274(02)00346-6; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40; Zell R, 2007, J GEN VIROL, V88, P536, DOI 10.1099/vir.0.82378-0	40	46	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11112	10.1371/journal.pone.0011112	http://dx.doi.org/10.1371/journal.pone.0011112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559552	Green Published, gold			2022-12-27	WOS:000278775900006
J	Lu, XY; Chen, XX; Huang, LD; Zhu, CQ; Gu, YY; Ye, S				Lu, Xiao-ye; Chen, Xiao-xiang; Huang, Li-dong; Zhu, Chang-qing; Gu, Yue-ying; Ye, Shuang			Anti-alpha-Internexin Autoantibody from Neuropsychiatric Lupus Induce Cognitive Damage via Inhibiting Axonal Elongation and Promote Neuron Apoptosis	PLOS ONE			English	Article							INTERMEDIATE-FILAMENT PROTEIN; CENTRAL-NERVOUS-SYSTEM; BRAIN-REACTIVE AUTOANTIBODIES; CEREBROSPINAL-FLUID; ERYTHEMATOSUS PATIENTS; AUTOIMMUNE MICE; PRONE MICE; ANTIPHOSPHOLIPID SYNDROME; INCLUSION DISEASE; CORTICAL-NEURONS	Background: Neuropsychiatric systemic lupus erythematosus (NPSLE) is a major complication for lupus patients, which often leads to cognitive disturbances and memory loss and contributes to a significant patient morbidity and mortality. The presence of anti-neuronal autoantibodies (aAbs) has been identified; as examples, anti-NMDA receptors and anti-Ribsomal P aAbs have been linked to certain pathophysiological features of NPSLE. Methods and Findings: In the current study, we used a proteomic approach to identify an intermediate neurofilament alpha-internexin (INA) as a pathogenetically relevant autoantigen in NPSLE. The significance of this finding was then validated in an expanded of a cohort of NPSLE patients (n = 67) and controls (n = 270) by demonstrating that high titers of anti-INA aAb was found in both the serum and cerebrospinal fluid (CSF) of similar to 50% NPSLE. Subsequently, a murine model was developed by INA immunization that resulted in pronounced cognitive dysfunction that mimicked features of NPSLE. Histopathology in affected animals displayed cortical and hippocampal neuron apoptosis. In vitro studies further demonstrated that anti-INA Ab mediated neuronal damage via inhibiting axonal elongation and eventually driving the cells to apoptosis. Conclusions: Taken together, this study identified a novel anti-neurofilament aAb in NPSLE, and established a hitherto undescribed mechanism of aAb-mediated neuron damage that could have relevance to the pathophysiology of NPSLE.	[Lu, Xiao-ye; Chen, Xiao-xiang; Gu, Yue-ying; Ye, Shuang] Shanghai Jiao Tong Univ, Sch Med, Dept Rheumatol, Shanghai 200030, Peoples R China; [Huang, Li-dong] Shanghai Jiao Tong Univ, Sch Med, Dept Neurobiol, Shanghai 200030, Peoples R China; [Zhu, Chang-qing] Shanghai Jiao Tong Univ, Sch Med, Dept Emergency Med, Renji Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Lu, XY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Rheumatol, Shanghai 200030, Peoples R China.	guyueying88@yahoo.com.cn; ye_shuang2000@yahoo.com.cn	LU, Xiaoye/K-3611-2019		Shanghai Health Bureau; Shanghai Jiao Tong University	Shanghai Health Bureau; Shanghai Jiao Tong University	This study was supported by Shanghai Health Bureau Outstanding Young Medical Professional Program (S.Y.) and Shanghai Jiao Tong University SMC Scholar (S.Y). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afeltra A, 2003, NEUROLOGY, V61, P108, DOI 10.1212/01.WNL.0000058904.94330.A7; Ainiala H, 2001, NEUROLOGY, V57, P496, DOI 10.1212/WNL.57.3.496; ALARCONSEGOVIA D, 1978, NATURE, V271, P67, DOI 10.1038/271067a0; AlarconSegovia D, 1996, IMMUNOL TODAY, V17, P163; Arabo A, 2005, BEHAV BRAIN RES, V165, P126, DOI 10.1016/j.bbr.2005.06.038; Arnold SE, 1996, J COMP NEUROL, V367, P293, DOI 10.1002/(SICI)1096-9861(19960401)367:2<293::AID-CNE10>3.0.CO;2-S; Athlan ES, 1997, J BIOL CHEM, V272, P31073, DOI 10.1074/jbc.272.49.31073; Barry DM, 2007, EXP CELL RES, V313, P2110, DOI 10.1016/j.yexcr.2007.03.011; Beaulieu JM, 1999, BIOCHEM CELL BIOL, V77, P41, DOI 10.1139/bcb-77-1-41; Bhanji RA, 2007, CLIN IMMUNOL, V125, P247, DOI 10.1016/j.clim.2007.07.016; Cairns NJ, 2004, ACTA NEUROPATHOL, V108, P213, DOI 10.1007/s00401-004-0882-7; Cairns NJ, 2004, NEUROLOGY, V63, P1376; Chan SO, 1996, NEUROCHEM RES, V21, P449, DOI 10.1007/BF02527709; Chan SO, 1997, BRAIN RES, V775, P107, DOI 10.1016/S0006-8993(97)00834-2; Chien CL, 2005, J NEUROSCI RES, V80, P693, DOI 10.1002/jnr.20506; CHIEN CL, 1994, GENE, V149, P289, DOI 10.1016/0378-1119(94)90163-5; Chien CL, 1996, J NEUROBIOL, V29, P304, DOI 10.1002/(SICI)1097-4695(199603)29:3<304::AID-NEU3>3.0.CO;2-D; CHING GY, 1991, J BIOL CHEM, V266, P19459; Ching GY, 1999, J NEUROSCI, V19, P2974; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Colasanti T, 2009, J NEUROIMMUNOL, V212, P3, DOI 10.1016/j.jneuroim.2009.05.003; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; DeGiorgio LA, 2001, NAT MED, V7, P1189, DOI 10.1038/nm1101-1189; Diamond B, 2006, ADV IMMUNOL, V89, P289, DOI 10.1016/S0065-2776(05)89007-8; Diamond B, 2003, ARTHRITIS RHEUM, V48, P2710, DOI 10.1002/art.11278; Diamond B, 2006, PLOS MED, V3, P2186, DOI 10.1371/journal.pmed.0030498; FLIEGNER KH, 1990, EMBO J, V9, P749, DOI 10.1002/j.1460-2075.1990.tb08169.x; FLIEGNER KH, 1994, J COMP NEUROL, V342, P161, DOI 10.1002/cne.903420202; Fragoso-Loyo H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003347; Ho CL, 1996, CANCER METAST REV, V15, P483, DOI 10.1007/BF00054014; HOFFMAN SA, 1987, CLIN EXP IMMUNOL, V70, P74; Huerta PT, 2006, P NATL ACAD SCI USA, V103, P678, DOI 10.1073/pnas.0510055103; Huizinga TWJ, 2008, LUPUS, V17, P376, DOI 10.1177/0961203308090112; KAPLAN MP, 1990, J NEUROSCI, V10, P2735; Katzav A, 2008, J AUTOIMMUN, V31, P393, DOI 10.1016/j.jaut.2008.09.002; Kimura A, 2008, LUPUS, V17, P16, DOI 10.1177/0961203307085112; Kowal C, 2004, IMMUNITY, V21, P179, DOI 10.1016/j.immuni.2004.07.011; Kowal C, 2006, P NATL ACAD SCI USA, V103, P19854, DOI 10.1073/pnas.0608397104; Kozora E, 2004, ARTHRIT RHEUM-ARTHR, V51, P810, DOI 10.1002/art.20692; Lalonde R, 2003, REV NEUROSCIENCE, V14, P369; Lariviere RC, 2004, J NEUROBIOL, V58, P131, DOI 10.1002/neu.10270; Lawrence DA, 2007, J NEUROIMMUNOL, V182, P185, DOI 10.1016/j.jneuroim.2006.10.017; Lee JY, 2009, NAT MED, V15, P91, DOI 10.1038/nm.1892; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; LEE MK, 1994, CURR OPIN CELL BIOL, V6, P34, DOI 10.1016/0955-0674(94)90113-9; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; Lefranc D, 2007, ARTHRITIS RHEUM-US, V56, P3420, DOI 10.1002/art.22863; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lu X, 2008, LUPUS, V17, P323, DOI 10.1177/0961203307088005; LU X, 2010, LUPUS           0223; Ma XX, 2006, J NEUROIMMUNOL, V179, P26, DOI 10.1016/j.jneuroim.2006.06.023; Maric D, 2001, BRAIN RES, V920, P183, DOI 10.1016/S0006-8993(01)03060-8; Matus S, 2007, J EXP MED, V204, P3221, DOI 10.1084/jem.20071285; Monastero R, 2001, J NEUROL SCI, V184, P33, DOI 10.1016/S0022-510X(00)00492-5; Mondal TK, 2008, BRAIN BEHAV IMMUN, V22, P949, DOI 10.1016/j.bbi.2008.01.013; NARENDRAN A, 1989, J NEUROIMMUNOL, V24, P113, DOI 10.1016/0165-5728(89)90105-7; Nie BM, 2008, NEUROPHARMACOLOGY, V54, P845, DOI 10.1016/j.neuropharm.2008.01.003; Nie BM, 2006, CHEM-BIOL INTERACT, V160, P225, DOI 10.1016/j.cbi.2006.02.001; Nived O, 2003, LUPUS, V12, P872, DOI 10.1191/0961203303lu495oa; PACHTER JS, 1985, J CELL BIOL, V101, P1316, DOI 10.1083/jcb.101.4.1316; Rajasalu T, 2004, IMMUNOL LETT, V94, P153, DOI 10.1016/j.imlet.2004.05.002; ROBBINS ML, 1988, ARTHRITIS RHEUM, V31, P623, DOI 10.1002/art.1780310507; Robertson J, 2002, BIOCHIMIE, V84, P1151, DOI 10.1016/S0300-9084(02)00025-1; Sabbadini MG, 1999, LUPUS, V8, P11, DOI 10.1191/096120399678847344; Sakic B, 2005, BIOL PSYCHIAT, V57, P679, DOI 10.1016/j.biopsych.2004.11.037; Sanna G, 2000, LUPUS, V9, P573, DOI 10.1191/096120300678828695; Sanna G, 2003, RHEUMATOLOGY, V42, P200, DOI 10.1093/rheumatology/keg080; Sasajima T, 2006, J NEUROIMMUNOL, V181, P150, DOI 10.1016/j.jneuroim.2006.09.003; Senecal JL, 2004, J RHEUMATOL, V31, P2093; SENECAL JL, 1988, ARTHRITIS RHEUM, V31, P864, DOI 10.1002/art.1780310707; Shea TB, 1999, CELL MOTIL CYTOSKEL, V43, P322, DOI 10.1002/(SICI)1097-0169(1999)43:4<322::AID-CM5>3.0.CO;2-B; Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002; Shoenfeld Y, 2003, LUPUS, V12, P436, DOI 10.1191/0961203303lu409oa; Shoenfeld Y, 2008, J AUTOIMMUN, V30, P74, DOI 10.1016/j.jaut.2007.11.011; Sidor MM, 2005, J NEUROIMMUNOL, V165, P104, DOI 10.1016/j.jneuroim.2005.04.022; Sled JG, 2009, ARTHRITIS RHEUM-US, V60, P1764, DOI 10.1002/art.24523; Stinton LM, 2004, CLIN IMMUNOL, V110, P30, DOI 10.1016/j.clim.2003.10.005; Tin SK, 2005, J NEUROIMMUNOL, V169, P153, DOI 10.1016/j.jneuroim.2005.07.015; Trysberg E, 2003, ARTHRITIS RHEUM, V48, P2881, DOI 10.1002/art.11279; Watanabe H, 2004, BIOCHEM BIOPH RES CO, V321, P949, DOI 10.1016/j.bbrc.2004.07.051; Williams RC, 2004, ARTHRITIS RHEUM-US, V50, P1239, DOI 10.1002/art.20156; Williams RC, 1999, CLIN EXP RHEUMATOL, V17, P643; Yuan AD, 2006, J NEUROSCI, V26, P10006, DOI 10.1523/JNEUROSCI.2580-06.2006; Zack DJ, 1996, J IMMUNOL, V157, P2082; Zameer A, 2004, J NEUROIMMUNOL, V146, P133, DOI 10.1016/j.jneuroim.2003.10.052; Zhang J, 2009, J AUTOIMMUN, V33, P270, DOI 10.1016/j.jaut.2009.03.011; Zhang WW, 2008, NEUROSCI LETT, V443, P241, DOI 10.1016/j.neulet.2008.07.048; 1999, ARTHRITIS RHEUM, V42, P599	88	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11124	10.1371/journal.pone.0011124	http://dx.doi.org/10.1371/journal.pone.0011124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559547	Green Submitted, gold, Green Published			2022-12-27	WOS:000278775900014
J	Spraggon, G; Koesema, E; Scarselli, M; Malito, E; Biagini, M; Norais, N; Emolo, C; Barocchi, MA; Giusti, F; Hilleringmann, M; Rappuoli, R; Lesley, S; Covacci, A; Masignani, V; Ferlenghi, I				Spraggon, Glen; Koesema, Eric; Scarselli, Maria; Malito, Enrico; Biagini, Massimiliano; Norais, Nathalie; Emolo, Carla; Barocchi, Michele Anne; Giusti, Fabiola; Hilleringmann, Markus; Rappuoli, Rino; Lesley, Scott; Covacci, Antonello; Masignani, Vega; Ferlenghi, Ilaria			Supramolecular Organization of the Repetitive Backbone Unit of the Streptococcus pneumoniae Pilus	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; STRUCTURAL GENOMICS; IV PILI; SORTASE; SURFACE; VIRULENCE; SOFTWARE; PYOGENES; ADHESION; SEQUENCE	Streptococcus pneumoniae, like many other Gram-positive bacteria, assembles long filamentous pili on their surface through which they adhere to host cells. Pneumococcal pili are formed by a backbone, consisting of the repetition of the major component RrgB, and two accessory proteins (RrgA and RrgC). Here we reconstruct by transmission electron microscopy and single particle image reconstruction method the three dimensional arrangement of two neighbouring RrgB molecules, which represent the minimal repetitive structural domain of the native pilus. The crystal structure of the D2-D4 domains of RrgB was solved at 1.6 angstrom resolution. Rigid-body fitting of the X-ray coordinates into the electron density map enabled us to define the arrangement of the backbone subunits into the S. pneumoniae native pilus. The quantitative fitting provide evidence that the pneumococcal pilus consists uniquely of RrgB monomers assembled in a head-to-tail organization. The presence of short intra-subunit linker regions connecting neighbouring domains provides the molecular basis for the intrinsic pilus flexibility.	[Spraggon, Glen; Koesema, Eric; Malito, Enrico; Lesley, Scott] Genom Inst Novartis Res Fdn, San Diego, CA USA; [Scarselli, Maria; Malito, Enrico; Biagini, Massimiliano; Norais, Nathalie; Emolo, Carla; Barocchi, Michele Anne; Hilleringmann, Markus; Rappuoli, Rino; Covacci, Antonello; Masignani, Vega; Ferlenghi, Ilaria] Novartis Vaccines & Diagnost, Siena, Italy; [Giusti, Fabiola] Univ Siena, Dept Evolut Biol, I-53100 Siena, Italy	Novartis; Novartis; University of Siena	Spraggon, G (corresponding author), Genom Inst Novartis Res Fdn, San Diego, CA USA.	gspraggon@gnf.org; ilaria.ferlenghi@novartis.com		Hilleringmann, Markus/0000-0001-7745-2038; Koesema, Eric/0000-0002-7743-0127	Novartis Vaccines and Diagnostics; Office of Science, Office of Basic Energy Sciences, Material Sciences Division of the U.S. Department of Energy [DE-AC03-76SF00098]	Novartis Vaccines and Diagnostics; Office of Science, Office of Basic Energy Sciences, Material Sciences Division of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by internal funding from Novartis Vaccines and Diagnostics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Peter Schultz for continued support. The work in this paper is based on experiments conducted at beamline 5.0.3 of the advanced light source (ALS). The ALS is supported by the Director, Office of Science, Office of Basic Energy Sciences, Material Sciences Division of the U.S. Department of Energy under contract No. DE-AC03-76SF00098 at Lawrence Berkeley National Laboratory. The Department of Evolutionary Biology of the University of Siena, Italy (Prof. Dallai R.) for the use of microscopy facilities and for all the valuable help.	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; ABE S, 1990, JPN J VET SCI, V52, P11; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Elena SF, 2005, INT MICROBIOL, V8, P271; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falker S, 2008, MOL MICROBIOL, V70, P595, DOI 10.1111/j.1365-2958.2008.06396.x; Falugi F, 2008, J INFECT DIS, V198, P1834, DOI 10.1086/593176; Gaspar AH, 2006, J BACTERIOL, V188, P1526, DOI 10.1128/JB.188.4.1526-1533.2006; Gianfaldoni C, 2007, INFECT IMMUN, V75, P1059, DOI 10.1128/IAI.01400-06; HARAUZ G, 1986, OPTIK, V73, P146; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Hilleringmann M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000026; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Kallstrom H, 1998, J BIOL CHEM, V273, P21777, DOI 10.1074/jbc.273.34.21777; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; Lesley M, 2002, CIN-COMPUT INFORM NU, V20, P229, DOI 10.1097/00024665-200211000-00008; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mishra A, 2007, J BACTERIOL, V189, P3156, DOI 10.1128/JB.01952-06; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Moschioni M, 2008, J INFECT DIS, V197, P888, DOI 10.1086/528375; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Quigley BR, 2009, MOL MICROBIOL, V72, P1379, DOI 10.1111/j.1365-2958.2009.06727.x; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Salih O, 2008, J MOL BIOL, V379, P174, DOI 10.1016/j.jmb.2008.03.056; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; VANHEEL M, 1984, ULTRAMICROSCOPY, V13, P165, DOI 10.1016/0304-3991(84)90066-4; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P111, DOI 10.1016/0304-3991(87)90078-7; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; WENYUAN S, 2002, INFECT IMMUN, V70, P1	56	50	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e10919	10.1371/journal.pone.0010919	http://dx.doi.org/10.1371/journal.pone.0010919			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559564	Green Published, Green Submitted, gold			2022-12-27	WOS:000278775900002
J	Nagarajan, H; Butler, JE; Klimes, A; Qiu, Y; Zengler, K; Ward, J; Young, ND; Methe, BA; Palsson, BO; Lovley, DR; Barrett, CL				Nagarajan, Harish; Butler, Jessica E.; Klimes, Anna; Qiu, Yu; Zengler, Karsten; Ward, Joy; Young, Nelson D.; Methe, Barbara A.; Palsson, Bernhard O.; Lovley, Derek R.; Barrett, Christian L.			De Novo Assembly of the Complete Genome of an Enhanced Electricity-Producing Variant of Geobacter sulfurreducens Using Only Short Reads	PLOS ONE			English	Article							DNA-SEQUENCES; ALGORITHMS; REDUCTION; MATTER	State-of-the-art DNA sequencing technologies are transforming the life sciences due to their ability to generate nucleotide sequence information with a speed and quantity that is unapproachable with traditional Sanger sequencing. Genome sequencing is a principal application of this technology, where the ultimate goal is the full and complete sequence of the organism of interest. Due to the nature of the raw data produced by these technologies, a full genomic sequence attained without the aid of Sanger sequencing has yet to be demonstrated. We have successfully developed a four-phase strategy for using only next-generation sequencing technologies (Illumina and 454) to assemble a complete microbial genome de novo. We applied this approach to completely assemble the 3.7 Mb genome of a rare Geobacter variant (KN400) that is capable of unprecedented current production at an electrode. Two key components of our strategy enabled us to achieve this result. First, we integrated the two data types early in the process to maximally leverage their complementary characteristics. And second, we used the output of different short read assembly programs in such a way so as to leverage the complementary nature of their different underlying algorithms or of their different implementations of the same underlying algorithm. The significance of our result is that it demonstrates a general approach for maximizing the efficiency and success of genome assembly projects as new sequencing technologies and new assembly algorithms are introduced. The general approach is a meta strategy, wherein sequencing data are integrated as early as possible and in particular ways and wherein multiple assembly algorithms are judiciously applied such that the deficiencies in one are complemented by another.	[Nagarajan, Harish] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Nagarajan, Harish; Qiu, Yu; Zengler, Karsten; Palsson, Bernhard O.; Barrett, Christian L.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Butler, Jessica E.; Klimes, Anna; Ward, Joy; Young, Nelson D.; Lovley, Derek R.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Methe, Barbara A.] J Craig Venter Inst, Dept Microbial & Environm Genom, Rockville, MD USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Massachusetts System; University of Massachusetts Amherst; J. Craig Venter Institute	Nagarajan, H (corresponding author), Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA.	cbarrett@ucsd.edu		Palsson, Bernhard/0000-0003-2357-6785; Zengler, Karsten/0000-0002-8062-3296; Butler, Jessica/0000-0003-2054-3777	Office of Science, Biological and Environmental Research (BER), United States Department of Energy [DE-FC02-02ER63446]	Office of Science, Biological and Environmental Research (BER), United States Department of Energy(United States Department of Energy (DOE))	This research was supported by the Office of Science, Biological and Environmental Research (BER), United States Department of Energy, Cooperative Agreement No. DE-FC02-02ER63446. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aury JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-603; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Aziz RK, 2010, NUCLEIC ACIDS RES; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; Croucher NJ, 2009, NAT REV MICROBIOL, V7, P621, DOI 10.1038/nrmicro2211; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Jeck WR, 2007, BIOINFORMATICS, V23, P2942, DOI 10.1093/bioinformatics/btm451; Lovley DR, 2008, CURR OPIN BIOTECH, V19, P564, DOI 10.1016/j.copbio.2008.10.005; Mahadevan R, 2006, APPL ENVIRON MICROB, V72, P1558, DOI 10.1128/AEM.72.2.1558-1568.2006; Mehta T, 2005, APPL ENVIRON MICROB, V71, P8634, DOI 10.1128/AEM.71.12.8634-8641.2005; Methe BA, 2003, SCIENCE, V302, P1967, DOI 10.1126/science.1088727; PEARSON WR, 1995, P NATL ACAD SCI USA, V85, P2444; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Salzberg SL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000186; Yi HN, 2009, BIOSENS BIOELECTRON, V24, P3498, DOI 10.1016/j.bios.2009.05.004; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	23	28	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e10922	10.1371/journal.pone.0010922	http://dx.doi.org/10.1371/journal.pone.0010922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544019	Green Published, gold, Green Submitted			2022-12-27	WOS:000278494900001
J	Gall, WE; Beebe, K; Lawton, KA; Adam, KP; Mitchell, MW; Nakhle, PJ; Ryals, JA; Milburn, MV; Nannipieri, M; Camastra, S; Natali, A; Ferrannini, E				Gall, Walter E.; Beebe, Kirk; Lawton, Kay A.; Adam, Klaus-Peter; Mitchell, Matthew W.; Nakhle, Pamela J.; Ryals, John A.; Milburn, Michael V.; Nannipieri, Monica; Camastra, Stefania; Natali, Andrea; Ferrannini, Ele		RISC Study Grp	alpha-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; 2-HYDROXYBUTYRIC ACID; SENSITIVITY; KETOBUTYRATE; PATHOGENESIS; RAT; HYPERINSULINEMIA; METABOLOMICS; METABOLISM; SECRETION	Background: Insulin resistance is a risk factor for type 2 diabetes and cardiovascular disease progression. Current diagnostic tests, such as glycemic indicators, have limitations in the early detection of insulin resistant individuals. We searched for novel biomarkers identifying these at-risk subjects. Methods: Using mass spectrometry, non-targeted biochemical profiling was conducted in a cohort of 399 nondiabetic subjects representing a broad spectrum of insulin sensitivity and glucose tolerance (based on the hyperinsulinemic euglycemic clamp and oral glucose tolerance testing, respectively). Results: Random forest statistical analysis selected alpha-hydroxybutyrate (alpha-HB) as the top-ranked biochemical for separating insulin resistant (lower third of the clamp-derived M-FFM = 33 [12] mu mol.min(-1).kg(FFM)(-1), median [interquartile range], n = 140) from insulin sensitive subjects (M-FFM = 66 [23] mu mol.min(-1).kg(FFM)(-1)) with a 76% accuracy. By targeted isotope dilution assay, plasma alpha-HB concentrations were reciprocally related to M-FFM; and by partition analysis, an alpha-HB value of 5 mu g/ml was found to best separate insulin resistant from insulin sensitive subjects. alpha-HB also separated subjects with normal glucose tolerance from those with impaired fasting glycemia or impaired glucose tolerance independently of, and in an additive fashion to, insulin resistance. These associations were also independent of sex, age and BMI. Other metabolites from this global analysis that significantly correlated to insulin sensitivity included certain organic acid, amino acid, lysophospholipid, acylcarnitine and fatty acid species. Several metabolites are intermediates related to alpha-HB metabolism and biosynthesis. Conclusions: alpha-hydroxybutyrate is an early marker for both insulin resistance and impaired glucose regulation. The underlying biochemical mechanisms may involve increased lipid oxidation and oxidative stress.	[Gall, Walter E.; Beebe, Kirk; Lawton, Kay A.; Adam, Klaus-Peter; Mitchell, Matthew W.; Nakhle, Pamela J.; Ryals, John A.; Milburn, Michael V.] Metabolon Inc, Res Triangle Pk, NC USA; [Nannipieri, Monica; Camastra, Stefania; Natali, Andrea; Ferrannini, Ele] Univ Pisa, Sch Med, RISC Relationship Insulin Sensit Cardiovasc Coord, I-56100 Pisa, Italy	Metabolon; University of Pisa	Gall, WE (corresponding author), Metabolon Inc, Res Triangle Pk, NC USA.	wgall@metabolon.com	Natali, Andrea/N-5535-2015; Camastra, Stefania/Q-1200-2016; Nannipieri, Monica/AAA-1464-2019	Natali, Andrea/0000-0002-8465-7717; Nannipieri, Monica/0000-0003-1346-2813; Mitchell, Matthew/0000-0002-2681-4091; Camastra, Stefania/0000-0001-9015-7244	EGIR-RISC	EGIR-RISC	EGIR-RISC funding support came from Merck Serono and Astra Zeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Metabolon, Inc. funded the retrospective analysis herein.	Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Abdul-Ghani MA, 2009, CURR DIABETES REP, V9, P193, DOI 10.1007/s11892-009-0032-7; Altmaier E, 2008, ENDOCRINOLOGY, V149, P3478, DOI 10.1210/en.2007-1747; Bergman RN, 2007, DIABETES, V56, P1489, DOI 10.2337/db07-9903; Boudonck KJ, 2009, TOXICOL PATHOL, V37, P280, DOI 10.1177/0192623309332992; BRASS EP, 1986, BIOCHIM BIOPHYS ACTA, V888, P18, DOI 10.1016/0167-4889(86)90065-0; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; EVANS AM, 2009, ANAL CHEM; Ferrannini E, 2007, J CLIN ENDOCR METAB, V92, P2885, DOI 10.1210/jc.2007-0334; GINSBERG H, 1974, DIABETES, V23, P674, DOI 10.2337/diab.23.8.674; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; HARRIS MI, 1995, CLIN INVEST MED, V18, P231; Hills SA, 2004, DIABETOLOGIA, V47, P566, DOI 10.1007/s00125-004-1335-5; Howard G, 1996, CIRCULATION, V93, P1809, DOI 10.1161/01.CIR.93.10.1809; Kim SH, 2008, DIABETES CARE, V31, P1433, DOI 10.2337/dc08-0045; LANDAAS S, 1975, CLIN CHIM ACTA, V58, P23, DOI 10.1016/0009-8981(75)90481-7; LANDAAS S, 1975, SCAND J CLIN LAB INV, V35, P259, DOI 10.3109/00365517509095738; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Lord RS, 2008, ALTERN MED REV, V13, P205; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Natali A, 1997, CIRCULATION, V96, P849; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; PAOLISSO G, 1992, DIABETES CARE, V15, P1, DOI 10.2337/diacare.15.1.1; PETTERSEN JE, 1973, CLIN CHIM ACTA, V48, P213, DOI 10.1016/0009-8981(73)90367-7; Reaven G M, 1978, Adv Metab Disord, V9, P313; REAVEN GM, 1983, AM J MED, V75, P85, DOI 10.1016/0002-9343(83)90258-9; Reaven GM, 1999, ANN NY ACAD SCI, V892, P45, DOI 10.1111/j.1749-6632.1999.tb07784.x; ROSALKI SB, 1960, NATURE, V188, P1110, DOI 10.1038/1881110a0; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; SHEN SW, 1970, J CLIN INVEST, V49, P2151, DOI 10.1172/JCI106433; Silva AR, 2001, BRAZ J MED BIOL RES, V34, P627, DOI 10.1590/S0100-879X2001000500010; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Tremblay F, 2007, ANNU REV NUTR, V27, P293, DOI 10.1146/annurev.nutr.25.050304.092545; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; YANG W, 1985, CLIN CHIM ACTA, V145, P173, DOI 10.1016/0009-8981(85)90284-0; Yip J, 1998, J CLIN ENDOCR METAB, V83, P2773, DOI 10.1210/jc.83.8.2773	40	458	478	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10883	10.1371/journal.pone.0010883	http://dx.doi.org/10.1371/journal.pone.0010883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526369	Green Published, gold, Green Submitted			2022-12-27	WOS:000278222100012
J	Lorain, S; Peccate, C; Le Hir, M; Garcia, L				Lorain, Stephanie; Peccate, Cecile; Le Hir, Maeva; Garcia, Luis			Exon Exchange Approach to Repair Duchenne Dystrophin Transcripts	PLOS ONE			English	Article							MESSENGER-RNA; GENE-THERAPY; MUSCULAR-DYSTROPHY; MOLECULAR-BASIS; MOUSE MODEL; MDX MOUSE; RESTORATION; PROTEIN; MICE; ENHANCER	Background: Trans-splicing strategies for mRNA repair involve engineered transcripts designed to anneal target mRNAs in order to interfere with their natural splicing, giving rise to mRNA chimeras where endogenous mutated exons have been replaced by exogenous replacement sequences. A number of trans-splicing molecules have already been proposed for replacing either the 59 or the 39 part of transcripts to be repaired. Here, we show the feasibility of RNA surgery by using a double trans-splicing approach allowing the specific substitution of a given mutated exon. Methodology/Principal Findings: As a target we used a minigene encoding a fragment of the mdx dystrophin gene enclosing the mutated exon (exon 23). This minigene was cotransfected with a variety of exon exchange constructions, differing in their annealing domains. We obtained accurate and efficient replacement of exon 23 in the mRNA target. Adding up a downstream intronic splice enhancer DISE in the exon exchange molecule enhanced drastically its efficiency up to 25-45% of repair depending on the construction in use. Conclusions/Significance: These results demonstrate the possibility to fix up mutated exons, refurbish deleted exons and introduce protein motifs, while keeping natural untranslated sequences, which are essential for mRNA stability and translation regulation. Conversely to the well-known exon skipping, exon exchange has the advantage to be compatible with almost any type of mutations and more generally to a wide range of genetic conditions. In particular, it allows addressing disorders caused by dominant mutations.	[Lorain, Stephanie; Peccate, Cecile; Le Hir, Maeva; Garcia, Luis] Univ Paris 06, CNRS, INSERM, Inst Myol,UMR S 974,U974,UMR 7215, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Lorain, S (corresponding author), Univ Paris 06, CNRS, INSERM, Inst Myol,UMR S 974,U974,UMR 7215, Paris, France.	stephanie.lorain@upmc.fr	García, Luis V/GQA-9712-2022	Peccate, Cecile/0000-0002-4125-3616; Peccate, Cecile/0000-0001-8895-5087; Lorain, Stephanie/0000-0001-5266-9994	Association Francaise contre les Myopathies; Association Mongasque contre les Myopathies; Duchenne Parent Project France; FP7 MyoAMP; ANR GENESPLICE	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Association Mongasque contre les Myopathies; Duchenne Parent Project France; FP7 MyoAMP; ANR GENESPLICE(French National Research Agency (ANR))	This work was supported by Association Francaise contre les Myopathies, Association Mongasque contre les Myopathies, Duchenne Parent Project France, FP7 MyoAMP and ANR GENESPLICE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benchaouir R, 2007, CELL STEM CELL, V1, P646, DOI 10.1016/j.stem.2007.09.016; Beroud C, 2007, HUM MUTAT, V28, P196, DOI 10.1002/humu.20428; Chao HJ, 2003, NAT MED, V9, P1015, DOI 10.1038/nm900; Coady TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003468; Deburgrave N, 2007, HUM MUTAT, V28, P183, DOI 10.1002/humu.20422; Denti MA, 2006, P NATL ACAD SCI USA, V103, P3758, DOI 10.1073/pnas.0508917103; Garcia-Blanco MA, 2003, J CLIN INVEST, V112, P474, DOI 10.1172/JCI200319462; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Kierlin-Duncan MN, 2007, RNA, V13, P1317, DOI 10.1261/rna.525607; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Liu XM, 2005, HUM GENE THER, V16, P1116, DOI 10.1089/hum.2005.16.1116; Mansfield SG, 2000, GENE THER, V7, P1885, DOI 10.1038/sj.gt.3301307; Mansfield SG, 2003, RNA, V9, P1290, DOI 10.1261/rna.5101903; Mansfield SG, 2004, TRENDS MOL MED, V10, P263, DOI 10.1016/j.molmed.2004.04.007; McCarthy EMS, 1998, HUM MOL GENET, V7, P1491, DOI 10.1093/hmg/7.9.1491; Mitchell LG, 2005, GENE THER, V12, P1477, DOI 10.1038/sj.gt.3302596; Puttaraju M, 1999, NAT BIOTECHNOL, V17, P246, DOI 10.1038/6986; Puttaraju M, 2001, MOL THER, V4, P105, DOI 10.1006/mthe.2001.0426; Rodriguez-Martin T, 2005, P NATL ACAD SCI USA, V102, P15659, DOI 10.1073/pnas.0503150102; Seth P, 2008, J BIOL CHEM, V283, P10058, DOI 10.1074/jbc.M800087200; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Snyder RO, 1997, HUM GENE THER, V8, P1891, DOI 10.1089/hum.1997.8.16-1891; Tahara M, 2004, NAT MED, V10, P835, DOI 10.1038/nm1086; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627; Zhang BH, 2008, J CELL MOL MED, V12, P3, DOI 10.1111/j.1582-4934.2007.00196.x	26	25	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10894	10.1371/journal.pone.0010894	http://dx.doi.org/10.1371/journal.pone.0010894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531943	gold, Green Published, Green Submitted			2022-12-27	WOS:000278222100023
J	Yokoyama, JS; Erdman, CA; Hamilton, SP				Yokoyama, Jennifer S.; Erdman, Carolyn A.; Hamilton, Steven P.			Array-Based Whole-Genome Survey of Dog Saliva DNA Yields High Quality SNP Data	PLOS ONE			English	Article							WIDE ASSOCIATION; DOMESTIC DOG; LARGE-SCALE; MUTATION	Background: Genome-wide association scans for genetic loci underlying both Mendelian and complex traits are increasingly common in canine genetics research. However, the demand for high-quality DNA for use on such platforms creates challenges for traditional blood sample ascertainment. Though the use of saliva as a means of collecting DNA is common in human studies, alternate means of DNA collection for canine research have instead been limited to buccal swabs, from which dog DNA is of insufficient quality and yield for use on most high-throughput array-based systems. We thus investigated an animal-based saliva collection method for ease of use and quality of DNA obtained and tested the performance of saliva-extracted canine DNA on genome-wide genotyping arrays. Methodology/Principal Findings: Overall, we found that saliva sample collection using this method was efficient. Extractions yielded high concentrations (similar to 125 ng/ul) of high-quality DNA that performed equally well as blood-extracted DNA on the Illumina Infinium canine genotyping platform, with average call rates >99%. Concordance rates between genotype calls of saliva-versus blood-extracted DNA samples from the same individual were also >99%. Additionally, in silico calling of copy number variants was successfully performed and verified by PCR. Conclusions/Significance: Our findings validate the use of saliva-obtained samples for genome-wide association studies in canines, highlighting an alternative means of collecting samples in a convenient and non-invasive manner.	[Hamilton, Steven P.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yokoyama, JS (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	Steve.Hamilton@ucsf.edu	Fiumefreddo, Andrea/T-2977-2019	Hamilton, Steven/0000-0001-8106-6260	NIMH [5 T32 MH20006-12]; National Institute of Mental Health [R21 MH084149]; American Kennel Club (ACORN) [850-A]; McKnight Foundation; Hellman Family Fund; University of California San Francisco; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020006, R21MH084149] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); American Kennel Club (ACORN); McKnight Foundation; Hellman Family Fund; University of California San Francisco(University of California System); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by Predoctoral Training Consortium in Affective Science Research Fellowship (NIMH-Predoctoral NRSA Type 5 T32 MH20006-12 to J.S.Y.); National Institute of Mental Health (R21 MH084149), the American Kennel Club (ACORN award 850-A), the McKnight Foundation, the Hellman Family Fund, and a University of California San Francisco bridge funding award (S. P. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Chang ML, 2007, J HERED, V98, P428, DOI 10.1093/jhered/esm044; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Dodman NH, 2010, MOL PSYCHIATR, V15, P8, DOI 10.1038/mp.2009.111; Drogemuller C, 2008, SCIENCE, V321, P1462, DOI 10.1126/science.1162525; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; Hansen TVO, 2007, CANCER EPIDEM BIOMAR, V16, P2072, DOI 10.1158/1055-9965.EPI-07-0611; IWASIOW RM, 2009, QUALITY YIELD PERFOR; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kirkness EF, 2003, SCIENCE, V301, P1898, DOI 10.1126/science.1086432; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Nishita DM, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-71; Parker HG, 2009, SCIENCE, V325, P995, DOI 10.1126/science.1173275; Short AD, 2005, J HERED, V96, P829, DOI 10.1093/jhered/esi126; Wiik AC, 2009, ANIM GENET, V40, P572, DOI 10.1111/j.1365-2052.2009.01877.x	16	12	12	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10809	10.1371/journal.pone.0010809	http://dx.doi.org/10.1371/journal.pone.0010809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520842	Green Submitted, gold, Green Published			2022-12-27	WOS:000278034800007
J	Teng, KL; Chen, H; Lai, JB; Zhang, ZH; Fang, YY; Xia, R; Zhou, XP; Guo, HS; Xie, Q				Teng, Kunling; Chen, Hao; Lai, Jianbin; Zhang, Zhonghui; Fang, Yuanyuan; Xia, Ran; Zhou, Xueping; Guo, Huishan; Xie, Qi			Involvement of C4 Protein of Beet Severe Curly Top Virus (Family Geminiviridae) in Virus Movement	PLOS ONE			English	Article							ABUTILON MOSAIC GEMINIVIRUS; FINGER E3 LIGASE; ARABIDOPSIS-THALIANA; MUTATIONAL ANALYSIS; SYSTEMIC INFECTION; GENE-EXPRESSION; VIRAL MOVEMENT; CAPSID PROTEIN; DNA; PLANTS	Background: Beet severe curly top virus (BSCTV) is a leafhopper transmitted geminivirus with a monopartite genome. C4 proteins encoded by geminivirus play an important role in virus/plant interaction. Methods and Findings: To understand the function of C4 encoded by BSCTV, two BSCTV mutants were constructed by introducing termination codons in ORF C4 without affecting the amino acids encoded by overlapping ORF Rep. BSCTV mutants containing disrupted ORF C4 retained the ability to replicate in Arabidopsis protoplasts and in the agro-inoculated leaf discs of N. benthamiana, suggesting C4 is not required for virus DNA replication. However, both mutants did not accumulate viral DNA in newly emerged leaves of inoculated N. benthamiana and Arabidopsis, and the inoculated plants were asymptomatic. We also showed that C4 expression in plant could help C4 deficient BSCTV mutants to move systemically. C4 was localized in the cytosol and the nucleus in both Arabidopsis protoplasts and N. benthamiana leaves and the protein appeared to bind viral DNA and ds/ssDNA nonspecifically, displaying novel DNA binding properties. Conclusions: Our results suggest that C4 protein in BSCTV is involved in symptom production and may facilitate virus movement instead of virus replication.	[Teng, Kunling; Chen, Hao; Lai, Jianbin; Zhang, Zhonghui; Fang, Yuanyuan; Xia, Ran; Guo, Huishan; Xie, Qi] Chinese Acad Sci, State Key Lab Plant Genom, Beijing, Peoples R China; [Teng, Kunling; Chen, Hao; Lai, Jianbin; Zhang, Zhonghui; Xia, Ran; Xie, Qi] Chinese Acad Sci, Natl Ctr Plant Gene Res, Inst Genet & Dev Biol, Beijing, Peoples R China; [Teng, Kunling; Fang, Yuanyuan; Guo, Huishan] Chinese Acad Sci, Natl Ctr Plant Gene Res, Inst Microbiol, Beijing, Peoples R China; [Zhou, Xueping] Zhejiang Univ, State Key Lab Rice Biol, Inst Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Zhejiang University	Teng, KL (corresponding author), Chinese Acad Sci, State Key Lab Plant Genom, Beijing, Peoples R China.	qxie@genetics.ac.cn	Zhang, Zhong-hui/AAI-6333-2020; Xie, Qi/P-1464-2016	Zhang, Zhong-hui/0000-0003-3732-8010; Xie, Qi/0000-0002-8262-9093	Natural Science Foundation of China [CNSF30325030/30525004/30530400]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China, and the grant number is CNSF30325030/30525004/30530400. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle HJ, 2002, ARCH VIROL, V147, P103, DOI 10.1007/s705-002-8305-8; Bechtold N, 1998, METH MOL B, V82, P259; Briddon RW, 1998, EUR J PLANT PATHOL, V104, P77, DOI 10.1023/A:1008669532438; BROUGH CL, 1992, PLANT MOL BIOL, V18, P703, DOI 10.1007/BF00020012; Chellappan P, 2005, P NATL ACAD SCI USA, V102, P10381, DOI 10.1073/pnas.0504439102; Chen H, 2010, PLANT J, V62, P12, DOI 10.1111/j.1365-313X.2009.04120.x; Dogra SC, 2009, PLANT MOL BIOL, V71, P25, DOI 10.1007/s11103-009-9506-x; English JJ, 1997, PLANT J, V12, P597, DOI 10.1046/j.1365-313X.1997.00597.x; ESAU K, 1973, VIROLOGY, V56, P454, DOI 10.1016/0042-6822(73)90049-4; ESAU K, 1977, J ULTRA MOL STRUCT R, V61, P78, DOI 10.1016/S0022-5320(77)90007-7; ETESSAMI P, 1991, J GEN VIROL, V72, P1005, DOI 10.1099/0022-1317-72-5-1005; Fauquet CM, 2008, ARCH VIROL, V153, P783, DOI 10.1007/s00705-008-0037-6; FONTES EPB, 1994, J BIOL CHEM, V269, P8459; FRISCHMUTH T, 1992, VIROLOGY, V189, P808, DOI 10.1016/0042-6822(92)90612-S; Frischmuth T, 1998, J GEN VIROL, V79, P1265, DOI 10.1099/0022-1317-79-5-1265; Guevara-Gonzalez RG, 1999, PHYTOPATHOLOGY, V89, P540, DOI 10.1094/PHYTO.1999.89.7.540; Hehnle S, 2004, J VIROL, V78, P7698, DOI 10.1128/JVI.78.14.7698-7706.2004; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Hoogstraten RA, 1996, MOL PLANT MICROBE IN, V9, P594, DOI 10.1094/MPMI-9-0594; JUPIN I, 1994, VIROLOGY, V204, P82, DOI 10.1006/viro.1994.1512; Klute KA, 1996, J GEN VIROL, V77, P1369, DOI 10.1099/0022-1317-77-7-1369; Kotlizky G, 2000, VIROLOGY, V274, P32, DOI 10.1006/viro.2000.0415; Lai JB, 2009, PLANT J, V57, P905, DOI 10.1111/j.1365-313X.2008.03737.x; Latham JR, 1997, PLANT J, V11, P1273, DOI 10.1046/j.1365-313X.1997.11061273.x; MILLSLUJAN K, PROTOPLASMA, V239, P95; Noris E, 1998, J VIROL, V72, P10050, DOI 10.1128/JVI.72.12.10050-10057.1998; NOUEIRY AO, 1994, CELL, V76, P925, DOI 10.1016/0092-8674(94)90366-2; Piroux N, 2007, VIROLOGY, V362, P428, DOI 10.1016/j.virol.2006.12.034; Pooma W, 1996, J GEN VIROL, V77, P1947, DOI 10.1099/0022-1317-77-8-1947; RIGDEN JE, 1993, VIROLOGY, V193, P1001, DOI 10.1006/viro.1993.1215; Rojas MR, 2005, ANNU REV PHYTOPATHOL, V43, P361, DOI 10.1146/annurev.phyto.43.040204.135939; Rojas MR, 1998, CELL, V95, P105, DOI 10.1016/S0092-8674(00)81786-9; Rojas MR, 2001, VIROLOGY, V291, P110, DOI 10.1006/viro.2001.1194; Sanderfoot AA, 1996, PLANT PHYSIOL, V110, P23, DOI 10.1104/pp.110.1.23; SANDERFOOT AA, 1995, PLANT CELL, V7, P1185, DOI 10.1105/tpc.7.8.1185; Sanderfoot AA, 1996, TRENDS CELL BIOL, V6, P353, DOI 10.1016/0962-8924(96)10031-3; Soto MJ, 2005, VIROLOGY, V341, P257, DOI 10.1016/j.virol.2005.07.009; STANLEY J, 1986, EMBO J, V5, P1761, DOI 10.1002/j.1460-2075.1986.tb04424.x; STENGER DC, 1992, J GEN VIROL, V73, P237, DOI 10.1099/0022-1317-73-2-237; Stenger DC, 1997, PHYTOPATHOLOGY, V87, P737, DOI 10.1094/PHYTO.1997.87.7.737; Vanitharani R, 2004, J VIROL, V78, P9487, DOI 10.1128/JVI.78.17.9487-9498.2004; WARD A, 1988, EMBO J, V7, P1583, DOI 10.1002/j.1460-2075.1988.tb02983.x; Ward BM, 1999, PLANT CELL, V11, P1267, DOI 10.1105/tpc.11.7.1267; Whitham SA, 1999, P NATL ACAD SCI USA, V96, P772, DOI 10.1073/pnas.96.2.772; Yazdi HRB, 2008, VIRUS GENES, V36, P539, DOI 10.1007/s11262-008-0224-2; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang SC, 2001, VIROLOGY, V290, P249, DOI 10.1006/viro.2001.1185; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	49	39	42	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11280	10.1371/journal.pone.0011280	http://dx.doi.org/10.1371/journal.pone.0011280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585583	Green Published, gold, Green Submitted			2022-12-27	WOS:000279135800002
J	Gomes, ALV; Wee, LJK; Khan, AM; Gil, LHVG; Marques, ETA; Calzavara-Silva, CE; Tan, TW				Gomes, Ana Lisa V.; Wee, Lawrence J. K.; Khan, Asif M.; Gil, Laura H. V. G.; Marques, Ernesto T. A., Jr.; Calzavara-Silva, Carlos E.; Tan, Tin Wee			Classification of Dengue Fever Patients Based on Gene Expression Data Using Support Vector Machines	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; INTERFERON; INFECTION; ALGORITHMS; PREDICT; INNATE	Background: Symptomatic infection by dengue virus (DENV) can range from dengue fever (DF) to dengue haemorrhagic fever (DHF), however, the determinants of DF or DHF progression are not completely understood. It is hypothesised that host innate immune response factors are involved in modulating the disease outcome and the expression levels of genes involved in this response could be used as early prognostic markers for disease severity. Methodology/Principal Findings: mRNA expression levels of genes involved in DENV innate immune responses were measured using quantitative real time PCR (qPCR). Here, we present a novel application of the support vector machines (SVM) algorithm to analyze the expression pattern of 12 genes in peripheral blood mononuclear cells (PBMCs) of 28 dengue patients (13 DHF and 15 DF) during acute viral infection. The SVM model was trained using gene expression data of these genes and achieved the highest accuracy of similar to 85% with leave-one-out cross-validation. Through selective removal of gene expression data from the SVM model, we have identified seven genes (MYD88, TLR7, TLR3, MDA5, IRF3, IFN-alpha and CLEC5A) that may be central in differentiating DF patients from DHF, with MYD88 and TLR7 observed to be the most important. Though the individual removal of expression data of five other genes had no impact on the overall accuracy, a significant combined role was observed when the SVM model of the two main genes (MYD88 and TLR7) was re-trained to include the five genes, increasing the overall accuracy to similar to 96%. Conclusions/Significance: Here, we present a novel use of the SVM algorithm to classify DF and DHF patients, as well as to elucidate the significance of the various genes involved. It was observed that seven genes are critical in classifying DF and DHF patients: TLR3, MDA5, IRF3, IFN-alpha, CLEC5A, and the two most important MYD88 and TLR7. While these preliminary results are promising, further experimental investigation is necessary to validate their specific roles in dengue disease.	[Gomes, Ana Lisa V.; Gil, Laura H. V. G.; Marques, Ernesto T. A., Jr.] Fiocruz MS, Aggeu Magalhaes Res Ctr, CPqAM, Dept Virol & Expt Therapy, Recife, PE, Brazil; [Wee, Lawrence J. K.; Khan, Asif M.; Tan, Tin Wee] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Ctr Vaccine Res, Dept Infect Dis & Microbiol, Pittsburgh, PA USA; [Calzavara-Silva, Carlos E.] Fiocruz MS, Dept Cellular & Mol Immunol, Rene Rachou Res Ctr, CPqRR, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fundacao Oswaldo Cruz	Gomes, ALV (corresponding author), Fiocruz MS, Aggeu Magalhaes Res Ctr, CPqAM, Dept Virol & Expt Therapy, Recife, PE, Brazil.	tinwee@bic.nus.edu.sg	Tan, Tin Wee/B-8963-2009; Khan, Mohammad Asif/F-4663-2010; Marques, Ernesto/L-4514-2013; Khan, M. Asif/ABE-7839-2021; Marques, Ernesto T. A/L-4967-2013; Gil, Laura Helena Vega Gonzales/AAX-5319-2021; Publica, Inct Saude/J-9544-2013; Calzavara-Silva, Carlos/ABF-2829-2021	Tan, Tin Wee/0000-0002-4062-2854; Khan, Mohammad Asif/0000-0001-9202-279X; Marques, Ernesto/0000-0003-3826-9358; Khan, M. Asif/0000-0001-9202-279X; Marques, Ernesto T. A/0000-0003-3826-9358; Gil, Laura Helena Vega Gonzales/0000-0002-8796-6080; Calzavara-Silva, Carlos/0000-0002-1406-6401	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Ciencia e Tecnologia do Estado de (FACEPE), Brazil; National Institutes of Health (NIH), USA	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de (FACEPE), Brazil; National Institutes of Health (NIH), USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Ciencia e Tecnologia do Estado de (FACEPE), Brazil, the National Institutes of Health (NIH), USA. The first author ALVG was a visiting scientist with the Department of Biochemistry, National University of Singapore (NUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chang C.- C., 2009, LIBSVM LIB SUPPORT V; Chen PC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-44; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Coffey LL, 2009, MICROBES INFECT, V11, P143, DOI 10.1016/j.micinf.2008.12.006; Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128; Cordeiro MT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004945; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; de Kruif MD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000215; Diamond MS, 2009, FRONT BIOSCI-LANDMRK, V14, P3024, DOI 10.2741/3432; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Holmes EC, 2000, TRENDS MICROBIOL, V8, P74, DOI 10.1016/S0966-842X(99)01669-8; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; KNIPE DP, 2007, FIELDS VIROLOGY, P250; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Munoz-Jordan JL, 2010, CURR TOP MICROBIOL, V338, P35, DOI 10.1007/978-3-642-02215-9_3; Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007892; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Sun PF, 2009, VIROLOGY, V383, P207, DOI 10.1016/j.virol.2008.10.022; Tang EK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-95; Tang YC, 2007, IEEE ACM T COMPUT BI, V4, P365, DOI 10.1109/TCBB.2007.1028; Tanner L, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000196; Ubol S, 2008, J INFECT DIS, V197, P1459, DOI 10.1086/587699; Wee LJK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S14; *WHO, 1997, HAEM FEV DIAGN TREAT; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	29	24	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11267	10.1371/journal.pone.0011267	http://dx.doi.org/10.1371/journal.pone.0011267			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585645	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000279135400013
J	Kojima, S; Gatfield, D; Esau, CC; Green, CB				Kojima, Shihoko; Gatfield, David; Esau, Christine C.; Green, Carla B.			MicroRNA-122 Modulates the Rhythmic Expression Profile of the Circadian Deadenylase Nocturnin in Mouse Liver	PLOS ONE			English	Article							NEURONAL DIFFERENTIATION; RNA REGULATION; MICRO-RNA; IN-VIVO; MIR-122; GENE; IDENTIFICATION; RETINA; TARGET; TISSUE	Nocturnin is a circadian clock-regulated deadenylase thought to control mRNA expression post-transcriptionally through poly(A) tail removal. The expression of Nocturnin is robustly rhythmic in liver at both the mRNA and protein levels, and mice lacking Nocturnin are resistant to diet-induced obesity and hepatic steatosis. Here we report that Nocturnin expression is regulated by microRNA-122 (miR-122), a liver specific miRNA. We found that the 3'-untranslated region (3'-UTR) of Nocturnin mRNA harbors one putative recognition site for miR-122, and this site is conserved among mammals. Using a luciferase reporter construct with wild-type or mutant Nocturnin 3'-UTR sequence, we demonstrated that overexpression of miR-122 can down-regulate luciferase activity levels and that this effect is dependent on the presence of the putative miR-122 recognition site. Additionally, the use of an antisense oligonucleotide to knock down miR-122 in vivo resulted in significant up-regulation of both Nocturnin mRNA and protein expression in mouse liver during the night, resulting in Nocturnin rhythms with increased amplitude. Together, these data demonstrate that the normal rhythmic profile of Nocturnin expression in liver is shaped in part by miR-122. Previous studies have implicated Nocturnin and miR-122 as important post-transcriptional regulators of both lipid metabolism and circadian clock controlled gene expression in the liver. Therefore, the demonstration that miR-122 plays a role in regulating Nocturnin expression suggests that this may be an important intersection between hepatic metabolic and circadian control.	[Kojima, Shihoko; Green, Carla B.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Kojima, Shihoko; Green, Carla B.] Univ Virginia, Dept Biol, Charlottesville, VA USA; [Gatfield, David] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Esau, Christine C.] Regulus Therapeut, Carlsbad, CA USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Virginia; University of Geneva; Isis Pharmaceuticals Inc	Kojima, S (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	Carla.Green@utsouthwestern.edu	Gatfield, David/C-2354-2011	Gatfield, David/0000-0001-5114-2824; Kojima (xiao dao zhi bao zi), Shihoko/0000-0001-9579-7830	Federation of European Biochemical Societies (FEBS); International Human Frontier Science Program Organization (HFSP); NIH [GM076626]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076626] Funding Source: NIH RePORTER	Federation of European Biochemical Societies (FEBS); International Human Frontier Science Program Organization (HFSP)(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D. G. received long-term fellowships from The Federation of European Biochemical Societies (FEBS) and The International Human Frontier Science Program Organization (HFSP). C. E. is employed by Regulus Therapeutics, but no further financial support (beyond salary) was provided to this project. This work was supported by NIH GM076626 (to C. B. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Baggs JE, 2003, CURR BIOL, V13, P189, DOI 10.1016/S0960-9822(03)00014-9; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Garbarino-Pico E, 2007, RNA, V13, P745, DOI 10.1261/rna.286507; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; Kadener S, 2009, GENE DEV, V23, P2179, DOI 10.1101/gad.1819509; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kojima S, 2003, BIOCHEM BIOPH RES CO, V301, P1, DOI 10.1016/S0006-291X(02)02938-8; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; MARTINELLI R, 2010, OBESITY SILVER SPRIN; Mendes ND, 2009, NUCLEIC ACIDS RES, V37, P2419, DOI 10.1093/nar/gkp145; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Nagel R, 2009, FEBS J, V276, P5447, DOI 10.1111/j.1742-4658.2009.07229.x; Nakanishi N, 2009, BIOCHEM BIOPH RES CO, V385, P492, DOI 10.1016/j.bbrc.2009.05.058; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Takanabe R, 2008, BIOCHEM BIOPH RES CO, V376, P728, DOI 10.1016/j.bbrc.2008.09.050; Wang Y, 2001, BMC Dev Biol, V1, P9, DOI 10.1186/1471-213X-1-9; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200	37	65	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11264	10.1371/journal.pone.0011264	http://dx.doi.org/10.1371/journal.pone.0011264			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582318	Green Published, gold, Green Submitted			2022-12-27	WOS:000279058500016
J	Chen, HC; Xie, J; Zhang, Z; Su, LT; Yue, LX; Runnels, LW				Chen, Hsiang-Chin; Xie, Jia; Zhang, Zheng; Su, Li-Ting; Yue, Lixia; Runnels, Loren W.			Blockade of TRPM7 Channel Activity and Cell Death by Inhibitors of 5-Lipoxygenase	PLOS ONE			English	Article							SLOW-REACTING SUBSTANCE; FOCAL CEREBRAL-ISCHEMIA; ARACHIDONIC-ACID; NORDIHYDROGUAIARETIC ACID; HIPPOCAMPAL-NEURONS; MYOCARDIAL ISCHEMIA; DIVALENT-CATIONS; MG2+ HOMEOSTASIS; ACTIVATION; ADHESION	TRPM7 is a ubiquitous divalent-selective ion channel with its own kinase domain. Recent studies have shown that suppression of TRPM7 protein expression by RNA interference increases resistance to ischemia-induced neuronal cell death in vivo and in vitro, making the channel a potentially attractive pharmacological target for molecular intervention. Here, we report the identification of the 5-lipoxygenase inhibitors, NDGA, AA861, and MK886, as potent blockers of the TRPM7 channel. Using a cell-based assay, application of these compounds prevented cell rounding caused by overexpression of TRPM7 in HEK-293 cells, whereas inhibitors of 12-lipoxygenase and 15-lipoxygenase did not prevent the change in cell morphology. Application of the 5-lipoxygenase inhibitors blocked heterologously expressed TRPM7 whole-cell currents without affecting the protein's expression level or its cell surface concentration. All three inhibitors were also effective in blocking the native TRPM7 current in HEK-293 cells. However, two other 5-lipoxygenase specific inhibitors, 5,6-dehydroarachidonic acid and zileuton, were ineffective in suppressing TRPM7 channel activity. Targeted knockdown of 5-lipoxygenase did not reduce TRPM7 whole-cell currents. In addition, application of 5-hydroperoxyeicosatetraenoic acid (5-HPETE), the product of 5-lipoxygenase, or 5-HPETE's downstream metabolites, leukotriene B4 and leukotriene D4, did not stimulate TRPM7 channel activity. These data suggested that NDGA, AA861, and MK886 reduced the TRPM7 channel activity independent of their effect on 5-lipoxygenase activity. Application of AA861 and NDGA reduced cell death for cells overexpressing TRPM7 cultured in low extracellular divalent cations. Moreover, treatment of HEK-293 cells with AA861 increased cell resistance to apoptotic stimuli to a level similar to that obtained for cells in which TRPM7 was knocked down by RNA interference. In conclusion, NDGA, AA861, and MK886 are potent blockers of the TRPM7 channel capable of attenuating TRPM7's function during cell stress, making them effective tools for the biophysical characterization and suppression of TRPM7 channel conductance in vivo.	[Xie, Jia; Zhang, Zheng; Yue, Lixia] Univ Connecticut, Ctr Hlth, Calhoun Cardiol Ctr, Farmington, CT USA; [Xie, Jia; Zhang, Zheng; Yue, Lixia] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT USA; [Chen, Hsiang-Chin; Su, Li-Ting; Runnels, Loren W.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	University of Connecticut; University of Connecticut; Rutgers State University New Brunswick; Rutgers State University Medical Center	Yue, LX (corresponding author), Univ Connecticut, Ctr Hlth, Calhoun Cardiol Ctr, Farmington, CT USA.	lyue@uchc.edu; runnellw@umdnj.edu	Xie, Jia/L-9921-2014	Runnels, Loren/0000-0002-2537-7360	National Institutes of Health, National Institute of General Medical Science (NIGMS) [1R01GM080753]; National Heart, Lung and Blood Institute (NHLBI) [HL078960]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080753] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medical Science (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was generously supported by the National Institutes of Health, National Institute of General Medical Science (NIGMS) (www.nigms.nih.gov) grant number 1R01GM080753 to LR and National Heart, Lung and Blood Institute (NHLBI) (www.nhlbi.nih.gov) grant number HL078960 to LY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Adamek A, 2007, EUR J PHARMACOL, V571, P51, DOI 10.1016/j.ejphar.2007.05.040; ASHIDA Y, 1983, PROSTAGLANDINS, V26, P955, DOI 10.1016/0090-6980(83)90157-0; Baskaya MK, 1996, J NEUROSURG, V85, P112, DOI 10.3171/jns.1996.85.1.0112; CHUN JS, 1992, MOL BIOL CELL, V3, P481, DOI 10.1091/mbc.3.5.481; Ciceri P, 2001, BRIT J PHARMACOL, V133, P1323, DOI 10.1038/sj.bjp.0704189; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Elizondo MR, 2005, CURR BIOL, V15, P667, DOI 10.1016/j.cub.2005.02.050; FIEDLER VB, 1985, J CARDIOVASC PHARM, V7, P983, DOI 10.1097/00005344-198509000-00027; Gwanyanya A, 2004, J PHYSIOL-LONDON, V559, P761, DOI 10.1113/jphysiol.2004.067637; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; Hermosura MC, 2002, J PHYSIOL-LONDON, V539, P445, DOI 10.1113/jphysiol.2001.013361; HOPE WC, 1983, BIOCHEM PHARMACOL, V32, P367, DOI 10.1016/0006-2952(83)90569-5; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; INOUE K, 2010, J BIOL CHEM; Jatana M, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-12; Jiang JM, 2005, J GEN PHYSIOL, V126, P137, DOI 10.1085/jgp.200409185; Jiang XP, 2003, J BIOL CHEM, V278, P42867, DOI 10.1074/jbc.M304487200; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kim BM, 2004, NEUROSCI LETT, V361, P159, DOI 10.1016/j.neulet.2004.01.019; Kitagawa K, 2004, BRAIN RES, V1004, P198, DOI 10.1016/j.brainres.2004.01.018; Kozak JA, 2005, J GEN PHYSIOL, V126, P499, DOI 10.1085/jgp.200509324; Kozak JA, 2002, J GEN PHYSIOL, V120, P221, DOI 10.1085/jgp.20028601; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; Langeslag M, 2007, J BIOL CHEM, V282, P232, DOI 10.1074/jbc.M605300200; LEFKOWITH JB, 1991, J BIOL CHEM, V266, P1071; Li MJ, 2007, J BIOL CHEM, V282, P25817, DOI 10.1074/jbc.M608972200; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Oancea E, 2006, CIRC RES, V98, P245, DOI 10.1161/01.RES.0000200179.29375.cc; Peters-Golden M, 2003, PROSTAG LEUKOTR ESS, V69, P99, DOI 10.1016/S0952-3278(03)00070-X; Rempe DA, 2009, NAT NEUROSCI, V12, P1215, DOI 10.1038/nn1009-1215; ROTHMAN SM, 1993, NEUROPHARMACOLOGY, V32, P1279, DOI 10.1016/0028-3908(93)90022-U; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; SALARI H, 1984, PROSTA LEUKOTR MED, V13, P53, DOI 10.1016/0262-1746(84)90102-1; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Shin J, 2002, P NATL ACAD SCI USA, V99, P10150, DOI 10.1073/pnas.152002699; Stockton RA, 2001, MOL BIOL CELL, V12, P1937, DOI 10.1091/mbc.12.7.1937; Su LT, 2010, J MOL BIOL, V396, P858, DOI 10.1016/j.jmb.2010.01.014; Su LT, 2006, J BIOL CHEM, V281, P11260, DOI 10.1074/jbc.M512885200; SUN HS, 2009, NAT NEUROSCI; Tian SL, 2007, NEUROSCI LETT, V419, P93, DOI 10.1016/j.neulet.2007.04.020; Uz T, 2008, NEUROSCI LETT, V436, P269, DOI 10.1016/j.neulet.2008.03.041; Wei WL, 2007, P NATL ACAD SCI USA, V104, P16323, DOI 10.1073/pnas.0701149104; Werz Oliver, 2002, Current Drug Targets - Inflammation and Allergy, V1, P23, DOI 10.2174/1568010023344959; YOSHIMOTO T, 1982, BIOCHIM BIOPHYS ACTA, V713, P470	49	58	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11161	10.1371/journal.pone.0011161	http://dx.doi.org/10.1371/journal.pone.0011161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567598	Green Published, gold, Green Submitted			2022-12-27	WOS:000278886300007
J	Liu, FJ; Barchowsky, A; Opresko, PL				Liu, Fu-Jun; Barchowsky, Aaron; Opresko, Patricia L.			The Werner Syndrome Protein Suppresses Telomeric Instability Caused by Chromium (VI) Induced DNA Replication Stress	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HUMAN LUNG-CELLS; HOMOLOGOUS RECOMBINATION; DYSFUNCTIONAL TELOMERES; MAMMALIAN TELOMERES; GENOMIC INSTABILITY; SYNDROME HELICASE; RECQ HELICASE; S-PHASE; CHROMOSOME INSTABILITY	Telomeres protect the chromosome ends and consist of guanine-rich repeats coated by specialized proteins. Critically short telomeres are associated with disease, aging and cancer. Defects in telomere replication can lead to telomere loss, which can be prevented by telomerase-mediated telomere elongation or activities of the Werner syndrome helicase/exonuclease protein (WRN). Both telomerase and WRN attenuate cytotoxicity induced by the environmental carcinogen hexavalent chromium (Cr(VI)), which promotes replication stress and DNA polymerase arrest. However, it is not known whether Cr(VI)induced replication stress impacts telomere integrity. Here we report that Cr(VI) exposure of human fibroblasts induced telomeric damage as indicated by phosphorylated H2AX (gamma H2AX) at telomeric foci. The induced gamma H2AX foci occurred in S-phase cells, which is indicative of replication fork stalling or collapse. Telomere fluorescence in situ hybridization (FISH) of metaphase chromosomes revealed that Cr(VI) exposure induced an increase in telomere loss and sister chromatid fusions that were rescued by telomerase activity. Human cells depleted for WRN protein exhibited a delayed reduction in telomeric and non-telomeric damage, indicated by gamma H2AX foci, during recovery from Cr(VI) exposure, consistent with WRN roles in repairing damaged replication forks. Telomere FISH of chromosome spreads revealed that WRN protects against Cr(VI)-induced telomere loss and downstream chromosome fusions, but does not prevent chromosome fusions that retain telomere sequence at the fusion point. Our studies indicate that environmentally induced replication stress leads to telomere loss and aberrations that are suppressed by telomerase-mediated telomere elongation or WRN functions in replication fork restoration.	[Liu, Fu-Jun; Barchowsky, Aaron; Opresko, Patricia L.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Liu, FJ (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA.	plo4@pitt.edu		Opresko, Patricia/0000-0002-6470-2189	National Institute of Environmental Health Sciences [R01ES015052]; Ellison Medical Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015052] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences (R01ES015052) and the Ellison Medical Foundation to P.L.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2009, AGING-US, V1, P219, DOI 10.18632/aging.100020; Arnoult N, 2009, GENE DEV, V23, P2915, DOI 10.1101/gad.544009; Baird DM, 2005, EXP GERONTOL, V40, P363, DOI 10.1016/j.exger.2005.02.008; Baird DM, 2004, HUM MOL GENET, V13, P1515, DOI 10.1093/hmg/ddh159; Balajee AS, 2004, EXP CELL RES, V300, P320, DOI 10.1016/j.yexcr.2004.07.022; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bridgewater LC, 1998, MOL CARCINOGEN, V23, P201; Bryant HE, 2006, MUTAT RES-FUND MOL M, V599, P116, DOI 10.1016/j.mrfmmm.2006.02.001; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; COGAN N, 1983, MUTAT RES, V683, P1; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Crabbe L, 2007, P NATL ACAD SCI USA, V104, P2205, DOI 10.1073/pnas.0609410104; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Davalos AR, 2003, J CELL BIOL, V162, P1197, DOI 10.1083/jcb.200304016; Dhillon KK, 2007, AGING CELL, V6, P53, DOI 10.1111/j.1474-9726.2006.00260.x; Gagos S, 2008, CANCER RES, V68, P8146, DOI 10.1158/0008-5472.CAN-08-0945; Glaviano A, 2006, ONCOGENE, V25, P3424, DOI 10.1038/sj.onc.1209399; Glaviano A, 2009, MUTAGENESIS, V24, P25, DOI 10.1093/mutage/gen048; Grandori C, 2003, GENE DEV, V17, P1569, DOI 10.1101/gad.1100303; Ha LN, 2004, CARCINOGENESIS, V25, P2265, DOI 10.1093/carcin/bgh242; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Li BM, 2009, AGING-US, V1, P289, DOI 10.18632/aging.100032; Liu FJ, 2009, TOXICOL SCI, V110, P307, DOI 10.1093/toxsci/kfp104; Liu L, 2003, J BIOL CHEM, V278, P31998, DOI 10.1074/jbc.M303553200; Multani AS, 2007, J CELL SCI, V120, P713, DOI 10.1242/jcs.03397; Newman JPA, 2008, J CELL PHYSIOL, V214, P796, DOI 10.1002/jcp.21276; Opresko PL, 2008, MECH AGEING DEV, V129, P79, DOI 10.1016/j.mad.2007.10.007; Opresko PL, 2007, MECH AGEING DEV, V128, P423, DOI 10.1016/j.mad.2007.05.009; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2005, NUCLEIC ACIDS RES, V33, P1230, DOI 10.1093/nar/gki273; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; *PHS, 2000, DEP HLTH HUM SERV AG; Pichierri P, 2001, MOL BIOL CELL, V12, P2412, DOI 10.1091/mbc.12.8.2412; Pirzio LM, 2008, J CELL BIOL, V180, P305, DOI 10.1083/jcb.200705126; Poon Steven S S, 2001, Curr Protoc Cell Biol, VChapter 18, DOI 10.1002/0471143030.cb1804s12; Quievryn G, 2003, BIOCHEMISTRY-US, V42, P1062, DOI 10.1021/bi0271547; Rizzo A, 2009, NUCLEIC ACIDS RES, V37, P5353, DOI 10.1093/nar/gkp582; Rog O, 2009, MOL CELL, V33, P559, DOI 10.1016/j.molcel.2009.01.027; ROSSI ML, DNA REPAIR AMST; Rubio MA, 2004, EXP CELL RES, V298, P17, DOI 10.1016/j.yexcr.2004.04.004; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Sidorova JM, 2008, CELL CYCLE, V7, P796, DOI 10.4161/cc.7.6.5566; Slade PG, 2005, CHEM RES TOXICOL, V18, P1140, DOI 10.1021/tx050033y; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Sowd G, 2008, NUCLEIC ACIDS RES, V36, P4242, DOI 10.1093/nar/gkn385; Stackpole MM, 2007, MUTAT RES-FUND MOL M, V625, P145, DOI 10.1016/j.mrfmmm.2007.06.003; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tamblyn L, 2009, MUTAT RES-FUND MOL M, V660, P57, DOI 10.1016/j.mrfmmm.2008.10.013; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wang X, 2008, MOL CELL, V31, P463, DOI 10.1016/j.molcel.2008.05.028; Wise Sandra S., 2008, Reviews on Environmental Health, V23, P39; Wise SS, 2004, MOL CELL BIOCHEM, V255, P103, DOI 10.1023/B:MCBI.0000007266.82705.d9; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; Xie H, 2005, MUTAT RES-GEN TOX EN, V586, P160, DOI 10.1016/j.mrgentox.2005.06.002; Xie H, 2009, TOXICOL APPL PHARM, V234, P293, DOI 10.1016/j.taap.2008.10.010; Xu J, 1996, CARCINOGENESIS, V17, P1511, DOI 10.1093/carcin/17.7.1511; Zecevic A, 2009, CELL CYCLE, V8, P2769, DOI 10.4161/cc.8.17.9410; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	60	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11152	10.1371/journal.pone.0011152	http://dx.doi.org/10.1371/journal.pone.0011152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585393	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000278886100016
J	Staubert, C; Boselt, I; Bohnekamp, J; Rompler, H; Enard, W; Schoneberg, T				Staeubert, Claudia; Boeselt, Iris; Bohnekamp, Jens; Roempler, Holger; Enard, Wolfgang; Schoeneberg, Torsten			Structural and Functional Evolution of the Trace Amine-Associated Receptors TAAR3, TAAR4 and TAAR5 in Primates	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; PROTEIN-COUPLED RECEPTORS; PHYLOGENETIC ANALYSIS; AMPHETAMINE; MODELS; FAMILY; SITES	The family of trace amine-associated receptors (TAAR) comprises 9 mammalian TAAR subtypes, with intact gene and pseudogene numbers differing considerably even between closely related species. To date the best characterized subtype is TAAR1, which activates the G(s) protein/adenylyl cyclase pathway upon stimulation by trace amines and psychoactive substances like MDMA or LSD. Recently, chemosensory function involving recognition of volatile amines was proposed for murine TAAR3, TAAR4 and TAAR5. Humans can smell volatile amines despite carrying open reading frame (ORF) disruptions in TAAR3 and TAAR4. Therefore, we set out to study the functional and structural evolution of these genes with a special focus on primates. Functional analyses showed that ligands activating the murine TAAR3, TAAR4 and TAAR5 do not activate intact primate and mammalian orthologs, although they evolve under purifying selection and hence must be functional. We also find little evidence for positive selection that could explain the functional differences between mouse and other mammals. Our findings rather suggest that the previously identified volatile amine TAAR3-5 agonists reflect the high agonist promiscuity of TAAR, and that the ligands driving purifying selection of these TAAR in mouse and other mammals still await discovery. More generally, our study points out how analyses in an evolutionary context can help to interpret functional data generated in single species.	[Staeubert, Claudia; Boeselt, Iris; Bohnekamp, Jens; Roempler, Holger; Schoeneberg, Torsten] Univ Leipzig, Fac Med, Inst Biochem, Leipzig, Germany; [Enard, Wolfgang] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany	Leipzig University; Max Planck Society	Staubert, C (corresponding author), Univ Leipzig, Fac Med, Inst Biochem, Leipzig, Germany.	schoberg@medizin.uni-leipzig.de	Enard, Wolfgang/K-3483-2014; Stäubert, Claudia/I-7397-2015	Stäubert, Claudia/0000-0003-0721-8507	Deutsche Forschungsgemeinschaft [SFB 610 TP A10]; Bundesministerium fur Bildung und Forschung (BMBF); LIFE (Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes and Environment); German National Academic Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); LIFE (Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes and Environment); German National Academic Foundation	This work was supported by the Deutsche Forschungsgemeinschaft, SFB 610 TP A10, Bundesministerium fur Bildung und Forschung (BMBF), LIFE (Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes and Environment) and the German National Academic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai T, 2003, P NATL ACAD SCI USA, V100, P7708, DOI 10.1073/pnas.1230533100; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; Bunzow JR, 2001, MOL PHARMACOL, V60, P1181, DOI 10.1124/mol.60.6.1181; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Dupanloup I, 2006, BIOINFORMATICS, V22, P1815, DOI 10.1093/bioinformatics/btl280; Fabre PH, 2009, MOL PHYLOGENET EVOL, V53, P808, DOI 10.1016/j.ympev.2009.08.004; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FELSENSTEIN J, 1993, PHYLIP  PHYLOGENY IN; Gloriam DEI, 2005, MOL PHYLOGENET EVOL, V35, P470, DOI 10.1016/j.ympev.2004.12.003; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; Grandy DK, 2007, PHARMACOL THERAPEUT, V116, P355, DOI 10.1016/j.pharmthera.2007.06.007; HASHIGUCHI Y, 2007, MOL BIOL EVOL; Hill Stephen J., 2001, Current Opinion in Pharmacology, V1, P526, DOI 10.1016/S1471-4892(01)00091-1; Hughes AL, 2007, HEREDITY, V99, P364, DOI 10.1038/sj.hdy.6801031; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Lindemann L, 2005, TRENDS PHARMACOL SCI, V26, P274, DOI 10.1016/j.tips.2005.03.007; Lindemann L, 2005, GENOMICS, V85, P372, DOI 10.1016/j.ygeno.2004.11.010; Murphy WJ, 2004, TRENDS GENET, V20, P631, DOI 10.1016/j.tig.2004.09.005; Page SL, 2001, MOL PHYLOGENET EVOL, V18, P14, DOI 10.1006/mpev.2000.0895; Reese EA, 2007, J PHARMACOL EXP THER, V321, P178, DOI 10.1124/jpet.106.115402; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sangkuhl Katrin, 2005, Hum Mutat, V25, P505, DOI 10.1002/humu.9337; Scanlan TS, 2004, NAT MED, V10, P638, DOI 10.1038/nm1051; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; SNEAD AN, 2008, BIOORG MED CHEM LETT; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarnow P, 2003, J BIOL CHEM, V278, P48666, DOI 10.1074/jbc.M309941200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wainscott DB, 2007, J PHARMACOL EXP THER, V320, P475, DOI 10.1124/jpet.106.112532; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	38	43	44	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11133	10.1371/journal.pone.0011133	http://dx.doi.org/10.1371/journal.pone.0011133			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559446	Green Published, gold, Green Submitted			2022-12-27	WOS:000278775900022
J	Oliveira, DL; Nakayasu, ES; Joffe, LS; Guimaraes, AJ; Sobreira, TJP; Nosanchuk, JD; Cordero, RJB; Frases, S; Casadevall, A; Almeida, IC; Nimrichter, L; Rodrigues, ML				Oliveira, Debora L.; Nakayasu, Ernesto S.; Joffe, Luna S.; Guimaraes, Allan J.; Sobreira, Tiago J. P.; Nosanchuk, Joshua D.; Cordero, Radames J. B.; Frases, Susana; Casadevall, Arturo; Almeida, Igor C.; Nimrichter, Leonardo; Rodrigues, Marcio L.			Characterization of Yeast Extracellular Vesicles: Evidence for the Participation of Different Pathways of Cellular Traffic in Vesicle Biogenesis	PLOS ONE			English	Article							UNCONVENTIONAL PROTEIN SECRETION; SACCHAROMYCES-CEREVISIAE; CRYPTOCOCCUS-NEOFORMANS; ENDOPLASMIC-RETICULUM; MASS-SPECTROMETRY; FINE-STRUCTURE; MECHANISM; IDENTIFICATION; PROTEOMICS; TRANSPORT	Background: Extracellular vesicles in yeast cells are involved in the molecular traffic across the cell wall. In yeast pathogens, these vesicles have been implicated in the transport of proteins, lipids, polysaccharide and pigments to the extracellular space. Cellular pathways required for the biogenesis of yeast extracellular vesicles are largely unknown. Methodology/Principal Findings: We characterized extracellular vesicle production in wild type (WT) and mutant strains of the model yeast Saccharomyces cerevisiae using transmission electron microscopy in combination with light scattering analysis, lipid extraction and proteomics. WT cells and mutants with defective expression of Sec4p, a secretory vesicle-associated Rab GTPase essential for Golgi-derived exocytosis, or Snf7p, which is involved in multivesicular body (MVB) formation, were analyzed in parallel. Bilayered vesicles with diameters at the 100-300 nm range were found in extracellular fractions from yeast cultures. Proteomic analysis of vesicular fractions from the cells aforementioned and additional mutants with defects in conventional secretion pathways (sec1-1, fusion of Golgi-derived exocytic vesicles with the plasma membrane; bos1-1, vesicle targeting to the Golgi complex) or MVB functionality (vps23, late endosomal trafficking) revealed a complex and interrelated protein collection. Semi-quantitative analysis of protein abundance revealed that mutations in both MVB- and Golgi-derived pathways affected the composition of yeast extracellular vesicles, but none abrogated vesicle production. Lipid analysis revealed that mutants with defects in Golgi-related components of the secretory pathway had slower vesicle release kinetics, as inferred from intracellular accumulation of sterols and reduced detection of these lipids in vesicle fractions in comparison with WT cells. Conclusions/Significance: Our results suggest that both conventional and unconventional pathways of secretion are required for biogenesis of extracellular vesicles, which demonstrate the complexity of this process in the biology of yeast cells.	[Oliveira, Debora L.; Joffe, Luna S.; Nimrichter, Leonardo; Rodrigues, Marcio L.] Inst Microbiol Prof Paulo de Goes, Lab Estudos Integrados Bioquim Microbiana, Rio De Janeiro, Brazil; [Nakayasu, Ernesto S.; Almeida, Igor C.] Univ Texas El Paso, Border Biomed Res Ctr, Dept Biol Sci, El Paso, TX 79968 USA; [Guimaraes, Allan J.; Nosanchuk, Joshua D.; Casadevall, Arturo] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Sobreira, Tiago J. P.] Univ Sao Paulo, Heart Inst InCor, Lab Genet & Mol Cardiol, Sao Paulo, Brazil; [Nosanchuk, Joshua D.; Cordero, Radames J. B.; Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Frases, Susana] Inst Nacl Metrol Normalizacao & Qualidade Ind, Lab Biotecnol, Rio De Janeiro, Brazil	University of Texas System; University of Texas El Paso; Yeshiva University; Albert Einstein College of Medicine; Universidade de Sao Paulo; Yeshiva University; Albert Einstein College of Medicine; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO)	Oliveira, DL (corresponding author), Inst Microbiol Prof Paulo de Goes, Lab Estudos Integrados Bioquim Microbiana, Rio De Janeiro, Brazil.	marcio@micro.ufrj.br	Nakayasu, Ernesto S./AAJ-8374-2020; Frases, Susana/W-9502-2019; Guimaraes, Allan/AAQ-2343-2020; Almeida, Igor C./AAF-9409-2019; Nimrichter, Leonardo/L-3545-2014; Guimaraes, Allan J/E-2160-2014; Rodrigues, Marcio/J-3727-2013; Cordero, Radamés JB/F-6912-2011; Sobreira, Tiago/C-1276-2008; Nosanchuk, Joshua/AAS-7801-2021	Nakayasu, Ernesto S./0000-0002-4056-2695; Frases, Susana/0000-0001-5875-9886; Guimaraes, Allan/0000-0002-2856-9667; Almeida, Igor C./0000-0002-2443-8213; Nimrichter, Leonardo/0000-0001-9281-6856; Guimaraes, Allan J/0000-0002-2856-9667; Rodrigues, Marcio/0000-0002-6081-3439; Cordero, Radamés JB/0000-0002-3026-7094; Sobreira, Tiago/0000-0002-0217-0084; 	Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); NIH [HL059842, AI033774, AI052733, AI033142, AI52733-06A1, AI056070-01A2]; Interhemispheric Research Training Grant in Infectious Diseases, Fogarty International Center (NIH) [D43-TW007129]; Hirschl/Weill-Caulier Career Scientist Award; Training Program in Cellular and Molecular 414 Biology and Genetics [T32 GM007491]; NIH/NCRR [5G12RR008124-16A1]; Graduate School, University of Texas at El-Paso (UTEP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil; Biomolecule Analysis Core Facility, Border Biomedical Research Center/Biology/University of Texas at El-Paso (NIH) [5G12RR008124-16A1, 5G12RR008124-16A1S1]; FOGARTY INTERNATIONAL CENTER [D43TW007129] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033774, R01AI056070, R37AI033142, R01AI052733, R01AI033142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER	Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interhemispheric Research Training Grant in Infectious Diseases, Fogarty International Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Hirschl/Weill-Caulier Career Scientist Award; Training Program in Cellular and Molecular 414 Biology and Genetics; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Graduate School, University of Texas at El-Paso (UTEP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Biomolecule Analysis Core Facility, Border Biomedical Research Center/Biology/University of Texas at El-Paso (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	LN and MLR are supported by grants from the Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). AC is supported by NIH awards HL059842, AI033774, AI052733, AI033142. AJG and LN were supported in part by an Interhemispheric Research Training Grant in Infectious Diseases, Fogarty International Center (NIH D43-TW007129). JDN is supported in part by NIH AI52733-06A1 and AI056070-01A2, and a Hirschl/Weill-Caulier Career Scientist Award. RJBC was supported by the Training Program in Cellular and Molecular 414 Biology and Genetics, T32 GM007491. ICA was partially supported by the NIH/NCRR grant 5G12RR008124-16A1. ESN was partially supported by the George A. Krutilek memorial graduate scholarship from Graduate School, University of Texas at El-Paso (UTEP). TJPS was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil. The authors thank the Biomolecule Analysis Core Facility, Border Biomedical Research Center/Biology/University of Texas at El-Paso (NIH grants #5G12RR008124-16A1 and 5G12RR008124-16A1S1), for the access to the LC-MS instrumentation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque PC, 2008, CELL MICROBIOL, V10, P1695, DOI 10.1111/j.1462-5822.2008.01160.x; Aoki N, 2007, ENDOCRINOLOGY, V148, P3850, DOI 10.1210/en.2006-1479; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Casadevall A, 2009, TRENDS MICROBIOL, V17, P158, DOI 10.1016/j.tim.2008.12.005; Chakraburtty K, 1998, BIOL CHEM, V379, P831, DOI 10.1515/bchm.1998.379.7.831; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; De Craene JO, 2006, MOL BIOL CELL, V17, P3009, DOI 10.1091/mbc.e06-01-0080; De Jesus M, 2009, EUKARYOT CELL, V8, P96, DOI 10.1128/EC.00331-08; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Eisenman HC, 2009, MICROBIOL-SGM, V155, P3860, DOI 10.1099/mic.0.032854-0; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Faca V, 2007, J PROTEOME RES, V6, P3558, DOI 10.1021/pr070233q; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gaigg B, 2001, MOL BIOL CELL, V12, P1147, DOI 10.1091/mbc.12.4.1147; Gatti JL, 2005, BIOL REPROD, V72, P1452, DOI 10.1095/biolreprod.104.036426; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Glick BS, 1998, CELL, V95, P883, DOI 10.1016/S0092-8674(00)81713-4; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Hu GG, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030042; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Inadome H, 2005, MOL CELL BIOL, V25, P7696, DOI 10.1128/MCB.25.17.7696-7710.2005; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jurado JD, 2007, TOXICON, V49, P339, DOI 10.1016/j.toxicon.2006.10.004; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kinseth MA, 2007, CELL, V130, P524, DOI 10.1016/j.cell.2007.06.029; Kovalchuke O, 1998, EUR J BIOCHEM, V258, P986, DOI 10.1046/j.1432-1327.1998.2580986.x; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Luo WJ, 1997, J CELL BIOL, V138, P731, DOI 10.1083/jcb.138.4.731; Martineau CN, 2007, GENETICS, V177, P1679, DOI 10.1534/genetics.107.081141; Mears R, 2004, PROTEOMICS, V4, P4019, DOI 10.1002/pmic.200400876; Nakayasu ES, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.13; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Nicola AM, 2009, EUKARYOT CELL, V8, P1373, DOI 10.1128/EC.00044-09; Nosanchuk Joshua D, 2008, Commun Integr Biol, V1, P37; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Oliveira DL, 2009, FUNGAL GENET BIOL, V46, P956, DOI 10.1016/j.fgb.2009.09.001; OLIVEIRA DL, INFECT IMMUN; Panepinto J, 2009, MOL MICROBIOL, V71, P1165, DOI 10.1111/j.1365-2958.2008.06588.x; Pereira RD, 1999, MOL CELL BIOCHEM, V201, P17, DOI 10.1023/A:1007007704657; Poisson Guylaine, 2007, Genomics Proteomics & Bioinformatics, V5, P121, DOI 10.1016/S1672-0229(07)60022-9; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Rodrigues ML, 2007, EUKARYOT CELL, V6, P48, DOI 10.1128/EC.00318-06; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; Schekman R, 2002, NAT MED, V8, P1055, DOI 10.1038/nm769; SCHEKMAN R, 1983, METHOD ENZYMOL, V96, P802; SCHEKMAN R, 2004, CELL, V116, pS19; Schekman Randy, 2004, Cell, VS116, pS13, DOI 10.1016/S0092-8674(03)00972-3; Schirle M, 2003, MOL CELL PROTEOMICS, V2, P1297, DOI 10.1074/mcp.M300087-MCP200; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Stephens DJ, 2001, J CELL SCI, V114, P1053; TAKEO K, 1973, J BACTERIOL, V113, P1442, DOI 10.1128/JB.113.3.1442-1448.1973; TAKEO K, 1973, J BACTERIOL, V113, P1449, DOI 10.1128/JB.113.3.1449-1454.1973; TU JL, 1993, GENETICS, V135, P17; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; WALWORTH NC, 1989, EMBO J, V8, P1685, DOI 10.1002/j.1460-2075.1989.tb03560.x; WERNERWASHBURNE M, 1987, MOL CELL BIOL, V7, P2568, DOI 10.1128/MCB.7.7.2568; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Wuestehube LJ, 1996, GENETICS, V142, P393; Yoneda A, 2006, MOL BIOL CELL, V17, P5131, DOI 10.1091/mbc.E06-08-0701	64	157	163	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11113	10.1371/journal.pone.0011113	http://dx.doi.org/10.1371/journal.pone.0011113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559436	gold, Green Submitted, Green Published			2022-12-27	WOS:000278741100024
J	McCormick, N; Velasquez, V; Finney, L; Vogt, S; Kelleher, SL				McCormick, Nicholas; Velasquez, Vanessa; Finney, Lydia; Vogt, Stefan; Kelleher, Shannon L.			X-Ray Fluorescence Microscopy Reveals Accumulation and Secretion of Discrete Intracellular Zinc Pools in the Lactating Mouse Mammary Gland	PLOS ONE			English	Article							MITOCHONDRIAL-FUNCTION; MILK SECRETION; PROLACTIN PRL; IN-VIVO; PROSTATE; TRANSPORTER; EXPRESSION; SELENIUM; LOCALIZATION; PATHWAYS	Background: The mammary gland is responsible for the transfer of a tremendous amount of zinc (similar to 1-3 mg zinc/day) from maternal circulation into milk during lactation to support the growth and development of the offspring. When this process is compromised, severe zinc deficiency compromises neuronal development and immune function and increases infant morbidity and/or mortality. It remains unclear as to how the lactating mammary gland dynamically integrates zinc import from maternal circulation with the enormous amount of zinc that is secreted into milk. Methodology/Principal Findings: Herein we utilized X-ray fluorescence microscopy (XFM) which allowed for the visualization and quantification of the process of zinc transfer through the mammary gland of the lactating mouse. Our data illustrate that a large amount of zinc first accumulates in the mammary gland during lactation. Interestingly, this zinc is not cytosolic, but accumulated in large, discrete sub-cellular compartments. These zinc pools were then redistributed to small intracellular vesicles destined for secretion in a prolactin-responsive manner. Confocal microscopy identified mitochondria and the Golgi apparatus as the sub-cellular compartments which accumulate zinc; however, zinc pools in the Golgi apparatus, but not mitochondria are redistributed to vesicles destined for secretion during lactation. Conclusions/Significance: Our data directly implicate the Golgi apparatus in providing a large, mobilizable zinc storage pool to assist in providing for the tremendous amount of zinc that is secreted into milk. Interestingly, our study also provides compelling evidence that mitochondrial zinc pools expand in the mammary gland during lactation which we speculate may play a role in regulating mammary gland function.	[McCormick, Nicholas; Velasquez, Vanessa; Kelleher, Shannon L.] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Finney, Lydia; Vogt, Stefan] Argonne Natl Lab, Argonne, IL 60439 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Energy (DOE); Argonne National Laboratory	McCormick, N (corresponding author), Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA.	slk39@psu.edu	Vogt, Stefan/B-9547-2009; Vogt, Stefan/J-7937-2013	Vogt, Stefan/0000-0002-8034-5513; Vogt, Stefan/0000-0002-8034-5513	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357, HD058614]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058614] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Use of the Advanced Photon Source at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357 and HD058614 to SLK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKLAND ML, 1992, J NUTR, V122, P1214, DOI 10.1093/jn/122.6.1214; Besecker B, 2008, AM J PHYSIOL-LUNG C, V294, pL1127, DOI 10.1152/ajplung.00057.2008; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Bratter P, 1997, J TRACE ELEM MED BIO, V11, P203; CAVALETTO M, 2008, MILK FAT GLOBULE MEM, P129; Cerveza PJ, 2000, ARCH BIOCHEM BIOPHYS, V373, P451, DOI 10.1006/abbi.1999.1572; Chi ZH, 2006, NEUROREPORT, V17, P1807, DOI 10.1097/01.wnr.0000239968.06438.c5; Conesa C, 2008, COMP BIOCHEM PHYS B, V150, P131, DOI 10.1016/j.cbpb.2008.02.005; Cooke PS, 2004, TOXICOL APPL PHARM, V194, P309, DOI 10.1016/j.taap.2003.09.016; Costello LC, 2005, MITOCHONDRION, V5, P143, DOI 10.1016/j.mito.2005.02.001; Costello LC, 2000, J INORG BIOCHEM, V78, P161, DOI 10.1016/S0162-0134(99)00225-1; Danscher G, 2005, J HISTOCHEM CYTOCHEM, V53, P141, DOI 10.1369/jhc.4R6460.2005; Dittmer PJ, 2009, J BIOL CHEM, V284, P16289, DOI 10.1074/jbc.M900501200; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; EIDE DJ, 2003, SLC39 FAMILY METAL I; Finney L, 2007, P NATL ACAD SCI USA, V104, P2247, DOI 10.1073/pnas.0607238104; FLINT DJ, 1994, ENDOCRINOLOGY, V135, P1119, DOI 10.1210/en.135.3.1119; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Guan ZX, 2003, J INORG BIOCHEM, V97, P199, DOI 10.1016/S0162-0134(03)00291-5; HISAYASU S, 1991, INT J HEMATOL, V54, P201; Hoac T, 2007, J AGR FOOD CHEM, V55, P4237, DOI 10.1021/jf070169x; Huang L, 2007, J BIOL CHEM, V282, P37053, DOI 10.1074/jbc.M706631200; Huang LP, 2002, J BIOL CHEM, V277, P26389, DOI 10.1074/jbc.M200462200; Inoue K, 2002, HUM MOL GENET, V11, P1775, DOI 10.1093/hmg/11.15.1775; Jahn GA, 1997, BIOL REPROD, V57, P894, DOI 10.1095/biolreprod57.4.894; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Kelleher SL, 2009, GENES NUTR, V4, P83, DOI 10.1007/s12263-009-0119-4; Kelleher SL, 2005, AM J PHYSIOL-CELL PH, V288, pC1042, DOI 10.1152/ajpcell.00471.2004; KELLEHER SL, 2009, NUTR TRANSFER MAMMAR, P15; Kirschke CP, 2003, J BIOL CHEM, V278, P4096, DOI 10.1074/jbc.M207644200; Leong WI, 2005, AM J CLIN NUTR, V81, P445; Leong WI, 2003, AM J PHYSIOL-GASTR L, V285, pG1153, DOI 10.1152/ajpgi.00107.2003; LINZELL JL, 1975, J PHYSIOL-LONDON, V253, P547, DOI 10.1113/jphysiol.1975.sp011206; Liu Y, 1997, PROSTATE, V30, P26, DOI 10.1002/(SICI)1097-0045(19970101)30:1<26::AID-PROS4>3.0.CO;2-J; Lopez V, 2009, BIOCHEM J, V422, P43, DOI 10.1042/BJ20081189; Matsuki N, 2005, J MEMBRANE BIOL, V203, P119, DOI 10.1007/s00232-005-0736-9; Matsuura W, 2009, BIOSCI BIOTECH BIOCH, V73, P1142, DOI 10.1271/bbb.80910; Michalczyk AA, 2002, BIOCHEM J, V364, P105, DOI 10.1042/bj3640105; MICHALKE B, 1991, J TRACE ELEM ELECT H, V5, P251; Ortega R, 2009, TOXICOL LETT, V188, P26, DOI 10.1016/j.toxlet.2009.02.024; PALMITER RD, 2003, ABC SOLUTE CARRIERS; Qian LX, 2009, AM J PHYSIOL-CELL PH, V297, pC369, DOI 10.1152/ajpcell.00589.2008; Rofe AM, 1999, PANCREAS, V19, P69, DOI 10.1097/00006676-199907000-00011; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sensi SL, 2002, NEUROBIOL DIS, V10, P100, DOI 10.1006/nbdi.2002.0493; Seve M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-32; Shennan DB, 2000, PHYSIOL REV, V80, P925, DOI 10.1152/physrev.2000.80.3.925; Sorensen MB, 1997, PROSTATE, V31, P125, DOI 10.1002/(SICI)1097-0045(19970501)31:2<125::AID-PROS8>3.0.CO;2-M; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Taylor KM, 2008, BIOCHEM SOC T, V36, P1247, DOI 10.1042/BST0361247; Wellenreuther G, 2009, BIOCHEM BIOPH RES CO, V380, P198, DOI 10.1016/j.bbrc.2009.01.074; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676; Yamaguchi S, 2009, P NATL ACAD SCI USA, V106, P10859, DOI 10.1073/pnas.0900602106	53	49	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11078	10.1371/journal.pone.0011078	http://dx.doi.org/10.1371/journal.pone.0011078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552032	gold, Green Submitted, Green Published			2022-12-27	WOS:000278662900018
J	Samsonovic, AV; Ascoli, GA				Samsonovic, Alexei V.; Ascoli, Giorgio A.			Principal Semantic Components of Language and the Measurement of Meaning	PLOS ONE			English	Article							MODEL	Metric systems for semantics, or semantic cognitive maps, are allocations of words or other representations in a metric space based on their meaning. Existing methods for semantic mapping, such as Latent Semantic Analysis and Latent Dirichlet Allocation, are based on paradigms involving dissimilarity metrics. They typically do not take into account relations of antonymy and yield a large number of domain-specific semantic dimensions. Here, using a novel self-organization approach, we construct a low-dimensional, context-independent semantic map of natural language that represents simultaneously synonymy and antonymy. Emergent semantics of the map principal components are clearly identifiable: the first three correspond to the meanings of "good/bad" (valence), "calm/excited" (arousal), and "open/closed" (freedom), respectively. The semantic map is sufficiently robust to allow the automated extraction of synonyms and antonyms not originally in the dictionaries used to construct the map and to predict connotation from their coordinates. The map geometric characteristics include a limited number (similar to 4) of statistically significant dimensions, a bimodal distribution of the first component, increasing kurtosis of subsequent (unimodal) components, and a U-shaped maximum-spread planar projection. Both the semantic content and the main geometric features of the map are consistent between dictionaries (Microsoft Word and Princeton's WordNet), among Western languages (English, French, German, and Spanish), and with previously established psychometric measures. By defining the semantics of its dimensions, the constructed map provides a foundational metric system for the quantitative analysis of word meaning. Language can be viewed as a cumulative product of human experiences. Therefore, the extracted principal semantic dimensions may be useful to characterize the general semantic dimensions of the content of mental states. This is a fundamental step toward a universal metric system for semantics of human experiences, which is necessary for developing a rigorous science of the mind.	[Samsonovic, Alexei V.; Ascoli, Giorgio A.] George Mason Univ, Krasnow Inst Adv Study, Ctr Neural Informat, Struct & Plast & Mol Neurosci Dept, Fairfax, VA 22030 USA	George Mason University	Samsonovic, AV (corresponding author), George Mason Univ, Krasnow Inst Adv Study, Ctr Neural Informat, Struct & Plast & Mol Neurosci Dept, Fairfax, VA 22030 USA.	ascoli@gmu.edu	Samsonovich, Alexei/M-5778-2016	Samsonovich, Alexei/0000-0003-4788-4408	Defense Advanced Research Projects Agency Information Processing Techniques Office Biologically-Inspired Cognitive Architectures	Defense Advanced Research Projects Agency Information Processing Techniques Office Biologically-Inspired Cognitive Architectures	This work was partially supported by the Defense Advanced Research Projects Agency Information Processing Techniques Office Biologically-Inspired Cognitive Architectures grant "Integrated Self-Aware Cognitive Architecture". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albus JS, 2007, SCIENCE, V317, P1321; Ascoli GA, 2008, BIOL BULL-US, V215, P204, DOI 10.2307/25470706; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Bo Pang, 2008, Foundations and Trends in Information Retrieval, V2, P1, DOI 10.1561/1500000001; BRADLEY MM, 1999, C1 U FL; Burgess C, 1997, LANG COGNITIVE PROC, V12, P177, DOI 10.1080/016909697386844; Chalmers KA, 1997, MEM COGNITION, V25, P780, DOI 10.3758/BF03211321; Clark JM, 2004, BEHAV RES METH INS C, V36, P371, DOI 10.3758/BF03195584; Cox R. F., 1994, MULTIDIMENSIONAL SCA; Cruse D., 1986, LEXICAL SEMANTICS; Deese J., 1965, STRUCTURE ASS LANGUA; Doxas I., 2007, P 29 ANN COGN SCI SO, P227; Egan Rose F., 1984, WEBSTERS NEW DICT SY, p5a; Fauconnier Gilles., 1994, MENTAL SPACES; Fellbaum Christiane, 1998, WORDNET ELECT DATABA; Frankl V., 1992, MANS SEARCH MEANING; Gardenfors P., 2004, CONCEPTUAL SPACES GE; GRAY WD, SERIES COGNITIVE MOD; Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101; Hardoon DR, 2004, NEURAL COMPUT, V16, P2639, DOI 10.1162/0899766042321814; Horowitz L.M., 2004, INTERPERSONAL FDN PS; Jones S, 2002, ANTONYMY CORPUS BASE; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Landauer TK, 2013, HDB LATENT SEMANTIC; Lang PJ, 1998, J CLIN NEUROPHYSIOL, V15, P397, DOI 10.1097/00004691-199809000-00004; Leary T., 1957, INTERPERSONAL DIAGNO; Leech G, 2001, WORD FREQUENCIES WRI; LEHRER A, 1982, LINGUIST PHILOS, V5, P483, DOI 10.1007/BF00355584; Likert R, 1932, ARCH PSYCHOL, V22, P55, DOI DOI 10.4135/9781412961288.N454; LVOV MR, 2006, DICT ANTONYMS RUSSIA; Murphy M.L., 2003, SEMANTIC RELATIONS L; Osgood C.E., 1975, CROSS CULTURAL UNIVE; Osgood C.E., 1957, MEASUREMENT MEANING; Parkin A. J., 1993, MEMORY PHENOMENA EXP; Ploux S, 2003, COMPUT LINGUIST, V29, P155, DOI 10.1162/089120103322145298; RITTER H, 1989, BIOL CYBERN, V61, P241, DOI 10.1007/BF00203171; Roget PM, 1852, ROGETS THESAURUS ENG; RUBIN DC, 1980, J VERB LEARN VERB BE, V19, P736, DOI 10.1016/S0022-5371(80)90415-6; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Samsonovich A.V., 2007, ADV ARTIFICIAL GEN I, P111; Samsonovich AV, 2010, COMPLEXITY, V15, P12, DOI 10.1002/cplx.20293; SAVIKAS A, 2005, WORD HACKS TIPS TOOL; SCHWAB D, 2002, P COLING 2002 19 INT, V2, P904; SPITZER M, 2008, PHILOS ETHICS HUMANI, V20, P3; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319	47	25	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e10921	10.1371/journal.pone.0010921	http://dx.doi.org/10.1371/journal.pone.0010921			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	609NG	20552009	Green Submitted, Green Published, gold			2022-12-27	WOS:000278662900002
J	Bang, C; Sabo, JL; Faeth, SH				Bang, Christofer; Sabo, John L.; Faeth, Stanley H.			Reduced Wind Speed Improves Plant Growth in a Desert City	PLOS ONE			English	Article							URBAN HEAT-ISLAND; ENCELIA-FARINOSA; BOUNDARY-LAYER; MECHANICAL STIMULI; SPECIES RICHNESS; SONORAN DESERT; BIOMASS; TEMPERATURE; PUBESCENCE; SHRUB	Background: The often dramatic effects of urbanization on community and ecosystem properties, such as primary productivity, abundances, and diversity are now well-established. In most cities local primary productivity increases and this extra energy flows upwards to alter diversity and relative abundances in higher trophic levels. The abiotic mechanisms thought to be responsible for increases in urban productivity are altered temperatures and light regimes, and increased nutrient and water inputs. However, another abiotic factor, wind speed, is also influenced by urbanization and well known for altering primary productivity in agricultural systems. Wind effects on primary productivity have heretofore not been studied in the context of urbanization. Methodology/Principal Findings: We designed a field experiment to test if increased plant growth often observed in cities is explained by the sheltering effects of built structures. Wind speed was reduced by protecting Encelia farinosa (brittlebush) plants in urban, desert remnant and outlying desert localities via windbreaks while controlling for water availability and nutrient content. In all three habitats, we compared E. farinosa growth when protected by experimental windbreaks and in the open. E. farinosa plants protected against ambient wind in the desert and remnant areas grew faster in terms of biomass and height than exposed plants. As predicted, sheltered plants did not differ from unprotected plants in urban areas where wind speed is already reduced. Conclusion/Significance: Our results indicate that reductions in wind speed due to built structures in cities contribute to increased plant productivity and thus also to changes in abundances and diversity of higher trophic levels. Our study emphasizes the need to incorporate wind speed in future urban ecological studies, as well as in planning for green space and sustainable cities.	[Bang, Christofer] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Sabo, John L.] Arizona State Univ, Fac Ecol Evolut & Environm Sci, Sch Life Sci, Tempe, AZ USA; [Faeth, Stanley H.] Univ N Carolina, Greensboro, NC 27412 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of North Carolina; University of North Carolina Greensboro	Bang, C (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	christofer.bang@gmail.com	Bang, Christofer/I-5732-2012		National Science Foundation (NSF) [DEB-0423704, DEB 0444228]; Central Arizona - Phoenix Long-Term Ecological Research (CAP LTER); Division Of Environmental Biology [1026865] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Central Arizona - Phoenix Long-Term Ecological Research (CAP LTER); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This material is based upon work supported by the National Science Foundation (NSF) under Grant No. DEB-0423704, Central Arizona - Phoenix Long-Term Ecological Research (CAP LTER) and NSF DEB 0444228 to SHF and JLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APHALO PJ, 1993, PLANT CELL ENVIRON, V16, P771, DOI 10.1111/j.1365-3040.1993.tb00499.x; Baker Lawrence A., 2002, Urban Ecosystems, V6, P183, DOI 10.1023/A:1026101528700; Bejaran RA, 2003, THEOR APPL CLIMATOL, V74, P93, DOI 10.1007/s00704-002-0714-4; BROWN MA, 1910, P IOWA ACAD SCI, V17, P13; Cardskadden H, 1998, J ENVIRON MANAGE, V52, P183, DOI 10.1006/jema.1997.0170; CHANGNON SA, 1992, B AM METEOROL SOC, V73, P619, DOI 10.1175/1520-0477(1992)073<0619:IWMIUA>2.0.CO;2; Cleugh HA, 1998, AGROFOREST SYST, V41, P85, DOI 10.1023/A:1006067721039; Colding J, 2007, LANDSCAPE URBAN PLAN, V81, P46, DOI 10.1016/j.landurbplan.2006.10.016; Coutand C, 2008, ANN BOT-LONDON, V101, P1421, DOI 10.1093/aob/mcn054; Daudet FA, 1999, AGR FOREST METEOROL, V97, P171, DOI 10.1016/S0168-1923(99)00079-9; EHLERINGER J, 1982, AM J BOT, V69, P670, DOI 10.2307/2442956; EHLERINGER JR, 1978, OECOLOGIA, V36, P151, DOI 10.1007/BF00349805; EHLERINGER JR, 1978, OECOLOGIA, V37, P183, DOI 10.1007/BF00344990; Ellis AW, 2000, CLIMATE RES, V15, P13, DOI 10.3354/cr015013; Ennos AR, 1997, TRENDS ECOL EVOL, V12, P108, DOI 10.1016/S0169-5347(96)10066-5; Faeth SH, 2005, BIOSCIENCE, V55, P399, DOI 10.1641/0006-3568(2005)055[0399:TDIUC]2.0.CO;2; Fernandez P, 2007, BASIC APPL ECOL, V8, P97, DOI 10.1016/j.baae.2006.05.001; FINNELL H. H., 1928, JOUR AMER SOC AGRON, V20, P1206; Gaston KJ, 2005, BIODIVERS CONSERV, V14, P3327, DOI 10.1007/s10531-004-9513-9; Gedge D., 2005, BIOLOGIST, V52, P161; Gilbert O.L., 1989, ECOLOGY URBAN HABITA; Gober P., 2006, METROPOLITAN PHOENIX, DOI DOI 10.9783/9780812205824; Goyal P, 2002, ATMOS ENVIRON, V36, P2071, DOI 10.1016/S1352-2310(01)00458-7; Gregg JW, 2003, NATURE, V424, P183, DOI 10.1038/nature01728; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hodges L, 2004, HORTSCIENCE, V39, P996, DOI 10.21273/HORTSCI.39.5.996; Housman DC, 2002, AM J BOT, V89, P1303, DOI 10.3732/ajb.89.8.1303; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; JAFFE MJ, 1980, BIOSCIENCE, V30, P239, DOI 10.2307/1307878; Jongejans E, 2006, OECOLOGIA, V147, P369, DOI 10.1007/s00442-005-0325-8; Kaye JP, 2006, TRENDS ECOL EVOL, V21, P192, DOI 10.1016/j.tree.2005.12.006; KUNZE A, 1995, BIOCHEM SYST ECOL, V23, P355, DOI 10.1016/0305-1978(95)00028-S; Kuttler W., 2008, URBAN ECOLOGY INT PE, P233, DOI [10.1007/978-0-387-73412-5_13, DOI 10.1007/978-0-387-73412-5_13]; LANDSBERG HE, 1970, SCIENCE, V170, P1265, DOI 10.1126/science.170.3964.1265; LEE DO, 1979, ATMOS ENVIRON, V13, P1175, DOI 10.1016/0004-6981(79)90042-8; Lee SH, 2010, THEOR APPL CLIMATOL, V100, P227, DOI 10.1007/s00704-009-0247-1; Lewis DB, 2006, GLOBAL CHANGE BIOL, V12, P703, DOI 10.1111/j.1365-2486.2006.01126.x; Li F, 2008, EUR PHYS J D, V50, P75, DOI 10.1140/epjd/e2008-00201-5; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.2307/3868314; MALIK MNA, 1981, AUST J PLANT PHYSIOL, V8, P285, DOI 10.1071/PP9810285; Martin CA, 2002, J ARID ENVIRON, V51, P235, DOI 10.1006/jare.2001.0946; MARTIN E. V., 1935, PLANT PHYSIOL, V10, P613, DOI 10.1104/pp.10.4.613; McGranahan G, 2005, MILLENNIUM ECOSYSTEM, V1; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Miao SG, 2009, ADV ATMOS SCI, V26, P1115, DOI 10.1007/s00376-009-7223-7; Miao SG, 2009, J APPL METEOROL CLIM, V48, P484, DOI 10.1175/2008JAMC1909.1; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; MOEN AN, 1974, ECOLOGY, V55, P1420, DOI 10.2307/1935471; MONSON RK, 1992, FUNCT ECOL, V6, P751, DOI 10.2307/2389973; MOONEY HA, 1976, SCIENCE, V194, P322, DOI 10.1126/science.194.4262.322; Morris CJG, 2001, J APPL METEOROL, V40, P169, DOI 10.1175/1520-0450(2001)040<0169:QOTIOW>2.0.CO;2; MURRAY RB, 1982, J RANGE MANAGE, V35, P451, DOI 10.2307/3898603; Nobel PS, 1997, ANN BOT-LONDON, V80, P731, DOI 10.1006/anbo.1997.0508; Nobel PS, 1998, PHOTOSYNTH RES, V56, P67, DOI 10.1023/A:1006079631961; NOWAK DJ, 1993, J ENVIRON MANAGE, V37, P207, DOI 10.1006/jema.1993.1017; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Pataki DE, 2006, GLOBAL CHANGE BIOL, V12, P2092, DOI 10.1111/j.1365-2486.2006.01242.x; Pickett STA, 2001, ANNU REV ECOL SYST, V32, P127, DOI 10.1146/annurev.ecolsys.32.081501.114012; RAO V. PANDURANGA, 1938, BULL TORREY BOT CLUB, V65, P229, DOI 10.2307/2480924; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Russell G., 1978, J APPL ECOL, V16, P507; Sandquist DR, 2003, AM J BOT, V90, P1481, DOI 10.3732/ajb.90.10.1481; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Snep R, 2009, LANDSCAPE URBAN PLAN, V91, P26, DOI 10.1016/j.landurbplan.2008.11.007; Stopa-Boryczka M, 1990, URBAN ECOLOGICAL STU, P26; Turbill C, 2008, J ZOOL, V276, P285, DOI 10.1111/j.1469-7998.2008.00487.x; UN, 2008, WORLD URB PROSP 2007; Van der Veken S, 2004, FLORA, V199, P516, DOI 10.1078/0367-2530-00180; von Stulpnagel A., 1990, URBAN ECOL, P175; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; WHITEHEAD F. H., 1962, NEW PHYTOL, V61, P59, DOI 10.1111/j.1469-8137.1962.tb06274.x; Wilcock C, 2002, TRENDS PLANT SCI, V7, P270, DOI 10.1016/S1360-1385(02)02258-6; Williams NSG, 2009, J ECOL, V97, P4, DOI 10.1111/j.1365-2745.2008.01460.x; Wilson JD, 2003, BOUND-LAY METEOROL, V109, P191, DOI 10.1023/A:1025414805676; ZHANG HH, 1995, AUST J PLANT PHYSIOL, V22, P833, DOI 10.1071/PP9950833	76	32	34	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11061	10.1371/journal.pone.0011061	http://dx.doi.org/10.1371/journal.pone.0011061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548790	Green Published, gold			2022-12-27	WOS:000278599600018
J	Kita, Y; Gunji, A; Sakihara, K; Inagaki, M; Kaga, M; Nakagawa, E; Hosokawa, T				Kita, Yosuke; Gunji, Atsuko; Sakihara, Kotoe; Inagaki, Masumi; Kaga, Makiko; Nakagawa, Eiji; Hosokawa, Toru			Scanning Strategies Do Not Modulate Face Identification: Eye-Tracking and Near-Infrared Spectroscopy Study	PLOS ONE			English	Article							OXYGENATED HEMOGLOBIN; PREFRONTAL CORTEX; UNFAMILIAR FACES; OWN FACE; SELF; RECOGNITION; AUTISM; FIXATION; FAMILIAR; CHILDREN	Background: During face identification in humans, facial information is sampled (seeing) and handled (processing) in ways that are influenced by the kind of facial image type, such as a self-image or an image of another face. However, the relationship between seeing and information processing is seldom considered. In this study, we aimed to reveal this relationship using simultaneous eye-tracking measurements and near-infrared spectroscopy (NIRS) in face identification tasks. Methodology/Principal Findings: 22 healthy adult subjects (8 males and 14 females) were shown facial morphing movies in which an initial facial image gradually changed into another facial image (that is, the subject's own face was changed to a familiar face). The fixation patterns on facial features were recorded, along with changes in oxyhemoglobin (oxyHb) levels in the frontal lobe, while the subjects identified several faces. In the self-face condition (self-face as the initial image), hemodynamic activity around the right inferior frontal gyrus (IFG) was significantly greater than in the familiar-face condition. On the other hand, the scanning strategy was similar in almost all conditions with more fixations on the eyes and nose than on other areas. Fixation time on the eye area did not correlate with changes in oxyHb levels, and none of the scanning strategy indices could estimate the hemodynamic changes. Conclusions/Significance: We conclude that hemodynamic activity, i.e., the means of processing facial information, is not always modulated by the face-scanning strategy, i.e., the way of seeing, and that the right IFG plays important roles in both self-other facial discrimination and self-evaluation.	[Kita, Yosuke; Hosokawa, Toru] Tohoku Univ, Grad Sch Educ, Sendai, Miyagi 980, Japan; [Kita, Yosuke] Japan Soc Promot Sci, Tokyo, Japan; [Kita, Yosuke; Gunji, Atsuko; Sakihara, Kotoe; Inagaki, Masumi; Kaga, Makiko] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Dev Disorders, Tokyo, Japan; [Nakagawa, Eiji] Natl Ctr Hosp Neurol & Psychiat, Natl Ctr Neurol & Psychiat, Dept Child Neurol, Tokyo, Japan	Tohoku University; Japan Society for the Promotion of Science; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan	Kita, Y (corresponding author), Tohoku Univ, Grad Sch Educ, Sendai, Miyagi 980, Japan.	kitay@ncnp.go.jp	Gunji, Atsuko/O-6323-2014	Gunji, Atsuko/0000-0001-8908-8739	Japan Society for the Promotion of Science (JSPS) [20-8503]; Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [4002]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The study was supported in part by a Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for the JSPS research fellows (20-8503 to YK) and a Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) Grant-in-Aid for Scientific Research on Innovative Areas (4002 to Ryusuke Kakigi and MI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff RR, 1999, J EXP PSYCHOL LEARN, V25, P997, DOI 10.1037/0278-7393.25.4.997; AMSTERDAM B, 1972, DEV PSYCHOBIOL, V5, P297, DOI 10.1002/dev.420050403; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Bookheimer SY, 2008, J INT NEUROPSYCH SOC, V14, P922, DOI 10.1017/S135561770808140X; Bredart S, 2006, Q J EXP PSYCHOL, V59, P46, DOI 10.1080/17470210500343678; BRUCE V, 1982, BRIT J PSYCHOL, V73, P105, DOI 10.1111/j.2044-8295.1982.tb01795.x; Bushnell I.W.R., 1998, DEV SENSORY MOTOR CO, P69; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Devue C, 2007, BRAIN RES, V1143, P169, DOI 10.1016/j.brainres.2007.01.055; Devue C, 2009, COGNITION, V111, P114, DOI 10.1016/j.cognition.2009.01.003; Druzgal TJ, 2001, NEURON, V32, P947, DOI 10.1016/S0896-6273(01)00519-0; ELLIS HD, 1979, PERCEPTION, V8, P431, DOI 10.1068/p080431; FIELD TM, 1984, INFANT BEHAV DEV, V7, P19, DOI 10.1016/S0163-6383(84)80019-3; Fukui Y, 2003, APPL OPTICS, V42, P2881, DOI 10.1364/AO.42.002881; Gruter T, 2008, J NEUROPSYCHOL, V2, P79, DOI 10.1348/174866407X231001; Gunji A, 2009, BRAIN DEV-JPN, V31, P139, DOI 10.1016/j.braindev.2008.04.011; HAITH MM, 1977, SCIENCE, V198, P853, DOI 10.1126/science.918670; Kawakubo Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006881; Keenan JP, 2000, NEUROPSYCHOLOGIA, V38, P1047, DOI 10.1016/S0028-3932(99)00145-1; Kircher TTJ, 2000, COGNITIVE BRAIN RES, V10, P133, DOI 10.1016/S0926-6410(00)00036-7; Kircher TTJ, 2001, COGNITION, V78, pB1, DOI 10.1016/S0010-0277(00)00104-9; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Leon-Carrion J, 2008, BEHAV BRAIN RES, V193, P248, DOI 10.1016/j.bbr.2008.06.013; Marumo K, 2009, NEUROSCI RES, V63, P89, DOI 10.1016/j.neures.2008.10.012; Matsuda G, 2006, NEUROIMAGE, V29, P706, DOI 10.1016/j.neuroimage.2005.08.019; Morris JP, 2007, SOC COGN AFFECT NEUR, V2, P31, DOI 10.1093/scan/nsl023; Morris JP, 2007, HUM BRAIN MAPP, V28, P691, DOI 10.1002/hbm.20301; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Platek SM, 2004, COGNITIVE BRAIN RES, V19, P114, DOI 10.1016/j.cogbrainres.2003.11.014; Platek SM, 2008, BRAIN RES, V1232, P173, DOI 10.1016/j.brainres.2008.07.010; Sadato N, 2008, BRAIN IMAGING BEHAV, V2, P335, DOI 10.1007/s11682-008-9044-1; Sadr J, 2003, PERCEPTION, V32, P285, DOI 10.1068/p5027; Schmitz TW, 2004, NEUROIMAGE, V22, P941, DOI 10.1016/j.neuroimage.2004.02.018; Stacey PC, 2005, BRIT J PSYCHOL, V96, P407, DOI 10.1348/000712605X47422; Sugiura M, 2006, NEUROIMAGE, V32, P1905, DOI 10.1016/j.neuroimage.2006.05.026; Tong F, 1999, J EXP PSYCHOL HUMAN, V25, P1016, DOI 10.1037/0096-1523.25.4.1016; Toyoda H, 2008, NEUROIMAGE, V39, P997, DOI 10.1016/j.neuroimage.2007.09.053; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; van der Geest JN, 2002, J CHILD PSYCHOL PSYC, V43, P669, DOI 10.1111/1469-7610.00055; Vogeley K, 1999, CONSCIOUS COGN, V8, P343, DOI 10.1006/ccog.1999.0394; YOUNG AW, 1985, PERCEPTION, V14, P737, DOI 10.1068/p140737	42	24	24	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11050	10.1371/journal.pone.0011050	http://dx.doi.org/10.1371/journal.pone.0011050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608QA	20548791	Green Published, Green Submitted, gold			2022-12-27	WOS:000278599600011
J	Niida, A; Imoto, S; Yamaguchi, R; Nagasaki, M; Miyano, S				Niida, Atsushi; Imoto, Seiya; Yamaguchi, Rui; Nagasaki, Masao; Miyano, Satoru			Gene Set-Based Module Discovery Decodes cis-Regulatory Codes Governing Diverse Gene Expression across Human Multiple Tissues	PLOS ONE			English	Article							ELEMENTS; MOTIFS; MOUSE	Decoding transcriptional programs governing transcriptomic diversity across human multiple tissues is a major challenge in bioinformatics. To address this problem, a number of computational methods have focused on cis-regulatory codes driving overexpression or underexpression in a single tissue as compared to others. On the other hand, we recently proposed a different approach to mine cis-regulatory codes: starting from gene sets sharing common cis-regulatory motifs, the method screens for expression modules based on expression coherence. However, both approaches seem to be insufficient to capture transcriptional programs that control gene expression in a subset of all samples. Especially, this limitation would be serious when analyzing multiple tissue data. To overcome this limitation, we developed a new module discovery method termed BEEM (Biclusering-based Extraction of Expression Modules) in order to discover expression modules that are functional in a subset of tissues. We showed that, when applied to expression profiles of human multiple tissues, BEEM finds expression modules missed by two existing approaches that are based on the coherent expression and the single tissue-specific differential expression. From the BEEM results, we obtained new insights into transcriptional programs controlling transcriptomic diversity across various types of tissues. This study introduces BEEM as a powerful tool for decoding regulatory programs from a compendium of gene expression profiles.	[Niida, Atsushi; Imoto, Seiya; Yamaguchi, Rui; Nagasaki, Masao; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan	University of Tokyo	Niida, A (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan.	aniida@ims.u-tokyo.ac.jp		Miyano, Satoru/0000-0002-1753-6616; Nagasaki, Masao/0000-0002-4292-8785	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Grant-in-Aid for the Global COE Program "Center of Education and Research for the Advanced Genome-Based Medicine" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1932, STAT METHODS RES WOR; Bergmann S, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031902; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Cheng Y., 2000, P 8 INT C INT SYST M, P93; Jakt LM, 2001, GENOME RES, V11, P112, DOI 10.1101/gr.148301; Kim SY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-330; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Niida Atsushi, 2010, V22, P121; Niida A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-71; Pennacchio LA, 2007, GENOME RES, V17, P201, DOI 10.1101/gr.5972507; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Smith AD, 2006, P NATL ACAD SCI USA, V103, P6275, DOI 10.1073/pnas.0508169103; Smith AD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100114; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136	19	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e10910	10.1371/journal.pone.0010910	http://dx.doi.org/10.1371/journal.pone.0010910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20544005	Green Published, gold, Green Submitted			2022-12-27	WOS:000278557600002
J	Arab, HH; Wani, G; Ray, A; Shah, ZI; Zhu, QZ; Wani, AA				Arab, Hany H.; Wani, Gulzar; Ray, Alo; Shah, Zubair I.; Zhu, Qianzheng; Wani, Altaf A.			Dissociation of CAK from Core TFIIH Reveals a Functional Link between XP-G/CS and the TFIIH Disassembly State	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; RNA-POLYMERASE-II; TRANSCRIPTION-COUPLED REPAIR; CYCLOBUTANE PYRIMIDINE DIMERS; COCKAYNE-SYNDROME; DNA-REPAIR; IN-VIVO; XERODERMA-PIGMENTOSUM; HUMAN-CELLS; INDUCED UBIQUITINATION	Transcription factor II H (TFIIH) is comprised of core TFIIH and Cdk-activating kinase (CAK) complexes. Here, we investigated the molecular and cellular manifestation of the TFIIH compositional changes by XPG truncation mutations. We showed that both core TFIIH and CAK are rapidly recruited to damage sites in repair-proficient cells. Chromatin immunoprecipitation against TFIIH and CAK components revealed a physical engagement of CAK in nucleotide excision repair (NER). While XPD recruitment to DNA damage was normal, CAK was not recruited in severe XP-G and XP-G/CS cells, indicating that the associations of CAK and XPD to core TFIIH are differentially affected. A CAK inhibition approach showed that CAK activity is not required for assembling pre-incision machinery in vivo or for removing genomic photolesions. Instead, CAK is involved in Ser5-phosphorylation and UV-induced degradation of RNA polymerase II. The CAK inhibition impaired transcription from undamaged and UV-damaged reporter, and partially decreased transcription of p53-dependent genes. The overall results demonstrated that a) XP-G/CS mutations affect the disassembly state of TFIIH resulting in the dissociation of CAK, but not XPD from core TFIIH, and b) CAK activity is not essential for global genomic repair but involved in general transcription and damage-induced RNA polymerase II degradation.	[Arab, Hany H.; Wani, Gulzar; Ray, Alo; Zhu, Qianzheng; Wani, Altaf A.] Ohio State Univ, Dept Radiol, Columbus, OH 43210 USA; [Wani, Altaf A.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Shah, Zubair I.; Wani, Altaf A.] Ohio State Univ, James Canc Hosp, Columbus, OH 43210 USA; [Shah, Zubair I.; Wani, Altaf A.] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA; [Wani, Altaf A.] King Saud Univ, Coll Sci, Riyadh 11451, Saudi Arabia	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; King Saud University	Arab, HH (corresponding author), Ohio State Univ, Dept Radiol, Columbus, OH 43210 USA.	zhu.49@osu.edu; wani.2@osu.edu	Zhu, Qianzheng/A-4902-2013; Arab, Hany/AAF-3652-2020	Arab, Hany/0000-0002-4195-6901	National Institute of Environmental Health Sciences [ES2388, ES12991]; National Cancer Institute [CA93413]; NATIONAL CANCER INSTITUTE [R01CA093413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002388, R01ES012991] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is supported by Public Health Service Grants ES2388 and ES12991 from National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/) and CA93413 from National Cancer Institute (http://www.cancer.gov/) to AAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Andressoo JO, 2005, ADV EXP MED BIOL, V570, P45, DOI 10.1007/1-4020-3764-3_3; Araujo SJ, 2000, GENE DEV, V14, P349; Balajee AS, 1997, P NATL ACAD SCI USA, V94, P4306, DOI 10.1073/pnas.94.9.4306; Bradsher J, 2000, J BIOL CHEM, V275, P2532, DOI 10.1074/jbc.275.4.2532; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Clarkson SG, 2003, BIOCHIMIE, V85, P1113, DOI 10.1016/j.biochi.2003.10.014; Coin F, 1998, COLD SPRING HARB SYM, V63, P105, DOI 10.1101/sqb.1998.63.105; Coin F, 1999, EMBO J, V18, P1357, DOI 10.1093/emboj/18.5.1357; Coin F, 2008, MOL CELL, V31, P9, DOI 10.1016/j.molcel.2008.04.024; Dubaele S, 2003, MOL CELL, V11, P1635, DOI 10.1016/S1097-2765(03)00182-5; Dunand-Sauthier I, 2005, J BIOL CHEM, V280, P7030, DOI 10.1074/jbc.M412228200; El-Mahdy MA, 2006, J BIOL CHEM, V281, P13404, DOI 10.1074/jbc.M511834200; Escargueil AE, 2008, J CELL SCI, V121, P1275, DOI 10.1242/jcs.023259; Evans E, 1997, EMBO J, V16, P625, DOI 10.1093/emboj/16.3.625; Evans E, 1997, EMBO J, V16, P6559, DOI 10.1093/emboj/16.21.6559; FEAVER WJ, 1994, CELL, V79, P1103, DOI 10.1016/0092-8674(94)90040-X; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Gervais V, 2004, NAT STRUCT MOL BIOL, V11, P616, DOI 10.1038/nsmb782; Giglia-Mari G, 2004, NAT GENET, V36, P714, DOI 10.1038/ng1387; Giglia-Mari G, 2006, PLOS BIOL, V4, P952, DOI 10.1371/journal.pbio.0040156; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; Hohl M, 2007, NUCLEIC ACIDS RES, V35, P3053, DOI 10.1093/nar/gkm092; Hoogstraten D, 2002, MOL CELL, V10, P1163, DOI 10.1016/S1097-2765(02)00709-8; Ito S, 2007, MOL CELL, V26, P231, DOI 10.1016/j.molcel.2007.03.013; Iyer N, 1996, BIOCHEMISTRY-US, V35, P2157, DOI 10.1021/bi9524124; Keriel A, 2002, CELL, V109, P125, DOI 10.1016/S0092-8674(02)00692-X; Lalle P, 2002, J INVEST DERMATOL, V118, P344, DOI 10.1046/j.0022-202x.2001.01673.x; Larochelle S, 2007, MOL CELL, V25, P839, DOI 10.1016/j.molcel.2007.02.003; Lee SK, 2002, CELL, V109, P823, DOI 10.1016/S0092-8674(02)00795-X; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Malik S, 2008, J BIOL CHEM, V283, P6897, DOI 10.1074/jbc.M707649200; Malik S, 2010, NUCLEIC ACIDS RES, V38, P1461, DOI 10.1093/nar/gkp1147; Matsuno M, 2007, GENES CELLS, V12, P1289, DOI 10.1111/j.1365-2443.2007.01133.x; MAYNE LV, 1982, CANCER RES, V42, P1473; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Nouspikel T, 1997, P NATL ACAD SCI USA, V94, P3116, DOI 10.1073/pnas.94.7.3116; Petit C, 1999, BIOCHIMIE, V81, P15, DOI 10.1016/S0300-9084(99)80034-0; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; Reardon JT, 1996, P NATL ACAD SCI USA, V93, P6482, DOI 10.1073/pnas.93.13.6482; Rockx DAP, 2000, P NATL ACAD SCI USA, V97, P10503, DOI 10.1073/pnas.180169797; ROY R, 1994, CELL, V79, P1093, DOI 10.1016/0092-8674(94)90039-6; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Scharer OD, 2008, DNA REPAIR, V7, P339, DOI 10.1016/j.dnarep.2007.10.007; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Thorel F, 2004, MOL CELL BIOL, V24, P10670, DOI 10.1128/MCB.24.24.10670-10680.2004; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tornaletti S, 1999, J BIOL CHEM, V274, P24124, DOI 10.1074/jbc.274.34.24124; Tornaletti S, 1997, J BIOL CHEM, V272, P31719, DOI 10.1074/jbc.272.50.31719; vanGool AJ, 1997, EMBO J, V16, P4155, DOI 10.1093/emboj/16.14.4155; VANHOFFEN A, 1995, EMBO J, V14, P360, DOI 10.1002/j.1460-2075.1995.tb07010.x; VENKATACHALAM S, 1995, CARCINOGENESIS, V16, P2029, DOI 10.1093/carcin/16.9.2029; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wang QE, 2003, DNA REPAIR, V2, P483, DOI 10.1016/S1568-7864(03)00002-8; WANI AA, 1987, PHOTOCHEM PHOTOBIOL, V46, P477, DOI 10.1111/j.1751-1097.1987.tb04798.x; Yasukawa T, 2008, EMBO J, V27, P3256, DOI 10.1038/emboj.2008.249; Yokoi M, 2000, J BIOL CHEM, V275, P9870, DOI 10.1074/jbc.275.13.9870; Zotter A, 2006, MOL CELL BIOL, V26, P8868, DOI 10.1128/MCB.00695-06	63	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11007	10.1371/journal.pone.0011007	http://dx.doi.org/10.1371/journal.pone.0011007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20543986	gold, Green Submitted, Green Published			2022-12-27	WOS:000278494900019
J	Yamashita, A; Nishikawa, S; Rancourt, DE				Yamashita, Akihiro; Nishikawa, Sandi; Rancourt, Derrick E.			Identification of Five Developmental Processes during Chondrogenic Differentiation of Embryonic Stem Cells	PLOS ONE			English	Article							IN-VITRO; ENDOCHONDRAL OSSIFICATION; TISSUE REGENERATION; CARTILAGE FORMATION; MOUSE; LINEAGE; CHONDROCYTES; COMMITMENT; COLLAGEN; BONE	Background: Chondrogenesis is the complex process that leads to the establishment of cartilage and bone formation. Due to their ability to differentiate in vitro and mimic development, embryonic stem cells (ESCs) show great potential for investigating developmental processes. In this study, we used chondrogenic differentiation of ESCs as a model to analyze morphogenetic events during chondrogenesis. Methodology/Principal Findings: ESCs were differentiated into the chondrocyte lineage, forming small cartilaginous aggregates in suspension. Differentiated ESCs showed that chondrogenesis was typically characterized by five overlapping stages. During the first stage, cell condensation and aggregate formation was observed. The second stage was characterized by differentiation into chondrocytes and fibril scaffold formation within spherical aggregates. Deposition of cartilaginous extracellular matrix and cartilage formation were hallmarks of the third stage. Apoptosis of chondrocytes, hypertrophy and/or degradation of cartilage occurred during the fourth stage. Finally, during the fifth stage, bone replacement with membranous calcified tissues took place. Conclusions/Significance: We demonstrate that ESCs show the chondrogenic differentiation pathway from the pluripotent stem cell to terminal skeletogenesis through these five stages in vitro. During each stage, morphological changes acquired in preceding stages played an important role in further development as a scaffold or template in subsequent stages. The study of chondrogenesis via ESC differentiation may be informative to our further understanding of skeletal growth and regeneration.	[Yamashita, Akihiro; Nishikawa, Sandi; Rancourt, Derrick E.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada	University of Calgary	Yamashita, A (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	rancourt@ucalgary.ca			Canadian Institutes of Health	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Regenerative Medicine Team Grant. AY is an Alberta Heritage Foundation of Medical Research Postdoctoral Fellow (07) and Japan Society for the Promotion of Science Postdoctoral Fellow for Research Abroad (08-09). DER is an Alberta Heritage Foundation for Medical Research Senior Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Elder BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002341; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hegert C, 2002, J CELL SCI, V115, P4617, DOI 10.1242/jcs.00171; Hoffman UM, 2003, J BONE JOINT SURG AM, V85A, P124, DOI 10.2106/00004623-200300002-00017; Hwang NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002498; Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; James CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008693; Jukes JM, 2008, P NATL ACAD SCI USA, V105, P6840, DOI 10.1073/pnas.0711662105; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kino-Oka M, 2005, TISSUE ENG, V11, P597, DOI 10.1089/ten.2005.11.597; Kramer J, 2005, CELL BIOL INT, V29, P139, DOI 10.1016/j.cellbi.2004.10.003; Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Nakayama N, 2003, J CELL SCI, V116, P2015, DOI 10.1242/jcs.00417; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Ofek G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002795; Quintana L, 2009, TISSUE ENG PART B-RE, V15, P29, DOI 10.1089/ten.teb.2008.0329; Sugiki T, 2007, J CELL BIOCHEM, V100, P1240, DOI 10.1002/jcb.21125; Wescoe KE, 2008, CELL BIOCHEM BIOPHYS, V52, P85, DOI 10.1007/s12013-008-9029-0; Yamashita A, 2006, CLONING STEM CELLS, V8, P3, DOI 10.1089/clo.2006.8.3; Yamashita A, 2009, CELL DEATH DIFFER, V16, P278, DOI 10.1038/cdd.2008.149; Yamashita A, 2006, FEBS LETT, V580, P4121, DOI 10.1016/j.febslet.2006.06.057; Yamashita A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009663; zur Nieden NI, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-1	26	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10998	10.1371/journal.pone.0010998	http://dx.doi.org/10.1371/journal.pone.0010998			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539759	Green Submitted, Green Published, gold			2022-12-27	WOS:000278465900013
J	Raymond, B; Shaffer, SA; Sokolov, S; Woehler, EJ; Costa, DP; Einoder, L; Hindell, M; Hosie, G; Pinkerton, M; Sagar, PM; Scott, D; Smith, A; Thompson, DR; Vertigan, C; Weimerskirch, H				Raymond, Ben; Shaffer, Scott A.; Sokolov, Serguei; Woehler, Eric J.; Costa, Daniel P.; Einoder, Luke; Hindell, Mark; Hosie, Graham; Pinkerton, Matt; Sagar, Paul M.; Scott, Darren; Smith, Adam; Thompson, David R.; Vertigan, Caitlin; Weimerskirch, Henri			Shearwater Foraging in the Southern Ocean: The Roles of Prey Availability and Winds	PLOS ONE			English	Article							SHORT-TAILED SHEARWATERS; CONTINUOUS PLANKTON RECORDER; CENTRAL-PLACE FORAGER; SOOTY SHEARWATERS; PUFFINUS-GRISEUS; INTRODUCED PREDATORS; SATELLITE TELEMETRY; MYCTOPHID FISHES; FEEDING ECOLOGY; STOMACH OIL	Background: Sooty (Puffinus griseus) and short-tailed (P. tenuirostris) shearwaters are abundant seabirds that range widely across global oceans. Understanding the foraging ecology of these species in the Southern Ocean is important for monitoring and ecosystem conservation and management. Methodology/Principal Findings: Tracking data from sooty and short-tailed shearwaters from three regions of New Zealand and Australia were combined with at-sea observations of shearwaters in the Southern Ocean, physical oceanography, near-surface copepod distributions, pelagic trawl data, and synoptic near-surface winds. Shearwaters from all three regions foraged in the Polar Front zone, and showed particular overlap in the region around 140 degrees E. Short-tailed shearwaters from South Australia also foraged in Antarctic waters south of the Polar Front. The spatial distribution of shearwater foraging effort in the Polar Front zone was matched by patterns in large-scale upwelling, primary production, and abundances of copepods and myctophid fish. Oceanic winds were found to be broad determinants of foraging distribution, and of the flight paths taken by the birds on long foraging trips to Antarctic waters. Conclusions/Significance: The shearwaters displayed foraging site fidelity and overlap of foraging habitat between species and populations that may enhance their utility as indicators of Southern Ocean ecosystems. The results highlight the importance of upwellings due to interactions of the Antarctic Circumpolar Current with large-scale bottom topography, and the corresponding localised increases in the productivity of the Polar Front ecosystem.	[Raymond, Ben; Einoder, Luke; Hosie, Graham] Australian Antarctic Div, Kingston, Tas, Australia; [Shaffer, Scott A.] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA; [Sokolov, Serguei] CSIRO Marine Res & Antarctic Climate & Ecosyst, CSIRO Wealth Oceans Natl Res Flagship, Cooperat Res Ctr, Hobart, Tas, Australia; [Woehler, Eric J.; Hindell, Mark; Vertigan, Caitlin] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [Costa, Daniel P.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Pinkerton, Matt; Thompson, David R.] Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand; [Sagar, Paul M.] Natl Inst Water & Atmospher Res Ltd, Christchurch, New Zealand; [Scott, Darren] Univ Otago, Dept Zool, Dunedin, New Zealand; [Smith, Adam] Massey Univ, Inst Informat & Math Sci, Auckland, New Zealand; [Weimerskirch, Henri] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France	Australian Antarctic Division; California State University System; San Jose State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania; University of California System; University of California Santa Cruz; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Otago; Massey University; Centre National de la Recherche Scientifique (CNRS)	Raymond, B (corresponding author), Australian Antarctic Div, Kingston, Tas, Australia.	ben.raymond@aad.gov.au	Weimerskirch, Henri/K-7306-2019; Thompson, David R/E-2431-2018; Hindell, Mark A/K-1131-2013; Weimerskirch, Henri/F-5562-2013; Shaffer, Scott A/D-5015-2009; Costa, Daniel/E-2616-2013	Weimerskirch, Henri/0000-0002-0457-586X; Thompson, David R/0000-0001-8518-6307; Shaffer, Scott A/0000-0002-7751-5059; Woehler, Eric/0000-0002-1125-0748; Smith, Adam/0000-0003-0059-6206; Costa, Daniel/0000-0002-0233-5782; Hindell, Mark/0000-0002-7823-7185; Einoder, Luke/0000-0002-9122-7053	Alfred P. Sloan Foundation; Gordon Foundation; Betty Moore Foundation; David Foundation; Lucile Packard Foundation; Australian Antarctic Program [472, 681, 2208, 3227]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Gordon Foundation; Betty Moore Foundation(Gordon and Betty Moore Foundation); David Foundation; Lucile Packard Foundation(The David & Lucile Packard Foundation); Australian Antarctic Program	This work was conducted as part of the Census of Antarctic Marine Life (CAML) and Tagging of Pacific Pelagics (TOPP) projects, and was supported in part by the Alfred P. Sloan, Gordon and Betty Moore, and David and Lucile Packard Foundations, and the Australian Antarctic Program (Projects 472, 681, 2208, and 3227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2010, MAR BIOL, V157, P915, DOI 10.1007/s00227-009-1367-y; Adams J, 2009, NEW ZEAL J ZOOL, V36, P355, DOI 10.1080/03014220909510160; Agnew DJ, 1997, ANTARCT SCI, V9, P235, DOI 10.1017/S095410209700031X; Baduini CL, 2001, FISH OCEANOGR, V10, P117, DOI 10.1046/j.1365-2419.2001.00156.x; *BIOMASS WORK PART, 1982, BIOMASS HDB, V18; BLOMQVIST S, 1984, MAR ECOL PROG SER, V20, P85, DOI 10.3354/meps020085; Bost C.A., 2008, P121; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Bradshaw CJA, 2004, ANIM BEHAV, V68, P1349, DOI 10.1016/j.anbehav.2003.12.013; BRIGGS KT, 1986, CONDOR, V88, P355, DOI 10.2307/1368883; Brodtkorb PA, 2000, INT OFFSHORE POLAR E, P343; BROWN RGB, 1978, CONDOR, V80, P123, DOI 10.2307/1367911; Burger AE, 2008, AUK, V125, P253, DOI 10.1525/auk.2008.1408; CAIRNS DK, 1992, CONDOR, V94, P811, DOI 10.2307/1369279; Catry P, 2004, AUK, V121, P1208, DOI 10.1642/0004-8038(2004)121[1208:SFTBAG]2.0.CO;2; Charrassin JB, 2008, P NATL ACAD SCI USA, V105, P11634, DOI 10.1073/pnas.0800790105; Cherel Y, 2005, OECOLOGIA, V145, P533, DOI 10.1007/s00442-005-0156-7; Clarke Rohan H., 2005, Marine Ornithology, V33, P7; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Connan M, 2005, MAR ECOL PROG SER, V290, P277, DOI 10.3354/meps290277; Connan M, 2007, LIMNOL OCEANOGR, V52, P2445, DOI 10.4319/lo.2007.52.6.2445; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; Cruz JB, 2001, NEW ZEAL J MAR FRESH, V35, P817, DOI 10.1080/00288330.2001.9517044; Diamond AW, 2003, ENVIRON MONIT ASSESS, V88, P153, DOI 10.1023/A:1025560805788; Duhamel G, 2000, POLAR BIOL, V23, P106, DOI 10.1007/s003000050015; Einoder LD, 2009, FISH RES, V95, P6, DOI 10.1016/j.fishres.2008.09.024; Einoder LD, 2005, T ROY SOC SOUTH AUST, V129, P209; Feldman G. C., 2010, OCEAN COLOR WEB SEAW; Felicisimo AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002928; Frederiksen M, 2007, MAR ECOL PROG SER, V352, P205, DOI 10.3354/meps07071; Fukami T, 2006, ECOL LETT, V9, P1299, DOI 10.1111/j.1461-0248.2006.00983.x; Gordon HB, 2002, CSIRO MK3 CLIMATE SY; Hamer KC, 2001, MAR ECOL PROG SER, V224, P283, DOI 10.3354/meps224283; HARPER P C, 1987, Notornis, V34, P169; Hodges C. L., 1994, Marine Ornithology, V22, P205; Hosie GW, 2003, PROG OCEANOGR, V58, P263, DOI 10.1016/j.pocean.2003.08.007; Hulley P.A., 1990, P146; Hunt BPV, 2005, DEEP-SEA RES PT I, V52, P1241, DOI 10.1016/j.dsr.2004.11.019; Igual JM, 2005, MAR BIOL, V146, P619, DOI 10.1007/s00227-004-1461-0; JACKSON S, 1988, CONDOR, V90, P20, DOI 10.2307/1368428; KERRY KR, 1983, EMU, V83, P35, DOI 10.1071/MU9830035; Kitson JC, 2000, NEW ZEAL J ZOOL, V27, P347, DOI 10.1080/03014223.2000.9518244; Klomp NI, 2000, MAR ECOL PROG SER, V194, P307, DOI 10.3354/meps194307; Kozlov A.N., 1995, CCAMLR Science, V2, P71; Lawton K, 2008, AQUAT CONSERV, V18, P309, DOI 10.1002/aqc.857; Lee R.F., 1989, P73; LIECHTI F, 1994, J THEOR BIOL, V170, P219, DOI 10.1006/jtbi.1994.1181; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; McKechnie S, 2006, NEW ZEAL J ZOOL, V33, P259, DOI 10.1080/03014223.2006.9518455; McLeod DJ, 2010, POLAR SCI, V4, P353, DOI 10.1016/j.polar.2010.03.004; Moller H, 2009, NEW ZEAL J ZOOL, V36, P325, DOI 10.1080/03014220909510158; Moller H, 2000, NEW ZEAL J ZOOL, V27, P255, DOI 10.1080/03014223.2000.9518233; Moller H, 2009, NEW ZEAL J ZOOL, V36, P211, DOI 10.1080/03014220909510152; Nicholls DG, 1997, EMU, V97, P240; Nicholls DG, 1998, EMU, V98, P79, DOI 10.1071/MU98007F; Pakhomov EA, 1996, MAR ECOL PROG SER, V134, P1, DOI 10.3354/meps134001; PARSLOW JS, 2001, J GEOPHYS RES, V106, P31557; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Phillips KL, 2001, MAR ECOL PROG SER, V215, P179, DOI 10.3354/meps215179; Phleger CF, 1999, ANTARCT SCI, V11, P436, DOI 10.1017/S0954102099000565; Phleger CF, 1997, ANTARCT SCI, V9, P258, DOI 10.1017/S0954102097000345; Pusch C, 2004, DEEP-SEA RES PT I, V51, P1685, DOI 10.1016/j.dsr.2004.06.008; Reda I, 2003, NRELTP56034302; Reid K, 2005, ICES J MAR SCI, V62, P366, DOI 10.1016/j.icesjms.2004.11.003; Reid PC, 2003, PROG OCEANOGR, V58, P117, DOI 10.1016/j.pocean.2003.08.002; ROBERTSON J. S., 1957, EMU, V57, P191; Robison BH, 2003, J MAR BIOL ASSOC UK, V83, P639, DOI 10.1017/S0025315403007586h; Ropert-Coudert Y, 2004, BEHAV ECOL, V15, P824, DOI 10.1093/beheco/arh086; Rosen Mikael, 2001, Acta Ethologica, V3, P135, DOI 10.1007/s102110100039; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Schultz MA, 2000, J AVIAN BIOL, V31, P287, DOI 10.1034/j.1600-048X.2000.310303.x; Serventy DL., 1971, HDB AUSTR SEABIRDS; Shaffer SA, 2005, MAR BIOL, V147, P833, DOI 10.1007/s00227-005-1631-8; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Shaffer SA, 2009, MAR ECOL PROG SER, V391, P209, DOI 10.3354/meps07932; SKIRA IJ, 1986, BIOL CONSERV, V37, P225, DOI 10.1016/0006-3207(86)90083-2; Soehle I. S., 2007, Notornis, V54, P180; Sohle IS, 2003, EMU, V103, P373, DOI 10.1071/MU03035; Sokolov S, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004072; Sokolov S, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005108; Sokolov S, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004329; Spear LB, 1997, IBIS, V139, P221, DOI 10.1111/j.1474-919X.1997.tb04620.x; Staniland IJ, 2007, MAR BIOL, V152, P233, DOI 10.1007/s00227-007-0698-9; Taylor G. A., 2008, Papers and Proceedings of the Royal Society of Tasmania, V142, P89; Terauds A, 2006, AQUAT CONSERV, V16, P133, DOI 10.1002/aqc.709; Tremblay Y, 2009, MAR ECOL PROG SER, V391, P153, DOI 10.3354/meps08146; VEIT RR, 1991, AUK, V108, P790; Veit RR, 1997, GLOB CHANGE BIOL, V3, P23, DOI 10.1046/j.1365-2486.1997.d01-130.x; Wakefield ED, 2009, ECOL MONOGR, V79, P663, DOI 10.1890/07-2111.1; Warham J., 1977, Proceedings of the New Zealand Ecological Society, V24, P84; Waugh SM, 1999, MAR ECOL PROG SER, V177, P243, DOI 10.3354/meps177243; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; WEIMERSKIRCH H, 1994, POLAR BIOL, V14, P123; Weimerskirch H, 1998, J ANIM ECOL, V67, P99, DOI 10.1046/j.1365-2656.1998.00180.x; Weimerskirch H, 1996, IBIS, V138, P786, DOI 10.1111/j.1474-919X.1996.tb08837.x; Weimerskirch H, 1998, MAR ECOL PROG SER, V167, P261, DOI 10.3354/meps167261; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Wienecke B, 2006, POLAR BIOL, V29, P424, DOI 10.1007/s00300-005-0074-5; WILLIAMS R, 1988, Papers and Proceedings of the Royal Society of Tasmania, V122, P233; Williams R, 1990, ANARE RES NOTES, V75; WILLIAMS R, 1997, VOYAGE REPORT VOYAGE; Woehler EJ, 1997, POLAR BIOL, V17, P371, DOI 10.1007/PL00013379; WOEHLER EJ, 1995, THESIS U CALIFORNIA; WOEHLER EJ, 1980, DISTRIBUTION ABUNDAN; Woehler EJ, 2006, MAR ECOL PROG SER, V324, P261, DOI 10.3354/meps324261; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; YAMAGUCHI Y, 1982, T TOKYO U FISHERIES, V5, P111; [No title captured]	109	48	48	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10960	10.1371/journal.pone.0010960	http://dx.doi.org/10.1371/journal.pone.0010960			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532034	Green Published, Green Submitted, gold			2022-12-27	WOS:000278380500006
J	Bertelli, C; Collyn, F; Croxatto, A; Ruckert, C; Polkinghorne, A; Kebbi-Beghdadi, C; Goesmann, A; Vaughan, L; Greub, G				Bertelli, Claire; Collyn, Francois; Croxatto, Antony; Rueckert, Christian; Polkinghorne, Adam; Kebbi-Beghdadi, Carole; Goesmann, Alexander; Vaughan, Lloyd; Greub, Gilbert			The Waddlia Genome: A Window into Chlamydial Biology	PLOS ONE			English	Article							ORDER CHLAMYDIALES; MEMBRANE-PROTEIN; FAM. NOV.; CHONDROPHILA; IDENTIFICATION; PEPTIDOGLYCAN; HOST; INFECTIONS; RICKETTSIA; SEQUENCES	Growing evidence suggests that a novel member of the Chlamydiales order, Waddlia chondrophila, is a potential agent of miscarriage in humans and abortion in ruminants. Due to the lack of genetic tools to manipulate chlamydia, genomic analysis is proving to be the most incisive tool in stimulating investigations into the biology of these obligate intracellular bacteria. 454/Roche and Solexa/Illumina technologies were thus used to sequence and assemble de novo the full genome of the first representative of the Waddliaceae family, W. chondrophila. The bacteria possesses a 2'116'312bp chromosome and a 15'593 bp low-copy number plasmid that might integrate into the bacterial chromosome. The Waddlia genome displays numerous repeated sequences indicating different genome dynamics from classical chlamydia which almost completely lack repetitive elements. Moreover, W. chondrophila exhibits many virulence factors also present in classical chlamydia, including a functional type III secretion system, but also a large complement of specific factors for resistance to host or environmental stresses. Large families of outer membrane proteins were identified indicating that these highly immunogenic proteins are not Chlamydiaceae specific and might have been present in their last common ancestor. Enhanced metabolic capability for the synthesis of nucleotides, amino acids, lipids and other co-factors suggests that the common ancestor of the modern Chlamydiales may have been less dependent on their eukaryotic host. The fine-detailed analysis of biosynthetic pathways brings us closer to possibly developing a synthetic medium to grow W. chondrophila, a critical step in the development of genetic tools. As a whole, the availability of the W. chondrophila genome opens new possibilities in Chlamydiales research, providing new insights into the evolution of members of the order Chlamydiales and the biology of the Waddliaceae.	[Bertelli, Claire; Collyn, Francois; Croxatto, Antony; Kebbi-Beghdadi, Carole; Greub, Gilbert] Univ Hosp Ctr, Inst Microbiol, Ctr Res Intracellular Bacteria, Lausanne, Switzerland; [Bertelli, Claire; Collyn, Francois; Croxatto, Antony; Kebbi-Beghdadi, Carole; Greub, Gilbert] Univ Lausanne, Lausanne, Switzerland; [Rueckert, Christian; Goesmann, Alexander] Univ Bielefeld, Ctr Biotechnol, Bielefeld, Germany; [Polkinghorne, Adam] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Polkinghorne, Adam; Vaughan, Lloyd] Univ Zurich, Inst Vet Pathol, Vetsuisse Fac, Zurich, Switzerland	University of Lausanne; University of Bielefeld; Queensland University of Technology (QUT); University of Zurich	Bertelli, C (corresponding author), Univ Hosp Ctr, Inst Microbiol, Ctr Res Intracellular Bacteria, Lausanne, Switzerland.	gilbert.greub@chuv.ch	Bertelli, Claire/H-9609-2015; Greub, Gilbert GG/K-5804-2017; Vaughan, Lloyd/GNP-4888-2022; Vaughan, L/E-6528-2011	Bertelli, Claire/0000-0003-0550-8981; Greub, Gilbert GG/0000-0001-9529-3317; Vaughan, L/0000-0003-3474-9426; Polkinghorne, Adam/0000-0002-6803-9222; Polkinghorne, Adam/0000-0002-6567-2962; Kebbi Beghdadi, Carole/0000-0003-1158-6361; Goesmann, Alexander/0000-0002-7086-2568; Ruckert-Reed, Christian/0000-0002-9722-4435	Infectigen Foundation [In010_2008]; Swiss National Science Foundation [310030-124843, 310030-130466]; Swiss State Secretariat for Education and Research (SER) [C07.0125]; Leenards Foundation	Infectigen Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss State Secretariat for Education and Research (SER); Leenards Foundation	This project was funded by the grant number In010_2008 from the Infectigen Foundation and by grants no 310030-124843 and 310030-130466 from the Swiss National Science Foundation. This project was also partially supported by a COST grant from the Swiss State Secretariat for Education and Research (SER) (C07.0125). GG is supported by the Leenards Foundation through a career award entitled 'Bourse Leenards pour la releve academique en medecine clinique a Lausanne'. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], CHLAMYDIA GENOMICS P; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Baud D, 2007, EMERG INFECT DIS, V13, P1239, DOI 10.3201/eid1308.070315; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Borel N, 2007, EMERG INFECT DIS, V13, P1904, DOI 10.3201/eid1312.070655; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chopra I, 1998, MICROBIOL-UK, V144, P2673, DOI 10.1099/00221287-144-10-2673; Collyn F, 2007, FEMS MICROBIOL LETT, V271, P187, DOI 10.1111/j.1574-6968.2007.00714.x; Corsaro D, 2007, SYST APPL MICROBIOL, V30, P221, DOI 10.1016/j.syapm.2006.06.001; Corsarol D, 2006, CLIN MICROBIOL REV, V19, P283, DOI 10.1128/CMR.19.2.283-297.2006; Crane DD, 2006, P NATL ACAD SCI USA, V103, P1894, DOI 10.1073/pnas.0508983103; CROXATTO A, 2010, MICROBIOLOGY, P340; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DILBECK PM, 1990, J CLIN MICROBIOL, V28, P814, DOI 10.1128/JCM.28.4.814-816.1990; Dilbeck-Robertson P, 2003, J VET DIAGN INVEST, V15, P568, DOI 10.1177/104063870301500609; DODD IB, 1987, J MOL BIOL, V194, P557, DOI 10.1016/0022-2836(87)90681-4; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; Eugster M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-231; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Fields KA, 2006, CHLAMYDIA GENOMICS P, P219; Findlay HE, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-5; Friedman MG, 2003, MICROBES INFECT, V5, P1013, DOI 10.1016/S1286-4579(03)00188-6; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Goy G, 2009, EUR J CLIN MICROBIOL, V28, P1483, DOI 10.1007/s10096-009-0804-7; Goy G, 2008, MICROBES INFECT, V10, P556, DOI 10.1016/j.micinf.2008.02.003; Goy G, 2009, ANTIMICROB AGENTS CH, V53, P2663, DOI 10.1128/AAC.00046-09; Greub G, 2009, CLIN MICROBIOL INFEC, V15, P18, DOI 10.1111/j.1469-0691.2008.02633.x; Greub G, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-48; Greub G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008423; Haferkamp I, 2004, NATURE, V432, P622, DOI 10.1038/nature03131; Haferkamp I, 2006, MOL MICROBIOL, V60, P1534, DOI 10.1111/j.1365-2958.2006.05193.x; Haider S, 2008, FEMS MICROBIOL LETT, V281, P198, DOI 10.1111/j.1574-6968.2008.01099.x; Hatch TP, 1996, J BACTERIOL, V178, P1; Henning K, 2002, VET MICROBIOL, V85, P285, DOI 10.1016/S0378-1135(01)00510-7; Herrmann B, 2008, EMERG INFECT DIS, V14, P1462, DOI 10.3201/eid1409.080153; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Igietseme Joseph U, 2003, Expert Rev Vaccines, V2, P129, DOI 10.1586/14760584.2.1.129; KOCAN KM, 1990, J BACTERIOL, V172, P5949, DOI 10.1128/jb.172.10.5949-5955.1990; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Linke Burkhard, 2006, Appl Bioinformatics, V5, P193, DOI 10.2165/00822942-200605030-00008; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Longbottom D, 1996, FEMS MICROBIOL LETT, V142, P277; Mackiewicz P, 2004, NUCLEIC ACIDS RES, V32, P3781, DOI 10.1093/nar/gkh699; McCoy AJ, 2006, TRENDS MICROBIOL, V14, P70, DOI 10.1016/j.tim.2005.12.004; McDonnell AV, 2006, PROTEINS, V63, P976, DOI 10.1002/prot.20942; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Michel R, 2004, ACTA PROTOZOOL, V43, P37; Nordfelth R, 2005, INFECT IMMUN, V73, P3104, DOI 10.1128/IAI.73.5.3104-3114.2005; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Rurangirwa FR, 1999, INT J SYST BACTERIOL, V49, P577, DOI 10.1099/00207713-49-2-577; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas V, 2006, ENVIRON MICROBIOL, V8, P2125, DOI 10.1111/j.1462-2920.2006.01094.x; Waldispuehl J, 2008, PROTEINS, V71, P1097, DOI 10.1002/prot.21788; Wehrl W, 2004, MOL MICROBIOL, V51, P319, DOI 10.1046/j.1365-2958.2003.03838.x; Yen TY, 2005, BIOCHEMISTRY-US, V44, P6250, DOI 10.1021/bi047775v; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935	62	79	79	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10890	10.1371/journal.pone.0010890	http://dx.doi.org/10.1371/journal.pone.0010890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531937	Green Published, gold, Green Submitted			2022-12-27	WOS:000278222100019
J	Bongaerts, P; Riginos, C; Ridgway, T; Sampayo, EM; van Oppen, MJH; Englebert, N; Vermeulen, F; Hoegh-Guldberg, O				Bongaerts, Pim; Riginos, Cynthia; Ridgway, Tyrone; Sampayo, Eugenia M.; van Oppen, Madeleine J. H.; Englebert, Norbert; Vermeulen, Francisca; Hoegh-Guldberg, Ove			Genetic Divergence across Habitats in the Widespread Coral Seriatopora hystrix and Its Associated Symbiodinium	PLOS ONE			English	Article							GREAT-BARRIER-REEF; LARGE DEPTH RANGES; ECOLOGICAL SPECIATION; POCILLOPORA-DAMICORNIS; MONTASTRAEA-ANNULARIS; SYMPATRIC SPECIATION; POPULATION-STRUCTURE; SCLERACTINIAN CORAL; COMMUNITY STRUCTURE; ACROPORA-PALIFERA	Background: Coral reefs are hotspots of biodiversity, yet processes of diversification in these ecosystems are poorly understood. The environmental heterogeneity of coral reef environments could be an important contributor to diversification, however, evidence supporting ecological speciation in corals is sparse. Here, we present data from a widespread coral species that reveals a strong association of host and symbiont lineages with specific habitats, consistent with distinct, sympatric gene pools that are maintained through ecologically-based selection. Methodology/Principal Findings: Populations of a common brooding coral, Seriatopora hystrix, were sampled from three adjacent reef habitats (spanning a similar to 30 m depth range) at three locations on the Great Barrier Reef (n = 336). The populations were assessed for genetic structure using a combination of mitochondrial (putative control region) and nuclear (three microsatellites) markers for the coral host, and the ITS2 region of the ribosomal DNA for the algal symbionts (Symbiodinium). Our results show concordant genetic partitioning of both the coral host and its symbionts across the different habitats, independent of sampling location. Conclusions/Significance: This study demonstrates that coral populations and their associated symbionts can be highly structured across habitats on a single reef. Coral populations from adjacent habitats were found to be genetically isolated from each other, whereas genetic similarity was maintained across similar habitat types at different locations. The most parsimonious explanation for the observed genetic partitioning across habitats is that adaptation to the local environment has caused ecological divergence of distinct genetic groups within S. hystrix.	[Bongaerts, Pim; Hoegh-Guldberg, Ove] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia; [Bongaerts, Pim; Ridgway, Tyrone; Sampayo, Eugenia M.; Englebert, Norbert; Vermeulen, Francisca] Univ Queensland, Ctr Marine Studies, St Lucia, Qld, Australia; [Bongaerts, Pim; Sampayo, Eugenia M.; Hoegh-Guldberg, Ove] Univ Queensland, ARC Ctr Excellence Coral Reef Studies, St Lucia, Qld, Australia; [Riginos, Cynthia] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Ridgway, Tyrone] Great Barrier Reef Marine Pk Author, Climate Change Grp, Townsville, Qld, Australia; [Sampayo, Eugenia M.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [van Oppen, Madeleine J. H.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [van Oppen, Madeleine J. H.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Vermeulen, Francisca] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	University of Queensland; University of Queensland; University of Queensland; University of Queensland; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Australian Institute of Marine Science; James Cook University; Victoria University Wellington	Bongaerts, P (corresponding author), Univ Queensland, Global Change Inst, St Lucia, Qld, Australia.	pim@uq.edu.au	van Oppen, Madeleine JH/C-3261-2008; Hoegh-Guldberg, Ove/ABA-5420-2020; Riginos, Cynthia/G-3320-2010; Hoegh-Guldberg, Ove/H-6169-2011	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Riginos, Cynthia/0000-0002-5485-4197; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Bongaerts, Pim/0000-0001-6747-6044; van Oppen, Madeleine/0000-0003-4607-0744	Australian Research Council (ARC) Centre; Project Aware Foundation; Professional Association of Diving Instructors (PADI) Foundation	Australian Research Council (ARC) Centre(Australian Research Council); Project Aware Foundation; Professional Association of Diving Instructors (PADI) Foundation	This study was funded by the Australian Research Council (ARC) Centre of Excellence for Coral Reef Studies (www.coralcoe.org.au), the Project Aware Foundation (www.projectaware.org) and the Professional Association of Diving Instructors (PADI) Foundation (www.padifoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYRE DJ, 1991, CORAL REEFS, V10, P13, DOI 10.1007/BF00301901; AYRE DJ, 1994, EVOLUTION, V48, P1183, DOI 10.1111/j.1558-5646.1994.tb05304.x; Ayre DJ, 2000, EVOLUTION, V54, P1590; Bak RPM, 1977, AAPG STUD GEOL, V4, P3, DOI 10.1306/St4393; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Baums IB, 2008, MOL ECOL, V17, P2796, DOI 10.1111/j.1365-294X.2008.03787.x; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; BENZIE JAH, 1995, MAR BIOL, V121, P731, DOI 10.1007/BF00349309; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bradshaw A.D., 1965, ADV GENET, V13, P15; Carlon DB, 2002, EVOLUTION, V56, P2227; Chen C, 2008, MOL PHYLOGENET EVOL, V46, P19, DOI 10.1016/j.ympev.2007.09.013; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Conde-Padin P, 2007, EVOL ECOL, V21, P635, DOI 10.1007/s10682-006-9142-8; Coyne J.A., 2004, SPECIATION; D'Croz L, 2004, CORAL REEFS, V23, P473, DOI 10.1007/s00338-004-0397-7; Diekmann OE, 2003, CORAL REEFS, V22, P29, DOI 10.1007/s00338-002-0273-2; Diekmann OE, 2001, MAR BIOL, V139, P221; Done T.J., 1982, Coral Reefs, V1, P95, DOI 10.1007/BF00301691; Douglas AE, 1998, HEREDITY, V81, P599, DOI 10.1038/sj.hdy.6884550; Duran S, 2006, MOL PHYLOGENET EVOL, V40, P292, DOI 10.1016/j.ympev.2006.02.018; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Flot JF, 2008, CORAL REEFS, V27, P789, DOI 10.1007/s00338-008-0407-2; Flot JF, 2008, CR BIOL, V331, P239, DOI 10.1016/j.crvi.2007.12.003; Forsman ZH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-45; Frade PR, 2008, MOL ECOL, V17, P691, DOI 10.1111/j.1365-294X.2007.03612.x; Frade PR, 2008, LIMNOL OCEANOGR, V53, P2711, DOI 10.4319/lo.2008.53.6.2711; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; HUNTER CL, 1993, EVOLUTION, V47, P1213, DOI 10.1111/j.1558-5646.1993.tb02148.x; Hunter CL, 1997, P 8 INT COR REEF S, V2, P1599; HUSTON MA, 1985, ANNU REV ECOL SYST, V16, P149, DOI 10.1146/annurev.es.16.110185.001053; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Iglesias-Prieto R, 1997, MAR BIOL, V130, P23, DOI 10.1007/s002270050221; Johannesson K, 2003, J SEA RES, V49, P107, DOI 10.1016/S1385-1101(02)00218-6; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; KNOWLTON N, 1992, SCIENCE, V255, P330, DOI 10.1126/science.255.5042.330; KNOWLTON N, 1994, TRENDS ECOL EVOL, V1, P7; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2004, CORAL REEFS, V23, P596, DOI 10.1007/s00338-004-0428-4; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; Langerhans RB, 2007, EVOLUTION, V61, P2056, DOI 10.1111/j.1558-5646.2007.00171.x; Loh WKW, 2001, MAR ECOL PROG SER, V222, P97, DOI 10.3354/meps222097; Lopez JV, 1999, BIOL BULL-US, V196, P80, DOI 10.2307/1543170; Maier E, 2005, MAR BIOL, V147, P1109, DOI 10.1007/s00227-005-0013-6; Maier E, 2009, CORAL REEFS, V28, P751, DOI 10.1007/s00338-009-0497-5; MAYR E, 1954, EVOLUTION, V8, P1, DOI 10.2307/2405661; Monismith SG, 2007, ANNU REV FLUID MECH, V39, P37, DOI 10.1146/annurev.fluid.38.050304.092125; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Ogden R, 2002, P NATL ACAD SCI USA, V99, P13612, DOI 10.1073/pnas.212248499; PEAKALL R, 2001, GENAIEX V5 GENETIC A; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Richmond JQ, 2002, EVOLUTION, V56, P1498, DOI 10.1111/j.0014-3820.2002.tb01461.x; Rocha LA, 2005, P ROY SOC B-BIOL SCI, V272, P573, DOI 10.1098/2004.3005; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Rundle Howard D., 2004, P192; Rutzler K, 2007, MAR ECOL-EVOL PERSP, V28, P95; Ryan PG, 2007, SCIENCE, V315, P1420, DOI 10.1126/science.1138829; Sampayo EM, 2007, THESIS U QUEENSLAND; Sampayo EM, 2007, MOL ECOL, V16, P3721, DOI 10.1111/j.1365-294X.2007.03403.x; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sherman CDH, 2008, HEREDITY, V100, P296, DOI 10.1038/sj.hdy.6801076; Stat M, 2008, CORAL REEFS, V27, P763, DOI 10.1007/s00338-008-0412-5; Stat M, 2006, PERSPECT PLANT ECOL, V8, P23, DOI 10.1016/j.ppees.2006.04.001; Swofford D. L., 1999, PAUP 4 0 PHYLOGENETI; Todd PA, 2008, BIOL REV, V83, P315, DOI 10.1111/j.1469-185X.2008.00045.x; Tonnis B, 2005, P ROY SOC B-BIOL SCI, V272, P819, DOI 10.1098/rspb.2004.3030; Underwood JN, 2007, MOL ECOL, V16, P771, DOI 10.1111/j.1365-294X.2006.03187.x; Underwood JN, 2006, MOL ECOL NOTES, V6, P176, DOI 10.1111/j.1471-8286.2005.01183.x; van Oppen MJH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003401; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733; VANMOORSEL GWNM, 1983, MAR ECOL PROG SER, V13, P273, DOI 10.3354/meps013273; Vermeij MJA, 2003, B MAR SCI, V73, P725; Vermeij MJA, 2002, MAR ECOL PROG SER, V233, P105, DOI 10.3354/meps233105; VERON J E N, 1976, Australian Institute of Marine Science Monograph Series, V1, P1; Veron J. E. N., 2000, CORALS WORLD, V2; Vollmer SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003718; Warner ME, 2006, LIMNOL OCEANOGR, V51, P1887, DOI 10.4319/lo.2006.51.4.1887; Wilding CS, 2001, J EVOLUTION BIOL, V14, P611, DOI 10.1046/j.1420-9101.2001.00304.x	88	132	135	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10871	10.1371/journal.pone.0010871	http://dx.doi.org/10.1371/journal.pone.0010871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523735	gold, Green Published, Green Accepted			2022-12-27	WOS:000278221900017
J	Wu, Q; Xu, FFL; Li, YJ; Prochownik, EV; Saunders, WS				Wu, Qian; Xu, Fengfeng L.; Li, Youjun; Prochownik, Edward V.; Saunders, William S.			The c-Myc Target Glycoprotein1b alpha Links Cytokinesis Failure to Oncogenic Signal Transduction Pathways in Cultured Human Cells	PLOS ONE			English	Article							GENOMIC INSTABILITY; FILAMIN-A; ACTIN-FILAMENTS; IB-ALPHA; ACTIVATION; COMPLEX; CANCER; RHO; TRANSFORMATION; TUMORIGENESIS	An increase in chromosome number, or polyploidization, is associated with a variety of biological changes including breeding of cereal crops and flowers, terminal differentiation of specialized cells such as megakaryocytes, cellular stress and oncogenic transformation. Yet it remains unclear how cells tolerate the major changes in gene expression, chromatin organization and chromosome segregation that invariably accompany polyploidization. We show here that cancer cells can initiate increases in chromosome number by inhibiting cell division through activation of glycoprotein1b alpha (Gp1b alpha), a component of the c-Myc signaling pathway. We are able to recapitulate cytokinesis failure in primary cells by overexpression of Gp1b alpha in a p53-deficient background. Gp1b alpha was found to localize to the cleavage furrow by microscopy analysis and, when overexpressed, to interfere with assembly of the cellular cortical contraction apparatus and normal division. These results indicate that cytokinesis failure and tetraploidy in cancer cells are directly linked to cellular hyperproliferation via c-Myc induced overexpression of Gp1b alpha.	[Wu, Qian; Xu, Fengfeng L.; Saunders, William S.] Univ Pittsburgh, Dept Biol, Pittsburgh, PA 15260 USA; [Li, Youjun; Prochownik, Edward V.] Childrens Hosp Pittsburgh, Sect Hematol Oncol, Pittsburgh, PA 15213 USA; [Prochownik, Edward V.] Univ Pittsburgh, Med Ctr, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Prochownik, Edward V.; Saunders, William S.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wu, Q (corresponding author), Univ Pittsburgh, Dept Biol, 4200 5th Ave, Pittsburgh, PA 15260 USA.	wsaund@pitt.edu			NIH [ROI DE 016086-01, RO1 CA105033]; NATIONAL CANCER INSTITUTE [R01CA105033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016086] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work is support by the NIH grants ROI DE 016086-01 to WSS and RO1 CA105033 to EVP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RK, 1997, INT J BIOCHEM CELL B, V29, P91, DOI 10.1016/S1357-2725(96)00122-7; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Canobbio H, 2004, CELL SIGNAL, V16, P1329, DOI 10.1016/j.cellsig.2004.05.008; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Drechsel DN, 1997, CURR BIOL, V7, P12, DOI 10.1016/S0960-9822(06)00023-6; Feng SJ, 2005, J BIOL CHEM, V280, P6709, DOI 10.1074/jbc.M413590200; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Hau PM, 2006, FEBS LETT, V580, P4727, DOI 10.1016/j.febslet.2006.07.059; Kaushansky K, 2008, BLOOD, V111, P981, DOI 10.1182/blood-2007-05-088500; Kruse K, 2000, PHYS REV LETT, V85, P1778, DOI 10.1103/PhysRevLett.85.1778; Li Y, 2008, ONCOGENE, V27, P1599, DOI 10.1038/sj.onc.1210794; Li YJ, 2007, P NATL ACAD SCI USA, V104, P3490, DOI 10.1073/pnas.0610163104; Li YJ, 2009, J BIOL CHEM, V284, P1410, DOI 10.1074/jbc.M806222200; LOEB LA, 1991, CANCER RES, V51, P3075; Lordier L, 2008, BLOOD, V112, P3164, DOI 10.1182/blood-2008-03-144956; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; NUNNALLY MH, 1980, J CELL BIOL, V87, P219, DOI 10.1083/jcb.87.1.219; Pi M, 2002, ENDOCRINOLOGY, V143, P3830, DOI 10.1210/en.2002-220240; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Ricke RM, 2008, TRENDS GENET, V24, P457, DOI 10.1016/j.tig.2008.07.002; Rogulski K, 2005, ONCOGENE, V24, P7524, DOI 10.1038/sj.onc.1208897; Rothermund K, 2005, CANCER RES, V65, P2097, DOI 10.1158/0008-5472.CAN-04-2928; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Srsen V, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-26; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Tanaka-Takiguchi Y, 2004, J MOL BIOL, V341, P467, DOI 10.1016/j.jmb.2004.06.019; Wang H, 2008, ONCOGENE, V27, P1905, DOI 10.1038/sj.onc.1210823; Watanabe N, 2004, EXP CELL RES, V301, P16, DOI 10.1016/j.yexcr.2004.08.020; Yin XY, 1999, ONCOGENE, V18, P1177, DOI 10.1038/sj.onc.1202410; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049	37	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10819	10.1371/journal.pone.0010819	http://dx.doi.org/10.1371/journal.pone.0010819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520840	gold, Green Published, Green Accepted			2022-12-27	WOS:000278034800014
J	Xu, YH; Deng, MJ; Peng, JF; Hu, ZH; Bao, LM; Wang, JM; Zheng, ZL				Xu, Yonghan; Deng, Minjuan; Peng, Jianfei; Hu, Zhanghua; Bao, Lieming; Wang, Junming; Zheng, Zhi-Liang			OsPIE1, the Rice Ortholog of Arabidopsis PHOTOPERIOD-INDEPENDENT EARLY FLOWERING1, Is Essential for Embryo Development	PLOS ONE			English	Article							CHROMATIN REMODELING COMPLEX; HISTONE VARIANT H2A.Z; ACTIN-RELATED-PROTEIN; SACCHAROMYCES-CEREVISIAE; SWR1 COMPLEX; DROSOPHILA-MELANOGASTER; FLORAL REPRESSION; SANT DOMAIN; HUMAN SRCAP; N-COR	Background: The SWR1 complex is important for the deposition of histone variant H2A.Z into chromatin necessary to robustly regulate gene expression during growth and development. In Arabidopsis thaliana, the catalytic subunit of the SWR1-like complex, encoded by PIE1 (PHOTOPERIOD-INDEPENDENT EARLY FLOWERING1), has been shown to function in multiple developmental processes including flowering time pathways and petal number regulation. However, the function of the PIE1 orthologs in monocots remains unknown. Methodology/Findings: We report the identification of the rice (Oryza sativa) ortholog, OsPIE1. Although OsPIE1 does not exhibit a conserved exon/intron structure as Arabidopsis PIE1, its encoded protein is highly similar to PIE1, sharing 53.9% amino acid sequence identity. OsPIE1 also has a very similar expression pattern as PIE1. Furthermore, transgenic expression of OsPIE1 completely rescued both early flowering and extra petal number phenotypes of the Arabidopsis pie1-2 mutant. However, homozygous T-DNA insertional mutants of OsPIE1 in rice were embryonically lethal, in contrast to the viable mutants in the orthologous genes for yeast, Drosophila and Arabidopsis (Swr1, DOMINO and PIE1, respectively). Conclusions/Significance: Taken together, our results suggest that OsPIE1 is the rice ortholog of Arabidopsis PIE1 and plays an essential role in rice embryo development.	[Xu, Yonghan; Deng, Minjuan; Hu, Zhanghua; Bao, Lieming] Zhejiang Acad Agr Sci, Prov Key Lab Genet Engn Plant Metab, Virol & Biotechnol Inst, Hangzhou, Zhejiang, Peoples R China; [Peng, Jianfei] Hunan Agr Univ, Coll Biosafety Sci & Technol, Changsha, Hunan, Peoples R China; [Wang, Junming] Zhejiang Acad Agr Sci, Crop Sci & Nucl Utilizat Inst, Hangzhou, Zhejiang, Peoples R China; [Zheng, Zhi-Liang] CUNY Herbert H Lehman Coll, Dept Biol Sci, Bronx, NY 10468 USA	Zhejiang Academy of Agricultural Sciences; Hunan Agricultural University; Zhejiang Academy of Agricultural Sciences; City University of New York (CUNY) System; Lehman College (CUNY)	Xu, YH (corresponding author), Zhejiang Acad Agr Sci, Prov Key Lab Genet Engn Plant Metab, Virol & Biotechnol Inst, Hangzhou, Zhejiang, Peoples R China.	zhiliang.zheng@lehman.cuny.edu						Aasland R, 1996, TRENDS BIOCHEM SCI, V21, P87, DOI 10.1016/S0968-0004(96)30009-1; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Choi K, 2005, PLANT CELL, V17, P2647, DOI 10.1105/tpc.105.035485; Choi K, 2007, DEVELOPMENT, V134, P1931, DOI 10.1242/dev.001891; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Almeida Alex-Alan F. de, 2007, Braz. J. Plant Physiol., V19, P83, DOI 10.1590/S1677-04202007000200001; Deal RB, 2005, PLANT CELL, V17, P2633, DOI 10.1105/tpc.105.035196; Eissenberg JC, 2005, MOL CELL BIOL, V25, P6559, DOI 10.1128/MCB.25.15.6559-6569.2005; Faast R, 2001, CURR BIOL, V11, P1183, DOI 10.1016/S0960-9822(01)00329-3; Ge L, 2000, PLANT CELL ENVIRON, V23, P1169, DOI 10.1046/j.1365-3040.2000.00618.x; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; HARATA M, 1994, P NATL ACAD SCI USA, V91, P8258, DOI 10.1073/pnas.91.17.8258; Hayama R, 2004, PLANT PHYSIOL, V135, P677, DOI 10.1104/pp.104.042614; He YH, 2009, MOL PLANT, V2, P554, DOI 10.1093/mp/ssp005; Jacq C, 1997, NATURE, V387, P75, DOI 10.1038/387s075; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jeong DH, 2006, PLANT J, V45, P123, DOI 10.1111/j.1365-313X.2005.02610.x; Johnston H, 1999, J BIOL CHEM, V274, P16370, DOI 10.1074/jbc.274.23.16370; Jonsson ZO, 2001, J BIOL CHEM, V276, P16279, DOI 10.1074/jbc.M011523200; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Lazaro A, 2008, J EXP BOT, V59, P653, DOI 10.1093/jxb/erm332; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu XW, 1996, MOL CELL BIOL, V16, P4305; March-Diaz R, 2008, PLANT J, V53, P475, DOI 10.1111/j.1365-313X.2007.03361.x; March-Diaz R, 2007, PLANT PHYSIOL, V143, P893, DOI 10.1104/pp.106.092270; March-Diaz R, 2009, MOL PLANT, V2, P565, DOI 10.1093/mp/ssp019; Martin-Trillo M, 2006, DEVELOPMENT, V133, P1241, DOI 10.1242/dev.02301; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Noh YS, 2003, PLANT CELL, V15, P1671, DOI 10.1105/tpc.012161; Ruhf ML, 2001, DEVELOPMENT, V128, P1429; Ruhl DD, 2006, BIOCHEMISTRY-US, V45, P5671, DOI 10.1021/bi060043d; Sambrook J., MOL CLONING LAB MANU; Santenard A, 2009, EPIGENETICS-US, V4, P80, DOI 10.4161/epi.4.2.7838; Sterner DE, 2002, J BIOL CHEM, V277, P8178, DOI 10.1074/jbc.M108601200; Svotelis A, 2009, BIOCHEM CELL BIOL, V87, P179, DOI 10.1139/O08-138; VANDAAL A, 1992, MOL BIOL CELL, V3, P593, DOI 10.1091/mbc.3.6.593; Wu CY, 2003, PLANT J, V35, P418, DOI 10.1046/j.1365-313X.2003.01808.x; Yi H, 2006, PLANT CELL, V18, P1575, DOI 10.1105/tpc.105.039719; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	41	3	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11299	10.1371/journal.pone.0011299	http://dx.doi.org/10.1371/journal.pone.0011299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585576	Green Published, gold			2022-12-27	WOS:000279135800008
J	Marozeau, J; Innes-Brown, H; Grayden, DB; Burkitt, AN; Blamey, PJ				Marozeau, Jeremy; Innes-Brown, Hamish; Grayden, David B.; Burkitt, Anthony N.; Blamey, Peter J.			The Effect of Visual Cues on Auditory Stream Segregation in Musicians and Non-Musicians	PLOS ONE			English	Article							COCHLEAR IMPLANT LISTENERS; INTERLEAVED MELODIES; BRAIN-STEM; PERCEPTION; SPEECH; DISCRIMINATION; NONMUSICIANS; ATTENTION	Background: The ability to separate two interleaved melodies is an important factor in music appreciation. This ability is greatly reduced in people with hearing impairment, contributing to difficulties in music appreciation. The aim of this study was to assess whether visual cues, musical training or musical context could have an effect on this ability, and potentially improve music appreciation for the hearing impaired. Methods: Musicians (N = 18) and non-musicians (N = 19) were asked to rate the difficulty of segregating a four-note repeating melody from interleaved random distracter notes. Visual cues were provided on half the blocks, and two musical contexts were tested, with the overlap between melody and distracter notes either gradually increasing or decreasing. Conclusions: Visual cues, musical training, and musical context all affected the difficulty of extracting the melody from a background of interleaved random distracter notes. Visual cues were effective in reducing the difficulty of segregating the melody from distracter notes, even in individuals with no musical training. These results are consistent with theories that indicate an important role for central (top-down) processes in auditory streaming mechanisms, and suggest that visual cues may help the hearing-impaired enjoy music.	[Marozeau, Jeremy; Innes-Brown, Hamish; Blamey, Peter J.] Bion Ear Inst, Melbourne, Vic, Australia; [Grayden, David B.; Burkitt, Anthony N.] Univ Melbourne, Melbourne, Vic, Australia	University of Melbourne	Marozeau, J (corresponding author), Bion Ear Inst, Melbourne, Vic, Australia.	jmarozeau@bionicear.org	Marozeau, Jeremy/E-9329-2017; Marozeau, Jeremy/AAA-1880-2021; Burkitt, Anthony/N-9077-2013; Innes-Brown, Hamish/H-3298-2019; Grayden, David B/L-5782-2018; Marozeau, Jeremy/L-2915-2019	Marozeau, Jeremy/0000-0002-4505-135X; Burkitt, Anthony/0000-0001-5672-2772; Innes-Brown, Hamish/0000-0002-1512-2823; Grayden, David B/0000-0002-5497-7234; Blamey, Peter/0000-0002-7579-2255	Jack Brockhoff Foundation; Goldman Sachs JBWere Foundation; Soma Health Pty Ltd; Victorian Government	Jack Brockhoff Foundation; Goldman Sachs JBWere Foundation; Soma Health Pty Ltd; Victorian Government	Financial support was provided by the Jack Brockhoff Foundation, Goldman Sachs JBWere Foundation, Soma Health Pty Ltd, Mr Robert Albert AO RFD RD, Miss Betty Amsden OAM, Bruce Parncutt and Robin Campbell, and The Frederick and Winnifred Grassick Memorial Fund. The Bionic Ear Institute acknowledges the support it receives from the Victorian Government through its Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSI, 2007, S342007 ANSI; BEAUVOIS MW, 1997, TIME DECAY AUDITORY; Bregman A.S., 1994, AUDITORY SCENE ANAL; Carlyon RP, 2003, PERCEPTION, V32, P1393, DOI 10.1068/p5035; Carlyon RP, 2001, J EXP PSYCHOL HUMAN, V27, P115, DOI 10.1037/0096-1523.27.1.115; Carlyon RP, 2004, TRENDS COGN SCI, V8, P465, DOI 10.1016/j.tics.2004.08.008; Chatterjee M, 2006, HEARING RES, V222, P100, DOI 10.1016/j.heares.2006.09.001; COOPER HR, 2008, AUDITORY GROUPING CO; COOPER HR, 2009, J ASS RES OTOLARYNGO; Cooper HR, 2007, HEARING RES, V225, P11, DOI 10.1016/j.heares.2006.11.010; Cooper HR, 2009, J ACOUST SOC AM, V126, P1975, DOI 10.1121/1.3203210; DOWLING WJ, 1987, PERCEPT PSYCHOPHYS, V41, P642, DOI 10.3758/BF03210496; DOWLING WJ, 1973, COGNITIVE PSYCHOL, V5, P322, DOI 10.1016/0010-0285(73)90040-6; DOWLING WJ, 1971, J ACOUST SOC AM S2, V49; Drennan WR, 2008, J REHABIL RES DEV, V45, P779, DOI 10.1682/JRRD.2007.08.0118; Gaab N, 2005, ANN NY ACAD SCI, V1060, P82, DOI 10.1196/annals.1360.040; Gaser C, 2003, ANN NY ACAD SCI, V999, P514, DOI 10.1196/annals.1284.062; Gfeller Kate E, 2006, Audiol Neurootol, V11 Suppl 1, P12, DOI 10.1159/000095608; Gregory RL, 1970, INTELLIGENT EYE; Marks LE, 2003, INT J PSYCHOPHYSIOL, V50, P125, DOI 10.1016/S0167-8760(03)00129-6; McDermott Hugh J, 2004, Trends Amplif, V8, P49, DOI 10.1177/108471380400800203; Moore BCJ, 2002, ACTA ACUST UNITED AC, V88, P320; Musacchia G, 2006, EXP BRAIN RES, V168, P1, DOI 10.1007/s00221-005-0071-5; Musacchia G, 2008, HEARING RES, V241, P34, DOI 10.1016/j.heares.2008.04.013; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Odgaard EC, 2004, COGN AFFECT BEHAV NE, V4, P127, DOI 10.3758/CABN.4.2.127; OLEARY A, 1984, PERCEPT PSYCHOPHYS, V35, P565, DOI 10.3758/BF03205954; Oxenham Andrew J, 2008, Trends Amplif, V12, P316, DOI 10.1177/1084713808325881; Pressnitzer D, 2006, CURR BIOL, V16, P1351, DOI 10.1016/j.cub.2006.05.054; Rahne T, 2007, BRAIN RES, V1144, P127, DOI 10.1016/j.brainres.2007.01.074; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Snyder JS, 2008, J EXP PSYCHOL HUMAN, V34, P1007, DOI 10.1037/0096-1523.34.4.1007; Snyder JS, 2009, J EXP PSYCHOL HUMAN, V35, P1232, DOI 10.1037/a0012741; Stainsby TH, 2004, HEARING RES, V192, P119, DOI 10.1016/j.heares.2004.02.003; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Vliegen J, 1999, J ACOUST SOC AM, V105, P339, DOI 10.1121/1.424503; Zendel BR, 2009, J COGNITIVE NEUROSCI, V21, P1488, DOI 10.1162/jocn.2009.21140	37	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11297	10.1371/journal.pone.0011297	http://dx.doi.org/10.1371/journal.pone.0011297			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	615KY	20585606	gold, Green Published			2022-12-27	WOS:000279135400031
J	Booij, L; Tremblay, RE; Leyton, M; Seguin, JR; Vitaro, F; Gravel, P; Perreau-Linck, E; Levesque, ML; Durand, F; Diksic, M; Turecki, G; Benkelfat, C				Booij, Linda; Tremblay, Richard E.; Leyton, Marco; Seguin, Jean R.; Vitaro, Frank; Gravel, Paul; Perreau-Linck, Elisabeth; Levesque, Melissa L.; Durand, France; Diksic, Mirko; Turecki, Gustavo; Benkelfat, Chawki			Brain Serotonin Synthesis in Adult Males Characterized by Physical Aggression during Childhood: A 21-Year Longitudinal Study	PLOS ONE			English	Article							TEMPORAL-LOBE LESIONS; METHYL-L-TRYPTOPHAN; SYNTHESIS CAPACITY; PERSONALITY-DISORDER; ANTISOCIAL-BEHAVIOR; SYNTHESIS RATES; FRONTAL-LOBE; EARLY-ONSET; BOYS; TRAJECTORIES	Background: Adults exhibiting severe impulsive and aggressive behaviors have multiple indices of low serotonin (5-HT) neurotransmission. It remains unclear though whether low 5-HT mediates the behavior or instead reflects a pre-existing vulnerability trait. Methodology/Principal Findings: In the present study, positron emission tomography with the tracer alpha-[C-11]methyl-L-tryptophan (C-11-AMT) was used to compare 5-HT synthesis capacity in two groups of adult males from a 21-year longitudinal study (mean age +/- SD: 27.1+/-0.7): individuals with a history of childhood-limited high physical aggression (C-LHPA; N = 8) and individuals with normal (low) patterns of physical aggression (LPA; N = 18). The C-LHPA males had significantly lower trapping of C-11-AMT bilaterally in the orbitofrontal cortex and self-reported more impulsiveness. Despite this, in adulthood there were no group differences in plasma tryptophan levels, genotyping, aggression, emotional intelligence, working memory, computerized measures of impulsivity, psychosocial functioning/adjustment, and personal and family history of mood and substance abuse disorders. Conclusions/Significance: These results force a re-examination of the low 5-HT hypothesis as central in the biology of violence. They suggest that low 5-HT does not mediate current behavior and should be considered a vulnerability factor for impulsive-aggressive behavior that may or may not be expressed depending on other biological factors, experience, and environmental support during development.	[Booij, Linda; Leyton, Marco; Gravel, Paul; Perreau-Linck, Elisabeth; Levesque, Melissa L.; Durand, France; Benkelfat, Chawki] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Tremblay, Richard E.] Univ Montreal, Dept Psychol, Montreal, PQ H3T 1C5, Canada; [Tremblay, Richard E.] Univ Montreal, Dept Pediat, Montreal, PQ H3T 1C5, Canada; [Tremblay, Richard E.] Univ Coll Dublin, Sch Publ Hlth & Populat Sci, Dublin 2, Ireland; [Tremblay, Richard E.] INSERM, U669, Paris, France; [Tremblay, Richard E.; Seguin, Jean R.; Vitaro, Frank] Univ Montreal, Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Tremblay, Richard E.; Seguin, Jean R.] Univ Montreal, Dept Psychiat, Montreal, PQ H3T 1C5, Canada; [Leyton, Marco; Diksic, Mirko; Benkelfat, Chawki] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Leyton, Marco; Diksic, Mirko; Benkelfat, Chawki] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ H3A 2B4, Canada; [Vitaro, Frank] Univ Montreal, Sch Psychoeduc, Montreal, PQ H3T 1C5, Canada; [Turecki, Gustavo] McGill Univ, Douglas Hosp, McGill Grp Suicide Studies, Montreal, PQ, Canada	McGill University; Universite de Montreal; Universite de Montreal; University College Dublin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal; Universite de Montreal; McGill University; McGill University; Universite de Montreal; McGill University	Booij, L (corresponding author), Univ Montreal, Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada.	chawki.benkelfat@mcgill.ca	Séguin, Jean R./B-5349-2008; Turecki, Gustavo/K-5100-2015; Tremblay, Richard E./O-1360-2014; Leyton, Marco/AAY-7557-2020	Séguin, Jean R./0000-0003-3359-6202; Leyton, Marco/0000-0002-1243-2252; Turecki, Gustavo/0000-0003-4075-2736	Canadian Institutes of Health Research (CIHR) [MOP57838]; Fonds de la recherche en sante Quebec (FRSQ); Netherlands Organization for Scientific research (NWO-VENI); FQRSC; SSHRC	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Netherlands Organization for Scientific research (NWO-VENI)(Netherlands Organization for Scientific Research (NWO)); FQRSC; SSHRC(Social Sciences and Humanities Research Council of Canada (SSHRC))	This study was supported by an operating grant from the Canadian Institutes of Health Research (CIHR) to Drs. C. Benkelfat and R. E. Tremblay (MOP57838). Dr. L. Booij was supported by a postdoctoral fellowship from the Fonds de la recherche en sante Quebec (FRSQ) and by an award from the Netherlands Organization for Scientific research (NWO-VENI). The longitudinal study was supported by grants to Dr. R. E. Tremblay and collaborators from CIHR, FRSQ, FQRSC and SSHRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge MS, 2008, J NEUROSCI, V28, P199, DOI 10.1523/JNEUROSCI.3973-07.2008; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Bar-On R, 2006, PSICOTHEMA, V18, P13; Barker ED, 2007, ARCH GEN PSYCHIAT, V64, P592, DOI 10.1001/archpsyc.64.5.592; Barker ED, 2006, J CHILD PSYCHOL PSYC, V47, P783, DOI 10.1111/j.1469-7610.2005.01585.x; Barker ED, 2009, AM J PSYCHIAT, V166, P900, DOI 10.1176/appi.ajp.2009.08121770; Beck A.T., 1987, MANUAL BECK DEPRESSI; Booij L, 2007, BIOL PSYCHIAT, V61, p172S; Bremner JD, 2001, DEV PSYCHOPATHOL, V13, P473, DOI 10.1017/S0954579401003042; Brendgen M, 2008, CHILD DEV, V79, P13, DOI 10.1111/j.1467-8624.2007.01108.x; Broidy LM, 2003, DEV PSYCHOL, V39, P222, DOI 10.1037/0012-1649.39.2.222; Brown A.D., 1979, P139; Chugani DC, 1998, SYNAPSE, V28, P33, DOI 10.1002/(SICI)1098-2396(199801)28:1<33::AID-SYN5>3.0.CO;2-D; Chugani DC, 2000, J CEREBR BLOOD F MET, V20, P2, DOI 10.1097/00004647-200001000-00002; Chugani DC, 1999, ANN NEUROL, V45, P287, DOI 10.1002/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9; COCCARO EF, 1989, ARCH GEN PSYCHIAT, V46, P587; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Constantino JN, 1997, AM J PSYCHIAT, V154, P1771, DOI 10.1176/ajp.154.12.1771; Cote SM, 2007, DEV PSYCHOPATHOL, V19, P37, DOI 10.1017/S0954579407070034; Cote SM, 2006, J ABNORM CHILD PSYCH, V34, P71, DOI 10.1007/s10802-005-9001-z; de Lara CL, 2007, BIOL PSYCHIAT, V62, P72, DOI 10.1016/j.biopsych.2006.09.008; Diksic M, 2001, J NEUROCHEM, V78, P1185, DOI 10.1046/j.1471-4159.2001.00536.x; Dionne G, 2003, DEV PSYCHOL, V39, P261, DOI 10.1037/0012-1649.39.2.261; Eagle DM, 2009, NEUROPSYCHOPHARMACOL, V34, P1311, DOI 10.1038/npp.2008.202; First M. B., 1997, STRUCTURED CLIN INTE; First MB, 2002, STRUCTURED CLIN INTE; HAAPASALO J, 1994, J CONSULT CLIN PSYCH, V62, P1044, DOI 10.1037/0022-006X.62.5.1044; Hasegawa S, 2005, BRAIN RES BULL, V67, P248, DOI 10.1016/j.brainresbull.2005.07.009; Hicks BM, 2004, ARCH GEN PSYCHIAT, V61, P922, DOI 10.1001/archpsyc.61.9.922; Howell S, 2007, AM J PRIMATOL, V69, P851, DOI 10.1002/ajp.20369; IABONI F, 1995, J ABNORM PSYCHOL, V104, P232, DOI 10.1037/0021-843X.104.1.232; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; LeMarquand DG, 1999, AM J PSYCHIAT, V156, P1771; Leyton M, 2006, EUR NEUROPSYCHOPHARM, V16, P220, DOI 10.1016/j.euroneuro.2005.09.006; Leyton M, 2005, INT J NEUROPSYCHOPH, V8, P633, DOI 10.1017/S1461145705005420; Leyton M, 2001, AM J PSYCHIAT, V158, P775, DOI 10.1176/appi.ajp.158.5.775; Loeber R, 2008, PHILOS T R SOC B, V363, P2491, DOI 10.1098/rstb.2008.0032; Lundquist P, 2007, J CEREBR BLOOD F MET, V27, P821, DOI 10.1038/sj.jcbfm.9600381; Mayer JD, 2003, EMOTION, V3, P97, DOI 10.1037/1528-3542.3.1.97; Nagin D, 1999, CHILD DEV, V70, P1181, DOI 10.1111/1467-8624.00086; Nagin DS, 2001, ARCH GEN PSYCHIAT, V58, P389, DOI 10.1001/archpsyc.58.4.389; New AS, 2002, ARCH GEN PSYCHIAT, V59, P621, DOI 10.1001/archpsyc.59.7.621; Nishizawa S, 1997, P NATL ACAD SCI USA, V94, P5308, DOI 10.1073/pnas.94.10.5308; Nishizawa S, 1998, J CEREBR BLOOD F MET, V18, P1121, DOI 10.1097/00004647-199810000-00009; Okazawa H, 2000, J PSYCHIATR NEUROSCI, V25, P359; Okazawa H, 1998, J COMPUT ASSIST TOMO, V22, P777, DOI 10.1097/00004728-199809000-00021; PETRIDES M, 1985, NEUROPSYCHOLOGIA, V23, P601, DOI 10.1016/0028-3932(85)90062-4; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Rosa-Neto P, 2005, EUR J NUCL MED MOL I, V32, P1199, DOI 10.1007/s00259-005-1829-5; Sampson RJ, 2003, CRIMINOLOGY, V41, P555, DOI 10.1111/j.1745-9125.2003.tb00997.x; Seguin JR, 2004, BRAIN COGNITION, V55, P185, DOI 10.1016/s0278-2626(03)00273-2; Seguin JR, 1999, J CHILD PSYCHOL PSYC, V40, P1197, DOI 10.1111/1469-7610.00536; SEGUIN JR, 1995, J ABNORM PSYCHOL, V104, P614, DOI 10.1037/0021-843X.104.4.614; Serbin LA, 1998, DEV PSYCHOL, V34, P1246, DOI 10.1037/0012-1649.34.6.1246; Shoaf SE, 1998, NEUROPSYCHOPHARMACOL, V19, P345, DOI 10.1016/S0893-133X(98)00032-3; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; Siever LJ, 1999, NEUROPSYCHOPHARMACOL, V20, P413, DOI 10.1016/S0893-133X(98)00111-0; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Tohyama Y, 2002, NEUROCHEM INT, V40, P603, DOI 10.1016/S0197-0186(01)00132-2; Tohyama Y, 2002, J NEUROCHEM, V80, P788, DOI 10.1046/j.0022-3042.2002.00757.x; TREMBLAY RE, 1991, J ABNORM CHILD PSYCH, V19, P285, DOI 10.1007/BF00911232; Tremblay RE, 2004, PEDIATRICS, V114, pE43, DOI 10.1542/peds.114.1.e43; TREMBLAY RE, 1994, ARCH GEN PSYCHIAT, V51, P732; Tremblay RE, 2008, PHILOS T R SOC B, V363, P2613, DOI 10.1098/rstb.2008.0030; Verney C, 2002, ANAT REC, V267, P87, DOI 10.1002/ar.10089; VIRKKUNEN M, 1994, ARCH GEN PSYCHIAT, V51, P28; Young S, 1999, TRYPTOPHAN SEROTONIN	67	40	41	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11255	10.1371/journal.pone.0011255	http://dx.doi.org/10.1371/journal.pone.0011255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	614KX	20582306	gold, Green Published			2022-12-27	WOS:000279058500007
J	Guerron, AD; Rawat, R; Sali, A; Spurney, CF; Pistilli, E; Cha, HJ; Pandey, GS; Gernapudi, R; Francia, D; Farajian, V; Escolar, DM; Bossi, L; Becker, M; Zerr, P; de la Porte, S; Gordish-Dressman, H; Partridge, T; Hoffman, EP; Nagaraju, K				Guerron, Alfredo D.; Rawat, Rashmi; Sali, Arpana; Spurney, Christopher F.; Pistilli, Emidio; Cha, Hee-Jae; Pandey, Gouri S.; Gernapudi, Ramkishore; Francia, Dwight; Farajian, Viken; Escolar, Diana M.; Bossi, Laura; Becker, Magali; Zerr, Patricia; de la Porte, Sabine; Gordish-Dressman, Heather; Partridge, Terence; Hoffman, Eric P.; Nagaraju, Kanneboyina			Functional and Molecular Effects of Arginine Butyrate and Prednisone on Muscle and Heart in the mdx Mouse Model of Duchenne Muscular Dystrophy	PLOS ONE			English	Article							GLUCOCORTICOID TREATMENT; MICE; STRENGTH; IMPROVES; CELLS; DEFLAZACORT; EXPRESSION; DIAPHRAGM; PERSISTENT; FIBROSIS	Background: The number of promising therapeutic interventions for Duchenne Muscular Dystrophy (DMD) is increasing rapidly. One of the proposed strategies is to use drugs that are known to act by multiple different mechanisms including inducing of homologous fetal form of adult genes, for example utrophin in place of dystrophin. Methodology/Principal Findings: In this study, we have treated mdx mice with arginine butyrate, prednisone, or a combination of arginine butyrate and prednisone for 6 months, beginning at 3 months of age, and have comprehensively evaluated the functional, biochemical, histological, and molecular effects of the treatments in this DMD model. Arginine butyrate treatment improved grip strength and decreased fibrosis in the gastrocnemius muscle, but did not produce significant improvement in muscle and cardiac histology, heart function, behavioral measurements, or serum creatine kinase levels. In contrast, 6 months of chronic continuous prednisone treatment resulted in deterioration in functional, histological, and biochemical measures. Arginine butyrate-treated mice gene expression profiling experiments revealed that several genes that control cell proliferation, growth and differentiation are differentially expressed consistent with its histone deacetylase inhibitory activity when compared to control (saline-treated) mdx mice. Prednisone and combination treated groups showed alterations in the expression of genes that control fibrosis, inflammation, myogenesis and atrophy. Conclusions/Significance: These data indicate that 6 months treatment with arginine butyrate can produce modest beneficial effects on dystrophic pathology in mdx mice by reducing fibrosis and promoting muscle function while chronic continuous treatment with prednisone showed deleterious effects to skeletal and cardiac muscle. Our results clearly indicate the usefulness of multiple assays systems to monitor both beneficial and toxic effects of drugs with broad range of in vivo activity.	[Guerron, Alfredo D.; Rawat, Rashmi; Sali, Arpana; Pandey, Gouri S.; Gernapudi, Ramkishore; Francia, Dwight; Farajian, Viken; Escolar, Diana M.; Gordish-Dressman, Heather; Partridge, Terence; Hoffman, Eric P.; Nagaraju, Kanneboyina] George Washington Univ, Sch Med & Hlth Sci, Dept Integrat Syst Biol, Childrens Natl Med Ctr,Ctr Genet Med Res, Washington, DC 20052 USA; [Spurney, Christopher F.] Childrens Natl Med Ctr, Div Cardiol, Washington, DC 20010 USA; [Pistilli, Emidio] Univ Penn, Pennsylvania Muscle Inst, Philadelphia, PA 19104 USA; [Cha, Hee-Jae] Kosin Univ, Coll Med, Dept Parasitol & Genet, Pusan, South Korea; [Bossi, Laura; Becker, Magali; Zerr, Patricia] Transgene SA, Illkirch Graffenstaden, France	Children's National Health System; George Washington University; Children's National Health System; University of Pennsylvania; Transgene SA	Guerron, AD (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Integrat Syst Biol, Childrens Natl Med Ctr,Ctr Genet Med Res, Washington, DC 20052 USA.	knagaraju@cnmcresearch.org	Nagaraju, Kanneboyina/AAV-7684-2021; de la Porte, Sabine/N-5275-2018; Cruz, Alfredo Daniel Guerron/V-5188-2019; de la PORTE, Sabine/AAE-4208-2022; Nagaraju, Kanneboyina/ABA-6525-2021; Cha, Hee-Jae/AFO-8772-2022	Cruz, Alfredo Daniel Guerron/0000-0002-4632-1681; de la PORTE, Sabine/0000-0002-7725-8646; Hoffman, Eric/0000-0001-6470-5139	Faust Pharmaceuticals; Foundation to Eradicate Dystrophy; US Department of Defense [W81XWH-05-1-0616]; National Institutes of Health [RO1-AR050478, 5U54HD053177]; National Institutes of Health, Department of Health and Human Services [5U54HD053177, M01-RR020359]; Crystal Ball, Richmond VA; Muscular Dystrophy Association USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD053177] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR020359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050478] Funding Source: NIH RePORTER	Faust Pharmaceuticals; Foundation to Eradicate Dystrophy; US Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crystal Ball, Richmond VA; Muscular Dystrophy Association USA(Muscular Dystrophy Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Dr. Nagaraju is supported by Faust Pharmaceuticals; the Foundation to Eradicate Dystrophy; the US Department of Defense (W81XWH-05-1-0616); the National Institutes of Health (RO1-AR050478 and 5U54HD053177); and the Department of Defense (W81XWH-05-1-0616). Dr. Hoffman's research is supported in part by grant M01-RR020359; 5U54HD053177, from the National Institutes of Health, Department of Health and Human Services; the Crystal Ball, Richmond VA, Muscular Dystrophy Association USA; and the US Department of Defense (W81XWH-05-1-0616). The study design, data collection, data analysis and interpretation was done primarily by the team at Children's National Medical Center. However, the study design and draft manuscript was made available for comments and suggestions by the Faust Pharmaceuticals scientific staff. Faust Pharmaceuticals scientific staff played no role in the data collection, interpretation and decision to publish manuscript.	Anderson JE, 2000, CELL TRANSPLANT, V9, P551, DOI 10.1177/096368970000900411; Anderson JE, 1996, MUSCLE NERVE, V19, P1576, DOI 10.1002/(SICI)1097-4598(199612)19:12<1576::AID-MUS7>3.0.CO;2-7; Archer JD, 2006, FASEB J, V20, P738, DOI 10.1096/fj.05-4821fje; Barton ER, 2005, MUSCLE NERVE, V32, P751, DOI 10.1002/mus.20425; CANDIDO EPM, 1978, CELL, V14, P105, DOI 10.1016/0092-8674(78)90305-7; Chazalette D, 2005, FEBS LETT, V579, P1079, DOI 10.1016/j.febslet.2004.12.081; Connolly AM, 2002, NEUROMUSCULAR DISORD, V12, P917, DOI 10.1016/S0960-8966(02)00180-3; De Luca A, 2003, J PHARMACOL EXP THER, V304, P453, DOI 10.1124/jpet.102.041343; De Luca A, 2002, NEUROMUSCULAR DISORD, V12, pS142, DOI 10.1016/S0960-8966(02)00100-1; Granchelli JA, 1996, RES COMMUN MOL PATH, V91, P287; Granchelli JA, 2000, NEUROMUSCULAR DISORD, V10, P235, DOI 10.1016/S0960-8966(99)00126-1; Hartel JV, 2001, MUSCLE NERVE, V24, P428, DOI 10.1002/1097-4598(200103)24:3<428::AID-MUS1018>3.3.CO;2-5; Hnia K, 2008, AM J PATHOL, V172, P1509, DOI 10.2353/ajpath.2008.071009; Hoey A. J., 2006, P AUSTR PHYSL SOC, V37, P57; HUDECKI MS, 1993, RES COMMUN CHEM PATH, V79, P45; Keeling RM, 2007, MUSCLE NERVE, V35, P43, DOI 10.1002/mus.20646; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; KumarSingh R, 1996, HUM MOL GENET, V5, P913, DOI 10.1093/hmg/5.7.913; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Miura P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002309; Morrissey JJ, 1996, J AM SOC NEPHROL, V7, P2202; Nagaraju K, 2000, J IMMUNOL, V164, P5459, DOI 10.4049/jimmunol.164.10.5459; Raben N, 2000, NEUROMUSCULAR DISORD, V10, P283, DOI 10.1016/S0960-8966(99)00117-0; REYES AA, 1994, AM J PHYSIOL, V267, P331; Spurney CF, 2008, NEUROMUSCULAR DISORD, V18, P371, DOI 10.1016/j.nmd.2008.03.008; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; St-Pierre SJG, 2004, FASEB J, V18, P1937, DOI 10.1096/fj.04-1859fje; SWEAT F, 1964, ARCH PATHOL, V78, P69; Voisin V, 2005, NEUROBIOL DIS, V20, P123, DOI 10.1016/j.nbd.2005.02.010; Yang LY, 1998, MUSCLE NERVE, V21, P394, DOI 10.1002/(SICI)1097-4598(199803)21:3<394::AID-MUS14>3.0.CO;2-#	30	35	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11220	10.1371/journal.pone.0011220	http://dx.doi.org/10.1371/journal.pone.0011220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574530	Green Submitted, Green Published, gold			2022-12-27	WOS:000279058300013
J	Drumond, A; Nieto, R; Trigo, R; Ambrizzi, T; Souza, E; Gimeno, L				Drumond, Anita; Nieto, Raquel; Trigo, Ricardo; Ambrizzi, Tercio; Souza, Everaldo; Gimeno, Luis			A Lagrangian Identification of the Main Sources of Moisture Affecting Northeastern Brazil during Its Pre-Rainy and Rainy Seasons	PLOS ONE			English	Article							GENERAL-CIRCULATION MODEL; SEA-SURFACE TEMPERATURE; GLOBAL WATER CYCLE; SOUTH-AMERICA; ATMOSPHERIC BRANCH; TROPICAL ATLANTIC; PART I; PRECIPITATION; RAINFALL; VALIDATION	This work examines the sources of moisture affecting the semi-arid Brazilian Northeast (NEB) during its pre-rainy and rainy season (JFMAM) through a Lagrangian diagnosis method. The FLEXPART model identifies the humidity contributions to the moisture budget over a region through the continuous computation of changes in the specific humidity along back or forward trajectories up to 10 days period. The numerical experiments were done for the period that spans between 2000 and 2004 and results were aggregated on a monthly basis. Results show that besides a minor local recycling component, the vast majority of moisture reaching NEB area is originated in the south Atlantic basin and that the nearby wet Amazon basin bears almost no impact. Moreover, although the maximum precipitation in the "Poligono das Secas'' region (PS) occurs in March and the maximum precipitation associated with air parcels emanating from the South Atlantic towards PS is observed along January to March, the highest moisture contribution from this oceanic region occurs slightly later (April). A dynamical analysis suggests that the maximum precipitation observed in the PS sector does not coincide with the maximum moisture supply probably due to the combined effect of the Walker and Hadley cells in inhibiting the rising motions over the region in the months following April.	[Drumond, Anita; Nieto, Raquel; Gimeno, Luis] Univ Vigo, Fac Ciencias, EPhysLab, Orense, Spain; [Trigo, Ricardo] Univ Lisbon, CGUL IDL, P-1699 Lisbon, Portugal; [Trigo, Ricardo] Univ Lusofona, Dept Engn, Lisbon, Portugal; [Ambrizzi, Tercio] Univ Sao Paulo, Dept Ciencias Atmosfericas, Inst Astron Geofis & Ciencias Atmosfericas, Sao Paulo, Brazil; [Souza, Everaldo] Fed Univ Para, BR-66059 Belem, Para, Brazil	Universidade de Vigo; Universidade de Lisboa; Lusofona University; Universidade de Sao Paulo; Universidade Federal do Para	Drumond, A (corresponding author), Univ Vigo, Fac Ciencias, EPhysLab, Orense, Spain.	anitadru@uvigo.es	Drumond, Anita RM/G-5767-2013; Ambrizzi, Tercio/A-4636-2008; Trigo, Ricardo/Q-8391-2019; Nieto, Raquel/AAT-8925-2020; Trigo, Ricardo M/B-7044-2008; GIMENO, LUIS/B-8137-2008; De Souza, Everaldo/V-5163-2017	Drumond, Anita RM/0000-0002-0432-8842; Trigo, Ricardo/0000-0002-4183-9852; Nieto, Raquel/0000-0002-8984-0959; Trigo, Ricardo M/0000-0002-4183-9852; GIMENO, LUIS/0000-0002-0778-3605; De Souza, Everaldo/0000-0001-6045-0984	Spanish Ministry of Science and Innovation [SB2006-0209, CGL2008-05968-C02-02/CLI]; Conselho de REitores das Universidades Portuguesas (CRUP) [E-16/2008]; Ministerio de Ciencia y Tecnologia (MCYT) [HP2007-0064]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao para o amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Conselho de REitores das Universidades Portuguesas (CRUP); Ministerio de Ciencia y Tecnologia (MCYT)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao para o amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Spanish Ministry of Science and Innovation through the program "Programa de ayudas para la movilidad de profesores de Universidad e investigadores espanoles y extranjeros'' (SB2006-0209) and the project CGL2008-05968-C02-02/CLI; Portuguese-Spanish integrated action funded by Conselho de REitores das Universidades Portuguesas (CRUP) (E-16/2008) and Ministerio de Ciencia y Tecnologia (MCYT) (HP2007-0064); the Brazilian Institutions Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao para o amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRUBAKER KL, 1993, J CLIMATE, V6, P1077, DOI 10.1175/1520-0442(1993)006<1077:EOCPR>2.0.CO;2; Burde GI, 2001, J CLIMATE, V14, P2497, DOI 10.1175/1520-0442(2001)014<2497:TEORPR>2.0.CO;2; Drumond A, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009547; Eltahir EAB, 1996, REV GEOPHYS, V34, P367, DOI 10.1029/96RG01927; Hastenrath S, 2001, INT J CLIMATOL, V21, P37, DOI 10.1002/joc.597; KALNAY E, 1996, B AM METEOROL SOC, V77, P471; MOLION L, 2002, BRAZILIAN J METEOROL, V17, P1; Moura AD, 2004, J CLIMATE, V17, P2667, DOI 10.1175/1520-0442(2004)017&lt;2667:CPFBNP&gt;2.0.CO;2; MOURA AD, 1981, J ATMOS SCI, V38, P2653, DOI 10.1175/1520-0469(1981)038<2653:OTDODI>2.0.CO;2; Nieto R, 2008, HYDROLOG SCI J, V53, P602, DOI 10.1623/hysj.53.3.602; Nieto R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027232; Nieto R, 2007, METEOROL Z, V16, P37, DOI 10.1127/0941-2948/2007/0176; Nobre P, 1996, J CLIMATE, V9, P2464, DOI 10.1175/1520-0442(1996)009<2464:VOSSTW>2.0.CO;2; Numaguti A, 1999, J GEOPHYS RES-ATMOS, V104, P1957, DOI 10.1029/1998JD200026; Pezzi LP, 2001, CLIM DYNAM, V17, P205, DOI 10.1007/s003820000104; RAO VB, 1995, INT J CLIMATOL, V15, P697, DOI 10.1002/joc.3370150608; Rao VB, 1997, AGR FOREST METEOROL, V85, P63, DOI 10.1016/S0168-1923(96)02390-8; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; SOUZA E, 2004, BRAZILIAN J METEOROL, V19, P113; SOUZA E, 2003, CLIMANALISE; Stohl A, 2005, J HYDROMETEOROL, V6, P961, DOI 10.1175/JHM470.1; Stohl A, 2004, J HYDROMETEOROL, V5, P656, DOI 10.1175/1525-7541(2004)005<0656:ALAOTA>2.0.CO;2; Stohl A, 1998, ATMOS ENVIRON, V32, P4245, DOI 10.1016/S1352-2310(98)00184-8; Sun LQ, 2006, J CLIMATE, V19, P1990, DOI 10.1175/JCLI3715.1; Trenberth KE, 1999, J CLIMATE, V12, P1368, DOI 10.1175/1520-0442(1999)012<1368:AMRROA>2.0.CO;2; Uvo CB, 1998, J CLIMATE, V11, P551, DOI 10.1175/1520-0442(1998)011<0551:TRBTPA>2.0.CO;2; Vera C, 2006, J CLIMATE, V19, P4977, DOI 10.1175/JCLI3896.1; WALISER DE, 1993, J CLIMATE, V6, P2162, DOI 10.1175/1520-0442(1993)006<2162:ASDCOT>2.0.CO;2; WHITE PW, 2002, IFS DOCUMENTATION; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2; Zhou JY, 2001, INT J CLIMATOL, V21, P1623, DOI 10.1002/joc.700	31	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11205	10.1371/journal.pone.0011205	http://dx.doi.org/10.1371/journal.pone.0011205			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585458	Green Published, gold, Green Submitted			2022-12-27	WOS:000278977200010
J	de Jong, EP; Xie, HW; Onsongo, G; Stone, MD; Chen, XB; Kooren, JA; Refsland, EW; Griffin, RJ; Ondrey, FG; Wu, BL; Le, CT; Rhodus, NL; Carlis, JV; Griffin, TJ				de Jong, Ebbing P.; Xie, Hongwei; Onsongo, Getiria; Stone, Matthew D.; Chen, Xiao-Bing; Kooren, Joel A.; Refsland, Eric W.; Griffin, Robert J.; Ondrey, Frank G.; Wu, Baolin; Le, Chap T.; Rhodus, Nelson L.; Carlis, John V.; Griffin, Timothy J.			Quantitative Proteomics Reveals Myosin and Actin as Promising Saliva Biomarkers for Distinguishing Pre-Malignant and Malignant Oral Lesions	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TANDEM MASS-SPECTROMETRY; MULTIDIMENSIONAL LIQUID-CHROMATOGRAPHY; WHOLE SALIVA; CANCER; EXPRESSION; IDENTIFICATION; CYTOSKELETON; INFLAMMATION; DISCOVERY	Background: Oral cancer survival rates increase significantly when it is detected and treated early. Unfortunately, clinicians now lack tests which easily and reliably distinguish pre-malignant oral lesions from those already transitioned to malignancy. A test for proteins, ones found in non-invasively-collected whole saliva and whose abundances distinguish these lesion types, would meet this critical need. Methodology/Principal Findings: To discover such proteins, in a first-of-its-kind study we used advanced mass spectrometry-based quantitative proteomics analysis of the pooled soluble fraction of whole saliva from four subjects with pre-malignant lesions and four with malignant lesions. We prioritized candidate biomarkers via bioinformatics and validated selected proteins by western blotting. Bioinformatic analysis of differentially abundant proteins and initial western blotting revealed increased abundance of myosin and actin in patients with malignant lesions. We validated those results by additional western blotting of individual whole saliva samples from twelve other subjects with pre-malignant oral lesions and twelve with malignant oral lesions. Sensitivity/specificity values for distinguishing between different lesion types were 100%/75% (p = 0.002) for actin, and 67%/83% (p < 0.00001) for myosin in soluble saliva. Exfoliated epithelial cells from subjects' saliva also showed increased myosin and actin abundance in those with malignant lesions, linking our observations in soluble saliva to abundance differences between pre-malignant and malignant cells. Conclusions/Significance: Salivary actin and myosin abundances distinguish oral lesion types with sensitivity and specificity rivaling other non-invasive oral cancer tests. Our findings provide a promising starting point for the development of non-invasive and inexpensive salivary tests to reliably detect oral cancer early.	[de Jong, Ebbing P.; Xie, Hongwei; Stone, Matthew D.; Kooren, Joel A.; Refsland, Eric W.; Griffin, Timothy J.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Onsongo, Getiria; Carlis, John V.] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA; [Ondrey, Frank G.] Univ Minnesota, Dept Otalaryngol, Minneapolis, MN USA; [Wu, Baolin; Le, Chap T.] Univ Minnesota, Dept Biostat, Minneapolis, MN USA; [Rhodus, Nelson L.] Univ Minnesota, Dept Oral Med Diag & Radiol, Minneapolis, MN USA; [Chen, Xiao-Bing] Sun Yat Sen Univ, Guanghua Sch Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Griffin, Robert J.] Univ Arkansas Med Sci, Dept Radiat Oncol, Little Rock, AR 72205 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Sun Yat Sen University; University of Arkansas System; University of Arkansas Medical Sciences	Griffin, TJ (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	tgriffin@umn.edu		de Jong, Ebbing/0000-0002-0362-1772; Griffin, Timothy/0000-0001-6801-2559; WU, BAOLIN/0000-0001-6676-0422; Griffin, Robert/0000-0002-3574-2958	NIDCR, National Institutes of Health [R01DE17734]; Minnesota Medical Foundation; American Cancer Society [IRG-58-001-46]; Eli Lilly and Co.; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017734] Funding Source: NIH RePORTER	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Minnesota Medical Foundation; American Cancer Society(American Cancer Society); Eli Lilly and Co.(Eli Lilly); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIDCR, National Institutes of Health Grant R01DE17734 and in part by grants from the Minnesota Medical Foundation, American Cancer Society Institutional Research Grant IRG-58-001-46, and a research award from Eli Lilly and Co. (to T.J.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt-Holland A, 2008, J INVEST DERMATOL, V128, P2498, DOI 10.1038/jid.2008.102; Cheng B, 2004, ORAL SURG ORAL MED O, V97, P465, DOI 10.1016/j.tripleo.2003.12.020; Feigin ME, 2009, CURR OPIN CELL BIOL, V21, P694, DOI 10.1016/j.ceb.2009.07.003; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Griffin TJ, 2007, J PROTEOME RES, V6, P4200, DOI 10.1021/pr070291b; Gurenlian JoAnn R, 2009, Dent Assist, V78, P8; Gurenlian JR., 2009, DENT ASSIST, V78, P41; Gurenlian JR, 2009, DENT ASSIST, V78, P12; Gurenlian JR, 2009, DENT ASSIST, V78, P38; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hofman LF, 2001, J NUTR, V131, p1621S, DOI 10.1093/jn/131.5.1621S; Hu S, 2008, CLIN CANCER RES, V14, P6246, DOI 10.1158/1078-0432.CCR-07-5037; Jokerst JV, 2010, NANOMEDICINE-UK, V5, P143, DOI 10.2217/NNM.09.94; Le CT, 2006, STAT METHODS MED RES, V15, P571, DOI 10.1177/0962280206070637; Li Q, 2009, J INT MED RES, V37, P446, DOI 10.1177/147323000903700220; Lingen MW, 2008, ORAL ONCOL, V44, P10, DOI 10.1016/j.oraloncology.2007.06.011; Liu SC, 2009, CANCER RES, V69, P6122, DOI 10.1158/0008-5472.CAN-08-3435; Lo WY, 2007, CLIN CHIM ACTA, V376, P101, DOI 10.1016/j.cca.2006.06.030; *NAT CANC I, 1993, SEER STAT REV 1975 2; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Qi YJ, 2005, PROTEOMICS, V5, P2960, DOI 10.1002/pmic.200401175; Ralhan R, 2008, MOL CELL PROTEOMICS, V7, P1162, DOI 10.1074/mcp.M700500-MCP200; Ralhan R, 2009, J PROTEOME RES, V8, P300, DOI 10.1021/pr800501j; Ram S, 2005, INT J ORAL MAX SURG, V34, P521, DOI 10.1016/j.ijom.2004.10.008; Rhodus N, 2007, INSIDE DENT, V3, P1; Rhodus Nelson L, 2005, Dent Clin North Am, V49, P143, DOI 10.1016/j.cden.2004.07.003; Rhodus NL, 2004, CANCER DETECT PREV, V29, P42, DOI 10.1016/j.cdp.2004.10.003; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Shi Lin, 2006, Zhonghua Kou Qiang Yi Xue Za Zhi, V41, P106; Turhani D, 2006, ELECTROPHORESIS, V27, P1417, DOI 10.1002/elps.200500510; Uzquiano MC, 2008, MODERN PATHOL, V21, P540, DOI 10.1038/modpathol.3801051; Van Dyke TE, 2008, J PERIODONTOL, V79, P1601, DOI 10.1902/jop.2008.080173; Wang Z, 2008, MOL CELL PROTEOMICS, V7, P1639, DOI 10.1074/mcp.M700520-MCP200; WARNAKULASURIYA KAAS, 1991, CANCER DETECT PREV, V15, P331; Wong DT, 2006, EXPERT REV MOL DIAGN, V6, P267, DOI 10.1586/14737159.6.3.267; XIE H, 2005, MOL CELL PROTEOMICS; Xie HW, 2008, MOL CELL PROTEOMICS, V7, P486, DOI 10.1074/mcp.M700146-MCP200; Zhong LP, 2007, ORAL SURG ORAL MED O, V104, P377, DOI 10.1016/j.tripleo.2006.07.019; Zhong LP, 2006, ARCH ORAL BIOL, V51, P1112, DOI 10.1016/j.archoralbio.2006.05.005	40	67	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11148	10.1371/journal.pone.0011148	http://dx.doi.org/10.1371/journal.pone.0011148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567502	Green Published, Green Submitted, gold			2022-12-27	WOS:000278886300004
J	Hlevnjak, M; Zitkovic, G; Zagrovic, B				Hlevnjak, Mario; Zitkovic, Gordan; Zagrovic, Bojan			Hydrophilicity Matching - A Potential Prerequisite for the Formation of Protein-Protein Complexes in the Cell	PLOS ONE			English	Article							LOCALIZATION; SIMULATIONS; RADII; RECOGNITION; ASSOCIATION; CYTOPLASM; DYNAMICS; MODEL; CUE; VAN	A binding event between two proteins typically consists of a diffusional search of binding partners for one another, followed by a specific recognition of the compatible binding sites resulting in the formation of the complex. However, it is unclear how binding partners find each other in the context of the crowded, constantly fluctuating, and interaction-rich cellular environment. Here we examine the non-specific component of protein-protein interactions, which refers to those physicochemical properties of the binding partners that are independent of the exact details of their binding sites, but which can affect their localization or diffusional search for one another. We show that, for a large set of high-resolution experimental 3D structures of binary, transient protein complexes taken from the DOCKGROUND database, the binding partners display a surprising, statistically significant similarity in terms of their total hydration free energies normalized by a size-dependent variable. We hypothesize that colocalization of binding partners, even within individual cellular compartments such as the cytoplasm, may be influenced by their relative hydrophilicity, potentially in response to local hydrophilic gradients.	[Hlevnjak, Mario; Zagrovic, Bojan] Mediterranean Inst Life Sci, Split, Croatia; [Zitkovic, Gordan] Univ Texas Austin, Dept Math, Austin, TX 78712 USA; [Zagrovic, Bojan] Univ Split, Dept Phys, Split, Croatia	University of Texas System; University of Texas Austin; University of Split	Zagrovic, B (corresponding author), Max F Perutz Labs GmbH, Dept Struct & Computat Biol, Lab Computat Biophys, Vienna, Austria.	bojan.zagrovic@univie.ac.at		Zagrovic, Bojan/0000-0003-3814-3675	National Foundation for Science, Higher Education and Technological Development of Croatia; EMBO (European Molecular Biology Organization); Unity Through Knowledge Fund	National Foundation for Science, Higher Education and Technological Development of Croatia; EMBO (European Molecular Biology Organization)(European Molecular Biology Organization (EMBO)); Unity Through Knowledge Fund	This work was supported in part by the National Foundation for Science, Higher Education and Technological Development of Croatia (http://www.nzz.hr) with an EMBO (European Molecular Biology Organization, http://www.embo.org) Installation grant to BZ, and the Unity Through Knowledge Fund (http://www.ukf.hr) with an UKF 1A grant to BZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agutter PS, 2000, BIOESSAYS, V22, P1018, DOI 10.1002/1521-1878(200011)22:11<1018::AID-BIES8>3.3.CO;2-P; Batada NN, 2006, PLOS COMPUT BIOL, V2, P343, DOI 10.1371/journal.pcbi.0020044; Batada NN, 2004, P NATL ACAD SCI USA, V101, P6445, DOI 10.1073/pnas.0401314101; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berg, 2018, RANDOM WALKS BIOL; Berg JM, 2006, BIOCHEMISTRY; Bickmore WA, 2002, EMBO J, V21, P1248, DOI 10.1093/emboj/21.6.1248; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Chen JH, 2008, CURR OPIN STRUC BIOL, V18, P140, DOI 10.1016/j.sbi.2008.01.003; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Du PF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-518; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Gabdoulline RR, 2002, CURR OPIN STRUC BIOL, V12, P204, DOI 10.1016/S0959-440X(02)00311-1; Gao Y, 2007, PROTEINS, V69, P845, DOI 10.1002/prot.21714; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KOTZ S, 1983, ENCY STAT SCI, V4, P212; Kundrotas PJ, 2006, BIOPHYS J, V91, P1724, DOI 10.1529/biophysj.106.086025; Lienqueo ME, 2002, J CHROMATOGR A, V978, P71, DOI 10.1016/S0021-9673(02)01358-4; Mahn A, 2009, J CHROMATOGR A, V1216, P1838, DOI 10.1016/j.chroma.2008.11.089; Niwa T, 2009, P NATL ACAD SCI USA, V106, P4201, DOI 10.1073/pnas.0811922106; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Qiu D, 1997, J PHYS CHEM A, V101, P3005, DOI 10.1021/jp961992r; Ramamurthi KS, 2009, P NATL ACAD SCI USA, V106, P13541, DOI 10.1073/pnas.0906851106; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; Ridgway D, 2008, BIOPHYS J, V94, P3748, DOI 10.1529/biophysj.107.116053; Rowland RS, 1996, J PHYS CHEM-US, V100, P7384, DOI 10.1021/jp953141+; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sutherland HGE, 2001, HUM MOL GENET, V10, P1995, DOI 10.1093/hmg/10.18.1995; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Vendruscolo M, 2008, MOL BIOSYST, V4, P1170, DOI 10.1039/b805710a; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; WALTER H, 1995, FEBS LETT, V361, P135, DOI 10.1016/0014-5793(95)00159-7; Wieczorek G, 2008, BIOPHYS J, V95, P5030, DOI 10.1529/biophysj.108.136291	34	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11169	10.1371/journal.pone.0011169	http://dx.doi.org/10.1371/journal.pone.0011169			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567518	Green Submitted, Green Published, gold			2022-12-27	WOS:000278886300015
J	Roa, S; Li, ZQ; Peled, JU; Zhao, CF; Edelmann, W; Scharff, MD				Roa, Sergio; Li, Ziqiang; Peled, Jonathan U.; Zhao, Chunfang; Edelmann, Winfried; Scharff, Matthew D.			MSH2/MSH6 Complex Promotes Error-Free Repair of AID-Induced dU:G Mispairs as well as Error-Prone Hypermutation of A:T Sites	PLOS ONE			English	Article							DNA-POLYMERASE-ETA; CLASS-SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; MISMATCH-REPAIR; MICE DEFICIENT; B-CELLS; IMMUNOGLOBULIN GENES; STRAND BIAS; MSH6; MUTATIONS	Mismatch repair of AID-generated dU:G mispairs is critical for class switch recombination (CSR) and somatic hypermutation (SHM) in B cells. The generation of a previously unavailable Msh2(-/-) Msh6(-/-) mouse has for the first time allowed us to examine the impact of the complete loss of MutS alpha on lymphomagenesis, CSR and SHM. The onset of T cell lymphomas and the survival of Msh2(-/-) Msh6(-/-) and Msh2(-/-) Msh6(-/-) Msh3(-/-) mice are indistinguishable from Msh2(-/-) mice, suggesting that MSH2 plays the critical role in protecting T cells from malignant transformation, presumably because it is essential for the formation of stable MutS alpha heterodimers that maintain genomic stability. The similar defects on switching in Msh2(-/-), Msh2(-/-)Msh6(-/-) and Msh2(-/-)Msh6(-/-)Msh3(-/-) mice confirm that MutS alpha but not MutS beta plays an important role in CSR. Analysis of SHM in Msh2(-/-)Msh6(-/-) mice not only confirmed the error-prone role of MutS alpha in the generation of strand biased mutations at A:T bases, but also revealed an error-free role of MutS alpha when repairing some of the dU:G mispairs generated by AID on both DNA strands. We propose a model for the role of MutS alpha at the immunoglobulin locus where the local balance of error-free and error-prone repair has an impact in the spectrum of mutations introduced during Phase 2 of SHM.	[Roa, Sergio; Li, Ziqiang; Peled, Jonathan U.; Zhao, Chunfang; Edelmann, Winfried; Scharff, Matthew D.] Albert Einstein Coll Med, Dept Cell Biol, New York, NY USA	Yeshiva University	Scharff, MD (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, New York, NY USA.	matthew.scharff@einstein.yu.edu	Roa, Sergio/H-9293-2015	Roa, Sergio/0000-0003-1095-0715; Peled, Jonathan/0000-0002-4029-7625	Spanish Ministry of Education and Science [EX-2006-0732]; LLS Fellowship; Albert Einstein College of Medicine [T32 GM 007288]; National Women's Division of the Albert Einstein College of Medicine;  [RO1CA76329];  [RO1CA93484];  [RO1CA72649];  [RO1CA102705]; NATIONAL CANCER INSTITUTE [R01CA102705, R01CA072649, R01CA076329, R01CA093484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	Spanish Ministry of Education and Science(Spanish Government); LLS Fellowship; Albert Einstein College of Medicine; National Women's Division of the Albert Einstein College of Medicine; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	SR is supported by the Postdoctoral Fellowship EX-2006-0732 from the Spanish Ministry of Education and Science. ZL was supported by the LLS Fellowship and his current address is Beijing Novo Nordisk Pharmaceuticals Science and Technology Co. Ltd., China. JUP is supported by the Medical Scientist Training Program T32 GM 007288 at Albert Einstein College of Medicine. WE is supported by RO1CA76329 and RO1CA93484. MDS is supported by RO1CA72649 and RO1CA102705 and by the Harry Eagle Chair provided by the National Women's Division of the Albert Einstein College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Campbell MR, 2005, CANCER RES, V65, P2626, DOI 10.1158/0008-5472.CAN-04-3158; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; Clark AB, 2007, NUCLEIC ACIDS RES, V35, P4114, DOI 10.1093/nar/gkm409; Delbos F, 2007, J EXP MED, V204, P17, DOI 10.1084/jem.20062131; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Edelmann W, 2000, CANCER RES, V60, P803; Edelmann W, 1997, CELL, V91, P467, DOI 10.1016/S0092-8674(00)80433-X; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; Franklin A, 2008, TRENDS IMMUNOL, V29, P167, DOI 10.1016/j.it.2008.01.008; Frey S, 1998, IMMUNITY, V9, P127, DOI 10.1016/S1074-7613(00)80594-4; Frieder D, 2009, MOL CELL BIOL, V29, P5148, DOI 10.1128/MCB.00647-09; Hegan DC, 2006, CARCINOGENESIS, V27, P2402, DOI 10.1093/carcin/bgl079; Jacobs H, 1998, J EXP MED, V187, P1735, DOI 10.1084/jem.187.11.1735; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; KRIJGER PH, 2009, J EXP MED; Kunkel TA, 2003, DNA REPAIR, V2, P135, DOI 10.1016/S1568-7864(02)00224-0; Langerak P, 2007, J EXP MED, V204, P1989, DOI 10.1084/jem.20070902; Li ZQ, 2006, IMMUNITY, V24, P393, DOI 10.1016/j.immuni.2006.02.011; Li ZQ, 2004, J EXP MED, V200, P47, DOI 10.1084/jem.20040355; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; MacCarthy T, 2009, DNA REPAIR, V8, P137, DOI 10.1016/j.dnarep.2008.09.006; Martin A, 2003, J EXP MED, V198, P1171, DOI 10.1084/jem.20030880; Martomo SA, 2004, J EXP MED, V200, P61, DOI 10.1084/jem.20040691; Mayorov VI, 2005, J IMMUNOL, V174, P7781, DOI 10.4049/jimmunol.174.12.7781; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Reynaud CA, 2009, PHILOS T R SOC B, V364, P613, DOI 10.1098/rstb.2008.0206; Roa S, 2008, P NATL ACAD SCI USA, V105, P16248, DOI 10.1073/pnas.0808182105; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323; Scott RH, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.048942; Shell SS, 2007, MOL CELL, V26, P565, DOI 10.1016/j.molcel.2007.04.024; Shen HM, 2006, J IMMUNOL, V177, P5386, DOI 10.4049/jimmunol.177.8.5386; Smits R, 2000, GENE CHROMOSOME CANC, V29, P229, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1033>3.0.CO;2-R; Steele EJ, 2009, MOL IMMUNOL, V46, P305, DOI 10.1016/j.molimm.2008.10.021; Storb U, 2009, CELL CYCLE, V8, P3097, DOI 10.4161/cc.8.19.9658; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Wei K, 2002, TRENDS MOL MED, V8, P346, DOI 10.1016/S1471-4914(02)02359-6; WEISS U, 1990, J EXP MED, V172, P1681, DOI 10.1084/jem.172.6.1681; Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579; Wilson TM, 2005, J EXP MED, V201, P637, DOI 10.1084/jem.20042066; Xiao Z, 2007, MOL IMMUNOL, V44, P2659, DOI 10.1016/j.molimm.2006.12.006	49	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11182	10.1371/journal.pone.0011182	http://dx.doi.org/10.1371/journal.pone.0011182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567595	Green Submitted, Green Published, gold			2022-12-27	WOS:000278886300024
J	Nakajima, Y; Nishikawa, A; Iguchi, A; Sakai, K				Nakajima, Yuichi; Nishikawa, Akira; Iguchi, Akira; Sakai, Kazuhiko			Gene Flow and Genetic Diversity of a Broadcast-Spawning Coral in Northern Peripheral Populations	PLOS ONE			English	Article							CLIMATE-CHANGE; MICROSATELLITE MARKERS; CARIBBEAN CORAL; REEF; DISPERSAL; CONNECTIVITY; REPRODUCTION; LOCI; RECRUITMENT	Recently, reef-building coral populations have been decreasing worldwide due to various disturbances. Population genetic studies are helpful for estimating the genetic connectivity among populations of marine sessile organisms with metapopulation structures such as corals. Moreover, the relationship between latitude and genetic diversity is informative when evaluating the fragility of populations. In this study, using highly variable markers, we examined the population genetics of the broadcast-spawning coral Acropora digitifera at 19 sites in seven regions along the 1,000 km long island chain of Nansei Islands, Japan. This area includes both subtropical and temperate habitats. Thus, the coral populations around the Nansei Islands in Japan are northern peripheral populations that would be subjected to environmental stresses different from those in tropical areas. The existence of high genetic connectivity across this large geographic area was suggested for all sites (F-ST <= 0.033) although small but significant genetic differentiation was detected among populations in geographically close sites and regions. In addition, A. digitifera appears to be distributed throughout the Nansei Islands without losing genetic diversity. Therefore, A. digitifera populations in the Nansei Islands may be able to recover relatively rapidly even when high disturbances of coral communities occur locally if populations on other reefs are properly maintained.	[Nakajima, Yuichi; Nishikawa, Akira; Iguchi, Akira; Sakai, Kazuhiko] Univ Ryukyus, Sesoko Stn, Trop Biosphere Res Ctr, Okinawa, Japan	University of the Ryukyus	Nakajima, Y (corresponding author), Univ Ryukyus, Sesoko Stn, Trop Biosphere Res Ctr, Okinawa, Japan.	yn_r160@yahoo.co.jp	Iguchi, Akira/I-3180-2016; Nakajima, Yuichi/A-4330-2013	Iguchi, Akira/0000-0002-8894-1977; Nakajima, Yuichi/0000-0001-6558-5378; Sakai, Kazuhiko/0000-0003-1905-5952	Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science [16310158, 18651112]; Grants-in-Aid for Scientific Research [21247006] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant for the 21st Century COE program "The Comprehensive Analyses on Biodiversity in Coral Reef and Island Ecosystems in Asian and Pacific Regions'' from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Monbukagakusho), and by the Japan Society for the Promotion of Science (Grants-In-Aid Nos. 16310158 and 18651112 to K. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayre DJ, 2004, ECOL LETT, V7, P273, DOI 10.1111/j.1461-0248.2004.00585.x; Baums IB, 2005, MAR ECOL PROG SER, V288, P115, DOI 10.3354/meps288115; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Coffroth MA, 1998, EVOLUTION, V52, P379, DOI 10.1111/j.1558-5646.1998.tb01639.x; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; EXCOFFIER L, 1992, GENETICS, V131, P479; Foret S, 2007, CORAL REEFS, V26, P475, DOI 10.1007/s00338-007-0206-1; GAINES SD, 1992, NATURE, V360, P579, DOI 10.1038/360579a0; Gilg MR, 2007, MAR ECOL PROG SER, V351, P151, DOI 10.3354/meps07145; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GOWER JC, 1966, BIOMETRIKA, V53, P588, DOI 10.1093/biomet/53.3-4.588; Hayashibara T, 2002, CORAL REEFS, V21, P224; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Hellberg ME, 2007, CORAL REEFS, V26, P463, DOI 10.1007/s00338-007-0205-2; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Isomura N, 2008, MOL ECOL RESOUR, V8, P587, DOI 10.1111/j.1471-8286.2007.02004.x; Kojima S, 2005, ECOL RES, V20, P686, DOI 10.1007/s11284-005-0082-5; KramarskyWinter E, 1997, NATURE, V387, P137, DOI 10.1038/387137a0; Lirman D, 2000, MAR ECOL PROG SER, V197, P209, DOI 10.3354/meps197209; Miller KJ, 2008, CONSERV BIOL, V22, P1245, DOI 10.1111/j.1523-1739.2008.00985.x; Miller KJ, 2004, HEREDITY, V92, P557, DOI 10.1038/sj.hdy.6800459; Ministry of the Environment of Japan, 2004, COR REEF MON INV IR; Nakajima Yuichi, 2009, Plankton & Benthos Research, V4, P38; Nakajima Y, 2009, ZOOL SCI, V26, P209, DOI 10.2108/zsj.26.209; Nishihira M., 1995, HERMATYPIC CORALS JA; Nishikawa A, 2005, ZOOL SCI, V22, P391, DOI 10.2108/zsj.22.391; Nishikawa A, 2005, CORAL REEFS, V24, P318, DOI 10.1007/s00338-005-0484-4; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Purcell JFH, 2006, P ROY SOC B-BIOL SCI, V273, P1483, DOI 10.1098/rspb.2006.3470; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Ridgway T, 2008, MAR ECOL PROG SER, V354, P161, DOI 10.3354/meps07245; Smith LD, 1999, J EXP MAR BIOL ECOL, V235, P147, DOI 10.1016/S0022-0981(98)00178-6; Underwood JN, 2009, EVOL APPL, V2, P222, DOI 10.1111/j.1752-4571.2008.00065.x; Underwood JN, 2009, ECOL APPL, V19, P18, DOI 10.1890/07-1461.1; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Van Oppen MJH, 2007, MOL ECOL NOTES, V7, P436, DOI 10.1111/j.1471-8286.2006.01610.x; Van Oppen MJH, 2006, MOL ECOL, V15, P3863, DOI 10.1111/j.1365-294X.2006.03026.x; van Oppen MJH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003401; Veron J.E.N., 2000, CORALS WORLD, V1-3; WALLACE CC, 1985, MAR BIOL, V88, P217, DOI 10.1007/BF00392585; Yasuda N, 2009, MOL ECOL, V18, P1574, DOI 10.1111/j.1365-294X.2009.04133.x	45	54	54	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11149	10.1371/journal.pone.0011149	http://dx.doi.org/10.1371/journal.pone.0011149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585399	Green Published, Green Submitted, gold			2022-12-27	WOS:000278886100014
J	Leonardi, R; Rehg, JE; Rock, CO; Jackowski, S				Leonardi, Roberta; Rehg, Jerold E.; Rock, Charles O.; Jackowski, Suzanne			Pantothenate Kinase 1 Is Required to Support the Metabolic Transition from the Fed to the Fasted State	PLOS ONE			English	Article							FATTY-ACID OXIDATION; ACTIVATED RECEPTOR-ALPHA; COA DEHYDROGENASE-DEFICIENCY; PEROXISOMAL NUDIX HYDROLASE; HEPATIC COENZYME-A; BETA-OXIDATION; FEEDBACK-REGULATION; GENE ENCODES; MALONYL-COA; PPAR-ALPHA	Coenzyme A (CoA) biosynthesis is regulated by the pantothenate kinases (PanK), of which there are four active isoforms. The PanK1 isoform is selectively expressed in liver and accounted for 40% of the total PanK activity in this organ. CoA synthesis was limited using a Pank1(-/-) knockout mouse model to determine whether the regulation of CoA levels was critical to liver function. The elimination of PanK1 reduced hepatic CoA levels, and fasting triggered a substantial increase in total hepatic CoA in both Pank1(-/-) and wild-type mice. The increase in hepatic CoA during fasting was blunted in the Pank1(-/-) mouse, and resulted in reduced fatty acid oxidation as evidenced by abnormally high accumulation of long-chain acyl-CoAs, acyl-carnitines, and triglycerides in the form of lipid droplets. The Pank1(-/-) mice became hypoglycemic during a fast due to impaired gluconeogenesis, although ketogenesis was normal. These data illustrate the importance of PanK1 and elevated liver CoA levels during fasting to support the metabolic transition from glucose utilization and fatty acid synthesis to gluconeogenesis and fatty acid oxidation. The findings also suggest that PanK1 may be a suitable target for therapeutic intervention in metabolic disorders that feature hyperglycemia and hypertriglyceridemia.	[Leonardi, Roberta; Rock, Charles O.; Jackowski, Suzanne] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Rehg, Jerold E.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Leonardi, R (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	suzanne.jackowski@stjude.org	Jackowski, Suzanne/N-8168-2018; Rehg, Jerold E/N-8111-2018	Jackowski, Suzanne/0000-0002-6855-1429; 	National Institutes of Health [GM062896]; Cancer Center (CORE) [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center (CORE); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM062896 (S.J.), a Cancer Center (CORE) Support Grant CA21765, and the American Lebanese Syrian Associated Charities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 1997, AM J PHYSIOL-REG I, V272, pR1641, DOI 10.1152/ajpregu.1997.272.5.R1641; ARGMANN CA, 2006, CURRENT PROTOCOLS MO, V5; Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLUNT AD, 1957, BRIT J NUTR, V11, P62, DOI 10.1079/BJN19570013; BNELER H, 2009, EXP NEUROL, V218, P235; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRASS EP, 1992, J NUTR, V122, P2094, DOI 10.1093/jn/122.11.2094; CAHILL GF, 2008, ANNU REV NUTR, V26, P1; Fan CY, 1998, J BIOL CHEM, V273, P15639, DOI 10.1074/jbc.273.25.15639; Fiermonte G, 2009, J BIOL CHEM, V284, P18152, DOI 10.1074/jbc.M109.014118; Fukao T, 2004, PROSTAG LEUKOTR ESS, V70, P243, DOI 10.1016/j.plefa.2003.11.001; Garland P B, 1968, Adv Enzyme Regul, V6, P3, DOI 10.1016/0065-2571(68)90005-8; Gasmi L, 2001, BIOCHEM J, V357, P33, DOI 10.1042/0264-6021:3570033; Hayflick SJ, 2003, CURR OPIN PEDIATR, V15, P572, DOI 10.1097/00008480-200312000-00005; HODGES RE, 1958, J CLIN INVEST, V37, P1642, DOI 10.1172/JCI103756; Hortnagel K, 2003, HUM MOL GENET, V12, P321, DOI 10.1093/hmg/ddg026; HURLEY LS, 1954, J NUTR, V54, P403; IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310; Ivanova PT, 2007, METHOD ENZYMOL, V432, P21, DOI 10.1016/S0076-6879(07)32002-8; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; Janssen U, 2002, J BIOL CHEM, V277, P19579, DOI 10.1074/jbc.M110993200; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Kelly CL, 1997, HUM MOL GENET, V6, P1451, DOI 10.1093/hmg/6.9.1451; KIRSCHBAUM N, 1990, J NUTR, V120, P1376, DOI 10.1093/jn/120.11.1376; Kompare M, 2008, SEMIN PEDIATR NEUROL, V15, P140, DOI 10.1016/j.spen.2008.05.008; KONDRUP J, 1973, BIOCHEM J, V132, P373, DOI 10.1042/bj1320373; Kuo YM, 2007, J INHERIT METAB DIS, V30, P310, DOI 10.1007/s10545-007-0560-8; Kuo YM, 2005, HUM MOL GENET, V14, P49, DOI 10.1093/hmg/ddi005; Kurtz DM, 1998, P NATL ACAD SCI USA, V95, P15592, DOI 10.1073/pnas.95.26.15592; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Leonardi R, 2007, FEBS LETT, V581, P4639, DOI 10.1016/j.febslet.2007.08.056; Leonardi R, 2007, P NATL ACAD SCI USA, V104, P1494, DOI 10.1073/pnas.0607621104; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; LUND H, 1986, BIOCHIM BIOPHYS ACTA, V876, P685, DOI 10.1016/0005-2760(86)90058-5; MARK M, 2007, CURRENT PROTOCOLS MO, V5; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; Miinalainen IJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000543; Nyman LR, 2005, MOL GENET METAB, V86, P179, DOI 10.1016/j.ymgme.2005.07.021; Ofman R, 2006, BIOCHEM J, V393, P537, DOI 10.1042/BJ20050893; OLBRICH A, 1981, ANAL BIOCHEM, V113, P386, DOI 10.1016/0003-2697(81)90093-2; Prohl C, 2001, MOL CELL BIOL, V21, P1089, DOI 10.1128/MCB.21.4.1089-1097.2001; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Reddy PH, 2009, EXP NEUROL, V218, P286, DOI 10.1016/j.expneurol.2009.03.042; Reilly SJ, 2008, J BIOCHEM, V144, P655, DOI 10.1093/jb/mvn114; Rinaldo P, 2002, ANNU REV PHYSIOL, V64, P477, DOI 10.1146/annurev.physiol.64.082201.154705; ROBISHAW JD, 1982, J BIOL CHEM, V257, P967; Rock CO, 2003, J BACTERIOL, V185, P3410, DOI 10.1128/JB.185.11.3410-3415.2003; Rock CO, 2002, GENE, V291, P35, DOI 10.1016/S0378-1119(02)00564-4; Rock CO, 2000, J BIOL CHEM, V275, P1377, DOI 10.1074/jbc.275.2.1377; ROSS BD, 1967, BIOCHEM J, V102, P942, DOI 10.1042/bj1020942; Schuler A Michele, 2002, ILAR J, V43, P57; SMITH CM, 1987, METABOLISM, V36, P115, DOI 10.1016/0026-0495(87)90003-5; SMITH CM, 1980, BIOCHEM J, V188, P175, DOI 10.1042/bj1880175; SMITH CM, 1978, J NUTR, V108, P854, DOI 10.1093/jn/108.5.854; SONG WJ, 1992, J BACTERIOL, V174, P6411, DOI 10.1128/JB.174.20.6411-6417.1992; SRINIVASAN V, 1976, INDIAN J BIOCHEM BIO, V13, P387; Stites T, 2006, J NUTR, V136, P390, DOI 10.1093/jn/136.2.390; STRAUSS W, 1998, CURRENT PROTOCOLS MO, V1; Tolwani RJ, 2005, PLOS GENET, V1, P205, DOI 10.1371/journal.pgen.0010023; Van Vlies N, 2005, BIOCHEM J, V387, P185, DOI 10.1042/BJ20041489; van Vlies N, 2007, BBA-BIOENERGETICS, V1767, P1134, DOI 10.1016/j.bbabio.2007.07.001; VANBOCXLAER JF, 1993, CLIN CHEM, V39, P1911; Ventura FV, 1998, EUR J BIOCHEM, V253, P614, DOI 10.1046/j.1432-1327.1998.2530614.x; VOLTTI H, 1979, BIOCHEM J, V182, P95, DOI 10.1042/bj1820095; Waddell L, 2006, MOL GENET METAB, V87, P32, DOI 10.1016/j.ymgme.2005.09.020; Wahren J, 2007, ANNU REV NUTR, V27, P329, DOI 10.1146/annurev.nutr.27.061406.093806; Williamson J R, 1968, Adv Enzyme Regul, V6, P67, DOI 10.1016/0065-2571(68)90008-3; WILLIAMSON JR, 1969, J BIOL CHEM, V244, P4607; WINTERS RW, 1952, ENDOCRINOLOGY, V50, P388, DOI 10.1210/endo-50-4-388; Wolfgang MJ, 2006, J BIOL CHEM, V281, P37265, DOI 10.1074/jbc.R600016200; Zhang YM, 2005, J BIOL CHEM, V280, P32594, DOI 10.1074/jbc.M506275200; Zhang YM, 2007, CHEM BIOL, V14, P291, DOI 10.1016/j.chembiol.2007.01.013; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	75	70	72	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11107	10.1371/journal.pone.0011107	http://dx.doi.org/10.1371/journal.pone.0011107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559429	Green Published, Green Submitted, gold			2022-12-27	WOS:000278741100020
J	Loughlin, DT; Artlett, CM				Loughlin, Danielle T.; Artlett, Carol M.			Precursor of Advanced Glycation End Products Mediates ER-Stress-Induced Caspase-3 Activation of Human Dermal Fibroblasts through NAD(P)H Oxidase 4	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NADPH OXIDASE; MATRIX INTERACTIONS; INDUCED APOPTOSIS; OXIDATIVE STRESS; FOOT ULCERS; CELL-DEATH; CHOP; RAGE; EXPRESSION	Background: The precursor for advanced glycation end products, 3-deoxyglucosone (3DG) is highly upregulated in skin explants of diabetic cutaneous wounds, and has been shown to negatively impact dermal fibroblasts, which are crucial in wound remodeling. 3DG induces apoptosis however; the mechanisms involved in the apoptotic action of 3DG in the pathogenesis of diabetic chronic wounds are poorly understood. Therefore, we sought to delineate novel mechanisms involved with the 3DG-collagen induced apoptosis. Methodology/Principal Findings: Using human dermal fibroblasts, we demonstrated that 3DG-modified collagen induces oxidative stress and caspase-3 activation. Oxidative stress was found to be dependent on the upregulation of NAD(P)H oxidase 4 (Nox4), a reactive oxygen species (ROS) Nox homologue, triggering endoplasmic reticulum (ER) stress, as assessed by the ER stress-induced apoptosis marker Growth Arrest and DNA Damage-inducible gene 153 (GADD153). We demonstrated that 3DG-collagen activated GADD153 via phosphorylation of p38 mitogen activated protein kinase (MAPK), and this was dependent on upstream ROS. Inhibition of ROS and/or p38 MAPK abrogated 3DG-collagen induced caspase-3 activation. Our investigations also demonstrated that 3DG-collagen-induced caspase-3 activation did not signal through the canonical receptor for advanced glycation end products (RAGE) but through integrin alpha 1 beta 1. To further verify the role of integrins, neutralization of integrins alpha 1 beta 1 prevented 3DG-collagen-induced upregulation of ROS, GADD153, and caspase-3 activation; suggesting that 3DG-collagen signaling to the fibroblast is dependent on integrins alpha 1 beta 1. Conclusions/Significance: Taken together, these findings demonstrate for the first time that a RAGE independent mechanism is involved in 3DG-collagen-induced apoptosis. Moreover, the ER stress pathway through activation of Nox4 by integrins alpha 1 beta 1 plays a key role in 3DG-collagen-induced caspase-3 activation, which may play an important role in the pathogenesis of diabetic wounds.	[Loughlin, Danielle T.; Artlett, Carol M.] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA	Drexel University	Loughlin, DT (corresponding author), Drexel Univ, Coll Med, Philadelphia, PA 19104 USA.	carol.artlett@drexelmed.edu			Department of Defense [WX81XWh-07-1-0450]; Dynamis Therapeutics, Inc.	Department of Defense(United States Department of Defense); Dynamis Therapeutics, Inc.	This work was funded by grants to C.M. Artlett from the Department of Defense WX81XWh-07-1-0450 and from Dynamis Therapeutics, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhani M, 2007, AM J PHYSIOL-CELL PH, V292, pC850, DOI 10.1152/ajpcell.00356.2006; Alikhani M, 2007, BONE, V40, P345, DOI 10.1016/j.bone.2006.09.011; Alikhani ZB, 2005, J BIOL CHEM, V280, P12087, DOI 10.1074/jbc.M406313200; AOKI Y, 1993, DIABETOLOGIA, V36, P79, DOI 10.1007/BF00399098; Ariyama Y, 2008, METABOLISM, V57, P1625, DOI 10.1016/j.metabol.2008.06.019; Arnesen SM, 2006, MECH AGEING DEV, V127, P726, DOI 10.1016/j.mad.2006.05.003; Aronson D, 2003, J HYPERTENS, V21, P3, DOI 10.1097/00004872-200301000-00002; Baba SP, 2009, DIABETES, V58, P2486, DOI 10.2337/db09-0375; Basta G, 2008, ATHEROSCLEROSIS, V196, P9, DOI 10.1016/j.atherosclerosis.2007.07.025; Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Bucciarelli LG, 2002, CELL MOL LIFE SCI, V59, P1117, DOI 10.1007/s00018-002-8491-x; Bucciarelli LG, 2002, CIRCULATION, V106, P2827, DOI 10.1161/01.CIR.0000039325.03698.36; Caron-Mazet J, 2007, ANN DERMATOL VENER, V134, P645, DOI 10.1016/S0151-9638(07)91825-6; CHEN J, 2009, MOL CELL BIOCH; Chen M, 1999, EXP CELL RES, V249, P231, DOI 10.1006/excr.1999.4473; Ding QX, 2005, BBA-MOL CELL RES, V1746, P18, DOI 10.1016/j.bbamcr.2005.08.006; Ding QX, 2005, NEUROSCI LETT, V373, P67, DOI 10.1016/j.neulet.2004.09.059; Eckes B, 2000, MATRIX BIOL, V19, P325, DOI 10.1016/S0945-053X(00)00077-9; Edderkaoui M, 2005, AM J PHYSIOL-GASTR L, V289, pG1137, DOI 10.1152/ajpgi.00197.2005; Forbes JM, 2004, DIABETES, V53, P1813, DOI 10.2337/diabetes.53.7.1813; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Honore S, 2003, EXP CELL RES, V285, P59, DOI 10.1016/S0014-4827(02)00038-1; Huijberts MSP, 2008, DIABETES-METAB RES, V24, pS19, DOI 10.1002/dmrr.861; Jang HJ, 2008, NEUROSCI LETT, V443, P17, DOI 10.1016/j.neulet.2008.07.049; Li, 2000, Arterioscler Thromb Vasc Biol, V20, pE1; Loughlin DT, 2009, WOUND REPAIR REGEN, V17, P739, DOI 10.1111/j.1524-475X.2009.00532.x; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; MAUCH C, 1990, RHEUM DIS CLIN N AM, V16, P93; Novo E, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-5; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Pedruzzi E, 2004, MOL CELL BIOL, V24, P10703, DOI 10.1128/MCB.24.24.10703-10717.2004; Ramasamy R, 2005, GLYCOBIOLOGY, V15, p16R, DOI 10.1093/glycob/cwi053; Ramsey SD, 1999, DIABETES CARE, V22, P382, DOI 10.2337/diacare.22.3.382; Sassi-Gaha S, 2010, MATRIX BIOL, V29, P127, DOI 10.1016/j.matbio.2009.09.007; Schilder YDC, 2009, FREE RADICAL BIO MED, V46, P1598, DOI 10.1016/j.freeradbiomed.2009.03.013; SCHNIDER SL, 1981, J CLIN INVEST, V67, P1630, DOI 10.1172/JCI110198; Sekine Y, 2006, CURR MOL MED, V6, P87, DOI 10.2174/156652406775574541; Sen CK, 2003, WOUND REPAIR REGEN, V11, P431, DOI 10.1046/j.1524-475X.2003.11607.x; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tagawa Y, 2008, FREE RADICAL BIO MED, V45, P50, DOI 10.1016/j.freeradbiomed.2008.03.003; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wautier MP, 2001, AM J PHYSIOL-ENDOC M, V280, pE685, DOI 10.1152/ajpendo.2001.280.5.E685; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamagishi S, 2002, J BIOL CHEM, V277, P20309, DOI 10.1074/jbc.M202634200; YAN SD, 1995, NAT MED, V1, P693, DOI 10.1038/nm0795-693; Yao DC, 2010, DIABETES, V59, P249, DOI 10.2337/db09-0801; Yokouchi M, 2008, J BIOL CHEM, V283, P4252, DOI 10.1074/jbc.M705951200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zou W, 2008, CANCER RES, V68, P7484, DOI 10.1158/0008-5472.CAN-08-1318	59	48	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11093	10.1371/journal.pone.0011093	http://dx.doi.org/10.1371/journal.pone.0011093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559423	Green Submitted, gold, Green Published			2022-12-27	WOS:000278741100009
J	Pulford, B; Reim, N; Bell, A; Veatch, J; Forster, G; Bender, H; Meyerett, C; Hafeman, S; Michel, B; Johnson, T; Wyckoff, AC; Miele, G; Julius, C; Kranich, J; Schenkel, A; Dow, S; Zabel, MD				Pulford, Bruce; Reim, Natalia; Bell, Aimee; Veatch, Jessica; Forster, Genevieve; Bender, Heather; Meyerett, Crystal; Hafeman, Scott; Michel, Brady; Johnson, Theodore; Wyckoff, A. Christy; Miele, Gino; Julius, Christian; Kranich, Jan; Schenkel, Alan; Dow, Steven; Zabel, Mark D.			Liposome-siRNA-Peptide Complexes Cross the Blood-Brain Barrier and Significantly Decrease PrPC on Neuronal Cells and PrPRES in Infected Cell Cultures	PLOS ONE			English	Article							PRION STRAIN DISCRIMINATION; SMALL INTERFERING RNA; CANINE KIDNEY-CELLS; HEPATITIS-B-VIRUS; LENTIVIRAL VECTORS; GENE-EXPRESSION; DNA COMPLEXES; NEUROLOGICAL DISORDERS; CYCLIC AMPLIFICATION; PROLONGS SURVIVAL	Background: Recent advances toward an effective therapy for prion diseases employ RNA interference to suppress PrPC expression and subsequent prion neuropathology, exploiting the phenomenon that disease severity and progression correlate with host PrPC expression levels. However, delivery of lentivirus encoding PrP shRNA has demonstrated only modest efficacy in vivo. Methodology/Principal Findings: Here we describe a new siRNA delivery system incorporating a small peptide that binds siRNA and acetylcholine receptors (AchRs), acting as a molecular messenger for delivery to neurons, and cationic liposomes that protect siRNA-peptide complexes from serum degradation. Conclusions/Significance: Liposome-siRNA-peptide complexes (LSPCs) delivered PrP siRNA specifically to AchR-expressing cells, suppressed PrPC expression and eliminated PrPRES formation in vitro. LSPCs injected intravenously into mice resisted serum degradation and delivered PrP siRNA throughout the brain to AchR and PrPC-expressing neurons. These data promote LSPCs as effective vehicles for delivery of PrP and other siRNAs specifically to neurons to treat prion and other neuropathological diseases.	[Pulford, Bruce; Reim, Natalia; Bell, Aimee; Veatch, Jessica; Forster, Genevieve; Bender, Heather; Meyerett, Crystal; Hafeman, Scott; Michel, Brady; Johnson, Theodore; Wyckoff, A. Christy; Julius, Christian; Schenkel, Alan; Dow, Steven; Zabel, Mark D.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Miele, Gino] Pfizer Global Res & Dev, Translat Med Res Collaborat, Dundee, Scotland; [Kranich, Jan] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia	Colorado State University; Pfizer; University of Dundee; Garvan Institute of Medical Research; St Vincents Hospital Sydney	Pulford, B (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	mark.zabel@colostate.edu		Kranich, Jan/0000-0002-9928-4132	Colorado State University Infectious Disease Initiative	Colorado State University Infectious Disease Initiative	This work was funded by the Colorado State University Infectious Disease Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARICHELLO JM, METHODS MOL BIOL, V605, P461; BECK E, 1969, BRAIN, V92, P699, DOI 10.1093/brain/92.4.699; BECK E, 1964, BRAIN, V87, P153, DOI 10.1093/brain/87.1.153; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1994, MOL MED, V1, P19; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Campochiaro PA, 2006, GENE THER, V13, P559, DOI 10.1038/sj.gt.3302653; D'Costa J, 2009, CURR OPIN MOL THER, V11, P554; Dissen GA, 2009, METHODS, V49, P70, DOI 10.1016/j.ymeth.2009.06.004; Dorn G, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh044; Dow SW, 1999, J IMMUNOL, V163, P1552; Dutertre M., CANC RES, V70, P896; Eckhardt BL, 2005, MOL CANCER RES, V3, P1; Erin N, 2009, INT J CANCER, V124, P1503, DOI 10.1002/ijc.24131; Fairman J, 2009, HUM VACCINES, V5, P141, DOI 10.4161/hv.5.3.6589; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Gallozzi M, 2008, TRANSGENIC RES, V17, P783, DOI 10.1007/s11248-008-9179-2; GIESE A, 1995, BRAIN PATHOL, V5, P213, DOI 10.1111/j.1750-3639.1995.tb00597.x; Giese A, 1998, BRAIN PATHOL, V8, P449; Giladi H, 2003, MOL THER, V8, P769, DOI 10.1016/S1525-0016(03)00244-2; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Gowen BB, 2009, ANTIVIR RES, V81, P37, DOI 10.1016/j.antiviral.2008.09.001; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Karapetyan YE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005730; Kim Y, 2009, ANTIVIR RES, V84, P185, DOI 10.1016/j.antiviral.2009.09.002; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Kutscher HL, 2010, J CONTROL RELEASE, V143, P31, DOI 10.1016/j.jconrel.2009.12.019; Lafon M, 2005, J NEUROVIROL, V11, P82, DOI 10.1080/13550280590900427; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Leng Q, 2008, CANCER GENE THER, V15, P485, DOI 10.1038/cgt.2008.29; Leng Q, 2009, DRUG FUTURE, V34, P721, DOI 10.1358/dof.2009.034.09.1413267; LENTZ TL, 1982, SCIENCE, V215, P182, DOI 10.1126/science.7053569; Lin KD, 1999, BIOTECHNIQUES, V26, P318, DOI 10.2144/99262rr02; Lundberg C, 2008, CURR GENE THER, V8, P461, DOI 10.2174/156652308786847996; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; MANSON JC, 1994, NEURODEGENERATION, V3, P331; Matveeva O, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm088; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Meyerett C, 2008, VIROLOGY, V382, P267, DOI 10.1016/j.virol.2008.09.023; MOHUCZYDOMINIAK D, 1992, J AM SOC NEPHROL, V3, P170; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; MULLIGAN RC, 1993, SCIENCE, V260, P926, DOI 10.1126/science.8493530; Nadler LS, 1999, AM J PHYSIOL-CELL PH, V277, pC1220, DOI 10.1152/ajpcell.1999.277.6.C1220; NANOU A, 2009, PROG BRAIN RES, V200, P175; Nichols TA, 2009, PRION, V3, P171, DOI 10.4161/pri.3.3.9819; Paddison PJ, 2002, CANCER CELL, V2, P17, DOI 10.1016/S1535-6108(02)00092-2; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; Pai SI, 2006, GENE THER, V13, P464, DOI 10.1038/sj.gt.3302694; Pfeifer A, 2006, J CLIN INVEST, V116, P3204, DOI 10.1172/JCI29236; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; ROTHDIENER M, J CONTROL RELEASE; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; SAILER A, 1994, CELL, V77, P967, DOI 10.1016/0092-8674(94)90436-7; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; Tilly G, 2003, BIOCHEM BIOPH RES CO, V305, P548, DOI 10.1016/S0006-291X(03)00805-2; Valori CF, 2008, CURR GENE THER, V8, P406, DOI 10.2174/156652308786848030; White MD, 2008, P NATL ACAD SCI USA, V105, P10238, DOI 10.1073/pnas.0802759105; Zabel MD, 2007, J IMMUNOL, V179, P6144, DOI 10.4049/jimmunol.179.9.6144; Zaks K, 2006, J IMMUNOL, V176, P7335, DOI 10.4049/jimmunol.176.12.7335; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	71	72	111	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11085	10.1371/journal.pone.0011085	http://dx.doi.org/10.1371/journal.pone.0011085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559428	Green Published, Green Submitted, gold			2022-12-27	WOS:000278741100004
J	Sabetta, JR; DePetrillo, P; Cipriani, RJ; Smardin, J; Burns, LA; Landry, ML				Sabetta, James R.; DePetrillo, Paolo; Cipriani, Ralph J.; Smardin, Joanne; Burns, Lillian A.; Landry, Marie L.			Serum 25-Hydroxyvitamin D and the Incidence of Acute Viral Respiratory Tract Infections in Healthy Adults	PLOS ONE			English	Article							TRANSCRIPTION-PCR ASSAY; VITAMIN-D; SEASONAL-VARIATION; MEDICAL-CENTER; UNITED-STATES; INFLUENZA; VIRUSES; IMMUNOFLUORESCENCE; EPIDEMIOLOGY; DEFENSINS	Background: Declining serum concentrations of 25-hydroxyvitamin D seen in the fall and winter as distance increases from the equator may be a factor in the seasonal increased prevalence of influenza and other viral infections. This study was done to determine if serum 25-hydroxyvitamin D concentrations correlated with the incidence of acute viral respiratory tract infections. Methodology/Findings: In this prospective cohort study serial monthly concentrations of 25-hydroxyvitamin D were measured over the fall and winter 2009-2010 in 198 healthy adults, blinded to the nature of the substance being measured. The participants were evaluated for the development of any acute respiratory tract infections by investigators blinded to the 25-hydroxyvitamin D concentrations. The incidence of infection in participants with different concentrations of vitamin D was determined. One hundred ninety-five (98.5%) of the enrolled participants completed the study. Light skin pigmentation, lean body mass, and supplementation with vitamin D were found to correlate with higher concentrations of 25-hydroxyvitamin D. Concentrations of 38 ng/ml or more were associated with a significant (p<0.0001) two-fold reduction in the risk of developing acute respiratory tract infections and with a marked reduction in the percentages of days ill. Conclusions/Significance: Maintenance of a 25-hydroxyvitamin D serum concentration of 38 ng/ml or higher should significantly reduce the incidence of acute viral respiratory tract infections and the burden of illness caused thereby, at least during the fall and winter in temperate zones. The findings of the present study provide direction for and call for future interventional studies examining the efficacy of vitamin D supplementation in reducing the incidence and severity of specific viral infections, including influenza, in the general population and in subpopulations with lower 25-hydroxyvitamin D concentrations, such as pregnant women, dark skinned individuals, and the obese.	[Sabetta, James R.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Sabetta, James R.; Cipriani, Ralph J.; Smardin, Joanne; Burns, Lillian A.] Greenwich Hosp, Infect Dis Sect, Greenwich, CT USA; [DePetrillo, Paolo] Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27103 USA; [Landry, Marie L.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA	Yale University; Wake Forest University; Wake Forest Baptist Medical Center; Yale University	Sabetta, JR (corresponding author), Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA.	jsabettamd@yahoo.com			Section of Infectious Diseases, Greenwich Hospital	Section of Infectious Diseases, Greenwich Hospital	This study was supported by a private grant from Jean and David Wallace of Greenwich, Connecticut to the Section of Infectious Diseases, Greenwich Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work on this study by the investigators was without any compensation, with all funding used for laboratory analysis and data recording.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Cantorna MT, 2008, MOL ASPECTS MED, V29, P369, DOI 10.1016/j.mam.2008.04.004; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; COX DR, 1972, J R STAT SOC B, V187, P220; DAHER KA, 1986, J VIROL, V60, P1068, DOI 10.1128/JVI.60.3.1068-1074.1986; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Ersfeld DL, 2004, CLIN BIOCHEM, V37, P867, DOI 10.1016/j.clinbiochem.2004.06.006; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Grant WB, 2008, PEDIATR INFECT DIS J, V27, P853, DOI 10.1097/INF.0b013e3181817bc1; Gropp R, 1999, HUM GENE THER, V10, P957, DOI 10.1089/10430349950018355; GWALTNEY JM, 1966, NEW ENGL J MED, V275, P1261, DOI 10.1056/NEJM196612082752301; Habib-Bein NF, 2003, J CLIN MICROBIOL, V41, P3597, DOI 10.1128/JCM.41.8.3597-3601.2003; HAMMOND GW, 1989, REV INFECT DIS, V11, P494; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; HOPESIMPSON RE, 1981, J HYG-CAMBRIDGE, V86, P35, DOI 10.1017/S0022172400068728; KHAJAVI A, 1977, CLIN PEDIATR, V16, P36, DOI 10.1177/000992287701600106; Landry ML, 2008, J CLIN VIROL, V43, P148, DOI 10.1016/j.jcv.2008.06.006; Landry ML, 2000, J CLIN MICROBIOL, V38, P708, DOI 10.1128/JCM.38.2.708-711.2000; LANDRY ML, 2009, J CLIN MICR IN PRESS; Li-Ng M, 2009, EPIDEMIOL INFECT, V137, P1396, DOI 10.1017/S0950268809002404; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Louie JK, 2005, CLIN INFECT DIS, V41, P822, DOI 10.1086/432800; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; Martineau AR, 2007, J STEROID BIOCHEM, V103, P793, DOI 10.1016/j.jsbmb.2006.12.052; MAXWELL JD, 1994, P NUTR SOC, V53, P533, DOI 10.1079/PNS19940063; MCLAUGHLIN M, 1974, LANCET, V1, P536; Najada AS, 2004, J TROP PEDIATRICS, V50, P364, DOI 10.1093/tropej/50.6.364; Nolte FS, 2007, J CLIN MICROBIOL, V45, P2779, DOI 10.1128/JCM.00669-07; Panozzo CA, 2007, PEDIATR INFECT DIS J, V26, pS41, DOI 10.1097/INF.0b013e318157da82; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; SCHAFFER FL, 1976, ARCH VIROL, V51, P263, DOI 10.1007/BF01317930; STAMP TCB, 1974, NATURE, V247, P563, DOI 10.1038/247563a0; THACKER SB, 1986, EPIDEMIOL REV, V8, P129, DOI 10.1093/oxfordjournals.epirev.a036291; TOR D, 2003, STAT MED, V27, P1069; Vieth R, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P995; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; 2005, 6 SIGMA DATA MINING	41	282	295	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11088	10.1371/journal.pone.0011088	http://dx.doi.org/10.1371/journal.pone.0011088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559424	gold, Green Published, Green Submitted			2022-12-27	WOS:000278741100005
J	Schutzer, SE; Liu, T; Natelson, BH; Angel, TE; Schepmoes, AA; Purvine, SO; Hixson, KK; Lipton, MS; Camp, DG; Coyle, PK; Smith, RD; Bergquist, J				Schutzer, Steven E.; Liu, Tao; Natelson, Benjamin H.; Angel, Thomas E.; Schepmoes, Athena A.; Purvine, Samuel O.; Hixson, Kim K.; Lipton, Mary S.; Camp, David G., II; Coyle, Patricia K.; Smith, Richard D.; Bergquist, Jonas			Establishing the Proteome of Normal Human Cerebrospinal Fluid	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; TIME TAG APPROACH; ACCURATE MASS; MULTIDIMENSIONAL CHROMATOGRAPHY; PROTEINS; PEPTIDE; IDENTIFICATIONS; STRATEGY; MS/MS; TOOL	Background: Knowledge of the entire protein content, the proteome, of normal human cerebrospinal fluid (CSF) would enable insights into neurologic and psychiatric disorders. Until now technologic hurdles and access to true normal samples hindered attaining this goal. Methods and Principal Findings: We applied immunoaffinity separation and high sensitivity and resolution liquid chromatography-mass spectrometry to examine CSF from healthy normal individuals. 2630 proteins in CSF from normal subjects were identified, of which 56% were CSF-specific, not found in the much larger set of 3654 proteins we have identified in plasma. We also examined CSF from groups of subjects previously examined by others as surrogates for normals where neurologic symptoms warranted a lumbar puncture but where clinical laboratory were reported as normal. We found statistically significant differences between their CSF proteins and our non-neurological normals. We also examined CSF from 10 volunteer subjects who had lumbar punctures at least 4 weeks apart and found that there was little variability in CSF proteins in an individual as compared to subject to subject. Conclusions: Our results represent the most comprehensive characterization of true normal CSF to date. This normal CSF proteome establishes a comparative standard and basis for investigations into a variety of diseases with neurological and psychiatric features.	[Schutzer, Steven E.; Natelson, Benjamin H.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA; [Schutzer, Steven E.; Natelson, Benjamin H.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol, Newark, NJ 07103 USA; [Liu, Tao; Angel, Thomas E.; Schepmoes, Athena A.; Purvine, Samuel O.; Hixson, Kim K.; Lipton, Mary S.; Camp, David G., II; Smith, Richard D.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Coyle, Patricia K.] SUNY Stony Brook, Dept Neurol, Stony Brook, NY 11794 USA; [Bergquist, Jonas] Uppsala Univ, Dept Phys & Analyt Chem, Uppsala, Sweden	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; United States Department of Energy (DOE); Pacific Northwest National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Uppsala University	Schutzer, SE (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA.	schutzer@umdnj.edu	Hixson, Kim/AAW-2332-2020; Bergquist, Jonas/C-5894-2015; Smith, Richard D/J-3664-2012; Purvine, Samuel O/O-3358-2017; Hixson, Kim/AAJ-7714-2020; Liu, Tao/A-9020-2013; Lipton, Mary S/H-3913-2012	Hixson, Kim/0000-0003-3915-7040; Smith, Richard D/0000-0002-2381-2349; Purvine, Samuel O/0000-0002-2257-2400; Hixson, Kim/0000-0003-3716-0326; Liu, Tao/0000-0001-9529-6550; Bergquist, Jonas/0000-0002-4597-041X	National Institutes of Health, through National Institute on Drug Abuse (NIDA) [DA021071]; National Center for Research Resources [RR018522]; Swedish Research Council [621-2005-5379, 621-2008-3562]; Uppsala Berzelii Technology Center for Neurodiagnostics; Department of Energy (DOE) [DE-AC05-76RL0 1830]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA021071] Funding Source: NIH RePORTER	National Institutes of Health, through National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala Berzelii Technology Center for Neurodiagnostics; Department of Energy (DOE)(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank the National Institutes of Health, through National Institute on Drug Abuse (NIDA) (grant DA021071), the National Center for Research Resources (RR018522), the Swedish Research Council (621-2005-5379, 621-2008-3562) and Uppsala Berzelii Technology Center for Neurodiagnostics for support of portions of the research. Pacific Northwest National Laboratory units are located in the Environmental Molecular Sciences Laboratory, a national scientific user facility, sponsored by the Department of Energy (DOE), operated by Battelle Memorial Institute for the DOE under Contract DE-AC05-76RL0 1830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergquist J, 2002, MASS SPECTROM REV, V21, P2, DOI 10.1002/mas.10016; Bhatia VN, 2009, ANAL CHEM, V81, P9819, DOI 10.1021/ac901335x; Ekegren T, 2008, J MASS SPECTROM, V43, P559, DOI 10.1002/jms.1409; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Jing Z, 2005, NEUROBIOL AGING, V26, P207, DOI 10.1016/j.neurobiolaging.2004.03.012; Lipton MS, 2002, P NATL ACAD SCI USA, V99, P11049, DOI 10.1073/pnas.172170199; Liu T, 2006, MOL CELL PROTEOMICS, V5, P2167, DOI 10.1074/mcp.T600039-MCP200; Liu T, 2006, MOL CELL PROTEOMICS, V5, P1899, DOI 10.1074/mcp.M600068-MCP200; Maccarrone G, 2004, ELECTROPHORESIS, V25, P2402, DOI 10.1002/elps.200305909; Mayampurath AM, 2008, BIOINFORMATICS, V24, P1021, DOI 10.1093/bioinformatics/btn063; Monroe ME, 2007, BIOINFORMATICS, V23, P2021, DOI 10.1093/bioinformatics/btm281; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Pan S, 2007, PROTEOMICS, V7, P469, DOI 10.1002/pmic.200600756; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Petyuk VA, 2007, GENOME RES, V17, P328, DOI 10.1101/gr.5799207; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Qian WJ, 2009, J PROTEOME RES, V8, P290, DOI 10.1021/pr800467r; Qian WJ, 2005, MOL CELL PROTEOMICS, V4, P700, DOI 10.1074/mcp.M500045-MCP200; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; Ramstrom M, 2005, J PROTEOME RES, V4, P410, DOI 10.1021/pr049812a; Ransohoff RM, 2009, NATURE, V457, P155, DOI 10.1038/457155a; Rozek W, 2007, J PROTEOME RES, V6, P4189, DOI 10.1021/pr070220c; Shaffer SA, 1997, RAPID COMMUN MASS SP, V11, P1813; Sickmann A, 2000, ELECTROPHORESIS, V21, P2721, DOI 10.1002/1522-2683(20000701)21:13<2721::AID-ELPS2721>3.0.CO;2-3; Smith RD, 2002, PROTEOMICS, V2, P513, DOI 10.1002/1615-9861(200205)2:5<513::AID-PROT513>3.0.CO;2-W; Wenner BR, 2004, J PROTEOME RES, V3, P97, DOI 10.1021/pr034070r; Xu J, 2006, INT REV NEUROBIOL, V73, P29, DOI 10.1016/S0074-7742(06)73002-1; Yuan XL, 2005, PROTEOMICS, V5, P541, DOI 10.1002/pmic.200400934; Yuan XL, 2002, ELECTROPHORESIS, V23, P1185, DOI 10.1002/1522-2683(200204)23:7/8<1185::AID-ELPS1185>3.0.CO;2-G; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071; Zougman A, 2008, J PROTEOME RES, V7, P386, DOI 10.1021/pr070501k; Zubarev R, 2007, MOL CELL PROTEOMICS, V6, P377, DOI 10.1074/mcp.M600380-MCP200	32	148	153	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e10980	10.1371/journal.pone.0010980	http://dx.doi.org/10.1371/journal.pone.0010980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552007	Green Published, Green Submitted, gold			2022-12-27	WOS:000278662900004
J	Shao, L; Wu, LH; Fang, H; Tong, WD; Fan, XH				Shao, Li; Wu, Leihong; Fang, Hong; Tong, Weida; Fan, Xiaohui			Does Applicability Domain Exist in Microarray-Based Genomic Research?	PLOS ONE			English	Article							GENE-EXPRESSION DATA; BREAST-CANCER; OLIGONUCLEOTIDE MICROARRAY; ESTROGEN-RECEPTOR; DNA MICROARRAYS; PREDICTION; CLASSIFICATION; MODELS; CHEMOTHERAPY; VALIDATION	Constructing an accurate predictive model for clinical decision-making on the basis of a relatively small number of tumor samples with high-dimensional microarray data remains a very challenging problem. The validity of such models has been seriously questioned due to their failure in clinical validation using independent samples. Besides the statistical issues such as selection bias, some studies further implied the probable reason was improper sample selection that did not resemble the genomic space defined by the training population. Assuming that predictions would be more reliable for interpolation than extrapolation, we set to investigate the impact of applicability domain (AD) on model performance in microarray-based genomic research by evaluating and comparing model performance for samples with different extrapolation degrees. We found that the issue of applicability domain may not exist in microarray-based genomic research for clinical applications. Therefore, it is not practicable to improve model validity based on applicability domain.	[Shao, Li; Wu, Leihong; Fan, Xiaohui] Zhejiang Univ, Pharmaceut Informat Inst, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Fang, Hong] US FDA, Z Tech Corp, Natl Ctr Toxicol Res, Jefferson, AR USA	Zhejiang University; US Food & Drug Administration (FDA)	Fan, XH (corresponding author), Zhejiang Univ, Pharmaceut Informat Inst, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China.	fanxh@zju.edu.cn	FAN, Xiaohui/F-6458-2010; Wu, Leihong/AAM-9483-2020	FAN, Xiaohui/0000-0002-6336-3007; Wu, Leihong/0000-0002-4093-3708	National Science Foundation of China [30801556, 30830121]; Science Foundation of Chinese University [2009QNA7031]; Zhejiang Provincial Natural Science Foundation of China [R2080693]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Chinese University(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Science Foundation of China (No. 30801556 and 30830121), Science Foundation of Chinese University (No. 2009QNA7031) and the Zhejiang Provincial Natural Science Foundation of China (No. R2080693). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Ayers M, 2004, J CLIN ONCOL, V22, P2284, DOI 10.1200/JCO.2004.05.166; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; DeRisi J, 1996, NAT GENET, V14, P457; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Eriksson L, 2003, ENVIRON HEALTH PERSP, V111, P1361, DOI 10.1289/ehp.5758; Fan XH, 2010, CLIN CANCER RES, V16, P629, DOI 10.1158/1078-0432.CCR-09-1815; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Iizuka N, 2003, LANCET, V361, P923, DOI 10.1016/S0140-6736(03)12775-4; Iwao-Koizumi K, 2005, J CLIN ONCOL, V23, P422, DOI 10.1200/JCO.2005.09.078; Kolossov E, 2007, SAR QSAR ENVIRON RES, V18, P89, DOI 10.1080/10629360601053984; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; *MAQC CONS, 2009, MAQC 2 PROJ COMPR ST; Mariadason JM, 2003, CANCER RES, V63, P8791; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Merseburger AS, 2003, ONCOL REP, V10, P223; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Mukhopadhyay A, 2009, PATTERN RECOGN, V42, P2744, DOI 10.1016/j.patcog.2009.04.018; Mulligan AM, 2008, CLIN CANCER RES, V14, P4168, DOI 10.1158/1078-0432.CCR-07-4543; Netzeva TI, 2005, ATLA-ALTERN LAB ANIM, V33, P155, DOI 10.1177/026119290503300209; Nguyen PL, 2008, J CLIN ONCOL, V26, P2373, DOI 10.1200/JCO.2007.14.4287; Oberthuer A, 2006, J CLIN ONCOL, V24, P5070, DOI 10.1200/JCO.2006.06.1879; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Reid JF, 2005, JNCI-J NATL CANCER I, V97, P927, DOI 10.1093/jnci/dji153; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; SACKETT DL, 1987, J GEN INTERN MED, V2, P40, DOI 10.1007/BF02596250; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Theodoridis S, 2006, PATTERN RECOGNITION, 3RD EDITION, P1; Tong WD, 2004, ENVIRON HEALTH PERSP, V112, P1249, DOI 10.1289/txg.7125; Tropsha A, 2003, QSAR COMB SCI, V22, P69, DOI 10.1002/qsar.200390007; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11055	10.1371/journal.pone.0011055	http://dx.doi.org/10.1371/journal.pone.0011055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548774	Green Published, gold, Green Submitted			2022-12-27	WOS:000278599600015
J	Yu, KD; Li, JJ; Di, GH; Wu, J; Shen, ZZ; Shao, ZM				Yu, Ke-Da; Li, Jun-Jie; Di, Gen-Hong; Wu, Jiong; Shen, Zhen-Zhou; Shao, Zhi-Ming			A Straightforward but Not Piecewise Relationship between Age and Lymph Node Status in Chinese Breast Cancer Patients	PLOS ONE			English	Article							FOLLOW-UP; TUMOR CHARACTERISTICS; AXILLARY DISSECTION; RANDOMIZED-TRIAL; ELDERLY-WOMEN; MANAGEMENT; MICROMETASTASES; RADIOTHERAPY; CARCINOMAS; BIOPSY	Purpose: To investigate the relationship between age and axillary lymph node (LN) involvement in Chinese breast cancer patients, and to replicate a recently identified piecewise relationship between age and LN involvement. Methods: A dataset, consisting of 3,715 patients (with complete information on study variables) with operable breast cancer consecutively surgically treated between 1996 and 2006, was derived from the database of Shanghai Cancer Hospital. Univariate and multivariate logistic regression were employed to analyze the relationship between age and LN. We subsequently performed a similar analysis on another dataset including 1,832 consecutive patients treated between 2007 and 2008 to replicate our findings in the first dataset. Results: A U-shaped relationship (previously observed in two European populations) between age and LN status failed to be replicated in our dataset of Chinese patients. Instead, we observed a linear rather than piecewise relationship. After multivariate adjustment, the linear relationship was still present. Moreover, the interaction between age and LN involvement was not modified by tumor size. The odds of LN involvement decreased by 1.5% for each year increase in age (OR 0.985, 95% CI 0.979-0.991, P<0.001). Breast cancer subtypes were also associated with LN status. Proportions of basal-like and ERBB2+ subtypes decreased with increasing age. The observations in the first dataset were successfully replicated in a second independent dataset. Conclusion: We confirmed a straightforward but not piecewise relationship between age and LN status in Chinese patients. The different pattern between Chinese and European elderly patients should be considered when making clinical decisions.	[Yu, Ke-Da; Li, Jun-Jie; Di, Gen-Hong; Wu, Jiong; Shen, Zhen-Zhou; Shao, Zhi-Ming] Fudan Univ, Dept Breast Surg, Ctr Canc, Shanghai 200433, Peoples R China; [Yu, Ke-Da; Li, Jun-Jie; Di, Gen-Hong; Wu, Jiong; Shen, Zhen-Zhou; Shao, Zhi-Ming] Fudan Univ, Inst Canc, Shanghai 200433, Peoples R China; [Yu, Ke-Da; Li, Jun-Jie; Di, Gen-Hong; Wu, Jiong; Shen, Zhen-Zhou; Shao, Zhi-Ming] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Yu, KD (corresponding author), Fudan Univ, Dept Breast Surg, Ctr Canc, Shanghai 200433, Peoples R China.	zhimingshao@yahoo.com		Di, Genhong/0000-0003-1171-7907	National Basic Research Program of China [2006CB910501]; Youth Foundation of Shanghai Public Health Bureau; Youth Foundation of Shanghai Medical College; National Natural Science Foundation of China [30971143, 30972936]	National Basic Research Program of China(National Basic Research Program of China); Youth Foundation of Shanghai Public Health Bureau; Youth Foundation of Shanghai Medical College; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by grants from the National Basic Research Program of China (2006CB910501), 2009 Youth Foundation of Shanghai Public Health Bureau, 2009 Youth Foundation of Shanghai Medical College, and the National Natural Science Foundation of China (30971143, 30972936). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertucci F, 2009, INT J CANCER, V124, P1338, DOI 10.1002/ijc.24055; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Crivellari D, 2007, J CLIN ONCOL, V25, P1882, DOI 10.1200/JCO.2006.10.2079; de Boer M, 2010, J NATL CANCER I, V102, P410, DOI 10.1093/jnci/djq008; Diab SG, 1999, J CLIN ONCOL, V17, P1442, DOI 10.1200/JCO.1999.17.5.1442; Diab SG, 2000, J NATL CANCER I, V92, P550, DOI 10.1093/jnci/92.7.550; Fan L, 2009, BREAST CANC IN PRESS; Fisher B, 2002, NEW ENGL J MED, V347, P567, DOI 10.1056/NEJMoa020128; Giuliano AE, 2010, ANN SURG, V251, P601, DOI 10.1097/SLA.0b013e3181d6115f; Hogan BV, 2010, SURG ONCOL, V19, P11, DOI 10.1016/j.suronc.2008.12.009; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Lee JH, 2010, CANCER RES TREAT, V42, P30, DOI 10.4143/crt.2010.42.1.30; Louis-Sylvestre C, 2004, J CLIN ONCOL, V22, P97, DOI 10.1200/JCO.2004.12.108; Ma CD, 2009, CRIT REV ONCOL HEMAT, V71, P258, DOI 10.1016/j.critrevonc.2008.11.005; Mamounas EP, 2009, J CLIN ONCOL, V27, P2900, DOI 10.1200/JCO.2009.22.0509; Martelli G, 2003, CANCER-AM CANCER SOC, V97, P1156, DOI 10.1002/cncr.11173; Martin J, 2005, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2005/01/007; Molino A, 2006, CRIT REV ONCOL HEMAT, V59, P226, DOI 10.1016/j.critrevonc.2006.01.007; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rakha EA, 2009, BREAST CANCER RES TR, V113, P411, DOI 10.1007/s10549-008-9952-1; Rutgers EJT, 2008, J CLIN ONCOL, V26, P698, DOI 10.1200/JCO.2007.14.4667; Singh R, 2004, CANCER-AM CANCER SOC, V100, P1807, DOI 10.1002/cncr.20206; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Takei H, 2010, BREAST CANCER-TOKYO, V17, P9, DOI 10.1007/s12282-009-0154-4; Veronesi U, 2005, ANN ONCOL, V16, P383, DOI 10.1093/annonc/mdi089; Wildiers H, 2009, J CLIN ONCOL, V27, P2931, DOI 10.1200/JCO.2008.16.7619; Yin WJ, 2009, BREAST CANCER RES TR, V115, P325, DOI 10.1007/s10549-008-0096-0; Yu KD, 2008, J CANCER RES CLIN, V134, P1347, DOI 10.1007/s00432-008-0414-2; Yu KD, 2007, BREAST, V16, P307, DOI 10.1016/j.breast.2006.12.011; Yu KD, 2007, ANN SURG ONCOL, V14, P2502, DOI 10.1245/s10434-007-9436-2	30	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e11035	10.1371/journal.pone.0011035	http://dx.doi.org/10.1371/journal.pone.0011035			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20543953	Green Submitted, Green Published, gold			2022-12-27	WOS:000278557600013
J	Paoloni, MC; Mazcko, C; Fox, E; Fan, T; Lana, S; Kisseberth, W; Vail, DM; Nuckolls, K; Osborne, T; Yalkowsy, S; Gustafson, D; Yu, YK; Cao, LA; Khanna, C				Paoloni, Melissa C.; Mazcko, Christina; Fox, Elizabeth; Fan, Timothy; Lana, Susan; Kisseberth, William; Vail, David M.; Nuckolls, Kaylee; Osborne, Tanasa; Yalkowsy, Samuel; Gustafson, Daniel; Yu, Yunkai; Cao, Liang; Khanna, Chand			Rapamycin Pharmacokinetic and Pharmacodynamic Relationships in Osteosarcoma: A Comparative Oncology Study in Dogs	PLOS ONE			English	Article							RENAL-ALLOGRAFT SURVIVAL; TARGETED THERAPY; CELL CANCER; MTOR; SARCOMA; BIOLOGY; MODEL; CYCLOSPORINE; PROGRESSION; ACTIVATION	Background: Signaling through the mTOR pathway contributes to growth, progression and chemoresistance of several cancers. Accordingly, inhibitors have been developed as potentially valuable therapeutics. Their optimal development requires consideration of dose, regimen, biomarkers and a rationale for their use in combination with other agents. Using the infrastructure of the Comparative Oncology Trials Consortium many of these complex questions were asked within a relevant population of dogs with osteosarcoma to inform the development of mTOR inhibitors for future use in pediatric osteosarcoma patients. Methodology/Principal Findings: This prospective dose escalation study of a parenteral formulation of rapamycin sought to define a safe, pharmacokinetically relevant, and pharmacodynamically active dose of rapamycin in dogs with appendicular osteosarcoma. Dogs entered into dose cohorts consisting of 3 dogs/cohort. Dogs underwent a pre-treatment tumor biopsy and collection of baseline PBMC. Dogs received a single intramuscular dose of rapamycin and underwent 48-hour whole blood pharmacokinetic sampling. Additionally, daily intramuscular doses of rapamycin were administered for 7 days with blood rapamycin trough levels collected on Day 8, 9 and 15. At Day 8 post-treatment collection of tumor and PBMC were obtained. No maximally tolerated dose of rapamycin was attained through escalation to the maximal planned dose of 0.08 mg/kg (2.5 mg/30kg dog). Pharmacokinetic analysis revealed a dose-dependent exposure. In all cohorts modulation of the mTOR pathway in tumor and PBMC (pS6RP/S6RP) was demonstrated. No change in pAKT/AKT was seen in tumor samples following rapamycin therapy. Conclusions/Significance: Rapamycin may be safely administered to dogs and can yield therapeutic exposures. Modulation pS6RP/S6RP in tumor tissue and PBMCs was not dependent on dose. Results from this study confirm that the dog may be included in the translational development of rapamycin and potentially other mTOR inhibitors. Ongoing studies of rapamycin in dogs will define optimal schedules for their use in cancer and evaluate the role of rapamycin use in the setting of minimal residual disease.	[Paoloni, Melissa C.; Mazcko, Christina; Khanna, Chand] NCI, Comparat Oncol Program, Ctr Canc Res, Bethesda, MD 20892 USA; [Fox, Elizabeth] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Fan, Timothy] Univ Illinois, Urbana, IL 61801 USA; [Lana, Susan; Gustafson, Daniel] Colorado State Univ, Ft Collins, CO 80523 USA; [Kisseberth, William] Ohio State Univ, Columbus, OH 43210 USA; [Vail, David M.] Univ Wisconsin, Madison, WI USA; [Nuckolls, Kaylee; Osborne, Tanasa; Khanna, Chand] NCI, Tumor Metastasis & Biol Sect, Ctr Canc Res, Bethesda, MD 20892 USA; [Yalkowsy, Samuel] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Illinois System; University of Illinois Urbana-Champaign; Colorado State University; University System of Ohio; Ohio State University; University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Arizona	Paoloni, MC (corresponding author), NCI, Comparat Oncol Program, Ctr Canc Res, Bethesda, MD 20892 USA.	khannac@mail.nih.gov	Kisseberth, William/A-2587-2013; Fox, Elizabeth/AAD-5341-2020; Cao, Liang/K-7806-2017	Fan, Timothy/0000-0003-2510-7050; Cao, Liang/0000-0001-7293-8338	Morris Animal Foundation; NATIONAL CANCER INSTITUTE [ZICBC010981, ZIGBC010569] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER	Morris Animal Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The Morris Animal Foundation provided generous support for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouzas L, 2010, UPSALA J MED SCI, V115, P125, DOI 10.3109/03009730903291026; Chon HS, 2006, CURR CANCER DRUG TAR, V6, P333, DOI 10.2174/156800906777441799; COLLIER DS, 1990, TRANSPLANT P, V22, P1674; Costa LJ, 2007, CANCER TREAT REV, V33, P78, DOI 10.1016/j.ctrv.2006.10.004; Ferrari S, 2007, CURR OPIN ONCOL, V19, P341, DOI 10.1097/CCO.0b013e328122d73f; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gordon IK, 2008, AM J VET RES, V69, P1079, DOI 10.2460/ajvr.69.8.1079; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; GUNJI Y, 1993, TRANSPLANT P, V25, P752; Hansen A, 2007, EXPERT REV ANTICANC, V7, P211, DOI 10.1586/14737140.7.2.211; Hartner WC, 1995, TRANSPLANTATION, V60, P1347; Hutson TE, 2007, CANCER J, V13, P282, DOI 10.1097/PPO.0b013e318156fe69; Jiang BH, 2008, DRUG RESIST UPDATE, V11, P63, DOI 10.1016/j.drup.2008.03.001; Jimeno A, 2008, J CLIN ONCOL, V26, P4172, DOI 10.1200/JCO.2008.16.2347; Kasper B, 2007, CURR OPIN ONCOL, V19, P336, DOI 10.1097/CCO.0b013e32812143ef; Kesari Santosh, 2006, Curr Oncol Rep, V8, P58, DOI 10.1007/s11912-006-0011-y; KNIGHT R, 1993, TRANSPLANTATION, V55, P947; *NCI, 2007, NCI BIOINF OR; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Paoloni M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-625; Paoloni MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004972; Perl AE, 2009, CLIN CANCER RES, V15, P6732, DOI 10.1158/1078-0432.CCR-09-0842; Petricoin EF, 2007, CANCER RES, V67, P3431, DOI 10.1158/0008-5472.CAN-06-1344; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Seddon Beatrice M, 2008, Paediatr Drugs, V10, P93, DOI 10.2165/00148581-200810020-00004; Stepkowski Stanislaw M., 1997, Archivum Immunologiae et Therapiae Experimentalis, V45, P383; Tallman MS, 2006, BEST PRACT RES CL HA, V19, P311, DOI 10.1016/j.beha.2005.11.006; Vail David M, 2004, Vet Comp Oncol, V2, P194, DOI 10.1111/j.1476-5810.2004.0053a.x; Vignot S, 2005, ANN ONCOL, V16, P525, DOI 10.1093/annonc/mdi113; von Mehren Margaret, 2003, Curr Treat Options Oncol, V4, P441; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wan XL, 2007, ONCOLOGIST, V12, P1007, DOI 10.1634/theoncologist.12-8-1007; Wan XL, 2005, CANCER RES, V65, P2406, DOI 10.1158/0008-5472.CAN-04-3135; Williams ME, 2005, CURR OPIN ONCOL, V17, P425, DOI 10.1097/01.cco.0000174039.69656.2b; WITHROW SJ, 1991, CLIN ORTHOP RELAT R, P159; Wysocki PJ, 2009, EXPERT REV MOL DIAGN, V9, P231, DOI [10.1586/erm.09.8, 10.1586/ERM.09.8]; Yao JC, 2007, BEST PRACT RES CL EN, V21, P163, DOI 10.1016/j.beem.2007.01.006; Zaidi Shane H, 2009, Curr Drug Discov Technol, V6, P103	38	42	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11013	10.1371/journal.pone.0011013	http://dx.doi.org/10.1371/journal.pone.0011013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20543980	Green Published, Green Submitted, gold			2022-12-27	WOS:000278494900025
J	Xu, YQ; Krause, A; Hamai, H; Harvey, BG; Worgall, TS; Worgall, S				Xu, Yaqin; Krause, Anja; Hamai, Hiroko; Harvey, Ben-Gary; Worgall, Tilla S.; Worgall, Stefan			Proinflammatory Phenotype and Increased Caveolin-1 in Alveolar Macrophages with Silenced CFTR mRNA	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NF-KAPPA-B; RESPIRATORY EPITHELIAL-CELLS; MUTANT CYSTIC-FIBROSIS; PSEUDOMONAS-AERUGINOSA; LIPID-METABOLISM; INDUCED APOPTOSIS; IN-VIVO; EXPRESSION; GENE	The inflammatory milieu in the respiratory tract in cystic fibrosis (CF) has been linked to the defective expression of the cystic transmembrane regulator (CFTR) in epithelial cells. Alveolar macrophages (AM), important contibutors to inflammatory responses in the lung, also express CFTR. The present study analyzes the phenotype of human AM with silenced CFTR. Expression of CFTR mRNA and the immature form of the CFTR protein decreased 100-fold and 5.2-fold, respectively, in AM transfected with a CFTR specific siRNA (CFTR-siRNA) compared to controls. Reduction of CFTR expression in AM resulted in increased secretion of IL-8, increased phosphorylation of NF-kappa B, a positive regulator of IL-8 expression, and decreased expression of I kappa B-alpha, the inhibitory protein of NF-kappa B activation. AM with silenced CFTR expression also showed increased apoptosis. We hypothesized that caveolin-1 (Cav1), a membrane protein that is colocalized with CFTR in lipid rafts and that is related to inflammation and apoptosis in macrophages, may be affected by decreased CFTR expression. Messenger RNA and protein levels of Cav1 were increased in AM with silenced CFTR. Expression and transcriptional activity of sterol regulatory element binding protein (SREBP), a negative transcriptional regulator of Cav1, was decreased in AM with silenced CFTR, but total and free cholesterol mass did not change. These findings indicate that silencing of CFTR in human AM results in an inflammatory phenotype and apoptosis, which is associated to SREBP-mediated regulation of Cav1.	[Xu, Yaqin; Worgall, Stefan] Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Krause, Anja; Harvey, Ben-Gary; Worgall, Stefan] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Hamai, Hiroko; Worgall, Tilla S.] Columbia Univ, Dept Pathol, New York, NY USA	Cornell University; Cornell University; Columbia University	Xu, YQ (corresponding author), Weill Cornell Med Coll, Dept Pediat, New York, NY USA.	stw2006@med.cornell.edu			Cystic Fibrosis Foundation, Bethesda, MD;  [R21 HL077557]	Cystic Fibrosis Foundation, Bethesda, MD; 	These studies were supported, in part, by R21 HL077557 (http://grants.nih.gov/grants/oer.htm) and the Cystic Fibrosis Foundation, Bethesda, MD (http://www.cff.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ali BR, 2009, MED HYPOTHESES, V72, P55, DOI 10.1016/j.mehy.2008.07.058; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Bajmoczi M, 2009, AM J PHYSIOL-CELL PH, V297, pC263, DOI 10.1152/ajpcell.00527.2008; Bist A, 1997, P NATL ACAD SCI USA, V94, P10693, DOI 10.1073/pnas.94.20.10693; Blaisdell CJ, 2004, AM J PHYSIOL-LUNG C, V286, pL420, DOI 10.1152/ajplung.00113.2003; Brennan S, 2009, EUR RESPIR J, V34, P655, DOI 10.1183/09031936.00178508; Brennan S, 2008, PAEDIATR RESPIR REV, V9, P271, DOI 10.1016/j.prrv.2008.05.008; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Bruscia EM, 2009, AM J RESP CELL MOL, V40, P295, DOI 10.1165/rcmb.2008-0170OC; Cannon CL, 2003, AM J RESP CELL MOL, V29, P188, DOI 10.1165/rcmb.4898; Dakin CJ, 2002, AM J RESP CRIT CARE, V165, P904, DOI 10.1164/ajrccm.165.7.2010139; del Fresno C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002667; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; DiMagno MJ, 2005, GASTROENTEROLOGY, V129, P665, DOI 10.1053/j.gastro.2005.05.059; Gargalovic P, 2003, J LIPID RES, V44, P1622, DOI 10.1194/jlr.M300140-JLR200; Gargalovic P, 2003, J LIPID RES, V44, P11, DOI 10.1194/jlr.R200005-JLR200; Gentzsch M, 2007, J CELL SCI, V120, P447, DOI 10.1242/jcs.03350; Gottlieb RA, 1996, P NATL ACAD SCI USA, V93, P3587, DOI 10.1073/pnas.93.8.3587; Hamai H, 2009, J LIPID RES, V50, P1101, DOI 10.1194/jlr.M800427-JLR200; Heda GD, 2000, BIOCHEM BIOPH RES CO, V271, P659, DOI 10.1006/bbrc.2000.2684; Hubeau C, 2001, J ALLERGY CLIN IMMUN, V108, P524, DOI 10.1067/mai.2001.118516; Jacquot J, 2008, INT J BIOCHEM CELL B, V40, P1703, DOI 10.1016/j.biocel.2008.02.002; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Knight RA, 1997, CLIN EXP IMMUNOL, V107, P542, DOI 10.1046/j.1365-2249.1997.d01-954.x; L'hoste S, 2009, FREE RADICAL BIO MED, V46, P1017, DOI 10.1016/j.freeradbiomed.2008.12.009; Li J, 2008, EXP EYE RES, V86, P684, DOI 10.1016/j.exer.2008.01.017; Li TB, 2006, AM J PHYSIOL-LUNG C, V290, pL649, DOI 10.1152/ajplung.00205.2005; Mailhot G, 2009, AM J PHYSIOL-GASTR L, V297, pG1239, DOI 10.1152/ajpgi.00206.2009; Maiuri L, 1997, FEBS LETT, V408, P225, DOI 10.1016/S0014-5793(97)00347-5; MCDONALD TV, 1992, J BIOL CHEM, V267, P3242; Moriceau S, 2010, J INNATE IMMUN, V2, P260, DOI 10.1159/000295791; Moss RB, 2000, CLIN EXP IMMUNOL, V120, P518, DOI 10.1046/j.1365-2249.2000.01232.x; Moss RB, 2004, CLIN EXP IMMUNOL, V135, P358, DOI 10.1111/j.1365-2249.2003.02389.x; Muhlebach MS, 1999, AM J RESP CRIT CARE, V160, P186, DOI 10.1164/ajrccm.160.1.9808096; Noe J, 2009, AM J RESP CELL MOL, V41, P314, DOI 10.1165/rcmb.2008-0264OC; Painter RG, 2008, J LEUKOCYTE BIOL, V83, P1345, DOI 10.1189/jlb.0907658; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; Perez A, 2007, AM J PHYSIOL-LUNG C, V292, pL383, DOI 10.1152/ajplung.00403.2005; Puchelle Edith, 2002, Paediatr Respir Rev, V3, P115, DOI 10.1016/S1526-0550(02)00005-7; Rajan S, 2000, AM J RESP CELL MOL, V23, P304, DOI 10.1165/ajrcmb.23.3.4098; Rottner M, 2007, FASEB J, V21, P2939, DOI 10.1096/fj.06-7614com; Russi TJ, 1997, LUNG SCI FDN, V1, P371; Tabary O, 2000, J IMMUNOL, V164, P3377, DOI 10.4049/jimmunol.164.6.3377; Vandivier RW, 2002, CHEST, V121, p89S, DOI 10.1378/chest.121.3_suppl.89S; Vandivier RW, 2002, J CLIN INVEST, V109, P661, DOI 10.1172/JCI200213572; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wang XM, 2006, AM J RESP CELL MOL, V34, P434, DOI 10.1165/rcmb.2005-0376OC; Weber AJ, 2001, AM J PHYSIOL-LUNG C, V281, pL71, DOI 10.1152/ajplung.2001.281.1.L71; White NM, 2007, AM J PHYSIOL-LUNG C, V292, pL476, DOI 10.1152/ajplung.00262.2006; White NM, 2004, AM J RESP CELL MOL, V31, P538, DOI 10.1165/rcmb.2004-0117OC; Worgall S, 2005, INFECT IMMUN, V73, P5262, DOI 10.1128/IAI.73.8.5262-5268.2005; Worgall TS, 2009, CURR OPIN CLIN NUTR, V12, P105, DOI 10.1097/MCO.0b013e32832595b7; Xu YQ, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-26; YOSHIMURA K, 1991, NUCLEIC ACIDS RES, V19, P5417, DOI 10.1093/nar/19.19.5417; Zaidi T, 2008, INVEST OPHTH VIS SCI, V49, P1000, DOI 10.1167/iovs.07-0993; Zaman MM, 2004, CLIN DIAGN LAB IMMUN, V11, P819, DOI 10.1128/CDLI.11.5.819-824.2004	58	40	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11004	10.1371/journal.pone.0011004	http://dx.doi.org/10.1371/journal.pone.0011004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20543983	Green Published, Green Submitted, gold			2022-12-27	WOS:000278494900016
J	Granjon, T; Maniti, O; Auchli, Y; Dahinden, P; Buchet, R; Marcillat, O; Dimroth, P				Granjon, Thierry; Maniti, Ofelia; Auchli, Yolanda; Dahinden, Pius; Buchet, Rene; Marcillat, Olivier; Dimroth, Peter			Structure-Function Relations in Oxaloacetate Decarboxylase Complex. Fluorescence and Infrared Approaches to Monitor Oxomalonate and Na+ Binding Effect	PLOS ONE			English	Article							RED-EDGE-EXCITATION; PROTEIN SECONDARY STRUCTURE; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; COUPLING MECHANISM; VIBRIO-CHOLERAE; BETA-SUBUNIT; PUMP; ION; SPECTROSCOPY	Background: Oxaloacetate decarboxylase (OAD) is a member of the Na+ transport decarboxylase enzyme family found exclusively in anaerobic bacteria. OAD of Vibrio cholerae catalyses a key step in citrate fermentation, converting the chemical energy of the decarboxylation reaction into an electrochemical gradient of Na+ ions across the membrane, which drives endergonic membrane reactions such as ATP synthesis, transport and motility. OAD is a membrane-bound enzyme composed of alpha, beta and gamma subunits. The a subunit contains the carboxyltransferase catalytic site. Methodology/Principal Findings: In this report, spectroscopic techniques were used to probe oxomalonate (a competitive inhibitor of OAD with respect to oxaloacetate) and Na+ effects on the enzyme tryptophan environment and on the secondary structure of the OAD complex, as well as the importance of each subunit in the catalytic mechanism. An intrinsic fluorescence approach, Red Edge Excitation Shift (REES), indicated that solvent molecule mobility in the vicinity of OAD tryptophans was more restricted in the presence of oxomalonate. It also demonstrated that, although the structure of OAD is sensitive to the presence of NaCl, oxomalonate was able to bind to the enzyme even in the absence of Na+. REES changes due to oxomalonate binding were also observed with the alpha gamma and alpha subunits. Infrared spectra showed that OAD, alpha gamma and alpha subunits have a main component band centered between 1655 and 1650 cm(-1) characteristic of a high content of alpha helix structures. Addition of oxomalonate induced a shift of the amide-I band of OAD toward higher wavenumbers, interpreted as a slight decrease of beta sheet structures and a concomitant increase of alpha helix structures. Oxomalonate binding to alpha gamma and alpha subunits also provoked secondary structure variations, but these effects were negligible compared to OAD complex. Conclusion: Oxomalonate binding affects the tryptophan environment of the carboxyltransferase subunit, whereas Na+ alters the tryptophan environment of the beta subunit, consistent with the function of these subunits within the enzyme complex. Formation of a complex between OAD and its substrates elicits structural changes in the alpha-helical as well as beta-strand secondary structure elements.	[Granjon, Thierry; Auchli, Yolanda; Dahinden, Pius; Dimroth, Peter] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland; [Granjon, Thierry; Maniti, Ofelia; Buchet, Rene; Marcillat, Olivier] Univ Lyon 1, CNRS, Inst Chim & Biochim Mol & Supramol, UMR 5246, F-69622 Villeurbanne, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Granjon, T (corresponding author), ETH, Inst Microbiol, CH-8092 Zurich, Switzerland.	thierry.granjon@univ-lyon1.fr	Maniti, Ofélia/AAQ-5624-2021; Rene, Buchet/I-9781-2019	Rene, Buchet/0000-0002-7966-3856	Swiss National Science Foundation; University of Lyon; CNRS; Rhone-Alpes region	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Lyon; CNRS(Centre National de la Recherche Scientifique (CNRS)); Rhone-Alpes region(Region Auvergne-Rhone-Alpes)	This work was supported by Swiss National Science Foundation, University of Lyon, CNRS, Rhone-Alpes region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6; Ausubel F. M., 1999, SHORT PROTOCOLS MOL; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; Birks J., 1970, PHOTOPHYSICS AROMATI, DOI DOI 10.1002/BBPC.19700741223; Bott M, 1997, ARCH MICROBIOL, V167, P78, DOI 10.1007/s002030050419; Buckel W, 2001, BBA-BIOENERGETICS, V1505, P15, DOI 10.1016/S0005-2728(00)00273-5; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Chattopadhyay A, 2003, CHEM PHYS LIPIDS, V122, P3, DOI 10.1016/S0009-3084(02)00174-3; CHATTOPADHYAY A, 1993, FEBS LETT, V335, P341, DOI 10.1016/0014-5793(93)80415-Q; CLADERA J, 1992, BIOCHEMISTRY-US, V31, P12363, DOI 10.1021/bi00164a010; Dahinden P, 2005, FEBS J, V272, P846, DOI 10.1111/j.1742-4658.2004.04524.x; Dahinden P, 2005, ARCH MICROBIOL, V183, P121, DOI 10.1007/s00203-004-0754-5; Dahinden P, 2004, ARCH MICROBIOL, V182, P414, DOI 10.1007/s00203-004-0706-0; Demchenko AP, 2002, LUMINESCENCE, V17, P19, DOI 10.1002/bio.671; DEMCHENKO AP, 1988, EUR BIOPHYS J BIOPHY, V16, P121, DOI 10.1007/BF00255522; DEMCHENKO AP, 1982, BIOPHYS CHEM, V15, P101, DOI 10.1016/0301-4622(82)80022-7; Dimroth P, 1998, ARCH MICROBIOL, V170, P69, DOI 10.1007/s002030050616; Dimroth P, 1997, BBA-BIOENERGETICS, V1318, P11, DOI 10.1016/S0005-2728(96)00127-2; DIMROTH P, 1988, EUR J BIOCHEM, V175, P175, DOI 10.1111/j.1432-1033.1988.tb14180.x; DIMROTH P, 1986, EUR J BIOCHEM, V156, P157, DOI 10.1111/j.1432-1033.1986.tb09561.x; DIMROTH P, 1983, EUR J BIOCHEM, V137, P107, DOI 10.1111/j.1432-1033.1983.tb07802.x; FABIAN H, 1992, BIOCHEMISTRY-US, V31, P6532, DOI 10.1021/bi00143a024; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; GOORMAGHTIGH E, 1994, ASSIGNMENTS MODELS C, P329; Granjon T, 2001, BIOCHEMISTRY-US, V40, P6016, DOI 10.1021/bi002293e; Hall PR, 2004, EMBO J, V23, P3621, DOI 10.1038/sj.emboj.7600373; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Jockel P, 2000, BIOCHEMISTRY-US, V39, P2307, DOI 10.1021/bi992261v; Jockel P, 2000, BIOCHEMISTRY-US, V39, P4320, DOI 10.1021/bi992817e; Jockel P, 1999, BIOCHEMISTRY-US, V38, P13461, DOI 10.1021/bi990303+; LAKOWICZ JR, 1984, BIOCHEMISTRY-US, V23, P3013, DOI 10.1021/bi00308a026; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; MUKHERJEE S, 1994, BIOCHEMISTRY-US, V33, P5089, DOI 10.1021/bi00183a012; Rawat SS, 2004, BIOPHYS J, V87, P831, DOI 10.1529/biophysj.104.041715; Sambrook J., 2002, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schmid M, 2002, BIOCHEMISTRY-US, V41, P1285, DOI 10.1021/bi015764l; Studer R, 2007, J MOL BIOL, V367, P547, DOI 10.1016/j.jmb.2006.12.035; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Susi H, 1972, Methods Enzymol, V26, P455; Tatulian SA, 1997, J MOL BIOL, V268, P809, DOI 10.1006/jmbi.1997.1014; TORRES J, 1995, BIOPHYS J, V68, P2049, DOI 10.1016/S0006-3495(95)80383-8; WOEHLKE G, 1992, J BIOL CHEM, V267, P22798	44	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10935	10.1371/journal.pone.0010935	http://dx.doi.org/10.1371/journal.pone.0010935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20543879	Green Published, gold, Green Submitted			2022-12-27	WOS:000278318700009
J	Lataillade, M; Chiarella, J; Yang, R; Schnittman, S; Wirtz, V; Uy, J; Seekins, D; Krystal, M; Mancini, M; McGrath, D; Simen, B; Egholm, M; Kozal, M				Lataillade, Max; Chiarella, Jennifer; Yang, Rong; Schnittman, Steven; Wirtz, Victoria; Uy, Jonathan; Seekins, Daniel; Krystal, Mark; Mancini, Marco; McGrath, Donnie; Simen, Birgitte; Egholm, Michael; Kozal, Michael			Prevalence and Clinical Significance of HIV Drug Resistance Mutations by Ultra-Deep Sequencing in Antiretroviral-Naive Subjects in the CASTLE Study	PLOS ONE			English	Article							TREATMENT-EXPERIENCED PATIENTS; REVERSE-TRANSCRIPTASE; VIROLOGICAL FAILURE; TREATMENT OUTCOMES; VIRAL VARIANTS; THERAPY; ATAZANAVIR/RITONAVIR; INHIBITORS; EFFICACY; TRANSMISSION	Background: CASTLE compared the efficacy of atazanavir/ritonavir with lopinavir/ritonavir, each in combination with tenofovir-emtricitabine in ARV-naive subjects from 5 continents. Objectives: Determine the baseline rate and clinical significance of TDR mutations using ultra-deep sequencing (UDS) in ARV-naive subjects in CASTLE. Methods: A case control study was performed on baseline samples for all 53 subjects with virologic failures (VF) at Week 48 and 95 subjects with virologic successes (VS) randomly selected and matched by CD4 count and viral load. UDS was performed using 454 Life Sciences/Roche technology. Results: Of 148 samples, 141 had successful UDS (86 subtype B, 55 non-B subtypes). Overall, 30.5% of subjects had a TDR mutation at baseline; 15.6% only had TDR(s) at <20% of the viral population. There was no difference in the rate of TDRs by B (30.2%) or non-B subtypes (30.9%). VF (51) and VS (90) had similar rates of any TDRs (25.5% vs. 33.3%), NNRTI TDRs (11.1% vs. 11.8%) and NRTI TDRs (24.4% vs. 25.5%). Of 9 (6.4%) subjects with M184V/I (7 at <20% levels), 6 experienced VF. 16 (11.3%) subjects had multiple TAMs, and 7 experienced VF. 3 (2.1%) subjects had both multiple TAMs+M184V, and all experienced VF. Of 14 (9.9%) subjects with PI TDRs (11 at <20% levels): only 1 experienced virologic failure. The majority of PI TDRs were found in isolation (e. g. 46I) at <20% levels, and had low resistance algorithm scores. Conclusion: Among a representative sample of ARV-naive subjects in CASTLE, TDR mutations were common (30.5%); B and non-B subtypes had similar rates of TDRs. Subjects with multiple PI TDRs were infrequent. Overall, TDRs did not affect virologic response for subjects on a boosted PI by week 48; however, a small subset of subjects with extensive NRTI backbone TDR patterns experienced virologic failure.	[Lataillade, Max; Yang, Rong; Schnittman, Steven; Wirtz, Victoria; Uy, Jonathan; Seekins, Daniel; Krystal, Mark; Mancini, Marco; McGrath, Donnie] Bristol Myers Squibb Co, Global Dev & Med Affairs, Wallingford, CT 06492 USA; [Lataillade, Max; Kozal, Michael] Yale Univ, Sch Med & Vet Affairs Connecticut Healthcare Syst, New Haven, CT USA; [Simen, Birgitte; Egholm, Michael] 454 Life Sci, Branford, CT USA	Bristol-Myers Squibb; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Lataillade, M (corresponding author), Bristol Myers Squibb Co, Global Dev & Med Affairs, 5 Res Pkwy, Wallingford, CT 06492 USA.	Michael.kozal@yale.edu		Simen, Birgitte/0000-0003-0503-0973; Kozal, Michael/0000-0002-3100-8254; , Michael/0000-0002-7719-7396	Bristol-Myers Squibb; Roche; VA MERIT Award	Bristol-Myers Squibb(Bristol-Myers Squibb); Roche(Roche Holding); VA MERIT Award(US Department of Veterans Affairs)	Bristol-Myers Squibb funded the study and Roche contributed to the funding of this study by the employment of Drs. Simen and Egholm. This study was a Bristol-Myers Squibb funded resistance study of the parent CASTLE study which was also funded by Bristol-Myers Squibb. Bristol-Myers Squibb had a role in the initial study design, data collection and analysis. The ultra-deep sequencing analysis was performed at Yale/VA under the direction of Dr. Kozal and the decision to prepare and publish the manuscript of the ultra-deep substudy was the decision of Dr. Kozal. Dr. Kozal was supported by a VA MERIT Award.	Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Clotet B, 2007, LANCET, V369, P1169, DOI 10.1016/S0140-6736(07)60497-8; Fleiss Joseph L, 1981, STAT METHODS RATES P; Goodman DD, 2009, ANTIVIR THER, V14, pA43; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; HUPPLERHULLSIEK K, 2008, VIROLOGIC SUCCESS DI; Jakobsen MR, 2010, CLIN INFECT DIS, V50, P566, DOI 10.1086/650001; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Kozal MJ, 2009, CLIN MICROBIOL INFEC, V15, P69, DOI 10.1111/j.1469-0691.2008.02687.x; Kozal MJ, 1996, NAT MED, V2, P753, DOI 10.1038/nm0796-753; Kuritzkes DR, 2008, J INFECT DIS, V197, P867, DOI 10.1086/528802; Lanier R, 2007, ANTIVIR THER, V12, pS150; Lataillade M, 2008, ANTIVIR THER, V13, pA135; Lataillade M, 2008, J INT AIDS SOC S1, V11, pP180; Le T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006079; Marcelin AG, 2004, J MED VIROL, V72, P162, DOI 10.1002/jmv.10550; Marcelin G, 2006, JAIDS-J ACQ IMM DEF, V42, P127; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McGrath D, 2006, ANTIVIR THER, V11, pS97; Metzner KJ, 2010, J INFECT DIS, V201, P1063, DOI 10.1086/651136; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Molina JM, 2008, LANCET, V372, P646, DOI 10.1016/S0140-6736(08)61081-8; Molina JM, 2008, 48 ANN ICAAC IDSA 46; Naeger LK, 2006, AIDS, V20, P847, DOI 10.1097/01.aids.0000218548.77457.76; Palmer S, 2006, AIDS, V20, P701, DOI 10.1097/01.aids.0000216370.69066.7f; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Peuchant O, 2008, AIDS, V22, P1417, DOI 10.1097/QAD.0b013e3283034953; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Stenman J, 2003, BIOTECHNIQUES, V34, P172, DOI 10.2144/03341dd05; Svarovskaia ES, 2007, JAIDS-J ACQ IMM DEF, V46, P174, DOI 10.1097/QAI.0b013e31814258c0; Vermeiren H, 2007, J VIROL METHODS, V145, P47, DOI 10.1016/j.jviromet.2007.05.009; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307	35	102	107	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10952	10.1371/journal.pone.0010952	http://dx.doi.org/10.1371/journal.pone.0010952			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532178	Green Published, gold, Green Submitted			2022-12-27	WOS:000278318700020
J	Colinet, H; Lee, SF; Hoffmann, A				Colinet, Herve; Lee, Siu Fai; Hoffmann, Ary			Functional Characterization of the Frost Gene in Drosophila melanogaster: Importance for Recovery from Chill Coma	PLOS ONE			English	Article							PYRRHOCORIS-APTERUS; OXIDATIVE STRESS; ION HOMEOSTASIS; COLD; EXPRESSION; INSECTS; SHOCK; RESISTANCE; INJURY; HOST	Background: Almost all animals, including insects, need to adapt to temperature fluctuations. The molecular basis of thermal adaptation is not well understood, although a number of candidate genes have been proposed. However, a functional link between candidate genes and thermal tolerance has rarely been established. The gene Frost (Fst)was first discovered when Drosophila flies were exposed to cold stress, but the biological function(s) of Fst has so far not been characterized. Because Fst is up-regulated after a cold stress, we tested whether it was essential for chill-coma recovery. Methodology/Principal Findings: A marked increase in Fst expression was detected (by RT-PCR) during recovery from cold stress, peaking at 42-fold after 2 h. The GAL4/UAS system was used to knock down expression of Fst and recovery ability was assessed in transgenic adults following 12 h of chill coma at 0 degrees C. The ability to recover from cold stress (short-, medium- and long-term) was significantly altered in the transgenic adults that had Fst silenced. These findings show that Fst plays an essential role in the recovery from chill coma in both males and females. Conclusions/Significance: The Frost gene is essential for cold tolerance in Drosophila melanogaster and may play an important role in thermal adaptation.	[Colinet, Herve] Catholic Univ Louvain, Earth & Life Inst, Biodivers Res Ctr, B-1348 Louvain, Belgium; [Colinet, Herve; Lee, Siu Fai; Hoffmann, Ary] Univ Melbourne, Dept Genet, Ctr Environm Stress & Adaptat Res, Inst Bio21, Parkville, Vic 3052, Australia	Universite Catholique Louvain; University of Melbourne	Colinet, H (corresponding author), Catholic Univ Louvain, Earth & Life Inst, Biodivers Res Ctr, B-1348 Louvain, Belgium.	herve.colinet@uclouvain.be	Hoffmann, Ary/C-2961-2011; Lee, Siu Fai/L-4690-2018; Colinet, hervé/B-3677-2019; Hoffmann, Ary/R-2972-2019; colinet, hervé/K-8768-2019	Colinet, hervé/0000-0002-8806-3107; Hoffmann, Ary/0000-0001-9497-7645; Lee, Siu Fai/0000-0001-6234-4819	Fonds de la Recherche Scientifique (FNRS) from Belgium; Australian Research Council; Commonwealth Environmental Research Fund	Fonds de la Recherche Scientifique (FNRS) from Belgium(Fonds de la Recherche Scientifique - FNRS); Australian Research Council(Australian Research Council); Commonwealth Environmental Research Fund	This study was supported by Fonds de la Recherche Scientifique (FNRS) from Belgium, and the Australian Research Council and the Commonwealth Environmental Research Fund. This paper is number BRC 169 of the Biodiversity Research Centre (UCL-Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affleck JG, 2006, TOXICOL SCI, V89, P495, DOI 10.1093/toxsci/kfj036; Anderson AR, 2005, GENET RES, V85, P15, DOI 10.1017/S0016672304007281; Apidianakis Y, 2005, P NATL ACAD SCI USA, V102, P2573, DOI 10.1073/pnas.0409588102; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Carsten LD, 2005, MOL ECOL, V14, P3203, DOI 10.1111/j.1365-294X.2005.02654.x; Chamilos G, 2008, P NATL ACAD SCI USA, V105, P9367, DOI 10.1073/pnas.0709578105; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; Clark MS, 2008, J COMP PHYSIOL B, V178, P917, DOI 10.1007/s00360-008-0286-4; Colinet H, 2007, INSECT BIOCHEM MOLEC, V37, P1177, DOI 10.1016/j.ibmb.2007.07.004; Colinet H, 2010, FEBS J, V277, P174, DOI 10.1111/j.1742-4658.2009.07470.x; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Denlinger DL, 1998, TEMPERATURES SENSITIVITY IN INSECTS AND APPLICATION IN INTEGRATED PEST MANAGEMENT, P55; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Doucet D, 2009, CELL MOL LIFE SCI, V66, P1404, DOI 10.1007/s00018-009-8320-6; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; FELTON GW, 1995, ARCH INSECT BIOCHEM, V29, P187, DOI 10.1002/arch.940290208; Gibert P, 2001, EVOLUTION, V55, P1063, DOI 10.1554/0014-3820(2001)055[1063:CCTAMC]2.0.CO;2; Goto SG, 2001, GENE, V270, P259, DOI 10.1016/S0378-1119(01)00465-6; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; Hoffmann AA, 2002, EVOLUTION, V56, P1068, DOI 10.1111/j.0014-3820.2002.tb01418.x; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hosler JS, 2000, J INSECT PHYSIOL, V46, P621, DOI 10.1016/S0022-1910(99)00148-1; Jensen HR, 2006, INSECT MOL BIOL, V15, P329, DOI 10.1111/j.1365-2583.2006.00648.x; Jensen LT, 2008, CELL STRESS CHAPERON, V13, P177, DOI 10.1007/s12192-008-0020-x; Kostal V, 2007, COMP BIOCHEM PHYS A, V147, P231, DOI 10.1016/j.cbpa.2006.12.033; Kostal V, 2006, COMP BIOCHEM PHYS B, V143, P171, DOI 10.1016/j.cbpb.2005.11.005; Kostal V, 2004, J EXP BIOL, V207, P1509, DOI 10.1242/jeb.00923; Kostal V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004546; Laayouni H, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-42; Lee RE, 2006, CRYOBIOLOGY, V52, P459, DOI 10.1016/j.cryobiol.2006.03.003; Liu GW, 2006, PHYSIOL GENOMICS, V25, P134, DOI 10.1152/physiolgenomics.00262.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Minois N, 1999, MECH AGEING DEV, V109, P53, DOI 10.1016/S0047-6374(99)00025-1; Morgan TJ, 2006, HEREDITY, V96, P232, DOI 10.1038/sj.hdy.6800786; Qin W, 2005, INSECT MOL BIOL, V14, P607, DOI 10.1111/j.1365-2583.2005.00589.x; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Rojas RR, 1996, CRYOBIOLOGY, V33, P447, DOI 10.1006/cryo.1996.0045; Sinclair BJ, 2007, INSECT MOL BIOL, V16, P435, DOI 10.1111/j.1365-2583.2007.00739.x; Syed ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003041; Takeyama K, 2000, J IMMUNOL, V164, P1546, DOI 10.4049/jimmunol.164.3.1546; Wang J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r69	44	45	46	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2010	5	6							e10925	10.1371/journal.pone.0010925	http://dx.doi.org/10.1371/journal.pone.0010925			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604NC	20532197	gold, Green Published			2022-12-27	WOS:000278284700008
J	Cornes, BK; Tang, CS; Leon, TYY; Hui, KJWS; So, MT; Miao, XP; Cherny, SS; Sham, PC; Tam, PKH; Garcia-Barcelo, MM				Cornes, Belinda K.; Tang, Clara S.; Leon, Thomas Y. Y.; Hui, Kenneth J. W. S.; So, Man-Ting; Miao, Xiaoping; Cherny, Stacey S.; Sham, Pak C.; Tam, Paul K. H.; Garcia-Barcelo, Maria-Merce			Haplotype Analysis Reveals a Possible Founder Effect of RET Mutation R114H for Hirschsprung's Disease in the Chinese Population	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; ASSOCIATION; GENE; RECONSTRUCTION; SUSCEPTIBILITY; ENHANCER; LOCUS	Background: Hirschsprung's disease (HSCR) is a congenital disorder associated with the lack of intramural ganglion cells in the myenteric and sub-mucosal plexuses along varying segments of the gastrointestinal tract. The RET gene is the major gene implicated in this gastrointestinal disease. A highly recurrent mutation in RET (RET(R114H)) has recently been identified in similar to 6-7% of the Chinese HSCR patients which, to date, has not been found in Caucasian patients or controls nor in Chinese controls. Due to the high frequency of RET(R114H) in this population, we sought to investigate whether this mutation may be a founder HSCR mutation in the Chinese population. Methodology and Principal Findings: To test whether all RET(R114) were originated from a single mutational event, we predicted the approximate age of RET(R114H) by applying a Bayesian method to RET SNPs genotyped in 430 Chinese HSCR patients (of whom 25 individuals had the mutation) to be between 4-23 generations old depending on growth rate. We reasoned that if RET(R114H) was a founder mutation then those with the mutation would share a haplotype on which the mutation resides. Including SNPs spanning 509.31 kb across RET from a recently obtained 500 K genome-wide dataset for a subset of 181 patients (14 RET(R114H) patients), we applied haplotype estimation methods to determine whether there were any segments shared between patients with RET(R114H) that are not present in those without the mutation or controls. Analysis yielded a 250.2 kb (51 SNP) shared segment over the RET gene (and downstream) in only those patients with the mutation with no similar segments found among other patients. Conclusions: This suggests that RET(R114H) is a founder mutation for HSCR in the Chinese population.	[Cornes, Belinda K.; Leon, Thomas Y. Y.; Hui, Kenneth J. W. S.; So, Man-Ting; Miao, Xiaoping; Tam, Paul K. H.; Garcia-Barcelo, Maria-Merce] Univ Hong Kong, Paediat Surg Div, Dept Surg, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Tang, Clara S.; Cherny, Stacey S.; Sham, Pak C.] Univ Hong Kong, Dept Psychiat, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Cornes, BK (corresponding author), Univ Hong Kong, Paediat Surg Div, Dept Surg, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China.	mmgarcia@hkucc.hku.hk	miao, xiaoping/C-4336-2011; Cherny, Stacey S/B-3315-2008; /C-4405-2009	miao, xiaoping/0000-0002-6818-9722; Cherny, Stacey S/0000-0002-0269-3352; Tang, Clara/0000-0003-0265-2638; /0000-0001-6231-3035	Hong Kong Research Grants Council [765407M, 775907M]; University of Hong Kong [200611159028]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong)	This work was supported by research grants from the Hong Kong Research Grants Council (765407M and 775907M to MMGB and PT respectively) and the University of Hong Kong Seed Funding Programme for Basic Research to MMGB (200611159028). Support was also obtained from the University of Hong Kong Strategic Research Theme of Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; CHAKRAVARTI A, 2001, METABOLIC MOL BASES, P6231; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; EMISON ES, SNP INTRON 1 E UNPUB; Garcia-Barcelo M, 2005, HUM MOL GENET, V14, P191, DOI 10.1093/hmg/ddi015; Garcia-Barcelo M, 2004, CLIN CHEM, V50, P93, DOI 10.1373/clinchem.2003.022061; Garcia-Barcelo MM, 2008, EUR J HUM GENET, V16, P833, DOI 10.1038/ejhg.2008.18; Garcia-Barcelo MM, 2009, P NATL ACAD SCI USA, V106, P2694, DOI 10.1073/pnas.0809630105; Garcia-Barcelo MM, 2003, J MED GENET, V40; GILKS W, MARKOV CHAIN MONTE C; Grice EA, 2005, HUM MOL GENET, V14, P3837, DOI 10.1093/hmg/ddi408; Lantieri F, 2006, ANN HUM GENET, V70, P12, DOI 10.1111/j.1529-8817.2005.00196.x; Li N, 2003, GENETICS, V165, P2213; LYONNET S, 1993, NAT GENET, V4, P346, DOI 10.1038/ng0893-346; Maksymowych WP, 2006, ARTHRITIS RHEUM-US, V54, P974, DOI 10.1002/art.21642; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reeve JP, 2002, BIOINFORMATICS, V18, P894, DOI 10.1093/bioinformatics/18.6.894; SCHUCHARDT A, 1995, J INTERN MED, V238, P327, DOI 10.1111/j.1365-2796.1995.tb01206.x; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501	22	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2010	5	6							e10918	10.1371/journal.pone.0010918	http://dx.doi.org/10.1371/journal.pone.0010918			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604NC	20532249	Green Published, Green Submitted, gold			2022-12-27	WOS:000278284700004
J	Ramer, MS; Cabrera, MAC; Alan, N; Scott, ALM; Inskip, JA				Ramer, Matt S.; Cabrera, Mario A. Cruz; Alan, Nima; Scott, Angela L. M.; Inskip, Jessica A.			A New Organellar Complex in Rat Sympathetic Neurons	PLOS ONE			English	Article							DRAGONFLY CORDULIA-AENEA; ANNULATE LAMELLAE; PELVIC GANGLION; GAMMA-TUBULIN; GENE-PRODUCTS; CYTOKINESIS; CELLS; EXPRESSION; CALCIUM; OOCYTES	Membranous compartments of neurons such as axons, dendrites and modified primary cilia are defining features of neuronal phenotype. This is unlike organelles deep to the plasma membrane, which are for the most part generic and not related directly to morphological, neurochemical or functional specializations. However, here we use multi-label immunohistochemistry combined with confocal and electron microscopy to identify a very large (similar to 6 microns in diameter), entirely intracellular neuronal organelle which occurs singly in a ubiquitous but neurochemically distinct and morphologically simple subset of sympathetic ganglion neurons. Although usually toroidal, it also occurs as twists or rods depending on its intracellular position: tori are most often perinuclear whereas rods are often found in axons. These 'loukoumasomes' (doughnut-like bodies) bind a monoclonal antibody raised against beta-III-tubulin (SDL.3D10), although their inability to bind other beta-III-tubulin monoclonal antibodies indicate that the responsible antigen is not known. Position-morphology relationships within neurons and their expression of non-muscle heavy chain myosin suggest a dynamic structure. They associate with nematosomes, enigmatic nucleolus-like organelles present in many neural and non-neural tissues, which we now show to be composed of filamentous actin. Loukoumasomes also separately interact with mother centrioles forming the basal body of primary cilia. They express gamma tubulin, a microtubule nucleator which localizes to non-neuronal centrosomes, and cenexin, a mother centriole-associated protein required for ciliogenesis. These data reveal a hitherto undescribed organelle, and depict it as an intracellular transport machine, shuttling material between the primary cilium, the nematosome, and the axon.	[Ramer, Matt S.; Cabrera, Mario A. Cruz; Alan, Nima; Scott, Angela L. M.; Inskip, Jessica A.] Univ British Columbia, ICORD, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Ramer, MS (corresponding author), Univ British Columbia, ICORD, Vancouver, BC V5Z 1M9, Canada.	ramer@icord.org			Michael Smith Foundation for Health Research [CI-SSH-00043(05-1)]	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was funded by the Michael Smith Foundation for Health Research (www.msfhr.org), grant #CI-SSH-00043(05-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Alberts B, 2008, MOL BIOL CELL; Anderson CR, 1998, CLIN EXP PHARMACOL P, V25, P449, DOI 10.1111/j.1440-1681.1998.tb02232.x; Anderson CR, 2002, NEUROSCIENCE, V109, P329, DOI 10.1016/S0306-4522(01)00497-3; BANERJEE A, 1990, J BIOL CHEM, V265, P1794; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; BOWERS CW, 1984, NEUROSCIENCE, V13, P87, DOI 10.1016/0306-4522(84)90261-6; Burgess DR, 2005, CURR BIOL, V15, pR310, DOI 10.1016/j.cub.2005.04.008; Chanthaphavong RS, 2004, CELL TISSUE RES, V317, P165, DOI 10.1007/s00441-004-0888-4; Corns RA, 2000, NEUROSCI LETT, V292, P91, DOI 10.1016/S0304-3940(00)01442-7; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Davies AM, 2009, AUTON NEUROSCI-BASIC, V151, P39, DOI 10.1016/j.autneu.2009.07.011; DEZEEUW CI, 1995, J NEUROSCI, V15, P1587; Ernsberger U, 2009, CELL TISSUE RES, V336, P349, DOI 10.1007/s00441-009-0784-z; FLUCK RA, 1991, J CELL BIOL, V115, P1259, DOI 10.1083/jcb.115.5.1259; Gabella Giorgio, 1995, P81; GRILLO MA, 1970, J CELL BIOL, V45, P100, DOI 10.1083/jcb.45.1.100; HALKKA L, 1975, J CELL SCI, V19, P103; HALKKA L, 1977, J CELL SCI, V26, P217; Hannan AJ, 1998, NEUROPHARMACOLOGY, V37, P593, DOI 10.1016/S0028-3908(98)00056-2; Hippenmeyer S, 2004, TRENDS NEUROSCI, V27, P482, DOI 10.1016/j.tins.2004.05.012; Huber K, 2006, DEV BIOL, V298, P335, DOI 10.1016/j.ydbio.2006.07.010; Ishikawa H, 2005, NAT CELL BIOL, V7, P517, DOI 10.1038/ncb1251; Janig W, 2003, ACTA PHYSIOL SCAND, V177, P255, DOI 10.1046/j.1365-201X.2003.01088.x; JULIAN M, 1993, J CELL SCI, V105, P145; KANERVA L, 1972, Z ZELLFORSCH MIK ANA, V129, P161, DOI 10.1007/BF00306933; KEAST JR, 1991, CELL TISSUE RES, V266, P405, DOI 10.1007/BF00318197; KESSEL RG, 1969, J CELL BIOL, V42, P185, DOI 10.1083/jcb.42.1.185; Kind PC, 1997, J NEUROSCI, V17, P1471; Leask A, 1997, NEUROSCI LETT, V229, P17, DOI 10.1016/S0304-3940(97)00412-6; Li C, 2006, J NEUROPHYSIOL, V95, P187, DOI 10.1152/jn.00779.2005; Li SH, 2000, MOL CELL NEUROSCI, V16, P168, DOI 10.1006/mcne.2000.0858; Liang P, 1997, J CELL SCI, V110, P1431; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; OCKLEFORD CD, 1987, J CELL SCI, V87, P27; Ou Y, 2009, EXP CELL RES, V315, P2802, DOI 10.1016/j.yexcr.2009.06.028; Peters A., 1991, FINE STRUCTURE NERVO; Richardson RJ, 2006, CELL TISSUE RES, V324, P9, DOI 10.1007/s00441-005-0105-0; Rivkin E, 2008, MOL REPROD DEV, V75, P1591, DOI 10.1002/mrd.20911; ROSE RD, 1988, J COMP NEUROL, V272, P365; Schatten H, 2008, HISTOCHEM CELL BIOL, V129, P667, DOI 10.1007/s00418-008-0427-6; SHU HB, 1995, J CELL SCI, V108, P2955; Silver RB, 1996, CELL CALCIUM, V20, P161, DOI 10.1016/S0143-4160(96)90105-0; SUZUKI K, 1995, BIOL BULL-US, V189, P201; TABATABAI M, 1986, BRAIN RES, V382, P61, DOI 10.1016/0006-8993(86)90111-3; Tilney LG, 1996, J CELL BIOL, V133, P61, DOI 10.1083/jcb.133.1.61; Webb SE, 2008, PHILOS T R SOC B, V363, P1363, DOI 10.1098/rstb.2007.2253; WILLISON K, 1989, CELL, V57, P621, DOI 10.1016/0092-8674(89)90131-1; Wolf E, 1999, J NEUROBIOL, V40, P366, DOI 10.1002/(SICI)1097-4695(19990905)40:3<366::AID-NEU8>3.0.CO;2-B; Young HM, 2004, AUTON NEUROSCI-BASIC, V112, P1, DOI 10.1016/j.autneu.2004.02.008	51	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e1000872	10.1371/journal.pone.0010872	http://dx.doi.org/10.1371/journal.pone.0010872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20531934	gold, Green Submitted, Green Published			2022-12-27	WOS:000278221900018
J	Xu, Y; Wagner, DR; Bekerman, E; Chiou, M; James, AW; Carter, D; Longaker, MT				Xu, Yue; Wagner, Diane R.; Bekerman, Elena; Chiou, Michael; James, Aaron W.; Carter, Dennis; Longaker, Michael T.			Connective Tissue Growth Factor in Regulation of RhoA Mediated Cytoskeletal Tension Associated Osteogenesis of Mouse Adipose-Derived Stromal Cells	PLOS ONE			English	Article							ADULT STEM-CELLS; GENE-EXPRESSION; MESENCHYMAL CELLS; RETINOIC ACID; BRANCHING MORPHOGENESIS; MECHANICAL-STRESS; EMBRYONIC LUNG; DIFFERENTIATION; BONE; STRAIN	Background: Cytoskeletal tension is an intracellular mechanism through which cells convert a mechanical signal into a biochemical response, including production of cytokines and activation of various signaling pathways. Methods/Principal Findings: Adipose-derived stromal cells (ASCs) were allowed to spread into large cells by seeding them at a low-density (1,250 cells/cm(2)), which was observed to induce osteogenesis. Conversely, ASCs seeded at a high-density (25,000 cells/cm(2)) featured small cells that promoted adipogenesis. RhoA and actin filaments were altered by changes in cell size. Blocking actin polymerization by Cytochalasin D influenced cytoskeletal tension and differentiation of ASCs. To understand the potential regulatory mechanisms leading to actin cytoskeletal tension, cDNA microarray was performed on large and small ASCs. Connective tissue growth factor (CTGF) was identified as a major regulator of osteogenesis associated with RhoA mediated cytoskeletal tension. Subsequently, knock-down of CTGF by siRNA in ASCs inhibited this osteogenesis. Conclusions/Significance: We conclude that CTGF is important in the regulation of cytoskeletal tension mediated ASC osteogenic differentiation.	[Xu, Yue; Wagner, Diane R.; Bekerman, Elena; Chiou, Michael; James, Aaron W.; Longaker, Michael T.] Stanford Univ, Hagey Pediat Regenerat Med Lab, Dept Surg, Sch Med, Stanford, CA 94305 USA; [Wagner, Diane R.; Carter, Dennis] Stanford Univ, Dept Mech Engn, Biomech Engn Div, Stanford, CA 94305 USA; [Wagner, Diane R.] Univ Notre Dame, Bioengn Grad Program & Aerosp & Mech Engn, Notre Dame, IN 46556 USA	Stanford University; Stanford University; University of Notre Dame	Longaker, MT (corresponding author), Stanford Univ, Hagey Pediat Regenerat Med Lab, Dept Surg, Sch Med, Stanford, CA 94305 USA.	Longaker@stanford.edu			National Institutes of Health [DE14526, DE13194]; Oak Foundation; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013194, R01DE014526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oak Foundation; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by National Institutes of Health grant numbers DE14526, DE13194 and the Oak Foundation to MTL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhadriraju K, 2007, EXP CELL RES, V313, P3616, DOI 10.1016/j.yexcr.2007.07.002; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chaqour B, 2006, FEBS J, V273, P3639, DOI 10.1111/j.1742-4658.2006.05360.x; Chiou M, 2006, BIOCHEM BIOPH RES CO, V343, P644, DOI 10.1016/j.bbrc.2006.02.171; Cicha I, 2008, ATHEROSCLEROSIS, V196, P136, DOI 10.1016/j.atherosclerosis.2007.03.016; Cicha I, 2009, BIOFACTORS, V35, P200, DOI 10.1002/biof.30; Djouad F, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2153; Fukunaga T, 2003, BONE, V33, P911, DOI 10.1016/j.bone.2003.07.010; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Gimble JM, 2004, ENDOCRINE, V23, P183, DOI 10.1385/ENDO:23:2-3:183; Gimble JM, 2003, CURR TOP DEV BIOL, V58, P137, DOI 10.1016/S0070-2153(03)58005-X; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Gimona M, 1996, P NATL ACAD SCI USA, V93, P9618, DOI 10.1073/pnas.93.18.9618; Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463; Guilak F, 2004, BIORHEOLOGY, V41, P389; Hitchon C, 2002, ARTHRITIS RHEUM, V46, P2587, DOI 10.1002/art.10520; Ingber D E, 2004, Mech Chem Biosyst, V1, P53; Ingber DE, 2005, SCAND J MED SCI SPOR, V15, P199, DOI 10.1111/j.1600-0838.2005.00481.x; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Inoue S, 2008, J BIOMAT SCI-POLYM E, V19, P893, DOI 10.1163/156856208784613541; Jagodzinski M, 2004, Eur Cell Mater, V7, P35; Kadota H, 2004, J BONE MINER METAB, V22, P293, DOI 10.1007/s00774-004-0486-2; Kaji H, 2003, LAB CHIP, V3, P208, DOI 10.1039/b304350a; Kitching R, 2002, J BONE MINER METAB, V20, P269, DOI 10.1007/s007740200039; Koike M, 2005, J BONE MINER METAB, V23, P219, DOI 10.1007/s00774-004-0587-y; Kubota S, 2007, INT REV CYTOL, V257, P1, DOI 10.1016/S0074-7696(07)57001-4; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Malladi P, 2006, TISSUE ENG, V12, P2031, DOI 10.1089/ten.2006.12.2031; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Moore KA, 2005, DEV DYNAM, V232, P268, DOI 10.1002/dvdy.20237; Moore KA, 2002, J SURG RES, V104, P95, DOI 10.1006/jsre.2002.6418; Muehlich S, 2007, AM J PHYSIOL-CELL PH, V292, pC1732, DOI 10.1152/ajpcell.00552.2006; Nakama LH, 2006, J ORTHOP RES, V24, P393, DOI 10.1002/jor.20053; Parisi MS, 2006, BONE, V38, P671, DOI 10.1016/j.bone.2005.10.005; Peake MA, 2000, J APPL PHYSIOL, V89, P2498, DOI 10.1152/jappl.2000.89.6.2498; Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432; Sakai H, 2006, BONE, V39, P1290, DOI 10.1016/j.bone.2006.06.012; Schild C, 2004, BBA-MOL CELL RES, V1691, P33, DOI 10.1016/j.bbamcr.2003.12.001; Sherlock G, 2001, Brief Bioinform, V2, P350, DOI 10.1093/bib/2.4.350; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; Simmons CA, 2003, J BIOMECH, V36, P1087, DOI 10.1016/S0021-9290(03)00110-6; Tang J, 2006, J BIOL CHEM, V281, P6664, DOI 10.1074/jbc.M506991200; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wan DC, 2006, P NATL ACAD SCI USA, V103, P12335, DOI 10.1073/pnas.0604849103; Webb K, 2006, J BIOMECH, V39, P1136, DOI 10.1016/j.jbiomech.2004.08.026; Wong M, 2003, BONE, V33, P685, DOI 10.1016/S8756-3282(03)00242-4; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200; Xu Y, 2005, CURR OPIN MOL THER, V7, P300; Yamaai T, 2005, J BONE MINER METAB, V23, P280, DOI 10.1007/s00774-004-0600-5; Yamashiro T, 2001, J DENT RES, V80, P461, DOI 10.1177/00220345010800021201; Yin J, 2008, AM J PHYSIOL-CELL PH, V295, pC378, DOI 10.1152/ajpcell.90624.2007; Zhao HJ, 2005, PROSTATE, V63, P187, DOI 10.1002/pros.20158	53	19	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11279	10.1371/journal.pone.0011279	http://dx.doi.org/10.1371/journal.pone.0011279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585662	Green Submitted, Green Published, gold			2022-12-27	WOS:000279135400023
J	Traggiai, E; Casati, A; Frascoli, M; Porcellini, S; Ponzoni, M; Sanvito, F; Leng, L; Bucala, R; Moretta, L; Grassi, F				Traggiai, Elisabetta; Casati, Anna; Frascoli, Michela; Porcellini, Simona; Ponzoni, Maurilio; Sanvito, Francesca; Leng, Lin; Bucala, Richard; Moretta, Lorenzo; Grassi, Fabio			Selective Preservation of Bone Marrow Mature Recirculating but Not Marginal Zone B Cells in Murine Models of Chronic Inflammation	PLOS ONE			English	Article							INDEPENDENT RESPONSES; MICE; DIFFERENTIATION; LYMPHOPOIESIS; CALRETICULIN; LYMPHOCYTES; ACTIVATION; EXPRESSION; INFECTION; SURVIVAL	Inflammation promotes granulopoiesis over B lymphopoiesis in the bone marrow (BM). We studied B cell homeostasis in two murine models of T cell mediated chronic inflammation, namely calreticulin-deficient fetal liver chimeras (FLC), which develop severe blepharitis and alopecia due to T cell hyper responsiveness, and inflammatory bowel disease (IBD) caused by injection of CD4(+) naive T cells into lymphopenic mice. We show herein that despite the severe depletion of B cell progenitors during chronic, peripheral T cell-mediated inflammation, the population of BM mature recirculating B cells is unaffected. These B cells are poised to differentiate to plasma cells in response to blood borne pathogens, in an analogous fashion to non-recirculating marginal zone (MZ) B cells in the spleen. MZ B cells nevertheless differentiate more efficiently to plasma cells upon polyclonal stimulation by Toll-like receptor (TLR) ligands, and are depleted during chronic T cell mediated inflammation in vivo. The preservation of mature B cells in the BM is associated with increased concentration of macrophage migration inhibitory factor (MIF) in serum and BM plasma. MIF produced by perivascular dendritic cells (DC) in the BM provides a crucial survival signal for recirculating B cells, and mice treated with a MIF inhibitor during inflammation showed significantly reduced mature B cells in the BM. These data indicate that MIF secretion by perivascular DC may promote the survival of the recirculating B cell pool to ensure responsiveness to blood borne microbes despite loss of the MZ B cell pool that accompanies depressed lymphopoiesis during inflammation.	[Traggiai, Elisabetta; Moretta, Lorenzo] Ist Giannina Gaslini, I-16148 Genoa, Italy; [Casati, Anna; Frascoli, Michela; Porcellini, Simona; Grassi, Fabio] Inst Biomed Res, Bellinzona, Switzerland; [Casati, Anna; Grassi, Fabio] Univ Milan, Dept Biol & Genet Med Sci, Milan, Italy; [Ponzoni, Maurilio; Sanvito, Francesca] San Raffaele Sci Hosp, Pathol Unit, Milan, Italy; [Leng, Lin; Bucala, Richard] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Moretta, Lorenzo] Univ Genoa, Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; Universita della Svizzera Italiana; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Yale University; University of Genoa	Traggiai, E (corresponding author), Ist Giannina Gaslini, I-16148 Genoa, Italy.	elisabetta.traggiai@gmail.com; fabio.grassi@irb.unisi.ch	Moretta, Lorenzo/AAA-7239-2020	Moretta, Lorenzo/0000-0003-4658-1747; GRASSI, FABIO/0000-0003-3348-1712; Leng, Lin/0000-0002-0605-358X	Swiss National Science Foundation; Fondazione Ticinese per la Ricerca sul Cancro; Fondazione per la Ricerca sulla Trasfusione e sui Trapianti; European Union [MUGEN LSHB-CT-2005-005203]; National Institutes of Health; Alliance for Lupus Research; Fondazione Stella Major	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondazione Ticinese per la Ricerca sul Cancro; Fondazione per la Ricerca sulla Trasfusione e sui Trapianti; European Union(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; Fondazione Stella Major	This work was supported by grants to F. G. from Swiss National Science Foundation, Fondazione Ticinese per la Ricerca sul Cancro, Fondazione per la Ricerca sulla Trasfusione e sui Trapianti, the Sixth Research Framework Programme of the European Union, Project MUGEN (MUGEN LSHB-CT-2005-005203) and to R. B. from the National Institutes of Health and Alliance for Lupus Research. A. C. is a recipient of a fellowship from Fondazione Stella Major. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman AH, 2003, J IMMUNOL, V171, P317, DOI 10.4049/jimmunol.171.1.317; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Carey JB, 2008, J EXP MED, V205, P2043, DOI 10.1084/jem.20080559; Cariappa A, 2005, IMMUNITY, V23, P397, DOI 10.1016/j.immuni.2005.09.004; Cariappa A, 2007, J IMMUNOL, V179, P2270, DOI 10.4049/jimmunol.179.4.2270; Cariappa A, 2007, BLOOD, V109, P2339, DOI 10.1182/blood-2006-05-021089; Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141; Conde C, 1998, J IMMUNOL, V161, P7023; Cournia Z, 2009, J MED CHEM, V52, P416, DOI 10.1021/jm801100v; DApuzzo M, 1997, EUR J IMMUNOL, V27, P1788, DOI 10.1002/eji.1830270729; Dios A, 2002, J MED CHEM, V45, P2410, DOI 10.1021/jm010534q; Feeney AJ, 2001, J IMMUNOL, V167, P3486, DOI 10.4049/jimmunol.167.6.3486; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; HERMANS MHA, 1989, J IMMUNOL, V142, P67; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Kallies A, 2007, CURR OPIN IMMUNOL, V19, P156, DOI 10.1016/j.coi.2007.01.003; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Marshall AJ, 1998, J IMMUNOL, V161, P6038; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Nagaoka H, 2000, J EXP MED, V191, P2113, DOI 10.1084/jem.191.12.2113; Porcellini S, 2006, J EXP MED, V203, P461, DOI 10.1084/jem.20051519; Sapoznikov A, 2008, NAT IMMUNOL, V9, P388, DOI 10.1038/ni1571; Thevenin C, 1998, J EXP MED, V188, P735, DOI 10.1084/jem.188.4.735; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104	31	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11262	10.1371/journal.pone.0011262	http://dx.doi.org/10.1371/journal.pone.0011262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582316	Green Published, Green Submitted, gold			2022-12-27	WOS:000279058500014
J	Renaudet, O; Dasgupta, G; Bettahi, I; Shi, A; Nesburn, AB; Dumy, P; BenMohamed, L				Renaudet, Olivier; Dasgupta, Gargi; Bettahi, Ilham; Shi, Alda; Nesburn, Anthony B.; Dumy, Pascal; BenMohamed, Lbachir			Linear and Branched Glyco-Lipopeptide Vaccines Follow Distinct Cross-Presentation Pathways and Generate Different Magnitudes of Antitumor Immunity	PLOS ONE			English	Article							CD8(+) T-CELL; MHC CLASS-I; TOLL-LIKE RECEPTOR-2; TOTALLY SYNTHETIC VACCINE; ANTIGEN-PRESENTING CELLS; DENDRITIC CELLS; IMMUNOLOGICAL EVALUATION; CARBOHYDRATE ANTIGENS; LYMPHOCYTE RESPONSES; PROTECTIVE IMMUNITY	Background: Glyco-lipopeptides, a form of lipid-tailed glyco-peptide, are currently under intense investigation as B-and T-cell based vaccine immunotherapy for many cancers. However, the cellular and molecular mechanisms of glycolipopeptides (GLPs) immunogenicity and the position of the lipid moiety on immunogenicity and protective efficacy of GLPs remain to be determined. Methods/Principal Findings: We have constructed two structural analogues of HER-2 glyco-lipopeptide (HER-GLP) by synthesizing a chimeric peptide made of one universal CD4(+) epitope (PADRE) and one HER-2 CD8(+) T-cell epitope (HER420-429). The C-terminal end of the resulting CD4-CD8 chimeric peptide was coupled to a tumor carbohydrate B-cell epitope, based on a regioselectively addressable functionalized templates (RAFT), made of four alpha-GalNAc molecules. The resulting HER glycopeptide (HER-GP) was then linked to a palmitic acid moiety, attached either at the N-terminal end (linear HER-GLP-1) or in the middle between the CD4+ and CD8+ T cell epitopes (branched HER-GLP-2). We have investigated the uptake, processing and cross-presentation pathways of the two HER-GLP vaccine constructs, and assessed whether the position of linkage of the lipid moiety would affect the B-and T-cell immunogenicity and protective efficacy. Immunization of mice revealed that the linear HER-GLP-1 induced a stronger and longer lasting HER420-429-specific IFN-gamma producing CD8(+) T cell response, while the branched HER-GLP-2 induced a stronger tumor-specific IgG response. The linear HER-GLP-1 was taken up easily by dendritic cells (DCs), induced stronger DCs maturation and produced a potent TLR-2-dependent T-cell activation. The linear and branched HER-GLP molecules appeared to follow two different cross-presentation pathways. While regression of established tumors was induced by both linear HER-GLP-1 and branched HER-GLP-2, the inhibition of tumor growth was significantly higher in HER-GLP-1 immunized mice (p<0.005). Significance: These findings have important implications for the development of effective GLP based immunotherapeutic strategies against cancers.	[Renaudet, Olivier; Dasgupta, Gargi; Bettahi, Ilham; Shi, Alda; Nesburn, Anthony B.; BenMohamed, Lbachir] Univ Calif Irvine, Sch Med, Lab Cellular & Mol Immunol, Gavin Herbert Eye Inst, Irvine, CA 92717 USA; [BenMohamed, Lbachir] Univ Calif Irvine, Inst Immunol, Med Ctr, Irvine, CA 92717 USA; [BenMohamed, Lbachir] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Med Ctr, Irvine, CA 92717 USA; [Renaudet, Olivier; Dumy, Pascal] Univ Grenoble 1, CNRS, UMR 5250, Dept Chim Mol, Grenoble, France; [Renaudet, Olivier; Dumy, Pascal] Univ Grenoble 1, ICMG, FR 2607, Grenoble, France	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Renaudet, O (corresponding author), Univ Calif Irvine, Sch Med, Lab Cellular & Mol Immunol, Gavin Herbert Eye Inst, Irvine, CA 92717 USA.	Lbenmoha@uci.edu	Renaudet, Olivier/B-6120-2014; dumy, pascal/C-4863-2008; Renaudet, Olivier/M-1492-2019	Renaudet, Olivier/0000-0003-4963-3848; dumy, pascal/0000-0002-7660-763X; 	National Institutes of Health (NIH) [EY-014900, EY-019896]; Discovery Eye Foundation; Universite Joseph Fourier (UJF Grenoble); Centre National pour la Recherche Scientifique (CNRS); Nanobio Program; COST Action D-34; NATIONAL EYE INSTITUTE [R01EY019896, R01EY014900] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Discovery Eye Foundation; Universite Joseph Fourier (UJF Grenoble); Centre National pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Nanobio Program; COST Action D-34(European Cooperation in Science and Technology (COST)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Grants EY-014900 and EY-019896 to LBM from the National Institutes of Health (NIH), The Discovery Eye Foundation, the Universite Joseph Fourier (UJF Grenoble), the Centre National pour la Recherche Scientifique (CNRS), the Nanobio Program and the COST Action D-34. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Andrieu M, 2003, J VIROL, V77, P1564, DOI 10.1128/JVI.77.2.1564-1570.2003; Bay S, 1997, J PEPT RES, V49, P620; Belizaire R, 2009, P NATL ACAD SCI USA, V106, P17463, DOI 10.1073/pnas.0908583106; Belnoue E, 2004, J IMMUNOL, V173, P4882, DOI 10.4049/jimmunol.173.8.4882; Belz GT, 2002, CRIT REV IMMUNOL, V22, P439; Benmohamed L, 2000, VACCINE, V18, P2843, DOI 10.1016/S0264-410X(00)00068-2; BenMohamed L, 2000, HUM IMMUNOL, V61, P764, DOI 10.1016/S0198-8859(00)00139-7; BenMohamed L, 2004, INFECT IMMUN, V72, P4376, DOI 10.1128/IAI.72.8.4376-4384.2004; BenMohamed L, 2002, IMMUNOLOGY, V106, P113, DOI 10.1046/j.1365-2567.2002.01396.x; BenMohamed L, 2002, EUR J IMMUNOL, V32, P2274, DOI 10.1002/1521-4141(200208)32:8<2274::AID-IMMU2274>3.0.CO;2-C; BenMohamed L, 1997, EUR J IMMUNOL, V27, P1242, DOI 10.1002/eji.1830270528; BenMohamed L, 2002, LANCET INFECT DIS, V2, P425, DOI 10.1016/S1473-3099(02)00318-3; Bettahi I, 2007, INVEST OPHTH VIS SCI, V48, P4643, DOI 10.1167/iovs.07-0356; Bettahi I, 2006, VIRAL IMMUNOL, V19, P220, DOI 10.1089/vim.2006.19.220; Bettahi I, 2009, CANCER IMMUNOL IMMUN, V58, P187, DOI 10.1007/s00262-008-0537-y; Borsutzky S, 2005, J IMMUNOL, V174, P6308, DOI 10.4049/jimmunol.174.10.6308; Bourgeois C, 2003, EUR J IMMUNOL, V33, P3225, DOI 10.1002/eji.200324576; Buskas T, 2005, ANGEW CHEM INT EDIT, V44, P5985, DOI 10.1002/anie.200501818; Casillas S, 1997, DIS COLON RECTUM, V40, P977, DOI 10.1007/BF02051209; Chen LY, 2004, EUR J IMMUNOL, V34, P952, DOI 10.1002/eji.200324359; Chentoufi AA, 2010, J IMMUNOL, V184, P2561, DOI 10.4049/jimmunol.0902322; Chentoufi AA, 2010, CLIN VACCINE IMMUNOL, V17, P342, DOI 10.1128/CVI.00347-09; Chentoufi AA, 2009, ARCH IMMUNOL THER EX, V57, P409, DOI 10.1007/s00005-009-0049-2; Curigliano G, 2006, ANN ONCOL, V17, P750, DOI 10.1093/annonc/mdj083; CURIGLIANO G, 2005, ANN ONCOL; Dasgupta G, 2010, FUTURE MICROBIOL, V5, P1, DOI 10.2217/FMB.09.101; Davila E, 2003, CANCER RES, V63, P3281; Deliyannis G, 2002, J VIROL, V76, P4212, DOI 10.1128/JVI.76.9.4212-4221.2002; Dhodapkar MV, 2000, J CLIN INVEST, V105, pR9, DOI 10.1172/JCI9051; Dorfel D, 2005, BLOOD, V105, P3199, DOI 10.1182/blood-2004-09-3556; Durier C, 2006, AIDS, V20, P1039, DOI 10.1097/01.aids.0000222077.68243.22; Ercolini AM, 2005, J EXP MED, V201, P1591, DOI 10.1084/jem.20042167; Fehr T, 2008, J IMMUNOL, V181, P165, DOI 10.4049/jimmunol.181.1.165; Gahery H, 2005, THERAPIE, V60, P243, DOI 10.2515/therapie:2005031; Gahery H, 2006, AIDS RES HUM RETROV, V22, P684, DOI 10.1089/aid.2006.22.684; Grigalevicius S, 2005, BIOCONJUGATE CHEM, V16, P1149, DOI 10.1021/bc050010v; Groothuis TAM, 2005, J EXP MED, V202, P1313, DOI 10.1084/jem.20051379; Hakomori S, 2001, ADV EXP MED BIOL, V491, P369; Hearn AR, 2004, J BIOL CHEM, V279, P51315, DOI 10.1074/jbc.M408279200; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; HOEFFEL G, 2007, IMMUNITY; Hosmalin A, 2001, IMMUNOL LETT, V79, P97, DOI 10.1016/S0165-2478(01)00271-1; Hotta C, 2006, IMMUNOLOGY, V117, P97, DOI 10.1111/j.1365-2567.2005.02270.x; Ingale S, 2007, NAT CHEM BIOL, V3, P663, DOI 10.1038/nchembio.2007.25; Ingale S, 2009, CHEMBIOCHEM, V10, P455, DOI 10.1002/cbic.200800596; Jackson DC, 2004, P NATL ACAD SCI USA, V101, P15440, DOI 10.1073/pnas.0406740101; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Keding SJ, 2004, P NATL ACAD SCI USA, V101, P11937, DOI 10.1073/pnas.0401894101; Khan R, 2009, J HOSP MED, V4, P68, DOI 10.1002/jhm.381; Khan S, 2009, MOL IMMUNOL, V46, P1084, DOI 10.1016/j.molimm.2008.10.006; Kudryashov V, 2001, P NATL ACAD SCI USA, V98, P3264, DOI 10.1073/pnas.051623598; Larsson M, 2001, TRENDS IMMUNOL, V22, P141, DOI 10.1016/S1471-4906(01)01860-9; Lazoura E, 2005, CURR MED CHEM, V12, P629, DOI 10.2174/0929867053202188; Lee K, 2010, EXPERT REV VACCINES, V9, P29, DOI [10.1586/erv.09.146, 10.1586/ERV.09.146]; Lo-Man R, 2004, CANCER RES, V64, P4987, DOI 10.1158/0008-5472.CAN-04-0252; Lubaroff DM, 2009, ADV DRUG DELIVER REV, V61, P268, DOI 10.1016/j.addr.2008.12.005; Manimala JC, 2005, CHEMBIOCHEM, V6, P2229, DOI 10.1002/cbic.200500165; Maraskovsky E, 2004, CLIN CANCER RES, V10, P2879, DOI 10.1158/1078-0432.CCR-03-0245; Margalit A, 2006, J IMMUNOL, V176, P217, DOI 10.4049/jimmunol.176.1.217; Mesa C, 2004, IMMUNOL CELL BIOL, V82, P644, DOI 10.1111/j.0818-9641.2004.01279.x; Monu N, 2007, CURR OPIN IMMUNOL, V19, P66, DOI 10.1016/j.coi.2006.11.017; Monzavi-Karbassi B, 2001, INT IMMUNOL, V13, P1361, DOI 10.1093/intimm/13.11.1361; Moron G, 2004, TRENDS IMMUNOL, V25, P92, DOI 10.1016/j.it.2003.11.008; Moron VG, 2003, J IMMUNOL, V171, P2242, DOI 10.4049/jimmunol.171.5.2242; Nava-Parada P, 2007, CANCER RES, V67, P1326, DOI 10.1158/0008-5472.CAN-06-3290; Nesburn AB, 2006, OCUL SURF, V4, P178, DOI 10.1016/S1542-0124(12)70164-7; Norell H, 2010, CANCER IMMUNOL IMMUN, V59, P851, DOI 10.1007/s00262-009-0810-8; PEETERS CCAM, 1991, INFECT IMMUN, V59, P3504, DOI 10.1128/IAI.59.10.3504-3510.1991; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Pfender NA, 2008, J IMMUNOL, V180, P1398, DOI 10.4049/jimmunol.180.3.1398; Qi XY, 2009, CLIN CANCER RES, V15, P5840, DOI 10.1158/1078-0432.CCR-08-3285; Radhakrishnan VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011433; Renaudet O., 2008, CHEMMEDCHEM, V2, P425; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Roth A, 2005, BRIT J CANCER, V92, P1421, DOI 10.1038/sj.bjc.6602526; Roy KC, 2008, J IMMUNOL, V180, P2942, DOI 10.4049/jimmunol.180.5.2942; Ruby CE, 2009, CANCER IMMUNOL IMMUN, V58, P1941, DOI 10.1007/s00262-009-0687-6; Samanta S, 2010, BIOMATERIALS, V31, P1787, DOI 10.1016/j.biomaterials.2009.10.027; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Shepherd C, 2010, CURR ONCOL REP, V12, P146, DOI 10.1007/s11912-010-0095-2; Slovin SF, 2005, IMMUNOL CELL BIOL, V83, P418, DOI 10.1111/j.1440-1711.2005.01350.x; Sorensen AL, 2006, GLYCOBIOLOGY, V16, P96, DOI 10.1093/glycob/cwj044; SORENSEN AL, 2005, GLYCOBIOLOGY; Spohn R, 2004, VACCINE, V22, P2494, DOI 10.1016/j.vaccine.2003.11.074; Springer GF, 1997, J MOL MED, V75, P594, DOI 10.1007/s001090050144; Svensson M, 1999, EUR J IMMUNOL, V29, P180, DOI 10.1002/(SICI)1521-4141(199901)29:01<180::AID-IMMU180>3.0.CO;2-W; Syrigos KN, 1999, ANTICANCER RES, V19, P5239; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Triantafilou M, 2004, J BIOL CHEM, V279, P40882, DOI 10.1074/jbc.M400466200; Tseng JC, 2006, J NUCL MED, V47, P1136; van der Bruggen P, 2006, CURR OPIN IMMUNOL, V18, P98, DOI 10.1016/j.coi.2005.11.013; Vazquez-Martin C, 2004, ONCOLOGY-BASEL, V67, P159, DOI 10.1159/000081003; Vicente-Suarez I, 2009, IMMUNOL LETT, V125, P114, DOI 10.1016/j.imlet.2009.06.007; Vichier-Guerre S, 2004, BIOORG MED CHEM LETT, V14, P3567, DOI 10.1016/j.bmcl.2004.04.047; Vichier-Guerre S, 2003, J PEPT RES, V62, P117, DOI 10.1034/j.1399-3011.2003.00074.x; Warger T, 2007, IMMUNOL LETT, V109, P13, DOI 10.1016/j.imlet.2007.01.007; Watchmaker PB, 2010, J IMMUNOL, V184, P591, DOI 10.4049/jimmunol.0902062; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Xiang SD, 2008, EXPERT REV VACCINES, V7, P1103, DOI 10.1586/14760584.7.7.1103; Zhang X, 2009, MUCOSAL IMMUNOL, V2, P129, DOI 10.1038/mi.2008.81; Zhang XL, 2005, J VIROL, V79, P15289, DOI 10.1128/JVI.79.24.15289-15301.2005; Zhu Q, 2010, J CLIN INVEST, V120, P607, DOI 10.1172/JCI39293; Zhu X., 2004, EUR J IMMUNOL, V34, P1142	106	66	70	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11216	10.1371/journal.pone.0011216	http://dx.doi.org/10.1371/journal.pone.0011216			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574522	Green Published, gold			2022-12-27	WOS:000279058300011
J	Martinez-Seara, H; Rog, T; Karttunen, M; Vattulainen, I; Reigada, R				Martinez-Seara, Hector; Rog, Tomasz; Karttunen, Mikko; Vattulainen, Ilpo; Reigada, Ramon			Cholesterol Induces Specific Spatial and Orientational Order in Cholesterol/Phospholipid Membranes	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PHOSPHATIDYLCHOLINE BILAYER; LIPID-MEMBRANES; STEROL STRUCTURE; FATTY-ACIDS; MODEL; RAFTS; PHOSPHOLIPIDS; PRESSURE; SPHINGOMYELIN	Background: In lipid bilayers, cholesterol facilitates the formation of the liquid-ordered phase and enables the formation of laterally ordered structures such as lipid rafts. While these domains have an important role in a variety of cellular processes, the precise atomic-level mechanisms responsible for cholesterol's specific ordering and packing capability have remained unresolved. Methodology/Principal Findings: Our atomic-scale molecular dynamics simulations reveal that this ordering and the associated packing effects in membranes largely result from cholesterol's molecular structure, which differentiates cholesterol from other sterols. We find that cholesterol molecules prefer to be located in the second coordination shell, avoiding direct cholesterol-cholesterol contacts, and form a three-fold symmetric arrangement with proximal cholesterol molecules. At larger distances, the lateral three-fold organization is broken by thermal fluctuations. For other sterols having less structural asymmetry, the three-fold arrangement is considerably lost. Conclusions/Significance: We conclude that cholesterol molecules act collectively in lipid membranes. This is the main reason why the liquid-ordered phase only emerges for Chol concentrations well above 10 mol% where the collective self-organization of Chol molecules emerges spontaneously. The collective ordering process requires specific molecular-scale features that explain why different sterols have very different membrane ordering properties: the three-fold symmetry in the Chol-Chol organization arises from the cholesterol off-plane methyl groups allowing the identification of raft-promoting sterols from those that do not promote rafts.	[Martinez-Seara, Hector; Reigada, Ramon] Univ Barcelona, Dept Phys Chem, Barcelona, Spain; [Martinez-Seara, Hector; Reigada, Ramon] Univ Barcelona, IQTCUB, Barcelona, Spain; [Rog, Tomasz; Vattulainen, Ilpo] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland; [Karttunen, Mikko] Univ Western Ontario, Dept Appl Math, London, ON N6A 5B9, Canada; [Vattulainen, Ilpo] Univ So Denmark, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark; [Vattulainen, Ilpo] Aalto Univ, Sch Sci & Technol, Dept Appl Phys, Espoo, Finland	University of Barcelona; University of Barcelona; Tampere University; Western University (University of Western Ontario); University of Southern Denmark; Aalto University	Reigada, R (corresponding author), Univ Barcelona, Dept Phys Chem, Barcelona, Spain.	reigada@ub.edu	Martinez-Seara, Hector/D-3734-2014; Karttunen, Mikko/G-4531-2010; Rog, Tomasz/ABE-3044-2020; Reigada, Ramon/A-2450-2012; Vattulainen, Ilpo T/G-4224-2014	Martinez-Seara, Hector/0000-0001-9716-1713; Karttunen, Mikko/0000-0002-8626-3033; Rog, Tomasz/0000-0001-6765-7013; Reigada, Ramon/0000-0003-2177-7014	Secretaria de Estado de Educacion, Universidades, Investigacion y Desarrollo [FIS200603525]; Departament d'Universitats, Recerca i Societat de la Informacio [2009-SGR1055]; Academy of Finland; National Sciences and Engineering Research Council; SharcNet of Canada	Secretaria de Estado de Educacion, Universidades, Investigacion y Desarrollo; Departament d'Universitats, Recerca i Societat de la Informacio; Academy of Finland(Academy of Finland); National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); SharcNet of Canada	Financial support was provided by the Secretaria de Estado de Educacion, Universidades, Investigacion y Desarrollo through project FIS200603525 (HMS, RR), by the Departament d'Universitats, Recerca i Societat de la Informacio through project 2009-SGR1055 (HMS, RR), by the Academy of Finland (TR, IV), and by the National Sciences and Engineering Research Council and SharcNet of Canada (MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittoniemi J, 2006, J PHYS CHEM B, V110, P25562, DOI 10.1021/jp064931u; Ali MR, 2007, P NATL ACAD SCI USA, V104, P5372, DOI 10.1073/pnas.0611450104; Almeida PFF, 2009, BBA-BIOMEMBRANES, V1788, P72, DOI 10.1016/j.bbamem.2008.08.007; Bachar M, 2004, J PHYS CHEM B, V108, P7170, DOI 10.1021/jp036981u; Beattie ME, 2005, BIOPHYS J, V89, P1760, DOI 10.1529/biophysj.104.049635; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Berkowitz ML, 2009, BBA-BIOMEMBRANES, V1788, P86, DOI 10.1016/j.bbamem.2008.09.009; BLOCH K, 1991, BIOCH LIPIDS LIPOPRO, P363; BLOOM M, 1991, Q REV BIOPHYS, V24, P293, DOI 10.1017/S0033583500003735; Chong PLG, 2009, BBA-BIOMEMBRANES, V1788, P2, DOI 10.1016/j.bbamem.2008.10.010; CHONG PLG, 1994, P NATL ACAD SCI USA, V91, P10069, DOI 10.1073/pnas.91.21.10069; Czub J, 2006, BIOPHYS J, V90, P2368, DOI 10.1529/biophysj.105.072801; Dupuy AD, 2008, P NATL ACAD SCI USA, V105, P2848, DOI 10.1073/pnas.0712379105; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Holtje M, 2001, BBA-BIOMEMBRANES, V1511, P156, DOI 10.1016/S0005-2736(01)00270-X; Huang JY, 1999, BIOPHYS J, V76, P2142, DOI 10.1016/S0006-3495(99)77369-8; Hung WC, 2007, BIOPHYS J, V92, P3960, DOI 10.1529/biophysj.106.099234; Ikonen E, 2006, PHYSIOL REV, V86, P1237, DOI 10.1152/physrev.00022.2005; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Karttunen M, 2008, CURR TOP MEMBR, V60, P49, DOI 10.1016/S1063-5823(08)00002-1; Koynova R, 1998, BBA-REV BIOMEMBRANES, V1376, P91, DOI 10.1016/S0304-4157(98)00006-9; Kucerka N, 2007, EUR PHYS J E, V23, P247, DOI 10.1140/epje/i2007-10202-8; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Kucerka N, 2008, BIOPHYS J, V95, P2356, DOI 10.1529/biophysj.108.132662; Li XM, 2003, BIOPHYS J, V85, P3788, DOI 10.1016/S0006-3495(03)74794-8; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Marrink SJ, 2008, J AM CHEM SOC, V130, P10, DOI 10.1021/ja076641c; Martinez-Seara H, 2008, BIOPHYS J, V95, P3295, DOI 10.1529/biophysj.108.138123; Martinez-Seara H, 2007, J PHYS CHEM B, V111, P11162, DOI 10.1021/jp071894d; Martinez-Seara H, 2009, J PHYS CHEM B, V113, P8347, DOI 10.1021/jp902131b; Martinez-Seara H, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2976443; Miao L, 2002, BIOPHYS J, V82, P1429, DOI 10.1016/S0006-3495(02)75497-0; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Niemela PS, 2007, PLOS COMPUT BIOL, V3, P304, DOI 10.1371/journal.pcbi.0030034; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Ollila OHS, 2007, J STRUCT BIOL, V159, P311, DOI 10.1016/j.jsb.2007.01.012; Ollila S, 2007, J PHYS CHEM B, V111, P3139, DOI 10.1021/jp065424f; Pan JJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021931; Pandit SA, 2004, BIOPHYS J, V87, P3312, DOI 10.1529/biophysj.104.046078; Pandit SA, 2009, BBA-BIOMEMBRANES, V1788, P136, DOI 10.1016/j.bbamem.2008.09.004; Patra M, 2004, J PHYS CHEM B, V108, P4485, DOI 10.1021/jp031281a; Pitman MC, 2004, BIOCHEMISTRY-US, V43, P15318, DOI 10.1021/bi048231w; Poyry S, 2008, J PHYS CHEM B, V112, P2922, DOI 10.1021/jp7100495; Radhakrishnan A, 2005, P NATL ACAD SCI USA, V102, P12662, DOI 10.1073/pnas.0506043102; Risselada HJ, 2008, P NATL ACAD SCI USA, V105, P17367, DOI 10.1073/pnas.0807527105; Rog T, 2006, BIOCHIMIE, V88, P449, DOI 10.1016/j.biochi.2005.10.005; Rog T, 2004, BIOPHYS CHEM, V107, P151, DOI 10.1016/j.bpc.2003.09.002; Rog T, 2001, BIOPHYS J, V81, P2190, DOI 10.1016/S0006-3495(01)75867-5; Rog T, 2007, BIOPHYS J, V92, P3346, DOI 10.1529/biophysj.106.095497; Rog T, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2996296; Rog T, 2009, J PHYS CHEM B, V113, P3413, DOI 10.1021/jp8077369; Rog T, 2009, BBA-BIOMEMBRANES, V1788, P97, DOI 10.1016/j.bbamem.2008.08.022; Silvius JR, 2003, BBA-BIOMEMBRANES, V1610, P174, DOI 10.1016/S0005-2736(03)00016-6; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stottrup BL, 2006, BIOPHYS J, V90, P3176, DOI 10.1529/biophysj.105.072959; Tieleman DP, 1996, J CHEM PHYS, V105, P4871, DOI 10.1063/1.472323; Tieleman DP, 2002, BIOPHYS J, V83, P1501, DOI 10.1016/S0006-3495(02)73920-9; Vainio S, 2006, J BIOL CHEM, V281, P348, DOI 10.1074/jbc.M509530200; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JW, 2004, BIOCHEMISTRY-US, V43, P1010, DOI 10.1021/bi035696y	64	88	88	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11162	10.1371/journal.pone.0011162	http://dx.doi.org/10.1371/journal.pone.0011162			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567600	gold, Green Published, Green Submitted			2022-12-27	WOS:000278886300008
J	Calounova, G; Livera, G; Zhang, XQ; Liu, K; Gosden, RG; Welsh, M				Calounova, Gabriela; Livera, Gabriel; Zhang, Xiao-Qun; Liu, Kui; Gosden, Roger G.; Welsh, Michael			The Src Homology 2 Domain-Containing Adapter Protein B (SHB) Regulates Mouse Oocyte Maturation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GROWTH-FACTOR; FOLLICLE DEVELOPMENT; FERTILITY PATHWAYS; C-KIT; DIFFERENTIATION; MICE; EXPRESSION; PROMOTES; PROLIFERATION	SHB (Src homology 2 domain-containing adapter protein B) is involved in receptor tyrosine kinase signaling. Mice deficient in the Shb gene have been found to exhibit a transmission ratio distortion with respect to inheritance of the Shb null allele among offspring and this phenomenon was linked to female gamete production. Consequently, we postulated that Shb plays a role for oocyte biology and thus decided to investigate oocyte formation, meiotic maturation, and early embryo development in relation to absence of the Shb gene. Oogenesis was apparently accelerated judging from the stages of oocyte development on fetal day 18.5 and one week postnatally in Shb(-/-) mice; but in adulthood ovarian follicle maturation was impaired in these mice. Completion of meiosis I (first polar body extrusion) was less synchronized, with a fraction of oocytes showing premature polar body extrusion in the absence of Shb. In vitro fertilization of mature oocytes isolated from Shb +/+, +/- and -/- mice revealed impaired early embryo development in the -/- embryos. Moreover, the absence of Shb enhanced ERK (extracellular-signal regulated kinase) and RSK (ribosomal S6 kinase) signaling in oocytes and these effects were paralleled by an increased ribosomal protein S6 phosphorylation and activation. It is concluded that SHB regulates normal oocyte and follicle development and that perturbation of SHB signaling causes defective meiosis I and early embryo development.	[Calounova, Gabriela; Welsh, Michael] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Livera, Gabriel] Univ Paris 07, CEA, INSERM, Lab Dev Gonads,UMR U967, Fontenay Aux Roses, France; [Zhang, Xiao-Qun] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Liu, Kui] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Gosden, Roger G.] Cornell Univ, Weill Med Coll, Ctr Reprod Med & Infertil, New York, NY 10021 USA	Uppsala University; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Uppsala University; Umea University; Cornell University	Calounova, G (corresponding author), Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden.	Michael.welsh@mcb.uu.se	LIVERA, Gabriel/F-5740-2019; Welsh, Michael/AAF-8564-2020	LIVERA, Gabriel/0000-0001-8436-4730; Welsh, Michael/0000-0002-5467-9755	Swedish Research Council [68X-10822]; Swedish Cancer Foundation [090779]; Swedish Diabetes Research Foundation; Wallenberg Family Foundation; Family Ernfors Fund; EMD Serono	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Swedish Diabetes Research Foundation; Wallenberg Family Foundation; Family Ernfors Fund; EMD Serono	Support from the Swedish Research Council (68X-10822), the Swedish Cancer Foundation (090779), the Swedish Diabetes Research Foundation, the Wallenberg Family Foundation and the Family Ernfors Fund is gratefully acknowledged. RGG is supported by an unrestricted grant from EMD Serono. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ABERCROMBIE M, 1946, J ANAT, V80, P37; Akerblom B, 2009, J ENDOCRINOL, V203, P271, DOI 10.1677/JOE-09-0198; Anneren C, 2003, CURR MOL MED, V3, P313, DOI 10.2174/1566524033479744; BUEHR M, 1993, DEV DYNAM, V198, P182, DOI 10.1002/aja.1001980304; Carabatsos MJ, 1998, DEV BIOL, V204, P373, DOI 10.1006/dbio.1998.9087; Dekel N, 2005, MOL CELL ENDOCRINOL, V234, P19, DOI 10.1016/j.mce.2004.09.010; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; FADDY MJ, 1987, CELL TISSUE KINET, V20, P551, DOI 10.1111/j.1365-2184.1987.tb01364.x; Funa NS, 2008, DIFFERENTIATION, V76, P443, DOI 10.1111/j.1432-0436.2007.00249.x; Funa NS, 2009, CANCER RES, V69, P2141, DOI 10.1158/0008-5472.CAN-08-3797; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; GONZALEZ R, 2009, REPROD TOXICOL; GONZALEZ R, 2009, TOXICOL IN VITRO; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Jagarlamudi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006186; Kawamura K, 2009, DEV BIOL, V327, P62, DOI 10.1016/j.ydbio.2008.11.033; Klinger FG, 2002, DEV BIOL, V244, P85, DOI 10.1006/dbio.2002.0592; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Kriz V, 2003, EXP CELL RES, V286, P40, DOI 10.1016/S0014-4827(03)00099-5; Kriz V, 2007, DEV DYNAM, V236, P2485, DOI 10.1002/dvdy.21257; Kriz V, 2006, J BIOL CHEM, V281, P34484, DOI 10.1074/jbc.M604084200; Kwintkiewicz J, 2009, SEMIN REPROD MED, V27, P43, DOI 10.1055/s-0028-1108009; Livera G, 2006, CELL TISSUE RES, V324, P507, DOI 10.1007/s00441-006-0167-7; Livera G, 2008, REPRODUCTION, V135, P3, DOI 10.1530/REP-07-0054; Matskova LV, 2007, ONCOGENE, V26, P4908, DOI 10.1038/sj.onc.1210298; MATSUI Y, 1990, NATURE, V347, P667, DOI 10.1038/347667a0; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; McClellan KA, 2003, DEV BIOL, V258, P334, DOI 10.1016/S0012-1606(03)00132-5; McGinnis LK, 2009, DEV BIOL, V327, P280, DOI 10.1016/j.ydbio.2008.11.038; Mokhtari D, 2009, BIOCHEM BIOPH RES CO, V387, P553, DOI 10.1016/j.bbrc.2009.07.051; PACKER AI, 1994, DEV BIOL, V161, P194, DOI 10.1006/dbio.1994.1020; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Rolny C, 2005, EXP CELL RES, V308, P381, DOI 10.1016/j.yexcr.2005.04.020; Roy A, 2006, REPRODUCTION, V131, P207, DOI 10.1530/rep.1.00530; Saldeen J, 2006, BIOCHEM BIOPH RES CO, V344, P517, DOI 10.1016/j.bbrc.2006.03.129	36	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11155	10.1371/journal.pone.0011155	http://dx.doi.org/10.1371/journal.pone.0011155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585392	Green Submitted, gold, Green Published			2022-12-27	WOS:000278886100018
J	Smith, GR; Shanley, DP				Smith, Graham R.; Shanley, Daryl P.			Modelling the Response of FOXO Transcription Factors to Multiple Post-Translational Modifications Made by Ageing-Related Signalling Pathways	PLOS ONE			English	Article							CELL-CYCLE REGULATION; EXTENDS LIFE-SPAN; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; DIETARY RESTRICTION; INSULIN-RECEPTOR; NUCLEOCYTOPLASMIC OSCILLATIONS; PROMOTES TUMORIGENESIS; TARGET GENES; FACTOR MSN2	FOXO transcription factors are an important, conserved family of regulators of cellular processes including metabolism, cell-cycle progression, apoptosis and stress resistance. They are required for the efficacy of several of the genetic interventions that modulate lifespan. FOXO activity is regulated by multiple post-translational modifications (PTMs) that affect its subcellular localization, half-life, DNA binding and transcriptional activity. Here, we show how a mathematical modelling approach can be used to simulate the effects, singly and in combination, of these PTMs. Our model is implemented using the Systems Biology Markup Language (SBML), generated by an ancillary program and simulated in a stochastic framework. The use of the ancillary program to generate the SBML is necessary because the possibility that many regulatory PTMs may be added, each independently of the others, means that a large number of chemically distinct forms of the FOXO molecule must be taken into account, and the program is used to generate them. Although the model does not yet include detailed representations of events upstream and downstream of FOXO, we show how it can qualitatively, and in some cases quantitatively, reproduce the known effects of certain treatments that induce various single and multiple PTMs, and allows for a complex spatiotemporal interplay of effects due to the activation of multiple PTM-inducing treatments. Thus, it provides an important framework to integrate current knowledge about the behaviour of FOXO. The approach should be generally applicable to other proteins experiencing multiple regulations.	[Smith, Graham R.; Shanley, Daryl P.] Newcastle Univ, Inst Ageing & Hlth, Henry Wellcome Lab Biogerontol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Smith, GR (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Henry Wellcome Lab Biogerontol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Daryl.Shanley@newcastle.ac.uk		Shanley, Daryl/0000-0003-3096-6386	BBSRC [BBC0082001]; EU [FP6 036894]	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU(European Commission)	This work was supported in part by the BBSRC (www.bbsrc.ac.uk)/EPSRC (www.epsrc.ac.uk) grant to CISBAN (BBC0082001), and was in part supported by, and carried out within, the EU (cordis.europa.eu/fp6/) funded Network of Excellence LifeSpan (FP6 036894). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador-Noguez D, 2004, AGING CELL, V3, P423, DOI 10.1111/j.1474-9728.2004.00125.x; Arden KC, 2006, EXP GERONTOL, V41, P709, DOI 10.1016/j.exger.2006.05.015; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Bakker WJ, 2004, J CELL BIOL, V164, P175, DOI 10.1083/jcb.200307056; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Blinov ML, 2004, BIOINFORMATICS, V20, P3289, DOI 10.1093/bioinformatics/bth378; Borisov NM, 2005, BIOPHYS J, V89, P951, DOI 10.1529/biophysj.105.060533; Brent MM, 2008, STRUCTURE, V16, P1407, DOI 10.1016/j.str.2008.06.013; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Colvin J, 2009, BIOINFORMATICS, V25, P910, DOI 10.1093/bioinformatics/btp066; Csikasz-Nagy A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.73; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Faeder James R., 2009, V500, P113, DOI 10.1007/978-1-59745-525-1_5; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Fu W, 2009, J BIOL CHEM, V284, P13987, DOI 10.1074/jbc.M901758200; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Garmendia-Torres C, 2007, CURR BIOL, V17, P1044, DOI 10.1016/j.cub.2007.05.032; Gershman B, 2007, PHYSIOL GENOMICS, V29, P24, DOI 10.1152/physiolgenomics.00061.2006; Gevorgyan A, 2008, BIOINFORMATICS, V24, P2245, DOI 10.1093/bioinformatics/btn425; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; Gillespie CS, 2006, BIOINFORMATICS, V22, P628, DOI 10.1093/bioinformatics/btk042; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Gonze D, 2008, J R SOC INTERFACE, V5, pS95, DOI 10.1098/rsif.2008.0141.focus; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Hanke S, 2009, MOL CELL PROTEOMICS, V8, P519, DOI 10.1074/mcp.M800407-MCP200; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Hirota K, 2003, J BIOL CHEM, V278, P13056, DOI 10.1074/jbc.C200553200; Hlavacek William S, 2006, Sci STKE, V2006, pre6, DOI 10.1126/stke.3442006re6; Hlavacek WS, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.80; Hollstein M, 2010, J PATHOL, V220, P164, DOI 10.1002/path.2637; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Honjoh S, 2009, NATURE, V457, P726, DOI 10.1038/nature07583; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Houthoofd K, 2003, EXP GERONTOL, V38, P947, DOI 10.1016/S0531-5565(03)00161-X; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Imae M, 2003, J MOL ENDOCRINOL, V30, P253, DOI 10.1677/jme.0.0300253; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Karpac J, 2009, TRENDS ENDOCRIN MET, V20, P100, DOI 10.1016/j.tem.2008.11.004; Kim S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000665; Kirkwood TBL, 2003, NAT REV MOL CELL BIO, V4, P243, DOI 10.1038/nrm1051; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; Kondo M, 2005, MECH AGEING DEV, V126, P642, DOI 10.1016/j.mad.2004.11.012; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kuningas M, 2007, J GERONTOL A-BIOL, V62, P960, DOI 10.1093/gerona/62.9.960; Le Novere N, 2001, BIOINFORMATICS, V17, P575, DOI 10.1093/bioinformatics/17.6.575; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Martin OC, 2009, GENETICS, V183, P673, DOI 10.1534/genetics.109.104174; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Mendes P, 2009, METHOD ENZYMOL, V467, P583, DOI 10.1016/S0076-6879(09)67022-1; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nowak K, 2007, BBA-GENE STRUCT EXPR, V1769, P244, DOI 10.1016/j.bbaexp.2007.04.001; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Partridge L, 2008, ONCOGENE, V27, P2351, DOI 10.1038/onc.2008.28; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Peng SL, 2008, ONCOGENE, V27, P2337, DOI 10.1038/onc.2008.26; Poolman MG, 2006, IEE P SYST BIOL, V153, P379, DOI 10.1049/ip-syb:20060012; Proctor CJ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-75; Proctor CJ, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-17; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Puszynski K, 2008, J THEOR BIOL, V254, P452, DOI 10.1016/j.jtbi.2008.05.039; Rena G, 2002, EMBO J, V21, P2263, DOI 10.1093/emboj/21.9.2263; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Schmierer B, 2008, P NATL ACAD SCI USA, V105, P6608, DOI 10.1073/pnas.0710134105; Schuur ER, 2001, J BIOL CHEM, V276, P33554, DOI 10.1074/jbc.M105555200; Sedaghat AR, 2002, AM J PHYSIOL-ENDOC M, V283, pE1084, DOI 10.1152/ajpendo.00571.2001; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Sesti G, 2001, FASEB J, V15, P2099, DOI 10.1096/fj.01-0009rev; Shapiro BE, 2003, BIOINFORMATICS, V19, P677, DOI 10.1093/bioinformatics/btg042; Smallbone K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-6; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; Tsai WB, 2008, NAT CELL BIOL, V10, P460, DOI 10.1038/ncb1709; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wilkinso D.J., 2006, STOCHASTIC MODELLING; Yalcin S, 2008, J BIOL CHEM, V283, P25692, DOI 10.1074/jbc.M800517200; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yamamura Y, 2006, J BIOL CHEM, V281, P5267, DOI 10.1074/jbc.M512151200; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang JY, 2006, INT J ONCOL, V29, P643; Yang J, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031910; Yu RX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001821; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106; Zhao HH, 2001, J BIOL CHEM, V276, P27907, DOI 10.1074/jbc.M104278200; Zick Yehiel, 2005, Sci STKE, V2005, ppe4, DOI 10.1126/stke.2682005pe4	137	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11092	10.1371/journal.pone.0011092	http://dx.doi.org/10.1371/journal.pone.0011092			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20567500	Green Submitted, Green Published, gold			2022-12-27	WOS:000278741100008
J	Starkey, JM; Zhao, YX; Sadygov, RG; Haidacher, SJ; LeJeune, WS; Dey, N; Luxon, BA; Kane, MA; Napoli, JL; Denner, L; Tilton, RG				Starkey, Jonathan M.; Zhao, Yingxin; Sadygov, Rovshan G.; Haidacher, Sigmund J.; LeJeune, Wanda S.; Dey, Nilay; Luxon, Bruce A.; Kane, Maureen A.; Napoli, Joseph L.; Denner, Larry; Tilton, Ronald G.			Altered Retinoic Acid Metabolism in Diabetic Mouse Kidney Identified by O-18 Isotopic Labeling and 2D Mass Spectrometry	PLOS ONE			English	Article							ALCOHOL-DEHYDROGENASE ADH1; VITAMIN-A; BINDING-PROTEIN; CYTOCHROME-P450 2E1; ACTIVATED RECEPTOR; OXIDATIVE STRESS; IN-VIVO; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; NUCLEAR RECEPTORS	Background: Numerous metabolic pathways have been implicated in diabetes-induced renal injury, yet few studies have utilized unbiased systems biology approaches for mapping the interconnectivity of diabetes-dysregulated proteins that are involved. We utilized a global, quantitative, differential proteomic approach to identify a novel retinoic acid hub in renal cortical protein networks dysregulated by type 2 diabetes. Methodology/Principal Findings: Total proteins were extracted from renal cortex of control and db/db mice at 20 weeks of age (after 12 weeks of hyperglycemia in the diabetic mice). Following trypsinization, O-18- and O-16-labeled control and diabetic peptides, respectively, were pooled and separated by two dimensional liquid chromatography (strong cation exchange creating 60 fractions further separated by nano-HPLC), followed by peptide identification and quantification using mass spectrometry. Proteomic analysis identified 53 proteins with fold change >= 1.5 and p <= 0.05 after Benjamini-Hochberg adjustment (out of 1,806 proteins identified), including alcohol dehydrogenase (ADH) and retinaldehyde dehydrogenase (RALDH1/ALDH1A1). Ingenuity Pathway Analysis identified altered retinoic acid as a key signaling hub that was altered in the diabetic renal cortical proteome. Western blotting and real-time PCR confirmed diabetes-induced upregulation of RALDH1, which was localized by immunofluorescence predominantly to the proximal tubule in the diabetic renal cortex, while PCR confirmed the downregulation of ADH identified with mass spectrometry. Despite increased renal cortical tissue levels of retinol and RALDH1 in db/db versus control mice, all-trans-retinoic acid was significantly decreased in association with a significant decrease in PPAR beta/delta mRNA. Conclusions/Significance: Our results indicate that retinoic acid metabolism is significantly dysregulated in diabetic kidneys, and suggest that a shift in all-trans-retinoic acid metabolism is a novel feature in type 2 diabetic renal disease. Our observations provide novel insights into potential links between altered lipid metabolism and other gene networks controlled by retinoic acid in the diabetic kidney, and demonstrate the utility of using systems biology to gain new insights into diabetic nephropathy.	[Zhao, Yingxin; Haidacher, Sigmund J.; LeJeune, Wanda S.; Dey, Nilay; Denner, Larry; Tilton, Ronald G.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX USA; [Starkey, Jonathan M.; Sadygov, Rovshan G.; Luxon, Bruce A.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA; [Tilton, Ronald G.] Univ Texas Med Branch, Dept Ophthalmol & Visual Sci, Galveston, TX USA; [Zhao, Yingxin; Denner, Larry; Tilton, Ronald G.] Univ Texas Med Branch, Stark Diabet Ctr, Galveston, TX USA; [Zhao, Yingxin; Haidacher, Sigmund J.; LeJeune, Wanda S.; Denner, Larry; Tilton, Ronald G.] Univ Texas Med Branch, McCoy Diabet Mass Spectrometry Res Lab, Galveston, TX USA; [Zhao, Yingxin; Sadygov, Rovshan G.; Luxon, Bruce A.; Denner, Larry] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX USA; [Luxon, Bruce A.] Univ Texas Med Branch, Inst Translat Sci Biomed Informat Program, Galveston, TX USA; [Kane, Maureen A.; Napoli, Joseph L.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California Berkeley	Starkey, JM (corresponding author), Univ Texas Med Branch, Dept Internal Med, Galveston, TX USA.	rgtilton@utmb.edu	Luxon, Bruce A/C-9140-2012	Starkey, Jonathan/0000-0002-9083-6455	American Diabetes Association; McCoy Diabetes Research Foundation; Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia [5T15LM007093]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017927] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007093] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); McCoy Diabetes Research Foundation; Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This project was supported by an American Diabetes Association (http://www.diabetes.org/) research grant (RGT), and the McCoy Diabetes Research Foundation (RGT and LD). JMS was supported by a training fellowship from the Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia (National Library of Medicine Training Program in Biomedical Informatics and Computational Biology Grant No. 5T15LM007093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn T, 2006, TOXICOL LETT, V166, P27, DOI 10.1016/j.toxlet.2006.05.009; Araki E, 2003, INTERNAL MED, V42, P7, DOI 10.2169/internalmedicine.42.7; Baena RM, 2002, EUR J CLIN NUTR, V56, P44, DOI 10.1038/sj.ejcn.1601279; Bai JX, 2006, J BIOL CHEM, V281, P5128, DOI 10.1074/jbc.M510484200; BASU TK, 1989, AM J CLIN NUTR, V50, P329, DOI 10.1093/ajcn/50.2.329; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Boerman MHEM, 1996, J BIOL CHEM, V271, P5610, DOI 10.1074/jbc.271.10.5610; BROWNLEE M, 1988, DIABETES METAB REV, V4, P437, DOI 10.1002/dmr.5610040503; Burns KD, 2000, AM J KIDNEY DIS, V36, P449, DOI 10.1053/ajkd.2000.16192; Deltour L, 1999, J BIOL CHEM, V274, P16796, DOI 10.1074/jbc.274.24.16796; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Duester G, 2003, CHEM-BIOL INTERACT, V143, P201, DOI 10.1016/S0009-2797(02)00204-1; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Elizondo G, 2000, J BIOL CHEM, V275, P39747, DOI 10.1074/jbc.M004987200; Elizondo G, 2009, BIOCHEM PHARMACOL, V77, P248, DOI 10.1016/j.bcp.2008.10.011; Gonzalez-Diaz H, 2008, PROTEOMICS, V8, P750, DOI 10.1002/pmic.200700638; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Han SY, 2004, IMMUNOL CELL BIOL, V82, P568, DOI 10.1111/j.1440-1711.2004.01287.x; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517; Liu X, 2008, ACTA PHARMACOL SIN, V29, P1035, DOI 10.1111/j.1745-7254.2008.00849.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2000, J NUTR, V130, P1958, DOI 10.1093/jn/130.8.1958; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; MARTINOLI L, 1993, INT J VITAM NUTR RES, V63, P87; Mishra R, 2004, AM J PHYSIOL-RENAL, V286, pF913, DOI 10.1152/ajprenal.00323.2003; Molotkov A, 2002, EUR J BIOCHEM, V269, P2607, DOI 10.1046/j.1432-1033.2002.02935.x; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; Nishikawa T, 2000, KIDNEY INT, V58, pS26, DOI 10.1046/j.1523-1755.2000.07705.x; Njar VCO, 2006, BIOORGAN MED CHEM, V14, P4323, DOI 10.1016/j.bmc.2006.02.041; Noy N, 2007, BIOCHEMISTRY-US, V46, P13461, DOI 10.1021/bi7018699; Oates, 1999, Expert Opin Investig Drugs, V8, P2095, DOI 10.1517/13543784.8.12.2095; Olmedilla B, 1997, CLIN CHEM, V43, P1066; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; POSCH KC, 1992, J BIOL CHEM, V267, P19676; Proctor G, 2006, DIABETES, V55, P2502, DOI 10.2337/db05-0603; Qian WJ, 2005, MOL CELL PROTEOMICS, V4, P700, DOI 10.1074/mcp.M500045-MCP200; Raza H, 2004, DIABETES, V53, P185, DOI 10.2337/diabetes.53.1.185; Rieck M, 2008, MOL PHARMACOL, V74, P1269, DOI 10.1124/mol.108.050625; Ritz E, 1999, AM J KIDNEY DIS, V34, P795, DOI 10.1016/S0272-6386(99)70035-1; Schmidt AM, 1996, DIABETES, V45, pS77, DOI 10.2337/diab.45.3.S77; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Sharma K, 2003, AM J PHYSIOL-RENAL, V284, pF1138, DOI 10.1152/ajprenal.00315.2002; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Starkey JM, 2006, DIABETES, V55, P1252, DOI 10.2337/db05-1554; Strange K, 2005, AM J PHYSIOL-CELL PH, V288, pC968, DOI 10.1152/ajpcell.00598.2004; Szabo C, 2005, PHARMACOL RES, V52, P60, DOI 10.1016/j.phrs.2005.02.015; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tilton RG, 2007, PROTEOMICS, V7, P1729, DOI 10.1002/pmic.200700017; Wang T, 2008, J PHARMACOL EXP THER, V324, P674, DOI 10.1124/jpet.107.131045; Wang XD, 2005, ALCOHOL, V35, P251, DOI 10.1016/j.alcohol.2005.04.006; Wang ZQ, 2003, BRIT J CLIN PHARMACO, V55, P77, DOI 10.1046/j.1365-2125.2003.01731.x; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801; Yao XD, 2001, ANAL CHEM, V73, P2836, DOI 10.1021/ac001404c; Zhao YX, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-15; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	63	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11095	10.1371/journal.pone.0011095	http://dx.doi.org/10.1371/journal.pone.0011095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559430	Green Submitted, Green Published, gold			2022-12-27	WOS:000278741100011
J	Rouge, C; Butel, MJ; Piloquet, H; Ferraris, L; Legrand, A; Vodovar, M; Voyer, M; de la Cochetiere, MF; Darmaun, D; Roze, JC				Rouge, Carole; Butel, Marie-Jose; Piloquet, Hugues; Ferraris, Laurent; Legrand, Arnaud; Vodovar, Michel; Voyer, Marcel; de la Cochetiere, Marie-France; Darmaun, Dominique; Roze, Jean-Christophe			Fecal Calprotectin Excretion in Preterm Infants during the Neonatal Period	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; BIRTH-WEIGHT INFANTS; NECROTIZING ENTEROCOLITIS; INTESTINAL PERMEABILITY; PROTEIN; CHILDREN; FECES; L1; SUPPLEMENTATION; COLONIZATION	Background: Fecal calprotectin has been proposed as a non-invasive marker of intestinal inflammation in inflammatory bowel disease in adults and children. Fecal calprotectin levels have been reported to be much higher in both healthy fullterm and preterm infants than in children and adults. Objective: To determine the time course of fecal calprotectin (f-calprotectin) excretion in preterm infants from birth until hospital discharge and to identify factors influencing f-calprotectin levels in the first weeks of life, including bacterial establishment in the gut. Methodology: F-calprotectin was determined using an ELISA assay in 147 samples obtained prospectively from 47 preterm infants (gestational age, and birth-weight interquartiles 27-29 weeks, and 880-1320 g, respectively) at birth, and at 2-week intervals until hospital discharge. Principal Findings: Although median f-calprotectin excretion was 138 mg/g, a wide range of inter-and intra-individual variation in f-calprotectin values (from day 3 to day 78) was observed (86% and 67%, respectively). In multivariate regression analysis, f-calprotectin correlated negatively with ante and per natal antibiotic treatment (p = 0.001), and correlated positively with the volume of enteral feeding (mL/kg/d) (p = 0.009), the need to interrupt enteral feeding (p = 0.001), and prominent gastrointestinal colonization by Clostridium sp (p = 0.019) and Staphylococcus sp (p = 0.047). Conclusion: During the first weeks of life, the high f-calprotectin values observed in preterm infants could be linked to the gut bacterial establishment.	[Rouge, Carole; Piloquet, Hugues; Darmaun, Dominique; Roze, Jean-Christophe] Univ Nantes, INRA, UMR 1280, CRNH, Nantes, France; [Rouge, Carole; Piloquet, Hugues; Darmaun, Dominique; Roze, Jean-Christophe] CHU Nantes, IMAD, F-44035 Nantes 01, France; [Butel, Marie-Jose; Ferraris, Laurent] Univ Paris 05, Fac Sci Pharmaceut & Biol, EA 4065, Paris, France; [Piloquet, Hugues; Legrand, Arnaud; Roze, Jean-Christophe] CHU Nantes, INSERM, Hop Mere Et Enfant, Neonatal Intens Care Unit,CIC 0004, F-44035 Nantes, France; [Vodovar, Michel; Voyer, Marcel] Inst Puericulture, Neonatal Intens Care Unit, Paris, France; [de la Cochetiere, Marie-France] Therapeut Clin & Expt Malad Infectieuses, EA 3826, Nantes, France	INRAE; Nantes Universite; Nantes Universite; CHU de Nantes; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Rouge, C (corresponding author), Univ Nantes, INRA, UMR 1280, CRNH, Nantes, France.	ddarmaun@chu-nantes.fr	roze, jean christophe/B-5433-2012; Rozé, Jean-Christophe/AAS-1314-2021; Darmaun, Dominique/X-8453-2018	Darmaun, Dominique/0000-0002-0366-3227; Roze, Jean-Christophe/0000-0003-3367-512X	Nestle; French Ministry of Health; Delegation a la Recherche Clinique [DRC 2004]; CHU de Nantes	Nestle(Nestle SA); French Ministry of Health; Delegation a la Recherche Clinique; CHU de Nantes	Carole Rouge was the recipient of a doctoral research fellowship from Nestle (Vers-chez-les-Blanc, Switzerland). Part of this work was supported by grants from: the Programme Hospitalier de Recherche Clinique (PHRC 2004) from the French Ministry of Health, and the Delegation a la Recherche Clinique (DRC 2004), CHU de Nantes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berni CR, 2004, DIGEST LIVER DIS, V36, P467, DOI DOI 10.1016/j.dld.2004.02.009; BERNTZEN HB, 1990, SCAND J CLIN LAB INV, V50, P769, DOI 10.3109/00365519009091071; Berstad A, 2000, SCAND J GASTROENTERO, V35, P64; Bjorkstrom MV, 2009, ACTA PAEDIATR, V98, P1762, DOI 10.1111/j.1651-2227.2009.01471.x; BRUN JG, 1994, SCAND J IMMUNOL, V40, P675, DOI 10.1111/j.1365-3083.1994.tb03523.x; Butel MJ, 1998, J MED MICROBIOL, V47, P391, DOI 10.1099/00222615-47-5-391; Campeotto F, 2004, ARCH DIS CHILD-FETAL, V89, pF353, DOI 10.1136/adc.2002.022368; Campeotto F, 2007, ACTA PAEDIATR, V96, P1531, DOI 10.1111/j.1651-2227.2007.00457.x; Campeotto F, 2009, J PEDIATR GASTR NUTR, V48, P507, DOI 10.1097/MPG.0b013e318186c4a6; Carroll D, 2003, LANCET, V361, P310, DOI 10.1016/S0140-6736(03)12333-1; Fagerberg UL, 2005, J PEDIATR GASTR NUTR, V40, P450, DOI 10.1097/01.MPG.0000154657.08994.94; Gisbert JP, 2009, DIGEST LIVER DIS, V41, P56, DOI 10.1016/j.dld.2008.05.008; Jaureguy F, 2004, J CLIN MICROBIOL, V42, P5184, DOI 10.1128/JCM.42.11.5184-5188.2004; Johne B., 1997, Molecular Pathology, V50, P113, DOI 10.1136/mp.50.3.113; Josefsson S, 2007, J PEDIATR GASTR NUTR, V44, P407, DOI 10.1097/MPG.0b013e3180320643; Jousimies-Somer HR, 2002, ANAEROBIC BACTERIOLO; Kok RG, 1996, APPL ENVIRON MICROB, V62, P3668, DOI 10.1128/AEM.62.10.3668-3672.1996; Konikoff MR, 2006, INFLAMM BOWEL DIS, V12, P524, DOI 10.1097/00054725-200606000-00013; Laforgia N, 2003, ACTA PAEDIATR, V92, P463; Magne F, 2006, FEMS MICROBIOL ECOL, V57, P128, DOI 10.1111/j.1574-6941.2006.00097.x; Mohan R, 2008, PEDIATR RES, V64, P418, DOI 10.1203/PDR.0b013e318181b7fa; Nissen AC, 2004, J PEDIATR GASTR NUTR, V38, P107, DOI 10.1097/00005176-200401000-00025; Olafsdottir E, 2002, ACTA PAEDIATR, V91, P45, DOI 10.1080/080352502753457932; Roseth AG, 1999, SCAND J GASTROENTERO, V34, P50; ROSETH AG, 1992, SCAND J GASTROENTERO, V27, P793, DOI 10.3109/00365529209011186; Roudiere L, 2009, J MICROBIOL METH, V79, P156, DOI 10.1016/j.mimet.2009.08.005; Rouge C, 2009, AM J CLIN NUTR, V89, P1828, DOI 10.3945/ajcn.2008.26919; Rugtveit J, 2002, J PEDIATR GASTR NUTR, V34, P323, DOI 10.1097/00005176-200203000-00022; SOHNLE PG, 1991, J INFECT DIS, V163, P187, DOI 10.1093/infdis/163.1.187; Splichal I, 2005, IMMUNOBIOLOGY, V209, P681, DOI 10.1016/j.imbio.2004.09.009; STEINBAKK M, 1990, LANCET, V336, P763, DOI 10.1016/0140-6736(90)93237-J; Ton H, 2000, CLIN CHIM ACTA, V292, P41, DOI 10.1016/S0009-8981(99)00206-5; WEAVER LT, 1984, ARCH DIS CHILD, V59, P236, DOI 10.1136/adc.59.3.236; Yang Q, 2008, NEONATOLOGY, V94, P267, DOI 10.1159/000151645	34	42	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11083	10.1371/journal.pone.0011083	http://dx.doi.org/10.1371/journal.pone.0011083			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552029	Green Published, gold, Green Submitted			2022-12-27	WOS:000278662900021
J	Weiss, G; Rasmussen, S; Fink, LN; Jarmer, H; Nielsen, BN; Frokiaer, H				Weiss, Gudrun; Rasmussen, Simon; Fink, Lisbeth Nielsen; Jarmer, Hanne; Nielsen, Birgit Nohr; Frokiaer, Hanne			Bifidobacterium bifidum Actively Changes the Gene Expression Profile Induced by Lactobacillus acidophilus in Murine Dendritic Cells	PLOS ONE			English	Article							JUN DIMERIZATION PROTEIN-2; LACTIC-ACID BACTERIA; SURFACE-MARKERS; INTERFERON; CYTOKINES; INTERLEUKIN-12; RECOGNITION; RESISTANCE; INDUCTION; RESPOND	Dendritic cells (DC) play a pivotal regulatory role in activation of both the innate as well as the adaptive immune system by responding to environmental microorganisms. We have previously shown that Lactobacillus acidophilus induces a strong production of the pro-inflammatory and Th1 polarizing cytokine IL-12 in DC, whereas bifidobacteria do not induce IL-12 but inhibit the IL-12 production induced by lactobacilli. In the present study, genome-wide microarrays were used to investigate the gene expression pattern of murine DC stimulated with Lactobacillus acidophilus NCFM and Bifidobacterium bifidum Z9. L. acidophilus NCFM strongly induced expression of interferon (IFN)-beta, other virus defence genes, and cytokine and chemokine genes related to the innate and the adaptive immune response. By contrast, B. bifidum Z9 up-regulated genes encoding cytokines and chemokines related to the innate immune response. Moreover, B. bifidum Z9 inhibited the expression of the Th1-promoting genes induced by L. acidophilus NCFM and had an additive effect on genes of the innate immune response and Th2 skewing genes. The gene encoding Jun dimerization protein 2 (JDP2), a transcription factor regulating the activation of JNK, was one of the few genes only induced by B. bifidum Z9. Neutralization of IFN-beta abrogated L. acidophilus NCFM-induced expression of Th1-skewing genes, and blocking of the JNK pathway completely inhibited the expression of IFN-beta. Our results indicate that B. bifidum Z9 actively inhibits the expression of genes related to the adaptive immune system in murine dendritic cells and that JPD2 via blocking of IFN-beta plays a central role in this regulatory mechanism.	[Weiss, Gudrun; Nielsen, Birgit Nohr; Frokiaer, Hanne] Univ Copenhagen, Dept Basic Sci & Environm, Fac Life Sci, Frederiksberg, Denmark; [Rasmussen, Simon; Fink, Lisbeth Nielsen; Jarmer, Hanne] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark	University of Copenhagen; Technical University of Denmark	Weiss, G (corresponding author), Univ Copenhagen, Dept Basic Sci & Environm, Fac Life Sci, Frederiksberg, Denmark.	hafr@life.ku.dk	Fink, Lisbeth/AAN-7830-2020; Fink, Lisbeth N/F-8344-2010; Rasmussen, Simon/AAA-2308-2020; Rasmussen, Simon/G-6258-2016	Fink, Lisbeth N/0000-0003-3621-8098; Rasmussen, Simon/0000-0001-6323-9041; Rasmussen, Simon/0000-0001-6323-9041; Frokiaer, Hanne/0000-0003-1472-9698; Weiss, Gudrun/0000-0001-7879-7054	Danish Ministry of Food, Agriculture and Fisheries; Danish Food Industry Agency [3304-FSE-06-0501-1]	Danish Ministry of Food, Agriculture and Fisheries; Danish Food Industry Agency	This study was supported by the Danish Ministry of Food, Agriculture and Fisheries, and The Danish Food Industry Agency (J.nr.3304-FSE-06-0501-1; www.dffe.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bogdan C, 2004, IMMUNOL REV, V202, P33, DOI 10.1111/j.0105-2896.2004.00207.x; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Charrel-Dennis M, 2008, CELL HOST MICROBE, V4, P543, DOI 10.1016/j.chom.2008.11.002; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000; Fink LN, 2007, INT IMMUNOL, V19, P1319, DOI 10.1093/intimm/dxm103; Fink LN, 2007, FEMS IMMUNOL MED MIC, V51, P535, DOI 10.1111/j.1574-695X.2007.00333.x; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gratz N, 2008, J BIOL CHEM, V283, P19879, DOI 10.1074/jbc.M802848200; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jin CY, 2001, FEBS LETT, V489, P34, DOI 10.1016/S0014-5793(00)02387-5; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Levings MK, 2001, J IMMUNOL, V166, P5530, DOI 10.4049/jimmunol.166.9.5530; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Mancuso G, 2007, J IMMUNOL, V178, P3126, DOI 10.4049/jimmunol.178.5.3126; O'Connell RM, 2005, J IMMUNOL, V174, P1602, DOI 10.4049/jimmunol.174.3.1602; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Romagnani S, 2002, MOL IMMUNOL, V38, P881, DOI 10.1016/S0161-5890(02)00013-5; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Stockinger S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000355; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Wardell SE, 2002, MOL CELL BIOL, V22, P5451, DOI 10.1128/MCB.22.15.5451-5466.2002; WORKMAN C, 2002, GENOME BIOL, V0003; Young SL, 2004, CLIN DIAGN LAB IMMUN, V11, P686, DOI 10.1128/CDLI.11.4.686-690.2004; Zeuthen LH, 2006, CLIN VACCINE IMMUNOL, V13, P365, DOI 10.1128/CVI.13.3.365-375.2006; Zeuthen LH, 2008, IMMUNOLOGY, V124, P489, DOI 10.1111/j.1365-2567.2007.02800.x	42	27	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11065	10.1371/journal.pone.0011065	http://dx.doi.org/10.1371/journal.pone.0011065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548777	gold, Green Submitted, Green Published			2022-12-27	WOS:000278599600021
J	Irvin, DK; Jouanneau, E; Duvall, G; Zhang, XX; Zhai, YY; Sarayba, D; Seksenyan, A; Panwar, A; Black, KL; Wheeler, CJ				Irvin, Dwain K.; Jouanneau, Emmanuel; Duvall, Gretchen; Zhang, Xiao-xue; Zhai, Yuying; Sarayba, Danielle; Seksenyan, Akop; Panwar, Akanksha; Black, Keith L.; Wheeler, Christopher J.			T Cells Enhance Stem-Like Properties and Conditional Malignancy in Gliomas	PLOS ONE			English	Article							DENDRITIC CELLS; IMMUNE-RESPONSE; VACCINATION; INHIBITION; SURVIVAL; GROWTH; TUMORS; IDENTIFICATION; ACTIVATION; MECHANISMS	Background: Small populations of highly tumorigenic stem-like cells (cancer stem cells; CSCs) can exist within, and uniquely regenerate cancers including malignant brain tumors (gliomas). Many aspects of glioma CSCs (GSCs), however, have been characterized in non-physiological settings. Methods: We found gene expression similarity superiorly defined glioma "stemness", and revealed that GSC similarity increased with lower tumor grade. Using this method, we examined stemness in human grade IV gliomas (GBM) before and after dendritic cell (DC) vaccine therapy. This was followed by gene expression, phenotypic and functional analysis of murine GL26 tumors recovered from nude, wild-type, or DC-vaccinated host brains. Results: GSC similarity was specifically increased in post-vaccine GBMs, and correlated best to vaccine-altered gene expression and endogenous anti-tumor T cell activity. GL26 analysis confirmed immune alterations, specific acquisition of stem cell markers, specifically enhanced sensitivity to anti-stem drug (cyclopamine), and enhanced tumorigenicity in wildtype hosts, in tumors in proportion to anti-tumor T cell activity. Nevertheless, vaccine-exposed GL26 cells were no more tumorigenic than parental GL26 in T cell-deficient hosts, though they otherwise appeared similar to GSCs enriched by chemotherapy. Finally, vaccine-exposed GBM and GL26 exhibited relatively homogeneous expression of genes expressed in progenitor cells and/or differentiation. Conclusions: T cell activity represents an inducible physiological process capable of proportionally enriching GSCs in human and mouse gliomas. Stem-like gliomas enriched by strong T cell activity, however, may differ from other GSCs in that their stem-like properties may be disassociated from increased tumor malignancy and heterogeneity under specific host immune conditions.	[Irvin, Dwain K.; Jouanneau, Emmanuel; Duvall, Gretchen; Zhang, Xiao-xue; Zhai, Yuying; Sarayba, Danielle; Seksenyan, Akop; Panwar, Akanksha; Black, Keith L.; Wheeler, Christopher J.] Cedars Sinai Med Ctr, Maxine Dunitz Neurosurg Inst, Dept Neurosurg, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Irvin, DK (corresponding author), Cedars Sinai Med Ctr, Maxine Dunitz Neurosurg Inst, Dept Neurosurg, Los Angeles, CA 90048 USA.	wheelerc@cshs.org		Black, Keith/0000-0002-0546-4934	Maxine Dunitz Neurosurgical Institute; National Institutes of Health [NS048959-01S1, NS054162-01]; California Endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS054162, R56NS048959, R01NS048959] Funding Source: NIH RePORTER	Maxine Dunitz Neurosurgical Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Maxine Dunitz Neurosurgical Institute, the National Institutes of Health [NS048959-01S1 to D. K. I. and NS054162-01 to C.J.W.]; and, in part, by The California Endowment to D.K.I.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Calzascia T, 2005, IMMUNITY, V22, P175, DOI 10.1016/j.immuni.2004.12.008; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Jiao ZX, 2006, DEV BIOL, V296, P396, DOI 10.1016/j.ydbio.2006.06.006; Jouanneau E, 2006, CANCER IMMUNOL IMMUN, V55, P254, DOI 10.1007/s00262-005-0040-7; Kanamori M, 2007, J NEUROSURG, V106, P417, DOI 10.3171/jns.2007.106.3.417; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu GT, 2005, ONCOGENE, V24, P5226, DOI 10.1038/sj.onc.1208519; Mao Y, 2007, FRONT BIOSCI-LANDMRK, V12, P2252, DOI 10.2741/2227; Masson F, 2007, J IMMUNOL, V179, P845, DOI 10.4049/jimmunol.179.2.845; MINAMI M, 1986, J IMMUNOL, V136, P3341; Oliver TG, 2004, NEURON, V42, P885, DOI 10.1016/j.neuron.2004.06.011; Pellegatta S, 2006, CANCER RES, V66, P10247, DOI 10.1158/0008-5472.CAN-06-2048; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Prins RM, 2004, J IMMUNOL, V172, P1602, DOI 10.4049/jimmunol.172.3.1602; Prins RM, 2003, CANCER RES, V63, P8487; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Riffaud L, 2009, J NEUROSURG, V111, P478, DOI 10.3171/2009.1.JNS081004; RUIZ IAA, 2004, CANC LETT, V204, P145; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Sanchez P, 2005, MECH DEVELOP, V122, P223, DOI 10.1016/j.mod.2004.10.002; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; SCHNECK J, 1989, CELL, V56, P47, DOI 10.1016/0092-8674(89)90982-3; Shai R, 2003, ONCOGENE, V22, P4918, DOI 10.1038/sj.onc.1206753; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Souweidane MM, 2009, NEUROSURGERY, V65, P72, DOI 10.1227/01.NEU.0000348011.98625.43; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; STUPP R, 2003, J CLIN ONCOL, V1091, P779; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wheeler CJ, 2008, CANCER RES, V68, P5955, DOI 10.1158/0008-5472.CAN-07-5973; Wheeler CJ, 1998, J IMMUNOL, V160, P4199; WHEELER CJ, 1992, NATURE, V357, P247, DOI 10.1038/357247a0; Xu QJ, 2009, STEM CELLS, V27, P1734, DOI 10.1002/stem.102; Xu QJ, 2008, STEM CELLS, V26, P3018, DOI 10.1634/stemcells.2008-0459; Yu JS, 2004, CANCER RES, V64, P4973, DOI 10.1158/0008-5472.CAN-03-3505	44	25	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10974	10.1371/journal.pone.0010974	http://dx.doi.org/10.1371/journal.pone.0010974			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539758	Green Submitted, Green Published, gold			2022-12-27	WOS:000278465900002
J	Almeida, OP; Alfonso, H; Hankey, GJ; Flicker, L				Almeida, Osvaldo P.; Alfonso, Helman; Hankey, Graeme J.; Flicker, Leon			Depression, Antidepressant Use and Mortality in Later Life: The Health in Men Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MAJOR DEPRESSION; MYOCARDIAL-INFARCTION; DIABETES-MELLITUS; WESTERN-AUSTRALIA; EXCESS MORTALITY; RATE-VARIABILITY; OLDER PERSONS; RISK; COMMUNITY	Context: Depression is associated with increased mortality, but it is unclear if this relationship is dose-dependent and if it can be modified by treatment with antidepressants. Objective: To determine if (1) the association between depression and mortality is independent of other common potential causes of death in later life, (2) there is a dose-response relationship between increasing severity of depression and mortality rates, and (3) the use of antidepressant drugs reduces mortality rates. Methods: Cohort study of 5,276 community-dwelling men aged 68-88 years living in Perth, Australia. We used the Geriatric Depression Scale 15-items (GDS-15) to ascertain the presence and severity of depression. GDS-15 >= 7 indicates the presence of clinically significant depression. Men were also grouped according to the severity of symptoms: "no symptoms'' (GDS-15=0), "questionable'' (1 <= GDS-15 <= 4), "mild to moderate'' (5 <= GDS-15 <= 9), and "severe'' (GDS-15 >= 10). Participants listed all medications used regularly. We used the Western Australian Data Linkage System to monitor mortality. Results: There were 883 deaths between the study assessment and the 30th June 2008 (mean follow-up of participants: 6.0 +/- 1.1 years). The adjusted mortality hazard (MH) of men with clinically significant depression was 1.98 (95%CI = 1.61-2.43), and increased with the severity of symptoms: 1.39 (95%CI = 1.13-1.71) for questionable, 2.71 (95%CI = 2.13-3.46) for mild/moderate, and 3.32 (95%CI: 2.31-4.78) for severe depression. The use of antidepressants increased MH (HR = 1.31, 95%CI = 1.02-1.68). Compared with men who were not depressed and were not taking antidepressants, MH increased from 1.22 (95%CI = 0.91-1.63) for men with no depression who were using antidepressants to 1.85 (95%CI = 1.47-2.32) for participants who were depressed but were not using antidepressants, and 2.97 (95%CI = 1.94-4.54) for those who were depressed and were using antidepressants. All analyses were adjusted for age, educational attainment, migrant status, physical activity, smoking and alcohol use and the Charlson comorbidity index. Conclusions: The mortality associated with depression increases with the severity of depressive symptoms and is largely independent of comorbid conditions. The use of antidepressants does not reduce the mortality rates of older men with persistent symptoms of depression.	[Almeida, Osvaldo P.; Alfonso, Helman; Flicker, Leon] Univ Western Australia, Western Australia Ctr Hlth & Ageing, Med Res Ctr, Perth, WA 6009, Australia; [Almeida, Osvaldo P.; Alfonso, Helman] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Almeida, Osvaldo P.] Royal Perth Hosp, Dept Psychiat, Perth, WA, Australia; [Hankey, Graeme J.] Royal Perth Hosp, Stroke Unit, Perth, WA, Australia; [Hankey, Graeme J.; Flicker, Leon] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Flicker, Leon] Royal Perth Hosp, Dept Geriatr Med, Perth, WA, Australia	University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia	Almeida, OP (corresponding author), Univ Western Australia, Western Australia Ctr Hlth & Ageing, Med Res Ctr, Perth, WA 6009, Australia.	osvaldo.almeida@uwa.edu.au	Almeida, Osvaldo P./A-4925-2008; Flicker, Leon/A-9039-2008; Hankey, Graeme J/H-4968-2014; Flicker, Leon/AAE-1530-2022	Almeida, Osvaldo P./0000-0002-8689-6199; Hankey, Graeme J/0000-0002-6044-7328; Flicker, Leon/0000-0002-3650-0475	National Health and Medical Research Council of Australia [279408, 379600, 403963, 513823, 634492]; MBF Foundation of Australia [DS 080608]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); MBF Foundation of Australia	The conduct of this project was supported by competitive unrestricted project grants from the National Health and Medical Research Council of Australia (grant numbers: 279408, 379600, 403963, 513823 and 634492), and from the MBF Foundation of Australia (grant number DS 080608). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2004, W AUSTR STAT IND 136; Adamson JA, 2005, J AM GERIATR SOC, V53, P1128, DOI 10.1111/j.1532-5415.2005.53355.x; Ahto M, 2007, INT J GERIATR PSYCH, V22, P757, DOI 10.1002/gps.1735; Almeida OP, 2005, J AFFECT DISORDERS, V86, P317, DOI 10.1016/j.jad.2005.02.014; Almeida OP, 1999, INT J GERIATR PSYCH, V14, P858, DOI 10.1002/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8; Almeida OP, 2008, ARCH GEN PSYCHIAT, V65, P1286, DOI 10.1001/archpsyc.65.11.1286; Almeida OP, 2007, AM J GERIAT PSYCHIAT, V15, P506, DOI 10.1097/01.JGP.0000246869.49892.77; Andersohn F, 2009, AM J PSYCHIAT, V166, P591, DOI 10.1176/appi.ajp.2008.08071065; Baldessarini RJ, 2007, HARVARD REV PSYCHIAT, V15, P133, DOI 10.1080/10673220701551102; Ben-Ezra M, 2006, J AM GERIATR SOC, V54, P906, DOI 10.1111/j.1532-5415.2006.00741.x; BIGGER JT, 1992, CIRCULATION, V85, P164, DOI 10.1161/01.CIR.85.1.164; Blazer DG, 2004, J AM GERIATR SOC, V52, P2052, DOI 10.1111/j.1532-5415.2004.52564.x; Blumenthal JA, 1999, ARCH INTERN MED, V159, P2349, DOI 10.1001/archinte.159.19.2349; BRANDES LJ, 1992, CANCER RES, V52, P3796; Carney RM, 2005, ARCH INTERN MED, V165, P1486, DOI 10.1001/archinte.165.13.1486; Carney RM, 2009, AM J PSYCHIAT, V166, P410, DOI 10.1176/appi.ajp.2008.08081239; Cassidy K, 2004, AUST NZ J PSYCHIAT, V38, P940, DOI 10.1080/j.1440-1614.2004.01485.x; Chahine LM, 2010, HARVARD REV PSYCHIAT, V18, P158, DOI 10.3109/10673221003747690; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cox LS, 2004, J GEN INTERN MED, V19, P828, DOI 10.1111/j.1525-1497.2004.30423.x; Cuijpers P, 2002, J AFFECT DISORDERS, V72, P227, DOI 10.1016/S0165-0327(01)00413-X; Dalton SO, 2000, EPIDEMIOLOGY, V11, P171, DOI 10.1097/00001648-200003000-00015; Dalton SO, 2008, EPIDEMIOLOGY, V19, P546, DOI 10.1097/EDE.0b013e318176bf98; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Ensinck KTJL, 2002, AM J EPIDEMIOL, V156, P1043, DOI 10.1093/aje/kwf148; Freedman L, 1999, EPIDEMIOLOGY, V10, P54, DOI 10.1097/00001648-199901000-00010; Gallo JJ, 2007, ANN INTERN MED, V146, P689, DOI 10.7326/0003-4819-146-10-200705150-00002; Gibbons RD, 2005, ARCH GEN PSYCHIAT, V62, P165, DOI 10.1001/archpsyc.62.2.165; Glassman AH, 2007, ARCH GEN PSYCHIAT, V64, P1025, DOI 10.1001/archpsyc.64.9.1025; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Katon W, 2005, ARCH INTERN MED, V165, P2497, DOI 10.1001/archinte.165.21.2497; Kerse N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002423; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Maraldi C, 2007, ARCH INTERN MED, V167, P1137, DOI 10.1001/archinte.167.11.1137; Mehta KM, 2003, J GERONTOL A-BIOL, V58, P461; Meijer WEE, 2004, ARCH INTERN MED, V164, P2367, DOI 10.1001/archinte.164.21.2367; Norman PE, 2009, INT J EPIDEMIOL, V38, P48, DOI 10.1093/ije/dyn041; Penninx BWJH, 1999, ARCH GEN PSYCHIAT, V56, P889, DOI 10.1001/archpsyc.56.10.889; Pfaff JJ, 2009, MED J AUSTRALIA, V190, pS75, DOI 10.5694/j.1326-5377.2009.tb02475.x; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Pulska T, 1997, INT J GERIATR PSYCH, V12, P942, DOI 10.1002/(SICI)1099-1166(199709)12:9<942::AID-GPS668>3.0.CO;2-Z; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ryan J, 2008, BRIT J PSYCHIAT, V192, P12, DOI 10.1192/bjp.bp.107.039164; Schoevers RA, 2009, INT J GERIATR PSYCH, V24, P169, DOI 10.1002/gps.2088; Schoevers RA, 2000, BRIT J PSYCHIAT, V177, P336, DOI 10.1192/bjp.177.4.336; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Surtees PG, 2008, NEUROLOGY, V70, P788, DOI 10.1212/01.wnl.0000304109.18563.81; Surtees PG, 2008, AM J PSYCHIAT, V165, P515, DOI 10.1176/appi.ajp.2007.07061018; Takeshita J, 2002, AM J PSYCHIAT, V159, P1127, DOI 10.1176/appi.ajp.159.7.1127; Taylor CB, 2005, ARCH GEN PSYCHIAT, V62, P792, DOI 10.1001/archpsyc.62.7.792; Thapa PB, 1998, NEW ENGL J MED, V339, P875, DOI 10.1056/NEJM199809243391303; Tiemeier H, 2005, J CLIN EPIDEMIOL, V58, P1134, DOI 10.1016/j.jclinepi.2005.07.001; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; van den Brink CL, 2005, AM J PUBLIC HEALTH, V95, P2029, DOI 10.2105/AJPH.2004.050914; Whang W, 2009, J AM COLL CARDIOL, V53, P950, DOI 10.1016/j.jacc.2008.10.060; Wilson RS, 2003, AM J EPIDEMIOL, V158, P827, DOI 10.1093/aje/kwg224; World Health Organisation, 2005, FRUIT VEG HLTH JOINT; Wulsin LR, 2005, PSYCHOSOM MED, V67, P697, DOI 10.1097/01.psy.0000181274.56785.28; Xu WN, 2006, LANCET ONCOL, V7, P301, DOI 10.1016/S1470-2045(06)70622-2; Zheng DY, 1997, ANN EPIDEMIOL, V7, P213, DOI 10.1016/S1047-2797(97)00014-8	62	61	61	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11266	10.1371/journal.pone.0011266	http://dx.doi.org/10.1371/journal.pone.0011266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	615KY	20585644	Green Submitted, Green Published, gold			2022-12-27	WOS:000279135400012
J	Beckers, GJL; Gahr, M				Beckers, Gabriel J. L.; Gahr, Manfred			Neural Processing of Short-Term Recurrence in Songbird Vocal Communication	PLOS ONE			English	Article							STIMULUS-SPECIFIC ADAPTATION; LOCAL-FIELD POTENTIALS; MALE ZEBRA FINCHES; AUDITORY-CORTEX; NATURAL SOUNDS; FUNCTIONAL-ORGANIZATION; CAUDAL TELENCEPHALON; MISMATCH NEGATIVITY; TAENOPYGIA-GUTTATA; RECEPTIVE-FIELDS	Background: Many situations involving animal communication are dominated by recurring, stereotyped signals. How do receivers optimally distinguish between frequently recurring signals and novel ones? Cortical auditory systems are known to be pre-attentively sensitive to short-term delivery statistics of artificial stimuli, but it is unknown if this phenomenon extends to the level of behaviorally relevant delivery patterns, such as those used during communication. Methodology/Principal Findings: We recorded and analyzed complete auditory scenes of spontaneously communicating zebra finch (Taeniopygia guttata) pairs over a week-long period, and show that they can produce tens of thousands of short-range contact calls per day. Individual calls recur at time scales (median interval 1.5 s) matching those at which mammalian sensory systems are sensitive to recent stimulus history. Next, we presented to anesthetized birds sequences of frequently recurring calls interspersed with rare ones, and recorded, in parallel, action and local field potential responses in the medio-caudal auditory forebrain at 32 unique sites. Variation in call recurrence rate over natural ranges leads to widespread and significant modulation in strength of neural responses. Such modulation is highly call-specific in secondary auditory areas, but not in the main thalamo-recipient, primary auditory area. Conclusions/Significance: Our results support the hypothesis that pre-attentive neural sensitivity to short-term stimulus recurrence is involved in the analysis of auditory scenes at the level of delivery patterns of meaningful sounds. This may enable birds to efficiently and automatically distinguish frequently recurring vocalizations from other events in their auditory scene.	[Beckers, Gabriel J. L.; Gahr, Manfred] Max Planck Inst Ornithol, Dept Behav Neurobiol, Seewiesen, Germany	Max Planck Society	Beckers, GJL (corresponding author), Max Planck Inst Ornithol, Dept Behav Neurobiol, Seewiesen, Germany.	beckers@orn.mpg.de			Max Planck Society	Max Planck Society(Max Planck Society)	The study was financed by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles M., 1982, LOCAL CORTICAL CIRCU; Alted F., 2002, PYTABLES HIERARCHICA; Amin N, 2007, J NEUROPHYSIOL, V97, P3517, DOI 10.1152/jn.01066.2006; BAAYEN R, 2008, J MEM LANG, V59, P412; BARLOW H, 1961, SENS COMMUN, P182; Blanche TJ, 2005, J NEUROPHYSIOL, V93, P2987, DOI 10.1152/jn.01023.2004; Boersma P., 1993, P I PHONETIC SCI, V17, P97; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Boumans T, 2007, EUR J NEUROSCI, V26, P2613, DOI 10.1111/j.1460-9568.2007.05865.x; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; Chew SJ, 1996, P NATL ACAD SCI USA, V93, P1950, DOI 10.1073/pnas.93.5.1950; Cohen L., 1995, TIME FREQUENCY ANAL; CONDON CD, 1991, BEHAV NEUROSCI, V105, P416, DOI 10.1037/0735-7044.105.3.416; Cousillas H, 2005, HEARING RES, V207, P10, DOI 10.1016/j.heares.2005.01.008; Csicsvari J, 2003, J NEUROPHYSIOL, V90, P1314, DOI 10.1152/jn.00116.2003; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; FORTUNE ES, 1992, J COMP NEUROL, V325, P388, DOI 10.1002/cne.903250306; FORTUNE ES, 1995, J COMP NEUROL, V360, P413, DOI 10.1002/cne.903600305; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gardner TJ, 2006, P NATL ACAD SCI USA, V103, P6094, DOI 10.1073/pnas.0601707103; Garrido MI, 2008, NEUROIMAGE, V42, P936, DOI 10.1016/j.neuroimage.2008.05.018; Gehr DD, 1999, NEUROREPORT, V10, P375, DOI 10.1097/00001756-199902050-00030; Gill P, 2008, J NEUROPHYSIOL, V99, P2809, DOI 10.1152/jn.01270.2007; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Jones E., 2001, SCIPY OPEN SOURCE SC; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lewicki MS, 1996, J NEUROSCI, V16, P6987; Malone BJ, 2001, J NEUROPHYSIOL, V86, P1113, DOI 10.1152/jn.2001.86.3.1113; Marler Peter, 2004, P132, DOI 10.1016/B978-012473070-0/50008-6; May P, 1999, J COMPUT NEUROSCI, V6, P99, DOI 10.1023/A:1008896417606; MULLER CM, 1985, EXP BRAIN RES, V59, P587; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; Nagel KI, 2008, NEURON, V58, P938, DOI 10.1016/j.neuron.2008.04.028; Nagel KI, 2006, NEURON, V51, P845, DOI 10.1016/j.neuron.2006.08.030; Nelken I, 2007, J PSYCHOPHYSIOL, V21, P214, DOI 10.1027/0269-8803.21.34.214; R Core Team, 2020, R LANG ENV STAT COMP; RIBLER R, 1996, NASA C PUBL, V3321, P3; Sen K, 2001, J NEUROPHYSIOL, V86, P1445, DOI 10.1152/jn.2001.86.3.1445; SQUIRES KC, 1976, SCIENCE, V193, P1142, DOI 10.1126/science.959831; Szymanski FD, 2009, J NEUROPHYSIOL, V102, P1483, DOI 10.1152/jn.00240.2009; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Terleph TA, 2006, J NEUROBIOL, V66, P281, DOI 10.1002/neu.20219; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Venables W., 2013, MODERN APPL STAT S, V53, P86; von der Behrens W, 2009, J NEUROSCI, V29, P13837, DOI 10.1523/JNEUROSCI.3475-09.2009; WILD JM, 1993, J COMP NEUROL, V337, P32; Winkler I, 2007, J PSYCHOPHYSIOL, V21, P147, DOI 10.1027/0269-8803.21.34.147; ZANN R, 1996, ZEBRA FINCH	55	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11129	10.1371/journal.pone.0011129	http://dx.doi.org/10.1371/journal.pone.0011129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567499	Green Submitted, Green Published, gold			2022-12-27	WOS:000278886300002
J	Ribeiro, SP; Rosa, DS; Fonseca, SG; Mairena, EC; Postol, E; Oliveira, SC; Guilherme, L; Kalil, J; Cunha-Neto, E				Ribeiro, Susan Pereira; Rosa, Daniela Santoro; Fonseca, Simone Goncalves; Mairena, Eliane Conti; Postol, Edilberto; Oliveira, Sergio Costa; Guilherme, Luiza; Kalil, Jorge; Cunha-Neto, Edecio			A Vaccine Encoding Conserved Promiscuous HIV CD4 Epitopes Induces Broad T Cell Responses in Mice Transgenic to Multiple Common HLA Class II Molecules	PLOS ONE			English	Article							IN-VIVO; IMMUNE-RESPONSE; INFECTION; STEP; PROTECTION; IMMUNOGENICITY; IDENTIFICATION; PROLIFERATION; REPLICATION; SPECIFICITY	Current HIV vaccine approaches are focused on immunogens encoding whole HIV antigenic proteins that mainly elicit cytotoxic CD8+ responses. Mounting evidence points toward a critical role for CD4+ T cells in the control of immunodeficiency virus replication, probably due to cognate help. Vaccine-induced CD4+ T cell responses might, therefore, have a protective effect in HIV replication. In addition, successful vaccines may have to elicit responses to multiple epitopes in a high proportion of vaccinees, to match the highly variable circulating strains of HIV. Using rational vaccine design, we developed a DNA vaccine encoding 18 algorithm-selected conserved, "promiscuous" ( multiple HLA-DR-binding) B-subtype HIV CD4 epitopes - previously found to be frequently recognized by HIV-infected patients. We assessed the ability of the vaccine to induce broad T cell responses in the context of multiple HLA class II molecules using different strains of HLA class II-transgenic mice (-DR2, -DR4, -DQ6 and -DQ8). Mice displayed CD4+ and CD8+ T cell responses of significant breadth and magnitude, and 16 out of the 18 encoded epitopes were recognized. By virtue of inducing broad responses against conserved CD4+ T cell epitopes that can be recognized in the context of widely diverse, common HLA class II alleles, this vaccine concept may cope both with HIV genetic variability and increased population coverage. The vaccine may thus be a source of cognate help for HIV-specific CD8+ T cells elicited by conventional immunogens, in a wide proportion of vaccinees.	[Ribeiro, Susan Pereira; Rosa, Daniela Santoro; Fonseca, Simone Goncalves; Kalil, Jorge; Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Lab Clin Immunol & Allergy LIM60, Div Clin Immunol & Allergy,Dept Med, Sao Paulo, Brazil; [Fonseca, Simone Goncalves; Mairena, Eliane Conti; Postol, Edilberto; Guilherme, Luiza; Kalil, Jorge; Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil; [Ribeiro, Susan Pereira; Rosa, Daniela Santoro; Mairena, Eliane Conti; Postol, Edilberto; Guilherme, Luiza; Kalil, Jorge; Cunha-Neto, Edecio] Inst Invest Immunol INCT, Sao Paulo, Brazil; [Oliveira, Sergio Costa] Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Minas Gerais	Ribeiro, SP (corresponding author), Univ Sao Paulo, Sch Med, Lab Clin Immunol & Allergy LIM60, Div Clin Immunol & Allergy,Dept Med, Sao Paulo, Brazil.	edecunha@gmail.com	Cunha-Neto, Edecio/B-4157-2009; Rosa, Daniela S/D-2190-2012; FONSECA, SIMONE GONÇALVES/U-9278-2019; Oliveira, Sergio Costa/AAG-5408-2021; Guglielmi, Luiza G/E-7676-2013; KALIL, JORGE/C-8029-2012	Cunha-Neto, Edecio/0000-0002-3699-3345; Rosa, Daniela S/0000-0003-4536-891X; Oliveira, Sergio Costa/0000-0003-4062-5577; KALIL, JORGE/0000-0001-8415-4274	Brazilian National Research Council (CNPq); Sao Paulo State Research Funding Agency (FAPESP); International Centre of Genetic Engineering and Biotechnology (ICGEB); Brazilian Ministry of Health (Brazil)	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo State Research Funding Agency (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); International Centre of Genetic Engineering and Biotechnology (ICGEB); Brazilian Ministry of Health (Brazil)	This research was supported by the Brazilian National Research Council (CNPq), Sao Paulo State Research Funding Agency (FAPESP), International Centre of Genetic Engineering and Biotechnology (ICGEB) and from the Brazilian Ministry of Health (Brazil). S. P. Ribeiro and D. S. Rosa are recipients of a Sao Paulo State Research Funding Agency (FAPESP) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; ATHERTON ND, 1989, CLIN CHEM, V35, P975; Barouch DH, 2010, ANNU REV MED, V61, P153, DOI 10.1146/annurev.med.042508.093728; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bian HJ, 2004, METHODS, V34, P468, DOI 10.1016/j.ymeth.2004.06.002; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Call MJ, 2009, J IMMUNOL, V182, P6342, DOI 10.4049/jimmunol.0803464; Chapoval SP, 1998, J IMMUNOL, V161, P2032; Corey L, 2009, AIDS, V23, P3, DOI 10.1097/QAD.0b013e32830e6d6d; DaSilva L, 2002, J INFECT DIS, V185, P1754, DOI 10.1086/340828; Fonseca SG, 2006, AIDS, V20, P2263, DOI 10.1097/01.aids.0000253353.48331.5f; Fuller DH, 2007, VIROLOGY, V364, P245, DOI 10.1016/j.virol.2007.02.024; Gandhi RT, 2002, ANNU REV MED, V53, P149, DOI 10.1146/annurev.med.53.082901.104011; Garcia TCM, 2008, ACTA TROP, V106, P162, DOI 10.1016/j.actatropica.2008.03.003; Gauduin MC, 2006, J EXP MED, V203, P2661, DOI 10.1084/jem.20060134; Geluk A, 1998, P NATL ACAD SCI USA, V95, P10797, DOI 10.1073/pnas.95.18.10797; Giraldo-Vela JP, 2008, J VIROL, V82, P859, DOI 10.1128/JVI.01816-07; GonzalezGay MA, 1996, HUM IMMUNOL, V50, P54, DOI 10.1016/0198-8859(96)00123-1; Gregory SH, 2009, VACCINE, V27, P5299, DOI 10.1016/j.vaccine.2009.06.101; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Ishioka GY, 1999, J IMMUNOL, V162, P3915; Iwai LK, 2003, MOL MED, V9, P209, DOI 10.1007/BF03402131; Kawamura K, 2000, J CLIN INVEST, V105, P977, DOI 10.1172/JCI8407; Khanolkar A, 2007, IMMUNOL RES, V39, P94, DOI 10.1007/s12026-007-0081-4; KORBER BTM, 2006, THEORETICAL BIOL BIO; Letvin NL, 2006, NAT REV IMMUNOL, V6, P930, DOI 10.1038/nri1959; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Livingston B, 2002, J IMMUNOL, V168, P5499, DOI 10.4049/jimmunol.168.11.5499; Martinez V, 2005, J INFECT DIS, V191, P2053, DOI 10.1086/430320; Martins MA, 2010, J VIROL, V84, P4352, DOI 10.1128/JVI.02365-09; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; OCONNOR SL, SCI TRANSL MED, V22; Pan SC, 1998, J IMMUNOL, V161, P2925; Pancre V, 2007, VACCINE, V25, P5927, DOI 10.1016/j.vaccine.2007.05.038; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; RESTIFO NP, 1995, J IMMUNOL, V154, P4414; Rosa DS, 2006, MICROBES INFECT, V8, P2130, DOI 10.1016/j.micinf.2006.03.012; Rosa DS, 2010, ARCH IMMUNOL THER EX, V58, P121, DOI 10.1007/s00005-010-0067-0; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Sacha JB, 2009, P NATL ACAD SCI USA, V106, P9791, DOI 10.1073/pnas.0813106106; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Suhrbier Andreas, 2002, Expert Rev Vaccines, V1, P207, DOI 10.1586/14760584.1.2.207; Tenzer S, 2009, NAT IMMUNOL, V10, P636, DOI 10.1038/ni.1728; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; Vaccari M, 2008, MUCOSAL IMMUNOL, V1, P497, DOI 10.1038/mi.2008.60; Vaccari M, 2008, J VIROL, V82, P9629, DOI 10.1128/JVI.00893-08; Watkins DI, 2008, MEM I OSWALDO CRUZ, V103, P119, DOI 10.1590/S0074-02762008000200001; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; Wilson DB, 2004, MOL IMMUNOL, V40, P1047, DOI 10.1016/j.molimm.2003.11.022; Wilson NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09; Wong FS, 2004, DIABETOLOGIA, V47, P1476, DOI 10.1007/s00125-004-1505-5; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	58	40	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11072	10.1371/journal.pone.0011072	http://dx.doi.org/10.1371/journal.pone.0011072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552033	Green Submitted, Green Published, gold			2022-12-27	WOS:000278662900012
J	Rose, AMC; Mueller, JE; Gerstl, S; Njanpop-Lafourcade, BM; Page, AL; Nicolas, P; Traore, RO; Caugant, DA; Guerin, PJ				Rose, Angela M. C.; Mueller, Judith E.; Gerstl, Sibylle; Njanpop-Lafourcade, Berthe-Marie; Page, Anne-Laure; Nicolas, Pierre; Traore, Ramata Ouedraogo; Caugant, Dominique A.; Guerin, Philippe J.			Meningitis Dipstick Rapid Test: Evaluating Diagnostic Performance during an Urban Neisseria meningitidis Serogroup A Outbreak, Burkina Faso, 2007	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PCR-BASED IDENTIFICATION; MENINGOCOCCAL MENINGITIS; BACTERIAL-MENINGITIS; FIELD-EVALUATION; MULTIPLEX PCR; NIGER; BELT; SURVEILLANCE; EPIDEMIC	Meningococcal meningitis outbreaks occur every year during the dry season in the "meningitis belt" of sub-Saharan Africa. Identification of the causative strain is crucial before launching mass vaccination campaigns, to assure use of the correct vaccine. Rapid agglutination (latex) tests are most commonly available in district-level laboratories at the beginning of the epidemic season; limitations include a short shelf-life and the need for refrigeration and good technical skills. Recently, a new dipstick rapid diagnostic test (RDT) was developed to identify and differentiate disease caused by meningococcal serogroups A, W135, C and Y. We evaluated the diagnostic performance of this dipstick RDT during an urban outbreak of meningitis caused by N. meningitidis serogroup A in Ouagadougou, Burkina Faso; first against an in-country reference standard of culture and/or multiplex PCR; and second against culture and/or a highly sensitive nested PCR technique performed in Oslo, Norway. We included 267 patients with suspected acute bacterial meningitis. Using the in-country reference standard, 50 samples (19%) were positive. Dipstick RDT sensitivity (N = 265) was 70% (95% CI 55-82) and specificity 97% (95% CI 93-99). Using culture and/or nested PCR, 126/259 (49%) samples were positive; dipstick RDT sensitivity (N = 257) was 32% (95% CI 24-41), and specificity was 99% (95% CI 95-100). We found dipstick RDT sensitivity lower than values reported from (i) assessments under ideal laboratory conditions (>90%), and (ii) a prior field evaluation in Niger [89% (95% CI 80-95)]. Specificity, however, was similar to (i), and higher than (ii) [62% (95% CI 48-75)]. At this stage in development, therefore, other tests (e. g., latex) might be preferred for use in peripheral health centres. We highlight the value of field evaluations for new diagnostic tests, and note relatively low sensitivity of a reference standard using multiplex vs. nested PCR. Although the former is the current standard for bacterial meningitis surveillance in the meningitis belt, nested PCR performed in a certified laboratory should be used as an absolute reference when evaluating new diagnostic tests.	[Rose, Angela M. C.; Gerstl, Sibylle; Page, Anne-Laure; Guerin, Philippe J.] Epictr, Paris, France; [Rose, Angela M. C.] Univ W Indies, Chron Dis Res Ctr, Bridgetown, Barbados; [Mueller, Judith E.; Njanpop-Lafourcade, Berthe-Marie] Agence Med Prevent, Paris, France; [Nicolas, Pierre] World Hlth Org Collaborating Ctr Reference & Res, IMTSSA, Marseille, France; [Traore, Ramata Ouedraogo] Ctr Hosp Univ Pediat Charles de Gaulle, Biol Lab, Ouagadougou, Burkina Faso; [Caugant, Dominique A.] Norwegian Inst Publ Hlth, World Hlth Org Collaborating Ctr Reference & Res, Oslo, Norway; [Caugant, Dominique A.] Univ Oslo, Inst Gen Practice & Community Med, N-0316 Oslo, Norway	University West Indies Mona Jamaica; University of the West Indies Open Campus; Agence de Medecine Preventive; World Health Organization; Norwegian Institute of Public Health (NIPH); World Health Organization; University of Oslo	Rose, AMC (corresponding author), Epictr, Paris, France.	angela.rose@cavehill.uwi.edu	Guerin, Philippe/AAH-8873-2021; , dcaugant/AAH-6843-2019; Rose, Angela/I-5584-2014; Rose, Angela MC/O-1645-2019	, dcaugant/0000-0003-2765-9844; Rose, Angela/0000-0002-2493-8082; Rose, Angela MC/0000-0002-2493-8082; Guerin, Philippe/0000-0002-6008-2963	Medecins Sans Frontieres - Luxembourg	Medecins Sans Frontieres - Luxembourg	This work was financially supported by Medecins Sans Frontieres - Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, Wkly Epidemiol Rec, V78, P294; Boisier P, 2009, TROP MED INT HEALTH, V14, P111, DOI 10.1111/j.1365-3156.2008.02192.x; Boisier P, 2007, CLIN INFECT DIS, V44, P657, DOI 10.1086/511646; Borel T, 2006, T ROY SOC TROP MED H, V100, P964, DOI 10.1016/j.trstmh.2006.03.002; CAMPAGNE G, 1981, B WHO, V77; Caugant DA, 1996, SCAND J INFECT DIS, V28, P149, DOI 10.3109/00365549609049066; Chanteau S, 2006, T ROY SOC TROP MED H, V100, P677, DOI 10.1016/j.trstmh.2005.09.006; Chanteau S, 2006, PLOS MED, V3, P1579, DOI 10.1371/journal.pmed.0030337; Chanteau S, 2007, VACCINE, V25, pA30, DOI 10.1016/j.vaccine.2007.04.037; Djibo S, 2003, TROP MED INT HEALTH, V8, P1118, DOI 10.1046/j.1360-2276.2003.01126.x; du Chatelet IP, 2005, CLIN INFECT DIS, V40, P17, DOI 10.1086/426436; FERMON F, 2004, MANAGEMENT EPIDEMIC; Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; Lafourcade BMN, 2010, J CLIN MICROBIOL, V48, P612, DOI 10.1128/JCM.01402-09; Murray CK, 2003, TROP MED INT HEALTH, V8, P876, DOI 10.1046/j.1365-3156.2003.01115.x; Nathan N, 2005, LANCET, V366, P308, DOI 10.1016/S0140-6736(05)66792-X; Nathan N, 2007, EMERG INFECT DIS, V13, P920, DOI 10.3201/eid1306.060940; NI HL, 1992, LANCET, V340, P1432, DOI 10.1016/0140-6736(92)92622-M; NJANPOPLAFOURCA.BM, 2005, REV FANCAISE LAB, V372, P33; Okoko BJ, 2009, VACCINE, V27, P2023, DOI 10.1016/j.vaccine.2008.11.092; Richardson DC, 2003, J CLIN MICROBIOL, V41, P3851, DOI 10.1128/JCM.41.8.3851-3853.2003; Rose AMC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007326; SPERBER G, 1992, B WORLD HEALTH ORGAN, V70, P359; Taha MK, 2005, J CLIN MICROBIOL, V43, P144, DOI 10.1128/JCM.43.1.144-149.2005; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000; *US CTR DIS CONTR, 2009, MAL RAP DIAGN TEST P; *WHO, WHOCDSEDC997EN	27	19	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11086	10.1371/journal.pone.0011086	http://dx.doi.org/10.1371/journal.pone.0011086			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552035	Green Published, Green Submitted, gold			2022-12-27	WOS:000278662900023
J	Gharaibeh, RZ; Newton, JM; Weller, JW; Gibas, CJ				Gharaibeh, Raad Z.; Newton, Joshua M.; Weller, Jennifer W.; Gibas, Cynthia J.			Application of Equilibrium Models of Solution Hybridization to Microarray Design and Analysis	PLOS ONE			English	Article							GENE-EXPRESSION; DNA MICROARRAYS; OLIGONUCLEOTIDE HYBRIDIZATION; MOLECULAR-INTERACTIONS; OPTIMIZATION; INFORMATION; PRINCIPLES; DISCOVERY; SOFTWARE; KINETICS	Background: The probe percent bound value, calculated using multi-state equilibrium models of solution hybridization, is shown to be useful in understanding the hybridization behavior of microarray probes having 50 nucleotides, with and without mismatches. These longer oligonucleotides are in widespread use on microarrays, but there are few controlled studies of their interactions with mismatched targets compared to 25-mer based platforms. Principal Findings: 50-mer oligonucleotides with centrally placed single, double and triple mismatches were spotted on an array. Over a range of target concentrations it was possible to discriminate binding to perfect matches and mismatches, and the type of mismatch could be predicted accurately in the concentration midrange (100 pM to 200 pM) using solution hybridization modeling methods. These results have implications for microarray design, optimization and analysis methods. Conclusions: Our results highlight the importance of incorporating biophysical factors in both the design and the analysis of microarrays. Use of the probe "percent bound" value predicted by equilibrium models of hybridization is confirmed to be important for predicting and interpreting the behavior of long oligonucleotide arrays, as has been shown for short oligonucleotide arrays.	[Gharaibeh, Raad Z.; Weller, Jennifer W.; Gibas, Cynthia J.] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA; [Newton, Joshua M.] Wake Forest Univ, Bowman Gray Sch Med, Dept Phys Assistant Studies, Winston Salem, NC USA	University of North Carolina; University of North Carolina Charlotte; Wake Forest University; Wake Forest Baptist Medical Center	Gharaibeh, RZ (corresponding author), Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA.	cgibas@uncc.edu		Gibas, Cynthia/0000-0002-1288-9543	National Institutes of Health [1R01GM072619-01]; UNC-Charlotte; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC-Charlotte; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health grant 1R01GM072619-01 to C.J.G and J.W.W. and by the UNC-Charlotte GASP program to R.Z.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdueva D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl435; Burden C.J., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1095, DOI 10.2202/1544-6115.1095]; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Chou CC, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh099; Chou HH, 2004, BIOINFORMATICS, V20, P2893, DOI 10.1093/bioinformatics/bth347; Dalma-Weiszhausz DD, 2006, METHOD ENZYMOL, V410, P3, DOI 10.1016/S0076-6879(06)10001-4; Dong YM, 2001, APPL ENVIRON MICROB, V67, P1911, DOI 10.1128/AEM.67.4.1911-1921.2001; Dorris DR, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-6; Dufva M, 2005, BIOMOL ENG, V22, P173, DOI 10.1016/j.bioeng.2005.09.003; Fish DJ, 2007, NUCLEIC ACIDS RES, V35, P7197, DOI 10.1093/nar/gkm865; Forman JE, 1998, ACS SYM SER, V682, P206; Gao Y, 2006, NUCLEIC ACIDS RES, V34, P3370, DOI 10.1093/nar/gkl422; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gharaibeh RZ, 2007, COMPUT BIOL CHEM, V31, P92, DOI 10.1016/j.compbiolchem.2007.02.008; Gharaibeh RZ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-452; Gibbs A, 1998, J VIROL METHODS, V74, P67, DOI 10.1016/S0166-0934(98)00070-6; Glazer M, 2006, ANAL BIOCHEM, V358, P225, DOI 10.1016/j.ab.2006.07.042; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gong P, 2008, P NATL ACAD SCI USA, V105, P5301, DOI 10.1073/pnas.0709416105; Halperin A, 2006, J PHYS-CONDENS MAT, V18, pS463, DOI 10.1088/0953-8984/18/18/S01; He ZL, 2005, APPL ENVIRON MICROB, V71, P3753, DOI 10.1128/AEM.71.7.3753-3760.2005; Hekstra D, 2003, NUCLEIC ACIDS RES, V31, P1962, DOI 10.1093/nar/gkg283; Held GA, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl122; Held GA, 2003, P NATL ACAD SCI USA, V100, P7575, DOI 10.1073/pnas.0832500100; Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438; Hooyberghs J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp109; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Kane MD, 2000, NUCLEIC ACIDS RES, V28, P4552, DOI 10.1093/nar/28.22.4552; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; KNUDTSON KL, 2003, CURRENT PROFILE MICR; Kreil DP, 2006, METHOD ENZYMOL, V410, P73, DOI 10.1016/S0076-6879(06)10004-X; Li SZ, 2008, NUCLEIC ACIDS RES, V36, P6585, DOI 10.1093/nar/gkn740; LIMA WF, 1992, BIOCHEMISTRY-US, V31, P12055, DOI 10.1021/bi00163a013; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Murphy D, 2002, ADV PHYSIOL EDUC, V26, P256, DOI 10.1152/advan.00043.2002; Naef F, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011906; Nordberg EK, 2005, BIOINFORMATICS, V21, P1365, DOI 10.1093/bioinformatics/bti182; Peterson AW, 2002, J AM CHEM SOC, V124, P14601, DOI 10.1021/ja0279996; R Development Core Team, 2007, R LANG ENV STAT COMP; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Relogio A, 2005, J BIOL CHEM, V280, P4779, DOI 10.1074/jbc.M411976200; Relogio A, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.11.e51; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; SantaLucia John Jr., 2007, V402, P3; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Southern E, 1999, NAT GENET, V21, P5, DOI 10.1038/4429; Stoughton RB, 2005, ANNU REV BIOCHEM, V74, P53, DOI 10.1146/annurev.biochem.74.082803.133212; Tomiuk S, 2001, Brief Bioinform, V2, P329, DOI 10.1093/bib/2.4.329; Weckx S, 2007, J PHYS CHEM B, V111, P13583, DOI 10.1021/jp075197x; Zhang L, 2003, NAT BIOTECHNOL, V21, P818, DOI 10.1038/nbt836	55	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11048	10.1371/journal.pone.0011048	http://dx.doi.org/10.1371/journal.pone.0011048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548788	Green Published, Green Submitted, gold			2022-12-27	WOS:000278599600009
J	Lee, JH; Kishikawa, M; Kumazoe, M; Yamada, K; Tachibana, H				Lee, Ju Hye; Kishikawa, Mutsumi; Kumazoe, Motofumi; Yamada, Koji; Tachibana, Hirofumi			Vitamin A Enhances Antitumor Effect of a Green Tea Polyphenol on Melanoma by Upregulating the Polyphenol Sensing Molecule 67-kDa Laminin Receptor	PLOS ONE			English	Article							TRANS-RETINOIC ACID; EPSILON-RI EXPRESSION; LEUKEMIA-CELLS; CANCER PREVENTION; NUCLEAR RECEPTORS; DIFFERENTIATION; EPIGALLOCATECHIN-3-O-GALLATE; INHIBITION; EGCG; (-)-EPIGALLOCATECHIN-3-O-GALLATE	Background: Green tea consumption has been shown to have cancer preventive qualities. Among the constituents of green tea, (-)-Epigallocatechin-3-O-gallate (EGCG) is the most effective at inhibiting carcinogenesis. However, the concentrations of EGCG that are required to elicit the anticancer effects in a variety of cancer cell types are much higher than the peak plasma concentration that occurs after drinking an equivalent of 2-3 cups of green tea. To obtain the anticancer effects of EGCG when consumed at a reasonable concentration in daily life, we investigated the combination effect of EGCG and food ingredient that may enhance the anticancer activity of EGCG on subcutaneous tumor growth in C57BL/6N mice challenged with B16 melanoma cells. Methodology/Principal Findings: All-trans-retinoic acid (ATRA) enhanced the expression of the 67-kDa laminin receptor (67LR) and increased EGCG-induced cell growth inhibition in B16 melanoma cells. The cell growth inhibition seen with the combined EGCG and ATRA treatment was abolished by treatment with an anti-67LR antibody. In addition, the combined EGCG and ATRA treatment significantly suppressed the melanoma tumor growth in mice. Expression of 67LR in the tumor increased upon oral administration of ATRA or a combined treatment of EGCG and ATRA treatment. Furthermore, RNAi-mediated silencing of the retinoic acid receptor (RAR) alpha attenuated the ATRA-induced enhancement of 67LR expression in the melanoma cells. An RAR agonist enhanced the expression levels of 67LR and increased EGCG-induced cell growth inhibition. Conclusions/Significance: Our findings provide a molecular basis for the combination effect seen with dietary components, and indicate that ATRA may be a beneficial food component for cancer prevention when combined with EGCG.	[Lee, Ju Hye; Kishikawa, Mutsumi; Kumazoe, Motofumi; Yamada, Koji; Tachibana, Hirofumi] Kyushu Univ, Dept Biosci & Biotechnol, Fac Agr, Hakozaki, Japan; [Tachibana, Hirofumi] Kyushu Univ, Lab Funct Food Design, Dept Funct Metab Design, Bioarchitecture Ctr, Fukuoka 812, Japan	Kyushu University; Kyushu University	Lee, JH (corresponding author), Kyushu Univ, Dept Biosci & Biotechnol, Fac Agr, Hakozaki, Japan.	tatibana@agr.kyushu-u.ac.jp	Komsa, Ildiko/G-7751-2011	Kumazoe, Motofumi/0000-0002-3002-2994	Kieikai research foundation;  [18208012]	Kieikai research foundation(Kieikai Research Foundation); 	This work was supported in part by grants-in-aid for scientific research (A) (Grant 18208012) (to H. T.) and Kieikai research foundation (to H. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; BOLLAG W, 1992, ANN ONCOL, V3, P513, DOI 10.1093/oxfordjournals.annonc.a058252; Britschgi A, 2010, BRIT J HAEMATOL, V149, P55, DOI 10.1111/j.1365-2141.2009.08040.x; Fujiki H, 2002, CANCER LETT, V188, P9, DOI 10.1016/S0304-3835(02)00379-8; Fujimura Y, 2005, BIOCHEM BIOPH RES CO, V336, P674, DOI 10.1016/j.bbrc.2005.08.146; Fujimura Y, 2004, FEBS LETT, V556, P204, DOI 10.1016/S0014-5793(03)01432-7; Fujimura Y, 2007, BIOCHEM BIOPH RES CO, V364, P79, DOI 10.1016/j.bbrc.2007.09.095; Fujimura Y, 2006, BIOCHEM BIOPH RES CO, V348, P524, DOI 10.1016/j.bbrc.2006.07.086; Galati G, 2006, FREE RADICAL BIO MED, V40, P570, DOI 10.1016/j.freeradbiomed.2005.09.014; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; Gudas Lorraine J., 1994, P443; Haque A, 2007, NEUROCHEM RES, V32, P2203, DOI 10.1007/s11064-007-9420-z; Huang HW, 2009, EUR J HAEMATOL, V83, P191, DOI 10.1111/j.1600-0609.2009.01277.x; Jimenez-Saenz M, 2006, J HEPATOL, V44, P616, DOI 10.1016/j.jhep.2005.11.041; Karmakar S., 2007, CANCER, V112, P596; LANCILLOTTI F, 1992, CANCER RES, V52, P6144; LEE MJ, 1995, CANCER EPIDEM BIOMAR, V4, P393; Lin YL, 1997, MOL PHARMACOL, V52, P465, DOI 10.1124/mol.52.3.465; Lin YL, 1996, J AGR FOOD CHEM, V44, P1387, DOI 10.1021/jf950652k; LIPPMAN SM, 1995, J CELL BIOCHEM, P1; MARTIGNONE S, 1993, J NATL CANCER I, V85, P398, DOI 10.1093/jnci/85.5.398; Martin PJ, 2005, NUCLEIC ACIDS RES, V33, P4311, DOI 10.1093/nar/gki745; Mazzanti G, 2009, EUR J CLIN PHARMACOL, V65, P331, DOI 10.1007/s00228-008-0610-7; Menard S, 1997, J CELL BIOCHEM, V67, P155, DOI 10.1002/(SICI)1097-4644(19971101)67:2<155::AID-JCB1>3.3.CO;2-O; Menard S, 1998, BREAST CANCER RES TR, V52, P137, DOI 10.1023/A:1006171403765; Okada N, 2009, BIOMED RES-TOKYO, V30, P201, DOI 10.2220/biomedres.30.201; Ozer EA, 2005, PEDIATR PULM, V39, P35, DOI 10.1002/ppul.20131; Ozpolat B, 2003, J PHARM PHARM SCI, V6, P292; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; Sang SM, 2005, J AGR FOOD CHEM, V53, P9478, DOI 10.1021/jf0519055; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; TALLMAN MS, 1992, J CLIN PHARMACOL, V32, P868, DOI 10.1002/j.1552-4604.1992.tb04633.x; Umeda D, 2005, BIOCHEM BIOPH RES CO, V333, P628, DOI 10.1016/j.bbrc.2005.05.108; Umeda D, 2008, J BIOL CHEM, V283, P3050, DOI 10.1074/jbc.M707892200; WANG ZY, 1989, MUTAT RES, V223, P273, DOI 10.1016/0165-1218(89)90120-1; Witcher M, 2003, BLOOD, V102, P237, DOI 10.1182/blood-2002-09-2725; Xia L, 2006, LEUKEMIA, V20, P1009, DOI 10.1038/sj.leu.2404198; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Yang CS, 1998, CANCER EPIDEM BIOMAR, V7, P351; Yano S, 2007, J AGR FOOD CHEM, V55, P7144, DOI 10.1021/jf071176o; Zhao J, 2008, EUR J PHARMACOL, V589, P127, DOI 10.1016/j.ejphar.2008.04.063	42	44	45	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11051	10.1371/journal.pone.0011051	http://dx.doi.org/10.1371/journal.pone.0011051			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548792	Green Submitted, gold, Green Published			2022-12-27	WOS:000278599600012
J	Atik, B; Johnston, SC; Dean, D				Atik, Berna; Johnston, S. Claiborne; Dean, Deborah			Association of Carotid Plaque Lp-PLA(2) with Macrophages and Chlamydia pneumoniae Infection among Patients at Risk for Stroke	PLOS ONE			English	Article							ACTIVATING-FACTOR ACETYLHYDROLASE; CORONARY-HEART-DISEASE; SMOOTH-MUSCLE-CELLS; C-REACTIVE PROTEIN; LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE-A2; LOW-DENSITY-LIPOPROTEIN; ENDOTHELIAL-CELLS; ATHEROSCLEROSIS RISK; ADHESION MOLECULES; WALL THICKNESS	Background: We previously showed that the burden of Chlamydia pneumoniae in carotid plaques was significantly associated with plaque interleukin (IL)-6, and serum IL-6 and C-reactive protein (CRP), suggesting that infected plaques contribute to systemic inflammatory markers in patients with stroke risk. Since lipoprotein-associated phospholipase A2 (Lp-PLA(2)) mediates inflammation in atherosclerosis, we hypothesized that serum Lp-PLA(2) mass and activity levels and plaque Lp-PLA(2) may be influenced by plaque C. pneumoniae infection. Methodology/Principal Findings: Forty-two patients underwent elective carotid endarterectomy. Tissue obtained at surgery was stained by immunohistochemistry for Lp-PLA(2) grade, macrophages, IL-6, C. pneumoniae and CD4+ and CD8+ cells. Serum Lp-PLA(2) activity and mass were measured using the colorimetric activity method (CAM (TM)) and ELISA, respectively. Serum homocysteine levels were measured by HPLC. Eleven (26.2%) patients were symptomatic with transient ischemic attacks. There was no correlation between patient risk factors (smoking, coronary artery disease, elevated cholesterol, diabetes, obesity, hypertension and family history of genetic disorders) for atherosclerosis and serum levels or plaque grade for Lp-PLA(2). Plaque Lp-PLA(2) correlated with serum homocysteine levels (p=0.013), plaque macrophages (p<0.01), and plaque C. pneumoniae (p<0.001), which predominantly infected macrophages, co-localizing with Lp-PLA(2). Conclusions: The significant association of plaque Lp-PLA(2) with plaque macrophages and C. pneumoniae suggests an interactive role in accelerating inflammation in atherosclerosis. A possible mechanism for C. pneumoniae in the atherogenic process may involve infection of macrophages that induce Lp-PLA(2) production leading to upregulation of inflammatory mediators in plaque tissue. Additional in vitro and in vivo research will be needed to advance our understanding of specific C. pneumoniae and Lp-PLA(2) interactions in atherosclerosis.	[Atik, Berna; Dean, Deborah] Childrens Hosp Oakland, Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA; [Johnston, S. Claiborne] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Dean, Deborah] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Dean, Deborah] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Dean, Deborah] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Atik, B (corresponding author), Childrens Hosp Oakland, Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA.	ddean@chori.org	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	Pacific Vascular Research Foundation; National Institutes of Health [R01 AI039499]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039499] Funding Source: NIH RePORTER	Pacific Vascular Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Pacific Vascular Research Foundation (www.pvrf.org), the National Institutes of Health, R01 AI039499 (to DD) in addition to reagents from diaDexus (www.diadexus.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberger A, 1997, CELL STRESS CHAPERON, V2, P94, DOI 10.1379/1466-1268(1997)002<0094:CEOIVE>2.3.CO;2; Antoniades C, 2009, EUR HEART J, V30, P6, DOI 10.1093/eurheartj/ehn515; Apfalter P, 2000, EUR J CLIN MICROBIOL, V19, P305, DOI 10.1007/s100960050481; Asano K, 1999, BIOCHEM BIOPH RES CO, V261, P511, DOI 10.1006/bbrc.1999.1066; Ballantyne CM, 2004, CIRCULATION, V109, P837, DOI 10.1161/01.CIR.0000116763.91992.F1; Blessing E, 2005, J ANTIMICROB CHEMOTH, V55, P1037, DOI 10.1093/jac/dki128; Bunk S, 2008, J IMMUNOL, V180, P5490, DOI 10.4049/jimmunol.180.8.5490; Caini P, 2007, J VIRAL HEPATITIS, V14, P22, DOI 10.1111/j.1365-2893.2006.00766.x; Carlquist JF, 2007, EXPERT REV MOL DIAGN, V7, P511, DOI 10.1586/14737159.7.5.511; Chambless LE, 2000, AM J EPIDEMIOL, V151, P478; Chang MY, 2003, ARTERIOSCL THROM VAS, V23, P809, DOI 10.1161/01.ATV.0000069208.20268.D0; Chiu B, 1997, CIRCULATION, V96, P2144; de Kruif MD, 2005, CARDIOVASC RES, V65, P317, DOI 10.1016/j.cardiores.2004.09.031; Furberg CD, 2008, J AM GERIATR SOC, V56, P792, DOI 10.1111/j.1532-5415.2008.01667.x; Gieffers J, 2001, CARDIOVASC DRUG THER, V15, P259, DOI 10.1023/A:1011972424529; Grayston JT, 2000, J INFECT DIS, V181, pS402, DOI 10.1086/315596; Hakkinen T, 1999, ARTERIOSCL THROM VAS, V19, P2909, DOI 10.1161/01.ATV.19.12.2909; Hauer AD, 2006, CARDIOVASC RES, V69, P280, DOI 10.1016/j.cardiores.2005.07.011; Hogdahl M, 2008, APMIS, V116, P1082, DOI 10.1111/j.1600-0463.2008.01145.x; Jaulmes A, 2006, FASEB J, V20, P1727, DOI 10.1096/fj.05-5514fje; Jitsuiki K, 2006, CIRC J, V70, P815, DOI 10.1253/circj.70.815; Johnston SC, 2005, ARTERIOSCL THROM VAS, V25, P2648, DOI 10.1161/01.ATV.0000189157.88630.d1; Johnston SC, 2001, STROKE, V32, P2748, DOI 10.1161/hs1201.099631; Kalayoglu MV, 1999, J INFECT DIS, V180, P780, DOI 10.1086/314931; Kardys I, 2006, ARTERIOSCL THROM VAS, V26, P631, DOI 10.1161/01.ATV.0000201289.83256.cf; Kiortsis DN, 2005, ANGIOLOGY, V56, P451, DOI 10.1177/000331970505600413; Koenig W, 2006, ARTERIOSCL THROM VAS, V26, P1586, DOI 10.1161/01.ATV.0000222983.73369.c8; KUME N, 1992, J CLIN INVEST, V90, P1138, DOI 10.1172/JCI115932; KUO CC, 1995, P NATL ACAD SCI USA, V92, P6911, DOI 10.1073/pnas.92.15.6911; LaBiche R, 2001, STROKE, V32, P855, DOI 10.1161/01.STR.32.4.855; Laitinen K, 1997, INFECT IMMUN, V65, P4832, DOI 10.1128/IAI.65.11.4832-4835.1997; Macphee CH, 1999, BIOCHEM J, V338, P479, DOI 10.1042/0264-6021:3380479; Mayr M, 2000, CIRCULATION, V102, P833; Mohler ER, 2008, J AM COLL CARDIOL, V51, P1632, DOI 10.1016/j.jacc.2007.11.079; Muhlestein JB, 1999, AM HEART J, V138, pS514, DOI 10.1016/S0002-8703(99)70289-9; Oldgren J, 2007, EUR HEART J, V28, P699, DOI 10.1093/eurheartj/ehl565; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; Persson M, 2008, ATHEROSCLEROSIS, V200, P191, DOI 10.1016/j.atherosclerosis.2007.12.001; QUINN MT, 1988, P NATL ACAD SCI USA, V85, P2805, DOI 10.1073/pnas.85.8.2805; Rajavashisth TB, 1999, CIRCULATION, V99, P3103, DOI 10.1161/01.CIR.99.24.3103; Ramirez JA, 1996, ANN INTERN MED, V125, P979, DOI 10.7326/0003-4819-125-12-199612150-00008; Rodel J, 2000, INFECT IMMUN, V68, P3635, DOI 10.1128/IAI.68.6.3635-3641.2000; SAIKKU P, 1992, J INFECTION, V25, P27, DOI 10.1016/0163-4453(92)91913-V; Sessa R, 2009, INT J IMMUNOPATH PH, V22, P9, DOI 10.1177/039463200902200102; TARBET EB, 1991, J BIOL CHEM, V266, P16667; Tsimikas S, 2009, EUR HEART J, V30, P107, DOI 10.1093/eurheartj/ehn502; VADAS P, 1993, AM J TROP MED HYG, V49, P455, DOI 10.4269/ajtmh.1993.49.455; Van Lenten BJ, 2001, CIRCULATION, V103, P2283	48	25	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e11026	10.1371/journal.pone.0011026	http://dx.doi.org/10.1371/journal.pone.0011026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20543948	Green Published, gold, Green Submitted			2022-12-27	WOS:000278557600005
J	Boyd, AS; Wood, KJ				Boyd, Ashleigh S.; Wood, Kathryn J.			Characteristics of the Early Immune Response Following Transplantation of Mouse ES Cell Derived Insulin-Producing Cell Clusters	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HUMAN ISLETS; T-CELLS; EXPRESSION; COMPLEMENT; PRIVILEGE; IMMUNOGENICITY; ENGRAFTMENT; REJECTION; TARGETS		[Boyd, Ashleigh S.; Wood, Kathryn J.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Transplantat Res Immunol Grp, Oxford OX3 9DU, England; [Boyd, Ashleigh S.] Boston Univ, Sch Med, Roger Williams Hosp, NIH Ctr Biomed Res Excellence COBRE Tissue Repair, Providence, RI USA	University of Oxford; Boston University; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); Roger Williams Medical Center	Boyd, AS (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Transplantat Res Immunol Grp, Oxford OX3 9DU, England.	aboyd@rwmc.org; kathryn.wood@nds.ox.ac.uk			Medical Research Council; BD Preanalytical Systems Europe; NIH [P20RR018757]; NIH COBRE; Wellcome Trust; European Union; Royal Society Wolfson Research; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018757] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BD Preanalytical Systems Europe; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); European Union(European Commission); Royal Society Wolfson Research(Royal Society of London); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for this project was provided to ASB by the Medical Research Council and BD Preanalytical Systems Europe through a Collaborative Studentship and by NIH grant P20RR018757. Additional support was provided by the NIH COBRE administrative core at Roger Williams Medical Center, Wellcome Trust and European Union through the Optistem Network. KJW holds a Royal Society Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DH, 1996, TRANSPLANTATION, V61, P817, DOI 10.1097/00007890-199603150-00024; Bertuzzi F, 2004, J CLIN ENDOCR METAB, V89, P5724, DOI 10.1210/jc.2004-0659; Blyszczuk P, 2004, INT J DEV BIOL, V48, P1095, DOI 10.1387/ijdb.041904pb; Bonde S, 2006, STEM CELLS, V24, P2192, DOI 10.1634/stemcells.2006-0022; Boyd AS, 2005, ADV DRUG DELIVER REV, V57, P1944, DOI 10.1016/j.addr.2005.08.004; Boyd AS, 2008, STEM CELLS, V26, P1128, DOI 10.1634/stemcells.2007-0762; Boyd AS, 2009, TRANSPLANTATION, V87, P1300, DOI 10.1097/TP.0b013e3181a19421; Burns WR, 2005, AM J TRANSPLANT, V5, P1226, DOI 10.1111/j.1600-6143.2005.00892.x; Carvalho-Gaspar M, 2005, J IMMUNOL METHODS, V301, P41, DOI 10.1016/j.jim.2005.03.003; El-Sawy T, 2005, CIRCULATION, V112, P320, DOI 10.1161/CIRCULATIONAHA.104.516708; El-Sawy T, 2004, AM J PATHOL, V165, P147, DOI 10.1016/S0002-9440(10)63283-X; Game DS, 2002, TRANSPL IMMUNOL, V10, P101, DOI 10.1016/S0966-3274(02)00055-2; Johansson U, 2003, BIOCHEM BIOPH RES CO, V308, P474, DOI 10.1016/S0006-291X(03)01392-5; Jones ND, 2006, J IMMUNOL, V176, P2316, DOI 10.4049/jimmunol.176.4.2316; Kapoor A, 2000, TRANSPLANT P, V32, P793, DOI 10.1016/S0041-1345(00)00985-4; Koch CA, 2004, J IMMUNOL, V172, P5143, DOI 10.4049/jimmunol.172.9.5143; Kondo T, 2000, TRANSPLANTATION, V69, P969; Kuttler B, 2002, TRANSPLANTATION, V74, P440, DOI 10.1097/00007890-200208270-00003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magliocca JF, 2006, STEM CELLS DEV, V15, P707, DOI 10.1089/scd.2006.15.707; Marsh JE, 1999, CURR OPIN NEPHROL HY, V8, P557, DOI 10.1097/00041552-199909000-00004; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Nicolls MR, 2001, CRIT REV IMMUNOL, V21, P87; Olszewski Waldemar L, 2005, Ann Transplant, V10, P5; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Quigg RJ, 2003, J IMMUNOL, V171, P3319, DOI 10.4049/jimmunol.171.7.3319; Robertson NJ, 2007, P NATL ACAD SCI USA, V104, P20920, DOI 10.1073/pnas.0710265105; Rus H, 2005, IMMUNOL RES, V33, P103, DOI 10.1385/IR:33:2:103; SACKS SH, 1993, LANCET, V342, P1273, DOI 10.1016/0140-6736(93)92362-W; Socha-Urbanek K, 1998, Ann Transplant, V3, P5; Turvey SE, 2000, TRANSPLANTATION, V69, P1972, DOI 10.1097/00007890-200005150-00043; Wu DC, 2008, STEM CELLS, V26, P1939, DOI 10.1634/stemcells.2008-0078; Yasunami Y, 2005, J EXP MED, V202, P913, DOI 10.1084/jem.20050448	33	23	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10965	10.1371/journal.pone.0010965	http://dx.doi.org/10.1371/journal.pone.0010965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532031	Green Submitted, gold, Green Published			2022-12-27	WOS:000278380500010
J	Polack, S; Eusebio, C; Mathenge, W; Wadud, Z; Rashid, M; Foster, A; Kuper, H				Polack, Sarah; Eusebio, Christina; Mathenge, Wanjiku; Wadud, Zazkia; Rashid, Mamunur; Foster, Allen; Kuper, Hannah			The Impact of Cataract Surgery on Activities and Time-Use: Results from a Longitudinal Study in Kenya, Bangladesh and the Philippines	PLOS ONE			English	Article							QUALITY-OF-LIFE; VISUAL IMPAIRMENT; OLDER-ADULTS; EYE DISEASE; VISION; LENS	Background: Cataract is the leading cause of blindness in the world, and blindness from cataract is particularly common in low-income countries. The aim of this study is to explore the impact of cataract surgery on daily activities and time-use in Kenya, Bangladesh and the Philippines. Methods/Principal Findings: Amulti-centre intervention study was conducted in three countries. Time-use data were collected through interview from cases aged >= 50 years with visually impairing cataract (VA<6/24) and age-and gender-matched controls with normal vision (VA>6/18). Cases were offered free/subsidized cataract surgery. Approximately one year later participants were re-interviewed about time-use. At baseline across the three countries there were 651 cases and 571 controls. Fifty-five percent of cases accepted surgery. Response rate at follow up was 84% (303 out of 361) for operated cases, and 80% (459 out of 571) for controls. At baseline, cases were less likely to carry out and spent less time on productive activities (paid and non-paid work) and spent more time in "inactivity'' compared to controls. Approximately one year after cataract surgery, operated cases were more likely to undertake productive activities compared to baseline (Kenya from 55% to 88%; Bangladesh 60% to 95% and Philippines 81% to 94%, p<0.001) and mean time spent on productive activities increased by one-two hours in each setting (p<0.001). Time spent in "inactivity'' in Kenya and Bangladesh decreased by approximately two hours (p<0.001). Frequency of reported assistance with activities was more than halved in each setting (p<0.001). Conclusions/Significance: The empirical evidence provided by this study of increased time spent on productive activities, reduced time in inactivity and reduced assistance following cataract surgery among older adults in low-income settings has positive implications for well-being and inclusion, and supports arguments of economic benefit at the household level from cataract surgery.	[Polack, Sarah; Foster, Allen; Kuper, Hannah] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Eusebio, Christina] Cataract Fdn Philippines, Bacolod, Philippines; [Mathenge, Wanjiku] Rift Valley Prov Hosp, Eye Unit, Nakuru, Kenya; [Wadud, Zazkia] Child Sight Fdn, Dhaka, Bangladesh; [Rashid, Mamunur] CSS Rawm Hosp, Khulna, Bangladesh	University of London; London School of Hygiene & Tropical Medicine	Polack, S (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Keppel St, London WC1, England.	sarah.polack@lshtm.ac.uk	MATHENGE, WANJIKU/W-3993-2019	Foster, Allen/0000-0003-2368-4436; Rashid, Mamunur/0000-0003-3862-6554	CBM; SightSavers International; ORBIS UK	CBM; SightSavers International; ORBIS UK	Funding: This study was funded by grants from CBM (http://www.cbmi.org/), SightSavers International (http://www.sightsavers.org/default.html) and ORBIS UK (http://www.orbis.org/). Representatives from these non-governmental organizations (NGO) were part of the steering committee for the study, which gave guidance towards conduct of the study but they were not involved in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLEGATE WB, 1987, JAMA-J AM MED ASSOC, V257, P1064; Baker LA, 2005, SOC INDIC RES, V73, P431, DOI 10.1007/s11205-005-0805-6; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fletcher A, 1998, AM J OPHTHALMOL, V125, P26, DOI 10.1016/S0002-9394(99)80231-1; Harvey A. S., 2000, DESIGNING HOUSEHOLD; Hawkins Barbara A, 2005, Prev Chronic Dis, V2, pA03; He MG, 1999, OPHTHALMOLOGY, V106, P1609, DOI 10.1016/S0161-6420(99)90460-8; JAVITT J, 1983, ACTA 24 INT C OPHTH, P1308; Kuper H, 2008, PLOS MED, V5, P1716, DOI 10.1371/journal.pmed.0050244; Mamidipudi PR, 2003, J CATARACT REFR SURG, V29, P1143, DOI 10.1016/S0886-3350(03)00043-9; McGwin G, 2003, J CATARACT REFR SURG, V29, P941, DOI 10.1016/S0886-3350(02)01846-1; Menec VH, 2003, J GERONTOL B-PSYCHOL, V58, pS74, DOI 10.1093/geronb/58.2.S74; Nirmalan PK, 2005, INVEST OPHTH VIS SCI, V46, P2308, DOI 10.1167/iovs.04-0830; Nutheti R, 2006, INVEST OPHTH VIS SCI, V47, P4742, DOI 10.1167/iovs.06-0020; Polack S, 2008, BRIT J OPHTHALMOL, V92, P1026, DOI 10.1136/bjo.2007.134791; Polack S, 2008, OPHTHAL EPIDEMIOL, V15, P372, DOI 10.1080/09286580802478716; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; STEINKAMP MW, 1987, INT J AGING HUM DEV, V25, P293, DOI 10.2190/V813-QA3G-6AQC-MWYM; Turner AG, 1996, INT J EPIDEMIOL, V25, P198, DOI 10.1093/ije/25.1.198; *UNDP, 1995, HDR, P87	21	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2010	5	6							e10913	10.1371/journal.pone.0010913	http://dx.doi.org/10.1371/journal.pone.0010913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QF	20531957	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000278222400008
J	Hastings, PJ; Hersh, MN; Thornton, PC; Fonville, NC; Slack, A; Frisch, RL; Ray, MP; Harris, RS; Leal, SM; Rosenberg, SM				Hastings, P. J.; Hersh, Megan N.; Thornton, P. C.; Fonville, Natalie C.; Slack, Andrew; Frisch, Ryan L.; Ray, Mellanie P.; Harris, Reuben S.; Leal, Suzanne M.; Rosenberg, Susan M.			Competition of Escherichia coli DNA Polymerases I, II and III with DNA Pol IV in Stressed Cells	PLOS ONE			English	Article							DEPENDENT ADAPTIVE MUTATION; FRAMESHIFT MUTATION; SLIDING-CLAMP; SOS RESPONSE; GENETIC REQUIREMENTS; INDUCED MUTAGENESIS; REPLICATION FORK; LESION-BYPASS; RECOMBINATION; FIDELITY	Escherichia coli has five DNA polymerases, one of which, the low-fidelity Pol IV or DinB, is required for stress-induced mutagenesis in the well-studied Lac frameshift-reversion assay. Although normally present at similar to 200 molecules per cell, Pol IV is recruited to acts of DNA double-strand-break repair, and causes mutagenesis, only when at least two cellular stress responses are activated: the SOS DNA-damage response, which upregulates DinB similar to 10-fold, and the RpoS-controlled general-stress response, which upregulates Pol IV about 2-fold. DNA Pol III was also implicated but its role in mutagenesis was unclear. We sought in vivo evidence on the presence and interactions of multiple DNA polymerases during stress-induced mutagenesis. Using multiply mutant strains, we provide evidence of competition of DNA Pols I, II and III with Pol IV, implying that they are all present at sites of stress-induced mutagenesis. Previous data indicate that Pol V is also present. We show that the interactions of Pols I, II and III with Pol IV result neither from, first, induction of the SOS response when particular DNA polymerases are removed, nor second, from proofreading of DNA Pol IV errors by the editing functions of Pol I or Pol III. Third, we provide evidence that Pol III itself does not assist with but rather inhibits Pol IV-dependent mutagenesis. The data support the remaining hypothesis that during the acts of DNA double-strand-break (DSB) repair, shown previously to underlie stress-induced mutagenesis in the Lac system, there is competition of DNA polymerases I, II and III with DNA Pol IV for action at the primer terminus. Up-regulation of Pol IV, and possibly other stress-response-controlled factor(s), tilt the competition in favor of error-prone Pol IV at the expense of more accurate polymerases, thus producing stress-induced mutations. This mutagenesis assay reveals the DNA polymerases operating in DSB repair during stress and also provides a sensitive indicator for DNA polymerase competition and choice in vivo.	[Hastings, P. J.; Hersh, Megan N.; Thornton, P. C.; Fonville, Natalie C.; Slack, Andrew; Frisch, Ryan L.; Ray, Mellanie P.; Harris, Reuben S.; Leal, Suzanne M.; Rosenberg, Susan M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Fonville, Natalie C.; Rosenberg, Susan M.] Baylor Coll Med, Interdept Grad Program Cell & Mol Biol, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dept Mol Virol, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dept Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Hastings, PJ (corresponding author), LaserGen Inc, Houston, TX USA.	hastings@bcm.edu	Romesberg, Floyd/M-2821-2017	Romesberg, Floyd/0000-0001-6317-1315; Rosenberg, Susan M./0000-0003-1444-473X	National Institutes of Health [R01-GM64022, R01-GM53158, T32-GM07526]; DOD; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053158, T32GM007526, R01GM064022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01-GM64022 (PJH) and R01-GM53158 (SMR), a DOD Breast Cancer Research Postdoctoral Fellowship to MNH, and National Institutes of Health training grant T32-GM07526 to RLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERLUND T, 1995, J BACTERIOL, V177, P6791, DOI 10.1128/jb.177.23.6791-6797.1995; Banach-Orlowska M, 2005, MOL MICROBIOL, V58, P61, DOI 10.1111/j.1365-2958.2005.04805.x; BATES H, 1989, J BACTERIOL, V171, P2480, DOI 10.1128/jb.171.5.2480-2484.1989; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BONNER CA, 1990, P NATL ACAD SCI USA, V87, P7663, DOI 10.1073/pnas.87.19.7663; Bunting KA, 2003, EMBO J, V22, P5883, DOI 10.1093/emboj/cdg568; CAIRNS J, 1991, GENETICS, V128, P695; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; Courcelle J, 2001, GENETICS, V158, P41; Curti E, 2009, MOL MICROBIOL, V71, P315, DOI 10.1111/j.1365-2958.2008.06526.x; DUNN SD, 1986, ANAL BIOCHEM, V157, P144, DOI 10.1016/0003-2697(86)90207-1; ELLEDGE SJ, 1983, J MOL BIOL, V164, P175, DOI 10.1016/0022-2836(83)90074-8; ESCARCELLER M, 1994, J BACTERIOL, V176, P6221, DOI 10.1128/jb.176.20.6221-6228.1994; FIJALKOWSKA IJ, 1993, GENETICS, V134, P1023; Fijalkowska IJ, 1997, J BACTERIOL, V179, P7435, DOI 10.1128/jb.179.23.7435-7445.1997; FOSTER PL, 1995, P NATL ACAD SCI USA, V92, P7951, DOI 10.1073/pnas.92.17.7951; Foster PL, 1996, GENETICS, V142, P25; FOSTER PL, 1994, SCIENCE, V265, P407, DOI 10.1126/science.8023164; Foster PL, 2000, COLD SPRING HARB SYM, V65, P21, DOI 10.1101/sqb.2000.65.21; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Fujii S, 2004, EMBO J, V23, P4342, DOI 10.1038/sj.emboj.7600438; Furukohri A, 2008, J BIOL CHEM, V283, P11260, DOI 10.1074/jbc.M709689200; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Galhardo RS, 2009, GENETICS, V182, P55, DOI 10.1534/genetics.109.100735; Gawel D, 2008, J BACTERIOL, V190, P1730, DOI 10.1128/JB.01463-07; Harris RS, 1997, MUTAT RES-FUND MOL M, V375, P19, DOI 10.1016/S0027-5107(96)00244-8; Harris RS, 1996, GENETICS, V142, P681; HARRIS RS, 1994, SCIENCE, V264, P258, DOI 10.1126/science.8146657; Harris RS, 1997, THESIS U ALBERTA EDM; Hastings PJ, 2004, PLOS BIOL, V2, P2220, DOI 10.1371/journal.pbio.0020399; Hastings PJ, 2000, CELL, V103, P723, DOI 10.1016/S0092-8674(00)00176-8; He AS, 2006, DNA REPAIR, V5, P258, DOI 10.1016/j.dnarep.2005.10.006; Heltzel JMH, 2009, P NATL ACAD SCI USA, V106, P12664, DOI 10.1073/pnas.0903460106; Indiani C, 2005, MOL CELL, V19, P805, DOI 10.1016/j.molcel.2005.08.011; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; JOYCE CM, 1985, J MOL BIOL, V186, P283, DOI 10.1016/0022-2836(85)90105-6; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; Kim SR, 2001, MOL GENET GENOMICS, V266, P207; Kobayashi S, 2002, J BIOL CHEM, V277, P34198, DOI 10.1074/jbc.M204826200; Kuban W, 2005, J BACTERIOL, V187, P6862, DOI 10.1128/JB.187.19.6862-6866.2005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Layton JC, 2003, MOL MICROBIOL, V50, P549, DOI 10.1046/j.1365-2958.2003.03704.x; Lombardo MJ, 2004, GENETICS, V166, P669, DOI 10.1534/genetics.166.2.669; MARSH L, 1985, J BACTERIOL, V162, P155, DOI 10.1128/JB.162.1.155-161.1985; Maul RW, 2005, J BACTERIOL, V187, P7607, DOI 10.1128/JB.187.22.7607-7618.2005; McKenzie GJ, 2000, P NATL ACAD SCI USA, V97, P6646, DOI 10.1073/pnas.120161797; McKenzie GJ, 2001, MOL CELL, V7, P571, DOI 10.1016/S1097-2765(01)00204-0; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Motamedi MR, 1999, GENE DEV, V13, P2889, DOI 10.1101/gad.13.21.2889; Nohmi T, 2006, ANNU REV MICROBIOL, V60, P231, DOI 10.1146/annurev.micro.60.080805.142238; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Opperman T, 1999, P NATL ACAD SCI USA, V96, P9218, DOI 10.1073/pnas.96.16.9218; Pages V, 2005, J MOL BIOL, V352, P501, DOI 10.1016/j.jmb.2005.07.063; Pages V, 2002, ONCOGENE, V21, P8957, DOI 10.1038/sj.onc.1206006; Pennington JM, 2007, NAT GENET, V39, P797, DOI 10.1038/ng2051; Petrosino JF, 2009, J BACTERIOL, V191, P5881, DOI 10.1128/JB.00732-09; Ponder RG, 2005, MOL CELL, V19, P791, DOI 10.1016/j.molcel.2005.07.025; Prieto AI, 2006, GENETICS, V174, P575, DOI 10.1534/genetics.106.060889; Rangarajan S, 1999, P NATL ACAD SCI USA, V96, P9224, DOI 10.1073/pnas.96.16.9224; ROSENBERG SM, 1994, SCIENCE, V265, P405, DOI 10.1126/science.8023163; Roth JR, 2006, ANNU REV MICROBIOL, V60, P477, DOI 10.1146/annurev.micro.60.080805.142045; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; SLATER SC, 1994, J BACTERIOL, V171, P3139; SOMMER S, 1993, MOL GEN GENET, V239, P137, DOI 10.1007/BF00281612; Sutton MD, 2004, J BACTERIOL, V186, P6738, DOI 10.1128/JB.186.20.6738-6748.2004; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Torkelson J, 1997, EMBO J, V16, P3303, DOI 10.1093/emboj/16.11.3303; Uchida K, 2008, MOL MICROBIOL, V70, P608, DOI 10.1111/j.1365-2958.2008.06423.x; Wagner J, 2000, J BACTERIOL, V182, P4587, DOI 10.1128/JB.182.16.4587-4595.2000; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104	70	34	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10862	10.1371/journal.pone.0010862	http://dx.doi.org/10.1371/journal.pone.0010862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523737	Green Published, Green Submitted, gold			2022-12-27	WOS:000278221900012
J	Pfenning, AR; Kim, TK; Spotts, JM; Hemberg, M; Su, D; West, AE				Pfenning, Andreas R.; Kim, Tae-Kyung; Spotts, James M.; Hemberg, Martin; Su, Dan; West, Anne E.			Genome-Wide Identification of Calcium-Response Factor (CaRF) Binding Sites Predicts a Role in Regulation of Neuronal Signaling Pathways	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; EPHRIN-AS; BDNF TRANSCRIPTION; GENE; EXPRESSION; PLASTICITY; RECEPTORS; MAPS	Calcium-Response Factor (CaRF) was first identified as a transcription factor based on its affinity for a neuronal-selective calcium-response element (CaRE1) in the gene encoding Brain-Derived Neurotrophic Factor (BDNF). However, because CaRF shares no homology with other transcription factors, its properties and gene targets have remained unknown. Here we show that the DNA binding domain of CaRF has been highly conserved across evolution and that CaRF binds DNA directly in a sequence-specific manner in the absence of other eukaryotic cofactors. Using a binding site selection screen we identify a high-affinity consensus CaRF response element (cCaRE) that shares significant homology with the CaRE1 element of Bdnf. In a genome-wide chromatin immunoprecipitation analysis (ChIP-Seq), we identified 176 sites of CaRF-specific binding (peaks) in neuronal genomic DNA. 128 of these peaks are within 10kB of an annotated gene, and 60 are within 1kB of an annotated transcriptional start site. At least 138 of the CaRF peaks contain a common 10-bp motif with strong statistical similarity to the cCaRE, and we provide evidence predicting that CaRF can bind independently to at least 64.5% of these motifs in vitro. Analysis of this set of putative CaRF targets suggests the enrichment of genes that regulate intracellular signaling cascades. Finally we demonstrate that expression of a subset of these target genes is altered in the cortex of Carf knockout (KO) mice. Together these data strongly support the characterization of CaRF as a unique transcription factor and provide the first insight into the program of CaRF-regulated transcription in neurons.	[Pfenning, Andreas R.] Duke Univ, Med Ctr, Program Computat Biol & Bioinformat, Durham, NC 27710 USA; [Kim, Tae-Kyung] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Spotts, James M.] Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA USA; [Spotts, James M.] Childrens Hosp Boston, Dept Neurol, Boston, MA USA; [Spotts, James M.] Childrens Hosp Boston, Dept Neurobiol, Boston, MA USA; [Hemberg, Martin] Childrens Hosp Boston, Dept Ophthalmol, Boston, MA USA; [Su, Dan; West, Anne E.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Duke University	Pfenning, AR (corresponding author), Duke Univ, Med Ctr, Program Computat Biol & Bioinformat, Durham, NC 27710 USA.	west@neuro.duke.edu	Kim, Tae-Kyung/AAX-4230-2020	Kim, Tae-Kyung/0000-0001-5161-9864; /0000-0002-3447-9801	NIH [R01 DA022202]; Harvard Medical School; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022202] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Medical School; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by NIH grant R01 DA022202 (A.E.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are deeply grateful to Michael E. Greenberg of Harvard Medical School for his support of this project and for the generous contribution of reagents.	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bateman E, 1998, PROG NUCLEIC ACID RE, V60, P133, DOI 10.1016/S0079-6603(08)60892-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davidson HT, 2009, EUR J NEUROSCI, V29, P42, DOI 10.1111/j.1460-9568.2008.06563.x; Efron B, 2008, STAT SCI, V23, P1, DOI 10.1214/07-STS236; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Hevroni D, 1998, J MOL NEUROSCI, V10, P75, DOI 10.1007/BF02737120; Hong EJ, 2005, CURR OPIN NEUROBIOL, V15, P21, DOI 10.1016/j.conb.2005.01.002; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; MCDOWELL KA, 2010, J NEUROSCI IN PRESS; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Narlikar L, 2007, PLOS COMPUT BIOL, V3, P2199, DOI 10.1371/journal.pcbi.0030215; Narlikar L, 2006, BIOINFORMATICS, V22, pE384, DOI 10.1093/bioinformatics/btl251; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; POLLOCK RM, 2001, CURR PROTOC MOL BIOL, pCH12; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rada-Iglesias A, 2008, GENOME RES, V18, P380, DOI 10.1101/gr.6880908; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Sakata K, 2009, P NATL ACAD SCI USA, V106, P5942, DOI 10.1073/pnas.0811431106; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; SKELLAM JG, 1946, J ROY STAT SOC A STA, V109, P296, DOI 10.2307/2981372; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	47	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10870	10.1371/journal.pone.0010870	http://dx.doi.org/10.1371/journal.pone.0010870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523734	Green Published, Green Submitted, gold			2022-12-27	WOS:000278221900016
J	Mumcuoglu, M; Bagislar, S; Yuzugullu, H; Alotaibi, H; Senturk, S; Telkoparan, P; Gur-Dedeoglu, B; Cingoz, B; Bozkurt, B; Tazebay, UH; Yulug, IG; Akcali, KC; Ozturk, M				Mumcuoglu, Mine; Bagislar, Sevgi; Yuzugullu, Haluk; Alotaibi, Hani; Senturk, Serif; Telkoparan, Pelin; Gur-Dedeoglu, Bala; Cingoz, Burcu; Bozkurt, Betul; Tazebay, Uygar H.; Yulug, Isik G.; Akcali, K. Can; Ozturk, Mehmet			The Ability to Generate Senescent Progeny as a Mechanism Underlying Breast Cancer Cell Heterogeneity	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; ESTROGEN-RECEPTOR-ALPHA; EXPRESSION; INACTIVATION; P21(WAF1/CIP1); TAMOXIFEN; SUBTYPES; CULTURE; CRISIS; TUMORS	Background: Breast cancer is a remarkably heterogeneous disease. Luminal, basal-like, "normal-like", and ERBB2+ subgroups were identified and were shown to have different prognoses. The mechanisms underlying this heterogeneity are poorly understood. In our study, we explored the role of cellular differentiation and senescence as a potential cause of heterogeneity. Methodology/Principal Findings: A panel of breast cancer cell lines, isogenic clones, and breast tumors were used. Based on their ability to generate senescent progeny under low-density clonogenic conditions, we classified breast cancer cell lines as senescent cell progenitor (SCP) and immortal cell progenitor (ICP) subtypes. All SCP cell lines expressed estrogen receptor (ER). Loss of ER expression combined with the accumulation of p21(Cip1) correlated with senescence in these cell lines. p21(Cip1) knockdown, estrogen-mediated ER activation or ectopic ER overexpression protected cells against senescence. In contrast, tamoxifen triggered a robust senescence response. As ER expression has been linked to luminal differentiation, we compared the differentiation status of SCP and ICP cell lines using stem/progenitor, luminal, and myoepithelial markers. The SCP cells produced CD24+ or ER+ luminal-like and ASMA+ myoepithelial-like progeny, in addition to CD44+ stem/progenitor-like cells. In contrast, ICP cell lines acted as differentiation-defective stem/progenitor cells. Some ICP cell lines generated only CD44+/CD24-/ER-/ASMA-progenitor/stem-like cells, and others also produced CD24+/ER-luminal-like, but not ASMA+ myoepithelial-like cells. Furthermore, gene expression profiles clustered SCP cell lines with luminal A and "normal-like" tumors, and ICP cell lines with luminal B and basal-like tumors. The ICP cells displayed higher tumorigenicity in immunodeficient mice. Conclusions/Significance: Luminal A and "normal-like" breast cancer cell lines were able to generate luminal-like and myoepithelial-like progeny undergoing senescence arrest. In contrast, luminal B/basal-like cell lines acted as stem/progenitor cells with defective differentiation capacities. Our findings suggest that the malignancy of breast tumors is directly correlated with stem/progenitor phenotypes and poor differentiation potential.	[Mumcuoglu, Mine; Bagislar, Sevgi; Yuzugullu, Haluk; Alotaibi, Hani; Senturk, Serif; Telkoparan, Pelin; Gur-Dedeoglu, Bala; Cingoz, Burcu; Tazebay, Uygar H.; Yulug, Isik G.; Akcali, K. Can; Ozturk, Mehmet] Bilkent Univ, BilGen Genet & Biotechnol Ctr, Dept Mol Biol & Genet, Ankara, Turkey; [Bagislar, Sevgi; Yuzugullu, Haluk; Ozturk, Mehmet] Univ Grenoble 1, INSERM, CRI, U823, Grenoble, France; [Bozkurt, Betul] Ankara Numune Res & Teaching Hosp, Dept Surg, Ankara, Turkey	Ihsan Dogramaci Bilkent University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Ankara Numune Training & Research Hospital	Mumcuoglu, M (corresponding author), Bilkent Univ, BilGen Genet & Biotechnol Ctr, Dept Mol Biol & Genet, Ankara, Turkey.	ozturkm@ujf-grenoble.fr	ozturk, mehmet/G-3330-2014; OZTURK, MEHMET/AAS-7241-2021; Dedeoglu, Bala Gur/O-1604-2014; Senturk, Serif/A-1263-2017; Alotaibi, Hani/W-7129-2019; Insal, Burcu/AAD-5924-2020; Alotaibi, Hani/R-3158-2016; Dedeoglu, Bala Gur/ABC-2436-2020	OZTURK, MEHMET/0000-0002-6092-9706; Dedeoglu, Bala Gur/0000-0002-4320-5685; Senturk, Serif/0000-0003-3963-2294; Alotaibi, Hani/0000-0001-7423-9653; Alotaibi, Hani/0000-0001-7423-9653; Dedeoglu, Bala Gur/0000-0002-4320-5685; Yulug, Isik/0000-0002-7577-2502; Insal, Burcu/0000-0003-3354-6424; Bagislar Bremang, Sevgi/0000-0003-3203-9607; Akcali, Kamil/0000-0002-7816-6938; TAZEBAY, UYGAR HALIS/0000-0003-1999-8213; TELKOPARAN-AKILLILAR, Pelin/0000-0003-0337-0763	TUBITAK (The Scientific and Technological Research Council of Turkey); DPT (State Planning Office of Turkey); TUBA (Turkish Academy of Sciences); Institut National de Cancer; INSERM of France	TUBITAK (The Scientific and Technological Research Council of Turkey)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); DPT (State Planning Office of Turkey)(Turkiye Cumhuriyeti Kalkinma Bakanligi); TUBA (Turkish Academy of Sciences)(Turkish Academy of Sciences); Institut National de Cancer; INSERM of France	This work was supported by TUBITAK (The Scientific and Technological Research Council of Turkey), DPT (State Planning Office of Turkey) and TUBA (Turkish Academy of Sciences). Additional funding was from Institut National de Cancer and INSERM of France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alotaibi H, 2006, BIOCHEM BIOPH RES CO, V345, P1487, DOI 10.1016/j.bbrc.2006.05.049; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; BERTHOIS Y, 1986, P NATL ACAD SCI USA, V83, P2496, DOI 10.1073/pnas.83.8.2496; Booth BW, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1538; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cariou S, 2000, P NATL ACAD SCI USA, V97, P9042, DOI 10.1073/pnas.160016897; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DUBIK D, 1992, ONCOGENE, V7, P1587; Early Breast Cancer Trialists' Collaborative Group, 1998, LANCET, V351, P1451; Ford CE, 2009, P NATL ACAD SCI USA, V106, P3919, DOI 10.1073/pnas.0809516106; Garbe JC, 2007, CELL CYCLE, V6, P1927, DOI 10.4161/cc.6.15.4519; Gur-Dedeoglu B, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-396; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Mukherjee S, 2005, J BIOL CHEM, V280, P17617, DOI 10.1074/jbc.M502278200; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ozturk N, 2006, P NATL ACAD SCI USA, V103, P2178, DOI 10.1073/pnas.0510877103; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Shyamala G, 2006, CANCER RES, V66, P10391, DOI 10.1158/0008-5472.CAN-06-0321; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Stampfer MR, 2003, CANCER LETT, V194, P199, DOI 10.1016/S0304-3835(02)00707-3; Stingl J, 2009, J PATHOL, V217, P229, DOI 10.1002/path.2457; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Wei WY, 1999, EXP CELL RES, V253, P519, DOI 10.1006/excr.1999.4665; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Yeh IT, 2008, ARCH PATHOL LAB MED, V132, P349, DOI 10.1043/1543-2165(2008)132[349:AOITBL]2.0.CO;2	34	16	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11288	10.1371/journal.pone.0011288	http://dx.doi.org/10.1371/journal.pone.0011288			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585577	Green Published, gold, Green Submitted			2022-12-27	WOS:000279135800003
J	Sayama, K; Kajiya, K; Sugawara, K; Sato, S; Hirakawa, S; Shirakata, Y; Hanakawa, Y; Dai, XJ; Ishimatsu-Tsuji, Y; Metzger, D; Chambon, P; Akira, S; Paus, R; Kishimoto, J; Hashimoto, K				Sayama, Koji; Kajiya, Kentaro; Sugawara, Koji; Sato, Shintaro; Hirakawa, Satoshi; Shirakata, Yuji; Hanakawa, Yasushi; Dai, Xiuju; Ishimatsu-Tsuji, Yumiko; Metzger, Daniel; Chambon, Pierre; Akira, Shizuo; Paus, Ralf; Kishimoto, Jiro; Hashimoto, Koji			Inflammatory Mediator TAK1 Regulates Hair Follicle Morphogenesis and Anagen Induction Shown by Using Keratinocyte-Specific TAK1-Deficient Mice	PLOS ONE			English	Article							B SIGNALING PATHWAYS; KAPPA-B; ECTODERMAL DYSPLASIA; INCONTINENTIA PIGMENTI; COMPREHENSIVE GUIDE; ECTODYSPLASIN-A; EDA GENE; PROTEIN; SKIN; EPIDERMIS	Transforming growth factor-beta-activated kinase 1 (TAK1) is a member of the NF-kappa B pathway and regulates inflammatory responses. We previously showed that TAK1 also regulates keratinocyte growth, differentiation, and apoptosis. However, it is unknown whether TAK1 has any role in epithelial-mesenchymal interactions. To examine this possibility, we studied the role of TAK1 in mouse hair follicle development and cycling as an instructive model system. By comparing keratinocyte-specific TAK1-deficient mice (Map3k7(fl/fl)K5-Cre) with control mice, we found that the number of hair germs (hair follicles precursors) in Map3k7(fl/fl)K5-Cre mice was significantly reduced at E15.5, and that subsequent hair follicle morphogenesis was retarded. Next, we analyzed the role of TAK1 in the cyclic remodeling in follicles by analyzing hair cycle progression in mice with a tamoxifen-inducible keratinocyte-specific TAK1 deficiency (Map3k7(fl/fl)K14-Cre-ER(T2)). After active hair growth (anagen) was induced by depilation, TAK1 was deleted by topical tamoxifen application. This resulted in significantly retarded anagen development in TAK1-deficient mice. Deletion of TAK1 in hair follicles that were already in anagen induced premature, apoptosis-driven hair follicle regression, along with hair follicle damage. These studies provide the first evidence that the inflammatory mediator TAK1 regulates hair follicle induction and morphogenesis, and is required for anagen induction and anagen maintenance.	[Sayama, Koji; Hirakawa, Satoshi; Shirakata, Yuji; Hanakawa, Yasushi; Dai, Xiuju; Hashimoto, Koji] Ehime Univ, Dept Dermatol, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Kajiya, Kentaro; Ishimatsu-Tsuji, Yumiko; Kishimoto, Jiro] Shiseido Innovat Sci Res & Dev Ctr, Skin Biol Res Grp, Yokohama, Kanagawa, Japan; [Sugawara, Koji; Paus, Ralf] Univ Lubeck, Dept Dermatol, Lubeck, Germany; [Sato, Shintaro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Tokyo, Japan; [Metzger, Daniel; Chambon, Pierre] Coll France, IGBMC, CNRS, INSERM,UdS, Illkirch Graffenstaden, France; [Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 565, Japan; [Paus, Ralf] Univ Manchester, Sch Translat Med, Manchester, Lancs, England	Ehime University; Shiseido Company, Limited; University of Lubeck; University of Tokyo; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Osaka University; University of Manchester	Sayama, K (corresponding author), Ehime Univ, Dept Dermatol, Grad Sch Med, Matsuyama, Ehime 790, Japan.	sayama@m.ehime-u.ac.jp	Akira, Shizuo/C-3134-2009; KISHIMOTO, JIRO/AAD-7857-2019; Tsuji, Yumiko/AAV-9817-2020; Paus, Ralf/F-6243-2011; Paus, Ralf/B-5279-2015	Sugawara, Koji/0000-0003-1662-3272; Paus, Ralf/0000-0002-3492-9358; Sato, Shintaro/0000-0001-5156-3354; Kajiya, Kentaro/0000-0002-5224-7051; Metzger, Daniel/0000-0002-5555-046X	Ministries of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; Deutsche Forschungsgemeinschaft [DFG 345 Pa/12-2]; College de France	Ministries of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); College de France	This study was supported in part by grants from the Ministries of Education, Culture, Sports, Science, and Technology of Japan to K.S. and K.H., by Health and Labor Sciences Research Grants (Research on Intractable Diseases) from the Ministry of Health, Labor, and Welfare of Japan to K.H., by the Deutsche Forschungsgemeinschaft (DFG 345 Pa/12-2) to R.P., and by the College de France to P.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Courtney JM, 2005, ARCH ORAL BIOL, V50, P159, DOI 10.1016/j.archoralbio.2004.11.019; Ferguson BM, 1997, HUM MOL GENET, V6, P1589, DOI 10.1093/hmg/6.9.1589; Fessing MY, 2006, AM J PATHOL, V169, P2075, DOI 10.2353/ajpath.2006.060227; Headon DJ, 2001, NATURE, V414, P913, DOI 10.1038/414913a; Hendrix S, 2005, J INVEST DERMATOL, V125, P42, DOI 10.1111/j.0022-202X.2005.23787.x; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kojima T, 2000, J BIOL CHEM, V275, P20742, DOI 10.1074/jbc.M002691200; Kumar A, 2001, J BIOL CHEM, V276, P2668, DOI 10.1074/jbc.M008356200; Li M, 2000, NATURE, V407, P633, DOI 10.1038/35036595; Lindner G, 2000, FASEB J, V14, P319, DOI 10.1096/fasebj.14.2.319; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Mecklenburg L, 2000, J INVEST DERMATOL, V114, P909, DOI 10.1046/j.1523-1747.2000.00954.x; Mikkola ML, 2003, CYTOKINE GROWTH F R, V14, P211, DOI 10.1016/S1359-6101(03)00020-0; Morlon A, 2005, HUM MOL GENET, V14, P3751, DOI 10.1093/hmg/ddi405; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Ohnemus U, 2006, ENDOCR REV, V27, P677, DOI 10.1210/er.2006-0020; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Paus R, 2004, DIFFERENTIATION, V72, P489, DOI 10.1111/j.1432-0436.2004.07209004.x; PAUS R, 1990, BRIT J DERMATOL, V122, P777, DOI 10.1111/j.1365-2133.1990.tb06266.x; Pispa J, 2008, HUM MOL GENET, V17, P3380, DOI 10.1093/hmg/ddn232; Sakurai H, 2002, BIOCHEM BIOPH RES CO, V297, P1277, DOI 10.1016/S0006-291X(02)02379-3; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Sayama K, 2006, J BIOL CHEM, V281, P22013, DOI 10.1074/jbc.M601065200; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Schmidt-Ullrich R, 2001, DEVELOPMENT, V128, P3843; Schmidt-Ullrich R, 2006, DEVELOPMENT, V133, P1045, DOI 10.1242/dev.02278; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Srivastava AK, 1997, P NATL ACAD SCI USA, V94, P13069, DOI 10.1073/pnas.94.24.13069; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Stratis A, 2006, J INVEST DERMATOL, V126, P614, DOI 10.1038/sj.jid.5700092; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Tong XM, 2006, GENE DEV, V20, P1353, DOI 10.1101/gad.1387406; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523; Zhang N, 2009, J GLOB INF MANAG, V17, P49, DOI 10.4018/jgim.2009010103	45	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11275	10.1371/journal.pone.0011275	http://dx.doi.org/10.1371/journal.pone.0011275			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585657	Green Published, Green Submitted, gold			2022-12-27	WOS:000279135400020
J	Van Sluis, GL; Nieuwdorp, M; Kamphuisen, PW; van der Vlag, J; Van Noorden, CJF; Spek, CA				Van Sluis, Geerte L.; Nieuwdorp, Max; Kamphuisen, Pieter W.; van der Vlag, Johan; Van Noorden, Cornelis J. F.; Spek, C. Arnold			A Low Molecular Weight Heparin Inhibits Experimental Metastasis in Mice Independently of the Endothelial Glycocalyx	PLOS ONE			English	Article							BOVINE TESTICULAR HYALURONIDASE; SULFATE PROTEOGLYCAN; CANCER; HEPARANASE; EXPRESSION; SYNDECAN-1; ANGIOGENESIS; CD44; MODE	Background: Some low molecular weight heparins (LMWHs) prolong survival of cancer patients and inhibit experimental metastasis. The underlying mechanisms are still not clear but it has been suggested that LMWHs (at least in part) limit metastasis by preventing cancer cell-induced destruction of the endothelial glycocalyx. Methodology/Principal Findings: To prove or refute this hypothesis, we determined the net effects of the endothelial glycocalyx in cancer cell extravasation and we assessed the anti-metastatic effect of a clinically used LMWH in the presence and absence of an intact endothelial glycocalyx. We show that both exogenous enzymatic degradation as well as endogenous genetic modification of the endothelial glycocalyx decreased pulmonary tumor formation in a murine experimental metastasis model. Moreover, LMWH administration significantly reduced the number of pulmonary tumor foci and thus experimental metastasis both in the presence or absence of an intact endothelial glycocalyx. Conclusions: In summary, this paper shows that the net effect of the endothelial glycocalyx enhances experimental metastasis and that a LMWH does not limit experimental metastasis by a process involving the endothelial glycocalyx.	[Van Sluis, Geerte L.; Nieuwdorp, Max; Kamphuisen, Pieter W.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Van Sluis, Geerte L.; Spek, C. Arnold] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Van Sluis, Geerte L.; Van Noorden, Cornelis J. F.] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [Van Sluis, Geerte L.] Univ Amsterdam, Acad Med Ctr, Dept Clin Oncol, NL-1105 AZ Amsterdam, Netherlands; [van der Vlag, Johan] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Nijmegen Ctr Mol Life Sci,Nephrol Res Lab, NL-6525 ED Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen	Van Sluis, GL (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.a.spek@amc.uva.nl	Van der Vlag, Johan/E-4636-2010; Spek, Arnold/AAC-5866-2019	Van der Vlag, Johan/0000-0001-7843-5918; Spek, Arnold/0000-0002-2149-4068; Kamphuisen, Pieter/0000-0002-6263-0177				Akl EA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006652; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bruggemann LW, 2008, THROMB HAEMOSTASIS, V99, P787, DOI 10.1160/TH07-11-0702; Bruggemann LW, 2008, J CELL MOL MED, V12, P2622, DOI 10.1111/j.1582-4934.2008.00316.x; EARNSHAW JS, 1985, BIOCHEM PHARMACOL, V34, P2199, DOI 10.1016/0006-2952(85)90418-6; Elkin M, 2001, FASEB J, V15, P1661, DOI 10.1096/fj.00-0895fje; Esmon CT, 2003, J THROMB HAEMOST, V1, P1343, DOI 10.1046/j.1538-7836.2003.00261.x; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Hostettler N, 2007, FASEB J, V21, P3562, DOI 10.1096/fj.07-8450com; IRIMURA T, 1986, BIOCHEMISTRY-US, V25, P5322, DOI 10.1021/bi00366a050; Kainulainen V, 1996, J BIOL CHEM, V271, P18759, DOI 10.1074/jbc.271.31.18759; Liu DC, 1996, P NATL ACAD SCI USA, V93, P7832, DOI 10.1073/pnas.93.15.7832; Maksimenko AV, 2003, BIOCHEMISTRY-MOSCOW+, V68, P862, DOI 10.1023/A:1025794830705; Maksimenko AV, 2001, EUR J PHARM BIOPHARM, V51, P33, DOI 10.1016/S0939-6411(00)00136-3; Masouleh BK, 2009, J IMMUNOL, V182, P4985, DOI 10.4049/jimmunol.0800574; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Mousa SA, 2006, THROMB HAEMOSTASIS, V96, P816, DOI 10.1160/TH06-05-0289; Muckenschnabel I, 1998, CANCER LETT, V131, P71, DOI 10.1016/S0304-3835(98)00203-1; Mulivor AW, 2002, AM J PHYSIOL-HEART C, V283, pH1282, DOI 10.1152/ajpheart.00117.2002; Mythreye K, 2009, CELL SIGNAL, V21, P1548, DOI 10.1016/j.cellsig.2009.05.001; Naor D, 2008, SEMIN CANCER BIOL, V18, P260, DOI 10.1016/j.semcancer.2008.03.015; Niers TMH, 2007, CRIT REV ONCOL HEMAT, V61, P195, DOI 10.1016/j.critrevonc.2006.07.007; Niers TMH, 2009, J THROMB HAEMOST, V7, P1595, DOI 10.1111/j.1538-7836.2009.03529.x; Nieuwdorp M, 2005, CURR OPIN LIPIDOL, V16, P507, DOI 10.1097/01.mol.0000181325.08926.9c; Rops AL, 2007, KIDNEY INT, V72, P1204, DOI 10.1038/sj.ki.5002514; SLUIS GLV, 2009, BLOOD, V114, P1968; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; van den Berg BM, 2003, CIRC RES, V92, P592, DOI 10.1161/01.RES.0000065917.53950.75; Vink H, 2000, CIRCULATION, V101, P1500, DOI 10.1161/01.CIR.101.13.1500; VLODAVSKY I, 1994, INVAS METAST, V14, P290; Vlodavsky I, 2007, THROMB RES, V120, pS112, DOI 10.1016/S0049-3848(07)70139-1; Yang Y, 2007, BLOOD, V110, P2041, DOI 10.1182/blood-2007-04-082495; Zeng CX, 1998, INT J CANCER, V77, P396; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811	37	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11200	10.1371/journal.pone.0011200	http://dx.doi.org/10.1371/journal.pone.0011200			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574516	gold, Green Published, Green Submitted			2022-12-27	WOS:000279058300006
J	del Rio, B; Seegers, JFML; Gomes-Solecki, M				del Rio, Beatriz; Seegers, Jos F. M. L.; Gomes-Solecki, Maria			Immune Response to Lactobacillus plantarum Expressing Borrelia burgdorferi OspA Is Modulated by the Lipid Modification of the Antigen	PLOS ONE			English	Article							CD8(+) T-CELLS; LACTOCOCCUS-LACTIS; ORAL IMMUNIZATION; MUCOSAL IMMUNIZATION; PROTECTIVE IMMUNITY; ESCHERICHIA-COLI; NEUTRALIZING ANTIBODIES; HELICOBACTER-PYLORI; TREPONEMA-PALLIDUM; ANATOMICAL BASIS	Background: Over the past decade there has been increasing interest in the use of lactic acid bacteria as mucosal delivery vehicles for vaccine antigens, microbicides and therapeutics. We investigated the mechanism by which a mucosal vaccine based in recombinant lactic acid bacteria breaks the immunological tolerance of the gut in order to elicit a protective immune response. Methodology/Principal Findings: We analyzed how the lipid modification of OspA affects the localization of the antigen in our delivery vehicle using a number of biochemistry techniques. Furthermore, we examined how OspA-expressing L. plantarum breaks the oral tolerance of the gut by stimulating human intestinal epithelial cells, peripheral blood mononuclear cells and monocyte derived dendritic cells and measuring cytokine production. We show that the leader peptide of OspA targets the protein to the cell envelope of L. plantarum, and it is responsible for protein export across the membrane. Mutation of the lipidation site in OspA redirects protein localization within the cell envelope. Further, we show that lipidated-OspA-expressing L. plantarum does not induce secretion of the pro-inflammatory cytokine IL-8 by intestinal epithelial cells. In addition, it breaks oral tolerance of the gut via Th1/Th2 cell mediated immunity, as shown by the production of pro-and anti-inflammatory cytokines by human dendritic cells, and by the production of IgG2a and IgG1 antibodies, respectively. Conclusions/Significance: Lipid modification of OspA expressed in L. plantarum modulates the immune response to this antigen through a Th1/Th2 immune response.	[del Rio, Beatriz; Gomes-Solecki, Maria] Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA; [Seegers, Jos F. M. L.] Lactrys Biopharmaceut BV, Leiden, Netherlands; [Gomes-Solecki, Maria] Biopeptides Corp, Valhalla, NY USA; [Gomes-Solecki, Maria] Biopeptides Corp, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center	del Rio, B (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA.	mgomesso@uthsc.edu	del Rio, beatriz/L-3082-2014	del Rio, beatriz/0000-0001-8107-1975	NIH-NIAID [R44 AI074092, R43 AI072810]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI074092, R43AI072810] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from NIH-NIAID, R44 AI074092 and R43 AI072810 to MGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R, 1996, VACCINE, V14, P1384, DOI 10.1016/S0264-410X(96)00036-9; Ascon MA, 1998, INFECT IMMUN, V66, P5470; Bermudez-Humaran LG, 2005, J IMMUNOL, V175, P7297, DOI 10.4049/jimmunol.175.11.7297; Bermudez-Humaran LG, 2003, FEMS MICROBIOL LETT, V224, P307, DOI 10.1016/S0378-1097(03)00475-0; Cho HJ, 2007, VACCINE, V25, P8049, DOI 10.1016/j.vaccine.2007.09.024; Daniel C, 2009, VACCINE, V27, P1141, DOI 10.1016/j.vaccine.2008.12.022; De BK, 2000, VACCINE, V18, P1811, DOI 10.1016/S0264-410X(99)00481-8; del Rio B, 2008, CLIN VACCINE IMMUNOL, V15, P1429, DOI 10.1128/CVI.00169-08; Dieye Y, 2003, APPL ENVIRON MICROB, V69, P7281, DOI 10.1128/AEM.69.12.7281-7288.2003; ERDILE LF, 1993, INFECT IMMUN, V61, P81, DOI 10.1128/IAI.61.1.81-90.1993; Gahery-Segard H, 2000, J VIROL, V74, P1694, DOI 10.1128/JVI.74.4.1694-1703.2000; Gomes-Solecki MJC, 2006, VACCINE, V24, P4440, DOI 10.1016/j.vaccine.2005.08.089; Gu Q, 2009, FEMS IMMUNOL MED MIC, V56, P197, DOI 10.1111/j.1574-695X.2009.00566.x; Hamilton-Miller JMT, 2003, INT J ANTIMICROB AG, V22, P360, DOI 10.1016/S0924-8579(03)00153-5; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Kajikawa A, 2007, VACCINE, V25, P3599, DOI 10.1016/j.vaccine.2007.01.055; Khoo UY, 1997, J IMMUNOL, V158, P3626; Kohler JJ, 2000, INFECT IMMUN, V68, P4370, DOI 10.1128/IAI.68.7.4370-4373.2000; Lee JS, 2006, J VIROL, V80, P4079, DOI 10.1128/JVI.80.8.4079-4087.2006; Li YG, 2007, VACCINE, V25, P902, DOI 10.1016/j.vaccine.2006.09.034; LINKAMSTER H, 1994, FEMS IMMUNOL MED MIC, V10, P55, DOI 10.1111/j.1574-695X.1994.tb00011.x; Maassen CBM, 1999, VACCINE, V17, P2117, DOI 10.1016/S0264-410X(99)00010-9; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Medina M, 2008, INFECT IMMUN, V76, P2696, DOI 10.1128/IAI.00119-08; Mestecky J, 2007, J IMMUNOL, V179, P5633, DOI 10.4049/jimmunol.179.9.5633; Mohamadzadeh M, 2009, P NATL ACAD SCI USA, V106, P4331, DOI 10.1073/pnas.0900029106; Moorthy G, 2007, VACCINE, V25, P3636, DOI 10.1016/j.vaccine.2007.01.070; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Mowat AM, 1997, IMMUNOL REV, V156, P145, DOI 10.1111/j.1600-065X.1997.tb00966.x; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; PERDIGON G, 1991, J DAIRY RES, V58, P485, DOI 10.1017/S0022029900030090; Peters C, 2003, J IMMUNOL, V170, P5176, DOI 10.4049/jimmunol.170.10.5176; Pouwels PH, 1996, J BIOTECHNOL, V44, P183, DOI 10.1016/0168-1656(95)00140-9; RADOLF JD, 1988, INFECT IMMUN, V56, P490, DOI 10.1128/IAI.56.2.490-498.1988; Rescigno M, 2001, IMMUNOBIOLOGY, V204, P572, DOI 10.1078/0171-2985-00094; Roy CR, 2007, NAT IMMUNOL, V8, P1179, DOI 10.1038/ni1528; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Scavone P, 2007, MICROBES INFECT, V9, P821, DOI 10.1016/j.micinf.2007.02.023; Sellati TJ, 1998, J IMMUNOL, V160, P5455; Shata MT, 2001, VACCINE, V20, P623, DOI 10.1016/S0264-410X(01)00330-9; Sim ACN, 2008, VACCINE, V26, P1145, DOI 10.1016/j.vaccine.2007.12.047; Skjolaas KA, 2007, VET IMMUNOL IMMUNOP, V115, P299, DOI 10.1016/j.vetimm.2006.10.012; Spear GT, 2008, J REPROD IMMUNOL, V78, P76, DOI 10.1016/j.jri.2007.11.001; Venema R, 2003, J BIOL CHEM, V278, P14739, DOI 10.1074/jbc.M209857200; WEIS JJ, 1994, INFECT IMMUN, V62, P4632, DOI 10.1128/IAI.62.10.4632-4636.1994; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Wu CM, 2007, FEMS IMMUNOL MED MIC, V50, P354, DOI 10.1111/j.1574-695X.2007.00255.x; Yigang XU, 2008, IMMUNOLOGY, V124, P68, DOI 10.1111/j.1365-2567.2007.02738.x	49	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11199	10.1371/journal.pone.0011199	http://dx.doi.org/10.1371/journal.pone.0011199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585451	gold, Green Submitted, Green Published			2022-12-27	WOS:000278977200006
J	Khademi, H; Etemadi, A; Kamangar, F; Nouraie, M; Shakeri, R; Abaie, B; Pourshams, A; Bagheri, M; Hooshyar, A; Islami, F; Abnet, CC; Pharoah, P; Brennan, P; Boffetta, P; Dawsey, SM; Malekzadeh, R				Khademi, Hooman; Etemadi, Arash; Kamangar, Farin; Nouraie, Mehdi; Shakeri, Ramin; Abaie, Behrooz; Pourshams, Akram; Bagheri, Mohammad; Hooshyar, Afshin; Islami, Farhad; Abnet, Christian C.; Pharoah, Paul; Brennan, Paul; Boffetta, Paolo; Dawsey, Sanford M.; Malekzadeh, Reza			Verbal Autopsy: Reliability and Validity Estimates for Causes of Death in the Golestan Cohort Study in Iran	PLOS ONE			English	Article							ADULT DEATHS; CHILDHOOD MORTALITY; NEONATAL DEATHS; ESOPHAGEAL CANCER; RISK-FACTORS; VALIDATION; CHILDREN; STATISTICS; ALGORITHMS; DISEASE	Verbal autopsy (VA) is one method to obtain valid estimates of causes of death in the absence of valid medical records. We tested the reliability and validity of a VA questionnaire developed for a cohort study in Golestan Province in northeastern Iran. Method: A modified version of the WHO adult verbal autopsy was used to assess the cause of death in the first 219 Golestan Cohort Study (GCS) subjects who died. The GCS cause of death was determined by two internists who independently reviewed all available medical records. Two other internists ("reviewers") independently reviewed only the VA answers and classified the cause of death into one of nine general categories; they repeated this evaluation one month later. The reliability of the VA was measured by calculating intra-reviewer and inter-reviewer kappa statistics. The validity of the VA was measured using the GCS cause of death as the gold standard. Results: VA showed both good validity (sensitivity, specificity, PPV, and NPV all above 0.81) and reliability (kappa > 0.75) in determining the general cause of death independent of sex and place of residence. The overall multi-rater agreement across four reviews was 0.84 (95% CI: 0.78-0.89). The results for identifying specific cancer deaths were also promising, especially for upper GI cancers (kappa = 0.95). The multi-rater agreement in cancer subgroup was 0.93 (95% CI: 0.85-0.99). Conclusions: VA seems to have good reliability and validity for determining the cause of death in a large-scale adult follow up study in a predominantly rural area of a middle-income country.	[Khademi, Hooman; Etemadi, Arash; Kamangar, Farin; Nouraie, Mehdi; Shakeri, Ramin; Abaie, Behrooz; Pourshams, Akram; Bagheri, Mohammad; Hooshyar, Afshin; Islami, Farhad; Malekzadeh, Reza] Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Ctr, Tehran, Iran; [Etemadi, Arash] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Kamangar, Farin; Abnet, Christian C.; Dawsey, Sanford M.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Kamangar, Farin] Morgan State Univ, Sch Community Hlth & Policy, Dept Publ Hlth Anal, Baltimore, MD 21239 USA; [Nouraie, Mehdi] Howard Univ, Dept Internal Med, Washington, DC 20059 USA; [Nouraie, Mehdi] Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20059 USA; [Islami, Farhad; Brennan, Paul] Int Agcy Res Canc, F-69372 Lyon, France; [Pharoah, Paul] Univ Cambridge, Dept Oncol, Cambridge, England; [Pharoah, Paul] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Boffetta, Paolo] Int Prevent Res Inst, Lyon, France	Tehran University of Medical Sciences; Tehran University of Medical Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Morgan State University; Howard University; Howard University; World Health Organization; International Agency for Research on Cancer (IARC); University of Cambridge; University of Cambridge; Icahn School of Medicine at Mount Sinai	Malekzadeh, R (corresponding author), Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Ctr, Tehran, Iran.	rmalekzadeh2@gmail.com	Etemadi, Arash/C-1386-2016; Boffetta, Paolo/AAI-7767-2021; Etemadi, Arash/Y-7082-2018; Abnet, Christian C/C-4111-2015; Nouraie, Seyed Mehdi/O-4071-2018; Khademi, Hooman/AAZ-8798-2020; Pharoah, Paul/V-6658-2019; Malekzadeh, Reza/U-1382-2017; Bagheri, Mohammad/K-7615-2019	Etemadi, Arash/0000-0002-3458-1072; Boffetta, Paolo/0000-0002-3811-2791; Etemadi, Arash/0000-0002-3458-1072; Abnet, Christian C/0000-0002-3008-7843; Nouraie, Seyed Mehdi/0000-0001-7465-0581; Pharoah, Paul/0000-0001-8494-732X; Malekzadeh, Reza/0000-0002-9820-6335; Bagheri, Mohammad/0000-0001-7844-569X; Pourshams, Akram/0000-0002-7950-3983; Malekzadeh, Reza/0000-0003-1043-3814; Islami, Farhad/0000-0002-7357-5994; , Ramin/0000-0003-0487-3629	Digestive Diseases Research Center of Tehran University of Medical Sciences; Cancer Research United Kingdom; Division of Cancer Epidemiology and Genetics of the National Cancer Institute; Social Security Organization of Iran, Golestan branch	Digestive Diseases Research Center of Tehran University of Medical Sciences; Cancer Research United Kingdom(Cancer Research UK); Division of Cancer Epidemiology and Genetics of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Social Security Organization of Iran, Golestan branch	This work was supported in part by intramural funds from the collaborating institutions, including Digestive Diseases Research Center of Tehran University of Medical Sciences (www.ddrc.ac.ir), Cancer Research United Kingdom (www.cancerresearchuk.org), and the Division of Cancer Epidemiology and Genetics of the National Cancer Institute (http://dceg.cancer.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank all the study participants and Behavarz for their cooperation. We also would like to show our appreciation to all follow-up team. We received special support from the Social Security Organization of Iran, Golestan branch.	Anker M, 1997, INT J EPIDEMIOL, V26, P1090, DOI 10.1093/ije/26.5.1090; [Anonymous], 1993, INT STAT CLASSIFICAT; Arudo J, 2003, AM J TROP MED HYG, V68, P30, DOI 10.4269/ajtmh.2003.68.30; Baiden F, 2007, B WORLD HEALTH ORGAN, V85, P570, DOI 10.2471/BLT.07.043745; Benara S. K., 1999, Indian Journal of Pediatrics, V66, P647, DOI 10.1007/BF02726242; Chandramohan D, 1998, STUD FAMILY PLANN, V29, P414, DOI 10.2307/172253; CHANDRAMOHAN D, 1994, INT J EPIDEMIOL, V23, P213, DOI 10.1093/ije/23.2.213; Chandramohan D, 1998, TROP MED INT HEALTH, V3, P436, DOI 10.1046/j.1365-3156.1998.00255.x; Coldham C, 2000, TROP MED INT HEALTH, V5, P134, DOI 10.1046/j.1365-3156.2000.00505.x; DATTA N, 1988, Indian Journal of Pediatrics, V55, P599, DOI 10.1007/BF02868443; DOWELL SF, 1993, AIDS, V7, P1255, DOI 10.1097/00002030-199309000-00016; Etard JF, 2004, INT J EPIDEMIOL, V33, P1286, DOI 10.1093/ije/dyh259; Fantahun M, 2006, B WORLD HEALTH ORGAN, V84, P204, DOI 10.2471/BLT.05.028712; FOTTRELL E, 2010, EPIDEMIOL REV; Franca E, 2008, INT J EPIDEMIOL, V37, P891, DOI 10.1093/ije/dyn121; Gajalakshmi V, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-47; Gajalakshmi V, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-7; GENTON B, 1995, ANN TROP MED PARASIT, V89, P359, DOI 10.1080/00034983.1995.11812965; *INDEPTH DSS, INT NETW FIELD SIT C; INDEPTH Network, INDEPTH STAND VERB A; Kahn K, 2000, TROP MED INT HEALTH, V5, P824, DOI 10.1046/j.1365-3156.2000.00638.x; KALTER HD, 1990, INT J EPIDEMIOL, V19, P380, DOI 10.1093/ije/19.2.380; Kamali A, 1996, INT J EPIDEMIOL, V25, P679, DOI 10.1093/ije/25.3.679; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Marsh DR, 2003, PAEDIATR PERINAT EP, V17, P132, DOI 10.1046/j.1365-3016.2003.00475.x; Meddings DR, 2004, B WORLD HEALTH ORGAN, V82, P281; Mobley CC, 1996, J TROP PEDIATRICS, V42, P365, DOI 10.1093/tropej/42.6.365; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Pourshams A, 2005, BRIT J CANCER, V92, P176, DOI 10.1038/sj.bjc.6602249; Pourshams A, 2010, INT J EPIDEMIOL, V39, P52, DOI 10.1093/ije/dyp161; Quigley MA, 1999, INT J EPIDEMIOL, V28, P1081, DOI 10.1093/ije/28.6.1081; Quigley MA, 1996, B WORLD HEALTH ORGAN, V74, P147; Rodriguez L, 1998, Indian J Pediatr, V65, P579, DOI 10.1007/BF02730899; Setel PW, 2006, PLOS MED, V3, P1282, DOI 10.1371/journal.pmed.0030268; Setel PW, 2005, B WORLD HEALTH ORGAN, V83, P611; SNOW RW, 1992, LANCET, V340, P351, DOI 10.1016/0140-6736(92)91414-4; Soleman N, 2006, B WORLD HEALTH ORGAN, V84, P239, DOI 10.2471/BLT.05.027003; VANEIJK AM, 2008, TROP MED INT HLTH; Winbo IGB, 1997, INT J EPIDEMIOL, V26, P1298, DOI 10.1093/ije/26.6.1298; Yang GH, 2006, INT J EPIDEMIOL, V35, P741, DOI 10.1093/ije/dyi181	41	61	61	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11183	10.1371/journal.pone.0011183	http://dx.doi.org/10.1371/journal.pone.0011183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567597	Green Submitted, Green Published, gold			2022-12-27	WOS:000278886300025
J	Valera, E; Isaacs, MJ; Kawakami, Y; Belmonte, JCI; Choe, S				Valera, Elvira; Isaacs, Michael J.; Kawakami, Yasuhiko; Izpisua Belmonte, Juan Carlos; Choe, Senyon			BMP-2/6 Heterodimer Is More Effective than BMP-2 or BMP-6 Homodimers as Inductor of Differentiation of Human Embryonic Stem Cells	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; ACTIVITY IN-VITRO; DEFINITIVE ENDODERM; SIGNALING PATHWAYS; OSTEOGENIC DIFFERENTIATION; MESODERM INDUCTION; SELF-RENEWAL; RECEPTOR; BETA; FGF	Background: Bone Morphogenetic Protein (BMP) signaling pathways are involved in differentiation of stem cells into diverse cell types, and thus BMPs can be used as main guidance molecules for in vitro differentiation of human stem cells. Methodology/Principal Findings: We have analyzed the ability for inducing differentiation of the heterodimer BMP-2/BMP-6 (BMP-2/6) compared to the homodimers BMP-2 or BMP-6, using human embryonic stem (hES) cells H9 as model system. When incubated in a medium with high concentration of basic fibroblastic growth factor (FGF2), 100 ng/ml of human recombinant BMPs induced morphological changes and differentiation of hES cells in 24 to 48 hours. After 5 days, expression of differentiation markers was induced and quantified by quantitative PCR (qPCR) and flow cytometry. BMP-2/6 exhibited stronger activity for the induction of the expression of trophectodermal (CDX2) and endodermal (SOX17, GATA4, AFP) markers than BMP-2 or BMP-6 homodimers. BMP-2/6 also induced the expression of BMPR2 gene more effectively than BMP-2 or BMP-6 when used at the same concentration and time. Moreover, the percentage of cells expressing the surface endodermal marker CXCR4 was also increased for the heterodimer when compared to both homodimers. BMP-2/6 was a more potent activator of Smad-dependent (SMAD1/5) and Smad-independent signaling (mitogen-activated protein kinases ERK and p38) than BMP-2 and BMP-6, and the activation of these pathways might play a role in its increased potency for inducing hES cell differentiation. Conclusions/Significance: Therefore, we conclude that BMP-2/6 is more potent than BMP-2 or BMP-6 for inducing differentiation of hES cells, and it can be used as a more powerful substitute of these BMPs in in vitro differentiation guidance.	[Valera, Elvira; Choe, Senyon] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA USA; [Valera, Elvira; Isaacs, Michael J.; Choe, Senyon] Joint Ctr Biosci, Inchon, South Korea; [Kawakami, Yasuhiko; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA USA	Salk Institute; Salk Institute	Choe, S (corresponding author), Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA USA.	choe@salk.edu		Kawakami, Yasuhiko/0000-0002-0043-9705	National Institutes of Health [HD013527, HD042167]; CIRM; Korea Stem Cell Research Center; WCU; G. Harold and Leila Y. Mathers Charitable Foundation; Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III (Spain); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD013527, R01HD042167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); Korea Stem Cell Research Center; WCU; G. Harold and Leila Y. Mathers Charitable Foundation; Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was partly supported by grants from the National Institutes of Health HD013527 (SC) and HD042167 (JCIB), CIRM (SC), Korea Stem Cell Research Center and WCU (SC), and the G. Harold and Leila Y. Mathers Charitable Foundation (JCIB). EV was the recipient of a fellowship from the Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III (Spain) in collaboration with the Salk Institute for Biological Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Aoki H, 2001, J CELL SCI, V114, P1483; Blake, 2007, SCI STKE, DOI DOI 10.1126/STKE.3992007CM1; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Czyz J, 2003, BIOL CHEM, V384, P1391, DOI 10.1515/BC.2003.155; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Groppe J, 1998, J BIOL CHEM, V273, P29052, DOI 10.1074/jbc.273.44.29052; Groppe J, 2003, J BONE JOINT SURG AM, V85A, P52, DOI 10.2106/00004623-200300003-00010; Hassel S, 2003, J BONE JOINT SURG AM, V85A, P44, DOI 10.2106/00004623-200300003-00009; Herpin A, 2007, FEBS J, V274, P2977, DOI 10.1111/j.1742-4658.2007.05840.x; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Isaacs MJ, 2010, MOL ENDOCRINOL, V24, P1469, DOI 10.1210/me.2009-0496; Israel DI, 1996, GROWTH FACTORS, V13, P291, DOI 10.3109/08977199609003229; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; King CC, 2008, REGEN MED, V3, P175, DOI 10.2217/17460751.3.2.175; Kobayashi M, 2008, CLONING STEM CELLS, V10, P495, DOI 10.1089/clo.2008.0030; Kugimiya F, 2005, J BIOL CHEM, V280, P35704, DOI 10.1074/jbc.M505166200; LaVaute TM, 2009, STEM CELLS, V27, P1741, DOI 10.1002/stem.99; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Mehta A, 2008, CELL BIOL INT, V32, P1412, DOI 10.1016/j.cellbi.2008.08.012; MIYAZONO K, 1994, ADV IMMUNOL, V55, P181; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Murphy CL, 2002, TISSUE ENG, V8, P551, DOI 10.1089/107632702760240472; Nakayama K, 2003, J BONE MINER RES, V18, P827, DOI 10.1359/jbmr.2003.18.5.827; Nishimatsu S, 1998, MECH DEVELOP, V74, P75, DOI 10.1016/S0925-4773(98)00070-7; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Nohe A, 2003, J CELL SCI, V116, P3277, DOI 10.1242/jcs.00519; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Rozen S, 2000, Methods Mol Biol, V132, P365; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Suzuki A, 1997, BIOCHEM BIOPH RES CO, V232, P153, DOI 10.1006/bbrc.1997.6219; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Wagner TU, 2007, FEBS J, V274, P2968, DOI 10.1111/j.1742-4658.2007.05839.x; Wang L, 2010, ANN BIOMED ENG, V38, P77, DOI 10.1007/s10439-009-9841-8; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zachos TA, 2006, J ORTHOP RES, V24, P1279, DOI 10.1002/jor.20068; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhao DX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006468; Zhou J, 2008, STEM CELLS DEV, V17, P737, DOI 10.1089/scd.2007.0186; Zhu W, 2006, BONE, V39, P61, DOI 10.1016/j.bone.2005.12.018	58	75	76	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11167	10.1371/journal.pone.0011167	http://dx.doi.org/10.1371/journal.pone.0011167			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567515	Green Published, gold, Green Submitted			2022-12-27	WOS:000278886300013
J	Sambo, MR; Trovoada, MJ; Benchimol, C; Quinhentos, V; Goncalves, L; Velosa, R; Marques, MI; Sepulveda, N; Clark, TG; Mustafa, S; Wagner, O; Coutinho, A; Penha-Goncalves, C				Sambo, Maria Rosario; Trovoada, Maria Jesus; Benchimol, Carla; Quinhentos, Vatusia; Goncalves, Ligia; Velosa, Rute; Marques, Maria Isabel; Sepulveda, Nuno; Clark, Taane G.; Mustafa, Stefan; Wagner, Oswald; Coutinho, Antonio; Penha-Goncalves, Carlos			Transforming Growth Factor Beta 2 and Heme Oxygenase 1 Genes Are Risk Factors for the Cerebral Malaria Syndrome in Angolan Children	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; ENDOTHELIAL-CELL ACTIVATION; N-TERMINAL DOMAIN; CLINICAL-FEATURES; GHANAIAN CHILDREN; TGF-BETA; ASSOCIATION; PROTECTION; INFECTION; PROMOTER	Background: Cerebral malaria (CM) represents a severe outcome of the Plasmodium falciparum infection. Recent genetic studies have correlated human genes with severe malaria susceptibility, but there is little data on genetic variants that increase the risk of developing specific malaria clinical complications. Nevertheless, susceptibility to experimental CM in the mouse has been linked to host genes including Transforming Growth Factor Beta 2 (TGFB2) and Heme oxygenase-1 (HMOX1). Here, we tested whether those genes were governing the risk of progressing to CM in patients with severe malaria syndromes. Methodology/Principal Findings: We report that the clinical outcome of P. falciparum infection in a cohort of Angolan children (n = 430) correlated with nine TGFB2 SNPs that modify the risk of progression to CM as compared to other severe forms of malaria. This genetic effect was explained by two haplotypes harboring the CM-associated SNPs (Pcorrec. = 0.035 and 0.036). In addition, one HMOX1 haplotype composed of five CM-associated SNPs increased the risk of developing the CM syndrome (Pcorrec. = 0.002) and was under-transmitted to children with uncomplicated malaria (P = 0.036). Notably, the HMOX1-associated haplotype conferred increased HMOX1 mRNA expression in peripheral blood cells of CM patients (P = 0.012). Conclusions/Significance: These results represent the first report on CM genetic risk factors in Angolan children and suggest the novel hypothesis that genetic variants of the TGFB2 and HMOX1 genes may contribute to confer a specific risk of developing the CM syndrome in patients with severe P. falciparum malaria. This work may provide motivation for future studies aiming to replicate our findings in larger populations and to confirm a role for these genes in determining the clinical course of malaria.	[Sambo, Maria Rosario; Trovoada, Maria Jesus; Goncalves, Ligia; Velosa, Rute; Marques, Maria Isabel; Sepulveda, Nuno; Coutinho, Antonio; Penha-Goncalves, Carlos] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Sambo, Maria Rosario; Benchimol, Carla; Quinhentos, Vatusia] Hosp Pediat David Bernardino, Luanda, Angola; [Sambo, Maria Rosario] Univ Agostinho Neto, Fac Med, Luanda, Angola; [Clark, Taane G.] London Sch Hyg & Trop Med, Dept Epidemiol & Publ Hlth, London WC1, England; [Clark, Taane G.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Mustafa, Stefan; Wagner, Oswald] Med Univ Vienna, Dept Lab Med, Vienna, Austria	Instituto Gulbenkian de Ciencia; University Agostinho Neto; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Medical University of Vienna	Sambo, MR (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	cpenha@igc.gulbenkian.pt	Sepulveda, Nuno/AAA-5544-2021; Gonçalves, Lígia Antunes/F-6242-2014; Penha-Goncalves, Carlos/F-4640-2012; Clark, Taane G./AAM-2570-2020; Sepulveda, Nuno/S-9936-2019	Gonçalves, Lígia Antunes/0000-0001-9804-6899; Clark, Taane G./0000-0001-8985-9265; Vieira, Rute/0000-0002-3599-7299; Marques, Maria Isabel/0000-0003-2261-7338; Sepulveda, Nuno/0000-0002-8542-1706; Coutinho, Antonio/0000-0002-0857-9227; Penha-Goncalves, Carlos/0000-0001-7225-1907	Instituto Gulbenkian de Ciencia	Instituto Gulbenkian de Ciencia	This project was supported by the Instituto Gulbenkian de Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636; Pinto EAE, 2008, TROP DOCT, V38, P66, DOI 10.1258/td.2006.006352; Aucan C, 2003, GENES IMMUN, V4, P275, DOI 10.1038/sj.gene.6363962; Bagot S, 2002, P NATL ACAD SCI USA, V99, P9919, DOI 10.1073/pnas.152215199; Bauer PR, 2002, MICROCIRCULATION, V9, P463, DOI 10.1038/sj.mn.7800159; Bellamy R, 1998, T ROY SOC TROP MED H, V92, P312, DOI 10.1016/S0035-9203(98)91026-4; Bienzle U, 2005, TROP MED INT HEALTH, V10, P668, DOI 10.1111/j.1365-3156.2005.01444.x; Burgner D, 2003, HUM GENET, V112, P379, DOI 10.1007/s00439-002-0882-4; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Cunha-Rodrigues M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-32; de Souza JB, 2002, MICROBES INFECT, V4, P291, DOI 10.1016/S1286-4579(02)01541-1; Deininger MH, 2000, J INFECT DIS, V181, P2111, DOI 10.1086/315493; Engwerda C, 2005, CURR TOP MICROBIOL, V297, P103; FAUARMENGOL LG, SNPASSOC R PACKAGE P; FernandezReyes D, 1997, HUM MOL GENET, V6, P1357, DOI 10.1093/hmg/6.8.1357; Fry AE, 2008, GENES IMMUN, V9, P462, DOI 10.1038/gene.2008.38; FRY AE, 2009, HUM MOL GENET, V29, P29; GREENWOOD BM, 1991, T ROY SOC TROP MED H, V85, P186, DOI 10.1016/0035-9203(91)90015-Q; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Gyan BA, 2004, CLIN EXP IMMUNOL, V138, P145, DOI 10.1111/j.1365-2249.2004.02590.x; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Issifou S, 2007, AM J TROP MED HYG, V77, P1015, DOI 10.4269/ajtmh.2007.77.1015; JALLOW M, 2009, NAT GENET, V24, P24; Koch O, 2002, J INFECT DIS, V185, P1684, DOI 10.1086/340516; Kun JFJ, 1999, AM J TROP MED HYG, V61, P776, DOI 10.4269/ajtmh.1999.61.776; Kwiatkowski D, 2008, NATURE, V456, P732, DOI 10.1038/nature07632; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Liu YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004037; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Mackintosh CL, 2004, TRENDS PARASITOL, V20, P597, DOI 10.1016/j.pt.2004.09.006; Mockenhaupt FP, 2004, BLOOD, V104, P2003, DOI 10.1182/blood-2003-11-4090; Ndiaye R, 2005, TISSUE ANTIGENS, V65, P474, DOI 10.1111/j.1399-0039.2005.00388.x; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; Ohashi J, 2001, JPN J INFECT DIS, V54, P114; Omer FM, 2000, PARASITOL TODAY, V16, P18, DOI 10.1016/S0169-4758(99)01562-8; Omer FM, 1998, J EXP MED, V188, P39, DOI 10.1084/jem.188.1.39; Omi K, 2003, AM J HUM GENET, V72, P364, DOI 10.1086/346091; Omi Kazuya, 2002, Southeast Asian J Trop Med Public Health, V33 Suppl 3, P1; Pain A, 2001, LANCET, V357, P1502, DOI 10.1016/S0140-6736(00)04662-6; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rihet P, 1998, AM J HUM GENET, V63, P498, DOI 10.1086/301967; Ruwende C, 1998, J MOL MED, V76, P581, DOI 10.1007/s001090050253; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Seldon MP, 2007, J IMMUNOL, V179, P7840, DOI 10.4049/jimmunol.179.11.7840; Snounou G, 1996, Methods Mol Biol, V50, P263; Soares MP, 2004, J IMMUNOL, V172, P3553, DOI 10.4049/jimmunol.172.6.3553; STEVENSON MM, 2010, TRENDS PARASITOL, P8; Takeda M, 2005, JPN J INFECT DIS, V58, P268; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Wambua S, 2006, PLOS MED, V3, P643, DOI 10.1371/journal.pmed.0030158; Williams TN, 2005, BLOOD, V106, P368, DOI 10.1182/blood-2005-01-0313; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744; Zhao JH, 2002, BIOINFORMATICS, V18, P1694, DOI 10.1093/bioinformatics/18.12.1694	58	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11141	10.1371/journal.pone.0011141	http://dx.doi.org/10.1371/journal.pone.0011141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585394	Green Published, Green Accepted, gold			2022-12-27	WOS:000278886100011
J	Marji, J; O'Donoghue, SI; McClintock, D; Satagopam, VP; Schneider, R; Ratner, D; Worman, HJ; Gordon, LB; Djabali, K				Marji, Jackleen; O'Donoghue, Sean I.; McClintock, Dayle; Satagopam, Venkata P.; Schneider, Reinhard; Ratner, Desiree; Worman, Howard J.; Gordon, Leslie B.; Djabali, Karima			Defective Lamin A-Rb Signaling in Hutchinson-Gilford Progeria Syndrome and Reversal by Farnesyltransferase Inhibition	PLOS ONE			English	Article							RETINOBLASTOMA GENE-PRODUCT; MOUSE MODEL; SYNDROME MUTATION; NUCLEAR LAMINA; PROTEIN; CELLS; MISREGULATION; PRELAMIN; DISEASE; MITOSIS	Hutchinson-Gilford Progeria Syndrome (HGPS) is a rare premature aging disorder caused by a de novo heterozygous point mutation G608G (GGC>GGT) within exon 11 of LMNA gene encoding A-type nuclear lamins. This mutation elicits an internal deletion of 50 amino acids in the carboxyl-terminus of prelamin A. The truncated protein, progerin, retains a farnesylated cysteine at its carboxyl terminus, a modification involved in HGPS pathogenesis. Inhibition of protein farnesylation has been shown to improve abnormal nuclear morphology and phenotype in cellular and animal models of HGPS. We analyzed global gene expression changes in fibroblasts from human subjects with HGPS and found that a lamin A-Rb signaling network is a major defective regulatory axis. Treatment of fibroblasts with a protein farnesyltransferase inhibitor reversed the gene expression defects. Our study identifies Rb as a key factor in HGPS pathogenesis and suggests that its modulation could ameliorate premature aging and possibly complications of physiological aging.	[Marji, Jackleen; McClintock, Dayle; Ratner, Desiree; Djabali, Karima] Columbia Univ, Dept Dermatol, Coll Phys & Surg, New York, NY 10027 USA; [O'Donoghue, Sean I.; Satagopam, Venkata P.; Schneider, Reinhard] EMBL, Heidelberg, Germany; [Worman, Howard J.] Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY USA; [Worman, Howard J.] Columbia Univ, Dept Pathol & Cell Biol, Coll Phys & Surg, New York, NY USA; [Gordon, Leslie B.] Brown Univ, Dept Pediat, Warren Albert Med Sch, Providence, RI 02912 USA; [Djabali, Karima] Tech Univ Munich, Dept Dermatol, Munich, Germany	Columbia University; European Molecular Biology Laboratory (EMBL); Columbia University; Columbia University; Brown University; Technical University of Munich	Marji, J (corresponding author), Columbia Univ, Dept Dermatol, Coll Phys & Surg, New York, NY 10027 USA.	kd206@columbia.edu	Luzuriaga, Jennifer/C-9494-2016; Gordon, Leslie B./AAJ-5793-2021; Schneider, Reinhard/C-5441-2009; O'Donoghue, Sean/A-9522-2012	Schneider, Reinhard/0000-0002-8278-1618; Ratner, Desiree/0000-0002-1217-1929; O'Donoghue, Sean/0000-0001-9520-6623; Satagopam, Venkata/0000-0002-6532-5880	National Institutes of Health [R01AG025240, K01AR048594, R01AG025302]; Irving Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR048594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025302, R01AG025240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irving Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the National Institutes of Health (R01AG025240) to H.J.W., and by the Irving Foundation and the National Institutes of Health (Grants K01AR048594 and R01AG025302) to K.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao HN, 2003, J HUM GENET, V48, P271, DOI 10.1007/s10038-003-0025-3; Cao K, 2007, P NATL ACAD SCI USA, V104, P4949, DOI 10.1073/pnas.0611640104; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; Capell BC, 2008, P NATL ACAD SCI USA, V105, P15902, DOI 10.1073/pnas.0807840105; CHAUDHARY N, 1993, J CELL BIOL, V122, P295, DOI 10.1083/jcb.122.2.295; Csoka AB, 2004, AGING CELL, V3, P235, DOI 10.1111/j.1474-9728.2004.00105.x; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; DEBUSK FL, 1972, J PEDIATR-US, V80, P697, DOI 10.1016/S0022-3476(72)80229-4; Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fong LG, 2006, SCIENCE, V311, P1621, DOI 10.1126/science.1124875; Fong LG, 2009, HUM MOL GENET, V18, P2462, DOI 10.1093/hmg/ddp184; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Gilford H, 1904, BRIT MED J, V1904, P914; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; GORDON LB, 2007, J GERONTOL A-BIOL, V63, P777; Hutchinson J, 1886, LANCET, V1, P923; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; LIN F, 1993, J BIOL CHEM, V268, P16321; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUTZ RJ, 1992, P NATL ACAD SCI USA, V89, P3000, DOI 10.1073/pnas.89.7.3000; Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; MANCINI MA, 1994, P NATL ACAD SCI USA, V91, P418, DOI 10.1073/pnas.91.1.418; Markiewicz E, 2005, J CELL SCI, V118, P409, DOI 10.1242/jcs.01630; McClintock D, 2006, P NATL ACAD SCI USA, V103, P2154, DOI 10.1073/pnas.0511133103; McClintock D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001269; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; OZAKI T, 1994, ONCOGENE, V9, P2649; Park WY, 2001, BIOCHEM BIOPH RES CO, V282, P934, DOI 10.1006/bbrc.2001.4632; RODRIGUEZ S, 2009, EUROPEAN J HUMAN GEN, V28; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Varela I, 2008, NAT MED, V14, P767, DOI 10.1038/nm1786; Wang Y, 2008, HUM MOL GENET, V17, P2357, DOI 10.1093/hmg/ddn136; Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Yang SH, 2006, J CLIN INVEST, V116, P2115, DOI 10.1172/JCI28968	43	48	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11132	10.1371/journal.pone.0011132	http://dx.doi.org/10.1371/journal.pone.0011132			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559568	gold, Green Published, Green Submitted			2022-12-27	WOS:000278775900021
J	Zhang, L; Chopp, M; Zhang, RL; Wang, L; Zhang, J; Wang, Y; Toh, Y; Santra, M; Lu, M; Zhang, ZG				Zhang, Li; Chopp, Michael; Zhang, Rui Lan; Wang, Lei; Zhang, Jing; Wang, Ying; Toh, Yier; Santra, Manoranjan; Lu, Mei; Zhang, Zheng Gang			Erythropoietin Amplifies Stroke-Induced Oligodendrogenesis in the Rat	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; PROGENITOR CELLS; SUBVENTRICULAR ZONE; WHITE-MATTER; ADULT-RAT; NEUROLOGICAL FUNCTION; CORTICAL ISCHEMIA; BRAIN-INJURY; OLIGODENDROCYTES; IDENTIFICATION	Background: Erythropoietin (EPO), a hematopoietic cytokine, enhances neurogenesis and angiogenesis during stroke recovery. In the present study, we examined the effect of EPO on oligodendrogenesis in a rat model of embolic focal cerebral ischemia. Methodology and Principal Findings: Recombinant human EPO (rhEPO) at a dose of 5,000 U/kg (n = 18) or saline (n = 18) was intraperitoneally administered daily for 7 days starting 24 h after stroke onset. Treatment with rhEPO augmented actively proliferating oligodendrocyte progenitor cells (OPCs) measured by NG2 immunoreactive cells within the peri-infarct white matter and the subventricular zone (SVZ), but did not protect against loss of myelinating oligodendrocytes measured by cyclic nucleotide phosphodiesterase (CNPase) positive cells 7 days after stroke. However, 28 and 42 days after stroke, treatment with rhEPO significantly increased myelinating oligodendrocytes and myelinated axons within the peri-infarct white matter. Using lentivirus to label subventricular zone (SVZ) neural progenitor cells, we found that in addition to the OPCs generated in the peri-infarct white matter, SVZ neural progenitor cells contributed to rhEPO-increased OPCs in the peri-infarct area. Using bromodeoxyuridine (BrdU) for birth-dating cells, we demonstrated that myelinating oligodendrocytes observed 28 days after stroke were derived from OPCs. Furthermore, rhEPO significantly improved neurological outcome 6 weeks after stroke. In vitro, rhEPO increased differentiation of adult SVZ neural progenitor cells into oligodendrocytes and enhanced immature oligodendrocyte cell proliferation. Conclusions: Our in vivo and in vitro data indicate that EPO amplifies stroke-induced oligodendrogenesis that could facilitate axonal re-myelination and lead to functional recovery after stroke.	[Zhang, Li; Chopp, Michael; Zhang, Rui Lan; Wang, Lei; Zhang, Jing; Wang, Ying; Toh, Yier; Santra, Manoranjan; Zhang, Zheng Gang] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA; [Lu, Mei] Henry Ford Hosp, Div Biostat & Res Epidemiol, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Oakland University; Henry Ford Health System; Henry Ford Hospital	Zhang, L (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	zhazh@neuro.hfh.edu	zhang, zheng/HCH-9684-2022		National Institute of Neurological Disorders and Stroke (NINDS) [PO1 NS23393, RO1 HL64766, RO1 NS62832]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS023393, R01NS062832] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disorders and Stroke (NINDS) grants PO1 NS23393, RO1 HL64766, and RO1 NS62832. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Carroll WM, 1998, BRAIN, V121, P293, DOI 10.1093/brain/121.2.293; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Dewar D, 2003, J CEREBR BLOOD F MET, V23, P263, DOI 10.1097/01.WCB.0000053472.41007.F9; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Gonzalez-Perez O, 2009, STEM CELLS, V27, P2032, DOI 10.1002/stem.119; Gotts JE, 2005, J NEUROSCI RES, V80, P160, DOI 10.1002/jnr.20434; Gregersen R, 2001, EXP BRAIN RES, V138, P384, DOI 10.1007/s002210100715; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Horner PJ, 2000, J NEUROSCI, V20, P2218; IMAMOTO K, 1978, J COMP NEUROL, V180, P139, DOI 10.1002/cne.901800109; Iwai M, 2007, STROKE, V38, P2795, DOI 10.1161/STROKEAHA.107.483008; Iwai M, 2010, STROKE, V41, P1032, DOI 10.1161/STROKEAHA.109.570325; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Keirstead HS, 1997, J NEUROPATH EXP NEUR, V56, P1191, DOI 10.1097/00005072-199711000-00003; Komitova M, 2006, EXP NEUROL, V199, P113, DOI 10.1016/j.expneurol.2005.12.007; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lee J, 2005, J CELL BIOL, V170, P661, DOI 10.1083/jcb.200411047; LEVINE SM, 1988, J COMP NEUROL, V277, P441, DOI 10.1002/cne.902770309; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Li L, 2009, STROKE, V40, P936, DOI 10.1161/STROKEAHA.108.527713; Mandai K, 1997, NEUROSCIENCE, V77, P849, DOI 10.1016/S0306-4522(97)00517-4; MATHEWS MB, 1984, NATURE, V309, P374, DOI 10.1038/309374a0; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Mizuno K, 2008, NEONATOLOGY, V94, P255, DOI 10.1159/000151644; Ness JK, 2005, GLIA, V50, P321, DOI 10.1002/glia.20206; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Norton WT, 1996, NEUROCHEM RES, V21, P495, DOI 10.1007/BF02527715; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; PATERSON JA, 1973, J COMP NEUROL, V149, P83, DOI 10.1002/cne.901490106; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petito CK, 1998, J NEUROPATH EXP NEUR, V57, P231, DOI 10.1097/00005072-199803000-00004; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Polito A, 2005, J ANAT, V207, P707, DOI 10.1111/j.1469-7580.2005.00454.x; REYNOLDS R, 1988, DEVELOPMENT, V102, P409; Roy NS, 1999, J NEUROSCI, V19, P9986, DOI 10.1523/jneurosci.19-22-09986.1999; Santra M, 2006, CANCER RES, V66, P11726, DOI 10.1158/0008-5472.CAN-06-1978; Sargin D, 2009, GLIA, V57, P693, DOI 10.1002/glia.20797; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Sugawa M, 2002, NEUROSCI RES, V44, P391, DOI 10.1016/S0168-0102(02)00161-X; Tanaka K, 2003, BRAIN RES, V989, P172, DOI 10.1016/S0006-8993(03)03317-1; TANIGUCHI Y, 2009, J NEUROSCI RES; van der Kooij MA, 2009, NEUROSCI LETT, V451, P109, DOI 10.1016/j.neulet.2008.12.013; VERITY AN, 1993, J NEUROCHEM, V60, P577, DOI 10.1111/j.1471-4159.1993.tb03188.x; Vitellaro-Zuccarello L, 2007, NEUROSCIENCE, V144, P865, DOI 10.1016/j.neuroscience.2006.10.023; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yam PS, 1998, J NEUROTRAUM, V15, P441, DOI 10.1089/neu.1998.15.441; Zhang J, 2005, BRAIN RES, V1034, P34, DOI 10.1016/j.brainres.2004.11.036; Zhang RL, 1997, BRAIN RES, V766, P83, DOI 10.1016/S0006-8993(97)00580-5; Zhang RL, 2006, J CEREBR BLOOD F MET, V26, P857, DOI 10.1038/sj.jcbfm.9600237; Zhao JW, 2009, EUR J NEUROSCI, V29, P1853, DOI 10.1111/j.1460-9568.2009.06736.x	53	68	71	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11016	10.1371/journal.pone.0011016	http://dx.doi.org/10.1371/journal.pone.0011016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552017	Green Submitted, gold, Green Published			2022-12-27	WOS:000278662900005
J	Lee, J; Moon, S; Cha, Y; Chung, YD				Lee, Jeongmi; Moon, Sungjin; Cha, Yoonseok; Chung, Yun Doo			Drosophila TRPN(=NOMPC) Channel Localizes to the Distal End of Mechanosensory Cilia	PLOS ONE			English	Article							HEARING; TRANSDUCTION; MECHANOTRANSDUCTION; NEURONS; EYES	Background: A TRPN channel protein is essential for sensory transduction in insect mechanosensory neurons and in vertebrate hair cells. The Drosophila TRPN homolog, NOMPC, is required to generate mechanoreceptor potentials and currents in tactile bristles. NOMPC is also required, together with a TRPV channel, for transduction by chordotonal neurons of the fly's antennal ear, but the TRPN or TRPV channels have distinct roles in transduction and in regulating active antennal mechanics. The evidence suggests that NOMPC is a primary mechanotransducer channel, but its subcellular location-key for understanding its exact role in transduction-has not yet been established. Methodology/Principal Findings: Here, by immunostaining, we locate NOMPC at the tips of mechanosensory cilia in both external and chordotonal sensory neurons, as predicted for a mechanotransducer channel. In chordotonal neurons, the TRPN and TRPV channels are respectively segregated into distal and proximal ciliary zones. This zonal separation is demarcated by and requires the ciliary dilation, an intraciliary assembly of intraflagellar transport (IFT) proteins. Conclusions: Our results provide a strong evidence for NOMPC as a primary transduction channel in Drosophila mechansensory organs. The data also reveals a structural basis for the model of auditory chordotonal transduction in which the TRPN and TRPV channels play sequential roles in generating and amplifying the receptor potential, but have opposing roles in regulating active ciliary motility.	[Lee, Jeongmi; Moon, Sungjin; Cha, Yoonseok; Chung, Yun Doo] Univ Seoul, Dept Life Sci, Seoul, South Korea	University of Seoul	Lee, J (corresponding author), Univ Seoul, Dept Life Sci, Seoul, South Korea.	ydchung@uos.ac.kr			National Research Foundation of Korea [KRF-2005-C00065, 2009-0070904]; Korean Ministry of Education, Science and Technology	National Research Foundation of Korea(National Research Foundation of Korea); Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was funded by the grants to Y.D.C. from the National Research Foundation of Korea (KRF-2005-C00065 and 2009-0070904). J.L., S. M. and Y.C. are supported by BK 21 Research Fellowship from Korean Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Cook B, 2008, NATURE, V452, P361, DOI 10.1038/nature06603; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Gopfert MC, 2006, NAT NEUROSCI, V9, P999, DOI 10.1038/nn1735; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; Gopfert MC, 2003, P NATL ACAD SCI USA, V100, P5514, DOI 10.1073/pnas.0737564100; Gopfert MC, 2005, P NATL ACAD SCI USA, V102, P325, DOI 10.1073/pnas.0405741102; Han YG, 2003, CURR BIOL, V13, P1679, DOI 10.1016/j.cub.2003.08.034; Husain N, 2006, DEV CELL, V11, P483, DOI 10.1016/j.devcel.2006.08.012; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Kernan MJ, 2007, PFLUG ARCH EUR J PHY, V454, P703, DOI 10.1007/s00424-007-0263-x; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Lee E, 2008, CURR BIOL, V18, P1899, DOI 10.1016/j.cub.2008.11.020; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; RUSCH A, 1990, HEARING RES, V48, P247, DOI 10.1016/0378-5955(90)90065-W; Shin JB, 2005, P NATL ACAD SCI USA, V102, P12572, DOI 10.1073/pnas.0502403102; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Sun YS, 2009, P NATL ACAD SCI USA, V106, P13606, DOI 10.1073/pnas.0906377106; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Yack JE, 2004, MICROSC RES TECHNIQ, V63, P315, DOI 10.1002/jemt.20051; Yorozu S, 2009, NATURE, V458, P201, DOI 10.1038/nature07843; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128	23	65	70	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11012	10.1371/journal.pone.0011012	http://dx.doi.org/10.1371/journal.pone.0011012			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20543979	Green Submitted, Green Published, gold			2022-12-27	WOS:000278494900024
J	Dell'Orco, D; Lundqvist, M; Oslakovic, C; Cedervall, T; Linse, S				Dell'Orco, Daniele; Lundqvist, Martin; Oslakovic, Cecilia; Cedervall, Tommy; Linse, Sara			Modeling the Time Evolution of the Nanoparticle-Protein Corona in a Body Fluid	PLOS ONE			English	Article							COPOLYMER NANOPARTICLES; PLASMA PROTEOME; ADSORPTION; LIPOPROTEINS; SUBFRACTIONS; SIZE	Background: Nanoparticles in contact with biological fluids interact with proteins and other biomolecules, thus forming a dynamic corona whose composition varies over time due to continuous protein association and dissociation events. Eventually equilibrium is reached, at which point the continued exchange will not affect the composition of the corona. Results: We developed a simple and effective dynamic model of the nanoparticle protein corona in a body fluid, namely human plasma. The model predicts the time evolution and equilibrium composition of the corona based on affinities, stoichiometries and rate constants. An application to the interaction of human serum albumin, high density lipoprotein (HDL) and fibrinogen with 70 nm N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles is presented, including novel experimental data for HDL. Conclusions: The simple model presented here can easily be modified to mimic the interaction of the nanoparticle protein corona with a novel biological fluid or compartment once new data will be available, thus opening novel applications in nanotoxicity and nanomedicine.	[Dell'Orco, Daniele] Carl von Ossietzky Univ Oldenburg, Biochem Sect, Inst Biol & Environm Sci, D-2900 Oldenburg, Germany; [Lundqvist, Martin] Lund Univ, Ctr Chem, Ctr Mol Prot Sci, Dept Biophys Chem, Lund, Sweden; [Oslakovic, Cecilia] Lund Univ, Malmo Univ Hosp, Sect Clin Chem, Dept Lab Med, Malmo, Sweden; [Cedervall, Tommy; Linse, Sara] Lund Univ, Ctr Chem, Ctr Mol Prot Sci, Dept Biochem, Lund, Sweden	Carl von Ossietzky Universitat Oldenburg; Lund University; Lund University; Skane University Hospital; Lund University	Dell'Orco, D (corresponding author), Carl von Ossietzky Univ Oldenburg, Biochem Sect, Inst Biol & Environm Sci, D-2900 Oldenburg, Germany.	daniele.dellorco@uni-oldenburg.de	Cedervall, Tommy/AAT-9766-2021; Lundqvist, Martin/K-3908-2012	Cedervall, Tommy/0000-0003-2255-8446; Lundqvist, Martin/0000-0003-1175-9103; DELL'ORCO, Daniele/0000-0002-3724-3044; Linse, Sara/0000-0001-9629-7109	EU; European Science Foundation [2828]	EU(European Commission); European Science Foundation(European Science Foundation (ESF)European Commission)	This work was supported by EU FP6 Strep Nanointeract. DDO was supported by a short-visit grant n. 2828 by the European Science Foundation within the project 'Mapping the detailed composition of Surface-Absorbed Protein Layers on Biomaterials and Nanoparticles'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Argani H, 2005, NEPHRON CLIN PRACT, V101, pC174, DOI 10.1159/000087411; Bakogianni MC, 2001, J DIABETES COMPLICAT, V15, P265, DOI 10.1016/S1056-8727(01)00159-3; Cedervall T, 2007, ANGEW CHEM INT EDIT, V46, P5754, DOI 10.1002/anie.200700465; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Dati F, 1996, EUR J CLIN CHEM CLIN, V34, P517; Dell'Orco D, 2009, MOL BIOSYST, V5, P1232, DOI 10.1039/b908123b; EISENBERG S, 1991, PRIMARY HYPERLIPOPRO, P23; GOTTO AMJ, METHODS ENZYMOLOGY, P3; Hellstrand E, 2009, FEBS J, V276, P3372, DOI 10.1111/j.1742-4658.2009.07062.x; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Hortin GL, 2006, CLIN CHEM, V52, P1223, DOI 10.1373/clinchem.2006.069252; Lagogianni I, 2005, CLIN BIOCHEM, V38, P286, DOI 10.1016/j.clinbiochem.2004.10.006; Lindman S, 2007, NANO LETT, V7, P914, DOI 10.1021/nI062743+; LUNDQVIST M, UNPUB; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Oslakovic C, 2009, J BIOL CHEM, V284, P5896, DOI 10.1074/jbc.M807286200; Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e; Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799	20	248	248	0	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10949	10.1371/journal.pone.0010949	http://dx.doi.org/10.1371/journal.pone.0010949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532175	Green Published, Green Submitted, gold			2022-12-27	WOS:000278318700018
J	Li, JH; Miyamoto, K; Sayeed, S; McClane, BA				Li, Jihong; Miyamoto, Kazuaki; Sayeed, Sameera; McClane, Bruce A.			Organization of the cpe Locus in CPE-Positive Clostridium perfringens Type C and D Isolates	PLOS ONE			English	Article							INTRAVENOUS-INJECTION MODEL; HUMAN GASTROINTESTINAL-DISEASES; PCR GENOTYPING ASSAY; ENTEROTOXIN GENE CPE; EPSILON-TOXIN; ENCODING PLASMIDS; BETA-TOXIN; BORNE; IDENTIFICATION; RESISTANCE	Clostridium perfringens enterotoxin (encoded by the cpe gene) contributes to several important human, and possibly veterinary, enteric diseases. The current study investigated whether cpe locus organization in type C or D isolates resembles one of the three (one chromosomal and two plasmid-borne) cpe loci commonly found amongst type A isolates. Multiplex PCR assays capable of detecting sequences in those type A cpe loci failed to amplify products from cpe-positive type C and D isolates, indicating these isolates possess different cpe locus arrangements. Therefore, restriction fragments containing the cpe gene were cloned and sequenced from two type C isolates and one type D isolate. The obtained cpe locus sequences were then used to construct an overlapping PCR assay to assess cpe locus diversity amongst other cpe-positive type C and D isolates. All seven surveyed cpe-positive type C isolates had a plasmid-borne cpe locus partially resembling the cpe locus of type A isolates carrying a chromosomal cpe gene. In contrast, all eight type D isolates shared the same plasmid-borne cpe locus, which differed substantially from the cpe locus present in other C. perfringens by containing two copies of an ORF with 67% identity to a transposase gene (COG4644) found in Tn1546, but not previously associated with the cpe gene. These results identify greater diversity amongst cpe locus organization than previously appreciated, providing new insights into cpe locus evolution. Finally, evidence for cpe gene mobilization was found for both type C and D isolates, which could explain their cpe plasmid diversity.	[Li, Jihong; Sayeed, Sameera; McClane, Bruce A.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Miyamoto, Kazuaki] Wakayama Med Univ, Sch Med, Dept Microbiol, Wakayama, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wakayama Medical University	Li, JH (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	bamcc@pitt.edu			National Institute of Allergy and Infectious Diseases [R37-AI19844-27, R01-AI05617706]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI019844, R01AI056177] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was generously supported by grants R37-AI19844-27 and R01-AI05617706 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTHUR M, 1993, J BACTERIOL, V175, P117, DOI 10.1128/JB.175.1.117-127.1993; Bannam TL, 2006, J BACTERIOL, V188, P4942, DOI 10.1128/JB.00298-06; Billington SJ, 1998, INFECT IMMUN, V66, P4531; BOS J, 2005, CLIN INFECT DIS, V15, P78; Brynestad S, 1999, FEMS MICROBIOL LETT, V170, P281, DOI 10.1016/S0378-1097(98)00557-6; Brynestad S, 1997, MICROBIOL-UK, V143, P2109, DOI 10.1099/00221287-143-7-2109; Brynestad S, 2001, INFECT IMMUN, V69, P3483, DOI 10.1128/IAI.69.5.3483-3487.2001; Carmichael LM, 1997, BIODEGRADATION, V8, P1, DOI 10.1023/A:1008258720649; Collie RE, 1998, ANAEROBE, V4, P69, DOI 10.1006/anae.1998.0152; Collie RE, 1998, J CLIN MICROBIOL, V36, P30, DOI 10.1128/JCM.36.1.30-36.1998; CORNILLOT E, 1995, MOL MICROBIOL, V15, P639, DOI 10.1111/j.1365-2958.1995.tb02373.x; CZECZULIN JR, 1993, INFECT IMMUN, V61, P3429, DOI 10.1128/IAI.61.8.3429-3439.1993; Deguchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005598; Fernandez-Miyakawa ME, 2007, INFECT IMMUN, V75, P1443, DOI 10.1128/IAI.01672-06; Fisher DJ, 2006, INFECT IMMUN, V74, P5200, DOI 10.1128/IAI.00534-06; Fisher DJ, 2005, MOL MICROBIOL, V56, P747, DOI 10.1111/j.1365-2958.2005.04573.x; Grant KA, 2008, FOODBORNE PATHOG DIS, V5, P629, DOI 10.1089/fpd.2007.0066; HLKINHELMO A, 2006, EMERG INFECT DIS, V12, P1724; Jost BH, 2005, INFECT IMMUN, V73, P652, DOI 10.1128/IAI.73.1.652-656.2005; KOKAIKUN JF, 1994, J CLIN MICROBIOL, V32, P2533, DOI 10.1128/JCM.32.10.2533-2539.1994; Lawrence GW, 1997, CLOSTRIDIA MOL GENET, P198; Li JH, 2007, APPL ENVIRON MICROB, V73, P7218, DOI 10.1128/AEM.01075-07; Li JH, 2007, INFECT IMMUN, V75, P1811, DOI 10.1128/IAI.01981-06; McClane B.A., 2006, PROKARYOTES, V3rd ed., P688; McClane BA., 2009, RES ADV APPL ENV MIC, V2, P1; McClane BA, 2007, FOOD MICROBIOLOGY: FUNDAMENTALS AND FRONTIERS, THIRD EDITION, P423; Miki Y, 2008, APPL ENVIRON MICROB, V74, P5366, DOI 10.1128/AEM.00783-08; Miyamoto K, 2006, J BACTERIOL, V188, P1585, DOI 10.1128/JB.188.4.1585-1598.2006; Miyamoto K, 2004, J CLIN MICROBIOL, V42, P1552, DOI 10.1128/JCM.42.4.1552-1558.2004; Miyamoto K, 2002, INFECT IMMUN, V70, P4261, DOI 10.1128/IAI.70.8.4261-4272.2002; Miyamoto K, 2008, J BACTERIOL, V190, P7178, DOI 10.1128/JB.00939-08; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Sayeed S, 2005, INFECT IMMUN, V73, P7413, DOI 10.1128/IAI.73.11.7413-7421.2005; Sayeed S, 2008, MOL MICROBIOL, V67, P15, DOI 10.1111/j.1365-2958.2007.06007.x; Sayeed S, 2007, INFECT IMMUN, V75, P2391, DOI 10.1128/IAI.02014-06; Sayeed S, 2010, INFECT IMMUN, V78, P495, DOI 10.1128/IAI.00838-09; Titball RV, 1999, ANAEROBE, V5, P51, DOI 10.1006/anae.1999.0191; Wen QY, 2003, J CLIN MICROBIOL, V41, P1494, DOI 10.1128/JCM.41.4.1494-1498.2003	38	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10932	10.1371/journal.pone.0010932	http://dx.doi.org/10.1371/journal.pone.0010932			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532170	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000278318700006
J	Tobler, U; Schmidt, BR				Tobler, Ursina; Schmidt, Benedikt R.			Within- and Among-Population Variation in Chytridiomycosis-Induced Mortality in the Toad Alytes obstetricans	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASE; AMPHIBIAN CHYTRID FUNGUS; BATRACHOCHYTRIUM-DENDROBATIDIS; DAPHNIA-MAGNA; RESISTANCE; EXTINCTION; ECOLOGY; EVOLUTION; SELECTION; PARASITE	Background: Chytridiomycosis is a fungal disease linked to local and global extinctions of amphibians. Susceptibility to chytridiomycosis varies greatly between amphibian species, but little is known about between-and within-population variability. However, this kind of variability is the basis for the evolution of tolerance and resistance evolution to disease. Methodology/Principal Findings: In a common garden experiment, we measured mortality after metamorphosis of Alytes obstetricans naturally infected with Batrachochytrium dendrobatidis. Mortality rates differed significantly among populations and ranged from 27 to 90%. Within populations, mortality strongly depended on mass at and time through metamorphosis. Conclusions/Significance: Although we cannot rule out that the differences observed resulted from differences in skin microbiota, different pathogen strains or environmental effects experienced by the host or the pathogen prior to the start of the experiment, we argue that genetic differences between populations are a likely source of at least part of this variation. To our knowledge, this is the first study showing differences in survival between and within populations under constant laboratory conditions. Assuming that some of this intraspecific variation has a genetic basis, this may suggest that there is the potential for the evolution of resistance or tolerance, which might allow population persistence.	[Tobler, Ursina; Schmidt, Benedikt R.] Univ Zurich, Inst Evolutionary Biol & Environm Sci, Zurich, Switzerland; [Schmidt, Benedikt R.] KARCH, Neuchatel, Switzerland	University of Zurich	Tobler, U (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Sci, Zurich, Switzerland.	ursina.tobler@ieu.uzh.ch	Schmidt, Benedikt R./B-8491-2008	Schmidt, Benedikt R./0000-0002-4023-1001	Zoological Institute; Forschungskredit of the University of Zurich; Vontobel Stiftung; Janggen-Poehn Stiftung; Basler Stiftung fuer biologische Forschung; Stiftung Dr. Joachim De Giacomi; Zoo Zuerich; Gruen Stadt Zuerich; European Union of Aquarium Curators; Zuercher Tierschutz; Natural Environment Research Council [NE/G001944/1] Funding Source: researchfish; NERC [NE/G001944/1] Funding Source: UKRI	Zoological Institute; Forschungskredit of the University of Zurich; Vontobel Stiftung; Janggen-Poehn Stiftung; Basler Stiftung fuer biologische Forschung; Stiftung Dr. Joachim De Giacomi; Zoo Zuerich; Gruen Stadt Zuerich; European Union of Aquarium Curators(European Commission); Zuercher Tierschutz; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study was financed by the following institutions and foundations: the Zoological Institute and the Forschungskredit of the University of Zurich, Vontobel Stiftung, Janggen-Poehn Stiftung, Basler Stiftung fuer biologische Forschung, Stiftung Dr. Joachim De Giacomi, Zoo Zuerich, Gruen Stadt Zuerich, European Union of Aquarium Curators, and Zuercher Tierschutz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2008, AM NAT, V172, pE67, DOI 10.1086/588077; Bell G, 2008, EVOL APPL, V1, P3, DOI 10.1111/j.1752-4571.2007.00011.x; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bielby J, 2008, CONSERV LETT, V1, P82, DOI 10.1111/j.1755-263X.2008.00015.x; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; BOSCH J, 2008, IUCN 2009 IUCN RED L; Bosch J, 2007, P ROY SOC B-BIOL SCI, V274, P253, DOI 10.1098/rspb.2006.3713; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2005, ECOLOGY, V86, P3149, DOI 10.1890/04-1428; Brucker RM, 2008, J CHEM ECOL, V34, P39, DOI 10.1007/s10886-007-9352-8; Cory JS, 2009, J ANIM ECOL, V78, P646, DOI 10.1111/j.1365-2656.2008.01519.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; Ebert D, 2000, OECOLOGIA, V122, P200, DOI 10.1007/PL00008847; Ebert D, 1998, P ROY SOC B-BIOL SCI, V265, P2127, DOI 10.1098/rspb.1998.0549; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fisher MC, 2009, MOL ECOL, V18, P415, DOI 10.1111/j.1365-294X.2008.04041.x; Garner TWJ, 2009, DIS AQUAT ORGAN, V83, P257, DOI 10.3354/dao02008; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; Garner TWJ, 2005, EMERG INFECT DIS, V11, P1639; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; Gomulkiewicz R, 2009, AM NAT, V174, pE218, DOI 10.1086/645086; Gosner K. L., 1960, Herpetologica, V16, P183; Green DM, 2003, BIOL CONSERV, V111, P331, DOI 10.1016/S0006-3207(02)00302-6; Haag CR, 2004, P ROY SOC B-BIOL SCI, V271, P2149, DOI 10.1098/rspb.2004.2841; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Hels T, 2002, ECOGRAPHY, V25, P730, DOI 10.1034/j.1600-0587.2002.250609.x; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kilpatrick AM, 2006, BIOL CONSERV, V128, P475, DOI 10.1016/j.biocon.2005.10.014; Lam BA, 2010, BIOL CONSERV, V143, P529, DOI 10.1016/j.biocon.2009.11.015; Lampo M, 1998, ECOL APPL, V8, P388, DOI 10.2307/2641079; Laugen AT, 2005, GENET RES, V86, P161, DOI 10.1017/S0016672305007810; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Miller MP, 2008, EVOL APPL, V1, P336, DOI 10.1111/j.1752-4571.2008.00018.x; Murray KA, 2009, CONSERV BIOL, V23, P1242, DOI 10.1111/j.1523-1739.2009.01211.x; NSW National Parks and Wildlife Service, 2001, 6 NSW NPWS; Orr HA, 2008, AM NAT, V172, P160, DOI 10.1086/589460; R Core Team, 2018, R LANG ENV STAT COMP; Rachowicz LJ, 2007, J ANIM ECOL, V76, P711, DOI 10.1111/j.1365-2656.2007.01256.x; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Richmond JQ, 2009, BIOSCIENCE, V59, P311, DOI 10.1525/bio.2009.59.4.9; Rollins-Smith LA, 1998, IMMUNOL REV, V166, P221, DOI 10.1111/j.1600-065X.1998.tb01265.x; Rowley JJL, 2007, DIS AQUAT ORGAN, V77, P1, DOI 10.3354/dao01830; Roy BA, 2000, EVOLUTION, V54, P51, DOI 10.1111/j.0014-3820.2000.tb00007.x; SCHMIDT B. R., 2009, METHODEN FELDHERPETO, P229; SCHMIDT BR, 2005, ROTE LISTE GEFA HRDE; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Spielman D, 2004, CONSERV GENET, V5, P439, DOI 10.1023/B:COGE.0000041030.76598.cd; Teacher AGF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004616; Tennessen JA, 2008, MOL BIOL EVOL, V25, P2669, DOI 10.1093/molbev/msn208; Tennessen JA, 2009, DEV COMP IMMUNOL, V33, P1247, DOI 10.1016/j.dci.2009.07.004; Van Buskirk J, 2002, EVOLUTION, V56, P361; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Walker SF, 2010, ECOL LETT, V13, P372, DOI 10.1111/j.1461-0248.2009.01434.x; Woodhams DC, 2006, OECOLOGIA, V146, P531, DOI 10.1007/s00442-005-0228-8; Zbinden M, 2008, J EVOLUTION BIOL, V21, P1068, DOI 10.1111/j.1420-9101.2008.01541.x	57	90	91	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2010	5	6							e10927	10.1371/journal.pone.0010927	http://dx.doi.org/10.1371/journal.pone.0010927			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604NC	20532196	Green Published, gold, Green Submitted			2022-12-27	WOS:000278284700010
J	Brown, CA; Brown, KS				Brown, Christopher A.; Brown, Kevin S.			Validation of Coevolving Residue Algorithms via Pipeline Sensitivity Analysis: ELSC and OMES and ZNMI, Oh My!	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CHORISMATE SYNTHASE; ALLOSTERIC COMMUNICATION; CORRELATED MUTATIONS; MUTUAL INFORMATION; PROTEINS; CONSERVATION; ACTIVATION; PREDICTION; NETWORKS	Correlated amino acid substitution algorithms attempt to discover groups of residues that co-fluctuate due to either structural or functional constraints. Although these algorithms could inform both ab initio protein folding calculations and evolutionary studies, their utility for these purposes has been hindered by a lack of confidence in their predictions due to hard to control sources of error. To complicate matters further, naive users are confronted with a multitude of methods to choose from, in addition to the mechanics of assembling and pruning a dataset. We first introduce a new pair scoring method, called ZNMI (Z-scored-product Normalized Mutual Information), which drastically improves the performance of mutual information for co-fluctuating residue prediction. Second and more important, we recast the process of finding coevolving residues in proteins as a data-processing pipeline inspired by the medical imaging literature. We construct an ensemble of alignment partitions that can be used in a cross-validation scheme to assess the effects of choices made during the procedure on the resulting predictions. This pipeline sensitivity study gives a measure of reproducibility (how similar are the predictions given perturbations to the pipeline?) and accuracy (are residue pairs with large couplings on average close in tertiary structure?). We choose a handful of published methods, along with ZNMI, and compare their reproducibility and accuracy on three diverse protein families. We find that (i) of the algorithms tested, while none appear to be both highly reproducible and accurate, ZNMI is one of the most accurate by far and (ii) while users should be wary of predictions drawn from a single alignment, considering an ensemble of sub-alignments can help to determine both highly accurate and reproducible couplings. Our cross-validation approach should be of interest both to developers and end users of algorithms that try to detect correlated amino acid substitutions.	[Brown, Christopher A.] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Brown, Kevin S.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Brown, Christopher A.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Brown, Kevin S.] Univ Calif Santa Barbara, Inst Collaborat Biotechnol, Santa Barbara, CA 93106 USA	Harvard University; University of California System; University of California Santa Barbara; Harvard University; University of California System; University of California Santa Barbara	Brown, CA (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	brown@physics.ucsb.edu		Brown, Kevin/0000-0003-2959-2401	NSF; Harvard University; Harvard Sheldon Traveling Fellowship; David and Lucile Packard Foundation; Institute for Collaborative Biotechnologies, U.S. Army Research Office [W911NF-09-D-0001]	NSF(National Science Foundation (NSF)); Harvard University; Harvard Sheldon Traveling Fellowship; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Institute for Collaborative Biotechnologies, U.S. Army Research Office	Funding: C. A. B. acknowledges financial support from the NSF, Harvard University HILS program, and a Harvard Sheldon Traveling Fellowship. K. S B. thanks the David and Lucile Packard Foundation and the Institute for Collaborative Biotechnologies through contract no. W911NF-09-D-0001 from the U.S. Army Research Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazy H, 2009, PROTEINS, V74, P545, DOI 10.1002/prot.22168; Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Baker D, 2000, NATURE, V405, P39, DOI 10.1038/35011000; Caporaso JG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-327; Chi CN, 2008, P NATL ACAD SCI USA, V105, P4679, DOI 10.1073/pnas.0711732105; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Dekker JP, 2004, BIOINFORMATICS, V20, P1565, DOI 10.1093/bioinformatics/bth128; Dias MVB, 2006, J STRUCT BIOL, V154, P130, DOI 10.1016/j.jsb.2005.12.008; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Efron B, 1998, INTRO BOOTSTRAP; Fatakia SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004681; FINN RD, 2007, NUCLEIC ACIDS RES, P1; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Fodor AA, 2004, J BIOL CHEM, V279, P19046, DOI 10.1074/jbc.M402560200; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; HENSTRAND J, 1995, PLANT PHYSIOL, P1127; Hornanova S, 2007, STUDIA THEOL-CZECH R, V9, P56; Huettel S. A., 2004, FUNCTIONAL MAGNETIC; Jaccard P., 1901, B SOC VAUD SCI N, V37, P241, DOI DOI 10.5169/SEALS-266450; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; LENA PD, 2009, ALGORITHMS BIOINFORM, P62; Little DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004762; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; MacKay D. J. C., 2003, INFORM THEORY INFERE; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Messac A., 2007, OPTIMISATION STRUCTU, P121, DOI [10.1142/9789812779670_0004, DOI 10.1142/9789812779670_0004]; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pan H, 2000, P NATL ACAD SCI USA, V97, P12020, DOI 10.1073/pnas.220240297; Perez-Iratxeta C, 2007, EMBO REP, V8, P1135, DOI 10.1038/sj.embor.7401117; Quevillon-Cheruel S, 2004, J BIOL CHEM, V279, P619, DOI 10.1074/jbc.M310380200; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Strother S, 2004, NEUROIMAGE, V23, pS196, DOI 10.1016/j.neuroimage.2004.07.022; Strother SC, 1997, HUM BRAIN MAPP, V5, P312, DOI 10.1002/(SICI)1097-0193(1997)5:4<312::AID-HBM18>3.0.CO;2-F; Strothert SC, 2002, NEUROIMAGE, V15, P747, DOI 10.1006/nimg.2001.1034; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Thomas MC, 2006, ELEMENTS INFORM THEO; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; WHITE PJ, 1988, BIOCHEM J, V251, P313, DOI 10.1042/bj2510313; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	47	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2010	5	6							e10779	10.1371/journal.pone.0010779	http://dx.doi.org/10.1371/journal.pone.0010779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QF	20531955	Green Submitted, gold, Green Published			2022-12-27	WOS:000278222400002
J	Bahlai, CA; Xue, YG; McCreary, CM; Schaafsma, AW; Hallett, RH				Bahlai, Christine A.; Xue, Yingen; McCreary, Cara M.; Schaafsma, Arthur W.; Hallett, Rebecca H.			Choosing Organic Pesticides over Synthetic Pesticides May Not Effectively Mitigate Environmental Risk in Soybeans	PLOS ONE			English	Article							PEST-MANAGEMENT; APPLE PRODUCTION; APHID; PREDATORS; SUPPRESSION; IMPACTS; SYSTEMS	Background: Selection of pesticides with small ecological footprints is a key factor in developing sustainable agricultural systems. Policy guiding the selection of pesticides often emphasizes natural products and organic-certified pesticides to increase sustainability, because of the prevailing public opinion that natural products are uniformly safer, and thus more environmentally friendly, than synthetic chemicals. Methodology/Principal Findings: We report the results of a study examining the environmental impact of several new synthetic and certified organic insecticides under consideration as reduced-risk insecticides for soybean aphid (Aphis glycines) control, using established and novel methodologies to directly quantify pesticide impact in terms of biocontrol services. We found that in addition to reduced efficacy against aphids compared to novel synthetic insecticides, organic approved insecticides had a similar or even greater negative impact on several natural enemy species in lab studies, were more detrimental to biological control organisms in field experiments, and had higher Environmental Impact Quotients at field use rates. Conclusions/Significance: These data bring into caution the widely held assumption that organic pesticides are more environmentally benign than synthetic ones. All pesticides must be evaluated using an empirically-based risk assessment, because generalizations based on chemical origin do not hold true in all cases.	[Bahlai, Christine A.; Xue, Yingen; McCreary, Cara M.; Hallett, Rebecca H.] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada; [Schaafsma, Arthur W.] Univ Guelph, Dept Plant Agr, Ridgetown, ON, Canada	University of Guelph; University of Guelph	Bahlai, CA (corresponding author), Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada.	rhallett@uoguelph.ca	Bahlai, Christie/L-5500-2019	Bahlai, Christie/0000-0002-8937-8709; Schaafsma, Arthur W/0000-0002-5527-5664	Natural Sciences and Engineering Council of Canada; Agriculture and Agri-Food Canada (AAFC); Ontario Ministry of Agriculture, Food and Rural Affairs - University of Guelph	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Agriculture and Agri-Food Canada (AAFC)(Agriculture & Agri Food Canada); Ontario Ministry of Agriculture, Food and Rural Affairs - University of Guelph	The authors acknowledge funding from the Natural Sciences and Engineering Council of Canada (http://www.nserc-crsng.gc.ca/), Agriculture and Agri-Food Canada (AAFC) (http://www.agr.gc.ca/index_e.php) and the Ontario Ministry of Agriculture, Food and Rural Affairs - University of Guelph partnership (http://www.uoguelph.ca/research/omafra/). The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. AAFC suggested the insecticide list for testing, and this is the only role any funders played in study design.	*AGR AGR CAN, 2003, PEST RISK RED MIN PR; AMES BN, 1990, P NATL ACAD SCI USA, V87, P7782, DOI 10.1073/pnas.87.19.7782; AVERY AA, 2006, ORGANIC PESTICIDE US, P58; BRATTSTEN LB, 1986, SCIENCE, V231, P1255, DOI 10.1126/science.231.4743.1255; *CAN GEN STAND BOA, 2008, ORG PROD SYST PERM S; Costamagna AC, 2007, ECOL APPL, V17, P441, DOI 10.1890/06-0284; Desneux N, 2006, ENVIRON ENTOMOL, V35, P1342, DOI 10.1603/0046-225X(2006)35[1342:SOPGOT]2.0.CO;2; Elliot SL, 2002, CROP PROT, V21, P427, DOI 10.1016/S0261-2194(02)00036-4; *EUR COMM, 1991, COUNC DIR 15 JUL 199; Heimpel GE, 2004, ANN ENTOMOL SOC AM, V97, P249, DOI 10.1603/0013-8746(2004)097[0249:PFIBCO]2.0.CO;2; HENDERSON CF, 1955, J ECON ENTOMOL, V48, P157, DOI 10.1093/jee/48.2.157; *HLTH CAN PEST MAN, 2009, PMRA REEV WORKPL APR; JAMES KH, 1990, RISK ANAL, V10, P367; Kleijn D, 2001, NATURE, V413, P723, DOI 10.1038/35099540; Kovach J., 1992, NEW YORK FOOD LIFE, V139, P1; Levitan L, 1995, AGR ECOSYST ENVIRON, V55, P153, DOI 10.1016/0167-8809(95)00622-Y; Lynch D, 2009, CAN J PLANT SCI, V89, P621, DOI 10.4141/CJPS08165; LYNCH S, 1996, P 3 NAT IPM S WORKSH; *MIN SCI TECHN PEO, 2001, NAT HIGH TECH R D PR; OLSON KD, 2008, FARMERS AWARENESS US; *OMAFRA, 2005, FIELD CROP PROT GUID; Ragsdale DW, 2004, ANN ENTOMOL SOC AM, V97, P204, DOI 10.1603/0013-8746(2004)097[0204:SABINA]2.0.CO;2; Reganold JP, 2001, NATURE, V410, P926, DOI 10.1038/35073574; Rutledge CE, 2004, ANN ENTOMOL SOC AM, V97, P240, DOI 10.1603/0013-8746(2004)097[0240:SAPATU]2.0.CO;2; *SAT CAN, 2009, CER OILS REV; Shepherd M., 2003, ASSESSMENT ENV IMPAC; Suckling DM, 1999, AGR ECOSYST ENVIRON, V73, P129, DOI 10.1016/S0167-8809(99)00022-5; Tette J., METHOD MEASURE ENV I; THOMPSON DG, 2006, REV ENV FATE EFFECTS, P245; Trewavas A, 2001, NATURE, V410, P409, DOI 10.1038/35068639; *UK DEP ENV FOOD R, 2005, DEP REP 2005; Xue Y, 2009, ENVIRON ENTOMOL, V38, P708, DOI 10.1603/022.038.0322	32	81	85	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11250	10.1371/journal.pone.0011250	http://dx.doi.org/10.1371/journal.pone.0011250			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582315	Green Submitted, Green Published, gold			2022-12-27	WOS:000279058500002
J	Chambrion, C; Le Naour, F				Chambrion, Celia; Le Naour, Francois			The Tetraspanins CD9 and CD81 Regulate CD9P1-Induced Effects on Cell Migration	PLOS ONE			English	Article							GROWTH-FACTOR; MICE LACKING; MAJOR CD9; PROTEIN; BINDING; EWI-2; WEB; CD151; ALPHA-3-BETA-1; ASSOCIATION	CD9P-1 is a cell surface protein with immunoglobulin domains and an unknown function that specifically associates with tetraspanins CD9 and CD81. Overexpression of CD9P-1 in HEK-293 cells induces dramatic changes in cell spreading and migration on various matrices. Experiments using time-lapse videomicroscopy revealed that CD9P-1 expression has led to higher cell motility on collagen I but lower motility on fibronectin through a beta 1-integrins dependent mechanism. On collagen I, the increase in cell motility induced by CD9P-1 expression was found to involve integrin alpha 2 beta 1 and CD9P-1 was observed to associate with this collagen receptor. The generation of CD9P-1 mutants demonstrated that the transmembrane and the cytoplasmic domains are necessary for inducing effects on cell motility. On the other hand, expression of tetraspanins CD9 or CD81 was shown to reverse the effects of CD9P-1 on cell motility on collagen I or fibronectin with a concomitant association with CD9P-1. Thus, the ratio of expression levels between CD9P-1 and its tetraspanin partners can regulate cell motility.	[Chambrion, Celia] INSERM, U1004, Villejuif, France; [Chambrion, Celia; Le Naour, Francois] Univ Paris 11, Inst Andre Lwoff, Villejuif, France; [Le Naour, Francois] INSERM, U785, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Chambrion, C (corresponding author), INSERM, U1004, Villejuif, France.	francois.le-naour@inserm.fr			Univ. Paris-Sud 11	Univ. Paris-Sud 11	This work was supported by BQR (bonus qualite recherche) from Univ. Paris-Sud 11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre M, 2006, PROTEOMICS, V6, P1437, DOI 10.1002/pmic.200500180; Andre M, 2007, PROTEOMICS, V7, P3880, DOI 10.1002/pmic.200700355; Andre M, 2009, J PROTEOMICS, V73, P93, DOI 10.1016/j.jprot.2009.08.005; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Charrin S, 2003, BIOCHEM J, V373, P409, DOI 10.1042/BJ20030343; Charrin S, 2001, J BIOL CHEM, V276, P14329, DOI 10.1074/jbc.M011297200; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Clark KL, 2001, J IMMUNOL, V167, P5115, DOI 10.4049/jimmunol.167.9.5115; Cowin AJ, 2006, J INVEST DERMATOL, V126, P680, DOI 10.1038/sj.jid.5700142; Crew VK, 2004, BLOOD, V104, P2217, DOI 10.1182/blood-2004-04-1512; Duffield A, 2003, P NATL ACAD SCI USA, V100, P15560, DOI 10.1073/pnas.2536699100; Feigelson SW, 2003, J BIOL CHEM, V278, P51203, DOI 10.1074/jbc.M303601200; Garcia E, 2005, TRAFFIC, V6, P488, DOI 10.1111/j.1600-0854.2005.00293.x; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; HIGASHIYAMA S, 1995, J CELL BIOL, V128, P929, DOI 10.1083/jcb.128.5.929; Horvath G, 1998, J BIOL CHEM, V273, P30537, DOI 10.1074/jbc.273.46.30537; IWAMOTO R, 1994, EMBO J, V13, P2322, DOI 10.1002/j.1460-2075.1994.tb06516.x; Kazarov AR, 2002, J CELL BIOL, V158, P1299, DOI 10.1083/jcb.200204056; Kolesnikova TV, 2004, BLOOD, V103, P3013, DOI 10.1182/blood-2003-07-2201; Lagaudriere-Gesbert C, 1997, CELL IMMUNOL, V182, P105, DOI 10.1006/cimm.1997.1223; Lammerding J, 2003, P NATL ACAD SCI USA, V100, P7616, DOI 10.1073/pnas.1337546100; Le Naour F, 2006, MOL CELL PROTEOMICS, V5, P845, DOI 10.1074/mcp.M500330-MCP200; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; Le Naour F, 2006, PROTEOMICS, V6, P6447, DOI 10.1002/pmic.200600282; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Lozahic S, 2000, EUR J IMMUNOL, V30, P900, DOI 10.1002/1521-4141(200003)30:3<900::AID-IMMU900>3.0.CO;2-X; Maecker HT, 1997, J EXP MED, V185, P1505, DOI 10.1084/jem.185.8.1505; Nishiuchi R, 2005, P NATL ACAD SCI USA, V102, P1939, DOI 10.1073/pnas.0409493102; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; RASBABD WS, 2007, IMAGEJ; Sachs N, 2006, J CELL BIOL, V175, P33, DOI 10.1083/jcb.200603073; Sala-Valdes M, 2006, J BIOL CHEM, V281, P19665, DOI 10.1074/jbc.M602116200; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Shoham T, 2003, J IMMUNOL, V171, P4062, DOI 10.4049/jimmunol.171.8.4062; Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808; Sterk LMT, 2002, J CELL SCI, V115, P2615; Sterk LMT, 2002, J CELL SCI, V115, P1161; Stipp CS, 2003, J CELL BIOL, V163, P1167, DOI 10.1083/jcb.200309113; Stipp CS, 2001, J BIOL CHEM, V276, P40545, DOI 10.1074/jbc.M107338200; Stipp CS, 2001, J BIOL CHEM, V276, P4853, DOI 10.1074/jbc.M009859200; Takada Y, 2007, GENOME BIOL, V8, P215; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; von Lindern JJ, 2003, J VIROL, V77, P3624, DOI 10.1128/JVI.77.6.3624-3633.2003; Winterwood NE, 2006, MOL BIOL CELL, V17, P2707, DOI 10.1091/mbc.E05-11-1042; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yu LR, 2007, J PROTEOME RES, V6, P4150, DOI 10.1021/pr070152u; Zhang XA, 2002, MOL BIOL CELL, V13, P1, DOI 10.1091/mbc.01-10-0481; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	48	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11219	10.1371/journal.pone.0011219	http://dx.doi.org/10.1371/journal.pone.0011219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574531	Green Published, Green Submitted, gold			2022-12-27	WOS:000279058300012
J	Osenberg, S; Yaacov, NP; Safran, M; Moshkovitz, S; Shtrichman, R; Sherf, O; Jacob-Hirsch, J; Keshet, G; Amariglio, N; Itskovitz-Eldor, J; Rechavi, G				Osenberg, Sivan; Yaacov, Nurit Paz; Safran, Michal; Moshkovitz, Sharon; Shtrichman, Ronit; Sherf, Ofra; Jacob-Hirsch, Jasmine; Keshet, Gilmor; Amariglio, Ninette; Itskovitz-Eldor, Joseph; Rechavi, Gideon			Alu Sequences in Undifferentiated Human Embryonic Stem Cells Display High Levels of A-to-I RNA Editing	PLOS ONE			English	Article							3' UNTRANSLATED REGIONS; DOUBLE-STRANDED-RNA; FEEDER-FREE GROWTH; GENE-EXPRESSION; MESSENGER-RNA; HUMAN TRANSCRIPTOME; NUCLEAR RETENTION; HUMAN BLASTOCYSTS; DEAMINASE ADAR1; INOSINE RNA	Adenosine to Inosine (A-to-I) RNA editing is a site-specific modification of RNA transcripts, catalyzed by members of the ADAR (Adenosine Deaminase Acting on RNA) protein family. RNA editing occurs in human RNA in thousands of different sites. Some of the sites are located in protein-coding regions but the majority is found in non-coding regions, such as 3'UTRs, 5'UTRs and introns - mainly in Alu elements. While editing is found in all tissues, the highest levels of editing are found in the brain. It was shown that editing levels within protein-coding regions are increased during embryogenesis and after birth and that RNA editing is crucial for organism viability as well as for normal development. In this study we characterized the A-to-I RNA editing phenomenon during neuronal and spontaneous differentiation of human embryonic stem cells (hESCs). We identified high editing levels of Alu repetitive elements in hESCs and demonstrated a global decrease in editing levels of non-coding Alu sites when hESCs are differentiating, particularly into the neural lineage. Using RNA interference, we showed that the elevated editing levels of Alu elements in undifferentiated hESCs are highly dependent on ADAR1. DNA microarray analysis showed that ADAR1 knockdown has a global effect on gene expression in hESCs and leads to a significant increase in RNA expression levels of genes involved in differentiation and development processes, including neurogenesis. Taken together, we speculate that A-to-I editing of Alu sequences plays a role in the regulation of hESC early differentiation decisions.	[Osenberg, Sivan; Yaacov, Nurit Paz; Safran, Michal; Moshkovitz, Sharon; Sherf, Ofra; Jacob-Hirsch, Jasmine; Keshet, Gilmor; Amariglio, Ninette; Rechavi, Gideon] Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Osenberg, Sivan; Yaacov, Nurit Paz; Rechavi, Gideon] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Itskovitz-Eldor, Joseph] Rambam Med Ctr, Dept Obstet & Gynecol, Haifa, Israel; [Shtrichman, Ronit; Itskovitz-Eldor, Joseph] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Sohnis & Forman Families Stem Cell Ctr, IL-31096 Haifa, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Osenberg, S (corresponding author), Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel.	Ninette.Amariglio@sheba.health.gov.il		Keshet, Gilmor/0000-0002-1907-3029	Flight Attendant Medical Research Institute (FAMRI); Bio-Med Morasha ISF [1942/08]; Israel Ministry for Science and Technology; Kahn Family Foundation	Flight Attendant Medical Research Institute (FAMRI); Bio-Med Morasha ISF; Israel Ministry for Science and Technology; Kahn Family Foundation	This work was supported in part by grants from the Flight Attendant Medical Research Institute (FAMRI), Bio-Med Morasha ISF (Grant No. 1942/08), and the Israel Ministry for Science and Technology (Scientific Infrastructure Program) as well as the Kahn Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amariglio N, 2007, BLOOD CELL MOL DIS, V39, P151, DOI 10.1016/j.bcmd.2007.04.003; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Amit M, 2002, J ANAT, V200, P225, DOI 10.1046/j.1469-7580.2002.00032.x; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Barbon A, 2003, MOL BRAIN RES, V117, P168, DOI 10.1016/S0169-328X(03)00317-6; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; Bodnar MS, 2004, STEM CELLS DEV, V13, P243, DOI 10.1089/154732804323099172; Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Dvash T, 2004, HUM REPROD, V19, P2875, DOI 10.1093/humrep/deh529; Eisenberg E, 2005, TRENDS GENET, V21, P77, DOI 10.1016/j.tig.2004.12.005; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; George CX, 2005, J BIOL CHEM, V280, P15020, DOI 10.1074/jbc.M500476200; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Heale BSE, 2009, EMBO J, V28, P3145, DOI 10.1038/emboj.2009.244; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Ji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008419; Kawahara Y, 2004, DEV BRAIN RES, V148, P151, DOI 10.1016/j.devbrainres.2003.11.008; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Knight SW, 2002, MOL CELL, V10, P809, DOI 10.1016/S1097-2765(02)00649-4; Koren-Michowitz M, 2008, LEUKEMIA RES, V32, P421, DOI 10.1016/j.leukres.2007.07.003; Lev-Maor G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r29; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Lykke-Andersen S, 2007, RNA, V13, P1732, DOI 10.1261/rna.567807; Maas Stefan, 2006, RNA Biol, V3, P1; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nie YZ, 2005, MOL CELL BIOL, V25, P6956, DOI 10.1128/MCB.25.16.6956-6963.2005; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; Ohman M, 2007, BIOCHIMIE, V89, P1171, DOI 10.1016/j.biochi.2007.06.002; Osenberg S, 2009, RNA, V15, P1632, DOI 10.1261/rna.1581809; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Paul MS, 1998, EMBO J, V17, P1120, DOI 10.1093/emboj/17.4.1120; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Peng PL, 2006, NEURON, V49, P719, DOI 10.1016/j.neuron.2006.01.025; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Scadden ADJ, 2001, EMBO J, V20, P4243, DOI 10.1093/emboj/20.15.4243; Schuldiner M, 2001, BRAIN RES, V913, P201, DOI 10.1016/S0006-8993(01)02776-7; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tonkin LA, 2002, EMBO J, V21, P6025, DOI 10.1093/emboj/cdf607; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Wang QQ, 2005, CURR BIOL, V15, P384, DOI 10.1016/j.cub.2005.01.046; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yang WD, 2005, J BIOL CHEM, V280, P3946, DOI 10.1074/jbc.M407876200; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4	67	64	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11173	10.1371/journal.pone.0011173	http://dx.doi.org/10.1371/journal.pone.0011173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574523	Green Published, gold, Green Submitted			2022-12-27	WOS:000279058300005
J	Terao, M; Watanabe, J; Yagi, A; Nishida, S				Terao, Masahiko; Watanabe, Junji; Yagi, Akihiro; Nishida, Shin'ya			Smooth Pursuit Eye Movements Improve Temporal Resolution for Color Perception	PLOS ONE			English	Article							IMPROVED VISUAL SENSITIVITY; CORTICAL AREAS MT; PERCEIVED MOTION; SMEAR; COMPRESSION; ADAPTATION; DIRECTION; NEURONS; SIGNALS; TIME	Human observers see a single mixed color (yellow) when different colors (red and green) rapidly alternate. Accumulating evidence suggests that the critical temporal frequency beyond which chromatic fusion occurs does not simply reflect the temporal limit of peripheral encoding. However, it remains poorly understood how the central processing controls the fusion frequency. Here we show that the fusion frequency can be elevated by extra-retinal signals during smooth pursuit. This eye movement can keep the image of a moving target in the fovea, but it also introduces a backward retinal sweep of the stationary background pattern. We found that the fusion frequency was higher when retinal color changes were generated by pursuit-induced background motions than when the same retinal color changes were generated by object motions during eye fixation. This temporal improvement cannot be ascribed to a general increase in contrast gain of specific neural mechanisms during pursuit, since the improvement was not observed with a pattern flickering without changing position on the retina or with a pattern moving in the direction opposite to the background motion during pursuit. Our findings indicate that chromatic fusion is controlled by a cortical mechanism that suppresses motion blur. A plausible mechanism is that eye-movement signals change spatiotemporal trajectories along which color signals are integrated so as to reduce chromatic integration at the same locations (i.e., along stationary trajectories) on the retina that normally causes retinal blur during fixation.	[Terao, Masahiko; Watanabe, Junji; Nishida, Shin'ya] NTT Corp, NTT Commun Sci Labs, Kyoto, Japan; [Terao, Masahiko] Univ Tokyo, Dept Life Sci, Meguro Ku, Tokyo, Japan; [Watanabe, Junji] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Terao, Masahiko; Yagi, Akihiro] Kwansei Gakuin Univ, Grad Sch Humanities, Nishinomiya, Hyogo, Japan	Nippon Telegraph & Telephone Corporation; University of Tokyo; Japan Society for the Promotion of Science; Kwansei Gakuin University	Terao, M (corresponding author), NTT Corp, NTT Commun Sci Labs, Kyoto, Japan.	masahiko_terao@mac.com			Nippon Telegraph and Telephone Corporation; Japan Society for the Promotion of Science	Nippon Telegraph and Telephone Corporation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by Nippon Telegraph and Telephone Corporation and the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON CH, 1990, NATURE, V343, P419, DOI 10.1038/343419b0; Bedell HE, 1996, CURR BIOL, V6, P1032, DOI 10.1016/S0960-9822(02)00650-4; BURR D, 1980, NATURE, V284, P164, DOI 10.1038/284164a0; Burr D, 2004, CURR BIOL, V14, pR381, DOI 10.1016/j.cub.2004.05.011; BURR D, 1986, TRENDS NEUROSCI, V9, P304, DOI 10.1016/0166-2236(86)90088-3; BURR DC, 1981, PROC R SOC SER B-BIO, V211, P321, DOI 10.1098/rspb.1981.0010; Burr DC, 1997, P ROY SOC B-BIOL SCI, V264, P431, DOI 10.1098/rspb.1997.0061; Cavanagh P, 2008, J VISION, V8, DOI 10.1167/8.12.1; DELANGEDZN H, 1958, J OPT SOC AM, V48, P777, DOI 10.1364/JOSA.48.000777; Gur M, 1997, VISION RES, V37, P377, DOI 10.1016/S0042-6989(96)00183-6; HONDA H, 1991, VISION RES, V31, P1915, DOI 10.1016/0042-6989(91)90186-9; Jiang Y, 2007, NAT NEUROSCI, V10, P657, DOI 10.1038/nn1879; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; LEE BB, 1989, J PHYSIOL-LONDON, V414, P223, DOI 10.1113/jphysiol.1989.sp017685; MATIN L, 1965, SCIENCE, V148, P1485, DOI 10.1126/science.148.3676.1485; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; Nishida S, 2007, CURR BIOL, V17, P366, DOI 10.1016/j.cub.2006.12.041; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Schutz AC, 2008, NAT NEUROSCI, V11, P1211, DOI 10.1038/nn.2194; Schutz AC, 2009, VISUAL NEUROSCI, V26, P329, DOI 10.1017/S0952523809990083; Schutz AC, 2007, J VISION, V7, DOI 10.1167/7.13.3; Shady S, 2004, P NATL ACAD SCI USA, V101, P5170, DOI 10.1073/pnas.0303452101; TERAO M, SOC NEUR ANN M CHIC; Tolias AS, 2005, NAT NEUROSCI, V8, P591, DOI 10.1038/nn1446; Tong JL, 2007, VISION RES, V47, P1011, DOI 10.1016/j.visres.2006.12.002; Tong JL, 2009, VISION RES, V49, P2835, DOI 10.1016/j.visres.2009.08.019; Tong JL, 2005, VISION RES, V45, P1519, DOI 10.1016/j.visres.2004.12.004; Vul E, 2006, NAT NEUROSCI, V9, P873, DOI 10.1038/nn1723; Watanabe J, 2007, J VISION, V7, DOI 10.1167/7.11.3; WISOWATY JJ, 1981, J OPT SOC AM, V71, P970, DOI 10.1364/JOSA.71.000970	31	11	13	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11214	10.1371/journal.pone.0011214	http://dx.doi.org/10.1371/journal.pone.0011214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574511	Green Published, Green Submitted, gold			2022-12-27	WOS:000279058300009
J	Fu, S; Tong, XH; Cai, CG; Zhao, Y; Wu, Y; Li, YY; Xu, JJ; Zhang, XJC; Xu, L; Chen, W; Rao, ZH				Fu, Sheng; Tong, Xiaohang; Cai, Chenguang; Zhao, Ying; Wu, Yang; Li, Yuanyuan; Xu, Junjie; Zhang, Xuejun C.; Xu, Long; Chen, Wei; Rao, Zihe			The Structure of Tumor Endothelial Marker 8 (TEM8) Extracellular Domain and Implications for Its Receptor Function for Recognizing Anthrax Toxin	PLOS ONE			English	Article							CAPILLARY MORPHOGENESIS PROTEIN-2; VON-WILLEBRAND-FACTOR; PROTECTIVE ANTIGEN; CRYSTAL-STRUCTURE; PORE FORMATION; A-DOMAIN; CELLULAR RECEPTORS; LETHAL FACTOR; IN-VIVO; BINDING	Anthrax toxin, which is released from the Gram-positive bacterium Bacillus anthracis, is composed of three proteins: protective antigen (PA), lethal factor (LF), and edema factor (EF). PA binds a receptor on the surface of the target cell and further assembles into a homo-heptameric pore through which EF and LF translocate into the cytosol. Two distinct cellular receptors for anthrax toxin, TEM8/ANTXR1 and CMG2/ANTXR2, have been identified, and it is known that their extracellular domains bind PA with low and high affinities, respectively. Here, we report the crystal structure of the TEM8 extracellular vWA domain at 1.7 angstrom resolution. The overall structure has a typical integrin fold and is similar to that of the previously published CMG2 structure. In addition, using structure-based mutagenesis, we demonstrate that the putative interface region of TEM8 with PA (consisting of residues 56, 57, and 154-160) is responsible for the PA-binding affinity differences between the two receptors. In particular, Leu56 was shown to be a key factor for the lower affinity of TEM8 towards PA compared with CMG2. Because of its high affinity for PA and low expression in normal tissues, an isolated extracellular vWA domain of the L56A TEM8 variant may serve as a potent antitoxin and a potential therapeutic treatment for anthrax infection. Moreover, as TEM8 is often over-expressed in tumor cells, our TEM8 crystal structure may provide new insights into how to design PA mutants that preferentially target tumor cells.	[Fu, Sheng; Tong, Xiaohang; Wu, Yang; Li, Yuanyuan; Zhang, Xuejun C.; Rao, Zihe] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Fu, Sheng; Tong, Xiaohang; Zhao, Ying; Wu, Yang; Li, Yuanyuan; Rao, Zihe] Tsinghua Univ, Struct Biol Lab, Beijing 100084, Peoples R China; [Cai, Chenguang; Xu, Junjie; Chen, Wei] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Xu, Long] Beijing Inst Biotechnol, Lab Prot Engn, Beijing, Peoples R China; [Rao, Zihe] Nankai Univ, Coll Sci, Tianjin 300071, Peoples R China; [Rao, Zihe] Nankai Univ, Tianjin State Lab Prot Sci, Tianjin 300071, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Tsinghua University; Beijing Institute of Microbiology & Epidemiology; Nankai University; Nankai University	Fu, S (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	chenwei0226@yahoo.com.cn; raozh@xtal.tsinghua.edu.cn	Rao, Zihe/HCH-6944-2022; li, yuanyuan/GZA-4435-2022; Wu, Yang/N-8460-2014	Wu, Yang/0000-0002-1544-1947	"973" Project [2006CB806503, 2007CB914301, 2007CB914304]; "863" Project [2006AA02A322]; National Major Project [2009ZX10004-304]; Ministry of Science and Technology [2006DFB32420]; National Institutes of Health/NIAID [U19AI06269]	"973" Project(National Basic Research Program of China); "863" Project(National High Technology Research and Development Program of China); National Major Project; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Institutes of Health/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the State "973" Project (Grant no. 2006CB806503, 2007CB914301 and 2007CB914304), "863" Project (Grant No. 2006AA02A322), the National Major Project (Grant No. 2009ZX10004-304), the Ministry of Science and Technology International Collaboration Project (Grant no. 2006DFB32420) and National Institutes of Health/NIAID, U19AI06269 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Beauregard KE, 2000, CELL MICROBIOL, V2, P251, DOI 10.1046/j.1462-5822.2000.00052.x; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Bradley KA, 2003, J BIOL CHEM, V278, P49342, DOI 10.1074/jbc.M307900200; Chen KH, 2007, J BIOL CHEM, V282, P9834, DOI 10.1074/jbc.M611142200; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hotchkiss KA, 2005, EXP CELL RES, V305, P133, DOI 10.1016/j.yexcr.2004.12.025; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; Krishnan V, 2007, J MOL BIOL, V367, P224, DOI 10.1016/j.jmb.2006.12.039; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P6367, DOI 10.1073/pnas.0401506101; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Liu SH, 2007, CELL MICROBIOL, V9, P977, DOI 10.1111/j.1462-5822.2006.00845.x; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melnyk RA, 2006, J BIOL CHEM, V281, P1630, DOI 10.1074/jbc.M511164200; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Mogridge J, 2002, BIOCHEMISTRY-US, V41, P1079, DOI 10.1021/bi015860m; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nabel GJ, 2009, NEW ENGL J MED, V361, P191, DOI 10.1056/NEJMe0903259; Nanda A, 2004, CANCER RES, V64, P817, DOI 10.1158/0008-5472.CAN-03-2408; Ponnuraj K, 2004, MOL CELL, V14, P17, DOI 10.1016/S1097-2765(04)00160-1; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Scobie HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000329; Scobie HM, 2006, PLOS PATHOG, V2, P949, DOI 10.1371/journal.ppat.0020111; Scobie HM, 2005, J INFECT DIS, V192, P1047, DOI 10.1086/432731; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Tama F, 2006, PROTEIN SCI, V15, P2190, DOI 10.1110/ps.062293906; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200; Wild MA, 2003, NAT BIOTECHNOL, V21, P1305, DOI 10.1038/nbt891; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106	40	25	28	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11203	10.1371/journal.pone.0011203	http://dx.doi.org/10.1371/journal.pone.0011203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585457	Green Submitted, gold, Green Published			2022-12-27	WOS:000278977200008
J	Bonte, D; De Roissart, A; Vandegehuchte, ML; Ballhorn, DJ; Van Leeuwen, T; de la Pena, E				Bonte, Dries; De Roissart, Annelies; Vandegehuchte, Martijn L.; Ballhorn, Daniel J.; Van Leeuwen, Thomas; de la Pena, Eduardo			Local Adaptation of Aboveground Herbivores towards Plant Phenotypes Induced by Soil Biota	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; BELOW-GROUND INTERACTIONS; ROOT HERBIVORY; SPIDER-MITE; TRADE-OFFS; MICROBIAL COMMUNITY; GENETIC-VARIATION; GROWTH; EVOLUTION; RESISTANCE	Background: Soil biota may trigger strong physiological responses in plants and consequently induce distinct phenotypes. Plant phenotype, in turn, has a strong impact on herbivore performance. Here, we tested the hypothesis that aboveground herbivores are able to adapt to plant phenotypes induced by soil biota. Methodology and Principal Findings: We bred spider mites for 15 generations on snap beans with three different belowground biotic interactions: (i) no biota (to serve as control), (ii) arbuscular mycorrhizal fungi and (ii) root-feeding nematodes. Subsequently, we conducted a reciprocal selection experiment using these spider mites, which had been kept on the differently treated plants. Belowground treatments induced changes in plant biomass, nutrient composition and water content. No direct chemical defence through cyanogenesis was detected in any of the plant groups. Growth rates of spider mites were higher on the ecotypes on which they were bred for 15 generations, although the statistical significance disappeared for mites from the nematode treatment when corrected for all multiple comparisons. Conclusion/Significance: These results demonstrate that belowground biota may indeed impose selection on the aboveground insect herbivores mediated by the host plant. The observed adaptation was driven by variable quantitative changes of the different separately studied life history traits (i. e. fecundity, longevity, sex-ratio, time to maturity).	[Bonte, Dries; De Roissart, Annelies; Vandegehuchte, Martijn L.; de la Pena, Eduardo] Univ Ghent, Dept Biol, B-9000 Ghent, Belgium; [Ballhorn, Daniel J.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA; [De Roissart, Annelies; Van Leeuwen, Thomas] Univ Ghent, Dept Crop Protect, B-9000 Ghent, Belgium	Ghent University; University of Minnesota System; University of Minnesota Twin Cities; Ghent University	Bonte, D (corresponding author), Univ Ghent, Dept Biol, B-9000 Ghent, Belgium.	Dries.Bonte@Ugent.be	Bonte, Dries/AAH-3913-2021; de la Pena, Eduardo/B-8037-2015; Van Leeuwen, Thomas/H-5036-2013	Bonte, Dries/0000-0002-3320-7505; de la Pena, Eduardo/0000-0002-6057-6664; Vandegehuchte, Martijn L./0000-0003-1283-4654; Van Leeuwen, Thomas/0000-0003-4651-830X	FWO Research Network; FWO [G.0057.09]; DFG [3966/1-1]	FWO Research Network(FWO); FWO(FWO); DFG(German Research Foundation (DFG))	DB, ADR, MV and EDLP were supported by the FWO Research Network "Eco-evolutionary dynamics in natural and anthropogenic communities" and FWO project G.0057.09. EDLP and TVL are postdoctoral fellows and MLV a PhD candidate at the Fund for Scientific Research, Flanders. DJB gratefully acknowledges funding through the DFG (grant 3966/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RE, 1965, PLANT DIS REPTR, V49; Agrawal AA, 2002, AM NAT, V159, P553, DOI 10.1086/339463; Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; Ballhorn DJ, 2007, J CHEM ECOL, V33, P2195, DOI 10.1007/s10886-007-9380-4; Ballhorn DJ, 2008, J ECOL, V96, P971, DOI 10.1111/j.1365-2745.2008.01404.x; Ballhorn DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005450; Bardgett RD, 2005, TRENDS ECOL EVOL, V20, P634, DOI 10.1016/j.tree.2005.08.005; Bardgett RD, 1998, SOIL BIOL BIOCHEM, V30, P1867, DOI 10.1016/S0038-0717(98)00069-8; Barot S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001248; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Bezemer TM, 2005, TRENDS ECOL EVOL, V20, P617, DOI 10.1016/j.tree.2005.08.006; Bezemer TM, 2005, ECOL LETT, V8, P652, DOI 10.1111/j.1461-0248.2005.00762.x; Blossey B, 2003, ANNU REV ENTOMOL, V48, P521, DOI 10.1146/annurev.ento.48.091801.112700; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Coley PD, 2006, OIKOS, V115, P219, DOI 10.1111/j.2006.0030-1299.14928.x; Denton CS, 1999, SOIL BIOL BIOCHEM, V31, P155, DOI 10.1016/S0038-0717(98)00118-7; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; FRITZ RS, 1990, OECOLOGIA, V82, P325, DOI 10.1007/BF00317479; FRITZ RS, 1988, ECOLOGY, V69, P845, DOI 10.2307/1941034; Fuller VL, 2008, NEW PHYTOL, V180, P27, DOI 10.1111/j.1469-8137.2008.02508.x; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Graham JH, 2000, PLANT SOIL, V220, P207, DOI 10.1023/A:1004709209009; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; Hoffmann D, 2009, OECOLOGIA, V158, P663, DOI 10.1007/s00442-008-1179-7; ISO, 2005, 59832 ISO; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Johnson MTJ, 2007, OIKOS, V116, P941, DOI 10.1111/j.0030-1299.2007.15773.x; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Johnson SN, 2009, FUNCT ECOL, V23, P699, DOI 10.1111/j.1365-2435.2009.01550.x; JOOSTEN L, 2009, PLANT SOIL; Kaplan I, 2008, ECOL LETT, V11, P841, DOI 10.1111/j.1461-0248.2008.01200.x; Karban R, 2004, EVOL ECOL, V18, P283, DOI 10.1023/B:EVEC.0000035063.70344.03; KOIDE R, 1985, NEW PHYTOL, V99, P449, DOI 10.1111/j.1469-8137.1985.tb03672.x; Koricheva J, 2009, ECOLOGY, V90, P2088, DOI 10.1890/08-1555.1; Lambrinos JG, 2004, ECOLOGY, V85, P2061, DOI 10.1890/03-8013; Magalhaes S, 2007, J EVOLUTION BIOL, V20, P2016, DOI 10.1111/j.1420-9101.2007.01365.x; MASTERS GJ, 1993, OIKOS, V66, P148, DOI 10.2307/3545209; MASTERS GJ, 1995, ACTA OECOL, V16, P135; Mopper S, 2000, ECOLOGY, V81, P1577, DOI 10.1890/0012-9658(2000)081[1577:SVILPS]2.0.CO;2; MOPPER S, 1995, EVOLUTION, V49, P810, DOI [10.2307/2410404, 10.1111/j.1558-5646.1995.tb02317.x]; Mopper S, 1996, TRENDS ECOL EVOL, V11, P235, DOI 10.1016/0169-5347(96)10036-7; NAHRSTEDT A, 1985, PLANT SYST EVOL, V150, P35, DOI 10.1007/BF00985566; Orians CM, 1996, OECOLOGIA, V105, P388, DOI 10.1007/BF00328742; Poll J, 2007, FEMS MICROBIOL ECOL, V62, P268, DOI 10.1111/j.1574-6941.2007.00383.x; Reynolds HL, 2006, OECOLOGIA, V147, P348, DOI 10.1007/s00442-005-0270-6; Scheirs J, 2005, EVOL ECOL, V19, P551, DOI 10.1007/s10682-005-2004-y; Schoonhoven L.M., 1998, INSECT PLANT BIOL PH; Shen CS, 1997, ECOL ENTOMOL, V22, P335, DOI 10.1046/j.1365-2311.1997.00078.x; Smiley RW, 2005, PLANT DIS, V89, P958, DOI 10.1094/PD-89-0958; Sudova R, 2008, PLANT SOIL, V308, P55, DOI 10.1007/s11104-008-9605-5; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson JN, 2005, CURR BIOL, V15, pR992, DOI 10.1016/j.cub.2005.11.046; Tikkanen OP, 2003, FOREST ECOL MANAG, V177, P587, DOI 10.1016/S0378-1127(02)00330-4; van Dam NM, 2005, ENTOMOL EXP APPL, V115, P161, DOI 10.1111/j.1570-7458.2005.00241.x; van Dam NM, 2003, BASIC APPL ECOL, V4, P63, DOI 10.1078/1439-1791-00133; Van der Putten WH, 2001, TRENDS ECOL EVOL, V16, P547, DOI 10.1016/S0169-5347(01)02265-0; Van Leeuwen T, 2008, P NATL ACAD SCI USA, V105, P5980, DOI 10.1073/pnas.0802224105; van Ruijven J, 2005, ECOL LETT, V8, P30, DOI 10.1111/j.1461-0248.2004.00688.x; VANDEGEHUCHTE ML, 2010, OIKOS IN PRESS; Vierheilig H, 1998, APPL ENVIRON MICROB, V64, P5004; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wolfe BE, 2005, ECOL LETT, V8, P218, DOI 10.1111/j.1461-0248.2004.00716.x; Yano S, 2002, EXP APPL ACAROL, V27, P1, DOI 10.1023/A:1021518221031; Yano S, 2001, EXP APPL ACAROL, V25, P371, DOI 10.1023/A:1017926017081	65	34	34	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11174	10.1371/journal.pone.0011174	http://dx.doi.org/10.1371/journal.pone.0011174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567507	gold, Green Published, Green Submitted			2022-12-27	WOS:000278886300017
J	Filteau, S; Kasonka, L; Gibson, R; Gompels, UA; Jaffar, S; Kafwembe, E; Monze, M; Sinkala, M; Tomkins, A; Zulu, R; Chisenga, M; Siame, J; Mabuda, HB; Baisley, K; Dale, H; Rehman, A; Bates, M; Mullen, A; Bwalya, HK; Chileshe, M; Kowa, PK; Kumwenda, M; Likando, M; Mambwe, S; Muzyamba, M; Mwale, A; Nyaywa, L; Kapambwe, M; Bima, H; Gosset, L; Hackett, L; Jackson, A; Njunju, E; Mwanza, S; Shampwaya, N; Kabanga, C; Chobo, J; Kapumba, W; Musonda, C; Soko, P				Filteau, Suzanne; Kasonka, Lackson; Gibson, Rosalind; Gompels, Ursula A.; Jaffar, Shabbar; Kafwembe, Emmanuel; Monze, Mwaka; Sinkala, Moses; Tomkins, Andrew; Zulu, Rodah; Chisenga, Molly; Siame, Joshua; Mabuda, Hildah Banda; Baisley, Kathy; Dale, Helen; Rehman, Andrea; Bates, Matthew; Mullen, Anne; Bwalya, Hellen Kangwa; Chileshe, Margaret; Kowa, Priscilla Kangwa; Kumwenda, Mabvuto; Likando, Munalula; Mambwe, Sydney; Muzyamba, Mutinta; Mwale, Anne; Nyaywa, Lungowe; Kapambwe, Mirriam; Bima, Humphrey; Gosset, Laura; Hackett, Louise; Jackson, Abigail; Njunju, Eric; Mwanza, Sydney; Shampwaya, Natalia; Kabanga, Concillia; Chobo, John; Kapumba, Winford; Musonda, Charity; Soko, Philip		Chilenje Infant Growth Nutr Infect	Micronutrient Fortification to Improve Growth and Health of Maternally HIV-Unexposed and Exposed Zambian Infants: A Randomised Controlled Trial	PLOS ONE			English	Article							COMPLEMENTARY FOODS; CHILDREN; MALARIA; IMPACT; ACID; BORN	Background: The period of complementary feeding, starting around 6 months of age, is a time of high risk for growth faltering and morbidity. Low micronutrient density of locally available foods is a common problem in low income countries. Children of HIV-infected women are especially vulnerable. Although antiretroviral prophylaxis can reduce breast milk HIV transmission in early infancy, there are no clear feeding guidelines for after 6 months. There is a need for acceptable, feasible, affordable, sustainable and safe (AFASS by WHO terminology) foods for both HIV-exposed and unexposed children after 6 months of age. Methods and Findings: We conducted in Lusaka, Zambia, a randomised double-blind trial of two locally made infant foods: porridges made of flour composed of maize, beans, bambaranuts and groundnuts. One flour contained a basal and the other a rich level of micronutrient fortification. Infants (n = 743) aged 6 months were randomised to receive either regime for 12 months. The primary outcome was stunting (length-for-age Z < -2) at age 18 months. No significant differences were seen between trial arms overall in proportion stunted at 18 months (adjusted odds ratio 0.87; 95% CI 0.50, 1.53; P = 0.63), mean length-for-age Z score, or rate of hospital referral or death. Among children of HIV-infected mothers who breastfed <6 months (53% of HIV-infected mothers), the richly-fortified porridge increased length-for-age and reduced stunting (adjusted odds ratio 0.17; 95% CI 0.04, 0.84; P = 0.03). Rich fortification improved iron status at 18 months as measured by hemoglobin, ferritin and serum transferrin receptors. Conclusions: In the whole study population, the rich micronutrient fortification did not reduce stunting or hospital referral but did improve iron status and reduce anemia. Importantly, in the infants of HIV-infected mothers who stopped breastfeeding before 6 months, the rich fortification improved linear growth. Provision of such fortified foods may benefit health of these high risk infants.	[Filteau, Suzanne; Gompels, Ursula A.; Jaffar, Shabbar] London Sch Hyg & Trop Med, London, England; [Kasonka, Lackson; Monze, Mwaka] UTH, Lusaka, Zambia; [Gibson, Rosalind] Univ Otago, Christchurch, New Zealand; [Kafwembe, Emmanuel] Trop Dis Res Ctr, Ndola, India; [Tomkins, Andrew] UCL, Inst Child Hlth, London, England; [Zulu, Rodah] Natl Inst Sci & Ind Res, Lusaka, Zambia	University of London; London School of Hygiene & Tropical Medicine; University of Otago; University of London; University College London	Filteau, S (corresponding author), London Sch Hyg & Trop Med, London, England.	Suzanne.Filteau@lshtm.ac.uk	Rehman, Andrea/AAP-3172-2020; Rehman, Andrea M/H-1351-2015	Rehman, Andrea/0000-0001-9967-5822; Rehman, Andrea M/0000-0001-9967-5822; Gompels, U/0000-0002-0577-8386; Bates, Matthew/0000-0003-0464-1529; Mullen, Anne/0000-0003-2973-1109	Bill and Melinda Gates Foundation [37253]; LSHTM; Lusaka District Health; Medical Research Council [G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); LSHTM; Lusaka District Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Main funder: Bill and Melinda Gates Foundation grant #37253. Contibution in kind (micronutrient premixes): DSM South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Quality Commodities, Lusaka, especially production manager, Mr. Chongo, for preparing and storing the flours; to the Data Safety and Monitoring Board - Dr. Paul Kelly, Dr. Jim Todd, Dr. Nigel Rollins - for their considered efforts to monitor and support the trial; to Max Katubulushi, UTH, for audit of the diet randomisation and distribution processes, and to Gabi Meineke, LSHTM, for help with financial and logistic management. We are particularly grateful to the mothers and children who participated in the study and to the staff of Lusaka District Health who permitted and supported the study.	Allen L, 2006, GUIDELINES FOOD FORT; [Anonymous], GUID PRINC FEED NONB; [Anonymous], 1995, OFFICIAL METHODS ANA; Arpadi S, 2009, AM J CLIN NUTR, V90, P344, DOI 10.3945/ajcn.2009.27745; Beesley R, 2000, T ROY SOC TROP MED H, V94, P295, DOI 10.1016/S0035-9203(00)90329-8; CHANDA P, 2009, MALARIA J; Chen H, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006090.pub2; Dewey Kathryn G., 2003, Food and Nutrition Bulletin, V24, P5; DOHLMAN E, 2003, INT TRADE FOOD SAFET; *FAM EARL WARN SYS, 2006, ZAMB SEC UPD; Fillol F, 2010, J NUTR, V140, P625, DOI 10.3945/jn.109.114223; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Filteau S, 2009, TROP MED INT HEALTH, V14, P276, DOI 10.1111/j.1365-3156.2009.02220.x; Gitau R, 2005, PUBLIC HEALTH NUTR, V8, P837, DOI 10.1079/PHN2005746; International Zinc Consultative Group, 2004, FOOD NUTR BULL, V25, pS99, DOI DOI 10.1177/15648265040251S205; Lartey A, 1999, AM J CLIN NUTR, V70, P391; LEHRFELD J, 1989, CEREAL CHEM, V66, P510; Lunney KM, 2008, J NUTR, V138, P351, DOI 10.1093/jn/138.2.351; Martorell R, 1988, ANTHROPOMETRIC STAND, V24, P425; Mofenson LM, 2009, JAIDS-J ACQ IMM DEF, V52, P305, DOI 10.1097/QAI.0b013e3181bbfe14; *MOST, 2005, FORT BAS MAIZ FLOUR; Owino VO, 2007, AM J CLIN NUTR, V86, P1094, DOI 10.1093/ajcn/86.4.1094; Owino VO, 2007, J SCI FOOD AGR, V87, P1021, DOI 10.1002/jsfa.2799; Ramakrishnan U, 2009, AM J CLIN NUTR, V89, P191, DOI 10.3945/ajcn.2008.26862; SAFRIN S, 1994, J INFECT DIS, V170, P912, DOI 10.1093/infdis/170.4.912; SAZAWAL S, 2006, LANCET, V367; Serlemitsos J. A., 2001, VITAMIN A FORTIFICAT; Shrimpton R, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e75; Sun HY, 2009, CURR OPIN INFECT DIS, V22, P394, DOI 10.1097/QCO.0b013e32832d7aff; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; *WHO, 2007, HIV INF FEED UPD; *WHO, 2009, REV NAT IMM COV 1980; *WHO, 1998, IMCI INF PACK GEN DE; *WHO, 2002, ONL STAT; *WHO, 2002, COMPL FEED SUMM GUID; World Health Organization, 2001, OPT DUR EXCL BREASTF; World Health Organization, 2006, CHILD GROWTH STAND; ZERFAS A, 1985, CHECKING CONTINUOUS	38	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11165	10.1371/journal.pone.0011165	http://dx.doi.org/10.1371/journal.pone.0011165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567511	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000278886300011
J	Hoehndorf, R; Ngomo, ACN; Dannemann, M; Kelso, J				Hoehndorf, Robert; Ngomo, Axel-Cyrille Ngonga; Dannemann, Michael; Kelso, Janet			Statistical Tests for Associations between Two Directed Acyclic Graphs	PLOS ONE			English	Article							GENE ONTOLOGY; SIMILARITY; PREDICTION	Biological data, and particularly annotation data, are increasingly being represented in directed acyclic graphs (DAGs). However, while relevant biological information is implicit in the links between multiple domains, annotations from these different domains are usually represented in distinct, unconnected DAGs, making links between the domains represented difficult to determine. We develop a novel family of general statistical tests for the discovery of strong associations between two directed acyclic graphs. Our method takes the topology of the input graphs and the specificity and relevance of associations between nodes into consideration. We apply our method to the extraction of associations between biomedical ontologies in an extensive use-case. Through a manual and an automatic evaluation, we show that our tests discover biologically relevant relations. The suite of statistical tests we develop for this purpose is implemented and freely available for download.	[Hoehndorf, Robert] Univ Leipzig, Res Grp Ontol Med, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Hoehndorf, Robert; Ngomo, Axel-Cyrille Ngonga] Univ Leipzig, Dept Comp Sci, Leipzig, Germany; [Hoehndorf, Robert; Dannemann, Michael; Kelso, Janet] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; [Hoehndorf, Robert] European Bioinformat Inst, Cambridge, England	Leipzig University; Leipzig University; Max Planck Society; European Molecular Biology Laboratory (EMBL)	Hoehndorf, R (corresponding author), Univ Leipzig, Res Grp Ontol Med, Inst Med Informat Stat & Epidemiol, Leipzig, Germany.	hoehndor@ebi.ac.uk	Kelso, Janet/N-1812-2019; Hoehndorf, Robert/H-6127-2019; Hoehndorf, Robert/A-9943-2011	Kelso, Janet/0000-0002-3618-322X; Hoehndorf, Robert/0000-0001-8149-5890; Hoehndorf, Robert/0000-0001-8149-5890	Max Planck Society; University of Leipzig	Max Planck Society(Max Planck SocietyFoundation CELLEX); University of Leipzig	The study was funded by the Max Planck Society and the University of Leipzig. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bada M, 2007, J BIOMED INFORM, V40, P300, DOI 10.1016/j.jbi.2006.07.003; Bard J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r21; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Couto F.M., 2005, P 14 ACM INT C INF K, P343, DOI DOI 10.1145/1099554.1099658; del Pozo A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-50; Doms A, 2005, NUCLEIC ACIDS RES, V33, pW783, DOI 10.1093/nar/gki470; Gaudan S, 2008, EURASIP J BIOINFORM, DOI 10.1155/2008/342746; GOLBREICH C, 2007, CEUR WORKSHOP P, V258; GRUBER TR, 1993, KNOWL ACQUIS, V5, P199, DOI 10.1006/knac.1993.1008; Herre H., 2006, 8 U LEIPZ I MED INF; Lin D, 1998, P 15 INT C MACH LEAR; Manning C.D., 1999, FDN STAT NATURAL LAN; Othman RM, 2008, J BIOMED INFORM, V41, P65, DOI 10.1016/j.jbi.2007.05.010; Pantel P., 2002, P 8 ACM SIGKDD INT C, P613; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Resnik P, 1995, INT JOINT CONF ARTIF, P448; Smith B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r46; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wu HW, 2005, NUCLEIC ACIDS RES, V33, P2822, DOI 10.1093/nar/gki573; Wu XM, 2006, NUCLEIC ACIDS RES, V34, P2137, DOI 10.1093/nar/gkl219	23	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e10996	10.1371/journal.pone.0010996	http://dx.doi.org/10.1371/journal.pone.0010996			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585388	Green Published, gold, Green Submitted			2022-12-27	WOS:000278886100004
J	Huang, HH; Su, M; Li, XY; Li, H; Tian, DP; Gao, YX; Guo, YB				Huang, Haihua; Su, Min; Li, Xiaoyun; Li, Hui; Tian, Dongping; Gao, Yuxia; Guo, Yubai			Y-Chromosome Evidence for Common Ancestry of Three Chinese Populations with a High Risk of Esophageal Cancer	PLOS ONE			English	Article							MODERN HUMAN-ORIGIN; FAMILIAL AGGREGATION; POLYMORPHISMS; AREA; LOCI; ASIA	High rates of esophageal cancer (EC) are found in people of the Henan Taihang Mountain, Fujian Minnan, and Chaoshan regions of China. Historical records describe great waves of populations migrating from north-central China (the Henan and Shanxi Hans) through coastal Fujian Province to the Chaoshan plain. Although these regions are geographically distant, we hypothesized that EC high-risk populations in these three areas could share a common ancestry. Accordingly, we used 16 East Asian-specific Y-chromosome biallelic markers (single nucleotide polymorphisms; Y-SNPs) and six Y-chromosome short tandem repeat (Y-STR) loci to infer the origin of the EC high-risk Chaoshan population (CSP) and the genetic relationship between the CSP and the EC high-risk Henan Taihang Mountain population (HTMP) and Fujian population (FJP). The predominant haplogroups in these three populations are O3*, O3e*, and O3e1, with no significant difference between the populations in the frequency of these genotypes. Frequency distribution and principal component analysis revealed that the CSP is closely related to the HTMP and FJP, even though the former is geographically nearer to other populations (Guangfu and Hakka clans). The FJP is between the CSP and HTMP in the principal component plot. The CSP, FJP and HTMP are more closely related to Chinese Hans than to minorities, except Manchu Chinese, and are descendants of Sino-Tibetans, not Baiyues. Correlation analysis, hierarchical clustering analysis, and phylogenetic analysis (neighbor-joining tree) all support close genetic relatedness among the CSP, FJP and HTMP. The network for haplogroup O3 (including O3*, O3e* and O3e1) showed that the HTMP have highest STR haplotype diversity, suggesting that the HTMP may be a progenitor population for the CSP and FJP. These findings support the potentially important role of shared ancestry in understanding more about the genetic susceptibility in EC etiology in high-risk populations and have implications for determining the molecular basis of this disease.	[Huang, Haihua; Su, Min; Li, Xiaoyun; Tian, Dongping; Gao, Yuxia; Guo, Yubai] Shantou Univ, Coll Med, Dept Pathol, Key Immunopathol Lab Guangdong Prov, Shantou, Guangdong, Peoples R China; [Huang, Haihua] Shantou Univ, Coll Med, Affiliated Hosp 2, Shantou, Guangdong, Peoples R China; [Li, Hui] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Li, Hui] Fudan Univ, Sch Life Sci, Ctr Anthropol Studies, Shanghai 200433, Peoples R China; [Li, Hui] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Shantou University; Shantou University; Fudan University; Fudan University; Yale University	Huang, HH (corresponding author), Shantou Univ, Coll Med, Dept Pathol, Key Immunopathol Lab Guangdong Prov, Shantou, Guangdong, Peoples R China.	minsu@stu.edu.cn	Li, Hui/A-2014-2010		National Natural Science Foundation of China [30210103904]; Key Natural Science Foundation of Guangdong Province, China [A1080203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (No. 30210103904) and Key Natural Science Foundation of Guangdong Province, China (No. A1080203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BA GJ, 2007, J FORENSIC MED, V23, P206; Chang-Claude J, 1997, INT J EPIDEMIOL, V26, P1159, DOI 10.1093/ije/26.6.1159; CHEN WS, 1996, CHIN J CANC, V15, P274; CHEN ZH, 2001, OUTLINE CHAOSHAN CUL, P40; Ellis N, 2002, GENOME RES, V12, P339; FEI XT, 1999, PATTERN DIVERSITY UN, P4; Feng C. J., 2005, FORENSIC SCI TECHNOL, V3, P23; GE JX, 1997, MIGRATION HIST CHINA, P7; He Yan, 2006, Yichuan, V28, P1495, DOI 10.1360/yc-006-1495; HU N, 1992, INT J EPIDEMIOL, V21, P877, DOI 10.1093/ije/21.5.877; HUANG T, 1999, ORIGIN DEV CHANSHAN, P1; Huang ZP, 2000, KEY ENG MAT, V177-1, P1, DOI 10.4028/www.scientific.net/KEM.177-180.1; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Ke YH, 2001, SCI CHINA SER C, V44, P225, DOI 10.1007/BF02879329; KUANG JZ, 2005, PENAL TECHNOL, V1, P19; Li Hui, 2003, Acta Genetica Sinica, V30, P873; Liu HX, 2007, J HUAZHONG U SCI-MED, V27, P601, DOI 10.1007/s11596-007-0532-0; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; PENG XE, 2003, CHIN J PREV CONTR CH, V11, P212; ROOHULLAH, 2005, PAK J MED RES, V44, P101; Sambrook J, 1996, MOL CLONING LAB MANU, P463; SI MQ, 2007, HIST MIRROR, V1, P120; Stewart B.W., 2003, WORLD CANC REPORT; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; SU M, 2005, P 1 ASS INT AC C ES, P149; Su M, 2004, WORLD J GASTROENTERO, V10, P2163; Su M, 2007, EUR J EPIDEMIOL, V22, P43, DOI 10.1007/s10654-006-9086-x; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; WEN B, 2004, THESIS FUDAN U, P1; Wu W. W., 2005, FORENSIC SCI TECHNOL, V5, P11; XIE CG, 2003, J HANSHAN TEACHERS C, V24, P1; YANG XX, 2005, J DALI U, V4, P24; [俞建昆 YU Jiankun], 2006, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V12, P247; Yu Liang, 2005, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V22, P337; ZHANG XH, 2006, J FORENSIC MED, V22, P210; Zhao Jian-Min, 2007, Zhonghua Yixue Yichuanxue Zazhi, V24, P94; ZOU XN, 2002, B CHIN CANC, V11, P446; 文波, 2003, [中国科学. C辑, 生命科学, Science in China], V33, P375; 王冬花, 2006, [中国法医学杂志, Chinese Journal of Forensic Medicine], V21, P302; 杨剑, 2002, [中国法医学杂志, Chinese Journal of Forensic Medicine], V17, P346; 李飚, 2006, [中国法医学杂志, Chinese Journal of Forensic Medicine], V21, P172; 陈水琴, 2005, [中国法医学杂志, Chinese Journal of Forensic Medicine], V20, P174	42	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11118	10.1371/journal.pone.0011118	http://dx.doi.org/10.1371/journal.pone.0011118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559544	Green Published, Green Submitted, gold			2022-12-27	WOS:000278775900009
J	Mancuso, M; Sammarco, MC; Grabczyk, E				Mancuso, Miriam; Sammarco, Mimi C.; Grabczyk, Ed			Transposon Tn7 Preferentially Inserts into GAA circle TTC Triplet Repeats under Conditions Conducive to Y circle R circle Y Triplex Formation	PLOS ONE			English	Article							DNA STRUCTURES; RNA-POLYMERASE; GENE; TRANSCRIPTION; RECOGNITION; LENGTH	Background: Expansion of an unstable GAA circle TTC repeat in the first intron of the FXN gene causes Friedreich ataxia by reducing frataxin expression. Structure formation by the repeat has been implicated in both frataxin repression and GAA circle TTC instability. The GAA circle TTC sequence is capable of adopting multiple non-B DNA structures including Y circle R circle Y and R circle R circle Y triplexes. Lower pH promotes the formation of Y circle R circle Y triplexes by GAA circle TTC. Here we used the bacterial transposon Tn7 as an in vitro tool to probe whether GAA circle TTC repeats can attract a well-characterized recombinase. Methodology/Principal Findings: Tn7 showed a pH-dependent preference for insertion into uninterrupted regions of a Friedreich ataxia patient-derived repeat, inserting 48, 39 and 14 percent of the time at pH 7, pH 8 and pH 9, respectively. Moreover, Tn7 also showed orientation and region specific insertion within the repeat at pH 7 and pH 8, but not at pH 9. In contrast, transposon Tn5 showed no strong preference for or against the repeat during in vitro transposition at any pH tested. Y circle R circle Y triplex formation was reduced in predictable ways by transposon interruption of the GAA circle TTC repeat. However, transposon interruptions in the GAA circle TTC repeats did not increase the in vitro transcription efficiency of the templates. Conclusions/Significance: We have demonstrated that transposon Tn7 will recognize structures that form spontaneously in GAA circle TTC repeats and insert in a specific orientation within the repeat. The conditions used for in vitro transposition span the physiologically relevant range suggesting that long GAA circle TTC repeats can form triplex structures in vivo, attracting enzymes involved in DNA repair, recombination and chromatin modification.	[Mancuso, Miriam; Sammarco, Mimi C.; Grabczyk, Ed] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA; [Mancuso, Miriam] Louisiana State Univ, Dept Med, Hlth Sci Ctr, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Mancuso, M (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA.	egrabc@lsuhsc.edu		Sammarco, Mimi/0000-0001-9491-5735	National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH) [R01NS046567]; Friedreich's Ataxia Research Alliance (FARA); Muscular Dystrophy Association (MDA); LSUHSC Research Enhancement Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046567] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Friedreich's Ataxia Research Alliance (FARA); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); LSUHSC Research Enhancement Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by National Institutes of Health (NIH) grant R01NS046567 from the National Institute of Neurological Disorders and Stroke and by grants from the Friedreich's Ataxia Research Alliance (FARA http://www.curefa.org/) and the Muscular Dystrophy Association (MDA http://www.mda.org/) to EG. Open Access publication charges for this article were paid by an LSUHSC Research Enhancement Fund grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asensio JL, 1998, J MOL BIOL, V275, P811, DOI 10.1006/jmbi.1997.1520; BAINTON RJ, 1993, CELL, V72, P931, DOI 10.1016/0092-8674(93)90581-A; Banerjee A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006193; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Biery MC, 2000, NUCLEIC ACIDS RES, V28, P1067, DOI 10.1093/nar/28.5.1067; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; COLLIER DA, 1990, J BIOL CHEM, V265, P10652; De Biase I, 2007, GENOMICS, V90, P1, DOI 10.1016/j.ygeno.2007.04.001; De Blase I, 2007, ANN NEUROL, V61, P55, DOI 10.1002/ana.21052; Ditch S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000704; Filla A, 1996, AM J HUM GENET, V59, P554; Filutowicz M, 1998, GENE, V223, P195, DOI 10.1016/S0378-1119(98)00367-9; FRANKKAMENETSKII MD, 1995, ANNU REV BIOCHEM, V64, P65, DOI 10.1146/annurev.bi.64.070195.000433; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P4930, DOI 10.1093/nar/28.24.4930; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; HTUN H, 1988, SCIENCE, V241, P1791, DOI 10.1126/science.3175620; HTUN H, 1989, SCIENCE, V243, P1571, DOI 10.1126/science.2648571; Kuduvalli PN, 2001, EMBO J, V20, P924, DOI 10.1093/emboj/20.4.924; Montermini L, 1997, ANN NEUROL, V41, P675, DOI 10.1002/ana.410410518; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Ohshima K, 1999, NEUROLOGY, V53, P1854, DOI 10.1212/WNL.53.8.1854; Pandolfo M, 2008, ARCH NEUROL-CHICAGO, V65, P1296, DOI 10.1001/archneur.65.10.1296; Parks AR, 2009, CELL, V138, P685, DOI 10.1016/j.cell.2009.06.011; Pearson CE, 1998, CURR OPIN STRUC BIOL, V8, P321, DOI 10.1016/S0959-440X(98)80065-1; Peters JE, 2001, GENE DEV, V15, P737, DOI 10.1101/gad.870201; Posey JE, 2006, PLOS BIOL, V4, P1934, DOI 10.1371/journal.pbio.0040350; Potaman VN, 2004, NUCLEIC ACIDS RES, V32, P1224, DOI 10.1093/nar/gkh274; Raghavan SC, 2006, BIOESSAYS, V28, P480, DOI 10.1002/bies.20353; Raghavan SC, 2005, J BIOL CHEM, V280, P22749, DOI 10.1074/jbc.M502952200; Rao JE, 2000, P NATL ACAD SCI USA, V97, P3936, DOI 10.1073/pnas.080061497; Rao JE, 2001, J MOL BIOL, V307, P1161, DOI 10.1006/jmbi.2001.4553; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Usdin K, 2000, CELL MOL LIFE SCI, V57, P914, DOI 10.1007/PL00000734; WADDELL CS, 1989, P NATL ACAD SCI USA, V86, P3958, DOI 10.1073/pnas.86.11.3958; WELLS RD, 1988, FASEB J, V2, P2939, DOI 10.1096/fasebj.2.14.3053307	40	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11121	10.1371/journal.pone.0011121	http://dx.doi.org/10.1371/journal.pone.0011121			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559546	Green Published, gold, Green Submitted			2022-12-27	WOS:000278775900012
J	Lee, S; Donehower, LA; Herron, AJ; Moore, DD; Fu, LN				Lee, Susie; Donehower, Lawrence A.; Herron, Alan J.; Moore, David D.; Fu, Loning			Disrupting Circadian Homeostasis of Sympathetic Signaling Promotes Tumor Development in Mice	PLOS ONE			English	Article							AUTONOMIC NERVOUS-SYSTEM; BREAST-CANCER RISK; GENE-EXPRESSION; GROWTH-HORMONE; SHIFT WORK; CLOCK; LIGHT; MELATONIN; LEPTIN; RECEPTOR	Background: Cell proliferation in all rapidly renewing mammalian tissues follows a circadian rhythm that is often disrupted in advanced-stage tumors. Epidemiologic studies have revealed a clear link between disruption of circadian rhythms and cancer development in humans. Mice lacking the circadian genes Period1 and 2 (Per) or Cryptochrome1 and 2 (Cry) are deficient in cell cycle regulation and Per2 mutant mice are cancer-prone. However, it remains unclear how circadian rhythm in cell proliferation is generated in vivo and why disruption of circadian rhythm may lead to tumorigenesis. Methodology/Principal Findings: Mice lacking Per1 and 2, Cry1 and 2, or one copy of Bmal1, all show increased spontaneous and radiation-induced tumor development. The neoplastic growth of Per-mutant somatic cells is not controlled cell-autonomously but is dependent upon extracellular mitogenic signals. Among the circadian output pathways, the rhythmic sympathetic signaling plays a key role in the central-peripheral timing mechanism that simultaneously activates the cell cycle clock via AP1-controlled Myc induction and p53 via peripheral clock-controlled ATM activation. Jet-lag promptly desynchronizes the central clock-SNS-peripheral clock axis, abolishes the peripheral clock-dependent ATM activation, and activates myc oncogenic potential, leading to tumor development in the same organ systems in wild-type and circadian gene-mutant mice. Conclusions/Significance: Tumor suppression in vivo is a clock-controlled physiological function. The central circadian clock paces extracellular mitogenic signals that drive peripheral clock-controlled expression of key cell cycle and tumor suppressor genes to generate a circadian rhythm in cell proliferation. Frequent disruption of circadian rhythm is an important tumor promoting factor.	[Lee, Susie; Fu, Loning] Baylor Coll Med, Childrens Nutr Res Ctr, ARS, USDA,Dept Pediat, Houston, TX 77030 USA; [Donehower, Lawrence A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Donehower, Lawrence A.; Moore, David D.; Fu, Loning] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Herron, Alan J.] Baylor Coll Med, Ctr Comparat Med, Dept Pathol, Houston, TX 77030 USA; [Donehower, Lawrence A.; Moore, David D.; Fu, Loning] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; United States Department of Agriculture (USDA); Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lee, S (corresponding author), Baylor Coll Med, Childrens Nutr Res Ctr, ARS, USDA,Dept Pediat, Houston, TX 77030 USA.	loningf@bcm.edu			National Institutes of Health (NIH) [CA107821-01A1]; United States Department of Agriculture (USDA) [CRIS 6250-51000-049, CRIS 6250-51000-055]; NATIONAL CANCER INSTITUTE [R03CA107821] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grant CA107821-01A1, and United States Department of Agriculture (USDA) grants CRIS 6250-51000-049 and CRIS 6250-51000-055 to L. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaminos M, 2005, CANCER RES, V65, P2565, DOI 10.1158/0008-5472.CAN-04-4283; Appleton DR, 2002, CELL PROLIFERAT, V35, P68, DOI 10.1046/j.1365-2184.35.s1.7.x; AUBERT C, 1980, J NEURAL TRANSM, V47, P121, DOI 10.1007/BF01670163; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; BEVILACQUA M, 1991, CANCER, V67, P2543, DOI 10.1002/1097-0142(19910515)67:10<2543::AID-CNCR2820671026>3.0.CO;2-L; Bjarnason GA, 2000, PROG CELL CYC RES, V4, P193; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chen ST, 2005, CARCINOGENESIS, V26, P1241, DOI 10.1093/carcin/bgi075; Dang CV, 2005, CANCER CELL, V8, P177, DOI 10.1016/j.ccr.2005.08.005; Davis S, 2001, JNCI-J NATL CANCER I, V93, P1557, DOI 10.1093/jnci/93.20.1557; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; ECHAVELLANOS JM, 1970, JNCI-J NATL CANCER I, V44, P581; Filipski E, 2005, JNCI-J NATL CANCER I, V97, P507, DOI 10.1093/jnci/dji083; Filipski E, 2002, J NATL CANCER I, V94, P690; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Furness JB, 2006, AUTON NEUROSCI-BASIC, V130, P1, DOI 10.1016/j.autneu.2006.05.003; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Gery S, 2005, BLOOD, V106, P2827, DOI 10.1182/blood-2005-01-0358; Gery S, 2007, CLIN CANCER RES, V13, P1399, DOI 10.1158/1078-0432.CCR-06-1730; Giglio Pierre, 2005, Curr Oncol Rep, V7, P61, DOI 10.1007/s11912-005-0027-8; HAMILTON T, 1969, BRIT J SURG, V56, P764, DOI 10.1002/bjs.1800561018; Hansen J, 2001, EPIDEMIOLOGY, V12, P74, DOI 10.1097/00001648-200101000-00013; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; Hoffman AE, 2009, CANCER RES, V69, P3605, DOI 10.1158/0008-5472.CAN-08-4572; HOSHINO S, 1994, J NEUROSURG, V80, P919, DOI 10.3171/jns.1994.80.5.0919; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Iwakuma T, 2003, MOL CANCER RES, V1, P993; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kiba T, 2004, PANCREAS, V29, pE51, DOI 10.1097/00006676-200408000-00019; Kim M, 1998, J NEURO-ONCOL, V36, P85, DOI 10.1023/A:1005716408970; KLEVECZ RR, 1987, CHRONOBIOL INT, V4, P513, DOI 10.3109/07420528709078543; Kloog I, 2009, CHRONOBIOL INT, V26, P108, DOI 10.1080/07420520802694020; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; KRISS VM, 1995, SKELETAL RADIOL, V24, P633; Lahti TA, 2008, INT J CANCER, V123, P2148, DOI 10.1002/ijc.23566; Levi FA, 2008, IEEE ENG MED BIOL, V27, P17, DOI 10.1109/MEMB.2007.907361; Li JC, 1997, BIOL SIGNAL, V6, P77; Lin YM, 2008, MOL CARCINOGEN, V47, P925, DOI 10.1002/mc.20446; Marino JL, 2008, EPIDEMIOLOGY, V19, P477, DOI 10.1097/EDE.0b013e31816b7378; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; MHATRE MC, 1984, JNCI-J NATL CANCER I, V72, P1411; OPARIL S, 1987, CAN J PHYSIOL PHARM, V65, P1548, DOI 10.1139/y87-244; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Panzer A, 1997, MED HYPOTHESES, V48, P523, DOI 10.1016/S0306-9877(97)90123-7; Pogue-Geile KL, 2006, CANCER LETT, V243, P55, DOI 10.1016/j.canlet.2005.11.049; Rao JM, 2008, MED HYPOTHESES, V71, P442, DOI 10.1016/j.mehy.2008.03.039; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Renehan AG, 2008, BEST PRACT RES CL EN, V22, P639, DOI 10.1016/j.beem.2008.08.011; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; RYDELL R, 1990, In Vivo (Attiki), V4, P385; Scarpace PJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE259, DOI 10.1152/ajpendo.1998.275.2.E259; Schemhammer ES, 2006, ENDOCR-RELAT CANCER, V13, P583, DOI 10.1677/erc.1.01149; Schibler U, 2009, J BIOL RHYTHM, V24, P3, DOI 10.1177/0748730408329383; SCHOENBERG BS, 1977, CANCER, V40, P1961, DOI 10.1002/1097-0142(197710)40:4+<1961::AID-CNCR2820400831>3.0.CO;2-G; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; Sephton SE, 2000, J NATL CANCER I, V92, P994, DOI 10.1093/jnci/92.12.994; SHAH PN, 1984, CANCER RES, V44, P3403; Shih MC, 2006, MOL CARCINOGEN, V45, P732, DOI 10.1002/mc.20198; Skibola CF, 2004, CANCER EPIDEM BIOMAR, V13, P779; Smaaland R, 1996, Prog Cell Cycle Res, V2, P241; Sood AK, 2006, CLIN CANCER RES, V12, P369, DOI 10.1158/1078-0432.CCR-05-1698; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tokunaga H, 2008, ACTA OBSTET GYN SCAN, V87, P1060, DOI 10.1080/00016340802348286; Touitou Y, 1996, BRIT J CANCER, V74, P1248, DOI 10.1038/bjc.1996.524; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; van den Heiligenberg S, 1999, LIFE SCI, V64, P2523, DOI 10.1016/S0024-3205(99)00210-6; Viswanathan AN, 2009, CANCER LETT, V281, P1, DOI 10.1016/j.canlet.2008.11.002; Westphal CH, 1997, NAT GENET, V16, P397, DOI 10.1038/ng0897-397; Wong HPS, 2007, TOXICOL SCI, V97, P279, DOI 10.1093/toxsci/kfm060; Wood PA, 2008, MOL CANCER RES, V6, P1786, DOI 10.1158/1541-7786.MCR-08-0196; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zhu Y, 2007, INT J CANCER, V120, P432, DOI 10.1002/ijc.22321; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	83	169	182	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10995	10.1371/journal.pone.0010995	http://dx.doi.org/10.1371/journal.pone.0010995			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539819	Green Published, Green Submitted, gold			2022-12-27	WOS:000278465900012
J	Lima, VD; Hogg, RS; Montaner, JSG				Lima, Viviane D.; Hogg, Robert S.; Montaner, Julio S. G.			Expanding HAART Treatment to All Currently Eligible Individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV PREVENTION; SCALING-UP; TRANSMISSION; ACCESS; IMPACT; INFECTION; GROWTH; CURB	Background: In 2008, the IAS-USA published the revised guidelines for the use of HAART in adults substantially increasing the number of individuals eligible for HAART. The epidemic in British Columbia (BC) is mainly among men who have sex with men and those with injection drug use. Here, we explored the potential impact of different HAART coverage scenarios, based on the new guidelines, on the HIV-related incidence, morbidity and mortality in BC, Canada. Methodology: We built a mathematical transmission model to investigate different HAART coverage scenarios (50%, 60%, 75% and 100%) of those medically eligible to receive HAART under the 2008 IAS guidelines. All new scenarios were compared to the current coverage in BC under the 2006 IAS guidelines (i.e. baseline scenario). In BC, it is estimated that 25-30% of individuals are unaware of their status. Costs were drug-related and reported in Canadian dollars. HIV-related morbidity and mortality were estimated based on the disability-adjusted life years (DALY) methodology. Principal Findings: Currently, there are 4379 individuals on HAART under the IAS 2006 guidelines and 6781 individuals who qualify for treatment based on the new guidelines. Within 5 years, increasing HAART coverage decreased yearly new infections by at least 44.8%. In the 50% scenario, in 5 years, DALY decreased by 53% corresponding to 4155 averted DALYs, and in 25 years it decreased by 66% corresponding to 5837 averted DALYs. The effect was even stronger if the 75% scenario was chosen instead. Compared to the 100% expansion scenario, we observed an excess in annual direct treatment expenditures at the end of 5 years of approximately 1 million dollars in the 75% scenario, and of approximately 2 million dollars in the 50% scenario. Conclusions/Significance: The individual and public health benefits of these new guidelines are immense. The results show that by increasing the number of individuals on HAART save lives, it is cost averting, and it positively impacts society by decreasing the number of new HIV infections. Thus, public health community should consider incremental gains when considering guidelines and policy.	[Lima, Viviane D.; Hogg, Robert S.; Montaner, Julio S. G.] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Lima, Viviane D.; Montaner, Julio S. G.] Univ British Columbia, Fac Med, Dept Med, Div Aids, Vancouver, BC, Canada; [Hogg, Robert S.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; Simon Fraser University	Lima, VD (corresponding author), St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	vlima@cfenet.ubc.ca	Hogg, Robert S/B-2783-2012; Montaner, Julio/K-7621-2012	Hogg, Robert S/0000-0003-3463-5488; 	Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; National Institute on Drug Abuse at the US National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026182] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); National Institute on Drug Abuse at the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Canadian Institutes of Health Research and Michael Smith Foundation for Health Research through fellowship awards to Dr. Lima. Dr. Montaner is a recipient of an Avant-Garde Award from the National Institute on Drug Abuse at the US National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2006, JAIDS-J ACQ IMM DEF, V41, P632, DOI 10.1097/01.qai.0000194234.31078.bf; [Anonymous], 14 C RETR OPP INF FE; [Anonymous], GLOB BURD DIS 2004 U; *BRIT COL CTR DIS, 2008, STI HIV ANN REP 2008; *BRIT COL CTR DIS, 2007, HIV AIDS ANN REP 200; *BRIT COL CTR EXC, 2010, HIV PREV BRIT COL; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; De Cock KM, 2009, LANCET, V373, P7, DOI 10.1016/S0140-6736(08)61732-8; DeCruttola V, 2008, AIDS, V22, P2554, DOI 10.1097/QAD.0b013e32831940d3; Dube S, 2008, JAIDS-J ACQ IMM DEF, V48, P72, DOI 10.1097/QAI.0b013e31816bcdbb; Egger M, 2008, LANCET, V371, P1558, DOI 10.1016/S0140-6736(08)60669-8; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Gazzard BG, 2008, HIV MED, V9, P563, DOI 10.1111/j.1468-1293.2008.00636.x; Gill VS, 2010, CLIN INFECT DIS, V50, P98, DOI 10.1086/648729; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hogg Robert S, 2005, Harm Reduct J, V2, P26, DOI 10.1186/1477-7517-2-26; Joy R, 2008, JAIDS-J ACQ IMM DEF, V47, P500, DOI 10.1097/QAI.0b013e3181648dfd; Katz MH, 2002, AM J PUBLIC HEALTH, V92, P388, DOI 10.2105/AJPH.92.3.388; Lagakos SW, 2008, NEW ENGL J MED, V358, P1543, DOI 10.1056/NEJMp0802028; LIMA V, 2009, 5 IAS C HIV PATH TRE; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Lima VD, 2007, AIDS, V21, P685, DOI 10.1097/QAD.0b013e32802ef30c; Markel H, 2005, NEW ENGL J MED, V353, P753, DOI 10.1056/NEJMp058146; Marshall BDL, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-7; Martinez V, 2008, CURR OPIN INFECT DIS, V21, P42, DOI 10.1097/QCO.0b013e3282f3d9d3; McInnes CW, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-5; Montaner J, 2009, AIDS, V23, P1031, DOI 10.1097/QAD.0b013e32832a128b; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; *PAN ANT GUID AD A, 2008, GUID US ANT AG HIV 1; Public Health Agency of Canada, 2007, HIV AIDS EP UPD NOV; Rotheram-Borus MJ, 2009, ANNU REV CLIN PSYCHO, V5, P143, DOI 10.1146/annurev.clinpsy.032408.153530; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556; SPAAR A, 2009, 5 IAS C HIV PATH TRE; *STAT CAN, 2010, CANSIM; Steinbrook R, 2008, NEW ENGL J MED, V359, P885, DOI 10.1056/NEJMp0805761; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; TOVANABUTRA S, 2002, J ACQ IMMUN DEF SYND, V3, P275; UNAIDS, 2008, REP GLOB AIDS EP; VERMUND SH, 2009, HIV AIDS, V4, P266; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; 2009, AIDS READ, V19, P229; 2010, SEEK TREAT OPTIMAL P	45	41	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10991	10.1371/journal.pone.0010991	http://dx.doi.org/10.1371/journal.pone.0010991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539817	Green Submitted, Green Published, gold			2022-12-27	WOS:000278465900009
J	Minea, RO; Helchowski, CM; Zidovetzki, SJ; Costa, FK; Swenson, SD; Markland, FS				Minea, Radu O.; Helchowski, Corey M.; Zidovetzki, Samuel J.; Costa, Fritz K.; Swenson, Stephen D.; Markland, Francis S., Jr.			Vicrostatin - An Anti-Invasive Multi-Integrin Targeting Chimeric Disintegrin with Tumor Anti-Angiogenic and Pro-Apoptotic Activities	PLOS ONE			English	Article							SNAKE-VENOM DISINTEGRIN; AGKISTRODON-CONTORTRIX-CONTORTRIX; ALPHA-V INTEGRINS; BREAST-CANCER; CELL-ADHESION; TYROSINE PHOSPHORYLATION; HOMODIMERIC DISINTEGRIN; ENDOGENOUS INHIBITORS; EXTRACELLULAR-MATRIX; DIMERIC DISINTEGRIN	Similar to other integrin-targeting strategies, disintegrins have previously shown good efficacy in animal cancer models with favorable pharmacological attributes and translational potential. Nonetheless, these polypeptides are notoriously difficult to produce recombinantly due to their particular structure requiring the correct pairing of multiple disulfide bonds for biological activity. Here, we show that a sequence-engineered disintegrin (called vicrostatin or VCN) can be reliably produced in large scale amounts directly in the oxidative cytoplasm of Origami B E. coli. Through multiple integrin ligation (i.e., alpha v beta 3, alpha v beta 5, and alpha 5 beta 1), VCN targets both endothelial and cancer cells significantly inhibiting their motility through a reconstituted basement membrane. Interestingly, in a manner distinct from other integrin ligands but reminiscent of some ECM-derived endogenous anti-angiogenic fragments previously described in the literature, VCN profoundly disrupts the actin cytoskeleton of endothelial cells (EC) inducing a rapid disassembly of stress fibers and actin reorganization, ultimately interfering with EC's ability to invade and form tubes (tubulogenesis). Moreover, here we show for the first time that the addition of a disintegrin to tubulogenic EC sandwiched in vitro between two Matrigel layers negatively impacts their survival despite the presence of abundant haptotactic cues. A liposomal formulation of VCN (LVCN) was further evaluated in vivo in two animal cancer models with different growth characteristics. Our data demonstrate that LVCN is well tolerated while exerting a significant delay in tumor growth and an increase in the survival of treated animals. These results can be partially explained by potent tumor anti-angiogenic and pro-apoptotic effects induced by LVCN.	[Minea, Radu O.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Minea, RO (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA.	markland@usc.edu	Markland, Frank/D-5073-2012		Army Ovarian Cancer Research Program [W81XWH-07-1-0298]; National Institutes of Health [1R41CA121452, 1R41CA126001]; California Breast Cancer Research Program [12IB-0153];  [BCTR0707423]; NATIONAL CANCER INSTITUTE [R41CA121452, R41CA126001] Funding Source: NIH RePORTER	Army Ovarian Cancer Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Breast Cancer Research Program; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by grant support to FSM (Susan G. Komen, http://ww5.komen.org, grant #BCTR0707423; Army Ovarian Cancer Research Program, http://cdmrp.army.mil/ocrp/default.htm, grant #W81XWH-07-1-0298; National Institutes of Health, www.nih.gov, grants #1R41CA121452 and 1R41CA126001), and to SDS (California Breast Cancer Research Program, http://www.cbcrp.org/, grant #12IB-0153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Artoni A, 2004, P NATL ACAD SCI USA, V101, P13114, DOI 10.1073/pnas.0404201101; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016; Bix G, 2005, TRENDS CELL BIOL, V15, P52, DOI 10.1016/j.tcb.2004.11.008; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; Brown DC, 2002, HISTOPATHOLOGY, V40, P2, DOI 10.1046/j.1365-2559.2002.01343.x; Carbonell WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005857; CARRINGTON JC, 1988, P NATL ACAD SCI USA, V85, P3391, DOI 10.1073/pnas.85.10.3391; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Clamp AR, 2005, BRIT J CANCER, V93, P967, DOI 10.1038/sj.bjc.6602820; Contois L, 2009, SEMIN CANCER BIOL, V19, P318, DOI 10.1016/j.semcancer.2009.05.002; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Dixelius J, 2002, CANCER RES, V62, P1944; Eble JA, 2010, MATRIX BIOL, V29, P239, DOI 10.1016/j.matbio.2010.01.004; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Ellis LM, 2009, NATURE, V458, P290, DOI 10.1038/458290a; Ferrara N, 2005, BIOCHEM BIOPH RES CO, V333, P328, DOI 10.1016/j.bbrc.2005.05.132; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fox SB, 2004, APMIS, V112, P413, DOI 10.1111/j.1600-0463.2004.apm11207-0803.x; Fujii Y, 2003, J MOL BIOL, V332, P1115, DOI 10.1016/S0022-2836(03)00991-4; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Golubkov Vladislav, 2003, Angiogenesis, V6, P213, DOI 10.1023/B:AGEN.0000021396.47009.b0; Goodman SL, 2002, J MED CHEM, V45, P1045, DOI 10.1021/jm0102598; GOULD RJ, 1990, P SOC EXP BIOL MED, V195, P168, DOI 10.3181/00379727-195-43129B; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hariharan S, 2007, ANN ONCOL, V18, P1400, DOI 10.1093/annonc/mdm140; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Huang TF, 2001, HAEMOSTASIS, V31, P192; Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918; Imai K, 2006, NAT REV CANCER, V6, P714, DOI 10.1038/nrc1913; Ivaska J, 2010, CELL TISSUE RES, V339, P111, DOI 10.1007/s00441-009-0857-z; Juarez P, 2008, MOL BIOL EVOL, V25, P2391, DOI 10.1093/molbev/msn179; Jurasz P, 2004, BRIT J PHARMACOL, V143, P819, DOI 10.1038/sj.bjp.0706013; Kim S, 2000, J BIOL CHEM, V275, P33920, DOI 10.1074/jbc.M003668200; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; Mahabeleshwar GH, 2008, CELL CYCLE, V7, P335, DOI 10.4161/cc.7.3.5234; Mahabeleshwar GH, 2006, J EXP MED, V203, P2495, DOI 10.1084/jem.20060807; McCarty JH, 2008, AM J PATHOL, V172, P1740, DOI 10.2353/ajpath.2008.070700; McLane MA, 1998, P SOC EXP BIOL MED, V219, P109, DOI 10.3181/00379727-219-44322; McLane MA, 2008, FRONT BIOSCI-LANDMRK, V13, P6617, DOI 10.2741/3177; Minea R, 2005, PATHOPHYSIOL HAEMO T, V34, P177, DOI 10.1159/000092419; Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x; Moiseeva N, 2008, ACTA CRYSTALLOGR D, V64, P466, DOI 10.1107/S0907444908002370; Napione L, 2007, AUTOIMMUN REV, V7, P18, DOI 10.1016/j.autrev.2007.03.007; Nash GF, 2002, LANCET ONCOL, V3, P425, DOI 10.1016/S1470-2045(02)00789-1; Nemeth JA, 2007, CANCER INVEST, V25, P632, DOI 10.1080/07357900701522638; OSBORNE CK, 1985, CANCER RES, V45, P584; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Park Sang-Hyun, 2004, Methods Mol Biol, V261, P161; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Petrelli A, 2009, EXPERT OPIN PHARMACO, V10, P589, DOI [10.1517/14656560902781907, 10.1517/14656560902781907 ]; PRICE JE, 1990, CANCER RES, V50, P717; PROTOPAPA E, 1993, EUR J CANCER, V29A, P1391, DOI 10.1016/0959-8049(93)90008-4; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Reardon DA, 2008, EXPERT OPIN INV DRUG, V17, P1225, DOI 10.1517/13543784.17.8.1225 ; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Ribatti D, 2009, LEUKEMIA RES, V33, P638, DOI 10.1016/j.leukres.2008.11.019; Ritter MR, 2001, TOXICON, V39, P283, DOI 10.1016/S0041-0101(00)00126-4; Ritter MR, 2000, J CELL BIOCHEM, V79, P28, DOI 10.1002/1097-4644(2000)79:1<28::AID-JCB40>3.0.CO;2-Y; SAUDEK V, 1991, BIOCHEMISTRY-US, V30, P7369, DOI 10.1021/bi00244a003; Schmitmeier S, 2005, NEUROSURGERY, V57, P141, DOI 10.1227/01.NEU.0000163426.25227.56; Serini G, 2006, EXP CELL RES, V312, P651, DOI 10.1016/j.yexcr.2005.10.020; Serini G, 2008, CURR OPIN HEMATOL, V15, P235, DOI 10.1097/MOH.0b013e3282fa745b; Serini G, 2009, ANGIOGENESIS, V12, P187, DOI 10.1007/s10456-009-9138-4; Shih T, 2006, CLIN THER, V28, P1779, DOI 10.1016/j.clinthera.2006.11.015; Silva R, 2008, ARTERIOSCL THROM VAS, V28, P1703, DOI 10.1161/ATVBAHA.108.172015; Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100; Sund M, 2005, P NATL ACAD SCI USA, V102, P2934, DOI 10.1073/pnas.0500180102; Swenson S, 2004, MOL CANCER THER, V3, P499; TRIKHA M, 1994, THROMB RES, V73, P39, DOI 10.1016/0049-3848(94)90052-3; TRIKHA M, 1994, CANCER RES, V54, P4993; Tucker Gordon C, 2006, Curr Oncol Rep, V8, P96, DOI 10.1007/s11912-006-0043-3; Varner J A, 1999, Angiogenesis, V3, P53, DOI 10.1023/A:1009019223744; Varshavsky A, 2008, CANCER RES, V68, P6922, DOI 10.1158/0008-5472.CAN-07-5408; Wierzbicka-Patynowski I, 1999, J BIOL CHEM, V274, P37809, DOI 10.1074/jbc.274.53.37809; Wiesner FG, 2009, BREAST, V18, P135, DOI 10.1016/j.breast.2009.02.009; Zhou Q, 2000, BREAST CANCER RES TR, V61, P249, DOI 10.1023/A:1006457903545; Zhou Q, 1999, Angiogenesis, V3, P259, DOI 10.1023/A:1009059210733; Zhou Q, 2000, BIOCHEM BIOPH RES CO, V267, P350, DOI 10.1006/bbrc.1999.1965	87	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10929	10.1371/journal.pone.0010929	http://dx.doi.org/10.1371/journal.pone.0010929			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532165	Green Published, Green Submitted, gold			2022-12-27	WOS:000278318700003
J	Robinson, E; Titov, N; Andrews, G; McIntyre, K; Schwencke, G; Solley, K				Robinson, Emma; Titov, Nickolai; Andrews, Gavin; McIntyre, Karen; Schwencke, Genevieve; Solley, Karen			Internet Treatment for Generalized Anxiety Disorder: A Randomized Controlled Trial Comparing Clinician vs. Technician Assistance	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; SOCIAL PHOBIA; PANIC DISORDER; SELF-HELP; VALIDATION; DEPRESSION; METAANALYSIS; POPULATION; PREVALENCE; SEVERITY	Background: Internet-based cognitive behavioural therapy (iCBT) for generalized anxiety disorder (GAD) has been shown to be effective when guided by a clinician. The present study sought to replicate this finding, and determine whether support from a technician is as effective as guidance from a clinician. Method: Randomized controlled non-inferiority trial comparing three groups: Clinician-assisted vs. technician-assisted vs. delayed treatment. Community-based volunteers applied to the VirtualClinic (www.virtualclinic.org.au) research program and 150 participants with GAD were randomized. Participants in the clinician-and technician-assisted groups received access to an iCBT program for GAD comprising six online lessons, weekly homework assignments, and weekly supportive contact over a treatment period of 10 weeks. Participants in the clinician-assisted group also received access to a moderated online discussion forum. The main outcome measures were the Penn State Worry Questionnaire (PSWQ) and the Generalized Anxiety Disorder-7 Item (GAD-7). Completion rates were high, and both treatment groups reduced scores on the PSWQ (p < 0.001) and GAD-7 (p < 0.001) compared to the delayed treatment group, but did not differ from each other. Within group effect sizes on the PSWQ were 1.16 and 1.07 for the clinician-and technician-assisted groups, respectively, and on the GAD-7 were 1.55 and 1.73, respectively. At 3 month follow-up participants in both treatment groups had sustained the gains made at post-treatment. Participants in the clinician-assisted group had made further gains on the PSWQ. Approximately 81 minutes of clinician time and 75 minutes of technician time were required per participant during the 10 week treatment program. Conclusions: Both clinician-and technician-assisted treatment resulted in large effect sizes and clinically significant improvements comparable to those associated with face-to-face treatment, while a delayed treatment/control group did not improve. These results provide support for large scale trials to determine the clinical effectiveness and acceptability of technician-assisted iCBT programs for GAD. This form of treatment has potential to increase the capacity of existing mental health services.	[Titov, Nickolai; Andrews, Gavin; Solley, Karen] Univ New S Wales, St Vincents Hosp, Sch Psychiat, Clin Res Unit Anxiety & Depress, Sydney, NSW, Australia	St Vincents Hospital Sydney; University of New South Wales Sydney	Robinson, E (corresponding author), Univ New S Wales, St Vincents Hosp, Sch Psychiat, Clin Res Unit Anxiety & Depress, Sydney, NSW, Australia.	nickt@unsw.edu.au	Andrews, Gavin/J-6537-2012	Andrews, Gavin/0000-0002-4315-2173; Titov, Nickolai/0000-0002-7268-729X	Australian Rotary Health Research Fund	Australian Rotary Health Research Fund	This study was investigator initiated. It was funded by departmental funds and by a grant from the Australian Rotary Health Research Fund (http://www.australianrotaryhealth.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andersson G, 2005, BRIT J PSYCHIAT, V187, P456, DOI 10.1192/bjp.187.5.456; Andersson G, 2006, J CONSULT CLIN PSYCH, V74, P677, DOI 10.1037/0022-006X.74.4.677; Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Andrews G, 2004, BRIT J PSYCHIAT, V184, P526, DOI 10.1192/bjp.184.6.526; Australian Bureau of Statistics [ABS], 2008, NAT SURV MENT HLTH W; BORKOVEC TD, 1972, J BEHAV THER EXP PSY, V3, P257, DOI 10.1016/0005-7916(72)90045-6; Carlbring P, 2005, BEHAV RES THER, V43, P1321, DOI 10.1016/j.brat.2004.10.002; Carlbring P, 2007, BRIT J PSYCHIAT, V190, P123, DOI 10.1192/bjp.bp.105.020107; Carlbring P, 2007, COMPUT HUM BEHAV, V23, P1421, DOI 10.1016/j.chb.2005.05.002; Devilly GJ, 2000, J BEHAV THER EXP PSY, V31, P73, DOI 10.1016/S0005-7916(00)00012-4; Dugas MJ, 2003, J CONSULT CLIN PSYCH, V71, P821, DOI 10.1037/0022-006X.71.4.821; Furmark T, 1999, SOC PSYCH PSYCH EPID, V34, P416, DOI 10.1007/s001270050163; Garb HN, 2007, PSYCHOL ASSESSMENT, V19, P4, DOI 10.1037/1040-3590.19.1.4; Hoffman DL, 2008, DEPRESS ANXIETY, V25, P72, DOI 10.1002/da.20257; Hofmann SG, 2008, J CLIN PSYCHIAT, V69, P621, DOI 10.4088/jcp.v69n0415; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Julious SA, 2004, STAT MED, V23, P1921, DOI 10.1002/sim.1783; Kessler R. C., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P165; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kiropoulos LA, 2008, J ANXIETY DISORD, V22, P1273, DOI 10.1016/j.janxdis.2008.01.008; Klein B, 2006, J BEHAV THER EXP PSY, V37, P213, DOI 10.1016/j.jbtep.2005.07.001; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Ladouceur R, 2000, J CONSULT CLIN PSYCH, V68, P957, DOI 10.1037/0022-006X.68.6.957; Lang AJ, 2004, J CLIN PSYCHIAT, V65, P14; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Marks I, 2007, HANDS ON HELP COMPUT; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Mitte K, 2005, PSYCHOL BULL, V131, P785, DOI 10.1037/0033-2909.131.5.785; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Perini S, 2009, AUST NZ J PSYCHIAT, V43, P571, DOI 10.1080/00048670902873722; Richards DA, 2009, BRIT J CLIN PSYCHOL, V48, P377, DOI 10.1348/014466509X405178; Shandley K, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1033; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sheehan DV., 1983, ANXIETY DIS; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Titov N, 2008, AUST NZ J PSYCHIAT, V42, P595, DOI 10.1080/00048670802119820; Titov N, 2008, AUST NZ J PSYCHIAT, V42, P585, DOI 10.1080/00048670802119762; Titov N, 2007, AUST NZ J PSYCHIAT, V41, P95, DOI 10.1080/00048670601109873; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P920, DOI 10.1080/00048670903179228; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P905, DOI 10.1080/00048670903179269; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P913, DOI 10.1080/00048670903179160; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P36, DOI 10.1080/00048670802534424; Vickers AJ, 2005, PSYCHOSOM MED, V67, P652, DOI 10.1097/01.psy.0000172624.52957.a8; Vickers Andrew J, 2005, BMC Med Res Methodol, V5, P35, DOI 10.1186/1471-2288-5-35; Wittchen HU, 2002, DEPRESS ANXIETY, V16, P162, DOI 10.1002/da.10065; [No title captured]; [No title captured]	48	149	155	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10942	10.1371/journal.pone.0010942	http://dx.doi.org/10.1371/journal.pone.0010942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	605AD	20532167	Green Published, gold, Green Submitted			2022-12-27	WOS:000278318700014
J	Ieronimakis, N; Balasundaram, G; Rainey, S; Srirangam, K; Yablonka-Reuveni, Z; Reyes, M				Ieronimakis, Nicholas; Balasundaram, Gayathri; Rainey, Sabrina; Srirangam, Kiran; Yablonka-Reuveni, Zipora; Reyes, Morayma			Absence of CD34 on Murine Skeletal Muscle Satellite Cells Marks a Reversible State of Activation during Acute Injury	PLOS ONE			English	Article							SELF-RENEWAL; STEM-CELLS; GENE-EXPRESSION; PAX7; QUIESCENT; PROGENITORS; MYOGENESIS; DIFFERENTIATION; SPECIFICATION; HETEROGENEITY	Background: Skeletal muscle satellite cells are myogenic progenitors that reside on myofiber surface beneath the basal lamina. In recent years satellite cells have been identified and isolated based on their expression of CD34, a sialomucin surface receptor traditionally used as a marker of hematopoietic stem cells. Interestingly, a minority of satellite cells lacking CD34 has been described. Methodology/Principal Findings: In order to elucidate the relationship between CD34+ and CD34- satellite cells we utilized fluorescence-activated cell sorting (FACS) to isolate each population for molecular analysis, culture and transplantation studies. Here we show that unless used in combination with alpha 7 integrin, CD34 alone is inadequate for purifying satellite cells. Furthermore, the absence of CD34 marks a reversible state of activation dependent on muscle injury. Conclusions/Significance: Following acute injury CD34- cells become the major myogenic population whereas the percentage of CD34+ cells remains constant. In turn activated CD34- cells can reverse their activation to maintain the pool of CD34+ reserve cells. Such activation switching and maintenance of reserve pool suggests the satellite cell compartment is tightly regulated during muscle regeneration.	[Ieronimakis, Nicholas; Balasundaram, Gayathri; Rainey, Sabrina; Srirangam, Kiran; Reyes, Morayma] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Yablonka-Reuveni, Zipora] Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ieronimakis, N (corresponding author), Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA.	morayma@u.washington.edu		Rainey, Sabrina/0000-0001-9717-7248	Jain Foundation, Inc.; University of Washington's Departments of Pathology and Lab Medicine; National Institutes of Health [5R03AR054955, 1R01AG035377, 5R01AG21566, 5R01AG013798, 1R21AR057794]; Muscular Dystrophy Association [135908]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR054955, R21AR057794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG035377, R01AG013798, R01AG021566] Funding Source: NIH RePORTER	Jain Foundation, Inc.; University of Washington's Departments of Pathology and Lab Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are grateful for the financial support provided by the Jain Foundation, Inc., the University of Washington's Departments of Pathology and Lab Medicine, and National Institutes of Health grant 5R03AR054955 to M. R., and NIH grants 1R01AG035377 and 5R01AG21566 to Z.Y.-R., all of which made this research possible. Z.Y.-R. acknowledges additional support from the NIH (5R01AG013798, 1R21AR057794) and the Muscular Dystrophy Association (135908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Blanco-Bose WE, 2001, EXP CELL RES, V265, P212, DOI 10.1006/excr.2001.5191; Bosnakovski D, 2008, STEM CELLS, V26, P3194, DOI 10.1634/stemcells.2007-1017; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; COVAULT J, 1986, J CELL BIOL, V102, P716, DOI 10.1083/jcb.102.3.716; DALBIS A, 1988, EUR J BIOCHEM, V174, P103, DOI 10.1111/j.1432-1033.1988.tb14068.x; Day K, 2007, DEV BIOL, V304, P246, DOI 10.1016/j.ydbio.2006.12.026; Day K, 2010, DEV BIOL, V340, P330, DOI 10.1016/j.ydbio.2010.01.006; Day K, 2009, DEV DYNAM, V238, P1001, DOI 10.1002/dvdy.21903; Gnocchi VF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005205; Graves DC, 2000, J HISTOCHEM CYTOCHEM, V48, P1173, DOI 10.1177/002215540004800902; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Ieronimakis N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001753; Kafadar KA, 2009, DEV BIOL, V326, P47, DOI 10.1016/j.ydbio.2008.10.036; Kastner S, 2000, J HISTOCHEM CYTOCHEM, V48, P1079, DOI 10.1177/002215540004800805; KELLY R, 1995, J CELL BIOL, V129, P383, DOI 10.1083/jcb.129.2.383; Kirillova I, 2007, DEV BIOL, V311, P449, DOI 10.1016/j.ydbio.2007.08.056; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lanza F, 2001, J BIOL REG HOMEOS AG, V15, P1; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; Nielsen JS, 2009, MICROCIRCULATION, V16, P487, DOI 10.1080/10739680902941737; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Ratajczak MZ, 2003, STEM CELLS, V21, P363, DOI 10.1634/stemcells.21-3-363; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Rooney JE, 2009, AM J PATHOL, V174, P256, DOI 10.2353/ajpath.2009.080522; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sato T, 1999, BLOOD, V94, P2548, DOI 10.1182/blood.V94.8.2548.420k38_2548_2554; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Silva R, 2008, ARTERIOSCL THROM VAS, V28, P1703, DOI 10.1161/ATVBAHA.108.172015; Springer ML, 2002, CELL MOTIL CYTOSKEL, V51, P177, DOI 10.1002/cm.10022; Tajbakhsh S, 1996, DEV DYNAM, V206, P291, DOI 10.1002/(SICI)1097-0177(199607)206:3<291::AID-AJA6>3.0.CO;2-D; Volonte D, 2004, FASEB J, V18, P237, DOI 10.1096/fj.04-2215fje; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yablonka-Reuveni Z, 2008, J Anim Sci, V86, pE207; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200; Yao CC, 1997, J CELL SCI, V110, P1477; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zammit PS, 2001, DIFFERENTIATION, V68, P193, DOI 10.1046/j.1432-0436.2001.680407.x	51	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2010	5	6							e10920	10.1371/journal.pone.0010920	http://dx.doi.org/10.1371/journal.pone.0010920			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604NC	20532193	Green Published, gold, Green Submitted			2022-12-27	WOS:000278284700005
J	Liu, Q; Kim, DI; Syme, J; LuValle, P; Burke, B; Roux, KJ				Liu, Qian; Kim, Dae In; Syme, Janet; LuValle, Phyllis; Burke, Brian; Roux, Kyle J.			Dynamics of Lamin-A Processing Following Precursor Accumulation	PLOS ONE			English	Article							HUTCHINSON-GILFORD-PROGERIA; PROTEASE INHIBITORS BLOCK; NUCLEAR-MEMBRANE PROTEIN; PRELAMIN-A; MOUSE MODEL; RESTRICTIVE DERMOPATHY; SYNDROME MUTATION; IN-VITRO; ZMPSTE24; DISEASE	Lamin A (LaA) is a component of the nuclear lamina, an intermediate filament meshwork that underlies the inner nuclear membrane (INM) of the nuclear envelope (NE). Newly synthesized prelamin A (PreA) undergoes extensive processing involving C-terminal farnesylation followed by proteolysis yielding non-farnesylated mature lamin A. Different inhibitors of these processing events are currently used therapeutically. Hutchinson-Gilford Progeria Syndrome (HGPS) is most commonly caused by mutations leading to an accumulation of a farnesylated LaA isoform, prompting a clinical trial using farnesyltransferase inhibitors (FTI) to reduce this modification. At therapeutic levels, HIV protease inhibitors (PI) can unexpectedly inhibit the final processing step in PreA maturation. We have examined the dynamics of LaA processing and associated cellular effects during PI or FTI treatment and following inhibitor washout. While PI reversibility was rapid, with respect to both LaA maturation and associated cellular phenotype, recovery from FTI treatment was more gradual. FTI reversibility is influenced by both cell type and rate of proliferation. These results suggest a less static lamin network than has previously been observed.	[Liu, Qian] Shandong Univ, Dept Histol & Embryol, Sch Med, Jinan 250100, Shandong, Peoples R China; [Liu, Qian; Kim, Dae In; Syme, Janet; LuValle, Phyllis; Burke, Brian; Roux, Kyle J.] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL USA; [Burke, Brian] Inst Med Biol, Singapore, Singapore	Shandong University; State University System of Florida; University of Florida; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Liu, Q (corresponding author), Shandong Univ, Dept Histol & Embryol, Sch Med, Jinan 250100, Shandong, Peoples R China.	kroux@ufl.edu	Roux, Kyle/AAH-2019-2021; Kim, Dae In/G-7291-2012	Roux, Kyle/0000-0001-7530-5528; 	Bankhead-Coley New Investigator Research (NIR) [08BN-05]; National Institutes of Health (NIH) [RO1 5R01GM084085-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084085] Funding Source: NIH RePORTER	Bankhead-Coley New Investigator Research (NIR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Bankhead-Coley New Investigator Research (NIR) 08BN-05 to K.J.R. (http://www.floridabiomed.com/funding_bc.html) and National Institutes of Health (NIH) RO1 5R01GM084085-02 to B. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrowman J, 2008, MOL BIOL CELL, V19, P5398, DOI 10.1091/mbc.E08-07-0704; BECK LA, 1990, J CELL BIOL, V110, P1489, DOI 10.1083/jcb.110.5.1489; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; Cao K, 2007, P NATL ACAD SCI USA, V104, P4949, DOI 10.1073/pnas.0611640104; Capanni C, 2005, HUM MOL GENET, V14, P1489, DOI 10.1093/hmg/ddi158; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; Capell BC, 2008, P NATL ACAD SCI USA, V105, P15902, DOI 10.1073/pnas.0807840105; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Caron M, 2007, CELL DEATH DIFFER, V14, P1759, DOI 10.1038/sj.cdd.4402197; Caron M, 2003, AIDS, V17, P2437, DOI 10.1097/00002030-200311210-00005; Coffinier C, 2008, J BIOL CHEM, V283, P9797, DOI 10.1074/jbc.M709629200; Coffinier C, 2007, P NATL ACAD SCI USA, V104, P13432, DOI 10.1073/pnas.0704212104; Colakoglu G, 2009, J CELL BIOL, V185, P769, DOI 10.1083/jcb.200809166; Corrigan DP, 2005, BIOCHEM J, V387, P129, DOI 10.1042/BJ20041359; Dahl KN, 2006, P NATL ACAD SCI USA, V103, P10271, DOI 10.1073/pnas.0601058103; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; DEBUSK FL, 1972, J PEDIATR-US, V80, P697, DOI 10.1016/S0022-3476(72)80229-4; Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104; DUNNIGAN MG, 1974, Q J MED, V43, P33; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fong LG, 2006, SCIENCE, V311, P1621, DOI 10.1126/science.1124875; Fong LG, 2004, P NATL ACAD SCI USA, V101, P18111, DOI 10.1073/pnas.0408558102; GERACE L, 1984, J CELL SCI, P137; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Hegele RA, 2007, J LIPID RES, V48, P1433, DOI 10.1194/jlr.R700004-JLR200; Hodzic DM, 2004, J BIOL CHEM, V279, P25805, DOI 10.1074/jbc.M313157200; Hudon SE, 2008, BIOCHEM BIOPH RES CO, V374, P365, DOI 10.1016/j.bbrc.2008.07.033; Kieran MW, 2007, PEDIATRICS, V120, P834, DOI 10.1542/peds.2007-1356; Kilic F, 1997, J BIOL CHEM, V272, P5298, DOI 10.1074/jbc.272.8.5298; KOBBERLING J, 1975, HUMANGENETIK, V29, P111, DOI 10.1007/BF00430347; LEE R, HUM MOL GENET, V19, P1603; LIN F, 1993, J BIOL CHEM, V268, P16321; Liu Q, 2007, J CELL BIOL, V178, P785, DOI 10.1083/jcb.200704108; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Navarro CL, 2004, HUM MOL GENET, V13, P2493, DOI 10.1093/hmg/ddh265; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; PANTE N, 1994, J CELL BIOL, V126, P603, DOI 10.1083/jcb.126.3.603; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Raharjo WH, 2001, J CELL SCI, V114, P4447; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; Sarkar PK, 2001, J CLIN PHARM THER, V26, P247, DOI 10.1046/j.1365-2710.2001.00349.x; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Sevenants L, 2005, EUR J PEDIATR, V164, P283, DOI 10.1007/s00431-005-1635-x; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Varela I, 2008, NAT MED, V14, P767, DOI 10.1038/nm1786; WEBER K, 1989, FEBS LETT, V257, P411, DOI 10.1016/0014-5793(89)81584-4; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Yang SH, 2008, BBA-MOL CELL BIOL L, V1781, P36, DOI 10.1016/j.bbalip.2007.11.003	51	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10874	10.1371/journal.pone.0010874	http://dx.doi.org/10.1371/journal.pone.0010874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526372	Green Published, gold, Green Submitted			2022-12-27	WOS:000278222100006
J	Weete, JD; Abril, M; Blackwell, M				Weete, John D.; Abril, Maritza; Blackwell, Meredith			Phylogenetic Distribution of Fungal Sterols	PLOS ONE			English	Article							FATTY-ACIDS; LIQUID-CHROMATOGRAPHY; CRONARTIUM-FUSIFORME; TAPHRINA-DEFORMANS; ERGOSTEROL; YEAST; BIOSYNTHESIS; ZYGOMYCOTA	Background: Ergosterol has been considered the "fungal sterol'' for almost 125 years; however, additional sterol data superimposed on a recent molecular phylogeny of kingdom Fungi reveals a different and more complex situation. Methodology/Principal Findings: The interpretation of sterol distribution data in a modern phylogenetic context indicates that there is a clear trend from cholesterol and other Delta(5) sterols in the earliest diverging fungal species to ergosterol in later diverging fungi. There are, however, deviations from this pattern in certain clades. Sterols of the diverse zoosporic and zygosporic forms exhibit structural diversity with cholesterol and 24-ethyl -Delta(5) sterols in zoosporic taxa, and 24-methyl sterols in zygosporic fungi. For example, each of the three monophyletic lineages of zygosporic fungi has distinctive major sterols, ergosterol in Mucorales, 22-dihydroergosterol in Dimargaritales, Harpellales, and Kickxellales (DHK clade), and 24-methyl cholesterol in Entomophthorales. Other departures from ergosterol as the dominant sterol include: 24-ethyl cholesterol in Glomeromycota, 24-ethyl cholest-7-enol and 24-ethyl-cholesta-7,24(28)-dienol in rust fungi, brassicasterol in Taphrinales and hypogeous pezizalean species, and cholesterol in Pneumocystis. Conclusions/Significance: Five dominant end products of sterol biosynthesis (cholesterol, ergosterol, 24-methyl cholesterol, 24-ethyl cholesterol, brassicasterol), and intermediates in the formation of 24-ethyl cholesterol, are major sterols in 175 species of Fungi. Although most fungi in the most speciose clades have ergosterol as a major sterol, sterols are more varied than currently understood, and their distribution supports certain clades of Fungi in current fungal phylogenies. In addition to the intellectual importance of understanding evolution of sterol synthesis in fungi, there is practical importance because certain antifungal drugs (e. g., azoles) target reactions in the synthesis of ergosterol. These findings also invalidate use of ergosterol as an indicator of biomass of certain fungal taxa (e. g., Glomeromycota). Data from this study are available from the Assembling the Fungal Tree of Life (AFTOL) Structural and Biochemical Database: http://aftol.umn.edu.	[Weete, John D.] Auburn Res & Technol Fdn, Auburn, AL USA; [Abril, Maritza; Blackwell, Meredith] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Weete, JD (corresponding author), Auburn Res & Technol Fdn, Auburn, AL USA.	mblackwell@lsu.edu			NSF [NSF-0732671]	NSF(National Science Foundation (NSF))	The authors acknowledge support from NSF-0732671 (AFTOL: Resolving the Evolutionary History of the Fungi) to M. Blackwell (see NSF.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benny GL, 2001, TRICHOMYCETES OTHER, P39; Binder M, 2005, SYST BIODIVERS, V3, P113, DOI 10.1017/S1477200005001623; BLOCH KE, 1983, CRC CR REV BIOCH MOL, V14, P47, DOI 10.3109/10409238309102790; CAMBIE RC, 1966, J CHEM SOC C, P72, DOI 10.1039/j39660000072; DEBIEU D, 1995, PHYTOCHEMISTRY, V39, P293, DOI 10.1016/0031-9422(95)00015-Y; Fontaine J, 2001, LIPIDS, V36, P1357, DOI 10.1007/s11745-001-0852-z; Grandmougin-Ferjani A, 1999, PHYTOCHEMISTRY, V50, P1027, DOI 10.1016/S0031-9422(98)00636-0; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kirk P., 2008, Ainsworth and Bisby�s Dictionary of the Fungi, DOI 10.1079/9780851998268.0000; LOEFFLER RST, 1992, PHYTOCHEMISTRY, V31, P1561, DOI 10.1016/0031-9422(92)83106-9; Mendoza L, 2002, ANNU REV MICROBIOL, V56, P315, DOI 10.1146/annurev.micro.56.012302.160950; Moss S. T., 1998, Botanical Journal of Scotland, V50, P137; Moss S.T., 1979, P175; NES WR, 1978, J BIOL CHEM, V253, P6218; NEWELL SY, 1988, APPL ENVIRON MICROB, V54, P1876, DOI 10.1128/AEM.54.7.1876-1879.1988; PETIT GR, 1962, J ORG CHEM, V27, P2696; RAMGOPAL M, 1983, P NATL ACAD SCI-BIOL, V80, P712, DOI 10.1073/pnas.80.3.712; RODRIGUEZ RJ, 1982, BIOCHEM BIOPH RES CO, V106, P435, DOI 10.1016/0006-291X(82)91129-9; RODRIGUEZ RJ, 1985, BIOCHIM BIOPHYS ACTA, V837, P336, DOI 10.1016/0005-2760(85)90057-8; SALMANOWICZ B, 1988, EUR J FOREST PATHOL, V18, P291; SINGH P, 1966, CURR SCI, V20, P515; Tanret C, 1889, CR SEANCES ACAD SCI, V108, P98; Wallander H, 1997, SOIL BIOL BIOCHEM, V29, P45, DOI 10.1016/S0038-0717(96)00263-5; WARNER SA, 1982, PHYTOCHEMISTRY, V21, P2135, DOI 10.1016/0031-9422(82)83069-0; Weete J. D., 1980, LIPID BIOCH FUNGI OT, P388; WEETE JD, 1989, EXP MYCOL, V13, P183, DOI 10.1016/0147-5975(89)90023-6; Weete JD, 1997, LIPIDS, V32, P1309, DOI 10.1007/s11745-006-0169-y; WEETE JD, 1979, CAN J MICROBIOL, V25, P1481, DOI 10.1139/m79-230; Weete JD, 1999, MYCOLOGIA, V91, P642, DOI 10.2307/3761250; WEETE JD, 1977, LIPIDS, V12, P398, DOI 10.1007/BF02533645; WEETE JD, 1991, LIPIDS, V26, P669, DOI 10.1007/BF02536434; WEETE JD, 1983, BIOCHIM BIOPHYS ACTA, V752, P19, DOI 10.1016/0005-2760(83)90228-X; Weete JD, 1989, ADV LIPID RES, V23, P484; WEETE JD, 1985, J MICROBIOL, V313, P1127; White MM, 2006, MYCOLOGIA, V98, P872, DOI 10.3852/mycologia.98.6.872	36	180	182	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10899	10.1371/journal.pone.0010899	http://dx.doi.org/10.1371/journal.pone.0010899			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526375	Green Published, Green Submitted, gold			2022-12-27	WOS:000278222100028
J	Ataide, R; Hasang, W; Wilson, DW; Beeson, JG; Mwapasa, V; Molyneux, ME; Meshnick, SR; Rogerson, SJ				Ataide, Ricardo; Hasang, Wina; Wilson, Danny W.; Beeson, James G.; Mwapasa, Victor; Molyneux, Malcolm E.; Meshnick, Steven R.; Rogerson, Stephen J.			Using an Improved Phagocytosis Assay to Evaluate the Effect of HIV on Specific Antibodies to Pregnancy-Associated Malaria	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; CHONDROITIN-SULFATE-A; VARIANT SURFACE-ANTIGENS; INFECTED ERYTHROCYTES; PARASITIZED ERYTHROCYTES; CELLS; ADHESION; DIFFERENTIATION; PATHOGENESIS; PROTECTION	Background: Pregnant women residing in malaria endemic areas are highly susceptible to Plasmodium falciparum malaria, particularly during their first pregnancy, resulting in low birth weight babies and maternal anaemia. This susceptibility is associated with placental sequestration of parasitised red blood cells expressing pregnancy-specific variant surface antigens. Acquisition of antibodies against these variant surface antigens may protect women and their offspring. Functions of such antibodies may include prevention of placental sequestration or opsonisation of parasitised cells for phagocytic clearance. Methodology/Findings: Here we report the development and optimisation of a new high-throughput flow cytometry-based phagocytosis assay using undifferentiated Thp-1 cells to quantitate the amount of opsonizing antibody in patient sera, and apply this assay to measure the impact of HIV on the levels of antibodies to a pregnancy malaria-associated parasite line in a cohort of Malawian primigravid women. The assay showed high reproducibility, with inter-experimental correlation of r(2) = 0.99. In primigravid women, concurrent malaria infection was associated with significantly increased antibodies, whereas HIV decreased the ability to acquire opsonising antibodies (Mann-Whitney ranksum: p = 0.013). This decrease was correlated with HIV-induced immunosuppression, with women with less than 350x10(6) CD4+ T-cells/L having less opsonising antibodies (coef: -11.95, P = 0.002). Levels of antibodies were not associated with protection from low birth weight or anaemia. Conclusions/Significance: This flow cytometry-based phagocytosis assay proved to be efficient and accurate for the measurement of Fc-receptor mediated phagocytosis-inducing antibodies in large cohorts. HIV was found to affect mainly the acquisition of antibodies to pregnancy-specific malaria in primigravidae. Further studies of the relationship between opsonising antibodies to malaria in pregnancy and HIV are indicated.	[Ataide, Ricardo; Hasang, Wina; Rogerson, Stephen J.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Ataide, Ricardo] Univ Porto, GABBA, Grad Program Areas Basic & Appl Biol, P-4100 Oporto, Portugal; [Wilson, Danny W.; Beeson, James G.] Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Melbourne, Vic 3050, Australia; [Mwapasa, Victor; Molyneux, Malcolm E.] Univ Malawi, Malawi Liverpool Wellcome Trust Clin Res Programm, Coll Med, Blantyre, Malawi; [Mwapasa, Victor] Univ Malawi, Dept Community Hlth, Univ Med, Blantyre, Malawi; [Molyneux, Malcolm E.] Univ Liverpool, Sch Trop Med, Liverpool L69 3BX, Merseyside, England; [Meshnick, Steven R.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA	University of Melbourne; Universidade do Porto; Walter & Eliza Hall Institute; University of Malawi; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of North Carolina; University of North Carolina Chapel Hill	Ataide, R (corresponding author), Univ Melbourne, Dept Med, PO Royal Melbourne Hosp, Melbourne, Vic, Australia.	sroger@unimelb.edu.au	Wilson, Danny W/E-6186-2019; Ataide, Ricardo/B-7307-2017	Wilson, Danny W/0000-0002-5073-1405; Ataide, Ricardo/0000-0002-1014-0432; Rogerson, Stephen/0000-0003-4287-1982; Mwapasa, Victor/0000-0002-2748-8902; Hasang, Wina/0000-0001-8664-7558	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/32985/2006]; NIH [AI 49084]; National Health and Medical Research Council, Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049084] Funding Source: NIH RePORTER	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	RA is supported by Fundacao para a Ciencia e Tecnologia, Portugal, reference SFRH/BD/32985/2006. The study was supported by a grant from NIH to SRM (NIH RO1 award number AI 49084). JGB and DWW were supported by the National Health and Medical Research Council, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessio M, 1996, J BIOL CHEM, V271, P1770, DOI 10.1074/jbc.271.3.1770; Beeson JG, 2005, CURR TOP MICROBIOL, V297, P187; Beeson JG, 2004, J INFECT DIS, V189, P540, DOI 10.1086/381186; Cox SE, 2005, INFECT IMMUN, V73, P2841, DOI 10.1128/IAI.73.5.2841-2847.2005; De Milito A, 2001, AIDS, V15, P957, DOI 10.1097/00002030-200105250-00003; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Feng GQ, 2009, J INFECT DIS, V200, P299, DOI 10.1086/599841; FLEIT HB, 1991, HUMAN MONOCYTE CELL, P556; French N, 2001, AIDS, V15, P899, DOI 10.1097/00002030-200105040-00010; Fried M, 2006, EXP PARASITOL, V113, P36, DOI 10.1016/j.exppara.2005.12.003; Garnham P. C. C., 1938, Transactions of the Royal Society of Tropical Medicine and Hygiene London, V32, P13, DOI 10.1016/S0035-9203(38)90094-X; Healey G, 2007, J IMMUNOL METHODS, V322, P50, DOI 10.1016/j.jim.2007.01.024; Idemyor V, 2007, HIV CLIN TRIALS, V8, P246, DOI 10.1310/hct0804-246; Jaworowski A, 2009, CLIN VACCINE IMMUNOL, V16, P312, DOI 10.1128/CVI.00356-08; Keen J, 2007, PLOS MED, V4, P912, DOI 10.1371/journal.pmed.0040181; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; Mount AM, 2004, LANCET, V363, P1860, DOI 10.1016/S0140-6736(04)16354-X; Onyenekwe C. C., 2007, Journal of Vector Borne Diseases, V44, P250; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; ROGERSON SJ, 1995, J EXP MED, V182, P15, DOI 10.1084/jem.182.1.15; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Serra-Casas E, 2010, J INFECT DIS, V201, P123, DOI 10.1086/648595; Slutsker L, 2007, CURR OPIN INFECT DIS, V20, P3, DOI 10.1097/QCO.0b013e328012c5cd; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Tippett E, 2007, J IMMUNOL METHODS, V325, P42, DOI 10.1016/j.jim.2007.05.012; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; TSUCHIYA MYY, 1980, ESTABLISHMENT CHARAC, P171; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Van Geertruyden JP, 2007, TRENDS PARASITOL, V23, P465, DOI 10.1016/j.pt.2007.08.006	33	44	45	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10807	10.1371/journal.pone.0010807	http://dx.doi.org/10.1371/journal.pone.0010807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520838	Green Published, gold			2022-12-27	WOS:000278034800005
J	Howard, J; Merrifield, M				Howard, Jeanette; Merrifield, Matt			Mapping Groundwater Dependent Ecosystems in California	PLOS ONE			English	Article							GREAT-BASIN; VEGETATION; MANAGEMENT	Background: Most groundwater conservation and management efforts focus on protecting groundwater for drinking water and for other human uses with little understanding or focus on the ecosystems that depend on groundwater. However, groundwater plays an integral role in sustaining certain types of aquatic, terrestrial and coastal ecosystems, and their associated landscapes. Our aim was to illuminate the connection between groundwater and surface ecosystems by identifying and mapping the distribution of groundwater dependent ecosystems (GDEs) in California. Methodology/Principal Findings: To locate where groundwater flow sustains ecosystems we identified and mapped groundwater dependent ecosystems using a GIS. We developed an index of groundwater dependency by analyzing geospatial data for three ecosystem types that depend on groundwater: (1) springs and seeps; (2) wetlands and associated vegetation alliances; and (3) stream discharge from groundwater sources (baseflow index). Each variable was summarized at the scale of a small watershed (Hydrologic Unit Code-12; mean size = 9,570 ha; n = 4,621), and then stratified and summarized to 10 regions of relative homogeneity in terms of hydrologic, ecologic and climatic conditions. We found that groundwater dependent ecosystems are widely, although unevenly, distributed across California. Although different types of GDEs are clustered more densely in certain areas of the state, watersheds with multiple types of GDEs are found in both humid (e. g. coastal) and more arid regions. Springs are most densely concentrated in the North Coast and North Lahontan, whereas groundwater dependent wetlands and associated vegetation alliances are concentrated in the North and South Lahontan and Sacramento River hydrologic regions. The percentage of land area where stream discharge is most dependent on groundwater is found in the North Coast, Sacramento River and Tulare Lake regions. GDE clusters are located at the highest percentage in the North Coast (an area of the highest annual rainfall totals), North Lahontan (an arid, high desert climate with low annual rainfall), and Sacramento River hydrologic regions. That GDEs occur in such distinct climatic and hydrologic settings reveals the widespread distribution of these ecosystems. Conclusions/Significance: Protection and management of groundwater-dependent ecosystems are hindered by lack of information on their diversity, abundance and location. By developing a methodology that uses existing datasets to locate GDEs, this assessment addresses that knowledge gap. We report here on the application of this method across California, but believe the method can be expanded to regions where spatial data exist.	[Howard, Jeanette; Merrifield, Matt] Nature Conservancy, San Francisco, CA USA	Nature Conservancy	Howard, J (corresponding author), Nature Conservancy, San Francisco, CA USA.	Jeanette_howard@tnc.org						*AMEC EARTH ENV, 2005, SANT CLAR RIV ENH MA; [Anonymous], OFFICIAL J EUROPEAN; Brown J., 2009, GROUNDWATER DEPENDEN; Brown J, 2011, FRONT ECOL ENVIRON, V9, P97, DOI 10.1890/090108; Brussard P. F., 1999, STATUS TRENDS NATION, P505; BURK N, 2005, 117 UT GEOL SURV; *CA DEP WAT RES, 1998, B CAL DEP WAT RES, V160; *CA DEP WAT RES, 2003, B CAL DEP WAT RES, V118; Eamus D, 2006, AUST J BOT, V54, P91, DOI 10.1071/BT06029; FOSTER S, 2006, GWMATE BRIEFING NOTE; Giordano M, 2007, AGRICULTURAL GROUNDWATER REVOLUTION: OPPORTUNITIES AND THREATS TO DEVELOPMENT, P1, DOI 10.1079/9781845931728.0000; *GREENINFO NETW, 2009, CAL PROT AR DAT V1 4; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; Institute of Hydrology, 1980, LOW FLOW STUD; MacKay H, 2006, AUST J BOT, V54, P231, DOI 10.1071/BT05047; Mount J.F., 1995, CALIFORNIA RIVERS ST; Murray Brad R., 2003, Ecological Management & Restoration, V4, P110, DOI 10.1046/j.1442-8903.2003.00144.x; Naumburg E, 2005, ENVIRON MANAGE, V35, P726, DOI 10.1007/s00267-004-0194-7; O'Grady AP, 2006, AUST J BOT, V54, P145, DOI 10.1071/BT04164; Patten DT, 2008, ENVIRON MANAGE, V41, P398, DOI 10.1007/s00267-007-9035-9; Pringle CM, 2000, ECOL APPL, V10, P971, DOI 10.1890/1051-0761(2000)010[0971:TTUSPL]2.0.CO;2; Pringle CM, 2001, ECOL APPL, V11, P981, DOI 10.1890/1051-0761(2001)011[0981:HCATMO]2.0.CO;2; Sax J. L., 2002, REV LAWS ESTABLISHIN; SIMLEY JD, 2009, 20093054 US GEOL SUR; Soil Survey Staff Natural Resources Conservation Service, US GEN SOIL MAP STAT; United States Environmental Protection Agency (USEPA) and United States Geological Survey (USGS), 2005, NAT HYDR DAT PLUS NH; US Fish and Wildlife Service, NAT WETL INV; *USDA FOR SERV, CALVEG MAPP CAL; van der Kamp G, 2009, HYDROGEOL J, V17, P203, DOI 10.1007/s10040-008-0367-1; Wahl KL, 1988, P S WAT USE DAT WAT, P239; Wahl KL, 1995, P TEX WAT 95 COMP C, P77; WOLOCK DM, 2003, 03146 US GEOL SURV	32	67	71	7	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11249	10.1371/journal.pone.0011249	http://dx.doi.org/10.1371/journal.pone.0011249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585640	Green Published, Green Submitted, gold			2022-12-27	WOS:000279135400011
J	Ganguly, A; Basu, S; Chakraborty, P; Chatterjee, S; Sarkar, A; Chatterjee, M; Choudhuri, SK				Ganguly, Avishek; Basu, Soumya; Chakraborty, Paramita; Chatterjee, Shilpak; Sarkar, Avijit; Chatterjee, Mitali; Choudhuri, Soumitra Kumar			Targeting Mitochondrial Cell Death Pathway to Overcome Drug Resistance with a Newly Developed Iron Chelate	PLOS ONE			English	Article							BREAST-CANCER CELLS; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; IN-VIVO; MEDIATED APOPTOSIS; ANTICANCER DRUGS; CARCINOMA-CELLS; COPPER CHELATE; TUMOR-CELLS; EXPRESSION	Background: Multi drug resistance (MDR) or cross-resistance to multiple classes of chemotherapeutic agents is a major obstacle to successful application of chemotherapy and a basic problem in cancer biology. The multidrug resistance gene, MDR1, and its gene product P-glycoprotein (P-gp) are an important determinant of MDR. Therefore, there is an urgent need for development of novel compounds that are not substrates of P-glycoprotein and are effective against drug-resistant cancer. Methodology/Principal Findings: In this present study, we have synthesized a novel, redox active Fe (II) complex (chelate), iron N-(2-hydroxy acetophenone) glycinate (FeNG). The structure of the complex has been determined by spectroscopic means. To evaluate the cytotoxic effect of FeNG we used doxorubicin resistant and/or sensitive T lymphoblastic leukemia cells and show that FeNG kills both the cell types irrespective of their MDR phenotype. Moreover, FeNG induces apoptosis in doxorubicin resistance T lymphoblastic leukemia cell through mitochondrial pathway via generation reactive oxygen species (ROS). This is substantiated by the fact that the antioxidant N-acetyle-cysteine (NAC) could completely block ROS generation and, subsequently, abrogated FeNG induced apoptosis. Therefore, FeNG induces the doxorubicin resistant T lymphoblastic leukemia cells to undergo apoptosis and thus overcome MDR. Conclusion/Significance: Our study provides evidence that FeNG, a redox active metal chelate may be a promising new therapeutic agent against drug resistance cancers.	[Ganguly, Avishek; Basu, Soumya; Chakraborty, Paramita; Chatterjee, Shilpak; Choudhuri, Soumitra Kumar] Chittaranjan Natl Canc Inst, Dept In Vitro Carcinogenesis & Cellular Chemother, Kolkata, India; [Sarkar, Avijit; Chatterjee, Mitali] Postgrad Inst Med Educ & Res, Dept Pharmacol, Kolkata, India	Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Ganguly, A (corresponding author), Chittaranjan Natl Canc Inst, Dept In Vitro Carcinogenesis & Cellular Chemother, Kolkata, India.	soumitra01@yahoo.com	Chakraborty, Paramita/AAL-9606-2020; Ganguly, Avishek/R-6138-2019; Basu, Soumya/Y-9112-2019; Chatterjee, Mitali/AAV-2129-2021	Chakraborty, Paramita/0000-0002-0320-8697; Basu, Soumya/0000-0002-1726-0154; 	Indian Council of Medical Research (ICMR), New Delhi [3/2/2/200/2009/NCD-III, 5/13/18/2007/NCD-III]	Indian Council of Medical Research (ICMR), New Delhi(Indian Council of Medical Research (ICMR))	This investigation received financial support from the Indian Council of Medical Research (ICMR), New Delhi, No. 3/2/2/200/2009/NCD-III and No. 5/13/18/2007/NCD-III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MS, 2000, J NEUROL SCI, V176, P88, DOI 10.1016/S0022-510X(00)00317-8; Baul TSB, 2001, APPL ORGANOMET CHEM, V15, P947; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007048; Dakternieks D, 1998, ORGANOMETALLICS, V17, P3058, DOI 10.1021/om9800290; Efferth T, 2003, MOL PHARMACOL, V64, P382, DOI 10.1124/mol.64.2.382; Efferth T, 2008, CLIN CANCER RES, V14, P2405, DOI 10.1158/1078-0432.CCR-07-4525; Engel RH, 2006, FRONT BIOSCI-LANDMRK, V11, P300, DOI 10.2741/1798; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Germann UA, 1996, EUR J CANCER, V32A, P927, DOI 10.1016/0959-8049(96)00057-3; Gillet JP, 2004, CANCER RES, V64, P8987, DOI 10.1158/0008-5472.CAN-04-1978; Giovannini C, 2002, FEBS LETT, V523, P200, DOI 10.1016/S0014-5793(02)02972-1; GOTTESMAN MM, 1993, CANCER RES, V53, P747; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Ikeda T, 2003, CANCER RES, V63, P5551; Iuchi K, 2008, BIOCHEM PHARMACOL, V76, P974, DOI 10.1016/j.bcp.2008.07.038; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; KIMMIG A, 1990, CANCER RES, V50, P6793; KOOPMAN G, 1994, BLOOD, V84, P1414; Latchoumycandane C, 2006, TOXICOL APPL PHARM, V217, P125, DOI 10.1016/j.taap.2006.08.001; Majumder S, 2003, EUR J MED CHEM, V38, P893, DOI 10.1016/j.ejmech.2003.08.002; Majumder S, 2006, CANCER LETT, V244, P16, DOI 10.1016/j.canlet.2005.11.030; Mantena SK, 2006, CARCINOGENESIS, V27, P2018, DOI 10.1093/carcin/bgl043; Maret W, 2010, METALLOMICS, V2, P117, DOI 10.1039/b915804a; Matarrese P, 2001, BIOCHEM J, V355, P587, DOI 10.1042/bj3550587; Mookerjee A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-267; Mookerjee A, 2006, CLIN CANCER RES, V12, P4339, DOI 10.1158/1078-0432.CCR-06-0001; Muscella A, 2008, BRIT J PHARMACOL, V153, P34, DOI 10.1038/sj.bjp.0707576; Muscella A, 2002, J ENDOCRINOL, V173, P315, DOI 10.1677/joe.0.1730315; PASTAN I, 1993, NEW ENGL J MED, V316, P385; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; RONINSON IB, 1992, BIOCHEM PHARMACOL, V43, P95, DOI 10.1016/0006-2952(92)90666-7; Sanchez-Alcazar JA, 2000, CELL DEATH DIFFER, V7, P1090, DOI 10.1038/sj.cdd.4400740; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; VANDENABEELE P, 2006, CELL DEATH DIFFER, pPE44; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Zimmermann KC, 2001, PHARMACOL THERAPEUT, V92, P57, DOI 10.1016/S0163-7258(01)00159-0	39	41	42	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11253	10.1371/journal.pone.0011253	http://dx.doi.org/10.1371/journal.pone.0011253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582168	gold, Green Published, Green Submitted			2022-12-27	WOS:000279058500005
J	Shulman, JM; Chibnik, LB; Aubin, C; Schneider, JA; Bennett, DA; De Jager, PL				Shulman, Joshua M.; Chibnik, Lori B.; Aubin, Cristin; Schneider, Julie A.; Bennett, David A.; De Jager, Philip L.			Intermediate Phenotypes Identify Divergent Pathways to Alzheimer's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; ZINC-FINGER PROTEIN; COGNITIVE IMPAIRMENT; SUSCEPTIBILITY GENES; CLINICAL-DIAGNOSIS; AD PATHOLOGY; ALLELE; RISK; VARIANTS	Background: Recent genetic studies have identified a growing number of loci with suggestive evidence of association with susceptibility to Alzheimer's disease (AD). However, little is known of the role of these candidate genes in influencing intermediate phenotypes associated with a diagnosis of AD, including cognitive decline or AD neuropathologic burden. Methods/Principal Findings: Thirty-two single nucleotide polymorphisms (SNPs) previously implicated in AD susceptibility were genotyped in 414 subjects with both annual clinical evaluation and completed brain autopsies from the Religious Orders Study and the Rush Memory and Aging Project. Regression analyses evaluated the relation of SNP genotypes to continuous measures of AD neuropathology and cognitive function proximate to death. A SNP in the zinc finger protein 224 gene (ZNF224, rs3746319) was associated with both global AD neuropathology (p = 0.009) and global cognition (p = 0.002); whereas, a SNP at the phosphoenolpyruvate carboxykinase locus (PCK1, rs8192708) was selectively associated with global cognition (p = 3.57 x 10(-4)). The association of ZNF224 with cognitive impairment was mediated by neurofibrillary tangles, whereas PCK1 largely influenced cognition independent of AD pathology, as well as Lewy bodies and infarcts. Conclusions/Significance: The findings support the association of several loci with AD, and suggest how intermediate phenotypes can enhance analysis of susceptibility loci in this complex genetic disorder.	[Shulman, Joshua M.; Chibnik, Lori B.; Aubin, Cristin; De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, Program Translat NeuroPsychiat Genom, Boston, MA 02115 USA; [Shulman, Joshua M.; Chibnik, Lori B.; Aubin, Cristin; De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA USA; [Shulman, Joshua M.; Chibnik, Lori B.; Aubin, Cristin; De Jager, Philip L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Schneider, Julie A.] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA; [Schneider, Julie A.; Bennett, David A.] Rush Univ, Med Ctr, Dept Neurol Sci, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Rush University; Rush University	Shulman, JM (corresponding author), Brigham & Womens Hosp, Dept Neurol, Program Translat NeuroPsychiat Genom, 75 Francis St, Boston, MA 02115 USA.	pdejager@rics.bwh.harvard.edu		Chibnik, Lori/0000-0001-6293-806X	NIH [K08AG034290, P30AG10161, R01AG15819, R01AG17917]; Beth Israel Deaconess Medical Center; Harvard/MIT Health Sciences and Technology; NATIONAL INSTITUTE ON AGING [R01AG015819, P30AG010161, R01AG017917, K08AG034290] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beth Israel Deaconess Medical Center; Harvard/MIT Health Sciences and Technology; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	JMS is supported by NIH grant K08AG034290 and by the Clinical Investigator Training Program: Beth Israel Deaconess Medical Center and Harvard/MIT Health Sciences and Technology, in collaboration with Pfizer Inc. and Merck & Co. The Religious Orders Study and the Rush Memory and Aging Project were supported by NIH grants P30AG10161, R01AG15819, R01AG17917. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham R, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-44; [Anonymous], 1997, Neurobiol Aging, V18, pS1; Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Arvanitakis Z, 2006, NEUROLOGY, V67, P1960, DOI 10.1212/01.wnl.0000247053.45483.4e; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bennett DA, 2005, J NEUROL NEUROSUR PS, V76, P1194, DOI 10.1136/jnnp.2004.054445; Bennett DA, 2006, LANCET NEUROL, V5, P406, DOI 10.1016/S1474-4422(06)70417-3; Bennett DA, 2002, NEUROLOGY, V59, P198, DOI 10.1212/WNL.59.2.198; Bennett DA, 2003, NEUROLOGY, V60, P246, DOI 10.1212/01.WNL.0000042478.08543.F7; Bennett DA, 2006, NEUROEPIDEMIOLOGY, V27, P169, DOI 10.1159/000096129; Bennett DA, 2009, NEUROLOGY, V72, P1495, DOI 10.1212/WNL.0b013e3181a2e87d; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bertram L, 2009, HUM MOL GENET, V18, pR137, DOI 10.1093/hmg/ddp406; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cao HN, 2004, J CLIN ENDOCR METAB, V89, P898, DOI 10.1210/jc.2003-031361; Carrasquillo MM, 2009, NAT GENET, V41, P192, DOI 10.1038/ng.305; COUSIN E, 2009, NEUROBIOLOG IN PRESS; Ertekin-Taner N, 2007, NEUROL CLIN, V25, P611, DOI 10.1016/j.ncl.2007.03.009; FEULNER TM, 2009, MOL PSYCHIA IN PRESS; Figgins JA, 2009, AM J MED GENET B, V150B, P520, DOI 10.1002/ajmg.b.30851; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Grupe A, 2007, HUM MOL GENET, V16, P865, DOI 10.1093/hmg/ddm031; Hamilton G, 2007, AM J MED GENET B, V144B, P508, DOI 10.1002/ajmg.b.30503; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; Li YH, 2006, HUM MOL GENET, V15, P2560, DOI 10.1093/hmg/ddl178; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Liu F, 2007, AM J HUM GENET, V81, P17, DOI 10.1086/518720; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; McQueen MB, 2007, AM J MED GENET B, V144B, P987, DOI 10.1002/ajmg.b.30500; Medugno L, 2005, GENE, V359, P35, DOI 10.1016/j.gene.2005.06.021; Medugno L, 2007, GENE, V403, P125, DOI 10.1016/j.gene.2007.07.036; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Mortimer JA, 2009, ALZ DIS ASSOC DIS, V23, P152, DOI 10.1097/WAD.0b013e318190a855; Papassotiropoulos A, 2003, ARCH NEUROL-CHICAGO, V60, P29, DOI 10.1001/archneur.60.1.29; Peskind ER, 2006, ARCH NEUROL-CHICAGO, V63, P936, DOI 10.1001/archneur.63.7.936; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Seshadri S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S15; Sonnen JA, 2007, ANN NEUROL, V62, P406, DOI 10.1002/ana.21208; Willer CJ, 2007, DIABETES, V56, P256, DOI 10.2337/db06-0461; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543	52	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11244	10.1371/journal.pone.0011244	http://dx.doi.org/10.1371/journal.pone.0011244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574532	gold, Green Published			2022-12-27	WOS:000279058300027
J	Spinella, F; Rosano, L; Del Duca, M; Di Castro, V; Nicotra, MR; Natali, PG; Bagnato, A				Spinella, Francesca; Rosano, Laura; Del Duca, Martina; Di Castro, Valeriana; Nicotra, Maria Rita; Natali, Pier Giorgio; Bagnato, Anna			Endothelin-1 Inhibits Prolyl Hydroxylase Domain 2 to Activate Hypoxia-Inducible Factor-1 alpha in Melanoma Cells	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; GROWTH-FACTOR; MALIGNANT-MELANOMA; FACTOR-I; GENE-EXPRESSION; B RECEPTOR; PROLINE HYDROXYLATION; TUMOR ANGIOGENESIS; OVARIAN-CARCINOMA; HIF-ALPHA	Background: The endothelin B receptor (ET(B)R) promotes tumorigenesis and melanoma progression through activation by endothelin (ET)-1, thus representing a promising therapeutic target. The stability of hypoxia-inducible factor (HIF)-1 alpha is essential for melanomagenesis and progression, and is controlled by site-specific hydroxylation carried out by HIF-prolyl hydroxylase domain (PHD) and subsequent proteosomal degradation. Principal Findings: Here we found that in melanoma cells ET-1, ET-2, and ET-3 through ET(B)R, enhance the expression and activity of HIF-1 alpha and HIF-2 alpha that in turn regulate the expression of vascular endothelial growth factor (VEGF) in response to ETs or hypoxia. Under normoxic conditions, ET-1 controls HIF-alpha stability by inhibiting its degradation, as determined by impaired degradation of a reporter gene containing the HIF-1 alpha oxygen-dependent degradation domain encompassing the PHD-targeted prolines. In particular, ETs through ET(B)R markedly decrease PHD2 mRNA and protein levels and promoter activity. In addition, activation of phosphatidylinositol 3-kinase (PI3K)-dependent integrin linked kinase (ILK)-AKT-mammalian target of rapamycin (mTOR) pathway is required for ET(B)R-mediated PHD2 inhibition, HIF-1 alpha, HIF-2 alpha, and VEGF expression. At functional level, PHD2 knockdown does not further increase ETs-induced in vitro tube formation of endothelial cells and melanoma cell invasiveness, demonstrating that these processes are regulated in a PHD2-dependent manner. In human primary and metastatic melanoma tissues as well as in cell lines, that express high levels of HIF-1 alpha, ET(B)R expression is associated with low PHD2 levels. In melanoma xenografts, ET(B)R blockade by ET(B)R antagonist results in a concomitant reduction of tumor growth, angiogenesis, HIF-1 alpha, and HIF-2 alpha expression, and an increase in PHD2 levels. Conclusions: In this study we identified the underlying mechanism by which ET-1, through the regulation of PHD2, controls HIF-1 alpha stability and thereby regulates angiogenesis and melanoma cell invasion. These results further indicate that targeting ET(B)R may represent a potential therapeutic treatment of melanoma by impairing HIF-1 alpha stability.	[Spinella, Francesca; Rosano, Laura; Del Duca, Martina; Di Castro, Valeriana; Natali, Pier Giorgio; Bagnato, Anna] Regina Elena Inst Canc Res, Lab Mol Pathol, Rome, Italy; [Nicotra, Maria Rita] CNR, Mol Biol & Pathol Inst, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Consiglio Nazionale delle Ricerche (CNR)	Spinella, F (corresponding author), Regina Elena Inst Canc Res, Lab Mol Pathol, Rome, Italy.	bagnato@ifo.it	Rosanò, Laura/AAB-7821-2019; Rosanò, Laura/I-9266-2012; Bagnato, Anna/G-9747-2016; Di Castro, Valeriana/H-8873-2017; ROSANO', Laura/AAK-1424-2020; Rosanò, Laura/B-2863-2018; spinella, francesca/AAZ-8982-2020	Rosanò, Laura/0000-0002-3981-8593; Bagnato, Anna/0000-0002-7269-9522; Di Castro, Valeriana/0000-0002-1899-3683; ROSANO', Laura/0000-0002-9962-6411; Rosanò, Laura/0000-0002-9962-6411; 	Associazione Italiana Ricerca sul Cancro; Ministero della Salute	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute(Ministry of Health, Italy)	Associazione Italiana Ricerca sul Cancro and Ministero della Salute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprelikova O, 2004, J CELL BIOCHEM, V92, P491, DOI 10.1002/jcb.20067; Bagnato A, 2004, CANCER RES, V64, P1436, DOI 10.1158/0008-5472.CAN-03-2344; Bagnato A, 2003, TRENDS ENDOCRIN MET, V14, P44, DOI 10.1016/S1043-2760(02)00010-3; Bedogni B, 2005, CANCER CELL, V8, P443, DOI 10.1016/j.ccr.2005.11.005; Berchner-Pfannschmidt U, 2007, J BIOL CHEM, V282, P1788, DOI 10.1074/jbc.M607065200; Berking C, 2004, CANCER RES, V64, P807, DOI 10.1158/0008-5472.CAN-03-3438; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Chudnovsky Y, 2005, J CLIN INVEST, V115, P813, DOI 10.1172/JCI200524808; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Dai DL, 2003, CLIN CANCER RES, V9, P4409; Daniotti M, 2004, ONCOGENE, V23, P5968, DOI 10.1038/sj.onc.1207780; Demunter A, 2001, VIRCHOWS ARCH, V438, P485, DOI 10.1007/s004280000362; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Giatromanolaki A, 2003, MELANOMA RES, V13, P493, DOI 10.1097/00008390-200310000-00008; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; GOLUB SH, 1976, J NATL CANCER I, V56, P167, DOI 10.1093/jnci/56.1.167; Grimshaw MJ, 2007, ENDOCR-RELAT CANCER, V14, P233, DOI 10.1677/ERC-07-0057; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Knowles HJ, 2004, CIRC RES, V95, P162, DOI 10.1161/01.RES.0000134924.89412.70; Knowles Jonathan, 2005, Current Vascular Pharmacology, V3, P309, DOI 10.2174/157016105774329462; Lacal PM, 2008, EUR J CANCER, V44, P1914, DOI 10.1016/j.ejca.2008.06.032; Lahav R, 2005, INT J DEV BIOL, V49, P173, DOI 10.1387/ijdb.041951rl; Lahav R, 2004, CANCER RES, V64, P8945, DOI 10.1158/0008-5472.CAN-04-1510; Lahav R, 1999, P NATL ACAD SCI USA, V96, P11496, DOI 10.1073/pnas.96.20.11496; LEVIN ER, 1995, NEW ENGL J MED, V333, P356, DOI 10.1056/NEJM199508103330607; McMahon S, 2006, J BIOL CHEM, V281, P24171, DOI 10.1074/jbc.M604507200; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; Patel N, 2008, BLOOD, V112, P856, DOI 10.1182/blood-2007-12-130567; Postovit LM, 2006, CANCER RES, V66, P7833, DOI 10.1158/0008-5472.CAN-06-0731; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Rosano L, 2006, MOL CANCER THER, V5, P833, DOI 10.1158/1535-7163.MCT-05-0523; Salani D, 2000, AM J PATHOL, V157, P1703, DOI 10.1016/S0002-9440(10)64807-9; Semenza GL, 2004, J APPL PHYSIOL, V96, P1173, DOI 10.1152/japplphysiol.00770.2003; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Spinella F, 2002, J BIOL CHEM, V277, P27850, DOI 10.1074/jbc.M202421200; SPINELLA F, 2009, CANCER RES, V69, P2224; Spinella F, 2007, CANCER RES, V67, P1725, DOI 10.1158/0008-5472.CAN-06-2606; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; Tang CH, 2007, J BIOL CHEM, V282, P25406, DOI 10.1074/jbc.M701001200; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; Wilson JL, 2006, CANCER RES, V66, P11802, DOI 10.1158/0008-5472.CAN-06-1222; Wu SR, 2008, MOL THER, V16, P1227, DOI 10.1038/mt.2008.90	50	44	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11241	10.1371/journal.pone.0011241	http://dx.doi.org/10.1371/journal.pone.0011241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574527	Green Published, gold, Green Submitted			2022-12-27	WOS:000279058300025
J	Lu, Y; Futtner, C; Rock, JR; Xu, X; Whitworth, W; Hogan, BLM; Onaitis, MW				Lu, Yun; Futtner, Christopher; Rock, Jason R.; Xu, Xia; Whitworth, Walter; Hogan, Brigid L. M.; Onaitis, Mark W.			Evidence That SOX2 Overexpression Is Oncogenic in the Lung	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; EMBRYONIC STEM-CELLS; BREAST-CANCER; MOUSE TRACHEA; DIFFERENTIATION; EXPRESSION; REGULATOR; ANTIGENS; TUMORS; ADULT	Background: SOX2 (Sry-box 2) is required to maintain a variety of stem cells, is overexpressed in some solid tumors, and is expressed in epithelial cells of the lung. Methodology/Principal Findings: We show that SOX2 is overexpressed in human squamous cell lung tumors and some adenocarcinomas. We have generated mouse models in which Sox2 is upregulated in epithelial cells of the lung during development and in the adult. In both cases, overexpression leads to extensive hyperplasia. In the terminal bronchioles, a trachea-like pseudostratified epithelium develops with p63-positive cells underlying columnar cells. Over 12-34 weeks, about half of the mice expressing the highest levels of Sox2 develop carcinoma. These tumors resemble adenocarcinoma but express the squamous marker, Trp63 (p63). Conclusions: These findings demonstrate that Sox2 overexpression both induces a proximal phenotype in the distal airways/alveoli and leads to cancer.	[Lu, Yun; Futtner, Christopher; Xu, Xia; Whitworth, Walter; Onaitis, Mark W.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Rock, Jason R.; Hogan, Brigid L. M.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Duke University	Lu, Y (corresponding author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.	mark.onaitis@duke.edu		Xu, Xia/0000-0002-1982-7062	National Institutes of Health (NIH) [2T32HL007538-26, R01 HL071303, K12-CA100639-03]; Howard Hughes Medical Institute; Gary Hock Fund; NATIONAL CANCER INSTITUTE [K12CA100639] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071303, R37HL071303, T32HL007538] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gary Hock Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	JRR is supported by National Institutes of Health (NIH) Interdisciplinary Training Program in Lung Disease 2T32HL007538-26, and research in BLMH's lab is supported by NIH R01 HL071303. MWO is supported by NIH K12-CA100639-03, a Howard Hughes Medical Institute Early Career Grant, and the Gary Hock Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 2010, HISTOPATHOLOGY, V56, P265, DOI 10.1111/j.1365-2559.2009.03463.x; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; BASS AJ, 2009, NATURE GENETICS; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Comtesse N, 2005, P NATL ACAD SCI USA, V102, P9601, DOI 10.1073/pnas.0500404102; Dong C, 2004, CYTOGENET GENOME RES, V105, P442, DOI 10.1159/000078217; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Glinsky GV, 2008, J CLIN ONCOL, V26, P2846, DOI 10.1200/JCO.2008.17.0266; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Gure AO, 2000, P NATL ACAD SCI USA, V97, P4198, DOI 10.1073/pnas.97.8.4198; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Li XL, 2004, INT J ONCOL, V24, P257; Maeshima AM, 2006, LUNG CANCER, V52, P53, DOI 10.1016/j.lungcan.2005.11.010; Nikitin AY, 2004, CANCER RES, V64, P3725; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Okubo T, 2005, DEVELOPMENT, V132, P1363, DOI 10.1242/dev.01678; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Rodriguez-Pinilla SM, 2007, MODERN PATHOL, V20, P474, DOI 10.1038/modpathol.3800760; Romano RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005623; Sanada Y, 2006, PANCREAS, V32, P164, DOI 10.1097/01.mpa.0000202947.80117.a0; Sattler HP, 2000, PROSTATE, V45, P207, DOI 10.1002/1097-0045(20001101)45:3<207::AID-PROS2>3.0.CO;2-H; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Sholl LM, 2010, APPL IMMUNOHISTO M M, V18, P55, DOI 10.1097/PAI.0b013e3181b16b88; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Tompkins DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008248; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Yuan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009112	35	158	167	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11022	10.1371/journal.pone.0011022	http://dx.doi.org/10.1371/journal.pone.0011022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548776	Green Submitted, Green Published, gold			2022-12-27	WOS:000278599600002
J	Scotcher, MC; Cheng, LW; Stanker, LH				Scotcher, Miles C.; Cheng, Luisa W.; Stanker, Larry H.			Detection of Botulinum Neurotoxin Serotype B at Sub Mouse LD50 Levels by a Sandwich Immunoassay and Its Application to Toxin Detection in Milk	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; DODECYL-SULFATE; SEQUENCE; BINDING; PROTEIN; REGION; IDENTIFICATION; OUTBREAK; TETANUS	Background: Botulinum neurotoxin (BoNT), the causative agent of botulism, a serious neuroparylatic disease, is produced by the anaerobic bacterium Clostridium botulinum and consists of a family of seven serotypes (A-H). We previously reported production of high-affinity monoclonal antibodies to BoNT serotype A. Methods and Findings: Recombinant peptide fragments of the light chain, the transmembrane and receptor-binding domains of the heavy chain of botulinum neurotoxin type B (BoNT/B) were expressed in Escherichia coli as GST-fusion proteins and purified. These proteins were used to immunize BALB/cJ mice for the generation of monoclonal antibodies (mAbs). Antibody-producing hybridomas were detected using either a direct binding ELISA binding to plate-immobilized BoNT/B, or with a capture-capture ELISA whereby the capacity of the antibody to capture BoNT/B from solution was tested. A total of five mAbs were selected, two of which bound the toxin light chain and three bound the receptor-binding domain of BoNT/B heavy chain. MAb MCS6-27 was identified via capture-capture ELISA and was the only mAb able to bind BoNT/B in solution under physiological conditions. MAbs F24-1, F26-16, F27-33 and F29-40 were identified via direct binding ELISA, and were able to capture BoNT/B in solution only in the presence of 0.5-0.9 mM sodium dodecyl sulphate (SDS). MAb MCS6-27 and an anti-BoNT/B polyclonal antibody were incorporated into a sandwich ELISA that did not require SDS. Conclusions: We report here the generation of monoclonal antibodies to serotype B and the subsequent development of a sensitive sandwich immunoassay. This immunoassay has a detection limit of 100 fg BoNT/B, fifty times more sensitive than the mouse bioassay detection limit of 5 pg BoNT/B. Additionally, this assay detected as little as 39 pg/mL of toxin in skim, 2% and whole milk.	[Scotcher, Miles C.; Cheng, Luisa W.; Stanker, Larry H.] ARS, Western Reg Res Ctr, USDA, Albany, CA USA	United States Department of Agriculture (USDA)	Scotcher, MC (corresponding author), ARS, Western Reg Res Ctr, USDA, Albany, CA USA.	larry.stanker@ars.usda.gov	Pacific-Southwest, RCE/B-6155-2009		United States Department of Agriculture, Agriculture Research Service, CRIS [5325-42000-043-00D]; U.S. Public Health Service [U54 AI065359]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER	United States Department of Agriculture, Agriculture Research Service, CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the United States Department of Agriculture, Agriculture Research Service, CRIS project 5325-42000-043-00D and the U.S. Public Health Service Grant U54 AI065359. The funders had no role in sudy design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, HDB EP CLIN LAB WORK; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; BHUYAN AK, 2009, MECH SDS INDUCED PRO; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; CAMPBELL K, 1993, BIOCHIM BIOPHYS ACTA, V1216, P487, DOI 10.1016/0167-4781(93)90020-E; Cheng LW, 2009, INFECT IMMUN, V77, P4305, DOI 10.1128/IAI.00405-09; Dembek ZF, 2007, DISASTER MED PUBLIC, V1, P122, DOI 10.1097/DMP.0b013e318158c5fd; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; LAMANNA C, 1959, SCIENCE, V130, P763, DOI 10.1126/science.130.3378.763; Livesay DR, 2004, PROTEIN ENG DES SEL, V17, P463, DOI 10.1093/protein/gzh058; Miller J.H., 1972, EXPT MOL GENETICS; MIYAZAWA K, 1984, INT J COSMETIC SCI, V6, P33, DOI 10.1111/j.1467-2494.1984.tb00356.x; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; MORRISON S, 2002, CURRENT PROTOCOLS IM; *NAT BOT SURV, 2001, BOT SURV SUMM COUNC; OMAHONY M, 1990, EPIDEMIOL INFECT, V104, P389, DOI 10.1017/S0950268800047403; REYNOLDS JA, 1970, P NATL ACAD SCI USA, V66, P1002, DOI 10.1073/pnas.66.3.1002; ROBINSON NC, 1975, BIOCHEMISTRY-US, V14, P369, DOI 10.1021/bi00673a025; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Scotcher MC, 2009, HYBRIDOMA, V28, P315, DOI 10.1089/hyb.2009.0022; Scotcher MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004924; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Stanker LH, 2008, J IMMUNOL METHODS, V336, P1, DOI 10.1016/j.jim.2008.03.003; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; TERRANOVA W, 1978, AM J EPIDEMIOL, V108, P150, DOI 10.1093/oxfordjournals.aje.a112599; Wang ZD, 2000, J IMMUNOL METHODS, V233, P167, DOI 10.1016/S0022-1759(99)00184-2; WOOD DL, 1984, P NATL ACAD SCI-BIOL, V81, P4756, DOI 10.1073/pnas.81.15.4756	27	35	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11047	10.1371/journal.pone.0011047	http://dx.doi.org/10.1371/journal.pone.0011047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548779	Green Published, Green Submitted, gold			2022-12-27	WOS:000278599600008
J	Pugeault, N; Worgotter, F; Kruger, N				Pugeault, Nicolas; Worgotter, Florentin; Kruger, Norbert			Disambiguating Multi-Modal Scene Representations Using Perceptual Grouping Constraints	PLOS ONE			English	Article							ORGANIZATION	In its early stages, the visual system suffers from a lot of ambiguity and noise that severely limits the performance of early vision algorithms. This article presents feedback mechanisms between early visual processes, such as perceptual grouping, stereopsis and depth reconstruction, that allow the system to reduce this ambiguity and improve early representation of visual information. In the first part, the article proposes a local perceptual grouping algorithm that - in addition to commonly used geometric information - makes use of a novel multi - modal measure between local edge/line features. The grouping information is then used to: 1) disambiguate stereopsis by enforcing that stereo matches preserve groups; and 2) correct the reconstruction error due to the image pixel sampling using a linear interpolation over the groups. The integration of mutual feedback between early vision processes is shown to reduce considerably ambiguity and noise without the need for global constraints.	[Pugeault, Nicolas] Univ Surrey, Ctr Vis Speech & Signal Proc, Guildford GU2 5XH, Surrey, England; [Worgotter, Florentin] Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Kruger, Norbert] Univ So Denmark, Maersk McKinney Moller Inst, Odense, Denmark	University of Surrey; University of Southern Denmark	Pugeault, N (corresponding author), Univ Surrey, Ctr Vis Speech & Signal Proc, Guildford GU2 5XH, Surrey, England.	n.pugeault@surrey.ac.uk	Pugeault, Nicolas/AAF-9768-2019; Kruger, Norbert/P-6315-2015; Pugeault, Nicolas/I-1873-2015	Pugeault, Nicolas/0000-0002-3455-6280; Kruger, Norbert/0000-0002-3931-116X; Pugeault, Nicolas/0000-0002-3455-6280	PACOplus; IRFO; Bernstein Center for Computational Neuroscience, Gottingen	PACOplus; IRFO; Bernstein Center for Computational Neuroscience, Gottingen	The work described in this paper was funded by the European projects PACOplus and IRFO. Florentin Woergoetter acknowledges funding by the Bernstein Center for Computational Neuroscience, Gottingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloimonos Y., 1989, INTEGRATION VISUAL M; Baseski E., 2007, ICCV WORKSH 3D REPR; Baumberg A, 2000, PROC CVPR IEEE, P774, DOI 10.1109/CVPR.2000.855899; Brown MZ, 2003, IEEE T PATTERN ANAL, V25, P993, DOI 10.1109/TPAMI.2003.1217603; BRUNSWIK E, 1953, AM J PSYCHOL, V66, P20, DOI 10.2307/1417965; CHUNG R, 1995, COMPUT VIS IMAGE UND, V62, P245, DOI 10.1006/cviu.1995.1053; Crevier D, 1999, COMPUT VIS IMAGE UND, V76, P36, DOI 10.1006/cviu.1999.0785; ELDER J, 1998, PERCEPTION S, V27; Elder JH, 2002, J VISION, V2, DOI 10.1167/2.4.5; Elder JH, 1999, INT J COMPUT VISION, V34, P97, DOI 10.1023/A:1008183703117; Faugeras O, 1993, 3 DIMENSIONAL COMPUT; Felsberg M, 2001, IEEE T SIGNAL PROCES, V49, P3136, DOI 10.1109/78.969520; Felsberg M, 2009, IMAGE VISION COMPUT, V27, P628, DOI 10.1016/j.imavis.2008.06.018; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; FREEMAN WT, 1991, IEEE T PATTERN ANAL, V13, P891, DOI 10.1109/34.93808; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; GEMAN S, 1992, NEURAL COMPUT, V4, P1, DOI 10.1162/neco.1992.4.1.1; Harris C., 1988, P ALVEY VISION C, DOI DOI 10.5244/C.2.23; Hartley R., 2000, MULTIPLE VIEW GEOMET, V2; HORAUD R, 1989, IEEE T PATTERN ANAL, V11, P1168, DOI 10.1109/34.42855; KIM NH, 1988, PATTERN RECOGN, V21, P505, DOI 10.1016/0031-3203(88)90009-X; KOENDERINK JJ, 1987, BIOL CYBERN, V55, P367, DOI 10.1007/BF00318371; Koffka K, 1935, PRINCIPLES GESTALT P; KOHLER K, 1947, GESTALT PSYCHOL INTR; Konig P, 2006, BIOL CYBERN, V94, P325, DOI [10.1007/s00422-006-0050-3, 10.1007/S00422-006-0050-3]; KOVESI P, 1999, VIDERE J COMPUTER VI, V1, P1; KRAFT D, 2009, SPECIAL ISSUE COGNIT, V5, P247; Kruger N, 2004, PATTERN RECOGN LETT, V25, P849, DOI 10.1016/j.patrec.2004.01.021; Kruger N, 1998, NEURAL PROCESS LETT, V8, P117, DOI 10.1023/A:1009688428205; KRUGER N, 2004, INTERDISCIPLINARY J, V1, P417; LEE SH, 1994, PATTERN RECOGN, V27, P961, DOI 10.1016/0031-3203(94)90138-4; Lowe D., 1999, P INT C COMP VIS, V2, P1150, DOI DOI 10.1109/ICCV.1999.790410; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; MAYHEW JEW, 1981, ARTIF INTELL, V17, P349, DOI 10.1016/0004-3702(81)90029-1; Mikolajczyk K, 2005, IEEE T PATTERN ANAL, V27, P1615, DOI 10.1109/TPAMI.2005.188; MOHAN R, 1992, IEEE T PATTERN ANAL, V14, P616, DOI 10.1109/34.141553; NAGEL HH, 1987, ARTIF INTELL, V33, P299, DOI 10.1016/0004-3702(87)90041-5; OHTA Y, 1985, IEEE T PATTERN ANAL, V7, P139, DOI 10.1109/TPAMI.1985.4767639; ORAM MW, 1994, NEURAL NETWORKS, V7, P945, DOI 10.1016/S0893-6080(05)80153-4; PARENT P, 1989, IEEE T PATTERN ANAL, V11, P823, DOI 10.1109/34.31445; PERONA P, 1998, P EUR C COMP VIS, V1, P655; POPOVIC M, ROBOTIC AUT IN PRESS; Pugeault N., 2003, P BMVC 2003, P271; PUGEAULT N, 2006, P IEEE SMC UK RI C A, P217; PUGEAULT N, 2006, P IEEE WORKSH PERC O, P195; PUGEAULT N, 2008, P INT C COMP VIS THE, V2, P186; PUGEAULT N, 2008, THESIS U GOTTINGEN; Rodrigues J, 2006, BIOSYSTEMS, V86, P75, DOI 10.1016/j.biosystems.2006.02.019; Rodrigues J, 2009, BIOSYSTEMS, V95, P206, DOI 10.1016/j.biosystems.2008.10.006; Sarkar S, 2000, IEEE T PATTERN ANAL, V22, P504, DOI 10.1109/34.857006; Schaffalitzky F, 2002, LECT NOTES COMPUT SC, V2350, P414; Scharstein D, 2002, INT J COMPUT VISION, V47, P7, DOI 10.1023/A:1014573219977; Schmid C, 2000, INT J COMPUT VISION, V37, P151, DOI 10.1023/A:1008199403446; Se S, 2001, IEEE INT CONF ROBOT, P2051, DOI 10.1109/ROBOT.2001.932909; SHAASHUA A, 1990, NEURAL INFORM PROCES, V3, P335; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; VANGOOL L, 1996, LECT NOTES COMPUTER, V1064, P642; VERRI A, 1986, J OPTICAL SOC AM, V3; WERTHEIMER M, 1935, LAWS ORGANSATION PER; *WIK, 2007, CUB HERM SPLIN; Wolff L. B., 1989, Proceedings CVPR '89 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No.89CH2752-4), P410, DOI 10.1109/CVPR.1989.37879	61	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e10663	10.1371/journal.pone.0010663	http://dx.doi.org/10.1371/journal.pone.0010663			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20544006	gold, Green Published, Green Accepted			2022-12-27	WOS:000278557600001
J	Guillaumot, P; Luquain, C; Malek, M; Huber, AL; Brugiere, S; Garin, J; Grunwald, D; Regnier, D; Petrilli, V; Lefai, E; Manie, SN				Guillaumot, Patricia; Luquain, Celine; Malek, Mouhannad; Huber, Anne-Laure; Brugiere, Sabine; Garin, Jerome; Grunwald, Didier; Regnier, Daniel; Petrilli, Virginie; Lefai, Etienne; Manie, Serge N.			Pdro, a Protein Associated with Late Endosomes and Lysosomes and Implicated in Cellular Cholesterol Homeostasis	PLOS ONE			English	Article							ACTIN-FILAMENTS; MACROPINOCYTOSIS; TRAFFICKING; METABOLISM; ACTIVATION; MEMBRANES; DYNAMICS; MOTILITY; DEPENDS	Background: Cellular cholesterol is a vital component of the cell membrane. Its concentration is tightly controlled by mechanisms that remain only partially characterized. In this study, we describe a late endosome/lysosomes-associated protein whose expression level affects cellular free cholesterol content. Methodology/Principal Findings: Using a restricted proteomic analysis of detergent-resistant membranes (DRMs), we have identified a protein encoded by gene C11orf59. It is mainly localized to late endosome/lysosome (LE/LY) compartment through N-terminal myristoylation and palmitoylation. We named it Pdro for protein associated with DRMs and endosomes. Very recently, three studies have reported on the same protein under two other names: the human p27RF-Rho that regulates RhoA activation and actin dynamics, and its rodent orthologue p18 that controls both LE/LY dynamics through the MERK-ERK pathway and the lysosomal activation of mammalian target of rapamycin complex 1 by amino acids. We found that, consistent with the presence of sterol-responsive element consensus sequences in the promoter region of C11orf59, Pdro mRNA and protein expression levels are regulated positively by cellular cholesterol depletion and negatively by cellular cholesterol loading. Conversely, Pdro is involved in the regulation of cholesterol homeostasis, since its depletion by siRNA increases cellular free cholesterol content that is accompanied by an increased cholesterol efflux from cells. On the other hand, cells stably overexpressing Pdro display reduced cellular free cholesterol content. Pdro depletion-mediated excess cholesterol results, at least in part, from a stimulated low-density lipoprotein (LDL) uptake and an increased cholesterol egress from LE/LY. Conclusions/Significance: LDL-derived cholesterol release involves LE/LY motility that is linked to actin dynamics. Because Pdro regulates these two processes, we propose that modulation of Pdro expression in response to sterol levels regulates LDL-derived cholesterol through both LDL uptake and LE/LY dynamics, to ultimately control free cholesterol homeostasis.	[Guillaumot, Patricia; Malek, Mouhannad; Huber, Anne-Laure; Regnier, Daniel; Petrilli, Virginie; Manie, Serge N.] Ctr Leon Berard, CNRS, UMR 5201, F-69373 Lyon, France; [Luquain, Celine] INSERM Insa Lyon, UMR 870, Villeurbanne, France; [Brugiere, Sabine; Garin, Jerome] CEA, INSERM, UJF, Lab Chim Proteines,ERM 201, Grenoble, France; [Grunwald, Didier] Inst Rech Technol & Sci Vivant, DSV, CEA, INSERM,U873,Lab Transduct Signal, Grenoble, France; [Lefai, Etienne] INSERM, U870, UMR 1235, INRA, Oullins, France	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Centre Leon Berard; Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm)	Guillaumot, P (corresponding author), Ctr Leon Berard, CNRS, UMR 5201, F-69373 Lyon, France.	manie@lyon.fnclcc.fr	Manie, Serge/ABC-8331-2021; Petrilli, Virginie/ABI-8199-2020; Lefai, Etienne/L-7961-2019; Lefai, Etienne/E-9615-2019	Lefai, Etienne/0000-0002-3042-7801; Lefai, Etienne/0000-0002-3042-7801; Sabine, BRUGIERE/0000-0002-0757-0968; Huber, Anne-Laure/0000-0002-3433-766X; manie, serge/0000-0002-9168-1977; Petrilli, Virginie/0000-0001-8502-6979	CNRS; Association pour la Recherche contre le Cancer (ARC) [SM 3811, 4915]; Fondation De France (FDF) [2002 010 893]; Ligue Nationale Contre le Cancer Comite du Rhone	CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Fondation De France (FDF)(Fondation de France); Ligue Nationale Contre le Cancer Comite du Rhone(Ligue nationale contre le cancer)	This work was supported by institutional grants from CNRS and additional support from Association pour la Recherche contre le Cancer (ARC: SM 3811 and 4915), Fondation De France (FDF: 2002 010 893) and Ligue Nationale Contre le Cancer Comite du Rhone. CL was supported by fellowships from FDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anczukow O, 2008, GENE CHROMOSOME CANC, V47, P418, DOI 10.1002/gcc.20546; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Berger AC, 2007, J CELL SCI, V120, P3640, DOI 10.1242/jcs.03487; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; CHAZOTTE B, 2008, CLOD SPRING HARB PRO; Cordonnier MN, 2001, MOL BIOL CELL, V12, P4013, DOI 10.1091/mbc.12.12.4013; Delton-Vandenbroucke I, 2007, J LIPID RES, V48, P543, DOI 10.1194/jlr.M600266-JLR200; Durrbach A, 1996, J CELL SCI, V109, P457; ENDO A, 1985, J MED CHEM, V28, P401, DOI 10.1021/jm00382a001; Ferro M, 2000, ELECTROPHORESIS, V21, P3517; Ganley IG, 2006, J BIOL CHEM, V281, P17890, DOI 10.1074/jbc.M601679200; Glebov OO, 2004, NAT CELL BIOL, V6, P238, DOI 10.1038/ncb1103; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hoshino D, 2009, J BIOL CHEM, V284, P27315, DOI 10.1074/jbc.M109.041400; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Kauppi M, 2002, J CELL SCI, V115, P899; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kritharides L, 1998, ARTERIOSCL THROM VAS, V18, P1589, DOI 10.1161/01.ATV.18.10.1589; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Lee E, 2002, TRAFFIC, V3, P186, DOI 10.1034/j.1600-0854.2002.030304.x; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Linder MD, 2007, MOL BIOL CELL, V18, P47, DOI 10.1091/mbc.E06-07-0575; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Pelletier L, 2006, CANCER RES, V66, P3681, DOI 10.1158/0008-5472.CAN-05-3870; Qin CB, 2006, ARTERIOSCL THROM VAS, V26, P372, DOI 10.1161/01.ATV.0000197848.67999.e1; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; VANDEURS B, 1995, EUR J CELL BIOL, V66, P309; Vidalain PO, 2000, EMBO J, V19, P3304, DOI 10.1093/emboj/19.13.3304; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; XU XX, 1991, J BIOL CHEM, V266, P17040; Yao WQ, 2009, ACTA BIOCH BIOPH SIN, V41, P773, DOI 10.1093/abbs/gmp066	38	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e10977	10.1371/journal.pone.0010977	http://dx.doi.org/10.1371/journal.pone.0010977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544018	Green Published, gold, Green Submitted			2022-12-27	WOS:000278494900006
J	Wu, DD; Jin, W; Hao, XD; Tang, NLS; Zhang, YP				Wu, Dong-Dong; Jin, Wei; Hao, Xiao-Dan; Tang, Nelson Leung Sang; Zhang, Ya-Ping			Evidence for Positive Selection on the Osteogenin (BMP3) Gene in Human Populations	PLOS ONE			English	Article							HUMAN GENOME; HAPLOTYPE RECONSTRUCTION; LACTASE-PERSISTENCE; DARWINIAN SELECTION; STATISTICAL-METHOD; SKIN PIGMENTATION; DNA POLYMORPHISM; BRAIN SIZE; SIGNATURES; HITCHHIKING	Background: Human skeletal system has evolved rapidly since the dispersal of modern humans from Africa, potentially driven by selection and adaptation. Osteogenin (BMP3) plays an important role in skeletal development and bone osteogenesis as an antagonist of the osteogenic bone morphogenetic proteins, and negatively regulates bone mineral density. Methodology/Principal Findings: Here, we resequenced the BMP3 gene from individuals in four geographically separated modern human populations. Features supportive of positive selection in the BMP3 gene were found including the presence of an excess of nonsynonymous mutations in modern humans, and a significantly lower genetic diversity that deviates from neutrality. The prevalent haplotypes of the first exon region in Europeans demonstrated features of long-range haplotype homogeneity. In contrast with findings in European, the derived allele SNP Arg192Gln shows higher extended haplotype homozygosity in East Asian. The worldwide allele frequency distribution of SNP shows not only a high-derived allele frequency in Asians, but also in Americans, which is suggestive of functional adaptation. Conclusions/Significance: In conclusion, we provide evidence for recent positive selection operating upon a crucial gene in skeletal development, which may provide new insight into the evolution of the skeletal system and bone development.	[Wu, Dong-Dong; Hao, Xiao-Dan; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Jin, Wei; Zhang, Ya-Ping] Yunnan Univ, Lab Conservat & Utilizat Bioresource, Kunming 650091, Peoples R China; [Wu, Dong-Dong; Hao, Xiao-Dan] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Tang, Nelson Leung Sang; Zhang, Ya-Ping] KIZ CUHK Joint Lab Bioresources & Mol Res Common, Kunming, Peoples R China; [Tang, Nelson Leung Sang] Chinese Univ Hong Kong, Fac Med, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; [Tang, Nelson Leung Sang] Chinese Univ Hong Kong, Lab Genet Dis Susceptibil, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese University of Hong Kong; Chinese University of Hong Kong	Wu, DD (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	zhangyp@mail.kiz.ac.cn	Wu, Dong-Dong/AAR-5615-2020; hao, xiaodan/ABD-7161-2021; Tang, Nelson L/P-5018-2017	Tang, Nelson L/0000-0002-3607-5819; Hao, Xiao-dan/0000-0002-4611-8325	National Basic Research Program of China (973 Program) [2007CB411600]; National Natural Science Foundation of China [30621092, 30430110]; Bureau of Science and Technology of Yunnan Province	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bureau of Science and Technology of Yunnan Province	This work was supported by grants from the National Basic Research Program of China (973 Program, 2007CB411600), the National Natural Science Foundation of China (30621092, 30430110), and Bureau of Science and Technology of Yunnan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Cann HM, 2002, SCIENCE, V296, P261; Daluiski A, 2001, NAT GENET, V27, P84, DOI 10.1038/83810; Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012; Evans PD, 2005, SCIENCE, V309, P1717, DOI 10.1126/science.1113722; Fay JC, 2000, GENETICS, V155, P1405; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Fujimoto A, 2008, HUM MOL GENET, V17, P835, DOI 10.1093/hmg/ddm355; FUN YX, 1997, GENETICS, V14, P915; Izagirre N, 2006, MOL BIOL EVOL, V23, P1697, DOI 10.1093/molbev/msl030; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lao O, 2007, ANN HUM GENET, V71, P354, DOI 10.1111/j.1469-1809.2006.00341.x; LARSEN CS, 1995, ANNU REV ANTHROPOL, V24, P185, DOI 10.1146/annurev.an.24.100195.001153; LAURA WG, 2008, DEV DYNAM, V237, P1691; LAURA WG, 2009, DEV DYNAM, V238, P2374; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mekel-Bobrov N, 2005, SCIENCE, V309, P1720, DOI 10.1126/science.1116815; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Sockol MD, 2007, P NATL ACAD SCI USA, V104, P12265, DOI 10.1073/pnas.0703267104; Soejima M, 2006, MOL BIOL EVOL, V23, P179, DOI 10.1093/molbev/msj018; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Varki A, 2005, GENOME RES, V15, P1746, DOI 10.1101/gr.3737405; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WU DD, 2010, HUM MOL GENET; Wu DD, 2008, CHINESE SCI BULL, V53, P1457, DOI 10.1007/s11434-008-0202-z; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397	39	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10959	10.1371/journal.pone.0010959	http://dx.doi.org/10.1371/journal.pone.0010959			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532035	Green Published, Green Submitted, gold			2022-12-27	WOS:000278380500005
J	Netzer, WJ; Powell, C; Nong, Y; Blundell, J; Wong, LL; Duff, K; Flajolet, M; Greengard, P				Netzer, William J.; Powell, Craig; Nong, Yi; Blundell, Jacqueline; Wong, Lili; Duff, Karen; Flajolet, Marc; Greengard, Paul			Lowering beta-Amyloid Levels Rescues Learning and Memory in a Down Syndrome Mouse Model	PLOS ONE			English	Article							GAMMA-SECRETASE INHIBITORS; ALZHEIMERS-DISEASE; TS65DN MOUSE; IN-VIVO; DEFICITS; PROTEIN; MICE; TRAFFICKING; BRAIN; CHROMOSOME-21	beta-amyloid levels are elevated in Down syndrome (DS) patients throughout life and are believed to cause Alzheimer's disease (AD) in adult members of this population. However, it is not known if beta-amyloid contributes to intellectual disability in younger individuals. We used a gamma-secretase inhibitor to lower beta-amyloid levels in young mice that model DS. This treatment corrected learning deficits characteristic of these mice, suggesting that beta-amyloid-lowering therapies might improve cognitive function in young DS patients.	[Netzer, William J.; Nong, Yi; Flajolet, Marc; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; [Powell, Craig; Blundell, Jacqueline] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Powell, Craig; Blundell, Jacqueline] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Wong, Lili; Duff, Karen] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY USA	Rockefeller University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Columbia University	Netzer, WJ (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA.	netzerw@rockefeller.edu	Kennedy, Kristen M/B-4699-2008	Kennedy, Kristen M/0000-0001-5373-9026; Powell, Craig/0000-0001-5451-2165; Duff, Karen/0000-0002-6177-868X	U.S. National Institutes of Health [AG09464, R01MH081164, R21HD065290]; Fisher Center for Alzheimer's Disease Research Foundation; F.M. Kirby Foundation, Inc.; Lowe Foundation (Erma Lowe Laboratory for Alzheimer's Disease Research); Crystal Charity Ball Program for the Prevention of Complications in Children with Down's Syndrome; Van Beber Family; David M. Crowley Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081164, K08MH065975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009464] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fisher Center for Alzheimer's Disease Research Foundation; F.M. Kirby Foundation, Inc.; Lowe Foundation (Erma Lowe Laboratory for Alzheimer's Disease Research); Crystal Charity Ball Program for the Prevention of Complications in Children with Down's Syndrome; Van Beber Family; David M. Crowley Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by U.S. National Institutes of Health Grants AG09464 (to P. G), R01MH081164, R21HD065290 (to C. M. P.), The Fisher Center for Alzheimer's Disease Research Foundation (http://www.alzinfo.org) and the F.M. Kirby Foundation, Inc. (to P. G.), the Lowe Foundation (Erma Lowe Laboratory for Alzheimer's Disease Research), the Crystal Charity Ball Program for the Prevention of Complications in Children with Down's Syndrome, the Van Beber Family and the David M. Crowley Foundation (to C. M. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeson EC, 2001, CYTOGENET CELL GENET, V93, P270, DOI 10.1159/000056997; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; CHOI JH, 2009, J NEUROCHEM; Comery TA, 2005, J NEUROSCI, V25, P8898, DOI 10.1523/JNEUROSCI.2693-05.2005; Costa ACS, 2008, NEUROPSYCHOPHARMACOL, V33, P1624, DOI 10.1038/sj.npp.1301535; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; EPSTEIN CJ, 1990, AM J MED GENET, P31; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; GODRIDGE H, 1987, J NEUROL NEUROSUR PS, V50, P775, DOI 10.1136/jnnp.50.6.775; Granholm ACE, 2000, EXP NEUROL, V161, P647, DOI 10.1006/exnr.1999.7289; Gyure KA, 2001, ARCH PATHOL LAB MED, V125, P489; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Horikoshi Y, 2004, BIOCHEM BIOPH RES CO, V319, P733, DOI 10.1016/j.bbrc.2004.05.051; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; HYMAN BT, 1992, PROG CLIN BIOL RES, V379, P123; Imbimbo BP, 2008, CURR TOP MED CHEM, V8, P54, DOI 10.2174/156802608783334015; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Lanz TA, 2003, J PHARMACOL EXP THER, V305, P864, DOI 10.1124/jpet.102.048280; Martinez-Cue C, 2002, BEHAV BRAIN RES, V134, P185, DOI 10.1016/S0166-4328(02)00026-8; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Refolo LM, 2001, NEUROBIOL DIS, V8, P890, DOI 10.1006/nbdi.2001.0422; Rueda N, 2008, NEUROSCI LETT, V433, P22, DOI 10.1016/j.neulet.2007.12.039; Salehi A, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000258; Savage MJ, 1998, J NEUROSCI, V18, P1743; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; WISHART JG, 1993, J INTELL DISABIL RES, V37, P389; Wolvetang EW, 2003, BBA-GENE STRUCT EXPR, V1628, P105, DOI 10.1016/S0167-4781(03)00121-0	36	56	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10943	10.1371/journal.pone.0010943	http://dx.doi.org/10.1371/journal.pone.0010943			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532168	Green Submitted, Green Published, gold			2022-12-27	WOS:000278318700015
J	Sela, N; Mersch, B; Hotz-Wagenblatt, A; Ast, G				Sela, Noa; Mersch, Britta; Hotz-Wagenblatt, Agnes; Ast, Gil			Characteristics of Transposable Element Exonization within Human and Mouse	PLOS ONE			English	Article							SELECTION PRESSURE; RNA SURVEILLANCE; GENOMES REVEALS; REPBASE UPDATE; EXON CREATION; MESSENGER-RNA; ANTISENSE RNA; ALU REPEATS; EVOLUTIONARY; DATABASE	Insertion of transposed elements within mammalian genes is thought to be an important contributor to mammalian evolution and speciation. Insertion of transposed elements into introns can lead to their activation as alternatively spliced cassette exons, an event called exonization. Elucidation of the evolutionary constraints that have shaped fixation of transposed elements within human and mouse protein coding genes and subsequent exonization is important for understanding of how the exonization process has affected transcriptome and proteome complexities. Here we show that exonization of transposed elements is biased towards the beginning of the coding sequence in both human and mouse genes. Analysis of single nucleotide polymorphisms (SNPs) revealed that exonization of transposed elements can be population-specific, implying that exonizations may enhance divergence and lead to speciation. SNP density analysis revealed differences between Alu and other transposed elements. Finally, we identified cases of primate-specific Alu elements that depend on RNA editing for their exonization. These results shed light on TE fixation and the exonization process within human and mouse genes.	[Sela, Noa; Ast, Gil] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet, IL-69978 Tel Aviv, Israel; [Mersch, Britta; Hotz-Wagenblatt, Agnes] German Canc Res Ctr, Dept Mol Biophys, D-6900 Heidelberg, Germany	Tel Aviv University; Sackler Faculty of Medicine; Helmholtz Association; German Cancer Research Center (DKFZ)	Sela, N (corresponding author), Univ Munich, Fac Biol, Dept Bot, Munich, Germany.	hotz-wagenblatt@dkfz-heidelberg.de; gilast@post.tau.ac.il	Sela, Noa/C-5133-2008	Sela, Noa/0000-0002-8282-215X	Israel Science Foundation [ISF 61/09]; DKFZ/MOST [ca-139]; Deutsche-Israel Project [DIP MI-1317]; Israel Cancer Research Foundation (ICRF); LMUexcellence fellowship	Israel Science Foundation(Israel Science Foundation); DKFZ/MOST; Deutsche-Israel Project; Israel Cancer Research Foundation (ICRF); LMUexcellence fellowship	Funding: This work was supported by a grant from the Israel Science Foundation (ISF 61/09), Joint Germany-Israeli Research Program (ca-139), Deutsche-Israel Project (DIP MI-1317), and Israel Cancer Research Foundation (ICRF). B.M. and A.H.-W. were supported by the Joint Germany-Israeli Research Program (ca-139) (DKFZ/MOST). N.S. is supported by the LMUexcellence fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-109; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chen WL, 2008, BRAIN RES, V1233, P176, DOI 10.1016/j.brainres.2008.07.096; Cordaux R, 2006, GENE, V373, P134, DOI 10.1016/j.gene.2006.01.019; Corvelo A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r141; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; DEININGER PL, 1993, EVOL BIOL, V27, P157; Gal-Mark N, 2008, NUCLEIC ACIDS RES, V36, P2012, DOI 10.1093/nar/gkn024; Gal-Mark N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000717; Gehring NH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000120; Gerber A, 1997, RNA, V3, P453; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Goren A, 2008, GENOME RES, V18, P214, DOI 10.1101/gr.6661308; GRAVELEY BR, 2007, TRENDS GENET; He SM, 2008, NUCLEIC ACIDS RES, V36, pD170, DOI 10.1093/nar/gkm1011; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Hull J, 2007, PLOS GENET, V3, P1009, DOI 10.1371/journal.pgen.0030099; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kapitonov VV, 2008, NAT REV GENET, V9, DOI 10.1038/nrg2165-c1; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; KISTER KP, 1987, NUCLEIC ACIDS RES, V15, P1905, DOI 10.1093/nar/15.5.1905; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Kriegs JO, 2007, TRENDS GENET, V23, P158, DOI 10.1016/j.tig.2007.02.002; Krull M, 2007, GENOME RES, V17, P1139, DOI 10.1101/gr.6320607; Kuhn RM, 2007, NUCLEIC ACIDS RES, V35, pD668, DOI 10.1093/nar/gkl928; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Kwan T, 2007, GENOME RES, V17, P1210, DOI 10.1101/gr.6281007; LABUDA D, 1989, NUCLEIC ACIDS RES, V17, P2477, DOI 10.1093/nar/17.7.2477; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Lev-Maor G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r29; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Levy A, 2008, NUCLEIC ACIDS RES, V36, pD47, DOI 10.1093/nar/gkm949; LIN L, 2009, HUM MOL GENET; Lin L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000225; Liu CN, 2005, NUCLEIC ACIDS RES, V33, pD112, DOI 10.1093/nar/gki041; Lo WS, 2004, MOL PSYCHIATR, V9, P603, DOI 10.1038/sj.mp.4001461; Magen A, 2005, NUCLEIC ACIDS RES, V33, P5574, DOI 10.1093/nar/gki858; MAKALOWSKI W, 1994, TRENDS GENET, V10, P188, DOI 10.1016/0168-9525(94)90254-2; Mersch B, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-78; Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006; Moller-Krull M, 2008, J MOL BIOL, V382, P601, DOI 10.1016/j.jmb.2008.07.014; Nakabayashi K, 2002, HUM MOL GENET, V11, P1743, DOI 10.1093/hmg/11.15.1743; Nekrutenko A, 2001, TRENDS GENET, V17, P619, DOI 10.1016/S0168-9525(01)02445-3; Nemes JP, 2000, HUM MOL GENET, V9, P1543, DOI 10.1093/hmg/9.10.1543; Ng SK, 2006, GENE, V368, P110, DOI 10.1016/j.gene.2005.10.034; Ram O, 2008, MOL CELL BIOL, V28, P3513, DOI 10.1128/MCB.02279-07; Resch A, 2004, NUCLEIC ACIDS RES, V32, P1261, DOI 10.1093/nar/gkh284; Roy M, 2008, RNA, V14, P2261, DOI 10.1261/rna.1024908; Schwartz S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000300; Sela N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r127; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Singer SS, 2004, J MOL BIOL, V341, P883, DOI 10.1016/j.jmb.2004.06.070; Sironi M, 2005, TRENDS GENET, V21, P484, DOI 10.1016/j.tig.2005.06.009; Sironi M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r120; SMIT AFA, VERSION OPEN 3 2 7; Sorek R, 2004, MOL CELL, V14, P221, DOI 10.1016/S1097-2765(04)00181-9; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; Sorek R, 2007, RNA, V13, P1603, DOI 10.1261/rna.682507; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; XIE H, 2009, NUCL ACIDS RES; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Yang JO, 2009, HUM MUTAT, V30, pE1010, DOI 10.1002/humu.21128; Zhang XHF, 2006, P NATL ACAD SCI USA, V103, P13427, DOI 10.1073/pnas.0603042103	73	51	53	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2010	5	6							e10907	10.1371/journal.pone.0010907	http://dx.doi.org/10.1371/journal.pone.0010907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QF	20532223	gold, Green Published, Green Submitted			2022-12-27	WOS:000278222400004
J	Gerardin, P; El Amrani, R; Cyrille, B; Gabriele, M; Guillermin, P; Boukerrou, M; Boumahni, B; Randrianaivo, H; Winer, A; Rouanet, JF; Bohrer, M; Jaffar-Bandjee, MC; Robillard, PY; Barau, G; Michault, A				Gerardin, Patrick; El Amrani, Rachid; Cyrille, Beatrice; Gabriele, Marc; Guillermin, Philippe; Boukerrou, Malik; Boumahni, Brahim; Randrianaivo, Hanitra; Winer, Arnaud; Rouanet, Jean-Fabien; Bohrer, Michel; Jaffar-Bandjee, Marie-Christine; Robillard, Pierre-Yves; Barau, Georges; Michault, Alain			Low Clinical Burden of 2009 Pandemic Influenza A (H1N1) Infection during Pregnancy on the Island of La Reunion	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; A(H1N1) INFECTION; NEONATAL OUTCOMES; H5N1 INFECTION; VIRUS; WOMEN; NEURAMINIDASE; SURVEILLANCE; TRANSMISSION; PATHOGENESIS	Background: Pregnant women have been identified as a group at risk, both for respiratory complications than for the admissions to the Intensive Care Unit (ICU) during the 2009 H1N1 influenza pandemic (pdm). The purpose of this prospective register-based cohort-study was to characterize the clinical virulence of the pdm (H1N1/09)v during pregnancy in La Reunion. Methods/Principal Findings: Over a twelve-week pdm wave (13 July to 3 October 2009), 294 pregnant women presented with an influenza-like illness (ILI) to one of the three maternity departments of the South Reunion area, Indian Ocean. Out of these, 278 were checked by RT-PCR for influenza viruses (157 positive and 121 negative, of whom, 141 with pdm flu and 132 with ILIs of non pdm origin, 5 untyped). The median body temperature was higher in women experiencing pdm flu than in those with non pdm ILI (38.9 degrees C versus 38.3 degrees C, P<0.0001), without evidence linked to circulating viremia. Oseltamivir was given for 86% of pdm flu cases in a median time inferior than 48 hrs (range 0-7 days). The hospitalization rate for pdm flu was of 60% and not associated with underlying conditions. Six viral pneumonia and fourteen asthma attacks were observed among 84 hospitalized pdm flu cases, of whom, only one led to the ICU for an acute lung injury. No maternal death occurred during the pdm wave. None adverse pregnancy outcome was associated with pdm flu. No congenital birth defect, nor early-onset neonatal influenza infection was attributable to pdm flu exposure. Conclusions/Significance: This report mitigates substantially the presumed severity of pandemic H1N1/09 influenza infection during pregnancy. The reasons for which the clinical burden of H1N1/09 influenza virus may differ worldwide raise questions about a differential local viral-strain effect and public health preparedness, notably in timely access to special care and antiviral treatments.	[Gerardin, Patrick; Boumahni, Brahim; Robillard, Pierre-Yves] CHR, Neonatal & Pediat Intens Care Unit, St Pierre, La Reunion, France; [Gerardin, Patrick] Ctr Clin Invest Clin Epidemiol Reunion, INSERM, CHR, URMLR, St Pierre, La Reunion, France; [Gerardin, Patrick] AP HP, INSERM, UMR S953, Paris, France; [El Amrani, Rachid; Cyrille, Beatrice; Gabriele, Marc; Guillermin, Philippe; Boukerrou, Malik; Barau, Georges] CHR, Obstet & Gynecol Unit, St Pierre, La Reunion, France; [Randrianaivo, Hanitra] CHR, Fetopathol Unit, St Pierre, La Reunion, France; [Winer, Arnaud] CHR, Intens Care Unit, St Pierre, La Reunion, France; [Rouanet, Jean-Fabien] CHR, Dept Med Informat, St Pierre, La Reunion, France; [Bohrer, Michel] CHR, Dept Med Informat, St Denis, La Reunion, France	CHU Reunion; CHU Reunion; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Reunion; CHU Reunion; CHU Reunion; CHU Reunion; CHU Reunion	Gerardin, P (corresponding author), CHR, Neonatal & Pediat Intens Care Unit, St Pierre, La Reunion, France.	patrick.gerardin@chr-reunion.fr	Robillard, Pierre-Yves/AAD-9774-2021	Winer, Arnaud/0000-0002-1188-082X	Centre Hospitalier Regional (CHR) of La Reunion	Centre Hospitalier Regional (CHR) of La Reunion	The Centre Hospitalier Regional (CHR) of La Reunion, the funding source for this study, employs the study authors, who were responsibile for study design, data collection and analysis and interpretation of the findings. The report received the approval for publication from Institut National de la Sante Et de la Recherche Medicale (INSERM). Additionally, some study authors are employed by the REPERE (REseau PErinatal REunion) network and Institut National de la Sante Et de la Recherche Medicale (INSERM), which report public health information to the CHR of La Reunion. The CHR of La Reunion had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. P Gerardin, G Barau and A Michault had full access to all data and the final responsibility for the decision to submit for publication.	Chien YS, 2010, J INFECTION, V60, P168, DOI 10.1016/j.jinf.2009.12.012; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; D'Ortenzio E, 2010, CLIN MICROBIOL INFEC, V16, P309, DOI 10.1111/j.1469-0691.2010.03171.x; D'Ortenzio E, 2009, EUROSURVEILLANCE, V14; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; Disson O, 2008, NATURE, V455, P1114, DOI 10.1038/nature07303; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; DORTENZIO E, 2009, EUROSURVEILLANCE, V14, P19257; FLAHAULT A, 2009, PLOS CURR INFLUENZA; Flahault Antoine, 2009, PLoS Curr, V1, pRRN1010; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; FUHRMAN C, 2009, EURO SURVEIL, V15; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060; Greer LG, 2010, OBSTET GYNECOL, V115, P711, DOI 10.1097/AOG.0b013e3181d44752; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Hewagama S, 2010, CLIN INFECT DIS, V50, P686, DOI 10.1086/650460; Irving WL, 2000, BRIT J OBSTET GYNAEC, V107, P1282, DOI 10.1111/j.1471-0528.2000.tb11621.x; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Kawachi S, 2009, J INFECT DIS, V200, P510, DOI 10.1086/605034; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; LECHAT MF, 1993, ENVIRON HEALTH PERSP, V101, P153, DOI 10.2307/3431389; Lim ML, 2010, BJOG-INT J OBSTET GY, V117, P551, DOI 10.1111/j.1471-0528.2010.02522.x; Ling LM, 2010, CLIN INFECT DIS, V50, P963, DOI 10.1086/651083; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; McCullers JA, 2003, J INFECT DIS, V187, P1000, DOI 10.1086/368163; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Nichols JE, 2001, J VIROL, V75, P5921, DOI 10.1128/JVI.73.13.5921-5929.2001; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Rasmussen SA, 2008, EMERG INFECT DIS, V14, P95, DOI 10.3201/eid1401.070667; RENAULT P, 2010, PLOS CURR INFLUENZA; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Seppelt I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1279; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Vivet-Lefebure A, 2007, GYNECOL OBSTET FERTI, V35, P530, DOI 10.1016/j.gyobfe.2007.04.010; Wallace LA, 2004, J CLIN VIROL, V31, P40, DOI 10.1016/j.jcv.2003.12.003; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Whitley RJ, 2006, J INFECT DIS, V194, pS133, DOI 10.1086/507548; Zarychanski Ryan, 2010, CMAJ, V182, P257, DOI 10.1503/cmaj.091884; Zou SM, 2006, TRANSFUS MED REV, V20, P181, DOI 10.1016/j.tmrv.2006.03.001; 2009, J GYNECOL OBSTET BIO, V38, P606	49	26	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10896	10.1371/journal.pone.0010896	http://dx.doi.org/10.1371/journal.pone.0010896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531946	Green Submitted, Green Published, gold			2022-12-27	WOS:000278222100025
J	Marley, A; von Zastrow, M				Marley, Aaron; von Zastrow, Mark			DISC1 Regulates Primary Cilia That Display Specific Dopamine Receptors	PLOS ONE			English	Article							CENTROSOME; DISRUPTED-IN-SCHIZOPHRENIA-1; SCHIZOPHRENIA; LOCALIZATION; EXPRESSION; PROTEINS; TRANSLOCATION; CANDIDATE; MEMBRANE; DISEASE	Background: Mutations in the DISC1 gene are strongly associated with major psychiatric syndromes such as schizophrenia. DISC1 encodes a cytoplasmic protein with many potential interaction partners, but its cellular functions remain poorly understood. We identified a role of DISC1 in the cell biology of primary cilia that display disease-relevant dopamine receptors. Methodology/Principal Findings: A GFP-tagged DISC1 construct expressed in NIH3T3 cells and rat striatal neurons localized near the base of primary cilia. RNAi-mediated knockdown of endogenous DISC1 resulted in a marked reduction in the number of cells expressing a primary cilium. FLAG-tagged versions of the cloned human D1, D2 and D5 dopamine receptors concentrated highly on the ciliary surface, and this reflects a specific targeting mechanism specific because D3 and D4 receptors localized to the plasma membrane but were not concentrated on cilia. Conclusions/Significance: These results identify a role of DISC1 in regulating the formation and/or maintenance of primary cilia, and establish subtype-specific targeting of dopamine receptors to the ciliary surface. Our findings provide new insight to receptor cell biology and suggest a relationship between DISC1 and neural dopamine signaling.	[Marley, Aaron] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Marley, A (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	mark.vonzastrow@ucsf.edu			NIH [DA012864, DA010711]; NATIONAL INSTITUTE ON DRUG ABUSE [R29DA010711, R01DA012864, R01DA010711, R37DA010711] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	NIH DA012864 and DA010711. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; BANKER G, 1998, CULTURING NERVE CELL; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Brailov I, 2000, BRAIN RES, V872, P271, DOI 10.1016/S0006-8993(00)02519-1; Brandon NJ, 2009, J NEUROSCI, V29, P12768, DOI 10.1523/JNEUROSCI.3355-09.2009; Cho DI, 2006, BIOCHEM BIOPH RES CO, V350, P634, DOI 10.1016/j.bbrc.2006.09.090; DAHL HA, 1963, Z ZELLFORSCH MIK ANA, V60, P369, DOI 10.1007/BF00336612; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; DELCERRO MP, 1969, ANAT RECORD, V165, P127, DOI 10.1002/ar.1091650202; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Durstewitz D, 2008, BIOL PSYCHIAT, V64, P739, DOI 10.1016/j.biopsych.2008.05.015; EASTWOOD SL, 2010, HUM MOL GEN IN PRESS; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Grimaldi B, 1998, N-S ARCH PHARMACOL, V357, P393, DOI 10.1007/PL00005184; Grunder G, 2009, NAT REV DRUG DISCOV, V8, P197, DOI 10.1038/nrd2806; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Harvey PD, 2006, SCHIZOPHRENIA BULL, V32, P250, DOI 10.1093/schbul/sbj011; Ishizuka K, 2007, MOL PSYCHIATR, V12, P897, DOI 10.1038/sj.mp.4002024; Jaaro-Peled H, 2009, TRENDS NEUROSCI, V32, P485, DOI 10.1016/j.tins.2009.05.007; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kamiya A, 2008, ARCH GEN PSYCHIAT, V65, P996, DOI 10.1001/archpsyc.65.9.996; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Meyer KD, 2008, GENE EXPR PATTERNS, V8, P494, DOI 10.1016/j.gep.2008.06.005; Millar JK, 2005, MOL CELL NEUROSCI, V30, P477, DOI 10.1016/j.mcn.2005.08.021; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Miyoshi K, 2004, BIOCHEM BIOPH RES CO, V317, P1195, DOI 10.1016/j.bbrc.2004.03.163; Molla-Herman A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003728; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Porteous D, 2008, CURR OPIN GENET DEV, V18, P229, DOI 10.1016/j.gde.2008.07.005; Sawa A, 2002, SCIENCE, V296, P692, DOI 10.1126/science.1070532; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Schwab SG, 2009, CURR OPIN PSYCHIATR, V22, P147, DOI 10.1097/YCO.0b013e328325a598; Shah AS, 2008, P NATL ACAD SCI USA, V105, P3380, DOI 10.1073/pnas.0712327105; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Tamminga CA, 2006, J CLIN PSYCHIAT, V67, P9; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31; Wong DF, 2009, NEUROPSYCHOPHARMACOL, V34, P187, DOI 10.1038/npp.2008.166; Wong SY, 2008, CURR TOP DEV BIOL, V85, P225, DOI 10.1016/S0070-2153(08)00809-0; Xu W, 2008, NEURON, V57, P248, DOI 10.1016/j.neuron.2007.11.027; Yoder BK, 1995, P ASSOC AM PHYSICIAN, V107, P314	47	67	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10902	10.1371/journal.pone.0010902	http://dx.doi.org/10.1371/journal.pone.0010902			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531939	Green Submitted, Green Published, gold			2022-12-27	WOS:000278222100031
J	Bar, N; Dikstein, R				Bar, Nadav; Dikstein, Rivka			miR-22 Forms a Regulatory Loop in PTEN/AKT Pathway and Modulates Signaling Kinetics	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; EXPRESSION; MICRORNAS; PROMOTER; MIRNAS; TRANSLATION; INHIBITION; ELEMENT; IMPACT	Background: The tumor suppressor PTEN (phosphatase and tensin homolog) is a lipid phosphatase that converts PIP3 into PIP2 and downregulates the kinase AKT and its proliferative and anti-apoptotic activities. The FoxO transcription factors are PTEN downstream effectors whose activity is negatively regulated by AKT-mediated phosphorylation. PTEN activity is frequently lost in many types of cancer, leading to increased cell survival and cell cycle progression. Principal Findings: Here we characterize the widely expressed miR-22 and report that miR-22 is a novel regulatory molecule in the PTEN/AKT pathway. miR-22 downregulates PTEN levels acting directly through a specific site on PTEN 3'UTR. Interestingly, miR-22 itself is upregulated by AKT, suggesting that miR-22 forms a feed-forward circuit in this pathway. Time-resolved live imaging of AKT-dependent FoxO1 phosphorylation revealed that miR-22 accelerated AKT activity upon growth factor stimulation, and attenuated its down regulation by serum withdrawal. Conclusions: Our results suggest that miR-22 acts to fine-tune the dynamics of PTEN/AKT/FoxO1 pathway.	[Bar, Nadav; Dikstein, Rivka] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Bar, N (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	rivka.dikstein@weizmann.ac.il			Wolfson Family Trust for MicroRNA Research at the Weizmann Institute; Israel Cancer Research Fund	Wolfson Family Trust for MicroRNA Research at the Weizmann Institute; Israel Cancer Research Fund	This work was supported by grants from the Wolfson Family Trust for MicroRNA Research at the Weizmann Institute and from the Israel Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainbinder E, 2004, MOL CELL BIOL, V24, P2444, DOI 10.1128/MCB.24.6.2444-2454.2004; Amir-Zilberstein L, 2007, MOL CELL BIOL, V27, P5246, DOI 10.1128/MCB.00586-07; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Elfakess R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003094; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Scherr M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm971; Sheng XY, 2002, BIOCHEM BIOPH RES CO, V292, P422, DOI 10.1006/bbrc.2002.6662; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; [No title captured]	31	117	123	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10859	10.1371/journal.pone.0010859	http://dx.doi.org/10.1371/journal.pone.0010859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523723	gold, Green Published, Green Submitted			2022-12-27	WOS:000278221900010
J	Carter, GG; Ratcliffe, JM; Galef, BG				Carter, Gerald G.; Ratcliffe, John M.; Galef, Bennett G.			Flower Bats (Glossophaga soricina) and Fruit Bats (Carollia perspicillata) Rely on Spatial Cues over Shapes and Scents When Relocating Food	PLOS ONE			English	Article							MEMORY; INFORMATION; DISCRIMINATION; STIMULUS; PREY	Background: Natural selection can shape specific cognitive abilities and the extent to which a given species relies on various cues when learning associations between stimuli and rewards. Because the flower bat Glossophaga soricina feeds primarily on nectar, and the locations of nectar-producing flowers remain constant, G. soricina might be predisposed to learn to associate food with locations. Indeed, G. soricina has been observed to rely far more heavily on spatial cues than on shape cues when relocating food, and to learn poorly when shape alone provides a reliable cue to the presence of food. Methodology/Principal Findings: Here we determined whether G. soricina would learn to use scent cues as indicators of the presence of food when such cues were also available. Nectar-producing plants fed upon by G. soricina often produce distinct, intense odors. We therefore expected G. soricina to relocate food sources using scent cues, particularly the flower-produced compound, dimethyl disulfide, which is attractive even to G. soricina with no previous experience of it. We also compared the learning of associations between cues and food sources by G. soricina with that of a related fruit-eating bat, Carollia perspicillata. We found that ( 1) G. soricina did not learn to associate scent cues, including dimethyl disulfide, with feeding sites when the previously rewarded spatial cues were also available, and ( 2) both the fruit-eating C. perspicillata and the flower-feeding G. soricina were significantly more reliant on spatial cues than associated sensory cues for relocating food. Conclusions/Significance: These findings, taken together with past results, provide evidence of a powerful, experience-independent predilection of both species to rely on spatial cues when attempting to relocate food.	[Carter, Gerald G.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Ratcliffe, John M.] Univ So Denmark, Inst Biol, Odense, Denmark; [Galef, Bennett G.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada	University System of Maryland; University of Maryland College Park; University of Southern Denmark; McMaster University	Carter, GG (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	gcarter@umd.edu	Galef, Bennett G/A-5678-2008		Natural Science and Engineering Council of Canada (NSERC); Danish Natural Science Research Council (FNU)	Natural Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Danish Natural Science Research Council (FNU)(Danish Natural Science Research Council)	This research was funded by Natural Science and Engineering Council of Canada (NSERC) grants to B. G. G. and Danish Natural Science Research Council (FNU) grants to J.M.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALCOMBE JP, 1990, ANIM BEHAV, V39, P960, DOI 10.1016/S0003-3472(05)80961-3; Batty ER, 2009, ANIM COGN, V12, P633, DOI 10.1007/s10071-009-0222-3; BRODBECK DR, 1995, J EXP PSYCHOL ANIM B, V21, P64, DOI 10.1037/0097-7403.21.1.64; BRODBECK DR, 1994, ANIM LEARN BEHAV, V22, P119, DOI 10.3758/BF03199912; Burns JG, 2006, BEHAV ECOL, V17, P48, DOI 10.1093/beheco/arj002; CLAYTON NS, 1994, J COMP PHYSIOL A, V174, P371; Day LB, 2003, J COMP PSYCHOL, V117, P440, DOI 10.1037/0735-7036.117.4.440; Fleming T.H., 1988, SHORT TAILED FRUIT B; Gould KL, 2010, PHILOS T R SOC B, V365, P901, DOI 10.1098/rstb.2009.0214; GUSTIN MK, 1987, ANIM BEHAV, V35, P13, DOI 10.1016/S0003-3472(87)80205-1; Hurly TA, 1996, ANIM BEHAV, V51, P177; KAMIN LJ, 1969, FUNDAMENTAL ISSUES A; KAMIN LJ, 1969, PUNISHMENT AVERSIVE, P597; Kanngiesser P, 2010, ANIM COGN, V13, P419, DOI 10.1007/s10071-009-0291-3; MACKINTOSH NJ, 1970, J COMP PHYSIOL PSYCH, V73, P78, DOI 10.1037/h0030021; MCCRACKEN GF, 1984, SCIENCE, V223, P1090, DOI 10.1126/science.223.4640.1090; Page RA, 2005, P ROY SOC B-BIOL SCI, V272, P841, DOI 10.1098/rspb.2004.2998; Page RA, 2006, CURR BIOL, V16, P1201, DOI 10.1016/j.cub.2006.04.038; Pavlov I.P., 1927, CONDITIONED REFLEXES; Ratcliffe JM, 2005, BIOL LETTERS, V1, P72, DOI 10.1098/rsbl.2004.0252; Ratcliffe JM, 2009, BEHAV PROCESS, V80, P247, DOI 10.1016/j.beproc.2008.12.010; Rescorla R. A., 1972, CLASSICAL CONDITIONI; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Siemers BM, 2001, ACTA CHIROPTEROL, V3, P211; Smulders TV, 2010, PHILOS T R SOC B, V365, P883, DOI 10.1098/rstb.2009.0211; Stich KP, 2006, J EXP BIOL, V209, P4802, DOI 10.1242/jeb.02574; TENNANT WA, 1975, J EXP PSYCHOL-ANIM B, V104, P22; Thiele J, 2005, ANIM BEHAV, V69, P315, DOI 10.1016/j.anbehav.2004.05.012; Vargas JP, 2004, J COMP PSYCHOL, V118, P206, DOI 10.1037/0735-7036.118.2.206; von Helversen O, 2003, BAT ECOLOGY, P346; von Helversen O, 2000, J COMP PHYSIOL A, V186, P143, DOI 10.1007/s003590050014; Winter Y, 2005, J EXP BIOL, V208, P539, DOI 10.1242/jeb.01416; Winter Y, 2003, J MAMMAL, V84, P886, DOI 10.1644/BWG-032; Winter Y, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P148, DOI 10.1017/CBO9780511542268.009; York HA, 2009, J MAMMAL, V90, P1469, DOI 10.1644/08-MAMM-A-382R.1	35	29	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10808	10.1371/journal.pone.0010808	http://dx.doi.org/10.1371/journal.pone.0010808			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520841	gold, Green Published, Green Submitted			2022-12-27	WOS:000278034800006
J	Imada, H; Hoki, M; Suehiro, Y; Okuyama, T; Kurabayashi, D; Shimada, A; Naruse, K; Takeda, H; Kubo, T; Takeuchi, H				Imada, Haruka; Hoki, Masahito; Suehiro, Yuji; Okuyama, Teruhiro; Kurabayashi, Daisuke; Shimada, Atsuko; Naruse, Kiyoshi; Takeda, Hiroyuki; Kubo, Takeo; Takeuchi, Hideaki			Coordinated and Cohesive Movement of Two Small Conspecific Fish Induced by Eliciting a Simultaneous Optomotor Response	PLOS ONE			English	Article							MEDAKA ORYZIAS-LATIPES; EMERGENT PROPERTIES; SCHOOLING BEHAVIOR; SHOALING BEHAVIOR; GENE INDUCTION; ZEBRAFISH; SIZE; QUANTIFICATION; GENERATION; SYSTEM	Background: In animal groups such as herds, schools, and flocks, a certain distance is maintained between adjacent individuals, allowing them to move as a cohesive unit. Proximate causations of the cohesive and coordinated movement under dynamic conditions, however, have been poorly understood. Methodology/Principal Findings: We established a novel and simple behavioral assay using pairs of small fish (medaka and dwarf pufferfish) by eliciting a simultaneous optomotor response (OMR). We demonstrated that two homospecific fish began to move cohesively and maintained a distance of 2 to 4 cm between them when an OMR was elicited simultaneously in the fish. The coordinated and cohesive movement was not exhibited under a static condition. During the cohesive movement, the relative position of the two fish was not stable. Furthermore, adult medaka exhibited the cohesive movement but larvae did not, despite the fact that an OMR could be elicited in larvae, indicating that this ability to coordinate movement develops during maturation. The cohesive movement was detected in homospecific pairs irrespective of body-color, sex, or albino mutation, but was not detected between heterospecific pairs, suggesting that coordinated movement is based on a conspecific interaction. Conclusions/Significance: Our findings demonstrate that coordinated behavior between a pair of animals was elicited by a simultaneous OMR in two small fish. This is the first report to demonstrate induction of a schooling-like movement in a pair of fish by an OMR and to investigate the effect of age, sex, body color, and species on coordination between animals under a dynamic condition.	[Imada, Haruka; Hoki, Masahito; Suehiro, Yuji; Okuyama, Teruhiro; Shimada, Atsuko; Takeda, Hiroyuki; Kubo, Takeo; Takeuchi, Hideaki] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Kurabayashi, Daisuke] Tokyo Inst Technol, Dept Mech & Control Engn, Tokyo 152, Japan; [Naruse, Kiyoshi] Natl Inst Basic Biol, Lab BioResource, Okazaki, Japan	University of Tokyo; Tokyo Institute of Technology; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Imada, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan.	takeuchi@biol.s.u-tokyo.ac.jp	Takeuchi, Hideaki/W-6739-2018; TAKEDA, HIROYUKI/G-4950-2014; Kurabayashi, Daisuke/C-6878-2015; TAKEUCHI, HIDEAKI/G-4969-2014; KUBO, TAKEO/G-4951-2014	Takeuchi, Hideaki/0000-0001-6610-3895; Kurabayashi, Daisuke/0000-0002-3186-6531; Kubo, Takeo/0000-0002-5914-5269	Ministry of Education, Culture, Sports, Science, and Technology [21700341]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was totally supported by the Ministry of Education, Culture, Sports, Science, and Technology, Scientific Research on Priority Areas (Area No. 454, Mobiligence Project) and Grant-in-Aid for Young Scientists (B) 21700341. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, LIVING GROUPS; AOKI I, 1984, B JPN SOC SCI FISH, V50, P751; Barber I, 2000, P ROY SOC B-BIOL SCI, V267, P151, DOI 10.1098/rspb.2000.0980; Carvalho PSM, 2002, ANIM BEHAV, V64, P1, DOI 10.1006/anbe.2002.3028; Crook AC, 1999, MAR ECOL PROG SER, V176, P17, DOI 10.3354/meps176017; Deguchi T, 2009, DEV GROWTH DIFFER, V51, P769, DOI 10.1111/j.1440-169X.2009.01135.x; EMLEN J. T., 1952, AUK, V69, P160; Engeszer RE, 2004, CURR BIOL, V14, P881, DOI 10.1016/j.cub.2004.04.042; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P629, DOI 10.1016/j.mod.2004.05.010; Harcourt JL, 2009, CURR BIOL, V19, P248, DOI 10.1016/j.cub.2008.12.051; Hiramatsu K, 2000, J FAC AGR KYUSHU U, V45, P237; Kamei Y, 2009, NAT METHODS, V6, P79, DOI [10.1038/NMETH.1278, 10.1038/nmeth.1278]; Kato S, 2004, J NEUROSCI METH, V134, P1, DOI 10.1016/j.jneumeth.2003.09.028; KRAUSE J, 1994, ETHOLOGY, V98, P128; Krause J, 2000, BIOL REV, V75, P477; KUROYANAGI Y, BRAIN RES, V1323, P33; MAGURRAN AE, 1986, J FISH BIOL, V29, P159, DOI 10.1111/j.1095-8649.1986.tb05007.x; Masuda R, 1998, J FISH BIOL, V52, P483, DOI 10.1006/jfbi.1997.0597; Miller N, 2007, BEHAV BRAIN RES, V184, P157, DOI 10.1016/j.bbr.2007.07.007; Nakamura S, 2008, DEV GROWTH DIFFER, V50, P415, DOI [10.1111/j.1440-169X.2008.01027.x, 10.1111/j.1440-169x.2008.01027.x]; NAKAMURA YOSHIO, 1952, BULL JAPANESE SOC SCI FISH, V18, P93; Nakayama K, 2005, ENVIRON TOXICOL CHEM, V24, P2588, DOI 10.1897/04-518R2.1; Okubo A., 1986, Advances in Biophysics, V22, P1, DOI 10.1016/0065-227X(86)90003-1; Parrish JK, 2002, BIOL BULL-US, V202, P296, DOI 10.2307/1543482; PARRISH KJ, 1997, ANIMAL GROUPS 3 DIME, P126; PARTRIDGE BL, 1980, BEHAV ECOL SOCIOBIOL, V6, P277, DOI 10.1007/BF00292770; PITCHER JT, 1972, ANIM BEHAV, V21, P673; Reebs SG, 2001, BEHAVIOUR, V138, P797, DOI 10.1163/156853901753172656; SHAW E, 1967, J COMP PHYSIOL PSYCH, V63, P385, DOI 10.1037/h0024636; SHAW E, 1965, ANIM BEHAV, V13, P330, DOI 10.1016/0003-3472(65)90052-7; SHAW E, 1970, DEV EVOLUTION BEHAVI, P453; Sinclair A.R.E., 1977, AFRICAN BUFFALO STUD; Soria M, 2007, J FISH BIOL, V71, P1257, DOI 10.1111/j.1095-8649.2007.01554.x; Taniguchi Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r116; Tsubokawa T, 2009, SOC NEUROSCI-UK, V4, P276, DOI 10.1080/17470910802625215; Viscido SV, 2007, ECOL MODEL, V206, P153, DOI 10.1016/j.ecolmodel.2007.03.042; Viscido SV, 2005, ECOL MODEL, V183, P347, DOI 10.1016/j.ecolmodel.2004.08.019	37	32	33	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11248	10.1371/journal.pone.0011248	http://dx.doi.org/10.1371/journal.pone.0011248			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582314	gold, Green Published, Green Submitted			2022-12-27	WOS:000279058500010
J	Thibodeaux, GN; Liang, XA; Moncivais, K; Umeda, A; Singer, O; Alfonta, L; Zhang, ZWJ				Thibodeaux, Gabrielle Nina; Liang, Xiang; Moncivais, Kathryn; Umeda, Aiko; Singer, Oded; Alfonta, Lital; Zhang, Zhiwen Jonathan			Transforming a Pair of Orthogonal tRNA-aminoacyl-tRNA Synthetase from Archaea to Function in Mammalian Cells	PLOS ONE			English	Article							SITE-SPECIFIC INCORPORATION; GENETIC-CODE; ESCHERICHIA-COLI; PROTEINS; SUPPRESSOR; ACIDS; AMBER	A previously engineered Methanocaldococcus jannaschii tRNA(CUA)(Tyr)-tyrosyl-tRNA synthetase pair orthogonal to Escherichia coli was modified to become orthogonal in mammalian cells. The resulting tRNA(CUA)(Tyr)-tyrosyl-tRNA synthetase pair was able to suppress an amber codon in the green fluorescent protein, GFP, and in a foldon protein in mammalian cells. The methodology reported here will allow rapid transformation of the much larger collection of existing tyrosyl-tRNA synthetases that were already evolved for the incorporation of an array of over 50 unnatural amino acids into proteins in Escherichia coli into proteins in mammalian cells. Thus we will be able to introduce a large array of possibilities for protein modifications in mammalian cells.	[Thibodeaux, Gabrielle Nina; Liang, Xiang; Moncivais, Kathryn; Umeda, Aiko; Zhang, Zhiwen Jonathan] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA; [Singer, Oded] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Alfonta, Lital] Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel	University of Texas System; University of Texas Austin; Salk Institute; Ben Gurion University	Thibodeaux, GN (corresponding author), Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA.	alfontal@bgu.ac.il; zhang@mail.utexas.edu	Alfonta, Lital/AAB-9689-2022; Alfonta, Lital/B-6101-2012	Alfonta, Lital/0000-0002-3805-8625; Alfonta, Lital/0000-0002-3805-8625	Edmond J. Safra Center for the Design and Engineering of Functional Biopolymers; Welch Foundation [F1618]; NIH [R01 CA120168]; NATIONAL CANCER INSTITUTE [R01CA120168] Funding Source: NIH RePORTER	Edmond J. Safra Center for the Design and Engineering of Functional Biopolymers; Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	L. A. acknowledges the Edmond J. Safra Center for the Design and Engineering of Functional Biopolymers for funding this research, (URL of Funding Agency: http://www.edmondjsafra.org/). Z. Z. acknowledges a Welch Foundation Research Grant (F1618) and NIH R01 CA120168. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen PR, 2009, ANGEW CHEM INT EDIT, V48, P4052, DOI 10.1002/anie.200900683; Chin JW, 2003, CHEM BIOL, V10, P511, DOI 10.1016/S1074-5521(03)00123-6; Drabkin HJ, 1996, MOL CELL BIOL, V16, P907; EDWARDS H, 1990, MOL CELL BIOL, V10, P1633, DOI 10.1128/MCB.10.4.1633; Kohrer C, 2001, P NATL ACAD SCI USA, V98, P14310, DOI 10.1073/pnas.251438898; Liu WS, 2007, NAT METHODS, V4, P239, DOI 10.1038/NMETH1016; Monahan SL, 2003, CHEM BIOL, V10, P573, DOI 10.1016/S1074-5521(03)00124-8; Nemoto N, 1999, FEBS LETT, V462, P43, DOI 10.1016/S0014-5793(99)01474-X; Nordin BE, 1999, J BIOL CHEM, V274, P6835, DOI 10.1074/jbc.274.11.6835; Sakamoto K, 2002, NUCLEIC ACIDS RES, V30, P4692, DOI 10.1093/nar/gkf589; Tsunoda M, 2007, NUCLEIC ACIDS RES, V35, P4289, DOI 10.1093/nar/gkm417; Wakasugi K, 1998, EMBO J, V17, P297, DOI 10.1093/emboj/17.1.297; Wang L, 2005, ANGEW CHEM INT EDIT, V44, P34, DOI 10.1002/anie.200460627; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wu X, 2009, J AM CHEM SOC, V131, P12497, DOI 10.1021/ja9026067; YOUNG JF, 1983, SCIENCE, V221, P873, DOI 10.1126/science.6308765; Zhang ZW, 2004, P NATL ACAD SCI USA, V101, P8882, DOI 10.1073/pnas.0307029101	17	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11263	10.1371/journal.pone.0011263	http://dx.doi.org/10.1371/journal.pone.0011263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582317	gold, Green Submitted, Green Published			2022-12-27	WOS:000279058500015
J	Melo, GC; Reyes-Lecca, RC; Vitor-Silva, S; Monteiro, WM; Martins, M; Benzecry, SG; Alecrim, MDC; Lacerda, MVG				Melo, Gisely Cardoso; Reyes-Lecca, Roberto Carlos; Vitor-Silva, Sheila; Monteiro, Wuelton Marcelo; Martins, Marilaine; Benzecry, Silvana Gomes; Costa Alecrim, Maria das Gracas; Guimaraes Lacerda, Marcus Vinicius			Concurrent Helminthic Infection Protects Schoolchildren with Plasmodium vivax from Anemia	PLOS ONE			English	Article							ASCARIS-LUMBRICOIDES INFECTION; HOOKWORM INFECTION; FALCIPARUM-MALARIA; CHILDREN; EPIDEMIOLOGY; HEMOGLOBIN; DISTRICT; AFRICA; ASSOCIATION; COMMUNITIES	Background: Plasmodium vivax is responsible for a significant portion of malaria cases worldwide, especially in Asia and Latin America, where geo-helminthiasis have a high prevalence. Impact of the interaction between vivax malaria and intestinal helminthes has been poorly explored. The objective of this study was to evaluate the influence of intestinal helminthiasis on the concentration of hemoglobin in children with Plasmodium vivax malaria in rural areas in the municipality of Careiro, in the Western Brazilian Amazon. Methodology/Principal Findings: A cohort study was conducted from April to November 2008, enrolling children from 5 to 14 years old in two rural areas endemic for malaria. A cross-sectional evaluation was performed in April to actively detect cases of malaria and document baseline hemoglobin and nutritional status. Children were followed-up for six months through passive case detection of malaria based on light microscopy. Throughout the follow-up interval, hemoglobin value and stool examination (three samples on alternate days) were performed on children who developed P. vivax malaria. For 54 schoolchildren with a single infection by P. vivax, hemoglobin during the malaria episode was similar to the baseline hemoglobin for children co-infected with Ascaris lumbricoides (n = 18), hookworm (n = 11) and Trichuris trichiura (n = 9). In children without intestinal helminthes, a significant decrease in the hemoglobin during the malarial attack was seen as compared to the baseline concentration. In the survival analysis, no difference was seen in the time (in days) from the baseline cross-sectional to the first malarial infection, between parasitized and nonparasitized children. Conclusion/Significance: For the first time, a cohort study showed that intestinal helminthes protect against hemoglobin decrease during an acute malarial attack by P. vivax.	[Melo, Gisely Cardoso; Vitor-Silva, Sheila; Monteiro, Wuelton Marcelo; Martins, Marilaine; Benzecry, Silvana Gomes; Costa Alecrim, Maria das Gracas; Guimaraes Lacerda, Marcus Vinicius] Univ State Amazonas, Manaus, Amazonas, Brazil; [Martins, Marilaine; Guimaraes Lacerda, Marcus Vinicius] Trop Med Fdn Amazonas, Manaus, Amazonas, Brazil; [Reyes-Lecca, Roberto Carlos] Univ Brasilia, BR-70910900 Brasilia, DF, Brazil; [Costa Alecrim, Maria das Gracas; Guimaraes Lacerda, Marcus Vinicius] Nilton Lins Univ Ctr, Manaus, Amazonas, Brazil	Universidade do Estado do Amazonas; Universidade de Brasilia; Centro Universitario Nilton Lins	Melo, GC (corresponding author), Univ State Amazonas, Manaus, Amazonas, Brazil.	marcuslacerda.br@gmail.com	melo, gisely/GZK-5350-2022		Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) [1514-08]; Superintendencia da Zona Franca de Manaus (SUFRAMA) [016/2004]	Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)(Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)); Superintendencia da Zona Franca de Manaus (SUFRAMA)	This study was funded by Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) (grant number 1514-08) and by Superintendencia da Zona Franca de Manaus (SUFRAMA) (Grant number 016/2004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MAL AM TIM SER EP DA; [Anonymous], 2008, WORLD MAL REP 2008; Araujo Claudio Fernández, 2005, Rev. Soc. Bras. Med. Trop., V38, P69; Boia M N, 1999, Cad Saude Publica, V15, P497, DOI 10.1590/S0102-311X1999000300006; Brabin BJ, 2001, J NUTR, V131, p604S, DOI 10.1093/jn/131.2.604S; Briand V, 2005, AM J TROP MED HYG, V72, P702, DOI 10.4269/ajtmh.2005.72.702; Brooker S, 1999, T ROY SOC TROP MED H, V93, P240, DOI 10.1016/S0035-9203(99)90007-X; Brooker S, 2007, AM J TROP MED HYG, V77, P88, DOI 10.4269/ajtmh.2007.77.88; Brooker S, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-99; Brutus L, 2007, AM J TROP MED HYG, V77, P1091, DOI 10.4269/ajtmh.2007.77.1091; Brutus L, 2006, AM J TROP MED HYG, V75, P194, DOI 10.4269/ajtmh.2006.75.194; BUCK AA, 1978, TROPENMED PARASITOL, V29, P61; Bueno LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009623; Caicedo O, 2009, AM J TROP MED HYG, V80, P146, DOI 10.4269/ajtmh.2009.80.146; Crawley J, 2004, AM J TROP MED HYG, V71, P25, DOI 10.4269/ajtmh.2004.71.25; Faust E.C., 1939, Journal of Parasitology Urbana, V25, P241, DOI 10.2307/3272508; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519; Korenromp EL, 2004, TROP MED INT HEALTH, V9, P1050, DOI 10.1111/j.1365-3156.2004.01317.x; Le Hesran JY, 2004, T ROY SOC TROP MED H, V98, P397, DOI 10.1016/j.trstmh.2003.10.009; LUTZ Adolpho, 1919, Memorias do Instituto Oswaldo Cruz, V11, P121, DOI 10.1590/S0074-02761919000100006; McDevitt Michael A, 2004, Curr Hematol Rep, V3, P97; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; MURRAY J, 1978, AM J CLIN NUTR, V31, P1363, DOI 10.1093/ajcn/31.8.1363; MURRAY MJ, 1977, AM J CLIN NUTR, V30, P2117, DOI 10.1093/ajcn/30.12.2117; Nacher M, 2005, ANN TROP MED PARASIT, V99, P623, DOI 10.1179/136485905X51364; Nacher M, 2004, CLIN REV ALLERG IMMU, V26, P85, DOI 10.1007/s12016-004-0003-3; Nacher M, 2000, PARASITE IMMUNOL, V22, P107, DOI 10.1046/j.1365-3024.2000.00284.x; Nacher M, 2001, AM J TROP MED HYG, V65, P834, DOI 10.4269/ajtmh.2001.65.834; Nacher M, 2001, J PARASITOL, V87, P912, DOI 10.1645/0022-3395(2001)087[0912:CASMPF]2.0.CO;2; Nacher M, 2001, AM J TROP MED HYG, V65, P644, DOI 10.4269/ajtmh.2001.65.644; Nacher M, 2001, AM J TROP MED HYG, V65, P335, DOI 10.4269/ajtmh.2001.65.335; Nacher M, 2001, AM J TROP MED HYG, V65, P136, DOI 10.4269/ajtmh.2001.65.136; Nacher M, 2002, J PARASITOL, V88, P55, DOI 10.1645/0022-3395(2002)088[0055:IHIAAW]2.0.CO;2; Ndyomugyenyi R, 2008, T ROY SOC TROP MED H, V102, P130, DOI 10.1016/j.trstmh.2007.09.015; O'Lorcain P, 2000, PARASITOLOGY, V121, pS51, DOI 10.1017/S0031182000006442; OLIVEIRA M, 2004, HEMATOLOGICAL CHARAC; Pearson Richard D., 2002, Curr Infect Dis Rep, V4, P59, DOI 10.1007/s11908-002-0068-1; Petney TN, 1998, INT J PARASITOL, V28, P377, DOI 10.1016/S0020-7519(97)00189-6; Shulman CE, 1996, T ROY SOC TROP MED H, V90, P535, DOI 10.1016/S0035-9203(96)90312-0; Sokhna C, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-43; STEPHENSON LS, 1985, AM J TROP MED HYG, V34, P519, DOI 10.4269/ajtmh.1985.34.519; Stephenson LS, 2000, PARASITOLOGY, V121, pS73, DOI 10.1017/S0031182000006867; Stephenson LS, 2000, PARASITOLOGY, V121, pS23, DOI 10.1017/S0031182000006491; Stoltzfus RJ, 2000, J NUTR, V130, P1724, DOI 10.1093/jn/130.7.1724; Tatala S, 1998, AM J CLIN NUTR, V68, P171, DOI 10.1093/ajcn/68.1.171; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Wammes LJ, 2010, EUR J IMMUNOL, V40, P437, DOI 10.1002/eji.200939699; *WHO, 2002, MAL FIL OTH PAR DIS; World Health Organization, 2006, MICR DIAGN MAL; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Yang Y, 2008, ENVIRON FLUID MECH, V8, P19, DOI 10.1007/s10652-008-9052-0	53	44	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11206	10.1371/journal.pone.0011206	http://dx.doi.org/10.1371/journal.pone.0011206			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574512	Green Submitted, Green Published, gold			2022-12-27	WOS:000279058300008
J	Ota, KT; Monsey, MS; Wu, MS; Schafe, GE				Ota, Kristie T.; Monsey, Melissa S.; Wu, Melissa S.; Schafe, Glenn E.			Synaptic Plasticity and NO-cGMP-PKG Signaling Regulate Pre- and Postsynaptic Alterations at Rat Lateral Amygdala Synapses Following Fear Conditioning	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; NITRIC-OXIDE; MEMORY CONSOLIDATION; STRUCTURAL-CHANGES; ERK/MAP KINASE; ACTIVATION; RECEPTOR; APLYSIA; NMDA	In vertebrate models of synaptic plasticity, signaling via the putative "retrograde messenger'' nitric oxide (NO) has been hypothesized to serve as a critical link between functional and structural alterations at pre- and postsynaptic sites. In the present study, we show that auditory Pavlovian fear conditioning is associated with significant and long-lasting increases in the expression of the postsynaptically-localized protein GluR1 and the presynaptically-localized proteins synaptophysin and synapsin in the lateral amygdala (LA) within 24 hrs following training. Further, we show that rats given intra-LA infusion of either the NR2B-selective antagonist Ifenprodil, the NOS inhibitor 7-Ni, or the PKG inhibitor Rp-8-Br-PET-cGMPS exhibit significant decreases in training-induced expression of GluR1, synaptophysin, and synapsin immunoreactivity in the LA, while those rats infused with the PKG activator 8-Br-cGMP exhibit a significant increase in these proteins in the LA. In contrast, rats given intra-LA infusion of the NO scavenger c-PTIO exhibit a significant decrease in synapsin and synaptophysin expression in the LA, but no significant impairment in the expression of GluR1. Finally, we show that intra-LA infusions of the ROCK inhibitor Y-27632 or the CaMKII inhibitor KN-93 impair training-induced expression of GluR1, synapsin, and synaptophysin in the LA. These findings suggest that the NO-cGMP-PKG, Rho/ROCK, and CaMKII signaling pathways regulate fear memory consolidation, in part, by promoting both pre- and post-synaptic alterations at LA synapses. They further suggest that synaptic plasticity in the LA during auditory fear conditioning promotes alterations at presynaptic sites via NO-driven "retrograde signaling''.	[Ota, Kristie T.; Monsey, Melissa S.; Wu, Melissa S.; Schafe, Glenn E.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Schafe, Glenn E.] Yale Univ, Interdept Neurosci Program, New Haven, CT USA	Yale University; Yale University	Ota, KT (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	glenn.schafe@yale.edu			National Institutes of Health [MH 073949]; Yale University; National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the National Institutes of Health (MH 073949 to G. E. S.) and by Yale University. K.T.O. is supported by a National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonov I, 2003, NEURON, V37, P135, DOI 10.1016/S0896-6273(02)01129-7; Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; Apergis-Schoute AM, 2005, J NEUROSCI, V25, P5730, DOI 10.1523/JNEUROSCI.0096-05.2005; Arancio O, 1996, CELL, V87, P1025, DOI 10.1016/S0092-8674(00)81797-3; ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; BAILEY CH, 1992, NEURON, V9, P749, DOI 10.1016/0896-6273(92)90037-E; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BONHOEFFER T, 1989, P NATL ACAD SCI USA, V86, P8113, DOI 10.1073/pnas.86.20.8113; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; FARB CR, 1995, J COMP NEUROL, V362, P86, DOI 10.1002/cne.903620106; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Gudi T, 2002, J BIOL CHEM, V277, P37382, DOI 10.1074/jbc.M204491200; Lamprecht R, 2006, NAT NEUROSCI, V9, P481, DOI 10.1038/nn1672; Lamprecht R, 2002, NEURON, V36, P727, DOI 10.1016/S0896-6273(02)01047-4; LIN XY, 1994, P ROY SOC B-BIOL SCI, V255, P215, DOI 10.1098/rspb.1994.0031; LISMAN JE, 1993, TRENDS NEUROSCI, V16, P141, DOI 10.1016/0166-2236(93)90122-3; Lu YF, 1999, J NEUROSCI, V19, P10250; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Monfort P, 2002, J NEUROSCI, V22, P10116; Murphy GG, 1997, SCIENCE, V278, P467, DOI 10.1126/science.278.5337.467; Murphy GG, 1996, P NATL ACAD SCI USA, V93, P9931, DOI 10.1073/pnas.93.18.9931; Nikonenko I, 2003, J NEUROSCI, V23, P8498; Ninan I, 2004, NEURON, V42, P129, DOI 10.1016/S0896-6273(04)00143-6; Ninan I, 2006, EMBO J, V25, P4361, DOI 10.1038/sj.emboj.7601318; Nithianantharajah J, 2008, NEUROBIOL LEARN MEM, V90, P36, DOI 10.1016/j.nlm.2007.12.002; Ota KT, 2008, LEARN MEMORY, V15, P792, DOI 10.1101/lm.1114808; OTA KT, 2010, LEARN MEM IN PRESS; Overeem KA, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/neuro.08.002.2010; Radley JJ, 2006, EUR J NEUROSCI, V24, P876, DOI 10.1111/j.1460-9568.2006.04962.x; Ressler KJ, 2002, J NEUROSCI, V22, P7892; Roberts AC, 2003, TRENDS NEUROSCI, V26, P662, DOI 10.1016/j.tins.2003.09.014; Rodrigues SM, 2004, J NEUROSCI, V24, P3281, DOI 10.1523/JNEUROSCI.5303-03.2004; Rodrigues SM, 2001, J NEUROSCI, V21, P6889, DOI 10.1523/JNEUROSCI.21-17-06889.2001; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Schafe GE, 2005, EUR J NEUROSCI, V22, P201, DOI 10.1111/j.1460-9568.2005.04209.x; Schafe GE, 2000, J NEUROSCI, V20, P8177; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Son H, 1998, LEARN MEMORY, V5, P231; THIEL G, 1993, BRAIN PATHOL, V3, P87, DOI 10.1111/j.1750-3639.1993.tb00729.x; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Toni N, 2001, J NEUROSCI, V21, P6245, DOI 10.1523/JNEUROSCI.21-16-06245.2001; Wang HG, 2005, NEURON, V45, P389, DOI 10.1016/j.neuron.2005.01.011; Yeh SH, 2006, MOL PHARMACOL, V69, P299, DOI 10.1124/mol.105.017194; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498; Zhuang SH, 2004, J BIOL CHEM, V279, P10397, DOI 10.1074/jbc.M313048200; ZHUO M, 1994, NATURE, V368, P635, DOI 10.1038/368635a0	51	61	61	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11236	10.1371/journal.pone.0011236	http://dx.doi.org/10.1371/journal.pone.0011236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574537	Green Published, gold			2022-12-27	WOS:000279058300020
J	Aruscavage, PJ; Hellwig, S; Bass, BL				Aruscavage, P. Joseph; Hellwig, Sabine; Bass, Brenda L.			Small DNA Pieces in C. elegans Are Intermediates of DNA Fragmentation during Apoptosis	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; ENDONUCLEASE-G; INNATE IMMUNITY; GENETIC-CONTROL; DEGRADATION; ROLES; NUC-1	While studying small noncoding RNA in C. elegans, we discovered that protocols used for isolation of RNA are contaminated with small DNA pieces. After electrophoresis on a denaturing gel, the DNA fragments appear as a ladder of bands,,10 nucleotides apart, mimicking the pattern of nuclease digestion of DNA wrapped around a nucleosome. Here we show that the small DNA pieces are products of the DNA fragmentation that occurs during apoptosis, and correspondingly, are absent in mutant strains incapable of apoptosis. In contrast, the small DNA pieces are present in strains defective for the engulfment process of apoptosis, suggesting they are produced in the dying cell prior to engulfment. While the small DNA pieces are also present in a number of strains with mutations in predicted nucleases, they are undetectable in strains containing mutations in nuc-1, which encodes a DNase II endonuclease. We find that the small DNA pieces can be labeled with terminal deoxynucleotidyltransferase only after phosphatase treatment, as expected if they are products of DNase II cleavage, which generates a 39 phosphate. Our studies reveal a previously unknown intermediate in the process of apoptotic DNA fragmentation and thus bring us closer to defining this important pathway.	[Aruscavage, P. Joseph; Bass, Brenda L.] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA; [Hellwig, Sabine] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Utah System of Higher Education; University of Utah; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Aruscavage, PJ (corresponding author), Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA.	bbass@biochem.utah.edu		Hellwig, Sabine/0000-0002-9809-947X	National Institutes of General Medical Sciences [RO1GM067106]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067106] Funding Source: NIH RePORTER	National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds to B.L.B. from National Institutes of General Medical Sciences (RO1GM067106; http://www.nigms.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENNER S, 1974, GENETICS, V77, P71; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Conradt Barbara, 2005, WormBook, P1; Conradt B, 2009, ANNU REV GENET, V43, P493, DOI 10.1146/annurev.genet.42.110807.091533; Duret L, 2000, GENETICS, V156, P1661; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; EMMONS SW, 1979, P NATL ACAD SCI USA, V76, P1333, DOI 10.1073/pnas.76.3.1333; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; Lai HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007348; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Lyon CJ, 2000, GENE, V252, P147, DOI 10.1016/S0378-1119(00)00213-4; Mukae N, 2002, GENE DEV, V16, P2662, DOI 10.1101/gad.1022802; NOLL M, 1974, NUCLEIC ACIDS RES, V1, P1573, DOI 10.1093/nar/1.11.1573; OBERHAMMER F, 1993, EMBO J, V12, P3679, DOI 10.1002/j.1460-2075.1993.tb06042.x; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Parrish JZ, 2003, MOL CELL, V11, P987, DOI 10.1016/S1097-2765(03)00095-9; PORTMAN DS, 2006, PROFILING C ELEGANS; PRUNELL A, 1979, SCIENCE, V204, P855, DOI 10.1126/science.441739; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Samejima K, 2005, NAT REV MOL CELL BIO, V6, P677, DOI 10.1038/nrm1715; SOLLNERWEBB B, 1978, CELL, V14, P611, DOI 10.1016/0092-8674(78)90246-5; Stanfield GM, 2000, MOL CELL, V5, P423, DOI 10.1016/S1097-2765(00)80437-2; SULSTON JE, 1976, PHILOS T ROY SOC B, V275, P287, DOI 10.1098/rstb.1976.0084; Welker NC, 2007, RNA, V13, P1090, DOI 10.1261/rna.542107; Widlak P, 2001, J BIOL CHEM, V276, P48404, DOI 10.1074/jbc.M108461200; Widlak P, 2009, CELL MOL LIFE SCI, V66, P263, DOI 10.1007/s00018-008-8472-9; Wu YC, 2000, GENE DEV, V14, P536; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0	33	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11217	10.1371/journal.pone.0011217	http://dx.doi.org/10.1371/journal.pone.0011217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585459	Green Published, Green Accepted, gold			2022-12-27	WOS:000278977200017
J	Kennedy, J; Katsuta, H; Jung, MH; Marselli, L; Goldfine, AB; Balis, UJ; Sgroi, D; Bonner-Weir, S; Weir, GC				Kennedy, Jeffrey; Katsuta, Hitoshi; Jung, Min-Ho; Marselli, Lorella; Goldfine, Allison B.; Balis, Ulysses J.; Sgroi, Dennis; Bonner-Weir, Susan; Weir, Gordon C.			Protective Unfolded Protein Response in Human Pancreatic Beta Cells Transplanted into Mice	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ACTIVATING TRANSCRIPTION FACTOR-3; LASER CAPTURE MICRODISSECTION; ISLET AMYLOID POLYPEPTIDE; ER STRESS; DIABETES-MELLITUS; OXIDATIVE STRESS; GENE-EXPRESSION; KINASE IRE1; PATHWAY		[Kennedy, Jeffrey; Katsuta, Hitoshi; Jung, Min-Ho; Marselli, Lorella; Goldfine, Allison B.; Bonner-Weir, Susan; Weir, Gordon C.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Islet Cell Biol & Regenerat Med,Res Div, Boston, MA 02115 USA; [Kennedy, Jeffrey; Katsuta, Hitoshi; Jung, Min-Ho; Marselli, Lorella; Goldfine, Allison B.; Bonner-Weir, Susan; Weir, Gordon C.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Balis, Ulysses J.; Sgroi, Dennis] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Mol Pathol Unit, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Kennedy, J (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Islet Cell Biol & Regenerat Med,Res Div, Boston, MA 02115 USA.	gordon.weir@joslin.harvard.edu	Sgroi, Dennis/AAV-2487-2021	Marselli, Lorella/0000-0002-6698-2962; Balis, Ulysses/0000-0002-4168-1477; Bonner-Weir, Susan/0000-0003-4682-0656	American Diabetes Association; Juvenile Diabetes Research Foundation; National Institutes of Health [RO1 DK66056, P30 DK36836]; Diabetes Research and Wellness Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066056, P30DK036836] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Research and Wellness Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the American Diabetes Association, the Juvenile Diabetes Research Foundation, the National Institutes of Health (RO1 DK66056 and P30 DK36836 - the Advanced Microscopy, Bioinformatics, and Genomics Cores of Joslin Diabetes and Endocrinology Research Center), and the Diabetes Research and Wellness Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfeldt MC, 2008, DIABETES, V57, P3034, DOI 10.2337/db07-1802; Araki E, 2003, EXP BIOL MED, V228, P1213, DOI 10.1177/153537020322801018; Cantley J, 2007, DIABETOLOGIA, V50, P1248, DOI 10.1007/s00125-007-0637-9; Carlsson PO, 2002, J CLIN ENDOCR METAB, V87, P5418, DOI 10.1210/jc.2002-020728; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4; HALBAN PA, 2010, J CLIN ENDOCRINOL ME; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Huang CJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1656, DOI 10.1152/ajpendo.00318.2007; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Hull RL, 2009, DIABETOLOGIA, V52, P1102, DOI 10.1007/s00125-009-1329-4; ISHIGAKI S, 2009, CELL DEATH DIFFER; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kaneto H, 2005, J MOL MED, V83, P429, DOI 10.1007/s00109-005-0640-x; Katiyar S, 2005, MOL BIOL CELL, V16, P4584, DOI 10.1091/mbc.E05-04-0345; King AJF, 2007, DIABETES, V56, P2312, DOI 10.2337/db07-0191; Kurisu J, 2003, GENES CELLS, V8, P189, DOI 10.1046/j.1365-2443.2003.00625.x; Lau J, 2009, CURR OPIN ORGAN TRAN, V14, P688, DOI 10.1097/MOT.0b013e32833239ff; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Laybutt DR, 2002, J BIOL CHEM, V277, P10912, DOI 10.1074/jbc.M111751200; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Linetsky E, 1997, DIABETES, V46, P1120, DOI 10.2337/diabetes.46.7.1120; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; MACDONALD MJ, 1992, HORM METAB RES, V24, P158, DOI 10.1055/s-2007-1003284; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Marselli L, 2008, J CLIN ENDOCR METAB, V93, P1046, DOI 10.1210/jc.2007-0931; Marselli L, 2009, METHODS MOL BIOL, V560, P87, DOI 10.1007/978-1-59745-448-3_8; Matsuda T, 2010, J CLIN INVEST, V120, P115, DOI 10.1172/JCI39721; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Rickels MR, 2005, DIABETES, V54, P100, DOI 10.2337/diabetes.54.1.100; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Weir GC, 2009, DIABETES OBES METAB, V11, P82, DOI 10.1111/j.1463-1326.2009.01113.x; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Weitgasser R, 1999, DIABETOLOGIA, V42, P256; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081	42	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11211	10.1371/journal.pone.0011211	http://dx.doi.org/10.1371/journal.pone.0011211			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585452	Green Published, gold			2022-12-27	WOS:000278977200014
J	Parker, R; Melathopoulos, AP; White, R; Pernal, SF; Guarna, MM; Foster, LJ				Parker, Robert; Melathopoulos, Andony P.; White, Rick; Pernal, Stephen F.; Guarna, M. Marta; Foster, Leonard J.			Ecological Adaptation of Diverse Honey Bee (Apis mellifera) Populations	PLOS ONE			English	Article							GENE-EXPRESSION VARIATION; RNA; QUANTIFICATION; HYMENOPTERA; CYSTEAMINE; PROTEOMICS; SELECTION; ONTOLOGY; VANIN-1; LARVAE	Background: Honey bees are complex eusocial insects that provide a critical contribution to human agricultural food production. Their natural migration has selected for traits that increase fitness within geographical areas, but in parallel their domestication has selected for traits that enhance productivity and survival under local conditions. Elucidating the biochemical mechanisms of these local adaptive processes is a key goal of evolutionary biology. Proteomics provides tools unique among the major 'omics disciplines for identifying the mechanisms employed by an organism in adapting to environmental challenges. Results: Through proteome profiling of adult honey bee midgut from geographically dispersed, domesticated populations combined with multiple parallel statistical treatments, the data presented here suggest some of the major cellular processes involved in adapting to different climates. These findings provide insight into the molecular underpinnings that may confer an advantage to honey bee populations. Significantly, the major energy-producing pathways of the mitochondria, the organelle most closely involved in heat production, were consistently higher in bees that had adapted to colder climates. In opposition, up-regulation of protein metabolism capacity, from biosynthesis to degradation, had been selected for in bees from warmer climates. Conclusions: Overall, our results present a proteomic interpretation of expression polymorphisms between honey bee ecotypes and provide insight into molecular aspects of local adaptation or selection with consequences for honey bee management and breeding. The implications of our findings extend beyond apiculture as they underscore the need to consider the interdependence of animal populations and their agro-ecological context.	[Parker, Robert; Guarna, M. Marta; Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V5Z 1M9, Canada; [Parker, Robert; Guarna, M. Marta; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Melathopoulos, Andony P.; Pernal, Stephen F.] Agr & Agri Food Canada, Beaverlodge, SK, Canada; [White, Rick] Univ British Columbia, Dept Stat, Stat Consulting & Res Lab, Vancouver, BC V6T 1W5, Canada	University of British Columbia; University of British Columbia; Agriculture & Agri Food Canada; University of British Columbia	Parker, R (corresponding author), Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V5Z 1M9, Canada.	ljfoster@interchange.ubc.ca		Parker, Robert/0000-0003-3989-8893; Guarna, Maria Marta/0000-0002-4638-9475	Genome British Columbia; British Columbia Honey Producers Association; Canadian Honey Council and Canadian Association of Professional Apiculturists; British Columbia Blueberry Council; British Columbia Cranberry Marketing Association; Agri-Food Canada's Advancing Canadian Agriculture and Agri-Food (ACAAF)	Genome British Columbia; British Columbia Honey Producers Association; Canadian Honey Council and Canadian Association of Professional Apiculturists; British Columbia Blueberry Council; British Columbia Cranberry Marketing Association; Agri-Food Canada's Advancing Canadian Agriculture and Agri-Food (ACAAF)(Agriculture & Agri Food Canada)	This work was supported by funding from Genome British Columbia, the British Columbia Honey Producers Association through the Boone-Hodgson-Wilkinson Fund, the Canadian Honey Council and Canadian Association of Professional Apiculturists through the Canadian Bee Research Fund, the British Columbia Blueberry Council, the British Columbia Cranberry Marketing Association and Agri-Food Canada's Advancing Canadian Agriculture and Agri-Food (ACAAF) program. The latter is part of a Collective Outcome project with the cooperation of the Investment Agriculture Foundation of British Columbia, the Alberta Agriculture and Food Council, the Saskatchewan Council for Community Development, the Manitoba Rural Adaptation Council, the Ontario Agricultural Adaptation Council, the Conseil pour le developpement de l'agriculture du Quebec, and Agri-Futures Nova Scotia. Mass spectrometry infrastructure used in this project was supported by the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund and the Michael Smith Foundation through the British Columbia Proteomics Network (BCPN). LJF is the Canada Research Chair in Quantitative Proteomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Arakawa Kazuharu, 2005, In Silico Biology, V5, P419; Berruyer C, 2006, J EXP MED, V203, P2817, DOI 10.1084/jem.20061640; Boersema PJ, 2008, PROTEOMICS, V8, P4624, DOI 10.1002/pmic.200800297; Bouga M, 2005, BIOCHEM GENET, V43, P471, DOI 10.1007/s10528-005-8163-2; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Chan QWT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r156; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Crane E., 1975, HONEY ACOMPREHENSIVE; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; de Hoog CL, 2004, ANNU REV GENOM HUM G, V5, P267, DOI 10.1146/annurev.genom.4.070802.110305; DIETZ A, 1992, HIVE HONEY BEE, P23; Fay JC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r26; Foret S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-472; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; FREE J. B., 1955, INSECTES SOCIAUX, V2, P195, DOI 10.1007/BF02224381; Fridlyand LE, 2006, MED HYPOTHESES, V67, P1034, DOI 10.1016/j.mehy.2006.04.057; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Herrero J, 2001, BIOINFORMATICS, V17, P126, DOI 10.1093/bioinformatics/17.2.126; Hutter S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r12; Ishihama Y, 2006, J PROTEOME RES, V5, P988, DOI 10.1021/pr050385q; JAENICKE R, 1991, EUR J BIOCHEM, V202, P715, DOI 10.1111/j.1432-1033.1991.tb16426.x; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Karr TL, 2008, HEREDITY, V100, P200, DOI 10.1038/sj.hdy.6801008; Khomenko T, 2009, AM J PHYSIOL-GASTR L, V296, pG1277, DOI 10.1152/ajpgi.90257.2008; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Kuehn BM, 2008, JAMA-J AM MED ASSOC, V300, P2715, DOI 10.1001/jama.2008.823; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; Martin D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r101; Mizoguchi E, 2006, GASTROENTEROLOGY, V130, P398, DOI 10.1053/j.gastro.2005.12.007; Montgomery D. C., 2005, DESIGN ANAL EXPT; MORTENSEN P, 2009, J PROTEOME RES; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; NIELSEN D, 1994, EXPERIENTIA, V50, P867, DOI 10.1007/BF01956474; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Pitari G, 2000, FEBS LETT, V483, P149, DOI 10.1016/S0014-5793(00)02110-4; Riessberger-Galle U, 2001, J INVERTEBR PATHOL, V77, P231, DOI 10.1006/jipa.2001.5032; Robinson GE, 2006, INSECT MOL BIOL, V15, P535, DOI 10.1111/j.1365-2583.2006.00698.x; Ruttner F., 1988, BIOGEOGRAPHY TAXONOM, DOI [10.1007/978-3-642-72649-1, DOI 10.1007/978-3-642-72649-1]; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; STURTEVANT AP, 1953, J ECON ENTOMOL, V46, P855, DOI 10.1093/jee/46.5.855; Szabo T. I., 1991, Bee Science, V1, P144; SZABO TI, 1987, J APICULT RES, V26, P47, DOI 10.1080/00218839.1987.11100734; SZABO TI, 1987, J APICULT RES, V26, P170, DOI 10.1080/00218839.1987.11100755; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; van Delden Wilke, 1997, EXS, V83, P97; Van Engelsdorp D, 2000, J ECON ENTOMOL, V93, P1606, DOI 10.1603/0022-0493-93.6.1606; Whitfield CW, 2006, SCIENCE, V314, P642, DOI 10.1126/science.1132772; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807	52	40	41	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11096	10.1371/journal.pone.0011096	http://dx.doi.org/10.1371/journal.pone.0011096			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559562	gold, Green Published, Green Submitted			2022-12-27	WOS:000278775900003
J	Labrosse, B; Tourdjman, M; Porcher, R; LeGoff, J; de Lamballerie, X; Simon, F; Molina, JM; Clavel, F				Labrosse, Beatrice; Tourdjman, Mathieu; Porcher, Raphael; LeGoff, Jerome; de Lamballerie, Xavier; Simon, Francois; Molina, Jean-Michel; Clavel, Francois			Detection of Extensive Cross-Neutralization between Pandemic and Seasonal A/H1N1 Influenza Viruses Using a Pseudotype Neutralization Assay	PLOS ONE			English	Article								Background: Cross-immunity between seasonal and pandemic A/H1N1 influenza viruses remains uncertain. In particular, the extent that previous infection or vaccination by seasonal A/H1N1 viruses can elicit protective immunity against pandemic A/H1N1 is unclear. Methodology/Principal Findings: Neutralizing titers against seasonal A/H1N1 (A/Brisbane/59/2007) and against pandemic A/H1N1 (A/California/04/2009) were measured using an HIV-1-based pseudovirus neutralization assay. Using this highly sensitive assay, we found that a large fraction of subjects who had never been exposed to pandemic A/H1N1 express high levels of pandemic A/H1N1 neutralizing titers. A significant correlation was seen between neutralization of pandemic A/H1N1 and neutralization of a standard seasonal A/H1N1 strain. Significantly higher pandemic A/H1N1 neutralizing titers were measured in subjects who had received vaccination against seasonal influenza in 2008-2009. Higher pandemic neutralizing titers were also measured in subjects over 60 years of age. Conclusions/Significance: Our findings reveal that the extent of protective cross-immunity between seasonal and pandemic A/H1N1 influenza viruses may be more important than previously estimated. This cross-immunity could provide a possible explanation of the relatively mild profile of the recent influenza pandemic.	[Labrosse, Beatrice; Clavel, Francois] Univ Paris Diderot, Inst Univ Hematol, Paris, France; [Labrosse, Beatrice; Clavel, Francois] INSERM, U941, Paris, France; [Tourdjman, Mathieu; Molina, Jean-Michel] Hop St Louis, Assistance Publ Hop Paris, Serv Malad Infect, Paris, France; [Porcher, Raphael] Hop St Louis, Assistance Publ Hop Paris, Dept Biostat, Paris, France; [LeGoff, Jerome; Simon, Francois; Clavel, Francois] Hop St Louis, Assistance Publ Hop Paris, Microbiol Lab, Paris, France; [de Lamballerie, Xavier] Univ Aix Marseille 2, F-13284 Marseille 07, France; [de Lamballerie, Xavier] Inst Rech Dev, Marseille, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD)	Labrosse, B (corresponding author), Univ Paris Diderot, Inst Univ Hematol, Paris, France.	francois.clavel@inserm.fr	le goff, jerome/B-3447-2016; LeGoff, jerome/AAP-7880-2021; LABROSSE, Béatrice/M-9920-2017	le goff, jerome/0000-0001-7111-1865; LABROSSE, Béatrice/0000-0002-0658-4903; Porcher, Raphael/0000-0002-5277-4679	Institut National de la Sante et de la Recherche Medicale (Inserm)	Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by the Institut National de la Sante et de la Recherche Medicale (Inserm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brammer L., 2009, Morbidity and Mortality Weekly Report, V58, P1236; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P941; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Del Giudice G, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000564; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; GREENBERG ME, 2009, N ENGL J MED; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; *I VEILL SAN, 2009, B GRIPP A, V66, P1; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Nougairede A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009214; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Vaillant L, 2009, EUROSURVEILLANCE, V14, P2; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P249; World Health Organization(WHO), 2009, CHAR EM INFL H1N1 VI; Xing Z, 2009, EMERG INFECT DIS, V15, P1847, DOI 10.3201/eid1511.090685	18	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e11036	10.1371/journal.pone.0011036	http://dx.doi.org/10.1371/journal.pone.0011036			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20543954	Green Published, gold, Green Submitted			2022-12-27	WOS:000278557600014
J	Mason-Gamer, RJ; Burns, MM; Naum, M				Mason-Gamer, Roberta J.; Burns, Melissa M.; Naum, Marianna			Reticulate Evolutionary History of a Complex Group of Grasses: Phylogeny of Elymus StStHH Allotetraploids Based on Three Nuclear Genes	PLOS ONE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYLASE GENE; BOUND STARCH SYNTHASE; DNA-SEQUENCES; GENOME ANALYSIS; ALLOPOLYPLOID SPECIATION; THINOPYRUM-INTERMEDIUM; HYBRID ORIGIN; RIBOSOMAL DNA; POACEAE; TRITICEAE	Background: Elymus (Poaceae) is a large genus of polyploid species in the wheat tribe Triticeae. It is polyphyletic, exhibiting many distinct allopolyploid genome combinations, and its history might be further complicated by introgression and lineage sorting. We focus on a subset of Elymus species with a tetraploid genome complement derived from Pseudoroegneria (genome St) and Hordeum (H). We confirm the species' allopolyploidy, identify possible genome donors, and pinpoint instances of apparent introgression or incomplete lineage sorting. Methodology/Principal Findings: We sequenced portions of three unlinked nuclear genes-phosphoenolpyruvate carboxylase, beta-amylase, and granule-bound starch synthase I-from 27 individuals, representing 14 Eurasian and North American StStHH Elymus species. Elymus sequences were combined with existing data from monogenomic representatives of the tribe, and gene trees were estimated separately for each data set using maximum likelihood. Trees were examined for evidence of allopolyploidy and additional reticulate patterns. All trees confirm the StStHH genome configuration of the Elymus species. They suggest that the StStHH group originated in North America, and do not support separate North American and European origins. Our results point to North American Pseudoroegneria and Hordeum species as potential genome donors to Elymus. Diploid P. spicata is a prospective St-genome donor, though conflict among trees involving P. spicata and the Eurasian P. strigosa suggests either introgression of GBSSI sequences from P. strigosa into North American Elymus and Pseudoroegneria, or incomplete lineage sorting of ancestral GBSSI polymorphism. Diploid H. californicum and/or allotetraploid H. jubatum are possible H-genome donors; direct involvement of an allotetraploid Hordeum species would simultaneously introduce two distinct H genomes to Elymus, consistent with some of the relationships among H-genome sequences in Hordeum and Elymus. Conclusions/Significance: Comparisons among molecular phylogenetic trees confirm allopolyploidy, identify potential genome donors, and highlight cases of apparent introgression or incomplete lineage sorting. The complicated history of this group emphasizes an inherent problem with interpreting conflicts among bifurcating trees-identifying introgression and determining its direction depend on which tree is chosen as a starting point of comparison. In spite of difficulties with interpretation, differences among gene trees allow us to identify reticulate species and develop hypotheses about underlying evolutionary processes.	[Mason-Gamer, Roberta J.; Burns, Melissa M.; Naum, Marianna] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mason-Gamer, RJ (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	robie@uic.edu			National Science Foundation [DEB-9974181]	National Science Foundation(National Science Foundation (NSF))	The work was supported by National Science Foundation DEB-9974181 to RJMG (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Arnheim N., 1983, P38; Blattner FR, 2004, MOL PHYLOGENET EVOL, V33, P289, DOI 10.1016/j.ympev.2004.05.012; Bradley RD, 1997, MOL BIOL EVOL, V14, P592, DOI 10.1093/oxfordjournals.molbev.a025797; Brysting AK, 2007, SYST BIOL, V56, P467, DOI 10.1080/10635150701424553; Chen Q, 1998, GENOME, V41, P580, DOI 10.1139/gen-41-4-580; Cronn R, 2003, EVOLUTION, V57, P2475, DOI 10.1111/j.0014-3820.2003.tb01493.x; Cronn R, 2002, THEOR APPL GENET, V104, P482, DOI 10.1007/s001220100741; Davis Jerrold I., 2007, Aliso, V23, P335; Devos KM, 1997, PLANT MOL BIOL, V35, P3, DOI 10.1023/A:1005820229043; DEWEY DR, 1970, AM J BOT, V57, P861, DOI 10.2307/2441345; DEWEY DR, 1967, AM J BOT, V54, P93, DOI 10.2307/2440890; DEWEY DR, 1975, AM J BOT, V62, P524, DOI 10.2307/2441961; DEWEY DR, 1968, AM J BOT, V55, P1133, DOI 10.2307/2440735; DEWEY DR, 1974, BOT GAZ, V135, P80, DOI 10.1086/336733; DEWEY DR, 1984, STADLER GENET S, V16, P209, DOI DOI 10.1007/978-1-4613-2429-4_; DEWEY DR, 1982, GRASSES GRASSLANDS S, P51; Doust AN, 2007, SYST BOT, V32, P531, DOI 10.1600/036364407782250670; Doyle JJ, 2002, EVOLUTION, V56, P1388, DOI 10.1111/j.0014-3820.2002.tb01452.x; Emshwiller E, 2002, AM J BOT, V89, P1042, DOI 10.3732/ajb.89.7.1042; Garcia PE, 2009, MOL PHYLOGENET EVOL, V50, P226, DOI 10.1016/j.ympev.2008.10.015; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Frati F, 1997, J MOL EVOL, V44, P145, DOI 10.1007/PL00006131; Friar EA, 2008, SYST BOT, V33, P589, DOI 10.1600/036364408785679815; Ge S, 1999, P NATL ACAD SCI USA, V96, P14400, DOI 10.1073/pnas.96.25.14400; Gonzalez MC, 2002, PLANT SCI, V162, P233, DOI 10.1016/S0168-9452(01)00548-9; *GRASS PHYL WORK G, 2001, ANN MISSOURI BOT GAR, V88, P372; Guggisberg A, 2006, SYST BOT, V31, P368, DOI 10.1600/036364406777585937; Hamby RK, 1992, MOL SYSTEMATICS PLAN, DOI DOI 10.1086/661633; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Helfgott DM, 2004, SYST BOT, V29, P850, DOI 10.1600/0363644042451017; Huelsenbeck JP, 1997, ANNU REV ECOL SYST, V28, P437, DOI 10.1146/annurev.ecolsys.28.1.437; Huelsenbeck JP, 1997, SCIENCE, V276, P227, DOI 10.1126/science.276.5310.227; Hughes CE, 2002, AM J BOT, V89, P1057, DOI 10.3732/ajb.89.7.1057; JAASKA V, 1992, HEREDITAS, V117, P11, DOI 10.1111/j.1601-5223.1992.tb00002.x; Jaaska V, 1998, TRITICEAE III, P209; Jarvinen P, 2004, AM J BOT, V91, P1834, DOI 10.3732/ajb.91.11.1834; JENSEN KB, 1990, BOT GAZ, V151, P245, DOI 10.1086/337824; Jensen KB, 1996, INT J PLANT SCI, V157, P136, DOI 10.1086/297330; JENSEN KB, 1993, GENOME, V36, P72, DOI 10.1139/g93-010; Joly S, 2006, AM J BOT, V93, P412, DOI 10.3732/ajb.93.3.412; JORGENSEN RA, 1988, ANN MO BOT GARD, V75, P1238, DOI 10.2307/2399282; Judo MSB, 1998, NUCLEIC ACIDS RES, V26, P1819, DOI 10.1093/nar/26.7.1819; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kellogg EA, 1996, SYST BOT, V21, P321, DOI 10.2307/2419662; Kim ST, 2008, AM J BOT, V95, P1122, DOI 10.3732/ajb.0700008; Kim SC, 2008, J PLANT RES, V121, P357, DOI 10.1007/s10265-008-0166-8; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KLEINHOFS A, 1997, BARLEY GENET NEWSL, V27, P105; Korzun V, 1997, THEOR APPL GENET, V95, P468, DOI 10.1007/s001220050584; LEPINIEC L, 1993, PLANT MOL BIOL, V21, P487, DOI 10.1007/BF00028806; Lihova J, 2006, MOL PHYLOGENET EVOL, V39, P759, DOI 10.1016/j.ympev.2006.01.027; LINDELAURSEN I, 1994, PLANT SYST EVOL, V192, P165, DOI 10.1007/BF00986250; Liu SC, 2009, J PLANT RES, V122, P305, DOI 10.1007/s10265-009-0223-y; LIU ZW, 1993, GENOME, V36, P102, DOI 10.1139/g93-014; Love A., 1984, Feddes Repertorium, V95, P425; LU BR, 1991, EUPHYTICA, V58, P81, DOI 10.1007/BF00035343; LU BR, 1995, PLANT SYST EVOL, V197, P1, DOI 10.1007/BF00984628; LU BR, 1993, PLANT SYST EVOL, V185, P35, DOI 10.1007/BF00937719; Mansion G, 2005, TAXON, V54, P931, DOI 10.2307/25065479; Mason-Gamer RJ, 2005, AM J BOT, V92, P1045, DOI 10.3732/ajb.92.6.1045; Mason-Gamer RJ, 2004, SYST BIOL, V53, P25, DOI 10.1080/10635150490424402; Mason-Gamer RJ, 1998, MOL BIOL EVOL, V15, P1658, DOI 10.1093/oxfordjournals.molbev.a025893; Mason-Gamer RJ, 2001, SYST BOT, V26, P757; Mason-Gamer RJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-92; Mason-Gamer RJ, 2008, MOL PHYLOGENET EVOL, V47, P598, DOI 10.1016/j.ympev.2008.02.008; Mason-Gamer RJ, 2010, MOL PHYLOGENET EVOL, V54, P10, DOI 10.1016/j.ympev.2009.10.002; Mason-Gamer Roberta J., 2007, Aliso, V23, P372; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.1093/sysbio/45.4.524; Mummenhoff K, 1997, CAN J BOT, V75, P469, DOI 10.1139/b97-051; Popp M, 2005, SYST BOT, V30, P302, DOI 10.1600/0363644054223648; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rodriguez F, 2009, SYST BOT, V34, P207, DOI 10.1600/036364409787602195; ROHDE W, 1988, NUCLEIC ACIDS RES, V16, P7185, DOI 10.1093/nar/16.14.7185; SALOMON B, 1993, GENOME, V36, P899, DOI 10.1139/g93-118; SALOMON B, 1994, PLANT SYST EVOL, V191, P199, DOI 10.1007/BF00984665; SALOMON B, 1992, PLANT SYST EVOL, V180, P1, DOI 10.1007/BF00940394; Seelanan T, 1997, SYST BOT, V22, P259, DOI 10.2307/2419457; SHARP PJ, 1988, THEOR APPL GENET, V75, P286, DOI 10.1007/BF00303966; Smedmark JEE, 2005, ORG DIVERS EVOL, V5, P275, DOI 10.1016/j.ode.2004.12.003; Stefanovic S, 2008, BOTANY, V86, P791, DOI 10.1139/B08-033; Sullivan J, 1997, SYST BIOL, V46, P426, DOI 10.2307/2413690; Sun GL, 2008, MOL PHYLOGENET EVOL, V46, P897, DOI 10.1016/j.ympev.2007.12.024; SWOFFORD DL, 1996, MOL SYSTEMATICS, V2, P407; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; TSUJIMOTO H, 1991, GENOME, V34, P782, DOI 10.1139/g91-122; Vander Stappen J, 2002, PLANT SYST EVOL, V234, P27, DOI 10.1007/s00606-002-0193-1; WAGNER A, 1994, SYST BIOL, V43, P250, DOI 10.2307/2413465; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Widmer A, 1999, AM J BOT, V86, P1282, DOI 10.2307/2656776; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Zhang XY, 1996, GENOME, V39, P1062, DOI 10.1139/g96-133; Ziegler P, 1999, J CEREAL SCI, V29, P195, DOI 10.1006/jcrs.1998.0238; Zwickl DJ., 2006, THESIS	94	33	34	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e10989	10.1371/journal.pone.0010989	http://dx.doi.org/10.1371/journal.pone.0010989			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20543952	Green Published, Green Submitted, gold			2022-12-27	WOS:000278557600004
J	Boettcher, M; Kischkel, F; Hoheisel, JD				Boettcher, Michael; Kischkel, Frank; Hoheisel, Joerg D.			High-Definition DNA Methylation Profiles from Breast and Ovarian Carcinoma Cell Lines with Differing Doxorubicin Resistance	PLOS ONE			English	Article							TOPOISOMERASE-II-ALPHA; CANCER-CELLS; EPIGENETIC REGULATION; PROGNOSTIC MARKER; MDR1 PROMOTER; MCJ GENE; EXPRESSION; CHEMOTHERAPY; ANTHRACYCLINES; TUMORS	Acquired drug resistance represents a frequent obstacle which hampers efficient chemotherapy of cancers. The contribution of aberrant DNA methylation to the development of drug resistant tumor cells has gained increasing attention over the past decades. Hence, the objective of the presented study was to characterize DNA methylation changes which arise from treatment of tumor cells with the chemotherapeutic drug doxorubicin. DNA methylation levels from CpG islands (CGIs) linked to twenty-eight genes, whose expression levels had previously been shown to contribute to resistance against DNA double strand break inducing drugs or tumor progression in different cancer types were analyzed. High-definition DNA methylation profiles which consisted of methylation levels from 800 CpG sites mapping to CGIs around the transcription start sites of the selected genes were determined. In order to investigate the influence of CGI methylation on the expression of associated genes, their mRNA levels were investigated via qRT-PCR. It was shown that the employed method is suitable for providing highly accurate methylation profiles, comparable to those obtained via clone sequencing, the gold standard for high-definition DNA methylation studies. In breast carcinoma cells with acquired resistance against the double strand break inducing drug doxorubicin, changes in methylation of specific cytosines from CGIs linked to thirteen genes were detected. Moreover, similarities between methylation profiles obtained from breast and ovarian carcinoma cell lines with acquired doxorubicin resistance were found. The expression levels of a subset of analyzed genes were shown to be linked to the methylation levels of the analyzed CGIs. Our results provide detailed DNA methylation information from two separate model systems for acquired doxorubicin resistance and suggest the occurrence of similar methylation changes in both systems upon exposure to the drug.	[Boettcher, Michael; Hoheisel, Joerg D.] Deutsch Krebsforschungszentrum, Div Funct Genome Anal, D-6900 Heidelberg, Germany; [Kischkel, Frank] TherapySelect GmbH & Co KG, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Boettcher, M (corresponding author), Deutsch Krebsforschungszentrum, Div Funct Genome Anal, D-6900 Heidelberg, Germany.	m.boettcher@dkfz.de		Boettcher, Michael/0000-0003-0986-4465	German Ministry of Education and Research (BMBF) [0313869]; company TherapySelect GmbH Co	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); company TherapySelect GmbH Co	This work has been supported by the German Ministry of Education and Research (BMBF) within the project 0313869. The BMBF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work has further been supported by the company TherapySelect GmbH & Co. KG. Doxorubicin was suggested by TherapySelect GmbH & Co. KG as a compound of biomedical interest but other than that, the company had no role in study design, data collection and analysis or decision to publish.	Ai LB, 2008, CARCINOGENESIS, V29, P510, DOI 10.1093/carcin/bgm280; Baum M, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng151; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Calcagno AM, 2008, BRIT J CANCER, V98, P1515, DOI 10.1038/sj.bjc.6604334; Chau BN, 2009, CANCER RES, V69, P1368, DOI 10.1158/0008-5472.CAN-08-2742; Chekhun VF, 2007, MOL CANCER THER, V6, P1089, DOI 10.1158/1535-7163.MCT-06-0663; Chekhun VF, 2006, CANCER LETT, V231, P87, DOI 10.1016/j.canlet.2005.01.038; Cheng XS, 1997, CANCER, V79, P521, DOI 10.1002/(SICI)1097-0142(19970201)79:3<521::AID-CNCR14>3.0.CO;2-5; David GL, 2004, CANCER BIOL THER, V3, P540, DOI 10.4161/cbt.3.6.845; Dejeux E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-68; Di Leo A, 2008, EUR J CANCER, V44, P2791, DOI 10.1016/j.ejca.2008.09.014; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Giacinti L, 2006, ONCOLOGIST, V11, P1, DOI 10.1634/theoncologist.11-1-1; Glasspool RM, 2006, BRIT J CANCER, V94, P1087, DOI 10.1038/sj.bjc.6603024; Greenberg RA, 2008, CHROMOSOMA, V117, P305, DOI 10.1007/s00412-008-0154-8; Hampton OA, 2009, GENOME RES, V19, P167, DOI 10.1101/gr.080259.108; Hatle KM, 2007, MOL CELL BIOL, V27, P2952, DOI 10.1128/MCB.01804-06; Hodges E, 2009, GENOME RES, V19, P1593, DOI 10.1101/gr.095190.109; Ikegami K, 2009, INT J DEV BIOL, V53, P203, DOI 10.1387/ijdb.082741ki; Jakoby W B, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P383; Jarvinen TAH, 1998, BRIT J CANCER, V77, P2267, DOI 10.1038/bjc.1998.377; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kantharidis P, 1997, CLIN CANCER RES, V3, P2025; KEITH WN, 1990, BRIT J CANCER, V61, P712, DOI 10.1038/bjc.1990.160; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liscovitch M, 2007, CANCER LETT, V245, P350, DOI 10.1016/j.canlet.2006.01.013; Masanek U, 1997, ANTI-CANCER DRUG, V8, P189, DOI 10.1097/00001813-199702000-00010; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Muller HM, 2003, CANCER RES, V63, P7641; Muller HM, 2004, ANN NY ACAD SCI, V1022, P44, DOI 10.1196/annals.1318.008; Mund C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni072; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Paige AJW, 2008, PHARMACOGENOMICS, V9, P1825, DOI 10.2217/14622416.9.12.1825; Pakneshan P, 2004, CLIN CANCER RES, V10, P3035, DOI 10.1158/1078-0432.CCR-03-0545; Pisano Carmela, 2009, Ther Clin Risk Manag, V5, P421; Rathi A, 2002, CLIN CANCER RES, V8, P3324; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Sharma D, 2004, CANCER BIOL THER, V3, P549, DOI 10.4161/cbt.3.6.1041; Strathdee G, 2005, GYNECOL ONCOL, V97, P898, DOI 10.1016/j.ygyno.2005.03.023; Strathdee G, 2004, CARCINOGENESIS, V25, P693, DOI 10.1093/carcin/bgh066; Tassone P, 2003, BRIT J CANCER, V88, P1285, DOI 10.1038/sj.bjc.6600859; Tian KG, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-327; Tian KG, 2005, CANCER RES, V65, P10024, DOI 10.1158/0008-5472.CAN-05-1944; Tubbs R, 2009, J CLIN ONCOL, V27, P3881, DOI 10.1200/JCO.2008.20.1566; Verma S, 2008, CANCER TREAT REV, V34, P391, DOI 10.1016/j.ctrv.2008.01.008; Yu YC, 2006, CLIN EXP METASTAS, V23, P65, DOI 10.1007/s10585-006-9020-3	48	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11002	10.1371/journal.pone.0011002	http://dx.doi.org/10.1371/journal.pone.0011002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544021	Green Submitted, Green Published, gold			2022-12-27	WOS:000278494900014
J	Aguilar-Valles, A; Flores, C; Luheshi, GN				Aguilar-Valles, Argel; Flores, Cecilia; Luheshi, Giamal N.			Prenatal Inflammation-Induced Hypoferremia Alters Dopamine Function in the Adult Offspring in Rat: Relevance for Schizophrenia	PLOS ONE			English	Article							MATERNAL IMMUNE ACTIVATION; NEURODEVELOPMENTAL ANIMAL-MODEL; IRON-DEFICIENCY; FETAL-BRAIN; PHARMACOLOGICAL CHANGES; PREPULSE INHIBITION; PEPTIDE HEPCIDIN; INFECTION; PREGNANCY; AMPHETAMINE	Maternal infection during pregnancy has been associated with increased incidence of schizophrenia in the adult offspring. Mechanistically, this has been partially attributed to neurodevelopmental disruption of the dopamine neurons, as a consequence of exacerbated maternal immunity. In the present study we sought to target hypoferremia, a cytokine-induced reduction of serum non-heme iron, which is common to all types of infections. Adequate iron supply to the fetus is fundamental for the development of the mesencephalic dopamine neurons and disruption of this following maternal infection can affect the offspring's dopamine function. Using a rat model of localized injury induced by turpentine, which triggers the innate immune response and inflammation, we investigated the effects of maternal iron supplementation on the offspring's dopamine function by assessing behavioral responses to acute and repeated administration of the dopamine indirect agonist, amphetamine. In addition we measured protein levels of tyrosine hydroxylase, and tissue levels of dopamine and its metabolites, in ventral tegmental area, susbtantia nigra, nucleus accumbens, dorsal striatum and medial prefrontal cortex. Offspring of turpentine-treated mothers exhibited greater responses to a single amphetamine injection and enhanced behavioral sensitization following repeated exposure to this drug, when compared to control offspring. These behavioral changes were accompanied by increased baseline levels of tyrosine hydroxylase, dopamine and its metabolites, selectively in the nucleus accumbens. Both, the behavioral and neurochemical changes were prevented by maternal iron supplementation. Localized prenatal inflammation induced a deregulation in iron homeostasis, which resulted in fundamental alterations in dopamine function and behavioral alterations in the adult offspring. These changes are characteristic of schizophrenia symptoms in humans.	[Aguilar-Valles, Argel; Flores, Cecilia; Luheshi, Giamal N.] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada	McGill University	Aguilar-Valles, A (corresponding author), McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	giamal.luheshi@mcgill.ca	Aguilar-Valles, Argel/B-4259-2009; Flores, Cecilia/N-7799-2017	Aguilar-Valles, Argel/0000-0002-2272-1138; Flores, Cecilia/0000-0001-8606-5910	Canadian Institute of Health Research; Natural Sciences and Engineering Research Council of Canada; Canadian Bureau for International Education	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Bureau for International Education	This study was supported by the Canadian Institute of Health Research (http://www.cihr-irsc.gc.ca/) and the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/). AAV was the recipient of a Government of Canada Award from the Canadian Bureau for International Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 1998, AM J PSYCHIAT, V155, P761; Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; Aguilar-Valles A, 2007, J PHYSIOL-LONDON, V583, P391, DOI 10.1113/jphysiol.2007.132829; Archer T, 2007, NEUROCHEM RES, V32, P1625, DOI 10.1007/s11064-007-9358-1; Ashdown H, 2006, MOL PSYCHIATR, V11, P47, DOI 10.1038/sj.mp.4001748; Babulas V, 2006, AM J PSYCHIAT, V163, P927, DOI 10.1176/appi.ajp.163.5.927; Baharnoori M, 2009, SCHIZOPHR RES, V107, P99, DOI 10.1016/j.schres.2008.10.003; Beard J, 2003, J NUTR, V133, p1468S, DOI 10.1093/jn/133.5.1468S; Beard JL, 2006, BEHAV BRAIN RES, V170, P224, DOI 10.1016/j.bbr.2006.02.024; Beard JL, 2003, ANNU REV NUTR, V23, P41, DOI 10.1146/annurev.nutr.23.020102.075739; Borrell J, 2002, NEUROPSYCHOPHARMACOL, V26, P204, DOI 10.1016/S0893-133X(01)00360-8; Breier A, 1997, P NATL ACAD SCI USA, V94, P2569, DOI 10.1073/pnas.94.6.2569; Brown A. S, 2010, AM J PSYCHIAT; Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052; Burhans MS, 2006, PHYSIOL BEHAV, V87, P917, DOI 10.1016/j.physbeh.2006.02.014; Burhans MS, 2005, NUTR NEUROSCI, V8, P31, DOI 10.1080/10284150500047070; Cai ZW, 2000, PEDIATR RES, V47, P64, DOI 10.1203/00006450-200001000-00013; Casanueva E, 2003, J NUTR, V133, p1700S, DOI 10.1093/jn/133.5.1700S; Chambers RA, 2001, BIOL PSYCHIAT, V50, P71, DOI 10.1016/S0006-3223(01)01134-9; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Connor JR, 2009, BRAIN, V132, P2403, DOI 10.1093/brain/awp125; Connor JR, 2001, PEDIATR NEUROL, V25, P118, DOI 10.1016/S0887-8994(01)00303-4; Coyle P, 2009, BEHAV BRAIN RES, V197, P210, DOI 10.1016/j.bbr.2008.08.022; Cui K, 2009, SCHIZOPHR RES, V113, P288, DOI 10.1016/j.schres.2009.05.003; De Domenico I, 2007, J CLIN INVEST, V117, P1755, DOI 10.1172/JCI32701; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Ellman LM, 2009, NEURON, V64, P25, DOI 10.1016/j.neuron.2009.09.024; Featherstone RE, 2007, PROG NEURO-PSYCHOPH, V31, P1556, DOI 10.1016/j.pnpbp.2007.08.025; Feleder C, 2010, BIOL PSYCHIAT, V67, P386, DOI 10.1016/j.biopsych.2009.09.028; Felt BT, 2006, BEHAV BRAIN RES, V171, P261, DOI 10.1016/j.bbr.2006.04.001; Flores C, 2000, J NEUROSCI, V20; Flores C, 2005, MOL PSYCHIATR, V10, P606, DOI 10.1038/sj.mp.4001607; Fortier ME, 2007, BEHAV BRAIN RES, V181, P270, DOI 10.1016/j.bbr.2007.04.016; Fortier ME, 2004, J PSYCHIATR RES, V38, P335, DOI 10.1016/j.jpsychires.2003.10.001; Gambling L, 2002, BIOL REPROD, V66, P516, DOI 10.1095/biolreprod66.2.516; Gambling L, 2009, AM J PHYSIOL-REG I, V296, pR1063, DOI 10.1152/ajpregu.90793.2008; Gayle DA, 2004, AM J PHYSIOL-REG I, V286, pR1024, DOI 10.1152/ajpregu.00664.2003; Grant A, 2009, EUR J NEUROSCI, V30, P1318, DOI 10.1111/j.1460-9568.2009.06919.x; GRIEGER TA, 1978, J PHYSIOL-LONDON, V279, P187, DOI 10.1113/jphysiol.1978.sp012339; Gruper Y, 2005, J CELL PHYSIOL, V204, P901, DOI 10.1002/jcp.20349; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; HILL JM, 1984, NEUROSCIENCE, V11, P595, DOI 10.1016/0306-4522(84)90046-0; Hofer T, 2008, EXP GERONTOL, V43, P563, DOI 10.1016/j.exger.2008.02.007; Jiang H, 2007, NEUROCHEM INT, V51, P32, DOI 10.1016/j.neuint.2007.03.006; KLUGER MJ, 1979, SCIENCE, V203, P374, DOI 10.1126/science.760197; Kwik-Uribe CL, 2000, J NUTR, V130, P2821, DOI 10.1093/jn/130.11.2821; Laruelle M, 1999, BIOL PSYCHIAT, V46, P56, DOI 10.1016/S0006-3223(99)00067-0; Lebel E, 2000, ENDOCRINOLOGY, V141, P3749, DOI 10.1210/en.141.10.3749; Lee MS, 2005, HUM VACCINES, V1, P6, DOI 10.4161/hv.1.1.1424; Legssyer R, 2003, BIOMETALS, V16, P425, DOI 10.1023/A:1022547819506; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Liverman CS, 2006, NEUROSCI LETT, V399, P220, DOI 10.1016/j.neulet.2006.01.064; Lowe GC, 2008, AM J PHYSIOL-REG I, V295, pR1563, DOI 10.1152/ajpregu.90350.2008; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; McArdle HJ, 2006, PLACENTA, V27, pS56, DOI 10.1016/j.placenta.2006.01.014; McArdle HJ, 2003, BIOMETALS, V16, P161, DOI 10.1023/A:1020714915767; Meyer U, 2008, MOL PSYCHIATR, V13, P208, DOI 10.1038/sj.mp.4002042; Meyer U, 2008, NEUROSCIENCE, V154, P701, DOI 10.1016/j.neuroscience.2008.04.031; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Meyer U, 2005, NEUROSCI BIOBEHAV R, V29, P913, DOI 10.1016/j.neubiorev.2004.10.012; Meyer U, 2007, NEUROSCIENTIST, V13, P241, DOI 10.1177/1073858406296401; Millard KN, 2004, GUT, V53, P655, DOI 10.1136/gut.2003.031153; Mok H, 2004, DEVELOPMENT, V131, P4871, DOI 10.1242/dev.01342; Mok H, 2004, DEVELOPMENT, V131, P1859, DOI 10.1242/dev.01081; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; MURRAY MJ, 1971, J NUTR, V101, P1583, DOI 10.1093/jn/101.11.1583; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nemeth E, 2006, ANNU REV NUTR, V26, P323, DOI 10.1146/annurev.nutr.26.061505.111303; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Ozawa K, 2006, BIOL PSYCHIAT, V59, P546, DOI 10.1016/j.biopsych.2005.07.031; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; POHL J, 2009, ENDOCRINOLOGY; Rebouche CJ, 2004, J BIOCHEM BIOPH METH, V58, P239, DOI 10.1016/j.jbbm.2003.11.003; Rees GS, 1999, CYTOKINE, V11, P95, DOI 10.1006/cyto.1998.0408; ROMERO E, 2006, NEUROPSYCHOPHARMACOL; ROMERO E, 2008, MOL PSYCHIAT; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Sorensen HJ, 2009, SCHIZOPHRENIA BULL, V35, P631, DOI 10.1093/schbul/sbn121; SULZER D, 1995, J NEUROSCI, V15, P4102; Unger EL, 2007, J NUTR, V137, P118, DOI 10.1093/jn/137.1.118; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; Vuillermot S, 2010, J NEUROSCI, V30, P1270, DOI 10.1523/JNEUROSCI.5408-09.2010; WUSTEMAN M, 1990, AM J PHYSIOL, V259, pE763, DOI 10.1152/ajpendo.1990.259.6.E763; Yetnikoff L, 2007, NEUROSCIENCE, V150, P764, DOI 10.1016/j.neuroscience.2007.09.069; Youdim M B, 1984, Adv Neurol, V40, P159; Zuckerman L, 2005, J PSYCHIATR RES, V39, P311, DOI 10.1016/j.jpsychires.2004.08.008; Zuckerman L, 2003, NEUROPSYCHOPHARMACOL, V28, P1778, DOI 10.1038/sj.npp.1300248	94	52	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10967	10.1371/journal.pone.0010967	http://dx.doi.org/10.1371/journal.pone.0010967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532043	Green Published, Green Submitted, gold			2022-12-27	WOS:000278380500012
J	Takeuchi, A; Hosokawa, M; Nojima, T; Hagiwara, M				Takeuchi, Akihide; Hosokawa, Motoyasu; Nojima, Takayuki; Hagiwara, Masatoshi			Splicing Reporter Mice Revealed the Evolutionally Conserved Switching Mechanism of Tissue-Specific Alternative Exon Selection	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-2; IN-VIVO; PREMESSENGER RNA; BINDING-PROTEIN; FACTOR FAMILY; FGFR2; IIIB; CELLS; IDENTIFICATION; ACTIVATION	Since alternative splicing of pre-mRNAs is essential for generating tissue-specific diversity in proteome, elucidating its regulatory mechanism is indispensable to understand developmental process or tissue-specific functions. We have been focusing on tissue-specific regulation of mutually exclusive selection of alternative exons because this implies the typical molecular mechanism of alternative splicing regulation and also can be good examples to elicit general rule of "splice code''. So far, mutually exclusive splicing regulation has been explained by the outcome from the balance of multiple regulators that enhance or repress either of alternative exons discretely. However, this "balance'' model is open to questions of how to ensure the selection of only one appropriate exon out of several candidates and how to switch them. To answer these questions, we generated an original bichromatic fluorescent splicing reporter system for mammals using fibroblast growth factor-receptor 2 (FGFR2) gene as model. By using this splicing reporter, we demonstrated that FGFR2 gene is regulated by the "switch-like'' mechanism, in which key regulators modify the ordered splice-site recognition of two mutually exclusive exons, eventually ensure single exon selection and their distinct switching. Also this finding elucidated the evolutionally conserved "splice code,'' in which combination of tissue-specific and broadly expressed RNA binding proteins regulate alternative splicing of specific gene in a tissue-specific manner. These findings provide the significant cue to understand how a number of spliced genes are regulated in various tissue-specific manners by a limited number of regulators, eventually to understand developmental process or tissue-specific functions.	[Takeuchi, Akihide; Nojima, Takayuki; Hagiwara, Masatoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Funct Genom, Bunkyo Ku, Tokyo, Japan; [Hosokawa, Motoyasu; Nojima, Takayuki; Hagiwara, Masatoshi] Tokyo Med & Dent Univ, Gene Express Lab, Sch Biomed Sci, Bunkyo Ku, Tokyo, Japan; [Takeuchi, Akihide; Hagiwara, Masatoshi] Kyoto Univ, Grad Sch Med, Dept Anat & Dev Biol, Sakyo Ku, Kyoto, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Kyoto University	Takeuchi, A (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Funct Genom, Bunkyo Ku, Tokyo, Japan.	m.hagiwara.end@mri.tmd.ac.jp	Takeuchi, Akihide/AAT-4675-2020	Takeuchi, Akihide/0000-0002-2781-0180; Nojima, Takayuki/0000-0003-1236-4162	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Science and Technology Agency (JST); New Energy and Industrial Technology Development Organization (NEDO); National Institute of Biomedical Innovation (NIBI)	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); National Institute of Biomedical Innovation (NIBI)(National Institute of Biomedical Innovation)	This work was supported by Grants-in-Aid for Science Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to A. T. and M. H.), Japan Science and Technology Agency (JST) (to M. H), New Energy and Industrial Technology Development Organization (NEDO) (to M. H), and the National Institute of Biomedical Innovation (NIBI) (to M. H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraniak AP, 2006, MOL CELL BIOL, V26, P1209, DOI 10.1128/MCB.26.4.1209-1222.2006; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bonano VI, 2006, RNA, V12, P2073, DOI 10.1261/rna.248506; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Carstens RP, 2000, MOL CELL BIOL, V20, P7388, DOI 10.1128/MCB.20.19.7388-7400.2000; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chen XH, 2004, CELL BIOL INT, V28, P791, DOI 10.1016/j.cellbi.2004.07.009; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Del Gatto-Konczak F, 1999, MOL CELL BIOL, V19, P251; DELGATTO F, 1995, MOL CELL BIOL, V15, P4825; Eswarakumar VP, 2002, DEVELOPMENT, V129, P3783; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; FINCH PW, 1995, DEV DYNAM, V203, P223, DOI 10.1002/aja.1002030210; GILBERT E, 1993, MOL CELL BIOL, V13, P5461, DOI 10.1128/MCB.13.9.5461; Heyd F, 2009, MOL CELL, V33, P674, DOI 10.1016/j.molcel.2009.03.001; Hovhannisyan RH, 2005, MOL CELL BIOL, V25, P250, DOI 10.1128/MCB.25.1.250-263.2005; Hovhannisyan RH, 2007, J BIOL CHEM, V282, P36265, DOI 10.1074/jbc.M704188200; Kabat JL, 2006, PLOS COMPUT BIOL, V2, P734, DOI 10.1371/journal.pcbi.0020086; KONARSKA MM, 1986, CELL, V46, P845, DOI 10.1016/0092-8674(86)90066-8; Kuroyanagi H, 2007, MOL CELL BIOL, V27, P8612, DOI 10.1128/MCB.01508-07; Kuroyanagi H, 2006, NAT METHODS, V3, P909, DOI 10.1038/NMETH944; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mauger DM, 2008, MOL CELL BIOL, V28, P5403, DOI 10.1128/MCB.00739-08; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Newman EA, 2006, RNA, V12, P1129, DOI 10.1261/rna.34906; Ohno G, 2008, GENE DEV, V22, P360, DOI 10.1101/gad.1620608; Orengo JP, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl967; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; SAVAGNER P, 1994, MOL BIOL CELL, V5, P851, DOI 10.1091/mbc.5.8.851; SAWA H, 1992, GENE DEV, V6, P244, DOI 10.1101/gad.6.2.244; Takeuchi A, 2006, J NEUROSCI, V26, P4460, DOI 10.1523/JNEUROSCI.4935-05.2006; Takeuchi A, 2003, NAT GENET, V33, P172, DOI 10.1038/ng1072; Takeuchi A, 1998, EUR J NEUROSCI, V10, P1613, DOI 10.1046/j.1460-9568.1998.00168.x; Wagner EJ, 2005, J BIOL CHEM, V280, P14017, DOI 10.1074/jbc.M414492200; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; YAN GC, 1993, MOL CELL BIOL, V13, P4513, DOI 10.1128/MCB.13.8.4513; Zahler Alan M, 2005, WormBook, P1; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	42	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10946	10.1371/journal.pone.0010946	http://dx.doi.org/10.1371/journal.pone.0010946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532173	Green Published, gold, Green Submitted			2022-12-27	WOS:000278318700017
J	Ghebremichael, S; Groenheit, R; Pennhag, A; Koivula, T; Andersson, E; Bruchfeld, J; Hoffner, S; Romanus, V; Kallenius, G				Ghebremichael, Solomon; Groenheit, Ramona; Pennhag, Alexandra; Koivula, Tuija; Andersson, Emmi; Bruchfeld, Judith; Hoffner, Sven; Romanus, Victoria; Kallenius, Gunilla			Drug Resistant Mycobacterium tuberculosis of the Beijing Genotype Does Not Spread in Sweden	PLOS ONE			English	Article							WESTERN CAPE PROVINCE; MOLECULAR EPIDEMIOLOGY; RIFAMPICIN-RESISTANCE; ISONIAZID RESISTANCE; GENOMIC DELETIONS; STRAIN FAMILY; MAJOR CAUSE; MUTATIONS; LINEAGE; PREDOMINANCE	Background: Drug resistant (DR) and multi-drug resistant (MDR) tuberculosis (TB) is increasing worldwide. In some parts of the world 10% or more of new TB cases are MDR. The Beijing genotype is a distinct genetic lineage of Mycobacterium tuberculosis, which is distributed worldwide, and has caused large outbreaks of MDR-TB. It has been proposed that certain lineages of M. tuberculosis, such as the Beijing lineage, may have specific adaptive advantages. We have investigated the presence and transmission of DR Beijing strains in the Swedish population. Methodology/Principal Findings: All DR M. tuberculosis complex isolates between 1994 and 2008 were studied. Isolates that were of Beijing genotype were investigated for specific resistance mutations and phylogenetic markers. Seventy (13%) of 536 DR strains were of Beijing genotype. The majority of the patients with Beijing strains were foreign born, and their country of origin reflects the countries where the Beijing genotype is most prevalent. Multidrug-resistance was significantly more common in Beijing strains than in non-Beijing strains. There was a correlation between the Beijing genotype and specific resistance mutations in the katG gene, the mabA-inhA-promotor and the rpoB gene. By a combined use of RD deletions, spoligotyping, IS1547, mutT gene polymorphism and Rv3135 gene analysis the Beijing strains could be divided into 11 genomic sublineages. Of the patients with Beijing strains 28 (41%) were found in altogether 10 clusters (2-5 per cluster), as defined by RFLP IS6110, while 52% of the patients with non-Beijing strains were in clusters. By 24 loci MIRU-VNTR 31 (45%) of the patients with Beijing strains were found in altogether 7 clusters (2-11 per cluster). Contact tracing established possible epidemiological linkage between only two patients with Beijing strains. Conclusions/Significance: Although extensive outbreaks with non-Beijing TB strains have occurred in Sweden, Beijing strains have not taken hold, in spite of the proximity to high prevalence countries such as Russia and the Baltic countries. The Beijing sublineages so far introduced in Sweden may not be adapted to spread in the Scandinavian population.	[Ghebremichael, Solomon; Groenheit, Ramona; Pennhag, Alexandra; Hoffner, Sven] Swedish Inst Infect Dis Control, Dept Bacteriol, Solna, Sweden; [Ghebremichael, Solomon; Groenheit, Ramona] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Koivula, Tuija] Swedish Inst Infect Dis Control, Ctr Microbiol Preparedness, Solna, Sweden; [Koivula, Tuija; Kallenius, Gunilla] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Andersson, Emmi] Karolinska Univ Hosp Huddinge, Unit Clin Microbiol F68, Stockholm, Sweden; [Bruchfeld, Judith] Karolinska Univ Hosp, Infect Dis Unit, Dept Med, Solna, Sweden; [Romanus, Victoria] Swedish Inst Infect Dis Control, Dept Epidemiol, Solna, Sweden	Swedish Institute for Infectious Disease Control; Karolinska Institutet; Swedish Institute for Infectious Disease Control; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Swedish Institute for Infectious Disease Control	Ghebremichael, S (corresponding author), Swedish Inst Infect Dis Control, Dept Bacteriol, Solna, Sweden.	gunilla.kallenius@ki.se	Källenius, Gunilla/AGZ-3956-2022; Andersson, Emmi/AAG-3350-2020	Groenheit, Ramona/0000-0003-2696-437X; Kallenius, Gunilla/0000-0002-8921-0551	Swedish Heart Lung Foundation; Swedish Research Council	Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants to Gunilla Kallenius from the Swedish Heart Lung Foundation and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anh DD, 2000, EMERG INFECT DIS, V6, P302; Bifani P, 2008, J INFECT DIS, V198, P90, DOI 10.1086/588822; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Braden CR, 2001, CLIN INFECT DIS, V33, pE42, DOI 10.1086/322635; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165, DOI 10.1164/ajrccm.164.7.2101031; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chan MY, 2001, EPIDEMIOL INFECT, V127, P169, DOI 10.1017/S0950268801005659; COLE ST, 1995, EUR RESPIR J, V8, pS701; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; Cox HS, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-134; Dahle UR, 2003, J CLIN MICROBIOL, V41, P67, DOI 10.1128/JCM.41.1.67-72.2003; Das S, 2004, INT J TUBERC LUNG D, V8, P267; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Drobniewski F, 2002, EMERG INFECT DIS, V8, P1320, DOI 10.3201/eid0811.020507; Fang ZG, 1997, J CLIN MICROBIOL, V35, P479, DOI 10.1128/JCM.35.2.479-481.1997; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Flores L, 2007, J CLIN MICROBIOL, V45, P3393, DOI 10.1128/JCM.00828-07; Frieden TR, 1996, TUBERCLE LUNG DIS, V77, P407, DOI 10.1016/S0962-8479(96)90112-4; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Ghebremichael S, 2008, MICROBES INFECT, V10, P699, DOI 10.1016/j.micinf.2008.03.006; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Glynn JR, 2005, EMERG INFECT DIS, V11, P150, DOI 10.3201/eid1101.040869; Guo HL, 2006, J MED MICROBIOL, V55, P1527, DOI 10.1099/jmm.0.46718-0; Hanekom M, 2008, J CLIN MICROBIOL, V46, P3338, DOI 10.1128/JCM.00770-08; Hanekom M, 2007, J CLIN MICROBIOL, V45, P2263, DOI 10.1128/JCM.02354-06; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Hillemann D, 2005, INT J TUBERC LUNG D, V9, P1161; Hillemann D, 2005, ANTIMICROB AGENTS CH, V49, P1229, DOI 10.1128/AAC.49.3.1229-1231.2005; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Iwamoto T, 2009, J CLIN MICROBIOL, V47, P3340, DOI 10.1128/JCM.01061-09; Jureen P, 2004, TUBERCULOSIS, V84, P311, DOI 10.1016/j.tube.2003.12.001; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kan B, 2008, INT J TUBERC LUNG D, V12, P199; Kong Y, 2006, J CLIN MICROBIOL, V44, P3940, DOI 10.1128/JCM.01146-06; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Kruuner A, 2001, J CLIN MICROBIOL, V39, P3339, DOI 10.1128/JCM.39.9.3339-3345.2001; Kubica T, 2005, INT J TUBERC LUNG D, V9, P646; Kubica T, 2004, INT J TUBERC LUNG D, V8, P1107; Li WM, 2005, INT J TUBERC LUNG D, V9, P1314; Lillebaek T, 2004, INT J TUBERC LUNG D, V8, P1001; Lillebaek T, 2003, EMERG INFECT DIS, V9, P1553, DOI 10.3201/eid0912.030276; Lipin MY, 2007, CLIN MICROBIOL INFEC, V13, P620, DOI 10.1111/j.1469-0691.2007.01711.x; Marais BJ, 2006, J CLIN MICROBIOL, V44, P3539, DOI 10.1128/JCM.01291-06; Mokrousov I, 2003, EUR J CLIN MICROBIOL, V22, P342, DOI 10.1007/s10096-003-0944-0; Mokrousov I, 2002, RES MICROBIOL, V153, P629, DOI 10.1016/S0923-2508(02)01374-8; Mokrousov I, 2002, ANTIMICROB AGENTS CH, V46, P1417, DOI 10.1128/AAC.46.5.1417-1424.2002; Mokrousov I, 2002, J CLIN MICROBIOL, V40, P1504, DOI 10.1128/JCM.40.4.1504-1507.2002; Moss AR, 1997, INT J TUBERC LUNG D, V1, P115; Musser JM, 2000, GENETICS, V155, P7; Niemann S, 2000, EMERG INFECT DIS, V6, P548, DOI 10.3201/eid0605.000518; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Nikolayevskyy VV, 2007, CLIN MICROBIOL INFEC, V13, P129, DOI 10.1111/j.1469-0691.2006.01583.x; Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07; Park YK, 2005, J MICROBIOL METH, V63, P165, DOI 10.1016/j.mimet.2005.03.002; Prammananan T, 2008, CLIN MICROBIOL INFEC, V14, P446, DOI 10.1111/j.1469-0691.2008.01951.x; Prodinger WM, 2001, EMERG INFECT DIS, V7, P483, DOI 10.3201/eid0703.017330; Puustinen K, 2003, J CLIN MICROBIOL, V41, P1525, DOI 10.1128/JCM.41.4.1525-1528.2003; Rad ME, 2003, EMERG INFECT DIS, V9, P838, DOI 10.3201/eid0907.020803; Richardson M, 2002, INT J TUBERC LUNG D, V6, P1001; Rindi L, 2009, INFECT GENET EVOL, V9, P48, DOI 10.1016/j.meegid.2008.09.006; Stavrum R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004540; Streicher EM, 2004, J CLIN MICROBIOL, V42, P891, DOI 10.1128/JCM.42.2.891-894.2004; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Suresh N, 2006, INFECT GENET EVOL, V6, P474, DOI 10.1016/j.meegid.2006.03.001; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Toungoussova OS, 2003, CLIN INFECT DIS, V37, P665, DOI 10.1086/377205; Toungoussova OS, 2002, J CLIN MICROBIOL, V40, P1930, DOI 10.1128/JCM.40.6.1930-1937.2002; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	74	45	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10893	10.1371/journal.pone.0010893	http://dx.doi.org/10.1371/journal.pone.0010893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531942	Green Submitted, gold, Green Published			2022-12-27	WOS:000278222100022
J	Lay, CC; Davis, MF; Chen-Bee, CH; Frostig, RD				Lay, Christopher C.; Davis, Melissa F.; Chen-Bee, Cynthia H.; Frostig, Ron D.			Mild Sensory Stimulation Completely Protects the Adult Rodent Cortex from Ischemic Stroke	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; RAT BARREL CORTEX; FUNCTIONAL-ORGANIZATION; INTRINSIC SIGNAL; FOCAL ISCHEMIA; INFARCT SIZE; PLASTICITY; OCCLUSION; CHLORIDE; MODEL	Despite progress in reducing ischemic stroke damage, complete protection remains elusive. Here we demonstrate that, after permanent occlusion of a major cortical artery (middle cerebral artery; MCA), single whisker stimulation can induce complete protection of the adult rat cortex, but only if administered within a critical time window. Animals that receive early treatment are histologically and behaviorally equivalent to healthy controls and have normal neuronal function. Protection of the cortex clearly requires reperfusion to the ischemic area despite permanent occlusion. Using blood flow imaging and other techniques we found evidence of reversed blood flow into MCA branches from an alternate arterial source via collateral vessels (inter-arterial connections), a potential mechanism for reperfusion. These findings suggest that the cortex is capable of extensive blood flow reorganization and more importantly that mild sensory stimulation can provide complete protection from impending stroke given early intervention. Such non-invasive, non-pharmacological intervention has clear translational potential.	[Lay, Christopher C.; Davis, Melissa F.; Chen-Bee, Cynthia H.; Frostig, Ron D.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA; [Lay, Christopher C.; Davis, Melissa F.; Frostig, Ron D.] Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92717 USA; [Frostig, Ron D.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Lay, CC (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA.	rfrostig@uci.edu		Davis, Melissa/0000-0003-2252-3075	National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS) [NS-48350, NS-55832]; University of California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055832, R01NS066001, R01NS048350] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of California(University of California System); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS) NS-48350, NS-55832, and the University of California Irvine's Faculty Mentor Program (FMP) 2009-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abookasis D, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3116709; Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Brett-Green BA, 2001, J NEUROSCI, V21, P9944, DOI 10.1523/JNEUROSCI.21-24-09944.2001; BRIERS JD, 1995, OPT COMMUN, V116, P36, DOI 10.1016/0030-4018(95)00042-7; BRINT S, 1988, J CEREBR BLOOD F MET, V8, P474, DOI 10.1038/jcbfm.1988.88; Burnett MG, 2006, STROKE, V37, P1327, DOI 10.1161/01.STR.0000217305.82123.d8; Chen-Bee CH, 2000, J NEUROSCI METH, V97, P157, DOI 10.1016/S0165-0270(00)00180-1; Chen-Bee CH, 2007, J NEUROSCI, V27, P4572, DOI 10.1523/JNEUROSCI.0326-07.2007; Chenbee CH, 1996, J NEUROPHYSIOL, V76, P884, DOI 10.1152/jn.1996.76.2.884; Choi B, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2341196; COYLE P, 1987, STROKE, V18, P1133, DOI 10.1161/01.STR.18.6.1133; Cramer SC, 2008, CURR OPIN NEUROL, V21, P76, DOI 10.1097/WCO.0b013e3282f36cb6; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195, DOI 10.1097/00004647-200103000-00002; FOX G, 1993, STROKE, V24, P2087, DOI 10.1161/01.STR.24.12.2087; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Frostig RD, 2006, CURR OPIN NEUROBIOL, V16, P445, DOI 10.1016/j.conb.2006.06.001; Frostig RD, 2009, FRONT NEUROSCI, P255; Frostig RD, 2008, J NEUROSCI, V28, P13274, DOI 10.1523/JNEUROSCI.4074-08.2008; Fuentes R, 2009, SCIENCE, V323, P1578, DOI 10.1126/science.1164901; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; Goldlust EJ, 1996, STROKE, V27, P1657, DOI 10.1161/01.STR.27.9.1657; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Lavie G, 2001, BRAIN RES, V901, P195, DOI 10.1016/S0006-8993(01)02356-3; Li P, 2008, J NEUROSCI, V28, P11970, DOI 10.1523/JNEUROSCI.3724-08.2008; LLOYDJONES D, 2009, CIRCULATION, V21, pE181; Luhmann HJ, 2005, BEHAV BRAIN RES, V157, P39, DOI 10.1016/j.bbr.2004.06.006; LUNDY EF, 1986, J PHARMACOL METHOD, V16, P201, DOI 10.1016/0160-5402(86)90042-2; MASINO SA, 1993, P NATL ACAD SCI USA, V90, P9998, DOI 10.1073/pnas.90.21.9998; Mehdiratta M, 2007, PROG CARDIOVASC DIS, V49, P430, DOI 10.1016/j.pcad.2006.12.001; MOLLER A, 2006, NEURONAL PLASTICITY; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Niiro M, 1996, J NEUROSCI METH, V64, P19, DOI 10.1016/0165-0270(95)00058-5; PARK CK, 1988, NEUROPATH APPL NEURO, V14, P289, DOI 10.1111/j.1365-2990.1988.tb00889.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Polley DB, 2004, NATURE, V429, P67, DOI 10.1038/nature02469; Polley DB, 1999, NEURON, V24, P623, DOI 10.1016/S0896-6273(00)81117-4; REIS DJ, 1991, J CEREBR BLOOD F MET, V11, P810, DOI 10.1038/jcbfm.1991.139; Sagher O, 2003, J NEUROSURG, V99, P131, DOI 10.3171/jns.2003.99.1.0131; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SCHROETER M, 1995, EXP BRAIN RES, V106, P1; SCHWARTING RKW, 1991, PSYCHOPHARMACOLOGY, V103, P19, DOI 10.1007/BF02244068; Shih AY, 2009, J CEREBR BLOOD F MET, V29, P738, DOI 10.1038/jcbfm.2008.166; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Wang-Fischer Y, 2009, MANUAL STROKE MODELS; WEI L, 1995, STROKE, V26, P1459, DOI 10.1161/01.STR.26.8.1459; Whitaker VR, 2007, J CEREBR BLOOD F MET, V27, P57, DOI 10.1038/sj.jcbfm.9600318; Xerri C, 2008, BEHAV BRAIN RES, V192, P26, DOI 10.1016/j.bbr.2008.02.038	52	48	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11270	10.1371/journal.pone.0011270	http://dx.doi.org/10.1371/journal.pone.0011270			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585659	gold, Green Published			2022-12-27	WOS:000279135400016
J	Djiane, A; Mlodzik, M				Djiane, Alexandre; Mlodzik, Marek			The Drosophila GIPC Homologue Can Modulate Myosin Based Processes and Planar Cell Polarity but Is Not Essential for Development	PLOS ONE			English	Article							PDZ DOMAIN; INTERACTING PROTEIN; C-TERMINUS; RECEPTOR; POLARIZATION; VI; DETERMINANTS; EPITHELIA; EXCLUSION; KERMIT	Epithelia often show, in addition to the ubiquitous apico-basal (A/B) axis, a polarization within the plane of the epithelium, perpendicular to the A/B axis. Such planar cell polarity (PCP) is for example evident in the regular arrangement of the stereocilia in the cochlea of the mammalian inner ear or in (almost) all Drosophila adult external structures. GIPCs (GAIP interacting protein, C terminus) were first identified in mammals and bind to the G alpha i GTPase activating protein RGS-GAIP. They have been proposed to act in a G-protein coupled complex controlling vesicular trafficking. Although GIPCs have been found to bind to numerous proteins including Frizzled receptors, which participate in PCP establishment, there is little in vivo evidence for the functional role(s) of GIPCs. We show here that overexpressed Drosophila dGIPC alters PCP generation in the wing. We were however unable to find any binding between dGIPC and the Drosophila receptors Fz1 and Fz2. The effect of overexpressed dGIPC is likely due to an effect on the actin cytoskeleton via myosins, since it is almost entirely suppressed by removing a genomic copy of the Myosin VI/jaguar gene. Surprisingly, although dGIPC can interfere with PCP generation and myosin based processes, the complete loss-of-function of dGIPC gives viable adults with no PCP or other detectable defects arguing for a non-essential role of dGIPC in viability and normal Drosophila development.	[Djiane, Alexandre] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Mlodzik, Marek] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY USA	University of Cambridge; Icahn School of Medicine at Mount Sinai	Djiane, A (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	marek.mlodzik@mssm.edu		Djiane, Alexandre/0000-0001-6210-2713	National Institutes of Health [RO1 GM62917]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health grant RO1 GM62917. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Aschenbrenner L, 2003, MOL BIOL CELL, V14, P2728, DOI 10.1091/mbc.E02-11-0767; Barros CS, 2003, DEV CELL, V5, P829, DOI 10.1016/S1534-5807(03)00359-9; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; Djiane A, 2000, DEVELOPMENT, V127, P3091; Djiane A, 2005, CELL, V121, P621, DOI 10.1016/j.cell.2005.03.014; Eaton S, 1997, CURR OPIN CELL BIOL, V9, P860, DOI 10.1016/S0955-0674(97)80089-0; El Mourabit H, 2002, MATRIX BIOL, V21, P207, DOI 10.1016/S0945-053X(01)00198-6; Feiguin F, 2001, DEV CELL, V1, P93, DOI 10.1016/S1534-5807(01)00010-7; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; Hirakawa T, 2003, J BIOL CHEM, V278, P49348, DOI 10.1074/jbc.M306557200; Hu LYA, 2003, J BIOL CHEM, V278, P26295, DOI 10.1074/jbc.M212352200; Katoh M, 2002, INT J MOL MED, V9, P585; Kearney JB, 2004, DEV BIOL, V275, P473, DOI 10.1016/j.ydbio.2004.08.047; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Ligensa T, 2001, J BIOL CHEM, V276, P33419, DOI 10.1074/jbc.M104509200; Morrison JK, 2008, GENETICS, V179, P711, DOI 10.1534/genetics.107.085969; Myster SH, 2003, J CELL BIOL, V160, P433, DOI 10.1083/jcb.200211083; Petritsch C, 2003, DEV CELL, V4, P273, DOI 10.1016/S1534-5807(03)00020-0; Rorth P, 1998, DEVELOPMENT, V125, P1049; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Tan C, 2001, DEVELOPMENT, V128, P3665; Toba G, 1999, GENETICS, V151, P725; Valdembri D, 2009, PLOS BIOL, V7, P115, DOI 10.1371/journal.pbio.1000025; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; Wang LH, 1999, J BIOL CHEM, V274, P14137, DOI 10.1074/jbc.274.20.14137; Wu JL, 2006, DEVELOPMENT, V133, P3651, DOI 10.1242/dev.02547	29	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11228	10.1371/journal.pone.0011228	http://dx.doi.org/10.1371/journal.pone.0011228			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574526	Green Submitted, Green Published, gold			2022-12-27	WOS:000279058300017
J	Yew, NS; Zhao, HM; Hong, EG; Wu, IH; Przybylska, M; Siegel, C; Shayman, JA; Arbeeny, CM; Kim, JK; Jiang, CW; Cheng, SH				Yew, Nelson S.; Zhao, Hongmei; Hong, Eun-Gyoung; Wu, I-Huan; Przybylska, Malgorzata; Siegel, Craig; Shayman, James A.; Arbeeny, Cynthia M.; Kim, Jason K.; Jiang, Canwen; Cheng, Seng H.			Increased Hepatic Insulin Action in Diet-Induced Obese Mice Following Inhibition of Glucosylceramide Synthase	PLOS ONE			English	Article							GANGLIOSIDE GM3; ADIPOSE-TISSUE; RESISTANCE; SENSITIVITY; STEATOSIS; LIVER; MECHANISMS; MEDIATORS; MUSCLE	Background: Obesity is characterized by the accumulation of fat in the liver and other tissues, leading to insulin resistance. We have previously shown that a specific inhibitor of glucosylceramide synthase, which inhibits the initial step in the synthesis of glycosphingolipids (GSLs), improved glucose metabolism and decreased hepatic steatosis in both ob/ob and diet-induced obese (DIO) mice. Here we have determined in the DIO mouse model the efficacy of a related small molecule compound, Genz-112638, which is currently being evaluated clinically for the treatment of Gaucher disease, a lysosomal storage disorder. Methodology/Principal Findings: DIO mice were treated with the Genz-112638 for 12 to 16 weeks by daily oral gavage. Genz-112638 lowered HbA1c levels and increased glucose tolerance. Whole body adiposity was not affected in normal mice, but decreased in drug-treated obese mice. Drug treatment also significantly lowered liver triglyceride levels and reduced the development of hepatic steatosis. We performed hyperinsulinemic-euglycemic clamps on the DIO mice treated with Genz-112638 and showed that insulin-mediated suppression of hepatic glucose production increased significantly compared to the placebo treated mice, indicating a marked improvement in hepatic insulin sensitivity. Conclusions/Significance: These results indicate that GSL inhibition in obese mice primarily results in an increase in insulin action in the liver, and suggests that GSLs may have an important role in hepatic insulin resistance in conditions of obesity.	[Yew, Nelson S.; Zhao, Hongmei; Wu, I-Huan; Przybylska, Malgorzata; Siegel, Craig; Arbeeny, Cynthia M.; Jiang, Canwen; Cheng, Seng H.] Genzyme Corp, Framingham, MA 01701 USA; [Hong, Eun-Gyoung; Kim, Jason K.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Hong, Eun-Gyoung] Hallym Univ, Coll Med, Dept Endocrinol & Med, Seoul, South Korea; [Shayman, James A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA	Sanofi-Aventis; Genzyme Corporation; Yale University; Hallym University; University of Michigan System; University of Michigan; University of Massachusetts System; University of Massachusetts Worcester	Yew, NS (corresponding author), Genzyme Corp, Framingham, MA 01701 USA.	nelson.yew@genzyme.com	Cheng, Seng H/AAC-6564-2022	Kim, Jason/0000-0002-7185-042X	Genzyme Corporation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080756, R01DK055823] Funding Source: NIH RePORTER	Genzyme Corporation(Sanofi-AventisGenzyme Corporation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Genzyme Corporation. Genzyme had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; BIJL N, 2009, HEPATOLOGY; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Buse JB, 2003, WILLIAMS TXB ENDOCRI, P1427; Edgerton DS, 2009, FRONT BIOSCI-LANDMRK, V14, P1169, DOI 10.2741/3301; Girard J, 2006, J CLIN INVEST, V116, P302, DOI 10.1172/JCI27743; Glaros EN, 2007, BIOCHEM PHARMACOL, V73, P1340, DOI 10.1016/j.bcp.2006.12.023; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Home PD, 2008, DIABETES OBES METAB, V10, P699, DOI 10.1111/j.1463-1326.2007.00761.x; Inokuchi J, 2006, BIOL PHARM BULL, V29, P1532, DOI 10.1248/bpb.29.1532; Iyer A, 2010, NAT REV ENDOCRINOL, V6, P71, DOI 10.1038/nrendo.2009.264; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kasahara K, 2000, GLYCOCONJUGATE J, V17, P153, DOI 10.1023/A:1026576804247; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Langeveld M, 2009, PROG LIPID RES, V48, P196, DOI 10.1016/j.plipres.2009.03.002; Lee L, 1999, J BIOL CHEM, V274, P14662, DOI 10.1074/jbc.274.21.14662; McEachern KA, 2007, MOL GENET METAB, V91, P259, DOI 10.1016/j.ymgme.2007.04.001; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Tagami S, 2002, J BIOL CHEM, V277, P3085, DOI 10.1074/jbc.M103705200; TURINSKY J, 1990, J BIOL CHEM, V265, P16880; van Eijk M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004723; Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719; Zhao HM, 2009, HEPATOLOGY, V50, P85, DOI 10.1002/hep.22970	28	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11239	10.1371/journal.pone.0011239	http://dx.doi.org/10.1371/journal.pone.0011239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574539	Green Submitted, Green Published, gold			2022-12-27	WOS:000279058300023
J	Zhou, KY; Wang, GT; Wang, YR; Jin, HH; Yang, SX; Liu, CB				Zhou, Keiyu; Wang, Guangtao; Wang, Yirong; Jin, Hanghuang; Yang, Shuxu; Liu, Chibo			The Potential Involvement of E-cadherin and beta-catenins in Meningioma	PLOS ONE			English	Article							BRAIN EDEMA; EXPRESSION; COMPLEX; GENE	Objective: To investigate the potential involvements of E-cadherin and beta-catenin in meningioma. Methods: Immunohistochemistry staining was performed on samples from patients with meningioma. The results were graded according to the positive ratio and intensity of tissue immunoreactivity. The expression of E-cadherin and beta-catenin in meningioma was analyzed by its relationship with WHO2007 grading, invasion, peritumoral edema and postoperative recurrence. Results: The positive rates of E-cadherin in meningioma WHO I, II, III were 92.69%, 33.33% and 0, respectively, (P<0.05); while the positive rates of beta-catenin in meningioma WHO I, II, III were 82.93%, 33.33% and 20.00%, respectively, (P<0.05). The positive rate of E-cadherin in meningioma without invasion (94.12%) was higher than that with invasion (46.67%) (P<0.05). The difference in the positive rate of beta-catenin between meningioma without invasion (88.24%) and meningioma with invasion (33.33%, P<0.05) was also statically significant. The positive rates of beta-cadherin in meningioma with peritumoral edema 0, 1, 2, 3 were 93.75%, 85.71%, 60.00% and 0 respectively, (P<0.05); the positive rates of beta-catenin in meningioma with peritumoral edema 0, 1, 2, 3 were 87.50%, 85.71%, 30.00% and 0 respectively, (P<0.01). The positive rates of E-cadherin in meningioma with postoperative recurrence were 33.33%, and the positive rate with postoperative non-recurrence was 90.00% (P<0.01). The positive rates of beta-catenin in meningioma with postoperative recurrence and non-recurrence were 11.11%, 85.00%, respectively (P<0.01). Conclusion: The expression levels of E-cadherin and beta-catenin correlated closely to the WHO 2007 grading criteria for meningioma. In atypical or malignant meningioma, the expression levels of E-cadherin and beta-catenin were significantly lower. The expression levels of E-cadherin and beta-catenin were also closely correlated with the invasion status of meningioma, the size of the peritumoral edema and the recurrent probabilities of the meningioma, all in an inverse correlationship. Taken together, the present study provided novel molecular targets in clinical treatments to meningioma.	[Zhou, Keiyu; Wang, Guangtao; Jin, Hanghuang] Taizhou Univ, Affiliated Taizhou Municipal Hosp, Dept Neurosurg, Taizhou, Peoples R China; [Wang, Yirong; Yang, Shuxu] Zhejiang Univ, Coll Med Sci, Dept Neurosurg, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Chibo] Taizhou Univ, Affiliated Taizhou Municipal Hosp, Dept Lab Med, Taizhou, Peoples R China	Taizhou University; Zhejiang University; Taizhou University	Zhou, KY (corresponding author), Taizhou Univ, Affiliated Taizhou Municipal Hosp, Dept Neurosurg, Taizhou, Peoples R China.	liuchibo@126.com			Affiliated Taizhou Municipal Hospital	Affiliated Taizhou Municipal Hospital	The study was supported by The Affiliated Taizhou Municipal Hospital.	Akat K, 2008, CELL TISSUE RES, V331, P401, DOI 10.1007/s00441-007-0512-5; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Asano K, 2004, J NEURO-ONCOL, V70, P3, DOI 10.1023/B:NEON.0000040811.14908.f2; BERX G, 1995, GENOMICS, V26, P281, DOI 10.1016/0888-7543(95)80212-5; Brunner EC, 2006, HISTOPATHOLOGY, V49, P178, DOI 10.1111/j.1365-2559.2006.02440.x; Curtis MW, 2008, CELL COMMUN ADHES, V15, P365, DOI 10.1080/15419060802460748; Durand A, 2008, CLIN NEUROPATHOL, V27, P334; Ellison DW, 2005, J CLIN ONCOL, V23, P7951, DOI 10.1200/JCO.2005.01.5479; Erdemir F, 2007, INT UROL NEPHROL, V39, P1031, DOI 10.1007/s11255-006-9159-5; Goldman CK, 1997, NEUROSURGERY, V40, P1269, DOI 10.1097/00006123-199706000-00029; Guzman P, 2006, REV MED CHILE, V134, P1002; Jagannathan J, 2008, SKULL BASE-INTERD AP, V18, P173, DOI 10.1055/s-2007-1003925; Klaeboe L, 2005, INT J CANCER, V117, P996, DOI 10.1002/ijc.21255; Marosi C, 2008, CRIT REV ONCOL HEMAT, V67, P153, DOI 10.1016/j.critrevonc.2008.01.010; Metindir J, 2008, EUR J GYNAECOL ONCOL, V29, P489; Motta FJN, 2008, GENET MOL RES, V7, P295, DOI 10.4238/vol7-2gmr424; Pokutta S, 2008, BIOCHEM SOC T, V36, P141, DOI 10.1042/BST0360141; Restucci B, 2007, ANTICANCER RES, V27, P3083; Shimada S, 2005, PATHOL INT, V55, P1, DOI 10.1111/j.1440-1827.2005.01786.x; Simis A, 2008, SURG NEUROL, V70, P471, DOI 10.1016/j.surneu.2008.03.006; Stemmler MP, 2008, MOL BIOSYST, V4, P835, DOI 10.1039/b719215k; Utsuki S, 2005, CLIN NEUROPATHOL, V24, P8; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Zidar N, 2008, VIRCHOWS ARCH, V453, P267, DOI 10.1007/s00428-008-0649-y	24	45	47	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11231	10.1371/journal.pone.0011231	http://dx.doi.org/10.1371/journal.pone.0011231			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574529	Green Submitted, Green Published, gold			2022-12-27	WOS:000279058300018
J	Horney, JA; Moore, Z; Davis, M; MacDonald, PDM				Horney, Jennifer A.; Moore, Zack; Davis, Meredith; MacDonald, Pia D. M.			Intent to Receive Pandemic Influenza A (H1N1) Vaccine, Compliance with Social Distancing and Sources of Information in NC, 2009	PLOS ONE			English	Article								Background: Public adherence to influenza vaccination recommendations has been low, particularly among younger adults and children under 2, despite the availability of safe and effective seasonal vaccine. Intention to receive 2009 pandemic influenza A (H1N1) vaccine has been estimated to be 50% in select populations. This report measures knowledge of and intention to receive pandemic vaccine in a population-based setting, including target groups for seasonal and H1N1 influenza. Methodology and Principal Findings: On August 28-29, 2009, we conducted a population-based survey in 2 counties in North Carolina. The survey used the 3067 two-stage cluster sampling methodology to identify 210 target households. Prevalence ratios (PR) and 95% confidence intervals (CI) were estimated. Knowledge of pandemic influenza A (H1N1) vaccine was high, with 165 (80%) aware that a vaccine was being prepared. A total of 133 (64%) respondents intended to receive pandemic vaccine, 134 (64%) intended to receive seasonal vaccine, and 109 (53%) intended to receive both. Reporting great concern about H1N1 infection (PR 1.55; 95% CI: 1.30, 1.85), receiving seasonal influenza vaccine in 2008-09 (PR 1.47; 95% CI: 1.18, 1.82), and intending to receive seasonal influenza vaccine in 2009-10 (PR 1.27; 95% CI: 1.14, 1.42) were associated with intention to receive pandemic vaccine. Not associated were knowledge of vaccine, employment, having children under age 18, gender, race/ethnicity and age. Reasons cited for not intending to get vaccinated include not being at risk for infection, concerns about vaccine side effects and belief that illness caused by pandemic H1N1 would be mild. Forty-five percent of households with children under 18 and 65% of working adults reported ability to comply with self-isolation at home for 7-10 days if recommended by authorities. Conclusions and Significance: This is the first report of a population based rapid assessment used to assess knowledge and intent to receive pandemic vaccine in a community sample. Intention to receive pandemic and seasonal vaccines was higher than previously published reports. To reach persons not intending to receive pandemic vaccine, public health communications should focus on the perceived risk of infection and concerns about vaccine safety.	[Horney, Jennifer A.; MacDonald, Pia D. M.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Moore, Zack] N Carolina Div Publ Hlth, Raleigh, NC USA; [Davis, Meredith] N Carolina Inst Publ Hlth, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill	Horney, JA (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA.	jen.horney@unc.edu	Horney, Jennifer/ABG-2433-2020	Horney, Jennifer/0000-0003-3060-0894; MacDonald, Pia/0000-0003-1340-8905	Robert Wood Johnson Foundation (RWJF)	Robert Wood Johnson Foundation (RWJF)(Robert Wood Johnson Foundation (RWJF))	This publication was supported by a quick strike grant from the Robert Wood Johnson Foundation (RWJF) as part of the Public Health Practice Based Research Networks (http://www.rwjf.org/). The contents are solely the responsibility of the authors and do not necessarily represent official views of RWJF. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AS, 1999, INT J QUAL HEALTH C, V11, P187, DOI 10.1093/intqhc/11.3.187; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; BLENDON RJ, 2009, SURVEY FINDS JUST 40; *CDCP, 2009, GEN INF 2009 H1N1 VA; *CDCP, 2009, INFL SELF REP VACC C; *CDCP, 2006, EST INFL VACC TARG P; *CDCP, 2009, GUID STAT LOC HLTH O; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Euler G. L., 2009, Morbidity and Mortality Weekly Report, V58, P1091; Frerichs RR, 2001, ANNU REV PUBL HEALTH, V22, P231, DOI 10.1146/annurev.publhealth.22.1.231; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; HENDERSON RH, 1973, B WORLD HEALTH ORGAN, V48, P183; Henrich N, 2009, Emerg Health Threats J, V2, pe8, DOI 10.3134/ehtj.09.008; Lemeshow S, 1985, World Health Stat Q, V38, P65; Malilay J, 1996, B WORLD HEALTH ORGAN, V74, P399; Maurer J, 2009, VACCINE, V27, P5732, DOI 10.1016/j.vaccine.2009.07.080; Moore Z., 2009, Morbidity and Mortality Weekly Report, V58, P1401; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Seale H, 2009, MED J AUSTRALIA, V191, P267, DOI 10.5694/j.1326-5377.2009.tb02781.x	19	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11226	10.1371/journal.pone.0011226	http://dx.doi.org/10.1371/journal.pone.0011226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	613KE	20585462	Green Published, gold			2022-12-27	WOS:000278977200019
J	Lotoski, LC; Simons, FER; Chooniedass, R; Liem, J; Ostopowich, I; Becker, AB; HayGlass, KT				Lotoski, Larisa C.; Simons, F. Estelle R.; Chooniedass, Rishma; Liem, Joel; Ostopowich, Isha; Becker, Allan B.; HayGlass, Kent T.			Are Plasma IL-10 Levels a Useful Marker of Human Clinical Tolerance in Peanut Allergy?	PLOS ONE			English	Article							FOOD HYPERSENSITIVITY; SERUM INTERLEUKIN-10; CELLS; PREVALENCE; CHILDREN; SENSITIZATION; ASSOCIATION; ANAPHYLAXIS; DERMATITIS; BIOMARKERS	Background: Food allergies are a major component of the burden of allergic disease. Accurate risk assessment for prediction of future clinical reactivity or clinical tolerance is limited by currently available techniques. Recent studies suggest that constitutively elevated global serum levels of IL-10, a cytokine that down-regulates both Th1 and Th2 cytokine production, may be useful in identifying human clinical tolerance to foods. Objective: Determine the usefulness of constitutive IL-10 levels as a marker of clinical tolerance to peanut in children and adults. Methodology/Principal Findings: 107 subjects who were clinically tolerant to peanut and 94 subjects who were clinically allergic to peanut participated. Plasma was analyzed via ELISA to quantify the frequency of individuals with constitutive IL-10 levels and the intensity of those responses. The data were then stratified by age, gender and clinical status to assess the utility of this putative biomarker in specific at-risk groups. All 201 subjects had readily quantified plasma IL-10. Levels were no higher in subjects who were clinically tolerant to peanut than those in individuals clinically allergic to peanut. Stratification by age, gender or both did not improve the capacity of IL-10 levels to identify clinical tolerance to peanut. Conclusions/Significance: Plasma IL-10 levels are neither a useful biomarker of clinical tolerance to peanut nor a potential tool for identification of clinical tolerance to peanut in humans.	[Lotoski, Larisa C.; Simons, F. Estelle R.; Ostopowich, Isha; Becker, Allan B.; HayGlass, Kent T.] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Simons, F. Estelle R.; Chooniedass, Rishma; Becker, Allan B.; HayGlass, Kent T.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada; [Liem, Joel] Windsor Allergy Asthma Educ Ctr, Windsor, ON, Canada	University of Manitoba; University of Manitoba	Lotoski, LC (corresponding author), Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.	hayglass@cc.umanitoba.ca		HayGlass, Kent/0000-0002-4621-7737	AllerGen NCE; Canadian Institutes for Health Research (CIHR)	AllerGen NCE; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Funded by operating grants and a studentship from AllerGen NCE and the Canadian Institutes for Health Research (CIHR). K. T. H. holds the Canada Research Chair in Immune Regulation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 2009, J ALLERGY CLIN IMMUN, V123, P735, DOI 10.1016/j.jaci.2009.02.030; Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Alonso R, 2007, ALLERGY, V62, P710, DOI 10.1111/j.1398-9995.2007.01333.x; Ben-Shoshan M, 2009, J ALLERGY CLIN IMMUN, V123, P783, DOI 10.1016/j.jaci.2009.02.004; Bock SA, 2007, J ALLERGY CLIN IMMUN, V119, P1016, DOI 10.1016/j.jaci.2006.12.622; Borekci B, 2007, AM J REPROD IMMUNOL, V58, P56, DOI 10.1111/j.1600-0897.2007.00491.x; Burks AW, 2008, LANCET, V371, P1538, DOI 10.1016/S0140-6736(08)60659-5; Campbell JD, 2009, J EXP MED, V206, P1535, DOI 10.1084/jem.20082901; Chun HY, 2007, J CLIN IMMUNOL, V27, P461, DOI 10.1007/s10875-007-9104-0; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Hourihane JO, 2005, CLIN EXP ALLERGY, V35, P1227, DOI 10.1111/j.1365-2222.2005.02312.x; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Jensen-Jarolim E, 2008, ALLERGY, V63, P610, DOI 10.1111/j.1398-9995.2008.01645.x; LeBovidge JS, 2009, J ALLERGY CLIN IMMUN, V124, P1282, DOI 10.1016/j.jaci.2009.08.045; Meiler F, 2008, J EXP MED, V205, P2887, DOI 10.1084/jem.20080193; Mortz CG, 2005, PEDIAT ALLERG IMM-UK, V16, P501, DOI 10.1111/j.1399-3038.2005.00302.x; Nakazato J, 2008, PEDIAT ALLERG IMM-UK, V19, P605, DOI 10.1111/j.1399-3038.2007.00692.x; Niggemann B, 2010, ALLERGY, V65, P2, DOI 10.1111/j.1398-9995.2009.02170.x; Ostblom E, 2008, ALLERGY, V63, P211, DOI 10.1111/j.1398-9995.2007.01559.x; Pereira B, 2005, J ALLERGY CLIN IMMUN, V116, P884, DOI 10.1016/j.jaci.2005.05.047; Qiao HL, 2007, EUR J CLIN PHARMACOL, V63, P263, DOI 10.1007/s00228-006-0245-5; SALKIE ML, 1984, CLIN BIOCHEM, V17, P362, DOI 10.1016/S0009-9120(84)90734-3; Sampson HA, 2001, J ALLERGY CLIN IMMUN, V107, P891, DOI 10.1067/mai.2001.114708; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schaub S, 2009, AM J TRANSPLANT, V9, P1347, DOI 10.1111/j.1600-6143.2009.02645.x; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, pS116, DOI 10.1016/j.jaci.2009.08.028; Simons FER, 2007, J ALLERGY CLIN IMMUN, V120, pS2, DOI [10.1016/j.jaci.2007.05.001, 10.1016/j.jaci.2007.05.016]; Stefura William P., 2008, V138, P107, DOI 10.1007/978-1-59745-366-0_10; Stone SF, 2009, J ALLERGY CLIN IMMUN, V124, P786, DOI 10.1016/j.jaci.2009.07.055; Summers CW, 2008, J ALLERGY CLIN IMMUN, V121, P632, DOI 10.1016/j.jaci.2007.12.003; Venter C, 2010, ALLERGY, V65, P103, DOI 10.1111/j.1398-9995.2009.02176.x; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901; Zhou XY, 2009, CURR OPIN IMMUNOL, V21, P281, DOI 10.1016/j.coi.2009.05.007	33	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11192	10.1371/journal.pone.0011192	http://dx.doi.org/10.1371/journal.pone.0011192			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567520	Green Published, Green Submitted, gold			2022-12-27	WOS:000278886300030
J	Rosenblum, G; Van den Steen, PE; Cohen, SR; Bitler, A; Brand, DD; Opdenakker, G; Sagi, I				Rosenblum, Gabriel; Van den Steen, Philippe E.; Cohen, Sidney R.; Bitler, Arkady; Brand, David D.; Opdenakker, Ghislain; Sagi, Irit			Direct Visualization of Protease Action on Collagen Triple Helical Structure	PLOS ONE			English	Article							CYANOGEN-BROMIDE PEPTIDES; CHICK CARTILAGE COLLAGEN; ATOMIC-FORCE MICROSCOPY; MATRIX METALLOPROTEINASES; GELATINASE-A; INTERSTITIAL COLLAGENASE; OSTEOGENESIS IMPERFECTA; NEUTROPHIL COLLAGENASE; SUBSTRATE-SPECIFICITY; CLEAVAGE	Enzymatic processing of extracellular matrix (ECM) macromolecules by matrix metalloproteases (MMPs) is crucial in mediating physiological and pathological cell processes. However, the molecular mechanisms leading to effective physiological enzyme-ECM interactions remain elusive. Only scant information is available on the mode by which matrix proteases degrade ECM substrates. An example is the enzymatic degradation of triple helical collagen II fragments, generated by the collagenase MMP-8 cleavage, during the course of acute inflammatory conditions by gelatinase B/MMP-9. As is the case for many other matrix proteases, it is not clear how MMP-9 recognizes, binds and digests collagen in this important physiological process. We used single molecule imaging to directly visualize this protease during its interaction with collagen fragments. We show that the initial binding is mediated by the diffusion of the protease along the ordered helix on the collagen L fragment, with preferential binding of the collagen tail. As the reaction progressed and prior to collagen degradation, gelatin-like morphologies resulting from the denaturation of the triple helical collagen were observed. Remarkably, this activity was independent of enzyme proteolysis and was accompanied by significant conformational changes of the working protease. Here we provide the first direct visualization of highly complex mechanisms of macromolecular interactions governing the enzymatic processing of ECM substrates by physiological protease.	[Rosenblum, Gabriel; Sagi, Irit] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Van den Steen, Philippe E.; Opdenakker, Ghislain] Univ Leuven, Immunobiol Lab, Rega Inst Med Res, Leuven, Belgium; [Cohen, Sidney R.; Bitler, Arkady] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel; [Brand, David D.] Univ Tennessee, Hlth Sci Ctr, Dept Vet Affairs, Memphis, TN USA	Weizmann Institute of Science; KU Leuven; Weizmann Institute of Science; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Rosenblum, G (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	irit.sagi@weizmann.ac.il	Cohen, Sidney R./J-7153-2012; Opdenakker, Ghislain/Q-3130-2017; Van den Steen, Philippe E/K-5132-2012; Opdenakker, Ghislain/V-8562-2019	Cohen, Sidney R./0000-0003-4255-3351; Opdenakker, Ghislain/0000-0003-1714-2294; Van den Steen, Philippe E/0000-0002-7334-9145; Opdenakker, Ghislain/0000-0003-1714-2294; Brand, David/0000-0002-9260-7963	Israel Science Foundation; Kimmelman Center at the Weizmann Institute; Ambach family fund; Geconcerteerde OnderzoeksActies [GOA 2007-2011]; Scientific Research-Flanders (FWO-Vlaanderen); Excellence Financing, Belgium [EF 05/015]	Israel Science Foundation(Israel Science Foundation); Kimmelman Center at the Weizmann Institute; Ambach family fund; Geconcerteerde OnderzoeksActies; Scientific Research-Flanders (FWO-Vlaanderen)(FWO); Excellence Financing, Belgium	This work is supported by the Israel Science Foundation, the Kimmelman Center at the Weizmann Institute, the Ambach family fund and by the Geconcerteerde OnderzoeksActies (GOA 2007-2011), the Fund for Scientific Research-Flanders (FWO-Vlaanderen) and Excellence Financing (EF 05/015), Belgium. P.V.d.S. is a postdoctoral researcher of the FWO-Vlaanderen. I. S. is the incumbent of the Pontecorvo professorial chair. The authors acknowledge support of the Gerhard Schmidt Minerva center for supramolecular architectures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Bozec L, 2005, BIOPHYS J, V88, P4223, DOI 10.1529/biophysj.104.055228; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Collier IE, 2001, BIOPHYS J, V81, P2370, DOI 10.1016/S0006-3495(01)75883-3; Coussens LM, 1996, CHEM BIOL, V3, P895, DOI 10.1016/S1074-5521(96)90178-7; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Geurts N, 2008, BIOCHEMISTRY-US, V47, P2689, DOI 10.1021/bi702260q; Gioia M, 2007, J MOL BIOL, V368, P1101, DOI 10.1016/j.jmb.2007.02.076; Gioia M, 2009, J MOL BIOL, V386, P419, DOI 10.1016/j.jmb.2008.12.021; HASTY KA, 1987, J BIOL CHEM, V262, P10048; JENNESS DD, 1976, BIOPOLYMERS, V15, P513, DOI 10.1002/bip.1976.360150308; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454; Kramer RZ, 2001, J MOL BIOL, V311, P131, DOI 10.1006/jmbi.2001.4849; Kuznetsova NV, 2003, J MOL BIOL, V331, P191, DOI 10.1016/S0022-2836(03)00715-0; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; Makareeva E, 2008, J BIOL CHEM, V283, P4787, DOI 10.1074/jbc.M705773200; MASURE S, 1991, EUR J BIOCHEM, V198, P391, DOI 10.1111/j.1432-1033.1991.tb16027.x; MILLER EJ, 1971, BIOCHEMISTRY-US, V10, P3030, DOI 10.1021/bi00792a007; Minond D, 2007, BIOCHEMISTRY-US, V46, P3724, DOI 10.1021/bi062199j; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R; O'Farrell TJ, 1998, ARCH BIOCHEM BIOPHYS, V354, P24, DOI 10.1006/abbi.1998.0662; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Ottl J, 2000, CHEM BIOL, V7, P119, DOI 10.1016/S1074-5521(00)00077-6; Overall CM, 2007, STRUCTURE, V15, P1159, DOI 10.1016/j.str.2007.10.001; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Pelman GR, 2005, J BIOL CHEM, V280, P2370, DOI 10.1074/jbc.M409603200; RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0; Rosenblum G, 2007, STRUCTURE, V15, P1227, DOI 10.1016/j.str.2007.07.019; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; SELAPASSWELL N, 2009, BIOCH BIOPHYS ACTA; Sun HB, 2000, ANAL BIOCHEM, V283, P153, DOI 10.1006/abio.2000.4629; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Van Den Steen PE, 2002, FASEB J, V16, DOI 10.1096/fj.01-0688com; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; WELGUS HG, 1981, J BIOL CHEM, V256, P9511; Xu XP, 2005, BIOCHEM J, V392, P127, DOI 10.1042/BJ20050650; YONATH A, 1975, FEBS LETT, V57, P93, DOI 10.1016/0014-5793(75)80159-1	44	56	57	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11043	10.1371/journal.pone.0011043	http://dx.doi.org/10.1371/journal.pone.0011043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585385	Green Published, Green Submitted, gold			2022-12-27	WOS:000278886100005
J	Bower, NI; Johnston, IA				Bower, Neil I.; Johnston, Ian A.			Transcriptional Regulation of the IGF Signaling Pathway by Amino Acids and Insulin-Like Growth Factors during Myogenesis in Atlantic Salmon	PLOS ONE			English	Article							MUSCLE-CELL DIFFERENTIATION; TROUT ONCORHYNCHUS-MYKISS; FACTOR BINDING PROTEIN-5; FACTOR-II RECEPTOR; SKELETAL-MUSCLE; GENE-EXPRESSION; IN-VITRO; PHOSPHATIDYLINOSITOL 3-KINASE; MESSENGER-RNA; C2C12 MYOBLASTS	The insulin-like growth factor signalling pathway is an important regulator of skeletal muscle growth. We examined the mRNA expression of components of the insulin-like growth factor (IGF) signalling pathway as well as Fibroblast Growth Factor 2 (FGF2) during maturation of myotubes in primary cell cultures isolated from fast myotomal muscle of Atlantic salmon (Salmo salar). The transcriptional regulation of IGFs and IGFBP expression by amino acids and insulin-like growth factors was also investigated. Proliferation of cells was 15% d(-1) at days 2 and 3 of the culture, increasing to 66% d(-1) at day 6. Three clusters of elevated gene expression were observed during the maturation of the culture associated with mono-nucleic cells (IGFBP5.1 and 5.2, IGFBP-6, IGFBP-rP1, IGFBP-2.2 and IGF-II), the initial proliferation phase (IGF-I, IGFBP-4, FGF2 and IGF-IRb) and terminal differentiation and myotube production (IGF2R, IGF-IRa). In cells starved of amino acids and serum for 72 h, IGF-I mRNA decreased 10-fold which was reversed by amino acid replacement. Addition of IGF-I and amino acids to starved cells resulted in an 18-fold increase in IGF-I mRNA indicating synergistic effects and the activation of additional pathway(s) leading to IGF-I production via a positive feedback mechanism. IGF-II, IGFBP-5.1 and IGFBP-5.2 expression was unchanged in starved cells, but increased with amino acid replacement. Synergistic increases in expression of IGFBP5.2 and IGFBP-4, but not IGFBP5.1 were observed with addition of IGF-I, IGF-II or insulin and amino acids to the medium. IGF-I and IGF-II directly stimulated IGFBP-6 expression, but not when amino acids were present. These findings indicate that amino acids alone are sufficient to stimulate myogenesis in myoblasts and that IGF-I production is controlled by both endocrine and paracrine pathways. A model depicting the transcriptional regulation of the IGF pathway in Atlantic salmon muscle following feeding is proposed.	[Bower, Neil I.; Johnston, Ian A.] Univ St Andrews, Scottish Oceans Inst, Sch Biol, St Andrews, Fife, Scotland	University of St Andrews	Bower, NI (corresponding author), Univ St Andrews, Scottish Oceans Inst, Sch Biol, St Andrews, Fife, Scotland.	nib@st-andrews.ac.uk	Johnston, Ian A./AAE-2044-2019; Johnston, Ian A/D-6592-2013; Bower, Neil/K-1478-2014	Johnston, Ian A/0000-0002-7796-5754; Bower, Neil/0000-0002-6764-6063	Biotechnology and Biological Research Council [BB/D015391/1]; Biotechnology and Biological Sciences Research Council [BB/D015391/1] Funding Source: researchfish; BBSRC [BB/D015391/1] Funding Source: UKRI	Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a grant from the Biotechnology and Biological Research Council (grant BB/D015391/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Jaquez HA, 2009, MOL CELL BIOL, V29, P4308, DOI 10.1128/MCB.01665-08; Adams GR, 2006, APPL PHYSIOL NUTR ME, V31, P782, DOI 10.1139/h06-053; Allendorf F.W., 1984, P1; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Anthony JC, 2000, J NUTR, V130, P2413; Atherton PJ, 2010, AMINO ACIDS, V38, P1533, DOI 10.1007/s00726-009-0377-x; Bach LA, 2005, GROWTH HORM IGF RES, V15, P185, DOI 10.1016/j.ghir.2005.04.001; BAILEY GS, 1978, P NATL ACAD SCI USA, V75, P5575, DOI 10.1073/pnas.75.11.5575; Bardonnet A, 2000, CAN J FISH AQUAT SCI, V57, P497, DOI 10.1139/cjfas-57-2-497; Boker C, 1997, J CELL SCI, V110, P1023; Bower NI, 2010, AM J PHYSIOL-REG I, V298, pR1615, DOI 10.1152/ajpregu.00114.2010; Bower NI, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-80; Bower NI, 2008, J EXP BIOL, V211, P3859, DOI 10.1242/jeb.024117; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Chauvigne F, 2003, GEN COMP ENDOCR, V132, P209, DOI 10.1016/S0016-6480(03)00081-9; Chu CH, 2008, J ENDOCRINOL, V197, P381, DOI 10.1677/JOE-07-0619; CLEGG CH, 1987, J CELL BIOL, V105, P949, DOI 10.1083/jcb.105.2.949; Clemmons DR, 2001, ENDOCR REV, V22, P800, DOI 10.1210/er.22.6.800; Clemmons DR, 1998, MOL CELL ENDOCRINOL, V140, P19, DOI 10.1016/S0303-7207(98)00024-0; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Duan C, 2002, J ENDOCRINOL, V175, P41, DOI 10.1677/joe.0.1750041; Duan C, 2000, CIRC RES, V86, P15, DOI 10.1161/01.RES.86.1.15; Duan CM, 1999, P NATL ACAD SCI USA, V96, P15274, DOI 10.1073/pnas.96.26.15274; Duan CM, 1999, J BIOL CHEM, V274, P37147, DOI 10.1074/jbc.274.52.37147; Engert JC, 1996, J CELL BIOL, V135, P431, DOI 10.1083/jcb.135.2.431; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; EWTON DZ, 1994, J CELL PHYSIOL, V161, P277, DOI 10.1002/jcp.1041610212; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Frost RA, 2002, ENDOCRINOLOGY, V143, P492, DOI 10.1210/en.143.2.492; Gabillard JC, 2006, J ENDOCRINOL, V191, P15, DOI 10.1677/joe.1.06869; GIORGETTI S, 1993, J BIOL CHEM, V268, P7358; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; JOHNSTON IA, 1993, MAR BIOL, V115, P7, DOI 10.1007/BF00349380; JONES JI, 1993, J CELL BIOL, V121, P679, DOI 10.1083/jcb.121.3.679; JONES JI, 1993, P NATL ACAD SCI USA, V90, P10553, DOI 10.1073/pnas.90.22.10553; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; KADRI S, 1995, FUNCT ECOL, V9, P790, DOI 10.2307/2390254; Kang JX, 1997, P NATL ACAD SCI USA, V94, P13671, DOI 10.1073/pnas.94.25.13671; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; KOUMANS JTM, 1990, CELL TISSUE RES, V261, P173, DOI 10.1007/BF00329450; Layne MD, 1999, EXP CELL RES, V249, P177, DOI 10.1006/excr.1999.4465; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Li MY, 2009, AM J PHYSIOL-REG I, V296, pR558, DOI 10.1152/ajpregu.90439.2008; Macqueen DJ, 2008, DEV GENES EVOL, V218, P1, DOI 10.1007/s00427-007-0194-8; MATHEWS LS, 1988, ENDOCRINOLOGY, V123, P2827, DOI 10.1210/endo-123-6-2827; Montserrat N, 2007, CELL TISSUE RES, V330, P503, DOI 10.1007/s00441-007-0507-2; Motyka B, 2000, CELL, V103, P491, DOI 10.1016/S0092-8674(00)00140-9; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Pintucci G, 2002, FASEB J, V16, P598, DOI 10.1096/fj.01-0815fje; Ren HX, 2008, J CELL BIOL, V182, P979, DOI 10.1083/jcb.200712110; Rousse S, 1998, ENDOCRINOLOGY, V139, P1487, DOI 10.1210/en.139.4.1487; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; SARBASSOV DD, 1995, P NATL ACAD SCI USA, V92, P10874, DOI 10.1073/pnas.92.24.10874; Schiller HB, 2009, MOL BIOL CELL, V20, P745, DOI 10.1091/mbc.E08-06-0569; Seiliez I, 2008, AM J PHYSIOL-REG I, V295, pR329, DOI 10.1152/ajpregu.00146.2008; Seurin D, 2002, EUR J CANCER, V38, P2058, DOI 10.1016/S0959-8049(02)00240-X; Shavlakadze T, 2006, GROWTH HORM IGF RES, V16, P157, DOI 10.1016/j.ghir.2005.11.003; SMITH CK, 1994, J CELL PHYSIOL, V159, P379, DOI 10.1002/jcp.1041590222; SPIZZ G, 1986, J BIOL CHEM, V261, P9483; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; TALBOT C, 1986, COMP BIOCHEM PHYS A, V85, P445, DOI 10.1016/0300-9629(86)90427-5; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XL, 2009, AM J PHYSIOL-REG I, V296, pR1348, DOI 10.1152/ajpregu.90969.2008; Weyman CM, 1998, ENDOCRINOLOGY, V139, P1794, DOI 10.1210/en.139.4.1794; Wilson EM, 2003, J BIOL CHEM, V278, P41109, DOI 10.1074/jbc.C300299200; Yamaguchi A, 2006, PFLUG ARCH EUR J PHY, V453, P203, DOI 10.1007/s00424-006-0127-9; Zhou JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003926	75	80	83	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11100	10.1371/journal.pone.0011100	http://dx.doi.org/10.1371/journal.pone.0011100			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559434	Green Submitted, Green Published, gold			2022-12-27	WOS:000278741100014
J	Casado, C; Colombo, S; Rauch, A; Martinez, R; Gunthard, HF; Garcia, S; Rodriguez, C; del Romero, J; Telenti, A; Lopez-Galindez, C				Casado, Concepcion; Colombo, Sara; Rauch, Andri; Martinez, Raquel; Guenthard, Huldrych F.; Garcia, Soledad; Rodriguez, Carmen; del Romero, Jorge; Telenti, Amalio; Lopez-Galindez, Cecilio			Host and Viral Genetic Correlates of Clinical Definitions of HIV-1 Disease Progression	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LONG-TERM NONPROGRESSORS; REPLICATION CAPACITY; EVOLUTION; CONTROLLERS; CONTRIBUTE; INFECTION; VIREMIA; RNA	Background: Various patterns of HIV-1 disease progression are described in clinical practice and in research. There is a need to assess the specificity of commonly used definitions of long term non-progressor (LTNP) elite controllers (LTNP-EC), viremic controllers (LTNP-VC), and viremic non controllers (LTNP-NC), as well as of chronic progressors (P) and rapid progressors (RP). Methodology and Principal Findings: We re-evaluated the HIV-1 clinical definitions, summarized in Table 1, using the information provided by a selected number of host genetic markers and viral factors. There is a continuous decrease of protective factors and an accumulation of risk factors from LTNP-EC to RP. Statistical differences in frequency of protective HLA-B alleles (p-0.01), HLA-C rs9264942 (p-0.06), and protective CCR5/CCR2 haplotypes (p-0.02) across groups, and the presence of viruses with an ancestral genotype in the "viral dating" (i.e., nucleotide sequences with low viral divergence from the most recent common ancestor) support the differences among principal clinical groups of HIV-1 infected individuals. Conclusions: A combination of host genetic and viral factors supports current clinical definitions that discriminate among patterns of HIV-1 progression. The study also emphasizes the need to apply a standardized and accepted set of clinical definitions for the purpose of disease stratification and research.	[Casado, Concepcion; Lopez-Galindez, Cecilio] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [Colombo, Sara; Martinez, Raquel; Telenti, Amalio] Univ Lausanne, Univ Hosp Ctr, Inst Microbiol, Lausanne, Switzerland; [Rauch, Andri] Univ Hosp Bern, Univ Clin Infect Dis, CH-3010 Bern, Switzerland; [Rauch, Andri] Univ Bern, Bern, Switzerland; [Guenthard, Huldrych F.] Univ Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Garcia, Soledad; Rodriguez, Carmen; del Romero, Jorge] IMSALUD Comunidad Autonoma Madrid, Ctr Sanitario Sandoval, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); University of Lausanne; University of Bern; University Hospital of Bern; University of Bern; University of Zurich	Casado, C (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain.	amalio.telenti@chuv.ch; clopez@isciii.es	Vandamme, Anne-Mieke/I-4127-2012; Casado, Concepcion/F-3060-2016; Rauch, Andri/E-9948-2017; gunthard, huldrych f/F-1724-2011; Telenti, Amalio/AAY-1674-2021; Lopez-Galindez, Cecilio/A-3603-2008	Vandamme, Anne-Mieke/0000-0002-6594-2766; Casado, Concepcion/0000-0003-3412-2877; Rauch, Andri/0000-0001-5297-6062; gunthard, huldrych f/0000-0002-1142-6723; Lopez-Galindez, Cecilio/0000-0002-2324-9584	Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) [36558/06, 36641/07, 36779/08, 360766/09]; Swiss National Science Foundation [33CSC0-108787]; SHCS research foundation;  [SAF 2007-61036]	Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SHCS research foundation; 	CLG is supported by grant SAF 2007-61036, by Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) grant 36558/06, 36641/07, 36779/08, 360766/09 and in part by the Red Tematica Cooperativa de Investigacion en SIDA (Red de grupos 173) of the Fondo de Investigaciones Sanitarias de la Seguridad Social (FISss). AT is supported by the Swiss National Science Foundation. This work has been partially financed within the framework of the Swiss HIV Cohort Study (SHCS) funded by the Swiss National Science Foundation (grant no# 33CSC0-108787) and by the SHCS research foundation. The funders had no role in study design, data collection and analysisis, decision, or preparation of the manuscript.	Bailey JR, 2007, J INFECT DIS, V196, P50, DOI 10.1086/518515; Bello G, 2005, J GEN VIROL, V86, P355, DOI 10.1099/vir.0.80410-0; Bello G, 2004, ARCH VIROL, V149, P1761, DOI 10.1007/s00705-004-0322-y; Bello G, 2007, VIROLOGY, V362, P294, DOI 10.1016/j.virol.2006.11.039; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Dalmau J, 2009, CLIN INFECT DIS, V48, P229, DOI 10.1086/595704; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; FELLAY J, 2007, WHOLE GENOME ASS STU, P944; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Fischer M, 2003, AIDS, V17, P195, DOI 10.1097/00002030-200301240-00009; Ganeshan S, 1997, J VIROL, V71, P663, DOI 10.1128/JVI.71.1.663-677.1997; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Grabar S, 2009, AIDS, V23, P1163, DOI 10.1097/QAD.0b013e32832b44c8; GROENINK M, 1993, SCIENCE, V260, P1513, DOI 10.1126/science.8502996; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hatano H, 2009, J VIROL, V83, P329, DOI 10.1128/JVI.01763-08; Hunt PW, 2009, J INFECT DIS, V200, P1636, DOI 10.1086/646610; Jensen MA, 2006, J VIROL, V80, P4698, DOI 10.1128/JVI.80.10.4698-4704.2006; Joos B, 2005, J VIROL, V79, P9026, DOI 10.1128/JVI.79.14.9026-9037.2005; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Lassen KG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000377; Mahalanabis M, 2009, J VIROL, V83, P662, DOI 10.1128/JVI.01328-08; Miura T, 2009, J VIROL, V83, P140, DOI 10.1128/JVI.01471-08; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Sandonis V, 2009, VIROLOGY, V391, P73, DOI 10.1016/j.virol.2009.05.022; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Urban TJ, 2009, NAT MED, V15, P1110, DOI 10.1038/nm1009-1110	30	75	80	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11079	10.1371/journal.pone.0011079	http://dx.doi.org/10.1371/journal.pone.0011079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552027	Green Published, gold, Green Submitted			2022-12-27	WOS:000278662900019
J	Ribelayga, C; Mangel, SC				Ribelayga, Christophe; Mangel, Stuart C.			Identification of a Circadian Clock-Controlled Neural Pathway in the Rabbit Retina	PLOS ONE			English	Article							HORIZONTAL CELLS; MAMMALIAN RETINA; ELECTRICAL SYNAPSES; RESPONSE PROPERTIES; AII AMACRINE; MOUSE RETINA; CONE INPUT; CAT RETINA; ROD; DOPAMINE	Background: Although the circadian clock in the mammalian retina regulates many physiological processes in the retina, it is not known whether and how the clock controls the neuronal pathways involved in visual processing. Methodology/Principal Findings: By recording the light responses of rabbit axonless (A-type) horizontal cells under dark-adapted conditions in both the day and night, we found that rod input to these cells was substantially increased at night under control conditions and following selective blockade of dopamine D(2), but not D(1), receptors during the day, so that the horizontal cells responded to very dim light at night but not in the day. Using neurobiotin tracer labeling, we also found that the extent of tracer coupling between rabbit rods and cones was more extensive during the night, compared to the day, and more extensive in the day following D(2) receptor blockade. Because A-type horizontal cells make synaptic contact exclusively with cones, these observations indicate that the circadian clock in the mammalian retina substantially increases rod input to A-type horizontal cells at night by enhancing rod-cone coupling. Moreover, the clock-induced increase in D(2) receptor activation during the day decreases rod-cone coupling so that rod input to A-type horizontal cells is minimal. Conclusions/Significance: Considered together, these results identify the rod-cone gap junction as a key site in mammals through which the retinal clock, using dopamine activation of D(2) receptors, controls signal flow in the day and night from rods into the cone system.	[Ribelayga, Christophe; Mangel, Stuart C.] Ohio State Univ, Coll Med, Dept Neurosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Ribelayga, C (corresponding author), Univ Texas Med Sch, Dept Ophthalmol & Visual Sci, Houston, TX USA.	mangel.1@osu.edu			National Institutes of Health [R01 EY005102]; NATIONAL EYE INSTITUTE [R01EY018640, R01EY005102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health Grant R01 EY005102 to S. C. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES A, 1992, J NEUROSCI, V12, P840, DOI 10.1523/jneurosci.12-03-00840.1992; Barlow R, 2001, Prog Brain Res, V131, P487; Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; BLOOMFIELD SA, 1982, J COMP NEUROL, V208, P288, DOI 10.1002/cne.902080306; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; Cameron MA, 2009, EUR J NEUROSCI, V29, P761, DOI 10.1111/j.1460-9568.2009.06631.x; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; DEVRIES SH, 1995, P NATL ACAD SCI USA, V92, P10658, DOI 10.1073/pnas.92.23.10658; DeVries SH, 2002, CURR BIOL, V12, P1900, DOI 10.1016/S0960-9822(02)01261-7; DMITRIEV AV, J NEUROSCI, V21, P2897; Dowling J. E., 1987, RETINA APPROACHABLE; DOWNING JEG, 1989, J COMP NEUROL, V289, P537, DOI 10.1002/cne.902890402; FAMIGLIETTI EV, 1995, VISUAL NEUROSCI, V12, P1151, DOI 10.1017/S0952523800006799; Field GD, 2005, ANNU REV PHYSIOL, V67, P491, DOI 10.1146/annurev.physiol.67.031103.151256; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Green CB, 2004, J BIOL RHYTHM, V19, P91, DOI 10.1177/0748730404263002; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Hornstein EP, 2005, J NEUROSCI, V25, P11201, DOI 10.1523/JNEUROSCI.3416-05.2005; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; Li HY, 2009, J NEUROSCI, V29, P15178, DOI 10.1523/JNEUROSCI.3517-09.2009; LIEBMAN PA, 1964, J OPT SOC AM, V54, P1451, DOI 10.1364/JOSA.54.001451; Long MA, 2005, NAT NEUROSCI, V8, P61, DOI 10.1038/nn1361; Mangel S C, 2001, Prog Brain Res, V131, P505; McMahon D G, 2001, Prog Brain Res, V131, P419; MILLS SL, 1994, VISUAL NEUROSCI, V11, P549, DOI 10.1017/S0952523800002455; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; NELSON R, 1977, J COMP NEUROL, V172, P109, DOI 10.1002/cne.901720106; Nikonov SS, 2008, NEURON, V59, P462, DOI 10.1016/j.neuron.2008.06.011; Pang JJ, 2004, J PHYSIOL-LONDON, V558, P897, DOI 10.1113/jphysiol.2003.059543; RAVIOLA E, 1983, VISION RES, V23, P1221, DOI 10.1016/0042-6989(83)90097-4; RAVIOLA E, 1973, P NATL ACAD SCI USA, V70, P1677, DOI 10.1073/pnas.70.6.1677; RAVIOLA E, 1990, J NEUROCYTOL, V19, P731, DOI 10.1007/BF01188041; Ribelayga C, 2004, J PHYSIOL-LONDON, V554, P467, DOI 10.1113/jphysiol.2003.053710; Ribelayga C, 2003, J COMP NEUROL, V467, P243, DOI 10.1002/cne.10927; Ribelayga C, 2002, J PHYSIOL-LONDON, V544, P801, DOI 10.1113/jphysiol.2002.023671; Ribelayga C, 2008, NEURON, V59, P790, DOI 10.1016/j.neuron.2008.07.017; SMITH RG, 1986, J NEUROSCI, V6, P3505; STEINBERG RH, 1969, VISION RES, V9, P1331, DOI 10.1016/0042-6989(69)90070-4; STELL WK, 1975, J COMP NEUROL, V159, P473, DOI 10.1002/cne.901590404; Sterling P., 2004, SYNAPTIC ORG BRAIN, P217; Trexler EB, 2005, J NEUROPHYSIOL, V93, P1476, DOI 10.1152/jn.00597.2004; Wang Y, 1996, P NATL ACAD SCI USA, V93, P4655, DOI 10.1073/pnas.93.10.4655; Warrant EJ, 1999, VISION RES, V39, P1611, DOI 10.1016/S0042-6989(98)00262-4; Weiler R, 2000, BRAIN RES REV, V32, P121, DOI 10.1016/S0165-0173(99)00071-5; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Xin DY, 1999, J COMP NEUROL, V405, P75, DOI 10.1002/(SICI)1096-9861(19990301)405:1<75::AID-CNE6>3.0.CO;2-D; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; Zhang DQ, 2008, P NATL ACAD SCI USA, V105, P14181, DOI 10.1073/pnas.0803893105	49	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11020	10.1371/journal.pone.0011020	http://dx.doi.org/10.1371/journal.pone.0011020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548772	Green Submitted, Green Published, gold			2022-12-27	WOS:000278599600001
J	Zimmermann, HW; Seidler, S; Nattermann, J; Gassler, N; Hellerbrand, C; Zernecke, A; Tischendorf, JJW; Luedde, T; Weiskirchen, R; Trautwein, C; Tacke, F				Zimmermann, Henning W.; Seidler, Sebastian; Nattermann, Jacob; Gassler, Nikolaus; Hellerbrand, Claus; Zernecke, Alma; Tischendorf, Jens J. W.; Luedde, Tom; Weiskirchen, Ralf; Trautwein, Christian; Tacke, Frank			Functional Contribution of Elevated Circulating and Hepatic Non-Classical CD14(+)CD16(+) Monocytes to Inflammation and Human Liver Fibrosis	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; STELLATE CELLS; BONE-MARROW; IMMUNE PARALYSIS; DENDRITIC CELLS; SUBSETS; CCR2; HETEROGENEITY; MACROPHAGES; ACTIVATION	Background: Monocyte-derived macrophages critically perpetuate inflammatory responses after liver injury as a prerequisite for organ fibrosis. Experimental murine models identified an essential role for the CCR2-dependent infiltration of classical Gr1/Ly6C(+) monocytes in hepatic fibrosis. Moreover, the monocyte-related chemokine receptors CCR1 and CCR5 were recently recognized as important fibrosis modulators in mice. In humans, monocytes consist of classical CD14(+)CD16(-) and non-classical CD14(+)CD16(+) cells. We aimed at investigating the relevance of monocyte subpopulations for human liver fibrosis, and hypothesized that 'non-classical' monocytes critically exert inflammatory as well as profibrogenic functions in patients during liver disease progression. Methodology/Principal Findings: We analyzed circulating monocyte subsets from freshly drawn blood samples of 226 patients with chronic liver disease (CLD) and 184 healthy controls by FACS analysis. Circulating monocytes were significantly expanded in CLD-patients compared to controls with a marked increase of the non-classical CD14(+)CD16(+) subset that showed an activated phenotype in patients and correlated with proinflammatory cytokines and clinical progression. Correspondingly, CD14(+)CD16(+) macrophages massively accumulated in fibrotic/cirrhotic livers, as evidenced by immunofluorescence and FACS. Ligands of monocyte-related chemokine receptors CCR2, CCR1 and CCR5 were expressed at higher levels in fibrotic and cirrhotic livers, while CCL3 and CCL4 were also systemically elevated in CLD-patients. Isolated monocyte/macrophage subpopulations were functionally characterized regarding cytokine/chemokine expression and interactions with primary human hepatic stellate cells (HSC) in vitro. CD14(+)CD16(+) monocytes released abundant proinflammatory cytokines. Furthermore, CD14(+)CD16(+), but not CD14(+)CD16-monocytes could directly activate collagen-producing HSC. Conclusions/Significance: Our data demonstrate the expansion of CD14(+)CD16(+) monocytes in the circulation and liver of CLD-patients upon disease progression and suggest their functional contribution to the perpetuation of intrahepatic inflammation and profibrogenic HSC activation in liver cirrhosis. The modulation of monocyte-subset recruitment into the liver via chemokines/chemokine receptors and their subsequent differentiation may represent promising approaches for therapeutic interventions in human liver fibrosis.	[Zimmermann, Henning W.; Seidler, Sebastian; Tischendorf, Jens J. W.; Luedde, Tom; Trautwein, Christian; Tacke, Frank] Univ Hosp Aachen, Dept Med 3, Aachen, Germany; [Nattermann, Jacob] Univ Bonn, Dept Med 1, D-5300 Bonn, Germany; [Gassler, Nikolaus] Univ Hosp Aachen, Inst Pathol, Aachen, Germany; [Hellerbrand, Claus] Univ Regensburg, Dept Med 1, Regensburg, Germany; [Zernecke, Alma] Univ Hosp Aachen, Inst Mol Cardiovasc Res, Aachen, Germany; [Weiskirchen, Ralf] Univ Hosp Aachen, Inst Clin Chem & Pathobiochem, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; University of Bonn; RWTH Aachen University; RWTH Aachen University Hospital; University of Regensburg; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Zimmermann, HW (corresponding author), Univ Hosp Aachen, Dept Med 3, Aachen, Germany.	frank.tacke@gmx.net	Weiskirchen, Ralf/O-1734-2018; Tacke, Frank/ABF-2212-2020; Luedde, Tom/AAE-9135-2022	Weiskirchen, Ralf/0000-0003-3888-0931; Luedde, Tom/0000-0002-6288-8821	German Research Foundation [DFG Ta434/2-1, DFG SFB/TRR 57]; START-Program; Interdisciplinary Centre for Clinical Research (IZKF), Faculty of Medicine at the RWTH Aachen University	German Research Foundation(German Research Foundation (DFG)); START-Program(Austrian Science Fund (FWF)); Interdisciplinary Centre for Clinical Research (IZKF), Faculty of Medicine at the RWTH Aachen University	This work was supported by the German Research Foundation (DFG Ta434/2-1 to F. T., DFG SFB/TRR 57), by the START-Program and the Interdisciplinary Centre for Clinical Research (IZKF) within the Faculty of Medicine at the RWTH Aachen University (to H.W.Z and F. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuebor MN, 2007, AM J PATHOL, V170, P1975, DOI 10.2353/ajpath.2007.060690; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hellerbrand C, 1996, HEPATOLOGY, V24, P670; Heymann Felix, 2009, Inflammation & Allergy Drug Targets, V8, P307; Imamura M, 2005, GASTROENTEROLOGY, V128, P138, DOI 10.1053/j.gastro.2004.10.005; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Karlmark Karlin Raja, 2008, Expert Rev Gastroenterol Hepatol, V2, P233, DOI 10.1586/17474124.2.2.233; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Koch A, 2009, CRIT CARE, V13, DOI 10.1186/cc7925; Leicester KL, 2006, LIVER INT, V26, P559, DOI 10.1111/j.1478-3231.2006.01255.x; Lin CY, 2007, J HEPATOL, V46, P816, DOI 10.1016/j.jhep.2006.12.018; Marra F, 1998, AM J PATHOL, V152, P423; Mitchell C, 2009, AM J PATHOL, V174, P1766, DOI 10.2353/ajpath.2009.080632; Muhlbauer M, 2003, GASTROENTEROLOGY, V125, P1085, DOI 10.1016/S0016-5085(03)01213-7; Panasiuk A, 2005, WORLD J GASTROENTERO, V11, P2754, DOI 10.3748/wjg.v11.i18.2754; Roderfeld M, 2010, HEPATOLOGY, V51, P267, DOI 10.1002/hep.23274; SAKAGAMI M, 2006, J LARYNGOL OTOL, V14, P1; Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Tacke F, 2003, J HEPATOL, V38, P447, DOI 10.1016/S0168-8278(02)00438-5; Tacke F, 2007, DIGEST DIS SCI, V52, P3404, DOI 10.1007/s10620-007-9758-8; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Wasmuth HE, 2005, J HEPATOL, V42, P195, DOI 10.1016/j.jhep.2004.10.019; Weiler-Normann C, 2007, Z GASTROENTEROL, V45, P43, DOI 10.1055/s-2006-927387; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	37	235	245	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11049	10.1371/journal.pone.0011049	http://dx.doi.org/10.1371/journal.pone.0011049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548789	gold, Green Submitted, Green Published			2022-12-27	WOS:000278599600010
J	Gurevich, V; Kassir, Y				Gurevich, Vyacheslav; Kassir, Yona			A Switch from a Gradient to a Threshold Mode in the Regulation of a Transcriptional Cascade Promotes Robust Execution of Meiosis in Budding Yeast	PLOS ONE			English	Article							MEIOTIC RECOMBINATION CHECKPOINT; PREMEIOTIC DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; MIDDLE SPORULATION; NEGATIVE FEEDBACK; S-PHASE; PACHYTENE CHECKPOINT; HISTONE DEACETYLASE; POSITIVE REGULATOR; GENE-EXPRESSION	Tight regulation of developmental pathways is of critical importance to all organisms, and is achieved by a transcriptional cascade ensuring the coordinated expression of sets of genes. We aimed to explore whether a strong signal is required to enter and complete a developmental pathway, by using meiosis in budding yeast as a model. We demonstrate that meiosis in budding yeast is insensitive to drastic changes in the levels of its consecutive positive regulators (Ime1, Ime2, and Ndt80). Entry into DNA replication is not correlated with the time of transcription of the early genes that regulate this event. Entry into nuclear division is directly regulated by the time of transcription of the middle genes, as premature transcription of their activator NDT80, leads to a premature entry into the first meiotic division, and loss of coordination between DNA replication and nuclear division. We demonstrate that Cdk1/Cln3 functions as a negative regulator of Ime2, and that ectopic expression of Cln3 delays entry into nuclear division as well as NDT80 transcription. Because Ime2 functions as a positive regulator for premeiotic DNA replication and NDT80 transcription, as well as a negative regulator of Cdk/Cln, we suggest that a double negative feedback loop between Ime2 and Cdk1/Cln3 promotes a bistable switch from the cell cycle to meiosis. Moreover, our results suggest a regulatory mode switch that ensures robust meiosis as the transcription of the early meiosis-specific genes responds in a graded mode to Ime1 levels, whereas that of the middle and late genes as well as initiation of DNA replication, are regulated in a threshold mode.	[Gurevich, Vyacheslav; Kassir, Yona] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Gurevich, V (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	ykassir@tx.technion.ac.il						Baugh LR, 2005, DEVELOPMENT, V132, P1843, DOI 10.1242/dev.01782; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Bolouri H, 2003, P NATL ACAD SCI USA, V100, P9371, DOI 10.1073/pnas.1533293100; Bolte M, 2002, P NATL ACAD SCI USA, V99, P4385, DOI 10.1073/pnas.072385099; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Chu S, 1998, SCIENCE, V282, P1421; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Colomina N, 1999, EMBO J, V18, P320, DOI 10.1093/emboj/18.2.320; Dirick L, 1998, SCIENCE, V281, P1854, DOI 10.1126/science.281.5384.1854; Eldar A, 2004, CURR OPIN GENET DEV, V14, P435, DOI 10.1016/j.gde.2004.06.009; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Foiani M, 1996, MOL GEN GENET, V253, P278, DOI 10.1007/s004380050323; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Goldmark JP, 2000, CELL, V103, P423, DOI 10.1016/S0092-8674(00)00134-3; Guttmann-Raviv N, 2002, MOL CELL BIOL, V22, P2047, DOI 10.1128/MCB.22.7.2047-2056.2002; Guttmann-Raviv N, 2001, GENETICS, V159, P1547; Hepworth SR, 1998, MOL CELL BIOL, V18, P5750, DOI 10.1128/MCB.18.10.5750; Kadosh D, 1998, GENE DEV, V12, P797, DOI 10.1101/gad.12.6.797; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kassir Y, 2003, INT REV CYTOL, V224, P111, DOI 10.1016/S0074-7696(05)24004-4; KASSIR Y, 1991, METHOD ENZYMOL, V194, P94; Leu JY, 1999, MOL CELL, V4, P805, DOI 10.1016/S1097-2765(00)80390-1; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Melen GJ, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100036; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Pak J, 2002, MOL CELL BIOL, V22, P6430, DOI 10.1128/MCB.22.18.6430-6440.2002; Pak J, 2002, MOL CELL BIOL, V22, P6417, DOI 10.1128/MCB.22.18.6417-6429.2002; Pierce M, 2003, MOL CELL BIOL, V23, P4814, DOI 10.1128/MCB.23.14.4814-4825.2003; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Raithatha SA, 2005, GENETICS, V169, P1329, DOI 10.1534/genetics.104.036103; Raithatha SA, 2008, YEAST, V25, P259, DOI 10.1002/yea.1585; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Rose MD., 1990, METHODS YEAST GENETI; Rubinstein A, 2007, P NATL ACAD SCI USA, V104, P6241, DOI 10.1073/pnas.0611168104; Schindler K, 2003, MOL CELL BIOL, V23, P8718, DOI 10.1128/MCB.23.23.8718-8728.2003; Schindler K, 2006, J BIOL CHEM, V281, P18307, DOI 10.1074/jbc.M602349200; SHEFERVAIDA M, 1995, DEV GENET, V16, P219, DOI 10.1002/dvg.1020160302; Shenhar G, 2001, MOL CELL BIOL, V21, P1603, DOI 10.1128/MCB.21.5.1603-1612.2001; Sopko R, 2002, MOL CELL BIOL, V22, P7024, DOI 10.1128/MCB.22.20.7024-7040.2002; Stuart D, 1998, GENE DEV, V12, P2698, DOI 10.1101/gad.12.17.2698; Szwarcwort-Cohen M, 2009, CELL CYCLE, V8, P647, DOI 10.4161/cc.8.4.7843; Wang HY, 2004, EMBO J, V23, P180, DOI 10.1038/sj.emboj.7600022; Xie JX, 1999, EMBO J, V18, P6448, DOI 10.1093/emboj/18.22.6448; Xing JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002140	48	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11005	10.1371/journal.pone.0011005	http://dx.doi.org/10.1371/journal.pone.0011005			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20543984	Green Published, Green Submitted, gold			2022-12-27	WOS:000278494900017
J	Varghese, V; Wang, E; Babrzadeh, F; Bachmann, MH; Shahriar, R; Liu, T; Mappala, SJM; Gharizadeh, B; Fessel, WJ; Katzenstein, D; Kassaye, S; Shafer, RW				Varghese, Vici; Wang, Elijah; Babrzadeh, Farbod; Bachmann, Michael H.; Shahriar, Rajin; Liu, Tommy; Mappala, Svetlana Jean M.; Gharizadeh, Baback; Fessel, W. Jeffrey; Katzenstein, David; Kassaye, Seble; Shafer, Robert W.			Nucleic Acid Template and the Risk of a PCR-Induced HIV-1 Drug Resistance Mutation	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE; SUBTYPE-C; K65R RESISTANCE; PROTEASE; POSITIONS; TENOFOVIR	Background: The HIV-1 nucleoside RT inhibitor (NRTI)-resistance mutation, K65R confers intermediate to high-level resistance to the NRTIs abacavir, didanosine, emtricitabine, lamivudine, and tenofovir; and low-level resistance to stavudine. Several lines of evidence suggest that K65R is more common in HIV-1 subtype C than subtype B viruses. Methods and Findings: We performed ultra-deep pyrosequencing (UDPS) and clonal dideoxynucleotide sequencing of plasma virus samples to assess the prevalence of minority K65R variants in subtype B and C viruses from untreated individuals. Although UDPS of plasma samples from 18 subtype C and 27 subtype B viruses showed that a higher proportion of subtype C viruses contain K65R (1.04% vs. 0.25%; p < 0.001), limiting dilution clonal sequencing failed to corroborate its presence in two of the samples in which K65R was present in >1.5% of UDPS reads. We therefore performed UDPS on clones and site-directed mutants containing subtype B- and C-specific patterns of silent mutations in the conserved KKK motif encompassing RT codons 64 to 66 and found that subtype-specific nucleotide differences were responsible for increased PCR-induced K65R mutation in subtype C viruses. Conclusions: This study shows that the RT KKK nucleotide template in subtype C viruses can lead to the spurious detection of K65R by highly sensitive PCR-dependent sequencing techniques. However, the study is also consistent with the subtype C nucleotide template being inherently responsible for increased polymerization-induced K65R mutations in vivo.	[Varghese, Vici; Shahriar, Rajin; Liu, Tommy; Mappala, Svetlana Jean M.; Katzenstein, David; Kassaye, Seble; Shafer, Robert W.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Wang, Elijah; Babrzadeh, Farbod; Gharizadeh, Baback] Stanford Univ, Sch Med, Stanford Genome Technol Ctr, Stanford, CA 94305 USA; [Bachmann, Michael H.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Fessel, W. Jeffrey] Kaiser Permanente Med Care Program No Calif, Clin Trials Unit, San Francisco, CA USA	Stanford University; Stanford University; Stanford University; Kaiser Permanente	Varghese, V (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	viciv@stanford.edu	Bachmann, Michael Hubertus/N-9339-2016	Bachmann, Michael Hubertus/0000-0002-0204-3720; katzenstein, david/0000-0002-8593-4560; varghese, vici/0000-0003-2669-5966	NIH [AI46148]; California HIV Research Program [D08-ST-033]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066922, R01AI046148] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California HIV Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	VV, TL, MHB, SJM, and RWS were supported by NIH grants AI46148. VV and RWS were also partly supported by grant D08-ST-033 from the California HIV Research Program [D08-ST-033]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b; Coutsinos D, 2009, J VIROL, V83, P2029, DOI 10.1128/JVI.01349-08; Doualla-Bell F, 2006, ANTIMICROB AGENTS CH, V50, P4182, DOI 10.1128/AAC.00714-06; Gallant JE, 2005, J INFECT DIS, V192, P1921, DOI 10.1086/498069; Grossman Z, 2004, AIDS, V18, P909, DOI 10.1097/00002030-200404090-00008; Harrigan PR, 2008, AIDS, V22, P2501, DOI 10.1097/QAD.0b013e328318f16c; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Invernizzi CF, 2009, J INFECT DIS, V200, P1202, DOI 10.1086/605894; Kieffer TL, 2005, J VIROL, V79, P1975, DOI 10.1128/JVI.79.3.1975-1980.2005; Learn GH, 1996, J VIROL, V70, P5720, DOI 10.1128/JVI.70.8.5720-5730.1996; Mitsuya Y, 2008, J VIROL, V82, P10747, DOI 10.1128/JVI.01827-07; Parikh UM, 2005, ANTIMICROB AGENTS CH, V49, P1139, DOI 10.1128/AAC.49.3.1139-1144.2005; Rhee SY, 2006, P NATL ACAD SCI USA, V103, P17355, DOI 10.1073/pnas.0607274103; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Shafer RW, 2001, J CLIN MICROBIOL, V39, P1522, DOI 10.1128/JCM.39.4.1522-1529.2001; TURNER D, 2004, ANTIVIR THER, V9, pS99	16	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10992	10.1371/journal.pone.0010992	http://dx.doi.org/10.1371/journal.pone.0010992			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539818	Green Published, gold, Green Submitted			2022-12-27	WOS:000278465900010
J	Collings, CK; Fernandez, AG; Pitschka, CG; Hawkins, TB; Anderson, JN				Collings, Clayton K.; Fernandez, Alfonso G.; Pitschka, Chad G.; Hawkins, Troy B.; Anderson, John N.			Oligonucleotide Sequence Motifs as Nucleosome Positioning Signals	PLOS ONE			English	Article							DEPENDENT DNA-STRUCTURE; T-G-G; HIGH-RESOLUTION; IN-VIVO; SACCHAROMYCES-CEREVISIAE; CONFORMATIONAL MAPS; DINUCLEOTIDE STEPS; HUMAN GENOME; CORE DNA; B-DNA	To gain a better understanding of the sequence patterns that characterize positioned nucleosomes, we first performed an analysis of the periodicities of the 256 tetranucleotides in a yeast genome-wide library of nucleosomal DNA sequences that was prepared by in vitro reconstitution. The approach entailed the identification and analysis of 24 unique tetranucleotides that were defined by 8 consensus sequences. These consensus sequences were shown to be responsible for most if not all of the tetranucleotide and dinucleotide periodicities displayed by the entire library, demonstrating that the periodicities of dinucleotides that characterize the yeast genome are, in actuality, due primarily to the 8 consensus sequences. A novel combination of experimental and bioinformatic approaches was then used to show that these tetranucleotides are important for preferred formation of nucleosomes at specific sites along DNA in vitro. These results were then compared to tetranucleotide patterns in genome-wide in vivo libraries from yeast and C. elegans in order to assess the contributions of DNA sequence in the control of nucleosome residency in the cell. These comparisons revealed striking similarities in the tetranucleotide occurrence profiles that are likely to be involved in nucleosome positioning in both in vitro and in vivo libraries, suggesting that DNA sequence is an important factor in the control of nucleosome placement in vivo. However, the strengths of the tetranucleotide periodicities were 3-4 fold higher in the in vitro as compared to the in vivo libraries, which implies that DNA sequence plays less of a role in dictating nucleosome positions in vivo. The results of this study have important implications for models of sequence-dependent positioning since they suggest that a defined subset of tetranucleotides is involved in preferred nucleosome occupancy and that these tetranucleotides are the major source of the dinucleotide periodicities that are characteristic of positioned nucleosomes.	[Collings, Clayton K.; Pitschka, Chad G.; Anderson, John N.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Fernandez, Alfonso G.] NCI, NIH, Bethesda, MD 20892 USA; [Hawkins, Troy B.] Indiana Univ Purdue Univ, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Indiana University System; Indiana University-Purdue University Indianapolis	Collings, CK (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	andersjn@purdue.edu			Department of Biological Sciences at Purdue University;  [R01LM8626]; NATIONAL LIBRARY OF MEDICINE [R01LM008626] Funding Source: NIH RePORTER	Department of Biological Sciences at Purdue University; ; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The Department of Biological Sciences at Purdue University provided the sources of funding that have supported the project. http://www.bio.purdue.edu/index.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the two anonymous reviewers for helpful suggestions and Dr. Peter Waddell for the use of computing resources, which were funded by R01LM8626 and used for the analysis of the C. elegans data.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Cairns BR, 2005, CURR OPIN GENET DEV, V15, P185, DOI 10.1016/j.gde.2005.01.003; Caserta M, 2009, NUCLEIC ACIDS RES, V37, P5309, DOI 10.1093/nar/gkp574; Choi JK, 2009, NAT GENET, V41, P498, DOI 10.1038/ng.319; Chung HR, 2009, J MOL BIOL, V386, P1411, DOI 10.1016/j.jmb.2008.11.049; COSTANZO G, 1990, J MOL BIOL, V216, P363, DOI 10.1016/S0022-2836(05)80327-4; Dixit SB, 2005, BIOPHYS J, V89, P3721, DOI 10.1529/biophysj.105.067397; ElHassan MA, 1997, PHILOS T R SOC A, V355, P43, DOI 10.1098/rsta.1997.0002; Fernandez AG, 2007, J MOL BIOL, V371, P649, DOI 10.1016/j.jmb.2007.05.090; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Fitzgerald DJ, 1999, J MOL BIOL, V293, P477, DOI 10.1006/jmbi.1999.3171; FITZGERALD DJ, 1994, J BIOL CHEM, V269, P21303; Fitzgerald DJ, 1998, NUCLEIC ACIDS RES, V26, P2526, DOI 10.1093/nar/26.11.2526; Fitzgerald DJ, 1999, J BIOL CHEM, V274, P27128, DOI 10.1074/jbc.274.38.27128; FITZGERALD DJ, 1999, GENE THEOR MOL BIOL, V4, P349; Gardiner EJ, 2003, J MOL BIOL, V332, P1025, DOI 10.1016/j.jmb.2003.08.006; GOODSELL DS, 1994, J MOL BIOL, V239, P79, DOI 10.1006/jmbi.1994.1352; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; HAYES JJ, 1990, P NATL ACAD SCI USA, V87, P7405, DOI 10.1073/pnas.87.19.7405; Hogan GJ, 2006, PLOS GENET, V2, P1433, DOI 10.1371/journal.pgen.0020158; HSIEH CH, 1988, CELL, V52, P535, DOI 10.1016/0092-8674(88)90466-7; Hughes Amanda, 2009, J Biol, V8, P96, DOI 10.1186/jbiol207; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; KOO HS, 1986, NATURE, V320, P501, DOI 10.1038/320501a0; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Liu HD, 2008, BIOPHYS J, V94, P4597, DOI 10.1529/biophysj.107.117028; LOWMAN H, 1990, BIOPOLYMERS, V30, P861, DOI 10.1002/bip.360300902; MAVRICH TN, 2008, NATURE, V45; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Ong MS, 2007, J MOL BIOL, V368, P1067, DOI 10.1016/j.jmb.2007.02.062; Packer MJ, 2000, J MOL BIOL, V295, P71, DOI 10.1006/jmbi.1999.3236; Packer MJ, 2000, J MOL BIOL, V295, P85, DOI 10.1006/jmbi.1999.3237; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; PRIVE GG, 1991, J MOL BIOL, V217, P177, DOI 10.1016/0022-2836(91)90619-H; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; RHODES D, 1979, NUCLEIC ACIDS RES, V6, P1805, DOI 10.1093/nar/6.5.1805; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; RICHMOND TJ, 1984, NATURE, V311, P532, DOI 10.1038/311532a0; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Salih F, 2007, J BIOMOL STRUCT DYN, V24, P489, DOI 10.1080/07391102.2007.10507137; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Schnitzler GR, 2008, CELL BIOCHEM BIOPHYS, V51, P67, DOI 10.1007/s12013-008-9015-6; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Scipioni A, 2004, BIOPHYS CHEM, V107, P7, DOI 10.1016/S0301-4622(03)00214-X; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; Segal MR, 2008, STAT APPL GENET MOL, V7; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Steffen N R, 2002, Bioinformatics, V18 Suppl 1, pS22; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; Thastrom A, 2004, J MOL BIOL, V338, P695, DOI 10.1016/j.jmb.2004.03.032; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Tillo D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009129; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Tolstorukov MY, 2007, J MOL BIOL, V371, P725, DOI 10.1016/j.jmb.2007.05.048; TRAVERS AA, 1989, ANNU REV BIOCHEM, V58, P427, DOI 10.1146/annurev.biochem.58.1.427; TRIFONOV EN, 1980, P NATL ACAD SCI-BIOL, V77, P3816, DOI 10.1073/pnas.77.7.3816; Urpi L, 1996, NAT STRUCT BIOL, V3, P325, DOI 10.1038/nsb0496-325; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; van Holde KE., 1989, SPRINGER SERIES MOL; van Vugt JJFA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006345; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Whitehouse I, 2006, NAT STRUCT MOL BIOL, V13, P633, DOI 10.1038/nsmb1111; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636	72	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10933	10.1371/journal.pone.0010933	http://dx.doi.org/10.1371/journal.pone.0010933			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532171	Green Published, Green Submitted, gold			2022-12-27	WOS:000278318700007
J	Homeier, T; Semmler, T; Wieler, LH; Ewers, C				Homeier, Timo; Semmler, Torsten; Wieler, Lothar H.; Ewers, Christa			The GimA Locus of Extraintestinal Pathogenic E. coli: Does Reductive Evolution Correlate with Habitat and Pathotype?	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; CELLS IN-VITRO; ENTEROCYTE EFFACEMENT; GENE LOCUS; STRAINS; INVASION; ISLANDS; CONTRIBUTES; IDENTIFICATION; VIRULENCE	IbeA (invasion of brain endothelium), which is located on a genomic island termed GimA, is involved in the pathogenesis of several extraintestinal pathogenic E. coli (ExPEC) pathotypes, including newborn meningitic E. coli (NMEC) and avian pathogenic E. coli (APEC). To unravel the phylogeny of GimA and to investigate its island character, the putative insertion locus of GimA was determined via Long Range PCR and DNA-DNA hybridization in 410 E. coli isolates, including APEC, NMEC, uropathogenic (UPEC), septicemia-associated E. coli (SEPEC), and human and animal fecal isolates as well as in 72 strains of the E. coli reference (ECOR) collection. In addition to a complete GimA (similar to 20.3 kb) and a locus lacking GimA we found a third pattern containing a 342 bp remnant of GimA in this strain collection. The presence of GimA was almost exclusively detected in strains belonging to phylogenetic group B2. In addition, the complete GimA was significantly more frequent in APEC and NMEC strains while the GimA remnant showed a higher association with UPEC strains. A detailed analysis of the ibeA sequences revealed the phylogeny of this gene to be consistent with that obtained by Multi Locus Sequence Typing of the strains. Although common criteria for genomic islands are partially fulfilled, GimA rather seems to be an ancestral part of phylogenetic group B2, and it would therefore be more appropriate to term this genomic region GimA locus instead of genomic island. The existence of two other patterns reflects a genomic rearrangement in a reductive evolution-like manner.	[Homeier, Timo; Semmler, Torsten; Wieler, Lothar H.; Ewers, Christa] Free Univ Berlin, Fac Vet, Inst Microbiol & Epizoot, D-1000 Berlin, Germany; [Homeier, Timo] Univ Leipzig, Inst Anim Hyg & Vet Publ Hlth, Fac Vet Med, Leipzig, Germany	Free University of Berlin; Leipzig University	Homeier, T (corresponding author), Free Univ Berlin, Fac Vet, Inst Microbiol & Epizoot, D-1000 Berlin, Germany.	ewers.christa@vetmed.fu-berlin.de	Ewers, Christa/AAL-9186-2020; Semmler, Torsten/O-9540-2019; Semmler, Torsten/Q-7716-2018	Semmler, Torsten/0000-0002-2225-7267; Semmler, Torsten/0000-0002-2225-7267; Wieler, Lothar H./0000-0003-4365-3717; Ewers, Christa/0000-0001-6167-1340	German Research Foundation [DFG-WI1436/5-3]; Federal Ministry of Education and Research (FBI-Zoo) [01KI07120]; Studienstiftung des Deutschen Volkes	German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research (FBI-Zoo)(Federal Ministry of Education & Research (BMBF)); Studienstiftung des Deutschen Volkes	Financial support was provided by the German Research Foundation (DFG-WI1436/5-3) and the Federal Ministry of Education and Research (FBI-Zoo, 01KI07120). TH was supported by a grant of the Studienstiftung des Deutschen Volkes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Antao EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007796; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bonacorsi S, 2005, INT J MED MICROBIOL, V295, P373, DOI 10.1016/j.ijmm.2005.07.011; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Chi F, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/520283; Chongtrakool P, 2006, ANTIMICROB AGENTS CH, V50, P1001, DOI 10.1128/AAC.50.3.1001-1012.2006; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Cortes MAM, 2008, INFECT IMMUN, V76, P4129, DOI 10.1128/IAI.00334-08; Culham DE, 2000, J BACTERIOL, V182, P6272, DOI 10.1128/JB.182.21.6272-6276.2000; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Ewers C, 2010, J ANTIMICROB CHEMOTH, V65, P651, DOI 10.1093/jac/dkq004; Ewers C, 2009, APPL ENVIRON MICROB, V75, P184, DOI 10.1128/AEM.01324-08; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Germon P, 2005, MICROBIOL-SGM, V151, P1179, DOI 10.1099/mic.0.27809-0; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; GROSS RJ, 1983, J HYG-CAMBRIDGE, V90, P195, DOI 10.1017/S0022172400028850; Gross W. G., 1994, P237; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Hejnova J, 2005, MICROBIOL-SGM, V151, P385, DOI 10.1099/mic.0.27469-0; Hochhut B, 2006, MOL MICROBIOL, V61, P584, DOI 10.1111/j.1365-2958.2006.05255.x; Hoffman JA, 2000, INFECT IMMUN, V68, P5062, DOI 10.1128/IAI.68.9.5062-5067.2000; HUANG SH, 1995, INFECT IMMUN, V63, P4470, DOI 10.1128/IAI.63.11.4470-4475.1995; Huang SH, 1999, INFECT IMMUN, V67, P2103, DOI 10.1128/IAI.67.5.2103-2109.1999; Huang SH, 2001, J INFECT DIS, V183, P1071, DOI 10.1086/319290; Huang Sheng-he, 2001, Functional and Integrative Genomics, V1, P312, DOI 10.1007/s101420100039; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; Johnson JR, 2002, J LAB CLIN MED, V139, P155, DOI 10.1067/mlc.2002.121550; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Jores J, 2004, INT J MED MICROBIOL, V294, P103, DOI 10.1016/j.ijmm.2004.06.024; Jores J, 2001, FEMS MICROBIOL LETT, V204, P75, DOI 10.1111/j.1574-6968.2001.tb10866.x; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Kim KS, 2002, J INFECT DIS, V186, pS220, DOI 10.1086/344284; Leib SL, 1999, INFECT DIS CLIN N AM, V13, P527, DOI 10.1016/S0891-5520(05)70093-3; Meseguer MA, 2003, INFECT GENET EVOL, V3, P47, DOI 10.1016/S1567-1348(02)00151-X; Mora A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-132; Mordhorst IL, 2009, ENVIRON MICROBIOL, V11, P3154, DOI 10.1111/j.1462-2920.2009.02019.x; Moulin-Schouleur M, 2007, J CLIN MICROBIOL, V45, P3366, DOI 10.1128/JCM.00037-07; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Prasadarao NV, 1996, INFECT IMMUN, V64, P146, DOI 10.1128/IAI.64.1.146-153.1996; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Sandner L, 2001, MICROBIOL-SGM, V147, P3149, DOI 10.1099/00221287-147-11-3149; Sankar TS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000405; Sokurenko EV, 1999, TRENDS MICROBIOL, V7, P191, DOI 10.1016/S0966-842X(99)01493-6; Tamames J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r94; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TANAKA T, 1989, MOL BIOL EVOL, V6, P447; Tartof SY, 2007, J MED MICROBIOL, V56, P1363, DOI 10.1099/jmm.0.47262-0; Threlfall EJ, 1998, INT J ANTIMICROB AG, V9, P201, DOI 10.1016/S0924-8579(97)00055-1; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Wang DD, 2001, J BACTERIOL, V183, P4210, DOI 10.1128/JB.183.14.4210-4216.2001; Wang Y, 1999, INFECT IMMUN, V67, P4751, DOI 10.1128/IAI.67.9.4751-4756.1999; Weissman SJ, 2006, MOL MICROBIOL, V59, P975, DOI 10.1111/j.1365-2958.2005.04985.x; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Zhang R, 2004, BIOINFORMATICS, V20, P612, DOI 10.1093/bioinformatics/btg453; Zou YM, 2008, MED MICROBIOL IMMUN, V197, P337, DOI 10.1007/s00430-007-0065-y	69	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10877	10.1371/journal.pone.0010877	http://dx.doi.org/10.1371/journal.pone.0010877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526361	gold, Green Published, Green Submitted			2022-12-27	WOS:000278222100008
J	Liao, CZ; Luo, YQ; Fang, CM; Li, B				Liao, Chengzhang; Luo, Yiqi; Fang, Changming; Li, Bo			Ecosystem Carbon Stock Influenced by Plantation Practice: Implications for Planting Forests as a Measure of Climate Change Mitigation	PLOS ONE			English	Article							SOIL CARBON; PINE PLANTATIONS; LAND-USE; TREE PLANTATIONS; SOUTHERN CHINA; CONVERSION; STORAGE; NITROGEN; METAANALYSIS; DYNAMICS	Uncertainties remain in the potential of forest plantations to sequestrate carbon (C). We synthesized 86 experimental studies with paired-site design, using a meta-analysis approach, to quantify the differences in ecosystem C pools between plantations and their corresponding adjacent primary and secondary forests (natural forests). Totaled ecosystem C stock in plant and soil pools was 284 Mg C ha(-1) in natural forests and decreased by 28% in plantations. In comparison with natural forests, plantations decreased aboveground net primary production, litterfall, and rate of soil respiration by 11, 34, and 32%, respectively. Fine root biomass, soil C concentration, and soil microbial C concentration decreased respectively by 66, 32, and 29% in plantations relative to natural forests. Soil available N, P and K concentrations were lower by 22, 20 and 26%, respectively, in plantations than in natural forests. The general pattern of decreased ecosystem C pools did not change between two different groups in relation to various factors: stand age (<25 years vs. <= 25 years), stand types (broadleaved vs. coniferous and deciduous vs. evergreen), tree species origin (native vs. exotic) of plantations, land-use history (afforestation vs. reforestation) and site preparation for plantations (unburnt vs. burnt), and study regions (tropic vs. temperate). The pattern also held true across geographic regions. Our findings argued against the replacement of natural forests by the plantations as a measure of climate change mitigation.	[Liao, Chengzhang; Luo, Yiqi; Fang, Changming; Li, Bo] Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers Sci & Ecol Engn, Coastal Ecosyst Res Stn Yangtze River Estuary,Min, Shanghai 200433, Peoples R China; [Luo, Yiqi] Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA	Fudan University; University of Oklahoma System; University of Oklahoma - Norman	Liao, CZ (corresponding author), Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers Sci & Ecol Engn, Coastal Ecosyst Res Stn Yangtze River Estuary,Min, Shanghai 200433, Peoples R China.	031023079@fudan.edu.cn	Li, Bo/B-8016-2010; Li, Bo/AAA-8968-2020	Li, Bo/0000-0002-0439-5666; Li, Bo/0000-0002-7294-6888	National Basic Research Program of China [2006CB403305]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (grant no. 2006CB403305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo CBM, 2009, FOREST ECOL MANAG, V257, P1776, DOI 10.1016/j.foreco.2009.01.034; Ashagrie Y, 2005, AGR ECOSYST ENVIRON, V106, P89, DOI 10.1016/j.agee.2004.07.015; Berg B., 2003, DECOMPOSITION PROCES; Berthrong ST, 2009, ECOL APPL, V19, P2228, DOI 10.1890/08-1730.1; Borken W, 2003, GLOBAL CHANGE BIOL, V9, P956, DOI 10.1046/j.1365-2486.2003.00631.x; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Chen GS, 2005, ANN FOREST SCI, V62, P659, DOI 10.1051/forest:2005073; Chen Sha, 2007, Zhiwu Shengtai Xuebao, V31, P431; Cromack K, 1999, SOIL SCI SOC AM J, V63, P232, DOI 10.2136/sssaj1999.03615995006300010034x; CUEVAS E, 1991, PLANT SOIL, V135, P257, DOI 10.1007/BF00010914; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Goma-Tchimbakala J, 2006, FOREST ECOL MANAG, V229, P304, DOI 10.1016/j.foreco.2006.04.009; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; HARMON ME, 1990, SCIENCE, V247, P699, DOI 10.1126/science.247.4943.699; Ishizuka S, 2005, NUTR CYCL AGROECOSYS, V71, P17, DOI 10.1007/s10705-004-0382-0; Jackson RB, 2005, SCIENCE, V310, P1944, DOI 10.1126/science.1119282; Kasel S, 2007, GEODERMA, V137, P401, DOI 10.1016/j.geoderma.2006.09.002; Laclau P, 2003, FOREST ECOL MANAG, V180, P317, DOI 10.1016/S0378-1127(02)00580-7; Lemenih M, 2004, FOREST ECOL MANAG, V194, P1, DOI 10.1016/j.foreco.2004.01.050; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; LIAO CZ, 2010, GLOBAL CHAN IN PRESS; Liu S., 1997, WETLANDS ECOLOGY MAN, V4, P257; Livesley SJ, 2009, GLOBAL CHANGE BIOL, V15, P425, DOI 10.1111/j.1365-2486.2008.01759.x; Luo Yand, 2006, SOIL RESP ENV; Luo YQ, 2006, ECOLOGY, V87, P53, DOI 10.1890/04-1724; Luo Yun-jian, 2006, Forest Research, V19, P791; Morishita T, 2007, SOIL SCI PLANT NUTR, V53, P678, DOI 10.1111/j.1747-0765.2007.00181.x; NIHLGARD B, 1972, OIKOS, V23, P69, DOI 10.2307/3543928; Ordonez JAB, 2008, FOREST ECOL MANAG, V255, P2074, DOI 10.1016/j.foreco.2007.12.024; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Pypker TG, 2005, AGR FOREST METEOROL, V130, P113, DOI 10.1016/j.agrformet.2005.03.003; Richter DD, 1999, NATURE, V400, P56, DOI 10.1038/21867; Smith CK, 2002, FOREST ECOL MANAG, V164, P257, DOI 10.1016/S0378-1127(01)00599-0; Tang XL, 2006, GLOBAL CHANGE BIOL, V12, P546, DOI 10.1111/j.1365-2486.2006.01109.x; Tateno R, 2007, FOREST ECOL MANAG, V241, P84, DOI 10.1016/j.foreco.2006.12.026; van Dijk AIJM, 2007, FOREST ECOL MANAG, V251, P1, DOI 10.1016/j.foreco.2007.06.010; Wall A, 2005, PLANT SOIL, V275, P247, DOI 10.1007/s11104-005-1869-4; Winjum JK, 1997, AGR FOREST METEOROL, V84, P153, DOI 10.1016/S0168-1923(96)02383-0; Yang YS, 2005, FOREST ECOL MANAG, V216, P216, DOI 10.1016/j.foreco.2005.05.030; Zheng H, 2008, FOREST ECOL MANAG, V255, P1113, DOI 10.1016/j.foreco.2007.10.015	40	96	103	8	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10867	10.1371/journal.pone.0010867	http://dx.doi.org/10.1371/journal.pone.0010867			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523733	Green Published, gold			2022-12-27	WOS:000278221900015
J	Sokolowski, P; Saison, F; Giles, W; McGrath, S; Smith, D; Smith, J; Smith, R				Sokolowski, Peter; Saison, Francis; Giles, Warwick; McGrath, Shaun; Smith, David; Smith, Julia; Smith, Roger			Human Uterine Wall Tension Trajectories and the Onset of Parturition	PLOS ONE			English	Article							TOTAL INTRAUTERINE VOLUME; MYOMETRIAL THICKNESS; GROWTH-RETARDATION; LABOR; PRESSURE; PREDICTION; PREGNANCY	Uterine wall tension is thought to be an important determinant of the onset of labor in pregnant women. We characterize human uterine wall tension using ultrasound from the second trimester of pregnancy until parturition and compare preterm, term and twin pregnancies. A total of 320 pregnant women were followed from first antenatal visit to delivery during the period 2000-2004 at the John Hunter Hospital, NSW, Australia. The uterine wall thickness, length, anterior-posterior diameter and transverse diameter were determined by serial ultrasounds. Subjects were divided into three groups: women with singleton pregnancies and spontaneous labor onset, either preterm or term and women with twin pregnancies. Intrauterine pressure results from the literature were combined with our data to form trajectories for uterine wall thickness, volume and tension for each woman using the prolate ellipsoid method and the groups were compared at 20, 25 and 30 weeks gestation. Uterine wall tension followed an exponential curve, with results increasing throughout pregnancy with the site of maximum tension on the anterior wall. For those delivering preterm, uterine wall thickness was increased P<0.05 compared with term. For twin pregnancies intrauterine volume was increased compared to singletons (P<0.001), but wall thickness was not. There was no evidence for increased tension in those delivering preterm or those with twin gestations. These data are not consistent with a role for high uterine wall tension as a causal factor in preterm spontaneous labor in singleton or twin gestations. It seems likely that hormonal differences in multiple gestations are responsible for increased rates of preterm birth in this group rather than increased tension.	[Sokolowski, Peter; Saison, Francis; Giles, Warwick; McGrath, Shaun; Smith, Julia; Smith, Roger] Univ Newcastle, Mothers & Babies Res Ctr, Hunter Med Res Inst, John Hunter Hosp, Newcastle, NSW 2308, Australia; [Sokolowski, Peter] Univ Newcastle, Sch Elect Engn & Comp Sci, Callaghan, NSW 2308, Australia; [Smith, David] Univ Western Australia, Fac Engn Comp & Math, Crawley, Australia	Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle; University of Newcastle; University of Western Australia	Sokolowski, P (corresponding author), Univ Newcastle, Mothers & Babies Res Ctr, Hunter Med Res Inst, John Hunter Hosp, Newcastle, NSW 2308, Australia.	peters@ieee.org	Smith, David W/H-5856-2014	Smith, David W/0000-0003-4864-0288; Smith, Roger/0000-0003-4720-0280; Sokolowski, Peter/0000-0001-8910-1294	Australian Postgraduate Award [2001-2002]; Thyne Reid Trust	Australian Postgraduate Award(Australian Government); Thyne Reid Trust	Peter Sokolowski received Australian Postgraduate Award support (2001-2002). Funding for this study was received from the Thyne Reid Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON AB, 1967, AM J OBSTET GYNECOL, V97, P992, DOI 10.1016/0002-9378(67)90529-7; Beeby PJ, 1996, J PAEDIATR CHILD H, V32, P512, DOI 10.1111/j.1440-1754.1996.tb00965.x; BLOCH E. D., 1997, 1 COURSE GEOMETRIC T; Buhimschi CS, 2005, AM J OBSTET GYNECOL, V193, P762, DOI 10.1016/j.ajog.2005.01.053; Conde-Agudelo A, 2000, OBSTET GYNECOL, V95, P899, DOI 10.1016/S0029-7844(99)00640-7; Csapo A, 1970, Obstet Gynecol Surv, V25, P403, DOI 10.1097/00006254-197005000-00001; Cunningham FG, 1997, WILLIAMS OBSTETRICS, P607; Degani S, 1998, J ULTRAS MED, V17, P661, DOI 10.7863/jum.1998.17.10.661; FISK NM, 1992, BRIT J OBSTET GYNAEC, V99, P18, DOI 10.1111/j.1471-0528.1992.tb14385.x; GARDNER MO, 1995, OBSTET GYNECOL, V85, P553, DOI 10.1016/0029-7844(94)00455-M; GOHARI P, 1977, AM J OBSTET GYNECOL, V127, P255, DOI 10.1016/0002-9378(77)90464-1; GROSSMAN M, 1982, J CLIN ULTRASOUND, V10, P17, DOI 10.1002/jcu.1870100104; James G., 1976, MATH DICT; LEVINE SC, 1979, J CLIN ULTRASOUND, V7, P21, DOI 10.1002/jcu.1870070109; Lye SJ, 2001, FRONT HORM RES, V27, P165; MANABE Y, 1992, PROSTAGLANDINS, V44, P119, DOI 10.1016/0090-6980(92)90073-3; Minakami H, 2000, Twin Res, V3, P2, DOI 10.1375/twin.3.1.2; Monga M, 2004, MATERNAL FETAL MED P, P69; PLATT JF, 1990, J CLIN ULTRASOUND, V18, P15, DOI 10.1002/jcu.1870180105; PROBSTEIN KF, 1994, PHYSICOCHEMICAL HYDR; Romero R, 1998, AM J OBSTET GYNECOL, V179, P186, DOI 10.1016/S0002-9378(98)70271-6; SFAKIANAKI AK, 2008, AM J OBSTET GYNECOL, V198, pNI162; Skowronski MD, 2006, IEEE T BIO-MED ENG, V53, P1983, DOI 10.1109/TBME.2006.877104; Smith R, 2009, J CLIN ENDOCR METAB, V94, P2066, DOI 10.1210/jc.2008-2257; STEER PJ, 1993, BRIT J OBSTET GYNAEC, V100, P32, DOI 10.1111/j.1471-0528.1993.tb10634.x; ULMSTEN U, 1979, ACTA OBSTET GYN SCAN, V58, P547, DOI 10.3109/00016347909154617; Warner BB, 2000, CLIN PERINATOL, V27, P347, DOI 10.1016/S0095-5108(05)70025-7; WATHES DC, 1982, J REPROD FERTIL, V65, P497, DOI 10.1530/jrf.0.0650497	28	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11037	10.1371/journal.pone.0011037	http://dx.doi.org/10.1371/journal.pone.0011037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585649	Green Submitted, Green Published, gold			2022-12-27	WOS:000279135400002
J	Ahmed, SSSJ; Santosh, W				Ahmed, Shiek S. S. J.; Santosh, Winkins			Metallomic Profiling and Linkage Map Analysis of Early Parkinson's Disease: A New Insight to Aluminum Marker for the Possible Diagnosis	PLOS ONE			English	Article							ALZHEIMER A-BETA; INTER-ELEMENT RELATIONS; OXIDATIVE STRESS; NEURODEGENERATION; SCHIZOPHRENIA; RISK; IRON; HOMEOSTASIS; COMPLEXITY; CU(II)	Background: Parkinson's disease (PD) is the most common neurodegenerative disorder. The diagnosis of PD is challenging and currently none of the biochemical tests have proven to help in diagnosis. Serum metallomic analysis may suggest the possibility of diagnosis of PD. Methodology/Results: The metallomic analysis was targeted on 31 elements obtained from 42 healthy controls and 45 drug naive PD patients using ICP-AES and ICP-MS to determine the concentration variations of elements between PD and normal. The targeted metallomic analysis showed the significant variations in 19 elements of patients compared to healthy control (p < 0.04). The partial least squares discriminant analysis (PLS-DA) showed aluminium, copper, iron, manganese and zinc are the key elements, contributes the separation of PD patients from control samples. The correlation coefficient analysis and element-element ratio confirm the imbalance of inter-elements relationship in PD patients' serum. Furthermore, elements linkage map analysis showed aluminium is a key element involved in triggering of phosphorus, which subsequently lead to imbalance of homeostatic in PD serum. The execution of neural network using elements concentrations provides 95% accuracy in detection of disease. Conclusions/Significance: These results suggest that there is a disturbance in the elements homeostasis and inter-elements relationship in PD patients' serum. The analysis of serum elements helps in linking the underlying cellular processes such as oxidative stress, neuronal dysfunction and apoptosis, which are the dominating factors in PD. Also, these results increase the prospect of detection of early PD from serum through neural network algorithm.	[Ahmed, Shiek S. S. J.; Santosh, Winkins] SRM Univ, Sch Bioengn, Dept Biotechnol, Kattankulathur, Tamil Nadu, India	SRM Institute of Science & Technology Chennai	Ahmed, SSSJ (corresponding author), SRM Univ, Sch Bioengn, Dept Biotechnol, Kattankulathur, Tamil Nadu, India.	parkinresearch@gmail.com	Santosh, Winkins/ACE-9180-2022	Santosh, Winkins/0000-0002-8368-6014	SRM University, Kattankulathur, Tamil Nadu, India	SRM University, Kattankulathur, Tamil Nadu, India	SRM University, Kattankulathur, Tamil Nadu, India provided funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT RA, 1992, EUR J CLIN NUTR, V46, P879; Ahmed SSSJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-63; AHMED SSS, 2009, VIB SPECTRO IN PRESS; ALIAS AG, 1972, BIOL PSYCHIAT, V4, P231; Alimonti A, 2007, NEUROTOXICOLOGY, V28, P450, DOI 10.1016/j.neuro.2006.12.001; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; BASUN H, 1991, J NEURAL TRANSM-PARK, V3, P231; Bharathi, 2006, BRAIN RES REV, V52, P275, DOI 10.1016/j.brainresrev.2006.04.003; Bharathi, 2006, Current Alzheimer Research, V3, P311, DOI 10.2174/156720506778249399; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; BUSH AI, 1993, J BIOL CHEM, V268, P16109; Carri MT, 2003, BRAIN RES BULL, V61, P365, DOI 10.1016/S0361-9230(03)00179-5; Cuajungco MP, 1997, BRAIN RES REV, V23, P219, DOI 10.1016/S0165-0173(97)00002-7; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; Gaeta A, 2005, BRIT J PHARMACOL, V146, P1041, DOI 10.1038/sj.bjp.0706416; GARRUTO RM, 1993, ALZHEIMERS DIS ADV C, P257; GELB, 1999, ARCH NEUROL-CHICAGO, V56, P33; Ghribi O, 2001, MOL BRAIN RES, V96, P30, DOI 10.1016/S0169-328X(01)00256-X; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; GILLIAN L, 1997, NATL COMMITTEE CLIN, V17, P1; Guttman M, 2003, CAN MED ASSOC J, V168, P293; Haaxma CA, 2007, J NEUROL NEUROSUR PS, V78, P819, DOI 10.1136/jnnp.2006.103788; Hagve Tor-Arne, 2009, Tidsskr Nor Laegeforen, V129, P863, DOI 10.4045/tidsskr.08.0084; Harrison-Findik DD, 2009, WORLD J GASTROENTERO, V15, P1186, DOI 10.3748/wjg.15.1186; Hasegawa T, 2003, ANAL SCI, V19, P147, DOI 10.2116/analsci.19.147; Hegde ML, 2004, J TRACE ELEM MED BIO, V18, P163, DOI 10.1016/j.jtemb.2004.09.003; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Hur CI, 2008, CLIN ORTHOP RELAT R, V466, P696, DOI 10.1007/s11999-007-0093-3; JIMENEZJIMENEZ FJ, 1992, J NEUROL SCI, V112, P30; KALRA J, 1992, MOL CELL BIOCHEM, V110, P165, DOI 10.1007/BF02454194; KOICHI W, 2003, BIOMED RES TRACE ELE, V14, P275; Kuloglu M, 2002, CELL BIOCHEM FUNCT, V20, P171, DOI 10.1002/cbf.940; Malecki EA, 2001, BRAIN RES BULL, V55, P225, DOI 10.1016/S0361-9230(01)00456-7; Mustak MS, 2008, CLIN CHIM ACTA, V394, P47, DOI 10.1016/j.cca.2008.04.003; *NAT COMM CLIN LAB, NAT COMM CLIN LAB ST; Nikolov IG, 2009, BLOOD PURIFICAT, V27, P350, DOI 10.1159/000209248; O'Keeffe GC, 2009, ANN NY ACAD SCI, V1180, P97, DOI 10.1111/j.1749-6632.2009.04943.x; OLATUNBOSUN DA, 1975, BRIT J PSYCHIAT, V127, P119, DOI 10.1192/bjp.127.2.119; Park W, 2009, DIABETES RES CLIN PR, V83, P119, DOI 10.1016/j.diabres.2008.08.018; Pfeiffer C. C., 1972, International Review of Neurobiology, P141; Rao KSJ, 1999, ALZHEIMERS REP, V2, P241; Savory J, 1999, NEUROTOXICOLOGY, V20, P805; Savory J, 2003, J INORG BIOCHEM, V97, P151, DOI 10.1016/S0162-0134(03)00258-7; SEILER HG, 1994, HDB METALS CLIN ANAL, P10; Strong Michael J., 1994, P39; TAKUYA H, 2001, ANAL SCI, V17, P979; Vasudevaraju BP, 2008, INDIAN J MED RES, V128, P545; Wooten GF, 2004, J NEUROL NEUROSUR PS, V75, P637, DOI 10.1136/jnnp.2003.020982; Youdim M. B. H., 1982, IRON DEFICIENCY BRAI, P39; ZECCA L, 1994, J NEUROCHEM, V62, P1097	50	64	66	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11252	10.1371/journal.pone.0011252	http://dx.doi.org/10.1371/journal.pone.0011252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582167	gold, Green Submitted, Green Published			2022-12-27	WOS:000279058500004
J	Shah, NR; Sunderland, A; Grdzelishvili, VZ				Shah, Nirav R.; Sunderland, Amanda; Grdzelishvili, Valery Z.			Cell Type Mediated Resistance of Vesicular Stomatitis Virus and Sendai Virus to Ribavirin	PLOS ONE			English	Article							HEPATITIS-C VIRUS; SUSTAINED VIROLOGICAL RESPONSE; MOUTH-DISEASE VIRUS; ANTIVIRAL ACTIVITY; LETHAL MUTAGENESIS; IMP DEHYDROGENASE; ADENOSINE KINASE; GENE-EXPRESSION; INFECTED-CELLS; IN-VITRO	Ribavirin (RBV) is a synthetic nucleoside analog with broad spectrum antiviral activity. Although RBV is approved for the treatment of hepatitis C virus, respiratory syncytial virus, and Lassa fever virus infections, its mechanism of action and therapeutic efficacy remains highly controversial. Recent reports show that the development of cell-based resistance after continuous RBV treatment via decreased RBV uptake can greatly limit its efficacy. Here, we examined whether certain cell types are naturally resistant to RBV even without prior drug exposure. Seven different cell lines from various host species were compared for RBV antiviral activity against two nonsegmented negative-strand RNA viruses, vesicular stomatitis virus (VSV, a rhabdovirus) and Sendai virus (SeV, a paramyxovirus). Our results show striking differences between cell types in their response to RBV, ranging from virtually no antiviral effect to very effective inhibition of viral replication. Despite differences in viral replication kinetics for VSV and SeV in the seven cell lines, the observed pattern of RBV resistance was very similar for both viruses, suggesting that cellular rather than viral determinants play a major role in this resistance. While none of the tested cell lines was defective in RBV uptake, dramatic variations were observed in the long-term accumulation of RBV in different cell types, and it correlated with the antiviral efficacy of RBV. While addition of guanosine neutralized RBV only in cells already highly resistant to RBV, actinomycin D almost completely reversed the RBV effect (but not uptake) in all cell lines. Together, our data suggest that RBV may inhibit the same virus via different mechanisms in different cell types depending on the intracellular RBV metabolism. Our results strongly point out the importance of using multiple cell lines of different origin when antiviral efficacy and potency are examined for new as well as established drugs in vitro.	[Shah, Nirav R.; Sunderland, Amanda; Grdzelishvili, Valery Z.] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte	Shah, NR (corresponding author), Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA.	vzgrdzel@uncc.edu	Grdzelishvili, Valery Z./AFL-6027-2022	Grdzelishvili, Valery/0000-0001-8715-3840	state of North Carolina; NIH [5R03AI078122]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI078122] Funding Source: NIH RePORTER	state of North Carolina; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by start-up funds provided by the state of North Carolina and by NIH Grant 5R03AI078122 (to V.Z.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen A, 2003, VIROLOGY, V311, P339, DOI 10.1016/S0042-6822(03)00144-2; BALZARINI J, 1993, J BIOL CHEM, V268, P24591; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Buckwold VE, 2003, ANTIMICROB AGENTS CH, V47, P2293, DOI 10.1128/AAC.47.7.2293-2298.2003; Crotty S, 2002, J MOL MED, V80, P86, DOI 10.1007/s00109-001-0308-0; Cuevas JM, 2009, J VIROL, V83, P5760, DOI 10.1128/JVI.00201-09; Cuevas Jose M., 2005, Infection Genetics and Evolution, V5, P55, DOI 10.1016/S1567-1348(04)00064-4; Das SC, 2006, J VIROL, V80, P6368, DOI 10.1128/JVI.00211-06; Dixit NM, 2006, CELL MOL LIFE SCI, V63, P832, DOI 10.1007/s00018-005-5455-y; Elia G, 2008, ANTIVIR RES, V77, P108, DOI 10.1016/j.antiviral.2007.09.004; Endres CJ, 2009, J PHARMACOL EXP THER, V329, P387, DOI 10.1124/jpet.108.145854; Fukuchi Y, 2010, J HEPATOL, V52, P486, DOI 10.1016/j.jhep.2010.01.011; Gish RG, 2006, J ANTIMICROB CHEMOTH, V57, P8, DOI 10.1093/jac/dki405; Glue P, 1999, SEMIN LIVER DIS, V19, P17; HRUSKA JF, 1980, ANTIMICROB AGENTS CH, V17, P770, DOI 10.1128/AAC.17.5.770; Ibarra KD, 2009, J VIROL, V83, P4538, DOI 10.1128/JVI.02280-08; Jarvis SM, 1998, BRIT J PHARMACOL, V123, P1587, DOI 10.1038/sj.bjp.0701775; Jordan I, 1999, J VIROL, V73, P7903, DOI 10.1128/JVI.73.9.7903-7906.1999; LARSON EW, 1976, ANTIMICROB AGENTS CH, V10, P770, DOI 10.1128/AAC.10.4.770; Leyssen P, 2005, J VIROL, V79, P1943, DOI 10.1128/JVI.79.3.1943-1947.2005; Loustaud-Ratti V, 2008, HEPATOLOGY, V47, P1453, DOI 10.1002/hep.22217; MALINOSKI F, 1980, VIROLOGY, V102, P473, DOI 10.1016/0042-6822(80)90117-8; Martin P, 2008, J GASTROEN HEPATOL, V23, P844, DOI 10.1111/j.1440-1746.2008.05398.x; Marucco DA, 2008, J ANTIMICROB CHEMOTH, V61, P919, DOI 10.1093/jac/dkn013; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Maynard M, 2008, ANTIVIR THER, V13, P607; Murphy AM, 2009, J VIROL, V83, P1669, DOI 10.1128/JVI.01438-08; PAGE T, 1990, INT J BIOCHEM, V22, P379, DOI 10.1016/0020-711X(90)90140-X; Parker WB, 2005, VIRUS RES, V107, P165, DOI 10.1016/j.virusres.2004.11.006; Pelaez A, 2009, J HEART LUNG TRANSPL, V28, P67, DOI 10.1016/j.healun.2008.10.008; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Pfeiffer JK, 2005, J VIROL, V79, P2346, DOI 10.1128/JVI.79.4.2346-2355.2005; SIDWELL RW, 1972, SCIENCE, V177, P705, DOI 10.1126/science.177.4050.705; SIDWELL RW, 1975, CHEMOTHERAPY, V21, P205, DOI 10.1159/000221861; Sierra M, 2007, J VIROL, V81, P2012, DOI 10.1128/JVI.01606-06; SMEE DF, 1982, ANTIMICROB AGENTS CH, V21, P66, DOI 10.1128/AAC.21.1.66; SMEE DF, 1986, ANTIMICROB AGENTS CH, V30, P117, DOI 10.1128/AAC.30.1.117; Sun YJ, 2007, ANTIMICROB AGENTS CH, V51, P84, DOI 10.1128/AAC.00790-06; TOLTZIS P, 1988, ANTIMICROB AGENTS CH, V32, P492, DOI 10.1128/AAC.32.4.492; TOLTZIS P, 1986, ANTIMICROB AGENTS CH, V29, P1010, DOI 10.1128/AAC.29.6.1010; Vignuzzi M, 2005, VIRUS RES, V107, P173, DOI 10.1016/j.virusres.2004.11.007; Wiegand MA, 2007, J VIROL, V81, P13835, DOI 10.1128/JVI.00914-07; WILLIS RC, 1978, P NATL ACAD SCI USA, V75, P3042, DOI 10.1073/pnas.75.7.3042; Wohnsland A, 2007, CLIN MICROBIOL REV, V20, P23, DOI 10.1128/CMR.00010-06; WRAY SK, 1985, ANTIVIR RES, V5, P29, DOI 10.1016/0166-3542(85)90012-9; Wu JZ, 2005, ANTIMICROB AGENTS CH, V49, P2164, DOI 10.1128/AAC.49.6.2164-2171.2005; Zhang J, 2007, CANCER METAST REV, V26, P85, DOI 10.1007/s10555-007-9044-4; Zhang YH, 2003, J VIROL, V77, P5933, DOI 10.1128/JVI.77.10.5933-5947.2003	49	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11265	10.1371/journal.pone.0011265	http://dx.doi.org/10.1371/journal.pone.0011265			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582319	Green Published, gold, Green Submitted			2022-12-27	WOS:000279058500017
J	Gesprasert, G; Wichukchinda, N; Mori, M; Shiino, T; Auwanit, W; Sriwanthana, B; Pathipvanich, P; Sawanpanyalert, P; Miura, T; Auewarakul, P; Thitithanyanont, A; Ariyoshi, K				Gesprasert, Goragoch; Wichukchinda, Nuanjun; Mori, Masahiko; Shiino, Teiichiro; Auwanit, Wattana; Sriwanthana, Busarawan; Pathipvanich, Panita; Sawanpanyalert, Pathom; Miura, Toshiyuki; Auewarakul, Prasert; Thitithanyanont, Arunee; Ariyoshi, Koya			HLA-Associated Immune Pressure on Gag Protein in CRF01_AE-Infected Individuals and Its Association with Plasma Viral Load	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-LYMPHOCYTE EPITOPES; ESCAPE MUTATIONS; HIV-1 INFECTION; VACCINE DESIGN; CLASS-I; TRANSMISSION; ADAPTATION; POLYMORPHISMS; POPULATION	Background: The human leukocyte antigen (HLA)-restricted cytotoxic T-lymphocyte (CTL) immune response is one of the major factors determining the genetic diversity of human immunodeficiency virus (HIV). There are few population-based analyses of the amino acid variations associated with the host HLA type and their clinical relevance for the Asian population. Here, we identified HLA-associated polymorphisms in the HIV-1 CRF01_AE Gag protein in infected married couples, and examined the consequences of these HLA-selected mutations after transmission to HLA-unmatched recipients. Methodology/Principal Findings: One hundred sixteen HIV-1-infected couples were recruited at a government hospital in northern Thailand. The 1.7-kb gag gene was amplified and directly sequenced. We identified 56 associations between amino acid variations in Gag and HLA alleles. Of those amino acid variations, 35 (62.5%) were located within or adjacent to regions reported to be HIV-specific CTL epitopes restricted by the relevant HLA. Interestingly, a significant number of HLA-associated amino acid variations appear to be unique to the CRF01_AE-infected Thai population. Variations in the capsid protein (p24) had the strongest associations with the viral load and CD4 cell count. The mutation and reversion rates after transmission to a host with a different HLA environment varied considerably. The p24 T242N variant escape from B57/58 CTL had a significant impact on the HIV-1 viral load of CRF01_AE-infected patients. Conclusions/Significance: HLA-associated amino acid mutations and the CTL selection pressures on the p24 antigen appear to have the most significant impact on HIV replication in a CRF01_AE-infected Asian population. HLA-associated mutations with a low reversion rate accumulated as a footprint in this Thai population. The novel HLA-associated mutations identified in this study encourage us to acquire more extensive information about the viral dynamics of HLA-associated amino acid polymorphisms in a given population as effective CTL vaccine targets.	[Gesprasert, Goragoch; Thitithanyanont, Arunee] Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok 10400, Thailand; [Wichukchinda, Nuanjun; Auwanit, Wattana; Sriwanthana, Busarawan; Sawanpanyalert, Pathom] Minist Publ Hlth, Natl Inst Hlth, Dept Med Sci, Nonthaburi, Thailand; [Mori, Masahiko; Ariyoshi, Koya] Nagasaki Univ, Inst Trop Med NEKKEN, Nagasaki 852, Japan; [Shiino, Teiichiro] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Pathipvanich, Panita] Lampang Hosp, Day Care Ctr, Lampang, Thailand; [Miura, Toshiyuki] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Tokyo, Japan; [Auewarakul, Prasert] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10400, Thailand; [Ariyoshi, Koya] Nagasaki Univ, Global COE Program, Nagasaki 852, Japan	Mahidol University; Ministry of Public Health - Thailand; Nagasaki University; National Institute of Infectious Diseases (NIID); University of Tokyo; Mahidol University; Nagasaki University	Thitithanyanont, A (corresponding author), Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok 10400, Thailand.	scaty@mahidol.ac.th	Thitithanyanont, Arunee/AAN-4383-2021; Auewarakul, Prasert/D-6015-2011	Thitithanyanont, Arunee/0000-0002-9756-4763; Auewarakul, Prasert/0000-0002-4745-4291	National Center for Genetic Engineering and Biotechnology (BIOTEC), Thailand; Japan International Cooperation Agency (JICA); Japan Ministry of Health, Labour and Welfare; Nagasaki University; Ministry of Public Health of Thailand; Department of Medical Sciences, Thailand	National Center for Genetic Engineering and Biotechnology (BIOTEC), Thailand; Japan International Cooperation Agency (JICA); Japan Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Nagasaki University; Ministry of Public Health of Thailand; Department of Medical Sciences, Thailand	This study was mainly supported by the National Center for Genetic Engineering and Biotechnology (BIOTEC), Thailand and the Japan International Cooperation Agency (JICA) and partially by the Japan Ministry of Health, Labour and Welfare, Nagasaki University gCOE Program, Ministry of Public Health of Thailand and Department of Medical Sciences, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Borroto R J, 1997, Rev Panam Salud Publica, V1, P3; Brockman MA, 2007, J VIROL, V81, P12608, DOI 10.1128/JVI.01369-07; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Chopera DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000033; Fongsatikul Ladda, 1997, Journal of the Medical Association of Thailand, V80, pS38; FRAHM BBN, 2008, HIV MOL IMMUNOLOGY 2, P3; Furutsuki T, 2004, J VIROL, V78, P8437, DOI 10.1128/JVI.78.16.8437-8445.2004; Geldmacher C, 2007, J VIROL, V81, P2440, DOI 10.1128/JVI.01847-06; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goulder PJR, 1996, AIDS RES HUM RETROV, V12, P1691, DOI 10.1089/aid.1996.12.1691; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lau KA, 2007, AIDS REV, V9, P218; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Matthews PC, 2009, J VIROL, V83, P4605, DOI 10.1128/JVI.02017-08; McMichael AJ, 2003, NAT MED, V9, P874, DOI 10.1038/nm0703-874; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Romphruk A, 1996, J Med Assoc Thai, V79, P732; Ruxrungtham K, 2004, LANCET, V364, P69, DOI 10.1016/S0140-6736(04)16593-8; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Stephens HAF, 2005, TRENDS IMMUNOL, V26, P41, DOI 10.1016/j.it.2004.11.001; Wichukchinda N, 2007, AIDS RES HUM RETROV, V23, P686, DOI 10.1089/aid.2006.0212; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	35	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11179	10.1371/journal.pone.0011179	http://dx.doi.org/10.1371/journal.pone.0011179			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567513	Green Published, gold, Green Submitted			2022-12-27	WOS:000278886300021
J	Lanyon, LJ; Denham, SL				Lanyon, Linda J.; Denham, Susan L.			Modelling Visual Neglect: Computational Insights into Conscious Perception	PLOS ONE			English	Article							OBJECT-BASED ATTENTION; INFERIOR TEMPORAL CORTEX; PARIETAL CORTEX; BIASED COMPETITION; ORBITOFRONTAL CORTEX; SELECTIVE ATTENTION; UNILATERAL NEGLECT; FRONTAL-LOBE; SEARCH; INHIBITION	Background: Visual neglect is an attentional deficit typically resulting from parietal cortex lesion and sometimes frontal lesion. Patients fail to attend to objects and events in the visual hemifield contralateral to their lesion during visual search. Methodology/Principal Finding: The aim of this work was to examine the effects of parietal and frontal lesion in an existing computational model of visual attention and search and simulate visual search behaviour under lesion conditions. We find that unilateral parietal lesion in this model leads to symptoms of visual neglect in simulated search scan paths, including an inhibition of return (IOR) deficit, while frontal lesion leads to milder neglect and to more severe deficits in IOR and perseveration in the scan path. During simulations of search under unilateral parietal lesion, the model's extrastriate ventral stream area exhibits lower activity for stimuli in the neglected hemifield compared to that for stimuli in the normally perceived hemifield. This could represent a computational correlate of differences observed in neuroimaging for unconscious versus conscious perception following parietal lesion. Conclusions/Significance: Our results lead to the prediction, supported by effective connectivity evidence, that connections between the dorsal and ventral visual streams may be an important factor in the explanation of perceptual deficits in parietal lesion patients and of conscious perception in general.	[Lanyon, Linda J.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Human Vis & Eye Movement Lab, Vancouver, BC V5Z 1M9, Canada; [Lanyon, Linda J.] Univ British Columbia, Dept Med Neurol, Vancouver, BC V5Z 1M9, Canada; [Lanyon, Linda J.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Denham, Susan L.] Univ Plymouth, Sch Psychol, Ctr Robot & Neural Syst, Plymouth PL4 8AA, Devon, England	University of British Columbia; University of British Columbia; University of British Columbia; University of Plymouth	Lanyon, LJ (corresponding author), Univ British Columbia, Dept Ophthalmol & Visual Sci, Human Vis & Eye Movement Lab, Vancouver, BC V5Z 1M9, Canada.	llanyon@eyecarecentre.org	Lanyon, Linda/L-9238-2019	Lanyon, Linda/0000-0002-0885-1825; denham, susan/0000-0002-0988-5672	Michael Smith Foundation for Health	Michael Smith Foundation for Health(Michael Smith Foundation for Health Research)	LL was supported by a Michael Smith Foundation for Health Research Post-Doctoral Fellowship (www.MSFHR.org) during the final stages and write-up of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrmann M, 2004, CORTEX, V40, P247, DOI 10.1016/S0010-9452(08)70120-5; Behrmann M, 1997, NEUROPSYCHOLOGIA, V35, P1445, DOI 10.1016/S0028-3932(97)00058-4; BINDER J, 1992, ARCH NEUROL-CHICAGO, V49, P1187, DOI 10.1001/archneur.1992.00530350109026; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Chelazzi L, 2001, CEREB CORTEX, V11, P761, DOI 10.1093/cercor/11.8.761; Chelazzi L, 1998, J NEUROPHYSIOL, V80, P2918, DOI 10.1152/jn.1998.80.6.2918; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Corchs S, 2002, CEREB CORTEX, V12, P339, DOI 10.1093/cercor/12.4.339; DAMASIO AR, 1980, NEUROPSYCHOLOGIA, V18, P123, DOI 10.1016/0028-3932(80)90058-5; Danziger S, 1998, J EXP PSYCHOL HUMAN, V24, P1467, DOI 10.1037/0096-1523.24.5.1467; Deco G, 2002, NEUROCOMPUTING, V44, P775, DOI 10.1016/S0925-2312(02)00471-X; Deco G, 2001, LECT NOTES ARTIF INT, V2036, P114; Deco G, 2002, EUR J NEUROSCI, V16, P1994, DOI 10.1046/j.1460-9568.2002.02279.x; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Driver J, 2001, NEUROIMAGE, V14, pS68, DOI 10.1006/nimg.2001.0842; Farivar R, 2009, J NEUROSCI, V29, P5336, DOI 10.1523/JNEUROSCI.4978-08.2009; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; HEILMAN KM, 1972, NEUROLOGY, V22, P660, DOI 10.1212/WNL.22.6.660; Heinke D, 2003, PSYCHOL REV, V110, P29, DOI 10.1037//0033-295X.110.1.29; Hodgson TL, 2002, NEUROPSYCHOLOGIA, V40, P1891, DOI 10.1016/S0028-3932(02)00064-7; Husain M, 2001, BRAIN, V124, P941, DOI 10.1093/brain/124.5.941; Husain M, 2007, TRENDS COGN SCI, V11, P30, DOI 10.1016/j.tics.2006.10.011; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Karnath HO, 1998, J COGNITIVE NEUROSCI, V10, P680, DOI 10.1162/089892998563095; Klein RM, 1999, PSYCHOL SCI, V10, P346, DOI 10.1111/1467-9280.00166; Lanyon L, 2005, PROG NEURAL PROCESS, V16, P239, DOI 10.1142/9789812701886_0025; Lanyon L, 2005, LECT NOTES COMPUT SC, V3368, P42; Lanyon LJ, 2009, COGN NEURODYNAMICS, V3, P223, DOI 10.1007/s11571-008-9073-x; Lanyon LJ, 2004, NEUROCOMPUTING, V58, P655, DOI 10.1016/j.neucom.2004.01.110; Lanyon LJ, 2004, NEURAL NETWORKS, V17, P873, DOI 10.1016/j.neunet.2004.03.012; Mannan SK, 2005, J COGNITIVE NEUROSCI, V17, P340, DOI 10.1162/0898929053124983; Milner A. D., 1995, VISUAL BRAIN ACTION; Motter BC, 1998, VISION RES, V38, P1805, DOI 10.1016/S0042-6989(97)00349-0; Mozer MC, 1997, J COGNITIVE NEUROSCI, V9, P171, DOI 10.1162/jocn.1997.9.2.171; Na DL, 1999, NEUROLOGY, V52, P1569, DOI 10.1212/WNL.52.8.1569; Niemeier M, 2000, NEUROLOGY, V54, P515, DOI 10.1212/WNL.54.2.515; POSNER MI, 1984, J NEUROSCI, V4, P1863; Pouget A, 1997, PHILOS T R SOC B, V352, P1449, DOI 10.1098/rstb.1997.0131; Rees G, 2002, NEUROCASE, V8, P387, DOI 10.1093/neucas/8.5.387; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Rees G, 2000, BRAIN, V123, P1624, DOI 10.1093/brain/123.8.1624; Rieger JW, 2008, BRAIN RES, V1233, P89, DOI 10.1016/j.brainres.2008.07.108; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rolls ET, 2002, COMPUTATIONAL NEUROS; Rushworth MFS, 2006, CEREB CORTEX, V16, P1418, DOI 10.1093/cercor/bhj079; Tipper SP, 1996, J EXP PSYCHOL HUMAN, V22, P1289, DOI 10.1037//0096-1523.22.5.1289; TSOTSOS JK, 1995, ARTIF INTELL, V78, P507, DOI 10.1016/0004-3702(95)00025-9; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Usher M, 1996, J COGNITIVE NEUROSCI, V8, P311, DOI 10.1162/jocn.1996.8.4.311; Vuilleumier P, 2001, P NATL ACAD SCI USA, V98, P3495, DOI 10.1073/pnas.051436898; WATSON RT, 1979, NEUROLOGY, V29, P690, DOI 10.1212/WNL.29.5.690; WEINTRAUB S, 1988, J NEUROL NEUROSUR PS, V51, P1481, DOI 10.1136/jnnp.51.12.1481	52	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11128	10.1371/journal.pone.0011128	http://dx.doi.org/10.1371/journal.pone.0011128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559559	Green Published, Green Submitted, gold			2022-12-27	WOS:000278775900018
J	Paige, SL; Osugi, T; Afanasiev, OK; Pabon, L; Reinecke, H; Murry, CE				Paige, Sharon L.; Osugi, Tomoaki; Afanasiev, Olga K.; Pabon, Lil; Reinecke, Hans; Murry, Charles E.			Endogenous Wnt/beta-Catenin Signaling Is Required for Cardiac Differentiation in Human Embryonic Stem Cells	PLOS ONE			English	Article							PRIMITIVE STREAK; WNT; CARDIOMYOCYTES; SPECIFICATION; INDUCTION	Background: Wnt/beta-catenin signaling is an important regulator of differentiation and morphogenesis that can also control stem cell fates. Our group has developed an efficient protocol to generate cardiomyocytes from human embryonic stem (ES) cells via induction with activin A and BMP4. Methodology/Principal Findings: We tested the hypothesis that Wnt/beta-catenin signals control both early mesoderm induction and later cardiac differentiation in this system. Addition of exogenous Wnt3a at the time of induction enhanced cardiac differentiation, while early inhibition of endogenous Wnt/beta-catenin signaling with Dkk1 inhibited cardiac differentiation, as indicated by quantitative RT-PCR analysis for beta-myosin heavy chain (beta-MHC), cardiac troponin T (cTnT), Nkx2.5, and flow cytometry analysis for sarcomeric myosin heavy chain (sMHC). Conversely, late antagonism of endogenously produced Wnts enhanced cardiogenesis, indicating a biphasic role for the pathway in human cardiac differentiation. Using quantitative RT-PCR, we show that canonical Wnt ligand expression is induced by activin A/BMP4 treatment, and the extent of early Wnt ligand expression can predict the subsequent efficiency of cardiogenesis. Measurement of Brachyury expression showed that addition of Wnt3a enhances mesoderm induction, whereas blockade of endogenously produced Wnts markedly inhibits mesoderm formation. Finally, we show that Wnt/beta-catenin signaling is required for Smad1 activation by BMP4. Conclusions/Significance: Our data indicate that induction of mesoderm and subsequent cardiac differentiation from human ES cells requires fine-tuned cross talk between activin A/BMP4 and Wnt/beta-catenin pathways. Controlling these pathways permits efficient generation of cardiomyocytes for basic studies or cardiac repair applications.	[Paige, Sharon L.; Osugi, Tomoaki; Afanasiev, Olga K.; Pabon, Lil; Reinecke, Hans; Murry, Charles E.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Paige, Sharon L.; Osugi, Tomoaki; Afanasiev, Olga K.; Pabon, Lil; Reinecke, Hans; Murry, Charles E.] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Paige, Sharon L.; Osugi, Tomoaki; Afanasiev, Olga K.; Pabon, Lil; Reinecke, Hans; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Paige, SL (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	murry@u.washington.edu			NIH [R01 HL64387, P01 HL03174, R01 HL084642, P01 GM081719, F30 HL095343]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064387, P01HL003174, F30HL095343, R01HL084642] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants R01 HL64387, P01 HL03174, R01 HL084642, and P01 GM081719. Sharon Paige was supported through NIH F30 HL095343. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Fukuda K, 2006, CIRC RES, V98, P1002, DOI 10.1161/01.RES.0000218272.18669.6e; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Golob JL, 2008, DEV DYNAM, V237, P1389, DOI 10.1002/dvdy.21545; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Liao R, 2007, PROG CARDIOVASC DIS, V50, P18, DOI 10.1016/j.pcad.2007.03.001; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Menasche P, 2007, PROG CARDIOVASC DIS, V50, P7, DOI 10.1016/j.pcad.2007.02.002; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Nakamura T, 2003, P NATL ACAD SCI USA, V100, P5834, DOI 10.1073/pnas.0935626100; Nakanishi M, 2009, FASEB J, V23, P114, DOI 10.1096/fj.08-111203; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Wu SM, 2008, CELL, V132, P537, DOI 10.1016/j.cell.2008.02.002; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971	22	196	213	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11134	10.1371/journal.pone.0011134	http://dx.doi.org/10.1371/journal.pone.0011134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559569	Green Submitted, Green Published, gold			2022-12-27	WOS:000278775900023
J	Undurraga, EA; Eisenberg, DTA; Magvanjav, O; Wang, RX; Leonard, WR; McDade, TW; Reyes-Garcia, V; Nyberg, C; Tanner, S; Huanca, T; Godoy, RA				Undurraga, Eduardo A.; Eisenberg, Dan T. A.; Magvanjav, Oyunbileg; Wang, Ruoxue; Leonard, William R.; McDade, Thomas W.; Reyes-Garcia, Victoria; Nyberg, Colleen; Tanner, Susan; Huanca, Tomas; Godoy, Ricardo A.		TAPS Bolivia Study Team	Human's Cognitive Ability to Assess Facial Cues from Photographs: A Study of Sexual Selection in the Bolivian Amazon	PLOS ONE			English	Article							PHYSICAL ATTRACTIVENESS; HEALTH; SYMMETRY; BEAUTY; FACE; INCOME; INTELLIGENCE; COMPETITION; EVOLUTION; ACCURACY	Background: Evolutionary theory suggests that natural selection favors the evolution of cognitive abilities which allow humans to use facial cues to assess traits of others. The use of facial and somatic cues by humans has been studied mainly in western industrialized countries, leaving unanswered whether results are valid across cultures. Methodology/Principal Findings: Our objectives were to test (i) if previous finding about raters' ability to get accurate information about an individual by looking at his facial photograph held in low-income non western rural societies and (ii) whether women and men differ in this ability. To answer the questions we did a study during July-August 2007 among the Tsimane', a native Amazonian society of foragers-farmers in Bolivia. We asked 40 females and 40 males 16-25 years of age to rate four traits in 93 facial photographs of other Tsimane' males. The four traits were based on sexual selection theory, and included health, dominance, knowledge, and sociability. The rating scale for each trait ranged from one (least) to four (most). The average rating for each trait was calculated for each individual in the photograph and regressed against objective measures of the trait from the person in the photograph. We found that (i) female Tsimane' raters were able to assess facial cues related to health, dominance, and knowledge and (ii) male Tsimane' raters were able to assess facial cues related to dominance, knowledge, and sociability. Conclusions/Significance: Our results support the existence of a human ability to identify objective traits from facial cues, as suggested by evolutionary theory.	[Undurraga, Eduardo A.; Magvanjav, Oyunbileg; Reyes-Garcia, Victoria; Godoy, Ricardo A.] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02254 USA; [Eisenberg, Dan T. A.; Leonard, William R.; McDade, Thomas W.; Nyberg, Colleen] Northwestern Univ, Dept Anthropol, Evanston, IL 60208 USA; [Wang, Ruoxue] Brandeis Univ, Dept Psychol, Waltham, MA 02254 USA; [Reyes-Garcia, Victoria] Univ Autonoma Barcelona, ICREA, E-08193 Barcelona, Spain; [Reyes-Garcia, Victoria] Univ Autonoma Barcelona, Inst Ciencia & Tecnol Ambientals, E-08193 Barcelona, Spain; [Tanner, Susan] Univ Georgia, Dept Anthropol, Athens, GA 30602 USA; [Huanca, Tomas] CBIDSI, San Borja, Bolivia; [TAPS Bolivia Study Team] Tsimane Amazonian Panel Study, San Borja, Bolivia	Brandeis University; Northwestern University; Brandeis University; Autonomous University of Barcelona; ICREA; Autonomous University of Barcelona; University System of Georgia; University of Georgia	Undurraga, EA (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02254 USA.	eundurra@brandeis.edu	Leonard, William R./I-5981-2019; Tanner, Susan/F-6687-2012; Eisenberg, Dan T.A./D-7691-2011; Undurraga, Eduardo/I-3739-2014; van Lent, Laurence/G-5298-2010; Reyes-Garcia, Victoria/C-4552-2008	Eisenberg, Dan T.A./0000-0003-0812-1862; Undurraga, Eduardo/0000-0002-4425-1253; van Lent, Laurence/0000-0002-9354-0932; Reyes-Garcia, Victoria/0000-0002-2914-8055; Leonard, William/0000-0002-6233-604X	National Science Foundation (NSF) [BCS-0134225, BCS-0200767, BCS-0322380]; Gran Consejo Tsimane'; ICREA Funding Source: Custom	National Science Foundation (NSF)(National Science Foundation (NSF)); Gran Consejo Tsimane'; ICREA(ICREA)	The Cultural and Physical Anthropology Programs, National Science Foundation (NSF) (BCS-0134225, BCS-0200767, BCS-0322380), provided funding for this research. DTAE is supported by an NSF Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Institutional Review Board for research with human subjects of Brandeis University approved the study protocol. The Great Tsimane' Council also approved the study. Thanks go to the Gran Consejo Tsimane' for their continuous support throughout this research project, to Jose Cari for helping to collect the data in the field, and to L. Zebrowitz for comments on earlier versions.	Anderson SL, 2008, J PERS SOC PSYCHOL, V95, P352, DOI 10.1037/0022-3514.95.2.352; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; ARNOLD D, 2006, INTRO WOMENS STUDIES; BERMAN P, 1988, MORE EFFICACY CHILD, P1; BIDDLE J, 1998, J LABOR EC, V16; Brabec M, 2007, AM J HUM BIOL, V19, P459, DOI 10.1002/ajhb.20606; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Buss D.M., 2006, EVOLUTION SOCIAL PSY, P263; Byron E., 2003, MARKET INTEGRATION H; Carels C, 2001, Clin Orthod Res, V4, P130, DOI 10.1034/j.1600-0544.2001.040303.x; Carre JM, 2009, PSYCHOL SCI, V20, P1194, DOI 10.1111/j.1467-9280.2009.02423.x; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; David M. Buss, 2007, [心理学报, Acta Psychologica Sinica], V39, P502; DAWKINS MS, 1991, ANIM BEHAV, V41, P865, DOI 10.1016/S0003-3472(05)80353-7; DEBRUINE LM, 2010, P ROYAL SOC; DURHAM WH, 1976, Q REV BIOL, V51, P385, DOI 10.1086/409471; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Fink B, 2007, AM J HUM BIOL, V19, P82, DOI 10.1002/ajhb.20583; Folland S, 2007, SOC SCI MED, V64, P2342, DOI 10.1016/j.socscimed.2007.03.003; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Foster Z, 2005, AM J PHYS ANTHROPOL, V126, P343, DOI 10.1002/ajpa.20098; Frisancho AR, 1990, ANTHROPOMETRIC STAND; Gangestad SW, 2005, ANNU REV ANTHROPOL, V34, P523, DOI 10.1146/annurev.anthro.33.070203.143733; Getty T, 2002, AM NAT, V159, P363, DOI 10.1086/338992; GIL DG, 1992, UNRAVELLING SOCIAL P; Godoy R, 2005, ECON EDUC REV, V24, P45, DOI 10.1016/j.econedurev.2003.11.008; GODOY RA, 2004, HUMAN ECOLOGY, V32; Godoy RA, 2006, SOC SCI MED, V63, P359, DOI 10.1016/j.socscimed.2006.01.021; Grammer K, 2005, PSYCHOL BULL, V131, P658, DOI 10.1037/0033-2909.131.5.658; Grammer K, 2003, BIOL REV, V78, P385, DOI 10.1017/S1464793102006085; GRAMMER K, 1994, J COMP PSYCHOL, V108, P233, DOI 10.1037/0735-7036.108.3.233; Gurven M, 2007, POPUL DEV REV, V33, P321, DOI 10.1111/j.1728-4457.2007.00171.x; Gurven M, 2009, HUM NATURE-INT BIOS, V20, P151, DOI 10.1007/s12110-009-9062-8; HAMERMESH DS, 1994, AM ECON REV, V84, P1174; Hassin R, 2000, J PERS SOC PSYCHOL, V78, P837, DOI 10.1037/0022-3514.78.5.837; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Hess Ursula, 2008, Affective Computing. Focus on Emotion Expression, Synthesis and Recognition, P45; Hess U., 2002, EMPIRICAL REFLECTION, P187; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Honekopp J, 2004, HUM NATURE-INT BIOS, V15, P147, DOI 10.1007/s12110-004-1018-4; Huanca Tomas, 2008, TSIMANE ORAL TRADITI; JONES D, 1993, HUM NATURE-INT BIOS, V4, P271, DOI 10.1007/BF02692202; JONES D, 1995, CURR ANTHROPOL, V36, P723, DOI 10.1086/204427; Kalick SM, 1998, PSYCHOL SCI, V9, P8, DOI 10.1111/1467-9280.00002; KAPLAN RM, 1978, SEX ROLES, V4, P195, DOI 10.1007/BF00287500; Kenrick D., 2006, EVOLUTION SOCIAL PSY, P211; KRAUT RE, 1979, J PERS SOC PSYCHOL, V37, P1539, DOI 10.1037/0022-3514.37.9.1539; Kumagai Yukie, 2008, Nihon Eiseigaku Zasshi, V63, P636, DOI 10.1265/jjh.63.636; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Law-Smith MJ, 2006, P ROY SOC B-BIOL SCI, V273, P135, DOI 10.1098/rspb.2005.3296; Leonard WR, 2008, ECON HUM BIOL, V6, P299, DOI 10.1016/j.ehb.2008.04.001; Lie HC, 2008, EVOLUTION, V62, P2473, DOI 10.1111/j.1558-5646.2008.00478.x; Little AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002106; Little AC, 2007, P ROY SOC B-BIOL SCI, V274, P3113, DOI 10.1098/rspb.2007.0895; LUCKER GW, 1981, J PSYCHOL, V107, P69, DOI 10.1080/00223980.1981.9915206; LUNDSTROM A, 1988, EUR J ORTHODONT, V10, P27, DOI 10.1093/ejo/10.1.27; Martinez-Rodriguez M.R., 2009, THESIS U GEORGIA; MAZUR A, 1994, ETHOL SOCIOBIOL, V15, P87, DOI 10.1016/0162-3095(94)90019-1; McDade TW, 2007, P NATL ACAD SCI USA, V104, P6134, DOI 10.1073/pnas.0609123104; Miller G, 2000, Novartis Found Symp, V233, P260; MINCER J, 1958, J POLIT ECON, V66, P281, DOI 10.1086/258055; Overing J., 2007, ANTHR LOVE ANGER AES; Pound N, 2009, P ROY SOC B-BIOL SCI, V276, P153, DOI 10.1098/rspb.2008.0990; Reis VA, 2001, BRAIN COGNITION, V46, P240, DOI 10.1016/S0278-2626(01)80075-0; Reyes-Garcia V, 2006, ECON BOT, V60, P62, DOI 10.1663/0013-0001(2006)60[62:CPAEVO]2.0.CO;2; Reyes-Garcia V, 2008, EVOL HUM BEHAV, V29, P275, DOI 10.1016/j.evolhumbehav.2008.02.002; Reyes-Garcia V, 2008, J DEV STUD, V44, P217, DOI 10.1080/00220380701789901; Rhodes G, 2007, PERCEPTION, V36, P1244, DOI 10.1068/p5712; Roberts SC, 2005, EVOL HUM BEHAV, V26, P213, DOI 10.1016/j.evolhumbehav.2004.09.002; RUBIO K, 2009, MODERNIZATION CULTUR; Rule NO, 2008, J PERS SOC PSYCHOL, V95, P1019, DOI 10.1037/a0013194; Rule NO, 2009, J EXP SOC PSYCHOL, V45, P1245, DOI 10.1016/j.jesp.2009.07.010; Rule NO, 2009, SEX ROLES, V61, P644, DOI 10.1007/s11199-009-9658-9; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; Sober E., 1998, OTHERS EVOLUTION PSY; Sundie J. M., 2006, EVOLUTION SOCIAL PSY, P287; Swaddle JP, 2002, P ROY SOC B-BIOL SCI, V269, P2285, DOI 10.1098/rspb.2002.2165; TAYLOR S, 2009, EVOLUTION SOCIAL PSY, P211; Von Rueden C., 2008, EVOLUTION HUMAN BEHA, V29; Wayland C, 2001, MED ANTHROPOL Q, V15, P171, DOI 10.1525/maq.2001.15.2.171; Weber M., 1947, THEORY SOCIAL EC ORG; Weeden J, 2005, PSYCHOL BULL, V131, P635, DOI 10.1037/0033-2909.131.5.635; Wolfe B., 2001, CONTRIBUTION HUMAN S, P221; Zaidel DW, 2005, BRAIN COGNITION, V57, P261, DOI 10.1016/j.bandc.2004.08.056; Zebrowitz LA, 2004, J NONVERBAL BEHAV, V28, P167, DOI 10.1023/B:JONB.0000039648.30935.1b; Zebrowitz LA, 2002, PERS SOC PSYCHOL B, V28, P238, DOI 10.1177/0146167202282009	87	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e11027	10.1371/journal.pone.0011027	http://dx.doi.org/10.1371/journal.pone.0011027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608BX	20543956	Green Published, gold, Green Submitted			2022-12-27	WOS:000278557600006
J	Bennett, SM; Mercer, JM; Noor, MAF				Bennett, Sarah M.; Mercer, John M.; Noor, Mohamed A. F.			Slip-Sliding Away: Serial Changes and Homoplasy in Repeat Number in the Drosophila yakuba Homolog of Human Cancer Susceptibility Gene BRCA2	PLOS ONE			English	Article							DIRECTED REPAIR; DNA-REPAIR; RECOMBINATION; MUTATION; BREAST	Several recent studies have examined the function and evolution of a Drosophila homolog to the human breast cancer susceptibility gene BRCA2, named dmbrca2. We previously identified what appeared to be a recent expansion in the RAD51-binding BRC-repeat array in the ancestor of Drosophila yakuba. In this study, we examine patterns of variation and evolution of the dmbrca2 BRC-repeat array within D. yakuba and its close relatives. We develop a model of how unequal crossing over may have produced the expanded form, but we also observe short repeat forms, typical of other species in the D. melanogaster group, segregating within D. yakuba and D. santomea. These short forms do not appear to be identical-by-descent, suggesting that the history of dmbrca2 in the D. melanogaster subgroup has involved repeat unit contractions resulting in homoplasious forms. We conclude that the evolutionary history of dmbrca2 in D. yakuba and perhaps in other Drosophila species may be more complicated than can be inferred from examination of the published single genome sequences per species.	[Bennett, Sarah M.; Mercer, John M.; Noor, Mohamed A. F.] Duke Univ, Dept Biol, Durham, NC 27706 USA	Duke University	Bennett, SM (corresponding author), Duke Univ, Dept Biol, Durham, NC 27706 USA.	noor@duke.edu		Noor, Mohamed/0000-0002-5400-4408	National Science Foundation [0509780, 0715484]; National Institutes of Health [GM076051, GM086445]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076051, R01GM086445] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Science Foundation awards 0509780 and 0715484, and National Institutes of Health awards GM076051 and GM086445. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard KR, 2008, HYDROMETALLURGY, V91, P1, DOI 10.1016/j.hydromet.2007.11.002; Bennett SM, 2009, GENETICA, V137, P213, DOI 10.1007/s10709-009-9376-9; Bork P, 1996, NAT GENET, V13, P22, DOI 10.1038/ng0596-22; Brough R, 2008, DNA REPAIR, V7, P10, DOI 10.1016/j.dnarep.2007.07.013; Buschiazzo E, 2006, BIOESSAYS, V28, P1040, DOI 10.1002/bies.20470; Carmon A, 2010, J MOL EVOL, V70, P260, DOI 10.1007/s00239-010-9327-1; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Coyne JA, 2002, EVOLUTION, V56, P2424, DOI 10.1111/j.0014-3820.2002.tb00168.x; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gloor G. B., 1992, DROSOPHILA INFORMATI, V71, P148; Gundmundsdottir K, 2006, ONCOGENE, V25, P5864; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r28; Klovstad M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040031; Llopart A, 2005, GENETICS, V171, P197, DOI 10.1534/genetics.104.033597; Lo T, 2003, DNA REPAIR, V2, P1015, DOI 10.1016/S1568-7864(03)00097-1; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Nagaraju G, 2007, DNA REPAIR, V6, P1018, DOI 10.1016/j.dnarep.2007.02.020; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Pellegrini L, 2004, TRENDS BIOCHEM SCI, V29, P310, DOI 10.1016/j.tibs.2004.04.009; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shivji MKK, 2006, NUCLEIC ACIDS RES, V34, P4000, DOI 10.1093/nar/gkl505; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TAJIMA F, 1989, GENETICS, V123, P585; Thornton K, 2005, GENETICS, V171, P2143, DOI 10.1534/genetics.105.043786; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Warren M, 2002, HUM MOL GENET, V11, P841, DOI 10.1093/hmg/11.7.841; Xia F, 2001, P NATL ACAD SCI USA, V98, P8644, DOI 10.1073/pnas.151253498	32	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11006	10.1371/journal.pone.0011006	http://dx.doi.org/10.1371/journal.pone.0011006			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20543987	gold, Green Published, Green Submitted			2022-12-27	WOS:000278494900018
J	Loudon, PT; Yager, EJ; Lynch, DT; Narendran, A; Stagnar, C; Franchini, AM; Fuller, JT; White, PA; Nyuandi, J; Wiley, CA; Murphey-Corb, M; Fuller, DH				Loudon, Peter T.; Yager, Eric J.; Lynch, Debbie T.; Narendran, Amithi; Stagnar, Cristy; Franchini, Anthony M.; Fuller, James T.; White, Phil A.; Nyuandi, Julia; Wiley, Clayton A.; Murphey-Corb, Michael; Fuller, Deborah H.			GM-CSF Increases Mucosal and Systemic Immunogenicity of an H1N1 Influenza DNA Vaccine Administered into the Epidermis of Non-Human Primates	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-VACCINE; ANTIBODY-SECRETING CELLS; IMMUNE-RESPONSES; A VIRUS; DENDRITIC CELLS; HETEROSUBTYPIC IMMUNITY; TRANSCUTANEOUS IMMUNIZATION; GENETIC IMMUNIZATION; ENHANCED PROTECTION; POWDER IMMUNIZATION	Background: The recent H5N1 avian and H1N1 swine-origin influenza virus outbreaks reaffirm that the threat of a worldwide influenza pandemic is both real and ever-present. Vaccination is still considered the best strategy for protection against influenza virus infection but a significant challenge is to identify new vaccine approaches that offer accelerated production, broader protection against drifted and shifted strains, and the capacity to elicit anti-viral immune responses in the respiratory tract at the site of viral entry. As a safe alternative to live attenuated vaccines, the mucosal and systemic immunogenicity of an H1N1 influenza (A/New Caledonia/20/99) HA DNA vaccine administered by particle-mediated epidermal delivery (PMED or gene gun) was analyzed in rhesus macaques. Methodology/Principal Findings: Macaques were immunized at weeks 0, 8, and 16 using a disposable single-shot particle-mediated delivery device designed for clinical use that delivers plasmid DNA directly into cells of the epidermis. Significant levels of hemagglutination inhibiting (HI) antibodies and cytokine-secreting HA-specific T cells were observed in the periphery of macaques following 1-3 doses of the PMED HA DNA vaccine. In addition, HA DNA vaccination induced detectable levels of HA-specific mucosal antibodies and T cells in the lung and gut-associated lymphoid tissues of vaccinated macaques. Importantly, co-delivery of a DNA encoding the rhesus macaque GM-CSF gene was found to significantly enhance both the systemic and mucosal immunogenicity of the HA DNA vaccine. Conclusions/Significance: These results provide strong support for the development of a particle-mediated epidermal DNA vaccine for protection against respiratory pathogens such as influenza and demonstrate, for the first time, the ability of skin-delivered GM-CSF to serve as an effective mucosal adjuvant for vaccine induction of immune responses in the gut and respiratory tract.	[Loudon, Peter T.; Lynch, Debbie T.; White, Phil A.] PowderMed Ltd, Oxford, England; [Yager, Eric J.; Narendran, Amithi; Stagnar, Cristy; Franchini, Anthony M.; Fuller, Deborah H.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Fuller, James T.] Recombiworks Ltd, Clifton Pk, NY USA; [Nyuandi, Julia; Murphey-Corb, Michael] Univ Pittsburgh, Sch Med, Dept Med Microbiol & Mol Genet, Pittsburgh, PA USA; [Wiley, Clayton A.] Univ Pittsburgh, Med Ctr, Dept Pathol, Div Neuropathol, Pittsburgh, PA USA	Pfizer; Albany Medical College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Loudon, PT (corresponding author), Pfizer PGRD, Sandwich, Kent, England.	FullerD@mail.amc.edu		White, Phil/0000-0002-6078-9061; Fuller, Deborah/0000-0001-7315-2441; Franchini, Anthony/0000-0003-3576-3211; Yager, Eric/0000-0001-6118-7487	National Institute of Allergy and Infectious Diseases, U.S.A; PowderMed, Ltd., Oxford, U.K.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074509] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, U.S.A(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PowderMed, Ltd., Oxford, U.K.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This study was jointly funded by grant U01 AI074509 (DHF) from the National Institute of Allergy and Infectious Diseases, U.S.A (http://www3.niaid.nih.gov/) and by PowderMed, Ltd., Oxford, U.K. PowderMed Ltd funded experiments supporting this study at Recombiworks, Ltd. PowderMed employees (PTL, DTL, PAW) were involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript. The Recombiworks employee (JTF) was involved in data collection and analysis and preparation of the manuscript but not in study design or the decision to publish.	Arrington J, 2002, J VIROL, V76, P4536, DOI 10.1128/JVI.76.9.4536-4546.2002; Baek KM, 2003, VACCINE, V21, P3684, DOI 10.1016/S0264-410X(03)00378-5; Belyakov IM, 2004, J CLIN INVEST, V113, P998, DOI 10.1172/JCI200420261; Bruder D, 2006, VIRAL IMMUNOL, V19, P147, DOI 10.1089/vim.2006.19.147; Calarota SA, 1999, J IMMUNOL, V163, P2330; Chen DX, 2004, VIRUS RES, V103, P147, DOI 10.1016/j.virusres.2004.02.027; Chen DX, 2001, J VIROL, V75, P7956, DOI 10.1128/JVI.75.17.7956-7965.2001; Chen DX, 2000, NAT MED, V6, P1187, DOI 10.1038/80538; Chen Z, 1999, VACCINE, V17, P653, DOI 10.1016/S0264-410X(98)00247-3; Chen Z, 2001, VACCINE, V19, P1446, DOI 10.1016/S0264-410X(00)00351-0; Chen Z, 2000, VACCINE, V18, P3214, DOI 10.1016/S0264-410X(00)00149-3; Condon C, 1996, NAT MED, V2, P1122, DOI 10.1038/nm1096-1122; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Daynes RA, 1996, INFECT IMMUN, V64, P1100, DOI 10.1128/IAI.64.4.1100-1109.1996; De Groot AS, 2009, VACCINE, V27, P5740, DOI 10.1016/j.vaccine.2009.07.040; Demberg T, 2009, INT REV IMMUNOL, V28, P20, DOI 10.1080/08830180802684331; Drape R.J., 2005, VACCINE; EISENBRAUN MD, 1993, DNA CELL BIOL, V12, P791, DOI 10.1089/dna.1993.12.791; Enioutina EY, 2000, VACCINE, V18, P2753, DOI 10.1016/S0264-410X(00)00059-1; Epstein SL, 1997, J IMMUNOL, V158, P1222; Falo LD, 1999, P ASSOC AM PHYSICIAN, V111, P211; Fuller DH, 2006, VIROLOGY, V348, P200, DOI 10.1016/j.virol.2005.12.008; Fuller DH, 2002, J VIROL, V76, P3309, DOI 10.1128/JVI.76.7.3309-3317.2002; Fuller DH, 1997, VACCINE, V15, P924, DOI 10.1016/S0264-410X(96)00271-X; FULLER DH, 2006, METHODS IN PRESS; FYNAN EF, 1993, P NATL ACAD SCI USA, V90, P11478, DOI 10.1073/pnas.90.24.11478; Gianfrani C, 2000, HUM IMMUNOL, V61, P438, DOI 10.1016/S0198-8859(00)00105-1; Glenn GM, 1998, J IMMUNOL, V161, P3211; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hasegawa H, 2007, EXPERT REV VACCINES, V6, P193, DOI 10.1586/14760584.6.2.193; Hutchinson KL, 2001, J MED VIROL, V65, P561, DOI 10.1002/jmv.2073; Ito R, 2003, VACCINE, V21, P2362, DOI 10.1016/S0264-410X(03)00078-1; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; JONES PD, 1987, CELL IMMUNOL, V109, P53, DOI 10.1016/0008-8749(87)90291-7; JONES PD, 1986, J VIROL, V60, P614, DOI 10.1128/JVI.60.2.614-619.1986; Jones S, 2009, VACCINE, V27, P2506, DOI 10.1016/j.vaccine.2009.02.061; Jonuleit H, 1996, ARCH DERMATOL RES, V289, P1, DOI 10.1007/s004030050144; JUSTEWICZ DM, 1995, J VIROL, V69, P7712, DOI 10.1128/JVI.69.12.7712-7717.1995; Kim JJ, 1999, J INTERF CYTOK RES, V19, P77, DOI 10.1089/107999099314441; Laddy DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002517; Lai L, 2007, VIROLOGY, V369, P153, DOI 10.1016/j.virol.2007.07.017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsen DL, 1998, J VIROL, V72, P1704, DOI 10.1128/JVI.72.2.1704-1708.1998; Lee SW, 1999, VACCINE, V17, P490, DOI 10.1016/S0264-410X(98)00223-0; Lena P, 2002, VACCINE, V20, pA69, DOI 10.1016/S0264-410X(02)00391-2; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; Lo CY, 2008, VACCINE, V26, P2062, DOI 10.1016/j.vaccine.2008.02.047; Looney RJ, 2001, J CLIN IMMUNOL, V21, P30, DOI 10.1023/A:1006736931381; MacGregor RR, 1998, J INFECT DIS, V178, P92, DOI 10.1086/515613; MacGregor RR, 2000, J INFECT DIS, V181, P406, DOI 10.1086/315199; Macklin MD, 1998, J VIROL, V72, P1491, DOI 10.1128/JVI.72.2.1491-1496.1998; Mitchell JA, 2003, VACCINE, V21, P902, DOI 10.1016/S0264-410X(02)00539-X; Murphey-Corb M, 1999, J IMMUNOL, V162, P540; NDHLOVU ZM, P NATL ACAD SCI US; Nichol KL, 2006, J INFECT DIS, V194, pS111, DOI 10.1086/507544; Olsen CW, 2000, VET MICROBIOL, V74, P149, DOI 10.1016/S0378-1135(00)00175-9; Operschall E, 1999, J CLIN VIROL, V13, P17, DOI 10.1016/S1386-6532(99)00008-6; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; Robinson Harriet L., 1997, Journal of Infectious Diseases, V176, pS50, DOI 10.1086/514176; Robinson HL, 2006, VIROLOGY, V352, P285, DOI 10.1016/j.virol.2006.02.011; Roy MJ, 2000, VACCINE, V19, P764, DOI 10.1016/S0264-410X(00)00302-9; RUTIGLIANO JA, J VIROL, V84, P1047; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Slingluff CL, 2009, CLIN CANCER RES, V15, P7036, DOI 10.1158/1078-0432.CCR-09-1544; WAGNER DK, 1987, J CLIN MICROBIOL, V25, P559, DOI 10.1128/JCM.25.3.559-562.1987; Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476; WEBSTER RG, 1994, VACCINE, V12, P1495, DOI 10.1016/0264-410X(94)90071-X; Xu R, 2008, VACCINE, V26, P4819, DOI 10.1016/j.vaccine.2008.06.103; Yager EJ, 2009, EXPERT REV VACCINES, V8, P1205, DOI [10.1586/erv.09.82, 10.1586/ERV.09.82]	69	54	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11021	10.1371/journal.pone.0011021	http://dx.doi.org/10.1371/journal.pone.0011021			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544035	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000278494900030
J	Kuijk, EW; de Gier, J; Lopes, SMCD; Chambers, I; van Pelt, AMM; Colenbrander, B; Roelen, BAJ				Kuijk, Ewart W.; de Gier, Jeffrey; Lopes, Susana M. Chuva de Sousa; Chambers, Ian; van Pelt, Ans M. M.; Colenbrander, Ben; Roelen, Bernard A. J.			A Distinct Expression Pattern in Mammalian Testes Indicates a Conserved Role for NANOG in Spermatogenesis	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; INHIBITOR TRICHOSTATIN-A; GERM-CELLS; MOUSE TESTIS; PLURIPOTENCY; GENERATION; GENES; CARCINOMA; CLONING; FETAL	Background: NANOG is a key player in pluripotency and its expression is restricted to pluripotent cells of the inner cell mass, the epiblast and to primordial germ cells. Spermatogenesis is closely associated with pluripotency, because through this process highly specialized sperm cells are produced that contribute to the formation of totipotent zygotes. Nevertheless, it is unknown if NANOG plays a role in this process. Methodology/Principal Findings: In the current study, NANOG expression was examined in testes of various mammals, including mouse and human. Nanog mRNA and NANOG protein were detected by RT-PCR, immunohistochemistry, and western blotting. Furthermore, eGFP expression was detected in the testis of a transgenic Nanog eGFP-reporter mouse. Surprisingly, although NANOG expression has previously been associated with undifferentiated cells with stem cell potential, expression in the testis was observed in pachytene spermatocytes and in the first steps of haploid germ cell maturation (spermiogenesis). Weak expression in type A spermatogonia was also observed. Conclusions: The findings of the current study strongly suggest a conserved role for NANOG in meiotic and post-meiotic stages of male germ cell development.	[Kuijk, Ewart W.; Colenbrander, Ben; Roelen, Bernard A. J.] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [Kuijk, Ewart W.] Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, Utrecht, Netherlands; [Kuijk, Ewart W.] Hubrecht Inst KNAW, Utrecht, Netherlands; [de Gier, Jeffrey] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Lopes, Susana M. Chuva de Sousa] Leiden Univ, Leiden Univ Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Chambers, Ian] Univ Edinburgh, Sch Biol Sci, Inst Stem Cell Res, Med Res Council Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [van Pelt, Ans M. M.] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynecol, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Edinburgh; University of Amsterdam; Academic Medical Center Amsterdam	Kuijk, EW (corresponding author), Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands.	b.a.j.roelen@uu.nl	Chambers, Ian/H-5416-2011; Kuijk, Ewart/I-2569-2019	Chambers, Ian/0000-0003-2605-1597; Kuijk, Ewart/0000-0002-1385-6516; van Pelt, Ans/0000-0001-9155-548X	Netherlands Organization for Scientific Research (NWO) [916.76.015]; Medical Research Council [G0700711B] Funding Source: researchfish	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	SMCDSL was financed by the Netherlands Organization for Scientific Research (NWO), VENI grant 916.76.015. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Conrad S, 2008, NATURE, V456, P344, DOI 10.1038/nature07404; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Fenic I, 2004, J ANDROL, V25, P811; Fenic I, 2008, J ANDROL, V29, P172, DOI 10.2164/jandrol.107.003848; Goel S, 2008, REPRODUCTION, V135, P785, DOI 10.1530/REP-07-0476; Golestaneh N, 2009, STEM CELLS DEV, V18, P1115, DOI 10.1089/scd.2008.0347; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Hoei-Hansen CE, 2005, HISTOPATHOLOGY, V47, P48, DOI 10.1111/j.1365-2559.2005.02182.x; Izadyar F, 2008, REPRODUCTION, V135, P771, DOI 10.1530/REP-07-0479; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P681, DOI 10.1095/biolreprod.107.066068; Ko K, 2009, CELL STEM CELL, V5, P87, DOI 10.1016/j.stem.2009.05.025; Kossack N, 2009, STEM CELLS, V27, P138, DOI 10.1634/stemcells.2008-0439; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Mitchell RT, 2008, HUM REPROD, V23, P2755, DOI 10.1093/humrep/den295; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Robertson M, 2006, MAMM GENOME, V17, P732, DOI 10.1007/s00335-005-0131-y; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Yamaguchi S, 2009, DEVELOPMENT, V136, P4011, DOI 10.1242/dev.041160; Zamudio NM, 2008, REPRODUCTION, V136, P131, DOI 10.1530/REP-07-0576	31	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10987	10.1371/journal.pone.0010987	http://dx.doi.org/10.1371/journal.pone.0010987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539761	Green Published, Green Submitted, gold			2022-12-27	WOS:000278465900007
J	Marozin, S; De Toni, EN; Rizzani, A; Altomonte, J; Junger, A; Schneider, G; Thasler, WE; Kato, N; Schmid, RM; Ebert, O				Marozin, Sabrina; De Toni, Enrico N.; Rizzani, Antonia; Altomonte, Jennifer; Junger, Alexandra; Schneider, Guenter; Thasler, Wolfgang E.; Kato, Nobuyuki; Schmid, Roland M.; Ebert, Oliver			Cell Cycle Progression or Translation Control Is Not Essential for Vesicular Stomatitis Virus Oncolysis of Hepatocellular Carcinoma	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; HERPES-SIMPLEX-VIRUS; PROTEIN-SYNTHESIS; CANCER-CELLS; HUMAN HEPATOCYTES; STEM-CELLS; INITIATION; REPLICATION; INTERFERON; THERAPY	The intrinsic oncolytic specificity of vesicular stomatitis virus (VSV) is currently being exploited to develop alternative therapeutic strategies for hepatocellular carcinoma (HCC). Identifying key regulators in diverse transduction pathways that define VSV oncolysis in cancer cells represents a fundamental prerequisite to engineering more effective oncolytic viral vectors and adjusting combination therapies. After having identified defects in the signalling cascade of type I interferon induction, responsible for attenuated antiviral responses in human HCC cell lines, we have now investigated the role of cell proliferation and translation initiation. Cell cycle progression and translation initiation factors eIF4E and eIF2B epsilon have been recently identified as key regulators of VSV permissiveness in T-lymphocytes and immortalized mouse embryonic fibroblasts, respectively. Here, we show that in HCC, decrease of cell proliferation by cell cycle inhibitors or siRNA-mediated reduction of G(1) cyclin-dependent kinase activities (CDK4) or cyclin D1 protein expression, do not significantly alter viral growth. Additionally, we demonstrate that translation initiation factors eIF4E and eIF2B epsilon are negligible in sustaining VSV replication in HCC. Taken together, these results indicate that cellular proliferation and the initiation phase of cellular protein synthesis are not essential for successful VSV oncolysis of HCC. Moreover, our observations indicate the importance of cell-type specificity for VSV oncolysis, an important aspect to be considered in virotherapy applications in the future.	[Marozin, Sabrina; Altomonte, Jennifer; Junger, Alexandra; Schneider, Guenter; Schmid, Roland M.; Ebert, Oliver] Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, D-8000 Munich, Germany; [De Toni, Enrico N.; Rizzani, Antonia] Univ Munich, Klinikum Grosshadern, Med Klin & Poliklin 2, D-8000 Munich, Germany; [Thasler, Wolfgang E.] Univ Munich, Klinikum Grosshadern, Chirurg Klin & Poliklin, D-8000 Munich, Germany; [Kato, Nobuyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Biol, Okayama, Japan	Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; University of Munich; Okayama University	Marozin, S (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, D-8000 Munich, Germany.	oliver.ebert@lrz.tum.de	Marozin, Sabrina/N-7033-2014; De Toni, Enrico N/C-6496-2008	Marozin, Sabrina/0000-0003-1650-9488; Altomonte, Jennifer/0000-0003-1079-3633	German Research Aid; Federal Ministry of Education and Research [01GU0505]; German Research Foundation, Bonn, Germany (DFG) [SFB 824 (Sonderforschungsbereich 824)]	German Research Aid; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation, Bonn, Germany (DFG)(German Research Foundation (DFG))	This work was supported in part by the German Research Aid (Max-Eder Research Program), the Federal Ministry of Education and Research (Grant 01GU0505) and the SFB 824 (DFG Sonderforschungsbereich 824), German Research Foundation, Bonn, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2003, J VIROL, V77, P4646, DOI 10.1128/JVI.77.8.4646-4657.2003; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Balachandran S, 2004, CANCER CELL, V5, P51, DOI 10.1016/S1535-6108(03)00330-1; Bianchini A, 2008, CARCINOGENESIS, V29, P2279, DOI 10.1093/carcin/bgn221; Cascone T, 2008, J CELL PHYSIOL, V216, P698, DOI 10.1002/jcp.21444; Chakraborty P, 2009, EMBO REP, V10, P1154, DOI 10.1038/embor.2009.179; CHIANG PC, 2009, BIOCH PHARM; Connor JH, 2002, J VIROL, V76, P10177, DOI 10.1128/JVI.76.20.10177-10187.2002; Cripe TP, 2009, MOL THER, V17, P1677, DOI 10.1038/mt.2009.193; Dancey JE, 2006, CANCER BIOL THER, V5, P1065, DOI 10.4161/cbt.5.9.3175; Dansako H, 2003, VIRUS RES, V97, P17, DOI 10.1016/S0168-1702(03)00218-1; Dansako H, 2007, FEBS J, V274, P4161, DOI 10.1111/j.1742-4658.2007.05942.x; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; DUNN EF, 2009, J VIROL; Ebert O, 2003, CANCER RES, V63, P3605; Ebert O, 2004, CANCER GENE THER, V26, P26; Fabregat I, 2009, WORLD J GASTROENTERO, V15, P513, DOI 10.3748/wjg.15.513; Gallagher JW, 2008, CANCER RES, V68, P8752, DOI 10.1158/0008-5472.CAN-08-1042; Hallenbeck PL, 1999, HUM GENE THER, V10, P1721, DOI 10.1089/10430349950017725; Hamid NA, 2009, CELL MOL LIFE SCI, V66, P1700, DOI 10.1007/s00018-009-8631-7; Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091; Ikeda M, 1998, VIRUS RES, V56, P157, DOI 10.1016/S0168-1702(98)00063-X; Joshi S, 2009, P NATL ACAD SCI USA, V106, P12097, DOI 10.1073/pnas.0900562106; Kato N, 1996, JPN J CANCER RES, V87, P787, DOI 10.1111/j.1349-7006.1996.tb02101.x; Kemeny N, 2006, HUM GENE THER, V17, P1214, DOI 10.1089/hum.2006.17.1214; Kjellerup RB, 2008, EXP DERMATOL, V17, P498, DOI 10.1111/j.1600-0625.2007.00672.x; Larsson O, 2007, CANCER RES, V67, P6814, DOI 10.1158/0008-5472.CAN-07-0752; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Lun XQ, 2009, CLIN CANCER RES, V15, P2777, DOI 10.1158/1078-0432.CCR-08-2342; Marozin S, 2008, MOL THER, V16, P1789, DOI 10.1038/mt.2008.201; Memmott RM, 2009, CELL SIGNAL, V21, P656, DOI 10.1016/j.cellsig.2009.01.004; Mishra L, 2009, HEPATOLOGY, V49, P318, DOI 10.1002/hep.22704; Newell P, 2009, J HEPATOL, V51, P725, DOI 10.1016/j.jhep.2009.03.028; Nguyen TLA, 2009, CELL MICROBIOL, V11, P889, DOI 10.1111/j.1462-5822.2009.01317.x; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Oliere S, 2008, J VIROL, V82, P5735, DOI 10.1128/JVI.02601-07; Orlando JS, 2006, J VIROL, V80, P4005, DOI 10.1128/JVI.80.8.4005-4016.2006; Rosenwald IB, 1999, ONCOGENE, V18, P2507, DOI 10.1038/sj.onc.1202563; Schang Luis M, 2003, Prog Cell Cycle Res, V5, P103; Sei S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-47; Sell S, 2008, J CLIN ONCOL, V26, P2800, DOI 10.1200/JCO.2007.15.5945; Shinozaki K, 2005, HEPATOLOGY, V41, P196, DOI 10.1002/hep.20536; Shinozaki K, 2004, MOL THER, V9, P368, DOI 10.1016/j.ymthe.2003.12.004; Silva RLA, 2008, CELL CYCLE, V7, P553, DOI 10.4161/cc.7.5.5486; Sun M, 2008, J VIROL, V82, P105, DOI 10.1128/JVI.01520-07; Thasler Wolfgang E., 2003, Cell and Tissue Banking, V4, P49, DOI 10.1023/A:1026392429112; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Wang F, 2009, J VIROL, V83, P5928, DOI 10.1128/JVI.02587-08; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Yang SX, 2007, ONCOL REP, V17, P281	51	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10988	10.1371/journal.pone.0010988	http://dx.doi.org/10.1371/journal.pone.0010988			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539760	Green Published, Green Submitted, gold			2022-12-27	WOS:000278465900008
J	Pansiot, J; Loron, G; Olivier, P; Fontaine, R; Charriaut-Marlangue, C; Mercier, JC; Gressens, P; Baud, O				Pansiot, Julien; Loron, Gauthier; Olivier, Paul; Fontaine, Romain; Charriaut-Marlangue, Christiane; Mercier, Jean-Christophe; Gressens, Pierre; Baud, Olivier			Neuroprotective Effect of Inhaled Nitric Oxide on Excitotoxic-Induced Brain Damage in Neonatal Rat	PLOS ONE			English	Article							WHITE-MATTER INJURY; ISCHEMIC BRAIN; PERIVENTRICULAR LEUKOMALACIA; RESPIRATORY-FAILURE; PREMATURE-INFANTS; GENE-EXPRESSION; NERVOUS-SYSTEM; OLIGODENDROCYTES; GLUTAMATE; LESIONS	Background: Inhaled nitric oxide (iNO) is one of the most promising therapies used in neonates. However, little information is known about its impact on the developing brain submitted to excitotoxic challenge. Methodology/Principal Findings: We investigated here the effect of iNO in a neonatal model of excitotoxic brain lesions. Rat pups and their dams were placed in a chamber containing 20 ppm NO during the first week of life. At postnatal day (P) 5, rat pups were submitted to intracranial injection of glutamate agonists. At P10, rat pups exposed to iNO exhibited a significant decrease of lesion size in both the white matter and cortical plate compared to controls. Microglia activation and astrogliosis were found significantly decreased in NO-exposed animals. This neuroprotective effect was associated with a significant decrease of several glutamate receptor subunits expression at P5. iNO was associated with an early (P1) downregulation of pCREB/pAkt expression and induced an increase in pAkt protein concentration in response to excitotoxic challenge (P7). Conclusion: This study is the first describe and investigate the neuroprotective effect of iNO in neonatal excitotoxic-induced brain damage. This effect may be mediated through CREB pathway and subsequent modulation of glutamate receptor subunits expression.	[Pansiot, Julien; Loron, Gauthier; Olivier, Paul; Charriaut-Marlangue, Christiane; Gressens, Pierre; Baud, Olivier] Hop Robert Debre, INSERM, UMR 676, F-75019 Paris, France; [Fontaine, Romain] Univ Paris 06, INSERM, UMR 711, Fac Med,Hop Salpetriere, Paris, France; [Mercier, Jean-Christophe] Hop Robert Debre, AP HP, Emergency Dept, F-75019 Paris, France; [Gressens, Pierre; Baud, Olivier] Hop Robert Debre, AP HP, Neonatal Intens Care Unit, F-75019 Paris, France; [Baud, Olivier] PremUP Fdn, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Baud, O (corresponding author), Hop Robert Debre, INSERM, UMR 676, F-75019 Paris, France.	olivier.baud@rdb.aphp.fr	gressens, pierre/M-7557-2017; , CHARRIAUT-MARLANGUE/H-3249-2019	gressens, pierre/0000-0002-0909-4221; LORON, Gauthier/0000-0001-9536-9510	Ikaria, Inc.; INSERM; INSERM AVENIR; Mairie de Paris; Ikaria (iNOTherapeutics)	Ikaria, Inc.; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INSERM AVENIR(Institut National de la Sante et de la Recherche Medicale (Inserm)); Mairie de Paris(Region Ile-de-France); Ikaria (iNOTherapeutics)	Funding: The experimental research program of Dr. Olivier Baud and his coworkers concerning iNO is partially supported by Ikaria, Inc. This study was financially supported by the INSERM, the INSERM AVENIR Program and the Mairie de Paris. Paul Olivier and Gauthier Loron were financially supported by Ikaria (iNOTherapeutics). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arul N, 2009, CLIN PERINATOL, V36, P43, DOI 10.1016/j.clp.2008.09.002; Ballard RA, 2006, NEW ENGL J MED, V355, P343, DOI 10.1056/NEJMoa061088; Barrington KJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000509.pub2; Baud O, 2004, EUR J NEUROSCI, V20, P1713, DOI 10.1111/j.1460-9568.2004.03616.x; Baud O, 2004, BRAIN PATHOL, V14, P1; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Cheung PY, 1998, LANCET, V351, P1181, DOI 10.1016/S0140-6736(05)79127-3; Chiueh CC, 1999, ANN NY ACAD SCI, V890, P301, DOI 10.1111/j.1749-6632.1999.tb08007.x; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Dommergues MA, 2000, ANN NEUROL, V47, P54, DOI 10.1002/1531-8249(200001)47:1<54::AID-ANA10>3.3.CO;2-P; Fontaine RH, 2008, P NATL ACAD SCI USA, V105, P16779, DOI 10.1073/pnas.0803004105; Fukunaga K, 2003, J PHARMACOL SCI, V92, P317; Gonzalez-Zulueta M, 2000, P NATL ACAD SCI USA, V97, P436, DOI 10.1073/pnas.97.1.436; Hagberg H, 2002, MENT RETARD DEV D R, V8, P30, DOI 10.1002/mrdd.10007; Haynes RL, 2005, BRAIN PATHOL, V15, P225; Husson I, 2002, ANN NEUROL, V51, P82, DOI 10.1002/ana.10072; Iadecola C, 1997, J NEUROSCI, V17, P9157; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Kinsella JP, 2006, NEW ENGL J MED, V355, P354, DOI 10.1056/NEJMoa060442; Kinsella JP, 1999, LANCET, V354, P1061, DOI 10.1016/S0140-6736(99)03558-8; Kitagawa K, 2007, FEBS J, V274, P3210, DOI 10.1111/j.1742-4658.2007.05890.x; Lau GC, 2004, J NEUROCHEM, V88, P564, DOI 10.1046/j.1471-4159.2003.02156.x; Li JR, 2005, P NATL ACAD SCI USA, V102, P9936, DOI 10.1073/pnas.0502552102; MARGAILL I, 1994, BRIT J PHARMACOL, V651, P92; MARRET S, 1995, J NEUROPATH EXP NEUR, V54, P358, DOI 10.1097/00005072-199505000-00009; Mayhan WG, 2000, BRAIN RES, V866, P101, DOI 10.1016/S0006-8993(00)02254-X; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; Mesples B, 2005, ACTA PAEDIATR, V94, P185, DOI 10.1080/08035250410022378; Mestan KKL, 2005, NEW ENGL J MED, V353, P23, DOI 10.1056/NEJMoa043514; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Rani CSS, 2005, MOL PHARMACOL, V67, P2126, DOI 10.1124/mol.104.007872; Rosenberg PA, 1999, J NEUROCHEM, V73, P476, DOI 10.1046/j.1471-4159.1999.0730476.x; Schreiber MD, 2003, NEW ENGL J MED, V349, P2099, DOI 10.1056/NEJMoa031154; Shouman B, 2006, BRIT J PHARMACOL, V148, P442, DOI 10.1038/sj.bjp.0706755; Steinhorn RH, 2007, CURR OPIN PEDIATR, V19, P137, DOI 10.1097/MOP.0b013e328082e2ed; YAMAMOTO S, 1992, J CEREBR BLOOD F MET, V12, P717, DOI 10.1038/jcbfm.1992.102; ZAHARCHUK G, 1997, MAGN RESON MED, V17, P9157	42	39	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2010	5	6							e10916	10.1371/journal.pone.0010916	http://dx.doi.org/10.1371/journal.pone.0010916			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QF	20532231	Green Published, gold, Green Submitted			2022-12-27	WOS:000278222400011
J	Hueber, SD; Weiller, GF; Djordjevic, MA; Frickey, T				Hueber, Stefanie D.; Weiller, Georg F.; Djordjevic, Michael A.; Frickey, Tancred			Improving Hox Protein Classification across the Major Model Organisms	PLOS ONE			English	Article							HOMEOTIC GENES; FUNCTIONAL EQUIVALENCE; DROSOPHILA EMBRYOS; SEGMENTAL IDENTITY; EVOLUTION; SEQUENCE; ORGANIZATION; SPECIFICITY; EXPRESSION; COMPLEX	The family of Hox-proteins has been a major focus of research for over 30 years. Hox-proteins are crucial to the correct development of bilateral organisms, however, some uncertainty remains as to which Hox-proteins are functionally equivalent across different species. Initial classification of Hox-proteins was based on phylogenetic analysis of the 60 amino acid homeodomain. This approach was successful in classifying Hox-proteins with differing homeodomains, but the relationships of Hox-proteins with nearly identical homeodomains, yet distinct biological functions, could not be resolved. Correspondingly, these 'problematic' proteins were classified into one large unresolved group. Other classifications used the relative location of the Hox-protein coding genes on the chromosome (synteny) to further resolve this group. Although widely used, this synteny-based classification is inconsistent with experimental evidence from functional equivalence studies. These inconsistencies led us to re-examine and derive a new classification for the Hox-protein family using all Hox-protein sequences available in the GenBank non-redundant protein database (NCBI-nr). We compare the use of the homeodomain, the homeodomain with conserved flanking regions (the YPWM and linker region), and full length Hox-protein sequences as a basis for classification of Hox-proteins. In contrast to previous attempts, our approach is able to resolve the relationships for the 'problematic' as well as ABD-B-like Hox-proteins. We highlight differences to previous classifications and clarify the relationships of Hox-proteins across the five major model organisms, Caenorhabditis elegans, Drosophila melanogaster, Branchiostoma floridae, Mus musculus and Danio rerio. Comparative and functional analysis of Hox-proteins, two fields crucial to understanding the development of bilateral organisms, have been hampered by difficulties in predicting functionally equivalent Hox-proteins across species. Our classification scheme offers a higher-resolution classification that is in accordance with phylogenetic as well as experimental data and, thereby, provides a novel basis for experiments, such as comparative and functional analyses of Hox-proteins.	[Hueber, Stefanie D.; Weiller, Georg F.; Djordjevic, Michael A.; Frickey, Tancred] Australian Natl Univ, Genom Interact Grp, Res Sch Biol, Coll Med Biol & Environm, Canberra, ACT, Australia	Australian National University	Hueber, SD (corresponding author), Australian Natl Univ, Genom Interact Grp, Res Sch Biol, Coll Med Biol & Environm, Canberra, ACT, Australia.	georg.weiller@anu.edu.au	Djordjevic, Michael/C-9945-2009; Weiller, Georg F/C-9911-2009	Djordjevic, Michael/0000-0002-9819-1372	Australian Research Council [CEO348212]	Australian Research Council(Australian Research Council)	Funding for this work has been provided by the Australian Research Council, Center for Excellence Grant (CEO348212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI N, 1991, MECH DEVELOP, V35, P55, DOI 10.1016/0925-4773(91)90041-4; ALTSHUL SF, 1997, NUCLEIC ACIDS RES, V25, P402; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Biggin MD, 1997, DEVELOPMENT, V124, P4425; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; Chauvet S, 2000, P NATL ACAD SCI USA, V97, P4064, DOI 10.1073/pnas.070046997; De Robertis EM, 2008, CELL, V132, P185, DOI 10.1016/j.cell.2008.01.003; de Rosa R, 1999, NATURE, V399, P772, DOI 10.1038/21631; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferrier DEK, 2000, EVOL DEV, V2, P284, DOI 10.1046/j.1525-142x.2000.00070.x; Foronda D, 2009, INT J DEV BIOL, V53, P1409, DOI 10.1387/ijdb.072462df; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; FRICKEY T, 2009, ALNEDIT RSBS BIOINFO; Frickey T, 2007, BIOINFORMATICS, V23, P1170, DOI 10.1093/bioinformatics/btm079; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Garcia-Fernandez J, 2005, HEREDITY, V94, P145, DOI 10.1038/sj.hdy.6800621; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; Gehring WJ, 2009, CURR TOP DEV BIOL, V88, P35, DOI 10.1016/S0070-2153(09)88002-2; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Goodman FR, 2002, AM J MED GENET, V112, P256, DOI 10.1002/ajmg.10776; Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077; HARDING K, 1985, SCIENCE, V229, P1236, DOI 10.1126/science.3898362; HEUER JG, 1992, DEVELOPMENT, V115, P35; Hueber SD, 2008, BIOESSAYS, V30, P965, DOI 10.1002/bies.20823; Hueber SD, 2007, DEVELOPMENT, V134, P381, DOI 10.1242/dev.02746; HUNTER CP, 1995, NATURE, V377, P229, DOI 10.1038/377229a0; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; KRUMLAUF R, 1992, BIOESSAYS, V14, P245, DOI 10.1002/bies.950140408; Lemons D, 2006, SCIENCE, V313, P1918, DOI 10.1126/science.1132040; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lewis EB, 2003, CURR BIOL, V13, pR587, DOI 10.1016/S0960-9822(03)00520-7; Lutz B, 1996, GENE DEV, V10, P176, DOI 10.1101/gad.10.2.176; MALICKI J, 1990, CELL, V63, P961, DOI 10.1016/0092-8674(90)90499-5; MALICKI J, 1993, MECH DEVELOP, V42, P139, DOI 10.1016/0925-4773(93)90003-G; MCGINNIS N, 1990, CELL, V63, P969, DOI 10.1016/0092-8674(90)90500-E; MCGINNIS W, 1994, SCI AM, V270, P58, DOI 10.1038/scientificamerican0294-58; MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2; Merabet S, 2009, BIOESSAYS, V31, P500, DOI 10.1002/bies.200800229; Minguillon C, 2005, INT J BIOL SCI, V1, P19; Monteiro AS, 2006, INT J BIOL SCI, V2, P95; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Percival-Smith A, 2005, GENOME, V48, P712, DOI 10.1139/G05-021; Prince VE, 2002, DEV BIOL, V249, P1, DOI 10.1006/dbio.2002.0745; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; REED HC, 2009, GENETICS; RUDDLE FH, 1994, ANNU REV GENET, V28, P423, DOI 10.1146/annurev.ge.28.120194.002231; Ruvkun G, 1998, SCIENCE, V282, P2033, DOI 10.1126/science.282.5396.2033; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115; Tvrdik P, 2006, DEV CELL, V11, P239, DOI 10.1016/j.devcel.2006.06.016; Veraksa A, 2000, MOL GENET METAB, V69, P85, DOI 10.1006/mgme.2000.2963; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; Zakany J, 1996, DEV BIOL, V176, P325, DOI 10.1006/dbio.1996.0137; ZHAO JJ, 1993, GENE DEV, V7, P343, DOI 10.1101/gad.7.3.343	57	19	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10820	10.1371/journal.pone.0010820	http://dx.doi.org/10.1371/journal.pone.0010820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520839	Green Published, gold			2022-12-27	WOS:000278034800015
J	Buglino, JA; Resh, MD				Buglino, John A.; Resh, Marilyn D.			Identification of Conserved Regions and Residues within Hedgehog Acyltransferase Critical for Palmitoylation of Sonic Hedgehog	PLOS ONE			English	Article							CHOLESTEROL MODIFICATION; LYSOPHOSPHOLIPID ACYLTRANSFERASE; LIPID MODIFICATIONS; MBOAT FAMILY; FATTY-ACIDS; PROTEIN; MEMBRANE; ENCODES; RANGE; SPECIFICITY	Background: Sonic hedgehog (Shh) is a palmitoylated protein that plays key roles in mammalian development and human cancers. Palmitoylation of Shh is required for effective long and short range Shh-mediated signaling. Attachment of palmitate to Shh is catalyzed by Hedgehog acyltransferase (Hhat), a member of the membrane bound O-acyl transferase (MBOAT) family of multipass membrane proteins. The extremely hydrophobic composition of MBOAT proteins has limited their biochemical characterization. Except for mutagenesis of two conserved residues, there has been no structure-function analysis of Hhat, and the regions of the protein required for Shh palmitoylation are unknown. Methodology/Principal Findings: Here we undertake a systematic approach to identify residues within Hhat that are required for protein stability and/or enzymatic activity. We also identify a second, novel MBOAT homology region (residues 196-234) that is required for Hhat activity. In total, ten deletion mutants and eleven point mutants were generated and analyzed. Truncations at the N- and C-termini of Hhat yielded inactive proteins with reduced stability. Four Hhat mutants with deletions within predicted loop regions and five point mutants retained stability but lost palmitoylation activity. We purified two point mutants, W378A and H379A, with defective Hhat activity. Kinetic analyses revealed alterations in apparent K(m) and V(max) for Shh and/or palmitoyl CoA, changes that likely explain the catalytic defects observed for these mutants. Conclusions/Significance: This study has pinpointed specific regions and multiple residues that regulate Hhat stability and catalysis. Our findings should be applicable to other MBOAT proteins that mediate lipid modification of Wnt proteins and ghrelin, and should serve as a model for understanding how secreted morphogens are modified by palmitoyl acyltransferases.	[Buglino, John A.; Resh, Marilyn D.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; [Buglino, John A.; Resh, Marilyn D.] Cornell Univ, Grad Program Biochem Cell & Mol Biol, Weill Grad Sch Med Sci, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Buglino, JA (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10021 USA.	m-resh@ski.mskcc.org		Resh, Marilyn/0000-0001-6118-9466	National Institutes of Health [GM57966, GM008539]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008539, R01GM057966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health grants GM57966 and GM008539. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTHIAUME L, 1995, METHOD ENZYMOL, V250, P454; Bosson R, 2006, MOL BIOL CELL, V17, P2636, DOI 10.1091/mbc.E06-02-0104; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Callejo A, 2006, DEVELOPMENT, V133, P471, DOI 10.1242/dev.02217; Callejo A, 2008, P NATL ACAD SCI USA, V105, P912, DOI 10.1073/pnas.0705603105; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chang CCY, 1998, J BIOL CHEM, V273, P35132, DOI 10.1074/jbc.273.52.35132; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Dawber RJ, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-21; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Gallet A, 2006, DEVELOPMENT, V133, P407, DOI 10.1242/dev.02212; Gallet A, 2003, DEV CELL, V4, P191, DOI 10.1016/S1534-5807(03)00031-5; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; Guo ZM, 2001, J LIPID RES, V42, P1282; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Ho KS, 2002, CURR OPIN NEUROBIOL, V12, P57, DOI 10.1016/S0959-4388(02)00290-8; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Joyce CW, 2000, MOL BIOL CELL, V11, P3675, DOI 10.1091/mbc.11.11.3675; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kohtz JD, 2001, DEVELOPMENT, V128, P2351; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Lee JD, 2001, DEV BIOL, V233, P122, DOI 10.1006/dbio.2001.0218; Lee JD, 2001, CURR BIOL, V11, P1147, DOI 10.1016/S0960-9822(01)00323-2; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Lin S, 2003, MOL BIOL CELL, V14, P2447, DOI 10.1091/mbc.E02-11-0725; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Matsuda S, 2008, GENES CELLS, V13, P879, DOI 10.1111/j.1365-2443.2008.01212.x; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Micchelli CA, 2002, DEVELOPMENT, V129, P843; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PESECKIS SM, 1993, J BIOL CHEM, V268, P5107; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Shindou H, 2009, BIOCHEM BIOPH RES CO, V383, P320, DOI 10.1016/j.bbrc.2009.04.013; Smotrys JE, 2005, J CELL BIOL, V170, P1091, DOI 10.1083/jcb.200507048; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Taylor FR, 2001, BIOCHEMISTRY-US, V40, P4359, DOI 10.1021/bi002487u; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200	43	42	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11195	10.1371/journal.pone.0011195	http://dx.doi.org/10.1371/journal.pone.0011195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585641	Green Submitted, Green Published, gold			2022-12-27	WOS:000279135400008
J	Pal, S; Dolai, S; Yadav, RK; Adak, S				Pal, Swati; Dolai, Subhankar; Yadav, Rajesh K.; Adak, Subrata			Ascorbate Peroxidase from Leishmania major Controls the Virulence of Infective Stage of Promastigotes by Regulating Oxidative Stress	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR-BETA; APOPTOTIC CELLS; DEVELOPMENTAL MODIFICATION; CYTOKINE PRODUCTION; IN-VITRO; TGF-BETA; METACYCLOGENESIS; DIFFERENTIATION; DONOVANI	Background: Peroxidase represents a heterogeneous group of distinct enzyme family that plays extremely diverse biological functions. Ascorbate peroxidase from Leishmania major (LmAPX) has been shown to be central to the redox defense system of Leishmania. To investigate further its exact physiological role in Leishmania, we attempted to create LmAPX-knockout mutants by gene replacement in L. major strains. Methodology/Principal Findings: The null mutant cell culture contains a higher percentage of metacyclic and apoptotic cells compared to both wild type and LmAPX overexpressing cells. Flowcytometric analysis reveals the presence of a higher concentration of intracellular H2O2, indicative of increased oxidative stress in parasites lacking LmAPX. IC50 value for exogenously added H2O2 shows that deletion of LmAPX in L. major renders the cell more susceptible to H2O2. Real time PCR studies demonstrate an elevated mRNA level of non-selenium glutathione peroxidase in LmAPX null mutant cell line, suggesting that these enzymes were induced to compensate the LmAPX enzyme. The null mutant cells exhibit hypervirulence after infection with macrophages as well as inoculation into BALB/c mice; in contrast, overexpressing cells show avirulence. Conclusions/Significance: Collectively, these data provide strong evidence that LmAPX is an important factor for controlling parasite differentiation and survival within macrophages.	[Pal, Swati; Dolai, Subhankar; Yadav, Rajesh K.; Adak, Subrata] Indian Inst Chem Biol, Div Struct Biol & Bioinformat, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Pal, S (corresponding author), Indian Inst Chem Biol, Div Struct Biol & Bioinformat, Kolkata, W Bengal, India.	adaks@iicb.res.in		Pal, Swati/0000-0001-6179-4316; YADAV, RAJESH/0000-0002-4239-0428	Department of Science and Technology [SR/SO/BB-54/2005]; Council of Scientific and Industrial Research (CSIR) [NWP 0038]	Department of Science and Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Department of Science and Technology Grant SR/SO/BB-54/2005, Council of Scientific and Industrial Research (CSIR) Project NWP 0038, CSIR Fellowships (to S.P., S.D. and R.K.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adak S, 2005, BIOCHEM J, V390, P465, DOI 10.1042/BJ20050311; Adak S, 2002, J BIOL CHEM, V277, P16167, DOI 10.1074/jbc.M201136200; Adak S, 2002, P NATL ACAD SCI USA, V99, P107, DOI 10.1073/pnas.012470099; BARRAL A, 1995, AM J PATHOL, V147, P947; BARRAL A, 1993, P NATL ACAD SCI USA, V90, P3442, DOI 10.1073/pnas.90.8.3442; Cadenas Enrique, 2004, Molecular Aspects of Medicine, V25, P17, DOI 10.1016/j.mam.2004.02.005; Castro H, 2008, ANTIOXID REDOX SIGN, V10, P1593, DOI 10.1089/ars.2008.2050; Choi WS, 2004, J BIOL CHEM, V279, P20451, DOI 10.1074/jbc.M311164200; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; Cunningham ML, 2001, SCIENCE, V292, P285, DOI 10.1126/science.1057740; DASILVA R, 1987, INFECT IMMUN, V55, P2802, DOI 10.1128/IAI.55.11.2802-2806.1987; Dolai S, 2007, BBA-GEN SUBJECTS, V1770, P247, DOI 10.1016/j.bbagen.2006.10.001; Dolai S, 2008, FREE RADICAL BIO MED, V45, P1520, DOI 10.1016/j.freeradbiomed.2008.08.029; Dolai S, 2009, EUKARYOT CELL, V8, P1721, DOI 10.1128/EC.00198-09; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fadok VA, 1998, BIOCHEM SOC T, V26, P653, DOI 10.1042/bst0260653; Flohe L, 2008, ANTIOXID REDOX SIGN, V10, P1485, DOI 10.1089/ars.2008.2059; GREEN SJ, 1990, J IMMUNOL, V145, P4290; Gurunathan S, 1997, J EXP MED, V186, P1137, DOI 10.1084/jem.186.7.1137; Henson PM, 2004, IMMUNITY, V21, P604, DOI 10.1016/j.immuni.2004.11.002; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; MCCONVILLE MJ, 1992, EMBO J, V11, P3593, DOI 10.1002/j.1460-2075.1992.tb05443.x; Wanderley JLM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005733; Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741; MURRAY HW, 1988, J INFECT DIS, V158, P1372, DOI 10.1093/infdis/158.6.1372; NELSON BJ, 1991, J IMMUNOL, V146, P1849; REINER NE, 1990, J CLIN INVEST, V85, P1914, DOI 10.1172/JCI114654; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; SACKS DL, 1990, MOL BIOCHEM PARASIT, V42, P225, DOI 10.1016/0166-6851(90)90165-I; SACKS DL, 1985, AM J TROP MED HYG, V34, P456, DOI 10.4269/ajtmh.1985.34.456; SACKS DL, 1985, J IMMUNOL, V135, P564; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; SACKS DL, 1989, EXP PARASITOL, V69, P100, DOI 10.1016/0014-4894(89)90176-8; Saraiva EM, 2005, EXP PARASITOL, V110, P39, DOI 10.1016/j.exppara.2005.01.004; SILVA JS, 1991, J EXP MED, V174, P539, DOI 10.1084/jem.174.3.539; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Yadav RK, 2008, BBA-PROTEINS PROTEOM, V1784, P863, DOI 10.1016/j.bbapap.2008.02.006	39	62	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11271	10.1371/journal.pone.0011271	http://dx.doi.org/10.1371/journal.pone.0011271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585663	gold, Green Published, Green Submitted			2022-12-27	WOS:000279135400017
J	Hasegawa, K; Miwa, J				Hasegawa, Koichi; Miwa, Johji			Genetic and Cellular Characterization of Caenorhabditis elegans Mutants Abnormal in the Regulation of Many Phase II Enzymes	PLOS ONE			English	Article							OXIDATIVE-STRESS-RESPONSE; C-ELEGANS; FACTOR SKN-1; LIFE-SPAN; ACRYLAMIDE; EXPRESSION; LONGEVITY; SPECIFICATION; INHIBITION; MECHANISMS	Background: The phase II detoxification enzymes execute a major protective role against xenobiotics as well as endogenous toxicants. To understand how xenobiotics regulate phase II enzyme expression, acrylamide was selected as a model xenobiotic chemical, as it induces a large number and a variety of phase II enzymes, including numerous glutathione S-transferases (GSTs) in Caenorhabditis elegans. Methodology/Principal Findings: To begin dissecting genetically xenobiotics response pathways (xrep), 24 independent mutants of C. elegans that exhibited abnormal GST expression or regulation against acrylamide were isolated by screening about 3.5 x 10(5) genomes of gst::gfp transgenic strains mutagenized with ethyl methanesulfonate (EMS). Complementation testing assigned the mutants to four different genes, named xrep-1, -2, -3, and -4. One of the genes, xrep-1, encodes WDR-23, a nematode homologue of WD repeat-containing protein WDR23. Loss-of-function mutations in xrep-1 mutants resulted in constitutive expression of many GSTs and other phase II enzymes in the absence of acrylamide, and the wild-type xrep-1 allele carried on a DNA construct successfully cured the mutant phenotype of the constitutive enzyme expression. Conclusions/Significance: Genetic and cellular characterization of xrep-1 mutants suggest that a large number of GSTs and other phase II enzymes induced by acrylamide are under negative regulation by XREP-1 (WDR-23), which is likely to be a functional equivalent of mammalian Keap1 and a regulator of SKN-1, a C. elegans analogue of cap-n-collar Nrf2 (nuclear factor erythroid 2-related factor 2).	[Hasegawa, Koichi; Miwa, Johji] Chubu Univ, Coll Biosci & Biotechnol, Aichi, Japan	Chubu University	Hasegawa, K (corresponding author), Chubu Univ, Coll Biosci & Biotechnol, Aichi, Japan.	miwa@isc.chubu.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology; Chubu University	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Chubu University	This work was supported by a Grant-in-Aid for Scientific Research to JM and a JSPS research fund to KH of the Japanese Ministry of Education, Culture, Sports, Science and Technology and by the Chubu University special research fund to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amzal B, 2009, ENVIRON HEALTH PERSP, V117, P1293, DOI 10.1289/ehp.0800317; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; An JH, 2005, P NATL ACAD SCI USA, V102, P16275, DOI 10.1073/pnas.0508105102; Benz CC, 2008, NAT REV CANCER, V8, P875, DOI 10.1038/nrc2522; BRENNER S, 1974, GENETICS, V77, P71; Choe KP, 2009, MOL CELL BIOL, V29, P2704, DOI 10.1128/MCB.01811-08; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Dybing E, 2008, TOXICOL LETT, V180, P110, DOI 10.1016/j.toxlet.2008.05.007; Friedman M, 2003, J AGR FOOD CHEM, V51, P4504, DOI 10.1021/jf030204+; Gao XQ, 2001, P NATL ACAD SCI USA, V98, P15221, DOI 10.1073/pnas.261572998; Hasegawa K, 2004, TOXICOL LETT, V152, P183, DOI 10.1016/j.toxlet.2004.04.037; HASEGAWA K, 2010, TRANSCRIPTO IN PRESS; Hasegawa K, 2008, TOXICOL SCI, V101, P215, DOI 10.1093/toxsci/kfm276; Hasegawa K, 2007, TOXICOL LETT, V175, P82, DOI 10.1016/j.toxlet.2007.09.013; Hasegawa K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009267; HAYES JD, 2005, ANN REV PHARM TOXICO, V88, P45; Hudson Andrew M., 2008, V48, P6, DOI 10.1007/978-0-387-09595-0_2; Johansson AS, 2001, J BIOL CHEM, V276, P33061, DOI 10.1074/jbc.M104539200; Joseph P, 2009, TOXICOL APPL PHARM, V238, P272, DOI 10.1016/j.taap.2009.01.011; Jowsey IR, 2001, BIOCHEM J, V359, P507, DOI 10.1042/0264-6021:3590507; Kahn NW, 2008, BIOCHEM J, V409, P205, DOI 10.1042/BJ20070521; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Lindblom TH, 2006, J EXP ZOOL PART A, V305A, P720, DOI 10.1002/jez.a.324; Maduro M, 1996, GENE, V183, P77, DOI 10.1016/S0378-1119(96)00491-X; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MITANI S, 1995, DEV GROWTH DIFFER, V37, P551; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; ODLAND L, 1994, TOXICOL IN VITRO, V8, P263, DOI 10.1016/0887-2333(94)90192-9; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; Park SK, 2009, AGING CELL, V8, P258, DOI 10.1111/j.1474-9726.2009.00473.x; Sumner SCJ, 2003, TOXICOL SCI, V75, P260, DOI 10.1093/toxsci/kfg191; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Tan SW, 2009, CRIT REV TOXICOL, V39, P228, DOI 10.1080/10408440802233259; Tareke E, 2002, J AGR FOOD CHEM, V50, P4998, DOI 10.1021/jf020302f; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030	39	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11194	10.1371/journal.pone.0011194	http://dx.doi.org/10.1371/journal.pone.0011194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20585349	Green Published, Green Submitted, gold			2022-12-27	WOS:000278886300032
J	Lagana, A; Russo, F; Sismeiro, C; Giugno, R; Pulvirenti, A; Ferro, A				Lagana, Alessandro; Russo, Francesco; Sismeiro, Catarina; Giugno, Rosalba; Pulvirenti, Alfredo; Ferro, Alfredo			Variability in the Incidence of miRNAs and Genes in Fragile Sites and the Role of Repeats and CpG Islands in the Distribution of Genetic Material	PLOS ONE			English	Article							VIRAL INTEGRATION; MESSENGER-RNAS; MICRORNA GENES; FRA3B; LUNG; ELEMENTS; FREQUENT; REVEALS; REGIONS; BREAKPOINTS	Background: Chromosomal fragile sites are heritable specific loci especially prone to breakage. Some of them are associated with human genetic disorders and several studies have demonstrated their importance in genome instability in cancer. MicroRNAs (miRNAs) are small non-coding RNAs responsible of post-transcriptional gene regulation and their involvement in several diseases such as cancer has been widely demonstrated. The altered expression of miRNAs is sometimes due to chromosomal rearrangements and epigenetic events, thus it is essential to study miRNAs in the context of their genomic locations, in order to find significant correlations between their aberrant expression and the phenotype. Principal Findings: Here we use statistical models to study the incidence of human miRNA genes on fragile sites and their association with cancer-specific translocation breakpoints, repetitive elements, and CpG islands. Our results show that, on average, fragile sites are denser in miRNAs and also in protein coding genes. However, the distribution of miRNAs and protein coding genes in fragile versus non-fragile sites depends on chromosome. We find also a positive correlation between fragility and repeats, and between miRNAs and CpG islands. Conclusion: Our results show that the relationship between site fragility and miRNA density is far more complex than previously thought. For example, we find that protein coding genes seem to be following similar patterns as miRNAs, if considered their overall distribution. However, once we allow for differences at the chromosome level in our statistical analysis, we find that distribution of miRNA and protein coding genes in fragile sites is very different from that of miRNA. This is a novel result that we believe may help discover new potential correlations between the localization of miRNAs and their crucial role in biological processes and in the development of diseases.	[Lagana, Alessandro; Giugno, Rosalba; Pulvirenti, Alfredo; Ferro, Alfredo] Univ Catania, Dept Math & Comp Sci, Catania, Italy; [Russo, Francesco; Ferro, Alfredo] Univ Catania, Dept Biomed Sci, Catania, Italy; [Sismeiro, Catarina] Univ London Imperial Coll Sci Technol & Med, Imperial Coll Business Sch, London, England	University of Catania; University of Catania; Imperial College London	Lagana, A (corresponding author), Univ Catania, Dept Math & Comp Sci, Catania, Italy.	lagana@dmi.unict.it; ferro@dmi.unict.it	Pulvirenti, Alfredo/I-7272-2018; Russo, Francesco/X-3055-2018	Pulvirenti, Alfredo/0000-0002-9764-0295; Russo, Francesco/0000-0001-9257-4359; Giugno, Rosalba/0000-0001-9843-7638	PROGETTO FIRB ITALY-ISRAEL [RBIN04BYZ7]	PROGETTO FIRB ITALY-ISRAEL	This research was supported by PROGETTO FIRB ITALY-ISRAEL Grant n. RBIN04BYZ7: "Algorithms for Patterns Discovery and Retrieval in discrete structures with applications to Bioinformatics." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becker NA, 2002, ONCOGENE, V21, P8713, DOI 10.1038/sj.onc.1205950; Bednarek AK, 2001, CANCER RES, V61, P8068; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; BORGAONKAR DS, 1975, CYTOGENET CELL GENET, V14, P252, DOI 10.1159/000130355; Brueckner B, 2007, CANCER RES, V67, P1419, DOI 10.1158/0008-5472.CAN-06-4074; Burrow AA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-59; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Daheron L, 2001, GENE CHROMOSOME CANC, V31, P382, DOI 10.1002/gcc.1157; Dallol A, 2002, CANCER RES, V62, P5874; Demirhan O, 2008, ALCOHOL ALCOHOLISM, V43, P127, DOI 10.1093/alcalc/agm155; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; FERRO A, 2009, NETTAB 2009 CAT IT J; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Glover TW, 2006, CANCER LETT, V232, P4, DOI 10.1016/j.canlet.2005.08.032; Goransson M, 2009, ONCOGENE, V28, P270, DOI 10.1038/onc.2008.378; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grover D, 2004, BIOINFORMATICS, V20, P813, DOI 10.1093/bioinformatics/bth005; Hewett DR, 1998, MOL CELL, V1, P773, DOI 10.1016/S1097-2765(00)80077-5; Huppi K, 2007, SEMIN CANCER BIOL, V17, P65, DOI 10.1016/j.semcancer.2006.10.004; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kim S, 2008, J VIROL, V82, P9964, DOI 10.1128/JVI.01299-08; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lagana A, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap008; Laissue P, 2009, J MED GENET, V46, P455, DOI 10.1136/jmg.2008.065086; Lehnert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004456; Levy A, 2008, NUCLEIC ACIDS RES, V36, pD47, DOI 10.1093/nar/gkm949; LEWANDOWSKA U, 2009, PHYSL PHARM S1, V60, P47; LI Y, 1925, CANCER SCI, V100, P1234; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Lukusa T, 2008, BBA-GENE REGUL MECH, V1779, P3, DOI 10.1016/j.bbagrm.2007.10.005; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Matuszek G, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-102; Mendes-da-Silva P, 2000, J CLIN PATHOL-MOL PA, V53, P184, DOI 10.1136/mp.53.4.184; MITELMAN F, 2008, MITELMAN DATABASE CH; Morelli C, 2002, ONCOGENE, V21, P7266, DOI 10.1038/sj.onc.1205573; Novo FJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-33; Paradee W, 1996, GENOMICS, V35, P87, DOI 10.1006/geno.1996.0326; POPESCU NC, 1990, HUM GENET, V84, P383; Rassool FV, 1996, GENOMICS, V35, P109, DOI 10.1006/geno.1996.0329; Ruiz-Herrera A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r115; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Schutte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339; Scotto L, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-58; Sevignani C, 2007, P NATL ACAD SCI USA, V104, P8017, DOI 10.1073/pnas.0702177104; Shivapurkar N, 1999, CLIN CANCER RES, V5, P17; Smalheiser NR, 2006, TRENDS GENET, V22, P532, DOI 10.1016/j.tig.2006.08.007; Smalheiser NR, 2005, TRENDS GENET, V21, P322, DOI 10.1016/j.tig.2005.04.008; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Sutherland GR, 2003, CYTOGENET GENOME RES, V100, P77, DOI 10.1159/000072840; SUTHERLAND GR, 1995, CURR OPIN GENET DEV, V5, P323, DOI 10.1016/0959-437X(95)80046-8; Vujovic Svetlana, 2009, Menopause Int, V15, P72, DOI 10.1258/mi.2009.009020; Wilke CM, 1996, HUM MOL GENET, V5, P187, DOI 10.1093/hmg/5.2.187; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu S, 1997, CELL, V88, P367, DOI 10.1016/S0092-8674(00)81875-9; Zahed L, 2002, CLIN GENET, V62, P310, DOI 10.1034/j.1399-0004.2002.620410.x; Zimonjic DB, 1997, CANCER RES, V57, P1166	63	40	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11166	10.1371/journal.pone.0011166	http://dx.doi.org/10.1371/journal.pone.0011166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567512	gold, Green Submitted, Green Published			2022-12-27	WOS:000278886300012
J	Secchiero, P; Zorzet, S; Tripodo, C; Corallini, F; Melloni, E; Caruso, L; Bosco, R; Ingrao, S; Zavan, B; Zauli, G				Secchiero, Paola; Zorzet, Sonia; Tripodo, Claudio; Corallini, Federica; Melloni, Elisabetta; Caruso, Lorenzo; Bosco, Raffaella; Ingrao, Sabrina; Zavan, Barbara; Zauli, Giorgio			Human Bone Marrow Mesenchymal Stem Cells Display Anti-Cancer Activity in SCID Mice Bearing Disseminated Non-Hodgkin's Lymphoma Xenografts	PLOS ONE			English	Article							STROMAL CELLS; ENDOTHELIAL-CELLS; LEUKEMIA CELLS; TUMOR STROMA; IN-VIVO; CANCER; GROWTH; PROLIFERATION; FIBROBLASTS; EXPRESSION	Background: Although multimodality treatment can induce high rate of remission in many subtypes of non-Hodgkin's lymphoma (NHL), significant proportions of patients relapse with incurable disease. The effect of human bone marrow (BM) mesenchymal stem cells (MSC) on tumor cell growth is controversial, and no specific information is available on the effect of BM-MSC on NHL. Methodology/Principal Findings: The effect of BM-MSC was analyzed in two in vivo models of disseminated non-Hodgkin's lymphomas with an indolent (EBV- Burkitt-type BJAB, median survival = 46 days) and an aggressive (EBV+ B lymphoblastoid SKW6.4, median survival = 27 days) behavior in nude-SCID mice. Intra-peritoneal (i.p.) injection of MSC (4 days after i.p. injection of lymphoma cells) significantly increased the overall survival at an optimal MSC: lymphoma ratio of 1: 10 in both xenograft models (BJAB+MSC, median survival = 58.5 days; SKW6.4+MSC, median survival = 40 days). Upon MSC injection, i.p. tumor masses developed more slowly and, at the histopathological observation, exhibited a massive stromal infiltration coupled to extensive intra-tumor necrosis. In in vitro experiments, we found that: i) MSC/lymphoma co-cultures modestly affected lymphoma cell survival and were characterized by increased release of pro-angiogenic cytokines with respect to the MSC, or lymphoma, cultures; ii) MSC induce the migration of endothelial cells in transwell assays, but promoted endothelial cell apoptosis in direct MSC/endothelial cell co-cultures. Conclusions/Significance: Our data demonstrate that BM-MSC exhibit anti-lymphoma activity in two distinct xenograft SCID mouse models of disseminated NHL.	[Secchiero, Paola; Corallini, Federica; Melloni, Elisabetta; Caruso, Lorenzo; Bosco, Raffaella; Zauli, Giorgio] Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy; [Zorzet, Sonia] Univ Trieste, Dept Life Sci, Trieste, Italy; [Tripodo, Claudio; Ingrao, Sabrina] Univ Palermo, Dept Human Pathol, Palermo, Italy; [Zavan, Barbara] Univ Padua, Dept Histol & Microbiol, Padua, Italy	University of Ferrara; University of Trieste; University of Palermo; University of Padua	Secchiero, P (corresponding author), Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy.	giorgio.zauli@unife.it	Zauli, Giorgio/ABE-8001-2020; Melloni, Elisabetta/AAW-7880-2021; Tripodo, Claudio/O-4536-2016; Tripodo, Claudio/AAB-6004-2022; Caruso, Lorenzo/AAH-8056-2021; Melloni, Elisabetta/AAB-3890-2019; secchiero, paola/G-9689-2015	Tripodo, Claudio/0000-0002-0821-6231; Tripodo, Claudio/0000-0002-0821-6231; Caruso, Lorenzo/0000-0001-9895-3990; Melloni, Elisabetta/0000-0002-7829-0824; secchiero, paola/0000-0003-4101-7987; Zauli, Giorgio/0000-0002-3750-8698; Sonia, Zorzet/0000-0001-5161-3542	Associazione Italiana per la Ricerca contro il Cancro (AIRC); CariFe Foundation	Associazione Italiana per la Ricerca contro il Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); CariFe Foundation(Fondazione Carife)	This work was supported by Associazione Italiana per la Ricerca contro il Cancro (AIRC) grant and by CariFe Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Ame-Thomas P, 2007, BLOOD, V109, P693, DOI 10.1182/blood-2006-05-020800; Armitage JO, 1998, J CLIN ONCOL, V16, P2780, DOI 10.1200/JCO.1998.16.8.2780; Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Choi YB, 2010, VIROLOGY, V397, P369, DOI 10.1016/j.virol.2009.11.024; Clarke CA, 2002, CANCER-AM CANCER SOC, V94, P2015, DOI 10.1002/cncr.10403; De Becker A, 2007, HAEMATOLOGICA, V92, P440, DOI 10.3324/haematol.10475; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Edelmann J, 2008, LEUKEMIA RES, V32, P1565, DOI 10.1016/j.leukres.2008.03.003; GUEST I, 2009, INT J CANC; Hamada H, 2005, CANCER SCI, V96, P149, DOI 10.1111/j.1349-7006.2005.00032.x; Iwamoto S, 2007, J CLIN INVEST, V117, P1049, DOI 10.1172/JCI30235; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; KAYA NE, 2007, LEUKEMIA RES, V31, P899; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Kidd S, 2008, CYTOTHERAPY, V10, P657, DOI 10.1080/14653240802486517; Lazennec G, 2008, STEM CELLS, V26, P1387, DOI 10.1634/stemcells.2007-1006; Lwin T, 2007, LEUKEMIA, V21, P1521, DOI 10.1038/sj.leu.2404723; Marini FC, 2009, CYTOTHERAPY, V11, P375, DOI 10.1080/14653240903098195; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Ning H, 2008, LEUKEMIA, V22, P593, DOI 10.1038/sj.leu.2405090; Otsu K, 2009, BLOOD, V113, P4197, DOI 10.1182/blood-2008-09-176198; Ramasamy R, 2007, LEUKEMIA, V21, P304, DOI 10.1038/sj.leu.2404489; Ruan J, 2006, CLIN CANCER RES, V12, P5622, DOI 10.1158/1078-0432.CCR-06-1204; Sato T, 2004, GYNECOL ONCOL, V92, P47, DOI 10.1016/j.ygyno.2003.09.012; Secchiero P, 2005, BLOOD, V105, P3413, DOI 10.1182/blood-2004-10-4111; Secchiero P, 2004, CELL MOL LIFE SCI, V61, P1965, DOI 10.1007/s00018-004-4197-6; Secchiero P, 2007, CURR DRUG METAB, V8, P395, DOI 10.2174/138920007780655432; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Trouillon R, 2010, BIOCHEMISTRY-US, V49, P3282, DOI 10.1021/bi902122w; Zhu W, 2006, EXP MOL PATHOL, V80, P267, DOI 10.1016/j.yexmp.2005.07.004; Zhu Y, 2009, LEUKEMIA, V23, P925, DOI 10.1038/leu.2008.384	39	108	116	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11140	10.1371/journal.pone.0011140	http://dx.doi.org/10.1371/journal.pone.0011140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585401	Green Published, Green Submitted, gold			2022-12-27	WOS:000278886100010
J	Madronal, N; Lopez-Aracil, C; Rangel, A; del Rio, JA; Delgado-Garcia, JM; Gruart, A				Madronal, Noelia; Lopez-Aracil, Cristina; Rangel, Alejandra; del Rio, Jose A.; Delgado-Garcia, Jose M.; Gruart, Agnes			Effects of Enriched Physical and Social Environments on Motor Performance, Associative Learning, and Hippocampal Neurogenesis in Mice	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ADULT NEUROGENESIS; DENTATE GYRUS; SYNAPTIC-TRANSMISSION; CELL-PROLIFERATION; CA3-CA1 SYNAPSE; TRANSGENIC MICE; BEHAVING MICE; GRANULE CELLS; NEURONS	We have studied the motor abilities and associative learning capabilities of adult mice placed in different enriched environments. Three-month-old animals were maintained for a month alone (AL), alone in a physically enriched environment (PHY), and, finally, in groups in the absence (SO) or presence (SOPHY) of an enriched environment. The animals' capabilities were subsequently checked in the rotarod test, and for classical and instrumental learning. The PHY and SOPHY groups presented better performances in the rotarod test and in the acquisition of the instrumental learning task. In contrast, no significant differences between groups were observed for classical eyeblink conditioning. The four groups presented similar increases in the strength of field EPSPs (fEPSPs) evoked at the hippocampal CA3-CA1 synapse across classical conditioning sessions, with no significant differences between groups. These trained animals were pulse-injected with bromodeoxyuridine (BrdU) to determine hippocampal neurogenesis. No significant differences were found in the number of NeuN/BrdU double-labeled neurons. We repeated the same BrdU study in one-month-old mice raised for an additional month in the above-mentioned four different environments. These animals were not submitted to rotarod or conditioned tests. Non-trained PHY and SOPHY groups presented more neurogenesis than the other two groups. Thus, neurogenesis seems to be related to physical enrichment at early ages, but not to learning acquisition in adult mice.	[Madronal, Noelia; Lopez-Aracil, Cristina; Delgado-Garcia, Jose M.; Gruart, Agnes] Pablo de Olavide Univ, Div Neurosci, Seville, Spain; [Rangel, Alejandra; del Rio, Jose A.] Univ Barcelona, Catalonian Inst Bioengn, Barcelona, Spain; [Rangel, Alejandra; del Rio, Jose A.] Univ Barcelona, Dept Cell Biol, Barcelona, Spain; [Rangel, Alejandra; del Rio, Jose A.] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain	Universidad Pablo de Olavide; University of Barcelona; University of Barcelona; CIBERNED	Madronal, N (corresponding author), Pablo de Olavide Univ, Div Neurosci, Seville, Spain.	agrumas@upo.es	Delgado-Garcia, Jose M./V-1567-2019; Del Rio Fernandez, Jose A/AAD-1121-2020; del rio, jose antonio/L-9232-2014	del rio, jose antonio/0000-0002-5214-4909; Rangel, Alejandra/0000-0001-6536-6263	Spanish Ministerio de Ciencia e Innovacion [BFU2009-10848, BFU2008-00899, BFU2008-03390]; Generalitat de Catalunya [SGR2009-0366]; Junta de Andalucia [CVI-02487]; Instituto Carlos III; FP7-EU [PRIORITY, DEVANX]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Junta de Andalucia(Junta de Andalucia); Instituto Carlos III(Instituto de Salud Carlos III); FP7-EU	Grant sponsor: Spanish Ministerio de Ciencia e Innovacion; Grant numbers: BFU2009-10848, BFU2008-00899, and BFU2008-03390. Grant sponsor: Generalitat de Catalunya; Grant number: SGR2009-0366. Grant sponsor: Junta de Andalucia; Grant number: CVI-02487. Grant sponsor: Instituto Carlos III. Grant sponsor: FP7-EU; Grant numbers: PRIORITY and DEVANX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrein I, 2009, BIOL LETTERS, V5, P141, DOI 10.1098/rsbl.2008.0511; BARNEA A, 1994, P NATL ACAD SCI USA, V91, P11217, DOI 10.1073/pnas.91.23.11217; BENNETT EL, 1969, SCIENCE, V163, P825, DOI 10.1126/science.163.3869.825; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; DELRIO JA, 1989, DEV BRAIN RES, V49, P311, DOI 10.1016/0165-3806(89)90033-3; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Dhanushkodi A, 2007, BEHAV NEUROSCI, V121, P491, DOI 10.1037/0735-7044.121.3.491; Dominguez-del-Toro E, 2004, EUR J NEUROSCI, V20, P1945, DOI 10.1111/j.1460-9568.2004.03643.x; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Eleore L, 2007, BEHAV NEUROSCI, V121, P1203, DOI 10.1037/0735-7044.121.6.1203; Fontana X, 2006, CEREB CORTEX, V16, P301, DOI 10.1093/cercor/bhi120; Foster TC, 2001, J NEUROPHYSIOL, V85, P1377, DOI 10.1152/jn.2001.85.4.1377; Gottlieb M, 2006, NEUROBIOL DIS, V23, P374, DOI 10.1016/j.nbd.2006.03.017; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1999, TRENDS COGN SCI, V3, P186, DOI 10.1016/S1364-6613(99)01310-8; GREEN EJ, 1986, J NEUROPHYSIOL, V55, P739, DOI 10.1152/jn.1986.55.4.739; GRUART A, 1995, J NEUROPHYSIOL, V74, P226, DOI 10.1152/jn.1995.74.1.226; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Gureviciene I, 2004, NEUROBIOL DIS, V15, P188, DOI 10.1016/j.nbd.2003.11.011; HANCOCK MB, 1984, J HISTOCHEM CYTOCHEM, V32, P311, DOI 10.1177/32.3.6198359; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; HEBB DO, AM PSYCHOL, V2, P306; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Klempin F, 2007, EUR ARCH PSY CLIN N, V257, P271, DOI 10.1007/s00406-007-0731-5; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Madronal N, 2007, J NEUROSCI, V27, P12139, DOI 10.1523/JNEUROSCI.3397-07.2007; Madronal N, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.007.2009; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; O'Callaghan RM, 2009, HIPPOCAMPUS, V19, P1019, DOI 10.1002/hipo.20591; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pham TM, 1999, BEHAV BRAIN RES, V103, P63, DOI 10.1016/S0166-4328(99)00019-4; Porras-Garcia E, 2005, EUR J NEUROSCI, V21, P979, DOI 10.1111/j.1460-9568.2005.03940.x; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; ROSENZWEIG M R, 1969, Developmental Psychobiology, V2, P87, DOI 10.1002/dev.420020208; ROSENZWEIG MR, 1978, BRAIN RES, V153, P563, DOI 10.1016/0006-8993(78)90340-2; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; SORIANO E, 1991, J HISTOCHEM CYTOCHEM, V39, P255, DOI 10.1177/39.3.1671576; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Takatsuki K, 2003, J NEUROSCI, V23, P17; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Waddell J, 2008, EUR J NEUROSCI, V27, P3020, DOI 10.1111/j.1460-9568.2008.06222.x	50	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11130	10.1371/journal.pone.0011130	http://dx.doi.org/10.1371/journal.pone.0011130			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559565	gold, Green Published, Green Submitted			2022-12-27	WOS:000278775900019
J	Smith, B; Treadwell, J; Zhang, DL; Ly, D; McKinnell, I; Walker, PR; Sikorska, M				Smith, Brandon; Treadwell, Julie; Zhang, Dongling; Ly, Dao; McKinnell, Iain; Walker, P. Roy; Sikorska, Marianna			Large-Scale Expression Analysis Reveals Distinct MicroRNA Profiles at Different Stages of Human Neurodevelopment	PLOS ONE			English	Article							NEURONAL DIFFERENTIATION; NERVOUS-SYSTEM; CELL-LINE; DEVELOPMENTAL REGULATION; MICROARRAY ANALYSIS; ALZHEIMERS-DISEASE; SMALL RNAS; REST; BRAIN; MOUSE	Background: MicroRNAs (miRNAs) are short non-coding RNAs predicted to regulate one third of protein coding genes via mRNA targeting. In conjunction with key transcription factors, such as the repressor REST (RE1 silencing transcription factor), miRNAs play crucial roles in neurogenesis, which requires a highly orchestrated program of gene expression to ensure the appropriate development and function of diverse neural cell types. Whilst previous studies have highlighted select groups of miRNAs during neural development, there remains a need for amenable models in which miRNA expression and function can be analyzed over the duration of neurogenesis. Principal Findings: We performed large-scale expression profiling of miRNAs in human NTera2/D1 (NT2) cells during retinoic acid (RA)-induced transition from progenitors to fully differentiated neural phenotypes. Our results revealed dynamic changes of miRNA patterns, resulting in distinct miRNA subsets that could be linked to specific neurodevelopmental stages. Moreover, the cell-type specific miRNA subsets were very similar in NT2-derived differentiated cells and human primary neurons and astrocytes. Further analysis identified miRNAs as putative regulators of REST, as well as candidate miRNAs targeted by REST. Finally, we confirmed the existence of two predicted miRNAs; pred-MIR191 and pred-MIR222 associated with SLAIN1 and FOXP2, respectively, and provided some evidence of their potential co-regulation. Conclusions: In the present study, we demonstrate that regulation of miRNAs occurs in precise patterns indicative of their roles in cell fate commitment, progenitor expansion and differentiation into neurons and glia. Furthermore, the similarity between our NT2 system and primary human cells suggests their roles in molecular pathways critical for human in vivo neurogenesis.	[Smith, Brandon; Treadwell, Julie; Zhang, Dongling; Ly, Dao; McKinnell, Iain; Walker, P. Roy; Sikorska, Marianna] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	National Research Council Canada	Smith, B (corresponding author), Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	brandon.smith@nrc-cnrc.gc.ca	Smith, Brandon/ABF-2934-2021		National Research Council Canada	National Research Council Canada	Funding for this work was provided by the National Research Council Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Artzi S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-39; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bani-Yaghoub M, 1999, NEUROREPORT, V10, P3843, DOI 10.1097/00001756-199912160-00022; Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Byrd AS, 2004, NEURON GLIA BIOL, V1, P317, DOI 10.1017/S1740925X05000207; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; DAMJANOV I, 1984, CELL DIFFER DEV, V15, P133, DOI 10.1016/0045-6039(84)90065-4; Dogini DB, 2008, J MOL NEUROSCI, V35, P331, DOI 10.1007/s12031-008-9068-4; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Goff Loyal A, 2005, RNA Biol, V2, P93, DOI 10.4161/rna.2.3.2059; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hirst CE, 2006, DEV BIOL, V293, P90, DOI 10.1016/j.ydbio.2006.01.023; Hohjoh H, 2007, BIOCHEM BIOPH RES CO, V362, P360, DOI 10.1016/j.bbrc.2007.07.189; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Huang B, 2009, ACTA BIOCH BIOPH SIN, V41, P231, DOI 10.1093/abbs/gmp006; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Johnson R, 2006, NUCLEIC ACIDS RES, V34, P3862, DOI 10.1093/nar/gkl525; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kong YW, 2008, P NATL ACAD SCI USA, V105, P8866, DOI 10.1073/pnas.0800650105; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Nouspikel T, 2000, MOL CELL BIOL, V20, P1562, DOI 10.1128/MCB.20.5.1562-1570.2000; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; PLEASURE SJ, 1993, J NEUROSCI RES, V35, P585, DOI 10.1002/jnr.490350603; Przyborski SA, 2000, EUR J NEUROSCI, V12, P3521, DOI 10.1046/j.1460-9568.2000.00230.x; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Strauss WM, 2006, MAMM GENOME, V17, P833, DOI 10.1007/s00335-006-0025-7; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Walker PR, 2006, CONT NEUROS, P59, DOI 10.1007/978-1-59745-021-8_6; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wheeler G, 2006, FEBS LETT, V580, P2195, DOI 10.1016/j.febslet.2006.03.019; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zeng Y, 2009, MOL PHARMACOL, V75, P259, DOI 10.1124/mol.108.052118; Zhang Man Cang, 2008, Fen Zi Xi Bao Sheng Wu Xue Bao, V41, P341; Zhou Guang-Sheng, 2008, Zhiwu Shengtai Xuebao, V32, P65	67	58	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11109	10.1371/journal.pone.0011109	http://dx.doi.org/10.1371/journal.pone.0011109			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559549	Green Published, Green Submitted, gold			2022-12-27	WOS:000278775900005
J	Makela, J; Koivuniemi, R; Korhonen, L; Lindholm, D				Makela, Johanna; Koivuniemi, Raili; Korhonen, Laura; Lindholm, Dan			Interferon-gamma Produced by Microglia and the Neuropeptide PACAP Have Opposite Effects on the Viability of Neural Progenitor Cells	PLOS ONE			English	Article							ACTIVATING POLYPEPTIDE PACAP; CENTRAL-NERVOUS-SYSTEM; VASOACTIVE-INTESTINAL-PEPTIDE; STEM-CELLS; RAT-BRAIN; IN-VITRO; GROWTH-FACTOR; NEUROGENESIS; PROLIFERATION; DEATH	Inflammation is part of many neurological disorders and immune reactions may influence neuronal progenitor cells (NPCs) contributing to the disease process. Our knowledge about the interplay between different cell types in brain inflammation are not fully understood. It is important to know the mechanisms and factors involved in order to enhance regeneration and brain repair. We show here that NPCs express receptors for interferon-gamma (IFN gamma), and IFN gamma activates the signal transducer and activator of transcription (STAT) protein-1. IFN gamma reduced cell proliferation in NPCs by upregulation of the cell cycle protein p21 as well as induced cell death of NPCs by activating caspase-3. Studies of putative factors for rescue showed that the neuropeptide, Pituitary adenylate cyclase-activating polypeptide (PACAP) increased cell viability, the levels of p-Bad and reduced caspase-3 activation in the NPCs. Medium from cultured microglia contained IFN gamma and decreased the viability of NPCs, whilst blocking with anti-IFN gamma antibodies counteracted this effect. The results show that NPCs are negatively influenced by IFN gamma whereas PACAP is able to modulate its action. The interplay between IFN gamma released from immune cells and PACAP is of importance in brain inflammation and may affect the regeneration and recruitment of NPCs in immune diseases. The observed effects of IFN gamma on NPCs deserve to be taken into account in human anti-viral therapies particularly in children with higher rates of brain stem cell proliferation.	[Makela, Johanna; Koivuniemi, Raili; Korhonen, Laura; Lindholm, Dan] Biomedicum 2 Helsinki, Minerva Med Res Inst, Helsinki, Finland; [Lindholm, Dan] Univ Helsinki, Inst Biomed Biochem, Helsinki, Finland	University of Helsinki; University of Helsinki	Makela, J (corresponding author), Biomedicum 2 Helsinki, Minerva Med Res Inst, Helsinki, Finland.	dan.lindholm@helsinki.fi	Lindholm, Dan/B-3777-2014; Korhonen, Laura/AAW-3256-2020; Koivuniemi, Raili/AAF-2173-2021	Koivuniemi, Raili/0000-0002-0359-7178; Korhonen, Laura/0000-0002-1837-5930	Sigrid Juselius; Liv och Halsa; Magnus Ehrnrooth and Signe and Ane Gyllenberg Foundations, Minerva; Academy of Finland	Sigrid Juselius(Sigrid Juselius Foundation); Liv och Halsa; Magnus Ehrnrooth and Signe and Ane Gyllenberg Foundations, Minerva; Academy of Finland(Academy of Finland)	Supported by Sigrid Juselius, Liv och Halsa, Magnus Ehrnrooth and Signe and Ane Gyllenberg Foundations, Minerva and the Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Arimura A, 2007, PEPTIDES, V28, P1617, DOI 10.1016/j.peptides.2007.06.006; Armstrong BD, 2008, NEUROSCIENCE, V151, P63, DOI 10.1016/j.neuroscience.2007.09.084; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Brannvall K, 2005, EUR J NEUROSCI, V21, P871, DOI 10.1111/j.1460-9568.2005.03942.x; Brannvall K, 2002, MOL CELL NEUROSCI, V21, P512, DOI 10.1006/mcne.2002.1194; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dafny N, 2005, EUR J PHARMACOL, V523, P1, DOI 10.1016/j.ejphar.2005.08.029; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; De Simone R, 1998, CYTOKINE, V10, P418, DOI 10.1006/cyto.1997.0314; Delcourt N, 2007, EMBO J, V26, P1542, DOI 10.1038/sj.emboj.7601608; Delgado M, 2003, J LEUKOCYTE BIOL, V73, P155, DOI 10.1189/jlb.0702372; Dogrukol-Ak D, 2004, CURR PHARM DESIGN, V10, P1325, DOI 10.2174/1381612043384934; Einstein O, 2003, MOL CELL NEUROSCI, V24, P1074, DOI 10.1016/j.mcn.2003.08.009; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gooch JL, 2000, CELL GROWTH DIFFER, V11, P335; Hoehn BD, 2005, STROKE, V36, P2718, DOI 10.1161/01.STR.0000190020.30282.cc; Jaworski DM, 2000, DEV BRAIN RES, V120, P27, DOI 10.1016/S0165-3806(99)00192-3; Lindberg C, 2005, J NEUROSCI RES, V82, P10, DOI 10.1002/jnr.20615; Lindholm D, 1998, ANN NY ACAD SCI, V865, P189, DOI 10.1111/j.1749-6632.1998.tb11178.x; Lindholm D, 2004, BIOCHEM BIOPH RES CO, V321, P753, DOI 10.1016/j.bbrc.2004.06.138; Lum M, 2009, J NEUROIMMUNOL, V206, P32, DOI 10.1016/j.jneuroim.2008.10.009; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Mercer A, 2004, J NEUROSCI RES, V76, P205, DOI 10.1002/jnr.20038; Mertens C, 2007, CELL, V131, DOI 10.1016/j.cell.2007.10.033; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nagao M, 2007, MOL CELL BIOL, V27, P3982, DOI 10.1128/MCB.00170-07; Ohta S, 2006, J NEUROSCI RES, V84, P1177, DOI 10.1002/jnr.21026; Ohtaki H, 2006, P NATL ACAD SCI USA, V103, P7488, DOI 10.1073/pnas.0600375103; Piltti K, 2006, ONCOGENE, V25, P4880, DOI 10.1038/sj.onc.1209492; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Rahpeymai Y, 2006, EMBO J, V25, P1364, DOI 10.1038/sj.emboj.7601004; Scharf E, 2008, J MOL NEUROSCI, V36, P79, DOI 10.1007/s12031-008-9097-z; Shioda Seiji, 2000, Acta Anatomica Nipponica, V75, P487; Sippel M, 2009, FEBS LETT, V583, P2213, DOI 10.1016/j.febslet.2009.06.018; Skoglosa Y, 1999, MOL BRAIN RES, V65, P1, DOI 10.1016/S0169-328X(98)00294-0; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Steen H, 2008, BIOCHEM BIOPH RES CO, V366, P432, DOI 10.1016/j.bbrc.2007.11.146; Sundberg M, 2006, J NEUROSCI, V26, P5402, DOI 10.1523/JNEUROSCI.4906-05.2006; Takei N, 1998, J NEUROSCI RES, V54, P698, DOI 10.1002/(SICI)1097-4547(19981201)54:5<698::AID-JNR15>3.0.CO;2-5; Takei N, 2000, EUR J NEUROSCI, V12, P2273, DOI 10.1046/j.1460-9568.2000.00118.x; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; VAUDRY D, 2000, PHARMACOL REV, V269, P324; Waschek JA, 2002, DEV NEUROSCI-BASEL, V24, P14, DOI 10.1159/000064942; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8	50	48	50	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11091	10.1371/journal.pone.0011091	http://dx.doi.org/10.1371/journal.pone.0011091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559421	Green Published, gold, Green Submitted			2022-12-27	WOS:000278741100007
J	Nowicki, D; Siegelmann, H				Nowicki, Dimitri; Siegelmann, Hava			Flexible Kernel Memory	PLOS ONE			English	Article							NEURONAL CORRELATE; NETWORK MODEL; TERM-MEMORY; DYNAMICS; RECONSOLIDATION; STORAGE; REPRESENTATIONS; CONSOLIDATION; MODULATION; ATTRACTORS	This paper introduces a new model of associative memory, capable of both binary and continuous-valued inputs. Based on kernel theory, the memory model is on one hand a generalization of Radial Basis Function networks and, on the other, is in feature space, analogous to a Hopfield network. Attractors can be added, deleted, and updated on-line simply, without harming existing memories, and the number of attractors is independent of input dimension. Input vectors do not have to adhere to a fixed or bounded dimensionality; they can increase and decrease it without relearning previous memories. A memory consolidation process enables the network to generalize concepts and form clusters of input data, which outperforms many unsupervised clustering techniques; this process is demonstrated on handwritten digits from MNIST. Another process, reminiscent of memory reconsolidation is introduced, in which existing memories are refreshed and tuned with new inputs; this process is demonstrated on series of morphed faces.	[Nowicki, Dimitri; Siegelmann, Hava] Univ Massachusetts, Dept Comp Sci, Biologically Inspired Neural & Dynam Syst Lab, Amherst, MA 01003 USA; [Nowicki, Dimitri] Natl Acad Sci Ukraine, Inst Math Machines & Syst Problems, Ctr Cybernet, Kiev, Ukraine; [Siegelmann, Hava] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA	University of Massachusetts System; University of Massachusetts Amherst; National Academy of Sciences Ukraine; V. M. Glushkov Institute of Cybernetics, National Academy of Sciences of Ukraine; Harvard University	Nowicki, D (corresponding author), Univ Massachusetts, Dept Comp Sci, Biologically Inspired Neural & Dynam Syst Lab, Amherst, MA 01003 USA.	nowicki@cs.umass.edu		Nowicki, Dmitry/0000-0001-8188-3957	Office of Naval Research [109-0138R]	Office of Naval Research(Office of Naval Research)	This work was supported by the Office of Naval Research grant #109-0138R (www.onr.navy.mil). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert A., 1972, REGRESSION MOORE PEN; Amit D. J., 1989, MODELING BRAIN FUNCT, DOI 10.1017/CBO9780511623257; Ben-Hur A., 2002, Journal of Machine Learning Research, V2, P125, DOI 10.1162/15324430260185565; BILLINGS SA, 1995, NEURAL NETWORKS, V8, P273, DOI 10.1016/0893-6080(94)00078-Z; Blumenfeld B, 2006, NEURON, V52, P383, DOI 10.1016/j.neuron.2006.08.016; CAPUTO B, 2002, ARTIFICIAL NEURAL NE, P134; Casali D, 2006, IEEE T NEURAL NETWOR, V17, P1165, DOI 10.1109/TNN.2006.877539; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; CHEUNG YM, 2002, NEUR INF PROC ICONIP, V2, P1032; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Cucker F, 2002, B AM MATH SOC, V39, P1; do Carmo M. P., 1992, RIEMANNIAN GEOMETRY; Dudai Y, 1997, NEURON, V18, P179, DOI 10.1016/S0896-6273(00)80257-3; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Durstewitz D, 2000, J NEUROPHYSIOL, V83, P1733, DOI 10.1152/jn.2000.83.3.1733; Eichenbaum H, 2006, NEURON, V50, P350, DOI 10.1016/j.neuron.2006.04.017; Erickson CA, 1999, J NEUROSCI, V19, P10404; Fusi S, 2007, NAT NEUROSCI, V10, P485, DOI 10.1038/nn1859; FUSTER JM, 1971, NEURON, V14, P477; Golub GH., 2013, MATRIX COMPUTATIONS; Gruber AJ, 2006, J COMPUT NEUROSCI, V20, P153, DOI 10.1007/s10827-005-5705-x; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Kay LM, 1996, INT J NEURAL SYST, V7, P489, DOI 10.1142/S0129065796000476; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lengyel M, 2005, NAT NEUROSCI, V8, P1677, DOI 10.1038/nn1561; Leutgeb JK, 2005, NEURON, V48, P345, DOI 10.1016/j.neuron.2005.09.007; Li ZP, 2001, NEURAL COMPUT, V13, P1749, DOI 10.1162/08997660152469332; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Medina JH, 2008, BEHAV BRAIN RES, V192, P61, DOI 10.1016/j.bbr.2008.02.006; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; MIYOSHI T, 1995, NEUR NETW P IEEE INT, P588; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Petersen P., 2006, RIEMANNIAN GEOMETRY, V2; POGGIO T, 1990, SCIENCE, V247, P978, DOI 10.1126/science.247.4945.978; Preminger S, 2005, PERCEPTION, V34, P14; Sanderson C., 2008, BIOMETRIC PERSON REC; Seung HS, 1998, NEURAL NETWORKS, V11, P1253, DOI 10.1016/S0893-6080(98)00064-1; Siegelmann HT, 2008, PHYSICA D, V237, P1207, DOI 10.1016/j.physd.2008.03.038; SINGER E, 2009, TECHNOL REV, V46, P138; Sun JC, 2004, LECT NOTES COMPUT SC, V3173, P578; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; TREVES A, 1990, PHYS REV A, V42, P2418, DOI 10.1103/PhysRevA.42.2418; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Vapnik V., 1998, STAT LEARNING THEORY; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; Zemel RS, 2001, NEURAL COMPUT, V13, P1045, DOI 10.1162/08997660151134325; Zhang BL, 2004, IEEE T NEURAL NETWOR, V15, P166, DOI 10.1109/TNN.2003.820673; Zhang R, 2002, INT C PATT RECOG, P289, DOI 10.1109/ICPR.2002.1047453	56	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e10955	10.1371/journal.pone.0010955	http://dx.doi.org/10.1371/journal.pone.0010955			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552013	gold, Green Published			2022-12-27	WOS:000278662900003
J	Yao, JH; Zhou, JY; Liu, QL; Lu, DR; Wang, L; Qiao, XJ; Jia, W				Yao, Jihua; Zhou, Jingyao; Liu, Qiaoling; Lu, Daru; Wang, Lu; Qiao, Xiaojing; Jia, William			Atoh8, a bHLH Transcription Factor, Is Required for the Development of Retina and Skeletal Muscle in Zebrafish	PLOS ONE			English	Article							CELL FATE SPECIFICATION; NERVOUS-SYSTEM; EXPRESSION; GENES; MATH6; DIFFERENTIATION; NETWORK; MODEL; MYOD	Background: Math6/atoh8, a bHLH transcription factor, is thought to be indispensable for early embryonic development and likely has important roles in vertebrate tissue-specific differentiation. However, the function of Atoh8 during early development is not clear because homozygous knockout causes embryonic lethality in mice. We have examined the effects of the atoh8 gene on the differentiation of retina and skeletal muscle during early development in zebrafish. Results: We isolated a Math6 homologue in zebrafish, designated as zebrafish atoh8. Whole -mount in situ hybridization analysis showed that zebrafish atoh8 is dynamically expressed mainly in developing retina and skeletal muscle. Atoh8-MO knock-down resulted in reduced eye size with disorganization of retinal lamination. The reduction of atoh8 function also affected the arrangement of paraxial cells and differentiated muscle fibers during somite morphogenesis. Conclusion: Our results show that Atoh8 is an important regulator for the development of both the retina and skeletal muscles necessary for neural retinal cell and myogenic differentiation during zebrafish embryogenesis.	[Yao, Jihua; Zhou, Jingyao; Lu, Daru; Wang, Lu; Qiao, Xiaojing; Jia, William] Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Liu, Qiaoling] Shanghai Res Ctr Biomodel Organisms, Pathol Lab, Shanghai, Peoples R China; [Jia, William] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada	Fudan University; University of British Columbia	Yao, JH (corresponding author), Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	yaojh1@gmail.com; wjia@interchange.ubc.ca	JIA, WILLIAM/AAE-4322-2020		National Natural Science Foundation of China [30771112]; State High Technology Development Program (863) [2006AA02Z161]; Natural Science Foundation of Shanghai, China [10ZR1403100]; Canadian Institute of Health Research [20R92354]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State High Technology Development Program (863)(National High Technology Research and Development Program of China); Natural Science Foundation of Shanghai, China(Natural Science Foundation of Shanghai); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the National Natural Science Foundation of China (30771112), the State High Technology Development Program (863, 2006AA02Z161), the Natural Science Foundation of Shanghai, China (10ZR1403100) for J. Yao and Canadian Institute of Health Research (20R92354) for W. Jia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai L, 2000, DEVELOPMENT, V127, P3021; Coutelle O, 2001, DEV BIOL, V236, P136, DOI 10.1006/dbio.2001.0193; Ekker SC, 2001, GENESIS, V30, P89, DOI 10.1002/gene.1038; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Hatakeyama J, 2004, SEMIN CELL DEV BIOL, V15, P83, DOI 10.1016/j.semcdb.2003.09.005; Hojo M, 2000, DEVELOPMENT, V127, P2515; Inoue C, 2001, GENES CELLS, V6, P977, DOI 10.1046/j.1365-2443.2001.00476.x; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lakowski J, 2007, DEV BIOL, V307, P498, DOI 10.1016/j.ydbio.2007.04.015; Lynn FC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002430; Ma QF, 1997, J NEUROSCI, V17, P3644; Masai I, 2000, NEURON, V27, P251, DOI 10.1016/S0896-6273(00)00034-9; Matter-Sadzinski L, 2005, DEVELOPMENT, V132, P3907, DOI 10.1242/dev.01960; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Nornes S, 1998, MECH DEVELOP, V77, P185, DOI 10.1016/S0925-4773(98)00156-7; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rohmann KN, 2007, DEV NEUROBIOL, V67, P1, DOI 10.1002/dneu.20303; Ross MD, 2006, DEV DYNAM, V235, P3102, DOI 10.1002/dvdy.20934; Sherpa T, 2008, DEV NEUROBIOL, V68, P166, DOI 10.1002/dneu.20568; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Yan RT, 2005, MOL NEUROBIOL, V32, P157, DOI 10.1385/MN:32:2:157	25	38	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10945	10.1371/journal.pone.0010945	http://dx.doi.org/10.1371/journal.pone.0010945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532172	Green Published, gold, Green Submitted			2022-12-27	WOS:000278318700016
J	Chia, N; Cann, I; Olsen, GJ				Chia, Nicholas; Cann, Isaac; Olsen, Gary J.			Evolution of DNA Replication Protein Complexes in Eukaryotes and Archaea	PLOS ONE			English	Article							MCM HELICASE ACTIVITY; CLAMP-LOADER COMPLEX; BIOCHEMICAL-CHARACTERIZATION; SULFOLOBUS-SOLFATARICUS; PYROCOCCUS-FURIOSUS; METHANOSARCINA-ACETIVORANS; MAXIMUM-LIKELIHOOD; AEROPYRUM-PERNIX; HEXAMERIC RING; GENE FAMILY	Background: The replication of DNA in Archaea and eukaryotes requires several ancillary complexes, including proliferating cell nuclear antigen (PCNA), replication factor C (RFC), and the minichromosome maintenance (MCM) complex. Bacterial DNA replication utilizes comparable proteins, but these are distantly related phylogenetically to their archaeal and eukaryotic counterparts at best. Methodology/Principal Findings: While the structures of each of the complexes do not differ significantly between the archaeal and eukaryotic versions thereof, the evolutionary dynamic in the two cases does. The number of subunits in each complex is constant across all taxa. However, they vary subtly with regard to composition. In some taxa the subunits are all identical in sequence, while in others some are homologous rather than identical. In the case of eukaryotes, there is no phylogenetic variation in the makeup of each complex-all appear to derive from a common eukaryotic ancestor. This is not the case in Archaea, where the relationship between the subunits within each complex varies taxon-to-taxon. We have performed a detailed phylogenetic analysis of these relationships in order to better understand the gene duplications and divergences that gave rise to the homologous subunits in Archaea. Conclusion/Significance: This domain level difference in evolution suggests that different forces have driven the evolution of DNA replication proteins in each of these two domains. In addition, the phylogenies of all three gene families support the distinctiveness of the proposed archaeal phylum Thaumarchaeota.	[Chia, Nicholas; Cann, Isaac; Olsen, Gary J.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Chia, Nicholas] Univ Illinois, Loomis Lab Phys, Urbana, IL 61801 USA; [Chia, Nicholas] Univ Illinois, Phys Frontier Ctr, Urbana, IL 61801 USA; [Cann, Isaac; Olsen, Gary J.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Cann, Isaac] Univ Illinois, Lab Anim Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Chia, N (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.	chian@uiuc.edu		Chia, Nicholas/0000-0001-9652-691X	Department of Energy [DOE-2005-05818]; National Science Foundation [NSF-0526747, MCB-0238451]; Institute for Genomic Biology	Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Institute for Genomic Biology	The authors acknowledge partial support from Department of Energy grant number DOE-2005-05818 and National Science Foundation grant numbers NSF-0526747 and MCB-0238451. NC is supported by the Institute for Genomic Biology Postdoctoral Fellows Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul S.F., 1997, NUCLEIC ACIDS RES, V25, P3390; Atanassova N, 2008, BIOCHEMISTRY-US, V47, P13362, DOI 10.1021/bi801479s; Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Berthon J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r71; Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Bouzat JL, 2000, J MOL EVOL, V51, P532, DOI 10.1007/s002390010117; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Brochier C, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-36; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Cann IKO, 2001, J BACTERIOL, V183, P2614, DOI 10.1128/JB.183.8.2614-2623.2001; Carpentieri F, 2002, J BIOL CHEM, V277, P12118, DOI 10.1074/jbc.M200091200; CARROLL SB, 2005, ENDLESS FORMS MOST B; Chen YH, 2005, J BIOL CHEM, V280, P41852, DOI 10.1074/jbc.M508684200; Chen YH, 2009, J BACTERIOL, V191, P6539, DOI 10.1128/JB.00414-09; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Costa A, 2006, NUCLEIC ACIDS RES, V34, P5829, DOI 10.1093/nar/gkl708; Dionne I, 2003, MOL CELL, V11, P275, DOI 10.1016/S1097-2765(02)00824-9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Grabowski B, 2003, ANNU REV MICROBIOL, V57, P487, DOI 10.1146/annurev.micro.57.030502.090709; Grainge I, 2003, NUCLEIC ACIDS RES, V31, P4888, DOI 10.1093/nar/gkg662; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haugland GT, 2006, NUCLEIC ACIDS RES, V34, P6337, DOI 10.1093/nar/gkl864; HOLLAND PWH, 1994, DEVELOPMENT S, V120, P125; HUNT LT, 1972, BIOCHEM BIOPH RES CO, V47, P699, DOI 10.1016/0006-291X(72)90548-7; Imamura K, 2007, MOL MICROBIOL, V64, P308, DOI 10.1111/j.1365-2958.2007.05645.x; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kanter DM, 2008, J BIOL CHEM, V283, P31172, DOI 10.1074/jbc.M804686200; Kasiviswanathan R, 2004, J BIOL CHEM, V279, P28358, DOI 10.1074/jbc.M403202200; Kauffman S.A., 1993, ORIGINS ORDER; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; Kornberg A., 1992, DNA REPLICATION; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; KURIYAN J, 1993, J MOL BIOL, V234, P915, DOI 10.1006/jmbi.1993.1644; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Lin LJ, 2010, J MOL BIOL, V397, P13, DOI 10.1016/j.jmb.2010.01.007; Liu Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-60; Lu SH, 2008, BIOCHEM BIOPH RES CO, V376, P369, DOI 10.1016/j.bbrc.2008.08.150; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; MIYACHI K, 1978, J IMMUNOL, V121, P2228; Morowitz H.J., 1993, BEGINNINGS CELLULAR; Ohno S., 1970, EVOLUTION GENE DUPLI; OHTA T, 1991, J MOL EVOL, V33, P34, DOI 10.1007/BF02100193; Olendzenski Lorraine, 1998, P165; Oparin A.I., 1964, CHEM ORIGIN LIFE; Oyama T, 2001, MOL CELL, V8, P455, DOI 10.1016/S1097-2765(01)00328-8; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Pape T, 2003, EMBO REP, V4, P1079, DOI 10.1038/sj.embor.7400010; Pisani FM, 2000, J MOL BIOL, V301, P61, DOI 10.1006/jmbi.2000.3964; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Shin JH, 2009, J BIOL CHEM, V284, P540, DOI 10.1074/jbc.M806803200; Skaer N, 2002, TRENDS GENET, V18, P399, DOI 10.1016/S0168-9525(02)02747-6; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Thommes P, 1997, EMBO J, V16, P3312, DOI 10.1093/emboj/16.11.3312; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WALTERS AD, 2010, MICROBIOLOG IN PRESS; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yoshimochi T, 2008, J BIOL CHEM, V283, P1601, DOI 10.1074/jbc.M707654200; You ZY, 1999, MOL CELL BIOL, V19, P8003; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; ZIPKAS D, 1975, P NATL ACAD SCI USA, V72, P1354, DOI 10.1073/pnas.72.4.1354	67	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2010	5	6							e10866	10.1371/journal.pone.0010866	http://dx.doi.org/10.1371/journal.pone.0010866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604NC	20532250	Green Published, gold			2022-12-27	WOS:000278284700002
J	Prost, S; Smirnov, N; Fedorov, VB; Sommer, RS; Stiller, M; Nagel, D; Knapp, M; Hofreiter, M				Prost, Stefan; Smirnov, Nickolay; Fedorov, Vadim B.; Sommer, Robert S.; Stiller, Mathias; Nagel, Doris; Knapp, Michael; Hofreiter, Michael			Influence of Climate Warming on Arctic Mammals? New Insights from Ancient DNA Studies of the Collared Lemming Dicrostonyx torquatus	PLOS ONE			English	Article							POPULATION-DYNAMICS; LATE PLEISTOCENE; SHORT-TERM; DIVERSITY; COALESCENT; INFERENCE; LEMMUS; VARIABILITY; DEMOGRAPHY; DISPERSAL	Background: Global temperature increased by approximately half a degree (Celsius) within the last 150 years. Even this moderate warming had major impacts on Earth's ecological and biological systems, especially in the Arctic where the magnitude of abiotic changes even exceeds those in temperate and tropical biomes. Therefore, understanding the biological consequences of climate change on high latitudes is of critical importance for future conservation of the species living in this habitat. The past 25,000 years can be used as a model for such changes, as they were marked by prominent climatic changes that influenced geographical distribution, demographic history and pattern of genetic variation of many extant species. We sequenced ancient and modern DNA of the collared lemming (Dicrostonyx torquatus), which is a key species of the arctic biota, from a single site (Pymva Shor, Northern Pre Urals, Russia) to see if climate warming events after the Last Glacial Maximum had detectable effects on the genetic variation of this arctic rodent species, which is strongly associated with a cold and dry climate. Results: Using three dimensional network reconstructions we found a dramatic decline in genetic diversity following the LGM. Model-based approaches such as Approximate Bayesian Computation and Markov Chain Monte Carlo based Bayesian inference show that there is evidence for a population decline in the collared lemming following the LGM, with the population size dropping to a minimum during the Greenland Interstadial 1 (Bolling/Allerod) warming phase at 14.5 kyrs BP. Conclusion: Our results show that previous climate warming events had a strong influence on genetic diversity and population size of collared lemmings. Due to its already severely compromised genetic diversity a similar population reduction as a result of the predicted future climate change could completely abolish the remaining genetic diversity in this population. Local population extinctions of collared lemmings would have severe effects on the arctic ecosystem, as collared lemmings are a key species in the trophic interactions and ecosystem processes in the Arctic.	[Prost, Stefan; Stiller, Mathias; Knapp, Michael; Hofreiter, Michael] Max Planck Inst Evolutionary Anthropol, Res Grp Mol Ecol, Leipzig, Germany; [Prost, Stefan; Nagel, Doris] Univ Vienna, Dept Paleontol, Vienna, Austria; [Smirnov, Nickolay] Russian Acad Sci, Inst Plant & Anim Ecol, Ekaterinburg, Russia; [Fedorov, Vadim B.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Sommer, Robert S.] Univ Kiel, Ctr Ecol, Kiel, Germany	Max Planck Society; University of Vienna; Russian Academy of Sciences; Institute of Plant & Animal Ecology of the Russian Academy of Sciences; University of Alaska System; University of Alaska Fairbanks; University of Kiel	Prost, S (corresponding author), Gregor Mendel Inst Mol Plant Biol, Vienna, Austria.	stefan.prost@gmi.oeaw.ac.at	Smirnov, Nikolay/Y-8256-2018; Hofreiter, Michael/A-3996-2017	Prost, Stefan/0000-0002-6229-3596; Hofreiter, Michael/0000-0003-0441-4705; Knapp, Michael/0000-0002-0937-5664	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	The authors' work was funded by the Max Planck Society (http://www.mpg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGADJANIAN AK, 1976, RUSSIAN TRANSLATION, V28, P379; Anderson CNK, 2005, BIOINFORMATICS, V21, P1733, DOI 10.1093/bioinformatics/bti154; Andreassen HP, 2001, ECOLOGY, V82, P2911, DOI 10.2307/2679970; [Anonymous], 2005, ARCTIC CLIMATE IMPAC; BATZLI GO, 1980, HERBIVORE BASED TROP, P335; Beaumont MA, 2002, GENETICS, V162, P2025; Beaumont MA., 2008, SIMULATION GENETICS, P134; Blackburn GS, 1998, CAN J ZOOL, V76, P2255, DOI 10.1139/cjz-76-12-2255; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Callaghan TV, 2004, AMBIO, V33, P436, DOI 10.1639/0044-7447(2004)033[0436:EOTSOA]2.0.CO;2; Callaghan TV, 2004, AMBIO, V33, P404, DOI 10.1639/0044-7447(2004)033[0404:BDAAOA]2.0.CO;2; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; DANSGAARD W, 1989, NATURE, V339, P532, DOI 10.1038/339532a0; De MacPhee R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-49; de Vernal A, 2008, SCIENCE, V320, P1622, DOI 10.1126/science.1153929; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; DRUMMOND AJ, TRACER V1 4; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ehrich D, 2005, J MAMMAL, V86, P380, DOI 10.1644/BER-126.1; ENINGER B, 2007, CALPAL 2007 COLOGNE; Excoffier L, 2000, J HERED, V91, P506, DOI 10.1093/jhered/91.6.506; Fairbanks RG, 2005, QUATERNARY SCI REV, V24, P1781, DOI 10.1016/j.quascirev.2005.04.007; Fedorov VB, 1999, J EVOLUTION BIOL, V12, P134; Fedorov VB, 2002, P ROY SOC B-BIOL SCI, V269, P2071, DOI 10.1098/rspb.2002.2126; Fedorov VB, 1999, HEREDITAS, V130, P301, DOI 10.1111/j.1601-5223.1999.00301.x; Fedorov VB, 2001, P ROY SOC B-BIOL SCI, V268, P809, DOI 10.1098/rspb.2001.1584; Fedorov VB, 1999, P ROY SOC B-BIOL SCI, V266, P621, DOI 10.1098/rspb.1999.0681; Gilg O, 2009, GLOBAL CHANGE BIOL, V15, P2634, DOI 10.1111/j.1365-2486.2009.01927.x; Golovachov IB, 2009, QUATERN INT, V201, P37, DOI 10.1016/j.quaint.2008.05.029; Graham RW, 1996, SCIENCE, V272, P1601; Guthrie RD, 2006, NATURE, V441, P207, DOI 10.1038/nature04604; GUTHRIE RD, 1968, ARCTIC, V21, P223; Hadly EA, 2004, PLOS BIOL, V2, P1600, DOI 10.1371/journal.pbio.0020290; HALL TA, 1999, NUCL ACIDS S SERIES, V44, P211; Hofreiter M, 2002, MOL BIOL EVOL, V19, P1244, DOI 10.1093/oxfordjournals.molbev.a004185; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Hoye TT, 2007, CURR BIOL, V17, pR449, DOI 10.1016/j.cub.2007.04.047; Hubberten HW, 2004, QUATERNARY SCI REV, V23, P1333, DOI 10.1016/j.quascirev.2003.12.012; Imbrie J, 1992, PALEOCEANOGRAPHY, V7, P701, DOI 10.1029/92PA02253; Ims RA, 2000, NATURE, V408, P194, DOI 10.1038/35041562; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Kowalski Kazimierz, 1995, Acta Zoologica Cracoviensia, V38, P85; LEHMAN SJ, 1992, NATURE, V356, P757, DOI 10.1038/356757a0; Leonard JA, 2007, CURR BIOL, V17, P1146, DOI 10.1016/j.cub.2007.05.072; Lin YTK, 2001, ECOL MONOGR, V71, P245, DOI 10.1890/0012-9615(2001)071[0245:TIOHQO]2.0.CO;2; Lindqvist C, 2010, P NATL ACAD SCI USA, V107; MACLEAN S F JR, 1974, Arctic and Alpine Research, V6, P1, DOI 10.2307/1550365; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Markova Anastasia K., 1997, Paleontologia i Evolucio, V28-29, P5; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; OGNEV S, 1967, MAMMALS USSR ADJACEN, V6; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; PEARSON OP, 1966, J ANIM ECOL, V35, P217, DOI 10.2307/2698; Pereira SL, 2004, GENOME, V47, P535, DOI 10.1139/G04-009; PITELKA FA, 1957, COLD SPRING HARB SYM, V22, P237, DOI 10.1101/SQB.1957.022.01.023; PITELKA FA, 1993, BIOL LEMMINGS, P214; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Ramakrishnan U, 2005, MOL ECOL, V14, P2915, DOI 10.1111/j.1365-294X.2005.02586.x; Ramakrishnan U, 2009, MOL ECOL, V18, P1310, DOI 10.1111/j.1365-294X.2009.04092.x; RODGERS AR, 1986, CAN J ZOOL, V64, P2717, DOI 10.1139/z86-396; Rompler H, 2006, NAT PROTOC, V1, P720, DOI 10.1038/nprot.2006.84; ROHLAND N, 2009, MOL ECOL RESOURCES; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sittler B, 2000, ARCTIC, V53, P53; Sommer RS, 2009, J BIOGEOGR, V36, P2013, DOI 10.1111/j.1365-2699.2009.02187.x; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Stiller M, 2009, GENOME RES, V19, P1843, DOI 10.1101/gr.095760.109; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Tzedakis PC, 1997, EARTH PLANET SC LETT, V150, P171, DOI 10.1016/S0012-821X(97)00078-2; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275; Wilson DJ, 1999, OIKOS, V87, P382, DOI 10.2307/3546754; Zazhigin V.S., 1976, P280	85	42	42	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10447	10.1371/journal.pone.0010447	http://dx.doi.org/10.1371/journal.pone.0010447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523724	Green Published, Green Submitted, gold			2022-12-27	WOS:000278221900001
J	Smout, S; Asseburg, C; Matthiopoulos, J; Fernandez, C; Redpath, S; Thirgood, S; Harwood, J				Smout, Sophie; Asseburg, Christian; Matthiopoulos, Jason; Fernandez, Carmen; Redpath, Stephen; Thirgood, Simon; Harwood, John			The Functional Response of a Generalist Predator	PLOS ONE			English	Article							HARRIER CIRCUS-CYANEUS; SINGLE-SPECIES MODELS; FISHERIES MANAGEMENT; SCIENTIFIC BASIS; HEN HARRIERS; PREY; CONSERVATION; SENSITIVITY; ASSUMPTIONS; ADVICE	Background: Predators can have profound impacts on the dynamics of their prey that depend on how predator consumption is affected by prey density (the predator's functional response). Consumption by a generalist predator is expected to depend on the densities of all its major prey species (its multispecies functional response, or MSFR), but most studies of generalists have focussed on their functional response to only one prey species. Methodology and principal findings: Using Bayesian methods, we fit an MSFR to field data from an avian predator (the hen harrier Circus cyaneus) feeding on three different prey species. We use a simple graphical approach to show that ignoring the effects of alternative prey can give a misleading impression of the predator's effect on the prey of interest. For example, in our system, a "predator pit'' for one prey species only occurs when the availability of other prey species is low. Conclusions and significance: The Bayesian approach is effective in fitting the MSFR model to field data. It allows flexibility in modelling over-dispersion, incorporates additional biological information into the parameter priors, and generates estimates of uncertainty in the model's predictions. These features of robustness and data efficiency make our approach ideal for the study of long-lived predators, for which data may be sparse and management/conservation priorities pressing.	[Smout, Sophie; Matthiopoulos, Jason; Harwood, John] Univ St Andrews, Scottish Oceans Inst, St Andrews, Fife, Scotland; [Smout, Sophie; Matthiopoulos, Jason; Harwood, John] Univ St Andrews, Ctr Res Environm & Ecol Modelling, St Andrews, Fife, Scotland; [Asseburg, Christian] Univ Eastern Finland, Ctr Pharmaceut Policy & Econ CEPPE, Kuopio, Finland; [Fernandez, Carmen] Inst Espanol Oceanog, Vigo, Spain; [Redpath, Stephen] Univ Aberdeen, Sch Biol Sci, Aberdeen Ctr Environm Sustainabil, Aberdeen, Scotland; [Redpath, Stephen; Thirgood, Simon] Macaulay Inst, Aberdeen, Scotland	University of St Andrews; University of St Andrews; University of Eastern Finland; Spanish Institute of Oceanography; University of Aberdeen; James Hutton Institute	Smout, S (corresponding author), Univ St Andrews, Scottish Oceans Inst, St Andrews, Fife, Scotland.	scs10@st-andrews.ac.uk	Matthiopoulos, Jason/N-9808-2013; Asseburg, Christian/AAK-2903-2020; Redpath, Stephen/B-4640-2012	Matthiopoulos, Jason/0000-0003-3639-8172; Asseburg, Christian/0000-0001-7196-3363; Redpath, Stephen/0000-0001-5399-9477	Scottish Higher Education Funding Council; Natural Environment Research Council; Nuffield Foundation; Natural Environment Research Council [smru10001] Funding Source: researchfish	Scottish Higher Education Funding Council; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Nuffield Foundation; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Christian Asseburg and Sophie Smout were supported by studentships from the Scottish Higher Education Funding Council (http://www.sfc.ac.uk/) and the Natural Environment Research Council (www.nerc.ac.uk) respectively. Carmen Fernandez was supported by a Nuffield Foundation grant (www.nuffieldfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; [Anonymous], 2001, RESOLVING HUMAN WILD; ASSEBURG C, 2006, BAYESIAN APPROACH MO; CHESSON J, 1983, ECOLOGY, V64, P1297, DOI 10.2307/1937838; Christensen NL, 1996, ECOL APPL, V6, P665, DOI 10.2307/2269460; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Essington TE, 2004, B MAR SCI, V74, P563; Etheridge B, 1997, J APPL ECOL, V34, P1081, DOI 10.2307/2405296; Forrester GE, 2004, ECOLOGY, V85, P1332, DOI 10.1890/03-0184; Gascoigne JC, 2004, J APPL ECOL, V41, P801, DOI 10.1111/j.0021-8901.2004.00944.x; Gentleman W, 2003, DEEP-SEA RES PT II, V50, P2847, DOI 10.1016/J.DSR2.2003.07.001; HANSKI I, 1991, J ANIM ECOL, V60, P353, DOI 10.2307/5465; Harwood J, 2003, TRENDS ECOL EVOL, V18, P617, DOI 10.1016/j.tree.2003.08.001; HILBORN R, 1992; Hilborn Ray, 1997, V28; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Hollowed AB, 2000, ICES J MAR SCI, V57, P707, DOI 10.1006/jmsc.2000.0734; Jost C, 2005, J ANIM ECOL, V74, P809, DOI 10.1111/j.1365-2656.2005.00977.x; JULIANO AA, 2001, NONLINEAR CURVE FITT; King R., 2009, BAYESIAN ANAL POPULA; Koen-Alonso M, 2005, CAN J FISH AQUAT SCI, V62, P1490, DOI 10.1139/F05-087; KOENALONSO M, 2007, ENERGETICS ECOSYSTEM; Lindstrom U, 2009, DEEP-SEA RES PT II, V56, P2068, DOI 10.1016/j.dsr2.2008.11.017; Link JS, 2002, CAN J FISH AQUAT SCI, V59, P1429, DOI 10.1139/F02-115; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MacCallum H., 2000, METHODS IN ECOLOGY; Mangel M, 1996, ECOL APPL, V6, P338, DOI 10.2307/2269369; Matthiopoulos J, 2008, MAMMAL REV, V38, P167, DOI 10.1111/j.1365-2907.2008.00123.x; Matthiopoulos J, 2007, ECOLOGY, V88, P2576, DOI 10.1890/06-0483.1; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; MESSIER F, 1994, ECOLOGY, V75, P478, DOI 10.2307/1939551; Murdoch WW, 2002, NATURE, V417, P541, DOI 10.1038/417541a; MURDOCH WW, 1969, ECOL MONOGR, V39, P335, DOI 10.2307/1942352; New LF, 2009, AM NAT, V174, P399, DOI 10.1086/603625; Perry DA, 1998, ANNU REV ECOL SYST, V29, P435, DOI 10.1146/annurev.ecolsys.29.1.435; PICOZZI N, 1978, IBIS, V120, P498, DOI 10.1111/j.1474-919X.1978.tb06814.x; Plaganyi EE, 2004, AFR J MAR SCI, V26, P261, DOI 10.2989/18142320409504061; REAL LA, 1977, AM NAT, V111, P289, DOI 10.1086/283161; Redpath S, 1998, BIRD STUDY, V45, P51, DOI 10.1080/00063659809461077; Redpath SM, 1999, J ANIM ECOL, V68, P879, DOI 10.1046/j.1365-2656.1999.00340.x; REDPATH SM, 1991, J APPL ECOL, V28, P659, DOI 10.2307/2404574; Redpath SM, 2002, IBIS, V144, pE33, DOI 10.1046/j.0019-1019.2001.00032.x; Roemer GW, 2002, P NATL ACAD SCI USA, V99, P791, DOI 10.1073/pnas.012422499; Schenk D, 2002, J ANIM ECOL, V71, P524, DOI 10.1046/j.1365-2656.2002.00620.x; Sinclair ARE, 1998, CONSERV BIOL, V12, P564, DOI 10.1046/j.1523-1739.1998.97030.x; Smout S, 2007, MAR ECOL PROG SER, V341, P277, DOI 10.3354/meps341277; SOLOMON ME, 1949, J ANIM ECOL, V18, P1, DOI 10.2307/1578; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Thirgood SJ, 2000, J ANIM ECOL, V69, P504, DOI 10.1046/j.1365-2656.2000.00413.x; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; YODZIS P, 1994, ECOL APPL, V4, P51, DOI 10.2307/1942114; Yodzis P, 1998, J ANIM ECOL, V67, P635, DOI 10.1046/j.1365-2656.1998.00224.x; Zabel RW, 2003, AM SCI, V91, P150	53	70	70	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10761	10.1371/journal.pone.0010761	http://dx.doi.org/10.1371/journal.pone.0010761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523722	Green Published, gold, Green Accepted			2022-12-27	WOS:000278221900006
J	Kim, BW; Kennedy, DN; Lehar, J; Lee, MJ; Blood, AJ; Lee, S; Perlis, RH; Smoller, JW; Morris, R; Fava, M; Breiter, HC				Kim, Byoung Woo; Kennedy, David N.; Lehar, Joseph; Lee, Myung Joo; Blood, Anne J.; Lee, Sang; Perlis, Roy H.; Smoller, Jordan W.; Morris, Robert; Fava, Maurizio; Breiter, Hans C.		Phenotype Genotype Project Addicti	Recurrent, Robust and Scalable Patterns Underlie Human Approach and Avoidance	PLOS ONE			English	Article							OPPONENT-PROCESS THEORY; MEDIAL FRONTAL-CORTEX; DECISION-MAKING; PROSPECT-THEORY; NEURAL SYSTEMS; REWARD VALUE; INFORMATION-THEORY; ENTROPY; RISK; COCAINE	Background: Approach and avoidance behavior provide a means for assessing the rewarding or aversive value of stimuli, and can be quantified by a keypress procedure whereby subjects work to increase (approach), decrease (avoid), or do nothing about time of exposure to a rewarding/aversive stimulus. To investigate whether approach/avoidance behavior might be governed by quantitative principles that meet engineering criteria for lawfulness and that encode known features of reward/aversion function, we evaluated whether keypress responses toward pictures with potential motivational value produced any regular patterns, such as a trade-off between approach and avoidance, or recurrent lawful patterns as observed with prospect theory. Methodology/Principal Findings: Three sets of experiments employed this task with beautiful face images, a standardized set of affective photographs, and pictures of food during controlled states of hunger and satiety. An iterative modeling approach to data identified multiple law-like patterns, based on variables grounded in the individual. These patterns were consistent across stimulus types, robust to noise, describable by a simple power law, and scalable between individuals and groups. Patterns included: (i) a preference trade-off counterbalancing approach and avoidance, (ii) a value function linking preference intensity to uncertainty about preference, and (iii) a saturation function linking preference intensity to its standard deviation, thereby setting limits to both. Conclusions/Significance: These law-like patterns were compatible with critical features of prospect theory, the matching law, and alliesthesia. Furthermore, they appeared consistent with both mean-variance and expected utility approaches to the assessment of risk. Ordering of responses across categories of stimuli demonstrated three properties thought to be relevant for preference-based choice, suggesting these patterns might be grouped together as a relative preference theory. Since variables in these patterns have been associated with reward circuitry structure and function, they may provide a method for quantitative phenotyping of normative and pathological function (e.g., psychiatric illness).	[Kim, Byoung Woo; Lee, Myung Joo; Blood, Anne J.; Lee, Sang; Morris, Robert; Breiter, Hans C.] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, MENC, Boston, MA 02114 USA; [Kim, Byoung Woo; Kennedy, David N.; Lee, Myung Joo; Blood, Anne J.; Lee, Sang; Perlis, Roy H.; Smoller, Jordan W.; Morris, Robert; Fava, Maurizio; Breiter, Hans C.] Harvard Univ, Sch Med, Boston, MA USA; [Kim, Byoung Woo; Lee, Myung Joo; Blood, Anne J.; Lee, Sang; Breiter, Hans C.] Massachusetts Gen Hosp, Dept Psychiat, Lab Neuroimaging & Genet, Boston, MA 02114 USA; [Kennedy, David N.] Massachusetts Gen Hosp, Dept Neurol, Ctr Morphometr Anal, Boston, MA 02114 USA; [Lehar, Joseph] Boston Univ, Dept Bioinformat, Boston, MA 02215 USA; [Blood, Anne J.; Breiter, Hans C.] Massachusetts Gen Hosp, Dept Psychiat, Mood & Motor Control Lab, Boston, MA 02114 USA; [Perlis, Roy H.; Fava, Maurizio] Massachusetts Gen Hosp, Dept Psychiat, Depress Clin, Boston, MA 02114 USA; [Perlis, Roy H.; Fava, Maurizio] Massachusetts Gen Hosp, Dept Psychiat, Res Program, Boston, MA 02114 USA; [Perlis, Roy H.; Smoller, Jordan W.] Massachusetts Gen Hosp, Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Kim, BW (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, MENC, Boston, MA 02114 USA.	hbreiter@partners.org	Kennedy, David N/H-3627-2012; Fava, Maurizio/AAH-3548-2020	Lauwereyns, Jan/0000-0003-0551-2550; Lee, Myungjoo/0000-0003-3722-9565	National Institute on Drug Abuse [14118, 026002, 026104]; Office of National Drug Control Policy - Counterdrug Technology Assessment Center, Washington, D.C.; MGH Department of Radiology; National Center for Research Resources [P41RR14075]; National Institute of Neurological Disorders and Stroke [34189, 052368];  [DABK39-03-0098];  [DABK39-03-C-0098]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001066, P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA026002, R01DA014118, R33DA026104, R01DA027804] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Office of National Drug Control Policy - Counterdrug Technology Assessment Center, Washington, D.C.; MGH Department of Radiology; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants to HCB (#14118, 026002, 026104) from the National Institute on Drug Abuse, and grants (DABK39-03-0098 & DABK39-03-C-0098; The MGH Phenotype Genotype Project in Addiction and Mood Disorder) from the Office of National Drug Control Policy - Counterdrug Technology Assessment Center, Washington, D.C. Further support, in part, was provided to HCB by the MGH Department of Radiology, and the National Center for Research Resources (P41RR14075). Other support was provided to DNK by the National Institute of Neurological Disorders and Stroke (#34189), and to SJB by the National Institute of Neurological Disorders and Stroke (#052368). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami C, 2004, PHYS LIFE REV, V1, P3, DOI 10.1016/j.plrev.2004.01.002; Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; [Anonymous], 1995, PHYS STAT US INT ANT; Bak P., 1996, NATURE WORKS SCI SEL; Bandura A, 1997, SELF EFFICACY EXERCI, P604, DOI DOI 10.1177/0957154X9400501708; Banks HT, 2009, TEXTB MATH, P1; BAUM WM, 1974, J EXP ANAL BEHAV, V22, P231, DOI 10.1901/jeab.1974.22-231; Baumeister RF, 2006, J PERS, V74, P1773, DOI 10.1111/j.1467-6494.2006.00428.x; Benson V, 1998, VITAL HLTH STAT 10, P1; BERNHEIM BD, 2009, NEUROECONOMICS SOBER; Berns GS, 2006, SCIENCE, V312, P754, DOI 10.1126/science.1123721; BERRIDGE KC, 1991, APPETITE, V16, P103, DOI 10.1016/0195-6663(91)90036-R; BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; Boettiger CA, 2009, PHARMACOL BIOCHEM BE, V93, P291, DOI 10.1016/j.pbb.2009.02.008; Boker S. M., 2006, MODELS INTENSIVE LON, P195, DOI [DOI 10.1093/ACPROF:OSO/9780195173444.003.0009, 10.1093/acprof:oso/9780195173444.003.0009]; Boker SM, 2001, DECADE BEHAV, P5, DOI 10.1037/10409-001; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Bossaerts P, 2007, ECONOMETRICA, V75, P993, DOI 10.1111/j.1468-0262.2007.00780.x; Breiter HC, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P1043; Breiter Hans C., 2006, P763; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Brookings T, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056120; CABANAC M, 1973, PHYSIOL BEHAV, V11, P345, DOI 10.1016/0031-9384(73)90010-3; CABANAC M, 1973, J PHYSIOL-PARIS, V66, P113; CABANAC M, 1971, SCIENCE, V173, P1103, DOI 10.1126/science.173.4002.1103; Camerer CF, 2004, SCAND J ECON, V106, P555, DOI 10.1111/j.0347-0520.2004.00377.x; Clithero JA, 2008, PLOS BIOL, V6, P2348, DOI 10.1371/journal.pbio.0060298; Cover T. M., 1991, ELEMENTS INFORM THEO; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; d'Acremont M, 2008, COGN AFFECT BEHAV NE, V8, P363, DOI 10.3758/CABN.8.4.363; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; DE KONINCK Y, 1994, J NEUROPHYSIOL, V71, P1318, DOI 10.1152/jn.1994.71.4.1318; Deci EL, 1985, INTRINSIC MOTIVATION; Delgado MR, 2008, SCIENCE, V321, P1849, DOI 10.1126/science.1158860; Doyle JC, 1992, FEEDBACK CONTROL THE; Elman I, 2005, PSYCHIAT RES, V135, P179, DOI 10.1016/j.psychres.2005.04.002; Evans JST, 2003, TRENDS COGN SCI, V7, P454, DOI 10.1016/j.tics.2003.08.012; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; FECHNER GT, 1907, ELEMENTE PSYCHOPHYSI, V2; First M.B., 2014, STRUCTURED CLIN INTE; Foote R, 2007, SCIENCE, V318, P410, DOI 10.1126/science.1141754; Franklin G.F., 2005, FEEDBACK CONTROL DYN; Friedland B., 2021, CONTROL SYSTEM DESIG; Friedman M., 1953, ESSAYS POSITIVE EC; FRISTON KJ, 1995, J CEREBR BLOOD F MET, V15, P361, DOI 10.1038/jcbfm.1995.45; Gallinat J, 2008, NEURODEGENER DIS, V5, P277, DOI 10.1159/000135612; Gallistel CR, 2007, J EXP ANAL BEHAV, V87, P161, DOI 10.1901/jeab.2007.92-05; Gasic GP, 2009, AM J MED GENET B; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Goldstein RZ, 2009, TRENDS COGN SCI, V13, P372, DOI 10.1016/j.tics.2009.06.004; Haggard P, 2004, CONSCIOUS COGN, V13, P646, DOI 10.1016/j.concog.2004.06.001; HANSSON SO, 2009, STANFORD ENCY PHILOS; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; Heinz A, 2007, ADDICTION, V102, P1696, DOI 10.1111/j.1360-0443.2007.01994.x; Heinz A, 2009, ADDICT BIOL, V14, P108, DOI 10.1111/j.1369-1600.2008.00136.x; Hering E., 1964, OUTLINES THEORY LIGH; Herrnstein RJ, 1970, J EXP ANAL BEHAV, V13, P243, DOI 10.1901/jeab.1970.13-243; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Herrnstein RJ, 1980, LIMITS ACTION ALLOCA, P143, DOI DOI 10.1016/B978-0-12-662650-6.50011-8; Huang Sui, 2006, P283; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kahneman Daniel, 2002, HEURISTICS BIASES PS, P48; Kennel MB, 2005, NEURAL COMPUT, V17, P1531, DOI 10.1162/0899766053723050; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Knutson B, 2007, J NEUROSCI, V27, P8174, DOI 10.1523/JNEUROSCI.1564-07.2007; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Kording K, 2007, SCIENCE, V318, P606, DOI 10.1126/science.1142998; Lang P.J., 2008, A8 U FLOR; LANG PJ, 1998, INT AFFECTIVE SYSTEM; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Levy B, 2008, LEARN MOTIV, V39, P136, DOI 10.1016/j.lmot.2007.09.002; Lewin K., 1935, DYNAMIC THEORY PERS; LIBET B, 1985, BEHAV BRAIN SCI, V8, P529, DOI 10.1017/S0140525X00044903; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Loewenstein G, 2008, ANNU REV PSYCHOL, V59, P647, DOI 10.1146/annurev.psych.59.103006.093710; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MACKAY DM, 1963, SCIENCE, V139, P1213, DOI 10.1126/science.139.3560.1213-a; Makris N, 2004, NEURON, V44, P729, DOI 10.1016/j.neuron.2004.10.027; Makris N, 2008, NEURON, V60, P174, DOI 10.1016/j.neuron.2008.08.011; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Mas-Colell A., 1995, MICROECONOMIC THEORY; MISCHEL W, 1972, J PERS SOC PSYCHOL, V21, P204, DOI 10.1037/h0032198; Mitra P., 2007, OBSERVED BRAIN DYNAM; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Moritz MA, 2005, P NATL ACAD SCI USA, V102, P17912, DOI 10.1073/pnas.0508985102; MOUNTCASTLE VB, 1963, J NEUROPHYSIOL, V26, P807, DOI 10.1152/jn.1963.26.5.807; Muhlenbein H, 2005, EVOL COMPUT, V13, P1, DOI 10.1162/1063656053583469; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paninski L, 2003, NEURAL COMPUT, V15, P1191, DOI 10.1162/089976603321780272; Pascual M, 2002, PHILOS T ROY SOC B, V357, P657, DOI 10.1098/rstb.2001.0983; Paulus MP, 2007, SCIENCE, V318, P602, DOI 10.1126/science.1142997; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Perelson Alan S., 2006, P451; Perlis RH, 2008, ARCH GEN PSYCHIAT, V65, P882, DOI 10.1001/archgenpsychiatry.2008.3; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Reeke GN, 2004, NEURAL COMPUT, V16, P941, DOI 10.1162/089976604773135050; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Rieke F., 1999, SPIKES EXPLORING NEU; Rolls ET, 2008, CEREB CORTEX, V18, P652, DOI 10.1093/cercor/bhm097; Savage L. J., 1972, FDN STAT; Savage Van M., 2006, P141; SCHNEIRLA TC, 1959, NEBR SYM MOTIV, V7, P1; Schweighofer N, 2006, PLOS COMPUT BIOL, V2, P1349, DOI 10.1371/journal.pcbi.0020152; Shannon C.E., 1949, MATH THEORY COMMUNIC, V1; Shizgal P., 1999, WELL BEING FDN HEDON, P502; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; SOLOMON RL, 1973, J ABNORM PSYCHOL, V81, P158, DOI 10.1037/h0034534; STEVENS SS, 1961, SCIENCE, V133, P80, DOI 10.1126/science.133.3446.80; Strauss MM, 2005, NEUROIMAGE, V26, P389, DOI 10.1016/j.neuroimage.2005.01.053; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; SUTTON JP, 1994, WORLD C NEUR NETW, V4, P667; Szostak JW, 2003, NATURE, V423, P689, DOI 10.1038/423689a; Tiesinga PHE, 2002, NETWORK-COMP NEURAL, V13, P41, DOI 10.1088/0954-898X/13/1/302; Tobler PN, 2007, J NEUROPHYSIOL, V97, P1621, DOI 10.1152/jn.00745.2006; Tobler PN, 2009, P NATL ACAD SCI USA, V106, P7185, DOI 10.1073/pnas.0809599106; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Trepel C, 2005, COGNITIVE BRAIN RES, V23, P34, DOI 10.1016/j.cogbrainres.2005.01.016; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Uher R, 2006, BEHAV BRAIN RES, V169, P111, DOI 10.1016/j.bbr.2005.12.008; Vandermeer J, 2006, SCIENCE, V311, P1000, DOI 10.1126/science.1121432; Viola P, 1996, ADV NEUR IN, V8, P851; von Neumann J., 1947, THEORY GAMES EC BEHA, V2nd ed; Wacker J, 2009, NEUROIMAGE, V46, P327, DOI 10.1016/j.neuroimage.2009.01.058; Walton ME, 2006, NEURAL NETWORKS, V19, P1302, DOI 10.1016/j.neunet.2006.03.005; Walton ME, 2007, ANN NY ACAD SCI, V1104, P340, DOI 10.1196/annals.1390.009; Walton ME, 2003, J NEUROSCI, V23, P6475; Walton ME, 2002, J NEUROSCI, V22, P10996; WARREN RP, 1963, SCIENCE, V140, P808, DOI 10.1126/science.140.3568.808; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Weber E. H., 1834, PULSU RESORPTIONE AU; White N. M., 1987, METHODS MEASURING RE, P591; Whitlow CT, 2004, DRUG ALCOHOL DEPEN, V76, P107, DOI 10.1016/j.drugalcdep.2004.04.009; Winstanley CA, 2009, CEREB CORTEX, V19, P435, DOI 10.1093/cercor/bhn094; Wise RA, 2009, TRENDS NEUROSCI, V32, P517, DOI 10.1016/j.tins.2009.06.004; Wrase J, 2007, NEUROIMAGE, V36, P1253, DOI 10.1016/j.neuroimage.2007.04.001; Yacubian J, 2007, NEUROIMAGE, V38, P557, DOI 10.1016/j.neuroimage.2007.08.007; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006; Yamamoto R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006042; Young ME, 2001, J EXP PSYCHOL LEARN, V27, P278, DOI 10.1037/0278-7393.27.1.278; Zak PJ, 2004, ANN NY ACAD SCI, V1032, P224, DOI 10.1196/annals.1314.025; Zak PJ, 2004, PHILOS T R SOC B, V359, P1737, DOI 10.1098/rstb.2004.1544; Zinn-Justin J, 2002, QUANTUM FIELD THEORY; [No title captured]	151	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2010	5	5							e10613	10.1371/journal.pone.0010613	http://dx.doi.org/10.1371/journal.pone.0010613			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	603PW	20532247	gold, Green Published			2022-12-27	WOS:000278221500002
J	Porter, KA; Kelley, LN; George, A; Harton, JA; Duus, KM				Porter, Kristen A.; Kelley, Lauren N.; George, Annette; Harton, Jonathan A.; Duus, Karen M.			Class II Transactivator (CIITA) Enhances Cytoplasmic Processing of HIV-1 Pr55Gag	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MHC CLASS-II; COMPLEX CLASS-II; INTRACELLULAR-TRANSPORT; SURFACE EXPRESSION; INFECTIOUS HIV-1; INVARIANT CHAIN; DENDRITIC CELLS; GTP-BINDING; TYPE-1	Background: The Pr55(gag) (Gag) polyprotein of HIV serves as a scaffold for virion assembly and is thus essential for progeny virion budding and maturation. Gag localizes to the plasma membrane (PM) and membranes of late endosomes, allowing for release of infectious virus directly from the cell membrane and/or upon exocytosis. The host factors involved in Gag trafficking to these sites are largely unknown. Upon activation, CD4+ T cells, the primary target of HIV infection, express the class II transcriptional activator (CIITA) and therefore the MHC class II isotype, HLA-DR. Similar to Gag, HLA-DR localizes to the PM and at the membranes of endosomes and specialized vesicular MHC class II compartments (MIICs). In HIV producer cells, transient HLA-DR expression induces intracellular Gag accumulation and impairs virus release. Methodology/Principal Findings: Here we demonstrate that both stable and transient expression of CIITA in HIV producer cells does not induce HLA-DR-associated intracellular retention of Gag, but does increase the infectivity of virions. However, neither of these phenomena is due to recapitulation of the class II antigen presentation pathway or CIITA-mediated transcriptional activation of virus genes. Interestingly, we demonstrate that CIITA, apart from its transcriptional effects, acts cytoplasmically to enhance Pr160(gag-pol) (Gag-Pol) levels and thereby the viral protease and Gag processing, accounting for the increased infectivity of virions from CIITA-expressing cells. Conclusions/Significance: This study demonstrates that CIITA enhances HIV Gag processing, and provides the first evidence of a novel, post-transcriptional, cytoplasmic function for a well-known transactivator.	[Porter, Kristen A.; Kelley, Lauren N.; George, Annette; Harton, Jonathan A.; Duus, Karen M.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	Albany Medical College	Porter, KA (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.	duusk@mail.amc.edu	Harton, Jonathan A/AAW-5283-2021; Porter, Kristen/AAF-4468-2021; Harton, Jonathan/F-2848-2010	Harton, Jonathan A/0000-0002-0350-1877; Harton, Jonathan/0000-0002-0350-1877; Porter, Kristen/0000-0002-9272-7180	Albany Medical College; National Institutes of Health/National Cancer Institute (NIH/NCI) [KO1CA095582]; NATIONAL CANCER INSTITUTE [K01CA095582] Funding Source: NIH RePORTER	Albany Medical College; National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Albany Medical College start-up funds (KMD, JAH) and National Institutes of Health/National Cancer Institute (NIH/NCI) KO1CA095582 (JAH) supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTHUR LO, 1992, SCIENCE, V258, P1935, DOI 10.1126/science.1470916; Berger AC, 2009, J CELL SCI, V122, P1, DOI 10.1242/jcs.035089; Bewry NN, 2007, J BIOL CHEM, V282, P26178, DOI 10.1074/jbc.M611747200; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Biswas P, 2004, J VIROL, V78, P2082, DOI 10.1128/JVI.78.4.2082-2087.2004; Blanco R, 2003, J BIOL CHEM, V278, P1086, DOI 10.1074/jbc.M205636200; Brierley I, 2006, VIRUS RES, V119, P29, DOI 10.1016/j.virusres.2005.10.008; Busch R, 2005, IMMUNOL REV, V207, P242, DOI 10.1111/j.0105-2896.2005.00306.x; Cantin R, 1997, J VIROL, V71, P1922, DOI 10.1128/JVI.71.3.1922-1930.1997; Cantin R, 1997, BLOOD, V90, P1091, DOI 10.1182/blood.V90.3.1091.1091_1091_1100; Carter CA, 2002, TRENDS MICROBIOL, V10, P203, DOI 10.1016/S0966-842X(02)02350-8; Chaudhry A, 2009, J IMMUNOL, V183, P2415, DOI 10.4049/jimmunol.0804014; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Chin KC, 1997, P NATL ACAD SCI USA, V94, P2501, DOI 10.1073/pnas.94.6.2501; DARKE PL, 1988, BIOCHEM BIOPH RES CO, V156, P297, DOI 10.1016/S0006-291X(88)80839-8; DAVIES MN, 2007, MOL IMMUNOL IN PRESS; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Duus KM, 2001, J VIROL, V75, P3916, DOI 10.1128/JVI.75.8.3916-3924.2001; ELLIOTT EA, 1994, J EXP MED, V179, P681, DOI 10.1084/jem.179.2.681; Esser MT, 2001, J VIROL, V75, P6173, DOI 10.1128/JVI.75.13.6173-6182.2001; Fauci AS, 1996, ANN INTERN MED, V124, P654, DOI 10.7326/0003-4819-124-7-199604010-00006; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; Finzi A, 2006, J VIROL, V80, P9789, DOI 10.1128/JVI.01055-06; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; FU XT, 1994, HUM IMMUNOL, V39, P253, DOI 10.1016/0198-8859(94)90268-2; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gluschankof P, 2002, VIROLOGY, V300, P160, DOI 10.1006/viro.2002.1531; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grigorov B, 2006, J MOL BIOL, V359, P848, DOI 10.1016/j.jmb.2006.04.017; Harila K, 2006, J VIROL, V80, P3765, DOI 10.1128/JVI.80.8.3765-3772.2006; Harton JA, 1999, SCIENCE, V285, P1402, DOI 10.1126/science.285.5432.1402; Harton JA, 2002, HUM IMMUNOL, V63, P588, DOI 10.1016/S0198-8859(02)00400-7; Hiltbold EM, 2002, CURR OPIN IMMUNOL, V14, P30, DOI 10.1016/S0952-7915(01)00295-3; Holling TM, 2004, BIOCHEM PHARMACOL, V68, P1209, DOI 10.1016/j.bcp.2004.03.046; Holling TM, 2004, HUM IMMUNOL, V65, P282, DOI 10.1016/j.humimm.2004.01.005; Holm GH, 2005, J VIROL, V79, P6299, DOI 10.1128/JVI.79.10.6299-6311.2005; Hussain A, 2008, J VIROL, V82, P893, DOI 10.1128/JVI.01373-07; Joshi A, 2009, J VIROL, V83, P5375, DOI 10.1128/JVI.00109-09; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; KAPLAN AH, 1994, J VIROL, V68, P6782, DOI 10.1128/JVI.68.10.6782-6786.1994; KAPLAN AH, 1993, J VIROL, V67, P4050, DOI 10.1128/JVI.67.7.4050-4055.1993; Klein KC, 2007, AIDS REV, V9, P150; Krawczyk M, 2006, TISSUE ANTIGENS, V67, P183, DOI 10.1111/j.1399-0039.2006.00557.x; Krawczyk M, 2007, NUCLEIC ACIDS RES, V35, P595, DOI 10.1093/nar/gkl980; Krawczyk M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000058; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; Lindhofer H, 1995, VIROLOGY, V214, P624, DOI 10.1006/viro.1995.0074; Lipman MCI, 2001, EUR J CLIN INVEST, V31, P926, DOI 10.1046/j.1365-2362.2001.00928.x; Liu XA, 2003, J VIROL, V77, P3470, DOI 10.1128/JVI.77.6.3470-3476.2003; LOEB DD, 1989, NATURE, V340, P397, DOI 10.1038/340397a0; Mattos-Graner RO, 2006, J BACTERIOL, V188, P3813, DOI 10.1128/JB.01845-05; Mehandru S, 2005, J ALLERGY CLIN IMMUN, V116, P419, DOI 10.1016/j.jaci.2005.05.040; Meissner EG, 2004, VIROLOGY, V328, P74, DOI 10.1016/j.virol.2004.07.019; MOLLE D, 2009, J BIOL CHEM; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Morner A, 1999, J VIROL, V73, P2343; MUELLER B, 2009, J BIOL CHEM; Nie Z, 2002, CELL DEATH DIFFER, V9, P1172, DOI 10.1038/sj.cdd.4401094; PARK JS, 1991, J VIROL, V65, P5111, DOI 10.1128/JVI.65.9.5111-5117.1991; Pelchen-Matthews A, 2004, TRENDS MICROBIOL, V12, P310, DOI 10.1016/j.tim.2004.05.004; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Pettit SC, 1998, ADV EXP MED BIOL, V436, P15; Pornillos O, 2003, J CELL BIOL, V162, P425, DOI 10.1083/jcb.200302138; Rocha N, 2008, EMBO J, V27, P1, DOI 10.1038/sj.emboj.7601945; Rulli SJ, 2006, VIROLOGY, V347, P364, DOI 10.1016/j.virol.2005.12.012; Schindler M, 2003, J VIROL, V77, P10548, DOI 10.1128/JVI.77.19.10548-10556.2003; Shacklett Barbara L, 2010, Curr Infect Dis Rep, V12, P19, DOI 10.1007/s11908-009-0072-9; Shehu-Xhilaga M, 2001, J VIROL, V75, P1834, DOI 10.1128/JVI.75.4.1834-1841.2001; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; Speck RR, 2000, ANTIMICROB AGENTS CH, V44, P1397, DOI 10.1128/AAC.44.5.1397-1403.2000; Stumptner-Cuvelette P, 2003, MOL BIOL CELL, V14, P4857, DOI 10.1091/mbc.E03-04-0211; TAN X, 1993, J VIROL, V67, P6447, DOI 10.1128/JVI.67.11.6447-6452.1993; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Welsch S, 2007, FEBS LETT, V581, P2089, DOI 10.1016/j.febslet.2007.03.060; YAHI N, 1992, J VIROL, V66, P4848, DOI 10.1128/JVI.66.8.4848-4854.1992; Zheng YH, 2003, NAT CELL BIOL, V5, P611, DOI 10.1038/ncb1000	79	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11304	10.1371/journal.pone.0011304	http://dx.doi.org/10.1371/journal.pone.0011304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585587	Green Submitted, gold, Green Published			2022-12-27	WOS:000279135800013
J	Coulon, V; Chebli, K; Cavelier, P; Blanchard, JM				Coulon, Vincent; Chebli, Karim; Cavelier, Patricia; Blanchard, Jean-Marie			A Novel Mouse c-fos Intronic Promoter That Responds to CREB and AP-1 Is Developmentally Regulated In Vivo	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR; GENE-EXPRESSION; POTENTIAL INVOLVEMENT; SIGNAL-TRANSDUCTION; CONTROL ELEMENTS; NERVOUS-SYSTEM; NULL MUTATION; TRANSCRIPTION; ACTIVATION; SEQUENCES	Background: The c-fos proto-oncogene is an archetype for rapid and integrative transcriptional activation. Innumerable studies have focused on the canonical promoter, located upstream from the transcriptional start site. However, several regulatory sequences have been found in the first intron. Methodology/Principal Findings: Here we describe an extremely conserved region in c-fos first intron that contains a putative TATA box, and functional TRE and CRE sites. This fragment drives reporter gene activation in fibroblasts, which is enhanced by increasing intracellular calcium and cAMP and by cotransfection of CREB or c-Fos/c-Jun expression vectors. We produced transgenic mice expressing a lacZ reporter controlled by the intronic promoter. Lac Z expression of this promoter is restricted to the developing central nervous system (CNS) and the mesenchyme of developing mammary buds in embryos 12.5 days post-conception, and to brain tissue in adults. RT-QPCR analysis of tissue mRNA, including the anlage of the mammary gland and the CNS, confirms the existence of a novel, nested mRNA initiated in the first intron. Conclusions/Significance: Our results provide evidence for a novel, developmentally regulated promoter in the first intron of the c-fos gene.	[Coulon, Vincent; Chebli, Karim; Cavelier, Patricia; Blanchard, Jean-Marie] Univ Montpellier I, Univ Montpellier 2, CNRS, Inst Genet Mol Montpellier, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Coulon, V (corresponding author), Univ Montpellier I, Univ Montpellier 2, CNRS, Inst Genet Mol Montpellier, Montpellier, France.	vincent.coulon@igmm.cnrs.fr	Coulon, Vincent/AFF-7934-2022; Coulon, Vincent/B-2437-2009	Coulon, Vincent/0000-0002-3168-8755; Coulon, Vincent/0000-0002-3168-8755	CNRS; Ligue Nationale Contre le Cancer; French Ministry of Research; French Ligue Nationale Contre le Cancer; Institut National du Cancer	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); French Ministry of Research(Ministry of Research, FranceEuropean Commission); French Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France)	This work was supported by grants from the CNRS (http://www.cnrs.fr/) and Ligue Nationale Contre le Cancer (http://www.ligue-cancer.net/). V. C. was supported by the French Ministry of Research (http://www.enseignementsup-recherche.gouv.fr/) and by the French Ligue Nationale Contre le Cancer, then Institut National du Cancer (http://www.e-cancer.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONNEROT C, 1987, P NATL ACAD SCI USA, V84, P6795, DOI 10.1073/pnas.84.19.6795; Boulon S, 2002, MOL CELL BIOL, V22, P7769, DOI 10.1128/MCB.22.22.7769-7779.2002; CAUBET JF, 1989, MOL CELL BIOL, V9, P2269, DOI 10.1128/MCB.9.5.2269; CHATTON B, 1994, ONCOGENE, V9, P375; COLLART MA, 1991, MOL CELL BIOL, V11, P2826, DOI 10.1128/MCB.11.5.2826; Coulon V, 1999, J BIOL CHEM, V274, P30439, DOI 10.1074/jbc.274.43.30439; Coulon V, 2007, J BIOL CHEM, V282, P33192, DOI 10.1074/jbc.M706119200; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DONY C, 1987, NATURE, V328, P711, DOI 10.1038/328711a0; DURET L, 1993, NUCLEIC ACIDS RES, V21, P2315, DOI 10.1093/nar/21.10.2315; FISCH TM, 1989, GENE DEV, V3, P198, DOI 10.1101/gad.3.2.198; FORT P, 1987, NUCLEIC ACIDS RES, V15, P5657, DOI 10.1093/nar/15.14.5657; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hafezi F, 1997, NAT MED, V3, P346, DOI 10.1038/nm0397-346; Herrera RE, 1997, CHROMOSOMA, V106, P284, DOI 10.1007/s004120050249; HIPSKIND RA, 1991, NATURE, V354, P531, DOI 10.1038/354531a0; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; KOVACS EJ, 1986, J IMMUNOL, V137, P3649; LAMB NJC, 1990, CELL, V61, P485, DOI 10.1016/0092-8674(90)90530-R; Lange CM, 2001, J NEUROCHEM, V77, P1293, DOI 10.1046/j.1471-4159.2001.00342.x; LEE G, 1994, MOL CELL BIOL, V14, P4579, DOI 10.1128/MCB.14.7.4579; Leonard WJ, 2001, INT J HEMATOL, V73, P271, DOI 10.1007/BF02981951; LUCIBELLO FC, 1990, EMBO J, V9, P2827, DOI 10.1002/j.1460-2075.1990.tb07471.x; Maisonnasse-Charital Y, 2009, GENE, V430, P116, DOI 10.1016/j.gene.2008.10.014; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MECHTI N, 1991, MOL CELL BIOL, V11, P2832, DOI 10.1128/MCB.11.5.2832; MOHUN TJ, 1989, DEVELOPMENT, V107, P835; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; PAYLOR R, 1994, BRAIN RES, V651, P275, DOI 10.1016/0006-8993(94)90707-2; Philip A, 2000, J BIOL CHEM, V275, P5911, DOI 10.1074/jbc.275.8.5911; PIECHACZYK M, 1994, CRIT REV ONCOL HEMAT, V17, P93, DOI 10.1016/1040-8428(94)90021-3; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Reichardt HM, 2001, EUR J ENDOCRINOL, V145, P519, DOI 10.1530/eje.0.1450519; Ren XM, 2009, GENOMICS, V93, P159, DOI 10.1016/j.ygeno.2008.09.017; RENZ M, 1985, EMBO J, V4, P3711, DOI 10.1002/j.1460-2075.1985.tb04139.x; ROBERTSON LM, 1995, NEURON, V14, P241, DOI 10.1016/0896-6273(95)90282-1; Routal RV, 1999, J ANAT, V195, P211, DOI 10.1046/j.1469-7580.1999.19520211.x; SADOSHIMA J, 1993, EMBO J, V12, P1681, DOI 10.1002/j.1460-2075.1993.tb05813.x; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; Susini S, 2000, FASEB J, V14, P128, DOI 10.1096/fasebj.14.1.128; THOMPSON MA, 1995, J BIOL CHEM, V270, P4224, DOI 10.1074/jbc.270.9.4224; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; van Haasteren G, 2000, NEUROENDOCRINOLOGY, V72, P368, DOI 10.1159/000054606; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Watanabe Y, 1996, J NEUROSCI, V16, P3827	53	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11235	10.1371/journal.pone.0011235	http://dx.doi.org/10.1371/journal.pone.0011235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574536	Green Published, gold, Green Submitted			2022-12-27	WOS:000279058300019
J	Mikheyev, AS; Vo, T; Wee, B; Singer, MC; Parmesan, C				Mikheyev, Alexander S.; Vo, Tanya; Wee, Brian; Singer, Michael C.; Parmesan, Camille			Rapid Microsatellite Isolation from a Butterfly by De Novo Transcriptome Sequencing: Performance and a Comparison with AFLP-Derived Distances	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; MARKERS; EST; ABUNDANT; LOCI; SSRS; DNA	Background: The isolation of microsatellite markers remains laborious and expensive. For some taxa, such as Lepidoptera, development of microsatellite markers has been particularly difficult, as many markers appear to be located in repetitive DNA and have nearly identical flanking regions. We attempted to circumvent this problem by bioinformatic mining of microsatellite sequences from a de novo-sequenced transcriptome of a butterfly (Euphydryas editha). Principal Findings: By searching the assembled sequence data for perfect microsatellite repeats we found 10 polymorphic loci. Although, like many expressed sequence tag-derived microsatellites, our markers show strong deviations from Hardy-Weinberg equilibrium in many populations, and, in some cases, a high incidence of null alleles, we show that they nonetheless provide measures of population differentiation consistent with those obtained by amplified fragment length polymorphism analysis. Estimates of pairwise population differentiation between 23 populations were concordant between microsatellite-derived data and AFLP analysis of the same samples (r = 0.71, p < 0.00001, 425 individuals from 23 populations). Significance: De novo transcriptional sequencing appears to be a rapid and cost-effective tool for developing microsatellite markers for difficult genomes.	[Mikheyev, Alexander S.; Vo, Tanya] Okinawa Inst Sci & Technol, Onna, Japan; [Wee, Brian] Natl Ecol Observ Network Inc, Washington, DC USA; [Singer, Michael C.; Parmesan, Camille] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	Okinawa Institute of Science & Technology Graduate University; University of Texas System; University of Texas Austin	Mikheyev, AS (corresponding author), Okinawa Inst Sci & Technol, Onna, Japan.	alexander.mikheyev@oist.jp	singer, michael c/I-6225-2012; Wee, Brian Peck-Sheng/P-3240-2019; Mikheyev, Alexander/E-7999-2013; Parmesan, Camille/GVT-5674-2022; Wee, Brian Peck-Sheng/B-8774-2016	Wee, Brian Peck-Sheng/0000-0002-0038-9381; Mikheyev, Alexander/0000-0003-4369-1019; Wee, Brian Peck-Sheng/0000-0002-0038-9381; Parmesan, Camille/0000-0002-1515-274X	United States Fish and Wildlife Service	United States Fish and Wildlife Service(US Fish & Wildlife Service)	This work has been funded by a grant from the United States Fish and Wildlife Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Coulibaly I, 2005, ANIM GENET, V36, P309, DOI 10.1111/j.1365-2052.2005.01305.x; Cruz F, 2005, GENE, V346, P241, DOI 10.1016/j.gene.2004.11.013; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagerberg AJ, 2001, INSECT MOL BIOL, V10, P225, DOI 10.1046/j.1365-2583.2001.00260.x; Garoia F, 2007, MOL ECOL, V16, P1377, DOI 10.1111/j.1365-294X.2007.03247.x; Grillo V, 2006, MOL BIOCHEM PARASIT, V148, P181, DOI 10.1016/j.molbiopara.2006.03.014; Johnson PCD, 2006, MOL BIOCHEM PARASIT, V148, P210, DOI 10.1016/j.molbiopara.2006.04.011; Meglecz E, 2004, MOL ECOL, V13, P1693, DOI 10.1111/j.1365-294X.2004.02163.x; Navajas MJ, 1998, INSECT MOL BIOL, V7, P249, DOI 10.1111/j.1365-2583.1998.00066.x; Neff BD, 2001, EVOLUTION, V55, P1717, DOI 10.1111/j.0014-3820.2001.tb00822.x; Neve G, 2000, TRENDS ECOL EVOL, V15, P376, DOI 10.1016/S0169-5347(00)01921-2; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Primmer CR, 1997, GENOME RES, V7, P471, DOI 10.1101/gr.7.5.471; Qiu XM, 2009, CONSERV GENET, V10, P1013, DOI 10.1007/s10592-008-9675-1; Rozen S, 2000, Methods Mol Biol, V132, P365; Scariot V, 2007, PLANT BREEDING, V126, P207, DOI 10.1111/j.1439-0523.2007.01326.x; Sharma RK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-53; Varshney RK, 2007, PLANT SCI, V173, P638, DOI 10.1016/j.plantsci.2007.08.010; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang S, 2009, J HERED, V100, P329, DOI 10.1093/jhered/esn100; Wee P-S, 2004, THESIS U TEXAS AUSTI; Woodhead M, 2005, MOL ECOL, V14, P1681, DOI 10.1111/j.1365-294X.2005.02543.x; WRIGHT JM, 1994, REV FISH BIOL FISHER, V4, P384, DOI 10.1007/BF00042912; Yang JB, 2009, CONSERV GENET, V10, P1621, DOI 10.1007/s10592-009-9814-3; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhang DX, 2004, TRENDS ECOL EVOL, V19, P507, DOI 10.1016/j.tree.2004.07.020	28	40	48	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11212	10.1371/journal.pone.0011212	http://dx.doi.org/10.1371/journal.pone.0011212			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585453	Green Published, Green Submitted, gold			2022-12-27	WOS:000278977200015
J	Zarate, JM; Delhommeau, K; Wood, S; Zatorre, RJ				Zarate, Jean Mary; Delhommeau, Karine; Wood, Sean; Zatorre, Robert J.			Vocal Accuracy and Neural Plasticity Following Micromelody-Discrimination Training	PLOS ONE			English	Article							OLD-WORLD MONKEY; AUDITORY-CORTEX; FREQUENCY DISCRIMINATION; PITCH DISCRIMINATION; HUMAN BRAIN; FUNCTIONAL ACTIVATION; PROBABILISTIC ATLAS; ANTERIOR CINGULATE; MUSICAL RHYTHMS; PREMOTOR AREAS	Background: Recent behavioral studies report correlational evidence to suggest that non-musicians with good pitch discrimination sing more accurately than those with poorer auditory skills. However, other studies have reported a dissociation between perceptual and vocal production skills. In order to elucidate the relationship between auditory discrimination skills and vocal accuracy, we administered an auditory-discrimination training paradigm to a group of non-musicians to determine whether training-enhanced auditory discrimination would specifically result in improved vocal accuracy. Methodology/Principal Findings: We utilized micromelodies (i.e., melodies with seven different interval scales, each smaller than a semitone) as the main stimuli for auditory discrimination training and testing, and we used single-note and melodic singing tasks to assess vocal accuracy in two groups of non-musicians (experimental and control). To determine if any training-induced improvements in vocal accuracy would be accompanied by related modulations in cortical activity during singing, the experimental group of non-musicians also performed the singing tasks while undergoing functional magnetic resonance imaging (fMRI). Following training, the experimental group exhibited significant enhancements in micromelody discrimination compared to controls. However, we did not observe a correlated improvement in vocal accuracy during single-note or melodic singing, nor did we detect any training-induced changes in activity within brain regions associated with singing. Conclusions/Significance: Given the observations from our auditory training regimen, we therefore conclude that perceptual discrimination training alone is not sufficient to improve vocal accuracy in non-musicians, supporting the suggested dissociation between auditory perception and vocal production.	[Zarate, Jean Mary; Delhommeau, Karine; Zatorre, Robert J.] McGill Univ, Montreal Neurol Inst, Cognit Neurosci Unit, Montreal, PQ, Canada; [Zarate, Jean Mary; Wood, Sean; Zatorre, Robert J.] Int Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada; [Wood, Sean] Univ Montreal, Dept Comp Sci, Montreal, PQ, Canada	McGill University; Universite de Montreal; Universite de Montreal	Zarate, JM (corresponding author), McGill Univ, Montreal Neurol Inst, Cognit Neurosci Unit, Montreal, PQ, Canada.	jean.zarate@mail.mcgill.ca	Zarate, Jean Mary/B-1450-2008; Zarate, Jean Mary/Q-1702-2019	Zarate, Jean Mary/0000-0002-7418-2199; Zarate, Jean Mary/0000-0002-7418-2199; Wood, Sean/0000-0002-6821-1619	Canadian Institutes of Health Research (CIHR) [11541, 14995]; Fondation Bettencourt Schueller; Eileen Peters McGill Majors Fellowship; Centre for Interdisciplinary Research in Music Media and Technology (CIRMMT)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fondation Bettencourt Schueller; Eileen Peters McGill Majors Fellowship; Centre for Interdisciplinary Research in Music Media and Technology (CIRMMT)	This work was supported by grants from the Canadian Institutes of Health Research (CIHR 11541, 14995; RJZ), Fondation Bettencourt Schueller (KD), the Eileen Peters McGill Majors Fellowship (JMZ), and the Centre for Interdisciplinary Research in Music Media and Technology (CIRMMT; JMZ, SW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan RL, 2007, NEUROIMAGE, V38, P261, DOI 10.1016/j.neuroimage.2007.06.004; Amir O, 2003, J ACOUST SOC AM, V113, P1102, DOI 10.1121/1.1536632; Bangert M, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-26; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Belin P, 1999, NEUROIMAGE, V10, P417, DOI 10.1006/nimg.1999.0480; Bella SD, 2007, J ACOUST SOC AM, V121, P1182, DOI 10.1121/1.2427111; Bosnyak DJ, 2004, CEREB CORTEX, V14, P1088, DOI 10.1093/cercor/bhh068; Bradshaw E, 2005, J VOICE, V19, P431, DOI 10.1016/j.jvoice.2004.07.010; Brown S, 2004, COGNITIVE BRAIN RES, V20, P363, DOI 10.1016/j.cogbrainres.2004.03.016; Burnett TA, 2002, J ACOUST SOC AM, V112, P1058, DOI 10.1121/1.1487844; Burnett TA, 1998, J ACOUST SOC AM, V103, P3153, DOI 10.1121/1.423073; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Celsis P, 1999, NEUROIMAGE, V9, P135, DOI 10.1006/nimg.1998.0389; Chen JL, 2008, CEREB CORTEX, V18, P2844, DOI 10.1093/cercor/bhn042; Chen JL, 2006, NEUROIMAGE, V32, P1771, DOI 10.1016/j.neuroimage.2006.04.207; Chouinard PA, 2006, NEUROSCIENTIST, V12, P143, DOI 10.1177/1073858405284255; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; de Cheveigne A, 2002, J ACOUST SOC AM, V111, P1917, DOI 10.1121/1.1458024; Delhommeau K, 2005, JARO-J ASSOC RES OTO, V6, P171, DOI 10.1007/s10162-005-5055-4; Delhommeau K, 2002, PERCEPT PSYCHOPHYS, V64, P426, DOI 10.3758/BF03194715; DEMANY L, 1985, J ACOUST SOC AM, V78, P1118, DOI 10.1121/1.393034; DIVENYI PL, 1978, J ACOUST SOC AM, V64, P1369, DOI 10.1121/1.382103; DOWLING WJ, 1978, PSYCHOL REV, V85, P341, DOI 10.1037/0033-295X.85.4.341; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; Fox PT, 2001, NEUROIMAGE, V13, P196, DOI 10.1006/nimg.2000.0659; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gaab N, 2003, NEUROIMAGE, V19, P1417, DOI 10.1016/S1053-8119(03)00224-6; Gaab N, 2006, NEUROIMAGE, V31, P255, DOI 10.1016/j.neuroimage.2005.11.046; Griffiths TD, 1999, NEUROREPORT, V10, P3825, DOI 10.1097/00001756-199912160-00019; Grimault N, 2003, HEARING RES, V184, P41, DOI 10.1016/S0378-5955(03)00214-4; Hyde KL, 2008, NEUROPSYCHOLOGIA, V46, P632, DOI 10.1016/j.neuropsychologia.2007.09.004; JELINEK F, 1997, STAT METHODS SPEECH, P39; Jones JA, 2000, J ACOUST SOC AM, V108, P1246, DOI 10.1121/1.1288414; Jones JA, 2005, CURR BIOL, V15, P1768, DOI 10.1016/j.cub.2005.08.063; Kleber B, 2007, NEUROIMAGE, V36, P889, DOI 10.1016/j.neuroimage.2007.02.053; Kleber B, 2010, CEREB CORTEX, V20, P1144, DOI 10.1093/cercor/bhp177; Kriegstein KV, 2004, NEUROIMAGE, V22, P948, DOI 10.1016/j.neuroimage.2004.02.020; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Lombard E, 1911, ANN MALADIES OREILLE, P101; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; MUFSON EJ, 1982, J COMP NEUROL, V212, P23, DOI 10.1002/cne.902120103; Mutschler I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000259; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Nikjeh DA, 2009, J ACOUST SOC AM, V125, P328, DOI 10.1121/1.3021309; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Perry DW, 1999, NEUROREPORT, V10, P3979, DOI 10.1097/00001756-199912160-00046; PETRIDES M, 1986, J NEUROSCI, V6, P2054; Pfordresher PQ, 2007, MUSIC PERCEPT, V25, P95, DOI 10.1525/MP.2007.25.2.95; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Rinne T, 2007, NEUROSCI LETT, V416, P247, DOI 10.1016/j.neulet.2007.01.077; Roth Daphne Ari-Even, 2003, Journal of Basic and Clinical Physiology and Pharmacology, V14, P137; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; SIEGEL GM, 1974, J ACOUST SOC AM, V56, P1618, DOI 10.1121/1.1903486; Tomaiuolo F, 1999, EUR J NEUROSCI, V11, P3033, DOI 10.1046/j.1460-9568.1999.00718.x; Tournoux P., 1988, COPLANAR STEREOTAXIC; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Warren JD, 2006, NEUROIMAGE, V31, P1389, DOI 10.1016/j.neuroimage.2006.01.034; Warren JD, 2003, P NATL ACAD SCI USA, V100, P10038, DOI 10.1073/pnas.1730682100; Watts C, 2005, J VOICE, V19, P534, DOI 10.1016/j.jvoice.2004.09.001; Westbury CF, 1999, CEREB CORTEX, V9, P392, DOI 10.1093/cercor/9.4.392; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Worsley KJ, 2005, NEUROIMAGE, V28, P1056, DOI 10.1016/j.neuroimage.2005.06.053; WORSLEY KJ, 2005, CONNECTIVITY ANATOMI; Zarate JM, 2008, NEUROIMAGE, V40, P1871, DOI 10.1016/j.neuroimage.2008.01.026; Zarate JM, 2010, NEUROPSYCHOLOGIA, V48, P607, DOI 10.1016/j.neuropsychologia.2009.10.025; Zatorre RJ, 2001, ANN NY ACAD SCI, V930, P193, DOI 10.1111/j.1749-6632.2001.tb05734.x; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	73	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11181	10.1371/journal.pone.0011181	http://dx.doi.org/10.1371/journal.pone.0011181			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567521	gold, Green Published, Green Submitted			2022-12-27	WOS:000278886300023
J	Marrazzo, JM; Thomas, KK; Fiedler, TL; Ringwood, K; Fredricks, DN				Marrazzo, Jeanne M.; Thomas, Katherine K.; Fiedler, Tina L.; Ringwood, Kathleen; Fredricks, David N.			Risks for Acquisition of Bacterial Vaginosis Among Women Who Report Sex with Women: A Cohort Study	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASE; PREGNANT-WOMEN; VAGINAL FLORA; AFRICAN WOMEN; METRONIDAZOLE; LESBIANS; BEHAVIOR; LACTOBACILLI; ASSOCIATIONS; METAANALYSIS	Background: Bacterial vaginosis (BV) is common in women who have sex with women. While cross-sectional data support a role for sexual transmission, risks for incident BV have not been prospectively studied in this group. Methodology/Principal Findings: We studied risks for BV acquisition in a prospective cohort study of women (age 16-35 years) who reported sex with other women (>= 1 partner, prior year). Women were followed for one year with examinations at quarterly visits and for genital symptoms at any time. Species-specific 16S rRNA gene PCRs for BV-associated bacteria (BVAB) were applied to vaginal fluid obtained at enrollment. Sexual behaviors were ascertained by computer-assisted interview. Of 335 participants, 239 had no BV at baseline; 199 were seen in follow-up (median follow-up 355 days, 4.0 visits/ subject). Forty women experienced >= 1 BV episode. Risks for incident BV were presentation <= 14 days since onset of menses (hazard ratio (HR) 2.3 (95% CI, 1.2-4.7), report of new sex partner with BV history (HR 3.63 (1.1-11.9)), change in vaginal discharge (HR 2.6 (1.3-5.2)) and detection of any of several BVAB in vaginal fluid at enrollment, including BVAB1 (HR 6.3 (1.4-28.1)), BVAB2 (HR 18.2 (6.4-51.8)), BVAB3 (HR 12.6 (2.7-58.4)), G. vaginalis (HR 3.9 (1.5-10.4)), Atopobium vaginae (HR 4.2 (1.9-9.3)), Leptotrichia spp (9.3 (3.0-24.4)), and Megasphaera-1 (HR 11.5 (5.0-26.6)). Detection of Lactobacillus crispatus at enrollment conferred reduced risk for subsequent BV (HR 0.18 (0.08-0.4)). Detailed analysis of behavioral data suggested a direct dose-response relationship with increasing number of episodes of receptive oral-vulvovaginal sex (HR 1.02 (95% CI, 1.00-1.04). Conclusions/Significance: Vaginal detection of several BVAB in BV-negative women predicted subsequent BV, suggesting that changes in vaginal microbiota precede BV by weeks or months. BV acquisition was associated with report of new partner with BV; associations with sexual practices - specifically, receptive oral sex - require further investigation.	[Marrazzo, Jeanne M.; Thomas, Katherine K.; Ringwood, Kathleen] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Fiedler, Tina L.; Fredricks, David N.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Marrazzo, JM (corresponding author), Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA.	jmm2@uw.edu		Marrazzo, Jeanne/0000-0002-9277-7364; Thomas, Katherine K/0000-0002-7024-468X	National Institute of Allergy and Infectious Diseases [RO1 AI052228, R01 AI061628]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052228, R01AI061628] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support: National Institute of Allergy and Infectious Diseases grants RO1 AI052228 (JMM) and R01 AI061628 (DNF) (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Baeten JM, 2001, AM J OBSTET GYNECOL, V185, P380, DOI 10.1067/mob.2001.115862; Bailey JV, 2004, SEX TRANSM DIS, V31, P691, DOI 10.1097/01.olq.0000143093.70899.68; Berger BJ, 1995, CLIN INFECT DIS, V21, P1402, DOI 10.1093/clinids/21.6.1402; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; Culhane JF, 2002, AM J OBSTET GYNECOL, V187, P1272, DOI 10.1067/mob.2002.127311; Eschenbach DA, 2000, CLIN INFECT DIS, V30, P901, DOI 10.1086/313818; Evans AL, 2007, SEX TRANSM INFECT, V83, P470, DOI 10.1136/sti.2006.022277; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks David N, 2005, Curr Infect Dis Rep, V7, P463, DOI 10.1007/s11908-005-0049-2; Fredricks DN, 1999, BIOTECHNIQUES, V26, P198, DOI 10.2144/99262bm04; GORBACH PM, 2009, EFFECT ACASI REPORTI; HILLIER SL, 1993, CLIN INFECT DIS, V16, pS273, DOI 10.1093/clinids/16.Supplement_4.S273; HILLIER SL, 2002, TRIAL INTRAVAGINAL L; Hillier SL MJ., 2008, SEX TRANSM DIS, P737; INFECT DIS, 2009, J INFECT DIS, V200, P1662; Kissinger P, 1999, AM J EPIDEMIOL, V149, P950, DOI 10.1093/oxfordjournals.aje.a009739; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Leitich H, 2003, AM J OBSTET GYNECOL, V189, P139, DOI 10.1067/mob.2003.339; Marrazzo JM, 2002, J INFECT DIS, V185, P1307, DOI 10.1086/339884; MARRAZZO JM, SEX TRANSM IN PRESS; MARRAZZO JM, 2008, EFFICACY BEHAV INTER; MARRAZZO JM, 2008, ANN INTERN IN PRESS; McClelland RS, 2008, SEX TRANSM DIS, V35, P617, DOI 10.1097/OLQ.0b013e31816907fa; Myer L, 2005, J INFECT DIS, V192, P1372, DOI 10.1086/462427; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Sanchez S, 2004, AM J OBSTET GYNECOL, V191, P1898, DOI 10.1016/j.ajog.2004.06.089; Schwebke JR, 2005, SEX TRANSM DIS, V32, P654, DOI 10.1097/01.olq.0000175396.10304.62; Sobel JD, 2006, AM J OBSTET GYNECOL, V194, P1283, DOI 10.1016/j.ajog.2005.11.041; Srinavasan S, 2008, HUMAN VAGINAL BACTER; Sweet R L, 2000, Infect Dis Obstet Gynecol, V8, P184, DOI 10.1155/S1064744900000260; SWIDSINSKI A, 2007, AM J OBSTET GYNECOL; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; Webb PM, 1999, J ADOLESCENT HEALTH, V24, P383, DOI 10.1016/S1054-139X(99)00005-1	36	59	61	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11139	10.1371/journal.pone.0011139	http://dx.doi.org/10.1371/journal.pone.0011139			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559445	gold, Green Published, Green Submitted			2022-12-27	WOS:000278775900026
J	Greenstein, RJ; Su, LY; Brown, ST				Greenstein, Robert J.; Su, Liya; Brown, Sheldon T.			The Thioamides Methimazole and Thiourea Inhibit Growth of M. avium Subspecies paratuberculosis in Culture	PLOS ONE			English	Article							MYCOBACTERIUM-PARATUBERCULOSIS; HASHIMOTOS-THYROIDITIS; GRAVES-DISEASE; CROHNS-DISEASE; DRUG-THERAPY; HYPERTHYROIDISM; MULTIPLICATION; TUBERCULOSIS; ACCUMULATION; MECHANISM	Background: Thyrotoxicosis is conceptualized as an "autoimmune'' disease with no accepted infectious etiology. There are increasingly compelling data that another "autoimmune'' affliction, Crohn disease, may be caused by Mycobacterium avium subspecies paratuberculosis (MAP). Like M. tb, MAP is systemic. We hypothesized that some cases of thyrotoxicosis may be initiated by a MAP infection. Because other thioamides treat tuberculosis, leprosy and M. avium complex, we hypothesized that a mode of action of some thioamide anti-thyrotoxicosis medications may include MAP growth inhibition. Methods: The effect of the thioamides, thiourea, methimazole and 6-propo-2-thiouracil (6-PTU) were studied in radiometric Bactec (R) culture, on ten strains of three mycobacterial species (six of MAP, two of M. avium and two of M. tb. complex). Data are presented as "cumulative growth index,'' (cGI) or "percent decrease in cumulative GI'' (%-Delta cGI). Principal Findings: Methimazole was the most effective thioamide at inhibiting MAP growth. At 128 mu g/ml: MAP UCF-4; 65%-Delta cGI & MAP ATCC 19698; 90%-Delta cGI. Thiourea inhibited MAP "Ben'' maximally; 70%-Delta cGI. Neither methimazole nor thiourea inhibited M. avium or M. tb. at the doses tested. 6-PTU has no inhibition on any strain studied, although a structurally analogous control, 5-PTU, was the most inhibitory thioamide tested. Significance: We show inhibition of MAP growth by the thioamides, thiourea and methimazole in culture. These data are compatible with the hypothesis that these thioamides may have anti-prokaryotic in addition to their well-established eukaryotic actions in thyrotoxic individuals.	[Greenstein, Robert J.] James J Peters VA Med Ctr, Dept Surg, Bronx, NY USA; [Greenstein, Robert J.; Su, Liya] James J Peters VA Med Ctr, Lab Mol Surg Res, Bronx, NY USA; [Brown, Sheldon T.] James J Peters VA Med Ctr, Dept Med, Bronx, NY USA; [Brown, Sheldon T.] Mt Sinai Sch Med, New York, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai	Greenstein, RJ (corresponding author), James J Peters VA Med Ctr, Dept Surg, Bronx, NY USA.	BGAxis@aol.com			Bronx Veterans Medical Research Foundation, Inc. at the James J. Peters VAMC Bronx NY	Bronx Veterans Medical Research Foundation, Inc. at the James J. Peters VAMC Bronx NY	The authors thank Becton-Dickinson for providing the Bactec (R) vials. Becton-Dickinson had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other extramural funds were obtained. This material is the result of work supported with resources and the use of facilities at the James J. Peters VAMC Bronx NY. Other than the JJP VAMC Bronx Research and Development Committee reviewing, and approving, our submitted research protocol the James J. Peters VAMC Bronx NY had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by the Bronx Veterans Medical Research Foundation, Inc. at the James J. Peters VAMC Bronx NY. The Bronx Veterans Medical Research Foundation, Inc. had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTRAM MA, 1986, J INFECT DIS, V154, P194, DOI 10.1093/infdis/154.1.194; BIANCHI GP, 1995, ITAL J GASTROENTEROL, V27, P291; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; CHIODINI RJ, 1986, J CLIN MICROBIOL, V24, P357, DOI 10.1128/JCM.24.3.357-363.1986; Cooper DS, 2005, NEW ENGL J MED, V352, P905, DOI 10.1056/NEJMra042972; D'Amore M, 2010, J MED MICROBIOL, V59, P137, DOI 10.1099/jmm.0.013474-0; DAMATO JJ, 1990, VET MICROBIOL, V22, P31, DOI 10.1016/0378-1135(90)90122-C; Fajardo TT, 2006, AM J TROP MED HYG, V74, P457, DOI 10.4269/ajtmh.2006.74.457; Greenstein RJ, 2009, SEQUELAE AND LONG-TERM CONSEQUENCES OF INFECTIOUS DISEASES, P135; Greenstein RJ, 2004, LANCET, V364, P396, DOI 10.1016/S0140-6736(04)16781-0; Greenstein RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000161; Greenstein RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000516; Greenstein RJ, 2009, INT J INFECT DIS, V13, pE254, DOI 10.1016/j.ijid.2008.10.016; Greenstein RJ, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-4; Greenstein RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002496; Inokuchi T, 2005, INTERNAL MED, V44, P303, DOI 10.2169/internalmedicine.44.303; JARNEROT G, 1975, ACTA MED SCAND, V197, P83; JOHNE HA, 1895, DTSCH Z TIERMED PATH, V21, P438; LAM DCC, 1979, BIOCHEM PHARMACOL, V28, P2289, DOI 10.1016/0006-2952(79)90692-0; Laurberg P, 2006, EUR J ENDOCRINOL, V155, P783, DOI 10.1530/eje.1.02295; LEVY L, 1978, P SOC EXP BIOL MED, V158, P582; LEVY L, 1975, AM REV RESPIR DIS, V111, P651; LEVY L, 1972, AM REV RESPIR DIS, V106, P917, DOI 10.1164/arrd.1972.106.6.917; LINDSAY RH, 1979, ENDOCRINOLOGY, V104, P1686, DOI 10.1210/endo-104-6-1686; LINDSAY RH, 1975, BIOCHEM PHARMACOL, V24, P463, DOI 10.1016/0006-2952(75)90129-X; MARCHANT B, 1971, METABOLISM, V20, P989, DOI 10.1016/0026-0495(71)90021-7; MARCHANT B, 1972, J CLIN ENDOCR METAB, V34, P847, DOI 10.1210/jcem-34-5-847; Nakamura H, 2007, J CLIN ENDOCR METAB, V92, P2157, DOI 10.1210/jc.2006-2135; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Phetsuksiri B, 2003, J BIOL CHEM, V278, P53123, DOI 10.1074/jbc.M311209200; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; RASTOGI N, 1992, ANTIMICROB AGENTS CH, V36, P2843, DOI 10.1128/AAC.36.12.2843; RIDLEY D. S., 1962, LEPROSY REV, V33, P119; Schurr E, 2009, NEW ENGL J MED, V361, P2666, DOI 10.1056/NEJMe0910690; Shah SA, 1998, J CLIN GASTROENTEROL, V26, P117, DOI 10.1097/00004836-199803000-00006; Small PM, 2001, NEW ENGL J MED, V345, P189, DOI 10.1056/NEJM200107193450307; Stewart B. A., 1982, Advances in Irrigation. Volume 1., P1; Wang F, 2007, J EXP MED, V204, P73, DOI 10.1084/jem.20062100; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	39	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11099	10.1371/journal.pone.0011099	http://dx.doi.org/10.1371/journal.pone.0011099			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559419	Green Published, gold, Green Submitted			2022-12-27	WOS:000278741100013
J	Burnside, K; Lembo, A; de los Reyes, M; Iliuk, A; BinhTran, NT; Connelly, JE; Lin, WJ; Schmidt, BZ; Richardson, AR; Fang, FC; Tao, WA; Rajagopal, L				Burnside, Kellie; Lembo, Annalisa; de los Reyes, Melissa; Iliuk, Anton; BinhTran, Nguyen-Thao; Connelly, James E.; Lin, Wan-Jung; Schmidt, Byron Z.; Richardson, Anthony R.; Fang, Ferric C.; Tao, Weiguo Andy; Rajagopal, Lakshmi			Regulation of Hemolysin Expression and Virulence of Staphylococcus aureus by a Serine/Threonine Kinase and Phosphatase	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; GROUP-B STREPTOCOCCUS; GROUP-A STREPTOCOCCUS; ALPHA-TOXIN; BETA-TOXIN; EUKARYOTIC-TYPE; PROTEIN-A; SURFACE-PROTEINS; INNATE IMMUNITY; DELTA-LYSIN	Exotoxins, including the hemolysins known as the alpha (alpha) and beta (beta) toxins, play an important role in the pathogenesis of Staphylococcus aureus infections. A random transposon library was screened for S. aureus mutants exhibiting altered hemolysin expression compared to wild type. Transposon insertions in 72 genes resulting in increased or decreased hemolysin expression were identified. Mutations inactivating a putative cyclic di-GMP synthetase and a serine/threonine phosphatase (Stp1) were found to reduce hemolysin expression, and mutations in genes encoding a two component regulator PhoR, LysR family transcriptional regulator, purine biosynthetic enzymes and a serine/threonine kinase (Stk1) increased expression. Transcription of the hla gene encoding alpha toxin was decreased in a Dstp1 mutant strain and increased in a Delta stk1 strain. Microarray analysis of a Delta stk1 mutant revealed increased transcription of additional exotoxins. A Delta stp1 strain is severely attenuated for virulence in mice and elicits less inflammation and IL-6 production than the Delta stk1 strain. In vivo phosphopeptide enrichment and mass spectrometric analysis revealed that threonine phosphorylated peptides corresponding to Stk1, DNA binding histone like protein (HU), serine-aspartate rich fibrinogen/bone sialoprotein binding protein (SdrE) and a hypothetical protein (NWMN_1123) were present in the wild type and not in the Delta stk1 mutant. Collectively, these studies suggest that Stk1 mediated phosphorylation of HU, SrdE and NWMN_1123 affects S. aureus gene expression and virulence.	[Burnside, Kellie; Lembo, Annalisa; de los Reyes, Melissa; BinhTran, Nguyen-Thao; Connelly, James E.; Lin, Wan-Jung; Schmidt, Byron Z.; Rajagopal, Lakshmi] Univ Washington, Dept Pediat Infect Dis, Seattle, WA 98195 USA; [Burnside, Kellie; Lembo, Annalisa; de los Reyes, Melissa; BinhTran, Nguyen-Thao; Connelly, James E.; Lin, Wan-Jung; Schmidt, Byron Z.; Rajagopal, Lakshmi] Seattle Childrens Hosp Res Inst, Seattle, WA USA; [Iliuk, Anton; Tao, Weiguo Andy] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Richardson, Anthony R.; Fang, Ferric C.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Richardson, Anthony R.; Fang, Ferric C.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Burnside, K (corresponding author), Univ Washington, Dept Pediat Infect Dis, Seattle, WA 98195 USA.	lakshmi.rajagopal@seattlechildrens.org	Tao, Andy/N-1290-2019; Tao, Weiguo/AAL-2777-2020	Tao, Weiguo/0000-0002-5535-5517; Fang, Ferric/0000-0002-3243-110X; Iliuk, Anton/0000-0002-2914-1363	Seattle Children's Research Institute; Deion Branch Athletic Foundation; National Institutes of Health (NIH) [AI070749, GM088317-01A1]; NSF [AI39557]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039557, R56AI070749, R01AI070749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088317] Funding Source: NIH RePORTER	Seattle Children's Research Institute; Deion Branch Athletic Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from Seattle Children's Research Institute, the Deion Branch Athletic Foundation and the National Institutes of Health (NIH) Grant AI070749 to L. R., NIH GM088317-01A1 and NSF-CAREER award to W. A. T. and AI39557 to F. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari RP, 2007, INFECT IMMUN, V75, P4534, DOI 10.1128/IAI.00679-07; Altemeier WA, 2007, J LEUKOCYTE BIOL, V82, P721, DOI 10.1189/jlb.1006652; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Bartlett AH, 2008, J INFECT DIS, V198, P1529, DOI 10.1086/592758; Begun J, 2005, INFECT IMMUN, V73, P872, DOI 10.1128/IAI.73.2.872-877.2005; Beltramini AM, 2009, INFECT IMMUN, V77, P1406, DOI 10.1128/IAI.01499-08; Benton BM, 2004, J BACTERIOL, V186, P8478, DOI 10.1128/JB.186.24.8478-8489.2004; Berner Reinhard, 2004, Expert Rev Anti Infect Ther, V2, P427, DOI 10.1586/14787210.2.3.427; BERNHEIM.AW, 1974, ANN NY ACAD SCI, V236, P292, DOI 10.1111/j.1749-6632.1974.tb41499.x; BHAKDI S, 1989, INFECT IMMUN, V57, P3512, DOI 10.1128/IAI.57.11.3512-3519.1989; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; BHAKOO M, 1982, BIOCHEMISTRY-US, V21, P6879, DOI 10.1021/bi00269a039; Buist G, 2006, MICROBIOL-SGM, V152, P2867, DOI 10.1099/mic.0.29113-0; CALLEGAN MC, 1994, INFECT IMMUN, V62, P2478, DOI 10.1128/IAI.62.6.2478-2482.1994; Cerutti H, 2009, EPIGENETICS-US, V4, P71, DOI 10.4161/epi.4.2.7781; Chaffin DO, 1998, GENE, V219, P91, DOI 10.1016/S0378-1119(98)00396-5; Chaffin DO, 2000, J BACTERIOL, V182, P4466, DOI 10.1128/JB.182.16.4466-4477.2000; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; DeLeo FR, 2008, J EXP MED, V205, P271, DOI 10.1084/jem.20080167; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Donat S, 2009, J BACTERIOL, V191, P4056, DOI 10.1128/JB.00117-09; Dragneva Y, 2001, INFECT IMMUN, V69, P2630, DOI 10.1128/IAI.69.4.2630-2635.2001; Fournier B, 2001, MOL MICROBIOL, V41, P247, DOI 10.1046/j.1365-2958.2001.02515.x; FREER JH, 1982, J THEOR BIOL, V94, P535, DOI 10.1016/0022-5193(82)90299-5; Giraudo AT, 1999, FEMS MICROBIOL LETT, V177, P15, DOI 10.1016/S0378-1097(99)00282-7; Giraudo AT, 1997, ARCH MICROBIOL, V168, P53, DOI 10.1007/s002030050469; Giraudo AT, 2003, CURR MICROBIOL, V46, P246, DOI 10.1007/s00284-002-3853-z; Glenny AT, 1935, J PATHOL BACTERIOL, V40, P201, DOI 10.1002/path.1700400202; Hayashida A, 2009, AM J PATHOL, V174, P509, DOI 10.2353/ajpath.2009.080394; HERBERT S, INFECT IMMUNITY; HOCH J, 2 COMPONENT SIGNAL T; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; Hume EBH, 2000, INFECT IMMUN, V68, P6052, DOI 10.1128/IAI.68.10.6052-6055.2000; Huseby M, 2007, J BACTERIOL, V189, P8719, DOI 10.1128/JB.00741-07; Husmann M, 2009, FEBS LETT, V583, P337, DOI 10.1016/j.febslet.2008.12.028; ILIUK A, 2009, METHOD MOL BIOL, V527, pR9; Iliuk Anton, 2009, V527, P117, DOI 10.1007/978-1-60327-834-8_10; Jeng A, 2003, J BACTERIOL, V185, P1208, DOI 10.1128/JB.185.4.1208-1217.2003; Josefsson E, 1998, MICROBIOL-UK, V144, P3387, DOI 10.1099/00221287-144-12-3387; Kielian T, 2001, INFECT IMMUN, V69, P6902, DOI 10.1128/IAI.69.11.6902-6911.2001; Kim CS, 2000, LARYNGOSCOPE, V110, P2085; Kim J, 2000, CELL STRESS CHAPERON, V5, P267, DOI 10.1379/1466-1268(2000)005<0267:SDPEAT>2.0.CO;2; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Krishna R.G., 1998, PROTEINS ANAL DESIGN, P121; Lin WJ, 2009, MOL MICROBIOL, V71, P1477, DOI 10.1111/j.1365-2958.2009.06616.x; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Manna AC, 2003, INFECT IMMUN, V71, P343, DOI 10.1128/IAI.71.1.343-353.2003; McNamara PJ, 2005, INFECT IMMUN, V73, P3806, DOI 10.1128/IAI.73.6.3806-3809.2005; McNamara PJ, 2000, J BACTERIOL, V182, P3197, DOI 10.1128/JB.182.11.3197-3203.2000; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; Nilsson IM, 1999, INFECT IMMUN, V67, P1045, DOI 10.1128/IAI.67.3.1045-1049.1999; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Oberto J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004367; OBrien L, 2002, MOL MICROBIOL, V44, P1033, DOI 10.1046/j.1365-2958.2002.02935.x; OCallaghan RJ, 1997, INFECT IMMUN, V65, P1571, DOI 10.1128/IAI.65.5.1571-1578.1997; OKADA N, 1993, MOL MICROBIOL, V7, P893, DOI 10.1111/j.1365-2958.1993.tb01180.x; Onogawa T, 2002, FEMS IMMUNOL MED MIC, V33, P15, DOI 10.1111/j.1574-695X.2002.tb00566.x; Otto M, 2010, MED RES REV, V30, P1, DOI 10.1002/med.20160; PATEL AH, 1987, INFECT IMMUN, V55, P3103, DOI 10.1128/IAI.55.12.3103-3110.1987; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; PROJAN SJ, 1989, NUCLEIC ACIDS RES, V17, P3305, DOI 10.1093/nar/17.8.3305; Raggiaschi R, 2005, BIOSCIENCE REP, V25, P33, DOI 10.1007/s10540-005-2846-0; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Rajagopal L, 2005, MOL MICROBIOL, V56, P1329, DOI 10.1111/j.1365-2958.2005.04620.x; Rajagopal L, 2006, MOL MICROBIOL, V62, P941, DOI 10.1111/j.1365-2958.2006.05431.x; Rajagopal L, 2009, FUTURE MICROBIOL, V4, P201, DOI 10.2217/17460913.4.2.201; Richardson AR, 2008, SCIENCE, V319, P1672, DOI 10.1126/science.1155207; Richardson AR, 2006, MOL MICROBIOL, V61, P927, DOI 10.1111/j.1365-2958.2006.05290.x; Rubin RJ, 1999, EMERG INFECT DIS, V5, P9, DOI 10.3201/eid0501.990102; Sabat A, 2006, J CLIN MICROBIOL, V44, P1135, DOI 10.1128/JCM.44.3.1135-1138.2006; Said-Salim B, 2003, J BACTERIOL, V185, P610, DOI 10.1128/JB.185.2.610-619.2003; Schafer D, 2009, J BACTERIOL, V191, P7306, DOI 10.1128/JB.00630-09; Schmidt KA, 2001, INFECT IMMUN, V69, P4749, DOI 10.1128/IAI.69.8.4749-4758.2001; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Sibbald MJJB, 2006, MICROBIOL MOL BIOL R, V70, P755, DOI 10.1128/MMBR.00008-06; Silvestroni A, 2009, J PROTEOME RES, V8, P2563, DOI 10.1021/pr900069n; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Styers David, 2006, Ann Clin Microbiol Antimicrob, V5, P2; Traber K, 2006, MOL MICROBIOL, V59, P1519, DOI 10.1111/j.1365-2958.2006.04986.x; VANDENESCH F, 1991, J BACTERIOL, V173, P6313, DOI 10.1128/jb.173.20.6313-6320.1991; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; WISEMAN GM, 1975, BACTERIOL REV, V39, P317, DOI 10.1128/MMBR.39.4.317-344.1975; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Yao J, 2006, RNA, V12, P1271, DOI 10.1261/rna.68706; Yarwood JM, 2003, J CLIN INVEST, V112, P1620, DOI 10.1172/JCI200320442	98	113	116	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11071	10.1371/journal.pone.0011071	http://dx.doi.org/10.1371/journal.pone.0011071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552019	Green Published, Green Submitted, gold			2022-12-27	WOS:000278662900011
J	Marshall, KM; Bradshaw, M; Johnson, EA				Marshall, Kristin M.; Bradshaw, Marite; Johnson, Eric A.			Conjugative Botulinum Neurotoxin-Encoding Plasmids in Clostridium botulinum	PLOS ONE			English	Article							INFANT BOTULISM; GENOME SEQUENCE; COMPLEX GENES; HALL-A; STRAINS; IDENTIFICATION; PERFRINGENS; EXPRESSION; DIVERSITY; PCW3	Background: Clostridium botulinum produces seven distinct serotypes of botulinum neurotoxins (BoNTs). The genes encoding different subtype neurotoxins of serotypes A, B, F and several dual neurotoxin-producing strains have been shown to reside on plasmids, suggesting that intra-and interspecies transfer of BoNT-encoding plasmids may occur. The objective of the present study was to determine whether these C. botulinum BoNT-encoding plasmids are conjugative. Methodology/Principal Findings: C. botulinum BoNT-encoding plasmids pBotCDC-A3 (strain CDC-A3), pCLJ (strain 657Ba) and pCLL (strain Eklund 17B) were tagged with the erythromycin resistance marker (Erm) using the ClosTron mutagenesis system by inserting a group II intron into the neurotoxin genes carried on these plasmids. Transfer of the tagged plasmids from the donor strains CDC-A3, 657Ba and Eklund 17B to tetracycline-resistant recipient C. botulinum strains was evaluated in mating experiments. Erythromycin and tetracycline resistant transconjugants were isolated from donor: recipient mating pairs tested. Transfer of the plasmids to the transconjugants was confirmed by pulsed-field gel electrophoresis (PFGE) and Southern hybridizations. Transfer required cell-to-cell contact and was DNase resistant. This indicates that transfer of these plasmids occurs via a conjugation mechanism. Conclusions/Significance: This is the first evidence supporting conjugal transfer of native botulinum neurotoxin-encoding plasmids in C. botulinum, and provides a probable mechanism for the lateral distribution of BoNT-encoding plasmids to other C. botulinum strains. The potential transfer of C. botulinum BoNT-encoding plasmids to other bacterial hosts in the environment or within the human intestine is of great concern for human pathogenicity and necessitates further characterization of these plasmids.	[Marshall, Kristin M.; Bradshaw, Marite; Johnson, Eric A.] Univ Wisconsin, Coll Agr & Life Sci, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Marshall, KM (corresponding author), US FDA, Natl Ctr Food Safety & Technol, Summit, NJ USA.	eajohnso@wisc.edu	Pacific-Southwest, RCE/B-6155-2009		Food Research Institute of the University of Wisconsin-Madison; NIH/NIAID Regional Center of Excellence; NIH [1-U54-AI-057153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359, U54AI057153] Funding Source: NIH RePORTER	Food Research Institute of the University of Wisconsin-Madison; NIH/NIAID Regional Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was sponsored by the Food Research Institute of the University of Wisconsin-Madison and by the NIH/NIAID Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) Program. The authors wish to acknowledge membership and support from the Pacific Southwest Regional Center of Excellence grant U54 AI065359 and from the Region V "Great Lakes" Regional center of Excellence (NIH award 1-U54-AI-057153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt JW, 2006, J MOL BIOL, V362, P733, DOI 10.1016/j.jmb.2006.07.040; Bannam TL, 2006, J BACTERIOL, V188, P4942, DOI 10.1128/JB.00298-06; BEVERLEY SM, 1988, NUCLEIC ACIDS RES, V16, P925, DOI 10.1093/nar/16.3.925; Blaiotta G, 2000, LETT APPL MICROBIOL, V31, P343, DOI 10.1046/j.1472-765x.2000.00801.x; Bradshaw M, 2004, ANAEROBE, V10, P321, DOI 10.1016/j.anaerobe.2004.07.001; Bradshaw M, 2010, MANUAL OF INDUSTRIAL MICROBIOLOGY AND BIOTECHNOLOGY, THIRD EDITION, P238; Brynestad S, 2001, INFECT IMMUN, V69, P3483, DOI 10.1128/IAI.69.5.3483-3487.2001; Carter AT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-115; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dineen SS, 2000, APPL ENVIRON MICROB, V66, P5480, DOI 10.1128/AEM.66.12.5480-5483.2000; Dover N, 2009, J CLIN MICROBIOL, V47, P2349, DOI 10.1128/JCM.00799-09; EKLUND MW, 1967, J BACTERIOL, V93, P1461, DOI 10.1128/JB.93.4.1461-1462.1967; Franciosa G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004829; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; HATHEWAY CL, 1981, J CLIN MICROBIOL, V14, P607, DOI 10.1128/JCM.14.6.607-611.1981; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Hill KK, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-66; Hughes ML, 2007, J BACTERIOL, V189, P7531, DOI 10.1128/JB.00767-07; Jacobson MJ, 2008, MICROBIOL-SGM, V154, P2408, DOI 10.1099/mic.0.2008/016915-0; Johnson EA, 1997, CLIN INFECT DIS, V25, pS168, DOI 10.1086/516239; Johnson EA, 2005, J CLIN MICROBIOL, V43, P2602, DOI 10.1128/JCM.43.6.2602-2607.2005; Johnson Eric A, 2008, Handb Clin Neurol, V91, P333, DOI 10.1016/S0072-9752(07)01511-4; LIN WJ, 1991, APPL ENVIRON MICROB, V57, P2946, DOI 10.1128/AEM.57.10.2946-2950.1991; LYNT RK, 1982, J FOOD PROTECT, V45, P466, DOI 10.4315/0362-028X-45.5.466; MARSHALL KM, 2009, THESIS U WISCONSIN M; Marshall KM, 2007, BIOCHEM BIOPH RES CO, V361, P49, DOI 10.1016/j.bbrc.2007.06.166; NEVE H, 1984, J BACTERIOL, V157, P833, DOI 10.1128/JB.157.3.833-838.1984; Peck MW, 2009, ADV MICROB PHYSIOL, V55, P183, DOI 10.1016/S0065-2911(09)05503-9; Rood JI, 2004, PLASMID BIOLOGY, P413; ROOD JI, 1978, PLASMID, V1, P563, DOI 10.1016/0147-619X(78)90013-6; Sakaguchi Y, 2005, P NATL ACAD SCI USA, V102, P17472, DOI 10.1073/pnas.0505503102; Sambrook J., 2001, MOL CLONING LAB MANU; Sayeed S, 2007, INFECT IMMUN, V75, P2391, DOI 10.1128/IAI.02014-06; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; Smedley JG, 2005, REV PHYSIOL BIOCH P, V152, P183, DOI 10.1007/s10254-004-0036-2; Smith TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001271; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Umeda K, 2009, J CLIN MICROBIOL, V47, P2720, DOI 10.1128/JCM.00077-09; Wang XM, 2000, APPL ENVIRON MICROB, V66, P4992, DOI 10.1128/AEM.66.11.4992-4997.2000; Ward AB, 2007, CLINICAL USES OF BOTULINUM TOXINS, P1, DOI 10.1017/CBO9780511544842; ZHOU YT, 1995, INFECT IMMUN, V63, P2087, DOI 10.1128/IAI.63.5.2087-2091.1995	44	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11087	10.1371/journal.pone.0011087	http://dx.doi.org/10.1371/journal.pone.0011087			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552020	Green Submitted, Green Published, gold			2022-12-27	WOS:000278662900024
J	Hedrick, T; Waters, J				Hedrick, Tristan; Waters, Jack			Physiological Properties of Cholinergic and Non-Cholinergic Magnocellular Neurons in Acute Slices from Adult Mouse Nucleus Basalis	PLOS ONE			English	Article							HYPERPOLARIZATION-ACTIVATED CURRENT; GUINEA-PIG BRAIN; FOREBRAIN NEURONS; SEPTAL NEURONS; IN-VITRO; ELECTROPHYSIOLOGICAL PROPERTIES; DISCHARGE PROPERTIES; IMMUNOHISTOCHEMICAL EVIDENCE; MEMBRANE-PROPERTIES; ALZHEIMERS-DISEASE	Background: The basal forebrain is a series of nuclei that provides cholinergic input to much of the forebrain. The most posterior of these nuclei, nucleus basalis, provides cholinergic drive to neocortex and is involved in arousal and attention. The physiological properties of neurons in anterior basal forebrain nuclei, including medial septum, the diagonal band of Broca and substantia innominata, have been described previously. In contrast the physiological properties of neurons in nucleus basalis, the most posterior nucleus of the basal forebrain, are unknown. Methodology/Principal Findings: Here we investigate the physiological properties of neurons in adult mouse nucleus basalis. We obtained cell-attached and whole-cell recordings from magnocellular neurons in slices from P42-54 mice and compared cholinergic and non-cholinergic neurons, distinguished retrospectively by anti-choline acetyltransferase immunocytochemistry. The majority (70-80%) of cholinergic and non-cholinergic neurons were silent at rest. Spontaneously active cholinergic and non-cholinergic neurons exhibited irregular spiking at 3 Hz and at 0.3 to 13.4 Hz, respectively. Cholinergic neurons had smaller, broader action potentials than non-cholinergic neurons (amplitudes 64 +/- 3.4 and 75 +/- 2 mV; half widths 0.52 +/- 0.04 and 0.33 +/- 0.02 ms). Cholinergic neurons displayed a more pronounced slow after-hyperpolarization than non-cholinergic neurons (13.3 +/- 2.2 and 3.6 +/- 0.5 mV) and were unable to spike at high frequencies during tonic current injection (maximum frequencies of similar to 20 Hz and >120 Hz). Conclusions/Significance: Our results indicate that neurons in nucleus basalis share similar physiological properties with neurons in anterior regions of the basal forebrain. Furthermore, cholinergic and non-cholinergic neurons in nucleus basalis can be distinguished by their responses to injected current. To our knowledge, this is the first description of the physiological properties of cholinergic and non-cholinergic neurons in the posterior aspects of the basal forebrain complex and the first study of basal forebrain neurons from the mouse.	[Hedrick, Tristan; Waters, Jack] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Hedrick, T (corresponding author), Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA.	jackwaters@northwestern.edu			Whitehall Foundation [2006-12-31]; National Institute on Aging [5T32AG020418-09, 5T32AG020418]; National Institute of Mental Health [2T32MH067564-06]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH085117, T32MH067564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020418] Funding Source: NIH RePORTER	Whitehall Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank the Whitehall Foundation (2006-12-31), National Institute on Aging (5T32AG020418-09 and 5T32AG020418) and National Institute of Mental Health (2T32MH067564-06) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN TGJ, 1993, J PHYSIOL-LONDON, V466, P173; Alonso A, 1996, EUR J NEUROSCI, V8, P169, DOI 10.1111/j.1460-9568.1996.tb01178.x; ALONSO A, 1994, J NEUROSCI, V14, P5778; Bengtson CP, 2000, J NEUROPHYSIOL, V83, P2649, DOI 10.1152/jn.2000.83.5.2649; Cape EG, 2000, J NEUROSCI, V20, P8452, DOI 10.1523/JNEUROSCI.20-22-08452.2000; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; DETOLEDO GA, 1988, J PHYSIOL-LONDON, V396, P399, DOI 10.1113/jphysiol.1988.sp016969; DILSAVER SC, 1986, BRAIN RES REV, V11, P285, DOI 10.1016/0165-0173(86)90016-0; FORT P, 1995, EUR J NEUROSCI, V7, P1502, DOI 10.1111/j.1460-9568.1995.tb01145.x; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Gorelova N, 1996, J NEUROPHYSIOL, V75, P707, DOI 10.1152/jn.1996.75.2.707; Gorelova N, 1996, J NEUROPHYSIOL, V75, P695, DOI 10.1152/jn.1996.75.2.695; GRIFFITH WH, 1991, ADV EXP MED BIOL, V295, P143; GRIFFITH WH, 1994, J NEUROPHYSIOL, V71, P2359, DOI 10.1152/jn.1994.71.6.2359; GRIFFITH WH, 1986, NEUROSCI LETT, V71, P169, DOI 10.1016/0304-3940(86)90553-7; GRIFFITH WH, 1988, J NEUROPHYSIOL, V59, P1590, DOI 10.1152/jn.1988.59.5.1590; Gritti I, 2003, J COMP NEUROL, V458, P11, DOI 10.1002/cne.10505; Han SH, 2005, MOL BRAIN RES, V134, P226, DOI 10.1016/j.molbrainres.2004.10.041; Hassani OK, 2009, J NEUROSCI, V29, P11828, DOI 10.1523/JNEUROSCI.1259-09.2009; Henny P, 2008, EUR J NEUROSCI, V27, P654, DOI 10.1111/j.1460-9568.2008.06029.x; KHATEB A, 1993, EUR J NEUROSCI, V5, P541, DOI 10.1111/j.1460-9568.1993.tb00519.x; KHATEB A, 1995, NEUROSCIENCE, V69, P495, DOI 10.1016/0306-4522(95)00264-J; KHATEB A, 1992, NEUROSCIENCE, V51, P489, DOI 10.1016/0306-4522(92)90289-E; Kilgard M, 2003, NEURON, V38, P678, DOI 10.1016/S0896-6273(03)00327-1; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; Lee MG, 2004, J NEUROPHYSIOL, V92, P1182, DOI 10.1152/jn.01003.2003; LOPEZBARNEO J, 1985, BRAIN RES, V347, P358, DOI 10.1016/0006-8993(85)90199-4; MACCAFERRI G, 1993, J NEUROPHYSIOL, V69, P2129, DOI 10.1152/jn.1993.69.6.2129; Maccaferri G, 1996, J PHYSIOL-LONDON, V497, P119, DOI 10.1113/jphysiol.1996.sp021754; Manns ID, 2003, J NEUROPHYSIOL, V89, P1057, DOI 10.1152/jn.00938.2002; Manns ID, 2000, J NEUROSCI, V20, P1505; Manns ID, 2001, NEUROSCIENCE, V107, P249, DOI 10.1016/S0306-4522(01)00302-5; MARKRAM H, 1990, BRAIN RES, V513, P171, DOI 10.1016/0006-8993(90)91106-Q; MATTHEWS RT, 1991, NEUROSCIENCE, V42, P451, DOI 10.1016/0306-4522(91)90388-5; MESULAM MM, 1983, J COMP NEUROL, V214, P170, DOI 10.1002/cne.902140206; MESULAM MM, 1995, SEMIN NEUROSCI, V7, P297, DOI 10.1006/smns.1995.0033; MURRAY CL, 1985, NEUROSCIENCE, V14, P1025, DOI 10.1016/0306-4522(85)90273-8; NAKAJIMA Y, 1985, P NATL ACAD SCI USA, V82, P6325, DOI 10.1073/pnas.82.18.6325; PAGE KJ, 1995, EUR J NEUROSCI, V7, P1012, DOI 10.1111/j.1460-9568.1995.tb01089.x; SEGAL M, 1986, J PHYSIOL-LONDON, V379, P309, DOI 10.1113/jphysiol.1986.sp016255; Sim JA, 1998, J NEUROPHYSIOL, V80, P1653, DOI 10.1152/jn.1998.80.4.1653; STANFIELD PR, 1985, NATURE, V315, P498, DOI 10.1038/315498a0; SUSZKIW JB, 1992, BRAIN RES, V588, P246, DOI 10.1016/0006-8993(92)91582-Y; WAINER BH, 1990, ASCENDING CHOLINERGI, P65; Waters DJ, 1998, J PHYSIOL-LONDON, V508, P453, DOI 10.1111/j.1469-7793.1998.453bq.x; Waters J, 2006, J NEUROSCI, V26, P8267, DOI 10.1523/JNEUROSCI.2152-06.2006; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341	47	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11046	10.1371/journal.pone.0011046	http://dx.doi.org/10.1371/journal.pone.0011046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548784	Green Submitted, gold, Green Published			2022-12-27	WOS:000278599600007
J	Shiino, T; Okabe, N; Yasui, Y; Sunagawa, T; Ujike, M; Obuchi, M; Kishida, N; Xu, H; Takashita, E; Anraku, A; Ito, R; Doi, T; Ejima, M; Sugawara, H; Horikawa, H; Yamazaki, S; Kato, Y; Oguchi, A; Fujita, N; Odagiri, T; Tashiro, M; Watanabe, H				Shiino, Teiichiro; Okabe, Nobuhiko; Yasui, Yoshinori; Sunagawa, Tomimasa; Ujike, Makoto; Obuchi, Masatsugu; Kishida, Noriko; Xu, Hong; Takashita, Emi; Anraku, Akane; Ito, Reiko; Doi, Teruko; Ejima, Miho; Sugawara, Hiromi; Horikawa, Hiroshi; Yamazaki, Shuji; Kato, Yumiko; Oguchi, Akio; Fujita, Nobuyuki; Odagiri, Takato; Tashiro, Masato; Watanabe, Haruo			Molecular Evolutionary Analysis of the Influenza A(H1N1)pdm, May-September, 2009: Temporal and Spatial Spreading Profile of the Viruses in Japan	PLOS ONE			English	Article							A H1N1; EPIDEMIOLOGY	Background: In March 2009, pandemic influenza A(H1N1) (A(H1N1)pdm) emerged in Mexico and the United States. In Japan, since the first outbreak of A(H1N1) pdm in Osaka and Hyogo Prefectures occurred in the middle of May 2009, the virus had spread over 16 of 47 prefectures as of June 4, 2009. Methods/Principal Findings: We analyzed all-segment concatenated genome sequences of 75 isolates of A(H1N1) pdm viruses in Japan, and compared them with 163 full-genome sequences in the world. Two analyzing methods, distance-based and Bayesian coalescent MCMC inferences were adopted to elucidate an evolutionary relationship of the viruses in the world and Japan. Regardless of the method, the viruses in the world were classified into four distinct clusters with a few exceptions. Cluster 1 was originated earlier than cluster 2, while cluster 2 was more widely spread around the world. The other two clusters (clusters 1.2 and 1.3) were suggested to be distinct reassortants with different types of segment assortments. The viruses in Japan seemed to be a multiple origin, which were derived from approximately 28 transported cases. Twelve cases were associated with monophyletic groups consisting of Japanese viruses, which were referred to as micro-clade. While most of the micro-clades belonged to the cluster 2, the clade of the first cases of infection in Japan originated from cluster 1.2. Micro-clades of Osaka/Kobe and the Fukuoka cases, both of which were school-wide outbreaks, were eradicated. Time of most recent common ancestor (tMRCA) for each micro-clade demonstrated that some distinct viruses were transmitted in Japan between late May and early June, 2009, and appeared to spread nation-wide throughout summer. Conclusions: Our results suggest that many viruses were transmitted from abroad in late May 2009 irrespective of preventive actions against the pandemic influenza, and that the influenza A(H1N1) pdm had become a pandemic stage in June 2009 in Japan.	[Shiino, Teiichiro; Okabe, Nobuhiko; Yasui, Yoshinori; Sunagawa, Tomimasa; Watanabe, Haruo] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan; [Ujike, Makoto; Obuchi, Masatsugu; Kishida, Noriko; Xu, Hong; Takashita, Emi; Anraku, Akane; Ito, Reiko; Doi, Teruko; Ejima, Miho; Sugawara, Hiromi; Odagiri, Takato; Tashiro, Masato] Natl Inst Infect Dis, Influenza Virus Res Ctr, Tokyo, Japan; [Horikawa, Hiroshi; Yamazaki, Shuji; Kato, Yumiko; Oguchi, Akio; Fujita, Nobuyuki] Natl Inst Technol & Evaluat, Dept Biotechnol, Genome Anal Ctr, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID)	Shiino, T (corresponding author), Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan.	tshiino@nih.go.jp	Ujike, Makoto/W-3508-2019	Ujike, Makoto/0000-0002-7145-7126	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Japan Science and Technology Agency (JST)	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan and the Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Centers for Disease Control and Prevention, 2009, MMWR-MORBID MORTAL W, V58, P435, DOI DOI 10.1007/S00134-010-2021-3; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fereidouni SR, 2009, EUROSURVEILLANCE, V14, P2; *HLTH WELF STAT FU, 2009, FIELD EP INV NOV INF; *INF DIS SURV CTR, 2010, IASR, V31, P69; Kawaguchi R, 2009, EMERG INFECT DIS, V15, P1685, DOI 10.3201/eid1510.091029; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; *MIN HLTH LAW, 2008, OFF NOT AM PREV CAR; *MIN HLTH LAW, 2009, OFF NOT; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Rambaut A., 2007, TRACER V1 4; Shimada T, 2009, EUROSURVEILLANCE, V14; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; *WHO, 2009, INFL A H1N1 UPD 40; YAHATA Y, 2009, FIELD EPIDEMIOLOGICA	24	37	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11057	10.1371/journal.pone.0011057	http://dx.doi.org/10.1371/journal.pone.0011057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548780	Green Published, gold, Green Submitted			2022-12-27	WOS:000278599600016
J	Kellner, H; Zak, DR; Vandenbol, M				Kellner, Harald; Zak, Donald R.; Vandenbol, Micheline			Fungi Unearthed: Transcripts Encoding Lignocellulolytic and Chitinolytic Enzymes in Forest Soil	PLOS ONE			English	Article							NITROGEN DEPOSITION; LACCASE GENES; INTEGRATED DATABASE; CARBON; DIVERSITY; LIGNIN; ECTOMYCORRHIZAL; DEGRADATION; PEROXIDASE; CLASSIFICATION	Background: Fungi are the main organisms responsible for the degradation of biopolymers such as lignin, cellulose, hemicellulose, and chitin in forest ecosystems. Soil surveys largely target fungal diversity, paying less attention to fungal activity. Methodology/Principal Findings: Here we have focused on the organic horizon of a hardwood forest dominated by sugar maple that spreads widely across Eastern North America. The sampling site included three plots receiving normal atmospheric nitrogen deposition and three that received an extra 3 g nitrogen m(2) y(1) in form of sodium nitrate pellets since 1994, which led to increased accumulation of organic matter in the soil. Our aim was to assess, in samples taken from all six plots, transcript-level expression of fungal genes encoding lignocellulolytic and chitinolytic enzymes. For this we collected RNA from the forest soil, reverse-transcribed it, and amplified cDNAs of interest, using both published primer pairs as well as 23 newly developed ones. We thus detected transcript-level expression of 234 genes putatively encoding 26 different groups of fungal enzymes, notably major ligninolytic and diverse aromatic-oxidizing enzymes, various cellulose-and hemicellulose-degrading glycoside hydrolases and carbohydrate esterases, enzymes involved in chitin breakdown, N-acetylglucosamine metabolism, and cell wall degradation. Among the genes identified, 125 are homologous to known ascomycete genes and 105 to basidiomycete genes. Transcripts corresponding to all 26 enzyme groups were detected in both control and nitrogen-supplemented plots. Conclusions/Significance: Many of these enzyme groups are known to be important in soil turnover processes, but the contribution of some is probably underestimated. Our data highlight the importance of ascomycetes, as well as basidiomycetes, in important biogeochemical cycles. In the nitrogen-supplemented plots, we have detected no transcript-level gap likely to explain the observed increased carbon storage, which is more likely due to community changes and perhaps transcriptional and/or post-transcriptional down-regulation of relevant genes.	[Kellner, Harald; Vandenbol, Micheline] Univ Liege, Unite Biol Anim & Microbienne, Gembloux, Belgium; [Zak, Donald R.] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Zak, Donald R.] Univ Michigan, Dep Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Liege; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kellner, H (corresponding author), Univ Liege, Unite Biol Anim & Microbienne, Gembloux, Belgium.	mail@haraldkellner.com	Kellner, Harald/B-8729-2009; Zak, Donald R/C-6004-2012		Belgian Research Foundation (FNRS) [2.4503.08]; Direct For Biological Sciences [0814623] Funding Source: National Science Foundation	Belgian Research Foundation (FNRS)(Fonds de la Recherche Scientifique - FNRS); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Grant was received from the Belgian Research Foundation (FNRS, http://www2.frs-fnrs.be/, grant no. 2.4503.08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly J, 2007, ISME J, V1, P632, DOI 10.1038/ismej.2007.68; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; Baldrian P, 2008, BR MYCOL SY, V28, P19; Baldrian P, 2009, OECOLOGIA, V161, P657, DOI 10.1007/s00442-009-1433-7; Berg B, 1997, EUR EAT DISORD REV, V5, P25, DOI 10.1002/(SICI)1099-0968(199703)5:1<25::AID-ERV186>3.0.CO;2-2; Bodeker ITM, 2009, ISME J, V3, P1387, DOI 10.1038/ismej.2009.77; BOOMINATHAN K, 1990, ARCH MICROBIOL, V153, P521, DOI 10.1007/BF00245259; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Burke RM, 2002, MYCORRHIZA, V12, P105, DOI 10.1007/s00572-002-0162-0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Courty PE, 2008, APPL ENVIRON MICROB, V74, P6598, DOI 10.1128/AEM.00584-08; Coutinho PM, 1999, ROY SOC CH, P3; Cullings K, 2009, OECOLOGIA, V161, P661, DOI 10.1007/s00442-009-1434-6; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; de Vries W, 2008, NATURE, V451, pE1, DOI 10.1038/nature06579; Deacon JW., 2005, FUNGAL BIOL; DeForest JL, 2004, SOIL SCI SOC AM J, V68, P132, DOI 10.2136/sssaj2004.1320; Dighton J., 2005, FUNGAL COMMUNITY ITS, V3rd; Edwards IP, 2008, APPL ENVIRON MICROB, V74, P3481, DOI 10.1128/AEM.02893-07; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Halaouli S, 2006, J APPL MICROBIOL, V100, P219, DOI 10.1111/j.1365-2672.2006.02866.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hoegger P., 2007, WOOD PRODUCTION WOOD, P383; Hofrichter M, 2002, ENZYME MICROB TECH, V30, P454, DOI 10.1016/S0141-0229(01)00528-2; Jacobsen J, 2005, J MICROBIOL METH, V60, P63, DOI 10.1016/j.mimet.2004.08.013; Kellner H, 2009, SOIL BIOL BIOCHEM, V41, P1380, DOI 10.1016/j.soilbio.2009.03.012; Kellner H, 2009, SOIL BIOL BIOCHEM, V41, P1344, DOI 10.1016/j.soilbio.2009.02.033; Kogel-Knabner I, 2002, SOIL BIOL BIOCHEM, V34, P139, DOI 10.1016/S0038-0717(01)00158-4; Levasseur A, 2008, FUNGAL GENET BIOL, V45, P638, DOI 10.1016/j.fgb.2008.01.004; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; Luis P, 2005, MICROB ECOL, V50, P570, DOI 10.1007/s00248-005-5047-2; Luis P, 2005, GEODERMA, V128, P18, DOI 10.1016/j.geoderma.2004.12.023; Luis P, 2004, SOIL BIOL BIOCHEM, V36, P1025, DOI 10.1016/j.soilbio.2004.02.017; Lyons JI, 2003, MICROB ECOL, V45, P270, DOI 10.1007/s00248-002-1055-7; Magnani F, 2007, NATURE, V447, P848, DOI 10.1038/nature05847; MORRIS DR, 1966, J BIOL CHEM, V241, P1763; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; Naumann A, 2007, WOOD PRODUCTION WOOD, ppp179; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Pecyna MJ, 2009, APPL MICROBIOL BIOT, V84, P885, DOI 10.1007/s00253-009-2000-1; Pregitzer KS, 2008, GLOBAL CHANGE BIOL, V14, P142, DOI 10.1111/j.1365-2486.2007.01465.x; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; RIEBLE S, 1994, J BACTERIOL, V176, P4838, DOI 10.1128/jb.176.16.4838-4844.1994; Schulze WX, 2005, OECOLOGIA, V142, P335, DOI 10.1007/s00442-004-1698-9; Sinsabaugh RL, 2010, SOIL BIOL BIOCHEM, V42, P391, DOI 10.1016/j.soilbio.2009.10.014; Sutton MA, 2008, GLOBAL CHANGE BIOL, V14, P2057, DOI 10.1111/j.1365-2486.2008.01636.x; Svedruzic D, 2005, ARCH BIOCHEM BIOPHYS, V433, P176, DOI 10.1016/j.abb.2004.08.032; Tian XJ, 2000, EUR J SOIL BIOL, V36, P81, DOI 10.1016/S1164-5563(00)01049-9; Ullrich R, 2005, FEBS LETT, V579, P6247, DOI 10.1016/j.febslet.2005.10.014; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; VANDERWOUDE MW, 1993, ARCH MICROBIOL, V160, P1; Zak DR, 2008, ECOL APPL, V18, P2016, DOI 10.1890/07-1743.1	55	75	76	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10971	10.1371/journal.pone.0010971	http://dx.doi.org/10.1371/journal.pone.0010971			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532045	Green Published, gold, Green Submitted			2022-12-27	WOS:000278380500015
J	Vellaichamy, A; Dezso, Z; JeBailey, L; Chinnaiyan, AM; Sreekumar, A; Nesvizhskii, AI; Omenn, GS; Bugrim, A				Vellaichamy, Adaikkalam; Dezso, Zoltan; JeBailey, Lellean; Chinnaiyan, Arul M.; Sreekumar, Arun; Nesvizhskii, Alexey I.; Omenn, Gilbert S.; Bugrim, Andrej			"Topological Significance" Analysis of Gene Expression and Proteomic Profiles from Prostate Cancer Cells Reveals Key Mechanisms of Androgen Response	PLOS ONE			English	Article							GROWTH-FACTOR; BINDING-PROTEIN; RECEPTOR EXPRESSION; MESSENGER-RNA; PATHWAY; ANTIGEN; LNCAP; MICROARRAY; ENRICHMENT; BETA	Background: The problem of prostate cancer progression to androgen independence has been extensively studied. Several studies systematically analyzed gene expression profiles in the context of biological networks and pathways, uncovering novel aspects of prostate cancer. Despite significant research efforts, the mechanisms underlying tumor progression are poorly understood. We applied a novel approach to reconstruct system-wide molecular events following stimulation of LNCaP prostate cancer cells with synthetic androgen and to identify potential mechanisms of androgen-independent progression of prostate cancer. Methodology/Principal Findings: We have performed concurrent measurements of gene expression and protein levels following the treatment using microarrays and iTRAQ proteomics. Sets of up-regulated genes and proteins were analyzed using our novel concept of "topological significance''. This method combines high-throughput molecular data with the global network of protein interactions to identify nodes which occupy significant network positions with respect to differentially expressed genes or proteins. Our analysis identified the network of growth factor regulation of cell cycle as the main response module for androgen treatment in LNCap cells. We show that the majority of signaling nodes in this network occupy significant positions with respect to the observed gene expression and proteomic profiles elicited by androgen stimulus. Our results further indicate that growth factor signaling probably represents a "second phase'' response, not directly dependent on the initial androgen stimulus. Conclusions/Significance: We conclude that in prostate cancer cells the proliferative signals are likely to be transmitted from multiple growth factor receptors by a multitude of signaling pathways converging on several key regulators of cell proliferation such as c-Myc, Cyclin D and CREB1. Moreover, these pathways are not isolated but constitute an interconnected network module containing many alternative routes from inputs to outputs. If the whole network is involved, a precisely formulated combination therapy may be required to fight the tumor growth effectively.	[Vellaichamy, Adaikkalam; Chinnaiyan, Arul M.; Sreekumar, Arun; Nesvizhskii, Alexey I.; Omenn, Gilbert S.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Vellaichamy, Adaikkalam; Chinnaiyan, Arul M.; Sreekumar, Arun; Nesvizhskii, Alexey I.; Omenn, Gilbert S.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Vellaichamy, Adaikkalam; Chinnaiyan, Arul M.; Sreekumar, Arun; Nesvizhskii, Alexey I.; Omenn, Gilbert S.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI USA; [Dezso, Zoltan; JeBailey, Lellean; Bugrim, Andrej] GeneGo Inc, St Joseph, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Vellaichamy, A (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.	andrej@genego.com	Nesvizhskii, Alexey/A-5410-2012; Vellaichamy, Adaikkalam/GWN-0713-2022	Nesvizhskii, Alexey/0000-0002-2806-7819; Vellaichamy, Adaikkalam/0000-0002-1740-1252; Omenn, Gilbert S./0000-0002-8976-6074	Michigan Proteomic Alliance for Cancer Research; National Institutes of Health (NIH) [CA134175-01, R01CA126239]; GeneGo, Inc; NATIONAL CANCER INSTITUTE [R01CA133458, R01CA126239, R43CA134175, R44CA134175] Funding Source: NIH RePORTER	Michigan Proteomic Alliance for Cancer Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GeneGo, Inc; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Michigan Proteomic Alliance for Cancer Research by National Institutes of Health (NIH) grant CA134175-01, grant R01CA126239 and by GeneGo, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boddy JL, 2005, CLIN CANCER RES, V11, P7658, DOI 10.1158/1078-0432.CCR-05-0460; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Cox B, 2005, METHODS, V35, P303, DOI 10.1016/j.ymeth.2004.08.021; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Dezso Z, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-36; Dozmorov MG, 2009, PROSTATE, V69, P1077, DOI 10.1002/pros.20960; Ergun A, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100125; Fan WQ, 2007, J BIOL CHEM, V282, P7329, DOI 10.1074/jbc.M610447200; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Greenbaum D, 2002, BIOINFORMATICS, V18, P585, DOI 10.1093/bioinformatics/18.4.585; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kim J, 2005, J MOL ENDOCRINOL, V34, P107, DOI 10.1677/jme.1.01701; Krueckl SL, 2004, CANCER RES, V64, P8620, DOI 10.1158/0008-5472.CAN-04-2446; Maeda H, 2009, BIOCHEM BIOPH RES CO, V381, P311, DOI 10.1016/j.bbrc.2009.01.096; Memarzadeh S, 2007, CANCER CELL, V12, P572, DOI 10.1016/j.ccr.2007.11.002; Ngan S, 2009, ONCOGENE, V28, P2051, DOI 10.1038/onc.2009.68; Okabe E, 1999, FEBS LETT, V447, P87, DOI 10.1016/S0014-5793(99)00275-6; Oosterhoff JK, 2005, ENDOCR-RELAT CANCER, V12, P135, DOI 10.1677/erc.1.00897; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Persad S, 2000, P NATL ACAD SCI USA, V97, P3207, DOI 10.1073/pnas.060579697; Rehault S, 2001, EUR J BIOCHEM, V268, P2960, DOI 10.1046/j.1432-1327.2001.02185.x; Rosini P, 2002, PROSTATE, V53, P310, DOI 10.1002/pros.10164; Sartor MA, 2009, BIOINFORMATICS, V25, P211, DOI 10.1093/bioinformatics/btn592; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Singh AP, 2008, CANCER LETT, V259, P28, DOI 10.1016/j.canlet.2007.09.018; Sorlie T, 2004, EUR J CANCER, V40, P2667, DOI 10.1016/j.ejca.2004.08.021; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sutkowski DM, 1999, JNCI-J NATL CANCER I, V91, P1663, DOI 10.1093/jnci/91.19.1663; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Vellaichamy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007075; Waters Katrina M., 2006, Briefings in Functional Genomics & Proteomics, V5, P261, DOI 10.1093/bfgp/ell019; Zhu B, 2005, CANC TREAT, V126, P157, DOI 10.1007/0-387-24361-5_7; Zhu ML, 2008, PROSTATE, V68, P287, DOI 10.1002/pros.20698	35	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10936	10.1371/journal.pone.0010936	http://dx.doi.org/10.1371/journal.pone.0010936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532174	Green Published, Green Submitted, gold			2022-12-27	WOS:000278318700010
J	Oberbach, A; Schlichting, N; Bluher, M; Kovacs, P; Till, H; Stolzenburg, JU; Neuhaus, J				Oberbach, Andreas; Schlichting, Nadine; Blueher, Matthias; Kovacs, Peter; Till, Holger; Stolzenburg, Jens-Uwe; Neuhaus, Jochen			Palmitate Induced IL-6 and MCP-1 Expression in Human Bladder Smooth Muscle Cells Provides a Link between Diabetes and Urinary Tract Infections	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NECROSIS-FACTOR-ALPHA; FACTOR-KAPPA-B; 3T3-L1 ADIPOCYTES; INSULIN-RESISTANCE; FATTY-ACIDS; TRANSCRIPTION FACTOR; INTERLEUKIN-6; DISEASE; ATHEROSCLEROSIS	Background: Urinary tract infections (UTI) are more frequent in type-2 diabetes mellitus patients than in subjects with normal glucose metabolism. The mechanisms underlying this higher prevalence of UTI are unknown. However, cytokine levels are altered in diabetic patients and may thus contribute to the development of UTI. Increased levels of free fatty acids (FFA), as observed in obese patients, can induce IL-6 production in various cell types. Therefore we studied the effects of the free fatty acid palmitate and bacterial lipopolysaccharide (LPS) on interleukin-6 (IL-6) and monocyte chemotactic protein-1 (MCP-1) expression and secretion in cultured human bladder smooth muscle cells (hBSMC). Methodology/Principal Findings: Biopsies were taken from patients undergoing cystectomy due to bladder cancer. Palmitate or LPS stimulated hBSMC were analysed for the production and secretion of the IL-6, gp80, gp80soluble, gp130, MCP-1, pSTAT3, SOCS3, NF-kappa B and SHP2 by quantitative PCR, ELISA, Western blotting, and confocal immunofluorescence. In signal transduction inhibition experiments we evaluated the involvement of NF-kB and MEK1 in IL-6 and MCP-1 regulation. Palmitate upregulates IL-6 mRNA expression and secretion via NF-kB dependent pathways in a concentration-and time-dependent manner. MCP-1 was moderately upregulated by palmitate but was strongly upregulated by LPS involving NF-kB and MEK1 dependent pathways. Soluble IL-6 receptor (gp80soluble) was downregulated by palmitate and LPS, while membrane-bound gp80 was moderately upregulated. LPS increased SOCS3 and SHP2, whereas palmitate only induced SOCS3. Secondary finding: most of the IL-6 is secreted. Conclusions/Significance: Bacterial infection (LPS) or metabolic alterations (palmitate) have distinct effects on IL-6 expression in hBSMC, (i) short term LPS induced autocrine JAK/STAT signaling and (ii) long-term endocrine regulation of IL-6 by palmitate. Induction of IL-6 in human bladder smooth muscle cells by fatty acids may represent a pathogenetic factor underlying the higher frequency and persistence of urinary tract infections in patients with metabolic diseases.	[Oberbach, Andreas; Schlichting, Nadine; Blueher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany; [Kovacs, Peter] Univ Leipzig, Fac Med, Interdisciplinary Ctr Clin Res, Leipzig, Germany; [Till, Holger] Univ Leipzig, Dept Pediat Surg, Leipzig, Germany; [Schlichting, Nadine; Stolzenburg, Jens-Uwe; Neuhaus, Jochen] Univ Leipzig, Dept Urol, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Oberbach, A (corresponding author), Univ Leipzig, Dept Med, Leipzig, Germany.	jochen.neuhaus@medizin.uni-leipzig.de		Kovacs, Peter/0000-0002-0290-5423	Deutsche Forschungsgemeinschaft (DFG) [BL 580/3-1]; Clinical Research group "Atherobesity'' [KFO 152, BL 833/1-1]; Interdisciplinary Centre of Clinical Research (IZKF), University of Leipzig [N06, B24]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Clinical Research group "Atherobesity''(German Research Foundation (DFG)); Interdisciplinary Centre of Clinical Research (IZKF), University of Leipzig	This work was supported by grants from Deutsche Forschungsgemeinschaft (DFG) BL 580/3-1 (MB), the Clinical Research group "Atherobesity'' KFO 152: project BL 833/1-1 (MB), the Interdisciplinary Centre of Clinical Research (IZKF) Leipzig at the Faculty of Medicine of the University of Leipzig (Project N06 to PK and project B24 to MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuwon KM, 2005, J NUTR, V135, P1841, DOI 10.1093/jn/135.8.1841; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Benfield T, 2007, DIABETOLOGIA, V50, P549, DOI 10.1007/s00125-006-0570-3; Bouchelouche K, 2006, UROLOGY, V67, P214, DOI 10.1016/j.urology.2005.07.049; Bouchelouche K, 2006, J UROLOGY, V175, P760, DOI 10.1016/S0022-5347(05)00167-9; Chakrabarti SK, 2009, OBESITY, V17, P1657, DOI 10.1038/oby.2009.192; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Davis JE, 2009, HORM METAB RES, V41, P523, DOI 10.1055/s-0029-1202852; Eitel K, 2003, DIABETES, V52, P991, DOI 10.2337/diabetes.52.4.991; Festa A, 2002, DIABETIC MED, V19, P939, DOI 10.1046/j.1464-5491.2002.00824.x; Geerlings SE, 2000, DIABETES CARE, V23, P1737, DOI 10.2337/diacare.23.12.1737; Harding GKM, 2002, NEW ENGL J MED, V347, P1576, DOI 10.1056/NEJMoa021042; Hoepelman AIM, 2003, INT J ANTIMICROB AG, V22, pS35, DOI 10.1016/S0924-8579(03)00234-6; Ishikado A, 2009, ATHEROSCLEROSIS, V205, P404, DOI 10.1016/j.atherosclerosis.2009.01.010; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Lim JH, 2009, EXP MOL MED, V41, P757, DOI 10.3858/emm.2009.41.10.082; Otto G, 1999, J INFECT DIS, V179, P172, DOI 10.1086/314534; Reape TJ, 1999, ATHEROSCLEROSIS, V147, P213, DOI 10.1016/S0021-9150(99)00346-9; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Saban MR, 2001, PHYSIOL GENOMICS, V5, P147, DOI 10.1152/physiolgenomics.2001.5.3.147; Schneeberger C, 2008, DIABETES CARE, V31, P1380, DOI 10.2337/dc07-2188; Staiger H, 2004, DIABETES, V53, P3209, DOI 10.2337/diabetes.53.12.3209; Stampfer MJ, 1996, JAMA-J AM MED ASSOC, V275, P1929, DOI 10.1001/jama.275.24.1929; Stapleton A, 2002, AM J MED, V113, p80S; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Wilding JPH, 2007, DIABETIC MED, V24, P934, DOI 10.1111/j.1464-5491.2007.02186.x; Yerneni KKV, 1999, DIABETES, V48, P855, DOI 10.2337/diabetes.48.4.855; Yohannes E, 2008, MOL CELL PROTEOMICS, V7, P1270, DOI 10.1074/mcp.M700563-MCP200; Zhao S, 2004, J CELL PHYSIOL, V199, P47, DOI 10.1002/jcp.10453	31	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10882	10.1371/journal.pone.0010882	http://dx.doi.org/10.1371/journal.pone.0010882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526368	gold, Green Published, Green Submitted			2022-12-27	WOS:000278222100011
J	Cervello, I; Gil-Sanchis, C; Mas, A; Delgado-Rosas, F; Martinez-Conejero, JA; Galan, A; Martinez-Romero, A; Martinez, S; Navarro, I; Ferro, J; Horcajadas, JA; Esteban, FJ; O'Connor, JE; Pellicer, A; Simon, C				Cervello, Irene; Gil-Sanchis, Claudia; Mas, Aymara; Delgado-Rosas, Francisco; Antonio Martinez-Conejero, Jose; Galan, Amparo; Martinez-Romero, Alicia; Martinez, Sebastian; Navarro, Ismael; Ferro, Jaime; Antonio Horcajadas, Jose; Jose Esteban, Francisco; Enrique O'Connor, Jose; Pellicer, Antonio; Simon, Carlos			Human Endometrial Side Population Cells Exhibit Genotypic, Phenotypic and Functional Features of Somatic Stem Cells	PLOS ONE			English	Article							STROMAL CELLS; EXPRESSION; IDENTIFICATION; MARKERS; CLONOGENICITY; PROFILE; GENES	During reproductive life, the human endometrium undergoes around 480 cycles of growth, breakdown and regeneration should pregnancy not be achieved. This outstanding regenerative capacity is the basis for women's cycling and its dysfunction may be involved in the etiology of pathological disorders. Therefore, the human endometrial tissue must rely on a remarkable endometrial somatic stem cells (SSC) population. Here we explore the hypothesis that human endometrial side population (SP) cells correspond to somatic stem cells. We isolated, identified and characterized the SP corresponding to the stromal and epithelial compartments using endometrial SP genes signature, immunophenotyping and characteristic telomerase pattern. We analyzed the clonogenic activity of SP cells under hypoxic conditions and the differentiation capacity in vitro to adipogenic and osteogenic lineages. Finally, we demonstrated the functional capability of endometrial SP to develop human endometrium after subcutaneous injection in NOD-SCID mice. Briefly, SP cells of human endometrium from epithelial and stromal compartments display genotypic, phenotypic and functional features of SSC.	[Cervello, Irene; Gil-Sanchis, Claudia; Mas, Aymara; Delgado-Rosas, Francisco; Antonio Martinez-Conejero, Jose; Martinez-Romero, Alicia; Martinez, Sebastian; Navarro, Ismael; Ferro, Jaime; Antonio Horcajadas, Jose; Pellicer, Antonio; Simon, Carlos] Univ Valencia, Fdn IVI, Inst Univ IVI, Valencia, Spain; [Cervello, Irene; Gil-Sanchis, Claudia; Mas, Aymara; Galan, Amparo; Simon, Carlos] CIPF, Valencia Stem Cell Bank, Valencia, Spain; [Antonio Martinez-Conejero, Jose; Antonio Horcajadas, Jose] iGenomix, Valencia, Spain; [Martinez-Romero, Alicia; Enrique O'Connor, Jose] CIPF, Lab Cyt, Valencia, Spain; [Jose Esteban, Francisco] Univ Jaen, Dept Expt Biol, Syst Biol Unit, Jaen, Spain; [Pellicer, Antonio] Hosp Univ La Fe, Dept Obstet & Gynecol, Valencia, Spain	University of Valencia; Prince Felipe Research Center; Prince Felipe Research Center; Universidad de Jaen; Hospital Universitari i Politecnic La Fe	Cervello, I (corresponding author), Univ Valencia, Fdn IVI, Inst Univ IVI, Valencia, Spain.	csimon@ivi.es	MARTINEZ, ANTONIO PELLICER/C-4832-2015; Martinez-Conejero, José/G-6979-2016; Mas, Aymara/E-4409-2018; Simon, Carlos/G-2186-2014; Galán, Amparo/ABG-8474-2020; Pellicer, Antonio/AAA-6005-2020; Esteban, Francisco J./H-5504-2015; Martínez-Romero, Alicia/ABH-3160-2020	Martinez-Conejero, José/0000-0002-6770-4702; Simon, Carlos/0000-0003-0902-9531; Galán, Amparo/0000-0003-4265-8516; Pellicer, Antonio/0000-0002-8254-863X; Esteban, Francisco J./0000-0002-7135-2973; Martínez-Romero, Alicia/0000-0002-5197-0635; Mas, Aymara/0000-0002-5866-6732; Cervello, Irene/0000-0003-4801-5538; Cervello, Irene/0000-0002-7018-4971	Spanish Ministry of Science and Innovation [SAF 2004-00204, SAF 2008-02048]; Regional Valencian Ministry of Education [PROMETEO/2008/163]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Valencian Ministry of Education	This work has been funded by grants SAF 2004-00204, SAF 2008-02048 supported by the Spanish Ministry of Science and Innovation (PI: C. S.), and by PROMETEO/2008/163 (PI: C. S.) supported by the Regional Valencian Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The company iGenomix has no competing interest related to patents or products.	Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Cervello I, 2007, HUM REPROD, V22, P45, DOI 10.1093/humrep/del332; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; Chan RWS, 2004, BIOL REPROD, V70, P1738, DOI 10.1095/biolreprod.103.024109; Cho NH, 2004, FERTIL STERIL, V81, P403, DOI 10.1016/j.fertnstert.2003.07.015; CHOI YH, 2009, INT J BIOCH CELL BIO; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dimitrov R, 2008, REPRODUCTION, V135, P551, DOI 10.1530/REP-07-0428; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Flasza M, 2003, CLONING STEM CELLS, V5, P339, DOI 10.1089/153623003772032844; Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008; Gage FH, 2000, BIOL PSYCHIAT, V48, DOI 10.1016/S0006-3223(00)01019-2; Gargett CE, 2007, HUM REPROD UPDATE, V13, P87, DOI 10.1093/humupd/dml045; Gotte M, 2008, J PATHOL, V215, P317, DOI 10.1002/path.2364; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Huang L, 2004, BONE, V34, P393, DOI 10.1016/j.bone.2003.10.013; Iohara K, 2008, STEM CELLS, V26, P2408, DOI 10.1634/stemcells.2008-0393; JAKS V, 2008, COLD SPRING HARB S Q; Jones RL, 2006, REPRODUCTION, V132, P217, DOI 10.1530/rep.1.01076; Kato K, 2007, HUM REPROD, V22, P1214, DOI 10.1093/humrep/del514; Kato K, 2010, AM J PATHOL, V176, P381, DOI 10.2353/ajpath.2010.090056; Kim CG, 2006, MOL CELLS, V21, P343; Larderet G, 2006, STEM CELLS, V24, P965, DOI 10.1634/stemcells.2005-0196; Li SX, 2008, INDIAN J MED RES, V127, P453; Martin U, 2008, METHODS, V45, P121, DOI 10.1016/j.ymeth.2008.05.009; Matthai C, 2006, MOL HUM REPROD, V12, P7, DOI 10.1093/molehr/gah254; Meng XL, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-57; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Ono M, 2007, P NATL ACAD SCI USA, V104, P18700, DOI 10.1073/pnas.0704472104; Padykula HA, 1991, ANN N Y ACAD SCI, V622, P47, DOI 10.1111/j.1749-6632.1991.tb37849.x; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2; Popovici RM, 1999, J CLIN ENDOCR METAB, V84, P2245, DOI 10.1210/jc.84.6.2245; PRIANISHNIKOV VA, 1978, CONTRACEPTION, V18, P213, DOI 10.1016/S0010-7824(78)80015-8; PROCKOP DJ, 1997, SCIENCE, V276, P71, DOI [DOI 10.1126/SCIENCE.276.5309.71, 10.1126/science.276.5309.71]; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sales-Pardo I, 2006, BLOOD, V108, P1774, DOI 10.1182/blood-2006-03-013615; Schwab KE, 2008, HUM REPROD, V23, P934, DOI 10.1093/humrep/den051; Schwab KE, 2007, HUM REPROD, V22, P2903, DOI 10.1093/humrep/dem265; Schwab KE, 2005, FERTIL STERIL, V84, P1124, DOI 10.1016/j.fertnstert.2005.02.056; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; SIMON C, 1993, J CLIN ENDOCR METAB, V77, P549, DOI 10.1210/jc.77.2.549; Taylor HS, 2004, JAMA-J AM MED ASSOC, V292, P81, DOI 10.1001/jama.292.1.81; Terunuma A, 2003, J INVEST DERMATOL, V121, P1095, DOI 10.1046/j.1523-1747.2003.12531.x; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Tsuji S, 2008, FERTIL STERIL, V90, P1528, DOI 10.1016/j.fertnstert.2007.08.005; Valbuena D, 2006, REPROD BIOMED ONLINE, V13, P875, DOI 10.1016/S1472-6483(10)61038-3; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Witten I. H., 2005, DATA MINING PRACTICA; Yajima T, 2009, INT J ONCOL, V35, P273, DOI 10.3892/ijo_00000337; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	55	137	150	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e10964	10.1371/journal.pone.0010964	http://dx.doi.org/10.1371/journal.pone.0010964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585575	Green Published, Green Submitted, gold			2022-12-27	WOS:000279135800001
J	Nieto, C; Sadowy, E; de la Campa, AG; Hryniewicz, W; Espinosa, M				Nieto, Concha; Sadowy, Ewa; de la Campa, Adela G.; Hryniewicz, Waleria; Espinosa, Manuel			The relBE2Spn Toxin-Antitoxin System of Streptococcus pneumoniae: Role in Antibiotic Tolerance and Functional Conservation in Clinical Isolates	PLOS ONE			English	Article							MESSENGER-RNA INTERFERASE; PROGRAMMED CELL-DEATH; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; SERINE HYDROXAMATE; VIBRIO-CHOLERAE; CATALYTIC SITE; PLASMID; LOCI; STRESS	Type II (proteic) chromosomal toxin-antitoxin systems (TAS) are widespread in Bacteria and Archaea but their precise function is known only for a limited number of them. Out of the many TAS described, the relBE family is one of the most abundant, being present in the three first sequenced strains of Streptococcus pneumoniae (D39, TIGR4 and R6). To address the function of the pneumococcal relBE2Spn TAS in the bacterial physiology, we have compared the response of the R6-relBE2Spn wild type strain with that of an isogenic derivative, Delta relB2Spn under different stress conditions such as carbon and amino acid starvation and antibiotic exposure. Differences on viability between the wild type and mutant strains were found only when treatment directly impaired protein synthesis. As a criterion for the permanence of this locus in a variety of clinical strains, we checked whether the relBE2Spn locus was conserved in around 100 pneumococcal strains, including clinical isolates and strains with known genomes. All strains, although having various types of polymorphisms at the vicinity of the TA region, contained a functional relBE2Spn locus and the type of its structure correlated with the multilocus sequence type. Functionality of this TAS was maintained even in cases where severe rearrangements around the relBE2Spn region were found. We conclude that even though the relBE2Spn TAS is not essential for pneumococcus, it may provide additional advantages to the bacteria for colonization and/or infection.	[Nieto, Concha; Espinosa, Manuel] CSIC, Ctr Invest Biol, Madrid, Spain; [Sadowy, Ewa; Hryniewicz, Waleria] Natl Med Inst, Warsaw, Poland; [de la Campa, Adela G.] Inst Salud Carlos III, Ctr Nacl Microbiol, Majadahonda, Spain; [de la Campa, Adela G.] Inst Salud Carlos III, CIBER Enfermedades Resp, Majadahonda, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); National Medicines Institute Lekow (NIL); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Nieto, C (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	mespinosa@cib.csic.es	Hryniewicz, Waleria/J-3168-2012; de la Campa, Adela G/K-1654-2014; Espinosa, Manuel/M-5282-2019; Sadowy, Ewa/U-7930-2018; Nieto, Concha/ABG-2127-2020	de la Campa, Adela G/0000-0002-3598-2548; Sadowy, Ewa/0000-0003-0284-6440; Nieto, Concha/0000-0003-0790-3440	European Union (EU) [CP223111]; Comunidad de Madrid [CM-BIO0260-2006]; Spanish Ministry of Science and Innovation [BIO2008-02154, BFU2007-63575, CSD-2008-00013]	European Union (EU)(CGIAREuropean Commission); Comunidad de Madrid(Comunidad de Madrid); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The research was performed under a collaborative project financed by the European Union (EU-CP223111, CAREPNEUMO, to M. E., E. S. and W. H.), by the Comunidad de Madrid (CM-BIO0260-2006, COMBACT, to M. E. and A. G. C.), and by the Spanish Ministry of Science and Innovation (Grants BIO2008-02154 to A. G. C, and BFU2007-63575 and CSD-2008-00013, INTERMODS, to M. E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebo P, 1996, FEMS MICROBIOL LETT, V140, P85; BRAVO A, 1988, MOL GEN GENET, V215, P146, DOI 10.1007/BF00331316; Budde PP, 2007, J BACTERIOL, V189, P491, DOI 10.1128/JB.00909-06; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Condon C, 2006, MOL MICROBIOL, V61, P573, DOI 10.1111/j.1365-2958.2006.05270.x; De Bast MS, 2008, J BACTERIOL, V190, P4603, DOI 10.1128/JB.00357-08; de la Campa AG, 2009, EMERG INFECT DIS, V15, P905, DOI 10.3201/eid1506.080684; de la Campa AG, 2004, EMERG INFECT DIS, V10, P1751, DOI 10.3201/eid1010.040382; Diago-Navarro E, 2009, FEBS J, V276, P4973, DOI 10.1111/j.1742-4658.2009.07199.x; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Fico S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-259; Francuski D, 2009, J MOL BIOL, V393, P898, DOI 10.1016/j.jmb.2009.08.048; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GIUDICELLI S, 1984, J BACTERIOL, V158, P1188, DOI 10.1128/JB.158.3.1188-1190.1984; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; Gupta A, 2009, FEMS MICROBIOL LETT, V290, P45, DOI 10.1111/j.1574-6968.2008.01400.x; Hanage WP, 2009, SCIENCE, V324, P1454, DOI 10.1126/science.1171908; Jones BV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-46; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kamphuis MB, 2006, J MOL BIOL, V357, P115, DOI 10.1016/j.jmb.2005.12.033; Khoo SK, 2007, J BIOL CHEM, V282, P19606, DOI 10.1074/jbc.M701703200; Kim YH, 2009, J BACTERIOL, V191, P1258, DOI 10.1128/JB.01465-08; Kolodkin-Gal I, 2006, J BACTERIOL, V188, P3420, DOI 10.1128/JB.188.9.3420-3423.2006; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; Kolodkin-Gal I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006785; Kolodkin-Gal I, 2008, PLOS BIOL, V6, P2774, DOI 10.1371/journal.pbio.0060319; LACKS S, 1968, GENETICS, V60, P685; Lemonnier M, 2003, NUCLEIC ACIDS RES, V31, P3918, DOI 10.1093/nar/gkg463; Li GY, 2006, J MOL BIOL, V357, P139, DOI 10.1016/j.jmb.2005.12.035; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Maniatis T., 1982, MOL CLONING; Mankin AS, 2008, CURR OPIN MICROBIOL, V11, P414, DOI 10.1016/j.mib.2008.08.003; Martner A, 2008, INFECT IMMUN, V76, P4079, DOI 10.1128/IAI.01747-07; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; Meinhart A, 2003, P NATL ACAD SCI USA, V100, P1661, DOI 10.1073/pnas.0434325100; Mine N, 2009, GENETICS, V181, P1557, DOI 10.1534/genetics.108.095190; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; NEUBAUER C, 2009, RELE CELL, V139, P1084; Nieto C, 2006, MOL MICROBIOL, V59, P1280, DOI 10.1111/j.1365-2958.2006.05027.x; Nieto C, 2007, J BACTERIOL, V189, P1266, DOI 10.1128/JB.01130-06; Oggioni MR, 1999, MICROBIOL-SGM, V145, P2647, DOI 10.1099/00221287-145-10-2647; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; PUYET A, 1993, J MOL BIOL, V230, P800, DOI 10.1006/jmbi.1993.1202; Sadowy E, 2006, CLIN VACCINE IMMUNOL, V13, P139, DOI 10.1128/CVI.13.1.139-144.2006; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; Szekeres S, 2007, MOL MICROBIOL, V63, P1588, DOI 10.1111/j.1365-2958.2007.05613.x; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; TOSA T, 1971, J BACTERIOL, V106, P972, DOI 10.1128/JB.106.3.972-982.1971; TOSA T, 1971, J BACTERIOL, V106, P966, DOI 10.1128/JB.106.3.966-971.1971; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; WOZNIAK RAF, 2009, PLOS GENET; ZHOU LX, 1995, PLASMID, V33, P127, DOI 10.1006/plas.1995.1014	62	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11289	10.1371/journal.pone.0011289	http://dx.doi.org/10.1371/journal.pone.0011289			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585658	gold, Green Published, Green Submitted			2022-12-27	WOS:000279135400030
J	Sanchez-Blazquez, P; Rodriguez-Munoz, M; Garzon, J				Sanchez-Blazquez, Pilar; Rodriguez-Munoz, Maria; Garzon, Javier			Mu-Opioid Receptors Transiently Activate the Akt-nNOS Pathway to Produce Sustained Potentiation of PKC-Mediated NMDAR-CaMKII Signaling	PLOS ONE			English	Article							PROTEIN-KINASE-II; NITRIC-OXIDE SYNTHASE; D-ASPARTATE RECEPTORS; G-ALPHA-SUBUNITS; MORPHINE ANTINOCICEPTIVE TOLERANCE; PERIAQUEDUCTAL GRAY-MATTER; RAT NEONATAL ASTROCYTES; DORSAL-HORN; SPINAL-CORD; GLUTAMATE RECEPTORS	Background: In periaqueductal grey (PAG) matter, cross-talk between the Mu-opioid receptor (MOR) and the glutamate N-methyl-D-Aspartate receptor (NMDAR)-CaMKII pathway supports the development of analgesic tolerance to morphine. In neurons, histidine triad nucleotide binding protein 1 (HINT1) connects the regulators of G protein signaling RGSZ1 and RGSZ2 to the C terminus of the MOR. In response to morphine, this HINT1-RGSZ complex binds PKC gamma, and afterwards, the interplay between PKC gamma, Src and Gz/Gi proteins leads to sustained potentiation of NMDAR-mediated glutamate responses. Methodology/Principal Findings: Following an intracerebroventricular (icv) injection of 10 nmol morphine, Akt was recruited to the synaptosomal membrane and activated by Thr308 and Ser473 phosphorylation. The Akt activation was immediately transferred to neural Nitric Oxide Synthase (nNOS) Ser1417. Afterwards, nitric oxide (NO)-released zinc ions recruited PKC gamma to the MOR to promote the Src-mediated phosphorylation of the Tyr1325 NMDAR2A subunit. This action increased NMDAR calcium flux and CaMKII was activated in a calcium-calmodulin dependent manner. CaMKII then acted on nNOS Ser847 to produce a sustained reduction in NO levels. The activation of the Akt-nNOS pathway was also reduced by the binding of these proteins to the MOR-HINT1 complex where they remained inactive. Tolerance to acute morphine developed as a result of phosphorylation of MOR cytosolic residues, uncoupling from the regulated G proteins which are transferred to RGSZ2 proteins. The diminished effect of morphine was prevented by LNNA, an inhibitor of nNOS function, and naltrindole, a delta-opioid receptor antagonist that also inhibits Akt. Conclusions/Significance: Analysis of the regulatory phosphorylation of the proteins included in the study indicated that morphine produces a transient activation of the Akt/PKB-nNOS pathway. This activation occurs upstream of PKC gamma and Src mediated potentiation of NMDAR activity, ultimately leading to morphine tolerance. In summary, the Akt-nNOS pathway acts as a primer for morphine-triggered events which leads to the sustained potentiation of the NMDAR-CaMKII pathway and MOR inhibition.	[Sanchez-Blazquez, Pilar; Garzon, Javier] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Sanchez-Blazquez, Pilar; Rodriguez-Munoz, Maria; Garzon, Javier] ISCII, CIBER Mental Hlth CIBERSAM, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Sanchez-Blazquez, P (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.	jgarzon@cajal.csic.es		Garzon, Javier/0000-0002-0053-258X; Rodriguez-Munoz, Maria/0000-0001-6611-8050; Sanchez Blazquez, Pilar/0000-0002-7211-4504	Instituto de Salud Carlos III (ISCIII); Fondo de Investigacion Sanitaria (FIS) [PI080417, PS09/00332]; Center for Biomedical Research in Mental Health Network (CIBERSAM)	Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Center for Biomedical Research in Mental Health Network (CIBERSAM)	The research was supported by the Instituto de Salud Carlos III (ISCIII), Fondo de Investigacion Sanitaria (FIS) PI080417 (Pilar Sanchez-Blazquez) and PS09/00332 (Javier Garzon). Maria Rodriguez-Munoz is currently supported by a Center for Biomedical Research in Mental Health Network (CIBERSAM) contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajit SK, 2007, CELL SIGNAL, V19, P723, DOI 10.1016/j.cellsig.2006.09.008; Ali DW, 2001, CURR OPIN NEUROBIOL, V11, P336, DOI 10.1016/S0959-4388(00)00216-6; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; BARBARO NM, 1988, PROG BRAIN RES, V77, P165; Barbier E, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-132; Bittar RG, 2005, J CLIN NEUROSCI, V12, P515, DOI 10.1016/j.jocn.2004.10.005; Bleakman D, 2006, SEMIN CELL DEV BIOL, V17, P592, DOI 10.1016/j.semcdb.2006.10.008; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; BOUHASSIRA D, 1988, J PHARMACOL EXP THER, V247, P332; Brenner GJ, 2004, EUR J NEUROSCI, V20, P375, DOI 10.1111/j.1460-9568.2004.03506.x; Chakravarthy B, 1999, TRENDS NEUROSCI, V22, P12, DOI 10.1016/S0166-2236(98)01288-0; Charlton JJ, 2008, NEURON, V58, P238, DOI 10.1016/j.neuron.2008.02.006; CHEN L, 1991, NEURON, V7, P319, DOI 10.1016/0896-6273(91)90270-A; Chen YL, 2004, CANCER RES, V64, P8723, DOI 10.1158/0008-5472.CAN-03-3091; Chen YL, 2006, J NEUROIMMUNE PHARM, V1, P270, DOI 10.1007/s11481-006-9028-0; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; ELLIOTT K, 1994, PAIN, V56, P69, DOI 10.1016/0304-3959(94)90151-1; Fan GH, 1999, MOL PHARMACOL, V56, P39, DOI 10.1124/mol.56.1.39; FIELDS HL, 1988, PROG BRAIN RES, V77, P245; Fiorentini C, 2003, J BIOL CHEM, V278, P20196, DOI 10.1074/jbc.M213140200; Garzon J, 2005, NEUROPSYCHOPHARMACOL, V30, P1632, DOI 10.1038/sj.npp.1300726; Garzon J, 2005, NEUROPHARMACOLOGY, V48, P853, DOI 10.1016/j.neuropharm.2005.01.004; Garzon J, 2005, J BIOL CHEM, V280, P8951, DOI 10.1074/jbc.M407005200; Garzon Javier, 2008, Curr Drug Abuse Rev, V1, P222; GEBHART GF, 1988, PROG BRAIN RES, V77, P229; Glass MJ, 2009, NEUROSCIENCE, V163, P857, DOI 10.1016/j.neuroscience.2009.07.020; Grosshans DR, 2001, J NEUROCHEM, V76, P737, DOI 10.1046/j.1471-4159.2001.00034.x; Guang W, 2004, MOL PHARMACOL, V66, P1285, DOI 10.1124/mol.66.5.; Gundelfinger ED, 2006, TRENDS BIOCHEM SCI, V31, P366, DOI 10.1016/j.tibs.2006.05.007; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Hayashi Y, 1999, J BIOL CHEM, V274, P20597, DOI 10.1074/jbc.274.29.20597; Heinricher MM, 2001, PAIN, V92, P129, DOI 10.1016/S0304-3959(00)00480-2; Inoue M, 2003, J NEUROSCI, V23, P6529; Kelker MS, 2007, BIOCHEMISTRY-US, V46, P2333, DOI 10.1021/bi602341c; Kim MS, 2001, BIOCHEM PHARMACOL, V61, P779, DOI 10.1016/S0006-2952(01)00541-X; Kissin I, 2000, ANESTH ANALG, V91, P1483, DOI 10.1097/00000539-200012000-00035; Komeima K, 2000, J BIOL CHEM, V275, P28139; LAZORTHES Y, 1988, PROG BRAIN RES, V77, P395; Lee J, 2004, IMMUNOPHARM IMMUNOT, V26, P17, DOI 10.1081/IPH-120029941; Leonard AS, 1997, J BIOL CHEM, V272, P12107, DOI 10.1074/jbc.272.18.12107; Liang D, 2004, NEUROSCIENCE, V123, P769, DOI 10.1016/j.neuroscience.2003.10.007; Lou LG, 1999, MOL PHARMACOL, V55, P557; Lu L, 2000, NEUROSCI LETT, V291, P191, DOI 10.1016/S0304-3940(00)01352-5; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Luginbuhl M, 2003, ANESTH ANALG, V96, P726, DOI 10.1213/01.ANE.0000048086.58161.18; MANSOUR A, 1988, TRENDS NEUROSCI, V11, P308, DOI 10.1016/0166-2236(88)90093-8; MAO JR, 1995, BRAIN RES, V677, P257, DOI 10.1016/0006-8993(95)00161-I; Marinelli S, 2002, J NEUROSCI, V22, P10847; MORI H, 1995, NEUROPHARMACOLOGY, V34, P1219, DOI 10.1016/0028-3908(95)00109-J; MOSKOWITZ AS, 1984, J NEUROSCI, V4, P1331; Muller DL, 2004, J PHARMACOL EXP THER, V310, P774, DOI 10.1124/jpet.104.066548; NAKANE M, 1991, BIOCHEM BIOPH RES CO, V180, P1396, DOI 10.1016/S0006-291X(05)81351-8; Narita M, 2004, NEUROSCIENCE, V124, P515, DOI 10.1016/j.neuroscience.2003.11.023; Owen SLF, 2007, ACTA NEUROCHIR SUPPL, V97, P111; Patten SA, 2009, P NATL ACAD SCI USA, V106, P6796, DOI 10.1073/pnas.0811171106; Pei L, 2004, J NEUROSCI, V24, P1149, DOI 10.1523/JNEUROSCI.3922-03.2004; Perroy J, 2008, J BIOL CHEM, V283, P6799, DOI 10.1074/jbc.M705661200; PORTOGHESE PS, 1988, EUR J PHARMACOL, V146, P185, DOI 10.1016/0014-2999(88)90502-X; Rameau GA, 2004, J BIOL CHEM, V279, P14307, DOI 10.1074/jbc.M311103200; Rameau GA, 2007, J NEUROSCI, V27, P3445, DOI 10.1523/JNEUROSCI.4799-06.2007; Rodriguez-Munoz M, 2008, CELL SIGNAL, V20, P1855, DOI 10.1016/j.cellsig.2008.06.015; Rodriguez-Munoz M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-19; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sanchez-Blazquez P, 2005, NEUROPHARMACOLOGY, V48, P134, DOI 10.1016/j.neuropharm.2004.08.016; Sanchez-Blazquez P, 2008, NEUROPHARMACOLOGY, V54, P319, DOI 10.1016/j.neuropharm.2007.10.002; Sanchez-Blazquez P, 2009, CELL SIGNAL, V21, P1444, DOI 10.1016/j.cellsig.2009.05.003; SanchezBlazquez P, 1995, J PHARMACOL EXP THER, V275, P1590; Schwindinger WF, 2001, ONCOGENE, V20, P1653, DOI 10.1038/sj.onc.1204181; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Su T, 2003, P NATL ACAD SCI USA, V100, P7824, DOI 10.1073/pnas.1332160100; Tan M, 2003, J NEUROSCI, V23, P10292; Toda N, 2009, ANESTHESIOLOGY, V110, P166, DOI 10.1097/ALN.0b013e31819146a9; TRUJILLO KA, 1991, SCIENCE, V251, P85, DOI 10.1126/science.1824728; Wang ZJJ, 2003, EUR J PHARMACOL, V465, P199, DOI 10.1016/S0014-2999(03)01484-5; YAKSH TL, 1976, BRAIN RES, V114, P83, DOI 10.1016/0006-8993(76)91009-X; Yin DL, 2006, J NEUROIMMUNOL, V174, P101, DOI 10.1016/j.jneuroim.2006.02.001; Zou XJ, 2004, BRAIN RES, V1020, P95, DOI 10.1016/j.brainres.2004.06.017	78	50	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11278	10.1371/journal.pone.0011278	http://dx.doi.org/10.1371/journal.pone.0011278			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585660	Green Submitted, Green Published, gold			2022-12-27	WOS:000279135400022
J	Vieira, ML; Atzingen, MV; Oliveira, TR; Oliveira, R; Andrade, DM; Vasconcellos, SA; Nascimento, ALTO				Vieira, Monica L.; Atzingen, Marina V.; Oliveira, Tatiane R.; Oliveira, Rosane; Andrade, Daniel M.; Vasconcellos, Silvio A.; Nascimento, Ana L. T. O.			In Vitro Identification of Novel Plasminogen-Binding Receptors of the Pathogen Leptospira interrogans	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; BORRELIA-BURGDORFERI; SURFACE PROTEIN; LIPL32; LIPOPROTEIN; ACTIVATION; INFECTION; SEQUENCE; SYSTEM; SERODIAGNOSIS	Background: Leptospirosis is a multisystem disease caused by pathogenic strains of the genus Leptospira. We have reported that Leptospira are able to bind plasminogen (PLG), to generate active plasmin in the presence of activator, and to degrade purified extracellular matrix fibronectin. Methodology/Principal Findings: We have now cloned, expressed and purified 14 leptospiral recombinant proteins. The proteins were confirmed to be surface exposed by immunofluorescence microscopy and were evaluated for their ability to bind plasminogen (PLG). We identified eight as PLG-binding proteins, including the major outer membrane protein LipL32, the previously published rLIC12730, rLIC10494, Lp29, Lp49, LipL40 and MPL36, and one novel leptospiral protein, rLIC12238. Bound PLG could be converted to plasmin by the addition of urokinase-type PLG activator (uPA), showing specific proteolytic activity, as assessed by its reaction with the chromogenic plasmin substrate, D-Val-Leu-Lys 4-nitroanilide dihydrochloride. The addition of the lysine analog 6-aminocaproic acid (ACA) inhibited the protein-PLG interaction, thus strongly suggesting the involvement of lysine residues in plasminogen binding. The binding of leptospiral surface proteins to PLG was specific, dose-dependent and saturable. PLG and collagen type IV competed with LipL32 protein for the same binding site, whereas separate binding sites were observed for plasma fibronectin. Conclusions/Significance: PLG-binding/activation through the proteins/receptors on the surface of Leptospira could help the bacteria to specifically overcome tissue barriers, facilitating its spread throughout the host.	[Vieira, Monica L.; Atzingen, Marina V.; Oliveira, Tatiane R.; Oliveira, Rosane; Andrade, Daniel M.; Nascimento, Ana L. T. O.] Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil; [Vieira, Monica L.; Oliveira, Rosane; Nascimento, Ana L. T. O.] Univ Sao Paulo, Inst Ciencias Biomed, Interunidades Biotecnol, BR-05508 Sao Paulo, Brazil; [Vasconcellos, Silvio A.] Univ Sao Paulo, Fac Med Vet & Zootecnia, Lab Zoonoses Bacterianas VPS, Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo	Vieira, ML (corresponding author), Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil.	tabet@butantan.gov.br	Vieira, Mônica Larucci/D-1634-2012; Nascimento, Ana L. T. O./E-8488-2012; atzingen, marina/F-9266-2013; Vieira, Mônica/AAE-9391-2021	Vieira, Mônica Larucci/0000-0002-4162-8086; Nascimento, Ana L. T. O./0000-0003-4851-0870; atzingen, marina/0000-0002-3276-895X; Vieira, Mônica/0000-0002-4162-8086	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); Fundacao Butantan, Brazil; FAPESP (Brazil)	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Butantan, Brazil; FAPESP (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - www.fapesp.br), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - www.cnpq.br) and Fundacao Butantan, Brazil. MLV, MVA, TRO and RO have fellowships from FAPESP (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Atzingen MV, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-70; ATZINGEN MV, 2009, J INFECT; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; Bergmann S, 2007, THROMB HAEMOSTASIS, V98, P512, DOI 10.1160/TH07-02-0117; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Branger C, 2001, INFECT IMMUN, V69, P6831, DOI 10.1128/IAI.69.11.6831-6838.2001; Brissette CA, 2009, INFECT IMMUN, V77, P300, DOI 10.1128/IAI.01133-08; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Carvalho E, 2009, FEBS LETT, V583, P1381, DOI 10.1016/j.febslet.2009.03.050; CASTELLINO FJA, 2003, PLASMINOGEN STRUCTUR; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Coleman JL, 1999, J LAB CLIN MED, V134, P567, DOI 10.1016/S0022-2143(99)90095-1; COLEMAN JL, 1995, INFECT IMMUN, V63, P2478, DOI 10.1128/IAI.63.7.2478-2484.1995; Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6; Crowe JD, 2003, MOL MICROBIOL, V47, P1637, DOI 10.1046/j.1365-2958.2003.03390.x; Degen JL, 2007, J THROMB HAEMOST, V5, P24, DOI 10.1111/j.1538-7836.2007.02519.x; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Fenno JC, 2000, INFECT IMMUN, V68, P1884, DOI 10.1128/IAI.68.4.1884-1892.2000; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001; FUCHS H, 1994, P NATL ACAD SCI USA, V91, P12594, DOI 10.1073/pnas.91.26.12594; Gamberini M, 2005, FEMS MICROBIOL LETT, V244, P305, DOI 10.1016/j.femsle.2005.02.004; Gomez RM, 2008, MICROB PATHOGENESIS, V45, P315, DOI 10.1016/j.micpath.2008.08.004; Goto H, 1998, P NATL ACAD SCI USA, V95, P10224, DOI 10.1073/pnas.95.17.10224; Grosskinsky S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004858; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Haake DA, 2002, CLIN INFECT DIS, V34, pE40, DOI 10.1086/339942; Haake DA, 2002, INFECT IMMUN, V70, P4936, DOI 10.1128/IAI.70.9.4936-4945.2002; Hauk P, 2008, INFECT IMMUN, V76, P2642, DOI 10.1128/IAI.01639-07; Hoke DE, 2008, INFECT IMMUN, V76, P2063, DOI 10.1128/IAI.01643-07; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Klempner MS, 1996, J INFECT DIS, V174, P97, DOI 10.1093/infdis/174.1.97; Lagal V, 2006, MICROBES INFECT, V8, P645, DOI 10.1016/j.micinf.2005.08.017; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; LeBouder F, 2008, J VIROL, V82, P6820, DOI 10.1128/JVI.00246-08; Ledoux D, 2000, J BIOL CHEM, V275, P29383, DOI 10.1074/jbc.M000837200; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; LONGHI MT, 2009, J MED MICROBIOL; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Murray GL, 2009, INFECT IMMUN, V77, P952, DOI 10.1128/IAI.01370-08; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; Nally JE, 2007, INFECT IMMUN, V75, P766, DOI 10.1128/IAI.00741-06; Nascimento ALTO, 2004, BRAZ J MED BIOL RES, V37, P459, DOI 10.1590/S0100-879X2004000400003; Neves FO, 2007, ARCH MICROBIOL, V188, P523, DOI 10.1007/s00203-007-0273-2; Nordstrand A, 2001, INFECT IMMUN, V69, P5832, DOI 10.1128/IAI.69.9.5832-5839.2001; Okumura Y, 1999, FEBS LETT, V442, P39, DOI 10.1016/S0014-5793(98)01612-3; Oliveira TR, 2008, CLIN VACCINE IMMUNOL, V15, P1715, DOI 10.1128/CVI.00214-08; Pathirana RD, 2006, MICROBIOL-SGM, V152, P2381, DOI 10.1099/mic.0.28787-0; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Plank R, 2000, MICROBES INFECT, V2, P1265, DOI 10.1016/S1286-4579(00)01280-6; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; Rojas M, 2008, ACTA TROP, V107, P54, DOI 10.1016/j.actatropica.2008.04.013; Rossmann E, 2007, J IMMUNOL, V178, P7292, DOI 10.4049/jimmunol.178.11.7292; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Sun HM, 2006, PHYSIOLOGY, V21, P281, DOI 10.1152/physiol.00059.2005; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; URANO T, 1987, J BIOL CHEM, V262, P15959; VERMA A, INFECT IMMUN; VIEIRA ML, J INFECT, V60, P52; Vieira ML, 2009, INFECT IMMUN, V77, P4092, DOI 10.1128/IAI.00353-09; Vinetz JM, 2001, CURR OPIN INFECT DIS, V14, P527, DOI 10.1097/00001432-200110000-00005; Viratyosin W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-181	72	59	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11259	10.1371/journal.pone.0011259	http://dx.doi.org/10.1371/journal.pone.0011259			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582320	gold, Green Published, Green Submitted			2022-12-27	WOS:000279058500011
J	Jinawath, N; Vasoontara, C; Jinawath, A; Fang, XP; Zhao, KJ; Yap, KL; Guo, T; Lee, CS; Wang, WJ; Balgley, BM; Davidson, B; Wang, TL; Shih, IM				Jinawath, Natini; Vasoontara, Chanont; Jinawath, Artit; Fang, Xueping; Zhao, Kejia; Yap, Kai-Lee; Guo, Tong; Lee, Cheng S.; Wang, Weijie; Balgley, Brian M.; Davidson, Ben; Wang, Tian-Li; Shih, Ie-Ming			Oncoproteomic Analysis Reveals Co-Upregulation of RELA and STAT5 in Carboplatin Resistant Ovarian Carcinoma	PLOS ONE			English	Article							BCL-X-L; CANCER-CELLS; IN-VITRO; PACLITAXEL RESISTANCE; TUMOR RECURRENCE; TRANSCRIPTION 5B; GENE-EXPRESSION; INHIBITOR; CHEMORESISTANCE; CISPLATIN		[Jinawath, Natini; Vasoontara, Chanont; Yap, Kai-Lee; Wang, Tian-Li; Shih, Ie-Ming] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Jinawath, Natini; Vasoontara, Chanont; Yap, Kai-Lee; Wang, Tian-Li; Shih, Ie-Ming] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; [Jinawath, Natini; Vasoontara, Chanont; Yap, Kai-Lee; Wang, Tian-Li; Shih, Ie-Ming] Johns Hopkins Med Inst, Dept Gynecol & Obstet, Baltimore, MD 21205 USA; [Jinawath, Natini] Mahidol Univ, Ramathibodi Hosp, Fac Med, Res Ctr, Bangkok 10400, Thailand; [Jinawath, Artit] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pathol, Bangkok 10400, Thailand; [Fang, Xueping; Zhao, Kejia; Guo, Tong; Lee, Cheng S.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Wang, Weijie] Human Genome Sci, Rockville, MD USA; [Balgley, Brian M.] Calibrant Biosyst, Gaithersburg, MD USA; [Davidson, Ben] Univ Oslo, Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Davidson, Ben] Univ Oslo, Fac Med, Oslo, Norway	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Mahidol University; Mahidol University; University System of Maryland; University of Maryland College Park; GlaxoSmithKline; Human Genome Sciences Inc; University of Oslo; University of Oslo	Jinawath, N (corresponding author), Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA.	ishih@jhmi.edu	sdsd, shihieih/ABE-6190-2020	Balgley, Brian/0000-0002-3509-4567; Yap, Kai Lee/0000-0003-4496-5464	HERA Women's Cancer Foundation OSB1; National Institutes of Health (NIH) [GM073723, CA 122715, OC0400600, RO1 CA 129080, RO1 CA 103937]; American Cancer Society [RSG-08-174-01-GMC]; NATIONAL CANCER INSTITUTE [R42CA122715, R41CA122715, R01CA103937, R01CA129080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073723] Funding Source: NIH RePORTER	HERA Women's Cancer Foundation OSB1; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by HERA Women's Cancer Foundation OSB1 (NJ), National Institutes of Health (NIH) GM073723 (CSL), NIH CA 122715 (BMB), OC0400600 (TLW), American Cancer Society RSG-08-174-01-GMC (TLW), NIH RO1 CA 129080 (IMS), and NIH RO1 CA 103937 (IMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanian C, 2005, J CLIN ONCOL, V23, P5943, DOI 10.1200/JCO.2005.16.006; Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Choi JH, 2009, CANCER RES, V69, P1407, DOI 10.1158/0008-5472.CAN-08-3602; Dong QG, 2002, ONCOGENE, V21, P6510, DOI 10.1038/sj.onc.1205848; Dumon S, 1999, ONCOGENE, V18, P4191, DOI 10.1038/sj.onc.1202796; Gesbert F, 2000, BLOOD, V96, P2269, DOI 10.1182/blood.V96.6.2269.h8002269_2269_2276; Hexner EO, 2008, BLOOD, V111, P5663, DOI 10.1182/blood-2007-04-083402; Jain KK, 2008, MOL ONCOL, V2, P153, DOI 10.1016/j.molonc.2008.05.003; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jinawath N, 2009, ONCOGENE, V28, P1941, DOI 10.1038/onc.2009.37; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kelly JA, 2003, J EXP MED, V198, P79, DOI 10.1084/jem.20021548; Konstantinopoulos PA, 2009, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-59; Kornfeld JW, 2008, FRONT BIOSCI-LANDMRK, V13, P6237, DOI 10.2741/3151; Lee TK, 2006, CANCER RES, V66, P9948, DOI 10.1158/0008-5472.CAN-06-1092; Leong PL, 2002, ONCOGENE, V21, P2846, DOI 10.1038/sj.onc.1205385; Mabuchi S, 2004, CLIN CANCER RES, V10, P7645, DOI 10.1158/1078-0432.CCR-04-0958; Mabuchi S, 2004, J BIOL CHEM, V279, P23477, DOI 10.1074/jbc.M313709200; Nakayama K, 2006, P NATL ACAD SCI USA, V103, P18739, DOI 10.1073/pnas.0604083103; Nam S, 2007, MOL CANCER THER, V6, P1400, DOI 10.1158/1535-7163.MCT-06-0446; Riggins RB, 2006, CANCER RES, V66, P7007, DOI 10.1158/0008-5472.CAN-05-3952; Shih LM, 2005, P NATL ACAD SCI USA, V102, P14004, DOI 10.1073/pnas.0504195102; Song J, 2007, CLIN CANCER RES, V13, P6842, DOI 10.1158/1078-0432.CCR-07-0569; Song J, 2009, NEOPLASIA, V11, P605, DOI 10.1593/neo.09286; Tan SH, 2008, CANCER RES, V68, P236, DOI 10.1158/0008-5472.CAN-07-2972; Villedieu M, 2007, GYNECOL ONCOL, V105, P31, DOI 10.1016/j.ygyno.2006.12.011; Wang YJ, 2005, EXPERT REV PROTEOMIC, V2, P659, DOI 10.1586/14789450.2.5.659; Williams J, 2005, GYNECOL ONCOL, V96, P287, DOI 10.1016/j.ygyno.2004.10.026; Witham J, 2007, CLIN CANCER RES, V13, P7191, DOI 10.1158/1078-0432.CCR-07-0362; Wong SCC, 2009, EXPERT REV PROTEOMIC, V6, P123, DOI [10.1586/epr.09.1, 10.1586/EPR.09.1]	33	57	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11198	10.1371/journal.pone.0011198	http://dx.doi.org/10.1371/journal.pone.0011198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585448	Green Submitted, Green Published, gold			2022-12-27	WOS:000278977200005
J	Verde, Z; Ruiz, JR; Santiago, C; Valle, B; Bandres, F; Calvo, E; Lucia, A; Gallego, FG				Verde, Zoraida; Ruiz, Jonatan R.; Santiago, Catalina; Valle, Beatriz; Bandres, Fernando; Calvo, Elpidio; Lucia, Alejandro; Gomez Gallego, Felix			A Novel, Single Algorithm Approach to Predict Acenocoumarol Dose Based on CYP2C9 and VKORC1 Allele Variants	PLOS ONE			English	Article							WARFARIN-TREATED PATIENTS; PHARMACOGENETICS; ANTICOAGULATION; RISK	The identification of CYP2C9 and VKORC1 genes has strongly stimulated the research on pharmacogenetics of coumarins in the last decade. We assessed the combined influence of CYP2C9 *2 and *3, and VKORC1 c.-1639G>A, 497C>G, and 1173C>T variants, on acenocoumarol dosage using a novel algorithm approach, in 193 outpatients who had achieved stable anticoagulation. We constructed an "acenocoumarol-dose genotype score'' (AGS, maximum score = 100) based on the number of alleles associated with higher acenocoumarol dosage carried by each subject for each polymorphism. The mean AGS was higher in the high-dose (>28mg/week) compared with the low-dose (<7mg/week) group (mean(SEM) of 84.1 +/- 3.4 vs. 62.2 +/- 4.8, P = 0.008). An AGS>70 was associated with an increased odds ratio (OR) of requiring high acenocoumarol dosage (OR: 3.347; 95%CI: 1.112-10.075; P = 0.032). In summary, although more research is necessary in other patient cohorts, and this algorithm should be replicated in an independent sample, our data suggest that the AGS algorithm could be used to help discriminating patients requiring high acenocoumarol doses to achieve stable anti-coagulation.	[Verde, Zoraida; Santiago, Catalina; Lucia, Alejandro; Gomez Gallego, Felix] Univ Europea Madrid, Madrid, Spain; [Ruiz, Jonatan R.] Karolinska Inst, Novum, Dept Biosci & Nutr, Unit Prevent Nutr, Huddinge, Sweden; [Valle, Beatriz; Calvo, Elpidio] Hosp Clin San Carlos, Madrid, Spain; [Bandres, Fernando] Fdn Tejerina, Madrid, Spain	European University of Madrid; Karolinska Institutet; Hospital Clinico San Carlos	Verde, Z (corresponding author), Univ Europea Madrid, Madrid, Spain.	alejandro.lucia@uem.es	RUIZ, JONATAN R/M-1338-2015; Santiago, Catalina/P-8177-2019; VERDE, ZORAIDA/A-9914-2012; Lucia, Alejandro/M-2759-2014; Santiago, Catalina/K-6803-2014; Gomez-Gallego, Felix/AAD-9617-2020; Gomez-Gallego, Felix/H-6925-2013	RUIZ, JONATAN R/0000-0002-7548-7138; Santiago, Catalina/0000-0003-3852-8217; VERDE, ZORAIDA/0000-0002-9260-7672; Lucia, Alejandro/0000-0002-3025-2060; Santiago, Catalina/0000-0003-3852-8217; Gomez-Gallego, Felix/0000-0002-1968-1761; BANDRES MOYA, FERNANDO/0000-0002-4675-8226; Lucia, Alejandro/0000-0002-5565-0997; Valle Borrego, Beatriz/0000-0001-8512-6283	Universidad Europea de Madrid; Fondo de Investigaciones Sanitarias (FIS) [PS09/00194]	Universidad Europea de Madrid; Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III)	This study was funded by Universidad Europea de Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study (genotyping cost) was funded by the Fondo de Investigaciones Sanitarias (FIS, ref. # PS09/00194).	Cooper GM, 2008, BLOOD, V112, P1022, DOI 10.1182/blood-2008-01-134247; Daly AK, 2009, GENOME MED, V1, DOI 10.1186/gm10; *FDA, FDA APPR UPD WARF CO; FERDER NS, J THROMB HAEMOST, V8, P95; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Meckley LM, 2008, THROMB HAEMOSTASIS, V100, P229, DOI 10.1160/TH07-09-0552; PEREZANDREU V, 2010, J THROMB HAEMOST; Ruiz JR, 2009, J PHYSIOL-LONDON, V587, P1527, DOI 10.1113/jphysiol.2008.166645; Sanderson S, 2005, GENET MED, V7, P97, DOI 10.1097/01.GIM.0000153664.65759.CF; Schalekamp T, 2010, CURR PHARM DESIGN, V16, P187, DOI 10.2174/138161210790112737; Schmeits PCJ, 2010, BRIT J HAEMATOL, V148, P955, DOI 10.1111/j.1365-2141.2009.08017.x; Schwarz UI, 2008, NEW ENGL J MED, V358, P999, DOI 10.1056/NEJMoa0708078; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Verde Z, 2009, THROMB HAEMOSTASIS, V101, P591, DOI 10.1160/TH08-09-0578; Williams AG, 2008, J PHYSIOL-LONDON, V586, P113, DOI 10.1113/jphysiol.2007.141887; Yin T, 2007, THROMB RES, V120, P1, DOI 10.1016/j.thromres.2006.10.021; ZWEIG MH, 1993, CLIN CHEM, V39, P561	17	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11210	10.1371/journal.pone.0011210	http://dx.doi.org/10.1371/journal.pone.0011210			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585445	Green Published, Green Submitted, gold			2022-12-27	WOS:000278977200013
J	Krintel, C; Klint, C; Lindvall, H; Morgelin, M; Holm, C				Krintel, Christian; Klint, Cecilia; Lindvall, Hakan; Morgelin, Matthias; Holm, Cecilia			Quarternary Structure and Enzymological Properties of the Different Hormone-Sensitive Lipase (HSL) Isoforms	PLOS ONE			English	Article							LIPOPROTEIN-LIPASE; TESTICULAR FORM; PROTEIN; PHOSPHORYLATION; IDENTIFICATION; ACTIVATION; DOMAIN; PURIFICATION; ORGANIZATION; HYDROLYSIS	Background: Hormone-sensitive lipase (HSL) is a key enzyme in the mobilization of energy in the form of fatty acids from intracellular stores of neutral lipids. The enzyme has been shown to exist in different isoforms with different molecular masses (84 kDa, 89 kDa and 117 kDa) expressed in a tissue-dependent manner, where the predominant 84 kDa form in adipocytes is the most extensively studied. Methodology/Principal Findings: In this study we employed negative stain electron microscopy (EM) to analyze the quarternary structure of the different HSL isoforms. The results show that all three isoforms adopt a head-to-head homodimeric organization, where each monomer contains two structural domains. We also used enzymatic assays to show that despite the variation in the size of the N-terminal domain all three isoforms exhibit similar enzymological properties with regard to psychrotolerance and protein kinase A (PKA)-mediated phosphorylation and activation. Conclusions/Significance: We present the first data on the quaternary structure and domain organization of the three HSL isoforms. We conclude that despite large differences in the size of the N-terminal, non-catalytic domain all three HSL isoforms exhibit the same three-dimensional architecture. Furthermore, the three HSL isoforms are very similar with regard to two unique enzymological characteristics of HSL, i.e., cold adaptation and PKA-mediated activation.	[Krintel, Christian; Klint, Cecilia; Lindvall, Hakan; Holm, Cecilia] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Krintel, Christian] Lund Univ, Div Diabet Metab & Endocrinol, Dept Mol Biophys, Lund, Sweden; [Morgelin, Matthias] Lund Univ, Div Infect Med, Dept Clin Sci, Lund, Sweden	Lund University; Lund University; Lund University	Krintel, C (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	cecilia.holm@med.lu.se		krintel, christian/0000-0001-5925-5639	Swedish Research Council [11284]; Swedish Diabetes Association; Research School in Pharmaceutical Sciences (FLAK); Novo Nordisk; A. Pahlsson and Torsten and Ragnar Soderberg	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; Research School in Pharmaceutical Sciences (FLAK); Novo Nordisk(Novo Nordisk); A. Pahlsson and Torsten and Ragnar Soderberg	Financial support was obtained from the Swedish Research Council (project no. 11284 to C.H.), the Swedish Diabetes Association, and the following foundations: Novo Nordisk, A. Pahlsson and Torsten and Ragnar Soderberg. C. Krintel was supported by the Research School in Pharmaceutical Sciences (FLAK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; BASCHONG W, 1985, HISTOCHEMISTRY, V83, P409, DOI 10.1007/BF00509201; Ben Ali Y, 2004, BIOCHEMISTRY-US, V43, P9298, DOI 10.1021/bi049479o; BENGTSSON G, 1977, BIOCHEM J, V167, P109, DOI 10.1042/bj1670109; Contreras JA, 1998, PROTEIN EXPRES PURIF, V12, P93, DOI 10.1006/prep.1997.0821; Contreras JA, 1996, J BIOL CHEM, V271, P31426, DOI 10.1074/jbc.271.49.31426; ENGEL J, 1987, METHOD ENZYMOL, V145, P3; Ficarro S, 2003, J BIOL CHEM, V278, P11579, DOI 10.1074/jbc.M202325200; FREDRIKSON G, 1981, J BIOL CHEM, V256, P6311; Granneman JG, 2008, TRENDS ENDOCRIN MET, V19, P3, DOI 10.1016/j.tem.2007.10.006; Griffon N, 2009, J BIOL CHEM, V284, P23322, DOI 10.1074/jbc.M109.037002; Grober J, 1997, BIOCHEM J, V328, P453, DOI 10.1042/bj3280453; HOLM C, 1987, BIOCHEM BIOPH RES CO, V148, P99, DOI 10.1016/0006-291X(87)91081-3; Holm C, 1999, METH MOL B, V109, P109; Holst LS, 1996, GENOMICS, V35, P441, DOI 10.1006/geno.1996.0383; Krintel C, 2009, FEBS J, V276, P4752, DOI 10.1111/j.1742-4658.2009.07172.x; Krintel C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003756; LANGIN D, 1993, P NATL ACAD SCI USA, V90, P4897, DOI 10.1073/pnas.90.11.4897; Laurell H, 2000, PROTEIN ENG, V13, P711, DOI 10.1093/protein/13.10.711; Lindvall H, 2004, J BIOL CHEM, V279, P3828, DOI 10.1074/jbc.M311365200; Mairal A, 2002, BIOCHEM BIOPH RES CO, V291, P286, DOI 10.1006/bbrc.2002.6427; Mulder H, 1999, DIABETES, V48, P228, DOI 10.2337/diabetes.48.1.228; Osterlund T, 1999, J BIOL CHEM, V274, P15382, DOI 10.1074/jbc.274.22.15382; Osterlund T, 1996, BIOCHEM J, V319, P411, DOI 10.1042/bj3190411; Shen WJ, 2000, BIOCHEMISTRY-US, V39, P2392, DOI 10.1021/bi992283h; Shen WJ, 1999, P NATL ACAD SCI USA, V96, P5528, DOI 10.1073/pnas.96.10.5528; SHIRAI K, 1982, J BIOL CHEM, V257, P1253; Smith AJ, 2007, J BIOL CHEM, V282, P32424, DOI 10.1074/jbc.M703730200; Strom K, 2009, FASEB J, V23, P2307, DOI 10.1096/fj.08-120923; Thorens B, 1995, DIABETES METAB, V21, P311; TORNQVIST H, 1972, J LIPID RES, V13, P424; Vallet-Erdtmann V, 2004, J BIOL CHEM, V279, P42875, DOI 10.1074/jbc.M403495200; Wong H, 1997, P NATL ACAD SCI USA, V94, P5594, DOI 10.1073/pnas.94.11.5594	34	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11193	10.1371/journal.pone.0011193	http://dx.doi.org/10.1371/journal.pone.0011193			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567594	Green Published, gold, Green Submitted			2022-12-27	WOS:000278886300031
J	Levi, B; James, AW; Nelson, ER; Vistnes, D; Wu, B; Lee, M; Gupta, A; Longaker, MT				Levi, Benjamin; James, Aaron W.; Nelson, Emily R.; Vistnes, Dean; Wu, Benjamin; Lee, Min; Gupta, Ankur; Longaker, Michael T.			Human Adipose Derived Stromal Cells Heal Critical Size Mouse Calvarial Defects	PLOS ONE			English	Article							ADULT STEM-CELLS; BONE MORPHOGENETIC PROTEIN-2; IN-VITRO; MESENCHYMAL CELLS; OSTEOGENIC DIFFERENTIATION; SKELETAL TISSUE; RETINOIC ACID; CHONDROGENIC DIFFERENTIATION; HUMAN FAT; VIVO	Background: Human adipose-derived stromal cells (hASCs) represent a multipotent cell stromal cell type with proven capacity to differentiate along an osteogenic lineage. This suggests that they may be used to heal defects of the craniofacial or appendicular skeleton. We sought to substantiate the use of undifferentiated hASCs in the regeneration of a non-healing mouse skeletal defect. Methodology/Principal Findings: Human ASCs were harvested from female lipoaspirate. Critical-sized (4 mm) calvarial defects were created in the parietal bone of adult male nude mice. Defects were either left empty, treated with an apatite coated PLGA scaffold alone, or a scaffold with human ASCs. MicroCT scans were obtained at stratified time points post-injury. Histology, in situ hybridization, and histomorphometry were performed. Near complete healing was observed among hASC engrafted calvarial defects. This was in comparison to control groups that showed little healing (*P < 0.01). Human ASCs once engrafted differentiate down an osteogenic lineage, determined by qRT-PCR and histological co-expression assays using GFP labeled cells. ASCs were shown to persist within a defect site for two weeks (shown by sex chromosome analysis and quantified using Luciferase+ ASCs). Finally, rBMP-2 was observed to increase hASC osteogenesis in vitro and osseous healing in vivo. Conclusions/Significance: Human ASCs ossify critical sized mouse calvarial defects without the need for pre-differentiation. Recombinant differentiation factors such as BMP-2 may be used to supplement hASC mediated repair. Interestingly, ASC presence gradually dissipates from the calvarial defect site. This study supports the potential translation for ASC use in the treatment of human skeletal defects.	[Levi, Benjamin; James, Aaron W.; Nelson, Emily R.; Vistnes, Dean; Gupta, Ankur; Longaker, Michael T.] Stanford Univ, Sch Med, Dept Surg, Div Plast & Reconstruct Surg,Hagey Pediat Regener, Stanford, CA 94305 USA; [Wu, Benjamin; Lee, Min] Univ Calif Los Angeles, Sch Med, Div Adv Prosthodont Biomat & Hosp Dent, Los Angeles, CA USA	Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Longaker, MT (corresponding author), Stanford Univ, Sch Med, Dept Surg, Div Plast & Reconstruct Surg,Hagey Pediat Regener, Stanford, CA 94305 USA.	Longaker@stanford.edu		Wu, Benjamin/0000-0001-5236-8534	National Institutes of Health, National Institute of Dental and Craniofacial Research [R01 DE-13194]; Oak Foundation; Hagey Foundation; National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [1F32AR057302-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR057302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013194] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Oak Foundation; Hagey Foundation; National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by National Institutes of Health, National Institute of Dental and Craniofacial Research grant R01 DE-13194, the Oak Foundation and Hagey Foundation to M.T.L. B.L. was supported by the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases grant 1F32AR057302-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalami OO, 2004, PLAST RECONSTR SURG, V114, P713, DOI 10.1097/01.PRS.0000131016.12754.30; Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045; Chim H, 2005, PLAST RECONSTR SURG, V116, P1726, DOI 10.1097/01.prs.0000182386.78775.cd; Cowan CM, 2005, TISSUE ENG, V11, P645, DOI 10.1089/ten.2005.11.645; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Dragoo JL, 2003, J ORTHOP RES, V21, P622, DOI 10.1016/S0736-0266(02)00238-3; Dragoo JL, 2005, PLAST RECONSTR SURG, V115, P1665, DOI 10.1097/01.PRS.0000161459.90856.AB; Dudas JR, 2006, ANN PLAS SURG, V56, P543, DOI 10.1097/01.sap.0000210629.17727.bd; Fang TD, 2006, PLAST RECONSTR SURG, V117, P1177, DOI 10.1097/01.prs.0000204581.59190.53; Gimble JM, 2004, ENDOCRINE, V23, P183, DOI 10.1385/ENDO:23:2-3:183; Gimble JM, 2003, CURR TOP DEV BIOL, V58, P137, DOI 10.1016/S0070-2153(03)58005-X; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Gimble JM, 2003, EXPERT OPIN BIOL TH, V3, P705, DOI 10.1517/14712598.3.5.705; Gosain AK, 2003, PLAST RECONSTR SURG, V112, P515, DOI 10.1097/01.PRS.0000070728.56716.51; Gosain AK, 2000, PLAST RECONSTR SURG, V106, P360, DOI 10.1097/00006534-200008000-00018; Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463; Guilak F, 2004, BIORHEOLOGY, V41, P389; Gupta DM, 2008, J CRANIOFAC SURG, V19, P192, DOI 10.1097/scs.0b013e31815c93b7; Gupta DM, 2009, J CRANIOFAC SURG, V20, P860, DOI 10.1097/SCS.0b013e3181a9574b; Hicok KC, 2004, TISSUE ENG, V10, P371, DOI 10.1089/107632704323061735; Huang JI, 2004, PLAST RECONSTR SURG, V113, P585, DOI 10.1097/01.PRS.0000101063.27008.E1; James AW, 2008, PLAST RECONSTR SURG, V122, P53, DOI 10.1097/PRS.0b013e31817747b5; James AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007120; James AW, 2009, PLAST RECONSTR SURG, V123, P31, DOI 10.1097/PRS.0b013e3181904c19; JAMES AW, 2010, TISSUE ENG A; Kulakov AA, 2008, B EXP BIOL MED+, V146, P522, DOI 10.1007/s10517-009-0322-8; Kwan MD, 2008, HUM MOL GENET, V17, pR93, DOI 10.1093/hmg/ddn071; Lecoeur L, 1997, BIOMATERIALS, V18, P989, DOI 10.1016/S0142-9612(97)00025-2; Lendeckel S, 2004, J CRANIO MAXILL SURG, V32, P370, DOI 10.1016/j.jcms.2004.06.002; LEVI B, 2010, PLAST RECONSTR S MAR; Mao JJ, 2006, J DENT RES, V85, P966, DOI 10.1177/154405910608501101; Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001; Panetta NJ, 2009, PANMINERVA MED, V51, P25; Panetta NJ, 2010, PLAST RECONSTR SURG, V125, P483, DOI 10.1097/PRS.0b013e3181c82d75; Panetta NJ, 2009, J CRANIOFAC SURG, V20, P1531, DOI 10.1097/SCS.0b013e3181b09c02; Panetta NJ, 2009, J CRANIOFAC SURG, V20, P347, DOI 10.1097/SCS.0b013e3181992371; Quarto N, 2008, BONE, V42, P1040, DOI 10.1016/j.bone.2008.01.026; Vilalta M, 2008, STEM CELLS DEV, V17, P993, DOI 10.1089/scd.2007.0201; Wan DC, 2007, J BIOL CHEM, V282, P26450, DOI 10.1074/jbc.M703282200; Wan DC, 2007, TISSUE ENG, V13, P1623, DOI 10.1089/ten.2006.0283; Wan DC, 2006, P NATL ACAD SCI USA, V103, P12335, DOI 10.1073/pnas.0604849103; Wolbank Susanne, 2007, Cell and Tissue Banking, V8, P163, DOI 10.1007/s10561-006-9027-7; Xu Y, 2005, CURR OPIN MOL THER, V7, P300; Xu Y, 2007, TISSUE ENG, V13, P2981, DOI 10.1089/ten.2007.0050; Xu Y, 2009, TISSUE ENG PT A, V15, P3697, DOI [10.1089/ten.tea.2009.0213, 10.1089/ten.TEA.2009.0213]; Xu Y, 2008, PLAST RECONSTR SURG, V122, P1649, DOI 10.1097/PRS.0b013e31818cbf44; Yoon E, 2007, TISSUE ENG, V13, P619, DOI 10.1089/ten.2006.0102; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	48	222	235	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11177	10.1371/journal.pone.0011177	http://dx.doi.org/10.1371/journal.pone.0011177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567510	Green Published, Green Submitted, gold			2022-12-27	WOS:000278886300019
J	Pallesen, KJ; Brattico, E; Bailey, CJ; Korvenoja, A; Koivisto, J; Gjedde, A; Carlson, S				Pallesen, Karen Johanne; Brattico, Elvira; Bailey, Christopher J.; Korvenoja, Antti; Koivisto, Juha; Gjedde, Albert; Carlson, Synnove			Cognitive Control in Auditory Working Memory Is Enhanced in Musicians	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; GENERAL FLUID INTELLIGENCE; INDIVIDUAL-DIFFERENCES; PREFRONTAL CORTEX; BRAIN ACTIVATION; NEURAL MECHANISMS; PITCH PERCEPTION; BROCAS AREA; NONMUSICIANS; TASK	Musical competence may confer cognitive advantages that extend beyond processing of familiar musical sounds. Behavioural evidence indicates a general enhancement of both working memory and attention in musicians. It is possible that musicians, due to their training, are better able to maintain focus on task-relevant stimuli, a skill which is crucial to working memory. We measured the blood oxygenation-level dependent (BOLD) activation signal in musicians and non-musicians during working memory of musical sounds to determine the relation among performance, musical competence and generally enhanced cognition. All participants easily distinguished the stimuli. We tested the hypothesis that musicians nonetheless would perform better, and that differential brain activity would mainly be present in cortical areas involved in cognitive control such as the lateral prefrontal cortex. The musicians performed better as reflected in reaction times and error rates. Musicians also had larger BOLD responses than non-musicians in neuronal networks that sustain attention and cognitive control, including regions of the lateral prefrontal cortex, lateral parietal cortex, insula, and putamen in the right hemisphere, and bilaterally in the posterior dorsal prefrontal cortex and anterior cingulate gyrus. The relationship between the task performance and the magnitude of the BOLD response was more positive in musicians than in non-musicians, particularly during the most difficult working memory task. The results confirm previous findings that neural activity increases during enhanced working memory performance. The results also suggest that superior working memory task performance in musicians rely on an enhanced ability to exert sustained cognitive control. This cognitive benefit in musicians may be a consequence of focused musical training.	[Pallesen, Karen Johanne; Koivisto, Juha; Carlson, Synnove] Univ Helsinki, Inst Biomed Physiol, Neurosci Unit, Helsinki, Finland; [Pallesen, Karen Johanne; Bailey, Christopher J.; Gjedde, Albert] Aarhus Univ, Ctr Funct Integrat Neurosci, Aarhus, Denmark; [Pallesen, Karen Johanne; Bailey, Christopher J.; Gjedde, Albert] Aarhus Univ Hosp, Pathophysiol & Expt Tomog Ctr, DK-8000 Aarhus, Denmark; [Brattico, Elvira] Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland; [Brattico, Elvira] Univ Jyvaskyla, Finnish Ctr Excellence Interdisciplinary Music Re, Jyvaskyla, Finland; [Korvenoja, Antti] Univ Helsinki, Cent Hosp, Med Imaging Ctr, Helsinki, Finland; [Carlson, Synnove] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Carlson, Synnove] Aalto Univ, Low Temp Lab, Brain Res Unit, FIN-02150 Espoo, Finland	University of Helsinki; Aarhus University; Aarhus University; University of Helsinki; University of Jyvaskyla; University of Helsinki; Helsinki University Central Hospital; Tampere University; Aalto University	Pallesen, KJ (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Neurosci & Pharmacol, Copenhagen, Denmark.	karenjohanne@pet.auh.dk	Brattico, Elvira/M-1455-2019; Carlson, Synnöve/G-2210-2013; Korvenoja, Antti/C-2292-2009; Gjedde, Albert/U-3751-2019; Korvenoja, Antti/AAG-1866-2019; Carlson, Synnöve/A-6337-2013; Carlson, Synnöve/AAM-2655-2021; Gjedde, Albert/I-2452-2019; Korvenoja, Antti/AAR-7461-2020	Korvenoja, Antti/0000-0003-4348-0449; Gjedde, Albert/0000-0002-3756-7401; Carlson, Synnöve/0000-0003-1462-7560; Korvenoja, Antti/0000-0003-4348-0449; Pallesen, Karen Johanne/0000-0001-7543-5891; Brattico, Elvira/0000-0003-0676-6464; Bailey, Christopher/0000-0003-3318-3344	Academy of Finland; University of Helsinki	Academy of Finland(Academy of Finland); University of Helsinki	The study was supported by the Academy of Finland (National Center of Excellence Program) and by a research grant from the University of Helsinki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2007, J NEUROSCI, V27, P3429, DOI 10.1523/JNEUROSCI.4273-06.2007; ALTENMULLER E, 1986, EUR ARCH PSY CLIN N, V235, P342, DOI 10.1007/BF00381003; Baddeley A. D, 1986, WORKING MEMORY; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Ben-Yehudah G, 2007, CEREBELLUM, V6, P193, DOI 10.1080/14734220701286195; BEVER TG, 1974, SCIENCE, V185, P537, DOI 10.1126/science.185.4150.537; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Brattico E, 2001, MUSIC PERCEPT, V19, P199, DOI 10.1525/mp.2001.19.2.199; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Carlson S, 1998, CEREB CORTEX, V8, P743, DOI 10.1093/cercor/8.8.743; Chan AS, 1998, NATURE, V396, P128, DOI 10.1038/24075; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; di Pellegrino G, 2007, J COGNITIVE NEUROSCI, V19, P275, DOI 10.1162/jocn.2007.19.2.275; EVANS C, 1993, P 40 ANN M SOC NUCL; Evers S, 1999, BRAIN, V122, P75, DOI 10.1093/brain/122.1.75; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fishman YI, 2001, J NEUROPHYSIOL, V86, P2761, DOI 10.1152/jn.2001.86.6.2761; Forgeard Marie, 2008, PLoS One, V3, pe3566, DOI 10.1371/journal.pone.0003566; Friston K.J., 1994, HUMAN BRAIN MAPPING, V1, P210; Fujioka T, 2005, J COGNITIVE NEUROSCI, V17, P1578, DOI 10.1162/089892905774597263; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Gaab N, 2003, ANN NY ACAD SCI, V999, P385, DOI 10.1196/annals.1284.048; Gaab N, 2003, NEUROREPORT, V14, P2291, DOI 10.1097/00001756-200312190-00001; Gaab N, 2006, NEUROIMAGE, V31, P255, DOI 10.1016/j.neuroimage.2005.11.046; Garavan H, 2000, MICROSC RES TECHNIQ, V51, P54, DOI 10.1002/1097-0029(20001001)51:1<54::AID-JEMT6>3.0.CO;2-J; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Herholz SC, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-42; Ho YC, 2003, NEUROPSYCHOLOGY, V17, P439, DOI 10.1037/0894-4105.17.3.439; Hubert V, 2007, HUM BRAIN MAPP, V28, P1415, DOI 10.1002/hbm.20354; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Jarrold C, 2006, NEUROSCIENCE, V139, P39, DOI 10.1016/j.neuroscience.2005.07.002; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; Jonides J, 1997, J COGNITIVE NEUROSCI, V9, P462, DOI 10.1162/jocn.1997.9.4.462; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kalakoski V, 2007, SCAND J PSYCHOL, V48, P87, DOI 10.1111/j.1467-9450.2007.00535.x; KAMEOKA A, 1969, J ACOUST SOC AM, V45, P1451, DOI 10.1121/1.1911623; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Khalfa S, 2005, NEUROREPORT, V16, P1981, DOI 10.1097/00001756-200512190-00002; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Koelsch S, 1999, NEUROREPORT, V10, P1309, DOI 10.1097/00001756-199904260-00029; Koesch S, 2002, CLIN NEUROPHYSIOL, V113, P862, DOI 10.1016/S1388-2457(02)00050-0; Leung HC, 2005, CEREB CORTEX, V15, P1742, DOI 10.1093/cercor/bhi051; Ligeois-Chauvel C, 1998, BRAIN, V121, P1853, DOI 10.1093/brain/121.10.1853; Luria A R, 1965, J Neurol Sci, V2, P288, DOI 10.1016/0022-510X(65)90113-9; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Martinkauppi S, 2000, CEREB CORTEX, V10, P889, DOI 10.1093/cercor/10.9.889; McAlonan K, 2006, J NEUROSCI, V26, P4444, DOI 10.1523/JNEUROSCI.5602-05.2006; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nystrom LE, 2000, NEUROIMAGE, V11, P424, DOI 10.1006/nimg.2000.0572; Ohbayashi M, 2003, SCIENCE, V301, P233, DOI 10.1126/science.1084884; Ohnishi T, 2001, CEREB CORTEX, V11, P754, DOI 10.1093/cercor/11.8.754; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Page MPA, 1998, PSYCHOL REV, V105, P761, DOI 10.1037/0033-295X.105.4.761-781; Pallesen KJ, 2005, ANN NY ACAD SCI, V1060, P450, DOI 10.1196/annals.1360.047; Pallesen KJ, 2009, J COGNITIVE NEUROSCI, V21, P1065, DOI 10.1162/jocn.2009.21086; Patston LLM, 2007, LATERALITY, V12, P262, DOI 10.1080/13576500701251981; PLOMP R, 1965, J ACOUST SOC AM, V38, P548, DOI 10.1121/1.1909741; Rama P, 2001, COGN AFFECT BEHAV NE, V1, P161, DOI 10.3758/CABN.1.2.161; Rama P, 2001, NEUROIMAGE, V13, P1090, DOI 10.1006/nimg.2001.0777; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; Samson S, 2002, BRAIN, V125, P511, DOI 10.1093/brain/awf051; Sayala S, 2006, CEREB CORTEX, V16, P609, DOI 10.1093/cercor/bhj007; Scelfo B, 2008, P NATL ACAD SCI USA, V105, P769, DOI 10.1073/pnas.0706342105; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Schlaug G, 2001, ANN NY ACAD SCI, V930, P281, DOI 10.1111/j.1749-6632.2001.tb05739.x; Schon D, 2005, MUSIC PERCEPT, V23, P105, DOI 10.1525/mp.2005.23.2.105; SHAPIRO BE, 1981, NEUROPSYCHOLOGIA, V19, P161, DOI 10.1016/0028-3932(81)90101-9; SIGNORET JL, 1987, REV NEUROL-FRANCE, V143, P172; Sluming V, 2007, J NEUROSCI, V27, P3799, DOI 10.1523/JNEUROSCI.0147-07.2007; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; STERNBERG S, 1969, ATTENTION PERFORMANC, V2; Tervaniemi M, 2001, ANN NY ACAD SCI, V930, P259, DOI 10.1111/j.1749-6632.2001.tb05737.x; Tillmann B, 2003, ANN NY ACAD SCI, V999, P209, DOI 10.1196/annals.1284.031; Tomasi D, 2007, BRAIN RES, V1132, P158, DOI 10.1016/j.brainres.2006.11.030; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaughn K, 2000, J AESTHET EDUC, V34, P149, DOI 10.2307/3333641; Vuust P, 2005, NEUROIMAGE, V24, P560, DOI 10.1016/j.neuroimage.2004.08.039; Warrier CM, 2004, BRAIN, V127, P1616, DOI 10.1093/brain/awh183; WICKENS DD, 1973, MEM COGNITION, V1, P485, DOI 10.3758/BF03208913; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; ZATORRE RJ, 1991, BRAIN, V114, P2403, DOI 10.1093/brain/114.6.2403; ZATORRE RJ, 1988, J ACOUST SOC AM, V84, P566, DOI 10.1121/1.396834; Zikopoulos B, 2006, J NEUROSCI, V26, P7348, DOI 10.1523/JNEUROSCI.5511-05.2006	93	141	145	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11120	10.1371/journal.pone.0011120	http://dx.doi.org/10.1371/journal.pone.0011120			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559545	Green Published, gold, Green Submitted			2022-12-27	WOS:000278775900011
J	Ushiki, T; Kizaka-Kondoh, S; Ashihara, E; Tanaka, S; Masuko, M; Hirai, H; Kimura, S; Aizawa, Y; Maekawa, T; Hiraoka, M				Ushiki, Takashi; Kizaka-Kondoh, Shinae; Ashihara, Eishi; Tanaka, Shotaro; Masuko, Masayoshi; Hirai, Hideyo; Kimura, Shinya; Aizawa, Yoshifusa; Maekawa, Taira; Hiraoka, Masahiro			Noninvasive Tracking of Donor Cell Homing by Near-Infrared Fluorescence Imaging Shortly after Bone Marrow Transplantation	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; SECONDARY LYMPHOID ORGANS; MICE; MOUSE; LYMPHOCYTES; PROGENITORS; ENGRAFTMENT; MECHANISMS; PREVENTION; INJECTION	Background: Many diseases associated with bone marrow transplantation (BMT) are caused by transplanted hematopoietic cells, and the onset of these diseases occurs after homing of donor cells in the initial phase after BMT. Noninvasive observation of donor cell homing shortly after transplantation is potentially valuable for improving therapeutic outcomes of BMT by diagnosing the early stages of these diseases. Methodology/Principal Findings: Freshly harvested near-infrared fluorescence-labeled cells were noninvasively observed for 24 h after BMT using a photon counting device to track their homing process. In a congenic BMT model, the homing of Alexa Fluor 750-labeled donor cells in the tibia was detected less than 1 h after BMT. In addition, subsequent cell distribution in an intraBM BMT model was successfully monitored for the first time using this method. In the allogeneic BMT model, T-cell depletion decreased the near-infrared fluorescence (NIRF) signals of the reticuloendothelial system. Conclusions/Significance: This approach in several murine BMT models revealed that the transplanted cells homed within 24 h after transplantation. NIRF labeling is useful for tracking transplanted cells in the initial phase after BMT, and this approach can contribute to in vivo studies aimed at improving the therapeutic outcomes of BMT.	[Ushiki, Takashi; Kizaka-Kondoh, Shinae; Tanaka, Shotaro; Hiraoka, Masahiro] Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Kyoto, Japan; [Ushiki, Takashi; Masuko, Masayoshi] Niigata Univ, Grad Sch Med & Dent Sci, Dept Hematol, Niigata, Japan; [Ashihara, Eishi; Hirai, Hideyo; Maekawa, Taira] Kyoto Univ Hosp, Dept Transfus Med & Cell Therapy, Kyoto 606, Japan; [Kimura, Shinya] Saga Univ, Fac Med, Dept Internal Med, Saga 840, Japan; [Aizawa, Yoshifusa] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiol, Niigata, Japan	Kyoto University; Niigata University; Kyoto University; Saga University; Niigata University	Ushiki, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Kyoto, Japan.	skondoh@kuhp.kyoto-u.ac.jp	Kondoh, Shinae/C-6937-2015; Kondoh, Shinae/AAF-8745-2020	Kondoh, Shinae/0000-0003-3085-5782; Kondoh, Shinae/0000-0003-3085-5782	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas, Cancer, from the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beilhack A, 2008, BLOOD, V111, P2919, DOI 10.1182/blood-2007-09-112789; Chatterjea-Matthes D, 2003, J IMMUNOL, V171, P1207, DOI 10.4049/jimmunol.171.3.1207; Chavakis E, 2008, J MOL CELL CARDIOL, V45, P514, DOI 10.1016/j.yjmcc.2008.01.004; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Forsberg EC, 2009, HAEMATOL-HEMATOL J, V94, P1477, DOI 10.3324/haematol.2009.013730; Hill GR, 2000, BLOOD, V95, P2754, DOI 10.1182/blood.V95.9.2754.009k25_2754_2759; Ikehara S, 2003, EXP HEMATOL, V31, P1142, DOI 10.1016/j.exphem.2003.08.020; Kalchenko V, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2364903; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Kaplan RN, 2007, TRENDS MOL MED, V13, P72, DOI 10.1016/j.molmed.2006.12.003; Kizaka-Kondoh S, 2009, CLIN CANCER RES, V15, P3433, DOI 10.1158/1078-0432.CCR-08-2267; Kolb HJ, 2008, BLOOD, V112, P4371, DOI 10.1182/blood-2008-03-077974; Kushida T, 2001, BLOOD, V97, P3292, DOI 10.1182/blood.V97.10.3292; Li Q, 2007, STEM CELLS, V25, P1186, DOI 10.1634/stemcells.2006-0354; Murai M, 2003, NAT IMMUNOL, V4, P154, DOI 10.1038/ni879; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Panoskaltsis-Mortari A, 2004, BLOOD, V103, P3590, DOI 10.1182/blood-2003-08-2827; Papayannopoulou T, 2003, CURR OPIN HEMATOL, V10, P214, DOI 10.1097/00062752-200305000-00004; PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647; Pignata C, 2001, BLOOD, V97, P880, DOI 10.1182/blood.V97.4.880; Schlake T, 1997, P NATL ACAD SCI USA, V94, P3842, DOI 10.1073/pnas.94.8.3842; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Srour EF, 2001, LEUKEMIA, V15, P1681, DOI 10.1038/sj.leu.2402256; Steiner D, 2009, STEM CELLS, V27, P1932, DOI 10.1002/stem.111; Stotler C, 2010, BONE MARROW TRANSPL, V45, P49, DOI 10.1038/bmt.2009.95; Vestweber D, 2008, NAT IMMUNOL, V9, P347, DOI 10.1038/ni0408-347; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Zeng LH, 2007, CANCER SCI, V98, P1394, DOI 10.1111/j.1349-7006.2007.00537.x; Zhang Y, 2002, J IMMUNOL, V169, P7111, DOI 10.4049/jimmunol.169.12.7111	30	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11114	10.1371/journal.pone.0011114	http://dx.doi.org/10.1371/journal.pone.0011114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559437	Green Submitted, Green Published, gold			2022-12-27	WOS:000278741100025
J	Yeh, YC; Xie, LP; Langdon, JM; Myers, AC; Oh, SY; Zhu, Z; MacDonald, SM				Yeh, Yueh-Chiao; Xie, Liping; Langdon, Jacqueline M.; Myers, Allen C.; Oh, Sun-Young; Zhu, Zhou; MacDonald, Susan M.			The Effects of Overexpression of Histamine Releasing Factor (HRF) in a Transgenic Mouse Model	PLOS ONE			English	Article							CONTROLLED TUMOR PROTEIN; HUMAN BASOPHILS; MOLECULAR-IDENTIFICATION; CALCIUM-BINDING; MESSENGER-RNA; IN-VITRO; IGE; CELLS; SECRETION; HOMOLOG	Background: Asthma is a disease that affects all ages, races and ethnic groups. Its incidence is increasing both in Westernized countries and underdeveloped countries. It involves inflammation, genetics and environment and therefore, proteins that exacerbate the asthmatic, allergic phenotype are important. Our laboratory purified and cloned a histamine releasing factor (HRF) that was a complete stimulus for histamine and IL-4 secretion from a subpopulation of allergic donors' basophils. Throughout the course of studying HRF, it was uncovered that HRF enhances or primes histamine release and IL-13 production from all anti-IgE antibody stimulated basophils. In order to further delineate the biology of HRF, we generated a mouse model. Methodology/Principal Findings: We constructed an inducible transgenic mouse model with HRF targeted to lung epithelial cells, via the Clara cells. In antigen naive mice, overproduction of HRF yielded increases in BAL macrophages and statistical increases in mRNA levels for MCP-1 in the HRF transgenic mice compared to littermate controls. In addition to demonstrating intracellular HRF in the lung epithelial cells, we have also been able to document HRF's presence extracellularly in the BAL fluid of these transgenic mice. Furthermore, in the OVA challenged model, we show that HRF exacerbates the allergic, asthmatic responses. We found statistically significant increases in serum and BAL IgE, IL-4 protein and eosinophils in transgenic mice compared to controls. Conclusions/Significance: This mouse model demonstrates that HRF expression enhances allergic, asthmatic inflammation and can now be used as a tool to further dissect the biology of HRF.	[Yeh, Yueh-Chiao] Nanhua Univ, Grad Inst Nat Healing Sci, Chiayi, Taiwan; [Langdon, Jacqueline M.; Myers, Allen C.; Oh, Sun-Young; Zhu, Zhou] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Xie, Liping] Aurora Sinai Med Ctr, Milwaukee, WI USA; [MacDonald, Susan M.] Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA	Nanhua University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Yeh, YC (corresponding author), Nanhua Univ, Grad Inst Nat Healing Sci, Chiayi, Taiwan.	smacdona@jhmi.edu		Yeh, Yueh-Chiao/0000-0002-6488-7144	National Institutes of Health Allergy, Immunology (AI) and Heart Lung (HL) [AI3265, HL079349]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079349] Funding Source: NIH RePORTER	National Institutes of Health Allergy, Immunology (AI) and Heart Lung (HL); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by National Institutes of Health Allergy, Immunology (AI) AI3265 and Heart Lung (HL) HL079349. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Bheekha-Escura R, 2000, BLOOD, V96, P2191; Bheekha-Escura R, 1999, J ALLERGY CLIN IMMUN, V103, P937, DOI 10.1016/S0091-6749(99)70442-2; Brusselle GG, 1997, AM J RESP CELL MOL, V17, P767, DOI 10.1165/ajrcmb.17.6.2820; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; CHITPATIMA ST, 1988, NUCLEIC ACIDS RES, V16, P2350, DOI 10.1093/nar/16.5.2350; Cohn L, 1998, J IMMUNOL, V161, P3813; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; Gnanasekar M, 2002, MOL BIOCHEM PARASIT, V121, P107, DOI 10.1016/S0166-6851(02)00027-0; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; ILIOPOULOS O, 1990, J ALLERGY CLIN IMMUN, V86, P851, DOI 10.1016/S0091-6749(05)80146-0; Kang HS, 2001, J IMMUNOL, V166, P6545, DOI 10.4049/jimmunol.166.11.6545; Korkmaz KS, 2002, J BIOL CHEM, V277, P36689, DOI 10.1074/jbc.M202414200; Langdon JM, 2004, BBA-MOL BASIS DIS, V1688, P232, DOI 10.1016/j.bbadis.2003.12.007; MACDONALD SM, 1987, J IMMUNOL, V139, P506; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; MacDonald SM, 2001, P NATL ACAD SCI USA, V98, P10829, DOI 10.1073/pnas.201191498; MACDONALD SM, 1993, ALLERGY PRINCIPLES P, P1; Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018; Min BK, 2008, CURR OPIN HEMATOL, V15, P59, DOI 10.1097/MOH.0b013e3282f13ce8; Moldes M, 2001, J BIOL CHEM, V276, P33938, DOI 10.1074/jbc.M105726200; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Rao KVN, 2002, J BIOL CHEM, V277, P31207, DOI 10.1074/jbc.M204114200; SAMPSON HA, 1989, NEW ENGL J MED, V321, P228, DOI 10.1056/NEJM198907273210405; Schroeder JT, 1997, J IMMUNOL, V159, P447; Schroeder JT, 1996, J EXP MED, V183, P1265, DOI 10.1084/jem.183.3.1265; Schroeder JT, 2001, J ALLERGY CLIN IMMUN, V107, P265, DOI 10.1067/mai.2001.112846; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Teshima S, 1998, J IMMUNOL, V161, P6356; Tuynder M, 2004, P NATL ACAD SCI USA, V101, P15364, DOI 10.1073/pnas.0406776101; Vonakis BM, 2003, J IMMUNOL, V171, P3742, DOI 10.4049/jimmunol.171.7.3742; Wantke F, 1999, J ALLERGY CLIN IMMUN, V103, P642, DOI 10.1016/S0091-6749(99)70237-X; WARNER JA, 1986, J IMMUNOL, V136, P2583; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; YENOFSKY R, 1983, MOL CELL BIOL, V3, P1197, DOI 10.1128/MCB.3.7.1197; Yoneda K, 2004, AM J PHYSIOL-LUNG C, V286, pL174, DOI 10.1152/ajplung.00118.2003; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	37	8	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11077	10.1371/journal.pone.0011077	http://dx.doi.org/10.1371/journal.pone.0011077			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552026	Green Submitted, Green Published, gold			2022-12-27	WOS:000278662900017
J	Torchia, MLG; Ciaglia, E; Masci, AM; Vitiello, L; Fogli, M; la Sala, A; Mavilio, D; Racioppi, L				Torchia, Maria Letizia Giardino; Ciaglia, Elena; Masci, Anna Maria; Vitiello, Laura; Fogli, Manuela; la Sala, Andrea; Mavilio, Domenico; Racioppi, Luigi			Dendritic Cells/Natural Killer Cross-Talk: A Novel Target for Human Immunodeficiency Virus Type-1 Protease Inhibitors	PLOS ONE			English	Article							ATHEROSCLEROTIC LESION FORMATION; HIV-1 PROTEASE; ANTIRETROVIRAL THERAPY; NK CELLS; T-CELLS; INFECTION; MACROPHAGES; DIFFERENTIATION; DYSLIPIDEMIA; ANTIFUNGAL	Background: HIV-1 Protease Inhibitors, namely PIs, originally designed to inhibit HIV-1 aspartic protease, can modulate the immune response by mechanisms largely unknown, and independent from their activity on viral replication. Here, we analyzed the ability of PIs to interfere with differentiation program of monocytes toward dendritic cell (DCs) lineage, a key process in the inflammatory response. Methodology/Principal Findings: Monocytes from healthy donors were isolated and induced to differentiate in vitro in the presence or absence of saquinavir, ritonavir, nelfinavir, indinavir or amprenavir (sqv, rtv, nlfv, idv, apv, respectively). These drugs demonstrated a differential ability to sustain the generation of immature DCs (iDCs) with an altered phenotype, including low levels of CD1a, CD86, CD36 and CD209. DCs generated in the presence of rtv also failed to acquire the typical phenotype of mature DCs (mDCs), and secreted lower amounts of IL-12 and IL-15. Accordingly, these aberrant mDCs failed to support activation of autologous Natural Killer (NK) cells, and resulted highly susceptible to NK cell-mediated cytotoxicity. Conclusions/Significance: Our findings uncover novel functional properties of PIs within the DC-NK cell cross-talk, unveiling the heterogeneous ability of members of this class drugs to drive the generation of atypical monocyte-derived DCs (MDDCs) showing an aberrant phenotype, a failure to respond appropriately to bacterial endotoxin, a weak ability to prime autologous NK cells, and a high susceptibility to NK cell killing. These unexpected properties might contribute to limit inflammation and viral spreading in HIV-1 infected patients under PIs treatment, and open novel therapeutical perspectives for this class drugs as immunomodulators in autoimmunity and cancer.	[Torchia, Maria Letizia Giardino; Ciaglia, Elena; Masci, Anna Maria; Vitiello, Laura; Racioppi, Luigi] Univ Naples Federico 2, Dept Cellular & Mol Biol & Pathol, Naples, Italy; [Masci, Anna Maria; Vitiello, Laura; la Sala, Andrea] IRCCS San Raffaele Pisana, Dept Med Sci & Rehabil, Lab Mol & Cellular Immunol, Rome, Italy; [Fogli, Manuela] Univ Brescia, Microbiol Sect, Dept Expt & Appl Med, Brescia, Italy; [Mavilio, Domenico] Ist Clin Humanitas, IRCCS, Clin & Expt Immunol Lab, Milan, Italy; [Racioppi, Luigi] Univ Naples Federico 2, CISI, Naples, Italy	University of Naples Federico II; IRCCS San Raffaele Pisana; University of Brescia; IRCCS Humanitas Research Hospital; University of Naples Federico II	Torchia, MLG (corresponding author), NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA.	racioppi@unina.it	racioppi, luigi/GNP-0349-2022; Vitiello, Laura/AAB-8836-2019; Ciaglia, E/AAA-7924-2019; Vitiello, Laura/G-7326-2014; la Sala, Andrea/A-3228-2009; racioppi, luigi/AGB-8665-2022; Mavilio, Domenico/E-5194-2017	racioppi, luigi/0000-0002-9207-6752; Vitiello, Laura/0000-0003-0776-3601; Ciaglia, E/0000-0002-8035-4583; Vitiello, Laura/0000-0003-0776-3601; la Sala, Andrea/0000-0003-1268-6516; Mavilio, Domenico/0000-0001-6147-0952; Masci, Anna Maria/0000-0003-1940-6740				Andre P, 1998, P NATL ACAD SCI USA, V95, P13120, DOI 10.1073/pnas.95.22.13120; Arrighi JF, 2004, J EXP MED, V200, P1279, DOI 10.1084/jem.20041356; BUGELSKI PJ, 1994, J LEUKOCYTE BIOL, V56, P374, DOI 10.1002/jlb.56.3.374; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; CHAN SH, 1991, J EXP MED, V173, P869, DOI 10.1084/jem.173.4.869; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; Dash C, 2003, CRIT REV BIOCHEM MOL, V38, P89, DOI 10.1080/713609213; DEGAETANO DK, 2004, LANCET INFECT DIS, V4, P213, DOI DOI 10.1016/S1473-3099(04)00971-5; Dressman J, 2003, J CLIN INVEST, V111, P389, DOI 10.1172/JCI200316261; Engering A, 2002, BLOOD, V100, P1780, DOI 10.1182/blood-2001-12-0179; Fauci AS, 2005, NAT REV IMMUNOL, V5, P835, DOI 10.1038/nri1711; Ferlazzo G, 2004, P NATL ACAD SCI USA, V101, P16606, DOI 10.1073/pnas.0407522101; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Fisher SD, 2006, ATHEROSCLEROSIS, V185, P1, DOI 10.1016/j.atherosclerosis.2005.09.025; Gruber A, 2001, J BIOL CHEM, V276, P47840, DOI 10.1074/jbc.M105582200; Hosseini H, 2001, J NEUROIMMUNOL, V118, P233, DOI 10.1016/S0165-5728(01)00352-6; Hui DY, 2003, J CLIN INVEST, V111, P317, DOI 10.1172/JCI200317746; Katoh N, 2006, CLIN EXP IMMUNOL, V146, P354, DOI 10.1111/j.1365-2249.2006.03197.x; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lagathu C, 2007, ANTIVIR THER, V12, P489; Lambert C, 2008, J IMMUNOL, V181, P8288, DOI 10.4049/jimmunol.181.12.8288; Lu W, 2000, BLOOD, V96, P250, DOI 10.1182/blood.V96.1.250.013k28_250_258; Mancino A, 2008, BLOOD, V112, P3723, DOI 10.1182/blood-2008-02-142091; Masci AM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-70; Mastrolorenzo A, 2007, CURR MED CHEM, V14, P2734, DOI 10.2174/092986707782360141; Mavilio D, 2006, J EXP MED, V203, P2339, DOI 10.1084/jem.20060894; Meroni L, 2005, JAIDS-J ACQ IMM DEF, V38, P310; Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956; Moretta L, 2006, IMMUNOL REV, V214, P219, DOI 10.1111/j.1600-065X.2006.00450.x; Pao V, 2008, CURR ATHEROSCLER REP, V10, P61, DOI 10.1007/s11883-008-0010-6; Pericolini E, 2008, J LEUKOCYTE BIOL, V83, P1286, DOI 10.1189/jlb.0707454; Phenix BN, 2001, BLOOD, V98, P1078, DOI 10.1182/blood.V98.4.1078; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Serghides L, 2002, AIDS, V16, P353, DOI 10.1097/00002030-200202150-00006; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Tasca S, 2003, AIDS, V17, P2291, DOI 10.1097/00002030-200311070-00003; Thomas CM, 2007, CURR OPIN LIPIDOL, V18, P561, DOI 10.1097/MOL.0b013e3282ef604f; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Weichold FF, 1999, J HUMAN VIROL, V2, P261; Whelan KT, 2003, EUR J IMMUNOL, V33, P2520, DOI 10.1002/eji.200323646; Zeldin RK, 2004, J ANTIMICROB CHEMOTH, V53, P4, DOI 10.1093/jac/dkh029	41	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11052	10.1371/journal.pone.0011052	http://dx.doi.org/10.1371/journal.pone.0011052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548796	gold, Green Published, Green Submitted			2022-12-27	WOS:000278599600013
J	Spirig, R; Djafarzadeh, S; Regueira, T; Shaw, SG; von Garnier, C; Takala, J; Jakob, SM; Rieben, R; Lepper, PM				Spirig, Rolf; Djafarzadeh, Siamak; Regueira, Tomas; Shaw, Sidney G.; von Garnier, Christophe; Takala, Jukka; Jakob, Stephan M.; Rieben, Robert; Lepper, Philipp M.			Effects of TLR Agonists on the Hypoxia-Regulated Transcription Factor HIF-1 alpha and Dendritic Cell Maturation under Normoxic Conditions	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; HEPARAN-SULFATE; ENDOTHELIAL GLYCOCALYX; GROWTH-FACTOR; ACTIVATION; HYALURONAN; EXPRESSION; RECEPTOR; TOLL-LIKE-RECEPTOR-4; LIPOPOLYSACCHARIDE	Dendritic cells (DC) are professional antigen presenting cells that represent an important link between innate and adaptive immunity. Danger signals such as toll-like receptor (TLR) agonists induce maturation of DC leading to a T-cell mediated adaptive immune response. In this study, we show that exogenous as well as endogenous inflammatory stimuli for TLR4 and TLR2 induce the expression of HIF-1 alpha in human monocyte-derived DC under normoxic conditions. On the functional level, inhibition of HIF-1 alpha using chetomin (CTM), YC-1 and digoxin lead to no consistent effect on MoDC maturation, or cytokine secretion despite having the common effect of blocking HIF-1 alpha stabilization or activity through different mechanisms. Stabilization of HIF-1 alpha protein by hypoxia or CoCl2 did not result in maturation of human DC. In addition, we could show that TLR stimulation resulted in an increase of HIF-1 alpha controlled VEGF secretion. These results show that stimulation of human MoDC with exogenous as well as endogenous TLR agonists induces the expression of HIF-1 alpha in a time-dependent manner. Hypoxia alone does not induce maturation of DC, but is able to augment maturation after TLR ligation. Current evidence suggests that different target genes may be affected by HIF-1 alpha under normoxic conditions with physiological roles that differ from those induced by hypoxia.	[Spirig, Rolf; Rieben, Robert] Univ Bern, Dept Clin Res, Cardiovasc Res Lab, Bern, Switzerland; [Djafarzadeh, Siamak; Regueira, Tomas; Takala, Jukka; Jakob, Stephan M.; Lepper, Philipp M.] Univ Bern, Dept Clin Res, Lab Intens Care, Bern, Switzerland; [Shaw, Sidney G.] Univ Bern, Dept Clin Res, Lab Vasoact Peptides, Bern, Switzerland; [von Garnier, Christophe] Univ Hosp Bern, Dept Pneumol, CH-3010 Bern, Switzerland; [Djafarzadeh, Siamak; Regueira, Tomas; Takala, Jukka; Jakob, Stephan M.; Lepper, Philipp M.] Univ Hosp Bern, Dept Intens Care Med, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Spirig, R (corresponding author), Univ Bern, Dept Clin Res, Cardiovasc Res Lab, Bern, Switzerland.	philipp.lepper@gmx.de	; Rieben, Robert/D-7044-2017	spirig, rolf/0000-0002-0304-8726; von Garnier, Christophe/0000-0003-3585-9176; Rieben, Robert/0000-0003-4179-8891	Foundation for Research in Anaesthesia and Intensive Care Medicine; EU; Swiss National Science Foundation [3200B0-116618]	Foundation for Research in Anaesthesia and Intensive Care Medicine; EU(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Foundation for Research in Anaesthesia and Intensive Care Medicine (to PL, to SD), the EU 6th Framework Integrated Research Project "Reprogramming the Immune System for the Establishment of Tolerance" (RISET) and the Swiss National Science Foundation grant no. 3200B0-116618 (to RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Beg AA, 2002, TRENDS IMMUNOL, V23, P509, DOI 10.1016/S1471-4906(02)02317-7; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chin K, 1997, ONCOGENE, V15, P437, DOI 10.1038/sj.onc.1201201; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Elia AR, 2008, J LEUKOCYTE BIOL, V84, P1472, DOI 10.1189/jlb.0208082; Feliers D, 2006, AM J PHYSIOL-RENAL, V290, pF927, DOI 10.1152/ajprenal.00331.2005; Hua F, 2008, J NEUROIMMUNOL, V199, P75, DOI 10.1016/j.jneuroim.2008.05.009; Hua F, 2007, J NEUROIMMUNOL, V190, P101, DOI 10.1016/j.jneuroim.2007.08.014; Huang YT, 2005, MOL CANCER THER, V4, P1628, DOI 10.1158/1535-7163.MCT-05-0090; Ihrcke NS, 1996, J CELL PHYSIOL, V168, P625, DOI 10.1002/(SICI)1097-4652(199609)168:3<625::AID-JCP15>3.3.CO;2-A; Jantsch J, 2008, J IMMUNOL, V180, P4697, DOI 10.4049/jimmunol.180.7.4697; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Kaczorowski DJ, 2007, TRANSPLANTATION, V84, P1279, DOI 10.1097/01.tp.0000287597.87571.17; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Luke HJ, 1999, BIOCHEM J, V343, P71, DOI 10.1042/0264-6021:3430071; MANCINO A, BLOOD, V112, P3734; Mansfield KD, 2004, J APPL PHYSIOL, V97, P1358, DOI 10.1152/japplphysiol.00449.2004; MENTZER SJ, 1986, CELL IMMUNOL, V101, P312, DOI 10.1016/0008-8749(86)90144-9; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Nieuwdorp M, 2006, DIABETES, V55, P480, DOI 10.2337/diabetes.55.02.06.db05-1103; Obregon C, 2006, AM J PATHOL, V169, P2127, DOI 10.2353/ajpath.2006.060453; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; PLATT JL, 1991, EUR J IMMUNOL, V21, P2887, DOI 10.1002/eji.1830211135; PLATT JL, 1990, J EXP MED, V171, P1363, DOI 10.1084/jem.171.4.1363; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Regamey N, 2007, AM J RESP CELL MOL, V37, P75, DOI 10.1165/rcmb.2006-0235OC; Rehm M, 2007, CIRCULATION, V116, P1896, DOI 10.1161/CIRCULATIONAHA.106.684852; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Slupski M, 2007, TRANSPL P, V39, P1350, DOI 10.1016/j.transproceed.2007.02.079; Spirig R, 2008, J IMMUNOL, V181, P878, DOI 10.4049/jimmunol.181.2.878; Sun HL, 2007, ONCOGENE, V26, P3941, DOI 10.1038/sj.onc.1210169; Tacchini L, 2008, J BIOL CHEM, V283, P20674, DOI 10.1074/jbc.M800365200; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Thomson AW, 1999, TRANSPLANTATION, V68, P1; Treins C, 2005, MOL ENDOCRINOL, V19, P1304, DOI 10.1210/me.2004-0239; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WU H, J CLIN INVEST, V117, P2847; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105	49	66	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e0010983	10.1371/journal.pone.0010983	http://dx.doi.org/10.1371/journal.pone.0010983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539755	Green Published, gold, Green Submitted			2022-12-27	WOS:000278465900005
J	Burch, N; Arnold, AS; Item, F; Summermatter, S; Santos, GBS; Christe, M; Boutellier, U; Toigo, M; Handschin, C				Burch, Nathalie; Arnold, Anne-Sophie; Item, Flurin; Summermatter, Serge; Santos, Gesa Brochmann Santana; Christe, Martine; Boutellier, Urs; Toigo, Marco; Handschin, Christoph			Electric Pulse Stimulation of Cultured Murine Muscle Cells Reproduces Gene Expression Changes of Trained Mouse Muscle	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; MAMMALIAN SKELETAL-MUSCLE; MESSENGER-RNA EXPRESSION; MITOCHONDRIAL BIOGENESIS; ENERGY-METABOLISM; MYOSIN ISOFORMS; FIBER TYPES; ERR-ALPHA; EXERCISE; PGC-1-ALPHA	Adequate levels of physical activity are at the center of a healthy lifestyle. However, the molecular mechanisms that mediate the beneficial effects of exercise remain enigmatic. This gap in knowledge is caused by the lack of an amenable experimental model system. Therefore, we optimized electric pulse stimulation of muscle cells to closely recapitulate the plastic changes in gene expression observed in a trained skeletal muscle. The exact experimental conditions were established using the peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) as a marker for an endurance-trained muscle fiber. We subsequently compared the changes in the relative expression of metabolic and myofibrillar genes in the muscle cell system with those observed in mouse muscle in vivo following either an acute or repeated bouts of treadmill exercise. Importantly, in electrically stimulated C2C12 mouse muscle cells, the qualitative transcriptional adaptations were almost identical to those in trained muscle, but differ from the acute effects of exercise on muscle gene expression. In addition, significant alterations in the expression of myofibrillar proteins indicate that this stimulation could be used to modulate the fiber-type of muscle cells in culture. Our data thus describe an experimental cell culture model for the study of at least some of the transcriptional aspects of skeletal muscle adaptation to physical activity. This system will be useful for the study of the molecular mechanisms that regulate exercise adaptation in muscle.	[Burch, Nathalie; Arnold, Anne-Sophie; Item, Flurin; Summermatter, Serge; Boutellier, Urs; Toigo, Marco; Handschin, Christoph] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Burch, Nathalie; Arnold, Anne-Sophie; Item, Flurin; Summermatter, Serge; Boutellier, Urs; Toigo, Marco; Handschin, Christoph] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Burch, Nathalie; Item, Flurin; Boutellier, Urs; Toigo, Marco] ETH, Inst Human Movement Sci, Zurich, Switzerland; [Arnold, Anne-Sophie; Summermatter, Serge; Santos, Gesa Brochmann Santana; Christe, Martine; Handschin, Christoph] Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, Basel, Switzerland	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel	Burch, N (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.	christoph.handschin@unibas.ch	Item, Flurin/GSN-0308-2022; Arnold, Anne-Sophie/A-9234-2014; Handschin, Christoph/E-6886-2015; Boutellier, Urs/A-8749-2011; Item, Flurin/H-9870-2012	Arnold, Anne-Sophie/0000-0002-2435-0297; Handschin, Christoph/0000-0003-0603-1097; Summermatter, Serge/0000-0003-4870-0148	Swiss National Science Foundation [SNF PP00A-110746]; Muscular Dystrophy Association USA [MDA68442]; SwissLife "Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung''; Swiss Society for Research on Muscle Diseases (SSEM); United Mitochondrial Disease Foundation (UMDF); Association Francaise contre les myopathies (AFM); University Research Priority Program; Hartmann Muller-Stiftung fur medizinische Forschung; Universities of Basel, Zurich; ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Muscular Dystrophy Association USA(Muscular Dystrophy Association); SwissLife "Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung''; Swiss Society for Research on Muscle Diseases (SSEM); United Mitochondrial Disease Foundation (UMDF); Association Francaise contre les myopathies (AFM)(Association Francaise contre les Myopathies); University Research Priority Program; Hartmann Muller-Stiftung fur medizinische Forschung; Universities of Basel, Zurich; ETH Zurich(ETH Zurich)	The research described in this manuscript was supported by grants from the Swiss National Science Foundation (SNF PP00A-110746 to CH), the Muscular Dystrophy Association USA (MDA68442 to CH), the SwissLife "Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung'' to CH, the Swiss Society for Research on Muscle Diseases (SSEM) to CH, the United Mitochondrial Disease Foundation (UMDF) to CH, the Association Francaise contre les myopathies (AFM) to CH, the University Research Priority Program "Integrative Human Physiology'' at the University of Zurich to UB, MT and CH, the "Hartmann Muller-Stiftung fur medizinische Forschung'' to MT, and the Universities of Basel, Zurich and the ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Booth FW, 2007, PHYSIOL GENOMICS, V28, P146, DOI 10.1152/physiolgenomics.00174.2006; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; Booth FW, 2002, J APPL PHYSIOL, V93, P3, DOI 10.1152/japplphysiol.00073.2002; Cairns SP, 2007, J APPL PHYSIOL, V103, P359, DOI 10.1152/japplphysiol.01267.2006; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Chow LS, 2007, J APPL PHYSIOL, V102, P1078, DOI 10.1152/japplphysiol.00791.2006; Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001; Coffey VG, 2006, INT J SPORT PHYSIOL, V1, P284, DOI 10.1123/ijspp.1.3.284; Coffey VG, 2006, AM J PHYSIOL-ENDOC M, V290, pE849, DOI 10.1152/ajpendo.00299.2005; Consitt LA, 2009, IUBMB LIFE, V61, P47, DOI 10.1002/iub.142; Corpeleijn E, 2009, OBES REV, V10, P178, DOI 10.1111/j.1467-789X.2008.00544.x; Ebeling P, 1998, FEBS LETT, V436, P301, DOI 10.1016/S0014-5793(98)01149-1; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fluck M, 2006, J EXP BIOL, V209, P2239, DOI 10.1242/jeb.02149; Fluck M, 2003, REV PHYSIOL BIOCH P, V146, P159, DOI 10.1007/s10254-002-0004-7; Fujita H, 2007, EXP CELL RES, V313, P1853, DOI 10.1016/j.yexcr.2007.03.002; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; HANDSCHIN C, 2010, J RECEPT SI IN PRESS; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Handschin C, 2009, TRENDS PHARMACOL SCI, V30, P322, DOI 10.1016/j.tips.2009.03.006; HOH JFY, 1991, NEWS PHYSIOL SCI, V6, P1; Holloway GP, 2009, APPL PHYSIOL NUTR ME, V34, P440, DOI 10.1139/H09-028; Hood DA, 2006, J EXP BIOL, V209, P2265, DOI 10.1242/jeb.02182; HOWALD H, 1982, INT J SPORTS MED, V3, P1, DOI 10.1055/s-2008-1026053; Huang YC, 2006, AM J PHYSIOL-CELL PH, V291, pC11, DOI 10.1152/ajpcell.00366.2005; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; IVY JL, 1991, SPORTS MED, V11, P6, DOI 10.2165/00007256-199111010-00002; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Marotta M, 2004, BIOTECHNIQUES, V36, P68, DOI 10.2144/04361ST01; Matsuoka Y, 2008, CELL TISSUE RES, V332, P123, DOI 10.1007/s00441-008-0582-z; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; NAUMANN K, 1994, DIFFERENTIATION, V55, P203, DOI 10.1046/j.1432-0436.1994.5530203.x; NEDACHI T, 2009, AM J PHYSL ENDOCRINO; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; Nielsen JN, 2003, ACTA PHYSIOL SCAND, V178, P309, DOI 10.1046/j.1365-201X.2003.01165.x; Norrbom J, 2004, J APPL PHYSIOL, V96, P189, DOI 10.1152/japplphysiol.00765.2003; Park H, 2008, J TISSUE ENG REGEN M, V2, P279, DOI 10.1002/term.93; Partridge T, 2005, J PHYSIOL-LONDON, V562, P646, DOI 10.1113/jphysiol.2004.080671; Pedrotty DM, 2005, AM J PHYSIOL-HEART C, V288, pH1620, DOI 10.1152/ajpheart.00610.2003; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Pette D, 2001, HISTOCHEM CELL BIOL, V115, P359, DOI 10.1007/s004180100268; Pilegaard H, 2005, METABOLISM, V54, P1048, DOI 10.1016/j.metabol.2005.03.008; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Putman CT, 2000, AM J PHYSIOL-CELL PH, V279, pC682, DOI 10.1152/ajpcell.2000.279.3.C682; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Santos JM, 2008, INT J SPORTS MED, V29, P785, DOI 10.1055/s-2008-1038404; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Silveira LR, 2006, BBA-MOL CELL RES, V1763, P969, DOI 10.1016/j.bbamcr.2006.06.010; Spangenburg EE, 2003, ACTA PHYSIOL SCAND, V178, P413, DOI 10.1046/j.1365-201X.2003.01158.x; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Staron RS, 1997, CAN J APPL PHYSIOL, V22, P307, DOI 10.1139/h97-020; Stern-Straeter J, 2005, J CELL MOL MED, V9, P883, DOI 10.1111/j.1582-4934.2005.tb00386.x; Taylor EB, 2005, AM J PHYSIOL-ENDOC M, V289, pE960, DOI 10.1152/ajpendo.00237.2005; Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1; Thelen MHM, 1997, BIOCHEM J, V321, P845, DOI 10.1042/bj3210845; THOMAS PE, 1993, MUSCLE NERVE, V16, P193, DOI 10.1002/mus.880160213; Vissing K, 2004, FASEB J, V18, P94, DOI 10.1096/fj.04-2084fje; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; YAMAGUCHI T, 2009, AM J PHYSL CELL PHYS	71	59	64	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10970	10.1371/journal.pone.0010970	http://dx.doi.org/10.1371/journal.pone.0010970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532042	Green Accepted, Green Published, gold			2022-12-27	WOS:000278380500014
J	Harp, JR; Onami, TM				Harp, John R.; Onami, Thandi M.			Naive T Cells Re-Distribute to the Lungs of Selectin Ligand Deficient Mice	PLOS ONE			English	Article							LEUKOCYTE-ADHESION-DEFICIENCY; FUCOSYL-TRANSFERASE-VII; NONLYMPHOID TISSUES; P-SELECTIN; TH1 CELLS; INTERLEUKIN-7 RECEPTOR; IMMUNE-RESPONSES; BONE-MARROW; FUC-TVII; EXPRESSION		[Harp, John R.; Onami, Thandi M.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Harp, JR (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	tonami@utk.edu			University of Tennessee;  [AI05771901]	University of Tennessee; 	This work was supported by AI05771901 and University of Tennessee start-up funds to Thandi M. Onami and in part by the NIGMS Consortium for Functional Glycomics. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdian S, 2006, AM J PHYSIOL-LUNG C, V291, pL828, DOI 10.1152/ajplung.00120.2006; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Becker TC, 2005, J IMMUNOL, V174, P1269, DOI 10.4049/jimmunol.174.3.1269; Beeh KM, 2006, PULM PHARMACOL THER, V19, P233, DOI 10.1016/j.pupt.2005.07.004; Benner R., 1981, IMMUNOLOGICAL METHOD, VII, P247; Cai YH, 2006, J IMMUNOL, V176, P6568, DOI 10.4049/jimmunol.176.11.6568; Clark JG, 2004, AM J RESP CELL MOL, V30, P220, DOI 10.1165/rcmb.2003-0208OC; Cose S, 2006, EUR J IMMUNOL, V36, P1423, DOI 10.1002/eji.200535539; Cox DP, 2008, ORAL SURG ORAL MED O, V105, P86, DOI 10.1016/j.tripleo.2007.02.026; Curtis JL, 2002, J IMMUNOL, V169, P2570, DOI 10.4049/jimmunol.169.5.2570; Di Rosa F, 2005, TRENDS IMMUNOL, V26, P360, DOI 10.1016/j.it.2005.04.011; Doerschuk C M, 2000, Respir Res, V1, P136, DOI 10.1186/rr24; DOERSCHUK CM, 1993, J APPL PHYSIOL, V74, P3040, DOI 10.1152/jappl.1993.74.6.3040; Erdmann I, 2002, J IMMUNOL, V168, P2139, DOI 10.4049/jimmunol.168.5.2139; Fabre S, 2008, J IMMUNOL, V181, P2980, DOI 10.4049/jimmunol.181.5.2980; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Greter M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000109; Halle S, 2009, J EXP MED, V206, P2593, DOI 10.1084/jem.20091472; Hofmann M, 2006, INT IMMUNOPHARMACOL, V6, P1902, DOI 10.1016/j.intimp.2006.07.030; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kocks JR, 2007, J EXP MED, V204, P723, DOI 10.1084/jem.20061424; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Lowe JB, 2003, CURR OPIN CELL BIOL, V15, P531, DOI 10.1016/j.ceb.2003.08.002; Lowe JB, 2002, IMMUNOL REV, V186, P19, DOI 10.1034/j.1600-065X.2002.18603.x; Lowe JB, 2001, CELL, V104, P809, DOI 10.1016/S0092-8674(01)00277-X; Luettig B, 2001, AM J RESP CELL MOL, V25, P69, DOI 10.1165/ajrcmb.25.1.4414; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/ng0501-69; M'Rini C, 2003, J EXP MED, V198, P1301, DOI 10.1084/jem.20030182; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Mitoma J, 2007, NAT IMMUNOL, V8, P409, DOI 10.1038/ni1442; Movahedi M, 2007, J CLIN IMMUNOL, V27, P302, DOI 10.1007/s10875-006-9069-4; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Naess A, 1999, SCAND J INFECT DIS, V31, P600, DOI 10.1080/00365549950164535; Onami TM, 2002, J IMMUNOL, V168, P6022, DOI 10.4049/jimmunol.168.12.6022; Pabst R, 2002, J ALLERGY CLIN IMMUN, V110, P209, DOI 10.1067/mai.2002.126836; Pabst R, 1988, Adv Exp Med Biol, V237, P553; Pabst R., 2008, ALLERGY ALLERGIC DIS, P1214; Piccio L, 2005, J IMMUNOL, V174, P5805, DOI 10.4049/jimmunol.174.9.5805; Ravnic DJ, 2007, J THORAC CARDIOV SUR, V133, P97, DOI 10.1016/j.jtcvs.2006.08.054; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Romano Suzanne J, 2005, Treat Respir Med, V4, P85, DOI 10.2165/00151829-200504020-00002; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Schreiber T, 2006, J IMMUNOL, V176, P1131, DOI 10.4049/jimmunol.176.2.1131; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Sikora L, 2003, AM J PATHOL, V162, P2019, DOI 10.1016/S0002-9440(10)64334-9; Smithson G, 2001, J EXP MED, V194, P601, DOI 10.1084/jem.194.5.601; Suvas PK, 2007, J IMMUNOL, V179, P8122, DOI 10.4049/jimmunol.179.12.8122; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Tschernig Thomas, 2009, BMC Pulm Med, V9, P39, DOI 10.1186/1471-2466-9-39; Underhill GH, 2005, BLOOD, V106, P3867, DOI 10.1182/blood-2005-03-0984; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2009, J BIOCHEM, V145, P643, DOI 10.1093/jb/mvp022; Weninger W, 2003, SEMIN IMMUNOL, V15, P257, DOI 10.1016/j.smim.2003.08.007; Westermann J, 2001, IMMUNOL REV, V184, P20, DOI 10.1034/j.1600-065x.2001.1840103.x; Westermann J, 2001, ANN INTERN MED, V135, P279, DOI 10.7326/0003-4819-135-4-200108210-00013; White SJ, 2001, J IMMUNOL, V167, P628, DOI 10.4049/jimmunol.167.2.628; Wolber FM, 1998, J IMMUNOL, V161, P4396; Yakubenia S, 2008, BLOOD, V112, P1472, DOI 10.1182/blood-2008-01-132035; Yakubenia S, 2006, FEBS J, V273, P4390, DOI 10.1111/j.1742-4658.2006.05438.x	69	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10973	10.1371/journal.pone.0010973	http://dx.doi.org/10.1371/journal.pone.0010973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532047	gold, Green Published			2022-12-27	WOS:000278380500017
J	Chang, LW; Kagaayi, J; Nakigozi, G; Ssempijja, V; Packer, AH; Serwadda, D; Quinn, TC; Gray, RH; Bollinger, RC; Reynolds, SJ				Chang, Larry W.; Kagaayi, Joseph; Nakigozi, Gertrude; Ssempijja, Victor; Packer, Arnold H.; Serwadda, David; Quinn, Thomas C.; Gray, Ronald H.; Bollinger, Robert C.; Reynolds, Steven J.			Effect of Peer Health Workers on AIDS Care in Rakai, Uganda: A Cluster-Randomized Trial	PLOS ONE			English	Article							IMPLEMENTATION RESEARCH; HIV PREVENTION; AFRICA; INTERVENTIONS; METAANALYSIS; ADHERENCE; COUNTRIES	Background: Human resource limitations are a challenge to the delivery of antiretroviral therapy (ART) in low-resource settings. We conducted a cluster randomized trial to assess the effect of community-based peer health workers (PHW) on AIDS care of adults in Rakai, Uganda. Methodology/Principal Findings: 15 AIDS clinics were randomized 2: 1 to receive the PHW intervention (n = 10) or control (n = 5). PHW tasks included clinic and home-based provision of counseling, clinical, adherence to ART, and social support. Primary outcomes were adherence and cumulative risk of virologic failure (>400 copies/mL). Secondary outcomes were virologic failure at each 24 week time point up to 192 weeks of ART. Analysis was by intention to treat. From May 2006 to July 2008, 1336 patients were followed. 444 (33%) of these patients were already on ART at the start of the study. No significant differences were found in lack of adherence (<95% pill count adherence risk ratio [RR] 0.55, 95% confidence interval [CI] 0.23-1.35; <100% adherence RR 1.10, 95% CI 0.94-1.30), cumulative risk of virologic failure (RR 0.81, 95% CI 0.61-1.08) or in shorter-term virologic outcomes (24 week virologic failure RR 0.93, 95% CI 0.65-1.32; 48 week, RR 0.83, 95% CI 0.47-1.48; 72 week, RR 0.81, 95% CI 0.44-1.49). However, virologic failure rates >= 96 weeks into ART were significantly decreased in the intervention arm compared to the control arm (96 week failure RR 0.50, 95% CI 0.31-0.81; 120 week, RR 0.59, 95% CI 0.22-1.60; 144 week, RR 0.39, 95% CI 0.16-0.95; 168 week, RR 0.30, 95% CI 0.097-0.92; 192 week, RR 0.067, 95% CI 0.0065-0.71). Conclusions/Significance: A PHW intervention was associated with decreased virologic failure rates occurring 96 weeks and longer into ART, but did not affect cumulative risk of virologic failure, adherence measures, or shorter-term virologic outcomes. PHWs may be an effective intervention to sustain long-term ART in low-resource settings.	[Chang, Larry W.; Quinn, Thomas C.; Bollinger, Robert C.; Reynolds, Steven J.] Johns Hopkins Sch Med, Div Infect Dis, Baltimore, MD USA; [Kagaayi, Joseph; Nakigozi, Gertrude; Ssempijja, Victor; Serwadda, David] Rakai Hlth Sci Program, Kalisizo, Uganda; [Packer, Arnold H.] Johns Hopkins Univ, Baltimore, MD USA; [Quinn, Thomas C.; Reynolds, Steven J.] NIAID, Immunoregulat Lab, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Gray, Ronald H.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Rakai Health Sciences Program; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Chang, LW (corresponding author), Johns Hopkins Sch Med, Div Infect Dis, Baltimore, MD USA.	lchang8@jhmi.edu		Bollinger, Robert/0000-0002-6798-6834; Reynolds, Steven/0000-0002-5403-2759	Doris Duke Charitable Foundation; Division of Intramural Research, The National Institute for Allergy and Infectious Diseases, National Institutes of Health; National Institutes of Health [2 T32-AI07291, 1 K23-MH086338]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000361, ZIAAI001040, T32AI007291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH086338] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Division of Intramural Research, The National Institute for Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the Doris Duke Charitable Foundation, The Division of Intramural Research, The National Institute for Allergy and Infectious Diseases, National Institutes of Health, and a National Institutes of Health Training Grant (2 T32-AI07291) and Career Development Grant (1 K23-MH086338). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Bangsberg DR, 2008, J INFECT DIS, V197, pS272, DOI 10.1086/533415; Barnighausen T, 2007, AIDS PATIENT CARE ST, V21, P799, DOI 10.1089/apc.2007.0193; Bisson GP, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000174; Chang LW, 2008, AIDS PATIENT CARE ST, V22, P173, DOI 10.1089/apc.2007.0234; Chang LVW, 2009, JAIDS-J ACQ IMM DEF, V50, P276, DOI 10.1097/QAI.0b013e3181988375; Chang Larry William, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P130, DOI 10.1177/1545109708318525; Cooper D, 2007, LANCET, V370, P7, DOI 10.1016/S0140-6736(07)61024-1; Gallant J E, 1998, J Int Assoc Physicians AIDS Care, V4, P32; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hayes RJ, 2009, INTERD STAT, P3; Lewin SA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub2; McCarthy EA, 2006, PLOS MED, V3, P989, DOI 10.1371/journal.pmed.0030304; Medley A, 2009, AIDS EDUC PREV, V21, P181, DOI 10.1521/aeap.2009.21.3.181; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mukherjee JS, 2007, AIDS CARE, V19, pS73, DOI 10.1080/09540120601114485; Oakley A, 2006, BRIT MED J, V332, P413, DOI 10.1136/bmj.332.7538.413; REYNOLDS SJ, 2006, 16 INT AIDS C TOR; Sanders D, 2006, PLOS MED, V3, P719, DOI 10.1371/journal.pmed.0030186; Todd J, 2003, INT J EPIDEMIOL, V32, P755, DOI 10.1093/ije/dyg150; *WHO, 2004, SCAL HIV AIDS CAR SE; Wilson DP, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-16; World Health Organisation, 2007, GLOB REC GUID TASK S; World Health Organization, 2007, ESSENTIAL PREVENTION; World Health Organization, 2006, ANT THER HIV INF AD; Zachariah R, 2009, LANCET INFECT DIS, V9, P711, DOI 10.1016/S1473-3099(09)70229-4; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	26	130	130	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2010	5	6							e10923	10.1371/journal.pone.0010923	http://dx.doi.org/10.1371/journal.pone.0010923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	604NC	20532194	Green Published, Green Submitted, gold			2022-12-27	WOS:000278284700006
J	Es-Salah-Lamoureux, Z; Fougere, R; Xiong, PY; Robertson, GA; Fedida, D				Es-Salah-Lamoureux, Zeineb; Fougere, Robert; Xiong, Ping Yu; Robertson, Gail A.; Fedida, David			Fluorescence-Tracking of Activation Gating in Human ERG Channels Reveals Rapid S4 Movement and Slow Pore Opening	PLOS ONE			English	Article							HERG K+ CHANNELS; VOLTAGE-CLAMP FLUOROMETRY; GATED POTASSIUM CHANNEL; CONFORMATIONAL-CHANGES; CARDIAC-ARRHYTHMIA; ION CHANNELS; INACTIVATION; SENSOR; MECHANISM; CURRENTS	Background: hERG channels are physiologically important ion channels which mediate cardiac repolarization as a result of their unusual gating properties. These are very slow activation compared with other mammalian voltage-gated potassium channels, and extremely rapid inactivation. The mechanism of slow activation is not well understood and is investigated here using fluorescence as a direct measure of S4 movement and pore opening. Methods and Findings: Tetramethylrhodamine-5-maleimide (TMRM) fluorescence at E519 has been used to track S4 voltage sensor movement, and channel opening and closing in hERG channels. Endogenous cysteines (C445 and C449) in the S1-S2 linker bound TMRM, which caused a 10 mV hyperpolarization of the V(1/2) of activation to -27.5 +/- 2.0 mV, and showed voltage-dependent fluorescence signals. Substitution of S1-S2 linker cysteines with valines allowed unobstructed recording of S3-S4 linker E519C and L520C emission signals. Depolarization of E519C channels caused rapid initial fluorescence quenching, fit with a double Boltzmann relationship, F-V(ON), with V(1/2),(1) = -37.8 +/- 1.7 mV, and V(1/2,2) = 43.5 +/- 7.9 mV. The first phase, VK(1/2,1), was similar to 20 mV negative to the conductance-voltage relationship measured from ionic tail currents (G-V(1/2) = -18.3 +/- 1.2 mV), and relatively unchanged in a non-inactivating E519C:S620T mutant (V(1/2) = -34.4 +/- 1.5 mV), suggesting the fast initial fluorescence quenching tracked S4 voltage sensor movement. The second phase of rapid quenching was absent in the S620T mutant. The E519C fluorescence upon repolarization (V(1/2) = -20.6 +/- 1.2, k = 11.4 mV) and L520C quenching during depolarization (V(1/2) = 226.8 +/- 1.0, k = 13.3 mV) matched the respective voltage dependencies of hERG ionic tails, and deactivation time constants from -40 to -110 mV, suggesting they detected pore-S4 rearrangements related to ionic current flow during pore opening and closing. Conclusion: The data indicate: 1) that rapid environmental changes occur at the outer end of S4 in hERG channels that underlie channel activation gating, and 2) that secondary slower changes reflect channel pore opening during sustained depolarizations, and channel closing upon repolarization. 3) No direct evidence was obtained of conformational changes related to inactivation from fluorophores attached at the outer end of S4.	[Es-Salah-Lamoureux, Zeineb; Fougere, Robert; Xiong, Ping Yu; Fedida, David] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Robertson, Gail A.] Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA	University of British Columbia; University of Wisconsin System; University of Wisconsin Madison	Es-Salah-Lamoureux, Z (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada.	fedida@interchange.ubc.ca	Es-Salah-Lamoureux, Zeineb/D-3908-2015	Es-Salah-Lamoureux, Zeineb/0000-0003-4530-6655; Robertson, Gail/0000-0003-4694-5790	Canadian Institutes of Health Research; Heart and the Stroke Foundation of British Columbia and Yukon; National Institutes of Health [HL081780]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081780] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and the Stroke Foundation of British Columbia and Yukon; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the Canadian Institutes of Health Research and the Heart and the Stroke Foundation of British Columbia and Yukon to D. Fedida, and by the National Institutes of Health grant HL081780 to G. A. Robertson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anumonwo JMB, 1999, BIOPHYS J, V77, P282, DOI 10.1016/S0006-3495(99)76889-X; Bannister JPA, 2005, P NATL ACAD SCI USA, V102, P18718, DOI 10.1073/pnas.0505766102; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Choveau FS, 2009, BIOPHYS J, V97, P1323, DOI 10.1016/j.bpj.2009.05.060; Clarke CE, 2006, J PHYSIOL-LONDON, V573, P291, DOI 10.1113/jphysiol.2006.108332; Claydon TW, 2007, BIOCHEM SOC T, V35, P1080, DOI 10.1042/BST0351080; Claydon TW, 2007, J GEN PHYSIOL, V129, P437, DOI 10.1085/jgp.200709774; Claydon TW, 2007, J PHARMACOL EXP THER, V320, P162, DOI 10.1124/jpet.106.110411; Elliott DJS, 2009, MOL MEMBR BIOL, V26, P435, DOI 10.3109/09687680903321081; Ficker E, 1998, CIRC RES, V82, P386, DOI 10.1161/01.RES.82.3.386; Furutani M, 1999, CIRCULATION, V99, P2290, DOI 10.1161/01.CIR.99.17.2290; Gandhi CS, 2000, NEURON, V27, P585, DOI 10.1016/S0896-6273(00)00068-4; Hesketh JC, 1999, AM J PHYSIOL-HEART C, V277, pH1956, DOI 10.1152/ajpheart.1999.277.5.H1956; Hill AP, 2007, BIOPHYS J, V92, P3915, DOI 10.1529/biophysj.106.101956; Horne AJ, 2009, CAN J PHYSIOL PHARM, V87, P411, DOI [10.1139/y09-024, 10.1139/Y09-024]; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Jiang M, 1999, AM J PHYSIOL-HEART C, V277, pH1283, DOI 10.1152/ajpheart.1999.277.4.H1283; Johnson JP, 1999, J GEN PHYSIOL, V113, P565, DOI 10.1085/jgp.113.4.565; Johnson JP, 2001, J NEUROSCI, V21, P4143, DOI 10.1523/JNEUROSCI.21-12-04143.2001; Ju PC, 2009, J BIOL CHEM, V284, P1000, DOI 10.1074/jbc.M806400200; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Liu J, 2003, J GEN PHYSIOL, V121, P599, DOI 10.1085/jgp.200308788; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Nakajima T, 1999, CARDIOVASC RES, V44, P283, DOI 10.1016/S0008-6363(99)00195-9; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Perrin MJ, 2008, MOL PHARMACOL, V74, P1443, DOI 10.1124/mol.108.049056; Piper DR, 2005, J BIOL CHEM, V280, P7206, DOI 10.1074/jbc.M411042200; Piper DR, 2003, P NATL ACAD SCI USA, V100, P10534, DOI 10.1073/pnas.1832721100; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Smith PL, 2002, J GEN PHYSIOL, V119, P275, DOI 10.1085/jgp.119.3.275; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Subbiah RN, 2004, J PHYSIOL-LONDON, V558, P417, DOI 10.1113/jphysiol.2004.062588; Thomas D, 2004, BRIT J PHARMACOL, V142, P485, DOI 10.1038/sj.bjp.0705795; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Vaid M, 2008, J GEN PHYSIOL, V132, P209, DOI 10.1085/jgp.200809978; WARMKE J, 1991, SCIENCE, V252, P1560, DOI 10.1126/science.1840699; Wynia-Smith SL, 2008, J GEN PHYSIOL, V132, P507, DOI 10.1085/jgp.200810083; Yi H, 2007, J PROTEOME RES, V6, P611, DOI 10.1021/pr060368g; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; Zhang M, 2005, J MEMBRANE BIOL, V207, P169, DOI 10.1007/s00232-005-0812-1; Zhang M, 2004, J GEN PHYSIOL, V124, P703, DOI 10.1085/jgp.200409119; Zhao JT, 2009, J CARDIOVASC ELECTR, V20, P923, DOI 10.1111/j.1540-8167.2009.01468.x; Zhuang XW, 2000, P NATL ACAD SCI USA, V97, P14241, DOI 10.1073/pnas.97.26.14241; Zou AR, 1998, J PHYSIOL-LONDON, V509, P129, DOI 10.1111/j.1469-7793.1998.129bo.x	47	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10876	10.1371/journal.pone.0010876	http://dx.doi.org/10.1371/journal.pone.0010876			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526358	Green Published, gold, Green Submitted			2022-12-27	WOS:000278222100007
J	Wang, YH; Gorvel, JP; Chu, YT; Wu, JJ; Lei, HY				Wang, Ya-Hui; Gorvel, Jean-Pierre; Chu, Yen-Ting; Wu, Jiunn-Jong; Lei, Huan-Yao			Helicobacter pylori Impairs Murine Dendritic Cell Responses to Infection	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; HOMOTYPIC PHAGOSOME FUSION; GASTRIC EPITHELIAL-CELLS; MACROPHAGES; INDUCTION; TOLL-LIKE-RECEPTOR-4; PHAGOCYTOSIS; INFLAMMATION; CHOLESTEROL; INHIBITION	Background: Helicobacter pylori, a human pathogen associated with chronic gastritis, peptic ulcer and gastric malignancies, is generally viewed as an extracellular microorganism. Here, we show that H. pylori replicates in murine bone marrow derived-dendritic cells (BMDCs) within autophagosomes. Methodology/Principal Findings: A 10-fold increase of CFU is found between 2 h and 6 h p.i. in H. pylori-infected BMDCs. Autophagy is induced around the bacterium and participates at late time points of infection for the clearance of intracellular H. pylori. As a consequence of infection, LC3, LAMP1 and MHC class II molecules are retained within the H. pylori-containing vacuoles and export of MHC class II molecules to cell surface is blocked. However, formalin-fixed H. pylori still maintain this inhibitory activity in BMDC derived from wild type mice, but not in from either TLR4 or TLR2-deficient mice, suggesting the involvement of H. pylori-LPS in this process. TNF-alpha, IL-6 and IL-10 expression was also modulated upon infection showing a TLR2-specific dependent IL-10 secretion. No IL-12 was detected favoring the hypothesis of a down modulation of DC functions during H. pylori infection. Furthermore, antigen-specific T cells proliferation was also impaired upon infection. Conclusions/Significance: H. pylori can infect and replicate in BMDCs and thereby affects DC-mediated immune responses. The implication of this new finding is discussed for the biological life cycle of H. pylori in the host.	[Wang, Ya-Hui] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Gorvel, Jean-Pierre] Aix Marseille Univ, Fac Sci Luminy, CIMI, UMR6546, Marseille, France; [Gorvel, Jean-Pierre] INSERM, U631, F-13258 Marseille, France; [Gorvel, Jean-Pierre] CNRS, UMR6102, Marseille, France; [Chu, Yen-Ting; Lei, Huan-Yao] Natl Cheng Kung Univ, Dept Microbiol, Tainan 70101, Taiwan; [Chu, Yen-Ting; Lei, Huan-Yao] Natl Cheng Kung Univ, Dept Immunol, Tainan 70101, Taiwan; Natl Cheng Kung Univ, Coll Med, Tainan 70101, Taiwan	National Cheng Kung University; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Wang, YH (corresponding author), Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan.	hylei@mail.ncku.edu.tw	Wu, Jiunn-Jong/E-6075-2011; Gorvel, Jean-Pierre/O-1332-2018	Gorvel, Jean-Pierre/0000-0002-2829-9804	National Science Council, Taiwan [NSC95-2320-B-006-063-MY2, NSC98-2320-B006-031-MY2]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by NSC95-2320-B-006-063-MY2 and NSC98-2320-B006-031-MY2 from National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algood HMS, 2006, CLIN MICROBIOL REV, V19, P597, DOI 10.1128/CMR.00006-06; Allen LAH, 2000, J EXP MED, V191, P115, DOI 10.1084/jem.191.1.115; Allen LAH, 2007, CELL MICROBIOL, V9, P817, DOI 10.1111/j.1462-5822.2007.00906.x; Bergman M, 2006, NAT REV MICROBIOL, V4, P151, DOI 10.1038/nrmicro1344; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Dubois A, 2007, CELL MICROBIOL, V9, P1108, DOI 10.1111/j.1462-5822.2007.00921.x; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Goluszko P, 2005, INFECT IMMUN, V73, P7791, DOI 10.1128/IAI.73.12.7791-7796.2005; Gong J, 2010, J STRUCT BIOL, V169, P323, DOI 10.1016/j.jsb.2009.12.007; Guiney DG, 2003, INFECT IMMUN, V71, P4163, DOI 10.1128/IAI.71.7.4163-4166.2003; Hafsi N, 2004, J IMMUNOL, V173, P1249, DOI 10.4049/jimmunol.173.2.1249; Kao JY, 2006, AM J PHYSIOL-GASTR L, V291, pG73, DOI 10.1152/ajpgi.00139.2005; Koppelman B, 1997, IMMUNITY, V7, P861, DOI 10.1016/S1074-7613(00)80404-5; Kranzer K, 2004, INFECT IMMUN, V72, P4416, DOI 10.1128/IAI.72.8.4416-4423.2004; Kwok T, 2002, INFECT IMMUN, V70, P2108, DOI 10.1128/IAI.70.4.2108-2120.2002; Lai CH, 2008, INFECT IMMUN, V76, P3293, DOI 10.1128/IAI.00365-08; Lepper PM, 2005, CELL MICROBIOL, V7, P519, DOI 10.1111/j.1462-5822.2005.00482.x; Li Y, 2008, J IMMUNOL, V181, P2781, DOI 10.4049/jimmunol.181.4.2781; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mandell L, 2004, INFECT IMMUN, V72, P6446, DOI 10.1128/IAI.72.11.6446-6454.2004; Mitchell P, 2007, INFECT IMMUN, V75, P810, DOI 10.1128/IAI.00228-06; Molinari M, 1998, J EXP MED, V187, P135, DOI 10.1084/jem.187.1.135; Moran AP, 2008, CARBOHYD RES, V343, P1952, DOI 10.1016/j.carres.2007.12.012; Obonyo M, 2007, INFECT IMMUN, V75, P2408, DOI 10.1128/IAI.01794-06; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Petersen AM, 2003, FEMS IMMUNOL MED MIC, V36, P117, DOI 10.1016/S0928-8244(03)00020-8; PHILIP S, 2000, INFECT IMMUN, V68, P4802; Pulendran B, 2005, J IMMUNOL, V174, P2457, DOI 10.4049/jimmunol.174.5.2457; Rad R, 2007, GASTROENTEROLOGY, V133, P150, DOI 10.1053/j.gastro.2007.04.071; Rittig MG, 2003, CELL MICROBIOL, V5, P887, DOI 10.1046/j.1462-5822.2003.00328.x; Sallusto F, 1999, J EXP MED, V189, P611, DOI 10.1084/jem.189.4.611; Schwartz JT, 2006, J LEUKOCYTE BIOL, V79, P1214, DOI 10.1189/jlb.0106030; Sendide K, 2005, J IMMUNOL, V175, P5324, DOI 10.4049/jimmunol.175.8.5324; Shiratsuchi A, 2004, J IMMUNOL, V172, P2039, DOI 10.4049/jimmunol.172.4.2039; Smythies LE, 2000, J IMMUNOL, V165, P1022, DOI 10.4049/jimmunol.165.2.1022; Steinberg BE, 2008, J CLIN INVEST, V118, P2002, DOI 10.1172/JCI35433; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tan MP, 2008, INFECT IMMUN, V76, P1289, DOI 10.1128/IAI.00779-07; Uno K, 2007, AM J PHYSIOL-GASTR L, V293, pG1004, DOI 10.1152/ajpgi.00096.2007; Wang YH, 2009, EXP BIOL MED, V234, P171, DOI 10.3181/0808-RM-252; Wunder C, 2006, NAT MED, V12, P1030, DOI 10.1038/nm1480; Yeung T, 2007, IMMUNOL REV, V219, P17, DOI 10.1111/j.1600-065X.2007.00546.x; Yokota SI, 2007, FEMS IMMUNOL MED MIC, V51, P140, DOI 10.1111/j.1574-695X.2007.00288.x; Zheng PY, 2003, CELL MICROBIOL, V5, P25, DOI 10.1046/j.1462-5822.2003.00250.x	49	19	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10844	10.1371/journal.pone.0010844	http://dx.doi.org/10.1371/journal.pone.0010844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523725	Green Published, Green Submitted, gold			2022-12-27	WOS:000278221900007
J	Lin, YP; McDonough, SP; Sharma, Y; Chang, YF				Lin, Yi-Pin; McDonough, Sean P.; Sharma, Yogendra; Chang, Yung-Fu			The Terminal Immunoglobulin-Like Repeats of LigA and LigB of Leptospira Enhance Their Binding to Gelatin Binding Domain of Fibronectin and Host Cells	PLOS ONE			English	Article							PROTEIN-A; MOLECULAR CHARACTERIZATION; BACTERIAL ADHERENCE; C-TERMINUS; INTERROGANS; AFFINITY; LIPL32; REGION; ADHESIN; EXPRESSION	Leptospira spp. are pathogenic spirochetes that cause the zoonotic disease leptospirosis. Leptospiral immunoglobulin (Ig)like protein B (LigB) contributes to the binding of Leptospira to extracellular matrix proteins such as fibronectin, fibrinogen, laminin, elastin, tropoelastin and collagen. A high-affinity Fn-binding region of LigB has been localized to LigBCen2, which contains the partial 11th and full 12th Ig-like repeats (LigBCen2R) and 47 amino acids of the non-repeat region (LigBCen2NR) of LigB. In this study, the gelatin binding domain of fibronectin was shown to interact with LigBCen2R (KD = 1.9160.40 mM). Not only LigBCen2R but also other Ig-like domains of Lig proteins including LigAVar7'-8, LigAVar10, LigAVar11, LigAVar12, LigAVar13, LigBCen7'-8, and LigBCen9 bind to GBD. Interestingly, a large gain in affinity was achieved through an avidity effect, with the terminal domains, 13th (LigA) or 12th (LigB) Ig-like repeat of Lig protein (LigAVar7'-13 and LigBCen7'-12) enhancing binding affinity approximately 51 and 28 fold, respectively, compared to recombinant proteins without this terminal repeat. In addition, the inhibited effect on MDCKs cells can also be promoted by Lig proteins with terminal domains, but these two domains are not required for gelatin binding domain binding and cell adhesion. Interestingly, Lig proteins with the terminal domains could form compact structures with a round shape mediated by multidomain interaction. This is the first report about the interaction of gelatin binding domain of Fn and Lig proteins and provides an example of Lig-gelatin binding domain binding mediating bacterial-host interaction.	[Lin, Yi-Pin; Chang, Yung-Fu] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [McDonough, Sean P.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Sharma, Yogendra] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Cornell University; Cornell University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Lin, YP (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	yc42@cornell.edu			Harry M. Zweig Memorial Fund for Equine Research; New York State Science and Technology Foundation (CAT); Biotechnology Research and Development Corporation (BRDC)	Harry M. Zweig Memorial Fund for Equine Research; New York State Science and Technology Foundation (CAT); Biotechnology Research and Development Corporation (BRDC)	This work was supported in part by the Harry M. Zweig Memorial Fund for Equine Research, the New York State Science and Technology Foundation (CAT), the Biotechnology Research and Development Corporation (BRDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzingen MV, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-70; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; BENEVIDES JM, 2004, RAMAN SPECTROSCOPY P, P17; Callahan B, 2010, J BACTERIOL, V192, P326, DOI 10.1128/JB.01032-09; Carvalho E, 2009, FEBS LETT, V583, P1381, DOI 10.1016/j.febslet.2009.03.050; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Dabo SM, 2006, INFECT IMMUN, V74, P2513, DOI 10.1128/IAI.74.5.2513-2521.2006; FAISAL SM, 2003, VACCINE, V21, P2383; Faisal SM, 2008, VACCINE, V26, P277, DOI 10.1016/j.vaccine.2007.10.029; Faisal SM, 2009, VACCINE, V27, P378, DOI 10.1016/j.vaccine.2008.10.089; Hammel M, 2007, PROTEIN SCI, V16, P2605, DOI 10.1110/ps.073170807; Hauk P, 2008, INFECT IMMUN, V76, P2642, DOI 10.1128/IAI.01639-07; Hauk P, 2009, J MOL BIOL, V390, P722, DOI 10.1016/j.jmb.2009.05.034; Hoke DE, 2008, INFECT IMMUN, V76, P2063, DOI 10.1128/IAI.01643-07; Ingham KC, 2004, J BIOL CHEM, V279, P42945, DOI 10.1074/jbc.M406984200; Joh D, 1998, EUR J BIOCHEM, V258, P897, DOI 10.1046/j.1432-1327.1998.2580897.x; Joh D, 1999, MATRIX BIOL, V18, P211, DOI 10.1016/S0945-053X(99)00025-6; Kingsley RA, 2004, MOL MICROBIOL, V52, P345, DOI 10.1111/j.1365-2958.2004.03995.x; Kreikemeyer B, 2004, J BIOL CHEM, V279, P15850, DOI 10.1074/jbc.M313613200; Laue T.M., 1992, COMPUTER AIDED INTER; Lin XP, 2008, J VET SCI, V9, P133; Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200; Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196; Lin YP, 2009, BIOCHEM BIOPH RES CO, V389, P57, DOI 10.1016/j.bbrc.2009.08.089; Lin YP, 2009, J BIOL CHEM, V284, P23547, DOI 10.1074/jbc.M109.031369; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; LITVINOVICH SV, 1991, J MOL BIOL, V217, P563, DOI 10.1016/0022-2836(91)90758-X; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Millard CJ, 2007, J BIOL CHEM, V282, P35530, DOI 10.1074/jbc.M707532200; Palaniappan RUM, 2006, INFECT IMMUN, V74, P1745, DOI 10.1128/IAI.74.3.1745-1750.2006; Palaniappan RUM, 2004, J MED MICROBIOL, V53, P975, DOI 10.1099/jmm.0.45568-0; Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; POTTS JR, 1994, CURR OPIN CELL BIOL, V6, P648, DOI 10.1016/0955-0674(94)90090-6; PRETORIUS HT, 1981, BIOCHEMISTRY-US, V20, P2777, DOI 10.1021/bi00513a011; Probert WS, 2001, INFECT IMMUN, V69, P4129, DOI 10.1128/IAI.69.6.4129-4133.2001; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwarz-Linek U, 2004, J BIOL CHEM, V279, P39017, DOI 10.1074/jbc.M405083200; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; SMITH AD, 1967, BIOCHEM J, V103, P483, DOI 10.1042/bj1030483; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Strickland AD, 2009, ANAL CHEM, V81, P2895, DOI 10.1021/ac801626x; Tu A.T., 1982, RAMAN SPECTROSCOPY B, P65; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; Vakonakis L, 2007, CURR OPIN CELL BIOL, V19, P578, DOI 10.1016/j.ceb.2007.09.005; VANHOLDE KE, 1971, PHYSICAL BIOCH, P79; Vivian JP, 2009, J MOL BIOL, V387, P1229, DOI 10.1016/j.jmb.2009.02.038; Yan WW, 2009, MICROBES INFECT, V11, P230, DOI 10.1016/j.micinf.2008.11.008	50	44	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11301	10.1371/journal.pone.0011301	http://dx.doi.org/10.1371/journal.pone.0011301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585579	Green Published, Green Submitted, gold			2022-12-27	WOS:000279135800010
J	Bojang, KA; Milligan, PJM; Conway, DJ; Sisay-Joof, F; Jallow, M; Nwakanma, DC; Abubakr, I; Njie, F; Greenwood, B				Bojang, Kalifa A.; Milligan, Paul J. M.; Conway, David J.; Sisay-Joof, Fatou; Jallow, Muminatou; Nwakanma, Davis C.; Abubakr, Ismaela; Njie, Fanta; Greenwood, Brian			Prevention of the Recurrence of Anaemia in Gambian Children Following Discharge from Hospital	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; SULFADOXINE-PYRIMETHAMINE; DIHYDROFOLATE-REDUCTASE; PRESCHOOL-CHILDREN; MALARIA; MORTALITY; TRANSMISSION; TRANSFUSION; IMPACT; IRON	Background: In malaria endemic countries, children who have experienced an episode of severe anaemia are at increased risk of a recurrence of anaemia. There is a need to find ways of protecting these at risk children from malaria and chemoprevention offers a potential way of achieving this objective. Methods: During the 2003 and 2004 malaria transmission seasons, 1200 Gambian children with moderate or severe anaemia (Hb concentration <7 g/dL) were randomised to receive either monthly sulfadoxine-pyrimethamine (SP) or placebo until the end of the malaria transmission season in which they were enrolled, in a double-blind trial. All study subjects were treated with oral iron for 28 days and morbidity was monitored through surveillance at health centres. The primary endpoint was the proportion of children with moderate or severe anaemia at the end of the transmission season. Secondary endpoints included the incidence of clinical episodes of malaria during the surveillance period, outpatient attendances, the prevalence of parasitaemia and splenomegaly, nutritional status at the end of the malaria transmission season and compliance with the treatment regimen. Results: The proportions of children with a Hb concentration of,7 g/dL at the end of the malaria transmission season were similar in the two study groups, 14/464 (3.0%) in children who received at least one dose of SP and 16/471 (3.4%) in those who received placebo, prevalence ratio 0.89 (0.44, 1.8) P = 0.742. The protective efficacy of SP against episodes of clinical malaria was 53% (95% CI 37%, 65%). Treatment with SP was safe and well tolerated; no serious adverse events related to SP administration were observed. Mortality following discharge from hospital was low among children who received SP or placebo (6 in the SP group and 9 in the placebo group respectively). Conclusions: Intermittent treatment with SP did not reduce the proportion of previously anaemic children with moderate or severe anaemia at the end of the malaria season, although it prevented malaria. The combination of appropriate antimalarial treatment plus one month of iron supplementation and good access to healthcare during follow-up proved effective in restoring haemoglobin to an acceptable level in the Gambian setting.	[Bojang, Kalifa A.; Conway, David J.; Sisay-Joof, Fatou; Jallow, Muminatou; Nwakanma, Davis C.; Abubakr, Ismaela; Njie, Fanta] MRC Labs, Banjul, Gambia; [Milligan, Paul J. M.; Greenwood, Brian] London Sch Hyg & Trop Med, London WC1, England	MRC Laboratory Molecular Biology; University of London; London School of Hygiene & Tropical Medicine	Bojang, KA (corresponding author), MRC Labs, Banjul, Gambia.	kbojang@mrc.gm	Milligan, Paul/D-8985-2017	Milligan, Paul/0000-0003-3430-3395; Bojang, Kalifa/0000-0001-7506-0938; Nwakanma, Davis/0000-0002-6706-6069; Conway, David/0000-0002-8711-3037	Gates malaria partnership	Gates malaria partnership	The study received financial support from the Gates malaria partnership. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Barnes KI, 2006, CLIN PHARMACOL THER, V80, P582, DOI 10.1016/j.clpt.2006.08.016; Biemba G, 2000, TROP MED INT HEALTH, V5, P9, DOI 10.1046/j.1365-3156.2000.00506.x; Bojang KA, 1997, T ROY SOC TROP MED H, V91, P557, DOI 10.1016/S0035-9203(97)90025-0; Brabin BJ, 2001, J NUTR, V131, p636S, DOI 10.1093/jn/131.2.636S; BREWSTER DR, 1993, ANN TROP PAEDIATR, V13, P133, DOI 10.1080/02724936.1993.11747637; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; CRAIGHEAD IB, 1993, TROP DOCT, V23, P59, DOI 10.1177/004947559302300207; Desai MR, 2003, J INFECT DIS, V187, P658, DOI 10.1086/367986; Dicko A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-123; Dunyo S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010014; Duraisingh MT, 1998, EXP PARASITOL, V89, P1, DOI 10.1006/expr.1998.4274; EMERTON DGC, 1992, T ROY SOC TROP MED H, V86, P476, DOI 10.1016/0035-9203(92)90073-L; Ghattas H, 2003, LANCET, V361, P2048, DOI 10.1016/S0140-6736(03)13617-3; GREENWOOD BM, 1991, T ROY SOC TROP MED H, V85, P186, DOI 10.1016/0035-9203(91)90015-Q; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; HEDBERG K, 1993, AM J TROP MED HYG, V48, P365, DOI 10.4269/ajtmh.1993.48.365; Kweku M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004000; Lackritz EM, 1997, AIDS, V11, P1487, DOI 10.1097/00002030-199712000-00013; LACKRITZ EM, 1992, LANCET, V340, P524, DOI 10.1016/0140-6736(92)91719-O; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Ntab B, 2007, AM J TROP MED HYG, V77, P411, DOI 10.4269/ajtmh.2007.77.411; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; SLUTSKER L, 1994, T ROY SOC TROP MED H, V88, P548, DOI 10.1016/0035-9203(94)90157-0; Sokhna C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001471; Verhoef H, 2002, LANCET, V360, P908, DOI 10.1016/S0140-6736(02)11027-0; WACHOLDER S, 1986, AM J EPIDEMIOL, V123, P174, DOI 10.1093/oxfordjournals.aje.a114212; Zucker JR, 2003, AM J TROP MED HYG, V68, P386, DOI 10.4269/ajtmh.2003.68.386; Zucker JR, 1996, AM J TROP MED HYG, V55, P655, DOI 10.4269/ajtmh.1996.55.655	33	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11227	10.1371/journal.pone.0011227	http://dx.doi.org/10.1371/journal.pone.0011227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574541	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000279058300016
J	Lee, JE; Lee, JY; Wilusz, J; Tian, B; Wilusz, CJ				Lee, Jerome E.; Lee, Ju Youn; Wilusz, Jeffrey; Tian, Bin; Wilusz, Carol J.			Systematic Analysis of Cis-Elements in Unstable mRNAs Demonstrates that CUGBP1 Is a Key Regulator of mRNA Decay in Muscle Cells	PLOS ONE			English	Article							BINDING PROTEIN CUGBP1; EMBRYONIC STEM-CELLS; MYOTONIC-DYSTROPHY; SKELETAL-MUSCLE; GENE-EXPRESSION; MOUSE MODELS; STEADY-STATE; STABILITY; DIFFERENTIATION; HUR	Background: Dramatic changes in gene expression occur in response to extracellular stimuli and during differentiation. Although transcriptional effects are important, alterations in mRNA decay also play a major role in achieving rapid and massive changes in mRNA abundance. Moreover, just as transcription factor activity varies between different cell types, the factors influencing mRNA decay are also cell-type specific. Principal Findings: We have established the rates of decay for over 7000 transcripts expressed in mouse C2C12 myoblasts. We found that GU-rich (GRE) and AU-rich (ARE) elements are over-represented in the 3'UTRs of short-lived mRNAs and that these mRNAs tend to encode factors involved in cell cycle and transcription regulation. Stabilizing elements were also identified. By comparing mRNA decay rates in C2C12 cells with those previously measured for pluripotent and differentiating embryonic stem (ES) cells, we identified several groups of transcripts that exhibit cell-type specific decay rates. Further, whereas in C2C12 cells the impact of GREs on mRNA decay appears to be greater than that of AREs, AREs are more significant in ES cells, supporting the idea that cis elements make a cell-specific contribution to mRNA stability. GREs are recognized by CUGBP1, an RNA-binding protein and instability factor whose function is affected in several neuromuscular diseases. We therefore utilized RNA immunoprecipitation followed by microarray (RIP-Chip) to identify CUGBP1-associated transcripts. These mRNAs also showed dramatic enrichment of GREs in their 3'UTRs and encode proteins linked with cell cycle, and intracellular transport. Interestingly several CUGBP1 substrate mRNAs, including those encoding the myogenic transcription factors Myod1 and Myog, are also bound by the stabilizing factor HuR in C2C12 cells. Finally, we show that several CUGBP1-associated mRNAs containing 3'UTR GREs, including Myod1, are stabilized in cells depleted of CUGBP1, consistent with the role of CUGBP1 as a destabilizing factor. Conclusions: Taken together, our results systematically establish cis-acting determinants of mRNA decay rates in C2C12 myoblast cells and demonstrate that CUGBP1 associates with GREs to regulate decay of a wide range of mRNAs including several that are critical for muscle development.	[Lee, Jerome E.; Wilusz, Jeffrey; Wilusz, Carol J.] Colorado State Univ, Program Cell & Mol Biol, Ft Collins, CO 80523 USA; [Wilusz, Jeffrey; Wilusz, Carol J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Lee, Ju Youn; Tian, Bin] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA	Colorado State University; Colorado State University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Lee, JE (corresponding author), Colorado State Univ, Program Cell & Mol Biol, Ft Collins, CO 80523 USA.	cwilusz@colostate.edu	Wilusz, Carol/AAC-2901-2021; Wilusz, Carol/F-7241-2017	Tian, Bin/0000-0001-8903-8256	Muscular Dystrophy Association [9426]; American Heart Association [10PRE2610140]; National Institutes of Health [R01GM084089, R01GM072481]; Colorado State University College Research Council; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072481, R01GM084089] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado State University College Research Council; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Muscular Dystrophy Association (Award 9426 to CJW), The American Heart Association (Award 10PRE2610140 to JEL), the National Institutes of Health (Award R01GM084089 to BT, and Award R01GM072481 to JW) and by a Colorado State University College Research Council Award to CJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botta A, 2007, GENE EXPRESSION, V13, P339; Briata P, 2005, MOL CELL, V20, P891, DOI 10.1016/j.molcel.2005.10.021; Chen HH, 2007, BIOCHEM BIOPH RES CO, V357, P56, DOI 10.1016/j.bbrc.2007.03.113; Chen YW, 2003, J APPL PHYSIOL, V95, P2485, DOI 10.1152/japplphysiol.01161.2002; Corbeil-Girard LP, 2005, NEUROBIOL DIS, V18, P551, DOI 10.1016/j.nbd.2004.10.019; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Duttagupta R, 2005, MOL CELL BIOL, V25, P5499, DOI 10.1128/MCB.25.13.5499-5513.2005; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Figueroa A, 2003, MOL CELL BIOL, V23, P4991, DOI 10.1128/MCB.23.14.4991-5004.2003; Fortier M, 2008, CELL DEATH DIFFER, V15, P1221, DOI 10.1038/cdd.2008.34; FRAICHARD A, 1995, J CELL SCI, V108, P3181; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Frost RA, 2003, ENDOCRINOLOGY, V144, P1770, DOI 10.1210/en.2002-220808; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; GHERZI R, 2009, CELL DEATH DIFFER; Gong CG, 2009, GENE DEV, V23, P54, DOI 10.1101/gad.1717309; Graindorge A, 2008, NUCLEIC ACIDS RES, V36, P1861, DOI 10.1093/nar/gkn031; Hegde RS, 2008, J CELL BIOL, V182, P225, DOI 10.1083/jcb.200804157; Hew Y, 2000, J BIOL CHEM, V275, P24857, DOI 10.1074/jbc.M002776200; Hu J, 2005, RNA, V11, P1485, DOI 10.1261/rna.2107305; Hui JY, 2003, RNA, V9, P931, DOI 10.1261/rna.5660803; Juretic N, 2007, J CELL PHYSIOL, V210, P819, DOI 10.1002/jcp.20902; Kang JS, 1998, J CELL BIOL, V143, P403, DOI 10.1083/jcb.143.2.403; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kollias HD, 2006, MOL CELL BIOL, V26, P6248, DOI 10.1128/MCB.00384-06; Kong J, 2006, MOL CELL BIOL, V26, P5603, DOI 10.1128/MCB.01845-05; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Ladd AN, 2001, MOL CELL BIOL, V21, P1285, DOI 10.1128/MCB.21.4.1285-1296.2001; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Marquis J, 2006, BIOCHEM J, V400, P291, DOI 10.1042/BJ20060490; Molin C, 2009, RNA, V15, P600, DOI 10.1261/rna.1403509; Moraes KCM, 2006, RNA, V12, P1084, DOI 10.1261/rna.59606; Morris AR, 2008, MOL CELL BIOL, V28, P4093, DOI 10.1128/MCB.00155-08; Mukherjee N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.44; Paillard L, 2002, J BIOL CHEM, V277, P3232, DOI 10.1074/jbc.M109362200; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; Raghavan A, 2002, NUCLEIC ACIDS RES, V30, P5529, DOI 10.1093/nar/gkf682; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Roberts R, 1997, P NATL ACAD SCI USA, V94, P13221, DOI 10.1073/pnas.94.24.13221; ROTWEIN P, 1995, MOL ENDOCRINOL, V9, P913, DOI 10.1210/me.9.7.913; Salehzada T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007563; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Shen X, 2003, DEV DYNAM, V226, P128, DOI 10.1002/dvdy.10200; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; Tachibana I, 1999, J CELL BIOL, V146, P893, DOI 10.1083/jcb.146.4.893; Takahashi N, 2000, BIOCHEM BIOPH RES CO, V277, P518, DOI 10.1006/bbrc.2000.3694; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Topisirovic I, 2009, MOL CELL BIOL, V29, P1152, DOI 10.1128/MCB.01532-08; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Wang GS, 2007, J CLIN INVEST, V117, P2802, DOI 10.1172/JCI32308; Warren GL, 2007, J PHYSIOL-LONDON, V582, P825, DOI 10.1113/jphysiol.2007.132373; Wein G, 2003, EUR J BIOCHEM, V270, P350, DOI 10.1046/j.1432-1033.2003.03396.x; Willett M, 2009, CELL SIGNAL, V21, P1504, DOI 10.1016/j.cellsig.2009.05.009; Wu XX, 2007, ENDOCRINE, V31, P5, DOI 10.1007/s12020-007-0007-x; Xin HW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-232; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403; Yu ZG, 2009, DIS MODEL MECH, V2, P500, DOI 10.1242/dmm.003301; Zhang LB, 2008, J BIOL CHEM, V283, P22457, DOI 10.1074/jbc.M802803200; Zhang Y, 2009, MOL CELL BIOL, V29, P3791, DOI 10.1128/MCB.01865-08	69	78	79	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11201	10.1371/journal.pone.0011201	http://dx.doi.org/10.1371/journal.pone.0011201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574513	gold, Green Published, Green Submitted			2022-12-27	WOS:000279058300007
J	Jaramillo-Gutierrez, G; Molina-Cruz, A; Kumar, S; Barillas-Mury, C				Jaramillo-Gutierrez, Giovanna; Molina-Cruz, Alvaro; Kumar, Sanjeev; Barillas-Mury, Carolina			The Anopheles gambiae Oxidation Resistance 1 (OXR1) Gene Regulates Expression of Enzymes That Detoxify Reactive Oxygen Species	PLOS ONE			English	Article							NF-KAPPA-B; PLASMODIUM-BERGHEI; STRESS; DROSOPHILA; FAMILY; CELLS; MOSQUITOS; RESPONSES; PROTEINS; IMMUNITY	Background: OXR1 is an ancient gene, present in all eukaryotes examined so far that confers protection from oxidative stress by an unknown mechanism. The most highly conserved region of the gene is the carboxyl-terminal TLDc domain, which has been shown to be sufficient to prevent oxidative damage. Methodology/Principal Findings: OXR1 has a complex genomic structure in the mosquito A. gambiae, and we confirm that multiple splice forms are expressed in adult females. Our studies revealed that OXR1 regulates the basal levels of catalase (CAT) and glutathione peroxidase (Gpx) expression, two enzymes involved in detoxification of hydrogen peroxide, giving new insight into the mechanism of action of OXR1. Gene silencing experiments indicate that the Jun Kinase (JNK) gene acts upstream of OXR1 and also regulates expression of CAT and GPx. Both OXR1 and JNK genes are required for adult female mosquitoes to survive chronic oxidative stress. OXR1 silencing decreases P. berghei oocyst formation. Unexpectedly, JNK silencing has the opposite effect and enhances Plasmodium infection in the mosquito, suggesting that JNK may also mediate some, yet to be defined, antiparasitic response. Conclusion: The JNK pathway regulates OXR1 expression and OXR1, in turn, regulates expression of enzymes that detoxify reactive oxygen species (ROS) in Anopheles gambiae. OXR1 silencing decreases Plasmodium infection in the mosquito, while JNK silencing has the opposite effect and enhances infection.	[Jaramillo-Gutierrez, Giovanna; Molina-Cruz, Alvaro; Kumar, Sanjeev; Barillas-Mury, Carolina] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Barillas-Mury, C (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.	cbarillas@niaid.nih.gov		Kumar, Sanjeev/0000-0003-3866-4593	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000947] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Billker O, 1997, PARASITOLOGY, V115, P1, DOI 10.1017/S0031182097008895; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; BRANDT SM, 2008, GENETICS; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Durand M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-13; Elliott NA, 2004, MOL CELL BIOL, V24, P3180, DOI 10.1128/MCB.24.8.3180-3187.2004; Fischer H, 2001, BIOCHEM BIOPH RES CO, V281, P795, DOI 10.1006/bbrc.2001.4345; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Gupta L, 2009, CELL HOST MICROBE, V5, P498, DOI 10.1016/j.chom.2009.04.003; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Iordanov MS, 1999, J BIOL CHEM, V274, P25801, DOI 10.1074/jbc.274.36.25801; Jaramillo-Gutierrez G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-154; Kuge S, 2001, MOL CELL BIOL, V21, P6139, DOI 10.1128/MCB.21.18.6139-6150.2001; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; MEYER M, 1994, CHEM-BIOL INTERACT, V91, P91, DOI 10.1016/0009-2797(94)90029-9; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Natoli R, 2008, INVEST OPHTH VIS SCI, V49, P4561, DOI 10.1167/iovs.08-1722; Pastor-Pareja JC, 2008, DIS MODEL MECH, V1, P144, DOI 10.1242/dmm.000950; Storz G, 1996, EXS, V77, P239; Stowers RS, 1999, DEV BIOL, V213, P116, DOI 10.1006/dbio.1999.9358; Vega-Rodriguez J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000302; Volkert MR, 2000, P NATL ACAD SCI USA, V97, P14530, DOI 10.1073/pnas.260495897; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Zhou LZH, 2001, FREE RADICAL BIO MED, V31, P1405, DOI 10.1016/S0891-5849(01)00719-5	28	58	64	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11168	10.1371/journal.pone.0011168	http://dx.doi.org/10.1371/journal.pone.0011168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567517	gold, Green Published, Green Submitted			2022-12-27	WOS:000278886300014
J	Dusa, A; Mouton, C; Pecquet, C; Herman, M; Constantinescu, SN				Dusa, Alexandra; Mouton, Celine; Pecquet, Christian; Herman, Murielle; Constantinescu, Stefan N.			JAK2 V617F Constitutive Activation Requires JH2 Residue F595: A Pseudokinase Domain Target for Specific Inhibitors	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; RECEPTOR SURFACE EXPRESSION; PROTEIN-TYROSINE KINASES; POLYCYTHEMIA-VERA; ERYTHROPOIETIN RECEPTOR; CRYSTAL-STRUCTURE; SIGNAL-TRANSDUCTION; MYELOPROLIFERATIVE DISORDERS; ESSENTIAL THROMBOCYTHEMIA; CYTOKINE RECEPTOR	The JAK2 V617F mutation present in over 95% of Polycythemia Vera patients and in 50% of Essential Thrombocythemia and Primary Myelofibrosis patients renders the kinase constitutively active. In the absence of a three-dimensional structure for the full-length protein, the mechanism of activation of JAK2 V617F has remained elusive. In this study, we used functional mutagenesis to investigate the involvement of the JH2 alpha C helix in the constitutive activation of JAK2 V617F. We show that residue F595, located in the middle of the alpha C helix of JH2, is indispensable for the constitutive activity of JAK2 V617F. Mutation of F595 to Ala, Lys, Val or Ile significantly decreases the constitutive activity of JAK2 V617F, but F595W and F595Y are able to restore it, implying an aromaticity requirement at position 595. Substitution of F595 to Ala was also able to decrease the constitutive activity of two other JAK2 mutants, T875N and R683G, as well as JAK2 K539L, albeit to a lower extent. In contrast, the F595 mutants are activated by erythropoietin-bound EpoR. We also explored the relationship between the dimeric conformation of EpoR and several JAK2 mutants. Since residue F595 is crucial to the constitutive activation of JAK2 V617F but not to initiation of JAK2 activation by cytokines, we suggest that small molecules that target the region around this residue might specifically block oncogenic JAK2 and spare JAK2 wild-type.	[Dusa, Alexandra; Mouton, Celine; Pecquet, Christian; Herman, Murielle; Constantinescu, Stefan N.] Ludwig Inst Canc Res Ltd, Brussels, Belgium; [Dusa, Alexandra; Mouton, Celine; Pecquet, Christian; Herman, Murielle; Constantinescu, Stefan N.] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium	Ludwig Institute for Cancer Research; Universite Catholique Louvain	Dusa, A (corresponding author), Ludwig Inst Canc Res Ltd, Brussels, Belgium.	Stefan.Constantinescu@bru.licr.org	Constantinescu, Stefan N/E-5277-2012	Constantinescu, Stefan N./0000-0002-8599-2699; Christian, Pecquet/0000-0002-8623-3483	Fonds National de la Recherche Scientifique (FNRS) Televie; Belgian American Educational Foundation; Fondation contre le cancer, Belgium; Atlantic Philanthropies, New York; Salus Sanguinis Foundation, Belgium; Action de Recherche Concertee (ARC) of the Universite catholique de Louvain [MEXP31]; Interuniversity Attraction Pole, Belgium [BCHM61B5]	Fonds National de la Recherche Scientifique (FNRS) Televie(Fonds de la Recherche Scientifique - FNRS); Belgian American Educational Foundation; Fondation contre le cancer, Belgium; Atlantic Philanthropies, New York; Salus Sanguinis Foundation, Belgium; Action de Recherche Concertee (ARC) of the Universite catholique de Louvain; Interuniversity Attraction Pole, Belgium(Belgian Federal Science Policy Office)	A. D. was funded by Fonds National de la Recherche Scientifique (FNRS) Televie and Belgian American Educational Foundation doctoral fellowships. Research was supported (for S.N.C.) by the Mandat Impulsion of the FNRS, grants from the Fondation contre le cancer, Belgium, by the Atlantic Philanthropies, New York, the Salus Sanguinis Foundation, Belgium, the Action de Recherche Concertee (ARC) MEXP31 of the Universite catholique de Louvain, and the Interuniversity Attraction Pole - Program BCHM61B5, Belgium. S.N.C. is a Research Associate of the FNRS, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Boggon TJ, 2005, BLOOD, V106, P996, DOI 10.1182/blood-2005-02-0707; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Dusa A, 2008, J BIOL CHEM, V283, P12941, DOI 10.1074/jbc.M709302200; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Girault JA, 1998, MOL MED, V4, P751, DOI 10.1007/BF03401769; Gonfloni S, 1999, NAT STRUCT BIOL, V6, P760; HARPUR AG, 1992, ONCOGENE, V7, P1347; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jeong EG, 2008, CLIN CANCER RES, V14, P3716, DOI 10.1158/1078-0432.CCR-07-4839; Kohlhuber F, 1997, MOL CELL BIOL, V17, P695, DOI 10.1128/MCB.17.2.695; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kubatzky KF, 2005, J BIOL CHEM, V280, P14844, DOI 10.1074/jbc.M411251200; Lee TS, 2009, CANCER-AM CANCER SOC, V115, P1692, DOI 10.1002/cncr.24183; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lindauer K, 2001, PROTEIN ENG, V14, P27, DOI 10.1093/protein/14.1.27; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Lu XH, 2008, J BIOL CHEM, V283, P5258, DOI 10.1074/jbc.M707125200; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; Mercher T, 2006, BLOOD, V108, P2770, DOI 10.1182/blood-2006-04-014712; Mesal RA, 2009, EXPERT OPIN EMERG DR, V14, P471, DOI 10.1517/14728210903066809; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radtke S, 2005, J BIOL CHEM, V280, P25760, DOI 10.1074/jbc.M500822200; Radtke S, 2002, J BIOL CHEM, V277, P11297, DOI 10.1074/jbc.M100822200; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Royer Y, 2005, J BIOL CHEM, V280, P27251, DOI 10.1074/jbc.M501376200; Saharinen P, 2003, MOL BIOL CELL, V14, P1448, DOI 10.1091/mbc.E02-06-0342; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Werning G, 2008, CANCER CELL, V13, P311, DOI 10.1016/j.ccr.2008.02.009; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; WILLIAMS NK, 2009, J MOL BIOL; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Zeqiraj E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000126; Ziemiecki Andrew, 1994, Trends in Cell Biology, V4, P207, DOI 10.1016/0962-8924(94)90143-0	46	64	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11157	10.1371/journal.pone.0011157	http://dx.doi.org/10.1371/journal.pone.0011157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585391	Green Published, gold, Green Submitted			2022-12-27	WOS:000278886100020
J	Symmonds, M; Emmanuel, JJ; Drew, ME; Batterham, RL; Dolan, RJ				Symmonds, Mkael; Emmanuel, Julian J.; Drew, Megan E.; Batterham, Rachel L.; Dolan, Raymond J.			Metabolic State Alters Economic Decision Making under Risk in Humans	PLOS ONE			English	Article							GHRELIN LEVELS; APPETITE; CHOICE; IMPULSIVITY; MODULATION; VARIANCE; LOGIC; RAT	Background: Animals' attitudes to risk are profoundly influenced by metabolic state (hunger and baseline energy stores). Specifically, animals often express a preference for risky (more variable) food sources when below a metabolic reference point (hungry), and safe (less variable) food sources when sated. Circulating hormones report the status of energy reserves and acute nutrient intake to widespread targets in the central nervous system that regulate feeding behaviour, including brain regions strongly implicated in risk and reward based decision-making in humans. Despite this, physiological influences per se have not been considered previously to influence economic decisions in humans. We hypothesised that baseline metabolic reserves and alterations in metabolic state would systematically modulate decision-making and financial risk-taking in humans. Methodology/Principal Findings: We used a controlled feeding manipulation and assayed decision-making preferences across different metabolic states following a meal. To elicit risk-preference, we presented a sequence of 200 paired lotteries, subjects' task being to select their preferred option from each pair. We also measured prandial suppression of circulating acyl-ghrelin (a centrally-acting orexigenic hormone signalling acute nutrient intake), and circulating leptin levels (providing an assay of energy reserves). We show both immediate and delayed effects on risky decision-making following a meal, and that these changes correlate with an individual's baseline leptin and changes in acyl-ghrelin levels respectively. Conclusions/Significance: We show that human risk preferences are exquisitely sensitive to current metabolic state, in a direction consistent with ecological models of feeding behaviour but not predicted by normative economic theory. These substantive effects of state changes on economic decisions perhaps reflect shared evolutionarily conserved neurobiological mechanisms. We suggest that this sensitivity in human risk-preference to current metabolic state has significant implications for both real-world economic transactions and for aberrant decision-making in eating disorders and obesity.	[Symmonds, Mkael; Dolan, Raymond J.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Emmanuel, Julian J.; Drew, Megan E.; Batterham, Rachel L.] UCL, Dept Metab & Expt Therapeut, UCL Div Med, London, England	University of London; University College London; University of London; University College London	Symmonds, M (corresponding author), UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England.	mkael@doctors.org.uk		Batterham, Rachel/0000-0002-5477-8585; Dolan, Ray/0000-0001-9356-761X	Wellcome Trust; Medical Research Council; UCL/UCLH Comprehensive Biomedical Research Centre; MRC [G0601342, G108/551] Funding Source: UKRI; Medical Research Council [G0601342, G108/551] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCL/UCLH Comprehensive Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Wellcome Trust Programme Grant to RJD. JE is in receipt of a Medical Research Council Training Fellowship. RLB receives funding from the UCL/UCLH Comprehensive Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella CL, 2008, EVOL HUM BEHAV, V29, P384, DOI 10.1016/j.evolhumbehav.2008.07.001; Bacon IE, 2010, BEHAV ECOL, V21, P626, DOI 10.1093/beheco/arq031; BARNARD CJ, 1985, BEHAV ECOL SOCIOBIOL, V16, P161, DOI 10.1007/BF00295150; Batterham RL, 2007, NATURE, V450, P106, DOI 10.1038/nature06212; CARACO T, 1981, BEHAV ECOL SOCIOBIOL, V8, P213, DOI 10.1007/BF00299833; CARACO T, 1990, ANIM BEHAV, V39, P338, DOI 10.1016/S0003-3472(05)80879-6; Chandarana K, 2009, GASTROENTEROLOGY, V136, P2115, DOI 10.1053/j.gastro.2009.02.047; Chaudhri OB, 2008, ANNU REV PHYSIOL, V70, P239, DOI 10.1146/annurev.physiol.70.113006.100506; CROY MI, 1991, ANIM BEHAV, V42, P131, DOI 10.1016/S0003-3472(05)80613-X; Cummings DE, 2006, PHYSIOL BEHAV, V89, P71, DOI 10.1016/j.physbeh.2006.05.022; Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; De Martino B, 2009, J NEUROSCI, V29, P3833, DOI 10.1523/JNEUROSCI.4832-08.2009; English PJ, 2002, J CLIN ENDOCR METAB, V87, P2984, DOI 10.1210/jc.87.6.2984; Fessler DMT, 2002, INT J EAT DISORDER, V31, P376, DOI 10.1002/eat.10035; Figlewicz DP, 2007, PHYSIOL BEHAV, V91, P473, DOI 10.1016/j.physbeh.2006.10.008; Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083; Grill HJ, 2002, FRONT NEUROENDOCRIN, V23, P2, DOI 10.1006/frne.2001.0224; HEY JD, 1994, ECONOMETRICA, V62, P1291, DOI 10.2307/2951750; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; HOUSTON AI, 1982, ANIM BEHAV, V30, P615, DOI 10.1016/S0003-3472(82)80075-4; Houston AI, 1999, MODELS ADAPTIVE BEHA; Hurly TA, 2003, ANIM BEHAV, V66, P751, DOI 10.1006/anbe.2003.2278; ISEN AM, 1983, ORGAN BEHAV HUM PERF, V31, P194, DOI 10.1016/0030-5073(83)90120-4; ISEN AM, 1987, ORGAN BEHAV HUM DEC, V39, P145, DOI 10.1016/0749-5978(87)90034-3; Kacelnik A, 1996, AM ZOOL, V36, P402; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Krugel U, 2003, EUR J PHARMACOL, V482, P185, DOI 10.1016/j.ejphar.2003.09.047; Marsh B, 2002, P NATL ACAD SCI USA, V99, P3352, DOI 10.1073/pnas.042491999; MCNAMARA JM, 1992, B MATH BIOL, V54, P355; Nasser JA, 2004, APPETITE, V43, P303, DOI 10.1016/j.appet.2004.04.006; Nederkoorn Chantal, 2006, Eat Behav, V7, P315, DOI 10.1016/j.eatbeh.2005.11.005; Pietras CJ, 2001, J EXP ANAL BEHAV, V76, P1, DOI 10.1901/jeab.2001.76-1; Pietras CJ, 2008, BEHAV PROCESS, V78, P358, DOI 10.1016/j.beproc.2008.01.016; Rasmussen EB, 2010, BEHAV PROCESS, V83, P23, DOI 10.1016/j.beproc.2009.09.001; REAL L, 1982, ECOLOGY, V63, P1617, DOI 10.2307/1940101; ROTHSCHILD M, 1971, J ECON THEORY, V3, P66, DOI 10.1016/0022-0531(71)90034-2; Seeley RJ, 2003, NAT REV NEUROSCI, V4, P901, DOI 10.1038/nrn1245; SHARPE WF, 1964, J FINANC, V19, P425, DOI 10.2307/2977928; STEPHENS DW, 1981, ANIM BEHAV, V29, P628, DOI 10.1016/S0003-3472(81)80128-5; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; WUNDERLE JM, 1987, BEHAV ECOL SOCIOBIOL, V21, P249, DOI 10.1007/BF00292506; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	44	56	58	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11090	10.1371/journal.pone.0011090	http://dx.doi.org/10.1371/journal.pone.0011090			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	612GZ	20585383	Green Published, gold			2022-12-27	WOS:000278886100007
J	Perez, LH; Butler, M; Creasey, T; Dzink-Fox, J; Gounarides, J; Petit, S; Ropenga, A; Ryder, N; Smith, K; Smith, P; Parkinson, SJ				Perez, Laurent-Herve; Butler, Matt; Creasey, Tammy; Dzink-Fox, JoAnn; Gounarides, John; Petit, Stephanie; Ropenga, Anna; Ryder, Neil; Smith, Kathryn; Smith, Philip; Parkinson, Scott J.			Direct Bacterial Killing In Vitro by Recombinant Nod2 Is Compromised by Crohn's Disease-Associated Mutations	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CARD15 MUTATIONS; SUSCEPTIBILITY; RECEPTORS; LAMPREY; INNATE	Background: A homeostatic relationship with the intestinal microflora is increasingly appreciated as essential for human health and wellbeing. Mutations in the leucine-rich repeat (LRR) domain of Nod2, a bacterial recognition protein, are associated with development of the inflammatory bowel disorder, Crohn's disease. We investigated the molecular mechanisms underlying disruption of intestinal symbiosis in patients carrying Nod2 mutations. Methodology/Principal Findings: In this study, using purified recombinant LRR domains, we demonstrate that Nod2 is a direct antimicrobial agent and this activity is generally deficient in proteins carrying Crohn's-associated mutations. Wildtype, but not Crohn's-associated, Nod2 LRR domains directly interacted with bacteria in vitro, altered their metabolism and disrupted the integrity of the plasma membrane. Antibiotic activity was also expressed by the LRR domains of Nod1 and other pattern recognition receptors suggesting that the LRR domain is a conserved anti-microbial motif supporting innate cellular immunity. Conclusions/Significance: The lack of anti-bacterial activity demonstrated with Crohn's-associated Nod2 mutations in vitro, supports the hypothesis that a deficiency in direct bacterial killing contributes to the association of Nod2 polymorphisms with the disease.	[Perez, Laurent-Herve; Butler, Matt; Creasey, Tammy; Petit, Stephanie; Ropenga, Anna; Smith, Kathryn; Smith, Philip; Parkinson, Scott J.] Novartis Inst Biomed Res, Gastrointestinal Dis Area, Horsham, W Sussex, England; [Dzink-Fox, JoAnn; Ryder, Neil] Novartis Inst Biomed Res, Infect Dis Area, Cambridge, MA USA	Novartis; Novartis	Perez, LH (corresponding author), Novartis Inst Biomed Res, Gastrointestinal Dis Area, Horsham, W Sussex, England.	Scott.Parkinson@novartis.com	Petit, Stephane/A-6578-2017; Perez, Laurent/ABA-4145-2021	Petit, Stephane/0000-0003-0573-8592; Perez, Laurent/0000-0002-8860-7928	Novartis Institutes for Biomedical Research	Novartis Institutes for Biomedical Research	Funding: The study was funded by the Novartis Institutes for Biomedical Research which employs all of the authors and supports their research activities. Outside of this influence, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Austin CM, 2008, J INFECT DIS, V197, P1713, DOI 10.1086/588384; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Bearson S, 1997, FEMS MICROBIOL LETT, V147, P173, DOI 10.1016/S0378-1097(96)00503-4; Bochud PY, 2003, J IMMUNOL, V170, P3451, DOI 10.4049/jimmunol.170.7.3451; Cameron HL, 2005, J PHARMACOL EXP THER, V314, P214, DOI 10.1124/jpet.105.085373; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; de Chambrun GP, 2008, CURR OPIN GASTROEN, V24, P440, DOI 10.1097/MOG.0b013e3283023be5; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; Fan WMT, 1996, PROG NUCL MAG RES SP, V28, P161, DOI 10.1016/0079-6565(95)01017-3; Ferguson GP, 1998, J BACTERIOL, V180, P4314, DOI 10.1128/JB.180.16.4314-4318.1998; Ferwerda G, 2007, J LEUKOCYTE BIOL, V82, P1011, DOI 10.1189/jlb.0307147; Gareau MG, 2008, CURR MOL MED, V8, P274, DOI 10.2174/156652408784533760; Herrin BR, 2008, P NATL ACAD SCI USA, V105, P2040, DOI 10.1073/pnas.0711619105; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lees Charlie W, 2009, Expert Rev Gastroenterol Hepatol, V3, P513, DOI 10.1586/egh.09.45; Lin CY, 2007, METABOLOMICS, V3, P55, DOI 10.1007/s11306-006-0043-1; Meinzer U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002769; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Nagawa F, 2007, NAT IMMUNOL, V8, P206, DOI 10.1038/ni1419; Naser SA, 2005, GASTROENTEROLOGY, V129, P1359, DOI 10.1053/j.gastro.2005.08.042; *NAT COMM CLIN LAB, M7A6 NCCLS; Nuding S, 2006, J MICROBIOL METH, V65, P335, DOI 10.1016/j.mimet.2005.08.004; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Pierce ES, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000234; Schafer J, 1996, J PHYS I, V6, P5, DOI 10.1051/jp1:1996129; Sechi LA, 2005, AM J GASTROENTEROL, V100, P1529, DOI 10.1111/j.1572-0241.2005.41415.x; Travassos LH, 2005, J BIOL CHEM, V280, P36714, DOI 10.1074/jbc.M501649200; Vinzing M, 2008, J IMMUNOL, V180, P6808, DOI 10.4049/jimmunol.180.10.6808; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	39	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2010	5	6							e10915	10.1371/journal.pone.0010915	http://dx.doi.org/10.1371/journal.pone.0010915			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QF	20531959	Green Submitted, Green Published, gold			2022-12-27	WOS:000278222400010
J	Goven, D; Boutten, A; Lecon-Malas, V; Marchal-Somme, J; Soler, P; Boczkowski, J; Bonay, M				Goven, Delphine; Boutten, Anne; Lecon-Malas, Veronique; Marchal-Somme, Joelle; Soler, Paul; Boczkowski, Jorge; Bonay, Marcel			Induction of Heme Oxygenase-1, Biliverdin Reductase and H-Ferritin in Lung Macrophage in Smokers with Primary Spontaneous Pneumothorax: Role of HIF-1 alpha	PLOS ONE			English	Article							HYPOXIA; EXPRESSION; CELLS; GENE; INFLAMMATION; SMOKING; RISK	Background: Few data concern the pathophysiology of primary spontaneous pneumothorax (PSP), which is associated with alveolar hypoxia/reoxygenation. This study tested the hypothesis that PSP is associated with oxidative stress in lung macrophages. We analysed expression of the oxidative stress marker 4-HNE; the antioxidant and anti-inflammatory proteins heme oxygenase-1 (HO-1), biliverdin reductase (BVR) and heavy chain of ferritin (H-ferritin); and the transcription factors controlling their expression Nrf2 and HIF-1 alpha, in lung samples from smoker and nonsmoker patients with PSP (PSP-S and PSP-NS), cigarette smoke being a risk factor of recurrence of the disease. Methodology/Principal Findings: mRNA was assessed by RT-PCR and proteins by western blot, immunohistochemistry and confocal laser analysis. 4-HNE, HO-1, BVR and H-ferritin were increased in macrophages from PSP-S as compared to PSP-NS and controls (C). HO-1 increase was associated with increased expression of HIF-1 alpha mRNA and protein in alveolar macrophages in PSP-S patients, whereas Nrf2 was not modified. To understand the regulation of HO-1, BVR and H-ferritin, THP-1 macrophages were exposed to conditions mimicking conditions in C, PSP-S and PSP-NS patients: cigarette smoke condensate (CS) or air exposure followed or not by hypoxia/reoxygenation. Silencing RNA experiments confirmed that HIF-1 alpha nuclear translocation was responsible for HO-1, BVR and H-ferritin induction mediated by CS and hypoxia/reoxygenation. Conclusions/Significance: PSP in smokers is associated with lung macrophage oxidative stress. The response to this condition involves HIF-1 alpha-mediated induction of HO-1, BVR and H-ferritin.	[Goven, Delphine; Boutten, Anne; Marchal-Somme, Joelle; Soler, Paul; Bonay, Marcel] Univ Denis Diderot Paris 7, INSERM, U700, Fac Med Site Bichat, Paris, France; [Boutten, Anne; Lecon-Malas, Veronique] Hop Bichat Claude Bernard, AP HP, Serv Biochim, F-75877 Paris, France; [Boczkowski, Jorge] Ctr Invest Clin 007, Paris, France; [Boczkowski, Jorge] Grp Hosp Univ Albert Chenevier Henri Mondor, Fac Med, INSERM, U955, Creteil, France; [Boczkowski, Jorge] Univ Paris 12, Fac Med, Creteil, France; [Bonay, Marcel] Hop Bichat Claude Bernard, AP HP, Serv Physiol Explorat Fonct, F-75877 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Goven, D (corresponding author), Univ Denis Diderot Paris 7, INSERM, U700, Fac Med Site Bichat, Paris, France.	marcel.bonay@bch.aphp.fr	Boczkowski, Jorge/S-7474-2018; Bonay, Marcel/ABG-2039-2020	Boczkowski, Jorge/0000-0001-6619-5785; Bonay, Marcel/0000-0003-1446-7456	Subvention de Recherche en Pneumologie, Appel d'Offre Automne, Societe de Pneumologie de Langue Francaise (SPLF); Societe de Pneumologie de Langue Francaise (SPLF)	Subvention de Recherche en Pneumologie, Appel d'Offre Automne, Societe de Pneumologie de Langue Francaise (SPLF); Societe de Pneumologie de Langue Francaise (SPLF)	Funding was provided by Subvention de Recherche en Pneumologie, Appel d'Offre Automne 2008, Societe de Pneumologie de Langue Francaise (SPLF), http://www.splf.org/s/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara N, 2007, AM J PHYSIOL-LUNG C, V293, pL170, DOI 10.1152/ajplung.00445.2006; Atzori L, 2004, RESP MED, V98, P530, DOI 10.1016/j.rmed.2003.11.007; BENSE L, 1987, CHEST, V92, P1009, DOI 10.1378/chest.92.6.1009; Berberat PO, 2003, FASEB J, V17, P1724, DOI 10.1096/fj.03-0229fje; Bonay Marcel, 2005, BMC Pulm Med, V5, P13, DOI 10.1186/1471-2466-5-13; Boutten A, 2010, EXPERT OPIN THER TAR, V14, P329, DOI 10.1517/14728221003629750; Bouvry D, 2006, AM J RESP CELL MOL, V35, P519, DOI 10.1165/rcmb.2005-0478OC; Ciencewicki J, 2008, J ALLERGY CLIN IMMUN, V122, P456, DOI 10.1016/j.jaci.2008.08.004; Cottin V, 1998, EUR RESPIR J, V12, P702, DOI 10.1183/09031936.98.12030702; De Smedt A, 2004, EUR RESPIR J, V23, P896, DOI 10.1183/09031936.04.00079304; Fields WR, 2005, TOXICOL SCI, V86, P84, DOI 10.1093/toxsci/kfi179; Fredenburgh LE, 2007, AM J RESP CELL MOL, V36, P158, DOI 10.1165/rcmb.2006-0331TR; Goven D, 2008, THORAX, V63, P916, DOI 10.1136/thx.2007.091181; Goven D, 2009, FEBS LETT, V583, P3508, DOI 10.1016/j.febslet.2009.10.010; Hashiba T, 2001, GENE THER, V8, P1499, DOI 10.1038/sj.gt.3301540; Hisada T, 2000, EUR J PHARMACOL, V399, P229, DOI 10.1016/S0014-2999(00)00369-1; Jia YX, 1999, INT ARCH ALLERGY IMM, V120, P141, DOI 10.1159/000024232; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Knowles HJ, 2006, CANCER RES, V66, P2600, DOI 10.1158/0008-5472.CAN-05-2351; Lee DW, 2006, CURR MOL MED, V6, P883, DOI 10.2174/156652406779010849; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; Li B, 2008, J BIOCHEM, V144, P643, DOI 10.1093/jb/mvn115; LIPPERT HL, 1991, EUR RESPIR J, V4, P324; Maestrelli P, 2001, AM J RESP CRIT CARE, V164, P1508, DOI 10.1164/ajrccm.164.8.2011083; Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC; MOLLIEX S, 1994, ANESTHESIOLOGY, V81, P668, DOI 10.1097/00000542-199409000-00021; Ning XH, 2007, AM J PHYSIOL-HEART C, V292, pH333, DOI 10.1152/ajpheart.00078.2006; Otterbein LE, 1999, J CLIN INVEST, V103, P1047, DOI 10.1172/JCI5342; Alok SP, 2007, J MOL CELL CARDIOL, V43, P580, DOI 10.1016/j.yjmcc.2007.08.003; PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x; Rahman I, 2006, EUR J PHARMACOL, V533, P222, DOI 10.1016/j.ejphar.2005.12.087; Rahman I, 2002, AM J RESP CRIT CARE, V166, P490, DOI 10.1164/rccm.2110101; Sahn SA, 2000, NEW ENGL J MED, V342, P868, DOI 10.1056/NEJM200003233421207; Schramel FMNH, 1997, EUR RESPIR J, V10, P1372, DOI 10.1183/09031936.97.10061372; Smit HJM, 1999, RESP MED, V93, P262, DOI 10.1016/S0954-6111(99)90022-7; Subotic D, 2005, MED HYPOTHESES, V64, P1144, DOI 10.1016/j.mehy.2004.12.012; Tabakoglu E, 2004, MEDIAT INFLAMM, V13, P209, DOI 10.1080/09511920410001713475; Walmsley SR, 2008, AM J RESP CELL MOL, V38, P251, DOI 10.1165/rcmb.2007-0331TR; Zeng R, 2008, J AM SOC NEPHROL, V19, P380, DOI 10.1681/ASN.2006111194	39	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10886	10.1371/journal.pone.0010886	http://dx.doi.org/10.1371/journal.pone.0010886			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526373	Green Published, gold			2022-12-27	WOS:000278222100015
J	Shang, H; Zhong, P; Liu, J; Han, XX; Dai, D; Zhang, M; Zhao, K; Xu, RZ; Yu, XF				Shang, Hong; Zhong, Ping; Liu, Jing; Han, Xiaoxu; Dai, Di; Zhang, Min; Zhao, Ke; Xu, Rongzhen; Yu, Xiao-Fang			High Prevalence and Genetic Diversity of HCV among HIV-1 Infected People from Various High-Risk Groups in China	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; INJECTION-DRUG USERS; CIRCULATING RECOMBINANT; ANTIRETROVIRAL THERAPY; TYPE-1 GENOME; HEROIN USERS; BLOOD-DONORS; NON-A; HIV	Background: Co-infection with HIV-1 and HCV is a significant global public health problem and a major consideration for anti-HIV-1 treatment. HCV infection among HIV-1 positive people who are eligible for the newly launched nationwide anti-HIV-1 treatment program in China has not been well characterized. Methodology: A nationwide survey of HIV-1 positive injection drug uses (IDU), former paid blood donors (FBD), and sexually transmitted cases from multiple provinces including the four most affected provinces in China was conducted. HCV prevalence and genetic diversity were determined. We found that IDU and FBD have extremely high rates of HCV infection (97% and 93%, respectively). Surprisingly, people who acquired HIV-1 through sexual contact also had a higher rate of HCV infection (20%) than the general population. HIV-1 subtype and HCV genotypes were amazingly similar among FBD from multiple provinces stretching from Central to Northeast China. However, although patterns of overland trafficking of heroin and distinct HIV-1 subtypes could be detected among IDU, HCV genotypes of IDU were more diverse and exhibited significant regional differences. Conclusion: Emerging HIV-1 and HCV co-infection and possible sexual transmission of HCV in China require urgent prevention measures and should be taken into consideration in the nationwide antiretroviral treatment program.	[Shang, Hong; Liu, Jing; Han, Xiaoxu; Dai, Di; Zhang, Min] China Med Univ, Hosp 1, Minist Hlth, Key Lab AIDS Immunol, Shenyang, Liaoning, Peoples R China; [Zhong, Ping] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Zhao, Ke; Yu, Xiao-Fang] Jilin Univ, Hosp 1, Ctr Virus & AIDS Res, Changchun, Jilin, Peoples R China; [Zhao, Ke; Yu, Xiao-Fang] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Xu, Rongzhen] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China	China Medical University; Shanghai Center for Disease Control & Prevention; Jilin University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Zhejiang University	Shang, H (corresponding author), China Med Univ, Hosp 1, Minist Hlth, Key Lab AIDS Immunol, Shenyang, Liaoning, Peoples R China.	hongshang100@hotmail.com; xfyu@jhsph.edu			11th Five-Year Plan [2008ZX10001-001]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016540] Funding Source: NIH RePORTER	11th Five-Year Plan(National Key Technology R&D Program); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the 11th Five-Year Plan (2008ZX10001-001), mega-projects of national science research for the tenth five-years-project on tackling key problems of national science and technology (2004BA719A12), application research program of prevention and control of AIDS by the Ministry of Health (WA2006-02), and Program of the innovative group of institution of higher education by the Education Department of Liaoning Province (2008T202). This work was also supported in part by NIH grant DA016540 (X.F. Yu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; Bonacini M, 1999, J VIRAL HEPATITIS, V6, P203, DOI 10.1046/j.1365-2893.1999.00153.x; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Garten RJ, 2008, WORLD J GASTROENTERO, V14, P1878, DOI 10.3748/wjg.14.1878; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; Garten RJ, 2004, INT J EPIDEMIOL, V33, P182, DOI 10.1093/ije/dyh019; Graf M, 1998, AIDS RES HUM RETROV, V14, P285, DOI 10.1089/aid.1998.14.285; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Monga HK, 2001, CLIN INFECT DIS, V33, P240, DOI 10.1086/321819; Noppornpath S, 2008, J GEN VIROL, V89, P1276, DOI 10.1099/vir.0.83593-0; Piroth L, 1998, AIDS, V12, P381, DOI 10.1097/00002030-199804000-00006; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Qian HZ, 2006, AIDS, V20, P1429, DOI 10.1097/01.aids.0000233577.33973.fa; Ragni MV, 2001, J INFECT DIS, V183, P1112, DOI 10.1086/319273; Sabin CA, 1997, J INFECT DIS, V175, P164, DOI 10.1093/infdis/175.1.164; Soto B, 1997, J HEPATOL, V26, P1, DOI 10.1016/S0168-8278(97)80001-3; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Sulkowski MS, 2007, J VIRAL HEPATITIS, V14, P371, DOI 10.1111/j.1365-2893.2006.00816.x; Sulkowski MS, 2002, HEPATOLOGY, V35, P182, DOI 10.1053/jhep.2002.30319; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; SUN XH, 1994, AIDS, V8, pS55; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Thomas DL, 2008, ANNU REV MED, V59, P473, DOI 10.1146/annurev.med.59.081906.081110; WANG Y, 1994, J HEPATOL, V21, P634, DOI 10.1016/S0168-8278(94)80112-6; Wang YZ, 2009, J CLIN VIROL, V44, P195, DOI 10.1016/j.jcv.2008.12.009; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Xia XS, 2008, J MED VIROL, V80, P1740, DOI 10.1002/jmv.21287; Xia XS, 2008, J MED VIROL, V80, P1142, DOI 10.1002/jmv.21204; Yu XF, 1999, J ACQ IMMUN DEF SYND, V22, P180; Yu XF, 1998, LANCET, V351, P1250, DOI 10.1016/S0140-6736(05)79316-8; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zhao Shu-Ming, 2008, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V16, P676; 马现君, 2007, [中华流行病学杂志, Chinese Journal of Epidemiology], V28, P733	36	30	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10631	10.1371/journal.pone.0010631	http://dx.doi.org/10.1371/journal.pone.0010631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523729	gold, Green Published, Green Submitted			2022-12-27	WOS:000278221900002
J	Lee, BY; McGlone, SM; Bailey, RR; Wiringa, AE; Zimmer, SM; Smith, KJ; Zimmerman, RK				Lee, Bruce Y.; McGlone, Sarah M.; Bailey, Rachel R.; Wiringa, Ann E.; Zimmer, Shanta M.; Smith, Kenneth J.; Zimmerman, Richard K.			To Test or to Treat? An Analysis of Influenza Testing and Antiviral Treatment Strategies Using Economic Computer Modeling	PLOS ONE			English	Article							COST-EFFECTIVENESS; HEALTHY-ADULTS; CLINICAL-DIAGNOSIS; A H1N1; OSELTAMIVIR; UTILITY; CHILDREN; ILLNESS; VIRUS; VACCINATION	Background: Due to the unpredictable burden of pandemic influenza, the best strategy to manage testing, such as rapid or polymerase chain reaction (PCR), and antiviral medications for patients who present with influenza-like illness (ILI) is unknown. Methodology/Principal Findings: We developed a set of computer simulation models to evaluate the potential economic value of seven strategies under seasonal and pandemic influenza conditions: (1) using clinical judgment alone to guide antiviral use, (2) using PCR to determine whether to initiate antivirals, (3) using a rapid (point-of-care) test to determine antiviral use, (4) using a combination of a point-of-care test and clinical judgment, (5) using clinical judgment and confirming the diagnosis with PCR testing, (6) treating all with antivirals, and (7) not treating anyone with antivirals. For healthy younger adults (, 65 years old) presenting with ILI in a seasonal influenza scenario, strategies were only cost-effective from the societal perspective. Clinical judgment, followed by PCR and point-of-care testing, was found to be cost-effective given a high influenza probability. Doubling hospitalization risk and mortality (representing either higher risk individuals or more virulent strains) made using clinical judgment to guide antiviral decision-making cost-effective, as well as PCR testing, point-of-care testing, and point-of-care testing used in conjunction with clinical judgment. For older adults (>= 65 years old), in both seasonal and pandemic influenza scenarios, employing PCR was the most cost-effective option, with the closest competitor being clinical judgment (when judgment accuracy >= 50%). Point-of-care testing plus clinical judgment was cost-effective with higher probabilities of influenza. Treating all symptomatic ILI patients with antivirals was cost-effective only in older adults. Conclusions/Significance: Our study delineated the conditions under which different testing and antiviral strategies may be cost-effective, showing the importance of accuracy, as seen with PCR or highly sensitive clinical judgment.	[Lee, Bruce Y.; McGlone, Sarah M.; Bailey, Rachel R.; Wiringa, Ann E.; Zimmer, Shanta M.; Smith, Kenneth J.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15260 USA; [Lee, Bruce Y.; McGlone, Sarah M.; Bailey, Rachel R.; Wiringa, Ann E.] Univ Pittsburgh, Sch Med, Dept Biomed Informat, Pittsburgh, PA USA; [Lee, Bruce Y.; McGlone, Sarah M.; Bailey, Rachel R.; Wiringa, Ann E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Zimmerman, Richard K.] Univ Pittsburgh, Dept Family Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lee, BY (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15260 USA.	BYL1@pitt.edu		Slayton, Rachel/0000-0003-4699-8040; Smith, Kenneth J/0000-0001-8088-566X; Wiringa, Ann/0000-0002-6600-3592; Zimmerman, Richard/0000-0001-5941-6092	National Institute of General Medical Sciences Models of Infectious Agent Study (MIDAS) [1U54GM088491-0109]; National Library of Medicine [5R01LM009132-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009132] Funding Source: NIH RePORTER	National Institute of General Medical Sciences Models of Infectious Agent Study (MIDAS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was supported by the National Institute of General Medical Sciences Models of Infectious Agent Study (MIDAS) grant 1U54GM088491-0109 and the National Library of Medicine grant 5R01LM009132-02. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; Briggs AH, 2002, MED DECIS MAKING, V22, P290, DOI 10.1177/027298902400448867; *BUR LAB STAT, 2009, OCC EMPL STAT MAY 20; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; *CDCP, 2009, UPD INT REC US ANT M; *CDCP, 2010, FLU ACT SURV FLU VIE; *CDCP, 2008, INFL ANT DRUG RES QU; *CDCP, 2009, 2009 2010 INFL SEAS; *CDCP, 2009, ANT DRUG RES STRAINS; *CDCP, 2009, INT REC CLIN INFL DI; Centers for Disease Control and Prevention, 2006, US INFL SENT PROV SU; Couch RB, 2000, NEW ENGL J MED, V343, P1778, DOI 10.1056/NEJM200012143432407; Cram P, 2001, PHARMACOECONOMICS, V19, P223, DOI 10.2165/00019053-200119030-00001; DEMICHELI V, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001269.PUB2.ART; ELLIS J, 2009, EVALUATION REAL TIME; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Ginocchio CC, 2009, J CLIN VIROL, V45, P191, DOI 10.1016/j.jcv.2009.06.005; Gold MR, 1998, MED CARE, V36, P778, DOI 10.1097/00005650-199806000-00002; Gordon A, 2009, EMERG INFECT DIS, V15, P408, DOI 10.3201/eid1503.080238; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Jefferson TO, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001265.pub2; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; LEVIT K, 2007, HCUP FACTS FIG 2007; Luce BR, 2008, VACCINE, V26, P2841, DOI 10.1016/j.vaccine.2008.03.046; Mauskopf JA, 2000, PHARMACOECONOMICS, V17, P611, DOI 10.2165/00019053-200017060-00007; Monto AS, 2008, PEDIATR INFECT DIS J, V27, pS110, DOI 10.1097/INF.0b013e318168b739; MOSCONA A, 2005, NEW ENGL J MED, V353, P1163; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Poland GA, 2009, CLIN INFECT DIS, V48, P1254, DOI 10.1086/598989; Postma Maarten J, 2008, J Med Econ, V11, P743, DOI 10.3111/13696990802505557; Rivetti D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub2; Roberts S, 2006, OBSTET GYNECOL, V107, P1323, DOI 10.1097/01.AOG.0000210225.45986.99; Rothberg MB, 2005, AM J MED, V118, P68, DOI 10.1016/j.amjmed.2004.03.044; Rothberg MB, 2003, J GEN INTERN MED, V18, P808, DOI 10.1046/j.1525-1497.2003.20822.x; Ruef C, 2007, INFECTION, V35, P49, DOI 10.1007/s15010-007-7207-4; SACKETT DL, 1978, J CHRON DIS, V31, P697, DOI 10.1016/0021-9681(78)90072-3; Sander B, 2006, PHARMACOECONOMICS, V24, P373, DOI 10.2165/00019053-200624040-00007; Sintchenko V, 2002, J CLIN VIROL, V25, P15, DOI 10.1016/S1386-6532(00)00182-7; Smith KJ, 2002, AM J MED, V113, P300, DOI 10.1016/S0002-9343(02)01222-6; Stein J, 2005, ANN EMERG MED, V46, P412, DOI 10.1016/j.annemergmed.2005.05.020; Talbird SE, 2009, AM J HEALTH-SYST PH, V66, P469, DOI 10.2146/ajhp080296; Tengs TO, 2000, MED CARE, V38, P583, DOI 10.1097/00005650-200006000-00004; *THOMPS HLTH INC, 2008, PDR RED BOOK; Thompson SG, 2005, MED DECIS MAKING, V25, P416, DOI 10.1177/0272989X05276862; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Uyeki TM, 2009, CLIN INFECT DIS, V48, pE89, DOI 10.1086/597828; van Hal SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006620; Vasoo S, 2009, CLIN INFECT DIS, V49, P1090, DOI 10.1086/644743; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; WILMOTH JR, 2008, HUMAN MORTALITY DATA; Zambon M, 2001, ARCH INTERN MED, V161, P2116, DOI 10.1001/archinte.161.17.2116	53	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11284	10.1371/journal.pone.0011284	http://dx.doi.org/10.1371/journal.pone.0011284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585642	Green Published, Green Accepted, gold			2022-12-27	WOS:000279135400026
J	Rassy, D; Bobes, RJ; Rosas, G; Anaya, VH; Brehm, K; Hernandez, B; Cervantes, J; Pedraza, S; Morales, J; Villalobos, N; de Aluja, AS; Laclette, JP; Nunes, CM; Biondi, GF; Fragoso, G; Hernandez, M; Sciutto, E				Rassy, Dunia; Bobes, Raul J.; Rosas, Gabriela; Anaya, Victor H.; Brehm, Klaus; Hernandez, Beatriz; Cervantes, Jacquelynne; Pedraza, Saul; Morales, Julio; Villalobos, Nelly; de Aluja, Aline S.; Laclette, Juan P.; Nunes, Caris M.; Biondi, Germano F.; Fragoso, Gladis; Hernandez, Marisela; Sciutto, Edda			Characterization of S3Pvac Anti-Cysticercosis Vaccine Components: Implications for the Development of an Anti-Cestodiasis Vaccine	PLOS ONE			English	Article							TAENIA-SOLIUM CYSTICERCOSIS; CRASSICEPS MURINE CYSTICERCOSIS; SYNTHETIC PEPTIDE VACCINE; PORCINE CYSTICERCOSIS; IMMUNE-RESPONSE; FIELD TRIAL; RECOMBINANT; PIGS; ONCOSPHERE; PROTECTION	Background: Cysticercosis and hydatidosis seriously affect human health and are responsible for considerable economic loss in animal husbandry in non-developed and developed countries. S3Pvac and EG95 are the only field trial-tested vaccine candidates against cysticercosis and hydatidosis, respectively. S3Pvac is composed of three peptides (KETc1, GK1 and KETc12), originally identified in a Taenia crassiceps cDNA library. S3Pvac synthetically and recombinantly expressed is effective against experimentally and naturally acquired cysticercosis. Methodology/ Principal Findings: In this study, the homologous sequences of two of the S3Pvac peptides, GK1 and KETc1, were identified and further characterized in Taenia crassiceps WFU, Taenia solium, Taenia saginata, Echinococcus granulosus and Echinococcus multilocularis. Comparisons of the nucleotide and amino acid sequences coding for KETc1 and GK1 revealed significant homologies in these species. The predicted secondary structure of GK1 is almost identical between the species, while some differences were observed in the C terminal region of KETc1 according to 3D modeling. A KETc1 variant with a deletion of three C-terminal amino acids protected to the same extent against experimental murine cysticercosis as the entire peptide. On the contrary, immunization with the truncated GK1 failed to induce protection. Immunolocalization studies revealed the non stage-specificity of the two S3Pvac epitopes and their persistence in the larval tegument of all species and in Taenia adult tapeworms. Conclusions/ Significance: These results indicate that GK1 and KETc1 may be considered candidates to be included in the formulation of a multivalent and multistage vaccine against these cestodiases because of their enhancing effects on other available vaccine candidates.	[Rassy, Dunia; Bobes, Raul J.; Cervantes, Jacquelynne; Pedraza, Saul; Morales, Julio; Laclette, Juan P.; Fragoso, Gladis; Hernandez, Marisela; Sciutto, Edda] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City 04510, DF, Mexico; [Rosas, Gabriela] Univ Autonoma Estado Morelos, Fac Med, Cuernavaca, Morelos, Mexico; [Anaya, Victor H.] Humboldt Univ, Inst Theoret Biol, Berlin, Germany; [Brehm, Klaus] Univ Wurzburg, Inst Hyg & Mikrobiol, Wurzburg, Germany; [Hernandez, Beatriz] Univ Nacl Autonoma Mexico, Fac Med, Mexico City 04510, DF, Mexico; [Villalobos, Nelly; de Aluja, Aline S.] Univ Nacl Autonoma Mexico, Fac Med Vet & Zootecnia, Mexico City 04510, DF, Mexico; [Nunes, Caris M.] Univ Estadual Paulista, Dept Apoio Prod & Saude Anim, Aracatuba, Sao Paolo, Brazil; [Biondi, Germano F.] Univ Estadual Paulista, Fac Med Vet & Zootecnia Botucatu, Dept Hyg Vet & Saude Publ, Botucatu, SP, Brazil	Universidad Nacional Autonoma de Mexico; Universidad Autonoma del Estado de Morelos; Humboldt University of Berlin; University of Wurzburg; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidade Estadual Paulista; Universidade Estadual Paulista	Rassy, D (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City 04510, DF, Mexico.	edda@servidor.unam.mx	Rosas, Gabriela/AAO-8127-2021; Nunes, Caris M/R-9337-2016	Nunes, Caris M/0000-0002-5463-3845; Anaya-Munoz, Victor Hugo/0000-0001-6136-7330; Sciutto, Edda/0000-0001-5608-5355	Consejo Nacional de Ciencia y Tecnologia [S52680-R/70072, CB-62471]; Direccion General de Asuntos del Personal Academico (DGAPA) [IN217908]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico (DGAPA)	This work was funded by the Consejo Nacional de Ciencia y Tecnologia S52680-R/70072, CB-62471 and Direccion General de Asuntos del Personal Academico (DGAPA) IN217908. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ASSANA E, 2010, INT J PARASITOLGAUDI, P18; BOUDET F, 1991, J IMMUNOL METHODS, V142, P73, DOI 10.1016/0022-1759(91)90294-P; Bystroff C, 2000, J MOL BIOL, V301, P173, DOI 10.1006/jmbi.2000.3837; Bystroff Christopher, 2002, Bioinformatics, V18 Suppl 1, pS54; Chang SL, 2006, J HELMINTHOL, V80, P219, DOI 10.1079/JOH2005333; Cruz-Revilla C, 2006, J PARASITOL, V92, P864, DOI 10.1645/GE-779R1.1; Diaz MA, 2003, VET IMMUNOL IMMUNOP, V93, P81, DOI 10.1016/S0165-2427(03)00071-0; Everhart ME, 2004, J PARASITOL, V90, P79, DOI 10.1645/GE-3255; Flisser A, 2004, INFECT IMMUN, V72, P5292, DOI 10.1128/IAI.72.9.5292-5297.2004; Fragoso G, 1998, INFECT IMMUN, V66, P760, DOI 10.1128/IAI.66.2.760-764.1998; FREEMAN R, 1962, CAN J ZOOL, V969, P1800; GarciaAllan C, 1996, J HELMINTHOL, V70, P271, DOI 10.1017/S0022149X00015558; Gauci C, 2003, MOL BIOCHEM PARASIT, V127, P193, DOI 10.1016/S0166-6851(03)00005-7; GEMMELL MA, 1969, EXP PARASITOL, V26, P67, DOI 10.1016/0014-4894(69)90096-4; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gonzalez AE, 2005, AM J TROP MED HYG, V72, P837, DOI 10.4269/ajtmh.2005.72.837; Gottstein B, 2005, Ther Umsch, V62, P685, DOI 10.1024/0040-5930.62.10.685; HARRISON L J S, 1989, Acta Leidensia, V57, P143; Hoberg EP, 2002, MICROBES INFECT, V4, P859, DOI 10.1016/S1286-4579(02)01606-4; Huerta M, 2001, VACCINE, V20, P262, DOI 10.1016/S0264-410X(01)00249-3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LARRALDE C, 1989, AM J TROP MED HYG, V40, P282, DOI 10.4269/ajtmh.1989.40.282; Leon-Cabrera S, 2009, METHODS, V49, P346, DOI 10.1016/j.ymeth.2009.07.007; Lightowlers MW, 1999, INT J PARASITOL, V29, P531, DOI 10.1016/S0020-7519(99)00003-X; Lightowlers MW, 1996, PARASITE IMMUNOL, V18, P507, DOI 10.1046/j.1365-3024.1996.d01-20.x; Lightowlers MW, 1996, EXP PARASITOL, V84, P330, DOI 10.1006/expr.1996.0121; Manoutcharian K, 2004, VET IMMUNOL IMMUNOP, V99, P11, DOI 10.1016/j.vetimm.2003.12.009; Manoutcharian K, 1996, J PARASITOL, V82, P250, DOI 10.2307/3284156; Mariaux J, 1996, INT J PARASITOL, V26, P231, DOI 10.1016/0020-7519(95)00129-8; Molinari JL, 1997, VET PARASITOL, V69, P55, DOI 10.1016/S0304-4017(96)01102-8; Montero E, 2007, EXP PARASITOL, V116, P191, DOI 10.1016/j.exppara.2006.12.015; Morales J, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000284; NASCIMENTO E, 1995, VET IMMUNOL IMMUNOP, V45, P127, DOI 10.1016/0165-2427(94)05327-O; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; ONYANGOABUJE JA, 1989, RES VET SCI, V47, P236, DOI 10.1016/S0034-5288(18)31212-8; Parkhouse RME, 2008, PARASITOL RES, V102, P921, DOI 10.1007/s00436-007-0853-8; Patarroyo ME, 2008, ACCOUNTS CHEM RES, V41, P377, DOI 10.1021/ar700120t; Plancarte A, 1999, INT J PARASITOL, V29, P643, DOI 10.1016/S0020-7519(99)00021-1; Rickard M D, 1991, Southeast Asian J Trop Med Public Health, V22 Suppl, P287; Rosas G, 2002, MICROBES INFECT, V4, P1417, DOI 10.1016/S1286-4579(02)00025-4; Rosas G, 1998, J PARASITOL, V84, P516, DOI 10.2307/3284715; Rosas G, 2006, MICROBES INFECT, V8, P1277, DOI 10.1016/j.micinf.2005.12.006; Schantz PM, 2006, PARASITOL INT, V55, pS7, DOI 10.1016/j.parint.2005.11.050; Sciutto E, 2007, PARASITOLOGY, V134, P129, DOI 10.1017/S0031182006001132; SCIUTTO E, 1995, VET PARASITOL, V60, P53, DOI 10.1016/0304-4017(94)00781-7; Sciutto E, 2008, CURR TOP MED CHEM, V8, P415, DOI 10.2174/156802608783790839; Sclutto E, 2007, J PARASITOL, V93, P824, DOI 10.1645/GE-1018R1.1; Seed, 2001, PARASITISM DIVERSITY; Segura-Velazquez R, 2006, VACCINE, V24, P1073, DOI 10.1016/j.vaccine.2005.09.014; SMITH KJ, 1972, INT J PARASITOL, V2, P261; Smyth JD, 1969, PHYSL CESTODES; Spiliotis M, 2008, INT J PARASITOL, V38, P1025, DOI 10.1016/j.ijpara.2007.11.002; SUK J S, 1980, Korean Journal of Parasitology, V18, P1, DOI 10.3347/kjp.1980.18.1.1; Toledo A, 1999, INFECT IMMUN, V67, P2522, DOI 10.1128/IAI.67.5.2522-2530.1999; Toledo A, 2001, INFECT IMMUN, V69, P1766, DOI 10.1128/IAI.69.3.1766-1773.2001; Willms K, 2004, PARASITOL RES, V93, P262, DOI 10.1007/s00436-004-1125-5; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	58	18	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11287	10.1371/journal.pone.0011287	http://dx.doi.org/10.1371/journal.pone.0011287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585656	Green Submitted, Green Published, gold			2022-12-27	WOS:000279135400029
J	Rignell-Hydbom, A; Elfving, M; Ivarsson, SA; Lindh, C; Jonsson, BAG; Olofsson, P; Rylander, L				Rignell-Hydbom, Anna; Elfving, Maria; Ivarsson, Sten A.; Lindh, Christian; Jonsson, Bo A. G.; Olofsson, Per; Rylander, Lars			A Nested Case-Control Study of Intrauterine Exposure to Persistent Organochlorine Pollutants in Relation to Risk of Type 1 Diabetes	PLOS ONE			English	Article							ENVIRONMENTAL CONTAMINANTS; INCIDENCE TRENDS; RISING INCIDENCE; 1ST YEAR; INSULIN; POPULATION; EUROPE; CHILDREN; MELLITUS; ONSET	Background: The incidence of type 1 diabetes in Europe is increasing at a rate of about 3% per year and there is also an increasing incidence throughout the world. Type 1 diabetes is a complex disease caused by multiple genetic and environmental factors. Persistent organochlorine pollutants (POPs) have been suggested as a triggering factor for developing childhood type 1 diabetes. The aim of this case-control study was to assess possible impacts of in utero exposure to POPs on type 1 diabetes. Methodology/Principal Findings: The study was performed as a case-control study within a biobank in Malmo, a city located in the Southern part of Sweden. The study included 150 cases (children who had their diagnosis mostly before 18 years of age) and 150 controls, matched for gender and day of birth. 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153) and the major DDT metabolite 1,1-dichloro-2,2-bis (p-chlorophenyl)-ethylene (p,p'-DDE) were used as a biomarkers for POP exposure. When comparing the quartile with the highest maternal serum concentrations of PCB-153 with the other quartiles, an odds ratio (OR) of 0.73 (95% confidence interval [CI] 0.42, 1.27) was obtained. Similar results was obtained for p,p'-DDE (OR 0.56, 95% CI 0.29, 1.08). Conclusions: The hypothesis that in utero exposure to POPs will trigger the risk for developing type 1 diabetes was not supported by the results. The risk estimates did, although not statistically significant, go in the opposite direction. However, it is not reasonable to believe that exposure to POPs should protect against type 1 diabetes.	[Rignell-Hydbom, Anna; Lindh, Christian; Jonsson, Bo A. G.; Rylander, Lars] Lund Univ, Div Occupat & Environm Med, Lund, Sweden; [Elfving, Maria] Lund Univ, Dept Pediat, Univ Lund Hosp, Lund, Sweden; [Ivarsson, Sten A.] Lund Univ, Dept Clin Sci, Unit Pediat Endocrinol, CRC, Malmo, Sweden; [Olofsson, Per] Lund Univ, Malmo Univ Hosp, Dept Obstet & Gynecol, Malmo, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital	Rignell-Hydbom, A (corresponding author), Lund Univ, Div Occupat & Environm Med, Lund, Sweden.	anna.rignell-hydbom@med.lu.se		Rylander, Lars/0000-0001-8288-8207; Jonsson, Bo/0000-0002-8767-0589; Lindh, Christian/0000-0001-7435-9890	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Medical Faculty, Lund University	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Medical Faculty, Lund University	The project was made possible by grants from the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, and the Medical Faculty, Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1991, PRACTICAL STATISTIC; Azam A, 2004, EXPERT OPIN BIOL TH, V4, P1569, DOI 10.1517/14712598.4.10.1569; BIGNERT A, COMMENTS NATL SWEDIS; BODANSKY HJ, 1992, BRIT MED J, V304, P1020, DOI 10.1136/bmj.304.6833.1020; Costa Lucio G., 2007, Arhiv za Higijenu Rada i Toksikologiju, V58, P367, DOI 10.2478/v10004-007-0025-3; Dahlquist GG, 1999, DIABETES CARE, V22, P1698, DOI 10.2337/diacare.22.10.1698; DAHLQUIST GG, 1995, DIABETES, V44, P408, DOI 10.2337/diabetes.44.4.408; Darnerud PO, 2006, FOOD CHEM TOXICOL, V44, P1597, DOI 10.1016/j.fct.2006.03.011; EBNER K, 1988, J ENVIRON SCI HEAL B, V23, P427, DOI 10.1080/03601238809372617; Elfving M, 2008, EXP DIABETES RES, DOI 10.1155/2008/271958; ENAN E, 1994, J BIOCHEM TOXICOL, V9, P97, DOI 10.1002/jbt.2570090207; Gale EAM, 2002, DIABETES, V51, P3353, DOI 10.2337/diabetes.51.12.3353; Gardner SG, 1997, BRIT MED J, V315, P713, DOI 10.1136/bmj.315.7110.713; Gillespie KM, 2004, LANCET, V364, P1699, DOI 10.1016/S0140-6736(04)17357-1; GINSBERGFELLNER F, 1985, LANCET, V2, P332; Glynn AW, 2000, SCI TOTAL ENVIRON, V263, P197, DOI 10.1016/S0048-9697(00)00703-8; Grandjean P, 2008, ENVIRON SCI TECHNOL, V42, P6991, DOI 10.1021/es800778q; Green A, 2000, LANCET, V355, P873; Green A, 2001, DIABETOLOGIA, V44, pB3, DOI 10.1007/PL00002950; Grimvall E, 1997, ARCH ENVIRON CON TOX, V32, P329, DOI 10.1007/s002449900193; Hertz-Picciotto I, 2008, BASIC CLIN PHARMACOL, V102, P146, DOI 10.1111/j.1742-7843.2007.00190.x; Hokanson R, 2004, HUM EXP TOXICOL, V23, P555, DOI 10.1191/0960327104ht488oa; Holladay SD, 1999, ENVIRON HEALTH PERSP, V107, P687, DOI 10.2307/3434328; Ilonen J, 2002, AM J MED GENET, V115, P30, DOI 10.1002/ajmg.10341; Jonsson Bo A G, 2005, Environ Health, V4, P27, DOI 10.1186/1476-069X-4-27; Longnecker MP, 2001, ENVIRON HEALTH PERSP, V109, P871, DOI 10.2307/3454649; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; OSTMAN J, 1986, ACTA MED SCAND, V220, P437; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Remillard RBJ, 2002, ENVIRON HEALTH PERSP, V110, P853, DOI 10.1289/ehp.02110853; Rignell-Hydbom A, 2004, HUM REPROD, V19, P2066, DOI 10.1093/humrep/deh362; Sjodin A, 2000, ENVIRON HEALTH PERSP, V108, P1035, DOI 10.2307/3434955; Smith SA, 2002, BIOCHEM SOC T, V30, P1086, DOI 10.1042/BST0301086; Stene LC, 2003, AM J CLIN NUTR, V78, P1128, DOI 10.1093/ajcn/78.6.1128; Tan J, 2009, CHEMOSPHERE, V74, P428, DOI 10.1016/j.chemosphere.2008.09.045; Tuomilehto J, 1999, DIABETOLOGIA, V42, P655, DOI 10.1007/s001250051212; VOGEL CFA, 2003, J BIOL CHEM, V18, P8886	37	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11281	10.1371/journal.pone.0011281	http://dx.doi.org/10.1371/journal.pone.0011281			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585661	Green Published, Green Submitted, gold			2022-12-27	WOS:000279135400024
J	Klassen, JL				Klassen, Jonathan L.			Phylogenetic and Evolutionary Patterns in Microbial Carotenoid Biosynthesis Are Revealed by Comparative Genomics	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; LYCOPENE BETA-CYCLASE; FUNCTIONAL-ANALYSIS; GENE-CLUSTER; MARINE BACTERIUM; COMBINATORIAL BIOSYNTHESIS; DEINOCOCCUS-RADIODURANS; STRUCTURAL DIVERSITY; PHYTOENE DESATURASE; HORIZONTAL TRANSFER	Background: Carotenoids are multifunctional, taxonomically widespread and biotechnologically important pigments. Their biosynthesis serves as a model system for understanding the evolution of secondary metabolism. Microbial carotenoid diversity and evolution has hitherto been analyzed primarily from structural and biosynthetic perspectives, with the few phylogenetic analyses of microbial carotenoid biosynthetic proteins using either used limited datasets or lacking methodological rigor. Given the recent accumulation of microbial genome sequences, a reappraisal of microbial carotenoid biosynthetic diversity and evolution from the perspective of comparative genomics is warranted to validate and complement models of microbial carotenoid diversity and evolution based upon structural and biosynthetic data. Methodology/Principal Findings: Comparative genomics were used to identify and analyze in silico microbial carotenoid biosynthetic pathways. Four major phylogenetic lineages of carotenoid biosynthesis are suggested composed of: (i) Proteobacteria; (ii) Firmicutes; (iii) Chlorobi, Cyanobacteria and photosynthetic eukaryotes; and (iv) Archaea, Bacteroidetes and two separate sub-lineages of Actinobacteria. Using this phylogenetic framework, specific evolutionary mechanisms are proposed for carotenoid desaturase CrtI-family enzymes and carotenoid cyclases. Several phylogenetic lineage-specific evolutionary mechanisms are also suggested, including: (i) horizontal gene transfer; (ii) gene acquisition followed by differential gene loss; (iii) co-evolution with other biochemical structures such as proteorhodopsins; and (iv) positive selection. Conclusions/Significance: Comparative genomics analyses of microbial carotenoid biosynthetic proteins indicate a much greater taxonomic diversity then that identified based on structural and biosynthetic data, and divides microbial carotenoid biosynthesis into several, well-supported phylogenetic lineages not evident previously. This phylogenetic framework is applicable to understanding the evolution of specific carotenoid biosynthetic proteins or the unique characteristics of carotenoid biosynthetic evolution in a specific phylogenetic lineage. Together, these analyses suggest a "bramble'' model for microbial carotenoid biosynthesis whereby later biosynthetic steps exhibit greater evolutionary plasticity and reticulation compared to those closer to the biosynthetic "root''. Structural diversification may be constrained ("trimmed'') where selection is strong, but less so where selection is weaker. These analyses also highlight likely productive avenues for future research and bioprospecting by identifying both gaps in current knowledge and taxa which may particularly facilitate carotenoid diversification.	Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Klassen, JL (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	jlk3@ualberta.ca	Klassen, Jonathan/B-5060-2010	Klassen, Jonathan/0000-0003-1745-8838	National Science and Engineering Research Council of Canada	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work has been supported by a National Science and Engineering Research Council of Canada Postgraduate Scholarship to Jonathan Klassen and a National Science and Engineering Research Council of Canada Discovery Grant to Julia Foght. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2000, NAT BIOTECHNOL, V18, P843, DOI 10.1038/78443; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARMSTRONG GA, 1990, P NATL ACAD SCI USA, V87, P9975, DOI 10.1073/pnas.87.24.9975; Auldridge ME, 2006, CURR OPIN PLANT BIOL, V9, P315, DOI 10.1016/j.pbi.2006.03.005; Breitenbach J, 1998, PLANT MOL BIOL, V36, P725, DOI 10.1023/A:1005997405431; Breitenbach J, 2001, Z NATURFORSCH C, V56, P915; Britton G, 1995, FASEB J, V9, P1551, DOI 10.1096/fasebj.9.15.8529834; Britton G., 2004, CAROTENOIDS HDB, DOI DOI 10.1007/978-3-0348-7836-4; Bryant DA, 2007, SCIENCE, V317, P523, DOI 10.1126/science.1143236; CHAMOVITZ D, 1991, PLANT MOL BIOL, V16, P967, DOI 10.1007/BF00016069; Cheng Q, 2006, J IND MICROBIOL BIOT, V33, P552, DOI 10.1007/s10295-006-0121-4; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cockell CS, 1998, J THEOR BIOL, V193, P717, DOI 10.1006/jtbi.1998.0738; COSTAS AMG, 2008, PHOTOSYNTHESIS ENERG, P1161; CUNNINGHAM FX, 1994, PLANT CELL, V6, P1107, DOI 10.1105/tpc.6.8.1107; Das A, 2007, APPL MICROBIOL BIOT, V77, P505, DOI 10.1007/s00253-007-1206-3; Del Campo JA, 2007, APPL MICROBIOL BIOT, V74, P1163, DOI 10.1007/s00253-007-0844-9; Domonkos I, 2009, PLANT CELL PHYSIOL, V50, P374, DOI 10.1093/pcp/pcn204; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FernandezGonzalez B, 1997, J BIOL CHEM, V272, P9728; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; Frank HA, 2004, BIOCHEMISTRY-US, V43, P8607, DOI 10.1021/bi0492096; Fraser NJ, 2001, PHOTOSYNTH RES, V70, P249, DOI 10.1023/A:1014715114520; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; Frigaard NU, 2004, J BACTERIOL, V186, P5210, DOI 10.1128/JB.186.16.5210-5220.2004; Frommolt R, 2008, MOL BIOL EVOL, V25, P2653, DOI 10.1093/molbev/msn206; Fuhrman JA, 2008, NAT REV MICROBIOL, V6, P488, DOI 10.1038/nrmicro1893; Gerjets T, 2009, BBA-MOL CELL BIOL L, V1791, P125, DOI 10.1016/j.bbalip.2008.12.006; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Gruszecki WI, 2005, BBA-MOL BASIS DIS, V1740, P108, DOI 10.1016/j.bbadis.2004.11.015; Gupta RS, 2003, PHOTOSYNTH RES, V76, P173, DOI 10.1023/A:1024999314839; Hemmi H, 2003, BIOCHEM BIOPH RES CO, V305, P586, DOI 10.1016/S0006-291X(03)00798-8; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Igarashi N, 2001, J MOL EVOL, V52, P333, DOI 10.1007/s002390010163; Iniesta AA, 2007, FEBS J, V274, P4306, DOI 10.1111/j.1742-4658.2007.05960.x; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Klassen JL, 2008, APPL ENVIRON MICROB, V74, P2016, DOI 10.1128/AEM.02306-07; Klassen JL, 2009, J BACTERIOL, V191, P7500, DOI 10.1128/JB.01060-09; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Krinsky Norman I., 2005, Molecular Aspects of Medicine, V26, P459; Krubasik P, 2000, BIOCHEM SOC T, V28, P806, DOI 10.1042/BST0280806; Krubasik P, 2001, EUR J BIOCHEM, V268, P3702, DOI 10.1046/j.1432-1327.2001.02275.x; Krugel H, 1999, BBA-MOL CELL BIOL L, V1439, P57, DOI 10.1016/S1388-1981(99)00075-X; Kupisz K, 2008, BBA-BIOMEMBRANES, V1778, P2334, DOI 10.1016/j.bbamem.2008.06.005; LANG HP, 1994, J BACTERIOL, V176, P3859, DOI 10.1128/JB.176.13.3859-3869.1994; Lanyi JK, 2008, BBA-BIOENERGETICS, V1777, P684, DOI 10.1016/j.bbabio.2008.05.005; Li FQ, 2007, PLANT PHYSIOL, V144, P1181, DOI 10.1104/PP.107.098996; LINDEN H, 1993, FEMS MICROBIOL LETT, V106, P99, DOI 10.1016/0378-1097(93)90062-7; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Lu YQ, 2003, MOL BIOL EVOL, V20, P1844, DOI 10.1093/molbev/msg197; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Maresca JA, 2008, J BACTERIOL, V190, P6384, DOI 10.1128/JB.00758-08; Maresca JA, 2008, PHOTOSYNTH RES, V97, P121, DOI 10.1007/s11120-008-9312-3; Maresca JA, 2007, P NATL ACAD SCI USA, V104, P11784, DOI 10.1073/pnas.0702984104; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD528, DOI 10.1093/nar/gkm846; MARTINEZFEREZ IM, 1992, PLANT MOL BIOL, V18, P981, DOI 10.1007/BF00019213; Masamoto K, 2001, PLANT CELL PHYSIOL, V42, P1398, DOI 10.1093/pcp/pce167; McCarren J, 2007, ENVIRON MICROBIOL, V9, P846, DOI 10.1111/j.1462-2920.2006.01203.x; MISAWA N, 1990, J BACTERIOL, V172, P6704, DOI 10.1128/jb.172.12.6704-6712.1990; Mortensen A, 2006, PURE APPL CHEM, V78, P1477, DOI 10.1351/pac200678081477; Nagashima KVP, 1997, J MOL EVOL, V45, P131, DOI 10.1007/PL00006212; Nishida Y, 2005, APPL ENVIRON MICROB, V71, P4286, DOI 10.1128/AEM.71.8.4286-4296.2005; Novichkov PS, 2009, J BACTERIOL, V191, P65, DOI 10.1128/JB.01237-08; Oparin A. I., 1938, ORIGINS LIFE EVOL B; Ouchane S, 1997, J BIOL CHEM, V272, P1670, DOI 10.1074/jbc.272.3.1670; Ourisson G, 1994, CHEM BIOL, V1, P11, DOI 10.1016/1074-5521(94)90036-1; Pelz A, 2005, J BIOL CHEM, V280, P32493, DOI 10.1074/jbc.M505070200; Phadwal K, 2005, GENE, V345, P35, DOI 10.1016/j.gene.2004.11.038; Rao AV, 2007, PHARMACOL RES, V55, P207, DOI 10.1016/j.phrs.2007.01.012; Rausher MD, 1999, MOL BIOL EVOL, V16, P266, DOI 10.1093/oxfordjournals.molbev.a026108; Sandmann G, 2002, PHYSIOL PLANTARUM, V116, P431, DOI 10.1034/j.1399-3054.2002.1160401.x; Sandmann G, 2002, CHEMBIOCHEM, V3, P629, DOI 10.1002/1439-7633(20020703)3:7<629::AID-CBIC629>3.0.CO;2-5; SANDMANN G, 1992, FEMS MICROBIOL LETT, V90, P253, DOI 10.1111/j.1574-6968.1992.tb05162.x; Sandmann G, 2009, ARCH BIOCHEM BIOPHYS, V483, P169, DOI 10.1016/j.abb.2008.10.004; Schmidt-Dannert C, 2000, CURR OPIN BIOTECH, V11, P255, DOI 10.1016/S0958-1669(00)00093-8; Sharma AK, 2006, TRENDS MICROBIOL, V14, P463, DOI 10.1016/j.tim.2006.09.006; Sharma AK, 2009, ISME J, V3, P726, DOI 10.1038/ismej.2009.13; Shindo K, 2008, J ANTIBIOT, V61, P185, DOI 10.1038/ja.2008.128; Sieiro C, 2003, INT MICROBIOL, V6, P11, DOI 10.1007/s10123-003-0097-0; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Stahl W, 2003, MOL ASPECTS MED, V24, P345, DOI 10.1016/S0098-2997(03)00030-X; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Steiger S, 2005, ARCH MICROBIOL, V184, P207, DOI 10.1007/s00203-005-0004-5; Steiger S, 2004, BIOTECHNOL LETT, V26, P813, DOI 10.1023/B:BILE.0000025880.91269.cf; Stickforth P, 2003, ARCH MICROBIOL, V179, P409, DOI 10.1007/s00203-003-0545-4; Takaichi S, 2007, CELL MOL LIFE SCI, V64, P2607, DOI 10.1007/s00018-007-7190-z; Takaichi S, 1999, ADV PHOTOSYNTH, V8, P39; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Tao L, 2005, APPL ENVIRON MICROB, V71, P3294, DOI 10.1128/AEM.71.6.3294-3301.2005; Tao L, 2004, MOL GENET GENOMICS, V271, P180, DOI 10.1007/s00438-003-0969-1; Tao L, 2007, GENE, V386, P90, DOI 10.1016/j.gene.2006.08.006; Tao L, 2006, MOL GENET GENOMICS, V276, P79, DOI 10.1007/s00438-006-0121-0; Teramoto M, 2004, FEBS LETT, V570, P184, DOI 10.1016/j.febslet.2004.05.085; Teramoto M, 2003, FEBS LETT, V545, P120, DOI 10.1016/S0014-5793(03)00513-1; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian B, 2007, BBA-GEN SUBJECTS, V1770, P902, DOI 10.1016/j.bbagen.2007.01.016; Umeno D, 2005, MICROBIOL MOL BIOL R, V69, P51, DOI 10.1128/MMBR.69.1.51-78.2005; Verdoes JC, 1999, MOL GEN GENET, V262, P453, DOI 10.1007/s004380051105; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Wang F, 2007, BIOTECHNOL ADV, V25, P211, DOI 10.1016/j.biotechadv.2006.12.001; WIELAND B, 1994, J BACTERIOL, V176, P7719, DOI 10.1128/JB.176.24.7719-7726.1994; Worobey M, 2001, MOL BIOL EVOL, V18, P1425, DOI 10.1093/oxfordjournals.molbev.a003928; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang L, 2007, ARCH MICROBIOL, V188, P411, DOI 10.1007/s00203-007-0262-5	108	69	72	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11257	10.1371/journal.pone.0011257	http://dx.doi.org/10.1371/journal.pone.0011257			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582313	Green Submitted, Green Published, gold			2022-12-27	WOS:000279058500008
J	Beauliere, A; Toure, S; Alexandre, PK; Kone, K; Pouhe, A; Kouadio, B; Journy, N; Son, J; Ettiegne-Traore, V; Dabis, F; Eholie, S; Anglaret, X				Beauliere, Arnousse; Toure, Siaka; Alexandre, Pierre-Kebreau; Kone, Koko; Pouhe, Alex; Kouadio, Bertin; Journy, Neige; Son, Jerome; Ettiegne-Traore, Virginie; Dabis, Francois; Eholie, Serge; Anglaret, Xavier			The Financial Burden of Morbidity in HIV-Infected Adults on Antiretroviral Therapy in Cote d'Ivoire	PLOS ONE			English	Article							CATASTROPHIC HEALTH EXPENDITURE; OUT-OF-POCKET; DEVELOPING-COUNTRIES; LOW-INCOME; UNIVERSAL COVERAGE; CARE EXPENDITURES; ACCESS; BARRIERS; HOUSEHOLDS; INSURANCE	Background: Large HIV care programs frequently subsidize antiretroviral (ARV) drugs and CD4 tests, but patients must often pay for other health-related drugs and services. We estimated the financial burden of health care for households with HIV-infected adults taking antiretroviral therapy (ART) in Cote d'Ivoire. Methodology/Principal Findings: We conducted a cross-sectional survey. After obtaining informed consent, we interviewed HIV-infected adults taking ART who had consecutively attended one of 18 HIV care facilities in Abidjan. We collected information on socioeconomic and medical characteristics. The main economic indicators were household capacity-to-pay (overall expenses minus food expenses), and health care expenditures. The primary outcome was the percentage of households confronted with catastrophic health expenditures (health expenditures were defined as catastrophic if they were greater than or equal to 40% of the capacity-to-pay). We recruited 1,190 adults. Median CD4 count was 187/mm(3), median time on ART was 14 months, and 72% of subjects were women. Mean household capacity-to-pay was $213.7/month, mean health expenditures were $24.3/month, and 12.3% of households faced catastrophic health expenditures. Of the health expenditures, 75.3% were for the study subject (ARV drugs and CD4 tests, 24.6%; morbidity events diagnosis and treatment, 50.1%; transportation to HIV care centres, 25.3%) and 24.7% were for other household members. When we stratified by most recent CD4 count, morbidity events related expenses were significantly lower when subjects had higher CD4 counts. Conclusions/Significance: Many households in Cote d'Ivoire face catastrophic health expenditures that are not attributable to ARV drugs or routine follow-up tests. Innovative schemes should be developed to help HIV-infected patients on ART face the cost of morbidity events.	[Beauliere, Arnousse; Journy, Neige; Son, Jerome; Dabis, Francois; Anglaret, Xavier] Univ Bordeaux 2, INSERM, U897, F-33076 Bordeaux, France; [Beauliere, Arnousse; Toure, Siaka; Kone, Koko; Kouadio, Bertin; Journy, Neige; Son, Jerome; Dabis, Francois; Eholie, Serge; Anglaret, Xavier] Programme PAC CI, Abidjan, Cote Ivoire; [Alexandre, Pierre-Kebreau] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Toure, Siaka; Pouhe, Alex; Kouadio, Bertin] Assoc ACONDA VS, Abidjan, Cote Ivoire; [Kone, Koko] IPNETP, Abidjan, Cote Ivoire; [Ettiegne-Traore, Virginie] Minist Sante & Hyg Publ, Programme Natl Prise Charge Personnes Infect VIH, Abidjan, Cote Ivoire; [Eholie, Serge] CHU Treichville, Serv Malad Infect & Trop, Abidjan, Cote Ivoire	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Beauliere, A (corresponding author), Univ Bordeaux 2, INSERM, U897, F-33076 Bordeaux, France.	arnousse.beauliere@isped.u-bordeaux2.fr	Eholie, Serge/T-6008-2019; Anglaret, Xavier/T-2757-2019; DABIS, FRANCOIS/S-9298-2019; Anglaret, Xavier/F-7333-2013	DABIS, FRANCOIS/0000-0002-1614-8857; Anglaret, Xavier/0000-0003-3319-8423	French National Agency for Research on AIDS and viral hepatitis [ANRS 12137]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058736] Funding Source: NIH RePORTER	French National Agency for Research on AIDS and viral hepatitis(ANRS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the French National Agency for Research on AIDS and viral hepatitis (ANRS 12137, France) (http://www.anrs.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, PRIM HLTH CAR NOW MO; Bennett S, 2004, HEALTH POLICY PLANN, V19, P147, DOI 10.1093/heapol/czh018; Boyer S, 2009, B WORLD HEALTH ORGAN, V87, P279, DOI 10.2471/BLT.07.049643; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Carrin G, 2005, TROP MED INT HEALTH, V10, P799, DOI 10.1111/j.1365-3156.2005.01455.x; Carrin G, 2008, B WORLD HEALTH ORGAN, V86, P857, DOI 10.2471/BLT.07.049387; Deaton A., 1997, The analysis of household surveys: a microeconometric approach to development policy.; Duraisamy P, 2006, AIDS CARE, V18, P121, DOI 10.1080/09540120500159359; Flores G, 2008, HEALTH ECON, V17, P1393, DOI 10.1002/hec.1338; Furber AS, 2004, BMJ-BRIT MED J, V329, P1281, DOI 10.1136/bmj.329.7477.1281; Gilson L, 2001, HEALTH POLICY, V58, P37, DOI 10.1016/S0168-8510(01)00153-1; Hounton SH, 2008, AIDS CARE, V20, P582, DOI 10.1080/09540120701868303; International Monetary Fund (IMF), 2009, COT IV POV RED STRAT; James CD, 2006, APPL HEALTH ECON HEA, V5, P137, DOI 10.2165/00148365-200605030-00001; Katz S, 2003, J AGING STUD, V17, P3, DOI 10.1016/S0890-4065(02)00086-5; Lange JMA, 2008, CURR OPIN HIV AIDS, V3, P509, DOI 10.1097/COH.0b013e3283031c67; Leive A, 2008, B WORLD HEALTH ORGAN, V86, P849, DOI 10.2471/BLT.07.049403; Lu CL, 2009, B WORLD HEALTH ORGAN, V87, P238, DOI 10.2471/BLT.08.054379; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; *MIN LUTT CONTR SI, 2008, SUIV DECL ENG VIH SI; Molyneux C, 2007, HEALTH POLICY PLANN, V22, P381, DOI 10.1093/heapol/czm031; Msellati P, 2003, AIDS, V17, pS63, DOI 10.1097/00002030-200317003-00009; Mukherjee JS, 2006, JAIDS-J ACQ IMM DEF, V43, pS123, DOI 10.1097/01.qai.0000248348.25630.74; Nombela N, 2006, JAIDS-J ACQ IMM DEF, V41, P225, DOI 10.1097/01.qai.0000179456.39185.9b; Onwujekwe O, 2009, HEALTH POLICY, V90, P223, DOI 10.1016/j.healthpol.2008.10.006; Palmer N, 2004, LANCET, V364, P1365, DOI 10.1016/S0140-6736(04)17195-X; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Pradhan M, 2002, HEALTH ECON, V11, P431, DOI 10.1002/hec.689; Ranson MK, 2002, B WORLD HEALTH ORGAN, V80, P613; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Russell S, 1996, HEALTH POLICY PLANN, V11, P219, DOI 10.1093/heapol/11.3.219; Russell S, 2006, SOC SCI MED, V63, P1732, DOI 10.1016/j.socscimed.2006.04.017; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Savedoff W., 2003, HLTH SYSTEMS PERFORM; Somkotra T, 2009, HEALTH AFFAIR, V28, pW467, DOI 10.1377/hlthaff.28.3.w467; Souteyrand YP, 2008, AIDS, V22, pS161, DOI 10.1097/01.aids.0000327637.59672.02; Su TT, 2006, B WORLD HEALTH ORGAN, V84, P21, DOI 10.2471/BLT.05.023739; Taverne B, 2008, POLITICAL EC HIV AID, P273; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; Van Damme W, 2003, LANCET, V362, P996, DOI 10.1016/S0140-6736(03)14375-9; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; Veenstra N, 2005, BEST PRACT RES CL OB, V19, P197, DOI 10.1016/j.bpobgyn.2004.10.005; VINARD P, 2008, POLITICAL EC HIV AID, P291; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; World Health Organization (WHO), 2009, WORLD HLTH STAT; WYSZEWIANSKI L, 1986, HEALTH SERV RES, V21, P617; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K, 2006, SOC SCI MED, V62, P866, DOI 10.1016/j.socscimed.2005.07.004; Zachariah R, 2008, T ROY SOC TROP MED H, V102, P288, DOI 10.1016/j.trstmh.2007.12.007	50	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11213	10.1371/journal.pone.0011213	http://dx.doi.org/10.1371/journal.pone.0011213			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	613KE	20585454	gold, Green Published, Green Submitted			2022-12-27	WOS:000278977200016
J	Kachhap, SK; Rosmus, N; Collis, SJ; Kortenhorst, MSQ; Wissing, MD; Hedayati, M; Shabbeer, S; Mendonca, J; Deangelis, J; Marchionni, L; Lin, JQ; Hoti, N; Nortier, JWR; DeWeese, TL; Hammers, H; Carducci, MA				Kachhap, Sushant K.; Rosmus, Nadine; Collis, Spencer J.; Kortenhorst, Madeleine S. Q.; Wissing, Michel D.; Hedayati, Mohammad; Shabbeer, Shabana; Mendonca, Janet; Deangelis, Justin; Marchionni, Luigi; Lin, Jianqing; Hoti, Naseruddin; Nortier, Johan W. R.; DeWeese, Theodore L.; Hammers, Hans; Carducci, Michael A.			Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; DOUBLE-STRAND BREAKS; TOPOISOMERASE-II; VALPROIC ACID; IN-VITRO; CELL-LINES; EXPRESSION; DAMAGE; COMPLEX; EPIGENOMICS		[Kachhap, Sushant K.; Rosmus, Nadine; Kortenhorst, Madeleine S. Q.; Wissing, Michel D.; Shabbeer, Shabana; Mendonca, Janet; Deangelis, Justin; Marchionni, Luigi; Lin, Jianqing; Hoti, Naseruddin; DeWeese, Theodore L.; Hammers, Hans; Carducci, Michael A.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Prostate Canc Program, Baltimore, MD 21218 USA; [Collis, Spencer J.; Hedayati, Mohammad; DeWeese, Theodore L.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA; [Nortier, Johan W. R.] Leiden Univ, Med Ctr, Div Med Oncol, Leiden, Netherlands	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kachhap, SK (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Prostate Canc Program, Baltimore, MD 21218 USA.	kachhsu@jhmi.edu	Marchionni, Luigi/S-6774-2017; Hoti, Naser/A-2530-2011; Carducci, Michael/R-8164-2019; qiao, zhixin/I-3408-2012	Marchionni, Luigi/0000-0002-7336-8071; Collis, Spencer/0000-0002-7874-1891	Flight Attendant Medical Research Institute; Prostate Cancer Foundation [P50-58236]; Dr. Saal van Zwanenberg Foundation	Flight Attendant Medical Research Institute; Prostate Cancer Foundation; Dr. Saal van Zwanenberg Foundation	The work is supported by Flight Attendant Medical Research Institute, David Koch Fund which was provided by the Prostate Cancer Foundation, Prostate Cancer Foundation Grant, Specialized Program of Research Excellence Grant P50-58236, and AEGON. MDW is supported by the Dr. Saal van Zwanenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimoolam S, 2007, P NATL ACAD SCI USA, V104, P19482, DOI 10.1073/pnas.0707828104; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bindra RS, 2007, ONCOGENE, V26, P2048, DOI 10.1038/sj.onc.1210001; Bindra RS, 2005, CANCER RES, V65, P11597, DOI 10.1158/0008-5472.CAN-05-2119; Borowiec JA, 2004, CELL CYCLE, V3, P627; Boutillier AL, 2003, J NEUROCHEM, V84, P814, DOI 10.1046/j.1471-4159.2003.01581.x; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Camphausen K, 2004, CLIN CANCER RES, V10, P6066, DOI 10.1158/1078-0432.CCR-04-0537; Camphausen K, 2007, J CLIN ONCOL, V25, P4051, DOI 10.1200/JCO.2007.11.6202; Carrassa L, 2003, CELL CYCLE, V2, P604, DOI 10.4161/cc.2.6.503; Chan Norman, 2007, Future Oncol, V3, P329, DOI 10.2217/14796694.3.3.329; Chinnaiyan P, 2005, INT J RADIAT ONCOL, V62, P223, DOI 10.1016/j.ijrobp.2004.12.088; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; DeMarzo AM, 2003, LANCET, V361, P955, DOI 10.1016/S0140-6736(03)12779-1; Demeter J, 2007, NUCLEIC ACIDS RES, V35, pD766, DOI 10.1093/nar/gkl1019; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; DRAKE FH, 1989, BIOCHEMISTRY-US, V28, P8154, DOI 10.1021/bi00446a029; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Inoue K, 2006, ARTERIOSCL THROM VAS, V26, P2652, DOI 10.1161/01.ATV.0000247247.89787.e7; Jeggo PA, 1998, ADV GENET, V38, P185, DOI 10.1016/S0065-2660(08)60144-3; Jones PA, 2002, ONCOGENE, V21, P5358, DOI 10.1038/sj.onc.1205597; Jung M, 2005, RADIAT RES, V163, P488, DOI 10.1667/RR3345; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kortenhorst MSQ, 2008, CLIN CANCER RES, V14, P6886, DOI 10.1158/1078-0432.CCR-08-0119; Lee E, 2004, TOXICOL SCI, V81, P121, DOI 10.1093/toxsci/kfh184; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lu Z, 2006, ONCOGENE, V25, P230, DOI 10.1038/sj.onc.1209025; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; MILNE JC, 2008, CURR OPIN CHEM BIOL; Mitsiades CS, 2004, P NATL ACAD SCI USA, V101, P540, DOI 10.1073/pnas.2536759100; Munshi A, 2005, CLIN CANCER RES, V11, P4912, DOI 10.1158/1078-0432.CCR-04-2088; Paoluzzi L, 2004, CANCER BIOL THER, V3, P612, DOI 10.4161/cbt.3.7.931; Petrini JHJ, 2007, SCIENCE, V316, P1138, DOI 10.1126/science.1143700; Polager S, 2002, ONCOGENE, V21, P437, DOI 10.1038/sj.onc.1205102; Rando OJ, 2007, CURR OPIN GENET DEV, V17, P94, DOI 10.1016/j.gde.2007.02.006; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shabbeer S, 2005, IDRUGS, V8, P144; Shabbeer S, 2007, PROSTATE, V67, P1099, DOI 10.1002/pros.20587; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Treszezamsky AD, 2007, CANCER RES, V67, P7078, DOI 10.1158/0008-5472.CAN-07-0601; Valentini A, 2007, DRUG METAB DISPOS, V35, P968, DOI 10.1124/dmd.107.014662; Walton TJ, 2008, PROSTATE, V68, P210, DOI 10.1002/pros.20673; Weichert W, 2008, BRIT J CANCER, V98, P604, DOI 10.1038/sj.bjc.6604199; Xia QH, 2006, CANCER RES, V66, P7237, DOI 10.1158/0008-5472.CAN-05-0487; You JS, 2008, ONCOGENE, V27, P1376, DOI 10.1038/sj.onc.1210776	54	126	133	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11208	10.1371/journal.pone.0011208	http://dx.doi.org/10.1371/journal.pone.0011208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585447	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000278977200011
J	Volkova, VV; Howey, R; Savill, NJ; Woolhouse, MEJ				Volkova, Victoriya V.; Howey, Richard; Savill, Nicholas J.; Woolhouse, Mark E. J.			Sheep Movement Networks and the Transmission of Infectious Diseases	PLOS ONE			English	Article							BOVINE TUBERCULOSIS; RISK-FACTORS; LIVESTOCK MOVEMENTS; ANIMAL MOVEMENTS; MOUTH-DISEASE; CATTLE; PARATUBERCULOSIS; HETEROGENEITIES; EPIDEMIOLOGY; DYNAMICS	Background and Methodology: Various approaches have been used to investigate how properties of farm contact networks impact on the transmission of infectious diseases. The potential for transmission of an infection through a contact network can be evaluated in terms of the basic reproduction number, R-0. The magnitude of R-0 is related to the mean contact rate of a host, in this case a farm, and is further influenced by heterogeneities in contact rates of individual hosts. The latter can be evaluated as the second order moments of the contact matrix (variances in contact rates, and co-variance between contacts to and from individual hosts). Here we calculate these quantities for the farms in a country-wide livestock network: >15,000 Scottish sheep farms in each of 4 years from July 2003 to June 2007. The analysis is relevant to endemic and chronic infections with prolonged periods of infectivity of affected animals, and uses different weightings of contacts to address disease scenarios of low, intermediate and high animal-level prevalence. Principal Findings and Conclusions: Analysis of networks of Scottish farms via sheep movements from July 2003 to June 2007 suggests that heterogeneities in movement patterns (variances and covariances of rates of movement on and off the farms) make a substantial contribution to the potential for the transmission of infectious diseases, quantified as R-0, within the farm population. A small percentage of farms (<20%) contribute the bulk of the transmission potential (>80%) and these farms could be efficiently targeted by interventions aimed at reducing spread of diseases via animal movement.	[Volkova, Victoriya V.; Howey, Richard; Savill, Nicholas J.; Woolhouse, Mark E. J.] Univ Edinburgh, Ctr Infect Dis, Sch Biol Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh	Volkova, VV (corresponding author), Univ Edinburgh, Ctr Infect Dis, Sch Biol Sci, Edinburgh, Midlothian, Scotland.	Victoriya.Volkova@ed.ac.uk		Savill, Nicholas/0000-0002-9769-6168; Woolhouse, Mark/0000-0003-3765-8167	Scottish Government; BBSRC; Wellcome Trust	Scottish Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was undertaken through the Centre of Excellence in Epidemiology, Population Health and Infectious Disease Control (EPIC) funded by the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. RH and MEJW acknowledge additional support from the BBSRC and the Wellcome Trust.	ANDERSON R M, 1991; Beard PM, 2001, J CLIN MICROBIOL, V39, P1517, DOI 10.1128/JCM.39.4.1517-1521.2001; Daniels MJ, 2003, J WILDLIFE DIS, V39, P10, DOI 10.7589/0090-3558-39.1.10; Delahay RJ, 2007, VET J, V173, P287, DOI 10.1016/j.tvjl.2005.11.011; DIEKMANN O, 1990, J MATH BIOL, V28, P365; DOROGOVTSEV SN, 2003, EVOLUTION NETWORKS B, P264; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; Galvani AP, 2005, NATURE, V438, P293, DOI 10.1038/438293a; Gilbert M, 2005, NATURE, V435, P491, DOI 10.1038/nature03548; Green DM, 2008, P R SOC B, V275, P1001, DOI 10.1098/rspb.2007.1601; Green DM, 2007, J GEN VIROL, V88, P3486, DOI 10.1099/vir.0.83225-0; Humblet MF, 2009, VET RES, V40, DOI 10.1051/vetres/2009033; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; Kenah E, 2007, J THEOR BIOL, V249, P706, DOI 10.1016/j.jtbi.2007.09.011; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; Lindstrom T, 2010, PREV VET MED, V95, P23, DOI 10.1016/j.prevetmed.2010.03.002; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Lord CC, 1996, MED VET ENTOMOL, V10, P19, DOI 10.1111/j.1365-2915.1996.tb00077.x; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Miller JC, 2009, J R SOC INTERFACE, V6, P1121, DOI 10.1098/rsif.2008.0524; Ortiz-Pelaez A, 2006, PREV VET MED, V76, P40, DOI 10.1016/j.prevetmed.2006.04.007; Ribbens S, 2009, PREV VET MED, V88, P57, DOI 10.1016/j.prevetmed.2008.08.002; Robinson SE, 2007, J R SOC INTERFACE, V4, P669, DOI 10.1098/rsif.2007.0214; Tarjan R., 1972, SIAM Journal on Computing, V1, P146, DOI 10.1137/0201010; van Schaik G, 2002, PREV VET MED, V54, P279, DOI 10.1016/S0167-5877(02)00004-1; van Schaik G, 1998, PREV VET MED, V34, P125, DOI 10.1016/S0167-5877(97)00085-8; Vernon MC, 2009, P ROY SOC B-BIOL SCI, V276, P469, DOI 10.1098/rspb.2008.1009; Volkova V, 2008, REPORT SEASONALITY M; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; WOOLHOUSE MEJ, 1991, P ROY SOC B-BIOL SCI, V245, P109, DOI 10.1098/rspb.1991.0095; Woolhouse MEJ, 2005, BIOL LETTERS, V1, P350, DOI 10.1098/rsbl.2005.0331	32	61	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11185	10.1371/journal.pone.0011185	http://dx.doi.org/10.1371/journal.pone.0011185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567504	gold, Green Published, Green Submitted			2022-12-27	WOS:000278886300027
J	Gainotti, S; Imperatori, SF; Spila-Alegiani, S; Maggiore, L; Galeotti, F; Vanacore, N; Petrini, C; Raschetti, R; Mariani, C; Clerici, F				Gainotti, Sabina; Imperatori, Susanna Fusari; Spila-Alegiani, Stefania; Maggiore, Laura; Galeotti, Francesca; Vanacore, Nicola; Petrini, Carlo; Raschetti, Roberto; Mariani, Claudio; Clerici, Francesca			How Are the Interests of Incapacitated Research Participants Protected through Legislation? An Italian Study on Legal Agency for Dementia Patients	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; SURROGATE CONSENT; DIAGNOSIS; PEOPLE	Background: Patients with dementia may have limited capacity to give informed consent to participate in clinical research. One possible way to safeguard the patients' interests in research is the involvement of a proxy in the recruitment process. In Italy, the system of proxy is determined by the courts. In this study we evaluate the timing for appointment of a legal proxy in Italy and identify predictive variables of appointment. Methodology/Principal Findings: Subjects were recruited among the outpatients seeking medical advice for cognitive complaints at the Centre for Research and Treatment of Cognitive Dysfunctions, University of Milan, "Luigi Sacco'' Hospital. The Centre was participating to the AdCare Study, a no-profit randomised clinical trial coordinated by the Italian National Institute of Health. The requirement that informed consent be given by a legal representative dramatically slowed down the recruitment process in AdCare, which was prematurely interrupted. The Centre for Research and Treatment of Cognitive Dysfunctions collected data on the timing required to appoint the legal representatives. Patients diagnosed with dementia and their caregivers were provided information on the Italian law on legal agency (law 6/2004). At each scheduled check-up the caregiver was asked whether she/he had applied to appoint a legal proxy for the patient and the time interval between the presentation of the law, the registration of the application at the law court chancellery and the sentence of appointment was registered. The study involved 169 demented patients. Seventy-eight patients (46.2%) applied to appoint a legal proxy. These subjects were usually younger, had been suffering from dementia for a longer time, had less than two children and made more use of memantine. The mean interval time between the presentation of the law and the patients' application to the law court chancellery was two months. The mean interval time between the patient's application to the law court chancellery and the sentence of appointment was four months. Conclusions/Significance: In Italy the requirement that legal representatives be appointed by the courts slows down subjects' participation in research. Other procedures for legal agency of the incapacitated patients may be adopted, taking as examples other EU countries' systems.	[Gainotti, Sabina; Spila-Alegiani, Stefania; Galeotti, Francesca; Vanacore, Nicola; Raschetti, Roberto] Natl Inst Hlth, Natl Ctr Epidemiol Surveillance & Hlth Promot, Rome, Italy; [Imperatori, Susanna Fusari; Maggiore, Laura; Mariani, Claudio; Clerici, Francesca] Univ Milan, Chair Neurol, Ctr Res & Treatment Cognit Dysfunct, L Sacco Hosp, Milan, Italy; [Petrini, Carlo] Natl Inst Hlth, Bioeth Unit, Off President, Rome, Italy	Istituto Superiore di Sanita (ISS); University of Milan; Luigi Sacco Hospital; Istituto Superiore di Sanita (ISS)	Gainotti, S (corresponding author), Natl Inst Hlth, Natl Ctr Epidemiol Surveillance & Hlth Promot, Rome, Italy.	francesca.clerici1@unimi.it	; gainotti, sabina/A-6651-2015	Petrini, Carlo/0000-0002-7895-4440; gainotti, sabina/0000-0002-6006-9064	Italian Association on Dementia Research: "Associazione per la Ricerca sulle Demenze - ARD ONLUS''; Italian Medicines Agency (AIFA) [FARM68SY5C]	Italian Association on Dementia Research: "Associazione per la Ricerca sulle Demenze - ARD ONLUS''; Italian Medicines Agency (AIFA)	This study was partially supported by the Italian Association on Dementia Research: "Associazione per la Ricerca sulle Demenze - ARD ONLUS'', and by the Italian Medicines Agency (AIFA) within the independent drug research program, contract no. FARM68SY5C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Appelbaum PS, 2007, NEW ENGL J MED, V357, P1834, DOI 10.1056/NEJMcp074045; BARBIERI MP, 2008, CAREGIVER AMMINISTRA; Campbell EG, 2006, NEW ENGL J MED, V355, P2321, DOI 10.1056/NEJMsa061457; Caulfield Timothy, 2005, Health Law Rev, V13, P58; Clerici F, 2009, DRUG AGING, V26, P321, DOI 10.2165/00002512-200926040-00003; Coppolino M, 2001, CHEST, V119, P603, DOI 10.1378/chest.119.2.603; *EUR FOR GOOD CLIN, EFGCP REP PROC ETH R; *EUR PARL, 2001, OFFICIAL J L, V121, P34; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kim SYH, 2009, NEUROLOGY, V72, P149, DOI 10.1212/01.wnl.0000339039.18931.a2; Kim SYH, 2005, NEUROLOGY, V65, P1395, DOI 10.1212/01.wnl.0000183144.61428.73; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; *NAT RES ETH SERV, 2007, RES INV AD UN CONS; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nuremberg Military Tribunals, 1949, NUREMBERG CODE REPRI, V2, P181; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; SACHS GA, 1994, CLIN RES, V42, P403; Stocking CB, 2006, NEUROLOGY, V66, P1361, DOI 10.1212/01.wnl.0000216424.66098.55; Stocking CB, 2003, NEUROLOGY, V61, P1649, DOI 10.1212/01.WNL.0000098888.97357.06; Warner J, 2008, LANCET, V372, P183, DOI 10.1016/S0140-6736(08)61049-1; World Medical Association, 2008, DECL HELS ETH PRINC; 2004, MONITEUR BELGE  0507	27	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11150	10.1371/journal.pone.0011150	http://dx.doi.org/10.1371/journal.pone.0011150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585400	Green Published, gold, Green Submitted			2022-12-27	WOS:000278886100015
J	Senapathy, P; Bhasi, A; Mattox, J; Dhandapany, PS; Sadayappan, S				Senapathy, Periannan; Bhasi, Ashwini; Mattox, Jeffrey; Dhandapany, Perundurai S.; Sadayappan, Sakthivel			Targeted Genome-Wide Enrichment of Functional Regions	PLOS ONE			English	Article							GENES; CAPTURE; PREDICT; PCR	Only a small fraction of large genomes such as that of the human contains the functional regions such as the exons, promoters, and polyA sites. A platform technique for selective enrichment of functional genomic regions will enable several next-generation sequencing applications that include the discovery of causal mutations for disease and drug response. Here, we describe a powerful platform technique, termed "functional genomic fingerprinting'' (FGF), for the multiplexed genomewide isolation and analysis of targeted regions such as the exome, promoterome, or exon splice enhancers. The technique employs a fixed part of a uniquely designed Fixed-Randomized primer, while the randomized part contains all the possible sequence permutations. The Fixed-Randomized primers bind with full sequence complementarity at multiple sites where the fixed sequence (such as the splice signals) occurs within the genome, and multiplex amplify many regions bounded by the fixed sequences (e. g., exons). Notably, validation of this technique using cardiac myosin binding protein-C (MYBPC3) gene as an example strongly supports the application and efficacy of this method. Further, assisted by genomewide computational analyses of such sequences, the FGF technique may provide a unique platform for high-throughput sample production and analysis of targeted genomic regions by the next-generation sequencing techniques, with powerful applications in discovering disease and drug response genes.	[Senapathy, Periannan; Bhasi, Ashwini; Mattox, Jeffrey] Genome Technol LLC, Dept Human Genet, Madison, WI USA; [Senapathy, Periannan; Bhasi, Ashwini] Int Ctr Adv Genom & Prote, Dept Bioinformat, Madras, Tamil Nadu, India; [Dhandapany, Perundurai S.] Mt Sinai Sch Med, Ctr Mol Cardiol, Dept Pediat & Genet, New York, NY USA; [Dhandapany, Perundurai S.] Mt Sinai Sch Med, Ctr Mol Cardiol, Dept Genom Sci, New York, NY USA; [Dhandapany, Perundurai S.] Mt Sinai Sch Med, Ctr Mol Cardiol, Child Hlth & Dev Inst, New York, NY USA; [Sadayappan, Sakthivel] Loyola Univ Chicago, Stritch Sch Med, Dept Cell & Mol Physiol, Maywood, IL USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Loyola University Chicago	Senapathy, P (corresponding author), Genome Technol LLC, Dept Human Genet, Madison, WI USA.	ps@genome.com	Senapathy, Periannan/N-1120-2019	Sadayappan, Sakthivel/0000-0003-2006-7678; Perundurai, Dhandapany/0000-0001-7831-9570	Genome Technologies, LLC; American Heart Association [0830311N]	Genome Technologies, LLC; American Heart Association(American Heart Association)	Funding for this project was provided by Genome Technologies, LLC. Sakthivel Sadayappan, Ph.D., was supported by an American Heart Association Scientist Development Grant (0830311N). Periannan Senapathy and Jeffrey Mattox are funder employees.	Aparicio SAJR, 2010, J PATHOL, V220, P307, DOI 10.1002/path.2636; Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; Bergmann C, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.032318; Bonin A, 2005, METHOD ENZYMOL, V395, P145, DOI 10.1016/S0076-6879(05)95010-6; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Forrest ARR, 2009, RNA BIOL, V6, P107, DOI 10.4161/rna.6.2.7931; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mueller UG, 1999, TRENDS ECOL EVOL, V14, P389, DOI 10.1016/S0169-5347(99)01659-6; Ng S, 2009, NAT GENET, V42, P30; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pizzo G, 2005, MICROBIOLOGICA, V28, P75; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Regulapati R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003456; Rozen S, 2000, Methods Mol Biol, V132, P365; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; SENAPATHY P, 1988, P NATL ACAD SCI USA, V85, P1129, DOI 10.1073/pnas.85.4.1129; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Solis AS, 2008, FRONT BIOSCI-LANDMRK, V13, P1926, DOI 10.2741/2812; ten Bosch JR, 2008, J MOL DIAGN, V10, P484, DOI 10.2353/jmoldx.2008.080027; Vorechovsky I, 2006, NUCLEIC ACIDS RES, V34, P4630, DOI 10.1093/nar/gkl535; WELSH J, 1991, NUCLEIC ACIDS RES, V19, P303, DOI 10.1093/nar/19.2.303; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213; Wong Kee Yew, 2004, J Bioinform Comput Biol, V2, P569, DOI 10.1142/S0219720004000740	28	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11138	10.1371/journal.pone.0011138	http://dx.doi.org/10.1371/journal.pone.0011138			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585402	gold, Green Published, Green Submitted			2022-12-27	WOS:000278886100009
J	Chen, KY; Gracheva, EO; Yu, SC; Sheng, Q; Richmond, J; Featherstone, DE				Chen, Kaiyun; Gracheva, Elena O.; Yu, Szi-Chieh; Sheng, Qi; Richmond, Janet; Featherstone, David E.			Neurexin in Embryonic Drosophila Neuromuscular Junctions	PLOS ONE			English	Article							GLUTAMATE-RECEPTOR SUBUNIT; ALPHA-LATROTOXIN RECEPTOR; CELL-ADHESION; SYNAPTIC-TRANSMISSION; NEUROLIGIN; PROTEIN; CASK; BINDING; PRESERVATION; RECRUITMENT	Background: Neurexin is a synaptic cell adhesion protein critical for synapse formation and function. Mutations in neurexin and neurexin-interacting proteins have been implicated in several neurological diseases. Previous studies have described Drosophila neurexin mutant phenotypes in third instar larvae and adults. However, the expression and function of Drosophila neurexin early in synapse development, when neurexin function is thought to be most important, has not been described. Methodology/Principal Findings: We use a variety of techniques, including immunohistochemistry, electron microscopy, in situ hybridization, and electrophysiology, to characterize neurexin expression and phenotypes in embryonic Drosophila neuromuscular junctions (NMJs). Our results surprisingly suggest that neurexin in embryos is present both pre and postsynaptically. Presynaptic neurexin promotes presynaptic active zone formation and neurotransmitter release, but along with postsynaptic neurexin, also suppresses formation of ectopic glutamate receptor clusters. Interestingly, we find that loss of neurexin only affects receptors containing the subunit GluRIIA. Conclusions/Significance: Our study extends previous results and provides important detail regarding the role of neurexin in Drosophila glutamate receptor abundance. The possibility that neurexin is present postsynaptically raises new hypotheses regarding neurexin function in synapses, and our results provide new insights into the role of neurexin in synapse development.	[Chen, Kaiyun; Gracheva, Elena O.; Yu, Szi-Chieh; Sheng, Qi; Richmond, Janet; Featherstone, David E.] Univ Illinois, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Chen, KY (corresponding author), Univ Illinois, Chicago, IL 60680 USA.	def@uic.edu		Gracheva, Elena O/0000-0002-0846-3427	National Institutes of Health (NIH/NINDS)	National Institutes of Health (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by grants from the National Institutes of Health (NIH/NINDS) to D.E.F. and J.E.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Bennett MR, 2008, AUST NZ J PSYCHIAT, V42, P662, DOI 10.1080/00048670802203467; Biederer T, 2001, J BIOL CHEM, V276, P47869, DOI 10.1074/jbc.M105287200; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Brose N, 1999, NATURWISSENSCHAFTEN, V86, P516, DOI 10.1007/s001140050666; Chen K, 2005, J NEUROSCI, V25, P6667, DOI 10.1523/JNEUROSCI.1527-05.2005; Chen KY, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-1; CRAIG AM, 2007, CURR OPIN NEUROBIOL; De Robertis EDP, 1964, HISTOPHYSIOLOGY SYNA; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Dudanova I, 2006, J NEUROSCI, V26, P10599, DOI 10.1523/JNEUROSCI.1913-06.2006; Featherstone DE, 2001, J NEUROSCI, V21, P4215, DOI 10.1523/JNEUROSCI.21-12-04215.2001; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; Featherstone DE, 2005, J NEUROSCI, V25, P3199, DOI 10.1523/JNEUROSCI.4201-04.2005; Featherstone DE, 2002, NAT NEUROSCI, V5, P141, DOI 10.1038/nn789; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Friedman JM, 2006, AM J HUM GENET, V79, P500, DOI 10.1086/507471; Glessner JT, 2009, AUTISM GENOME WIDE C; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Gray E. G., 1966, International Review of General and Experimental Zoology, V2, P139; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; Hata Y, 1996, J NEUROSCI, V16, P2488; Heine M, 2008, P NATL ACAD SCI USA, V105, P20947, DOI 10.1073/pnas.0804007106; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; Kattenstroth G, 2004, P NATL ACAD SCI USA, V101, P2607, DOI 10.1073/pnas.0308626100; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Kirov G, 2009, SCHIZOPHRENIA BULL, V35, P851, DOI 10.1093/schbul/sbp079; KITTEL RJ, 2006, SCIENCE; LEVINSON JN, 2005, J BIOL CHEM; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Lise MF, 2006, CELL MOL LIFE SCI, V63, P1833, DOI 10.1007/s00018-006-6061-3; Lucic V, 2005, STRUCTURE, V13, P423, DOI 10.1016/j.str.2005.02.005; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Martin JR, 1996, EMBO J, V15, P1865, DOI 10.1002/j.1460-2075.1996.tb00537.x; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; PETRENKO AG, 1991, NATURE, V353, P65, DOI 10.1038/353065a0; Prokop A, 1999, CELL TISSUE RES, V297, P169, DOI 10.1007/s004410051345; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; Rostaing P, 2004, J HISTOCHEM CYTOCHEM, V52, P1, DOI 10.1177/002215540405200101; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SCHUSTER CM, 1991, SCIENCE, V254, P112, DOI 10.1126/science.1681587; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sugita S, 1999, NEURON, V22, P489, DOI 10.1016/S0896-6273(00)80704-7; SUN M, 2009, NEUROSCI RES; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Washbourne P, 2004, J NEUROSCI, V24, P9244, DOI 10.1523/JNEUROSCI.3339-04.2004; Weimer Robby M., 2006, V351, P203; Zahir FR, 2008, J MED GENET, V45, P239, DOI 10.1136/jmg.2007.054437; Zeng XK, 2007, FEBS LETT, V581, P2509, DOI 10.1016/j.febslet.2007.04.068; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005; Zordan MA, 2005, J NEUROPHYSIOL, V94, P1074, DOI 10.1152/jn.00954.2004	68	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11115	10.1371/journal.pone.0011115	http://dx.doi.org/10.1371/journal.pone.0011115			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559439	Green Submitted, Green Published, gold			2022-12-27	WOS:000278741100026
J	Leung, YK; Du, JA; Huang, Y; Yao, XQ				Leung, Yuk Ki; Du, Juan; Huang, Yu; Yao, Xiaoqiang			Cyclic Nucleotide-Gated Channels Contribute to Thromboxane A(2)-Induced Contraction of Rat Small Mesenteric Arteries	PLOS ONE			English	Article							INDUCED CA2+ INFLUX; SMOOTH-MUSCLE; ROD; ACTIVATION; EXPRESSION; CNGA2; CELLS; PHOTORECEPTORS; CALCIUM; KINASE	Background: Thromboxane A(2) (TxA(2))-induced smooth muscle contraction has been implicated in cardiovascular, renal and respiratory diseases. This contraction can be partly attributed to TxA(2)-induced Ca2+ influx, which resulted in vascular contraction via Ca2+-calmodulin-MLCK pathway. This study aims to identify the channels that mediate TxA(2)-induced Ca2+ influx in vascular smooth muscle cells. Methodology/Principal Findings: Application of U-46619, a thromboxane A(2) mimic, resulted in a constriction in endothelium-denuded small mesenteric artery segments. The constriction relies on the presence of extracellular Ca2+, because removal of extracellular Ca2+ abolished the constriction. This constriction was partially inhibited by an L-type Ca2+ channel inhibitor nifedipine (0.5-1 mu M). The remaining component was inhibited by L-cis-diltiazem, a selective inhibitor for CNG channels, in a dose-dependent manner. Another CNG channel blocker LY83583 [6-(phenylamino)-5,8-quinolinedione] had similar effect. In the primary cultured smooth muscle cells derived from rat aorta, application of U46619 (100 nM) induced a rise in cytosolic Ca2+ ([ Ca2+](i)), which was inhibited by L-cis-diltiazem. Immunoblot experiments confirmed the presence of CNGA(2) protein in vascular smooth muscle cells. Conclusions/Significance: These data suggest a functional role of CNG channels in U-46619-induced Ca2+ influx and contraction of smooth muscle cells.	[Leung, Yuk Ki; Du, Juan; Huang, Yu; Yao, Xiaoqiang] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Leung, Yuk Ki; Du, Juan; Huang, Yu; Yao, Xiaoqiang] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Du, Juan] Anhui Med Univ, Dept Physiol, He Fei, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Anhui Medical University	Leung, YK (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.	yao2068@cuhk.edu.hk	Leung, Yuk Ki/J-9365-2015; Yao, Xiaoqiang/I-5413-2016; Huang, Yu/K-2866-2017	Leung, Yuk Ki/0000-0002-5726-0140; Yao, Xiaoqiang/0000-0002-0687-8186; Huang, Yu/0000-0002-1277-6784	Hong Kong Research Grants Council [CUHK477307, CUHK477408, CUHK479109]; Chinese University of Hong Kong (CUHK); Li Ka Shing Institute of Health Sciences	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Chinese University of Hong Kong (CUHK)(Chinese University of Hong Kong); Li Ka Shing Institute of Health Sciences	This study was supported by Hong Kong Research Grants Council Grants (CUHK477307, CUHK477408 and CUHK479109), Focused Investment Scheme of the Chinese University of Hong Kong (CUHK) and Li Ka Shing Institute of Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARITA H, 1989, PROG LIPID RES, V28, P273, DOI 10.1016/0163-7827(89)90002-7; Bonigk W, 1999, J NEUROSCI, V19, P5332; Cassar S, 2004, MOL VIS, V10, P808; Cheng KT, 2003, HISTOCHEM CELL BIOL, V120, P475, DOI 10.1007/s00418-003-0596-2; Cheng KT, 2008, ARTERIOSCL THROM VAS, V28, P913, DOI 10.1161/ATVBAHA.107.148338; Ding CL, 1997, AM J PHYSIOL-CELL PH, V272, pC1335, DOI 10.1152/ajpcell.1997.272.4.C1335; FRINGS S, 1992, J GEN PHYSIOL, V100, P45, DOI 10.1085/jgp.100.1.45; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; HAYNES LW, 1992, J GEN PHYSIOL, V100, P783, DOI 10.1085/jgp.100.5.783; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kruse LS, 2006, NEUROSCI LETT, V404, P202, DOI 10.1016/j.neulet.2006.05.045; Kwan HY, 2010, J VASC RES, V47, P148, DOI 10.1159/000235969; Kwan HY, 2009, CIRC RES, V104, P670, DOI 10.1161/CIRCRESAHA.108.188748; LeindersZufall T, 1997, J NEUROSCI, V17, P4136; OGLETREE ML, 1987, FED PROC, V46, P133; RISPOLI G, 1988, EUR BIOPHYS J BIOPHY, V16, P65; Sakariassen KS, 2009, FUTUR CARDIOL, V5, P479, DOI [10.2217/fca.09.33, 10.2217/FCA.09.33]; Sakurada S, 2003, CIRC RES, V93, P548, DOI 10.1161/01.RES.0000090998.08629.60; Shen B, 2008, J MOL CELL CARDIOL, V45, P437, DOI 10.1016/j.yjmcc.2008.06.005; SHORE SA, 1989, LUNG CELL BIOL, V41, P1012; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; STERN JH, 1986, P NATL ACAD SCI USA, V83, P1163, DOI 10.1073/pnas.83.4.1163; Tosun M, 1998, J PHARMACOL EXP THER, V284, P921; Tsang SY, 2004, HYPERTENSION, V44, P78, DOI 10.1161/01.HYP.0000131659.27081.19; Wilson DP, 2005, BIOCHEM J, V389, P763, DOI 10.1042/BJ20050237; Yao XQ, 1999, CARDIOVASC RES, V41, P282, DOI 10.1016/S0008-6363(98)00158-8; Yao XQ, 1999, LIFE SCI, V65, P55, DOI 10.1016/S0024-3205(99)00218-0	27	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11098	10.1371/journal.pone.0011098	http://dx.doi.org/10.1371/journal.pone.0011098			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559420	gold, Green Submitted, Green Published			2022-12-27	WOS:000278741100012
J	Lepoittevin, C; Frigerio, JM; Garnier-Gere, P; Salin, F; Cervera, MT; Vornam, B; Harvengt, L; Plomion, C				Lepoittevin, Camille; Frigerio, Jean-Marc; Garnier-Gere, Pauline; Salin, Franck; Cervera, Maria-Teresa; Vornam, Barbara; Harvengt, Luc; Plomion, Christophe			In Vitro vs In Silico Detected SNPs for the Development of a Genotyping Array: What Can We Learn from a Non-Model Species?	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; EXPRESSED SEQUENCE TAGS; LINKAGE-DISEQUILIBRIUM; ERRORS; GENOME; IDENTIFICATION; DNA; PERFORMANCE; TECHNOLOGY; IMPACT	Background: There is considerable interest in the high-throughput discovery and genotyping of single nucleotide polymorphisms (SNPs) to accelerate genetic mapping and enable association studies. This study provides an assessment of EST-derived and resequencing-derived SNP quality in maritime pine (Pinus pinaster Ait.), a conifer characterized by a huge genome size (similar to 23.8 Gb/C). Methodology/Principal Findings: A 384-SNPs GoldenGate genotyping array was built from i/ 184 SNPs originally detected in a set of 40 re-sequenced candidate genes (in vitro SNPs), chosen on the basis of functionality scores, presence of neighboring polymorphisms, minor allele frequencies and linkage disequilibrium and ii/ 200 SNPs screened from ESTs (in silico SNPs) selected based on the number of ESTs used for SNP detection, the SNP minor allele frequency and the quality of SNP flanking sequences. The global success rate of the assay was 66.9%, and a conversion rate (considering only polymorphic SNPs) of 51% was achieved. In vitro SNPs showed significantly higher genotyping-success and conversion rates than in silico SNPs (+11.5% and +18.5%, respectively). The reproducibility was 100%, and the genotyping error rate very low (0.54%, dropping down to 0.06% when removing four SNPs showing elevated error rates). Conclusions/Significance: This study demonstrates that ESTs provide a resource for SNP identification in non-model species, which do not require any additional bench work and little bio-informatics analysis. However, the time and cost benefits of in silico SNPs are counterbalanced by a lower conversion rate than in vitro SNPs. This drawback is acceptable for population-based experiments, but could be dramatic in experiments involving samples from narrow genetic backgrounds. In addition, we showed that both the visual inspection of genotyping clusters and the estimation of a per SNP error rate should help identify markers that are not suitable to the GoldenGate technology in species characterized by a large and complex genome.	[Lepoittevin, Camille; Frigerio, Jean-Marc; Garnier-Gere, Pauline; Salin, Franck; Plomion, Christophe] INRA, BIOGECO UMR1202, Cestas, France; [Lepoittevin, Camille; Frigerio, Jean-Marc; Garnier-Gere, Pauline; Salin, Franck; Plomion, Christophe] Univ Bordeaux, BIOGECO UMR1202, Talence, France; [Lepoittevin, Camille; Harvengt, Luc] FCBA, Biotechnol Lab, Nangis, France; [Cervera, Maria-Teresa] INIA, Dept Ecol & Genet Forestal, Madrid, Spain; [Vornam, Barbara] Univ Gottingen, Gottingen, Germany	INRAE; UDICE-French Research Universities; Universite de Bordeaux; University of Gottingen	Lepoittevin, C (corresponding author), INRA, BIOGECO UMR1202, Cestas, France.	camille.lepoittevin@pierroton.inra.fr	Harvengt, Luc/G-4569-2011; Cervera, M. Teresa/G-9181-2012; plomion, christophe/F-7578-2013	Harvengt, Luc/0000-0003-1524-5273; Cervera, M. Teresa/0000-0001-6797-2347; Lepoittevin, Camille/0000-0002-1270-9629; plomion, christophe/0000-0002-3176-2767	Agence Nationale de la Recherche Genoplante [GNP05013C]; Agence Nationale de la Recherche Plates-Formes Technologiques du Vivant [07PFTV002]; Aquitaine Region [20061201004PFM]; European Union [FP7-211868]	Agence Nationale de la Recherche Genoplante(French National Research Agency (ANR)); Agence Nationale de la Recherche Plates-Formes Technologiques du Vivant(French National Research Agency (ANR)); Aquitaine Region(Region Nouvelle-Aquitaine); European Union(European Commission)	This research was supported by grants from Agence Nationale de la Recherche Genoplante (GenoQB project, GNP05013C) and Agence Nationale de la Recherche Plates-Formes Technologiques du Vivant (BOOST-SNP project, 07PFTV002), the Aquitaine Region (20061201004PFM) and the European Union (NOVELTREE project, FP7-211868). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2001, EUR J HUM GENET, V9, P130, DOI 10.1038/sj.ejhg.5200594; Akey JM, 2001, AM J HUM GENET, V68, P1447, DOI 10.1086/320607; Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Batley J, 2003, PLANT PHYSIOL, V132, P84, DOI 10.1104/pp.102.019422; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Chagne D., 2007, Association mapping in plants, P77, DOI 10.1007/978-0-387-36011-9_5; Cunningham JM, 2008, CANCER EPIDEM BIOMAR, V17, P1781, DOI 10.1158/1055-9965.EPI-07-2849; Deleu W, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-90; Eckert AJ, 2009, TREE GENET GENOMES, V5, P225, DOI 10.1007/s11295-008-0183-8; Edwards D., 2007, Association mapping in plants, P53, DOI 10.1007/978-0-387-36011-9_4; Eveno E, 2008, MOL BIOL EVOL, V25, P417, DOI 10.1093/molbev/msm272; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Ganal MW, 2009, CURR OPIN PLANT BIOL, V12, P211, DOI 10.1016/j.pbi.2008.12.009; Garcia-Closas M, 2007, PLOS GENET, V3, P287, DOI 10.1371/journal.pgen.0030029; Gibbs JR, 2006, PLOS GENET, V2, P1511, DOI 10.1371/journal.pgen.0020150; Gordon D, 2002, HUM HERED, V54, P22, DOI 10.1159/000066696; Gordon D, 2001, AM J HUM GENET, V69, P371, DOI 10.1086/321981; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; Gupta PK, 2001, CURR SCI INDIA, V80, P524; Hackett CA, 2003, HEREDITY, V90, P33, DOI 10.1038/sj.hdy.6800173; Hao K, 2004, GENOMICS, V84, P623, DOI 10.1016/j.ygeno.2004.05.003; Henikoff S, 2003, ANNU REV PLANT BIOL, V54, P375, DOI 10.1146/annurev.arplant.54.031902.135009; HENRY RJ, 2008, PLANT GENOTYPING, V2; Hyten DL, 2008, THEOR APPL GENET, V116, P945, DOI 10.1007/s00122-008-0726-2; Kang SJ, 2004, GENET EPIDEMIOL, V26, P132, DOI 10.1002/gepi.10301; Labate JA, 2005, MOL BREEDING, V16, P343, DOI 10.1007/s11032-005-1911-5; Le Dantec L, 2004, PLANT MOL BIOL, V54, P461, DOI 10.1023/B:PLAN.0000036376.11710.6f; Lin Charles H., 2009, V496, P129, DOI 10.1007/978-1-59745-553-4_10; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Montpetit A, 2006, PLOS GENET, V2, P282, DOI 10.1371/journal.pgen.0020027; Murray BG, 1998, ANN BOT-LONDON, V82, P3, DOI 10.1006/anbo.1998.0764; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Oliphant A, 2002, BIOTECHNIQUES, P56; Pavy N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-21; Pavy N, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-174; Picoult-Newberg L, 1999, GENOME RES, V9, P167; Pindo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-12; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Pot D, 2005, NEW PHYTOL, V167, P101, DOI 10.1111/j.1469-8137.2005.01417.x; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Rafalski JA, 2002, PLANT SCI, V162, P329, DOI 10.1016/S0168-9452(01)00587-8; Rice KM, 2003, ANN HUM GENET, V67, P165, DOI 10.1046/j.1469-1809.2003.00020.x; Rostoks N, 2006, P NATL ACAD SCI USA, V103, P18656, DOI 10.1073/pnas.0606133103; Saunders IW, 2007, GENOMICS, V90, P291, DOI 10.1016/j.ygeno.2007.05.011; Schmid KJ, 2003, GENOME RES, V13, P1250, DOI 10.1101/gr.728603; Shen R, 2005, MUTAT RES-FUND MOL M, V573, P70, DOI 10.1016/j.mrfmmm.2004.07.022; Slate J, 2009, GENETICA, V136, P97, DOI 10.1007/s10709-008-9317-z; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; Sobrino B, 2005, FORENSIC SCI INT, V154, P181, DOI 10.1016/j.forsciint.2004.10.020; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558; Wang SL, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r8; Wang SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-450	53	45	46	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e11034	10.1371/journal.pone.0011034	http://dx.doi.org/10.1371/journal.pone.0011034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20543950	Green Published, Green Submitted, gold			2022-12-27	WOS:000278557600012
J	Moller, G; Husen, B; Kowalik, D; Hirvela, L; Plewczynski, D; Rychlewski, L; Messinger, J; Thole, H; Adamski, J				Moeller, Gabriele; Husen, Bettina; Kowalik, Dorota; Hirvela, Leena; Plewczynski, Dariusz; Rychlewski, Leszek; Messinger, Josef; Thole, Hubert; Adamski, Jerzy			Species Used for Drug Testing Reveal Different Inhibition Susceptibility for 17beta-Hydroxysteroid Dehydrogenase Type 1	PLOS ONE			English	Article							SELECTIVE NONSTEROIDAL INHIBITORS; PRE-RECEPTOR REGULATION; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE-1; BREAST-CANCER; PROGNOSTIC-SIGNIFICANCE; BIOLOGICAL EVALUATION; POTENT INHIBITORS; CRYSTAL-STRUCTURE; DESIGN; 17-BETA-HSD1	Steroid-related cancers can be treated by inhibitors of steroid metabolism. In searching for new inhibitors of human 17beta-hydroxysteroid dehydrogenase type 1 (17 beta-HSD 1) for the treatment of breast cancer or endometriosis, novel substances based on 15-substituted estrone were validated. We checked the specificity for different 17 beta-HSD types and species. Compounds were tested for specificity in vitro not only towards recombinant human 17 beta-HSD types 1, 2, 4, 5 and 7 but also against 17 beta-HSD 1 of several other species including marmoset, pig, mouse, and rat. The latter are used in the processes of pharmacophore screening. We present the quantification of inhibitor preferences between human and animal models. Profound differences in the susceptibility to inhibition of steroid conversion among all 17 beta-HSDs analyzed were observed. Especially, the rodent 17 beta-HSDs 1 were significantly less sensitive to inhibition compared to the human ortholog, while the most similar inhibition pattern to the human 17 beta-HSD 1 was obtained with the marmoset enzyme. Molecular docking experiments predicted estrone as the most potent inhibitor. The best performing compound in enzymatic assays was also highly ranked by docking scoring for the human enzyme. However, species-specific prediction of inhibitor performance by molecular docking was not possible. We show that experiments with good candidate compounds would out-select them in the rodent model during preclinical optimization steps. Potentially active human-relevant drugs, therefore, would no longer be further developed. Activity and efficacy screens in heterologous species systems must be evaluated with caution.	[Moeller, Gabriele; Kowalik, Dorota; Adamski, Jerzy] Helmholtz Zentrum Munchen, Inst Expt Genet, Genome Anal Ctr, Neuherberg, Germany; [Husen, Bettina; Messinger, Josef; Thole, Hubert] Solvay Pharmaceut Res Labs, Hannover, Germany; [Hirvela, Leena] Hormos Med, Turku, Finland; [Plewczynski, Dariusz] Warsaw Univ, Interdisciplinary Ctr Math & Computat Modelling, Warsaw, Poland; [Rychlewski, Leszek] Bioinfobank Inst, Poznan, Poland; [Adamski, Jerzy] Tech Univ Munich, Lehrstuhl Expt Genet, D-8050 Freising Weihenstephan, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Solvay SA; University of Warsaw; Interdisciplinary Centre for Mathematical & Computational Modelling; Technical University of Munich	Moller, G (corresponding author), Helmholtz Zentrum Munchen, Inst Expt Genet, Genome Anal Ctr, Neuherberg, Germany.	adamski@helmholtz-muenchen.de		Plewczynski, Dariusz/0000-0002-3840-7610; Adamski, Jerzy/0000-0001-9259-0199; Moller, Gabriele/0000-0002-2730-1351	OxyGreen [KBBE-2007-212281]; Polish Ministry of Education and Science [PBZ-MNiI-2/1/2005, N N301 159735]; Polish Ministry of Science and Higher Education [N301 159735]; Helmholtz Zentrum Munchen Laboratory; Solvay Pharmaceutical Research Laboratory	OxyGreen; Polish Ministry of Education and Science(Ministry of Science and Higher Education, Poland); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Helmholtz Zentrum Munchen Laboratory; Solvay Pharmaceutical Research Laboratory(Solvay SA)	The consensus docking part of the manuscript was supported by the OxyGreen (KBBE-2007-212281) project as well as the Polish Ministry of Education and Science (PBZ-MNiI-2/1/2005, N N301 159735). The work of DP was supported by Polish Ministry of Science and Higher Education N301 159735 grant. This work was further supported by the Helmholtz Zentrum Munchen and Solvay Pharmaceutical Research Laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, the manuscript was cleared for submission under the funder's manuscript approval standard operating procedures.	ADAMSKI J, 1991, EUR J CELL BIOL, V54, P166; Allan GM, 2008, BIOORGAN MED CHEM, V16, P4438, DOI 10.1016/j.bmc.2008.02.059; Allan GM, 2006, J MED CHEM, V49, P1325, DOI 10.1021/jm050830t; Arampatzis S, 2005, J MOL ENDOCRINOL, V35, P89, DOI 10.1677/jme.1.01736; Azzi A, 1996, NAT STRUCT BIOL, V3, P665, DOI 10.1038/nsb0896-665; Berube M, 2004, ORG LETT, V6, P3127, DOI 10.1021/ol048820u; Bey E, 2009, J MED CHEM, V52, P6724, DOI 10.1021/jm901195w; Brodie A, 2006, J STEROID BIOCHEM, V102, P97, DOI 10.1016/j.jsbmb.2006.09.002; Brown WM, 2003, CHEM-BIOL INTERACT, V143, P481, DOI 10.1016/S0009-2797(02)00184-9; Brozic P, 2008, CURR MED CHEM, V15, P137; Day JM, 2008, ENDOCR-RELAT CANCER, V15, P665, DOI 10.1677/ERC-08-0042; Day K, 2008, J GENDER STUD, V17, P1, DOI 10.1080/09589230701838321; Deluca D, 2006, MOL CELL ENDOCRINOL, V248, P218, DOI 10.1016/j.mce.2005.11.037; Fischer DS, 2005, J MED CHEM, V48, P5749, DOI 10.1021/jm050348a; Foster PA, 2008, ANTI-CANCER AGENT ME, V8, P732, DOI 10.2174/187152008785914815; Frotscher MT, 2008, J MED CHEM, V51, P2158, DOI 10.1021/jm701447v; GEISSLER WM, 1994, NAT GENET, V7, P34, DOI 10.1038/ng0594-34; Gunn D, 2005, BIOORG MED CHEM LETT, V15, P3053, DOI 10.1016/j.bmcl.2005.04.025; Gunnarsson C, 2005, BRIT J CANCER, V92, P547, DOI 10.1038/sj.bjc.6602375; Gunnarsson C, 2008, BREAST CANCER RES TR, V108, P35, DOI 10.1007/s10549-007-9579-7; HALLER F, J MOL BIOL IN PRESS, DOI DOI 10.1016/J.JMB.2010.1004.1002; Hardy LW, 2004, DRUG DISCOV TODAY, V9, P117, DOI 10.1016/S1359-6446(03)02969-6; Huang YW, 2001, MOL ENDOCRINOL, V15, P2010, DOI 10.1210/me.15.11.2010; Jansson AK, 2006, CANCER RES, V66, P11471, DOI 10.1158/0008-5472.CAN-06-1448; Jin Y, 2007, ANNU REV PHARMACOL, V47, P263, DOI 10.1146/annurev.pharmtox.47.120505.105337; Koczyk G, 2007, J MOL MODEL, V13, P445, DOI 10.1007/s00894-006-0165-4; Koski MK, 2005, J MOL BIOL, V345, P1157, DOI 10.1016/j.jmb.2004.11.009; Kruchten P, 2009, CR CHIM, V12, P1110, DOI 10.1016/j.crci.2009.05.005; Kruchten P, 2009, J STEROID BIOCHEM, V114, P200, DOI 10.1016/j.jsbmb.2009.02.006; Kruchten P, 2009, MOL CELL ENDOCRINOL, V301, P154, DOI 10.1016/j.mce.2008.09.035; Lawrence HR, 2005, J MED CHEM, V48, P2759, DOI 10.1021/jm049045r; Leenders F, 1996, J BIOL CHEM, V271, P5438, DOI 10.1074/jbc.271.10.5438; Lin SX, 1999, J STEROID BIOCHEM, V69, P425, DOI 10.1016/S0960-0760(99)00062-X; Lukacik P, 2006, MOL CELL ENDOCRINOL, V248, P61, DOI 10.1016/j.mce.2005.12.007; Lukacik P, 2007, BIOCHEM J, V402, P419, DOI 10.1042/BJ20061319; Luu-The V, 2001, J STEROID BIOCHEM, V76, P143, DOI 10.1016/S0960-0760(00)00155-2; Luu-The V, 2008, BEST PRACT RES CL EN, V22, P207, DOI 10.1016/j.beem.2008.01.008; Marchais-Oberwinkler S, 2008, J MED CHEM, V51, P4685, DOI 10.1021/jm800367k; MESSINGER J, 2008, Patent No. 2004080271; MESSINGER J, 2008, Patent No. 200408027; MESSINGER J, 2008, Patent No. 1685150; MESSINGER J, 2008, Patent No. 20080146531; Messinger J, 2009, MOL CELL ENDOCRINOL, V301, P216, DOI 10.1016/j.mce.2008.10.022; Mindnich R, 2004, MOL CELL ENDOCRINOL, V218, P7, DOI 10.1016/j.mce.2003.12.006; Moeller G, 2009, MOL CELL ENDOCRINOL, V301, P7, DOI 10.1016/j.mce.2008.10.040; Ngatcha BT, 2005, J MED CHEM, V48, P5257, DOI 10.1021/jm058179h; Oduwole OO, 2004, CANCER RES, V64, P7604, DOI 10.1158/0008-5472.CAN-04-0446; Peltoketo H, 1999, J MOL ENDOCRINOL, V23, P1, DOI 10.1677/jme.0.0230001; Peltoketo H, 1999, J STEROID BIOCHEM, V69, P431, DOI 10.1016/S0960-0760(99)00064-3; Penning TM, 2003, HUM REPROD UPDATE, V9, P193, DOI 10.1093/humupd/dmg022; Penning TM, 2008, MOL CELL ENDOCRINOL, V281, P1, DOI 10.1016/j.mce.2007.10.008; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; PLEWCZYNSKI D, 2008, J MOL MODEL, V15, P484; Poirier D, 2006, MOL CELL ENDOCRINOL, V248, P236, DOI 10.1016/j.mce.2005.10.017; Poirier D, 2003, CURR MED CHEM, V10, P453, DOI 10.2174/0929867033368222; Poirier D, 2002, BIOORG MED CHEM LETT, V12, P2833, DOI 10.1016/S0960-894X(02)00637-6; Poirier D, 2009, ANTI-CANCER AGENT ME, V9, P642, DOI 10.2174/187152009788680000; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Prehn C, 2009, J STEROID BIOCHEM, V114, P72, DOI 10.1016/j.jsbmb.2008.12.024; PRESLOCK JP, 1980, J STEROID BIOCHEM, V13, P965, DOI 10.1016/0022-4731(80)90172-7; Purohit A, 2008, ANTICANCER RES, V28, P1517; Qiu W, 2004, MOL ENDOCRINOL, V18, P1798, DOI 10.1210/me.2004-0032; Qiu W, 2002, FASEB J, V16, P1829, DOI 10.1096/fj.02-0026fje; Rasiah KK, 2009, MOL CELL ENDOCRINOL, V301, P89, DOI 10.1016/j.mce.2008.11.021; Schuster D, 2006, J CHEM INF MODEL, V46, P1301, DOI 10.1021/ci050237k; Schwarz S, 1996, STEROIDS, V61, P710, DOI 10.1016/S0039-128X(96)00200-0; Suzuki T, 2007, INT J CANCER, V120, P285, DOI 10.1002/ijc.22317; Tremblay MR, 2005, J ENZYM INHIB MED CH, V20, P153, DOI 10.1080/14756360500043307; VICKER N, 2004, Patent No. 2004085457; Vicker N, 2006, CHEMMEDCHEM, V1, P464, DOI 10.1002/cmdc.200500087; Vihko P, 2006, MOL CELL ENDOCRINOL, V248, P141, DOI 10.1016/j.mce.2005.12.005; Vihko P, 2004, MOL CELL ENDOCRINOL, V215, P83, DOI 10.1016/j.mce.2003.11.021; Woo LWL, 2007, J MED CHEM, V50, P3540, DOI 10.1021/jm061462b	73	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e10969	10.1371/journal.pone.0010969	http://dx.doi.org/10.1371/journal.pone.0010969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544026	Green Submitted, Green Published, gold			2022-12-27	WOS:000278494900003
J	de Mello, JCM; de Araujo, ESS; Stabellini, R; Fraga, AM; de Souza, JES; Sumita, DR; Camargo, AA; Pereira, LV				Moreira de Mello, Joana Carvalho; Souza de Araujo, Erica Sara; Stabellini, Raquel; Fraga, Ana Maria; Santana de Souza, Jorge Estefano; Sumita, Denilce R.; Camargo, Anamaria A.; Pereira, Lygia V.			Random X Inactivation and Extensive Mosaicism in Human Placenta Revealed by Analysis of Allele-Specific Gene Expression along the X Chromosome	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HUMAN CHORIONIC VILLI; EARLY MOUSE EMBRYOS; TROPHOBLASTIC CELLS; DNA-REPLICATION; YOLK-SAC; MAMMALS; REACTIVATION; MEMBRANES; PATTERNS	Imprinted inactivation of the paternal X chromosome in marsupials is the primordial mechanism of dosage compensation for X-linked genes between females and males in Therians. In Eutherian mammals, X chromosome inactivation (XCI) evolved into a random process in cells from the embryo proper, where either the maternal or paternal X can be inactivated. However, species like mouse and bovine maintained imprinted XCI exclusively in extraembryonic tissues. The existence of imprinted XCI in humans remains controversial, with studies based on the analyses of only one or two X-linked genes in different extraembryonic tissues. Here we readdress this issue in human term placenta by performing a robust analysis of allele-specific expression of 22 X-linked genes, including XIST, using 27 SNPs in transcribed regions. We show that XCI is random in human placenta, and that this organ is arranged in relatively large patches of cells with either maternal or paternal inactive X. In addition, this analysis indicated heterogeneous maintenance of gene silencing along the inactive X, which combined with the extensive mosaicism found in placenta, can explain the lack of agreement among previous studies. Our results illustrate the differences of XCI mechanism between humans and mice, and highlight the importance of addressing the issue of imprinted XCI in other species in order to understand the evolution of dosage compensation in placental mammals.	[Moreira de Mello, Joana Carvalho; Souza de Araujo, Erica Sara; Stabellini, Raquel; Fraga, Ana Maria; Pereira, Lygia V.] Univ Sao Paulo, Dept Genet & Biol Evolut, Genet Mol Lab, Sao Paulo, Brazil; [Santana de Souza, Jorge Estefano; Camargo, Anamaria A.] Ludwig Inst Canc Res, Sao Paulo Branch, Sao Paulo, Brazil	Universidade de Sao Paulo; Ludwig Institute for Cancer Research	de Mello, JCM (corresponding author), Univ Sao Paulo, Dept Genet & Biol Evolut, Genet Mol Lab, Sao Paulo, Brazil.	lpereira@usp.br	Camargo, Anamaria A/E-9388-2012; Pereira, Lygia V/C-1049-2012	Camargo, Anamaria A/0000-0002-6076-9597; Pereira, Lygia V/0000-0002-0002-725X	Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding: This work was funded by Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP: www.fapesp.br) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq: www.cnpq.br). JCMM, ESSA, RS, AMF receive fellowships from FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos-Landgraf JM, 2006, AM J HUM GENET, V79, P493, DOI 10.1086/507565; Anderson CL, 1999, AM J HUM GENET, V65, P699, DOI 10.1086/302556; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Brown CJ, 1997, AM J HUM GENET, V60, P1333, DOI 10.1086/515488; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; COOPER DW, 1971, NATURE-NEW BIOL, V230, P155, DOI 10.1038/newbio230155a0; Dhara SK, 2004, NUCLEIC ACIDS RES, V32, P3995, DOI 10.1093/nar/gkh746; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Ge B, 2005, GENOME RES, V15, P1584, DOI 10.1101/gr.4023805; Goto T, 1997, MOL HUM REPROD, V3, P77, DOI 10.1093/molehr/3.1.77; HARRISON KB, 1986, CYTOGENET CELL GENET, V41, P163, DOI 10.1159/000132221; HARRISON KB, 1989, CYTOGENET CELL GENET, V52, P37, DOI 10.1159/000132835; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Looijenga LHJ, 1999, AM J HUM GENET, V64, P1445, DOI 10.1086/302382; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Migeon B R, 1978, Basic Life Sci, V12, P379; Migeon BR, 2005, AM J HUM GENET, V77, P355, DOI 10.1086/432815; MIGEON BR, 1986, P NATL ACAD SCI USA, V83, P2182, DOI 10.1073/pnas.83.7.2182; MIGEON BR, 1979, AM J HUM GENET, V31, P581; MOHANDAS TK, 1989, SOMAT CELL MOLEC GEN, V15, P131, DOI 10.1007/BF01535073; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Reik W, 2005, NAT REV GENET, V6, P403, DOI 10.1038/nrg1602; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; ROPERS HH, 1978, HUM GENET, V43, P265, DOI 10.1007/BF00278833; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; SHARMAN GB, 1971, NATURE, V230, P231, DOI 10.1038/230231a0; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Stabellini Raquel, 2009, Epigenetics, V4, P388; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Uehara S, 2000, J HUM GENET, V45, P119, DOI 10.1007/s100380050197; van den Berg IM, 2009, AM J HUM GENET, V84, P771, DOI 10.1016/j.ajhg.2009.05.003; Vasques LR, 2002, CYTOGENET GENOME RES, V99, P30, DOI 10.1159/000071570; Vasques LR, 2001, DNA RES, V8, P173, DOI 10.1093/dnares/8.4.173; Wagschal A, 2006, CYTOGENET GENOME RES, V113, P90, DOI 10.1159/000090819; WAKE N, 1976, NATURE, V262, P580, DOI 10.1038/262580a0; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9; Willemsen R, 2002, HUM GENET, V110, P601, DOI 10.1007/s00439-002-0723-5; Xue F, 2002, NAT GENET, V31, P216, DOI 10.1038/ng900; Zeng SM, 2003, PLACENTA, V24, P270, DOI 10.1053/plac.2002.0889	44	88	91	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10947	10.1371/journal.pone.0010947	http://dx.doi.org/10.1371/journal.pone.0010947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532033	gold, Green Published, Green Submitted			2022-12-27	WOS:000278380500001
J	Ir, P; Men, C; Lucas, H; Meessen, B; Decoster, K; Bloom, G; Van Damme, W				Ir, Por; Men, Chean; Lucas, Henry; Meessen, Bruno; Decoster, Kristof; Bloom, Gerald; Van Damme, Wim			Self-Reported Serious Illnesses in Rural Cambodia: A Cross-Sectional Survey	PLOS ONE			English	Article							CATASTROPHIC HEALTH EXPENDITURE; DEVELOPING-COUNTRIES; INTERVIEW SURVEYS; LOW-INCOME; USER FEES; CARE; POVERTY; EQUITY; ACCESS; HOUSEHOLDS	Background: There is substantial evidence that ill-health is a major cause of impoverishment in developing countries. Major illnesses can have a serious economic impact on poor households through treatment costs and income loss. However, available methods for measuring the impact of ill-health on household welfare display several shortcomings and new methods are thus needed. To understand the potential complex impact of major illnesses on household livelihoods, a study on poverty and illness was conducted in rural Cambodia, as part of an international comparative research project. A cross-sectional survey was performed to identify households affected by major illness for further in-depth interviews. Methodology and Principal Findings: 5,975 households in three rural health districts were randomly selected through a two-stage cluster sampling and interviewed. 27% of the households reported at least one member with a serious illness in the year preceding the survey and 15% of the household members reported suffering from at least one serious illness. The most reported conditions include common tropical infectious diseases, chronic diseases (notably hypertension and heart diseases) and road traffic accidents. Such conditions were particularly concentrated among the poor, children under five, women, and the elderly. Poor women often reported complications related to pregnancy and delivery as serious illnesses. Conclusions and Significance: Despite some methodological limitations, this study provides new information on the frequency of self-reported serious illnesses among the rural Cambodia's population, which serves as a basis for further in-depth investigation on 'major illnesses' and their economic consequences on poor households. This can in turn help policy makers to formulate appropriate interventions to protect the poor from the financial burden associated with ill-health. Our findings suggest that every year a considerable proportion of rural population in Cambodia, especially the poor and vulnerable, are affected by serious illnesses, both communicable and non-communicable diseases.	[Ir, Por] Minist Hlth, Prov Hlth Dept, Siem Reap, Cambodia; [Ir, Por; Meessen, Bruno; Decoster, Kristof; Van Damme, Wim] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Men, Chean] Ctr Adv Studies, Phnom Penh, Cambodia; [Lucas, Henry; Bloom, Gerald] Univ Sussex, Inst Dev Studies, Brighton, E Sussex, England	Institute of Tropical Medicine (ITM); University of Sussex	Ir, P (corresponding author), Minist Hlth, Prov Hlth Dept, Siem Reap, Cambodia.	irpor@yahoo.com	Van Damme, Wim/F-7404-2011	Van Damme, Wim/0000-0002-6344-3007; Bloom, Gerald/0000-0002-7047-2412; Meessen, Bruno/0000-0002-0359-8621	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was funded by the Sixth Framework Programme of the European Commission (http://www.povill.com/en_index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigdeli M, 2009, B WORLD HEALTH ORGAN, V87, P560, DOI 10.2471/BLT.08.053058; BOERMA JT, 1991, INT J EPIDEMIOL, V20, P1073, DOI 10.1093/ije/20.4.1073; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; *DEP PLANN HLTH IN, 2006, HLTH COV PLAN 2004 2; *DEP PLANN HLTH IN, 2008, NAT HLTH STAT 2007; FABRICANT SJ, 1993, B WORLD HEALTH ORGAN, V71, P341; FASSIN D, 1991, REV EPIDEMIOL SANTE, V39, P89; Flores G, 2008, HEALTH ECON, V17, P1393, DOI 10.1002/hec.1338; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Hardeman W, 2004, HEALTH POLICY PLANN, V19, P22, DOI 10.1093/heapol/czh003; Jacobs B, 2006, HEALTH POLICY PLANN, V21, P27, DOI 10.1093/heapol/czj001; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Kenjiro Y, 2005, DEV CHANGE, V36, P759, DOI 10.1111/j.0012-155X.2005.00433.x; Khun S, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-10; King H, 2005, LANCET, V366, P1633, DOI 10.1016/S0140-6736(05)67662-3; Leonard L, 2005, SOC SCI MED, V61, P229, DOI 10.1016/j.socscimed.2004.11.050; Limwattananon S, 2007, B WORLD HEALTH ORGAN, V85, P600, DOI 10.2471/BLT.06.033720; LUCAS H, 2008, STUDIES HLTH SERVICE, V23, P29; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; Meessen B, 2003, TROP MED INT HEALTH, V8, P581, DOI 10.1046/j.1365-3156.2003.01081.x; *NAT I PUBL HLTH O, 2006, CAMB DEM HLTH SURV 2; National Center for HIV/AIDS Dermatology and STD (NCHADS), 2008, HIV SENT SURV 2006; National Institute of Statistics, 2009, GEN POP CENS CAMB 20; *OXF, 2000, HLTH LANDL; Paxton S, 2007, ASIA-PAC J PUBLIC HE, V19, P8, DOI 10.1177/10105395070190010301; Pilsczek FH, 2001, CAN MED ASSOC J, V165, P37; RODGERS Y, 2009, GENDER DEV IN PRESS; ROSS DA, 1986, STUD FAMILY PLANN, V17, P78, DOI 10.2307/1967068; Russell S, 2005, HEALTH POLICY PLANN, V20, P277, DOI 10.1093/heapol/czi035; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; *UNFPA CAMB, OBST DEL TRAIN HLTH; Van Damme W, 2003, LANCET, V362, P996, DOI 10.1016/S0140-6736(03)14375-9; Van Damme W, 2004, TROP MED INT HEALTH, V9, P273, DOI 10.1046/j.1365-3156.2003.01194.x; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; Wagstaff A, 2002, B WORLD HEALTH ORGAN, V80, P97; Whitehead M, 2001, LANCET, V358, P833, DOI 10.1016/S0140-6736(01)05975-X; *WHO, 2009, PREV CHRON DIS VIT I; World Health Organization, WHO FACT SHEET CARD; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; CAMBODIA COUNTRY PRO	42	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10930	10.1371/journal.pone.0010930	http://dx.doi.org/10.1371/journal.pone.0010930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	605AD	20532180	Green Submitted, Green Published, gold			2022-12-27	WOS:000278318700004
J	Gorelick, R; Bertram, SM				Gorelick, Root; Bertram, Susan M.			Multi-Way Multi-Group Segregation and Diversity Indices	PLOS ONE			English	Article							METHODOLOGICAL ANALYSIS; GENDER SEGREGATION; SEX SEGREGATION; DIVISION; ENTROPY; LINKAGE; LABOR	Background: How can we compute a segregation or diversity index from a three-way or multi-way contingency table, where each variable can take on an arbitrary finite number of values and where the index takes values between zero and one? Previous methods only exist for two-way contingency tables or dichotomous variables. A prototypical three-way case is the segregation index of a set of industries or departments given multiple explanatory variables of both sex and race. This can be further extended to other variables, such as disability, number of years of education, and former military service. Methodology/Principal Findings: We extend existing segregation indices based on Euclidean distance (square of coefficient of variation) and Boltzmann/Shannon/Theil index from two-way to multi-way contingency tables by including multiple summations. We provide several biological applications, such as indices for age polyethism and linkage disequilibrium. We also provide a new heuristic conceptualization of entropy-based indices. Higher order association measures are often independent of lower order ones, hence an overall segregation or diversity index should be the arithmetic mean of the normalized association measures at all orders. These methods are applicable when individuals self-identify as multiple races or even multiple sexes and when individuals work part-time in multiple industries. Conclusions/Significance: The policy implications of this work are enormous, allowing people to rigorously test whether employment or biological diversity has changed.	[Gorelick, Root; Bertram, Susan M.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Gorelick, Root] Carleton Univ, Sch Math & Stat, Ottawa, ON K1S 5B6, Canada	Carleton University; Carleton University	Gorelick, R (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	Root_Gorelick@carleton.ca	Bertram, Susan M/L-6992-2013	Bertram, Susan M/0000-0002-6326-579X	Natural Science and Engineering Research Council of Canada (NSERC)	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding: Both authors individually hold Natural Science and Engineering Research Council of Canada (NSERC) Discovery Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram SM, 2009, ANIM BEHAV, V77, P201, DOI 10.1016/j.anbehav.2008.09.028; Boltzmann L, 1872, WIEN BER, V66, P275, DOI DOI 10.1007/978-3-322-84986-1_3; Bridges WP, 2003, DEMOGRAPHY, V40, P543, DOI 10.2307/1515159; Cazelles B, 2004, ECOL LETT, V7, P755, DOI 10.1111/j.1461-0248.2004.00629.x; CHARLES M, 1995, AM J SOCIOL, V100, P931, DOI 10.1086/230605; CORTESE CF, 1976, AM SOCIOL REV, V41, P630, DOI 10.2307/2094840; Duncan OD, 1955, AM SOCIOL REV, V20, P210, DOI 10.2307/2088328; Evangelista HBA, 2009, BRAZ J PHYS, V39, P396, DOI 10.1590/S0103-97332009000400008; Geiringer H, 1944, ANN MATH STAT, V15, P25, DOI 10.1214/aoms/1177731313; Gorelick R, 2007, INSECT SOC, V54, P105, DOI 10.1007/s00040-007-0923-z; Gorelick R, 2004, AM NAT, V164, P677, DOI 10.1086/424968; Gorelick R, 2004, GENETICS, V166, P1581, DOI 10.1534/genetics.166.3.1581; GORELICK R, 2007, BIOL THEORY, V2, P180; Gorelick R, 2006, ECOGRAPHY, V29, P525, DOI 10.1111/j.0906-7590.2006.04601.x; Grusky DB, 1998, DEMOGRAPHY, V35, P497, DOI 10.2307/3004017; Jahn J, 1947, AM SOCIOL REV, V12, P293, DOI 10.2307/2086519; JAMES DR, 1985, SOCIOL METHODOL, P1; Jost L, 2010, DIVERS DISTRIB, V16, P65, DOI 10.1111/j.1472-4642.2009.00626.x; Liu ZQ, 2005, GENET EPIDEMIOL, V29, P353, DOI 10.1002/gepi.20092; MASSEY DS, 1988, SOC FORCES, V67, P281, DOI 10.2307/2579183; Permanyer I, 2010, SOC INDIC RES, V95, P181, DOI 10.1007/s11205-009-9463-4; Reardon SF, 2002, SOCIOL METHODOL, V32, P33, DOI 10.1111/1467-9531.00110; Robinson CL, 2005, WORK OCCUPATION, V32, P5, DOI 10.1177/0730888404272008; Sapiro V, 2001, WOMEN POLIT, V22, P1, DOI 10.1300/J014v22n01_01; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SMITH DL, 1976, SOC FORCES, V55, P520, DOI 10.2307/2576240; THEIL H, 1967, EC NFORM THEORY; Watts M, 1998, DEMOGRAPHY, V35, P489, DOI 10.2307/3004016; Yu DA., 2000, STAT METHODS CATEGOR	30	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2010	5	6							e10912	10.1371/journal.pone.0010912	http://dx.doi.org/10.1371/journal.pone.0010912			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	603QF	20532222	Green Published, gold			2022-12-27	WOS:000278222400007
J	Huang, X; van den Berg, A; Gao, ZF; Visser, L; Nolte, I; Vos, H; Hepkema, B; Kooistra, W; Poppema, S; Diepstra, A				Huang, Xin; van den Berg, Anke; Gao, Zifen; Visser, Lydia; Nolte, Ilja; Vos, Hans; Hepkema, Bouke; Kooistra, Wierd; Poppema, Sibrand; Diepstra, Arjan			Expression of HLA Class I and HLA Class II by Tumor Cells in Chinese Classical Hodgkin Lymphoma Patients	PLOS ONE			English	Article							REED-STERNBERG CELLS; COMPLEX CLASS-I; CD4(+) T-CELLS; DISEASE; EPITOPE; HLA-A-ASTERISK-02; IDENTIFICATION; PROTEIN	Background: In Caucasian populations, the tumor cells of Epstein Barr virus (EBV)-positive classical Hodgkin Lymphomas (cHL) patients more frequently express HLA class I and HLA class II molecules compared to EBV-negative cHL patients. HLA expression (in relation to EBV) in Asian cHL patients has not been previously investigated. Methodology/Principal Findings: We randomly selected 145 cHL patients with formalin-fixed, paraffin embedded tissue blocks available from 5 hospitals from the Northern part of China. Hematoxylin & Eosin-stained slides were used to reclassify the histological subtypes according to the WHO classification. EBV status was determined by visualization of EBERs in tumor cells using in situ hybridization. Membranous expression of HLA molecules was detected by immunohistochemistry using antibodies HC-10 (class I heavy chain) and anti-beta 2-microglobulin for HLA class I, and CR3/43 for HLA class II. EBV+ tumor cells were observed in 40% (58/145) of the cHL patients. As expected, the percentage of EBV+ cases was much higher in the mixed cellularity subtype (71%) than in the nodular sclerosis subtype (16%) (p<0.001). Expression of HLA class I was observed in 79% of the EBV+ cHL cases and in 30% of the EBV- cases (p<0.001). For HLA class II, 52% of EBV+ cHL cases were positive, compared to 43% in EBV- cases (p = 0.28). Conclusions: The results in the Northern China population were similar to those in the Caucasian population for HLA class I, but not for HLA class II.	[Huang, Xin; van den Berg, Anke; Visser, Lydia; Vos, Hans; Kooistra, Wierd; Poppema, Sibrand; Diepstra, Arjan] Univ Groningen, Dept Pathol & Med Biol, Univ Med Ctr Groningen, Groningen, Netherlands; [Huang, Xin; Gao, Zifen] Peking Univ, Dept Pathol, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Nolte, Ilja] Univ Groningen, Unit Genet Epidemiol & Bioinformat, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Hepkema, Bouke] Univ Groningen, Dept Lab Med, Univ Med Ctr Groningen, Groningen, Netherlands	University of Groningen; Peking University; University of Groningen; University of Groningen	Huang, X (corresponding author), Univ Groningen, Dept Pathol & Med Biol, Univ Med Ctr Groningen, Groningen, Netherlands.	a.diepstra@path.umcg.nl	Visser, Lydia/D-7675-2012; Poppema, Sibrand/D-1204-2012; van den Berg, Anke/H-1718-2011	van den Berg, Anke/0000-0002-8894-2638; Diepstra, Arjan/0000-0001-9239-1050	Bernoulli Bursary	Bernoulli Bursary	This work was supported by Bernoulli Bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro T, 2008, CLIN CANCER RES, V14, P685, DOI 10.1158/1078-0432.CCR-07-1246; Bryden H, 1997, INT J CANCER, V72, P614, DOI 10.1002/(SICI)1097-0215(19970807)72:4<614::AID-IJC11>3.0.CO;2-B; Campoli M, 2008, ONCOGENE, V27, P5869, DOI 10.1038/onc.2008.273; DE JD, 2008, J INTERN MED, V264, P528; Diepstra A, 2008, TISSUE ANTIGENS, V71, P219, DOI 10.1111/j.1399-0039.2008.01005.x; Diepstra A, 2005, LANCET, V365, P2216, DOI 10.1016/S0140-6736(05)66780-3; Diepstra A, 2007, J CLIN ONCOL, V25, P3101, DOI 10.1200/JCO.2006.10.0917; Gandhi MK, 2004, BRIT J HAEMATOL, V125, P267, DOI 10.1111/j.1365-2141.2004.04902.x; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Lee SP, 1998, BLOOD, V92, P1020, DOI 10.1182/blood.V92.3.1020.415a20_1020_1030; Murray PG, 1998, BLOOD, V92, P2477, DOI 10.1182/blood.V92.7.2477.2477_2477_2483; Nakatsuka S, 2006, INT J HEMATOL, V83, P391, DOI 10.1532/IJH97.05184; Niens M, 2007, BLOOD, V110, P3310, DOI 10.1182/blood-2007-05-086934; Omiya R, 2002, J IMMUNOL, V169, P2172, DOI 10.4049/jimmunol.169.4.2172; Oudejans JJ, 1996, BLOOD, V87, P3844, DOI 10.1182/blood.V87.9.3844.bloodjournal8793844; STAM NJ, 1986, J IMMUNOL, V137, P2299; Swerdlow SH, 2008, WHO CLASSIFICATION T; Voo KS, 2002, CANCER RES, V62, P7195; Wang RF, 2003, METHODS, V29, P227, DOI 10.1016/S1046-2023(02)00345-6	19	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10865	10.1371/journal.pone.0010865	http://dx.doi.org/10.1371/journal.pone.0010865			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526359	gold, Green Published, Green Submitted			2022-12-27	WOS:000278222100003
J	Frank, DM; Sarkar, S				Frank, David M.; Sarkar, Sahotra			Group Decisions in Biodiversity Conservation: Implications from Game Theory	PLOS ONE			English	Article							EXTRINSIC REWARDS; MULTIPLE CRITERIA; HOMO-ECONOMICUS; CORAL-REEFS; RED GROUSE; WILD DOGS; AREA; FOOD	Background: Decision analysis and game theory [1,2] have proved useful tools in various biodiversity conservation planning and modeling contexts [3-5]. This paper shows how game theory may be used to inform group decisions in biodiversity conservation scenarios by modeling conflicts between stakeholders to identify Pareto-inefficient Nash equilibria. These are cases in which each agent pursuing individual self-interest leads to a worse outcome for all, relative to other feasible outcomes. Three case studies from biodiversity conservation contexts showing this feature are modeled to demonstrate how game-theoretical representation can inform group decision-making. Methodology and Principal Findings: The mathematical theory of games is used to model three biodiversity conservation scenarios with Pareto-inefficient Nash equilibria: (i) a two-agent case involving wild dogs in South Africa; (ii) a three-agent raptor and grouse conservation scenario from the United Kingdom; and (iii) an n-agent fish and coral conservation scenario from the Philippines. In each case there is reason to believe that traditional mechanism-design solutions that appeal to material incentives may be inadequate, and the game-theoretical analysis recommends a resumption of further deliberation between agents and the initiation of trust-and confidence-building measures. Conclusions and Significance: Game theory can and should be used as a normative tool in biodiversity conservation contexts: identifying scenarios with Pareto-inefficient Nash equilibria enables constructive action in order to achieve (closer to) optimal conservation outcomes, whether by policy solutions based on mechanism design or otherwise. However, there is mounting evidence [6] that formal mechanism-design solutions may backfire in certain cases. Such scenarios demand a return to group deliberation and the creation of reciprocal relationships of trust.	[Frank, David M.; Sarkar, Sahotra] Univ Texas Austin, Dept Philosophy, Austin, TX 78712 USA; [Sarkar, Sahotra] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Frank, DM (corresponding author), Univ Texas Austin, Dept Philosophy, Austin, TX 78712 USA.	sarkar@mail.utexas.edu	Dao, Rock/E-5736-2014		National Science Foundation (NSF) [SES-0645884, DEB-0553768]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by National Science Foundation (NSF) Grant No. SES-0645884. It also benefited from discussions of the National Center for Ecological Analysis and Synthesis Working Group on Complex Environmental Decisions (funded by NSF Grant DEB-0553768). NSF website: http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson E, 2006, SOCIAL PSYCHOL; Arrow KJ, 1986, SOCIAL CHOICE MULTIC; Bhat MG, 1999, ECOL ECON, V29, P391, DOI 10.1016/S0921-8009(98)00066-4; Bowles S, 2008, SCIENCE, V320, P1605, DOI 10.1126/science.1152110; Brown A.F., 1995, HEATHS MOORLAND CULT, P51; Cardenas JC, 2000, WORLD DEV, V28, P1719, DOI 10.1016/S0305-750X(00)00055-3; Creel S., 2002, AFRICAN WILD DOG BEH; Deci EL, 1999, PSYCHOL BULL, V125, P627, DOI 10.1037/0033-2909.125.6.627; Dodds WK, 2005, ENVIRON VALUE, V14, P411, DOI 10.3197/096327105774462683; Faith D. P, 1995, BIODIVERSITY REGIONA; Falkinger J, 2000, AM ECON REV, V90, P247, DOI 10.1257/aer.90.1.247; Fehr E, 2003, NATURE, V422, P137, DOI 10.1038/nature01474; GIBSON CC, 1995, WORLD DEV, V23, P941, DOI 10.1016/0305-750X(95)00025-8; Gintis H, 2009, GAME THEORY EVOLVING: A PROBLEM-CENTERED INTRODUCTION TO MODELING STRATEGIC INTERACTION, SECOND EDITION, P1; Gintis H, 2000, ECOL ECON, V35, P311, DOI 10.1016/S0921-8009(00)00216-0; Gneezy U, 2000, J LEGAL STUD, V29, P1, DOI 10.1086/468061; GORDON H. SCOTT, 1953, JOUR FISH RES BD CANADA, V10, P442; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; Gusset M, 2008, BIODIVERS CONSERV, V17, P83, DOI 10.1007/s10531-007-9232-0; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; HUDSON P, 2001, HEATHS MOORLANDS CUL, P282; Keeney RL, 1993, DECISIONS MULTIPLE O, DOI DOI 10.1017/CBO9781139174084; Lindsey PA, 2005, BIOL CONSERV, V123, P339, DOI 10.1016/j.biocon.2004.12.002; Lindsey PA, 2004, S AFR J WILDL RES, V34, P77; Maddock A, 1999, CONSERV BIOL, V13, P412, DOI 10.1046/j.1523-1739.1999.013002412.x; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Maynard Smith J., 1982, pi; Mcmanus JW, 1997, ENVIRON MANAGE, V21, P69, DOI 10.1007/s002679900006; McManus JW, 1997, CORAL REEFS, V16, pS121, DOI 10.1007/s003380050248; Moffett A, 2006, DIVERS DISTRIB, V12, P125, DOI 10.1111/j.1366-9516.2005.00202.x; Moffett A, 2006, BIOL CONSERV, V129, P181, DOI 10.1016/j.biocon.2005.10.033; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Newton I., 1979, POPULATION ECOLOGY R; Ogada MO, 2003, CONSERV BIOL, V17, P1521, DOI 10.1111/j.1523-1739.2003.00061.x; *ORG EC COOP DEV, 1997, SUST FISH EC ASP MAN; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Pinkerton Evelyn, 1989, COOPERATIVE MANAGEME; REDFORD KH, 2001, CONSERVATION EXPLOIT, P00370; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Ryan RM, 2000, CONTEMP EDUC PSYCHOL, V25, P54, DOI 10.1006/ceps.1999.1020; Sarkar S, 2002, J BIOSCIENCES, V27, P299, DOI 10.1007/BF02704961; Sarkar S., 2005, BIODIVERSITY ENV PHI, DOI DOI 10.1017/CBO9780511498558; Sarkar S, 2004, CONSERV SOC, V2, P433; Sarkar S, 2008, BIOL PHILOS, V23, P217, DOI 10.1007/s10539-007-9092-8; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Sarkar S, 2008, RESONANCE, V13, P627, DOI 10.1007/s12045-008-0069-y; Sumaila UR, 1999, MAR POLICY, V23, P1, DOI 10.1016/S0308-597X(97)00045-6; Thirgood S, 2000, CONSERV BIOL, V14, P95, DOI 10.1046/j.1523-1739.2000.99013.x; Thirgood S, 1997, NATURE, V390, P547, DOI 10.1038/37450; THOMPSON DBA, 1995, BIOL CONSERV, V71, P163, DOI 10.1016/0006-3207(94)00043-P; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Ward JM, 1996, AUK, V113, P200; WATSON A, 1989, IBIS, V131, P336, DOI 10.1111/j.1474-919X.1989.tb02783.x; WATSON J, 1997, GOLDEN EAGLE; White AT, 2000, MAR POLLUT BULL, V40, P598, DOI 10.1016/S0025-326X(00)00022-9; WIERSMA UJ, 1992, J OCCUP ORGAN PSYCH, V65, P101, DOI 10.1111/j.2044-8325.1992.tb00488.x; [No title captured]	59	14	14	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10688	10.1371/journal.pone.0010688	http://dx.doi.org/10.1371/journal.pone.0010688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	603QA	20523732	Green Published, Green Submitted, gold			2022-12-27	WOS:000278221900003
J	Brumm, H; Farrington, H; Petren, K; Fessl, B				Brumm, Henrik; Farrington, Heather; Petren, Kenneth; Fessl, Birgit			Evolutionary Dead End in the Galapagos: Divergence of Sexual Signals in the Rarest of Darwin's Finches	PLOS ONE			English	Article							CHARACTER DISPLACEMENT; ALLOPATRIC SPECIATION; PREMATING ISOLATION; ADAPTIVE RADIATION; SECONDARY CONTACT; SYMPATRIC MORPHS; MANGROVE FINCH; BIRD SONG; SELECTION; DISCRIMINATION	Understanding the mechanisms underlying speciation remains a challenge in evolutionary biology. The adaptive radiation of Darwin's finches is a prime example of species formation, and their study has revealed many important insights into evolutionary processes. Here, we report striking differences in mating signals (songs), morphology and genetics between the two remnant populations of Darwin's mangrove finch Camarhynchus heliobates, one of the rarest species in the world. We also show that territorial males exhibited strong discrimination of sexual signals by locality: in response to foreign songs, males responded weaker than to songs from their own population. Female responses were infrequent and weak but gave approximately similar results. Our findings not only suggest speciation in the mangrove finch, thereby providing strong support for the central role of sexual signals during speciation, but they have also implications for the conservation of this iconic bird. If speciation is complete, the eastern species will face imminent extinction, because it has a population size of only 5-10 individuals.	[Brumm, Henrik] Max Planck Inst Ornithol, Commun & Social Behav Grp, Seewiesen, Germany; [Farrington, Heather; Petren, Kenneth] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA; [Fessl, Birgit] Charles Darwin Res Stn, Santa Cruz, Galapagos, Ecuador; [Fessl, Birgit] Durrell Wildlife Conservat Trust, Jersey, Channel Islands, England	Max Planck Society; University of Cincinnati	Brumm, H (corresponding author), Max Planck Inst Ornithol, Commun & Social Behav Grp, Seewiesen, Germany.	brumm@orn.mpg.de		Fessl, Birgit/0000-0003-1260-6002; Petren, Kenneth/0000-0002-7936-6042	United Kingdom government [15005]; German Research Foundation [Br 2309/6-1]; Association for the Study of Animal Behaviour	United Kingdom government; German Research Foundation(German Research Foundation (DFG)); Association for the Study of Animal Behaviour	Funding was provided by the United Kingdom government's Darwin Initiative Fund (project #15005), the German Research Foundation (award Br 2309/6-1), and the Association for the Study of Animal Behaviour (Christopher Barnard Award for Outstanding Contributions by a New Investigator to HB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1963, ANIMAL SPECIES EVOLU; Barker NK, 2008, ORNITOL NEOTROP, V19, P175; Bowman R. I., 1983, PATTERNS EVOLUTION G; Brumm H, 2009, ADV STUD BEHAV, V40, P1, DOI 10.1016/S0065-3454(09)40001-9; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Darwin C, 1859, ORIGIN SPECIES MEANS; Dvorak M, 2004, ORYX, V38, P171, DOI 10.1017/S0030605304000316; Fessl B, 2010, PHILOS T R SOC B, V365, P1019, DOI 10.1098/rstb.2009.0288; GIBBS HL, 1987, NATURE, V327, P511, DOI 10.1038/327511a0; GRANT BR, 1989, AM NAT, V133, P377, DOI 10.1086/284924; Grant BR, 1996, EVOLUTION, V50, P2471, DOI 10.1111/j.1558-5646.1996.tb03633.x; Grant BR, 2002, BIOL J LINN SOC, V76, P545, DOI 10.1046/j.1095-8312.2002.00076.x; Grant P.R., 1999, RECOGNITION STATES L, V2; Grant P. R., 2008, WHY SPECIES MULTIPLY; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Grant PR, 2009, P NATL ACAD SCI USA, V106, P20141, DOI 10.1073/pnas.0911761106; Grant PR, 1997, CONSERV BIOL, V11, P119, DOI 10.1046/j.1523-1739.1997.95399.x; HOLM S, 1979, SCAND J STAT, V6, P65; Huber SK, 2007, P R SOC B, V274, P1709, DOI 10.1098/rspb.2007.0224; Irwin DE, 2001, NATURE, V409, P333, DOI 10.1038/35053059; Lachlan RF, 2004, EVOLUTION, V58, P2049; LACK D, 1961, DARWINS FINCHES; Marshall DC, 2000, EVOLUTION, V54, P1313, DOI 10.1111/j.0014-3820.2000.tb00564.x; Nicholls JA, 2006, J ANIM ECOL, V75, P549, DOI 10.1111/j.1365-2656.2006.01075.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Petren K, 1999, P ROY SOC B-BIOL SCI, V266, P321, DOI 10.1098/rspb.1999.0641; Petren K, 2005, MOL ECOL, V14, P2943, DOI 10.1111/j.1365-294X.2005.02632.x; Petren K, 1998, MOL ECOL, V7, P1782, DOI 10.1046/j.1365-294x.1998.00518.x; Petren K, 2010, PHILOS T R SOC B, V365, P1009, DOI 10.1098/rstb.2009.0316; Podos J, 2001, NATURE, V409, P185, DOI 10.1038/35051570; Podos J, 2007, ADV STUD BEHAV, V37, P403, DOI 10.1016/S0065-3454(07)37009-5; Podos J, 2007, ANIM BEHAV, V73, P833, DOI 10.1016/j.anbehav.2006.11.001; Podos J, 2010, PHILOS T R SOC B, V365, P1031, DOI 10.1098/rstb.2009.0289; Ptacek MB, 2002, GENETICA, V116, P329, DOI 10.1023/A:1021201030017; RATCLIFFE LM, 1985, ANIM BEHAV, V33, P290, DOI 10.1016/S0003-3472(85)80143-3; Saetre GP, 1997, NATURE, V387, P589; Sato A, 1999, P NATL ACAD SCI USA, V96, P5101, DOI 10.1073/pnas.96.9.5101; SNODGRASS RE, 1904, P WASHINGTON ACAD SC, V0005; Tebbich S, 2010, PHILOS T R SOC B, V365, P1099, DOI 10.1098/rstb.2009.0291; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; WILEY RH, 1991, AM NAT, V138, P973, DOI 10.1086/285263	41	7	8	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11191	10.1371/journal.pone.0011191	http://dx.doi.org/10.1371/journal.pone.0011191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585648	Green Submitted, gold, Green Published			2022-12-27	WOS:000279135400007
J	Pappas, C; Viswanathan, K; Chandrasekaran, A; Raman, R; Katz, JM; Sasisekharan, R; Tumpey, TM				Pappas, Claudia; Viswanathan, Karthik; Chandrasekaran, Aarthi; Raman, Rahul; Katz, Jacqueline M.; Sasisekharan, Ram; Tumpey, Terrence M.			Receptor Specificity and Transmission of H2N2 Subtype Viruses Isolated from the Pandemic of 1957	PLOS ONE			English	Article							INFLUENZA-A VIRUSES; BINDING PROPERTIES; HEMAGGLUTININ; ORIGIN; SWINE; HA	Influenza viruses of the H2N2 subtype have not circulated among humans in over 40 years. The occasional isolation of avian H2 strains from swine and avian species coupled with waning population immunity to H2 hemagglutinin (HA) warrants investigation of this subtype due to its pandemic potential. In this study we examined the transmissibility of representative human H2N2 viruses, A/Albany/6/58 (Alb/58) and A/El Salvador/2/57 (ElSalv/57), isolated during the 1957/58 pandemic, in the ferret model. The receptor binding properties of these H2N2 viruses was analyzed using dose-dependent direct glycan array-binding assays. Alb/58 virus, which contains the 226L/228S amino acid combination in the HA and displayed dual binding to both alpha 2,6 and alpha 2,3 glycan receptors, transmitted efficiently to naive ferrets by respiratory droplets. Inefficient transmission was observed with ElSalv/57 virus, which contains the 226Q/228G amino acid combination and preferentially binds alpha 2,3 over alpha 2,6 glycan receptors. However, a unique transmission event with the ElSalv/57 virus occurred which produced a 226L/228G H2N2 natural variant virus that displayed an increase in binding specificity to alpha 2,6 glycan receptors and enhanced respiratory droplet transmissibility. Our studies provide a correlation between binding affinity to glycan receptors with terminal alpha 2,6-linked sialic acid and the efficiency of respiratory droplet transmission for pandemic H2N2 influenza viruses.	[Pappas, Claudia; Katz, Jacqueline M.; Tumpey, Terrence M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA; [Viswanathan, Karthik; Chandrasekaran, Aarthi; Raman, Rahul; Sasisekharan, Ram] Harvard Univ, MIT, Div Hlth Sci & Technol,Dept Biol Engn, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Centers for Disease Control & Prevention - USA; Harvard University; Massachusetts Institute of Technology (MIT)	Pappas, C (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.	tft9@cdc.gov			Centers for Disease Control and Prevention; NIH [U54 GM62116]; Singapore-MIT Alliance for Research and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore-MIT Alliance for Research and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The source of funding for this work was the Centers for Disease Control and Prevention. This work was partially supported by NIH grant U54 GM62116 (R. S) and the Singapore-MIT Alliance for Research and Technology (R. S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Dowdle WR, 2006, EMERG INFECT DIS, V12, P34, DOI 10.3201/eid1201.051013; Dowdle WR, 1999, B WORLD HEALTH ORGAN, V77, P820; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Glaser L, 2006, GLYCOCONJUGATE J, V23, P93, DOI 10.1007/s10719-006-5441-0; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Klimov AI, 1996, INT CONGR SER, V1123, P546; Lindstrom SE, 2004, VIROLOGY, V328, P101, DOI 10.1016/j.virol.2004.06.009; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; Ma W, 2007, P NATL ACAD SCI USA, V104, P20949, DOI 10.1073/pnas.0710286104; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Makarova NA, 1999, J GEN VIROL, V80, P3167, DOI 10.1099/0022-1317-80-12-3167; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; REED LJ, 1938, AM J HYG, V27; ROGERS GN, 1989, VIROLOGY, V173, P317, DOI 10.1016/0042-6822(89)90249-3; SCHAFER JR, 1993, VIROLOGY, V194, P781, DOI 10.1006/viro.1993.1319; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Stephenson I, 2003, J MED VIROL, V70, P391, DOI 10.1002/jmv.10408; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; US Animal Health Association, 2006, REP COMM TRANSM DIS, P314; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xu R, 2010, J VIROL, V84, P1715, DOI 10.1128/JVI.02162-09; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07	35	91	94	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11158	10.1371/journal.pone.0011158	http://dx.doi.org/10.1371/journal.pone.0011158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574518	Green Published, Green Submitted, gold			2022-12-27	WOS:000279058300004
J	Buescher, E; Achberger, T; Amusan, I; Giannini, A; Ochsenfeld, C; Rus, A; Lahner, B; Hoekenga, O; Yakubova, E; Harper, JF; Guerinot, ML; Zhang, M; Salt, DE; Baxter, IR				Buescher, Elizabeth; Achberger, Tilman; Amusan, Idris; Giannini, Anthony; Ochsenfeld, Cherie; Rus, Ana; Lahner, Brett; Hoekenga, Owen; Yakubova, Elena; Harper, Jeffrey F.; Guerinot, Mary Lou; Zhang, Min; Salt, David E.; Baxter, Ivan R.			Natural Genetic Variation in Selected Populations of Arabidopsis thaliana Is Associated with Ionomic Differences	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; MINERAL CONCENTRATIONS; PHOSPHATE DEFICIENCY; ALUMINUM TOLERANCE; LANDSBERG ERECTA; HIGH-RESOLUTION; QTL ANALYSIS; IDENTIFICATION; ACCUMULATION; PLANTS	Controlling elemental composition is critical for plant growth and development as well as the nutrition of humans who utilize plants for food. Uncovering the genetic architecture underlying mineral ion homeostasis in plants is a critical first step towards understanding the biochemical networks that regulate a plant's elemental composition (ionome). Natural accessions of Arabidopsis thaliana provide a rich source of genetic diversity that leads to phenotypic differences. We analyzed the concentrations of 17 different elements in 12 A. thaliana accessions and three recombinant inbred line (RIL) populations grown in several different environments using high-throughput inductively coupled plasma-mass spectroscopy (ICP-MS). Significant differences were detected between the accessions for most elements and we identified over a hundred QTLs for elemental accumulation in the RIL populations. Altering the environment the plants were grown in had a strong effect on the correlations between different elements and the QTLs controlling elemental accumulation. All ionomic data presented is publicly available at www.ionomicshub.org.	[Buescher, Elizabeth; Amusan, Idris] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Achberger, Tilman; Ochsenfeld, Cherie; Zhang, Min] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Giannini, Anthony] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Rus, Ana; Lahner, Brett; Yakubova, Elena; Salt, David E.; Baxter, Ivan R.] Purdue Univ, Ctr Plant Environm Stress Physiol, W Lafayette, IN 47907 USA; [Hoekenga, Owen] Cornell Univ, USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Harper, Jeffrey F.] Univ Nevada, Reno, NV 89557 USA; [Guerinot, Mary Lou] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Baxter, Ivan R.] ARS, USDA, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, St Louis, MO USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Cornell University; United States Department of Agriculture (USDA); Nevada System of Higher Education (NSHE); University of Nevada Reno; Dartmouth College; Donald Danforth Plant Science Center; United States Department of Agriculture (USDA)	Buescher, E (corresponding author), Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA.	ibaxter@danforthcenter.org	Baxter, Ivan R/A-1052-2009	Baxter, Ivan R/0000-0001-6680-1722; Hoekenga, Owen/0000-0003-4427-2000	NSF [DBI-0077378, IOS-0419695, DBI-0419435]; National Institutes of Health, the National Institute of General Medicine [R01 GM78536-01A1]; Indiana 21st Century Research and Technology Fund [912010479]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078536] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); National Institutes of Health, the National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana 21st Century Research and Technology Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was funded by a grant from the NSF Plant Genome Research Program (DBI-0077378) awarded to Mary Lou Guerinot, David Eide, Jeff Harper, David E. Salt, Julian Schroeder and John Ward, NSF Arabidopsis 2010 program (IOS-0419695) awarded to Mary Lou Guerinot, Jeff Harper, David E. Salt, Julian Schroeder and John Ward, National Institutes of Health, the National Institute of General Medicine (R01 GM78536-01A1) awarded to David E. Salt, Mary Lou Guerinot and Ivan Baxter and the Indiana 21st Century Research and Technology Fund (912010479) to David E. Salt. Owen Hoekenga was supported by the NSF Plant Genome Research Program (DBI-0419435) awarded to Leon Kochian, Edward Buckler, Owen Hoekenga and Jocelyn Rose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Blanco C, 2000, TRENDS PLANT SCI, V5, P22, DOI 10.1016/S1360-1385(99)01510-1; Basten CJ, 2000, QTL CARTOGRAPHER VER; Baxter I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000004; Baxter I, 2007, PLANT PHYSIOL, V143, P600, DOI 10.1104/pp.106.092528; Baxter I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000492; Baxter IR, 2008, P NATL ACAD SCI USA, V105, P12081, DOI 10.1073/pnas.0804175105; Bentsink L, 2003, THEOR APPL GENET, V106, P1234, DOI 10.1007/s00122-002-1177-9; Borevitz JO, 2003, PLANT PHYSIOL, V132, P718, DOI 10.1104/pp.103.023549; Broadley MR, 2008, PLANT PHYSIOL, V146, P1707, DOI 10.1104/pp.107.114645; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; CHURCHILL GA, 1994, GENETICS, V138, P963; Ernst WHO, 2000, ENVIRON EXP BOT, V43, P55, DOI 10.1016/S0098-8472(99)00048-9; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Ghandilyan A, 2009, NEW PHYTOL, V184, P180, DOI 10.1111/j.1469-8137.2009.02953.x; Ghandilyan A, 2009, J EXP BOT, V60, P1409, DOI 10.1093/jxb/erp084; Hirsch J, 2006, BIOCHIMIE, V88, P1767, DOI 10.1016/j.biochi.2006.05.007; Hoekenga OA, 2003, PLANT PHYSIOL, V132, P936, DOI 10.1104/pp.103.023085; Hoekenga OA, 2006, P NATL ACAD SCI USA, V103, P9738, DOI 10.1073/pnas.0602868103; JANSEN RC, 1994, GENETICS, V136, P1447; Keurentjes JJB, 2008, CURR OPIN PLANT BIOL, V11, P123, DOI 10.1016/j.pbi.2008.01.006; Kobayashi Y, 2002, PLANT CELL PHYSIOL, V43, P1526, DOI 10.1093/pcp/pcf174; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865; Liu J, 2009, PLANT SOIL, V320, P255, DOI 10.1007/s11104-009-9891-6; Loudet O, 2003, PLANT PHYSIOL, V131, P345, DOI 10.1104/pp.102.010785; Loudet O, 2007, NAT GENET, V39, P896, DOI 10.1038/ng2050; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Morrissey J, 2009, PLANT CELL; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Otegui MS, 2002, PLANT CELL, V14, P1311, DOI 10.1105/tpc.010486; Paran I, 2003, TRENDS GENET, V19, P303, DOI 10.1016/S0168-9525(03)00117-3; Payne KA, 2004, NEW PHYTOL, V162, P535, DOI 10.1111/j.1469-8137.2004.01026.x; RABOY V, 1984, CROP SCI, V24, P431, DOI 10.2135/cropsci1984.0011183X002400030001x; Rauh BL, 2002, THEOR APPL GENET, V104, P743, DOI 10.1007/s00122-001-0815-y; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Salt DE, 2008, ANNU REV PLANT BIOL, V59, P709, DOI 10.1146/annurev.arplant.59.032607.092942; Singer T, 2006, PLOS GENET, V2, P1352, DOI 10.1371/journal.pgen.0020144; Vreugdenhil D, 2004, PLANT CELL ENVIRON, V27, P828, DOI 10.1111/j.1365-3040.2004.01189.x; Ward JT, 2008, PLANT PHYSIOL, V147, P1181, DOI 10.1104/pp.108.118562; Waters BM, 2008, NEW PHYTOL, V179, P1033, DOI 10.1111/j.1469-8137.2008.02544.x; Waters BM, 2008, NEW PHYTOL, V177, P389, DOI 10.1111/j.1469-8137.2007.02288.x; Wu J, 2008, PLANT SOIL, V310, P25, DOI 10.1007/s11104-008-9625-1; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang LH, 2006, NEW PHYTOL, V170, P33, DOI 10.1111/j.1469-8137.2006.01635.x; Zhang LH, 2006, PHYSIOL PLANTARUM, V128, P212, DOI 10.1111/j.1399-3054.2006.00739.x	46	62	63	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11081	10.1371/journal.pone.0011081	http://dx.doi.org/10.1371/journal.pone.0011081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559418	Green Published, gold, Green Submitted			2022-12-27	WOS:000278741100003
J	Das, M; Chu, PL; Santos, GM; Scheer, S; Vittinghoff, E; McFarland, W; Colfax, GN				Das, Moupali; Chu, Priscilla Lee; Santos, Glenn-Milo; Scheer, Susan; Vittinghoff, Eric; McFarland, Willi; Colfax, Grant N.			Decreases in Community Viral Load Are Accompanied by Reductions in New HIV Infections in San Francisco	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; PERINATAL TRANSMISSION; UNITED-STATES; PUBLIC-HEALTH; PARTNER NOTIFICATION; SEXUAL TRANSMISSION; SIMPLIFYING CONSENT; SURVEILLANCE DATA; COITAL ACT	Background: At the individual level, higher HIV viral load predicts sexual transmission risk. We evaluated San Francisco's community viral load (CVL) as a population level marker of HIV transmission risk. We hypothesized that the decrease in CVL in San Francisco from 2004-2008, corresponding with increased rates of HIV testing, antiretroviral therapy (ART) coverage and effectiveness, and population-level virologic suppression, would be associated with a reduction in new HIV infections. Methodology/Principal Findings: We used San Francisco's HIV/AIDS surveillance system to examine the trends in CVL. Mean CVL was calculated as the mean of the most recent viral load of all reported HIV-positive individuals in a particular community. Total CVL was defined as the sum of the most recent viral loads of all HIV-positive individuals in a particular community. We used Poisson models with robust standard errors to assess the relationships between the mean and total CVL and the primary outcome: annual numbers of newly diagnosed HIV cases. Both mean and total CVL decreased from 2004-2008 and were accompanied by decreases in new HIV diagnoses from 798 (2004) to 434 (2008). The mean (p = 0.003) and total CVL (p = 0.002) were significantly associated with new HIV cases from 2004-2008. Conclusions/Significance: Reductions in CVL are associated with decreased HIV infections. Results suggest that wide-scale ART could reduce HIV transmission at the population level. Because CVL is temporally upstream of new HIV infections, jurisdictions should consider adding CVL to routine HIV surveillance to track the epidemic, allocate resources, and to evaluate the effectiveness of HIV prevention and treatment efforts.	[Das, Moupali; Chu, Priscilla Lee; Santos, Glenn-Milo; Scheer, Susan; McFarland, Willi; Colfax, Grant N.] San Francisco Dept Publ Hlth, San Francisco, CA USA; [Das, Moupali; Vittinghoff, Eric; McFarland, Willi; Colfax, Grant N.] Univ Calif San Francisco, San Francisco, CA 94143 USA	San Francisco Department of Public Health; University of California System; University of California San Francisco	Das, M (corresponding author), San Francisco Dept Publ Hlth, San Francisco, CA USA.	moupali.das-douglas@ucsf.edu		Santos, Glenn-Milo/0000-0003-1009-5317	California HIV/AIDS [ID08-PHFE-018]	California HIV/AIDS	California HIV/AIDS Research Program Innovative Developmental Exploratory Award (ID08-PHFE-018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens K, 2007, JAIDS-J ACQ IMM DEF, V46, P479, DOI 10.1097/QAI.0b013e3181594c61; [Anonymous], 2009, GUID US ANT AG HIV 1; [Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P597; Arnold M, 2009, SOC SCI MED, V69, P121, DOI 10.1016/j.socscimed.2009.04.019; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Castro A, 2005, PLOS MED, V2, P1217, DOI 10.1371/journal.pmed.0020338; Chen KT, 2009, AIDS PATIENT CARE ST, V23, P195, DOI 10.1089/apc.2008.0047; CHU PL, 2008, 17 INT AIDS C MEX CI; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Das-Douglas M, 2008, AM J PUBLIC HEALTH, V98, P1544, DOI 10.2105/AJPH.2008.142596; De Cock KM, 2008, LANCET, V371, P2068, DOI 10.1016/S0140-6736(08)60732-1; Dickover RE, 1996, JAMA-J AM MED ASSOC, V275, P599, DOI 10.1001/jama.275.8.599; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Frieden TR, 2009, ARCH INTERN MED, V169, P1650, DOI 10.1001/archinternmed.2009.309; Frieden TR, 2005, NEW ENGL J MED, V353, P2397, DOI 10.1056/NEJMsb053133; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Harries AD, 2009, JAIDS-J ACQ IMM DEF, V52, pS14, DOI 10.1097/QAI.0b013e3181bbc99e; *HIV AIDS STAT EP, 2009, HIV AIDS EP ANN REP; Karon JM, 2008, STAT MED, V27, P4617, DOI 10.1002/sim.3144; Katz MH, 2002, AM J PUBLIC HEALTH, V92, P388, DOI 10.2105/AJPH.92.3.388; Kellogg TA, 2001, J ACQ IMMUN DEF SYND, V28, P380, DOI 10.1097/00126334-200112010-00012; Kim JY, 2006, NEW ENGL J MED, V355, P645, DOI 10.1056/NEJMp068166; Koenig SP, 2004, AIDS, V18, pS21, DOI 10.1097/00002030-200406003-00005; Krieger N, 2006, J URBAN HEALTH, V83, P355, DOI 10.1007/s11524-006-9040-y; Krieger N, 2003, EPIDEMIOLOGY, V14, P384, DOI 10.1097/01.ede.0000071473.69307.8a; Libamba E, 2005, INT J TUBERC LUNG D, V9, P1062; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; LINGAPPA J, 2009, HIV 1 PLASMA RNA RIS; Mackenzie J, 1907, Q J MED, V1, P39; Marcus JL, 2009, AIDS, V23, P1024, DOI 10.1097/QAD.0b013e32832921a7; McCormick AW, 2007, CLIN INFECT DIS, V44, P1115, DOI 10.1086/512816; Mofenson LM, 1999, NEW ENGL J MED, V341, P385, DOI 10.1056/NEJM199908053410601; Mukherjee JS, 2006, JAIDS-J ACQ IMM DEF, V43, pS123, DOI 10.1097/01.qai.0000248348.25630.74; Nakhaee F, 2009, SEX HEALTH, V6, P129, DOI 10.1071/SH08007; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; REYNOLDS S, 2009, ART REDUCED RATE SEX; Salomon JA, 2008, AIDS, V22, pS149, DOI 10.1097/01.aids.0000327636.82542.87; *SAN FRANC AIDS OF, 2003, HIV AIDS EP ANN REP; *SAN FRANC AIDS OF, 2006, HIV AIDS EP ANN REP; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Scheer S, 2009, AIDS, V23, P533, DOI 10.1097/QAD.0b013e328322432b; SULLIVAN P, 2009, REDUCTION HIV TRANSM; Truong HHA, 2006, AIDS, V20, P2193, DOI 10.1097/01.aids.0000252059.85236.af; Truong HHM, 2009, JAIDS-J ACQ IMM DEF, V51, P502, DOI 10.1097/QAI.0b013e3181a25383; Wand H, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-19; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; Zetola NM, 2008, PUBLIC HEALTH REP, V123, P41, DOI 10.1177/00333549081230S306; Zetola NM, 2007, J CLIN VIROL, V40, P68, DOI 10.1016/j.jcv.2007.06.004; Zetola NM, 2009, AM J PUBLIC HEALTH, V99, P1924, DOI 10.2105/AJPH.2009.173591; Zetola NM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-17; Zetola NM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002591; 2008, PEDIATRICS, V122, P1127	64	560	566	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11068	10.1371/journal.pone.0011068	http://dx.doi.org/10.1371/journal.pone.0011068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608QA	20548786	Green Published, Green Submitted, gold			2022-12-27	WOS:000278599600024
J	Kapoor, K; Rehan, M; Lynn, AM; Prasad, R				Kapoor, Khyati; Rehan, Mohd; Lynn, Andrew M.; Prasad, Rajendra			Employing Information Theoretic Measures and Mutagenesis to Identify Residues Critical for Drug-Proton Antiport Function in Mdr1p of Candida albicans	PLOS ONE			English	Article							MAJOR FACILITATOR SUPERFAMILY; HUMAN PATHOGENIC YEAST; ANTIFUNGAL EFFLUX; PROTEIN; ALIGNMENT; IDENTIFICATION; STRATEGY; CDR1P; PUMP	By employing information theoretic measures, this study presents a structure and functional analysis of a multidrug-proton antiporter Mdr1p of Candida albicans. Since CaMdr1p belongs to drug-proton antiporter (DHA1) family of Major Facilitator Superfamily (MFS) of transporters, we contrasted DHA1 (antiporters) with Sugar Porter family (symporters). Cumulative Relative Entropy (CRE) calculated for these two sets of alignments enabled us to selectively identify conserved residues of not only CaMdr1p but for the entire DHA1 family. Based on CRE, the highest scoring thirty positions were selected and predicted to impart functional specificity to CaMdr1p as well as to other drug-proton antiporters. Nineteen positions wherein the CaMdr1p residue matched with the most frequent amino acid at a particular alignment position of DHA1 members were subjected to site-directed mutagenesis and were replaced with either alanine or leucine. All these mutant variants, except one, displayed either complete or selective sensitivity to the tested drugs. The enhanced susceptibility of these mutant variants was corroborated with the simultaneously abrogated efflux of substrates. Taken together, based on scaled CRE between two MFS sub-families, we could accurately predict the functionally relevant residues of CaMdr1p. An extrapolation of these predictions to the entire DHA1 family members as validated from previously published data shows that these residues are functionally critical in other members of the DHA1 family also.	[Kapoor, Khyati; Prasad, Rajendra] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Rehan, Mohd; Lynn, Andrew M.] Jawaharlal Nehru Univ, Sch Informat Technol, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Kapoor, K (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	andrew@mail.jnu.ac.in; rp47jnu@gmail.com	Rehan, Mohd/H-9835-2012	Rehan, Mohd/0000-0003-4898-6043	Department of Science and Technology, Indo-Swiss [INT/SWISS/P-31/2009]; Department of Biotechnology [BT/PR9100/Med/29/03/2007, BT/PR9563/BRB/10/567/2007, BT/PR11158/BRB/10/640/2008]; Council of Scientific and Industrial Research, India	Department of Science and Technology, Indo-Swiss(Department of Science & Technology (India)); Department of Biotechnology; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	The work presented in this paper has been supported in parts by grants to one of us (RP) from Department of Science and Technology, Indo-Swiss, (INT/SWISS/P-31/2009), Department of Biotechnology (BT/PR9100/Med/29/03/2007, BT/PR9563/BRB/10/567/2007, BT/PR11158/BRB/10/640/2008). KK acknowledges Council of Scientific and Industrial Research, India, for the award of senior research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Chakrabarti S, 2007, J MOL BIOL, V373, P801, DOI 10.1016/j.jmb.2007.08.036; Chandrasekaran A, 2006, J NEUROCHEM, V98, P1551, DOI 10.1111/J.1471-4159.2006.03975.X; Decottignies A, 1998, J BIOL CHEM, V273, P12612, DOI 10.1074/jbc.273.20.12612; Durbin R., 1998, BIOL SEQUENCE ANAL P; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gaur M, 2005, J MOL MICROB BIOTECH, V9, P3, DOI 10.1159/000088141; Gaur M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-579; Ginn SL, 2000, J BACTERIOL, V182, P1492, DOI 10.1128/JB.182.6.1492-1498.2000; Hannenhalli SS, 2000, J MOL BIOL, V303, P61, DOI 10.1006/jmbi.2000.4036; Ivnitski-Steele I, 2009, ANAL BIOCHEM, V394, P87, DOI 10.1016/j.ab.2009.07.001; Jeon J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000522; Kapoor K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000624; KIMURA M, 1979, SCI AM, V241, P98, DOI 10.1038/scientificamerican1179-98; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Lo LW, 2003, P NATL ACAD SCI USA, V100, P4463, DOI 10.1073/pnas.0737647100; Nakamura K, 2001, ANTIMICROB AGENTS CH, V45, P3366, DOI 10.1128/AAC.45.12.3366-3374.2001; Ohno S., 1970, EVOLUTION GENE DUPLI; Pasrija R, 2007, EUKARYOT CELL, V6, P443, DOI 10.1128/EC.00315-06; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Pirovano W, 2008, BIOINFORMATICS, V24, P492, DOI 10.1093/bioinformatics/btm636; Prasad R, 2005, INT REV CYTOL, V242, P215; Saini P, 2005, J ANTIMICROB CHEMOTH, V56, P77, DOI 10.1093/jac/dki183; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Smriti, 2002, YEAST, V19, P303, DOI 10.1002/yea.818; Srivastava PK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-104; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146	32	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11041	10.1371/journal.pone.0011041	http://dx.doi.org/10.1371/journal.pone.0011041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548793	gold, Green Submitted, Green Published			2022-12-27	WOS:000278599600004
J	Kirkpatrick, CL; Marchetti, P; Purrello, F; Piro, S; Bugliani, M; Bosco, D; de Koning, EJP; Engelse, MA; Kerr-Conte, J; Pattou, F; Wollheim, CB				Kirkpatrick, Clare L.; Marchetti, Piero; Purrello, Francesco; Piro, Salvatore; Bugliani, Marco; Bosco, Domenico; de Koning, Eelco J. P.; Engelse, Marten A.; Kerr-Conte, Julie; Pattou, Francois; Wollheim, Claes B.			Type 2 Diabetes Susceptibility Gene Expression in Normal or Diabetic Sorted Human Alpha and Beta Cells: Correlations with Age or BMI of Islet Donors	PLOS ONE			English	Article							INSULIN-DEGRADING ENZYME; GENOME-WIDE ASSOCIATION; ACTIVATED-RECEPTOR-GAMMA; MORBIDLY OBESE-PATIENTS; HUMAN PANCREATIC-ISLETS; TCF7L2 GENE; FTO GENE; IN-VIVO; VARIANTS; HETEROGENEITY	Background: Genome-wide association studies have identified susceptibility genes for development of type 2 diabetes. We aimed to examine whether a subset of these (comprising FTO, IDE, KCNJ11, PPARG and TCF7L2) were transcriptionally restricted to or enriched in human beta cells by sorting islet cells into alpha and beta-specific fractions. We also aimed to correlate expression of these transcripts in both alpha and beta cell types with phenotypic traits of the islet donors and to compare diabetic and non-diabetic cells. Methodology/Principal Findings: Islet cells were sorted using a previously published method and RNA was extracted, reverse transcribed and used as the template for quantitative PCR. Sorted cells were also analysed for insulin and glucagon immunostaining and insulin secretion from the beta cells as well as insulin, glucagon and GLP-1 content. All five genes were expressed in both alpha and beta cells, with significant enrichment of KCNJ11 in the beta cells and of TCF7L2 in the alpha cells. The ratio of KCNJ11 in beta to alpha cells was negatively correlated with BMI, while KCNJ11 expression in alpha cells was negatively correlated with age but not associated with BMI. Beta cell expression of glucagon, TCF7L2 and IDE was increased in cells from islets that had spent more time in culture prior to cell sorting. In beta cells, KCNJ11, FTO and insulin were positively correlated with each other. Diabetic alpha and beta cells had decreased expression of insulin, glucagon and FTO. Conclusions/Significance: This study has identified novel patterns of expression of type 2 diabetes susceptibility genes within sorted islet cells and suggested interactions of gene expression with age or BMI of the islet donors. However, expression of these genes in islets is less associated with BMI than has been found for other tissues.	[Kirkpatrick, Clare L.; Wollheim, Claes B.] Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland; [Marchetti, Piero; Bugliani, Marco] Cisanello Hosp, Metab Unit, Dept Endocrinol & Metab, Pisa, Italy; [Purrello, Francesco; Piro, Salvatore] Univ Catania, Dept Internal Med, Garibaldi Nesima Hosp, Catania, Italy; [Bosco, Domenico] Univ Hosp, Cell Isolat & Transplantat Ctr, Geneva, Switzerland; [de Koning, Eelco J. P.; Engelse, Marten A.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Kerr-Conte, Julie; Pattou, Francois] Univ Lille Nord France, Univ Hosp Lille, INSERM, U859, Lille, France	University of Geneva; Presidio Ospedaliero Garibaldi-Nesima; University of Catania; University of Geneva; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille	Kirkpatrick, CL (corresponding author), Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland.	claes.wollheim@unige.ch	Piro, Salvatore/P-7585-2019; Marchetti, Piero/J-7439-2013; Bugliani, Marco/I-3168-2019; Kirkpatrick, Clare L/M-1890-2018; Piro, Salvatore/H-9353-2012; Purrello, Francesco/K-9721-2016; Pattou, Francois/O-6151-2017; de Koning, Eelco JP/H-6030-2011	Piro, Salvatore/0000-0002-1781-0902; Marchetti, Piero/0000-0003-4907-0635; Bugliani, Marco/0000-0002-1744-1561; Kirkpatrick, Clare L/0000-0001-8564-8559; Piro, Salvatore/0000-0002-1781-0902; Purrello, Francesco/0000-0003-3313-8543; Pattou, Francois/0000-0001-8388-3766; de Koning, Eelco JP/0000-0002-1232-7022; Bosco, Domenico/0000-0003-3453-9613	Swiss National Science Foundation [310000-116750/1]; Eurodia 6th Framework Programme [LSHM-CT-2006-518153]; EFSD-Lilly [2008]; Juvenile Diabetes Research Foundation [31-2008-416]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Eurodia 6th Framework Programme; EFSD-Lilly(Eli Lilly); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This work was funded by the Swiss National Science Foundation (310000-116750/1), the Eurodia 6th Framework Programme (LSHM-CT-2006-518153) and an EFSD-Lilly grant (2008). Human islets were obtained thanks to a grant from the Juvenile Diabetes Research Foundation (31-2008-416). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett RG, 2003, DIABETES, V52, P2315, DOI 10.2337/diabetes.52.9.2315; Bennett RG, 2000, J BIOL CHEM, V275, P36621, DOI 10.1074/jbc.M006170200; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Brody F, 2007, SURG ENDOSC, V21, P941, DOI 10.1007/s00464-006-9098-3; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Cnop M, 2008, BIOCHEM SOC T, V36, P348, DOI 10.1042/BST0360348; Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624; Du J, 2009, BIOCHEM BIOPH RES CO, V383, P485, DOI 10.1016/j.bbrc.2009.04.047; Dunning BE, 2007, ENDOCR REV, V28, P253, DOI 10.1210/er.2006-0026; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Florez JC, 2004, DIABETES, V53, P1360, DOI 10.2337/diabetes.53.5.1360; Franklin I, 2005, DIABETES, V54, P1808, DOI 10.2337/diabetes.54.6.1808; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fujita Y, 2010, GASTROENTEROLOGY, V138, P1966, DOI 10.1053/j.gastro.2010.01.049; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grunnet LG, 2009, DIABETES, V58, P2402, DOI 10.2337/db09-0205; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Hattersley AT, 1998, DIABETIC MED, V15, P15, DOI 10.1002/(SICI)1096-9136(199801)15:1<15::AID-DIA562>3.0.CO;2-M; Hindle AK, 2009, SURG ENDOSC, V23, P700, DOI 10.1007/s00464-008-0001-2; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Karaca M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005555; Katsuta H, 2010, DIABETOLOGIA, V53, P128, DOI 10.1007/s00125-009-1570-x; Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Marselli L, 2008, J CLIN ENDOCR METAB, V93, P1046, DOI 10.1210/jc.2007-0931; Osmark P, 2009, DIABETOLOGIA, V52, P850, DOI 10.1007/s00125-009-1293-z; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Redonnet A, 2002, INT J OBESITY, V26, P920, DOI 10.1038/sj.ijo.0802025; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shu L, 2008, DIABETES, V57, P645, DOI 10.2337/db07-0847; Shu LA, 2009, HUM MOL GENET, V18, P2388, DOI 10.1093/hmg/ddp178; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Ugleholdt R, 2004, ENDOCRINOLOGY, V145, P1349, DOI 10.1210/en.2003-0801; VidalPuig AJ, 1997, J CLIN INVEST, V99, P2416, DOI 10.1172/JCI119424; Willer CJ, 2007, DIABETES, V56, P256, DOI 10.2337/db06-0461; Xavier GD, 2009, DIABETES, V58, P894, DOI 10.2337/db08-1187; Zabena C, 2009, OBES SURG, V19, P87, DOI 10.1007/s11695-008-9727-0; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	43	40	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11053	10.1371/journal.pone.0011053	http://dx.doi.org/10.1371/journal.pone.0011053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548773	gold, Green Published, Green Submitted			2022-12-27	WOS:000278599600014
J	Fridley, BL; Jenkins, G; Deyo-Svendsen, ME; Hebbring, S; Freimuth, R				Fridley, Brooke L.; Jenkins, Gregory; Deyo-Svendsen, Matthew E.; Hebbring, Scott; Freimuth, Robert			Utilizing Genotype Imputation for the Augmentation of Sequence Data	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INFERRING MISSING GENOTYPES; INFERENCE; ACCURACY	Background: In recent years, capabilities for genotyping large sets of single nucleotide polymorphisms (SNPs) has increased considerably with the ability to genotype over 1 million SNP markers across the genome. This advancement in technology has led to an increase in the number of genome-wide association studies (GWAS) for various complex traits. These GWAS have resulted in the implication of over 1500 SNPs associated with disease traits. However, the SNPs identified from these GWAS are not necessarily the functional variants. Therefore, the next phase in GWAS will involve the refining of these putative loci. Methodology: A next step for GWAS would be to catalog all variants, especially rarer variants, within the detected loci, followed by the association analysis of the detected variants with the disease trait. However, sequencing a locus in a large number of subjects is still relatively expensive. A more cost effective approach would be to sequence a portion of the individuals, followed by the application of genotype imputation methods for imputing markers in the remaining individuals. A potentially attractive alternative option would be to impute based on the 1000 Genomes Project; however, this has the drawbacks of using a reference population that does not necessarily match the disease status and LD pattern of the study population. We explored a variety of approaches for carrying out the imputation using a reference panel consisting of sequence data for a fraction of the study participants using data from both a candidate gene sequencing study and the 1000 Genomes Project. Conclusions: Imputation of genetic variation based on a proportion of sequenced samples is feasible. Our results indicate the following sequencing study design guidelines which take advantage of the recent advances in genotype imputation methodology: Select the largest and most diverse reference panel for sequencing and genotype as many "anchor" markers as possible.	[Fridley, Brooke L.; Jenkins, Gregory; Deyo-Svendsen, Matthew E.; Freimuth, Robert] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Hebbring, Scott] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Fridley, BL (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA.	fridley.brooke@mayo.edu	Fridley, Brooke L/D-8315-2015	Fridley, Brooke L/0000-0001-7739-7956; Freimuth, Robert/0000-0002-9673-5612	National Institutes of Health [U01 GM61388, R01 GM28157]; Minnesota Partnership for Biotechnology and Medical Genomics [H9046000431]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028157, U01GM061388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Partnership for Biotechnology and Medical Genomics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: The research was supported by the National Institutes of Health U01 GM61388, R01 GM28157 and Minnesota Partnership for Biotechnology and Medical Genomics grant H9046000431. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BIERNACKA JM, 2008, ASSESSMENT GENOTYPE; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Dai JY, 2006, GENET EPIDEMIOL, V30, P690, DOI 10.1002/gepi.20180; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; FOULKES AS, 2007, STAT MED; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; *GENOMEWEB, 2009, 1000 GEN PROJ SEQ NE; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Kuehn BM, 2008, JAMA-J AM MED ASSOC, V300, P2715, DOI 10.1001/jama.2008.823; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Nicolae DL, 2006, GENET EPIDEMIOL, V30, P718, DOI 10.1002/gepi.20182; NOTHNAGEL M, 2008, HUM GENET; Pei YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003551; Roberts A, 2007, BIOINFORMATICS, V23, pI401, DOI 10.1093/bioinformatics/btm220; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sun YV, 2008, EUR J HUM GENET, V16, P487, DOI 10.1038/sj.ejhg.5201988; Yu ZX, 2007, HUM GENET, V122, P495, DOI 10.1007/s00439-007-0427-y; [No title captured]	25	17	19	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11018	10.1371/journal.pone.0011018	http://dx.doi.org/10.1371/journal.pone.0011018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20543988	Green Published, gold, Green Submitted			2022-12-27	WOS:000278494900028
J	Ohad, I; Raanan, H; Keren, N; Tchernov, D; Kaplan, A				Ohad, Itzhak; Raanan, Hagai; Keren, Nir; Tchernov, Dan; Kaplan, Aaron			Light-Induced Changes within Photosystem II Protects Microcoleus sp in Biological Desert Sand Crusts against Excess Light	PLOS ONE			English	Article							CYCLIC ELECTRON FLOW; CHARGE RECOMBINATION; STATE TRANSITIONS; PHOTOINHIBITION; ACCLIMATION; OXYGEN; THERMOLUMINESCENCE; PHOTOSYNTHESIS; FLUORESCENCE; CYANOBACTERIUM	The filamentous cyanobacterium Microcoleus vaginatus, a major primary producer in desert biological sand crusts, is exposed to frequent hydration (by early morning dew) followed by desiccation during potentially damaging excess light conditions. Nevertheless, its photosynthetic machinery is hardly affected by high light, unlike "model'' organisms whereby light-induced oxidative stress leads to photoinactivation of the oxygen-evolving photosystem II (PSII). Field experiments showed a dramatic decline in the fluorescence yield with rising light intensity in both drying and artificially maintained wet plots. Laboratory experiments showed that, contrary to "model'' organisms, photosynthesis persists in Microcoleus sp. even at light intensities 2-3 times higher than required to saturate oxygen evolution. This is despite an extensive loss (85-90%) of variable fluorescence and thermoluminescence, representing radiative PSII charge recombination that promotes the generation of damaging singlet oxygen. Light induced loss of variable fluorescence is not inhibited by the electron transfer inhibitors 3-(3,4-dichlorophenyl)-1,1-dimethylurea (DCMU), 2,5-dibromo-3-methyl-6-isopropylbenzoquinone (DBMIB), nor the uncoupler carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP), thus indicating that reduction of plastoquinone or O-2, or lumen acidification essential for non-photochemical quenching (NPQ) are not involved. The rate of Q(A)(-) re-oxidation in the presence of DCMU is enhanced with time and intensity of illumination. The difference in temperatures required for maximal thermoluminescence emissions from S-2/Q(A)(-) (Q band, 22 degrees C) and S-2,S-3/Q(B)(-) (B band, 25 degrees C) charge recombinations is considerably smaller in Microcoleus as compared to "model'' photosynthetic organisms, thus indicating a significant alteration of the S-2/Q(A)(-) redox potential. We propose that enhancement of non-radiative charge recombination with rising light intensity may reduce harmful radiative recombination events thereby lowering O-1(2) generation and oxidative photodamage under excess illumination. This effective photo-protective mechanism was apparently lost during the evolution from the ancestor cyanobacteria to the higher plant chloroplast.	[Ohad, Itzhak] Hebrew Univ Jerusalem, Dept Biol Chem, Jerusalem, Israel; [Raanan, Hagai; Keren, Nir; Kaplan, Aaron] Hebrew Univ Jerusalem, Dept Plant & Environm Sci, Jerusalem, Israel; [Tchernov, Dan] Hebrew Univ Jerusalem, Interuniv Inst Marine Sci Eilat, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Ohad, I (corresponding author), Hebrew Univ Jerusalem, Dept Biol Chem, Jerusalem, Israel.	aaronka@vms.huji.ac.il	Tchernov, Dan/AAE-2545-2021; Kaplan, Aaron/GLN-5655-2022; Keren, Nir/GON-9181-2022	Tchernov, Dan/0000-0003-1135-8270; Kaplan, Aaron/0000-0002-0815-5731; Keren, Nir/0000-0002-7356-8831	German DFG; BMBF-MOST; Bogan Foundation; Israeli Science Foundation (ISF); German-Israeli Science Foundation (GIF)	German DFG(German Research Foundation (DFG)); BMBF-MOST(Federal Ministry of Education & Research (BMBF)); Bogan Foundation; Israeli Science Foundation (ISF)(Israel Science Foundation); German-Israeli Science Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development)	Support for this study was obtained from the German DFG, the BMBF-MOST, and the Bogan Foundation to AK, the Israeli Science Foundation (ISF) and the German-Israeli Science Foundation (GIF) to AK and NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adir N, 2003, PHOTOSYNTH RES, V76, P343, DOI 10.1023/A:1024969518145; Allakhverdiev SI, 1997, BIOCHEMISTRY-US, V36, P4149, DOI 10.1021/bi962170n; Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; BONDARAVA N, 2009, PHYSIOL PLANTARUM, V138, P463; Campbell D, 1996, PLANT PHYSIOL, V111, P1293, DOI 10.1104/pp.111.4.1293; Cardol P, 2008, P NATL ACAD SCI USA, V105, P7881, DOI 10.1073/pnas.0802762105; Cser K, 2007, BBA-BIOENERGETICS, V1767, P233, DOI 10.1016/j.bbabio.2007.01.022; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; Eisenstadt D, 2008, ENVIRON MICROBIOL, V10, P1997, DOI 10.1111/j.1462-2920.2008.01616.x; Eisenstadt D, 2010, PHOTOSYNTH RES, V103, P97, DOI 10.1007/s11120-009-9518-z; Fufezan C, 2007, J BIOL CHEM, V282, P12492, DOI 10.1074/jbc.M610951200; GLEITER HM, 1990, Z NATURFORSCH C, V45, P353; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Harel Y, 2004, PLANT PHYSIOL, V136, P3070, DOI 10.1104/pp.104.047712; Hassidim M, 1997, J PHYCOL, V33, P811, DOI 10.1111/j.0022-3646.1997.00811.x; Heber U, 2007, J EXP BOT, V58, P2745, DOI 10.1093/jxb/erm139; Helman Y, 2003, CURR BIOL, V13, P230, DOI 10.1016/S0960-9822(03)00046-0; Hwang HJ, 2008, BIOCHEMISTRY-US, V47, P9747, DOI 10.1021/bi800568p; Ivanov AG, 2006, FEBS LETT, V580, P2797, DOI 10.1016/j.febslet.2006.04.018; Jacobs AFG, 2000, INT J BIOMETEOROL, V43, P184, DOI 10.1007/s004840050007; Kaminskaya O, 2007, BIOCHEMISTRY-US, V46, P1091, DOI 10.1021/bi0613022; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V313, P349; Krieger-Liszkay A, 1998, BIOCHEMISTRY-US, V37, P17339, DOI 10.1021/bi9822628; Krieger-Liszkay A, 2006, J EXP BOT, V57, P1677, DOI 10.1093/jxb/erl002; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; LITTMANN T, 2008, ECOL STUD, P49; MAENPAA P, 1995, PLANT PHYSIOL, V107, P187, DOI 10.1104/pp.107.1.187; Miyake C, 2002, PLANT CELL PHYSIOL, V43, P951, DOI 10.1093/pcp/pcf113; Mullineaux CW, 2005, J EXP BOT, V56, P389, DOI 10.1093/jxb/eri064; Ohad I, 2005, PHOTOCH PHOTOBIO SCI, V4, P977, DOI 10.1039/b506300k; OHAD I, 1990, J BIOL CHEM, V265, P1972; Prasil O, 1996, PHOTOSYNTH RES, V48, P395, DOI 10.1007/BF00029472; Rappaport F, 2005, BIOPHYS J, V88, P1948, DOI 10.1529/biophysj.104.050237; Rappaport F, 2002, BIOCHEMISTRY-US, V41, P8518, DOI 10.1021/bi025725p; Szczepaniak M, 2009, BIOPHYS J, V96, P621, DOI 10.1016/j.bpj.2008.09.036; Tandori J, 2001, PHOTOSYNTH RES, V70, P175, DOI 10.1023/A:1017907404325; Tang D, 2007, J ARID ENVIRON, V71, P312, DOI 10.1016/j.jaridenv.2007.05.004; Umate P, 2007, J BIOL CHEM, V282, P9758, DOI 10.1074/jbc.M608117200; Vasil'ev S, 2003, FEBS LETT, V543, P159, DOI 10.1016/S0014-5793(03)00442-3; Vass I, 2007, ANN NY ACAD SCI, V1113, P114, DOI 10.1196/annals.1391.017; Vass I, 2009, TRENDS PLANT SCI, V14, P200, DOI 10.1016/j.tplants.2009.01.009; Wilson A, 2008, P NATL ACAD SCI USA, V105, P12075, DOI 10.1073/pnas.0804636105; Wohri AB, 2010, SCIENCE, V328, P630, DOI 10.1126/science.1186159; ZER H, 1994, J BIOL CHEM, V269, P17670	45	50	50	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11000	10.1371/journal.pone.0011000	http://dx.doi.org/10.1371/journal.pone.0011000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544016	gold, Green Published, Green Submitted			2022-12-27	WOS:000278494900012
J	Rowe, JS; Shah, SS; Motlhagodi, S; Bafana, M; Tawanana, E; Truong, HT; Wood, SM; Zetola, NM; Steenhoff, AP				Rowe, Jack S.; Shah, Samir S.; Motlhagodi, Stephen; Bafana, Margaret; Tawanana, Ephraim; Truong, Hong T.; Wood, Sarah M.; Zetola, Nicola M.; Steenhoff, Andrew P.			An Epidemiologic Review of Enteropathogens in Gaborone, Botswana: Shifting Patterns of Resistance in an HIV Endemic Region	PLOS ONE			English	Article							ENTERIC INFECTIONS; SOUTH-AFRICA; DIARRHEA; CHILDREN; PARASITES; ZIMBABWE; COHORT; ADULTS; ZAMBIA	Background: The epidemiology of diarrheal disease in Botswana, an HIV endemic region, is largely unknown. Our primary objective was to characterize the prevalent bacterial and parasitic enteropathogens in Gaborone, Botswana. Secondary objectives included determining corresponding antimicrobial resistance patterns and the value of stool white and red blood cells for predicting bacterial and parasitic enteropathogens. Methodology/Principal Findings: A retrospective cross-sectional study examined laboratory records of stool specimens analyzed by the Botswana National Health Laboratory in Gaborone, Botswana from February 2003 through July 2008. In 4485 specimens the median subject age was 23 [interquartile range 1.6-34] years. Overall, 14.4% (644 of 4485) of samples yielded a pathogen. Bacteria alone were isolated in 8.2% (367 of 4485), parasites alone in 5.6% (253 of 4485) and both in 0.5% (24 of 4485) of samples. The most common bacterial pathogens were Shigella spp. and Salmonella spp., isolated from 4.0% (180 of 4485) and 3.9% (175 of 4485) of specimens, respectively. Escherichia coli (22 of 4485) and Campylobacter spp. (22 of 4485) each accounted for 0.5% of pathogens. Comparing antimicrobial resistance among Shigella spp. and Salmonella spp. between two periods, February 2003 to February 2004 and July 2006 to July 2008, revealed an increase in ampicillin resistance among Shigella spp. from 43% to 83% (p<0.001). Among Salmonella spp., resistance to chloramphenicol decreased from 56% to 6% (p<0.001). The absence of stool white and red blood cells correlated with a high specificity and negative predictive value. Conclusions/Significance: Most gastroenteritis stools were culture and microscopy negative suggesting that viral pathogens were the majority etiologic agents in this Botswana cohort. Shigella spp. and Salmonella spp. were the most common bacteria; Isospora spp. and Cryptosporidium spp. were the most common parasites. Resistance to commonly used antimicrobials is high and should be closely monitored.	[Rowe, Jack S.; Truong, Hong T.; Zetola, Nicola M.; Steenhoff, Andrew P.] Botswana UPenn Partnership, Gaborone, Botswana; [Rowe, Jack S.; Shah, Samir S.; Steenhoff, Andrew P.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Motlhagodi, Stephen; Bafana, Margaret; Tawanana, Ephraim] Botswana Natl Hlth Lab, Gaborone, Botswana; [Motlhagodi, Stephen; Bafana, Margaret; Tawanana, Ephraim; Zetola, Nicola M.; Steenhoff, Andrew P.] Princess Marina Hosp, Gaborone, Botswana; [Shah, Samir S.; Wood, Sarah M.; Steenhoff, Andrew P.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Rowe, JS (corresponding author), Botswana UPenn Partnership, Gaborone, Botswana.	steenhoff@email.chop.edu	wood, sarah/GRR-3687-2022; Shah, Samir/B-2661-2015	Shah, Samir/0000-0001-7902-7000	University of Pennsylvania Center for AIDS Research [IP30AI45008-01]; Infectious Diseases Society; UPenn Center; Robert Wood Johnson Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER	University of Pennsylvania Center for AIDS Research; Infectious Diseases Society; UPenn Center; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by the University of Pennsylvania Center for AIDS Research IP30AI45008-01 to APS (http://www.uphs.upenn.edu/aids/), Infectious Diseases Society of America Medical Student Award & UPenn Center for Clinical Epidemiology and Biostatistics Medical Student Award to JSR (http://www.idsociety.org/Content.aspx?id=1852). SSS was supported by the Robert Wood Johnson Foundation through its Physician Faculty Scholar Program (http://rwjfpfsp.stanford.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachou H, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-27; Brink AK, 2002, J INFECTION, V45, P99, DOI 10.1053/jinf.2002.1002; Brooks JT, 2006, CLIN INFECT DIS, V43, P393, DOI 10.1086/505866; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Clinical and Laboratory Standards Institute (CLSI), 2009, PERF STAND ANT DISK, V10th; Cranendonk R J, 2003, East Afr Med J, V80, P398; Gumbo T, 1999, AIDS, V13, P819, DOI 10.1097/00002030-199905070-00011; Huicho L, 1996, PEDIATR INFECT DIS J, V15, P486, DOI 10.1097/00006454-199606000-00004; Karanja Robert M, 2007, Afr Health Sci, V7, P62; KHUMALONGWENYA B, 1994, E AFR MED J, V71, P379; Lin J, 2002, J TROP PEDIATRICS, V48, P252, DOI 10.1093/tropej/48.4.252; Luo NP, 1996, E AFR MED J, V73, P395; Mandomando IM, 2007, AM J TROP MED HYG, V76, P522, DOI 10.4269/ajtmh.2007.76.522; Morse TD, 2007, EPIDEMIOL INFECT, V135, P1307, DOI 10.1017/S0950268806007758; Mwansa J, 2002, EMERG INFECT DIS, V8, P92, DOI 10.3201/eid0801.010018; Nakano T, 1998, ACTA PAEDIATR JAPON, V40, P259; Obimbo EM, 2004, PEDIATR INFECT DIS J, V23, P536, DOI 10.1097/01.inf.0000129692.42964.30; Reither K, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-104; Samie A, 2007, J INFECTION, V54, P558, DOI 10.1016/j.jinf.2006.10.047; Simango C, 2000, TROP MED INT HEALTH, V5, P503, DOI 10.1046/j.1365-3156.2000.00587.x; Simango C., 1997, Central African Journal of Medicine, V43, P172; Temu M M, 2007, Tanzan Health Res Bull, V9, P186; Urio EM, 2001, TROP MED INT HEALTH, V6, P55, DOI 10.1046/j.1365-3156.2001.00668.x; *WHO, 2008, BOTSW EP FACT SHEET; World Health Organization, 2003, MANUAL LAB IDENTIFIC	25	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2010	5	6							e10924	10.1371/journal.pone.0010924	http://dx.doi.org/10.1371/journal.pone.0010924			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604NC	20543877	Green Published, gold, Green Submitted			2022-12-27	WOS:000278284700007
J	Liu, ZZ; Li, A; Schulz, V; Chen, M; Tuck, D				Liu, Zongzhi; Li, Ao; Schulz, Vincent; Chen, Min; Tuck, David			MixHMM: Inferring Copy Number Variation and Allelic Imbalance Using SNP Arrays and Tumor Samples Mixed with Stromal Cells	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; HIDDEN-MARKOV MODEL; CANCER-CELLS; ASSOCIATION; DETECT; TOOL	Background: Genotyping platforms such as single nucleotide polymorphism (SNP) arrays are powerful tools to study genomic aberrations in cancer samples. Allele specific information from SNP arrays provides valuable information for interpreting copy number variation (CNV) and allelic imbalance including loss-of-heterozygosity (LOH) beyond that obtained from the total DNA signal available from array comparative genomic hybridization (aCGH) platforms. Several algorithms based on hidden Markov models (HMMs) have been designed to detect copy number changes and copy-neutral LOH making use of the allele information on SNP arrays. However heterogeneity in clinical samples, due to stromal contamination and somatic alterations, complicates analysis and interpretation of these data. Methods: We have developed MixHMM, a novel hidden Markov model using hidden states based on chromosomal structural aberrations. MixHMM allows CNV detection for copy numbers up to 7 and allows more complete and accurate description of other forms of allelic imbalance, such as increased copy number LOH or imbalanced amplifications. MixHMM also incorporates a novel sample mixing model that allows detection of tumor CNV events in heterogeneous tumor samples, where cancer cells are mixed with a proportion of stromal cells. Conclusions: We validate MixHMM and demonstrate its advantages with simulated samples, clinical tumor samples and a dilution series of mixed samples. We have shown that the CNVs of cancer cells in a tumor sample contaminated with up to 80% of stromal cells can be detected accurately using Illumina BeadChip and MixHMM.	[Liu, Zongzhi; Li, Ao; Tuck, David] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Schulz, Vincent] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Chen, Min] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Liu, ZZ (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.	david.tuck@yale.edu		Chen, Min/0000-0002-0676-3143; Schulz, Vincent/0000-0001-6333-4284	Yale Center of Excellence in Molecular Hematology (NIDDK) [DK072442]; Yale Comprehensive Cancer Center; Targeted Area of Research Excellence Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072442] Funding Source: NIH RePORTER	Yale Center of Excellence in Molecular Hematology (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Yale Comprehensive Cancer Center; Targeted Area of Research Excellence Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: Yale Center of Excellence in Molecular Hematology (NIDDK DK072442), Yale Comprehensive Cancer Center, Targeted Area of Research Excellence Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assie G, 2008, AM J HUM GENET, V82, P903, DOI 10.1016/j.ajhg.2008.01.012; Attiyeh EF, 2009, GENOME RES, V19, P276, DOI 10.1101/gr.075671.107; Cahan P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn110; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Fenton LF., 1960, IRE T COMMUN SYST, V8, P57, DOI [DOI 10.1109/TCOM.1960.1097606, 10.1109/TCOM.1960.1097606]; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Lai W, 2008, BIOINFORMATICS, V24, P1014, DOI 10.1093/bioinformatics/btn067; Li C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-204; McCarroll SA, 2008, HUM MOL GENET, V17, pR135, DOI 10.1093/hmg/ddn282; Nancarrow DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001093; NAVIN N, 2009, GENOME RES; Ohashi J, 2009, J HUM GENET, V54, P169, DOI 10.1038/jhg.2009.8; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Speleman F, 2008, CYTOGENET GENOME RES, V123, P176, DOI 10.1159/000184706; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; Staaf J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r136; SUN W, 2009, NUCLEIC ACIDS RES; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang P, 2009, METHODS MOL BIOL, V556, P99, DOI 10.1007/978-1-60327-192-9_8; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	25	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2010	5	6							e10909	10.1371/journal.pone.0010909	http://dx.doi.org/10.1371/journal.pone.0010909			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QF	20532221	gold, Green Submitted, Green Published			2022-12-27	WOS:000278222400006
J	Liu, SH; Navarro, G; Mauvais-Jarvis, F				Liu, Suhuan; Navarro, Guadalupe; Mauvais-Jarvis, Franck			Androgen Excess Produces Systemic Oxidative Stress and Predisposes to beta-Cell Failure in Female Mice	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; NONOBESE DIABETIC MICE; INSULIN-RESISTANCE; MOLECULAR-MECHANISMS; ENDOTHELIAL-CELLS; PANCREATIC-ISLETS; CANCER CELLS; TFM MOUSE; STREPTOZOTOCIN; GENERATION	In women, excess production of the male hormone, testosterone (T), is accompanied by insulin resistance. However, hyperandrogenemia is also associated with beta-cell dysfunction and type 2 diabetes raising the possibility that androgen receptor (AR) activation predisposes to beta-cell failure. Here, we tested the hypothesis that excess AR activation produces systemic oxidative stress thereby contributing to beta-cell failure. We used normal female mice (CF) and mice with androgen resistance by testicular feminization (Tfm). These mice were exposed to androgen excess and a beta-cell stress induced by streptozotocin (STZ). We find that following exposure to T, or the selective AR-agonist dehydrotestosterone (DHT), CF mice challenged with STZ, which are normally protected, are prone to beta-cell failure and insulin-deficient diabetes. Conversely, T-induced predisposition to beta-cell failure is abolished in Tfm mice. We do not observe any proapoptotic effect of DHT alone or in the presence of H2O2 in cultured mouse and human islets. However, we observe that exposure of CF mice to T or DHT provokes systemic oxidative stress, which is eliminated in Tfm mice. This work has significance for hyperandrogenic women; excess activation of AR by testosterone may provoke systemic oxidative stress. In the presence of a prior beta-cell stress, this may predispose to beta-cell failure.	[Liu, Suhuan; Navarro, Guadalupe; Mauvais-Jarvis, Franck] Northwestern Univ, Dept Med, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Liu, Suhuan; Mauvais-Jarvis, Franck] Northwestern Univ, NW Comprehens Ctr Obes, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Liu, SH (corresponding author), Northwestern Univ, Dept Med, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA.	f-mauvais-jarvis@northwestern.edu	Tuluc, Petronel/C-2527-2011		National Institutes of Health (NIH) [RO1 DK074970, P50 HD044405]; Juvenile Diabetes Research Foundation [1-2006-837]; March of Dimes [6-FY07-678]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Juvenile Diabetes Research Foundation International (JDRFI); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD044405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM079300] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); March of Dimes(March of Dimes); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Juvenile Diabetes Research Foundation International (JDRFI)(Juvenile Diabetes Research Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health (NIH) RO1 DK074970, P50 HD044405, Juvenile Diabetes Research Foundation 1-2006-837, March of Dimes 6-FY07-678. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the Integrated Islet Distribution Program (IIDP) funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and with support from the Juvenile Diabetes Research Foundation International (JDRFI).	Achard C., 1921, B ACAD NATL MED, V86, P51; ARMSTRONG D, 1994, ADV EXP MED BIOL, V366, P43; Bao M, 2002, J IMMUNOL, V168, P5369, DOI 10.4049/jimmunol.168.10.5369; CHAREST NJ, 1991, MOL ENDOCRINOL, V5, P573, DOI 10.1210/mend-5-4-573; Cunningham RL, 2009, ENDOCRINOLOGY, V150, P5539, DOI 10.1210/en.2009-0640; Death AK, 2004, ENDOCRINOLOGY, V145, P1889, DOI 10.1210/en.2003-0789; Diamond MP, 1998, J CLIN ENDOCR METAB, V83, P4420, DOI 10.1210/jc.83.12.4420; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; DUNAIF A, 1989, DIABETES, V38, P1165, DOI 10.2337/diabetes.38.9.1165; Dunaif A, 1996, J CLIN ENDOCR METAB, V81, P942, DOI 10.1210/jc.81.3.942; FOX HS, 1992, J EXP MED, V175, P1409, DOI 10.1084/jem.175.5.1409; Friesen NTE, 2004, DIABETOLOGIA, V47, P676, DOI 10.1007/s00125-004-1367-x; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gille L, 2002, PHARMACOL TOXICOL, V90, P317, DOI 10.1034/j.1600-0773.2002.900605.x; Gonzalez F, 2006, J CLIN ENDOCR METAB, V91, P336, DOI 10.1210/jc.2005-1696; Goodarzi MO, 2005, J CLIN ENDOCR METAB, V90, P310, DOI 10.1210/jc.2004-1006; HOLMANG A, 1992, AM J PHYSIOL, V262, pE851, DOI 10.1152/ajpendo.1992.262.6.E851; HOLMANG A, 1990, AM J PHYSIOL, V259, P555; HOLTE J, 1994, J CLIN ENDOCR METAB, V78, P1052, DOI 10.1210/jc.78.5.1052; Kan WH, 2008, J APPL PHYSIOL, V105, P595, DOI 10.1152/japplphysiol.00012.2008; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Ling SH, 2002, ENDOCRINOLOGY, V143, P1119, DOI 10.1210/en.143.3.1119; Liu SH, 2009, DIABETES, V58, P2292, DOI 10.2337/db09-0257; LYON MF, 1970, NATURE, V227, P1217, DOI 10.1038/2271217a0; MACLAREN NK, 1980, DIABETES, V29, P710, DOI 10.2337/diab.29.9.710; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; MORROW PL, 1980, DIABETOLOGIA, V18, P247, DOI 10.1007/BF00251924; MURPHY L, 1994, ENDOCRINOLOGY, V135, P1372, DOI 10.1210/en.135.4.1372; OMEARA NM, 1993, J CLIN ENDOCR METAB, V76, P1241, DOI 10.1210/jc.76.5.1241; PAIK SG, 1982, DIABETES, V31, P724, DOI 10.2337/diabetes.31.8.724; Pansarasa O, 2002, EUR J APPL PHYSIOL, V87, P550, DOI 10.1007/s00421-002-0668-3; PEARCE RB, 1995, AUTOIMMUNITY, V20, P247, DOI 10.3109/08916939508995702; Ripple MO, 1999, ANTIOXID REDOX SIGN, V1, P71, DOI 10.1089/ars.1999.1.1-71; Rosmalen JGM, 2001, LAB INVEST, V81, P231, DOI 10.1038/labinvest.3780231; ROSSINI AA, 1978, ENDOCRINOLOGY, V103, P1518, DOI 10.1210/endo-103-4-1518; Sorescu D, 2002, CIRCULATION, V105, P1429, DOI 10.1161/01.CIR.0000012917.74432.66; STEIN J, 1935, AM J OBSTET GYNECOL, V20, P181; Yin N, 2004, CANCER RES, V64, P5870, DOI 10.1158/0008-5472.CAN-04-0655	39	60	61	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11302	10.1371/journal.pone.0011302	http://dx.doi.org/10.1371/journal.pone.0011302			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585581	Green Submitted, gold, Green Published			2022-12-27	WOS:000279135800011
J	Angelini, DJ; Su, QN; Kolosova, IA; Fan, CL; Skinner, JT; Yamaji-Kegan, K; Collector, M; Sharkis, SJ; Johns, RA				Angelini, Daniel J.; Su, Qingning; Kolosova, Irina A.; Fan, Chunling; Skinner, John T.; Yamaji-Kegan, Kazuyo; Collector, Michael; Sharkis, Saul J.; Johns, Roger A.			Hypoxia-Induced Mitogenic Factor (HIMF/FIZZ1/RELM alpha) Recruits Bone Marrow-Derived Cells to the Murine Pulmonary Vasculature	PLOS ONE			English	Article							PROGENITOR CELLS; STEM-CELLS; HYPERTENSION; LUNG; ATHEROSCLEROSIS; CONTRIBUTE; SIMVASTATIN; EXPRESSION; FAMILY; FIZZ1	Background: Pulmonary hypertension (PH) is a disease of multiple etiologies with several common pathological features, including inflammation and pulmonary vascular remodeling. Recent evidence has suggested a potential role for the recruitment of bone marrow-derived (BMD) progenitor cells to this remodeling process. We recently demonstrated that hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELM alpha) is chemotactic to murine bone marrow cells in vitro and involved in pulmonary vascular remodeling in vivo. Methodology/Principal Findings: We used a mouse bone marrow transplant model in which lethally irradiated mice were rescued with bone marrow transplanted from green fluorescent protein (GFP)(+) transgenic mice to determine the role of HIMF in recruiting BMD cells to the lung vasculature during PH development. Exposure to chronic hypoxia and pulmonary gene transfer of HIMF were used to induce PH. Both models resulted in markedly increased numbers of BMD cells in and around the pulmonary vasculature; in several neomuscularized small (similar to 20 mm) capillary-like vessels, an entirely new medial wall was made up of these cells. We found these GFP(+) BMD cells to be positive for stem cell antigen-1 and c-kit, but negative for CD31 and CD34. Several of the GFP(+) cells that localized to the pulmonary vasculature were alpha-smooth muscle actin(+) and localized to the media layer of the vessels. This finding suggests that these cells are of mesenchymal origin and differentiate toward myofibroblast and vascular smooth muscle. Structural location in the media of small vessels suggests a functional role in the lung vasculature. To examine a potentialmechanism for HIMF-dependent recruitment of mesenchymal stem cells to the pulmonary vasculature, we performed a cell migration assay using cultured human mesenchymal stem cells (HMSCs). The addition of recombinant HIMF induced migration of HMSCs in a phosphoinosotide-3-kinase-dependent manner. Conclusions/Significance: These results demonstrate HIMF-dependent recruitment of BMD mesenchymal-like cells to the remodeling pulmonary vasculature.	[Angelini, Daniel J.; Su, Qingning; Kolosova, Irina A.; Fan, Chunling; Skinner, John T.; Yamaji-Kegan, Kazuyo; Johns, Roger A.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Collector, Michael; Sharkis, Saul J.] Johns Hopkins Univ, Sch Med, Dept Oncol & Canc Biol, Baltimore, MD 21205 USA; [Johns, Roger A.] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Angelini, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.	rajohns@jhmi.edu			NIH SCCOR [P50 084946]; NIH NHLBI [39706]; NIH [T32 GM075774-09, PO1 CA070970]; Maryland Stem Cell Fund Exploratory Grant; NATIONAL CANCER INSTITUTE [P01CA070970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM075774] Funding Source: NIH RePORTER	NIH SCCOR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Fund Exploratory Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH SCCOR P50 084946 (RAJ), NIH NHLBI 39706 (RAJ), NIH fellowship T32 GM075774-09 (DJA), Maryland Stem Cell Fund Exploratory Grant (IAK), and NIH PO1 CA070970 (SJS, MC). The funders had no role in study design, data collection and anaysis, decision to publish, or preparation of the manuscript.	Aliotta JM, 2006, EXP HEMATOL, V34, P230, DOI 10.1016/j.exphem.2005.11.007; ANGELINI D, 2009, AM THOR SOC INT C; Angelini DJ, 2009, AM J PHYSIOL-LUNG C, V296, pL582, DOI 10.1152/ajplung.90526.2008; Biankin SA, 2007, PATHOLOGY, V39, P247, DOI 10.1080/00313020701230807; Caplice NM, 2003, P NATL ACAD SCI USA, V100, P4754, DOI 10.1073/pnas.0730743100; Chung MJ, 2007, J PATHOL, V212, P180, DOI 10.1002/path.2161; Davie NJ, 2004, AM J PHYSIOL-LUNG C, V286, pL668, DOI 10.1152/ajplung.00108.2003; Girgis RE, 2003, AM J PHYSIOL-HEART C, V285, pH938, DOI 10.1152/ajpheart.01097.2002; Girgis RE, 2007, AM J PHYSIOL-LUNG C, V292, pL1105, DOI 10.1152/ajplung.00411.2006; Hayashida K, 2005, CHEST, V127, P1793, DOI 10.1378/chest.127.5.1793; Herzog EL, 2003, BLOOD, V102, P3483, DOI 10.1182/blood-2003-05-1664; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Hombach-Klonisch S, 2008, J MOL MED, V86, P1301, DOI 10.1007/s00109-008-0383-6; Lanzkron SM, 1999, BLOOD, V93, P1916, DOI 10.1182/blood.V93.6.1916.406k15_1916_1921; Lindvall J, 2002, BIOCHEM BIOPH RES CO, V293, P1319, DOI 10.1016/S0006-291X(02)00382-0; Liu TJ, 2004, AM J PATHOL, V164, P1315, DOI 10.1016/S0002-9440(10)63218-X; Quinlan TR, 2000, AM J PHYSIOL-LUNG C, V279, pL641, DOI 10.1152/ajplung.2000.279.4.L641; Saiura A, 2001, NAT MED, V7, P382, DOI 10.1038/86394; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Spees JL, 2008, FASEB J, V22, P1226, DOI 10.1096/fj.07-8076com; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; Su QN, 2007, FASEB J, V21, P1376, DOI 10.1096/fj.06-6527com; Teng XW, 2003, CIRC RES, V92, P1065, DOI 10.1161/01.RES.0000073999.07698.33; Tong QS, 2006, AM J RESP CELL MOL, V35, P444, DOI 10.1165/rcmb.2005-0424OC; Xue C, 1996, HYPERTENSION, V28, P743, DOI 10.1161/01.HYP.28.5.743; Yamaji-Kegan K, 2006, AM J PHYSIOL-LUNG C, V291, pL1159, DOI 10.1152/ajplung.00168.2006	26	36	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11251	10.1371/journal.pone.0011251	http://dx.doi.org/10.1371/journal.pone.0011251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582166	Green Submitted, Green Published, gold			2022-12-27	WOS:000279058500003
J	Vitzthum, K; Scutaru, C; Musial-Bright, L; Quarcoo, D; Welte, T; Spallek, M; Groneberg-Kloft, B				Vitzthum, Karin; Scutaru, Cristian; Musial-Bright, Lindy; Quarcoo, David; Welte, Tobias; Spallek, Michael; Groneberg-Kloft, Beatrix			Scientometric Analysis and Combined Density-Equalizing Mapping of Environmental Tobacco Smoke (ETS) Research	PLOS ONE			English	Article							OCCUPATIONAL-HEALTH; CIGARETTE-SMOKING; SECONDHAND SMOKE; RESEARCH OUTPUT; IMPACT FACTORS; EXPOSURE; SCIENCE; DISEASE; ASTHMA; INDEX	Background: Passive exposure to environmental tobacco smoke (ETS) is estimated to exert a major burden of disease. Currently, numerous countries have taken legal actions to protect the population against ETS. Numerous studies have been conducted in this field. Therefore, scientometric methods should be used to analyze the accumulated data since there is no such approach available so far. Methods and Results: A combination of scientometric methods and novel visualizing procedures were used, including density-equalizing mapping and radar charting techniques. 6,580 ETS-related studies published between 1900 and 2008 were identified in the ISI database. Using different scientometric approaches, a continuous increase of both quantitative and qualitative parameters was found. The combination with density-equalizing calculations demonstrated a leading position of the United States (2,959 items published) in terms of quantitative research activities. Charting techniques demonstrated that there are numerous bi- and multilateral networks between different countries and institutions in this field. Again, a leading position of American institutions was found. Conclusions: This is the first comprehensive scientometric analysis of data on global scientific activities in the field of environmental tobacco smoke research. The present findings can be used as a benchmark for funding allocation processes.	[Vitzthum, Karin; Scutaru, Cristian; Musial-Bright, Lindy; Quarcoo, David; Spallek, Michael] Free Univ Berlin, Charite Univ Med, Inst Occupat Med, Dept Informat Sci, D-1000 Berlin, Germany; [Groneberg-Kloft, Beatrix] Free Univ Berlin, Charite Univ Med, Otto Heubner Ctr, D-1000 Berlin, Germany; [Vitzthum, Karin; Scutaru, Cristian; Musial-Bright, Lindy; Quarcoo, David; Spallek, Michael; Groneberg-Kloft, Beatrix] Humboldt Univ, Berlin, Germany; [Vitzthum, Karin; Scutaru, Cristian; Welte, Tobias] Hanover Med Sch, Dept Resp Med, Hanover, NH USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin	Vitzthum, K (corresponding author), Free Univ Berlin, Charite Univ Med, Inst Occupat Med, Dept Informat Sci, D-1000 Berlin, Germany.	karin.vitzthum@charite.de	Scutaru, Cristian/AAD-4098-2020	Scutaru, Cristian/0000-0003-0753-9730; Quarcoo, David/0000-0001-6398-2118				Almeida OP, 2008, AM J GERIAT PSYCHIAT, V16, P92, DOI 10.1097/JGP.0b013e318157cad2; *AM CANC S, 2004, TOB FREE IN; Apter AJ, 2008, J ALLERGY CLIN IMMUN, V121, P839, DOI 10.1016/j.jaci.2007.12.1176; BLASHFIELD RK, 1982, SCHIZOPHRENIA BULL, V8, P1, DOI 10.1093/schbul/8.1.1; Bonita R, 1999, TOB CONTROL, V8, P156, DOI 10.1136/tc.8.2.156; Borger Julia-Annik, 2008, J Occup Med Toxicol, V3 Suppl 1, pS7, DOI 10.1186/1745-6673-3-S1-S7; Carmella SG, 2009, CHEM RES TOXICOL, V22, P734, DOI 10.1021/tx800479s; Charavaryamath C, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-10; Chen RL, 2009, NEW ENGL J MED, V360, P1911, DOI 10.1056/NEJMc090277; de Solla Price D., 1977, SCI TECHNOLOGY SOC C; DEGRANDAORIVE JI, 2009, GAC SANIT; Garfield E, 1999, OCCUP MED-OXFORD, V49, P571, DOI 10.1093/occmed/49.8.571; GARFIELD E, 2007, 11 INT C INT SOC SCI; Gastner MT, 2004, P NATL ACAD SCI USA, V101, P7499, DOI 10.1073/pnas.0400280101; Gehanno JF, 2000, OCCUP ENVIRON MED, V57, P706, DOI 10.1136/oem.57.10.706; Groneberg-Kloft B, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-6; Groneberg-Kloft Beatrix, 2007, Cough, V3, P6, DOI 10.1186/1745-9974-3-6; Groneberg-Kloft B, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-16; Groneberg-Kloft Beatrix, 2008, Health Res Policy Syst, V6, P6, DOI 10.1186/1478-4505-6-6; Groneberg-Kloft B, 2009, J ASTHMA, V46, P147, DOI 10.1080/02770900802503115; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; de Granda-Orive JI, 2007, ARCH BRONCONEUMOL, V43, P212, DOI 10.1157/13100540; JACKSON R, 1988, INT J DERMATOL, V27, P16, DOI 10.1111/j.1365-4362.1988.tb02325.x; JI M, 2009, AM J PREV MED; Kraus T, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-4; Kusma B, 2009, INT J ENV RES PUB HE, V6, P1856, DOI 10.3390/ijerph6061856; Leone A, 2003, CURR PHARM DESIGN, V9, P2417, DOI 10.2174/1381612033453802; Llewellyn DJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b462; Max W, 2009, INT J ENV RES PUB HE, V6, P1633, DOI 10.3390/ijerph6051633; MCCUNNEY RJ, 1992, J OCCUP ENVIRON MED, V34, P279, DOI 10.1097/00043764-199203000-00012; Mohebbi Iraj, 2007, J Occup Med Toxicol, V2, P8, DOI 10.1186/1745-6673-2-8; *NAT HLTH I, 2010, HLTH NEWS; Ould-Kadi Farid, 2007, J Occup Med Toxicol, V2, P11, DOI 10.1186/1745-6673-2-11; Rachiotis G, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-313; Rogers JM, 2009, REPROD TOXICOL, V28, P152, DOI 10.1016/j.reprotox.2009.03.012; Rosenlund M, 2001, EPIDEMIOLOGY, V12, P558, DOI 10.1097/00001648-200109000-00016; Schick S, 2005, TOB CONTROL, V14, P396, DOI 10.1136/tc.2005.011288; Schoeffel N, 2010, J EUR ACAD DERMATOL, V24, P85, DOI 10.1111/j.1468-3083.2009.03293.x; Sevinc A, 2005, J NATL MED ASSOC, V97, P116; Sevinc A, 2004, J NATL MED ASSOC, V96, P980; SMALL J, 2010, SMOKING BAN CALIFORN; Smith DR, 2007, IND HEALTH, V45, P730, DOI 10.2486/indhealth.45.730; Smith DR, 2008, IND HEALTH, V46, P519, DOI 10.2486/indhealth.46.519; Takahashi K, 1999, OCCUP MED-OXFORD, V49, P57, DOI 10.1093/occmed/49.1.57-a; *UN SD, 2009, DEM PROD; Weitzman M, 2005, CIRCULATION, V112, P862, DOI 10.1161/CIRCULATIONAHA.104.520650; Yelin E, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-2	47	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11254	10.1371/journal.pone.0011254	http://dx.doi.org/10.1371/journal.pone.0011254			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582305	Green Published, Green Submitted, gold			2022-12-27	WOS:000279058500006
J	Hubbe, M; Neves, WA; Harvati, K				Hubbe, Mark; Neves, Walter A.; Harvati, Katerina			Testing Evolutionary and Dispersion Scenarios for the Settlement of the New World	PLOS ONE			English	Article							MODERN HUMAN-POPULATIONS; UPPER CAVE; CLIMATE SIGNATURES; NATURAL-SELECTION; SKELETAL REMAINS; GENETIC-ANALYSIS; SOUTH-AMERICA; MORPHOLOGY; PLEISTOCENE; ORIGINS	Background: Discussion surrounding the settlement of the New World has recently gained momentum with advances in molecular biology, archaeology and bioanthropology. Recent evidence from these diverse fields is found to support different colonization scenarios. The currently available genetic evidence suggests a "single migration'' model, in which both early and later Native American groups derive from one expansion event into the continent. In contrast, the pronounced anatomical differences between early and late Native American populations have led others to propose more complex scenarios, involving separate colonization events of the New World and a distinct origin for these groups. Methodology/Principal Findings: Using large samples of Early American crania, we: 1) calculated the rate of morphological differentiation between Early and Late American samples under three different time divergence assumptions, and compared our findings to the predicted morphological differentiation under neutral conditions in each case; and 2) further tested three dispersal scenarios for the colonization of the New World by comparing the morphological distances among early and late Amerindians, East Asians, Australo-Melanesians and early modern humans from Asia to geographical distances associated with each dispersion model. Results indicate that the assumption of a last shared common ancestor outside the continent better explains the observed morphological differences between early and late American groups. This result is corroborated by our finding that a model comprising two Asian waves of migration coming through Bering into the Americas fits the cranial anatomical evidence best, especially when the effects of diversifying selection to climate are taken into account. Conclusions: We conclude that the morphological diversity documented through time in the New World is best accounted for by a model postulating two waves of human expansion into the continent originating in East Asia and entering through Beringia.	[Hubbe, Mark] Univ Catolica Norte, Inst Invest Arqueol & Museo, San Pedro De Atacama, Chile; [Neves, Walter A.] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Lab Estudos Evolut Humanos, Sao Paulo, Brazil; [Harvati, Katerina] Univ Tubingen, Inst Uhr & Fruhgeschichte, Paleoanthropol Sect, Tubingen, Germany; [Harvati, Katerina] Univ Tubingen, Archaeol Mittelalters & Senckenberg Ctr Human Evo, Tubingen, Germany	Universidad Catolica del Norte; Universidade de Sao Paulo; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Hubbe, M (corresponding author), Univ Catolica Norte, Inst Invest Arqueol & Museo, San Pedro De Atacama, Chile.	mhubbe@ucn.cl	Hubbe, Mark/AAC-1043-2020; Hubbe, Mark/G-3440-2012	Hubbe, Mark/0000-0003-4433-3942	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [11070091]; Fundacao de Amparo a Ciencia do Estado de Sao Paulo (FAPESP) [04/01253-0]; Conselho Nacional de Pesquisa (CNPq) [301126-04.6]; Max Planck Gesellschaft; EVAN Marie Curie Research Training Network [MRTN-CT-019564]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fundacao de Amparo a Ciencia do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Max Planck Gesellschaft(Max Planck Society); EVAN Marie Curie Research Training Network(European Commission)	This work has been supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT 11070091), Fundacao de Amparo a Ciencia do Estado de Sao Paulo (FAPESP 04/01253-0), Conselho Nacional de Pesquisa (CNPq 301126-04.6), the Max Planck Gesellschaft and the EVAN Marie Curie Research Training Network MRTN-CT-019564. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CRAMONTAUBADEL N, 2009, AM J PHYS ANTHROPOL, V140, P205; Cunningham DL, 2003, J HUM EVOL, V45, P1, DOI 10.1016/S0047-2484(03)00064-2; Cunningham DL, 2002, J HUM EVOL, V42, P627, DOI 10.1006/jhev.2001.0547; DARROCH JN, 1985, BIOMETRIKA, V72, P241, DOI 10.2307/2336077; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Dillehay TD, 2009, P NATL ACAD SCI USA, V106, P971, DOI 10.1073/pnas.0808424106; Dixon EJ, 2001, QUATERNARY SCI REV, V20, P277; DOW MM, 1985, AM J PHYS ANTHROPOL, V68, P367, DOI 10.1002/ajpa.1330680307; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Gonzalez-Jose R, 2005, AM J PHYS ANTHROPOL, V128, P772, DOI 10.1002/ajpa.20165; Gonzalez-Jose R, 2008, AM J PHYS ANTHROPOL, V137, P175, DOI 10.1002/ajpa.20854; GOWER JC, 1969, APPL STATIST, V18, P54, DOI DOI 10.2307/2346439; Harvati K, 2006, ANAT REC PART A, V288A, P1225, DOI 10.1002/ar.a.20395; Harvati K, 2009, J HUM EVOL, V57, P751, DOI 10.1016/j.jhevol.2009.07.008; Howells W.W., 1973, PAPERS PEABODY MUSEU, V67; HOWELLS WW, 1989, PAPERS PEABODY MUSEU, V79; Hubbe M, 2009, ANAT REC, V292, P1720, DOI 10.1002/ar.20976; KAMMINGA J, 1988, J HUM EVOL, V17, P739, DOI 10.1016/0047-2484(88)90064-4; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Konigsberg LW, 1997, J HUM EVOL, V32, P479, DOI 10.1006/jhev.1996.0125; LANDE R, 1979, EVOLUTION, V33, P402, DOI 10.2307/2407630; LANDE R, 1976, EVOLUTION, V30, P314, DOI 10.1111/j.1558-5646.1976.tb00911.x; LYNCH M, 1990, AM NAT, V136, P727, DOI 10.1086/285128; LYNCH M, 1988, GENET RES, V51, P137, DOI 10.1017/S0016672300024150; Mahalanobis P.C., 1936, P NAT I SCI INDIA, V2, P49; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; MANTEL N, 1967, CANCER RES, V27, P209; Neves WA, 2005, P NATL ACAD SCI USA, V102, P18309, DOI 10.1073/pnas.0507185102; Neves WA, 1989, J HUM EVOL, V34, P219; Neves WA, 2007, AM J PHYS ANTHROPOL, V133, P1080, DOI 10.1002/ajpa.20637; ODEN NL, 1992, AM J PHYS ANTHROPOL, V89, P257, DOI 10.1002/ajpa.1330890209; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Powell J.F., 2005, 1 AM RACE EVOLUTION; Relethford JH, 2002, AM J PHYS ANTHROPOL, V118, P393, DOI 10.1002/ajpa.10079; Relethford JH, 2004, HUM BIOL, V76, P499, DOI 10.1353/hub.2004.0060; RELETHFORD JH, 1994, AM J PHYS ANTHROPOL, V95, P53, DOI 10.1002/ajpa.1330950105; Roseman CC, 2004, P NATL ACAD SCI USA, V101, P12824, DOI 10.1073/pnas.0402637101; SMOUSE PE, 1992, YEARB PHYS ANTHROPOL, V35, P187; Sokal R.R., 2012, BIOMETRY; *STATSOFT INC, 2007, EL STAT TXB; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; TURELLI M, 1988, EVOLUTION, V42, P1085, DOI [10.2307/2408923, 10.1111/j.1558-5646.1988.tb02526.x]; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166; WRIGHT RVS, 1995, J HUM EVOL, V29, P181, DOI 10.1006/jhev.1995.1053; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009	47	48	57	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11105	10.1371/journal.pone.0011105	http://dx.doi.org/10.1371/journal.pone.0011105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	610NX	20559441	Green Published, Green Submitted, gold			2022-12-27	WOS:000278741100018
J	Schonrock, N; Ke, YD; Humphreys, D; Staufenbiel, M; Ittner, LM; Preiss, T; Gotz, J				Schonrock, Nicole; Ke, Yazi D.; Humphreys, David; Staufenbiel, Matthias; Ittner, Lars M.; Preiss, Thomas; Goetz, Juergen			Neuronal MicroRNA Deregulation in Response to Alzheimer's Disease Amyloid-beta	PLOS ONE			English	Article							PRECURSOR-PROTEIN; POSTTRANSCRIPTIONAL REGULATION; MEDIATOR PROTEIN-2; TRANSGENIC MOUSE; EXPRESSION; BRAIN; HIPPOCAMPAL; TISSUE; MODEL; NEUROGENESIS	Normal brain development and function depends on microRNA (miRNA) networks to fine tune the balance between the transcriptome and proteome of the cell. These small non-coding RNA regulators are highly enriched in brain where they play key roles in neuronal development, plasticity and disease. In neurodegenerative disorders such as Alzheimer's disease (AD), brain miRNA profiles are altered; thus miRNA dysfunction could be both a cause and a consequence of disease. Our study dissects the complexity of human AD pathology, and addresses the hypothesis that amyloid-beta (A beta) itself, a known causative factor of AD, causes neuronal miRNA deregulation, which could contribute to the pathomechanisms of AD. We used sensitive TaqMan low density miRNA arrays (TLDA) on murine primary hippocampal cultures to show that about half of all miRNAs tested were down-regulated in response to A beta peptides. Time-course assays of neuronal A beta treatments show that A beta is in fact a powerful regulator of miRNA levels as the response of certain mature miRNAs is extremely rapid. Bioinformatic analysis predicts that the deregulated miRNAs are likely to affect target genes present in prominent neuronal pathways known to be disrupted in AD. Remarkably, we also found that the miRNA deregulation in hippocampal cultures was paralleled in vivo by a deregulation in the hippocampus of A beta 42-depositing APP23 mice, at the onset of Ab plaque formation. In addition, the miRNA deregulation in hippocampal cultures and APP23 hippocampus overlaps with those obtained in human AD studies. Taken together, our findings suggest that neuronal miRNA deregulation in response to an insult by A beta may be an important factor contributing to the cascade of events leading to AD.	[Schonrock, Nicole; Ke, Yazi D.; Ittner, Lars M.; Goetz, Juergen] Univ Sydney, Brain & Mind Res Inst, Alzheimers & Parkinsons Dis Lab, Sydney, NSW, Australia; [Humphreys, David; Preiss, Thomas] VCCRI, Div Mol Genet, Sydney, NSW, Australia; [Staufenbiel, Matthias] Novartis Inst BioMed Res, Basel, Switzerland; [Preiss, Thomas] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Preiss, Thomas] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia	University of Sydney; Victor Chang Cardiac Research Institute; Novartis; University of New South Wales Sydney; University of New South Wales Sydney	Schonrock, N (corresponding author), Univ Sydney, Brain & Mind Res Inst, Alzheimers & Parkinsons Dis Lab, Sydney, NSW, Australia.	nschonrock@med.usyd.edu.au; jgoetz@med.usyd.edu.au	Götz, Jürgen/C-2448-2014; Ke, Yazi/ABC-3052-2020; Preiss, Thomas/F-7355-2010	Götz, Jürgen/0000-0001-8501-7896; Ke, Yazi/0000-0002-1423-0451; Preiss, Thomas/0000-0001-6273-784X; Humphreys, David/0000-0003-4140-0089; Ittner, Lars/0000-0001-6738-3825	Human Frontier Science Program; National Health and Medical Research Council (NHMRC); Australian Research Council (ARC); University of Sydney; J.O. & J.R. Wicking Trust; Wenkart Foundation; GlaxoSmithKline; Alzheimer's Australia	Human Frontier Science Program(Human Frontier Science Program); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); University of Sydney(University of Sydney); J.O. & J.R. Wicking Trust; Wenkart Foundation; GlaxoSmithKline(GlaxoSmithKline); Alzheimer's Australia	N.S. is supported by the Human Frontier Science Program. L. I. is supported by the National Health and Medical Research Council (NHMRC) and the Australian Research Council (ARC), and J.G. is supported by grants from the University of Sydney, the National Health and Medical Research Council (NHMRC), the Australian Research Council (ARC), and the J.O. & J.R. Wicking Trust. Postgraduate scholarship support has been provided by the Wenkart Foundation, GlaxoSmithKline and Alzheimer's Australia. Novartis (via Matthias Staufenbiel) provided the APP23 mouse strain. All experiments were performed in Sydney, and Novartis did not fund any aspect of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; David DC, 2006, PROTEOMICS, V6, P6566, DOI 10.1002/pmic.200600634; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Eckert A, 2008, J MOL MED, V86, P1255, DOI 10.1007/s00109-008-0391-6; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Ferrari A, 2003, J BIOL CHEM, V278, P40162, DOI 10.1074/jbc.M308243200; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Gotz J, 2008, J ALZHEIMERS DIS, V14, P423; Gotz J, 2007, BRAIN PATHOL, V17, P91, DOI 10.1111/j.1750-3639.2007.00051.x; Gotz J, 2009, J ALZHEIMERS DIS, V18, P243, DOI 10.3233/JAD-2009-1143; Gotz J, 2004, INT J DEV NEUROSCI, V22, P453, DOI 10.1016/j.ijdevneu.2004.07.013; Gotz Jurgen, 2008, Neuropsychiatr Dis Treat, V4, P1033; Gu YJ, 2000, BIOCHEMISTRY-US, V39, P4267, DOI 10.1021/bi992323h; Guerreiro N, 2008, J ALZHEIMERS DIS, V13, P17; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Hallbergson AF, 2003, J CLIN INVEST, V112, P1128, DOI 10.1172/JCI200320098; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Hebert SS, 2009, NEUROBIOL DIS, V33, P422, DOI 10.1016/j.nbd.2008.11.009; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kuhn DE, 2008, BIOCHEM BIOPH RES CO, V370, P473, DOI 10.1016/j.bbrc.2008.03.120; LAU P, 2010, SEMIN CELL DEV BIOL; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lubec G, 1999, J NEURAL TRANSM-SUPP, P161; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; Nelson PT, 2009, NEUROSCI LETT, V466, P69, DOI 10.1016/j.neulet.2009.04.044; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; PODLISNY MB, 1987, SCIENCE, V238, P669, DOI 10.1126/science.2960019; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Shibata M, 2008, J NEUROSCI, V28, P10415, DOI 10.1523/JNEUROSCI.3219-08.2008; Sizova D, 2007, NEUROBIOL AGING, V28, P357, DOI 10.1016/j.neurobiolaging.2006.01.011; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Theuns J, 2006, AM J HUM GENET, V78, P936, DOI 10.1086/504044; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Van Dam D, 2003, EUR J NEUROSCI, V17, P388, DOI 10.1046/j.1460-9568.2003.02444.x; Van Dam D, 2005, CNS SPECTRUMS, V10, P207, DOI 10.1017/S1092852900010051; Vercauteren FGG, 2004, MOL BRAIN RES, V132, P241, DOI 10.1016/j.molbrainres.2004.10.012; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yoshida H, 1998, J BIOL CHEM, V273, P9761, DOI 10.1074/jbc.273.16.9761; Young KF, 2009, NEUROCHEM INT, V55, P796, DOI 10.1016/j.neuint.2009.08.002; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576	70	149	159	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11070	10.1371/journal.pone.0011070	http://dx.doi.org/10.1371/journal.pone.0011070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552018	Green Published, gold, Green Submitted			2022-12-27	WOS:000278662900010
J	Choong, LY; Lim, S; Chong, PK; Wong, CY; Shah, N; Lim, YP				Choong, Lee Yee; Lim, Simin; Chong, Poh Kuan; Wong, Chow Yin; Shah, Nilesh; Lim, Yoon Pin			Proteome-Wide Profiling of the MCF10AT Breast Cancer Progression Model	PLOS ONE			English	Article							CELL LINEAGE MODEL; DIFFERENTIAL EXPRESSION; FUNCTIONAL-ANALYSIS; PHOSPHOPROTEOMICS; TRANSFORMATION; SIGNATURES; CALCIUM; SURFACE; FAMILY; TARGET	Background: Mapping the expression changes during breast cancer development should facilitate basic and translational research that will eventually improve our understanding and clinical management of cancer. However, most studies in this area are challenged by genetic and environmental heterogeneities associated with cancer. Methodology/Principal Findings: We conducted proteomics of the MCF10AT breast cancer model, which comprises of 4 isogenic xenograft-derived human cell lines that mimic different stages of breast cancer progression, using iTRAQ-based tandem mass spectrometry. Of more than 1200 proteins detected, 98 proteins representing at least 20 molecular function groups including kinases, proteases, adhesion, calcium binding and cytoskeletal proteins were found to display significant expression changes across the MCF10AT model. The number of proteins that showed different expression levels increased as disease progressed from AT1k pre-neoplastic cells to low grade CA1h cancer cells and high grade cancer cells. Bioinformatics revealed that MCF10AT model of breast cancer progression is associated with a major re-programming in metabolism, one of the first identified biochemical hallmarks of tumor cells (the "Warburg effect"). Aberrant expression of 3 novel breast cancer-associated proteins namely AK1, ATOX1 and HIST1H2BM were subsequently validated via immunoblotting of the MCF10AT model and immunohistochemistry of progressive clinical breast cancer lesions. Conclusion/Significance: The information generated by this study should serve as a useful reference for future basic and translational cancer research. Dysregulation of ATOX1, AK1 and HIST1HB2M could be detected as early as the pre-neoplastic stage. The findings have implications on early detection and stratification of patients for adjuvant therapy.	[Choong, Lee Yee; Lim, Simin; Chong, Poh Kuan; Shah, Nilesh; Lim, Yoon Pin] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Wong, Chow Yin] Singapore Gen Hosp, Dept Gen Surg, Singapore 169608, Singapore; [Lim, Yoon Pin] Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore 117548, Singapore; [Lim, Yoon Pin] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore	National University of Singapore; Singapore General Hospital; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII)	Choong, LY (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore.	csilyp@nus.edu.sg			Biomedical Research Council (BMRC), Agency for Science, Technology and Research (A*STAR)	Biomedical Research Council (BMRC), Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	This research was supported by funding from the Biomedical Research Council (BMRC), Agency for Science, Technology and Research (A*STAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; Cariati M, 2008, INT J CANCER, V122, P298, DOI 10.1002/ijc.23103; Chen YH, 2007, MOL CELL PROTEOMICS, V6, P2072, DOI 10.1074/mcp.M700395-MCP200; Chong PK, 2008, PROTEOMICS, V8, P4370, DOI 10.1002/pmic.200800051; Dawson PJ, 1996, AM J PATHOL, V148, P313; Dressman MA, 2003, CANCER RES, V63, P2194; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; FINNEY L, 2008, CLIN EXP PHARM PHYSL; GODFROID E, 1991, J CELL SCI, V99, P595; Goodman VL, 2005, CURR CANCER DRUG TAR, V5, P543, DOI 10.2174/156800905774574066; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; Heppner GH, 2000, BREAST CANCER RES, V2, P331; *ING, ING PATHW AN; Itoh S, 2008, J BIOL CHEM, V283, P9157, DOI 10.1074/jbc.M709463200; Ji JF, 2004, J CANCER RES CLIN, V130, P480, DOI 10.1007/s00432-004-0555-x; Kadota M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009201; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lim S, 2009, J PROTEOME RES, V8, P4062, DOI 10.1021/pr900430n; Lim YP, 2003, MOL CANCER THER, V2, P1369; Lim YP, 1999, J BIOL CHEM, V274, P19025, DOI 10.1074/jbc.274.27.19025; Liu F, 2008, NEOPLASIA, V10, P1275, DOI 10.1593/neo.08810; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; MILLER FR, 1993, J NATL CANCER I, V85, P1725, DOI 10.1093/jnci/85.21.1725; Miller FR, 2000, J MAMMARY GLAND BIOL, V5, P379, DOI 10.1023/A:1009577811584; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Morandell S, 2006, PROTEOMICS, V6, P4047, DOI 10.1002/pmic.200600058; Nagaraja GM, 2006, ONCOGENE, V25, P2328, DOI 10.1038/sj.onc.1209265; Olopade OI, 2008, CLIN CANCER RES, V14, P7988, DOI 10.1158/1078-0432.CCR-08-1211; Rhee DK, 2008, GENOMICS, V92, P419, DOI 10.1016/j.ygeno.2008.08.005; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Shekhar MPV, 2004, AM J PATHOL, V165, P1931, DOI 10.1016/S0002-9440(10)63245-2; Silverstein MJ, 2003, BREAST, V12, P457, DOI 10.1016/S0960-9776(03)00153-X; Starcevic SL, 2003, TOXICOL SCI, V75, P74, DOI 10.1093/toxsci/kfg154; Starcevic SL, 2001, J NATL CANCER I, V93, P776, DOI 10.1093/jnci/93.10.776; Strickland LB, 2000, BREAST CANCER RES TR, V64, P235, DOI 10.1023/A:1026562720218; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8; Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200; Worsham MJ, 2006, BREAST CANCER RES TR, V96, P177, DOI 10.1007/s10549-005-9077-8; Yamamoto S, 2005, ANN SURG ONCOL, V12, P925, DOI 10.1245/ASO.2005.07.002; Yao R, 2007, ANTICANCER RES, V27, P3051; Young CD, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1852	47	32	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e11030	10.1371/journal.pone.0011030	http://dx.doi.org/10.1371/journal.pone.0011030			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20543960	Green Published, Green Submitted, gold			2022-12-27	WOS:000278557600009
J	Dankel, SN; Fadnes, DJ; Stavrum, AK; Stansberg, C; Holdhus, R; Hoang, T; Veum, VL; Christensen, BJ; Vage, V; Sagen, JV; Steen, VM; Mellgren, G				Dankel, Simon N.; Fadnes, Dag J.; Stavrum, Anne-Kristin; Stansberg, Christine; Holdhus, Rita; Hoang, Tuyen; Veum, Vivian L.; Christensen, Bjorn Jostein; Vage, Villy; Sagen, Jorn V.; Steen, Vidar M.; Mellgren, Gunnar			Switch from Stress Response to Homeobox Transcription Factors in Adipose Tissue After Profound Fat Loss	PLOS ONE			English	Article							INFLAMMATION-RELATED GENES; INSULIN-RESISTANCE; EXTRACELLULAR-MATRIX; EXPRESSION PROFILES; PULMONARY-FIBROSIS; OBESE SUBJECTS; WEIGHT-LOSS; SURGERY; ADIPOGENESIS; INFILTRATION	Background: In obesity, impaired adipose tissue function may promote secondary disease through ectopic lipid accumulation and excess release of adipokines, resulting in systemic low-grade inflammation, insulin resistance and organ dysfunction. However, several of the genes regulating adipose tissue function in obesity are yet to be identified. Methodology/Principal Findings: In order to identify novel candidate genes that may regulate adipose tissue function, we analyzed global gene expression in abdominal subcutaneous adipose tissue before and one year after bariatric surgery (biliopancreatic diversion with duodenal switch, BPD/DS) (n = 16). Adipose tissue from lean healthy individuals was also analyzed (n = 13). Two different microarray platforms (AB 1700 and Illumina) were used to measure the differential gene expression, and the results were further validated by qPCR. Surgery reduced BMI from 53.3 to 33.1 kg/m(2). The majority of differentially expressed genes were down-regulated after profound fat loss, including transcription factors involved in stress response, inflammation, and immune cell function (e. g., FOS, JUN, ETS, C/EBPB, C/EBPD). Interestingly, a distinct set of genes was up-regulated after fat loss, including homeobox transcription factors (IRX3, IRX5, HOXA5, HOXA9, HOXB5, HOXC6, EMX2, PRRX1) and extracellular matrix structural proteins (COL1A1, COL1A2, COL3A1, COL5A1, COL6A3). Conclusions/Significance: The data demonstrate a marked switch of transcription factors in adipose tissue after profound fat loss, providing new molecular insight into a dichotomy between stress response and metabolically favorable tissue development. Our findings implicate homeobox transcription factors as important regulators of adipose tissue function.	[Dankel, Simon N.; Hoang, Tuyen; Veum, Vivian L.; Sagen, Jorn V.; Mellgren, Gunnar] Univ Bergen, Inst Med, Bergen, Norway; [Dankel, Simon N.; Hoang, Tuyen; Veum, Vivian L.; Sagen, Jorn V.; Mellgren, Gunnar] Haukeland Hosp, Hormone Lab, N-5021 Bergen, Norway; [Fadnes, Dag J.] Forde Cent Hosp, Dept Med, Forde, Norway; [Fadnes, Dag J.] Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway; [Stavrum, Anne-Kristin; Stansberg, Christine; Holdhus, Rita; Steen, Vidar M.] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Stavrum, Anne-Kristin; Stansberg, Christine; Holdhus, Rita; Steen, Vidar M.] Univ Bergen, Dept Clin Med, Bergen, Norway; [Christensen, Bjorn Jostein] Haukeland Hosp, Dept Surg, N-5021 Bergen, Norway; [Christensen, Bjorn Jostein] Univ Bergen, Dept Surg Sci, Bergen, Norway; [Vage, Villy] Forde Cent Hosp, Dept Surg, Forde, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen	Dankel, SN (corresponding author), Univ Bergen, Inst Med, Bergen, Norway.	gunnar.mellgren@med.uib.no	Mellgren, Gunnar/AAG-6573-2020	Mellgren, Gunnar/0000-0001-6282-4986; Stansberg, Christine/0000-0002-3665-7843; Dankel, Simon/0000-0001-6972-1824	Research Council of Norway (RCN); Norwegian Cancer Society; Samarbeidsorganet Helse Vest RHF; Meltzerfondet; Programstyret for ernaering at the University of Bergen	Research Council of Norway (RCN)(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Samarbeidsorganet Helse Vest RHF; Meltzerfondet; Programstyret for ernaering at the University of Bergen	Funding for this project was provided by the Research Council of Norway (RCN)(http://www.forskningsradet.no), The Norwegian Cancer Society (http://www.kreftforeningen.no), Samarbeidsorganet Helse Vest RHF (http://www.helse-bergen.no/forskning/samarbeidsorganet), Meltzerfondet (http://meltzerfondet.no) and Programstyret for ernaering at the University of Bergen (http://www.uib.no/mofa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343; Bikman BT, 2008, J CLIN ENDOCR METAB, V93, P4656, DOI 10.1210/jc.2008-1030; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bouchard L, 2010, AM J CLIN NUTR, V91, P309, DOI 10.3945/ajcn.2009.28085; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Cantile M, 2003, J CELL PHYSIOL, V194, P225, DOI 10.1002/jcp.10210; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Clement K, 2004, FASEB J, V18, P1657, DOI 10.1096/fj.04-2204com; Cowherd RM, 1997, BIOCHEM BIOPH RES CO, V237, P470, DOI 10.1006/bbrc.1997.7160; Daftary GS, 2006, ENDOCR REV, V27, P331, DOI 10.1210/er.2005-0018; Dahlman I, 2005, AM J CLIN NUTR, V81, P1275; Eddy AA, 2006, J AM SOC NEPHROL, V17, P2999, DOI 10.1681/ASN.2006050503; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fellenberg K, 2001, P NATL ACAD SCI USA, V98, P10781, DOI 10.1073/pnas.181597298; Feng YX, 2005, CELL PHYSIOL BIOCHEM, V16, P237, DOI 10.1159/000089849; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Hansen SL, 2003, AM J PATHOL, V163, P2421, DOI 10.1016/S0002-9440(10)63597-3; Hardie WD, 2007, AM J RESP CELL MOL, V37, P309, DOI 10.1165/rcmb.2006-0455OC; Heilbronn L, 2004, INT J OBESITY, V28, pS12, DOI 10.1038/sj.ijo.0802853; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Hess DS, 2005, OBES SURG, V15, P408, DOI 10.1381/0960892053576695; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Hombria JCG, 2003, DIFFERENTIATION, V71, P461, DOI 10.1046/j.1432-0436.2003.7108004.x; Hueber SD, 2008, BIOESSAYS, V30, P965, DOI 10.1002/bies.20823; Kallio P, 2007, AM J CLIN NUTR, V85, P1417, DOI 10.1093/ajcn/85.5.1417; Keophiphath M, 2009, MOL ENDOCRINOL, V23, P11, DOI 10.1210/me.2008-0183; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Kolehmainen M, 2008, INT J OBESITY, V32, P292, DOI 10.1038/sj.ijo.0803718; Lee YH, 2005, DIABETOLOGIA, V48, P1776, DOI 10.1007/s00125-005-1867-3; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mandeville I, 2006, AM J PATHOL, V169, P1312, DOI 10.2353/ajpath.2006.051333; Mutch DM, 2009, AM J CLIN NUTR, V89, P51, DOI 10.3945/ajcn.2008.26802; Nakerakanti SS, 2006, J BIOL CHEM, V281, P25259, DOI 10.1074/jbc.M600466200; Norman JT, 2000, KIDNEY INT, V58, P2351, DOI 10.1046/j.1523-1755.2000.00419.x; Pasarica M, 2009, J CLIN ENDOCR METAB, V94, P5155, DOI 10.1210/jc.2009-0947; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; POULOS SP, 2009, MOL CELL ENDOCRINOL; Shi H, 2006, DIABETES, V55, P699, DOI 10.2337/diabetes.55.03.06.db05-0841; Shi H, 2004, J BIOL CHEM, V279, P34733, DOI 10.1074/jbc.M403886200; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Strieter RM, 2007, J CLIN INVEST, V117, P549, DOI 10.1172/JCI30562; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; Wang KC, 2009, TRENDS CELL BIOL, V19, P268, DOI 10.1016/j.tcb.2009.03.007; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246	53	92	96	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e11033	10.1371/journal.pone.0011033	http://dx.doi.org/10.1371/journal.pone.0011033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20543949	Green Submitted, Green Published, gold			2022-12-27	WOS:000278557600011
J	Pinhasi, R; Gasparian, B; Areshian, G; Zardaryan, D; Smith, A; Bar-Oz, G; Higham, T				Pinhasi, Ron; Gasparian, Boris; Areshian, Gregory; Zardaryan, Diana; Smith, Alexia; Bar-Oz, Guy; Higham, Thomas			First Direct Evidence of Chalcolithic Footwear from the Near Eastern Highlands	PLOS ONE			English	Article							ANATOMICAL EVIDENCE; BODY-SIZE; SHOE; CALIBRATION; ANTIQUITY; JAPANESE; SHAPE; SEX	In 2008, a well preserved and complete shoe was recovered at the base of a Chalcolithic pit in the cave of Areni-1, Armenia. Here, we discuss the chronology of this find, its archaeological context and its relevance to the study of the evolution of footwear. Two leather samples and one grass sample from the shoe were dated at the Oxford Radiocarbon Accelerator Unit (ORAU). A third leather sample was dated at the University of California-Irvine Accelerator Mass Spectrometry Facility (UCIAMS). The R_Combine function for the three leather samples provides a date range of 3627-3377 Cal BC (95.4% confidence interval) and the calibrated range for the straw is contemporaneous (3627-3377 Cal BC). The shoe was stuffed with loose, unfastened grass (Poaceae) without clear orientation which was more than likely used to maintain the shape of the shoe and/or prepare it for storage. The shoe is 24.5 cm long (European size 37), 7.6 to 10 cm wide, and was made from a single piece of leather that wrapped around the foot. It was worn and shaped to the wearer's right foot, particularly around the heel and hallux where the highest pressure is exerted in normal gait. The Chalcolithic shoe provides solid evidence for the use of footwear among Old World populations at least since the Chalcolithic. Other 4(th) millennium discoveries of shoes (Italian and Swiss Alps), and sandals (Southern Israel) indicate that more than one type of footwear existed during the 4(th) millennium BC, and that we should expect to discover more regional variations in the manufacturing and style of shoes where preservation conditions permit.	[Pinhasi, Ron] Natl Univ Ireland Univ Coll Cork, Dept Archaeol, Cork, Ireland; [Gasparian, Boris; Zardaryan, Diana] Natl Acad Sci, Inst Archaeol & Ethnol, Yerevan, Armenia; [Areshian, Gregory] Univ Calif Los Angeles, Cotsen Inst Archaeol, Los Angeles, CA USA; [Smith, Alexia] Univ Connecticut, Dept Anthropol, Storrs, CT USA; [Bar-Oz, Guy] Univ Haifa, Zinman Inst Archaeol, IL-31999 Haifa, Israel; [Higham, Thomas] Univ Oxford, Oxford Radiocarbon Accelerator Unit, Oxford, England	University College Cork; National Academy of Sciences of Armenia; Institute of Archaeology & Ethnography - NAS RA; University of California System; University of California Los Angeles; University of Connecticut; University of Haifa; University of Oxford	Pinhasi, R (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Archaeol, Cork, Ireland.	r.pinhasi@ucc.ie	Higham, Tom/Y-2707-2019; Pinhasi, Ron/AAT-1531-2020; BarOz, Guy/ABF-6518-2020	Higham, Tom/0000-0002-5949-598X; Pinhasi, Ron/0000-0003-1629-8131; BarOz, Guy/0000-0002-1009-5619	America Corporation; National Geographic Society; British Academy; Cotsen Institute of Archaeology at UCLA; Steinmetz Foundation; Chitjian Trust; Boochever Foundation; Natural Environment Research Council [NRCF010002] Funding Source: researchfish; NERC [NRCF010002] Funding Source: UKRI	America Corporation; National Geographic Society(National Geographic Society); British Academy; Cotsen Institute of Archaeology at UCLA; Steinmetz Foundation; Chitjian Trust; Boochever Foundation; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work has been supported by the Armenian Branch of the Gfoeller Fund of America Corporation, the National Geographic Society, the British Academy, the Cotsen Institute of Archaeology at UCLA, the Steinmetz Foundation, the Chitjian Trust, and the Boochever Foundation for funding the research at Areni-1 cave. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashizawa K, 1997, ANN HUM BIOL, V24, P117, DOI 10.1080/03014469700004862; Buikstra J. E., 1994, STANDARDS DATA COLLE; COPLEN TB, 1994, PURE APPL CHEM, V66, P273, DOI 10.1351/pac199466020273; D'Aout K, 2009, FOOTWEAR SCI, V1, P81, DOI 10.1080/19424280903386411; Dee M, 2000, NUCL INSTRUM METH B, V172, P449, DOI 10.1016/S0168-583X(00)00337-2; GOEDECKERCIOLEK R, 1993, JB ROMISCH GERMANISC, P100; GOUBITZ Olaf, 2001, STEPPING TIME ARCHAE; GRIENER TM, 1990, NATICKTR91006 ARM NA; HAINES BM, 1975, J MATER SCI, V10, P525, DOI 10.1007/BF00543698; Hald M., 1972, PRIMITIVE SHOES ARCH; HAWES MR, 1994, ERGONOMICS, V37, P187, DOI 10.1080/00140139408963637; Iscan MY, 2005, FORENSIC SCI INT, V147, P107, DOI 10.1016/j.forsciint.2004.09.069; Jull A. J. T., 1998, IAA REPORTS, V5, P110; Kusumoto A, 1996, ANN HUM BIOL, V23, P373, DOI 10.1080/03014469600004622; Kutschera W, 2000, NUCL INSTRUM METH B, V164, P12, DOI 10.1016/S0168-583X(99)01196-9; Kuttruff JT, 1998, SCIENCE, V281, P72, DOI 10.1126/science.281.5373.72; LUCAS AT, 1956, COUNTY LOUTH ARCHAEO, V13, P309; Ozden H, 2005, FORENSIC SCI INT, V147, P181, DOI 10.1016/j.forsciint.2004.09.072; Ramsey CB, 2001, RADIOCARBON, V43, P355; Ramsey CB, 1997, NUCL INSTRUM METH B, V123, P539, DOI 10.1016/S0168-583X(96)00612-X; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Schick T., 1998, IAA REPORTS, V5; SIMFOOK L, 1958, J BONE JOINT SURG AM, V40, P1058, DOI 10.2106/00004623-195840050-00007; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Trinkaus E, 2005, J ARCHAEOL SCI, V32, P1515, DOI 10.1016/j.jas.2005.04.006; Trinkaus E, 2008, J ARCHAEOL SCI, V35, P1928, DOI 10.1016/j.jas.2007.12.002; Zipfel B, 2007, FOOT, V17, P205, DOI DOI 10.1016/J.FOOT.2007.06.002	27	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e10984	10.1371/journal.pone.0010984	http://dx.doi.org/10.1371/journal.pone.0010984			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608BX	20543959	Green Published, Green Submitted, gold			2022-12-27	WOS:000278557600003
J	Hansen, TB; Bramsen, JB; Kjems, J				Hansen, Thomas Birkballe; Bramsen, Jesper Bertram; Kjems, Jorgen			Re-Inspection of Small RNA Sequence Datasets Reveals Several Novel Human miRNA Genes	PLOS ONE			English	Article							MICRORNA PRECURSORS; IDENTIFICATION; CLASSIFICATION; TRANSCRIPTION; PREDICTION; BIOGENESIS; SUBSET; DROSHA		[Hansen, Thomas Birkballe; Bramsen, Jesper Bertram; Kjems, Jorgen] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark	Aarhus University	Hansen, TB (corresponding author), Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark.	tbh@mb.au.dk	Kjems, Jorgen/I-3490-2016	Kjems, Jorgen/0000-0003-4128-9317; Hansen, Thomas/0000-0002-7573-9657	EU [LSHG-CT-2006-037900]; Danish Council for Independent Research	EU(European Commission); Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	This work was supported by the SIROCCO EU consortium (LSHG-CT-2006-037900) and The Danish Council for Independent Research vertical bar Natural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Andronescu M, 2005, J MOL BIOL, V345, P987, DOI 10.1016/j.jmb.2004.10.082; Batuwita R, 2009, BIOINFORMATICS, V25, P989, DOI 10.1093/bioinformatics/btp107; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Guarnieri DJ, 2008, ANN MED, V40, P197, DOI 10.1080/07853890701771823; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Hertel J, 2006, BIOINFORMATICS, V22, pE197, DOI 10.1093/bioinformatics/btl257; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Maroney PA, 2008, NAT PROTOC, V3, P279, DOI 10.1038/nprot.2007.530; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sewer A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-267; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Zhu JY, 2009, J VIROL, V83, P3333, DOI 10.1128/JVI.01689-08	32	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10961	10.1371/journal.pone.0010961	http://dx.doi.org/10.1371/journal.pone.0010961			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532037	Green Submitted, Green Published, gold			2022-12-27	WOS:000278380500007
J	Cai, Q; Brysbaert, M				Cai, Qing; Brysbaert, Marc			SUBTLEX-CH: Chinese Word and Character Frequencies Based on Film Subtitles	PLOS ONE			English	Article							ENGLISH; LEXICON; NORMS	Background: Word frequency is the most important variable in language research. However, despite the growing interest in the Chinese language, there are only a few sources of word frequency available to researchers, and the quality is less than what researchers in other languages are used to. Methodology: Following recent work by New, Brysbaert, and colleagues in English, French and Dutch, we assembled a database of word and character frequencies based on a corpus of film and television subtitles (46.8 million character, 33.5 million words). In line with what has been found in the other languages, the new word and character frequencies explain significantly more of the variance in Chinese word naming and lexical decision performance than measures based on written texts. Conclusions: Our results confirm that word frequencies based on subtitles are a good estimate of daily language exposure and capture much of the variance in word processing efficiency. In addition, our database is the first to include information about the contextual diversity of the words and to provide good frequency estimates for multi-character words and the different syntactic roles in which the words are used. The word frequencies are freely available for research purposes.	[Cai, Qing; Brysbaert, Marc] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium	Ghent University	Cai, Q (corresponding author), Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium.	qing.cai@ugent.be	Brysbaert, Marc/A-3910-2011	Brysbaert, Marc/0000-0002-3645-3189	Government of Flanders	Government of Flanders	This work has been supported by an Odysseus Grant from the Government of Flanders (the Dutch-speaking region of Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman JS, 2006, PSYCHOL SCI, V17, P814, DOI 10.1111/j.1467-9280.2006.01787.x; [Anonymous], 1990, DICT MODERN CHINESE; Baayen R. H., 1993, CELEX LEXICAL DATABA; Baayen R. H, 1995, CELEX LEXICAL DATABA; BAI X, 2008, J EXP PSYCHOL HUM PE, V34; Balota DA, 2004, J EXP PSYCHOL GEN, V133, P283, DOI 10.1037/0096-3445.133.2.283; Balota DA, 2007, BEHAV RES METHODS, V39, P445, DOI 10.3758/BF03193014; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Feng Z.W, 2006, INT J CORPUS LINGUIS, V11, P173, DOI DOI 10.1075/IJCL.11.2.03FEN; Keuleers E., BEHAV RES M IN PRESS; Language Teaching and Research Institute of Beijing Language and Culture University, 1986, DICT MOD CHIN FREQ; LIU Y, 2006, AGE ACQUISITION ITS; Liu YY, 2007, BEHAV RES METHODS, V39, P192, DOI 10.3758/BF03193147; Myers J, 2006, J MEM LANG, V54, P300, DOI 10.1016/j.jml.2005.11.005; Myers J., 2006, REPRESENTATION PROCE, P169, DOI 10.1093/acprof:oso/9780199228911.003.0008; New B, 2007, APPL PSYCHOLINGUIST, V28, P661, DOI 10.1017/S014271640707035X; Packard J. L., 2000, MORPHOLOGY CHINESE L; Perfetti CA, 1998, J EXP PSYCHOL LEARN, V24, P101, DOI 10.1037/0278-7393.24.1.101; SUN MS, 2001, APPL LINGUISTICS BEI, P84; WONG K, 2010, INTRO CHINESE NATURA, DOI DOI 10.2200/S00211ED1V01Y200909HLT004; Xiao R., 2009, FREQUENCY DICT MANDA; Xing, 1997, 5 WORLD CHIN TEACH S; [俞士汶 Yu Shiwen], 2002, [中文信息学报, Journal of Chinese Information Processing], V16, P58; [俞士汶 Yu Shiwen], 2002, [中文信息学报, Journal of Chinese Information Processing], V16, P49; Zhang H.P., 2003, P 2 SIGHAN WORKSH CH, P184, DOI [10.3115/1119250.1119280, DOI 10.3115/1119250.1119280]; ZHANG K, 2002, P 1 SIGHAN WORKSH CH, P71; ZHANG R, 2008, ACM T SPEECH LANG PR, V5, DOI DOI 10.1145/1363108.1363109; Zhou XL, 1995, LANG COGNITIVE PROC, V10, P545, DOI 10.1080/01690969508407114	28	390	397	16	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2010	5	6							e10729	10.1371/journal.pone.0010729	http://dx.doi.org/10.1371/journal.pone.0010729			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	604NC	20532192	gold, Green Submitted, Green Published			2022-12-27	WOS:000278284700001
J	Zhu, JF; Zhang, YT; Alber, MS; Newman, SA				Zhu, Jianfeng; Zhang, Yong-Tao; Alber, Mark S.; Newman, Stuart A.			Bare Bones Pattern Formation: A Core Regulatory Network in Varying Geometries Reproduces Major Features of Vertebrate Limb Development and Evolution	PLOS ONE			English	Article							APICAL ECTODERMAL RIDGE; EMBRYONIC CHICK LIMB; DISCONTINUOUS GALERKIN METHODS; REACTION-DIFFUSION MODEL; FINITE-ELEMENT-METHOD; GENE-EXPRESSION; MICROMASS CULTURE; MOUSE LIMB; HOX GENES; MESENCHYMAL CONDENSATION	Background: Major unresolved questions regarding vertebrate limb development concern how the numbers of skeletal elements along the proximodistal (P-D) and anteroposterior (A-P) axes are determined and how the shape of a growing limb affects skeletal element formation. There is currently no generally accepted model for these patterning processes, but recent work on cartilage development (chondrogenesis) indicates that precartilage tissue self-organizes into nodular patterns by cell-molecular circuitry with local auto-activating and lateral inhibitory (LALI) properties. This process is played out in the developing limb in the context of a gradient of fibroblast growth factor (FGF) emanating from the apical ectodermal ridge (AER). Results: We have simulated the behavior of the core chondrogenic mechanism of the developing limb in the presence of an FGF gradient using a novel computational environment that permits simulation of LALI systems in domains of varying shape and size. The model predicts the normal proximodistal pattern of skeletogenesis as well as distal truncations resulting from AER removal. Modifications of the model's parameters corresponding to plausible effects of Hox proteins and formins, and of the reshaping of the model limb, bud yielded simulated phenotypes resembling mutational and experimental variants of the limb. Hypothetical developmental scenarios reproduce skeletal morphologies with features of fossil limbs. Conclusions: The limb chondrogenic regulatory system operating in the presence of a gradient has an inherent, robust propensity to form limb-like skeletal structures. The bare bones framework can accommodate ancillary gene regulatory networks controlling limb bud shaping and establishment of Hox expression domains. This mechanism accounts for major features of the normal limb pattern and, under variant geometries and different parameter values, those of experimentally manipulated, genetically aberrant and evolutionary early forms, with no requirement for an independent system of positional information.	[Zhu, Jianfeng; Zhang, Yong-Tao; Alber, Mark S.] Univ Notre Dame, Dept Math, Notre Dame, IN 46556 USA; [Alber, Mark S.] Univ Notre Dame, Ctr Study Biocomplex, Notre Dame, IN 46556 USA; [Newman, Stuart A.] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA	University of Notre Dame; University of Notre Dame; New York Medical College	Zhu, JF (corresponding author), Univ Notre Dame, Dept Math, Notre Dame, IN 46556 USA.	newman@nymc.edu	Newman, Stuart/W-1617-2019; Alber, Mark/AAR-1280-2020		National Science Foundation (NSF) [EF-0526854, DMS-0810413, DMS-0800612]; Oak Ridge Associated Universities (ORAU)	National Science Foundation (NSF)(National Science Foundation (NSF)); Oak Ridge Associated Universities (ORAU)	S. A. Newman acknowledges support from the National Science Foundation (NSF) Frontiers in Integrative Biological Research program (grant EF-0526854). Y.-T. Zhang's research is partially supported by NSF grant DMS-0810413 and the Oak Ridge Associated Universities (ORAU) Ralph E. Powe Junior Faculty Enhancement Award. This research of M. S. Alber is partially supported by NSF grant DMS-0800612. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber M, 2005, NONLINEARITY, V18, P125, DOI 10.1088/0951-7715/18/1/007; Alber M, 2008, B MATH BIOL, V70, P460, DOI 10.1007/s11538-007-9264-3; Bai ST, 2000, J BIOL CHEM, V275, P8267, DOI 10.1074/jbc.275.12.8267; Benazet JD, 2009, SCIENCE, V323, P1050, DOI 10.1126/science.1168755; Chaturvedi R, 2005, J R SOC INTERFACE, V2, P237, DOI 10.1098/rsif.2005.0033; Cheng Y, 2008, MATH COMPUT, V77, P699, DOI 10.1090/S0025-5718-07-02045-5; Chimal-Monroy J, 2003, DEV BIOL, V257, P292, DOI 10.1016/S0012-1606(03)00066-6; Christley S, 2007, PLOS COMPUT BIOL, V3, P743, DOI 10.1371/journal.pcbi.0030076.eor; Damon BJ, 2008, DEV BIOL, V321, P319, DOI 10.1016/j.ydbio.2008.06.018; Darwin C, 1859, ORIGIN SPECIES MEANS; De Boor C., 2001, PRACTICAL GUIDE SPLI; Deschamps J, 2004, SCIENCE, V304, P1610, DOI 10.1126/science.1099162; Dillon R, 1999, J THEOR BIOL, V197, P295, DOI 10.1006/jtbi.1998.0876; Forgacs G, 2005, BIOLOGICAL PHYSICS OF THE DEVELOPING EMBRYO, P1, DOI 10.1017/CBO9780511755576; Franssen RA, 2005, J MORPHOL, V265, P87, DOI 10.1002/jmor.10339; FRENZ DA, 1989, DEV BIOL, V136, P97, DOI 10.1016/0012-1606(89)90133-4; Fujimaki R, 2006, J BONE MINER METAB, V24, P191, DOI 10.1007/s00774-005-0671-y; GOETINCK PF, 1964, J EXP ZOOL, V155, P161, DOI 10.1002/jez.1401550204; GREGG BC, 1989, DEVELOPMENT, V105, P769; Hentschel HGE, 2004, P ROY SOC B-BIOL SCI, V271, P1713, DOI 10.1098/rspb.2004.2772; Johnson  C., 1987, NUMERICAL SOLUTION P, P278; KOSHER RA, 1979, J EMBRYOL EXP MORPH, V50, P75; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; LEFEVER R, 1967, J CHEM PHYS, V47, P1045, DOI 10.1063/1.1711987; LEONARD CM, 1991, DEV BIOL, V145, P99, DOI 10.1016/0012-1606(91)90216-P; Li SG, 1996, J EXP ZOOL, V274, P234, DOI 10.1002/(SICI)1097-010X(19960301)274:4<234::AID-JEZ4>3.0.CO;2-Q; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Mackem S, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.271pe33; Madzvamuse A, 2005, J SCI COMPUT, V24, P247, DOI 10.1007/s10915-004-4617-7; Maini PK, 2006, SCIENCE, V314, P1397, DOI 10.1126/science.1136396; MATSUTANI E, 1982, DEV BIOL, V92, P544, DOI 10.1016/0012-1606(82)90199-3; Meinhardt H., 2009, ALGORITHMIC BEAUTY S; Meinhardt H, 2008, CURR TOP DEV BIOL, V81, P1, DOI 10.1016/S0070-2153(07)81001-5; Miura T, 2000, DEV DYNAM, V217, P241, DOI 10.1002/(SICI)1097-0177(200003)217:3<241::AID-DVDY2>3.0.CO;2-K; Miura T, 2000, ANAT RECORD, V258, P100; Miura T, 2006, J THEOR BIOL, V240, P562, DOI 10.1016/j.jtbi.2005.10.016; Moftah MZ, 2002, DEV BIOL, V249, P270, DOI 10.1006/dbio.2002.0766; Montero JA, 2008, DEV BIOL, V321, P343, DOI 10.1016/j.ydbio.2008.06.022; Morishita Y, 2009, DEV DYNAM, V238, P415, DOI 10.1002/dvdy.21840; Morishita Y, 2008, B MATH BIOL, V70, P1957, DOI 10.1007/s11538-008-9334-1; Motani R, 1999, J VERTEBR PALEONTOL, V19, P28, DOI 10.1080/02724634.1999.10011120; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Newman SA, 2005, J EXP ZOOL PART B, V304B, P593, DOI 10.1002/jez.b.21066; NEWMAN SA, 1979, SCIENCE, V205, P662, DOI 10.1126/science.462174; Newman SA, 1996, BIOESSAYS, V18, P171, DOI 10.1002/bies.950180302; NEWMAN SA, 1980, J EMBRYOL EXP MORPH, V56, P191; NEWMAN SA, 1977, VERTEBRATE LIMB SOMI, P181; Newman Stuart A., 2007, Birth Defects Research, V81, P305, DOI 10.1002/bdrc.20112; Newman SA, 2008, CURR TOP DEV BIOL, V81, P311, DOI 10.1016/S0070-2153(07)81011-8; Niedzwiedzki G, 2010, NATURE, V463, P43, DOI 10.1038/nature08623; Nikbakht N, 1997, CELL MOL LIFE SCI, V53, P447, DOI 10.1007/s000180050054; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; Pan YH, 2005, DEV BIOL, V286, P472, DOI 10.1016/j.ydbio.2005.08.037; Pavel E, 2007, INT J DEV BIOL, V51, P273, DOI 10.1387/ijdb.062249ep; Pearse RV, 2007, DEV BIOL, V310, P388, DOI 10.1016/j.ydbio.2007.08.002; Perez WD, 2010, DEV DYNAM, V239, P446, DOI 10.1002/dvdy.22183; Pizette S, 2000, DEV BIOL, V219, P237, DOI 10.1006/dbio.2000.9610; ROS MA, 1994, DEV BIOL, V166, P59, DOI 10.1006/dbio.1994.1296; RUBIN L, 1972, DEV BIOL, V28, P94, DOI 10.1016/0012-1606(72)90129-7; Salazar-Ciudad I, 2003, DEVELOPMENT, V130, P2027, DOI 10.1242/dev.00425; Saunders J. W., 1968, EPITHELIAL MESENCHYM, P78; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; SCHNELL S, MULTISCALE MODELS DE; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; Shubin N, 2009, NATURE, V457, P818, DOI 10.1038/nature07891; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; SUMMERBELL D, 1976, J EMBRYOL EXP MORPH, V35, P241; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Tabin C, 2007, GENE DEV, V21, P1433, DOI 10.1101/gad.1547407; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; THOROGOOD PV, 1975, J EMBRYOL EXP MORPH, V33, P581; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Vargesson N, 2001, DEV DYNAM, V220, P87; Yang YZ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.253pe3; YOKOUCHI Y, 1995, GENE DEV, V9, P2509, DOI 10.1101/gad.9.20.2509; Yonei-Tamura S, 2008, EVOL DEV, V10, P737, DOI 10.1111/j.1525-142X.2008.00288.x; Yoon BS, 2006, DEVELOPMENT, V133, P4667, DOI 10.1242/dev.02680; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhou F, 2009, HUM MOL GENET, V18, P2472, DOI 10.1093/hmg/ddp185; Zhu J, 2009, MATH MODEL NAT PHENO, V4, P131, DOI 10.1051/mmnp/20094405; Zhu JF, 2009, J SCI COMPUT, V40, P391, DOI 10.1007/s10915-008-9218-4	83	67	68	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10892	10.1371/journal.pone.0010892	http://dx.doi.org/10.1371/journal.pone.0010892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531940	Green Submitted, Green Published, gold			2022-12-27	WOS:000278222100021
J	Rui, DL; Muraro, D				Rui Dilao; Muraro, Daniele			A Software Tool to Model Genetic Regulatory Networks. Applications to the Modeling of Threshold Phenomena and of Spatial Patterning in Drosophila	PLOS ONE			English	Article							POSITIONAL INFORMATION; MELANOGASTER; EXPRESSION; BIOLOGY; EMBRYO	We present a general methodology in order to build mathematical models of genetic regulatory networks. This approach is based on the mass action law and on the Jacob and Monod operon model. The mathematical models are built symbolically by the Mathematica software package GeneticNetworks. This package accepts as input the interaction graphs of the transcriptional activators and repressors of a biological process and, as output, gives the mathematical model in the form of a system of ordinary differential equations. All the relevant biological parameters are chosen automatically by the software. Within this framework, we show that concentration dependent threshold effects in biology emerge from the catalytic properties of genes and its associated conservation laws. We apply this methodology to the segment patterning in Drosophila early development and we calibrate the genetic transcriptional network responsible for the patterning of the gap gene proteins Hunchback and Knirps, along the antero-posterior axis of the Drosophila embryo. In this approach, the zygotically produced proteins Hunchback and Knirps do not diffuse along the antero-posterior axis of the embryo of Drosophila, developing a spatial pattern due to concentration dependent thresholds. This shows that patterning at the gap genes stage can be explained by the concentration gradients along the embryo of the transcriptional regulators.	[Rui Dilao; Muraro, Daniele] Univ Tecn Lisboa, Nonlinear Dynam Grp, Inst Super Tecn, Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico	Rui, DL (corresponding author), Univ Tecn Lisboa, Nonlinear Dynam Grp, Inst Super Tecn, Lisbon, Portugal.	rui@sd.ist.utl.pt	Dilão, Rui M A/L-5958-2013	Dilão, Rui M A/0000-0003-0190-4565	European project GENNETEC [FP6 STREP IST 034952]	European project GENNETEC	This work has been supported by European project GENNETEC, FP6 STREP IST 034952. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves F, 2005, CR BIOL, V328, P429, DOI 10.1016/j.crvi.2005.01.009; Alves F, 2006, J THEOR BIOL, V241, P342, DOI 10.1016/j.jtbi.2005.11.034; Coppey M, 2007, DEV BIOL, V312, P623, DOI 10.1016/j.ydbio.2007.09.058; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; DILAO R, 2010, ARXIV09124391V1; Dilao R, 2010, J THEOR BIOL, V264, P847, DOI 10.1016/j.jtbi.2010.03.012; Dilao R, 2009, LECT NOTES COMPUT SC, V5483, P176, DOI 10.1007/978-3-642-01184-9_16; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; ELLNER SP, 2006, DYNAMIC MODELS BIOL, P8; Fomekong-Nanfack Y, 2007, BIOINFORMATICS, V23, P3356, DOI 10.1093/bioinformatics/btm433; GILBERT SF, 1997, DEV BIOL, P547; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Horn F, 1972, ARCH RATIONAL MECH A, V47, P187, DOI DOI 10.1007/BF00251225); JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jaeger J, 2007, MECH DEVELOP, V124, P108, DOI 10.1016/j.mod.2006.11.001; Kerszberg M, 2007, CELL, V130, P205, DOI 10.1016/j.cell.2007.06.038; KLIPP E, 2005, SYSTEMS BIOL PRACTIC, P282; Maiwald T, 2008, BIOINFORMATICS, V24, P2037, DOI 10.1093/bioinformatics/btn350; Manu, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000303; NICOLIS G, 1977, SELF ORG NONEQUILIBR, P395; NussleinVolhard C, 1996, SCI AM, V275, P54; Perkins TJ, 2006, PLOS COMPUT BIOL, V2, P417, DOI 10.1371/journal.pcbi.0020051; Pisarev A, 2009, NUCLEIC ACIDS RES, V37, pD560, DOI 10.1093/nar/gkn717; Poustelnikova E, 2004, BIOINFORMATICS, V20, P2212, DOI 10.1093/bioinformatics/bth222; Reinitz J, 2007, NATURE, V448, P420, DOI 10.1038/448420a; Sanchez L, 2001, J THEOR BIOL, V211, P115, DOI 10.1006/jtbi.2001.2335; Tyson JJ, 2007, NATURE, V445, P823, DOI 10.1038/445823a; van Kampen NG, 2007, NORTH-HOLL PERS LIBR, P166; VOLPERT AI, 1994, TRAVELING WAVE SOLUT, P299	32	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10743	10.1371/journal.pone.0010743	http://dx.doi.org/10.1371/journal.pone.0010743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523731	Green Submitted, Green Published, gold			2022-12-27	WOS:000278221900004
J	Fletcher, MA; Zeng, XR; Maher, K; Levis, S; Hurwitz, B; Antoni, M; Broderick, G; Klimas, NG				Fletcher, Mary A.; Zeng, Xiao R.; Maher, Kevin; Levis, Silvina; Hurwitz, Barry; Antoni, Michael; Broderick, Gordon; Klimas, Nancy G.			Biomarkers in Chronic Fatigue Syndrome: Evaluation of Natural Killer Cell Function and Dipeptidyl Peptidase IV/CD26	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; IMMUNOLOGICAL ABNORMALITIES; T-CELLS; CD26; EXPRESSION; DYSFUNCTION; RETROVIRUS; BLOOD; PREVALENCE; DEFICIENCY	Background: Chronic Fatigue Syndrome (CFS) studies from our laboratory and others described decreased natural killer cell cytotoxicity (NKCC) and elevated proportion of lymphocytes expressing the activation marker, dipeptidyl peptidase IV (DPPIV) also known as CD26. However, neither these assays nor other laboratory tests are widely accepted for the diagnosis or prognosis of CFS. This study sought to determine if NKCC or DPPIV/CD26 have diagnostic accuracy for CFS. Methods/Results: Subjects included female and male CFS cases and healthy controls. NK cell function was measured with a bioassay, using K562 cells and Cr-51 release. Lymphocyte associated DPPIV/CD26 was assayed by qualitative and quantitative flow cytometry. Serum DPPIV/CD26 was measured by ELISA. Analysis by receiver operating characteristic (ROC) curve assessed biomarker potential. Cytotoxic function of NK cells for 176 CFS subjects was significantly lower than in the 230 controls. According to ROC analysis, NKCC was a good predictor of CFS status. There was no significant difference in NK cell counts between cases and controls. Percent CD2+ lymphocytes (T cells and NK cells) positive for DPPIV/C26 was elevated in CFS cases, but there was a decrease in the number of molecules (rMol) of DPPIV/C26 expressed on T cells and NK cells and a decrease in the soluble form of the enzyme in serum. Analyses by ROC curves indicated that all three measurements of DPPIV/CD26 demonstrated potential as biomarkers for CFS. None of the DPPIV/C26 assays were significantly correlated with NKCC. Conclusions: By ROC analysis, NKCC and three methods of measuring DPPIV/C26 examined in this study had potential as biomarkers for CFS. Of these, NKCC, %CD2+CD26+ lymphocytes and rMol CD26/CD2+ lymphocyte, required flow cytometry, fresh blood and access to a high complexity laboratory. Soluble DPPIV/C26 in serum is done with a standard ELISA assay, or with other soluble factors in a multiplex type of ELISA. Dipeptidyl peptidase IV on lymphocytes or in serum was not predictive of NKCC suggesting that these should be considered as non-redundant biomarkers. Abnormalities in DPPIV/CD26 and in NK cell function have particular relevance to the possible role of infection in the initiation and/or the persistence of CFS.	[Fletcher, Mary A.; Zeng, Xiao R.; Maher, Kevin; Levis, Silvina; Klimas, Nancy G.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA; [Fletcher, Mary A.; Zeng, Xiao R.; Levis, Silvina; Klimas, Nancy G.] Miami Vet Hlth Care Ctr, Miami, FL USA; [Fletcher, Mary A.; Hurwitz, Barry; Antoni, Michael; Klimas, Nancy G.] Univ Miami, Dept Psychol, Coral Gables, FL 33124 USA; [Broderick, Gordon] Univ Alberta, Dept Med, Edmonton, AB, Canada	University of Miami; University of Miami; University of Alberta	Fletcher, MA (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA.	mfletche@med.miami.edu		Antoni, Michael/0000-0002-3971-0873	NIAAA [R21AA016635]; NIAID [R01AI065723, UO1 AI459940]; CFIDS Assoc. of America; NHLBI [RO1 HL65668]; NIAMD [R01 AR48932-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048932] Funding Source: NIH RePORTER	NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CFIDS Assoc. of America; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMD; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the NIAAA: R21AA016635 (PI MA Fletcher); NIAID: R01AI065723 (PI MA Fletcher); CFIDS Assoc. of America: (PI N Klimas); NIAID: UO1 AI459940 (PI N Klimas), NHLBI: RO1 HL65668 (PI B Hurwitz); NIAMD: R01 AR48932-01A1 (PI S Levis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Aspler AL, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-44; BARKER E, 1994, CLIN INFECT DIS, V18, pS136, DOI 10.1093/clinids/18.Supplement_1.S136; Busso N, 2005, AM J PATHOL, V166, P433, DOI 10.1016/S0002-9440(10)62266-3; CALIGIURI M, 1987, J IMMUNOL, V139, P3306; Chandler HK, 2008, DISABIL REHABIL, V30, P1185, DOI 10.1080/09638280701500109; DEFREITAS E, 1991, P NATL ACAD SCI USA, V88, P2922, DOI 10.1073/pnas.88.7.2922; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Evengard B, 2003, PSYCHIAT CLIN NEUROS, V57, P361, DOI 10.1046/j.1440-1819.2003.01132.x; Evengard B, 2002, DRUGS, V62, P2433, DOI 10.2165/00003495-200262170-00003; FLETCHER MA, 1987, DIAGN CLIN IMMUNOL, V5, P69; Fuite J, 2008, GENOMICS, V92, P393, DOI 10.1016/j.ygeno.2008.08.008; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gerrity TR, 2002, NEUROIMMUNOMODULAT, V10, P134, DOI 10.1159/000067176; Glaser R, 2006, VIROLOGY, V346, P205, DOI 10.1016/j.virol.2005.10.034; Glaser R, 2005, BRAIN BEHAV IMMUN, V19, P91, DOI 10.1016/j.bbi.2004.09.001; Holmes MJ, 1997, J PSYCHIATR RES, V31, P115, DOI 10.1016/S0022-3956(96)00048-9; Hurwitz BE, 2010, CLIN SCI, V118, P125, DOI 10.1042/CS20090055; Ibegbu CC, 2009, IMMUNOLOGY, V126, P346, DOI 10.1111/j.1365-2567.2008.02899.x; Jason LA, 2003, J HEALTH PSYCHOL, V8, P459, DOI 10.1177/13591053030084005; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; Jason Leonard A, 2006, Health Care Women Int, V27, P615, DOI 10.1080/07399330600803766; Jason Leonard A, 2008, Dyn Med, V7, P6, DOI 10.1186/1476-5918-7-6; KHAN AS, 1993, ANN INTERN MED, V118, P241, DOI 10.7326/0003-4819-118-4-199302150-00001; KLIMAS NG, 1990, J CLIN MICROBIOL, V28, P1403, DOI 10.1128/JCM.28.6.1403-1410.1990; Kogelnik AM, 2006, J CLIN VIROL, V37, pS33, DOI 10.1016/S1386-6532(06)70009-9; LANDAY AL, 1991, LANCET, V338, P707, DOI 10.1016/0140-6736(91)91440-6; Ledina D, 2007, MED SCI MONITOR, V13, pCS88; LEVINE PH, 1992, CANCER RES, V52, pS5516; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Lyall M, 2003, J PSYCHOSOM RES, V55, P79, DOI 10.1016/S0022-3999(02)00515-9; MAHER K, 2006, APPL IMMUNOL REV, V5, P353; Maher K, 2003, HDB CHRONIC FATIGUE, P124; Maher KJ, 2005, CLIN EXP IMMUNOL, V142, P505, DOI 10.1111/j.1365-2249.2005.02935.x; MUSCAT C, 1994, CLIN EXP IMMUNOL, V98, P252; Raison CL, 2009, BRAIN BEHAV IMMUN, V23, P327, DOI 10.1016/j.bbi.2008.11.005; Reeves WC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-25; Reyes M, 2003, ARCH INTERN MED, V163, P1530, DOI 10.1001/archinte.163.13.1530; Reynolds Kenneth J, 2004, Cost Eff Resour Alloc, V2, P4, DOI 10.1186/1478-7547-2-4; Richter B, 2008, VASC HEALTH RISK MAN, V4, P753, DOI 10.2147/VHRM.S1707; Siegel SD, 2006, J PSYCHOSOM RES, V60, P559, DOI 10.1016/j.jpsychores.2006.03.001; Straburzynska-Lupa A, 2010, CLIN EXP RHEUMATOL, V28, P19; Thornberry NA, 2009, BEST PRACT RES CL EN, V23, P479, DOI 10.1016/j.beem.2009.03.004; Yan SL, 2003, EUR J IMMUNOL, V33, P1519, DOI 10.1002/eji.200323469; Yang SS, 2006, J GASTROEN HEPATOL, V21, P1789, DOI 10.1111/j.1440-1746.2006.04677.x; ZWEIG MH, 1993, CLIN CHEM, V39, P561	46	82	85	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2010	5	5							e10817	10.1371/journal.pone.0010817	http://dx.doi.org/10.1371/journal.pone.0010817			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CE	20520837	Green Published, gold			2022-12-27	WOS:000278034800013
J	Pasco-Viel, E; Charles, C; Chevret, P; Semon, M; Tafforeau, P; Viriot, L; Laudet, V				Pasco-Viel, Emmanuel; Charles, Cyril; Chevret, Pascale; Semon, Marie; Tafforeau, Paul; Viriot, Laurent; Laudet, Vincent			Evolutionary Trends of the Pharyngeal Dentition in Cypriniformes (Actinopterygii: Ostariophysi)	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; TOOTH DEVELOPMENT; TELEOSTEI CYPRINIFORMES; MOLECULAR SYSTEMATICS; COBITOIDEA TELEOSTEI; FISH; REPLACEMENT; PAEDOCYPRIS; CYPRINIDAE; TEETH	Background: The fish order Cypriniformes is one of the most diverse ray-finned fish groups in the world with more than 3000 recognized species. Cypriniformes are characterized by a striking distribution of their dentition: namely the absence of oral teeth and presence of pharyngeal teeth on the last gill arch (fifth ceratobranchial). Despite this limited localisation, the diversity of tooth patterns in Cypriniformes is astonishing. Here we provide a further description of this diversity using X-ray microtomography and we map the resulting dental characters on a phylogenetic tree to explore evolutionary trends. Results: We performed a pilot survey of dental formulae and individual tooth shapes in 34 adult species of Cypriniformes by X-ray microtomography (using either conventional X-ray machine, or synchrotron microtomography when necessary) or by dissecting. By mapping morphological results in a phylogenetic tree, it emerges that the two super-families Cobitoidea and Cyprinoidea have followed two distinct evolutionary pathways. Furthermore, our analysis supports the hypothesis of a three-row dentition as ancestral for Cyprinoidea and a general trend in tooth row reduction in most derived lineages. Yet, this general scheme must be considered with caution as several events of tooth row gain and loss have occurred during evolutionary history of Cyprinoidea. Significance: Dentition diversity in Cypriniformes constitutes an excellent model to study the evolution of complex morphological structures. This morphological survey clearly advocates for extending the use of X-ray microtomography to study tooth morphology in Cypriniformes. Yet, our survey also underlines that improved knowledge of Cypriniformes life traits, such as feeding habits, is required as current knowledge is not sufficient to conclude on the link between diet and dental morphology.	[Pasco-Viel, Emmanuel; Chevret, Pascale; Semon, Marie; Viriot, Laurent; Laudet, Vincent] Univ Lyon, CNRS, INRA, Ecole Normale Super Lyon,Inst Genom Fonct Lyon, Lyon, France; [Charles, Cyril; Viriot, Laurent] Univ Poitiers, iPHEP, CNRS, UMR 6046, Poitiers, France; [Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; European Synchrotron Radiation Facility (ESRF)	Pasco-Viel, E (corresponding author), Univ Lyon, CNRS, INRA, Ecole Normale Super Lyon,Inst Genom Fonct Lyon, Lyon, France.	Laurent.Viriot@ens-lyon.fr; Vincent.Laudet@ens-lyon.fr	Charles, Cyril/E-7606-2011; Chevret, Pascale/B-7299-2009	Charles, Cyril/0000-0002-6930-039X; Viriot, Laurent/0000-0003-2092-588X; Tafforeau, Paul/0000-0002-5962-1683; Semon, Marie/0000-0003-3479-7524	Ministere de l'Education Nationale de la Recherche et de Technologie (MENRT); Centre National de la Recherche Scientifique (CNRS); European Synchrotron Radiation Facility (ESRF); Ecole Normale Superieure (ENS) of Lyon; Agence Nationale pour la Recherche (ANR) [ANR-09-BLAN-0127-02]	Ministere de l'Education Nationale de la Recherche et de Technologie (MENRT); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); European Synchrotron Radiation Facility (ESRF); Ecole Normale Superieure (ENS) of Lyon; Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR))	This work has been funded by the Ministere de l'Education Nationale de la Recherche et de Technologie (MENRT, www.education.gouv.fr), the Centre National de la Recherche Scientifique (CNRS, www.cnrs.fr), the European Synchrotron Radiation Facility (ESRF, www.esrf.eu) and Ecole Normale Superieure (ENS) of Lyon (www.ens-lyon.fr) as well as by Agence Nationale pour la Recherche (ANR) grant Bouillabaisse (www.agence-nationale-recherche.fr/ANR-09-BLAN-0127-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker D, 2007, BIOINFORMATICS, V23, P14, DOI 10.1093/bioinformatics/btl558; Borday-Birraux V, 2006, EVOL DEV, V8, P130, DOI 10.1111/j.1525-142X.2006.00084.x; Boulenger G.A., 1909, CATALOGUE FRESHWATER, VI; BOULENGER GA, 1909, CATALOGUE FRESHWATER, V2; Britz R, 2009, J MORPHOL, V270, P389, DOI 10.1002/jmor.10698; Britz R, 2009, P ROY SOC B-BIOL SCI, V276, P2179, DOI 10.1098/rspb.2009.0141; Caton J, 2009, J ANAT, V214, P502, DOI 10.1111/j.1469-7580.2008.01014.x; CAVENDER TM, 1991, CYPRINID FISHES SYST, P34; CHANG M, 2008, SPECIAL PUBLICATIONS, V295, P337; Chen WJ, 2009, MOL PHYLOGENET EVOL, V52, P544, DOI 10.1016/j.ympev.2009.01.006; Chu Y.T., 1935, BIOL BULL+, V2, P1, DOI DOI 10.2307/1436747; Collin R, 2008, TRENDS ECOL EVOL, V23, P602, DOI 10.1016/j.tree.2008.06.013; Conway KW, 2008, ZOOTAXA, P1; Conway-Morris Simon., 1998, CRUCIBLE CREATION BU; Davidson EH, 2006, REG GEN GEN REG; Debiais-Thibaud M, 2008, EVOL DEV, V10, P464, DOI 10.1111/j.1525-142X.2008.00257.x; Debiais-Thibaud M, 2007, J EXP ZOOL PART B, V308B, P693, DOI 10.1002/jez.b.21183; EASTMAN JT, 1973, COPEIA, P45; Fraser GJ, 2009, PLOS BIOL, V7, P233, DOI 10.1371/journal.pbio.1000031; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; GAYET M, 1987, Contributions from the Museum of Paleontology University of Michigan, V27, P151; Golubtsov AS, 2005, J FISH BIOL, V67, P286, DOI 10.1111/j.0022-1112.2005.00724.x; GOSLINE WA, 1973, COPEIA, P761; HANKEN J, 1993, ANNU REV ECOL SYST, V24, P501, DOI 10.1146/annurev.es.24.110193.002441; He SP, 2008, MOL PHYLOGENET EVOL, V46, P818, DOI 10.1016/j.ympev.2007.06.001; Heckel J., 1858, SUSSWASSERFISCHE OST; Honeycutt Rodney L, 2008, J Biol, V7, P9, DOI 10.1186/jbiol71; Huysseune A, 2008, EVOL DEV, V10, P6, DOI 10.1111/j.1525-142X.2007.00209.x; Huysseune A, 2004, BIOESSAYS, V26, P665, DOI 10.1002/bies.20039; Huysseune A, 2009, J ANAT, V214, P465, DOI 10.1111/j.1469-7580.2009.01053.x; Jackman WR, 2006, P NATL ACAD SCI USA, V103, P19390, DOI 10.1073/pnas.0609575103; Jayaram K. C., 1981, FRESHWATER FISHES IN; JORDAN DS, 1896, FISHES N MIDDLE AM, V1; Kottelat M, 2006, P ROY SOC B-BIOL SCI, V273, P895, DOI 10.1098/rspb.2005.3419; Kuratani S, 2009, DEV BIOL, V332, P61, DOI 10.1016/j.ydbio.2009.05.564; Lazzari V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003607; Liu J, 2009, SCI CHINA SER D, V52, P189, DOI 10.1007/s11430-009-0022-2; Mayden RL, 2007, J EXP ZOOL PART B, V308B, P642, DOI 10.1002/jez.b.21175; Mayden RL, 2009, MOL PHYLOGENET EVOL, V51, P500, DOI 10.1016/j.ympev.2008.12.015; NAKAJIMA T, 1987, COPEIA, P208; Nelson J.S., 1991, CYPRINID FISHES SYST, P353; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Organ CL, 2007, NATURE, V446, P180, DOI 10.1038/nature05621; Organ CL, 2009, NATURE, V461, P389, DOI 10.1038/nature08350; Otero O, 2001, J VERTEBR PALEONTOL, V21, P386, DOI 10.1671/0272-4634(2001)021[0386:TOKCFO]2.0.CO;2; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Patterson C., 1993, FOSS REC, V2, P622; Regan CT., 1911, FRESHWATER FISHES BR, DOI [10.5962/bhl.title.13625, DOI 10.5962/BHL.TITLE.13625]; Renaud S, 2005, P ROY SOC B-BIOL SCI, V272, P609, DOI 10.1098/rspb.2004.2992; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruber L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-38; Saitoh K, 2006, J MOL EVOL, V63, P826, DOI 10.1007/s00239-005-0293-y; Scott JL, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1002; Slechtova V, 2007, MOL PHYLOGENET EVOL, V44, P1358, DOI 10.1016/j.ympev.2007.02.019; Stock DW, 2007, J EXP ZOOL PART B, V308B, P523, DOI 10.1002/jez.b.21187; Stock DW, 2006, DEVELOPMENT, V133, P3127, DOI 10.1242/dev.02459; Streelman JT, 2007, ANNU REV ECOL EVOL S, V38, P655, DOI 10.1146/annurev.ecolsys.38.091206.095537; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Talwar P.K., 1992, INLAND FISHES INDIA, V1-2; Tang QY, 2006, MOL PHYLOGENET EVOL, V39, P347, DOI 10.1016/j.ympev.2005.08.007; TAYLOR W R, 1985, Cybium, V9, P107; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Tummers M, 2009, J EXP ZOOL PART B, V312B, P309, DOI 10.1002/jez.b.21280; Van der heyden C, 2001, ARCH ORAL BIOL, V46, P1051, DOI 10.1016/S0003-9969(01)00064-4; Van der Heyden C, 2000, DEV DYNAM, V219, P486; Wang X, 2007, J NEUROIMMUNE PHARM, V2, P42, DOI 10.1007/s11481-006-9059-6; Wautier K, 2001, ARCH ORAL BIOL, V46, P67, DOI 10.1016/S0003-9969(00)00091-1; Winfield IJ, 1991, CYPRINID FISHES SYST; Xiao WH, 2001, MOL PHYLOGENET EVOL, V18, P163, DOI 10.1006/mpev.2000.0879; Zardoya R, 1999, J MOL EVOL, V49, P227, DOI 10.1007/PL00006545; Zhang ZY, 2009, SCIENCE, V323, P1232, DOI 10.1126/science.1167418	71	43	47	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11293	10.1371/journal.pone.0011293	http://dx.doi.org/10.1371/journal.pone.0011293			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585584	Green Published, Green Submitted, gold			2022-12-27	WOS:000279135800006
J	Kazembe, LN; Mpeketula, PMG				Kazembe, Lawrence N.; Mpeketula, Placid M. G.			Quantifying Spatial Disparities in Neonatal Mortality Using a Structured Additive Regression Model	PLOS ONE			English	Article							SPACE-TIME DATA; INFANT-MORTALITY; RURAL MALAWI; SPLINES; PERSPECTIVE; MORBIDITY; COUNTRIES; PATTERNS; OUTCOMES	Background: Neonatal mortality contributes a large proportion towards early childhood mortality in developing countries, with considerable geographical variation at small areas within countries. Methods: A geo-additive logistic regression model is proposed for quantifying small-scale geographical variation in neonatal mortality, and to estimate risk factors of neonatal mortality. Random effects are introduced to capture spatial correlation and heterogeneity. The spatial correlation can be modelled using the Markov random fields (MRF) when data is aggregated, while the two dimensional P-splines apply when exact locations are available, whereas the unstructured spatial effects are assigned an independent Gaussian prior. Socio-economic and bio-demographic factors which may affect the risk of neonatal mortality are simultaneously estimated as fixed effects and as nonlinear effects for continuous covariates. The smooth effects of continuous covariates are modelled by second-order random walk priors. Modelling and inference use the empirical Bayesian approach via penalized likelihood technique. The methodology is applied to analyse the likelihood of neonatal deaths, using data from the 2000 Malawi demographic and health survey. The spatial effects are quantified through MRF and two dimensional P-splines priors. Results: Findings indicate that both fixed and spatial effects are associated with neonatal mortality. Conclusions: Our study, therefore, suggests that the challenge to reduce neonatal mortality goes beyond addressing individual factors, but also require to understanding unmeasured covariates for potential effective interventions.	[Kazembe, Lawrence N.] Univ Malawi, Chancellor Coll, Dept Math Sci, Appl Stat & Epidemiol Res Unit, Zomba, Malawi; [Mpeketula, Placid M. G.] Univ Malawi, Chancellor Coll, Dept Biol, Zomba, Malawi	University of Malawi; University of Malawi	Kazembe, LN (corresponding author), Univ Malawi, Chancellor Coll, Dept Math Sci, Appl Stat & Epidemiol Res Unit, Zomba, Malawi.	lkazembe@yahoo.com						Adebayo SB, 2004, ECON HUM BIOL, V2, P229, DOI 10.1016/j.ehb.2004.04.004; [Anonymous], 2003, 131 IFPRI; Balk D., 2004, Population, Space and Place, V10, P175, DOI 10.1002/psp.328; Banerjee S., 2004, HIERARCHICAL MODELIN; Belitz C, 2010, STATISTICAL MODELLING AND REGRESSION STRUCTURES, P155, DOI 10.1007/978-3-7908-2413-1_9; Besag J, 1995, BIOMETRIKA, V82, P733, DOI 10.2307/2337341; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Bolstad WM, 2001, J AM STAT ASSOC, V96, P12, DOI 10.1198/016214501750332659; Brezger A, 2005, J STAT SOFTW, V14, P1; Chaix B, 2005, AM J EPIDEMIOL, V162, P171, DOI 10.1093/aje/kwi175; *CHILD HLTH RES PR, 1999, RED PER NEON MORT SP; Congdon P, 2010, INT J ENV RES PUB HE, V7, P333, DOI 10.3390/ijerph7020333; d'Orsi Eleonora, 2005, Cad. Saúde Pública, V21, P786, DOI 10.1590/S0102-311X2005000300012; Elliot P, 2000, SPATIAL EPIDEMIOLOGY; Fahrmeir L, 2004, STAT SINICA, V14, P731; Gemperli A, 2004, AM J EPIDEMIOL, V159, P64, DOI 10.1093/aje/kwh001; GEMPERLI A, 2003, J MODERN APPL STAT M, V2, P497; Heard Nathan J, 2004, Afr J Reprod Health, V8, P164, DOI 10.2307/3583189; *INT FOOD POL RES, 2002, MAL ATL SOC STAT; Kammann EE, 2003, J R STAT SOC C-APPL, V52, P1, DOI 10.1111/1467-9876.00385; Kandala NB, 2006, APPL STOCH MODEL BUS, V22, P139, DOI 10.1002/asmb.624; Kazembe LN, 2007, EUR J EPIDEMIOL, V22, P545, DOI 10.1007/s10654-007-9145-y; Kneib T, 2006, BIOMETRICS, V62, P109, DOI 10.1111/j.1541-0420.2005.00392.x; KNEIB T, 2006, THESIS U MUNICH MUNI; Kneib T, 2007, SCAND J STAT, V34, P207, DOI 10.1111/j.1467-9469.2006.00524.x; Kulmala T, 2000, ACTA OBSTET GYN SCAN, V79, P984, DOI 10.1034/j.1600-0412.2000.079011984.x; Kulmala T, 2000, PAEDIATR PERINAT EP, V14, P219, DOI 10.1046/j.1365-3016.2000.00270.x; Lang S, 2004, J COMPUT GRAPH STAT, V13, P183, DOI 10.1198/1061860043010; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2004, LANCET, V364, P399, DOI 10.1016/S0140-6736(04)16783-4; Lin XH, 1999, J ROY STAT SOC B, V61, P381, DOI 10.1111/1467-9868.00183; MANDA SOM, 1999, GENUS, V54, P141; National Statistics Office and ORC Macro, 2001, MAL DEM HLTH SURV 20; Tomkins A, 2003, T ROY SOC TROP MED H, V97, P16, DOI 10.1016/S0035-9203(03)90007-1; UNICEF, 2008, STAT WORLDS CHILD 20, P1; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374; World Health Organization, 2005, WORLD HLTH REP 2005	37	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11180	10.1371/journal.pone.0011180	http://dx.doi.org/10.1371/journal.pone.0011180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567519	Green Published, Green Submitted, gold			2022-12-27	WOS:000278886300022
J	Wertheim, JO				Wertheim, Joel O.			The Re-Emergence of H1N1 Influenza Virus in 1977: A Cautionary Tale for Estimating Divergence Times Using Biologically Unrealistic Sampling Dates	PLOS ONE			English	Article							LENGTH DNA-COPY; A VIRUS; CLONING; EMERGENCE; EVOLUTION; GENOME	In 1977, H1N1 influenza A virus reappeared after a 20-year absence. Genetic analysis indicated that this strain was missing decades of nucleotide sequence evolution, suggesting an accidental release of a frozen laboratory strain into the general population. Recently, this strain and its descendants were included in an analysis attempting to date the origin of pandemic influenza virus without accounting for the missing decades of evolution. Here, we investigated the effect of using viral isolates with biologically unrealistic sampling dates on estimates of divergence dates. Not accounting for missing sequence evolution produced biased results and increased the variance of date estimates of the most recent common ancestor of the re-emergent lineages and across the entire phylogeny. Reanalysis of the H1N1 sequences excluding isolates with unrealistic sampling dates indicates that the 1977 re-emergent lineage was circulating for approximately one year before detection, making it difficult to determine the geographic source of reintroduction. We suggest that a new method is needed to account for viral isolates with unrealistic sampling dates.	Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA	University of California System; University of California San Diego	Wertheim, JO (corresponding author), Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA.	jwertheim@ucsd.edu			 [NIH-AI07384];  [NSF-0714991];  [NIH-AI47745]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007384] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JOW was funded by a fellowship from NIH-AI07384. Additional support came from NSF-0714991 and NIH-AI47745. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEKLEMISHEV AB, 1984, BIOORG KHIM+, V10, P1535; BEKLEMISHEV AB, 1985, BIOORG KHIM+, V11, P641; BEKLEMISHEV AB, 1985, BIOORG KHIM+, V11, P628; BEVERIDGE WIB, 1978, NEW SCI, P790; Bush RM, 2000, P NATL ACAD SCI USA, V97, P6974, DOI 10.1073/pnas.97.13.6974; dos Reis M, 2009, J MOL EVOL, V69, P333, DOI 10.1007/s00239-009-9282-x; Drummond A, 2003, ADV PARASIT, V54, P331, DOI 10.1016/S0065-308X(03)54008-8; Drummond AJ, 2003, TRENDS ECOL EVOL, V18, P481, DOI 10.1016/S0169-5347(03)00216-7; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; FITCH WM, 1991, P NATL ACAD SCI USA, V88, P4270, DOI 10.1073/pnas.88.10.4270; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Kerr PJ, 2009, J VIROL, V83, P12129, DOI 10.1128/JVI.01523-09; Krasnitz M, 2008, J VIROL, V82, P8947, DOI 10.1128/JVI.00101-08; MCKINLEY RL, 1988, J EDUC MEAS, V25, P233, DOI 10.1111/j.1745-3984.1988.tb00305.x; NAKAJIMA K, 1978, NATURE, V274, P334, DOI 10.1038/274334a0; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; SCHOLTISSEK C, 1978, VIROLOGY, V89, P613, DOI 10.1016/0042-6822(78)90203-9; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; World Health Organization, 1978, WKLY EPIDEMIOL REC, V53, P21; Worobey M, 2008, J VIROL, V82, P3769, DOI 10.1128/JVI.02207-07; Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322	21	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11184	10.1371/journal.pone.0011184	http://dx.doi.org/10.1371/journal.pone.0011184			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567599	Green Published, Green Submitted, gold			2022-12-27	WOS:000278886300026
J	Duch, J; Waitzman, JS; Amaral, LAN				Duch, Jordi; Waitzman, Joshua S.; Amaral, Luis A. Nunes			Quantifying the Performance of Individual Players in a Team Activity	PLOS ONE			English	Article							COLLABORATION	Background: Teamwork is a fundamental aspect of many human activities, from business to art and from sports to science. Recent research suggest that team work is of crucial importance to cutting-edge scientific research, but little is known about how teamwork leads to greater creativity. Indeed, for many team activities, it is not even clear how to assign credit to individual team members. Remarkably, at least in the context of sports, there is usually a broad consensus on who are the top performers and on what qualifies as an outstanding performance. Methodology/Principal Findings: In order to determine how individual features can be quantified, and as a test bed for other team-based human activities, we analyze the performance of players in the European Cup 2008 soccer tournament. We develop a network approach that provides a powerful quantification of the contributions of individual players and of overall team performance. Conclusions/Significance: We hypothesize that generalizations of our approach could be useful in other contexts where quantification of the contributions of individual team members is important.	[Duch, Jordi; Waitzman, Joshua S.; Amaral, Luis A. Nunes] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Duch, Jordi; Amaral, Luis A. Nunes] Northwestern Univ, NW Inst Complex Syst, Evanston, IL USA; [Duch, Jordi] Univ Rovira & Virgili, Dept Comp Sci & Math, Tarragona, Spain; [Amaral, Luis A. Nunes] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL USA	Northwestern University; Northwestern University; Universitat Rovira i Virgili; Howard Hughes Medical Institute; Northwestern University	Duch, J (corresponding author), Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.	amaral@northwestern.edu	Amaral, LAN/A-4980-2008; Duch, Jordi/A-7000-2008; Amaral, Luis N./C-5485-2009	Amaral, LAN/0000-0002-3762-789X; Duch, Jordi/0000-0003-2639-6333; Waitzman, Joshua/0000-0003-3364-6281	National Science Foundation (NSF) [SBE-0830388, IIS-0838564]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work has been funded through National Science Foundation (NSF) (http://www.nsf.gov/) awards SBE-0830388 and IIS-0838564. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PATTERN RECOGN LETT; Brillinger DR, 2007, J QUANT ANAL SPORTS, V3, DOI 10.2202/1559-0410.1048; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; KATZENBACK JR, 1993, WISDOM TEAMS; Lucifora C., 2003, Journal of Sports Economics, V4, P35, DOI 10.1177/1527002502239657; ROSEN S, 1981, AM ECON REV, V71, P845; Scott J., 2000, SOCIAL STRUCTURE, V2nd; Tufte ER., 1997, VISUAL EXPLANATIONS; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Whitfield J, 2008, NATURE, V455, P720, DOI 10.1038/455720a; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; [No title captured]	14	203	207	3	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e10937	10.1371/journal.pone.0010937	http://dx.doi.org/10.1371/journal.pone.0010937			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585387	gold, Green Published, Green Submitted			2022-12-27	WOS:000278886100001
J	Yewdall, AW; Drutman, SB; Jinwala, F; Bahjat, KS; Bhardwaj, N				Yewdall, Alice W.; Drutman, Scott B.; Jinwala, Felecia; Bahjat, Keith S.; Bhardwaj, Nina			CD8+T Cell Priming by Dendritic Cell Vaccines Requires Antigen Transfer to Endogenous Antigen Presenting Cells	PLOS ONE			English	Article							T-CELLS; IN-VIVO; APOPTOTIC CELLS; IMMUNE-SYSTEM; LYMPH-NODES; IMMUNOTHERAPY; MATURATION; COMPLEXES; OVALBUMIN; RESPONSES	Background: Immunotherapeutic strategies to stimulate anti-tumor immunity are promising approaches for cancer treatment. A major barrier to their success is the immunosuppressive microenvironment of tumors, which inhibits the functions of endogenous dendritic cells (DCs) that are necessary for the generation of anti-tumor CD8+ T cells. To overcome this problem, autologous DCs are generated ex vivo, loaded with tumor antigens, and activated in this non-suppressive environment before administration to patients. However, DC-based vaccines rarely induce tumor regression. Methodology/Principal Findings: We examined the fate and function of these DCs following their injection using murine models, in order to better understand their interaction with the host immune system. Contrary to previous assumptions, we show that DC vaccines have an insignificant role in directly priming CD8+ T cells, but instead function primarily as vehicles for transferring antigens to endogenous antigen presenting cells, which are responsible for the subsequent activation of T cells. Conclusions/Significance: This reliance on endogenous immune cells may explain the limited success of current DC vaccines to treat cancer and offers new insight into how these therapies can be improved. Future approaches should focus on creating DC vaccines that are more effective at directly priming T cells, or abrogating the tumor induced suppression of endogenous DCs.	[Yewdall, Alice W.; Drutman, Scott B.; Jinwala, Felecia; Bhardwaj, Nina] NYU, Sch Med, Inst Canc, New York, NY USA; [Bahjat, Keith S.] Providence Canc Ctr, Earle A Chiles Res Inst, Portland, OR USA	New York University	Yewdall, AW (corresponding author), Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA.	Nina.Bhardwaj@nyumc.org		Bhardwaj, Nina/0000-0003-1865-4187	Cancer Research Institute; Doris Duke Charitable Foundation; National Institutes of Health (NIH) [A1044628, A1071078, A1061684]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044628, R01AI071078] Funding Source: NIH RePORTER	Cancer Research Institute; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by the Cancer Research Institute, the Doris Duke Charitable Foundation, and the National Institutes of Health (NIH) grants A1044628, A1071078, and A1061684 to N.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Andre F, 2004, J IMMUNOL, V172, P2126, DOI 10.4049/jimmunol.172.4.2126; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baumjohann D, 2006, EUR J IMMUNOL, V36, P2544, DOI 10.1002/eji.200535742; BERENDT MJ, 1978, J EXP MED, V148, P1550, DOI 10.1084/jem.148.6.1550; Bhardwaj N, 2007, J CLIN INVEST, V117, P1130, DOI 10.1172/JCI32136; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Bui JD, 2007, CURR OPIN IMMUNOL, V19, P203, DOI 10.1016/j.coi.2007.02.001; CARBONE FR, 1990, J EXP MED, V171, P377, DOI 10.1084/jem.171.2.377; Dolan BP, 2006, J IMMUNOL, V176, P1447, DOI 10.4049/jimmunol.176.3.1447; Dolan BP, 2006, J IMMUNOL, V177, P6018, DOI 10.4049/jimmunol.177.9.6018; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Harshyne LA, 2001, J IMMUNOL, V166, P3717, DOI 10.4049/jimmunol.166.6.3717; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Labeur MS, 1999, J IMMUNOL, V162, P168; Lesterhuis WJ, 2008, CRIT REV ONCOL HEMAT, V66, P118, DOI 10.1016/j.critrevonc.2007.12.007; Li M, 2001, J IMMUNOL, V166, P6099, DOI 10.4049/jimmunol.166.10.6099; Luketic L, 2007, J IMMUNOL, V179, P5024, DOI 10.4049/jimmunol.179.8.5024; Luo XR, 2007, P NATL ACAD SCI USA, V104, P2821, DOI 10.1073/pnas.0611646104; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Munz C, 2005, J EXP MED, V202, P203, DOI 10.1084/jem.20050810; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; NIKOLICZUGIC J, 1990, EUR J IMMUNOL, V20, P2431, DOI 10.1002/eji.1830201111; O'Neill DW, 2004, BLOOD, V104, P2235, DOI 10.1182/blood-2003-12-4392; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Salio M, 2004, J EXP MED, V199, P567, DOI 10.1084/jem.20031059; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Schadendorf D, 2006, ANN ONCOL, V17, P563, DOI 10.1093/annonc/mdj138; Schlecht G, 2004, BLOOD, V104, P1808, DOI 10.1182/blood-2004-02-0426; SHASTRI N, 1993, J IMMUNOL, V150, P2724; Smith AL, 1999, J EXP MED, V189, P593, DOI 10.1084/jem.189.3.593; Soruri A, 2005, INT J BIOCHEM CELL B, V37, P241, DOI 10.1016/j.biocel.2004.07.003; Steinman RM, 2007, EUR J IMMUNOL, V37, pS53, DOI 10.1002/eji.200737400; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002; Vugmeyster Y, 1998, P NATL ACAD SCI USA, V95, P12492, DOI 10.1073/pnas.95.21.12492; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062	53	85	87	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11144	10.1371/journal.pone.0011144	http://dx.doi.org/10.1371/journal.pone.0011144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585396	Green Published, gold, Green Submitted			2022-12-27	WOS:000278886100012
J	Minozzi, G; Buggiotti, L; Stella, A; Strozzi, F; Luini, M; Williams, JL				Minozzi, Giulietta; Buggiotti, Laura; Stella, Alessandra; Strozzi, Francesco; Luini, Mario; Williams, John L.			Genetic Loci Involved in Antibody Response to Mycobacterium avium ssp. paratuberculosis in Cattle	PLOS ONE			English	Article							SUBSP PARATUBERCULOSIS; CROHNS-DISEASE; ASSOCIATION ANALYSIS; JOHNES-DISEASE; INFECTION; IDENTIFICATION; RESISTANCE; BLIMP-1; SUSCEPTIBILITY; POLYMORPHISMS	Background: Mycobacterium avium subsp. paratuberculosis (MAP) causes chronic enteritis in a wide range of animal species. In cattle, MAP causes a chronic disease called Johne's disease, or paratuberculosis, that is not treatable and the efficacy of vaccine control is controversial. The clinical phase of the disease is characterised by diarrhoea, weight loss, drop in milk production and eventually death. Susceptibility to MAP infection is heritable with heritability estimates ranging from 0.06 to 0.10. There have been several studies over the last few years that have identified genetic loci putatively associated with MAP susceptibility, however, with the availability of genome-wide high density SNP maker panels it is now possible to carry out association studies that have higher precision. Methodology/Principal Findings: The objective of the current study was to localize genes having an impact on Johne's disease susceptibility using the latest bovine genome information and a high density SNP panel (Illumina BovineSNP50 BeadChip) to perform a case/control, genome-wide association analysis. Samples from MAP case and negative controls were selected from field samples collected in 2007 and 2008 in the province of Lombardy, Italy. Cases were defined as animals serologically positive for MAP by ELISA. In total 966 samples were genotyped: 483 MAP ELISA positive and 483 ELISA negative. Samples were selected randomly among those collected from 119 farms which had at least one positive animal. Conclusion/Significance: The analysis of the genotype data identified several chromosomal regions associated with disease status: a region on chromosome 12 with high significance (P<5x10(-6)), while regions on chromosome 9, 11, and 12 had moderate significance (P<5x10(-5)). These results provide evidence for genetic loci involved in the humoral response to MAP. Knowledge of genetic variations related to susceptibility will facilitate the incorporation of this information into breeding programmes for the improvement of health status.	[Minozzi, Giulietta; Stella, Alessandra; Strozzi, Francesco; Williams, John L.] Polo Univ, Lodi, Italy; [Buggiotti, Laura] Ist Sperimentale Italiano Lazzaro Spallanzani, Lodi, Italy; [Stella, Alessandra] CNR, Ist Biol & Biotecnol Agr, Lodi, Italy; [Luini, Mario] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Lodi, Italy	IRCCS Lazzaro Spallanzani; Consiglio Nazionale delle Ricerche (CNR); IZS Lombardia e Emilia	Minozzi, G (corresponding author), Polo Univ, Parco Tecnol Padano, Lodi, Italy.	giulietta.minozzi@tecnoparco.org	Stella, Alessandra/AAY-7322-2020; Minozzi, Giulietta/K-8126-2017; stella, Alessandra/AAG-6401-2021; stella, Alessandra/ABB-1952-2021; Buggiotti, Laura/G-9777-2014	Minozzi, Giulietta/0000-0002-0020-8798; stella, Alessandra/0000-0003-2850-3964; stella, Alessandra/0000-0003-2850-3964; Buggiotti, Laura/0000-0002-7404-7800; Williams, John/0000-0001-5188-7957; Strozzi, Francesco/0000-0002-6845-6982	EC [FP7-KBBE-2007-1-1-2-211602]; Cariplo Foundation	EC(European CommissionEuropean Commission Joint Research Centre); Cariplo Foundation(Fondazione Cariplo)	This work was supported by the EC MacroSys project ref number FP7-KBBE-2007-1-1-2-211602, and partially by the Cariplo Foundation. Funding for GM and LB was provided by the EC MacroSys project ref number FP7-KBBE-2007-1-1-2-211602, and JLW and FS were funded by the Cariplo Foundation for research support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Ansari M, 2009, BLOOD, V114, P1383, DOI 10.1182/blood-2008-11-191098; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Beard PM, 2001, J CLIN MICROBIOL, V39, P1517, DOI 10.1128/JCM.39.4.1517-1521.2001; Bull TJ, 2003, J CLIN MICROBIOL, V41, P2915, DOI 10.1128/JCM.41.7.2915-2923.2003; Cetinkaya B, 1997, PREV VET MED, V32, P253, DOI 10.1016/S0167-5877(97)00028-7; Chang DH, 2000, NAT IMMUNOL, V1, P169, DOI 10.1038/77861; Clarke CJ, 1997, J COMP PATHOL, V116, P217, DOI 10.1016/S0021-9975(97)80001-1; Collins MT, 2005, CLIN DIAGN LAB IMMUN, V12, P685, DOI 10.1128/CDLI.12.6.685-692.2005; de Almeida DE, 2008, VET IMMUNOL IMMUNOP, V125, P234, DOI 10.1016/j.vetimm.2008.05.019; Falconer D. S., 1996, INTRO QUANTITATIVE G; Ghadiali AH, 2004, J CLIN MICROBIOL, V42, P5345, DOI 10.1128/JCM.42.11.5345-5348.2004; Gonda MG, 2007, ANIM GENET, V38, P389, DOI 10.1111/j.1365-2052.2007.01627.x; Gonda MG, 2006, J DAIRY SCI, V89, P1804, DOI 10.3168/jds.S0022-0302(06)72249-4; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Greig A, 1999, J CLIN MICROBIOL, V37, P1746, DOI 10.1128/JCM.37.6.1746-1751.1999; Harris JE, 2001, J FOOD PROTECT, V64, P2103, DOI 10.4315/0362-028X-64.12.2103; Hasonova L, 2006, VET MED-CZECH, V51, P193, DOI 10.17221/5539-VETMED; Hinger M, 2008, J DAIRY SCI, V91, P3237, DOI 10.3168/jds.2008-1021; Hinger M, 2007, J DAIRY SCI, V90, P1957, DOI 10.3168/jds.2006-510; Hugot JP, 2006, ANN NY ACAD SCI, V1072, P9, DOI 10.1196/annals.1326.011; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Khare S, 2009, VET PATHOL, V46, P717, DOI 10.1354/vp.08-VP-0187-G-FL; Koets AP, 2000, J DAIRY SCI, V83, P2702, DOI 10.3168/jds.S0022-0302(00)75164-2; LARSEN AB, 1975, AM J VET RES, V36, P255; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; MCCLURE HM, 1987, J INFECT DIS, V155, P1011, DOI 10.1093/infdis/155.5.1011; Mendoza JL, 2009, WORLD J GASTROENTERO, V15, P417, DOI 10.3748/wjg.15.417; Mortensen H, 2004, J DAIRY SCI, V87, P2108, DOI 10.3168/jds.S0022-0302(04)70029-6; Mrode R, 2009, J DAIRY SCI, V92, P5760, DOI 10.3168/jds.2008-1931; Mucha R, 2009, VET IMMUNOL IMMUNOP, V128, P381, DOI 10.1016/j.vetimm.2008.12.007; Nielsen SS, 2009, PREV VET MED, V88, P1, DOI 10.1016/j.prevetmed.2008.07.003; Olsen I, 2002, VET QUART, V24, P12, DOI 10.1080/01652176.2002.9695120; Pinedo PJ, 2009, PREV VET MED, V91, P189, DOI 10.1016/j.prevetmed.2009.05.020; Pinedo PJ, 2009, VET MICROBIOL, V134, P346, DOI 10.1016/j.vetmic.2008.09.052; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Roussel AJ, 2005, JAVMA-J AM VET MED A, V226, P773, DOI 10.2460/javma.2005.226.773; Schwartz D, 2000, CLIN MICROBIOL INFEC, V6, P303, DOI 10.1046/j.1469-0691.2000.00093.x; Settles M, 2009, ANIM GENET, V40, P655, DOI 10.1111/j.1365-2052.2009.01896.x; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Stabel J. R., 2006, Animal Health Research Reviews, V7, P61, DOI 10.1017/S1466252307001168; Taylor KH, 2006, MAMM GENOME, V17, P892, DOI 10.1007/s00335-005-0148-2; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Whitlock RH, 1996, VET CLIN N AM-FOOD A, V12, P345, DOI 10.1016/S0749-0720(15)30410-2; Whitlock RH, 2000, VET MICROBIOL, V77, P387, DOI 10.1016/S0378-1135(00)00324-2; Whittington RJ, 2001, AUST VET J, V79, P267, DOI 10.1111/j.1751-0813.2001.tb11980.x; Zwick LS, 2002, J VET DIAGN INVEST, V14, P326, DOI 10.1177/104063870201400409	48	52	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11117	10.1371/journal.pone.0011117	http://dx.doi.org/10.1371/journal.pone.0011117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559561	Green Published, gold, Green Submitted			2022-12-27	WOS:000278775900008
J	Mowat, FM; Luhmann, UFO; Smith, AJ; Lange, C; Duran, Y; Harten, S; Shukla, D; Maxwell, PH; Ali, RR; Bainbridge, JWB				Mowat, Freya M.; Luhmann, Ulrich F. O.; Smith, Alexander J.; Lange, Clemens; Duran, Yanai; Harten, Sarah; Shukla, Deepa; Maxwell, Patrick H.; Ali, Robin R.; Bainbridge, James W. B.			HIF-1alpha and HIF-2alpha Are Differentially Activated in Distinct Cell Populations in Retinal Ischaemia	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; OXYGEN-INDUCED RETINOPATHY; FACTOR-ALPHA; TARGET GENE; O-2 HOMEOSTASIS; FACTOR-I; ERYTHROPOIETIN; EXPRESSION; NEOVASCULARIZATION; HIF-1-ALPHA	Background: Hypoxia plays a key role in ischaemic and neovascular disorders of the retina. Cellular responses to oxygen are mediated by hypoxia-inducible transcription factors (HIFs) that are stabilised in hypoxia and induce the expression of a diverse range of genes. The purpose of this study was to define the cellular specificities of HIF-1alpha and HIF-2alpha in retinal ischaemia, and to determine their correlation with the pattern of retinal hypoxia and the expression profiles of induced molecular mediators. Methodology/Principal Findings: We investigated the tissue distribution of retinal hypoxia during oxygen-induced retinopathy (OIR) in mice using the bio-reductive drug pimonidazole. We measured the levels of HIF-1alpha and HIF-2alpha proteins by Western blotting and determined their cellular distribution by immunohistochemistry during the development of OIR. We measured the temporal expression profiles of two downstream mediators, vascular endothelial growth factor (VEGF) and erythropoietin (Epo) by ELISA. Pimonidazole labelling was evident specifically in the inner retina. Labelling peaked at 2 hours after the onset of hypoxia and gradually declined thereafter. Marked binding to Muller glia was evident during the early hypoxic stages of OIR. Both HIF-1alpha and HIF-2alpha protein levels were significantly increased during retinal hypoxia but were evident in distinct cellular distributions; HIF-1alpha stabilisation was evident in neuronal cells throughout the inner retinal layers whereas HIF-2alpha was restricted to Muller glia and astrocytes. Hypoxia and HIF-alpha stabilisation in the retina were closely followed by upregulated expression of the downstream mediators VEGF and EPO. Conclusions/Significance: Both HIF-1alpha and HIF-2alpha are activated in close correlation with retinal hypoxia but have contrasting cell specificities, consistent with differential roles in retinal ischaemia. Our findings suggest that HIF-2alpha activation plays a key role in regulating the response of Muller glia to hypoxia.	[Mowat, Freya M.; Luhmann, Ulrich F. O.; Smith, Alexander J.; Lange, Clemens; Duran, Yanai; Ali, Robin R.; Bainbridge, James W. B.] UCL, Inst Ophthalmol, Dept Genet, London, England; [Harten, Sarah; Shukla, Deepa; Maxwell, Patrick H.] UCL, Div Med, London, England	University of London; University College London; University of London; University College London	Mowat, FM (corresponding author), UCL, Inst Ophthalmol, Dept Genet, London, England.	j.bainbridge@ucl.ac.uk	Smith, Alexander/A-5142-2009; Maxwell, Patrick H/C-5557-2008; Luhmann, Ulrich/D-8905-2012; MOWAT, FREYA/AAD-5102-2021	Maxwell, Patrick H/0000-0002-0338-2679; Ali, Robin/0000-0003-3126-6517; Bainbridge, James/0000-0003-1318-8201; Mowat, Freya/0000-0002-8726-8768; Wilkinson, Sarah/0000-0002-1912-8384	Wellcome Trust [074617/Z/04/Z]; Medical Research Council [G03000341]; Department of Health through National Institute for Health Research to Moorfields Eye Hospital National Health Service Foundation Trust and University College London Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology; National Institute for Health Research [NF-SI-0507-10315] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health through National Institute for Health Research to Moorfields Eye Hospital National Health Service Foundation Trust and University College London Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by Wellcome Trust Grant 074617/Z/04/Z (http://www.wellcome.ac.uk/) and Medical Research Council Grant G03000341 (http://www.mrc.ac.uk/index.htm). JWBB receives financial support from the Department of Health through the award made by the National Institute for Health Research to Moorfields Eye Hospital National Health Service Foundation Trust and University College London Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Bai YY, 2009, J PATHOL, V219, P446, DOI 10.1002/path.2611; Brafman A, 2004, INVEST OPHTH VIS SCI, V45, P3796, DOI 10.1167/iovs.04-0052; Chavez JC, 2006, J NEUROSCI, V26, P9471, DOI 10.1523/JNEUROSCI.2838-06.2006; Chen J, 2008, J CLIN INVEST, V118, P526, DOI [10.1172/JC133813, 10.1172/JCI33813]; Chen WQ, 2008, NEUROBIOL DIS, V31, P433, DOI 10.1016/j.nbd.2008.05.020; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Cringle SJ, 2002, INVEST OPHTH VIS SCI, V43, P1922; Crosson LA, 2009, MOL VIS, V15, P296; Danylkova NO, 2006, BRAIN RES, V1096, P20, DOI 10.1016/j.brainres.2006.04.061; de Gooyer TE, 2006, INVEST OPHTH VIS SCI, V47, P5561, DOI 10.1167/iovs.06-0647; Ding K, 2005, INVEST OPHTH VIS SCI, V46, P1010, DOI 10.1167/iovs.04-0788; Dioum EM, 2008, INVEST OPHTH VIS SCI, V49, P2714, DOI 10.1167/iovs.07-1469; ERNEST JT, 1984, INVEST OPHTH VIS SCI, V25, P1129; Furlan D, 2007, SURG ONCOL, V16, pS25, DOI 10.1016/j.suronc.2007.10.014; Gardiner TA, 2005, AM J PATHOL, V166, P637, DOI 10.1016/S0002-9440(10)62284-5; Geisen P, 2008, MOL VIS, V14, P345; Grimm C, 2005, SEMIN CELL DEV BIOL, V16, P531, DOI 10.1016/j.semcdb.2005.03.004; GROSS MW, 1995, INT J CANCER, V61, P567, DOI 10.1002/ijc.2910610422; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Katsura Y, 2005, DIABETES CARE, V28, P2252, DOI 10.2337/diacare.28.9.2252; Kaur C, 2006, INVEST OPHTH VIS SCI, V47, P1126, DOI 10.1167/iovs.05-0518; King CE, 2007, EXP NEUROL, V205, P48, DOI 10.1016/j.expneurol.2007.01.017; Lau KW, 2007, BRIT J CANCER, V96, P1284, DOI 10.1038/sj.bjc.6603675; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Maxwell PH, 2002, SEMIN CELL DEV BIOL, V13, P29, DOI 10.1006/scdb.2001.0287; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Morita M, 2003, EMBO J, V22, P1134, DOI 10.1093/emboj/cdg117; Ozaki H, 1999, INVEST OPHTH VIS SCI, V40, P182; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Rosenberger C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017223.49823.2A; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Saito Y, 2008, INVEST OPHTH VIS SCI, V49, P1591, DOI 10.1167/iovs.07-1356; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Semenza GL, 2003, ANNU REV MED, V54, P17, DOI 10.1146/annurev.med.54.101601.152418; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Thiersch M, 2009, EUR J NEUROSCI, V29, P2291, DOI 10.1111/j.1460-9568.2009.06781.x; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Weishaupt JH, 2004, INVEST OPHTH VIS SCI, V45, P1514, DOI 10.1167/iovs.03-1039; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Yu AY, 1998, AM J PHYSIOL-LUNG C, V275, pL818, DOI 10.1152/ajplung.1998.275.4.L818; Yu DY, 2006, INVEST OPHTH VIS SCI, V47, P1109, DOI 10.1167/iovs.05-1118; Yu DY, 2001, PROG RETIN EYE RES, V20, P175, DOI 10.1016/S1350-9462(00)00027-6; Zhong LC, 2007, INVEST OPHTH VIS SCI, V48, P1212, DOI 10.1167/iovs.06-0757; Zhu YL, 2007, INVEST OPHTH VIS SCI, V48, P1735, DOI 10.1167/iovs.06-1037	55	71	73	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11103	10.1371/journal.pone.0011103	http://dx.doi.org/10.1371/journal.pone.0011103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559438	Green Published, gold, Green Submitted			2022-12-27	WOS:000278741100016
J	Kamilar, JM; Muldoon, KM				Kamilar, Jason M.; Muldoon, Kathleen M.			The Climatic Niche Diversity of Malagasy Primates: A Phylogenetic Perspective	PLOS ONE			English	Article							ANCESTRAL STATES; COMMUNITY; EVOLUTIONARY; MADAGASCAR; ECOLOGY; LEMURS; SIGNAL; CONSERVATISM; SEPARATION; GRADIENT	Background: Numerous researchers have posited that there should be a strong negative relationship between the evolutionary distance among species and their ecological similarity. Alternative evidence suggests that members of adaptive radiations should display no relationship between divergence time and ecological similarity because rapid evolution results in near-simultaneous speciation early in the clade's history. In this paper, we performed the first investigation of ecological diversity in a phylogenetic context using a mammalian adaptive radiation, the Malagasy primates. Methodology/Principal Findings: We collected data for 43 extant species including: 1) 1064 species by locality samples, 2) GIS climate data for each sampling locality, and 3) the phylogenetic relationships of the species. We calculated the niche space of each species by summarizing the climatic variation at localities of known occurrence. Climate data from all species occurrences at all sites were entered into a principal components analysis. We calculated the mean value of the first two PCA axes, representing rainfall and temperature diversity, for each species. We calculated the K statistic using the Physig program for Matlab to examine how well the climatic niche space of species was correlated with phylogeny. Conclusions/Significance: We found that there was little relationship between the phylogenetic distance of Malagasy primates and their rainfall and temperature niche space, i.e., closely related species tend to occupy different climatic niches. Furthermore, several species from different genera converged on a similar climatic niche. These results have important implications for the evolution of ecological diversity, and the long-term survival of these endangered species.	[Kamilar, Jason M.] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA; [Kamilar, Jason M.] Yale Univ, Yale Mol Anthropol Lab, New Haven, CT 06520 USA; [Muldoon, Kathleen M.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Anat, Hanover, NH 03756 USA; [Muldoon, Kathleen M.] Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA	Yale University; Yale University; Dartmouth College; Dartmouth College	Kamilar, JM (corresponding author), Yale Univ, Dept Anthropol, New Haven, CT 06520 USA.	jason.kamilar@yale.edu	Kamilar, Jason/E-1990-2011	Kamilar, Jason/0000-0001-6082-9396				Ackerly DD, 2000, EVOLUTION, V54, P1480, DOI 10.1111/j.0014-3820.2000.tb00694.x; Anderson TM, 2004, AM NAT, V164, P709, DOI 10.1086/425372; Andreasson U, 2007, BIOMARK MED, V1, P59, DOI 10.2217/17520363.1.1.59; Andriaholinirina N., 2006, Primate Report, V74, P25; [Anonymous], NATURAL HIST MADAGAS; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Burney DA, 2004, J HUM EVOL, V47, P25, DOI 10.1016/j.jhevol.2004.05.005; Chapman CA, 1999, J TROP ECOL, V15, P189, DOI 10.1017/S0266467499000759; Chazdon RL, 2003, ECOL MONOGR, V73, P331, DOI 10.1890/02-4037; Dammhahn M, 2008, OECOLOGIA, V157, P473, DOI 10.1007/s00442-008-1079-x; Edwards EJ, 2006, AM NAT, V167, P777, DOI 10.1086/504605; Fleagle JG, 1996, J HUM EVOL, V30, P489, DOI 10.1006/jhev.1996.0039; Fleagle John G., 1999, P92, DOI 10.1017/CBO9780511542381.007; GANZHORN JU, 1989, OECOLOGIA, V79, P279, DOI 10.1007/BF00388489; Ganzhorn JU, 1997, J ZOOL, V241, P533, DOI 10.1111/j.1469-7998.1997.tb04845.x; Godfrey Laurie G., 2004, Lemur News, V9, P9; GODFREY LR, 1997, NATURAL CHANGE HUMAN, P218; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hladik C.M., 1980, P41; Horvath JE, 2008, GENOME RES, V18, P489, DOI 10.1101/gr.7265208; Jernvall J, 1998, P NATL ACAD SCI USA, V95, P11279, DOI 10.1073/pnas.95.19.11279; Johnson MTJ, 2007, TRENDS ECOL EVOL, V22, P250, DOI 10.1016/j.tree.2007.01.014; Jury MR., 2003, NATURAL HIST MADAGAS, P75; Kamilar JM, 2010, J BIOGEOGR, V37, P801, DOI 10.1111/j.1365-2699.2009.02267.x; Kamilar JM, 2009, AM J PHYS ANTHROPOL, V139, P382, DOI 10.1002/ajpa.20993; Knouft JH, 2006, ECOLOGY, V87, pS29, DOI 10.1890/0012-9658(2006)87[29:PAOTEO]2.0.CO;2; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Losos JB, 2003, NATURE, V424, P542, DOI 10.1038/nature01814; Losos JB, 1999, ANIM BEHAV, V58, P1319, DOI 10.1006/anbe.1999.1261; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Louis Edward E. Jr, 2008, Primate Conservation, V23, P19, DOI 10.1896/052.023.0103; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Martins EP, 1999, SYST BIOL, V48, P642, DOI 10.1080/106351599260210; Mayor MI, 2004, INT J PRIMATOL, V25, P875, DOI 10.1023/B:IJOP.0000029127.31190.e9; McGarigal K., 2000, MULTIVARIATE STAT WI; MITTERMEIER RA, 2006, LEMURS MADAGASCAR; Muldoon KM, 2010, J BIOGEOGR, V37, P1144, DOI 10.1111/j.1365-2699.2010.02276.x; Muldoon KM, 2009, J MAMMAL, V90, P1111, DOI 10.1644/08-MAMM-A-242.1; MULDOON KM, 2009, AMERCAN J PHYS ANTHR, V44, P270; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Orlando L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-121; Ossi K, 2006, BEHAV ECOL SOCIOBIOL, V61, P53, DOI 10.1007/s00265-006-0236-7; Pastorini J, 2003, P NATL ACAD SCI USA, V100, P5879, DOI 10.1073/pnas.1031673100; Pearson RG, 2009, EVOLUTION, V63, P959, DOI 10.1111/j.1558-5646.2008.00596.x; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427; Rice NH, 2003, BIOL J LINN SOC, V80, P369, DOI 10.1046/j.1095-8312.2003.00242.x; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schreier BM, 2009, BIOTROPICA, V41, P283, DOI 10.1111/j.1744-7429.2008.00486.x; Swenson NG, 2006, ECOLOGY, V87, P2418, DOI 10.1890/0012-9658(2006)87[2418:TPAPOS]2.0.CO;2; Tattersall I, 2007, EVOL ANTHROPOL, V16, P12, DOI 10.1002/evan.20126; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webster AJ, 2002, P ROY SOC B-BIOL SCI, V269, P143, DOI 10.1098/rspb.2001.1873; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiens JJ, 2006, AM NAT, V168, P579, DOI 10.1086/507882; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Yoder AD, 2004, MOL ECOL, V13, P757, DOI 10.1046/j.1365-294X.2004.02106.x; Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122; Yoder AD, 2006, DEV PRIMATOL, P255, DOI 10.1007/0-387-31710-4_9	63	62	63	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11073	10.1371/journal.pone.0011073	http://dx.doi.org/10.1371/journal.pone.0011073			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552016	Green Submitted, Green Published, gold			2022-12-27	WOS:000278662900013
J	Aslam, A; Chan, H; Warrell, DA; Misbah, S; Ogg, GS				Aslam, Aamir; Chan, Hsien; Warrell, David A.; Misbah, Siraj; Ogg, Graham S.			Tracking Antigen-Specific T-Cells during Clinical Tolerance Induction in Humans	PLOS ONE			English	Article							GRASS-POLLEN IMMUNOTHERAPY; BEE VENOM IMMUNOTHERAPY; BLOOD MONONUCLEAR-CELLS; VARICELLA-ZOSTER-VIRUS; ALTERED PEPTIDE LIGAND; CAT-ALLERGIC SUBJECTS; HOUSE-DUST MITE; INTERFERON-GAMMA; REGULATORY CELLS; MULTIPLE-SCLEROSIS	Allergen immunotherapy presents an opportunity to define mechanisms of induction of clinical tolerance in humans. Significant progress has been made in our understanding of changes in T cell responses during immunotherapy, but existing work has largely been based on functional T cell assays. HLA-peptide-tetrameric complexes allow the tracking of antigen-specific T-cell populations based on the presence of specific T-cell receptors and when combined with functional assays allow a closer assessment of the potential roles of T-cell anergy and clonotype evolution. We sought to develop tools to facilitate tracking of antigen-specific T-cell populations during wasp-venom immunotherapy in people with wasp-venom allergy. We first defined dominant immunogenic regions within Ves v 5, a constituent of wasp venom that is known to represent a target antigen for T-cells. We next identified HLA-DRB1*1501 restricted epitopes and used HLA class II tetrameric complexes alongside cytokine responses to Ves v 5 to track T-cell responses during immunotherapy. In contrast to previous reports, we show that there was a significant initial induction of IL-4 producing antigen-specific T-cells within the first 3-5 weeks of immunotherapy which was followed by reduction of circulating effector antigen-specific T-cells despite escalation of wasp-venom dosage. However, there was sustained induction of IL-10-producing and FOXP3 positive antigen-specific T cells. We observed that these IL-10 producing cells could share a common precursor with IL-4-producing T cells specific for the same epitope. Clinical tolerance induction in humans is associated with dynamic changes in frequencies of antigen-specific T-cells, with a marked loss of IL-4-producing T-cells and the acquisition of IL-10-producing and FOXP3-positive antigen-specific CD4+ T-cells that can derive from a common shared precursor to pre-treatment effector T-cells. The development of new approaches to track antigen specific T-cell responses during immunotherapy can provide novel insights into mechanisms of tolerance induction in humans and identify new potential treatment targets.	[Aslam, Aamir; Chan, Hsien; Ogg, Graham S.] Univ Oxford, MRC, Human Immunol Unit,Weatherall Inst Mol Med, Natl Inst Hlth Res,Biomed Res Ctr, Oxford, England; [Warrell, David A.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Misbah, Siraj] John Radcliffe Hosp, Dept Clin Immunol, Oxford OX3 9DU, England	University of Oxford; University of Oxford; University of Oxford	Aslam, A (corresponding author), Univ Oxford, MRC, Human Immunol Unit,Weatherall Inst Mol Med, Natl Inst Hlth Res,Biomed Res Ctr, Oxford, England.	graham.ogg@ndm.ox.ac.uk		Ogg, Graham/0000-0002-3097-045X	Medical Research Council; National Institute of Health Research Biomedical Research Centre; Medical Research Council [G84/6616, G1000800h] Funding Source: researchfish; MRC [G84/6616] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was funded by the Medical Research Council and National Institute of Health Research Biomedical Research Centre Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 1998, J CLIN INVEST, V102, P98, DOI 10.1172/JCI2250; Akdis CA, 1999, FASEB J, V13, P603, DOI 10.1096/fasebj.13.6.603; Akdis CA, 1996, J CLIN INVEST, V98, P1676, DOI 10.1172/JCI118963; Akdis CA, 1997, J ALLERGY CLIN IMMUN, V99, P345, DOI 10.1016/S0091-6749(97)70052-6; Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Alexander C, 2005, ALLERGY, V60, P1269, DOI 10.1111/j.1398-9995.2005.00885.x; Alexander C, 2005, CLIN EXP ALLERGY, V35, P52, DOI 10.1111/j.1365-2222.2005.02143.x; Ali FR, 2004, AM J RESP CRIT CARE, V169, P20, DOI 10.1164/rccm.200305-690OC; Ardern-Jones MR, 2007, P NATL ACAD SCI USA, V104, P5557, DOI 10.1073/pnas.0700733104; Aslam A, 2006, CLIN EXP ALLERGY, V36, P1274, DOI 10.1111/j.1365-2222.2006.02569.x; Bateman EAL, 2006, J ALLERGY CLIN IMMUN, V118, P1350, DOI 10.1016/j.jaci.2006.07.040; Bellinghausen I, 1997, EUR J IMMUNOL, V27, P1131, DOI 10.1002/eji.1830270513; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; Bohle B, 2005, CLIN EXP ALLERGY, V35, P367, DOI 10.1111/j.1365-2222.2005.02180.x; Bohle B, 2007, J ALLERGY CLIN IMMUN, V120, P707, DOI 10.1016/j.jaci.2007.06.013; BOUSQUET J, 1987, J ALLERGY CLIN IMMUN, V79, P947, DOI 10.1016/0091-6749(87)90245-4; BOUSQUET J, 1987, ALLERGY, V42, P401, DOI 10.1111/j.1398-9995.1987.tb00355.x; Brown SGA, 2004, J ALLERGY CLIN IMMUN, V114, P371, DOI 10.1016/j.jaci.2004.04.029; Coombes JL, 2005, IMMUNOL REV, V204, P184, DOI 10.1111/j.0105-2896.2005.00250.x; Currier JR, 2002, J IMMUNOL METHODS, V260, P157, DOI 10.1016/S0022-1759(01)00535-X; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Durham SR, 1996, J ALLERGY CLIN IMMUN, V97, P1356, DOI 10.1016/S0091-6749(96)70205-1; Ebner C, 1997, CLIN EXP ALLERGY, V27, P1007, DOI 10.1111/j.1365-2222.1997.tb01252.x; Eusebius NP, 2002, INT ARCH ALLERGY IMM, V127, P234, DOI 10.1159/000053868; Ewbank PA, 2003, J ALLERGY CLIN IMMUN, V111, P155, DOI 10.1067/mai.2003.41; Francis JN, 2003, J ALLERGY CLIN IMMUN, V111, P1255, DOI 10.1067/mai.2003.1570; Gabrielsson S, 2001, ALLERGY, V56, P293, DOI 10.1034/j.1398-9995.2001.00472.x; Gafvelin G, 2005, INT ARCH ALLERGY IMM, V138, P59, DOI 10.1159/000087358; Gardner LM, 2004, CLIN EXP ALLERGY, V34, P1209, DOI 10.1111/j.1365-2222.2004.02009.x; GILLMAN SA, 1980, ANN ALLERGY, V45, P351; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; Hall G, 2003, VACCINE, V21, P549, DOI 10.1016/S0264-410X(02)00394-8; Haselden BM, 2001, J ALLERGY CLIN IMMUN, V108, P349, DOI 10.1067/mai.2001.117461; Jeal H, 2006, AM J RESP CRIT CARE, V174, P21, DOI 10.1164/rccm.200506-964OC; Jones L, 2007, EUR J IMMUNOL, V37, P3393, DOI 10.1002/eji.200737648; Jutel M, 2003, EUR J IMMUNOL, V33, P1205, DOI 10.1002/eji.200322919; JUTEL M, 1995, J IMMUNOL, V154, P4187; Kappos L, 2000, NAT MED, V6, P1176, DOI 10.1038/80525; Larche M, 2007, J ALLERGY CLIN IMMUN, V119, P906, DOI 10.1016/j.jaci.2007.02.015; Lefranc MP, 2005, NUCLEIC ACIDS RES, V33, pD593, DOI 10.1093/nar/gki065; Macaubas C, 2006, J IMMUNOL, V176, P5069, DOI 10.4049/jimmunol.176.8.5069; Major T, 2002, VACCINE, V20, P1532, DOI 10.1016/S0264-410X(01)00496-0; Majori M, 1998, EUR RESPIR J, V11, P1263, DOI 10.1183/09031936.98.11061263; Majori M, 2000, CLIN EXP ALLERGY, V30, P341, DOI 10.1046/j.1365-2222.2000.00701.x; Malavige GN, 2008, CLIN EXP IMMUNOL, V152, P522, DOI 10.1111/j.1365-2249.2008.03633.x; Marcotte GV, 1998, J ALLERGY CLIN IMMUN, V101, P506, DOI 10.1016/S0091-6749(98)70358-6; MCHUGH SM, 1995, CLIN EXP ALLERGY, V25, P828, DOI 10.1111/j.1365-2222.1995.tb00025.x; MCMENAMIN C, 1993, J EXP MED, V178, P889, DOI 10.1084/jem.178.3.889; Meiler F, 2008, J EXP MED, V205, P2887, DOI 10.1084/jem.20080193; MULLER U, 1979, ALLERGY, V34, P369, DOI 10.1111/j.1398-9995.1979.tb02006.x; Muller U, 1998, J ALLERGY CLIN IMMUN, V101, P747, DOI 10.1016/S0091-6749(98)70402-6; Nouri-Aria KT, 2004, J IMMUNOL, V172, P3252, DOI 10.4049/jimmunol.172.5.3252; O'Brien RM, 2000, CLIN EXP ALLERGY, V30, P333; Oldfield WLG, 2002, LANCET, V360, P47, DOI 10.1016/S0140-6736(02)09332-7; Oldfield WLG, 2001, J IMMUNOL, V167, P1734, DOI 10.4049/jimmunol.167.3.1734; Pereira-Santos MC, 2008, CLIN EXP ALLERGY, V38, P291, DOI 10.1111/j.1365-2222.2007.02887.x; Platts-Mills T, 2001, LANCET, V357, P752, DOI 10.1016/S0140-6736(00)04168-4; Radulovic S, 2008, J ALLERGY CLIN IMMUN, V121, P1467, DOI 10.1016/j.jaci.2008.03.013; RENZ H, 1994, J IMMUNOL, V152, P351; Richards DF, 2000, EUR J IMMUNOL, V30, P2344, DOI 10.1002/1521-4141(2000)30:8<2344::AID-IMMU2344>3.0.CO;2-7; ROCKLIN RE, 1980, NEW ENGL J MED, V302, P1213, DOI 10.1056/NEJM198005293022201; Sade K, 2003, ALLERGY, V58, P430, DOI 10.1034/j.1398-9995.2003.00055.x; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Schuerwegh AJ, 2001, CLIN EXP ALLERGY, V31, P740, DOI 10.1046/j.1365-2222.2001.01066.x; SECRIST H, 1993, J EXP MED, V178, P2123, DOI 10.1084/jem.178.6.2123; Smith TRF, 2004, ALLERGY, V59, P1097, DOI 10.1111/j.1398-9995.2004.00601.x; TAMIR R, 1987, J ALLERGY CLIN IMMUN, V79, P591, DOI 10.1016/S0091-6749(87)80154-9; Tarzi M, 2006, CLIN EXP ALLERGY, V36, P465, DOI 10.1111/j.1365-2222.2006.02469.x; VARNEY VA, 1993, J CLIN INVEST, V92, P644, DOI 10.1172/JCI116633; Verhoef A, 2005, PLOS MED, V2, P253, DOI 10.1371/journal.pmed.0020078; Wachholz PA, 2002, IMMUNOLOGY, V105, P56, DOI 10.1046/j.1365-2567.2002.01338.x; Wachholz PA, 2004, CURR OPIN ALLERGY CL, V4, P313, DOI 10.1097/01.all.0000136753.35948.c0; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Zuany-Amorim C, 2002, NAT MED, V8, P625, DOI 10.1038/nm0602-625	76	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e11028	10.1371/journal.pone.0011028	http://dx.doi.org/10.1371/journal.pone.0011028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20543955	Green Submitted, gold, Green Published			2022-12-27	WOS:000278557600007
J	Palma, C; Vendetti, S; Cassone, A				Palma, Carla; Vendetti, Silvia; Cassone, Antonio			Role of 4-1BB Receptor in the Control Played by CD8(+) T Cells on IFN-gamma Production by Mycobacterium tuberculosis Antigen-Specific CD4(+) T Cells	PLOS ONE			English	Article							PROTECTIVE IMMUNE-RESPONSE; INTERFERON-GAMMA; PULMONARY TUBERCULOSIS; MONOCLONAL-ANTIBODIES; BCG VACCINATION; IN-VIVO; INFECTION; MICE; CD137; BETA	Background: Antigen-specific IFN-gamma producing CD4(+) T cells are the main mediators of protection against Mycobacterium tuberculosis infection both under natural conditions and following vaccination. However these cells are responsible for lung damage and poor vaccine efficacy when not tightly controlled. Discovering new tools to control nonprotective antigenspecific IFN-gamma production without affecting protective IFN-gamma is a challenge in tuberculosis research. Methods and Findings: Immunization with DNA encoding Ag85B, a candidate vaccine antigen of Mycobacterium tuberculosis, elicited in mice a low but protective CD4(+) T cell-mediated IFN-gamma response, while in mice primed with DNA and boosted with Ag85B protein a massive increase in IFN-gamma response was associated with loss of protection. Both protective and non-protective Ag85B-immunization generated antigen-specific CD8(+) T cells which suppressed IFN-gamma-secreting CD4(+) T cells. However, ex vivo ligation of 4-1BB, a member of TNF-receptor super-family, reduced the massive, non-protective IFN-gamma responses by CD4(+) T cells in protein-boosted mice without affecting the low protective IFN-gamma-secretion in mice immunized with DNA. This selective inhibition was due to the induction of 4-1BB exclusively on CD8(+) T cells of DNA-primed and protein-boosted mice following Ag85B protein stimulation. The 4-1BB-mediated IFN-gamma inhibition did not require soluble IL10, TGF-beta, XCL-1 and MIP-1 beta. In vivo Ag85B stimulation induced 4-1BB expression on CD8(+) T cells and in vivo 4-1BB ligation reduced the activation, IFN-gamma production and expansion of Ag85B-specific CD4(+) T cells of DNA-primed and protein-boosted mice. Conclusion/Significance: Antigen-specific suppressor CD8(+) T cells are elicited through immunization with the mycobacterial antigen Ag85B. Ligation of 4-1BB receptor further enhanced their suppressive activity on IFN-gamma-secreting CD4(+) T cells. The selective expression of 4-1BB only on CD8(+) T cells in mice developing a massive, non-protective IFN-gamma response opens novel strategies for intervention in tuberculosis pathology and vaccination through T-cell co-stimulatorybased molecular targeting.	[Palma, Carla; Vendetti, Silvia; Cassone, Antonio] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS)	Palma, C (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	c.palma@iss.it	PALMA, CARLA/C-8821-2016; Cassone, Antonio/J-4666-2019; VENDETTI, SILVIA/M-4369-2015	PALMA, CARLA/0000-0003-2583-5306; VENDETTI, SILVIA/0000-0002-8443-496X	Ministero della Salute (Italy) [H51]; European Commission [LSHP-CT-2003-503240]	Ministero della Salute (Italy)(Ministry of Health, Italy); European Commission(European CommissionEuropean Commission Joint Research Centre)	Funding: This work was supported by the Ministero della Salute (Italy) grant H51 and European Commission grant LSHP-CT-2003-503240, MUVAPRED Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005930; Accapezzato D, 2004, J CLIN INVEST, V113, P963, DOI [10.1172/JCI200420415, 10.1172/JCI200420515]; Barker LF, 2009, CURR OPIN IMMUNOL, V21, P331, DOI 10.1016/j.coi.2009.05.017; Bean AGD, 1999, J IMMUNOL, V162, P3504; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; BOESEN H, 1995, INFECT IMMUN, V63, P1491, DOI 10.1128/IAI.63.4.1491-1497.1995; Boussaud V, 1998, EUR RESPIR J, V12, P926, DOI 10.1183/09031936.98.12040926; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; Cannons JL, 2001, J IMMUNOL, V167, P1313, DOI 10.4049/jimmunol.167.3.1313; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; Choi BK, 2006, CYTOKINE, V34, P233, DOI 10.1016/j.cyto.2006.04.008; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Dannenberg AM, 2001, TUBERCULOSIS, V81, P229, DOI 10.1054/tube.2001.0287; Delgado JC, 2002, P NATL ACAD SCI USA, V99, P7576, DOI 10.1073/pnas.062056099; Dietrich J, 2006, J IMMUNOL, V177, P6353, DOI 10.4049/jimmunol.177.9.6353; Doherty TM, 2004, J INFECT DIS, V190, P2146, DOI 10.1086/425931; Ehlers S, 2001, J EXP MED, V194, P1847, DOI 10.1084/jem.194.12.1847; Elias D, 2005, T ROY SOC TROP MED H, V99, P363, DOI 10.1016/j.trstmh.2004.08.006; Elpek KG, 2007, J IMMUNOL, V179, P7295, DOI 10.4049/jimmunol.179.11.7295; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Garba ML, 2002, J IMMUNOL, V168, P2247, DOI 10.4049/jimmunol.168.5.2247; Giscombe R, 2006, J INTERN MED, V260, P224, DOI 10.1111/j.1365-2796.2006.01688.x; Gonzalez-Juarrero M, 2002, CELL IMMUNOL, V220, P13, DOI 10.1016/S0008-8749(03)00010-8; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Haynes LM, 2000, J NEUROIMMUNOL, V106, P43, DOI 10.1016/S0165-5728(00)00212-5; Hoft DF, 2008, J INFECT DIS, V198, P1491, DOI 10.1086/592450; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; HUARD B, 1994, EUR J IMMUNOL, V24, P3216, DOI 10.1002/eji.1830241246; Jamieson SE, 2004, GENES IMMUN, V5, P46, DOI 10.1038/sj.gene.6364029; Jones HP, 2002, J IMMUNOL, V168, P3493, DOI 10.4049/jimmunol.168.7.3493; Joosten SA, 2007, P NATL ACAD SCI USA, V104, P8029, DOI 10.1073/pnas.0702257104; Jung YJ, 2005, J EXP MED, V201, P1915, DOI 10.1084/jem.20050265; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kim YH, 2009, J LEUKOCYTE BIOL, V85, P817, DOI 10.1189/jlb.0408246; Koch R., 1890, DEUT MED WOCHENSCHR, V16, P1029, DOI [10.1055/s-0029-1207546, DOI 10.1055/S-0029-1207546]; KWON BS, 1989, P NATL ACAD SCI USA, V86, P1963, DOI 10.1073/pnas.86.6.1963; Leal IS, 2001, IMMUNOLOGY, V104, P157, DOI 10.1046/j.1365-2567.2001.01305.x; Li L, 2007, TUBERCULOSIS, V87, P526, DOI 10.1016/j.tube.2007.07.004; Lund FE, 2006, MOL MED, V12, P328, DOI 10.2119/2006-00099.Lund; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Melero I, 2008, TRENDS PHARMACOL SCI, V29, P383, DOI 10.1016/j.tips.2008.05.005; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Mittler RS, 1999, J EXP MED, V190, P1535, DOI 10.1084/jem.190.10.1535; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Olofsson PS, 2008, CIRCULATION, V117, P1292, DOI 10.1161/CIRCULATIONAHA.107.699173; Ordway D, 2007, J LEUKOCYTE BIOL, V82, P1221, DOI 10.1189/jlb.0607426; ORMER FM, 2003, J IMMUNOL, V171, P5430; Palma C, 2008, VACCINE, V26, P4237, DOI 10.1016/j.vaccine.2008.05.050; Palma C, 2007, CELL MICROBIOL, V9, P1455, DOI 10.1111/j.1462-5822.2007.00884.x; POLLOK KE, 1993, J IMMUNOL, V150, P771; Quinn KM, 2008, EUR J IMMUNOL, V38, P695, DOI 10.1002/eji.200737888; Read S, 1998, EUR J IMMUNOL, V28, P3435, DOI 10.1002/(SICI)1521-4141(199811)28:11<3435::AID-IMMU3435>3.3.CO;2-G; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Schwander SK, 1998, J INFECT DIS, V178, P1434, DOI 10.1086/314454; Seo SK, 2004, NAT MED, V10, P1088, DOI 10.1038/nm1107; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; *WHO, 2008, 2008393 WHOHTMTB; Wilcox RA, 2002, J CLIN INVEST, V109, P651, DOI 10.1172/JCI200214184; Workman CJ, 2002, EUR J IMMUNOL, V32, P2255, DOI 10.1002/1521-4141(200208)32:8<2255::AID-IMMU2255>3.0.CO;2-A; Zhang LJ, 2006, AUTOIMMUNITY, V39, P269, DOI 10.1080/08916930600753903	63	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11019	10.1371/journal.pone.0011019	http://dx.doi.org/10.1371/journal.pone.0011019			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544034	Green Published, Green Submitted, gold			2022-12-27	WOS:000278494900029
J	Normand-Lauziere, F; Frisch, F; Labbe, SM; Bherer, P; Gagnon, R; Cunnane, SC; Carpentier, AC				Normand-Lauziere, Francois; Frisch, Frederique; Labbe, Sebastien M.; Bherer, Patrick; Gagnon, Rene; Cunnane, Stephen C.; Carpentier, Andre C.			Increased Postprandial Nonesterified Fatty Acid Appearance and Oxidation in Type 2 Diabetes Is Not Fully Established in Offspring of Diabetic Subjects	PLOS ONE			English	Article							SKELETAL-MUSCLE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; SUBSTRATE OXIDATION; VLDL-TRIACYLGLYCEROL; WHOLE-BODY; PLASMA; LIPOLYSIS; METABOLISM; KINETICS	Background: It has been proposed that abnormal postprandial plasma nonesterified fatty acid (NEFA) metabolism may participate in the development of tissue lipotoxicity and type 2 diabetes (T2D). We previously found that non-diabetic offspring of two parents with T2D display increased plasma NEFA appearance and oxidation rates during intravenous administration of a fat emulsion. However, it is currently unknown whether plasma NEFA appearance and oxidation are abnormal during the postprandial state in these subjects at high-risk of developing T2D. Methodology: Palmitate appearance and oxidation rates and glycerol appearance rate were determined in eleven healthy offspring of two parents with T2D (positive family history, FH+), 13 healthy subjects without first-degree relatives with T2D (FH-) and 12 subjects with T2D at fasting, during normoglycemic hyperinsulinemic clamp and during continuous oral intake of a standard liquid meal to achieve steady postprandial NEFA and triacylglycerols (TG) without and with insulin infusion to maintain similar glycemia in all three groups. Principal Findings: Plasma palmitate appearance and oxidation were higher at fasting and during the clamp conditions in the T2D group (all P < 0.05). In the postprandial state, palmitate appearance, oxidative and non oxidative rates were all elevated in T2D (all P < 0.05) but not in FH+. Both T2D and FH+ displayed elevated postprandial TG vs. FH-(P < 0.001). Acute correction of hyperglycemia during the postprandial state did not affect these group differences. Increased waist circumference and BMI were positively associated with elevated postprandial plasma palmitate appearance and oxidation. Conclusions/Significance: Postprandial plasma NEFA intolerance observed in subjects with T2D is not fully established in non-diabetic offspring of both parents with T2D, despite the presence of increased postprandial plasma TG in the later. Elevated postprandial plasma NEFA appearance and oxidation in T2D is observed despite acute correction of the exaggerated glycemic excursion in this group.	[Normand-Lauziere, Francois; Frisch, Frederique; Labbe, Sebastien M.; Bherer, Patrick; Carpentier, Andre C.] Univ Sherbrooke, Div Endocrinol, Dept Med, Sherbrooke, PQ J1K 2R1, Canada; [Bherer, Patrick; Gagnon, Rene] Univ Sherbrooke, Dept Pediat, Div Genet, Sherbrooke, PQ J1K 2R1, Canada; [Cunnane, Stephen C.] Res Ctr Aging, Sherbrooke, PQ, Canada	University of Sherbrooke; University of Sherbrooke	Normand-Lauziere, F (corresponding author), Univ Sherbrooke, Div Endocrinol, Dept Med, Sherbrooke, PQ J1K 2R1, Canada.	andre.carpentier@usherbrooke.ca			Canadian Institutes of Health Research [CIHR MOP 53094]; Fonds de la recherche en sante du Quebec (FRSQ); Canadian Diabetes Association; NSERC	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canadian Diabetes Association; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding: This work was supported by a grant from the Canadian Institutes of Health Research (CIHR MOP 53094) and was performed at the Centre de recherche clinique Etienne-Le Bel, a research center funded by the Fonds de la recherche en sante du Quebec (FRSQ). ACC is currently the recipient of a FRSQ Senior Scholarship Award. FNL is the recipient of a FRSQ Research Studentship Award. SML is the recipient of a Canadian Diabetes Association Doctoral Studentship Award. SCC is a Canada Research Chair and his component of this project was supported by NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; Axelsen M, 1999, ANN INTERN MED, V131, P27, DOI 10.7326/0003-4819-131-1-199907060-00006; Barrows BR, 2005, DIABETES, V54, P2668, DOI 10.2337/diabetes.54.9.2668; Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; Bergouignan A, 2008, AM J PHYSIOL-ENDOC M, V294, pE645, DOI 10.1152/ajpendo.00720.2007; BEYLOT M, 1987, J LIPID RES, V28, P414; Bickerton AST, 2008, DIABETOLOGIA, V51, P1466, DOI 10.1007/s00125-008-1040-x; Bickerton AST, 2007, DIABETES, V56, P168, DOI 10.2337/db06-0822; Blaak EE, 2000, AM J PHYSIOL-ENDOC M, V279, pE146, DOI 10.1152/ajpendo.2000.279.1.E146; Blaak EE, 2006, J CLIN ENDOCR METAB, V91, P1462, DOI 10.1210/jc.2005-1598; Blaak EE, 2004, DIABETOLOGIA, V47, P1462, DOI 10.1007/s00125-004-1471-y; Blaak EE, 2002, DIABETES, V51, P784, DOI 10.2337/diabetes.51.3.784; Blaak EE, 2000, DIABETES, V49, P2102, DOI 10.2337/diabetes.49.12.2102; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Brassard P, 2008, J CLIN ENDOCR METAB, V93, P837, DOI 10.1210/jc.2007-1670; Carpentier A, 2001, DIABETES, V50, P1402, DOI 10.2337/diabetes.50.6.1402; Carpentier AC, 2005, AM J PHYSIOL-ENDOC M, V289, pE849, DOI 10.1152/ajpendo.00073.2005; Carpentier AC, 2007, AM J PHYSIOL-ENDOC M, V292, pE693, DOI 10.1152/ajpendo.00423.2006; Carpentier AC, 2010, J CLIN ENDOCR METAB, V95, P1256, DOI 10.1210/jc.2009-1932; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Gastaldelli A, 2009, HEPATOLOGY, V50, P1087, DOI 10.1002/hep.23116; Guo ZK, 1999, DIABETES, V48, P1586, DOI 10.2337/diabetes.48.8.1586; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Heath RB, 2007, AM J PHYSIOL-ENDOC M, V292, pE732, DOI 10.1152/ajpendo.00409.2006; Heilbronn LK, 2007, DIABETES, V56, P2046, DOI 10.2337/db06-1687; Holloszy JO, 2009, AM J CLIN NUTR, V89, p463S, DOI 10.3945/ajcn.2008.26717C; Hulver MW, 2003, AM J PHYSIOL-ENDOC M, V284, pE741, DOI 10.1152/ajpendo.00514.2002; Jocken JWE, 2008, DIABETOLOGIA, V51, P320, DOI 10.1007/s00125-007-0866-y; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lavoie F, 2009, J CLIN ENDOCR METAB, V94, P998, DOI 10.1210/jc.2008-1021; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; Mensink M, 2001, DIABETES, V50, P2548, DOI 10.2337/diabetes.50.11.2548; Miles JM, 2004, DIABETES, V53, P521, DOI 10.2337/diabetes.53.3.521; Miles JM, 2003, DIABETES, V52, P675, DOI 10.2337/diabetes.52.3.675; Mittendorfer B, 2003, DIABETES, V52, P1641, DOI 10.2337/diabetes.52.7.1641; Nair KS, 2008, DIABETES, V57, P1166, DOI 10.2337/db07-1556; Nielsen S, 2004, J CLIN INVEST, V113, P1582, DOI [10.1172/JCI200421047, 10.1172/JCI21047]; Park Y, 2000, AM J PHYSIOL-ENDOC M, V279, pE1258, DOI 10.1152/ajpendo.2000.279.6.E1258; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Ravikumar B, 2005, AM J PHYSIOL-ENDOC M, V288, pE789, DOI 10.1152/ajpendo.00557.2004; ROUST LR, 1993, DIABETES, V42, P1567, DOI 10.2337/diabetes.42.11.1567; Schiffelers SLH, 2001, INT J OBESITY, V25, P33, DOI 10.1038/sj.ijo.0801528; Sidossis LS, 1998, AM J PHYSIOL-ENDOC M, V275, pE798, DOI 10.1152/ajpendo.1998.275.5.E798; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; WOLFE RR, 1992, RADIOACTIVE STABLE I, P235	46	33	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10956	10.1371/journal.pone.0010956	http://dx.doi.org/10.1371/journal.pone.0010956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532041	Green Published, Green Submitted, gold			2022-12-27	WOS:000278380500002
J	Cork, DJ; Lembark, S; Tovanabutra, S; Robb, ML; Kim, JH				Cork, Douglas J.; Lembark, Steven; Tovanabutra, Sodsai; Robb, Merlin L.; Kim, Jerome H.			W-Curve Alignments for HIV-1 Genomic Comparisons	PLOS ONE			English	Article							CHAOS GAME REPRESENTATION; IMMUNODEFICIENCY-VIRUS TYPE-1; GRAPHICAL REPRESENTATION; NEUTRALIZING ANTIBODIES; DNA-SEQUENCES	Background: The W-curve was originally developed as a graphical visualization technique for viewing DNA and RNA sequences. Its ability to render features of DNA also makes it suitable for computational studies. Its main advantage in this area is utilizing a single-pass algorithm for comparing the sequences. Avoiding recursion during sequence alignments offers advantages for speed and in-process resources. The graphical technique also allows for multiple models of comparison to be used depending on the nucleotide patterns embedded in similar whole genomic sequences. The W-curve approach allows us to compare large numbers of samples quickly. Method: We are currently tuning the algorithm to accommodate quirks specific to HIV-1 genomic sequences so that it can be used to aid in diagnostic and vaccine efforts. Tracking the molecular evolution of the virus has been greatly hampered by gap associated problems predominantly embedded within the envelope gene of the virus. Gaps and hypermutation of the virus slow conventional string based alignments of the whole genome. This paper describes the W-curve algorithm itself, and how we have adapted it for comparison of similar HIV-1 genomes. A treebuilding method is developed with the W-curve that utilizes a novel Cylindrical Coordinate distance method and gap analysis method. HIV-1 C2-V5 env sequence regions from a Mother/Infant cohort study are used in the comparison. Findings: The output distance matrix and neighbor results produced by the W-curve are functionally equivalent to those from Clustal for C2-V5 sequences in the mother/infant pairs infected with CRF01_AE. Conclusions: Significant potential exists for utilizing this method in place of conventional string based alignment of HIV-1 genomes, such as Clustal X. With W-curve heuristic alignment, it may be possible to obtain clinically useful results in a short time-short enough to affect clinical choices for acute treatment. A description of the W-curve generation process, including a comparison technique of aligning extremes of the curves to effectively phase-shift them past the HIV-1 gap problem, is presented. Besides yielding similar neighbor-joining phenogram topologies, most Mother and Infant C2-V5 sequences in the cohort pairs geometrically map closest to each other, indicating that W-curve heuristics overcame any gap problem.	[Cork, Douglas J.; Tovanabutra, Sodsai; Robb, Merlin L.; Kim, Jerome H.] US Mil HIV Res Program, Rockville, MD USA; [Cork, Douglas J.; Tovanabutra, Sodsai] Henry M Jackson Fdn Adv Mil Med, Rockville, MD USA; [Cork, Douglas J.] IIT, Chicago, IL 60616 USA; [Lembark, Steven] Workhorse Comp, Woodhaven, NY USA; [Robb, Merlin L.; Kim, Jerome H.] Walter Reed Army Inst Res, Div Retrovirol, Rockville, MD USA	Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Illinois Institute of Technology; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Cork, DJ (corresponding author), US Mil HIV Res Program, Rockville, MD USA.	dcork@hivresearch.org			HIV-1 Research Project (MHRP) [W81XWH-07-2-0067-P00001]; Henry Jackson Foundation (HJF); Workhorse Computing; Military Medicine, Inc.; U.S. Department of Defense (DOD); NICHD [R01 HD34343-03]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034343] Funding Source: NIH RePORTER	HIV-1 Research Project (MHRP); Henry Jackson Foundation (HJF); Workhorse Computing; Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding: Military HIV-1 Research Project (MHRP)/Henry Jackson Foundation (HJF) and Workhorse Computing. This work was funded by MHRP (Military HIV-1 Research Project) cooperative agreement (W81XWH-07-2-0067-P00001) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD). The cohort work was supported through NICHD by R01 HD34343-03 and partly by a cooperative agreement between the Henry M. Jackson Foundation for the Advancement of Military Medicine and the U.S. Dept. of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JS, 2001, BIOINFORMATICS, V17, P429, DOI 10.1093/bioinformatics/17.5.429; Barnsley M, 1993, FRACTALS EVERYWHERE; BASU S, 1992, J MOL BIOL, V228, P715; Brown BK, 2008, VIROLOGY, V375, P529, DOI 10.1016/j.virol.2008.02.022; Cork Douglas J., 2008, International Journal of Medical Engineering and Informatics, V1, P227, DOI 10.1504/IJMEI.2008.020752; Cork DJ, 2002, ANN NY ACAD SCI, V980, P32, DOI 10.1111/j.1749-6632.2002.tb04887.x; CORK DJ, 2003, DIMACS SERIES DISCRE, V61, P123; Deschavanne PJ, 1999, MOL BIOL EVOL, V16, P1391, DOI 10.1093/oxfordjournals.molbev.a026048; Felsenstein J., 1992, PHYLIP PHYLOGENY INF; Feng J, 2008, CHEM PHYS LETT, V454, P355, DOI 10.1016/j.cplett.2008.01.041; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; HILL KA, 1992, J MOL EVOL, V35, P261; Huang GH, 2009, BIOPHYS CHEM, V143, P55, DOI 10.1016/j.bpc.2009.03.013; JEFFREY HJ, 1990, NUCLEIC ACIDS RES, V18, P2163, DOI 10.1093/nar/18.8.2163; Joseph J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-243; Mandelbrot BB, 2004, FRACTAL GEOMETRY NAT; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; Nyambi PN, 1996, J VIROL, V70, P6235, DOI 10.1128/JVI.70.9.6235-6243.1996; OLIVER JL, 1993, J THEOR BIOL, V160, P457, DOI 10.1006/jtbi.1993.1030; Peitgen H.O., 1992, CHAOS FRACTALS NEW F; Polonis VR, 2001, AIDS RES HUM RETROV, V17, P69, DOI 10.1089/088922201750056807; SCARLATTI G, 1993, J INFECT DIS, V168, P207, DOI 10.1093/infdis/168.1.207; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tovanabutra S, 2007, AIDS, V21, P1050, DOI 10.1097/QAD.0b013e32810c8cf3; Wang YW, 2005, GENE, V346, P173, DOI 10.1016/j.gene.2004.10.021; WU D, 1993, VISUALIZATION 199 CP, V33, P308; Yu ZG, 2004, J THEOR BIOL, V226, P341, DOI 10.1016/j.jtbi.2003.09.009	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2010	5	6							e10829	10.1371/journal.pone.0010829	http://dx.doi.org/10.1371/journal.pone.0010829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QF	20532248	Green Published, Green Submitted, gold			2022-12-27	WOS:000278222400003
J	Sharma, R; Tsuchiya, M; Skobe, Z; Tannous, BA; Bartlett, JD				Sharma, Ramaswamy; Tsuchiya, Masahiro; Skobe, Ziedonis; Tannous, Bakhos A.; Bartlett, John D.			The Acid Test of Fluoride: How pH Modulates Toxicity	PLOS ONE			English	Article							RAT INCISOR ENAMEL; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; SODIUM-FLUORIDE; SECRETORY PATHWAY; DEPENDENT EVENT; MESSENGER-RNAS; ULTRASTRUCTURAL-CHANGES; DENTAL FLUOROSIS; RENAL CLEARANCE	Background: It is not known why the ameloblasts responsible for dental enamel formation are uniquely sensitive to fluoride (F-). Herein, we present a novel theory with supporting data to show that the low pH environment of maturating stage ameloblasts enhances their sensitivity to a given dose of F-. Enamel formation is initiated in a neutral pH environment (secretory stage); however, the pH can fall to below 6.0 as most of the mineral precipitates (maturation stage). Low pH can facilitate entry of F- into cells. Here, we asked if F- was more toxic at low pH, as measured by increased cell stress and decreased cell function. Methodology/Principal Findings: Treatment of ameloblast-derived LS8 cells with F- at low pH reduced the threshold dose of F- required to phosphorylate stress-related proteins, PERK, eIF2 alpha, JNK and c-jun. To assess protein secretion, LS8 cells were stably transduced with a secreted reporter, Gaussia luciferase, and secretion was quantified as a function of F- dose and pH. Luciferase secretion significantly decreased within 2 hr of F- treatment at low pH versus neutral pH, indicating increased functional toxicity. Rats given 100 ppm F- in their drinking water exhibited increased stress-mediated phosphorylation of eIF2 alpha in maturation stage ameloblasts (pH<6.0) as compared to secretory stage ameloblasts (pH similar to 7.2). Intriguingly, F--treated rats demonstrated a striking decrease in transcripts expressed during the maturation stage of enamel development (Klk4 and Amtn). In contrast, the expression of secretory stage genes, AmelX, Ambn, Enam and Mmp20, was unaffected. Conclusions: The low pH environment of maturation stage ameloblasts facilitates the uptake of F 2, causing increased cell stress that compromises ameloblast function, resulting in dental fluorosis.	[Sharma, Ramaswamy; Skobe, Ziedonis; Bartlett, John D.] Harvard Univ, Sch Dent Med, Forsyth Inst, Dept Cytokine Biol, Boston, MA 02115 USA; [Sharma, Ramaswamy; Skobe, Ziedonis; Bartlett, John D.] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Tsuchiya, Masahiro] Tohoku Univ, Div Aging & Geriatr Dent, Sendai, Miyagi 980, Japan; [Tannous, Bakhos A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA USA; [Tannous, Bakhos A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol, Boston, MA USA; [Tannous, Bakhos A.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Forsyth Institute; Harvard School of Dental Medicine; Harvard University; Harvard School of Dental Medicine; Tohoku University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sharma, R (corresponding author), Harvard Univ, Sch Dent Med, Forsyth Inst, Dept Cytokine Biol, 188 Longwood Ave, Boston, MA 02115 USA.	jbartlett@forsyth.org	Bartlett, John/L-9832-2017; Sharma, Ramaswamy/F-8401-2012; Tsuchiya, Masahiro/C-5553-2018	Tsuchiya, Masahiro/0000-0002-7000-4547; Bartlett, John/0000-0003-2052-6299	National Institute of Dental and Craniofacial Research [DE018106]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018106] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grant DE018106 from the National Institute of Dental and Craniofacial Research (www.nidcr.nih.gov) to JDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGMARMANSSON B, 1984, CARIES RES, V18, P25, DOI 10.1159/000260743; Aoba T, 2002, CRIT REV ORAL BIOL M, V13, P155, DOI 10.1177/154411130201300206; AZAR HA, 1961, ANN INTERN MED, V55, P193, DOI 10.7326/0003-4819-55-2-193; Badr CE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000571; BAWDEN JW, 1995, J DENT RES, V74, P1349, DOI 10.1177/00220345950740070501; Beltran-Aguilar Eugenio D., 2005, Morbidity and Mortality Weekly Report, V54, P1; Bronckers ALJJ, 2009, J DENT RES, V88, P877, DOI 10.1177/0022034509343280; BRUSSOCK SM, 1987, J DENT RES, V66, P1594, DOI 10.1177/00220345870660101701; CDC, 1995, MMWR-MORBID MORTAL W, V44, P1; CHRISTENSEN R, 1990, J DENT RES, V69, P185; CONCONI FM, 1966, J MOL BIOL, V19, P525, DOI 10.1016/S0022-2836(66)80020-7; Dean HT, 1936, AM J PUBLIC HEALTH N, V26, P567, DOI 10.2105/AJPH.26.6.567; DenBesten P K, 1989, Adv Dent Res, V3, P199; DENBESTEN PK, 1992, J DENT RES, V71, P1238, DOI 10.1177/00220345920710051701; DenBesten PK, 2002, ARCH ORAL BIOL, V47, P763, DOI 10.1016/S0003-9969(02)00117-6; DENBESTEN PK, 1986, J DENT RES, V65, P1272, DOI 10.1177/00220345860650101401; EKSTRAND J, 1980, EUR J CLIN PHARMACOL, V18, P189, DOI 10.1007/BF00561589; EKSTRAND J, 1982, ACTA PHARMACOL TOX, V50, P321; Fawell J., 2006, FLUORIDE DRINKING WA; Fejerskov O, 1990, J Dent Res, V69 Spec No, P692; GARANT PR, 1972, J ULTRA MOL STRUCT R, V40, P333, DOI 10.1016/S0022-5320(72)90105-0; GARANT PR, 1984, TISSUE CELL, V16, P635, DOI 10.1016/0040-8166(84)90037-5; Garcia-Montalvo EA, 2009, TOXICOLOGY, V263, P75, DOI 10.1016/j.tox.2009.06.008; GODCHAUX W, 1976, J BIOL CHEM, V251, P292; Gow A, 2003, NEUROMOL MED, V4, P73, DOI 10.1385/NMM:4:1-2:73; Gstraunthaler G, 2000, AM J PHYSIOL-RENAL, V278, pF227, DOI 10.1152/ajprenal.2000.278.2.F227; GSTRAUNTHALER G, 1992, AM J PHYSIOL, V263, pC47, DOI 10.1152/ajpcell.1992.263.1.C47; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; He H, 1998, BBA-BIOMEMBRANES, V1372, P244, DOI 10.1016/S0005-2736(98)00064-9; HELGELAND K, 1976, SCAND J DENT RES, V84, P276; Hirano S, 1997, ARCH TOXICOL, V72, P52, DOI 10.1007/s002040050468; HOLLAND RI, 1979, CELL BIOL INT REP, V3, P701, DOI 10.1016/0309-1651(79)90074-2; HOLLAND RI, 1979, ACTA PHARMACOL TOX, V45, P96; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Holzer P, 2000, CURR OPIN GASTROEN, V16, P469, DOI 10.1097/00001574-200011000-00003; JARNBERG PO, 1981, ANESTHESIOLOGY, V54, P48; KALLENBA.E, 1967, ANAT REC, V157, P683, DOI 10.1002/ar.1091570413; KAWASE T, 1989, ARCH ORAL BIOL, V34, P103, DOI 10.1016/0003-9969(89)90133-7; KRUGER BJ, 1968, ARCH ORAL BIOL, V13, P969, DOI 10.1016/0003-9969(68)90012-5; Kubota K, 2005, J BIOL CHEM, V280, P23194, DOI 10.1074/jbc.M503288200; LIN SY, 1966, J MOL BIOL, V21, P51, DOI 10.1016/0022-2836(66)90079-9; Matsuo S, 2000, ARCH TOXICOL, V73, P611, DOI 10.1007/s002040050015; Matsuo S, 1996, ARCH TOXICOL, V70, P420, DOI 10.1007/s002040050294; Menoyo I, 2005, ARZNEIMITTELFORSCH, V55, P455; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; OGILVIE AL, 1953, J DENT RES, V32, P386, DOI 10.1177/00220345530320031301; RIGALLI A, 1990, CALCIFIED TISSUE INT, V46, P333, DOI 10.1007/BF02563825; Robinson C, 2004, CARIES RES, V38, P268, DOI 10.1159/000077766; ROUCH AJ, 1992, KIDNEY INT, V41, P342, DOI 10.1038/ki.1992.47; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; SCHUSTER GS, 1981, CARIES RES, V15, P32, DOI 10.1159/000260497; Sharma R, 2008, ENVIRON HEALTH PERSP, V116, P1142, DOI 10.1289/ehp.11375; SHINODA H, 1975, CALC TISS RES, V18, P91, DOI 10.1007/BF02546229; SHINODA H, 1978, CALC TISS RES, V25, P75, DOI 10.1007/BF02010754; Simmer JP, 1998, J DENT RES, V77, P377, DOI 10.1177/00220345980770020601; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Smith C E, 1996, Adv Dent Res, V10, P159; Smith CE, 2005, J BONE MINER RES, V20, P240, DOI 10.1359/JBMR.041002; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Smith CE, 2006, EUR J ORAL SCI, V114, P147, DOI 10.1111/j.1600-0722.2006.00273.x; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Toyosawa S, 1996, CELL TISSUE RES, V285, P217, DOI 10.1007/s004410050639; TRILLER M, 1979, J DENT RES, V58, P1028, DOI 10.1177/002203457905800216011; Tsuchiya M, 2009, EUR J ORAL SCI, V117, P105, DOI 10.1111/j.1600-0722.2009.00612.x; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; VESCO C, 1970, Journal of Molecular Biology, V47, P335, DOI 10.1016/0022-2836(70)90306-2; Whitford GM, 1982, J APPL TOXICOL, V2, P303, DOI 10.1002/jat.2550020608; WHITFORD GM, 1979, AM J PHYSIOL, V236, pF141, DOI 10.1152/ajprenal.1979.236.2.F141; WHITFORD GM, 1984, CALCIFIED TISSUE INT, V36, P302, DOI 10.1007/BF02405334; WHITFORD GM, 1977, INFECT IMMUN, V18, P680, DOI 10.1128/IAI.18.3.680-687.1977; WHITFORD GM, 1991, P SOC EXP BIOL MED, V196, P178, DOI 10.3181/00379727-196-43176; WHITFORD GM, 1977, AM J PHYSIOL, V232, pF10, DOI 10.1152/ajprenal.1977.232.1.F10; WHITFORD GM, 1995, CARIES RES, V29, P20, DOI 10.1159/000262035; WHITFORD GM, 1976, AM J PHYSIOL, V230, P527, DOI 10.1152/ajplegacy.1976.230.2.527; Wright JT, 1996, J DENT RES, V75, P1936, DOI 10.1177/00220345960750120401; Zhang C, 2001, BIOCHEM BIOPH RES CO, V289, P718, DOI 10.1006/bbrc.2001.6044; Zhou R, 1996, ARCH ORAL BIOL, V41, P739, DOI 10.1016/S0003-9969(96)00078-7	78	36	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10895	10.1371/journal.pone.0010895	http://dx.doi.org/10.1371/journal.pone.0010895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531944	Green Published, Green Submitted, gold			2022-12-27	WOS:000278222100024
J	Shiozawa, Y; Jung, YH; Ziegler, AM; Pedersen, EA; Wang, JH; Wang, Z; Song, JH; Wang, JC; Lee, CH; Sud, S; Pienta, KJ; Krebsbach, PH; Taichman, RS				Shiozawa, Yusuke; Jung, Younghun; Ziegler, Anne M.; Pedersen, Elisabeth A.; Wang, Jianhua; Wang, Zhuo; Song, Junhui; Wang, Jingcheng; Lee, Clara H.; Sud, Sudha; Pienta, Kenneth J.; Krebsbach, Paul H.; Taichman, Russell S.			Erythropoietin Couples Hematopoiesis with Bone Formation	PLOS ONE			English	Article							STEM-CELL NICHE; OSTEOGENIC GROWTH PEPTIDE; PARATHYROID-HORMONE; IN-VIVO; MARROW; STIMULATION; DERIVATIVES; MECHANISM; TISSUE; BLOOD	Background: It is well established that bleeding activates the hematopoietic system to regenerate the loss of mature blood elements. We have shown that hematopoietic stem cells (HSCs) isolated from animals challenged with an acute bleed regulate osteoblast differentiation from marrow stromal cells. This suggests that HSCs participate in bone formation where the molecular basis for this activity is the production of BMP2 and BMP6 by HSCs. Yet, what stimulates HSCs to produce BMPs is unclear. Methodology/Principal Findings: In this study, we demonstrate that erythropoietin (Epo) activates Jak-Stat signaling pathways in HSCs which leads to the production of BMPs. Critically, Epo also directly activates mesenchymal cells to form osteoblasts in vitro, which in vivo leads to bone formation. Importantly, Epo first activates osteoclastogenesis which is later followed by osteoblastogenesis that is induced by either Epo directly or the expression of BMPs by HSCs to form bone. Conclusions/Significance: These data for the first time demonstrate that Epo regulates the formation of bone by both direct and indirect pathways, and further demonstrates the exquisite coupling between hematopoesis and osteopoiesis in the marrow.	[Shiozawa, Yusuke; Jung, Younghun; Ziegler, Anne M.; Pedersen, Elisabeth A.; Wang, Jianhua; Wang, Jingcheng; Lee, Clara H.; Taichman, Russell S.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Wang, Zhuo; Song, Junhui; Krebsbach, Paul H.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Wang, Jianhua] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200030, Peoples R China; [Sud, Sudha; Pienta, Kenneth J.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Sud, Sudha; Pienta, Kenneth J.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Shanghai Jiao Tong University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Shiozawa, Y (corresponding author), Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA.	rtaich@umich.edu	Krebsbach, Paul H./AAC-4765-2021; Pienta, Kenneth/E-7679-2015	Taichman, Russell S./0000-0002-7890-0020; Pienta, Kenneth/0000-0002-4138-2186	Pediatric Oncology Research Fellowship; University of Michigan Dental School's Student Research Program; American Association of Dental Researcher's Student Fellowship Award; Department of Defense [PC073952]; National Institutes of Health [DK082481, DE020721, 1RC1DE020721]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC1DE020721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082481] Funding Source: NIH RePORTER	Pediatric Oncology Research Fellowship; University of Michigan Dental School's Student Research Program; American Association of Dental Researcher's Student Fellowship Award; Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was directly supported by a Pediatric Oncology Research Fellowship (Y.S.), the University of Michigan Dental School's Student Research Program (A.M.Z), and an American Association of Dental Researcher's Student Fellowship Award (A.M.Z.). This study was supported by grants from the Department of Defense (PC073952) and National Institutes of Health (DK082481, DE020721, 1RC1DE020721). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcasoy MO, 2008, BRIT J HAEMATOL, V141, P14, DOI 10.1111/j.1365-2141.2008.07014.x; BAB I, 1992, EMBO J, V11, P1867, DOI 10.1002/j.1460-2075.1992.tb05238.x; Bab Itai A., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P31; BRYAN L S Jr, 1964, Bull Hist Med, V38, P516; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; DOMRACHEVA EV, 1985, TERAPEVT ARKH, V57, P40; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; FOLDES J, 1989, J BONE MINER RES, V4, P643; GAZIT D, 1990, ENDOCRINOLOGY, V126, P2607, DOI 10.1210/endo-126-5-2607; Goddard JC, 2004, J ROY SOC MED, V97, P191, DOI 10.1258/jrsm.97.4.191; Goltzman D, 2008, ARCH BIOCHEM BIOPHYS, V473, P218, DOI 10.1016/j.abb.2008.03.003; GREENBERG Z, 1995, J CLIN ENDOCR METAB, V80, P2330, DOI 10.1210/jc.80.8.2330; Gurevitch O, 1999, TRANSPLANTATION, V68, P1362, DOI 10.1097/00007890-199911150-00024; Holstein JH, 2007, LIFE SCI, V80, P893, DOI 10.1016/j.lfs.2006.11.023; HOWARD GA, 1981, P NATL ACAD SCI-BIOL, V78, P3204, DOI 10.1073/pnas.78.5.3204; Ihle J N, 1993, Semin Immunol, V5, P375, DOI 10.1006/smim.1993.1043; ILIZAROV G A, 1986, Patologicheskaya Fiziologiya i Eksperimental'naya Terapiya, P54; Jung YG, 2008, STEM CELLS, V26, P2042, DOI 10.1634/stemcells.2008-0149; Junk AK, 2002, P NATL ACAD SCI USA, V99, P10659, DOI 10.1073/pnas.152321399; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; LEE MY, 1991, BLOOD, V77, P2135; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Lucas TS, 1997, CLIN ORTHOP RELAT R, P267; Mennini T, 2006, MOL MED, V12, P153, DOI 10.2119/2006-00045.Mennini; Mizutani K, 2009, J CELL BIOCHEM, V106, P563, DOI 10.1002/jcb.22021; STEPANOVA NV, 1991, FIZIOL ZH SSSR, V37, P19; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Takenaka Tsuneo, 2003, International Urology and Nephrology, V35, P407, DOI 10.1023/B:UROL.0000022950.00626.e4; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Yamaza T, 2009, BLOOD, V113, P2595, DOI 10.1182/blood-2008-10-182246; Yazigi A., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P463; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	33	123	134	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10853	10.1371/journal.pone.0010853	http://dx.doi.org/10.1371/journal.pone.0010853			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523730	Green Published, Green Submitted, gold			2022-12-27	WOS:000278221900008
J	Young, JM; Adetifa, IMO; Ota, MOC; Sutherland, JS				Young, James M.; Adetifa, Ifedayo M. O.; Ota, Martin O. C.; Sutherland, Jayne S.			Expanded Polyfunctional T Cell Response to Mycobacterial Antigens in TB Disease and Contraction Post-Treatment	PLOS ONE			English	Article							TUBERCULOSIS-SPECIFIC CD4(+); PERIPHERAL-BLOOD; INTERFERON-GAMMA; MEMORY; INFECTION; DISTINCT	Background: T cells producing multiple factors have been shown to be required for protection from disease progression in HIV but we have recently shown this not to be the case in TB. Subjects with active disease had a greater proportion of polyfunctional cells responding to ESAT-6/CFP-10 stimulation than their infected but non-diseased household contacts (HHC). We therefore wanted to assess this profile in subjects who had successfully completed standard TB chemotherapy. Methods: We performed a cross-sectional study using PBMC from TB cases (pre- and post-treatment) and HHC. Samples were stimulated overnight with TB antigens (ESAT-6/CFP-10 and PPD) and their CD4+ and CD8+ T cells were assessed for production of CD107a, IFN-gamma, IL-2 and TNF-alpha and the complexity of the responses was determined using SPICE and PESTLE software. Results and Conclusions: We found that an increase in complexity (i.e., production of more than 1 factor simultaneously) of the T cell profile was associated with TB disease and that this was significantly reduced following TB treatment. This implies that T cells are able to respond adequately to TB antigens with active disease (at least initially) but the ability of this response to protect the host from disease progression is hampered, presumably due to immune evasion strategies by the bacteria. These findings have implications for the development of new diagnostics and vaccine strategies.	[Young, James M.; Adetifa, Ifedayo M. O.; Ota, Martin O. C.; Sutherland, Jayne S.] MRC Labs, Bacterial Dis Programme, Banjul, Gambia	MRC Laboratory Molecular Biology	Young, JM (corresponding author), Univ Manchester, Manchester M13 9PL, Lancs, England.	jsutherland@mrc.gm		Sutherland, Jayne/0000-0002-7083-4997	Bill & Melinda Gates Foundation; Medical Research Council (UK), Gambia; Medical Research Council [MC_U190071468] Funding Source: researchfish; MRC [MC_U190071468] Funding Source: UKRI	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council (UK), Gambia(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Jointly funded by Bill & Melinda Gates Foundation, Grand Challenge 6 (http://www.gatesfoundation.org/Pages/home.aspx) and Medical Research Council (UK), The Gambia (www.mrc.gm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL B, 2010, AM J RESP CRIT  0218; Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636; Bekker LG, 2000, INFECT IMMUN, V68, P6954, DOI 10.1128/IAI.68.12.6954-6961.2000; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Dlugovitzky D, 1999, SCAND J IMMUNOL, V49, P210, DOI 10.1046/j.1365-3083.1999.00492.x; Goldsack L, 2007, TUBERCULOSIS, V87, P465, DOI 10.1016/j.tube.2007.07.001; Goletti D, 2006, J INFECT DIS, V194, P984, DOI 10.1086/507427; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Hernandez-Pando R, 2009, ARCH IMMUNOL THER EX, V57, P355, DOI 10.1007/s00005-009-0042-9; Hoang TTKT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005928; Khader SA, 2008, CYTOKINE, V41, P79, DOI 10.1016/j.cyto.2007.11.022; Morosini M, 2005, INT J TUBERC LUNG D, V9, P753; Mueller H, 2008, CYTOKINE, V43, P143, DOI 10.1016/j.cyto.2008.05.002; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Stenger S, 2005, ANN RHEUM DIS, V64, P24, DOI 10.1136/ard.2005.042531; Sutherland JS, 2010, J IMMUNOL, V184, P6537, DOI 10.4049/jimmunol.1000399; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; *WHO, WHO 2008 TUB FACTS S, P1; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005	21	51	53	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11237	10.1371/journal.pone.0011237	http://dx.doi.org/10.1371/journal.pone.0011237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574540	gold, Green Published, Green Submitted			2022-12-27	WOS:000279058300021
J	Mensch, J; Carreira, V; Lavagnino, N; Goenaga, J; Folguera, G; Hasson, E; Fanara, JJ				Mensch, Julian; Carreira, Valeria; Lavagnino, Nicolas; Goenaga, Julieta; Folguera, Guillermo; Hasson, Esteban; Jose Fanara, Juan			Stage-Specific Effects of Candidate Heterochronic Genes on Variation in Developmental Time along an Altitudinal Cline of Drosophila melanogaster	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LARVAL DEVELOPMENT; BODY-SIZE; EVOLUTION; SELECTION; POPULATIONS; MASTERMIND; RESISTANCE; VIABILITY; GENOMICS	Background: Previously, we have shown there is clinal variation for egg-to-adult developmental time along geographic gradients in Drosophila melanogaster. Further, we also have identified mutations in genes involved in metabolic and neurogenic pathways that affect development time (heterochronic genes). However, we do not know whether these loci affect variation in developmental time in natural populations. Methodology/Principal Findings: Here, we constructed second chromosome substitution lines from natural populations of Drosophila melanogaster from an altitudinal cline, and measured egg-adult development time for each line. We found not only a large amount of genetic variation for developmental time, but also positive associations of the development time with thermal amplitude and altitude. We performed genetic complementation tests using substitution lines with the longest and shortest developmental times and heterochronic mutations. We identified segregating variation for neurogenic and metabolic genes that largely affected the duration of the larval stages but had no impact on the timing of metamorphosis. Conclusions/Significance: Altitudinal clinal variation in developmental time for natural chromosome substitution lines provides a unique opportunity to dissect the response of heterochronic genes to environmental gradients. Ontogenetic stage-specific variation in invected, mastermind, cricklet and CG14591 may affect natural variation in development time and thermal evolution.	[Mensch, Julian; Carreira, Valeria; Lavagnino, Nicolas; Goenaga, Julieta; Folguera, Guillermo; Hasson, Esteban; Jose Fanara, Juan] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, Lab Evoluc, Buenos Aires, DF, Argentina	University of Buenos Aires	Mensch, J (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, Lab Evoluc, Buenos Aires, DF, Argentina.	jmensch@ege.fcen.uba.ar	Goenaga, Julieta/O-4643-2016; MENSCH, JULIAN/GYD-5497-2022; Carreira, Valeria/AAG-2196-2020	Goenaga, Julieta/0000-0002-2894-1166; MENSCH, JULIAN/0000-0002-2298-4309; Lavagnino, Nicolas Jose/0000-0001-9737-3820; Goenaga, Julieta/0000-0002-9822-5800	University of Buenos Aires [X099, X076]; Fondo para la Investigacion Cientifica y Tecnologica [PICT 32146]; Ministerio de Ciencia e Innovacion [PCI 2006-A7-0537]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas [PIP 112-200801-01459, PIP 112-200801-02042]	University of Buenos Aires(University of Buenos Aires); Fondo para la Investigacion Cientifica y Tecnologica; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consejo Nacional de Investigaciones Cientificas y Tecnologicas	This work was supported by the University of Buenos Aires (grants X099 and X076), the Fondo para la Investigacion Cientifica y Tecnologica (grant PICT 32146), the Ministerio de Ciencia e Innovacion (grant PCI 2006-A7-0537) and the Consejo Nacional de Investigaciones Cientificas y Tecnologicas (grants PIP 112-200801-01459 and PIP 112-200801-02042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anholt RRH, 2004, NAT REV GENET, V5, P838, DOI 10.1038/nrg1472; Bettler D, 1996, GENETICS, V143, P859; Campbell PM, 2001, INSECT BIOCHEM MOLEC, V31, P513, DOI 10.1016/S0965-1748(01)00035-2; Carreira VP, 2009, HEREDITY, V102, P246, DOI 10.1038/hdy.2008.117; Chippindale Adam K., 2004, P413, DOI 10.1142/9789812567222_0034; Chippindale AK, 1997, EVOLUTION, V51, P1536, DOI [10.2307/2411206, 10.1111/j.1558-5646.1997.tb01477.x]; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Crone EJ, 2007, INSECT BIOCHEM MOLEC, V37, P540, DOI 10.1016/j.ibmb.2007.02.010; Davidowitz G, 2004, INTEGR COMP BIOL, V44, P443, DOI 10.1093/icb/44.6.443; De Jong G, 2003, J GENET, V82, P207, DOI 10.1007/BF02715819; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Edwards AC, 2009, GENETICS, V182, P889, DOI 10.1534/genetics.109.101691; Fanara JJ, 2006, J EVOLUTION BIOL, V19, P900, DOI 10.1111/j.1420-9101.2006.01084.x; Fanara JJ, 2002, GENETICS, V162, P1321; Folguera G, 2008, BIOL J LINN SOC, V95, P233, DOI 10.1111/j.1095-8312.2008.01053.x; Geiger-Thornsberry GL, 2004, MECH AGEING DEV, V125, P179, DOI 10.1016/j.mad.2003.12.008; Gotthard K, 2001, EXPTL BIOL REV, P287; Gustavson E, 1996, GENETICS, V142, P893; Harbison ST, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r36; Harshman LG, 1999, J EVOLUTION BIOL, V12, P370, DOI 10.1046/j.1420-9101.1999.00024.x; JAMES AC, 1995, J EVOLUTION BIOL, V8, P315, DOI 10.1046/j.1420-9101.1995.8030315.x; Jordan KW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r172; MACKAY TF, 2008, PROPOSAL SEQUENCE DR; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Mackay TFC, 2004, NAT GENET, V36, P1145, DOI 10.1038/ng1104-1145; Mensch J, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-78; Nunney L, 1996, EVOLUTION, V50, P1193, DOI 10.2307/2410660; Nunney L, 2007, J EVOLUTION BIOL, V20, P141, DOI 10.1111/j.1420-9101.2006.01214.x; Paaby AB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001987; Prasad NG, 2001, EVOLUTION, V55, P1363, DOI 10.1111/j.0014-3820.2001.tb00658.x; Schmid AT, 1996, J EXP ZOOL, V274, P207, DOI 10.1002/(SICI)1097-010X(19960301)274:4<207::AID-JEZ1>3.0.CO;2-T; Soto EM, 2008, ENTOMOL EXP APPL, V126, P18, DOI 10.1111/j.1570-7458.2007.00631.x; Stearns S.C., 1992, pi; van't Land J, 1999, J EVOLUTION BIOL, V12, P222, DOI 10.1046/j.1420-9101.1999.00029.x; VANDELDEN W, 1991, GENETICS, V127, P507; Wang P, 2007, GENETICS, V177, P1655, DOI 10.1534/genetics.107.079731	36	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11229	10.1371/journal.pone.0011229	http://dx.doi.org/10.1371/journal.pone.0011229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585460	Green Published, gold, Green Submitted			2022-12-27	WOS:000278977200020
J	Drewe, JA; Tomlinson, AJ; Walker, NJ; Delahay, RJ				Drewe, Julian A.; Tomlinson, Alexandra J.; Walker, Neil J.; Delahay, Richard J.			Diagnostic Accuracy and Optimal Use of Three Tests for Tuberculosis in Live Badgers	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS INFECTION; MELES-MELES; SEROLOGICAL TESTS; GOLD STANDARD; CATTLE; SENSITIVITY; SPECIFICITY; ANTIBODIES; EPIDEMIOLOGY; POPULATION	Background: Accurate diagnosis of tuberculosis (TB) due to infection with Mycobacterium bovis is notoriously difficult in live animals, yet important if we are to understand the epidemiology of TB and devise effective strategies to limit its spread. Currently available tests for diagnosing TB in live Eurasian badgers (Meles meles) remain unvalidated against a reliable gold standard. The aim of the present study was to evaluate the diagnostic accuracy and optimal use of three tests for TB in badgers in the absence of a gold standard. Methodology/Principal Findings: A Bayesian approach was used to evaluate the diagnostic accuracy and optimal use of mycobacterial culture, gamma-interferon assay and a commercially available serological test using multiple samples collected from 305 live wild badgers. Although no single test was judged to be sufficiently sensitive and specific to be used as a sole diagnostic method, selective combined use of the three tests allowed guidelines to be formulated that allow a diagnosis to be made for individual animals with an estimated overall accuracy of 93% (range: 75% to 97%). Employing this approach in the study population of badgers resulted in approximately 13 out of 14 animals having their true infection status correctly classified from samples collected on a single capture. Conclusions/Significance: This method of interpretation represents a marked improvement on the current procedure for diagnosing M. bovis infection in live badgers. The results should be of use to inform future test and intervention strategies with the aim of reducing the incidence of TB in free-living wild badger populations.	[Drewe, Julian A.] Univ London Royal Vet Coll, Ctr Emerging Endem & Exot Dis, London, England; [Drewe, Julian A.; Tomlinson, Alexandra J.; Walker, Neil J.; Delahay, Richard J.] Food & Environm Res Agcy, Woodchester Pk, Glos, England	University of London; University of London Royal Veterinary College; Food & Environment Research Agency	Drewe, JA (corresponding author), Univ London Royal Vet Coll, Ctr Emerging Endem & Exot Dis, London, England.	jdrewe@rvc.ac.uk	Delahay, Richard/J-2261-2014; Delahay, Richard/GSI-4663-2022; Drewe, Julian A/A-6562-2009		Royal Veterinary College Animal Care Trust; Department for Environment, Food and Rural Affairs (Defra)	Royal Veterinary College Animal Care Trust; Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA))	Funding for the long-term badger study was provided by the Department for Environment, Food and Rural Affairs (Defra; http://www.defra.gov.uk/index.htm). JAD was funded by the Royal Veterinary College Animal Care Trust (http://www.rvc.ac.uk/ACT/Index.cfm). The manuscript was approved by both Defra and the RVC (manuscript number P/VCS/00068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYES T, 1763, MFRS PHILOS T, V53, P370; Bengis R.G., 1998, ZOO WILD ANIMAL MED, P101; Branscum AJ, 2005, PREV VET MED, V68, P145, DOI 10.1016/j.prevetmed.2004.12.005; Chambers MA, 2002, VET MICROBIOL, V86, P183, DOI 10.1016/S0378-1135(02)00012-3; Chambers MA, 2008, J CLIN MICROBIOL, V46, P1498, DOI 10.1128/JCM.02117-07; Chambers MA, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-42; CHEESEMAN CL, 1982, J ZOOL, V197, P289; CLIFTONHADLEY RS, 1995, VET REC, V137, P555, DOI 10.1136/vr.137.22.555; CLIFTONHADLEY RS, 1993, EPIDEMIOL INFECT, V111, P9, DOI 10.1017/S0950268800056624; Corner LAL, 2006, VET MICROBIOL, V112, P303, DOI 10.1016/j.vetmic.2005.11.015; Crawshaw TR, 2008, VET REC, V163, P473, DOI 10.1136/vr.163.16.473; Dalley D, 2008, TUBERCULOSIS, V88, P235, DOI 10.1016/j.tube.2007.11.001; de Leeuw ANS, 2004, VET J, V167, P186, DOI 10.1016/S1090-0233(03)00113-8; *DEFR, 2009, MONTHL PUBL NAT STAT; Delahay RJ, 2000, J ANIM ECOL, V69, P428, DOI 10.1046/j.1365-2656.2000.00406.x; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Donnelly CA, 2007, INT J INFECT DIS, V11, P300, DOI 10.1016/j.ijid.2007.04.001; Drewe JA, 2009, J VET DIAGN INVEST, V21, P31, DOI 10.1177/104063870902100105; Enoe C, 2000, PREV VET MED, V45, P61, DOI 10.1016/S0167-5877(00)00117-3; Gavier-Widen D, 2001, VET REC, V148, P299, DOI 10.1136/vr.148.10.299; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Greenwald R, 2003, DIAGN MICR INFEC DIS, V46, P197, DOI 10.1016/S0732-8893(03)00046-4; Greiner M, 2000, PREV VET MED, V45, P3, DOI 10.1016/S0167-5877(00)00114-8; HANNA J, 1992, VET MICROBIOL, V31, P243, DOI 10.1016/0378-1135(92)90082-5; HUI SL, 1980, BIOMETRICS, V36, P167, DOI 10.2307/2530508; Jenkins HE, 2008, EPIDEMIOL INFECT, V136, P1350, DOI 10.1017/S0950268807009909; Johnson WO, 2001, AM J EPIDEMIOL, V153, P921, DOI 10.1093/aje/153.9.921; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Lyashchenko KP, 1998, INFECT IMMUN, V66, P5344, DOI 10.1128/IAI.66.11.5344-5349.1998; Murphy D, 2010, RES VET SCI, V88, P1, DOI 10.1016/j.rvsc.2009.05.020; NEILL SD, 1988, VET REC, V123, P340, DOI 10.1136/vr.123.13.340; RITACCO V, 1991, RES VET SCI, V50, P365, DOI 10.1016/0034-5288(91)90143-C; Smith R., 2006, VET CLIN EPIDEMIOLOG, V3rd ed.; STAINSBY K, 1989, TUBERCLE, V70, P287, DOI 10.1016/0041-3879(89)90023-8; Toft N, 2005, PREV VET MED, V68, P19, DOI 10.1016/j.prevetmed.2005.01.006; Toft N, 2007, VET MICROBIOL, V120, P77, DOI 10.1016/j.vetmic.2006.10.025; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Vose D., 2008, RISK ANAL QUANTITATI; Waters WR, 2006, CLIN VACCINE IMMUNOL, V13, P648, DOI 10.1128/CVI.00061-06; WOOD PR, 1992, VET MICROBIOL, V31, P71, DOI 10.1016/0378-1135(92)90142-G	41	47	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11196	10.1371/journal.pone.0011196	http://dx.doi.org/10.1371/journal.pone.0011196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20585404	Green Submitted, Green Published, gold			2022-12-27	WOS:000278886300033
J	Ozcivici, E; Luu, YK; Rubin, CT; Judex, S				Ozcivici, Engin; Luu, Yen K.; Rubin, Clinton T.; Judex, Stefan			Low-Level Vibrations Retain Bone Marrow's Osteogenic Potential and Augment Recovery of Trabecular Bone during Reambulation	PLOS ONE			English	Article							MICRO-COMPUTED TOMOGRAPHY; GROWTH-FACTOR-I; LOW-MAGNITUDE; HIGH-FREQUENCY; MECHANICAL SIGNALS; WEIGHT-BEARING; TISSUE MINERALIZATION; DAILY EXPOSURE; ENHANCE; DIFFERENTIATION	Mechanical disuse will bias bone marrow stromal cells towards adipogenesis, ultimately compromising the regenerative capacity of the stem cell pool and impeding the rapid and full recovery of bone morphology. Here, it was tested whether brief daily exposure to high-frequency, low-magnitude vibrations can preserve the marrow environment during disuse and enhance the initiation of tissue recovery upon reambulation. Male C57BL/6J mice were subjected to hindlimb unloading (HU, n = 24), HU interrupted by weight-bearing for 15 min/d (HU+SHAM, n = 24), HU interrupted by low-level whole body vibrations (0.2 g, 90 Hz) for 15 min/d (HU+VIB, n = 24), or served as age-matched controls (AC, n = 24). Following 3 w of disuse, half of the mice in each group were released for 3 w of reambulation (RA), while the others were sacrificed. RA+VIB mice continued to receive vibrations for 15 min/d while RA+SHAM continued to receive sham loading. After disuse, HU+VIB mice had a 30% greater osteogenic marrow stromal cell population, 30% smaller osteoclast surface, 76% greater osteoblast surface but similar trabecular bone volume fraction compared to HU. After 3 w of reambulation, trabecular bone of RA+VIB mice had a 30% greater bone volume fraction, 51% greater marrow osteoprogenitor population, 83% greater osteoblast surfaces, 59% greater bone formation rates, and a 235% greater ratio of bone lining osteoblasts to marrow adipocytes than RA mice. A subsequent experiment indicated that receiving the mechanical intervention only during disuse, rather than only during reambulation, was more effective in altering trabecular morphology. These data indicate that the osteogenic potential of bone marrow cells is retained by low-magnitude vibrations during disuse, an attribute which may have contributed to an enhanced recovery of bone morphology during reambulation.	[Ozcivici, Engin; Luu, Yen K.; Rubin, Clinton T.; Judex, Stefan] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Judex, S (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.	stefan.judex@stonybrook.edu	Ozcivici, Engin/AAN-1313-2021	Ozcivici, Engin/0000-0003-4464-0475	NASA; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	NASA(National Aeronautics & Space Administration (NASA)); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was kindly funded by NASA and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahdjoudj S, 2002, J BONE MINER RES, V17, P668, DOI 10.1359/jbmr.2002.17.4.668; Baldwin KM, 1996, MED SCI SPORT EXER, V28, P1247, DOI 10.1097/00005768-199610000-00007; Basso N, 2005, BONE, V37, P370, DOI 10.1016/j.bone.2005.04.033; Basso N, 2005, BONE, V36, P173, DOI 10.1016/j.bone.2004.09.016; Boudignon BM, 2007, J APPL PHYSIOL, V103, P125, DOI 10.1152/japplphysiol.00111.2007; Brouwers JEM, 2007, J ORTHOP RES, V25, P1325, DOI 10.1002/jor.20439; Burghardt AJ, 2008, CALCIFIED TISSUE INT, V83, P129, DOI 10.1007/s00223-008-9158-x; Chappard D., 2008, Morphologie, V92, P162, DOI 10.1016/j.morpho.2008.10.003; CHENG CB, 1999, INT J FUZZY SYST, V1, P14; David V, 2007, ENDOCRINOLOGY, V148, P2553, DOI 10.1210/en.2006-1704; Fritton SP, 2000, J BIOMECH, V33, P317, DOI 10.1016/S0021-9290(99)00210-9; Garman R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000653; Garman R, 2007, J ORTHOP RES, V25, P732, DOI 10.1002/jor.20354; Gilsanz V, 2006, J BONE MINER RES, V21, P1464, DOI 10.1359/JBMR.060612; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Huang RP, 1999, J GERONTOL A-BIOL, V54, pB352, DOI 10.1093/gerona/54.8.B352; Judex S, 2002, FASEB J, V16, P1280, DOI 10.1096/fj.01-0913fje; Judex S, 2000, BONE, V26, P153, DOI 10.1016/S8756-3282(99)00256-2; Judex S, 2007, J BIOMECH, V40, P1333, DOI 10.1016/j.jbiomech.2006.05.014; KARINKANTA S, 2008, OSTEOPOROS INT; Kazakia GJ, 2008, MED PHYS, V35, P3170, DOI 10.1118/1.2924210; KEILA S, 1994, J BONE MINER RES, V9, P321; Kim CH, 2003, J BONE MINER RES, V18, P2116, DOI 10.1359/jbmr.2003.18.12.2116; Klinck RJ, 2008, MED ENG PHYS, V30, P888, DOI 10.1016/j.medengphy.2007.11.004; Lang T, 2004, J BONE MINER RES, V19, P1006, DOI 10.1359/JBMR.040307; Lang TF, 2006, J BONE MINER RES, V21, P1224, DOI 10.1359/JBMR.060509; LEBLANC AD, 1990, J BONE MINER RES, V5, P843; LEBLANC AD, 2002, J MUSCULOSKEL NEURON, V2, P235; Li CY, 2005, BONE, V37, P287, DOI 10.1016/j.bone.2005.04.041; Li CY, 2005, J BONE MINER RES, V20, P117, DOI 10.1359/JBMR.041010; Lian J B, 1995, Iowa Orthop J, V15, P118; Lublinsky S, 2007, CALCIFIED TISSUE INT, V81, P285, DOI 10.1007/s00223-007-9063-8; Luu YK, 2010, INT J OBESITY, V34, P401, DOI 10.1038/ijo.2009.240; Luu YK, 2009, MED ENG PHYS, V31, P34, DOI 10.1016/j.medengphy.2008.03.006; Luu YK, 2009, J BONE MINER RES, V24, P50, DOI [10.1359/jbmr.080817, 10.1359/JBMR.080817]; Maddalozzo GF, 2008, INT J OBESITY, V32, P1348, DOI 10.1038/ijo.2008.111; Marwick C, 2000, JAMA-J AM MED ASSOC, V283, P2093, DOI 10.1001/jama.283.16.2093; MERRY K, 1993, J CELL SCI, V104, P1013; Milgrom C, 2000, BRIT J SPORT MED, V34, P195, DOI 10.1136/bjsm.34.3.195; MILLER LM, 2007, J BONE MINER RES; Mirza BI, 2008, J APPL PHYS, V104, DOI 10.1063/1.2982374; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Ozcivici E, 2007, J BIOMECH, V40, P3404, DOI 10.1016/j.jbiomech.2007.05.015; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; Rittweger J, 2009, BONE, V44, P214, DOI 10.1016/j.bone.2008.10.044; Rubin C, 2001, FASEB J, V15, P2225, DOI 10.1096/fj.01-0166com; Rubin C, 2004, J BONE MINER RES, V19, P343, DOI 10.1359/JBMR.0301251; Rubin CT, 2007, P NATL ACAD SCI USA, V104, P17879, DOI 10.1073/pnas.0708467104; Sakata T, 2003, BONE, V32, P669, DOI 10.1016/S8756-3282(03)00088-7; Smith SM, 2008, BONE, V42, P572, DOI 10.1016/j.bone.2007.11.015; Travlos GS, 2006, TOXICOL PATHOL, V34, P548, DOI 10.1080/01926230600939856; VAN VP, 1994, BLOOD, V84, P753; Vico L, 2000, LANCET, V355, P1607, DOI 10.1016/S0140-6736(00)02217-0; Yavuzer G, 2002, INT J REHABIL RES, V25, P235, DOI 10.1097/00004356-200209000-00010; Zayzafoon M, 2004, ENDOCRINOLOGY, V145, P2421, DOI 10.1210/en.2003-1156	55	87	92	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11178	10.1371/journal.pone.0011178	http://dx.doi.org/10.1371/journal.pone.0011178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567514	Green Published, gold			2022-12-27	WOS:000278886300020
J	Apicella, CL; Cesarini, D; Johannesson, M; Dawes, CT; Lichtenstein, P; Wallace, B; Beauchamp, J; Westberg, L				Apicella, Coren L.; Cesarini, David; Johannesson, Magnus; Dawes, Christopher T.; Lichtenstein, Paul; Wallace, Bjoern; Beauchamp, Jonathan; Westberg, Lars			No Association between Oxytocin Receptor (OXTR) Gene Polymorphisms and Experimentally Elicited Social Preferences	PLOS ONE			English	Article							GENOME-WIDE; AUTISM LOCI; BEHAVIOR; TRUST; REPLICATION; DEFICITS; SEARCH	Background: Oxytocin (OXT) has been implicated in a suite of complex social behaviors including observed choices in economic laboratory experiments. However, actual studies of associations between oxytocin receptor (OXTR) gene variants and experimentally elicited social preferences are rare. Methodology/Principal Findings: We test hypotheses of associations between social preferences, as measured by behavior in two economic games, and 9 single nucleotide polymorphisms (SNPs) of the OXTR gene in a sample of Swedish twins (n = 684). Two standard economic games, the dictator game and the trust game, both involving real monetary consequences, were used to elicit such preferences. After correction for multiple hypothesis testing, we found no significant associations between any of the 9 single nucleotide polymorphisms (SNPs) and behavior in either of the games. Conclusion: We were unable to replicate the most significant association reported in previous research between the amount donated in a dictator game and an OXTR genetic variant.	[Apicella, Coren L.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Apicella, Coren L.] Harvard Univ, Dept Human Evolutionary Biol, Boston, MA 02115 USA; [Cesarini, David] MIT, Dept Econ, Cambridge, MA 02139 USA; [Dawes, Christopher T.] Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA; [Johannesson, Magnus; Wallace, Bjoern] Stockholm Sch Econ, Dept Econ, S-11383 Stockholm, Sweden; [Lichtenstein, Paul] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Beauchamp, Jonathan] Harvard Univ, Dept Econ, Boston, MA 02115 USA; [Westberg, Lars] Univ Gothenburg, Dept Pharmacol, Inst Neurosci & Physiol, Gothenburg, Sweden	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; Stockholm School of Economics; Karolinska Institutet; Harvard University; University of Gothenburg	Apicella, CL (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.	apicella@fas.harvard.edu	Johannesson, Magnus/E-9680-2011	Johannesson, Magnus/0000-0001-8759-6393; lichtenstein, paul/0000-0003-3037-5287; Cesarini, David/0000-0002-0043-009X; Apicella, Coren/0000-0002-9661-6998	Swedish Resarch Council; Jan Wallander and Tom Hedelius Foundation; Swedish Research Council; Swedish Council; Ministry for Higher Education	Swedish Resarch Council; Jan Wallander and Tom Hedelius Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council(Swedish Research Council); Ministry for Higher Education	LW thanks Fredrik och Ingrid Thuringsstiftelse, Ake Wibergsstiftelse, Ahlen-Stiftelsen, Jeanssons-stiftelsen, Magnus Bergvalls stiftelse, Soderstrom-Konigska stiftelsen, Marta Lundqvist stiftelse and the Swedish Resarch Council for financial support. MJ thanks the Jan Wallander and Tom Hedelius Foundation, the Swedish Research Council, and the Swedish Council for Working Life and Social Research for financial support. The Swedish Twin Registry is supported by grants from the Swedish Research Council and the The Ministry for Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004; Bales KL, 2004, DEV PSYCHOBIOL, V44, P123, DOI 10.1002/dev.10165; Benjamin D., 2007, BIOSOCIAL SURVEYS, P304; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Cesarini D, 2008, P NATL ACAD SCI USA, V105, P3721, DOI 10.1073/pnas.0710069105; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Charness G, 2002, Q J ECON, V117, P817, DOI 10.1162/003355302760193904; Cleves M., 1999, STAT TECH B, V48, P34; Costa B, 2009, PSYCHONEUROENDOCRINO, V34, P1506, DOI 10.1016/j.psyneuen.2009.05.006; Ditzen B, 2009, BIOL PSYCHIAT, V65, P728, DOI 10.1016/j.biopsych.2008.10.011; Domes G, 2010, PSYCHONEUROENDOCRINO, V35, P83, DOI 10.1016/j.psyneuen.2009.06.016; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Eckel CC, 1996, GAME ECON BEHAV, V16, P181, DOI 10.1006/game.1996.0081; Fehr E, 2002, ECON J, V112, pC1, DOI 10.1111/1468-0297.00027; FISCHBACHER U, 2008, 200807 CEDEX; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Gintis H, 2003, EVOL HUM BEHAV, V24, P153, DOI 10.1016/S1090-5138(02)00157-5; Henrich J., 2005, FDN HUMAN SOCIALITY; Hertwig R, 2001, BEHAV BRAIN SCI, V24, P383, DOI 10.1017/S0140525X01004149; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; INOUE T, 1994, J BIOL CHEM, V269, P32451; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Ioannidis JPA, 2007, HUM HERED, V64, P203, DOI 10.1159/000103512; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Israel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005535; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Kurzban R, 2005, P NATL ACAD SCI USA, V102, P1803, DOI 10.1073/pnas.0408759102; Lauritsen MB, 2006, MOL PSYCHIATR, V11, P37, DOI 10.1038/sj.mp.4001754; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Lerer E, 2008, MOL PSYCHIATR, V13, P980, DOI 10.1038/sj.mp.4002087; McCauley JL, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-1; NEALE BM, 2007, STAT GENETICS; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Ross HE, 2009, FRONT NEUROENDOCRIN, V30, P534, DOI 10.1016/j.yfrne.2009.05.004; SUMA J, 2007, NEUROSCI LETT, V417, P6; Takayanagi Y, 2005, P NATL ACAD SCI USA, V102, P16096, DOI 10.1073/pnas.0505312102; TANSEY KE, 2010, NEUROSCI LE IN PRESS; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wermter AK, 2010, AM J MED GENET B, V153B, P629, DOI 10.1002/ajmg.b.31032; Winslow JT, 2002, NEUROPEPTIDES, V36, P221, DOI 10.1054/npep.2002.0909; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013; Ylisaukko-oja T, 2006, ANN NEUROL, V59, P145, DOI 10.1002/ana.20722; Yrigollen CM, 2008, BIOL PSYCHIAT, V63, P911, DOI 10.1016/j.biopsych.2007.11.015; Zak PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001128; Zak PJ, 2005, HORM BEHAV, V48, P522, DOI 10.1016/j.yhbeh.2005.07.009; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821	49	77	79	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11153	10.1371/journal.pone.0011153	http://dx.doi.org/10.1371/journal.pone.0011153			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585395	Green Published, gold, Green Submitted			2022-12-27	WOS:000278886100017
J	Chen, BJ; Deoliveira, D; Spasojevic, I; Sempowski, GD; Jiang, C; Owzar, K; Wang, XJ; Gesty-Palmer, D; Cline, JM; Bourland, JD; Dugan, G; Meadows, SK; Daher, P; Muramoto, G; Chute, JP; Chao, NJ				Chen, Benny J.; Deoliveira, Divino; Spasojevic, Ivan; Sempowski, Gregory D.; Jiang, Chen; Owzar, Kouros; Wang, Xiaojuan; Gesty-Palmer, Diane; Cline, J. Mark; Bourland, J. Daniel; Dugan, Greg; Meadows, Sarah K.; Daher, Pamela; Muramoto, Garrett; Chute, John P.; Chao, Nelson J.			Growth Hormone Mitigates against Lethal Irradiation and Enhances Hematologic and Immune Recovery in Mice and Nonhuman Primates	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TUMOR NECROSIS FACTOR; T-CELL DEVELOPMENT; FACTOR-I; HEMATOPOIETIC STEM; NEUROENDOCRINE HORMONES; ERYTHROPOIESIS INVITRO; IONIZING-RADIATION; PROGENITOR CELLS; BONE-MARROW	Medications that can mitigate against radiation injury are limited. In this study, we investigated the ability of recombinant human growth hormone (rhGH) to mitigate against radiation injury in mice and nonhuman primates. BALB/c mice were irradiated with 7.5 Gy and treated post-irradiation with rhGH intravenously at a once daily dose of 20 mu g/dose for 35 days. rhGH protected 17 out of 28 mice (60.7%) from lethal irradiation while only 3 out of 28 mice (10.7%) survived in the saline control group. A shorter course of 5 days of rhGH post-irradiation produced similar results. Compared with the saline control group, treatment with rhGH on irradiated BALB/c mice significantly accelerated overall hematopoietic recovery. Specifically, the recovery of total white cells, CD4 and CD8 T cell subsets, B cells, NK cells and especially platelets post radiation exposure were significantly accelerated in the rhGH-treated mice. Moreover, treatment with rhGH increased the frequency of hematopoietic stem/progenitor cells as measured by flow cytometry and colony forming unit assays in bone marrow harvested at day 14 after irradiation, suggesting the effects of rhGH are at the hematopoietic stem/progenitor level. rhGH mediated the hematopoietic effects primarily through their niches. Similar data with rhGH were also observed following 2 Gy sublethal irradiation of nonhuman primates. Our data demonstrate that rhGH promotes hematopoietic engraftment and immune recovery post the exposure of ionizing radiation and mitigates against the mortality from lethal irradiation even when administered after exposure.	[Chen, Benny J.; Deoliveira, Divino; Spasojevic, Ivan; Sempowski, Gregory D.; Wang, Xiaojuan; Gesty-Palmer, Diane; Meadows, Sarah K.; Daher, Pamela; Muramoto, Garrett; Chute, John P.; Chao, Nelson J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Sempowski, Gregory D.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Owzar, Kouros] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA; [Chao, Nelson J.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Sempowski, Gregory D.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC USA; [Jiang, Chen; Owzar, Kouros] Duke Univ, Med Ctr, RadCCORE Biostat Core, Durham, NC USA; [Cline, J. Mark; Dugan, Greg] Wake Forest Univ, Bowman Gray Sch Med, Comparat Med Sect, Winston Salem, NC USA; [Bourland, J. Daniel] Wake Forest Univ, Bowman Gray Sch Med, Dept Radiat Oncol, Winston Salem, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Chen, BJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	chen0032@mc.duke.edu		Sempowski, Gregory/0000-0003-0391-6594	National Institutes of Health [U19AI067798]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UC6AI058607, U19AI067798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grant U19AI067798. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, STAT MODELS S; BLUM JE, 1988, INT J RADIAT ONCOL, V15, P547, DOI 10.1016/0360-3016(88)90293-3; BROXMEYER HE, 1991, CANCER CELL-MON REV, V3, P480; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Burgess W, 2003, J NEUROIMMUNOL, V135, P82, DOI 10.1016/S0165-5728(02)00443-5; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chen BJ, 2004, BLOOD, V103, P4344, DOI 10.1182/blood-2003-07-2534; Chen BJ, 2003, EXP HEMATOL, V31, P953, DOI 10.1016/S0301-472X(03)00196-6; Chute JP, 2007, BLOOD, V109, P2365, DOI 10.1182/blood-2006-05-022640; Cline JM, 2009, AM J PRIMATOL, V71, P722, DOI 10.1002/ajp.20680; Dainiak N, 2002, EXP HEMATOL, V30, P513, DOI 10.1016/S0301-472X(02)00802-0; Elliott TB, 2002, ANTIMICROB AGENTS CH, V46, P3463, DOI 10.1128/AAC.46.11.3463-3471.2002; Garrett RW, 2009, CELL STEM CELL, V4, P503, DOI 10.1016/j.stem.2009.05.011; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; GOLDE DW, 1977, SCIENCE, V196, P1112, DOI 10.1126/science.870971; Gratwohl A, 1998, BLOOD, V92, P765; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Herodin F, 2005, EXP HEMATOL, V33, P1071, DOI 10.1016/j.exphem.2005.04.007; Hudak S, 1998, EXP HEMATOL, V26, P515; Joshi SS, 2003, CYTOTHERAPY, V5, P542, DOI 10.1080/14653240310003648; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lempereur L, 2003, BRIT J PHARMACOL, V138, P1411, DOI 10.1038/sj.bjp.0705173; Lutgens LCHW, 2003, INT J RADIAT ONCOL, V57, P1067, DOI 10.1016/S0360-3016(03)00781-8; MAOR G, 1989, ENDOCRINOLOGY, V125, P1239, DOI 10.1210/endo-125-3-1239; MERCHAV S, 1993, J CELL PHYSIOL, V157, P178, DOI 10.1002/jcp.1041570123; MERCHAV S, 1988, BRIT J HAEMATOL, V70, P267, DOI 10.1111/j.1365-2141.1988.tb02480.x; MERCHAV S, 1992, J CLIN ENDOCR METAB, V74, P447, DOI 10.1210/jc.74.2.447; MERCHAV S, 1988, J CLIN INVEST, V81, P791, DOI 10.1172/JCI113385; Mettler FA, 2002, NEW ENGL J MED, V346, P1554, DOI 10.1056/NEJMra000365; Minshall C, 1996, J IMMUNOL, V156, P939; MURPHY WJ, 1992, J IMMUNOL, V149, P3851; MURPHY WJ, 1992, J IMMUNOL, V148, P3799; Napolitano LA, 2008, J CLIN INVEST, V118, P1085, DOI 10.1172/JCI32830; Neta, 1996, Semin Radiat Oncol, V6, P306, DOI 10.1016/S1053-4296(96)80026-9; NETA R, 1988, J IMMUNOL, V140, P108; NETA R, 1994, J IMMUNOL, V153, P4230; NETA R, 1988, LYMPHOKINE RES, V7, P403; Pinheiro J, 2001, MIXED EFFECTS MODELS; Porter RL, 2008, ARCH BIOCHEM BIOPHYS, V473, P193, DOI 10.1016/j.abb.2008.04.001; Pruijt JFM, 1999, BLOOD, V93, P107, DOI 10.1182/blood.V93.1.107.401k14_107_112; R Core Team, 2020, R LANG ENV STAT COMP; Roberts R, 2008, CLIN PHARMACOL THER, V83, P918, DOI 10.1038/clpt.2008.23; RODRIGUEZTARDUCHY G, 1992, J IMMUNOL, V149, P535; TANIKAWA S, 1990, BLOOD, V76, P445; TSARFATY G, 1994, EXP HEMATOL, V22, P1273; Uckun FM, 1997, CLIN CANCER RES, V3, P325; UCKUN FM, 1990, BLOOD, V75, P638; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Welniak LA, 2002, J LEUKOCYTE BIOL, V71, P381; Welniak LA, 2000, LEUKEMIA LYMPHOMA, V38, P435, DOI 10.3109/10428190009059263; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; Wood CE, 2006, CANCER RES, V66, P1241, DOI 10.1158/0008-5472.CAN-05-2067; Wyatt D, 2004, EUR J ENDOCRINOL, V151, pS55, DOI 10.1530/eje.0.151S055; Xu J, 2003, J IMMUNOL, V171, P938, DOI 10.4049/jimmunol.171.2.938; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; ZSEBO KM, 1992, P NATL ACAD SCI USA, V89, P9464, DOI 10.1073/pnas.89.20.9464	57	40	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11056	10.1371/journal.pone.0011056	http://dx.doi.org/10.1371/journal.pone.0011056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585403	Green Published, Green Submitted, gold			2022-12-27	WOS:000278886100006
J	Rotman, E; Amado, L; Kuzminov, A				Rotman, Ella; Amado, Luciana; Kuzminov, Andrei			Unauthorized Horizontal Spread in the Laboratory Environment: The Tactics of Lula, a Temperate Lambdoid Bacteriophage of Escherichia coli	PLOS ONE			English	Article							PHAGE PHI-80; DNA-REPAIR; RECOMBINATION; AEROSOLS; INACTIVATION; EXCISION; MECHANISM; SURVIVAL; IRRADIATION; INDUCTION	We investigated the characteristics of a lambdoid prophage, nicknamed Lula, contaminating E. coli strains from several sources, that allowed it to spread horizontally in the laboratory environment. We found that new Lula infections are inconspicuous; at the same time, Lula lysogens carry unusually high titers of the phage in their cultures, making them extremely infectious. In addition, Lula prophage interferes with P1 phage development and induces its own lytic development in response to P1 infection, turning P1 transduction into an efficient vehicle of Lula spread. Thus, using Lula prophage as a model, we reveal the following principles of survival and reproduction in the laboratory environment: 1) stealth (via laboratory material commensality), 2) stability (via resistance to specific protocols), 3) infectivity (via covert yet aggressive productivity and laboratory protocol hitchhiking). Lula, which turned out to be identical to bacteriophage phi80, also provides an insight into a surprising persistence of T1-like contamination in BAC libraries.	[Rotman, Ella; Amado, Luciana; Kuzminov, Andrei] Univ Illinois, Dept Microbiol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign	Rotman, E (corresponding author), Univ Illinois, Dept Microbiol, Urbana, IL USA.	kuzminov@life.uiuc.edu			American Cancer Society [RSG-05-135-01-GMC]; National Institutes of Health [GM 073115]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073115] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant # RSG-05-135-01-GMC from the American Cancer Society and by grant # GM 073115 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAD FX, 1994, APPL ENVIRON MICROB, V60, P3704, DOI 10.1128/AEM.60.10.3704-3710.1994; ADAMS MH, 1948, J GEN PHYSIOL, V31, P417, DOI 10.1085/jgp.31.5.417; AIZAWA S, 1975, VIROLOGY, V67, P168, DOI 10.1016/0042-6822(75)90414-6; Amado L, 2006, J BIOL CHEM, V281, P22635, DOI 10.1074/jbc.M602320200; ANDERSON RE, 1952, J BACTERIOL, V64, P473, DOI 10.1002/path.1700640307; Bachmann B.J., 1987, ESCHERICHIA COLI SAL, P1190; *BACPAC RES, 2010, STAND OP PROC T1 PHA; BARNHART BJ, 1970, J BACTERIOL, V103, P9, DOI 10.1128/JB.103.1.9-15.1970; BOGOSIAN G, 2006, BACTERIOPHAGES, P667; Bolt EL, 2002, MOL CELL, V10, P187, DOI 10.1016/S1097-2765(02)00560-9; Burman WJ, 1997, AM J RESP CRIT CARE, V155, P321, DOI 10.1164/ajrccm.155.1.9001331; Campbell-Renton ML, 1942, J PATHOL BACTERIOL, V54, P235, DOI 10.1002/path.1700540211; CSONKA LN, 1979, GENETICS, V93, P321; DELAPPE N, 2009, MBC MICROBIOL, V9, P155; DERMODY JJ, 1979, J BACTERIOL, V139, P701, DOI 10.1128/JB.139.2.701-704.1979; *ECOLIWIKI, 2008, METH DEAL POSS T1 IN; EDLIN G, 1977, J VIROL, V21, P560, DOI 10.1128/JVI.21.2.560-564.1977; Ellis EL, 1939, J GEN PHYSIOL, V22, P365, DOI 10.1085/jgp.22.3.365; *EMP GEN, 2010, WHAT IS T1 PHAG; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Haynes R.H., 1981, MOL BIOL YEAST SACCH, P371; Hendrix R. W, 1983, LAMBDA, VII; HOWARDFL.P, 1973, BRIT MED BULL, V29, P226, DOI 10.1093/oxfordjournals.bmb.a071012; HOWARDFL.P, 1969, J BACTERIOL, V97, P1134, DOI 10.1128/JB.97.3.1134-1141.1969; Hughes P, 2007, BIOTECHNIQUES, V43, P575, DOI 10.2144/000112598; JAMES HS, 2008, BUSINESS DILEMMAS RE; Jepson CD, 2004, VACCINE, V22, P2413, DOI 10.1016/j.vaccine.2003.11.065; JONES KE, 1981, APPL ENVIRON MICROB, V41, P1072, DOI 10.1128/AEM.41.4.1072-1073.1981; Katz KC, 2002, J CLIN MICROBIOL, V40, P2686, DOI 10.1128/JCM.40.7.2686-2688.2002; KENNY MT, 1968, APPL MICROBIOL, V16, P1146, DOI 10.1128/AEM.16.8.1146-1150.1968; KOZYREV DP, 1987, GENETIKA+, V23, P793; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Kuzminov Andrei, 2005, P349; LLOYD RG, 1991, J BACTERIOL, V173, P1004, DOI 10.1128/jb.173.3.1004-1011.1991; MANDAL TN, 1993, J BACTERIOL, V175, P4325, DOI 10.1128/JB.175.14.4325-4334.1993; MATSUSHIRO A, 1963, VIROLOGY, V19, P475, DOI 10.1016/0042-6822(63)90041-2; MUNDY C, 2000, PHAGE CONTAMINATION; RADMAN M, 1970, J MOL BIOL, V49, P203, DOI 10.1016/0022-2836(70)90386-4; ROTTEM S, 1993, TRENDS BIOTECHNOL, V11, P143, DOI 10.1016/0167-7799(93)90089-R; RYBCHIN VN, 1984, GENE, V27, P3, DOI 10.1016/0378-1119(84)90233-6; SEGAWA T, 1973, VIROLOGY, V54, P287, DOI 10.1016/0042-6822(73)90139-6; SONGER JR, 1967, APPL MICROBIOL, V15, P35, DOI 10.1128/AEM.15.1.35-42.1967; TAKEBE H, 1967, VIROLOGY, V33, P638, DOI 10.1016/0042-6822(67)90064-5; THOMS B, 1987, J BACTERIOL, V169, P1731, DOI 10.1128/jb.169.4.1731-1736.1987; TROUWBOR.T, 1974, APPL MICROBIOL, V27, P834, DOI 10.1128/AEM.27.5.834-837.1974; TROUWBORST T, 1972, APPL MICROBIOL, V23, P938, DOI 10.1128/AEM.23.5.938-941.1972; TROUWBORST T, 1972, J GEN VIROL, V15, P235, DOI 10.1099/0022-1317-15-3-235; TROUWBORST T, 1973, APPL MICROBIOL, V26, P252, DOI 10.1128/AEM.26.3.252-257.1973; Van Valen L.M., 1991, EVOLUTIONARY THEORY, V10, P71; Vostrov AA, 1996, J BACTERIOL, V178, P1484, DOI 10.1128/jb.178.5.1484-1486.1996	50	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11106	10.1371/journal.pone.0011106	http://dx.doi.org/10.1371/journal.pone.0011106			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559442	Green Published, gold, Green Submitted			2022-12-27	WOS:000278741100019
J	Kizilyaprak, C; Spehner, D; Devys, D; Schultz, P				Kizilyaprak, Caroline; Spehner, Daniele; Devys, Didier; Schultz, Patrick			In Vivo Chromatin Organization of Mouse Rod Photoreceptors Correlates with Histone Modifications	PLOS ONE			English	Article							CRYOELECTRON MICROSCOPY; NUCLEAR ARCHITECTURE; H4-K16 ACETYLATION; GENE-EXPRESSION; ACTIVE GENES; GENOME; FIBERS; TRANSCRIPTION; CHROMOSOMES; CODE	Background: The folding of genetic information into chromatin plays important regulatory roles in many nuclear processes and particularly in gene transcription. Post translational histone modifications are associated with specific chromatin condensation states and with distinct transcriptional activities. The peculiar chromatin organization of rod photoreceptor nuclei, with a large central domain of condensed chromatin surrounded by a thin border of extended chromatin was used as a model to correlate in vivo chromatin structure, histone modifications and transcriptional activity. Methodology: We investigated the functional relationships between chromatin compaction, distribution of histone modifications and location of RNA polymerase II in intact murine rod photoreceptors using cryo-preparation methods, electron tomography and immunogold labeling. Our results show that the characteristic central heterochromatin of rod nuclei is organized into concentric domains characterized by a progressive loosening of the chromatin architecture from inside towards outside and by specific combinations of silencing histone marks. The peripheral heterochromatin is formed by closely packed 30nm fibers as revealed by a characteristic optical diffraction signal. Unexpectedly, the still highly condensed most external heterochromatin domain contains acetylated histones, which are usually associated with active transcription and decondensed chromatin. Histone acetylation is thus not sufficient in vivo for complete chromatin decondensation. The euchromatin domain contains several degrees of chromatin compaction and the histone tails are hyperacetylated, enriched in H3K4 monomethylation and hypo trimethylated on H3K9, H3K27 and H4K20. The transcriptionally active RNA polymerases II molecules are confined in the euchromatin domain and are preferentially located at the vicinity of the interface with heterochromatin. Conclusions: Our results show that transcription is located in the most decondensed and highly acetylated chromatin regions, but since acetylation is found associated with compact chromatin it is not sufficient to decondense chromatin in vivo. We also show that a combination of histone marks defines distinct concentric heterochromatin domains.	[Kizilyaprak, Caroline; Spehner, Daniele; Devys, Didier; Schultz, Patrick] IGBMC, Illkirch Graffenstaden, France; [Kizilyaprak, Caroline; Spehner, Daniele; Devys, Didier; Schultz, Patrick] INSERM, U964, Illkirch Graffenstaden, France; [Kizilyaprak, Caroline; Spehner, Daniele; Devys, Didier; Schultz, Patrick] CNRS, UMR7104, Illkirch Graffenstaden, France; [Kizilyaprak, Caroline; Spehner, Daniele; Devys, Didier; Schultz, Patrick] Univ Strasbourg, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kizilyaprak, C (corresponding author), IGBMC, Illkirch Graffenstaden, France.	patrick.schultz@igbmc.u-strasbg.fr		Devys, Didier/0000-0001-9655-3512; schultz, patrick/0000-0002-7310-6186	Fondation pour la Recherche Medicale; Ligue Contre le Cancer; Institut National de la Sante et de la Recherche Medicale; Center National pour la Recherche Scientifique; Strasbourg University; Association pour la Recherche sur le Cancer; Agence Nationale pour la Recherche; European Community Commission SPINE2 complexes [LSHG-CT-2006-031220]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ligue Contre le Cancer(Ligue nationale contre le cancer); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Center National pour la Recherche Scientifique; Strasbourg University; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Community Commission SPINE2 complexes	Funding: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by the Fondation pour la Recherche Medicale, the Ligue Contre le Cancer, the Institut National de la Sante et de la Recherche Medicale, the Center National pour la Recherche Scientifique, the Strasbourg University, the Association pour la Recherche sur le Cancer, the Agence Nationale pour la Recherche and the European Community Commission SPINE2 complexes (Contract No. LSHG-CT-2006-031220) under the Integrated Programme "Quality of Life and Management of Living Resources".	Abou-Sleymane G, 2006, HUM MOL GENET, V15, P691, DOI 10.1093/hmg/ddi483; ALLFREY VG, 1964, SCIENCE, V144, P559, DOI 10.1126/science.144.3618.559; Bassett A, 2009, CURR OPIN GENET DEV, V19, P159, DOI 10.1016/j.gde.2009.02.010; BELLARD M, 1977, COLD SPRING HARB SYM, V42, P779, DOI 10.1101/SQB.1978.042.01.078; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Blackshaw S, 2001, CELL, V107, P579, DOI 10.1016/S0092-8674(01)00574-8; Bouchet-Marquis C, 2006, HISTOCHEM CELL BIOL, V125, P43, DOI 10.1007/s00418-005-0093-x; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Eltsov M, 2008, P NATL ACAD SCI USA, V105, P19732, DOI 10.1073/pnas.0810057105; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Griffiths G, 1993, FINE STRUCTURE IMMUN, P371, DOI [10.1007/978-3-642-77095-1_11, DOI 10.1007/978-3-642-77095-1_11]; Hamiche A, 1996, J MOL BIOL, V257, P30, DOI 10.1006/jmbi.1996.0144; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Heitz E, 1928, JAHRB WISS BOT, V69, P762; HOROWITZ RA, 1994, J CELL BIOL, V125, P1, DOI 10.1083/jcb.125.1.1; Horowitz-Scherer RA, 2006, CHROMOSOMA, V115, P1, DOI 10.1007/s00412-005-0035-3; HUMBEL B, 2007, HDB CRYOPREPARATION, P321; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; MCDOWALL AW, 1986, EMBO J, V5, P1395, DOI 10.1002/j.1460-2075.1986.tb04373.x; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; OUDET P, 1975, CELL, V4, P281, DOI 10.1016/0092-8674(75)90149-X; PAULSON JR, 1983, J CELL BIOL, V96, P1132, DOI 10.1083/jcb.96.4.1132; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; ROSE SM, 1984, J BIOL CHEM, V259, P8534; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; SMITH RD, 1983, P NATL ACAD SCI-BIOL, V80, P5505, DOI 10.1073/pnas.80.18.5505; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; THOMA F, 1977, CELL, V12, P101, DOI 10.1016/0092-8674(77)90188-X; TOKUYASU KT, 1980, HISTOCHEM J, V12, P381, DOI 10.1007/BF01011956; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; Wilson MT, 1998, J MICROSC-OXFORD, V189, P219, DOI 10.1046/j.1365-2818.1998.00315.x; WOODCOCK CL, 1993, P NATL ACAD SCI USA, V90, P9021, DOI 10.1073/pnas.90.19.9021; Wu JJ, 2006, CANCER RES, V66, P6899, DOI 10.1158/0008-5472.CAN-06-0276; YANIV M, 1986, CRIT REV BIOCHEM MOL, V21, P1, DOI 10.3109/10409238609113607; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9	47	47	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e11039	10.1371/journal.pone.0011039	http://dx.doi.org/10.1371/journal.pone.0011039			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20543957	Green Submitted, Green Published, gold			2022-12-27	WOS:000278557600016
J	Dalvai, M; Bystricky, K				Dalvai, Mathieu; Bystricky, Kerstin			Cell Cycle and Anti-Estrogen Effects Synergize to Regulate Cell Proliferation and ER Target Gene Expression	PLOS ONE			English	Article							BREAST-CANCER-CELLS; ESTROGEN-RECEPTOR; C-MYC; MCF7 CELLS; IN-VIVO; TAMOXIFEN; PROGRESSION; APOPTOSIS; ACTIVATION; GROWTH	Antiestrogens are designed to antagonize hormone induced proliferation and ER alpha target gene expression in mammary tumor cells. Commonly used drugs such as OH-Tamoxifen and ICI 182780 (Fulvestrant) block cell cycle progression in G0/G1. Inversely, the effect of cell cycle stage on ER regulated gene expression has not been tested directly. We show that in ER alpha-positive breast cancer cells (MCF-7) the estrogen receptor gene and downstream target genes are cell cycle regulated with expression levels varying as much as three-fold between phases of the cell cycle. Steroid free culture conditions commonly used to assess the effect of hormones or antiestrogens on gene expression also block MCF-7 cells in G1-phase when several ER alpha target genes are overexpressed. Thus, cell cycle effects have to be taken into account when analyzing the impact of hormonal treatments on gene transcription. We found that antiestrogens repress transcription of several ER alpha target genes specifically in S phase. This observation corroborates the more rapid and strong impact of antiestrogen treatments on cell proliferation in thymidine, hydroxyurea or aphidicolin arrested cells and correlates with an increase of apoptosis compared to similar treatments in lovastatin or nocodazol treated cells. Hence, cell cycle effects synergize with the action of antiestrogens. An interesting therapeutic perspective could be to enhance the action of anti-estrogens by associating hormone-therapy with specific cell cycle drugs.	[Dalvai, Mathieu; Bystricky, Kerstin] Univ Toulouse, UPS, Lab Biol Mol Eucaryote, Toulouse, France; [Dalvai, Mathieu; Bystricky, Kerstin] CNRS, Lab Biol Mol Eucaryote, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Dalvai, M (corresponding author), Univ Toulouse, UPS, Lab Biol Mol Eucaryote, Toulouse, France.	kerstin@biotoul.fr	Bystricky, Kerstin/AAA-3003-2020; BYSTRICKY, Kerstin/B-8670-2009	Bystricky, Kerstin/0000-0001-6717-3721; BYSTRICKY, Kerstin/0000-0001-6717-3721	CNRS (Centre National de la recherche scientifique); INCA (Institut national du Cancer); La Ligue Nationale Contre le Cancer	CNRS (Centre National de la recherche scientifique)(Centre National de la Recherche Scientifique (CNRS)); INCA (Institut national du Cancer)(Institut National du Cancer (INCA) France); La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	MD was a recipient of a post-doctoral fellowship from the CNRS (Centre National de la recherche scientifique). This project was supported by grants from INCA (Institut national du Cancer) and La Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold A, 2005, J CLIN ONCOL, V23, P4215, DOI 10.1200/JCO.2005.05.064; Beatson G., 1896, LANCET, V2, P104, DOI DOI 10.1016/S0140-6736(01)72307-0; Beatson GW, 1896, LANCET, V2, P162, DOI DOI 10.1016/S0140-6736(01)72384-7; Cariou S, 2000, P NATL ACAD SCI USA, V97, P9042, DOI 10.1073/pnas.160016897; COEZY E, 1982, CANCER RES, V42, P317; Collins P, 1999, NAT MED, V5, P1130, DOI 10.1038/13453; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; DUBIK D, 1992, ONCOGENE, V7, P1587; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; HENDERSON BE, 1988, CANCER RES, V48, P246; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Jamerson MH, 2004, J MAMMARY GLAND BIOL, V9, P27, DOI 10.1023/B:JOMG.0000023586.69263.0b; JORDAN VC, 1984, PHARMACOL REV, V36, P245; KEYOMARSI K, 1991, CANCER RES, V51, P3602; Kilker RL, 2006, CANCER RES, V66, P11478, DOI 10.1158/0008-5472.CAN-06-1755; Kim BJ, 2008, BIOL CELL, V100, P675, DOI 10.1042/BC20070158; Mandlekar S, 2000, CANCER RES, V60, P6601; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; Marino M, 2002, MOL BIOL CELL, V13, P3720, DOI 10.1091/mbc.E02-03-0153; Martin G, 1996, CANCER LETT, V100, P227, DOI 10.1016/0304-3835(95)04091-9; Maynadier M, 2008, FASEB J, V22, P671, DOI 10.1096/fj.07-9322com; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; MUSGROVE EA, 1993, MOL CELL BIOL, V13, P3577, DOI 10.1128/MCB.13.6.3577; Narayanan R, 2005, MOL CELL BIOL, V25, P2885, DOI 10.1128/MCB.25.8.2885-2898.2005; OSBORNE CK, 1983, CANCER RES, V43, P3583; PERRY RR, 1995, ANN SURG ONCOL, V2, P238, DOI 10.1007/BF02307030; PHAM TA, 1991, P NATL ACAD SCI USA, V88, P3125, DOI 10.1073/pnas.88.8.3125; Prall OWJ, 1998, MOL CELL BIOL, V18, P4499, DOI 10.1128/MCB.18.8.4499; Prall OWJ, 1998, J STEROID BIOCHEM, V65, P169, DOI 10.1016/S0960-0760(98)00021-1; REDDEL RR, 1983, CANCER RES, V43, P4618; Riggins RB, 2005, VITAM HORM, V71, P201, DOI 10.1016/S0083-6729(05)71007-4; Said TK, 1997, ENDOCRINOLOGY, V138, P3933, DOI 10.1210/en.138.9.3933; Seshadri R, 1996, CLIN CANCER RES, V2, P1177; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Soria G, 2008, J CELL SCI, V121, P3271, DOI 10.1242/jcs.027730; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Soulez M, 2001, J MOL ENDOCRINOL, V27, P259, DOI 10.1677/jme.0.0270259; Stendahl M, 2004, BRIT J CANCER, V90, P1942, DOI 10.1038/sj.bjc.6601831; SUTHERLAND RL, 1983, EUR J CANCER CLIN ON, V19, P615, DOI 10.1016/0277-5379(83)90177-3; Wang C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003523; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; WATTS CKW, 1995, MOL ENDOCRINOL, V9, P1804, DOI 10.1210/me.9.12.1804; Webb P, 2003, J BIOL CHEM, V278, P6912, DOI 10.1074/jbc.M208501200; Xue LY, 2003, EXP CELL RES, V283, P135, DOI 10.1016/S0014-4827(02)00032-0; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500	47	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11011	10.1371/journal.pone.0011011	http://dx.doi.org/10.1371/journal.pone.0011011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20543978	Green Submitted, Green Published, gold			2022-12-27	WOS:000278494900023
J	den Hertog, AL; Visser, DW; Ingham, CJ; Fey, FHAG; Klatser, PR; Anthony, RM				den Hertog, Alice L.; Visser, Dennis W.; Ingham, Colin J.; Fey, Frank H. A. G.; Klatser, Paul R.; Anthony, Richard M.			Simplified Automated Image Analysis for Detection and Phenotyping of Mycobacterium tuberculosis on Porous Supports by Monitoring Growing Microcolonies	PLOS ONE			English	Article							MGIT 960 SYSTEM; MICROSCOPIC-OBSERVATION; GROWTH	Background: Even with the advent of nucleic acid (NA) amplification technologies the culture of mycobacteria for diagnostic and other applications remains of critical importance. Notably microscopic observed drug susceptibility testing (MODS), as opposed to traditional culture on solid media or automated liquid culture, has shown potential to both speed up and increase the provision of mycobacterial culture in high burden settings. Methods: Here we explore the growth of Mycobacterial tuberculosis microcolonies, imaged by automated digital microscopy, cultured on a porous aluminium oxide (PAO) supports. Repeated imaging during colony growth greatly simplifies "computer vision'' and presumptive identification of microcolonies was achieved here using existing publically available algorithms. Our system thus allows the growth of individual microcolonies to be monitored and critically, also to change the media during the growth phase without disrupting the microcolonies. Transfer of identified microcolonies onto selective media allowed us, within 1-2 bacterial generations, to rapidly detect the drug susceptibility of individual microcolonies, eliminating the need for time consuming subculturing or the inoculation of multiple parallel cultures. Significance: Monitoring the phenotype of individual microcolonies as they grow has immense potential for research, screening, and ultimately M. tuberculosis diagnostic applications. The method described is particularly appealing with respect to speed and automation.	[den Hertog, Alice L.; Klatser, Paul R.; Anthony, Richard M.] Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands; [Ingham, Colin J.] Microdish BV, Houten, Netherlands; [Fey, Frank H. A. G.] CCM Ctr Concepts Mechatron, Nuenen, Netherlands		den Hertog, AL (corresponding author), Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands.	a.d.hertog@kit.nl	Anthony, Richard/AAP-3406-2020; Anthony, Richard M/G-5654-2010	Anthony, Richard/0000-0002-0550-5273; Anthony, Richard M/0000-0002-0550-5273; Klatser, Paul/0000-0003-3868-2409; Klatser, Paul/0000-0003-2127-9138	Microned [AP9-1]	Microned	Microned (Project AP9-1) provided financial support for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RM, 2009, INT J TUBERC LUNG D, V13, P1051; Caviedes L, 2000, J CLIN MICROBIOL, V38, P1203, DOI 10.1128/JCM.38.3.1203-1208.2000; Ejigu GS, 2008, INT J TUBERC LUNG D, V12, P332; Guillier L, 2006, J MICROBIOL METH, V65, P324, DOI 10.1016/j.mimet.2005.08.007; Hanna BA, 1999, J CLIN MICROBIOL, V37, P748, DOI 10.1128/JCM.37.3.748-752.1999; Ingham CJ, 2005, APPL ENVIRON MICROB, V71, P8978, DOI 10.1128/AEM.71.12.8978-8981.2005; Ingham CJ, 2007, P NATL ACAD SCI USA, V104, P18217, DOI 10.1073/pnas.0701693104; LEDERBERG J, 1952, J BACTERIOL, V63, P399, DOI 10.1128/JB.63.3.399-406.1952; Mejia GI, 1999, INT J TUBERC LUNG D, V3, P138; Moore DAJ, 2004, J CLIN MICROBIOL, V42, P4432, DOI 10.1128/JCM.42.10.4432-4437.2004; Pinto N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040027; Somoskovi A, 2000, J CLIN MICROBIOL, V38, P2395; *WHO STAG TB, 2007, 7 M REP; Zimic M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009577	14	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11008	10.1371/journal.pone.0011008	http://dx.doi.org/10.1371/journal.pone.0011008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544033	Green Published, Green Submitted, gold			2022-12-27	WOS:000278494900020
J	Hoare, A; Kerr, SJ; Ruxrungtham, K; Ananworanich, J; Law, MG; Cooper, DA; Phanuphak, P; Wilson, DP				Hoare, Alexander; Kerr, Stephen J.; Ruxrungtham, Kiat; Ananworanich, Jintanat; Law, Matthew G.; Cooper, David A.; Phanuphak, Praphan; Wilson, David P.			Hidden Drug Resistant HIV to Emerge in the Era of Universal Treatment Access in Southeast Asia	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE INHIBITORS; ACTIVE ANTIRETROVIRAL THERAPY; VIRAL LOAD; VIROLOGICAL FAILURE; MUTATION PATTERNS; NAIVE INDIVIDUALS; BASE-LINE; ADHERENCE; TRANSMISSION	Background: Universal access to first-line antiretroviral therapy (ART) for HIV infection is becoming more of a reality in most low and middle income countries in Asia. However, second-line therapies are relatively scarce. Methods and Findings: We developed a mathematical model of an HIV epidemic in a Southeast Asian setting and used it to forecast the impact of treatment plans, without second-line options, on the potential degree of acquisition and transmission of drug resistant HIV strains. We show that after 10 years of universal treatment access, up to 20% of treatment-naive individuals with HIV may have drug-resistant strains but it depends on the relative fitness of viral strains. Conclusions: If viral load testing of people on ART is carried out on a yearly basis and virological failure leads to effective second-line therapy, then transmitted drug resistance could be reduced by 80%. Greater efforts are required for minimizing first-line failure, to detect virological failure earlier, and to procure access to second-line therapies.	[Hoare, Alexander; Kerr, Stephen J.; Ananworanich, Jintanat; Law, Matthew G.; Cooper, David A.; Wilson, David P.] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; [Kerr, Stephen J.; Ruxrungtham, Kiat; Ananworanich, Jintanat; Phanuphak, Praphan] Thai Red Cross AIDS Res Ctr, HIV Netherlands Australia Thailand Res Collaborat, Bangkok, Thailand; [Ruxrungtham, Kiat; Ananworanich, Jintanat; Phanuphak, Praphan] Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand	University of New South Wales Sydney; Kirby Institute; Thai Red Cross Society; Chulalongkorn University	Hoare, A (corresponding author), Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia.	Dwilson@nchecr.unsw.edu.au	Kerr, Stephen/J-6126-2012; Ananworanich, Jintanat/AAC-6348-2021; Wilson, David P/G-4614-2013	Kerr, Stephen/0000-0002-1919-4525; Ananworanich, Jintanat/0000-0003-1369-3224; Law, Matthew/0000-0002-3540-8837	Australian Research Council [DP0771620, FT0991990]; National Health and Medical Research Council [CDA568705]; National Institutes of Health [U01-AI069907]; Australian Government Department of Health and Ageing; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069907] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge funding from the Australian Research Council (DP0771620, FT0991990), National Health and Medical Research Council (CDA568705), and National Institutes of Health (U01-AI069907). The National Centre in HIV Epidemiology and Clinical Research is funded by the Australian Government Department of Health and Ageing, and is affiliated with the Faculty of Medicine, University of New South Wales. The funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	Apisarnthanarak A, 2008, HIV MED, V9, P322, DOI 10.1111/j.1468-1293.2008.00562.x; Apisarnthanarak A, 2008, CLIN INFECT DIS, V46, P1630, DOI 10.1086/587753; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bangsberg DR, 2004, J INFECT DIS, V190, P162, DOI 10.1086/420790; Bangsberg DR, 2003, AIDS, V17, P1925, DOI 10.1097/00002030-200309050-00011; Blower S, 2005, AIDS, V19, P1, DOI 10.1097/00002030-200501030-00001; Blower Sally, 2003, Current Drug Targets - Infectious Disorders, V3, P345, DOI 10.2174/1568005033480999; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Booth CL, 2007, J ANTIMICROB CHEMOTH, V59, P1047, DOI 10.1093/jac/dkm082; Brown T, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010165; BUNJUMNONG O, 2002, THAILAND ACCESS ANTI; Chang SY, 2008, J ANTIMICROB CHEMOTH, V61, P689, DOI 10.1093/jac/dkn002; Chasombat Sanchai, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P704; Chasombat S, 2009, JAIDS-J ACQ IMM DEF, V50, P506, DOI 10.1097/QAI.0b013e3181967602; Chetchotisakd Ploenchan, 2006, J Int Assoc Physicians AIDS Care (Chic), V5, P152, DOI 10.1177/1545109706294288; Choi JY, 2008, JAIDS-J ACQ IMM DEF, V49, P237, DOI 10.1097/QAI.0b013e318188a919; Cohen GM, 2007, AIDS, V21, pS81, DOI 10.1097/01.aids.0000279710.47298.5c; Dorrucci M, 2005, AIDS, V19, P331; Gatanaga H, 2007, ANTIVIR RES, V75, P75, DOI 10.1016/j.antiviral.2006.11.012; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; HO DD, 1989, NEW ENGL J MED, V321, P1621, DOI 10.1056/NEJM198912143212401; Hoare A, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-4; Hogg RS, 2006, PLOS MED, V3, P1570, DOI 10.1371/journal.pmed.0030356; Jittamala P, 2009, PEDIATR INFECT DIS J, V28, P826, DOI 10.1097/INF.0b013e3181a458f9; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; King MS, 2005, J INFECT DIS, V191, P2046, DOI 10.1086/430387; Kumarasamy N, 2009, CLIN INFECT DIS, V49, P306, DOI 10.1086/600044; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; Maggiolo F, 2007, HIV CLIN TRIALS, V8, P282, DOI 10.1310/hct0805-282; Maneesriwongul WL, 2006, JAIDS-J ACQ IMM DEF, V43, pS119, DOI 10.1097/01.qai.0000248346.79888.78; *NCHADS, 2009, ANN REP 2008 NCHADS; Peuchant O, 2008, AIDS, V22, P1417, DOI 10.1097/QAD.0b013e3283034953; Phillips AN, 2007, LANCET, V370, P1923, DOI 10.1016/S0140-6736(07)61815-7; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rojanapithayalkorn W, 2006, REPROD HEALTH MATTER, V14, P41, DOI 10.1016/S0968-8080(06)28270-3; Ruxrungtham K, 2008, HIV MED, V9, P883, DOI 10.1111/j.1468-1293.2008.00644.x; Ruxrungtham K, 2004, LANCET, V364, P69, DOI 10.1016/S0140-6736(04)16593-8; Sanchez MS, 2005, B MATH BIOL, V67, P761, DOI 10.1016/j.bulm.2004.10.001; Schuurman R, 1999, J CLIN MICROBIOL, V37, P2291, DOI 10.1128/JCM.37.7.2291-2296.1999; Sirivichoyaku S, 2008, ANTIVIR THER, V13, P109; Srasuebkul Preeyaporn, 2007, AIDS Res Ther, V4, P18, DOI 10.1186/1742-6405-4-18; SUNGKANUPARPH S, 2010, ASIAN BIOME IN PRESS; Sungkanuparph S, 2007, CLIN INFECT DIS, V44, P447, DOI 10.1086/510745; Tam LWY, 2008, JAIDS-J ACQ IMM DEF, V49, P266, DOI 10.1097/QAI.0b013e318189a753; Tang JW, 2004, J CLIN VIROL, V30, P1, DOI 10.1016/j.jcv.2003.12.002; *UNAIDS, 2008, 2008 REP GLOB AIDS E; Van Laethem K, 2007, J CLIN VIROL, V39, P43, DOI 10.1016/j.jcv.2007.02.003; Weniger B G, 1991, AIDS, V5 Suppl 2, pS71, DOI 10.1097/00002030-199101001-00011; *WHO, 2009, M REP REV WHO ART GU; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; Wilson DP, 2006, P NATL ACAD SCI USA, V103, P14228, DOI 10.1073/pnas.0509689103; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008; World Health Organization, 2008, UN ACC SCAL PRIOR HI; World Health Organization, 2003, SCAL ANT THER RES LT; World Health Organization, 2009, RAP ADV ANT THER HIV; Yam WC, 2006, J CLIN VIROL, V35, P454, DOI 10.1016/j.jcv.2005.10.012; Zhou J, 2005, JAIDS-J ACQ IMM DEF, V38, P174, DOI 10.1097/01.qai.0000145351.96815.d5	58	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e10981	10.1371/journal.pone.0010981	http://dx.doi.org/10.1371/journal.pone.0010981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544022	Green Published, gold, Green Submitted			2022-12-27	WOS:000278494900007
J	Ayyadurai, S; Lepidi, H; Nappez, C; Raoult, D; Drancourt, M				Ayyadurai, Saravanan; Lepidi, Hubert; Nappez, Claude; Raoult, Didier; Drancourt, Michel			Lovastatin Protects against Experimental Plague in Mice	PLOS ONE			English	Article							YERSINIA-PESTIS; GENOME SEQUENCE; RESISTANCE; STATINS; SUSCEPTIBILITIES; STREPTOMYCIN; DOXYCYCLINE; INFECTION; SELECTION	Background: Plague is an ectoparasite-borne deadly infection caused by Yersinia pestis, a bacterium classified among the group A bioterrorism agents. Thousands of deaths are reported every year in some African countries. Tetracyclines and cotrimoxazole are used in the secondary prophylaxis of plague in the case of potential exposure to Y. pestis, but cotrimoxazole-resistant isolates have been reported. There is a need for additional prophylactic measures. We aimed to study the effectiveness of lovastatin, a cholesterol-lowering drug known to alleviate the symptoms of sepsis, for plague prophylaxis in an experimental model. Methodology: Lovastatin dissolved in Endolipide was intraperitoneally administered to mice (20 mg/kg) every day for 6 days prior to a Y. pestis Orientalis biotype challenge. Non-challenged, lovastatin-treated and challenged, untreated mice were also used as control groups in the study. Body weight, physical behavior and death were recorded both prior to infection and for 10 days post-infection. Samples of the blood, lungs and spleen were collected from dead mice for direct microbiological examination, histopathology and culture. The potential antibiotic effect of lovastatin was tested on blood agar plates. Conclusions/Significance: Lovastatin had no in-vitro antibiotic effect against Y. pestis. The difference in the mortality between control mice (11/15; 73.5%) and lovastatin-treated mice (3/15; 20%) was significant (P<0.004; Mantel-Haenszel test). Dead mice exhibited Y. pestis septicemia and inflammatory destruction of lung and spleen tissues not seen in lovastatin-treated surviving mice. These data suggest that lovastatin may help prevent the deadly effects of plague. Field observations are warranted to assess the role of lovastatin in the prophylaxis of human plague.	[Ayyadurai, Saravanan; Lepidi, Hubert; Nappez, Claude; Raoult, Didier; Drancourt, Michel] Univ Mediterranee, Unite Rech Malad Infect & Trop Emergentes, Fac Med, CNRS,UMR 6236,IRD 198,IFR48, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Ayyadurai, S (corresponding author), Univ Mediterranee, Unite Rech Malad Infect & Trop Emergentes, Fac Med, CNRS,UMR 6236,IRD 198,IFR48, Marseille, France.	Michel.Drancourt@univmed.fr	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974	URMITE	URMITE	The study is financed by the authors' laboratory URMITE, 27, bd Jean Moulin 13005 Marseille, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIBEK K, BIOHAZARD CHILLING T, P336; Auerbach RK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000770; Botelho-Nevers E, 2008, INT J ANTIMICROB AG, V32, P344, DOI 10.1016/j.ijantimicag.2008.04.027; Botelho-Nevers E, 2008, J ANTIMICROB CHEMOTH, V62, P845, DOI 10.1093/jac/dkn282; Brouillard JE, 2006, PHARMACOTHERAPY, V26, P3, DOI 10.1592/phco.2006.26.1.3; Butler T, 2009, CLIN INFECT DIS, V49, P736, DOI 10.1086/604718; Catron DM, 2004, INFECT IMMUN, V72, P1036, DOI 10.1128/IAI.72.2.1036-1042.2004; CHAPIN KC, 2007, MANUAL CLIN MICROBIO, P257; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Eppinger M, 2009, J BACTERIOL, V191, P7628, DOI 10.1128/JB.01227-09; Frean J, 2003, J ANTIMICROB CHEMOTH, V52, P294, DOI 10.1093/jac/dkg363; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; Galimand M, 2006, ANTIMICROB AGENTS CH, V50, P3233, DOI 10.1128/AAC.00306-06; Guiyoule A, 2001, EMERG INFECT DIS, V7, P43, DOI 10.3201/eid0701.010106; Hernandez E, 2003, J ANTIMICROB CHEMOTH, V52, P1029, DOI 10.1093/jac/dkg484; Hinnebusch BJ, 2002, MOL MICROBIOL, V46, P349, DOI 10.1046/j.1365-2958.2002.03159.x; Hurtle W, 2003, J CLIN MICROBIOL, V41, P3273, DOI 10.1128/JCM.41.7.3273-3283.2003; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Louie A, 2007, ANTIMICROB AGENTS CH, V51, P2661, DOI 10.1128/AAC.00073-07; MANTEL N, 1959, J NATL CANCER I, V22, P719; Merx MW, 2005, CIRCULATION, V112, P117, DOI 10.1161/CIRCULATIONAHA.104.502195; Nduka OO, 2009, CRIT CARE CLIN, V25, P677, DOI 10.1016/j.ccc.2009.08.002; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; Pouillot F, 2005, MICROBIOL-SGM, V151, P3759, DOI 10.1099/mic.0.28274-0; Russell P, 1996, J ANTIMICROB CHEMOTH, V37, P769, DOI 10.1093/jac/37.4.769; Song JL, 2003, MED MYCOL, V41, P417, DOI 10.1080/1369378031000137233; Tleyjeh IM, 2009, ARCH INTERN MED, V169, P1658, DOI 10.1001/archinternmed.2009.286; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Wong JD, 2000, ANTIMICROB AGENTS CH, V44, P1995, DOI 10.1128/AAC.44.7.1995-1996.2000	32	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2010	5	6							e10928	10.1371/journal.pone.0010928	http://dx.doi.org/10.1371/journal.pone.0010928			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604NC	20532198	Green Published, gold, Green Submitted			2022-12-27	WOS:000278284700011
J	Liu, SJ; Li, ST; Du, YG				Liu, Sijin; Li, Shitao; Du, Yuguo			Polychlorinated Biphenyls (PCBs) Enhance Metastatic Properties of Breast Cancer Cells by Activating Rho-Associated Kinase (ROCK)	PLOS ONE			English	Article							REGULATED EIF2-ALPHA KINASE; ENDOCRINE DISRUPTORS; ESTROGEN-RECEPTOR; HUMAN HEALTH; RISK; EXPOSURE; INVASION; ORGANOCHLORINES; BONE; INVOLVEMENT	Background: Polychlorinated biphenyls (PCBs) are a family of structurally related chlorinated aromatic hydrocarbons. Numerous studies have documented a wide spectrum of biological effects of PCBs on human health, such as immunotoxicity, neurotoxocity, estrogenic or antiestrogenic activity, and carcinogensis. The role of PCBs as etiologic agents for breast cancer has been intensively explored in a variety of in vivo, animal and epidemiologic studies. A number of investigations indicated that higher levels of PCBs in mammary tissues or sera correlated to breast cancer risk, and PCBs might be implicated in advancing breast cancer progression. Methodology/Principal Findings: In the current study, we for the first time report that PCBs greatly promote the ROCK activity and therefore increase cell motility for both non-metastatic and metastatic human breast cancer cells in vitro. In the in vivo study, PCBs significantly advance disease progression, leading to enhanced capability of metastatic breast cancer cells to metastasize to bone, lung and liver. Additionally, PCBs robustly induce the production of intracellular reactive oxygen species (ROS) in breast cancer cells; ROS mechanistically elevate ROCK activity. Conclusions/Significance: PCBs enhance the metastatic propensity of breast cancer cells by activating the ROCK signaling, which is dependent on ROS induced by PCBs. Inhibition of ROCK may stand for a unique way to restrain metastases in breast cancer upon PCB exposure.	[Liu, Sijin; Du, Yuguo] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Chem & Ecotoxicol, Beijing, Peoples R China; [Li, Shitao] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Harvard University; Harvard Medical School	Liu, SJ (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Chem & Ecotoxicol, POB 934, Beijing, Peoples R China.	sjliu@rcees.ac.cn		Li, Shitao/0000-0002-1398-8519	Chinese Academy of Sciences; National Natural Science Foundation of China (NSFC)	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the "Hundreds Talents'' program of the Chinese Academy of Sciences (http://english.cas.cn/), and National Natural Science Foundation of China (NSFC) (http://www.nsfc.gov.cn/Portal0/default106.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SF, 1996, SCIENCE, V272, P1489, DOI 10.1126/science.272.5267.1489; Bonefeld-Jorgensen EC, 2001, TOXICOLOGY, V158, P141, DOI 10.1016/S0300-483X(00)00368-1; Bourguignon LYW, 1999, CELL MOTIL CYTOSKEL, V43, P269, DOI 10.1002/(SICI)1097-0169(1999)43:4<269::AID-CM1>3.0.CO;2-5; Calle EE, 2002, CA-CANCER J CLIN, V52, P301, DOI 10.3322/canjclin.52.5.301; Carpenter David O., 2006, Reviews on Environmental Health, V21, P1; Dada LA, 2007, J CELL SCI, V120, P2214, DOI 10.1242/jcs.003038; DeCaprio AP, 2005, ENVIRON RES, V98, P284, DOI 10.1016/j.envres.2004.09.004; Demers A, 2000, CANCER EPIDEM BIOMAR, V9, P161; FOSSI MC, 1995, ENVIRON POLLUT, V90, P15, DOI 10.1016/0269-7491(94)00098-X; Golden R, 2009, CRIT REV TOXICOL, V39, P299, DOI 10.1080/10408440802291521; Holford TR, 2000, INT J EPIDEMIOL, V29, P975, DOI 10.1093/ije/29.6.975; Humphrey HEB, 2000, ENVIRON HEALTH PERSP, V108, P167, DOI 10.2307/3454516; Imamura F, 2000, JPN J CANCER RES, V91, P811, DOI 10.1111/j.1349-7006.2000.tb01018.x; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; KORACH KS, 1988, MOL PHARMACOL, V33, P120; Kuperwasser C, 2005, CANCER RES, V65, P6130, DOI 10.1158/0008-5472.CAN-04-1408; Lane J, 2008, INT J ONCOL, V33, P585, DOI 10.3892/ijo_00000044; Li B, 2006, FEBS LETT, V580, P4252, DOI 10.1016/j.febslet.2006.06.056; Liu SJ, 2008, BRIT J HAEMATOL, V143, P129, DOI 10.1111/j.1365-2141.2008.07293.x; Liu SJ, 2007, J CLIN INVEST, V117, P3296, DOI 10.1172/JCI32084; Liu SJ, 2009, CANCER RES, V69, P8742, DOI 10.1158/0008-5472.CAN-09-1541; Millikan R, 2000, CANCER EPIDEM BIOMAR, V9, P1233; MURPHY LE, ENV HLTH PERSPECT, V118, P297; Negri E, 2003, EUR J CANCER PREV, V12, P509, DOI 10.1097/00008469-200312000-00010; Park JS, 2007, ENVIRON HEALTH PERSP, V115, P20, DOI 10.1289/ehp.8913; Potin S, 2007, FEBS LETT, V581, P118, DOI 10.1016/j.febslet.2006.12.016; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Safe S, 2004, TOXICOLOGY, V205, P3, DOI 10.1016/j.tox.2004.06.032; Salehi F, 2008, J TOXICOL ENV HEAL B, V11, P276, DOI 10.1080/10937400701875923; Shiraishi F, 2003, CHEMOSPHERE, V52, P33, DOI 10.1016/S0045-6535(03)00261-3; Snedeker SM, 2001, ENVIRON HEALTH PERSP, V109, P35, DOI [10.2307/3434845, 10.2307/3434918]; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Suva LJ, 2009, ENDOCR-RELAT CANCER, V16, P703, DOI 10.1677/ERC-09-0012; Tang Y, 2008, FRONT BIOSCI-LANDMRK, V13, P759, DOI 10.2741/2718; Woolcott CG, 2001, CANCER CAUSE CONTROL, V12, P395, DOI 10.1023/A:1011289905751; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Yamaguchi T, 2003, BIOL PHARM BULL, V26, P1706, DOI 10.1248/bpb.26.1706; Yoshioka K, 2003, P NATL ACAD SCI USA, V100, P7247, DOI 10.1073/pnas.1232344100; ZHAO X, CHEMOSPHERE, V78, P659	40	53	57	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11272	10.1371/journal.pone.0011272	http://dx.doi.org/10.1371/journal.pone.0011272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585605	Green Submitted, gold, Green Published			2022-12-27	WOS:000279135400018
J	Jiang, H; Ren, F; Sun, JL; He, L; Li, WW; Xie, YN; Wang, Q				Jiang, Hui; Ren, Fei; Sun, Jiangling; He, Lin; Li, Weiwei; Xie, Yannan; Wang, Qun			Molecular Cloning and Gene Expression Analysis of the Leptin Receptor in the Chinese Mitten Crab Eriocheir sinensis	PLOS ONE			English	Article							TROPHOBLASTIC CELLS; JAPONICA-SINENSIS; BOVINE OOCYTES; HEPATOPANCREAS; PREGNANCY; REPRODUCTION; TRANSCRIPT; SALINITIES; SURVIVAL; STRESS	Background: Leptin is an adipocyte-derived hormone with multiple functions that regulates energy homeostasis and reproductive functions. Increased knowledge of leptin receptor function will enhance our understanding of the physiological roles of leptin in animals. Methodology/Principal Findings: In the present study, a full-length leptin receptor (lepr) cDNA, consisting of 1,353 nucleotides, was cloned from Chinese mitten crab (Eriocheir sinensis) using rapid amplification of cDNA ends (RACE) following the identification of a single expressed sequence tag (EST) clone in a cDNA library. The lepr cDNA consisted of a 22-nucleotide 5'-untranslated region (5' UTR), a 402-nucleotide open reading frame (ORF) and a 929-nucleotide 3' UTR. Multiple sequence alignments revealed that Chinese mitten crab lepr shared a conserved vacuolar protein sorting 55 (Vps55) domain with other species. Chinese mitten crab lepr expression was determined in various tissues and at three different reproductive stages using quantitative real-time RT-PCR. Lepr expression was highest in the intestine, thoracic ganglia, gonad, and accessory gonad, moderate in hepatopancreas and cranial ganglia, and low in muscle, gill, heart, haemocytes, and stomach. Furthermore, lepr expression was significantly higher in the intestine, gonad and thoracic ganglia in immature crabs relative to precocious and mature crabs. In contrast, lepr expression was significantly lower in the hepatopancreas of immature crabs relative to mature crabs. Conclusions/Significance: We are the first to identify the lepr gene and to determine its gene expression patterns in various tissues and at three different reproductive stages in Chinese mitten crab. Taken together, our results suggest that lepr may be involved in the nutritional regulation of metabolism and reproduction in Chinese mitten crabs.	[Jiang, Hui; Ren, Fei; Sun, Jiangling; He, Lin; Li, Weiwei; Xie, Yannan; Wang, Qun] E China Normal Univ, Dept Biol, Shanghai 200062, Peoples R China	East China Normal University	Wang, Q (corresponding author), E China Normal Univ, Dept Biol, Shanghai 200062, Peoples R China.	qun_300@hotmail.com	Wang, Qun/I-7778-2013; LI, WEIWEI/J-3538-2013	Wang, Qun/0000-0001-7929-7692; 	National Nature Science Foundation of China [30671607, 30972241]; Shanghai Science and Technology Project [09391911100]; ECNU [2010042]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Project; ECNU	This research was supported by grants from the National Nature Science Foundation of China (No. 30671607,30972241), Shanghai Science and Technology Project (Grant no. 09391911100), and PhD Program Scholarship Fund of ECNU (No. 2010042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assumpcao TCF, 2008, INSECT BIOCHEM MOLEC, V38, P213, DOI 10.1016/j.ibmb.2007.11.001; BABU B T, 1989, Folia Morphologica (Prague), V37, P388; CHENG SP, 2009, SURGERY; Churbanov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-261; Fang JJ, 2009, MOL BIOL REP, V36, P1521, DOI 10.1007/s11033-008-9346-9; HENAULT MA, 1995, BIOL REPROD, V52, P390, DOI 10.1095/biolreprod52.2.390; Henson MC, 2006, BIOL REPROD, V74, P218, DOI 10.1095/biolreprod.105.045120; Herborg LM, 2006, J EXP MAR BIOL ECOL, V329, P1, DOI 10.1016/j.jembe.2005.08.001; Huang Y, 2001, BBA-GENE STRUCT EXPR, V1517, P327, DOI 10.1016/S0167-4781(00)00266-9; Jiang H, 2009, COMP BIOCHEM PHYS D, V4, P227, DOI 10.1016/j.cbd.2009.05.001; Jiang H, 2009, MAR BIOTECHNOL, V11, P317, DOI 10.1007/s10126-008-9146-1; Kalinina M V, 2008, Ontogenez, V39, P58; Kratzsch J, 2000, CURR OPIN OBSTET GYN, V12, P501, DOI 10.1097/00001703-200012000-00008; Kronfeld-Schor N, 2000, BIOL REPROD, V63, P274, DOI 10.1095/biolreprod63.1.274; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Li EC, 2008, AQUACULTURE, V274, P80, DOI 10.1016/j.aquaculture.2007.11.001; Li XD, 2007, AQUACULTURE, V272, P361, DOI 10.1016/j.aquaculture.2007.08.029; Magarinos MP, 2007, BIOL REPROD, V76, P203, DOI 10.1095/biolreprod.106.051391; Mollineau WM, 2009, ANAT HISTOL EMBRYOL, V38, P204, DOI 10.1111/j.1439-0264.2008.00922.x; Morash BA, 2003, MOL CELL ENDOCRINOL, V210, P1, DOI 10.1016/j.mce.2003.09.003; Normant M, 2002, THERMOCHIM ACTA, V394, P233, DOI 10.1016/S0040-6031(02)00259-9; Paula-Lopes FF, 2007, BIOL REPROD, V76, P532, DOI 10.1095/biolreprod.106.054551; Paz GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003098; Perez-Perez A, 2008, ARCH BIOCHEM BIOPHYS, V477, P390, DOI 10.1016/j.abb.2008.06.015; Rudnick DA, 2003, BASIC APPL ECOL, V4, P249, DOI 10.1078/1439-1791-00152; Smith GD, 2002, THERIOGENOLOGY, V57, P73, DOI 10.1016/S0093-691X(01)00658-6; Sui L, 2007, AQUACULTURE, V273, P139, DOI 10.1016/j.aquaculture.2007.09.016; Torres G, 2007, COMP BIOCHEM PHYS A, V147, P460, DOI 10.1016/j.cbpa.2007.01.020; Wang HZ, 2006, AQUACULTURE, V255, P456, DOI 10.1016/j.aquaculture.2006.01.005; Wang YP, 1997, J BIOL CHEM, V272, P16216, DOI 10.1074/jbc.272.26.16216; Wen XB, 2002, COMP BIOCHEM PHYS A, V131, P675, DOI 10.1016/S1095-6433(01)00515-3; Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301; Yamaguchi S, 2008, ECOTOXICOLOGY, V17, P772, DOI 10.1007/s10646-008-0228-7; Yang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001472; Yuen BSJ, 2004, BIOL REPROD, V70, P1650, DOI 10.1095/biolreprod.103.025254; Zarubin TP, 2009, MOL BIOL REP, V36, P1231, DOI 10.1007/s11033-008-9302-8; Zhao JM, 2007, MOL IMMUNOL, V44, P360, DOI 10.1016/j.molimm.2006.02.025	38	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11175	10.1371/journal.pone.0011175	http://dx.doi.org/10.1371/journal.pone.0011175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567508	Green Published, Green Submitted, gold			2022-12-27	WOS:000278886300018
J	Catania, KC				Catania, Kenneth C.			Born Knowing: Tentacled Snakes Innately Predict Future Prey Behavior	PLOS ONE			English	Article							HUNTING ARCHER FISH; MAUTHNER CELL; RESPONSES; PREDATOR; START; EXPLOITATION; SPEED; TIME	Background: Aquatic tentacled snakes (Erpeton tentaculatus) can take advantage of their prey's escape response by startling fish with their body before striking. The feint usually startles fish toward the snake's approaching jaws. But when fish are oriented at a right angle to the jaws, the C-start escape response translates fish parallel to the snake's head. To exploit this latter response, snakes must predict the future location of the fish. Adult snakes can make this prediction. Is it learned, or are tentacled snakes born able to predict future fish behavior? Methods and Findings: Laboratory-born, naive snakes were investigated as they struck at fish. Trials were recorded at 250 or 500 frames per second. To prevent learning, snakes were placed in a water container with a clear transparency sheet or glass bottom. The chamber was placed over a channel in a separate aquarium with fish below. Thus snakes could see and strike at fish, without contact. The snake's body feint elicited C-starts in the fish below the transparency sheet, allowing strike accuracy to be quantified in relationship to the C-starts. When fish were oriented at a right angle to the jaws, naive snakes biased their strikes to the future location of the escaping fish's head, such that the snake's jaws and the fish's translating head usually converged. Several different types of predictive strikes were observed. Conclusions: The results show that some predators have adapted their nervous systems to directly compensate for the future behavior of prey in a sensory realm that usually requires learning. Instead of behavior selected during their lifetime, newborn tentacled snakes exhibit behavior that has been selected on a different scale-over many generations. Counter adaptations in fish are not expected, as tentacled snakes are rare predators exploiting fish responses that are usually adaptive.	Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37203 USA	Vanderbilt University	Catania, KC (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37203 USA.	ken.catania@vanderbilt.edu			National Science Foundation [0844743]; MacArthur Award	National Science Foundation(National Science Foundation (NSF)); MacArthur Award	Funding was provided by the National Science Foundation award # 0844743 and a MacArthur Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunskill R.W, 1978, ILLUSTRATED HDB VERN; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; Canfield JG, 2003, BRAIN BEHAV EVOLUT, V61, P148, DOI 10.1159/000069751; Canfield JG, 1996, BRAIN BEHAV EVOLUT, V48, P137, DOI 10.1159/000113193; Catania KC, 2010, J EXP BIOL, V213, P359, DOI 10.1242/jeb.039685; Catania KC, 2009, P NATL ACAD SCI USA, V106, P11183, DOI 10.1073/pnas.0905183106; Catania KC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003472; CHARNOV EL, 1976, AM NAT, V110, P141, DOI 10.1086/283054; Dawkins R., 1982, pi; Eaton R.C., 1984, P213; EATON RC, 1977, J EXP BIOL, V66, P65; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; Hale ME, 2002, EVOLUTION, V56, P993; HARTLINE PH, 1978, SCIENCE, V199, P1225, DOI 10.1126/science.628839; Hoogland R., 1957, Behaviour, V10, P205; Jablonski PG, 2001, BRAIN BEHAV EVOLUT, V58, P218, DOI 10.1159/000057565; Jablonski PG, 2001, P ROY SOC B-BIOL SCI, V268, P1017, DOI 10.1098/rspb.2001.1623; Jablonski PG, 1999, BEHAV ECOL, V10, P7, DOI 10.1093/beheco/10.1.7; Korn H, 2005, NEURON, V47, P13, DOI 10.1016/j.neuron.2005.05.019; Makino CL, 2003, CURR OPIN NEUROBIOL, V13, P404, DOI 10.1016/S0959-4388(03)00091-6; McHenry MJ, 2009, BIOL LETTERS, V5, P477, DOI 10.1098/rsbl.2009.0048; Murphy J. C., 2007, HOMALOPSID SNAKES EV; Preuss T, 2006, J NEUROSCI, V26, P3454, DOI 10.1523/JNEUROSCI.5259-05.2006; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Reimchen TE, 2002, EVOLUTION, V56, P2472; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Smith TL, 2002, J ZOOL, V256, P233, DOI 10.1017/S0952836902000274; STEIN BE, 1975, SCIENCE, V189, P224, DOI 10.1126/science.1094540; Stein BE., 1993, MERGING SENSES; Stephens D.W., 1986, pi; TAYLOR EDWARD H., 1965, UNIV KANS SCI BULL, V45, P609; Weiss SA, 2008, P NATL ACAD SCI USA, V105, P18047, DOI 10.1073/pnas.0806145105; Whitlock GG, 1999, NEURON, V23, P337, DOI 10.1016/S0896-6273(00)80784-9; WINOKUR R M, 1977, Herpetologica, V33, P247; Wohl S, 2007, J EXP BIOL, V210, P311, DOI 10.1242/jeb.02646; Wohl S, 2006, J EXP BIOL, V209, P141, DOI 10.1242/jeb.01981; Zottoli SJ, 2000, NEUROSCIENTIST, V6, P26, DOI 10.1177/107385840000600111	38	24	24	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e10953	10.1371/journal.pone.0010953	http://dx.doi.org/10.1371/journal.pone.0010953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585384	Green Published, gold			2022-12-27	WOS:000278886100003
J	Lyn-Kew, K; Rich, E; Zeng, XY; Wen, HT; Kunkel, SL; Newstead, MW; Bhan, U; Standiford, TJ				Lyn-Kew, Kenneth; Rich, Eric; Zeng, Xianying; Wen, Haitao; Kunkel, Steven L.; Newstead, Michael W.; Bhan, Urvashi; Standiford, Theodore J.			IRAK-M Regulates Chromatin Remodeling in Lung Macrophages during Experimental Sepsis	PLOS ONE			English	Article							UP-REGULATION; ENDOTOXIN TOLERANCE; SEPTIC PATIENTS; METHYLATION; EXPRESSION; MONOCYTES; IMMUNOSUPPRESSION; INFLAMMATION; CELLS	Sepsis results in a profound state of immunosuppression, which is temporally associated with impaired leukocyte function. The mechanism of leukocyte reprogramming in sepsis is incompletely understood. In this study, we explored mechanisms contributing to dysregulated inflammatory cytokine expression by pulmonary macrophages during experimental sepsis. Pulmonary macrophages (PM) recovered from the lungs of mice undergoing cecal ligation and puncture (CLP) display transiently reduced expression of some, but not all innate genes in response to LPS. Impaired expression of TNF-alpha and iNOS was associated with reduced acetylation and methylation of specific histones (AcH4 and H3K4me3) and reduced binding of RNA polymerase II to the promoters of these genes. Transient impairment in LPS-induced cytokine responses in septic PM temporally correlated with induction of IRAK-M mRNA and protein, which occurred in a MyD88-dependent fashion. PM isolated from IRAK-M-/- mice were largely refractory to CLP-induced impairment in cytokine expression, chromatin remodeling, recruitment of RNA polymerase II, and induction of histone deacetylase-2 observed during sepsis. Our findings indicate that systemic sepsis induces epigenetic silencing of cytokine gene expression in lung macrophages, and IRAK-M appears to be a critical mediator of this response.	[Lyn-Kew, Kenneth; Rich, Eric; Zeng, Xianying; Newstead, Michael W.; Bhan, Urvashi; Standiford, Theodore J.] Univ Michigan, Sch Med, Dept Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48104 USA; [Wen, Haitao; Kunkel, Steven L.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lyn-Kew, K (corresponding author), Univ Michigan, Sch Med, Dept Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48104 USA.	tstandif@umich.edu	Wen, Haitao/AAJ-7621-2020		NIH/NHLBI [P50 HL074024]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL094762, P50HL074024, R01HL031237] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by NIH/NHLBI grant P50 HL074024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2000, AM J RESP CRIT CARE, V162, P1877, DOI 10.1164/ajrccm.162.5.2003058; Adib-Conquy M, 2006, CRIT CARE MED, V34, P2377, DOI 10.1097/01.CCM.0000233875.93866.88; Aung HT, 2006, FASEB J, V20, P1315, DOI 10.1096/fj.05-5360com; Bone RC, 1996, CRIT CARE MED, V24, P1125, DOI 10.1097/00003246-199607000-00010; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chan C, 2005, J IMMUNOL, V175, P461, DOI 10.4049/jimmunol.175.1.461; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; Escoll P, 2003, BIOCHEM BIOPH RES CO, V311, P465, DOI 10.1016/j.bbrc.2003.10.019; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Hall MW, 2007, PEDIATR RES, V62, P597, DOI 10.1203/PDR.0b013e3181559774; Harada K, 2006, LIVER INT, V26, P935, DOI 10.1111/j.1478-3231.2006.01325.x; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Lyn-Kew K, 2008, CURR PHARM DESIGN, V14, P1870, DOI 10.2174/138161208784980545; MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493; Nakayama K, 2004, J BIOL CHEM, V279, P6629, DOI 10.1074/jbc.M308620200; Reddy RC, 2010, CURR OPIN HEMATOL, V17, P18, DOI 10.1097/MOH.0b013e32833338f3; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rosati O, 2002, BIOCHEM BIOPH RES CO, V293, P1472, DOI 10.1016/S0006-291X(02)00411-4; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Seki M, 2010, J IMMUNOL, V184, P1410, DOI 10.4049/jimmunol.0901709; Steinhauser ME, 1999, J IMMUNOL, V162, P392; Strickland FM, 2008, AUTOIMMUNITY, V41, P278, DOI 10.1080/08916930802024616; van der Poll T, 1999, INFECT DIS CLIN N AM, V13, P413, DOI 10.1016/S0891-5520(05)70083-0; Volk HD, 2000, CHEM IMMUNOL, V74, P162; Wen HT, 2008, BLOOD, V111, P1797, DOI 10.1182/blood-2007-08-106443; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403	28	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11145	10.1371/journal.pone.0011145	http://dx.doi.org/10.1371/journal.pone.0011145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585389	gold, Green Published, Green Submitted			2022-12-27	WOS:000278886100013
J	Gutte, H; Oxbol, J; Kristoffersen, US; Mortensen, J; Kjaer, A				Gutte, Henrik; Oxbol, Jytte; Kristoffersen, Ulrik Sloth; Mortensen, Jann; Kjaer, Andreas			Gene Expression of ANP, BNP and ET-1 in the Heart of Rats during Pulmonary Embolism	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; RIGHT-VENTRICULAR DYSFUNCTION; ACTIVATION; FAILURE	Aims: Atrial natriuretic petide (ANP), brain natriuretic peptide (BNP) and endothelin-1 (ET-1) may reflect the severity of right ventricular dysfunction (RVD) in patients with pulmonary embolism (PE). The exact nature and source of BNP, ANP and ET-1 expression and secretion following PE has not previously been studied. Methods and Results: Polystyrene microparticles were injected to induce PE in rats. Gene expression of BNP, ANP and ET-1 were determined in the 4 cardiac chambers by quantitative real time polymerase chain reaction (QPCR). Plasma levels of ANP, BNP, ET-1 and cardiac troponin I (TNI) were measured in plasma. PE dose-dependently increased gene expression of ANP and BNP in the right ventricle (RV) and increased gene expression of ANP in the right atrium (RA). In contrast PE dose-dependently decreased BNP gene expression in both the left ventricle (LV) and the left atrium (LA). Plasma levels of BNP, TNI and ET-1 levels dose-dependently increased with the degree of PE. Conclusion: We found a close correlation between PE degree and gene-expression of ANP, and BNP in the cardiac chambers with a selective increase in the right chambers of the heart. The present data supports the idea of natriuretic peptides as valuable biomarkers of RVD in PE.	[Gutte, Henrik; Kristoffersen, Ulrik Sloth; Mortensen, Jann; Kjaer, Andreas] Copenhagen Univ Hosp, Rigshosp, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark; [Gutte, Henrik; Oxbol, Jytte; Kristoffersen, Ulrik Sloth; Kjaer, Andreas] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Gutte, H (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark.	henrikgb@gmail.com	; Kjaer, Andreas/E-8932-2015	Gutte, Henrik/0000-0001-5494-5323; Mortensen, Jann/0000-0002-1399-8995; Kjaer, Andreas/0000-0002-2706-5547	Novo Nordisk Foundation; Lundbeck Foundation; A.P. Moller Foundation; Danish Heart Foundation [09-04-R72-A2356-22560]; Danish Medical Research Council [959592772]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); A.P. Moller Foundation; Danish Heart Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The financial support from Novo Nordisk Foundation (www.novonordiskfonden.dk), Lundbeck Foundation (www.lundbeckfonden.dk), A.P. Moller Foundation (www.apmollerfonde.dk), The Danish Heart Foundation (grant no. 09-04-R72-A2356-22560; www.hjerteforeningen.dk), and Danish Medical Research Council (grant no. 959592772; www.fi.dk) is gratefully acknowledged. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Becattini C, 2007, CIRCULATION, V116, P427, DOI 10.1161/CIRCULATIONAHA.106.680421; Bin Yap L, 2004, CHEST, V126, P1330, DOI 10.1378/chest.126.4.1330; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; COMINI L, 1995, AM J PHYSIOL-HEART C, V268, pH391, DOI 10.1152/ajpheart.1995.268.1.H391; DAGNINO L, 1991, MOL ENDOCRINOL, V5, P1292, DOI 10.1210/mend-5-9-1292; de Bold AJ, 2001, CAN J PHYSIOL PHARM, V79, P705, DOI 10.1139/cjpp-79-8-705; GOLDHABER SZ, 1993, LANCET, V341, P507, DOI 10.1016/0140-6736(93)90274-K; Jones AE, 2003, AM J PHYSIOL-LUNG C, V284, pL1072, DOI 10.1152/ajplung.00283.2002; Kaczynska A, 2008, CLIN CHIM ACTA, V398, P1, DOI 10.1016/j.cca.2008.07.020; Kiely DG, 2005, RESP MED, V99, P1286, DOI 10.1016/j.rmed.2005.02.029; Kjaer A, 2001, CLIN PHYSIOL, V21, P661, DOI 10.1046/j.1365-2281.2001.00371.x; Koyanagi T, 2008, AM J PHYSIOL-HEART C, V295, pH220, DOI 10.1152/ajpheart.00289.2008; Kucher N, 2003, CIRCULATION, V107, P2545, DOI 10.1161/01.CIR.0000074039.45523.BE; LaPointe MC, 2005, PEPTIDES, V26, P944, DOI 10.1016/j.peptides.2004.08.028; Lee JH, 2001, AM J RESP CRIT CARE, V164, P1282, DOI 10.1164/ajrccm.164.7.2011011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lourenco AP, 2006, AM J PHYSIOL-HEART C, V291, pH1587, DOI 10.1152/ajpheart.01004.2005; LUALDI JC, 1995, AM HEART J, V130, P1276, DOI 10.1016/0002-8703(95)90155-8; Luchner A, 1998, AM J PHYSIOL-HEART C, V274, pH1684, DOI 10.1152/ajpheart.1998.274.5.H1684; MUKOYAMA M, 1990, LANCET, V335, P801, DOI 10.1016/0140-6736(90)90925-U; Nagaya N, 1998, J AM COLL CARDIOL, V31, P202, DOI 10.1016/S0735-1097(97)00452-X; OGAWA Y, 1991, CIRC RES, V69, P491, DOI 10.1161/01.RES.69.2.491; OGAWA Y, 1990, ENDOCRINOLOGY, V126, P2225, DOI 10.1210/endo-126-4-2225; Pruszczyk P, 2003, EUR RESPIR J, V22, P649, DOI 10.1183/09031936.03.00023303; Roncon-Albuquerque R, 2006, LIFE SCI, V78, P2633, DOI 10.1016/j.lfs.2005.10.021; Sawada Y, 1997, J BIOL CHEM, V272, P20545, DOI 10.1074/jbc.272.33.20545; STELZNER TJ, 1992, AM J PHYSIOL, V262, pL614, DOI 10.1152/ajplung.1992.262.5.L614; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; Watts JA, 2006, J MOL CELL CARDIOL, V41, P296, DOI 10.1016/j.yjmcc.2006.05.011	30	8	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11111	10.1371/journal.pone.0011111	http://dx.doi.org/10.1371/journal.pone.0011111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559433	gold, Green Submitted, Green Published			2022-12-27	WOS:000278741100023
J	Zern, BJ; Chu, HH; Wang, YD				Zern, Blaine J.; Chu, Hunghao; Wang, Yadong			Control Growth Factor Release Using a Self-Assembled [polycation:heparin] Complex	PLOS ONE			English	Article							FACTOR DELIVERY; SUSTAINED-RELEASE; HEPARIN; HYDROGELS; BINDING; MATRICES; SCAFFOLDS; PEPTIDES; AFFINITY; GELS	The importance of growth factors has been recognized for over five decades; however their utilization in medicine has yet to be fully realized. This is because free growth factors have short half-lives in plasma, making direct injection inefficient. Many growth factors are anchored and protected by sulfated glycosaminoglycans in the body. We set out to explore the use of heparin, a well-characterized sulfated glycosaminoglycan, for the controlled release of fibroblast growth factor-2 (FGF-2). Heparin binds a multitude of growth factors and maintains their bioactivity for an extended period of time. We used a biocompatible polycation to precipitate out the [heparin: FGF-2] complex from neutral buffer to form a release matrix. We can control the release rate of FGF-2 from the resultant matrix by altering the molecular weight of the polycation. The FGF-2 released from the delivery complex maintained its bioactivity and initiated cellular responses that were at least as potent as fresh bolus FGF-2 and fresh heparin stabilized FGF-2. This new delivery platform is not limited to FGF-2 but applicable to the large family of heparin-binding growth factors.	Georgia Inst Technol, Sch Chem & Biochem, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Zern, BJ (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.	yaw20@pitt.edu		Wang, Yadong/0000-0003-2067-382X	NSF [DMR-1005766]	NSF(National Science Foundation (NSF))	Funding: This research is supported by an NSF Grant #DMR-1005766. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit DSW, 2005, ACTA BIOMATER, V1, P461, DOI 10.1016/j.actbio.2005.03.002; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034; Cai SS, 2005, BIOMATERIALS, V26, P6054, DOI 10.1016/j.biomaterials.2005.03.012; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; Cleland JL, 2001, J CONTROL RELEASE, V72, P13, DOI 10.1016/S0168-3659(01)00258-9; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; Guan J, 2007, J CONTROL RELEASE, V120, P70, DOI 10.1016/j.jconrel.2007.04.002; GULER HP, 1989, ACTA ENDOCRINOL-COP, V121, P753, DOI 10.1530/acta.0.1210753; Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A; Henry TD, 2001, AM HEART J, V142, P872, DOI 10.1067/mhj.2001.118471; Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004; Hosaka A, 2004, CIRCULATION, V110, P3322, DOI 10.1161/01.CIR.0000147779.17602.18; Hsieh PCH, 2006, CIRCULATION, V114, P637, DOI 10.1161/CIRCULATIONAHA.106.639831; Ishihara M, 2003, J BIOMED MATER RES A, V64A, P551, DOI 10.1002/jbm.a.10427; Jeon O, 2006, BIOMATERIALS, V27, P1598, DOI 10.1016/j.biomaterials.2005.08.030; Lee KW, 2004, TRANSPLANT P, V36, P2464, DOI 10.1016/j.transproceed.2004.08.078; LEE MK, 1991, P NATL ACAD SCI USA, V88, P2768, DOI 10.1073/pnas.88.7.2768; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Lopez JJ, 1997, AM J PHYSIOL-HEART C, V273, pH1317, DOI 10.1152/ajpheart.1997.273.3.H1317; Nie T, 2007, J CONTROL RELEASE, V122, P287, DOI 10.1016/j.jconrel.2007.04.019; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Pellegrini L, 2001, CURR OPIN STRUC BIOL, V11, P629, DOI 10.1016/S0959-440X(00)00258-X; Rajangam K, 2006, NANO LETT, V6, P2086, DOI 10.1021/nl0613555; Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029; Sakiyama SE, 1999, FASEB J, V13, P2214, DOI 10.1096/fasebj.13.15.2214; Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7; Seal BL, 2003, BIOMACROMOLECULES, V4, P1572, DOI 10.1021/bm0342032; Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; Steffens GCM, 2004, TISSUE ENG, V10, P1502, DOI 10.1089/ten.2004.10.1502; Takahashi Y, 2007, TISSUE ENG, V13, P293, DOI 10.1089/ten.2006.0088; Tanihara M, 2001, J BIOMED MATER RES, V56, P216, DOI 10.1002/1097-4636(200108)56:2<216::AID-JBM1086>3.0.CO;2-N; WAKEFIELD LM, 1990, J CLIN INVEST, V86, P1976, DOI 10.1172/JCI114932; Xian W, 2005, J CELL BIOL, V171, P663, DOI 10.1083/jcb.200505098	36	39	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11017	10.1371/journal.pone.0011017	http://dx.doi.org/10.1371/journal.pone.0011017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20543985	Green Published, Green Submitted, gold			2022-12-27	WOS:000278494900027
J	Goncalves, MAFV; Janssen, JM; Holkers, M; de Vries, AAF				Goncalves, Manuel A. F. V.; Janssen, Josephine M.; Holkers, Maarten; de Vries, Antoine A. F.			Rapid and Sensitive Lentivirus Vector-Based Conditional Gene Expression Assay to Monitor and Quantify Cell Fusion Activity	PLOS ONE			English	Article							HUMAN GENOME; ADENOVIRUS; COMPLEMENTATION; INTEGRATION; DYSTROPHIN	Cell-to-cell fusion is involved in multiple fundamental biological processes. Prominent examples include osteoclast and giant cell formation, fertilization and skeletal myogenesis which involve macrophage, sperm-egg and myoblast fusion, respectively. Indeed, the importance of cell fusion is underscored by the wide range of homeostatic as well as pathologic processes in which it plays a key role. Therefore, rapid and sensitive systems to trace and measure cell fusion events in various experimental systems are in demand. Here, we introduce a bipartite cell fusion monitoring system based on a genetic switch responsive to the site-specific recombinase FLP. To allow flexible deployment in both dividing as well as nondividing cell populations, inducer and reporter modules were incorporated in lentivirus vector particles. Moreover, the recombinase-inducible transcription units were designed in such a way as to minimize basal activity and chromosomal position effects in the "off'' and "on'' states, respectively. The lentivirus vector-based conditional gene expression assay was validated in primary human mesenchymal stem cells and in a differentiation model based on muscle progenitor cells from a Duchenne muscular dystrophy patient using reporter genes compatible with live-and single-cell imaging and with whole population measurements. Using the skeletal muscle cell differentiation model, we showed that the new assay displays low background activity, a 2-log dynamic range, high sensitivity and is amenable to the investigation of cell fusion kinetics. The utility of the bipartite cell fusion monitoring system was underscored by a study on the impact of drug-and RNAi-mediated p38 MAPK inhibition on human myocyte differentiation. Finally, building on the capacity of lentivirus vectors to readily generate transgenic animals the present FLP-inducible system should be adaptable, alone or together with Cre/loxP-based assays, to cell lineage tracing and conditional gene manipulation studies in vivo.	[Goncalves, Manuel A. F. V.; Janssen, Josephine M.; Holkers, Maarten; de Vries, Antoine A. F.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Goncalves, MAFV (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands.	m.goncalves@lumc.nl	de Vries, Antoine/ABG-5787-2021; Goncalves, Manuel AFV/V-2248-2019	Goncalves, Manuel AFV/0000-0002-8111-1073; Janssen, Josephine Martine/0000-0002-3430-7014	Dutch Duchenne Parent Project (DPP); Association Francaise contre les Myopathies (AFM) [12259-SR-GROUPE E]	Dutch Duchenne Parent Project (DPP); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	This work was supported by research grants from the Dutch Duchenne Parent Project (DPP) and the Association Francaise contre les Myopathies (AFM; 12259-SR-GROUPE E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Carter A, 2008, J NATL CANCER I, V100, P1279, DOI 10.1093/jnci/djn336; Cudre-Mauroux C, 2003, HUM GENE THER, V14, P1525, DOI 10.1089/104303403322495034; Goncalves MAFV, 2006, REV MED VIROL, V16, P167, DOI 10.1002/rmv.494; Goncalves MAFV, 2005, BIOESSAYS, V27, P506, DOI 10.1002/bies.20218; Goncalves MAFV, 2006, HUM MOL GENET, V15, P213, DOI 10.1093/hmg/ddi438; Goncalves MAFV, 2008, MOL THER, V16, P741, DOI 10.1038/mt.2008.16; Goncalves MAFV, 2006, MOL THER, V13, P976, DOI 10.1016/j.ymthe.2005.11.018; Goncalves MAFV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003084; Hoffmann D, 2006, GENE THER, V13, P1534, DOI 10.1038/sj.gt.3302806; Holkers M, 2006, BIOTECHNIQUES, V41, P711, DOI 10.2144/000112307; Huang SMA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006871; Klinghoffer RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006892; Li H, 2001, HUM GENE THER, V12, P2155, DOI 10.1089/10430340152710504; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Michiels F, 2003, NAT BIOTECHNOL, V21, P199, DOI 10.1038/nbt0203-199a; Michiels F, 2002, NAT BIOTECHNOL, V20, P1154, DOI 10.1038/nbt746; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mohler WA, 1996, P NATL ACAD SCI USA, V93, P12423, DOI 10.1073/pnas.93.22.12423; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Pfeifer Alexander, 2009, V530, P391, DOI 10.1007/978-1-59745-471-1_21; RENTIER B, 1978, J VIROL, V28, P567, DOI 10.1128/JVI.28.2.567-577.1978; Sambrook J., 2001, MOL CLONING LAB MANU; Santos EB, 2009, NAT MED, V15, P338, DOI 10.1038/nm.1930; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shinn-Thomas Jessica H., 2008, V475, P347, DOI 10.1007/978-1-59745-250-2_20; Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; van Nierop GP, 2009, NUCLEIC ACIDS RES, V37, P5725, DOI 10.1093/nar/gkp643; Vassilopoulos G, 2003, CURR OPIN GENET DEV, V13, P480, DOI 10.1016/S0959-437X(03)00110-2; Vignery A, 2005, TRENDS CELL BIOL, V15, P188, DOI 10.1016/j.tcb.2005.02.008; Wu X, 2004, CELL MOL LIFE SCI, V61, P2588, DOI 10.1007/s00018-004-4206-9; YOFFE B, 1987, P NATL ACAD SCI USA, V84, P1429, DOI 10.1073/pnas.84.5.1429	35	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10954	10.1371/journal.pone.0010954	http://dx.doi.org/10.1371/journal.pone.0010954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532169	gold, Green Submitted, Green Published			2022-12-27	WOS:000278318700021
J	Taneja, NK; Dhingra, S; Mittal, A; Naresh, M; Tyagi, JS				Taneja, Neetu Kumra; Dhingra, Sakshi; Mittal, Aditya; Naresh, Mohit; Tyagi, Jaya Sivaswami			Mycobacterium tuberculosis Transcriptional Adaptation, Growth Arrest and Dormancy Phenotype Development Is Triggered by Vitamin C	PLOS ONE			English	Article							ASCORBIC-ACID; 2-COMPONENT SYSTEM; RESPONSE REGULATOR; HYPOXIC RESPONSE; CARBON-MONOXIDE; CROSS-TALK; SENSOR; DEVS; PROTEIN; EXPRESSION	Background: Tubercle bacilli are thought to persist in a dormant state during latent tuberculosis (TB) infection. Although little is known about the host factors that induce and maintain Mycobacterium tuberculosis (M. tb) within latent lesions, O-2 depletion, nutrient limitation and acidification are some of the stresses implicated in bacterial dormancy development/growth arrest. Adaptation to hypoxia and exposure to NO/CO is implemented through the DevRS/DosT two-component system which induces the dormancy regulon. Methodology/Principal Findings: Here we show that vitamin C (ascorbic acid/AA) can serve as an additional signal to induce the DevR regulon. Physiological levels of AA scavenge O-2 and rapidly induce the DevR regulon at an estimated O-2 saturation of <30%. The kinetics and magnitude of the response suggests an initial involvement of DosT and a sustained DevS-mediated response during bacterial adaptation to increasing hypoxia. In addition to inducing DevR regulon mechanisms, vitamin C induces the expression of selected genes previously shown to be responsive to low pH and oxidative stress, triggers bacterial growth arrest and promotes dormancy phenotype development in M. tb grown in axenic culture and intracellularly in THP-1 cells. Conclusions/Significance: Vitamin C mimics multiple intracellular stresses and has wide-ranging regulatory effects on gene expression and physiology of M. tb which leads to growth arrest and a 'dormant' drug-tolerant phenotype, but in a manner independent of the DevRS/DosT sytem. The 'AA-dormancy infection model' offers a potential alternative to other models of non-replicating persistence of M. tb and may be useful for investigating host-'dormant' M. tb interactions. Our findings offer a new perspective on the role of nutritional factors in TB and suggest a possible role for vitamin C in TB.	[Taneja, Neetu Kumra; Dhingra, Sakshi; Tyagi, Jaya Sivaswami] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India; [Mittal, Aditya] Indian Inst Technol Delhi, Sch Biol Sci, New Delhi, India; [Naresh, Mohit] Indian Inst Technol Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Taneja, NK (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India.	jstyagi@aiims.ac.in	Mittal, Aditya/E-3087-2010	Mittal, Aditya/0000-0002-4030-0951; TANEJA, NEETU/0000-0002-2390-7647	Department of Biotechnology (DBT); Department of Biotechnology, Government of India; Council for Scientific and Industrial Research (CSIR); DBT	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); DBT(Department of Biotechnology (DBT) India)	JST and AM are thankful to the Department of Biotechnology (DBT) for research funding. JST is thankful to the Department of Biotechnology, Government of India, for a Tata Innovation Fellowship. NKT and SD are thankful to the Council for Scientific and Industrial Research (CSIR) and DBT for Senior and Junior Research Fellowships, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDOSCA JB, 1948, DIS CHEST, V14, P107, DOI 10.1378/chest.14.1.107; BERGSTEN P, 1990, J BIOL CHEM, V265, P2584; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Boon C, 2002, J BACTERIOL, V184, P6760, DOI 10.1128/JB.184.24.6760-6767.2002; Bowie AG, 2000, J IMMUNOL, V165, P7180, DOI 10.4049/jimmunol.165.12.7180; Carcamo JM, 2002, BLOOD, V99, P3205, DOI 10.1182/blood.V99.9.3205; Chauhan S, 2008, J BACTERIOL, V190, P4301, DOI 10.1128/JB.01308-07; Cho HY, 2009, J BIOL CHEM, V284, P13057, DOI 10.1074/jbc.M808905200; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; Field CJ, 2002, J LEUKOCYTE BIOL, V71, P16; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; Fontan P, 2008, INFECT IMMUN, V76, P717, DOI 10.1128/IAI.00974-07; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Gomes MS, 1999, INFECT IMMUN, V67, P3199, DOI 10.1128/IAI.67.7.3199-3206.1999; Gupta RK, 2009, J MED CHEM, V52, P6324, DOI 10.1021/jm900358q; Hemila H, 1999, AM J EPIDEMIOL, V150, P632, DOI 10.1093/oxfordjournals.aje.a010062; Honaker RW, 2009, INFECT IMMUN, V77, P3258, DOI 10.1128/IAI.01449-08; Ioanoviciu A, 2007, BIOCHEMISTRY-US, V46, P4250, DOI 10.1021/bi602422p; Ioanoviciu A, 2009, BIOCHEMISTRY-US, V48, P5839, DOI 10.1021/bi802309y; Jariwalla R. J., 1996, ASCORBIC ACID BIOCH, P215; Karakousis PC, 2004, J EXP MED, V200, P647, DOI 10.1084/jem.20040646; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; Kumar A, 2008, J BIOL CHEM, V283, P18032, DOI 10.1074/jbc.M802274200; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Laggner H, 1999, EUR J BIOCHEM, V262, P659, DOI 10.1046/j.1432-1327.1999.00403.x; Lee JM, 2008, J BACTERIOL, V190, P6795, DOI 10.1128/JB.00401-08; Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09; Mandl J, 2009, BRIT J PHARMACOL, V157, P1097, DOI 10.1111/j.1476-5381.2009.00282.x; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; May JM, 2005, FREE RADICAL BIO MED, V39, P1449, DOI 10.1016/j.freeradbiomed.2005.07.006; McConkey M, 1933, J EXP MED, V58, P503, DOI 10.1084/jem.58.4.503; Mowry S, 1999, J CHEM EDUC, V76, P970, DOI 10.1021/ed076p970; Mulder MA, 1999, MICROBIOL-SGM, V145, P2507, DOI 10.1099/00221287-145-9-2507; MUNETA P, 1985, AM POTATO J, V62, P531, DOI 10.1007/BF02854400; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Rodrigue S, 2007, J BACTERIOL, V189, P1505, DOI 10.1128/JB.01371-06; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Saini DK, 2004, FEBS LETT, V565, P75, DOI 10.1016/j.febslet.2004.02.092; Sala C, 2003, J BACTERIOL, V185, P5357, DOI 10.1128/JB.185.18.5357-5362.2003; Sardiwal S, 2005, J MOL BIOL, V353, P929, DOI 10.1016/j.jmb.2005.09.011; SCARPA M, 1983, J BIOL CHEM, V258, P6695; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sharma D, 2006, FEMS IMMUNOL MED MIC, V48, P329, DOI 10.1111/j.1574-695X.2006.00160.x; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; SHULER ML, 1992, BIOPROCESS ENG BASIC, P163; Singh A, 2003, FEMS MICROBIOL LETT, V227, P53, DOI 10.1016/S0378-1097(03)00648-7; Sousa EHS, 2007, PROTEIN SCI, V16, P1708, DOI 10.1110/ps.072897707; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; WASHKO PW, 1993, J BIOL CHEM, V268, P15531; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; WELCH RW, 1995, J BIOL CHEM, V270, P12584, DOI 10.1074/jbc.270.21.12584; Wolucka BA, 2006, FEBS J, V273, P4435, DOI 10.1111/j.1742-4658.2006.05443.x; Yukl ET, 2007, BIOCHEMISTRY-US, V46, P9728, DOI 10.1021/bi7008695	58	94	99	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10860	10.1371/journal.pone.0010860	http://dx.doi.org/10.1371/journal.pone.0010860			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523728	Green Published, Green Submitted, gold			2022-12-27	WOS:000278221900011
J	Ahmad, KF; Lim, WA				Ahmad, K. Farid; Lim, Wendell A.			The Minimal Autoinhibited Unit of the Guanine Nucleotide Exchange Factor Intersectin	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; ACTIN-DEPOLYMERIZING PROTEIN; TYROSINE KINASE HCK; RHO-GTPASES; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; N-WASP; GUANOSINE TRIPHOSPHATASES; ENDOCYTIC MACHINERY; DBL FAMILY	Intersectin-1L is a member of the Dbl homology (DH) domain guanine nucleotide exchange factors (GEF) which control Rho-family GTPase signaling. Intersectin-1L is a GEF that is specific for Cdc42. It plays an important role in endocytosis, and is regulated by several partners including the actin regulator N-WASP. Intact intersectin-1L shows low Cdc42 exchange activity, although the isolated catalytic DH domain shows high activity. This finding suggests that the molecule is autoinhibited. To investigate the mechanism of autoinhibition we have constructed a series of domain deletions. We find that the five SH3 domains of intersectin are important for autoinhibition, with the fifth domain (SH3(E)) being sufficient for the bulk of the autoinhibitory effect. This SH3 domain appears to primarily interact with the DH domain. We have determined the crystal structure of the SH3(E)-DH domain construct, which shows a domain swapped arrangement in which the SH3 from one monomer interacts with the DH domain of the other monomer. Analytical ultracentrifugation and gel filtration, however, show that under biochemical concentrations, the construct is fully monomeric. Thus we propose that the actual autoinhibited structure contains the related intramolecular SH3(E)-DH interaction. We propose a model in which this intramolecular interaction may block or distort the GTPase binding region of the DH domain.	[Ahmad, K. Farid; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Ahmad, KF (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	lim@cmp.ucsf.edu			National Institutes of Health (NIH) [R01-GM062583, R01-GM055040]; Howard Hughes Medical Institute (HHMI); National Cancer Institute of Canada; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055040, R01GM062583] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants from the National Institutes of Health (NIH) (R01-GM062583 and R01-GM055040) and the Howard Hughes Medical Institute (HHMI) to WAL. KFA was supported by postdoctoral fellowships from National Cancer Institute of Canada and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Baisamy L, 2005, J BIOL CHEM, V280, P15405, DOI 10.1074/jbc.M414440200; Baumeister MA, 2003, J BIOL CHEM, V278, P11457, DOI 10.1074/jbc.M211901200; Bi F, 2001, MOL CELL BIOL, V21, P1463, DOI 10.1128/MCB.21.5.1463-1474.2001; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Guipponi M, 1998, GENOMICS, V53, P369, DOI 10.1006/geno.1998.5521; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; HART MJ, 1994, J BIOL CHEM, V269, P62; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; Hussain NK, 1999, J BIOL CHEM, V274, P15671, DOI 10.1074/jbc.274.22.15671; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Lemmon MA, 1998, CURR TOP MICROBIOL, V228, P39; Lim WA, 2002, CURR OPIN STRUC BIOL, V12, P61, DOI 10.1016/S0959-440X(02)00290-7; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Liu XH, 1998, CELL, V95, P269, DOI 10.1016/S0092-8674(00)81757-2; Liu YS, 1998, P NATL ACAD SCI USA, V95, P3437, DOI 10.1073/pnas.95.7.3437; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McPherson PS, 2002, TRENDS CELL BIOL, V12, P312, DOI 10.1016/S0962-8924(02)02309-7; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Mosca R, 2008, NUCLEIC ACIDS RES, V36, pW42, DOI 10.1093/nar/gkn197; Murayama K, 2007, J BIOL CHEM, V282, P4238, DOI 10.1074/jbc.C600234200; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; O'Bryan JP, 2001, ONCOGENE, V20, P6300, DOI 10.1038/sj.onc.1204773; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Pucharcos C, 2001, BBA-GENE STRUCT EXPR, V1521, P1, DOI 10.1016/S0167-4781(01)00276-7; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; RON D, 1991, NEW BIOL, V3, P372; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Rossman KL, 2000, METHOD ENZYMOL, V325, P25; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rumenapp U, 1999, FEBS LETT, V459, P313, DOI 10.1016/S0014-5793(99)01270-3; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Sengar AS, 1999, EMBO J, V18, P1159, DOI 10.1093/emboj/18.5.1159; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Snyder JT, 2001, J BIOL CHEM, V276, P45868, DOI 10.1074/jbc.M106731200; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Stam JC, 1997, J BIOL CHEM, V272, P28447, DOI 10.1074/jbc.272.45.28447; Sterpetti P, 1999, MOL CELL BIOL, V19, P1334; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yeh BJ, 2007, NATURE, V447, P596, DOI 10.1038/nature05851; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033; Zamanian JL, 2003, MOL BIOL CELL, V14, P1624, DOI 10.1091/mbc.E02-08-0494; Zhu KJ, 2001, MOL CELL BIOL, V21, P425, DOI 10.1128/MCB.21.2.425-437.2001	67	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11291	10.1371/journal.pone.0011291	http://dx.doi.org/10.1371/journal.pone.0011291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585582	Green Published, Green Submitted, gold			2022-12-27	WOS:000279135800005
J	Gawecka, JE; Griffiths, GS; Ek-Rylander, B; Ramos, JW; Matter, ML				Gawecka, Joanna E.; Griffiths, Genevieve S.; Ek-Rylander, Barbro; Ramos, Joe W.; Matter, Michelle L.			R-Ras Regulates Migration through an Interaction with Filamin A in Melanoma Cells	PLOS ONE			English	Article							BREAST EPITHELIAL-CELLS; FIBRONECTIN MATRIX; INTEGRIN ACTIVATION; CYTOPLASMIC DOMAIN; ACTIN; BINDING; ADHESION; KINASE; EFFECTOR; IDENTIFICATION	Background: Changes in cell adhesion and migration in the tumor microenvironment are key in the initiation and progression of metastasis. R-Ras is one of several small GTPases that regulate cell adhesion and migration on the extracellular matrix, however the mechanism has not been completely elucidated. Using a yeast two-hybrid approach we sought to identify novel R-Ras binding proteins that might mediate its effects on integrins. Methods and Findings: We identified Filamin A (FLNa) as a candidate interacting protein. FLNa is an actin-binding scaffold protein that also binds to integrin beta 1, beta 2 and beta 7 tails and is associated with diverse cell processes including cell migration. Indeed, M2 melanoma cells require FLNa for motility. We further show that R-Ras and FLNa interact in co-immunoprecipitations and pull-down assays. Deletion of FLNa repeat 3 (FLNa Delta 3) abrogated this interaction. In M2 melanoma cells active R-Ras co-localized with FLNa but did not co-localize with FLNa lacking repeat 3. Thus, activated R-Ras binds repeat 3 of FLNa. The functional consequence of this interaction was that active R-Ras and FLNa coordinately increased cell migration. In contrast, co-expression of R-Ras and FLNa Delta 3 had a significantly reduced effect on migration. While there was enhancement of integrin activation and fibronectin matrix assembly, cell adhesion was not altered. Finally, siRNA knockdown of endogenous R-Ras impaired FLNa-dependent fibronectin matrix assembly. Conclusions: These data support a model in which R-Ras functionally associates with FLNa and thereby regulates integrin-dependent migration. Thus in melanoma cells R-Ras and FLNa may cooperatively promote metastasis by enhancing cell migration.	[Gawecka, Joanna E.; Ramos, Joe W.] Univ Hawaii Manoa, Canc Res Ctr Hawaii, Honolulu, HI 96822 USA; [Griffiths, Genevieve S.; Matter, Michelle L.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA; [Ek-Rylander, Barbro] Karolinska Univ Hosp, Karolinska Inst, Div Pathol, Dept Lab Med, Huddinge, Sweden	Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Karolinska Institutet; Karolinska University Hospital	Gawecka, JE (corresponding author), Univ Hawaii Manoa, Canc Res Ctr Hawaii, Honolulu, HI 96822 USA.	matter@hawaii.edu	Matter, Michelle/GSN-9703-2022; Ramos, Joe/G-4074-2010	Ramos, Joe/0000-0002-9708-2115; Matter, Michelle/0000-0002-5988-9663	National Institutes of Health NIH/NCRR [P20RR016453]; Geist Foundation [200842993]; Department of Defense [05245002]; NATIONAL CANCER INSTITUTE [R01CA093849] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016453] Funding Source: NIH RePORTER	National Institutes of Health NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Geist Foundation; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the National Institutes of Health NIH/NCRR P20RR016453 (M.L.M), the Geist Foundation 200842993 (M.L.M.) and the Department of Defense 05245002 (J.W.R.). The funders had no role in study, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldassarre M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007830; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bourdoulous S, 1998, J CELL BIOL, V143, P267, DOI 10.1083/jcb.143.1.267; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Cukier IH, 2007, FEBS LETT, V581, P1661, DOI 10.1016/j.febslet.2007.03.041; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; de Curtis I, 2001, EMBO REP, V2, P277, DOI 10.1093/embo-reports/kve072; Ehrhardt A, 2002, EXP HEMATOL, V30, P1089, DOI 10.1016/S0301-472X(02)00904-9; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Feral CC, 2007, J CELL BIOL, V178, P701, DOI 10.1083/jcb.200705090; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Goldfinger LE, 2006, J CELL BIOL, V174, P877, DOI 10.1083/jcb.200603111; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Green JA, 2009, J BIOL CHEM, V284, P8148, DOI 10.1074/jbc.M805934200; Holly SP, 2005, MOL BIOL CELL, V16, P2458, DOI 10.1091/mbc.E03-12-0917; Hughes PE, 2002, MOL BIOL CELL, V13, P2256, DOI 10.1091/mbc.01-10-0480; Jeong HW, 2005, CANCER RES, V65, P507; Katz ME, 1997, CURR OPIN GENET DEV, V7, P75, DOI 10.1016/S0959-437X(97)80112-8; Keely PJ, 1999, J CELL BIOL, V145, P1077, DOI 10.1083/jcb.145.5.1077; KIM H, AM J PHYSL CELL PHYS, V298, pC221; Kim H, 2010, EXP CELL RES, V316, P1829, DOI 10.1016/j.yexcr.2010.02.007; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; MCHUGH BJ, J CELL SCI, V123, P51; Mora N, 2007, CANCER IMMUNOL IMMUN, V56, P535, DOI 10.1007/s00262-006-0205-z; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Oertli B, 2000, ONCOGENE, V19, P4961, DOI 10.1038/sj.onc.1203876; Ott I, 1998, J CELL BIOL, V140, P1241, DOI 10.1083/jcb.140.5.1241; Pentikainen U, 2009, J MOL BIOL, V393, P644, DOI 10.1016/j.jmb.2009.08.035; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; Ramos JW, 1998, J BIOL CHEM, V273, P33897, DOI 10.1074/jbc.273.51.33897; Ramsay AG, 2007, CANCER METAST REV, V26, P567, DOI 10.1007/s10555-007-9078-7; Rincon-Arano H, 2003, CANCER, V97, P575, DOI 10.1002/cncr.11093; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Sechler JL, 2000, J CELL SCI, V113, P1491; Sechler JL, 1997, MOL BIOL CELL, V8, P2563, DOI 10.1091/mbc.8.12.2563; SHARMA CP, 1995, J IMMUNOL, V154, P3461; Stossel TP, 2003, DEV CELL, V4, P444, DOI 10.1016/S1534-5807(03)00098-4; Sverdlov M, 2009, MOL BIOL CELL, V20, P4531, DOI 10.1091/mbc.E08-10-0997; Takaya A, 2007, MOL BIOL CELL, V18, P1850, DOI 10.1091/mbc.E06-08-0765; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wozniak MA, 2005, MOL BIOL CELL, V16, P84, DOI 10.1091/mbc.E04-04-0277; Wu CY, 1996, CELL ADHES COMMUN, V4, P149, DOI 10.3109/15419069609014219; WU CY, 1993, J BIOL CHEM, V268, P21883; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X	51	47	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11269	10.1371/journal.pone.0011269	http://dx.doi.org/10.1371/journal.pone.0011269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585650	Green Published, Green Submitted, gold			2022-12-27	WOS:000279135400015
J	Almanza, G; Fernandez, A; Volinia, S; Cortez-Gonzalez, X; Croce, CM; Zanetti, M				Almanza, Gonzalo; Fernandez, Antonio; Volinia, Stefano; Cortez-Gonzalez, Xochitl; Croce, Carlo M.; Zanetti, Maurizio			Selected MicroRNAs Define Cell Fate Determination of Murine Central Memory CD8 T Cells	PLOS ONE			English	Article							PROTECTIVE IMMUNITY; POTASSIUM CHANNEL; IL-7 RECEPTOR; EFFECTOR; DIFFERENTIATION; EXPRESSION; MIR-150; NAIVE; PROLIFERATION; REQUIREMENT	During an immune response T cells enter memory fate determination, a program that divides them into two main populations: effector memory and central memory T cells. Since in many systems protection appears to be preferentially mediated by T cells of the central memory it is important to understand when and how fate determination takes place. To date, cell intrinsic molecular events that determine their differentiation remains unclear. MicroRNAs are a class of small, evolutionarily conserved RNA molecules that negatively regulate gene expression, causing translational repression and/or messenger RNA degradation. Here, using an in vitro system where activated CD8 T cells driven by IL-2 or IL-15 become either effector memory or central memory cells, we assessed the role of microRNAs in memory T cell fate determination. We found that fate determination to central memory T cells is under the balancing effects of a discrete number of microRNAs including miR-150, miR-155 and the let-7 family. Based on miR-150 a new target, KChIP. 1 (K+ channel interacting protein 1), was uncovered, which is specifically upregulated in developing central memory CD8 T cells. Our studies indicate that cell fate determination such as surface phenotype and self-renewal may be decided at the pre-effector stage on the basis of the balancing effects of a discrete number of microRNAs. These results may have implications for the development of T cell vaccines and T cell-based adoptive therapies.	[Almanza, Gonzalo; Fernandez, Antonio; Cortez-Gonzalez, Xochitl; Zanetti, Maurizio] Univ Calif San Diego, Dept Med, Immunol Lab, La Jolla, CA 92093 USA; [Almanza, Gonzalo; Fernandez, Antonio; Cortez-Gonzalez, Xochitl; Zanetti, Maurizio] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Volinia, Stefano; Croce, Carlo M.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Volinia, Stefano; Croce, Carlo M.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Volinia, Stefano] Univ Ferrara, Dept Morphol & Embryol, Telethon Facil Data Min Anal DNA Microarrays, I-44100 Ferrara, Italy	University of California System; University of California San Diego; University of California System; University of California San Diego; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Ferrara	Almanza, G (corresponding author), Univ Calif San Diego, Dept Med, Immunol Lab, La Jolla, CA 92093 USA.	mzanetti@ucsd.edu	Volinia, Stefano/A-3029-2010; Young, Richard A/F-6495-2012; Volinia, Stefano/AAA-9264-2019	Volinia, Stefano/0000-0003-0910-3893; Young, Richard A/0000-0001-8855-8647; Volinia, Stefano/0000-0003-0910-3893; Fernandez-Perez, Antonio/0000-0002-3781-7327	National Institutes of Health (NIH) [RO1AI062894, PO1CA76259]; NATIONAL CANCER INSTITUTE [P01CA076259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062894] Funding Source: NIH RePORTER; Fondazione Telethon Funding Source: Custom	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fondazione Telethon(Fondazione Telethon)	This work was supported by National Institutes of Health (NIH) grants RO1AI062894 (to M.Z.) and PO1CA76259 (to C. M. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; Baron V, 2003, IMMUNITY, V18, P193, DOI 10.1016/S1074-7613(03)00020-7; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Castiglioni P, 2004, VACCINE, V23, P699, DOI 10.1016/j.vaccine.2004.06.028; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; HOZUMI K, 1994, INT IMMUNOL, V6, P1451, DOI 10.1093/intimm/6.9.1451; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Joshi NS, 2008, J IMMUNOL, V180, P1309, DOI 10.4049/jimmunol.180.3.1309; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; LEWIS RS, 1988, SCIENCE, V239, P771, DOI 10.1126/science.2448877; Li M, 2000, NAT NEUROSCI, V3, P202, DOI 10.1038/72898; Lieu YK, 2004, P NATL ACAD SCI USA, V101, P14853, DOI 10.1073/pnas.0405338101; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Moskophidis D, 1998, J EXP MED, V188, P223, DOI 10.1084/jem.188.2.223; Mueller YM, 2003, INT IMMUNOL, V15, P49, DOI 10.1093/intimm/dxg013; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Sato N, 2007, P NATL ACAD SCI USA, V104, P588, DOI 10.1073/pnas.0610115104; Savignac M, 2005, EMBO J, V24, P3555, DOI 10.1038/sj.emboj.7600810; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Vaccari M, 2005, J IMMUNOL, V175, P3502, DOI 10.4049/jimmunol.175.6.3502; Vella AT, 1998, P NATL ACAD SCI USA, V95, P3810, DOI 10.1073/pnas.95.7.3810; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang M, 2008, J PATHOL, V215, P13, DOI 10.1002/path.2333; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zanetti M, 2006, TRENDS IMMUNOL, V27, P511, DOI 10.1016/j.it.2006.09.004; Zaph C, 2004, NAT MED, V10, P1104, DOI 10.1038/nm1108; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	51	41	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11243	10.1371/journal.pone.0011243	http://dx.doi.org/10.1371/journal.pone.0011243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582165	Green Submitted, Green Published, gold			2022-12-27	WOS:000279058500009
J	Bojang, K; Akor, F; Bittaye, O; Conway, D; Bottomley, C; Milligan, P; Greenwood, B				Bojang, Kalifa; Akor, Francis; Bittaye, Ousman; Conway, David; Bottomley, Christian; Milligan, Paul; Greenwood, Brian			A Randomised Trial to Compare the Safety, Tolerability and Efficacy of Three Drug Combinations for Intermittent Preventive Treatment in Children	PLOS ONE			English	Article							SULFADOXINE-PYRIMETHAMINE; PLASMODIUM-FALCIPARUM; SENEGALESE CHILDREN; WEST-AFRICA; MALARIA; AMODIAQUINE; IMPACT; REGIMENS; DENSITY; GAMBIA	Background: Results from trials of intermittent preventive treatment (IPT) in infants and children have shown that IPT provides significant protection against clinical malaria. Sulfadoxine-pyrimethamine (SP) given alone or in combination with other drugs has been used for most IPT programmes. However, SP resistance is increasing in many parts of Africa. Thus, we have investigated whether SP plus AQ, SP plus piperaquine (PQ) and dihydroartemisinin (DHA) plus PQ might be equally safe and effective when used for IPT in children in an area of seasonal transmission. Methods: During the 2007 malaria transmission season, 1008 Gambian children were individually randomized to receive SP plus amodiaquine (AQ), SP plus piperaquine (PQ) or dihydroartemisinin (DHA) plus PQ at monthly intervals on three occasions during the peak malaria transmission season. To determine the risk of side effects following drug administration, participants in each treatment group were visited at home three days after the start of each round of drug administration and a side effects questionnaire completed. To help establish whether adverse events were drug related, the same questionnaire was administered to 286 age matched control children recruited from adjacent villages. Morbidity was monitored throughout the malaria transmission season and study children were seen at the end of the malaria transmission season. Results: All three treatment regimens showed good safety profiles. No severe adverse event related to IPT was reported. The most frequent adverse events reported were coughing, diarrhoea, vomiting, abdominal pain and loss of appetite. Cough was present in 15.2%, 15.4% and 18.7% of study subjects who received SP plus AQ, DHA plus PQ or SP plus PQ respectively, compared to 19.2% in a control group. The incidence of malaria in the DHA plus PQ, SP plus AQ and SP plus PQ groups were 0.10 cases per child year (95% CI: 0.05, 0.22), 0.06 (95% CI: 0.022, 0.16) and 0.06 (95% CI: 0.02, 0.15) respectively. The incidence of malaria in the control group was 0.79 cases per child year (0.58, 1.08). Conclusion: All the three regimens of IPT in children were safe and highly efficacious	[Bojang, Kalifa; Akor, Francis; Bittaye, Ousman; Conway, David] MRC Labs, Banjul, Gambia; [Bottomley, Christian; Milligan, Paul; Greenwood, Brian] London Sch Hyg & Trop Med, London WC1, England	MRC Laboratory Molecular Biology; University of London; London School of Hygiene & Tropical Medicine	Bojang, K (corresponding author), MRC Labs, Banjul, Gambia.	kbojang@mrc.gm	Milligan, Paul/D-8985-2017; Akor, Francis/L-3836-2019	Milligan, Paul/0000-0003-3430-3395; Akor, Francis/0000-0002-5181-8609; Conway, David/0000-0002-8711-3037; Bottomley, Christian/0000-0002-5241-8412; Bojang, Kalifa/0000-0001-7506-0938	Gates malaria partnership; MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837] Funding Source: researchfish	Gates malaria partnership; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study received financial support from the Gates malaria partnership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Dicko A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-123; Dunyo S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010014; GOSLING R, DRUG OPTIONS I UNPUB; GREENWOOD BM, 1993, T ROY SOC TROP MED H, V87, P3, DOI 10.1016/0035-9203(93)90169-Q; GREENWOOD BM, 1991, T ROY SOC TROP MED H, V85, P186, DOI 10.1016/0035-9203(91)90015-Q; Greenwood B, 2007, CLIN INFECT DIS, V45, P26, DOI 10.1086/518574; Kweku M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004000; Myint HY, 2007, T ROY SOC TROP MED H, V101, P858, DOI 10.1016/j.trstmh.2007.05.018; Olliaro P, 1996, LANCET, V348, P1196, DOI 10.1016/S0140-6736(96)06217-4; PHILLIPSHOWARD PA, 1990, J ROY SOC MED, V83, P82, DOI 10.1177/014107689008300208; PUSSARD E, 1987, EUR J CLIN PHARMACOL, V33, P409, DOI 10.1007/BF00637639; Schellenberg D, 2006, TRENDS PARASITOL, V22, P296, DOI 10.1016/j.pt.2006.05.006; Sokhna C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001471; Steketee RW, 1996, AM J TROP MED HYG, V55, P24, DOI 10.4269/ajtmh.1996.55.24; THOMSON MC, 1994, T ROY SOC TROP MED H, V88, P638, DOI 10.1016/0035-9203(94)90204-6; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003; World Health Organization, 2000, EM OTH COMM DIS STRA, P1	18	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11225	10.1371/journal.pone.0011225	http://dx.doi.org/10.1371/journal.pone.0011225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574538	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000279058300015
J	Treuner-Lange, A				Treuner-Lange, Anke			The Phosphatomes of the Multicellular Myxobacteria Myxococcus xanthus and Sorangium cellulosum in Comparison with Other Prokaryotic Genomes	PLOS ONE			English	Article							PROTEIN SER/THR KINASE; SP STRAIN PCC-6803; BACILLUS-SUBTILIS; ARSENATE REDUCTASE; CATALYTIC DOMAIN; PHOSPHORYLATION; SEQUENCE; SUPERFAMILY; THREONINE; EVOLUTION	Background: Analysis of the complete genomes from the multicellular myxobacteria Myxococcus xanthus and Sorangium cellulosum identified the highest number of eukaryotic-like protein kinases (ELKs) compared to all other genomes analyzed. High numbers of protein phosphatases (PPs) could therefore be anticipated, as reversible protein phosphorylation is a major regulation mechanism of fundamental biological processes. Methodology: Here we report an intensive analysis of the phosphatomes of M. xanthus and S. cellulosum in which we constructed phylogenetic trees to position these sequences relative to PPs from other prokaryotic organisms. Principal Findings: Predominant observations were: (i) M. xanthus and S. cellulosum possess predominantly Ser/Thr PPs; (ii) S. cellulosum encodes the highest number of PP2c-type phosphatases so far reported for a prokaryotic organism; (iii) in contrast to M. xanthus only S. cellulosum encodes high numbers of SpoIIE-like PPs; (iv) there is a significant lack of synteny among M. xanthus and S. cellulosum, and (v) the degree of co-organization between kinase and phosphatase genes is extremely low in these myxobacterial genomes. Conclusions: We conclude that there has been a greater expansion of ELKs than PPs in multicellular myxobacteria.	Univ Giessen, Inst Mikrobiol & Mol Biol, Giessen, Germany	Justus Liebig University Giessen	Treuner-Lange, A (corresponding author), Univ Giessen, Inst Mikrobiol & Mol Biol, Giessen, Germany.	Anke.Treunerlange@mpi-marburg.mpg.de	Treuner-Lange, Anke U/AFQ-5368-2022; Mahmud, Taifo/A-1492-2015	Treuner-Lange, Anke U/0000-0001-6435-5642; Mahmud, Taifo/0000-0001-9639-526X	Deutsche Forschungsgemeinschaft [DFG Tr429/41]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant of the Deutsche Forschungsgemeinschaft (DFG Tr429/41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreeva AV, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-47; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P3746, DOI 10.1093/nar/26.16.3746; Aravind L, 2000, CURR BIOL, V10, pR53, DOI 10.1016/S0960-9822(00)00335-3; Bennett MS, 2001, P NATL ACAD SCI USA, V98, P13577, DOI 10.1073/pnas.241397198; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Bork P, 1996, PROTEIN SCI, V5, P1421, DOI 10.1002/pro.5560050720; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Buttani V, 2006, FEBS LETT, V580, P3818, DOI 10.1016/j.febslet.2006.06.007; Clemente-Blanco A, 2006, J CELL SCI, V119, P1130, DOI 10.1242/jcs.02820; Cohen P T, 1996, Adv Pharmacol, V36, P67; Cohen PTW, 2004, TOP CURR GENET, V5, P1; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gaidenko TA, 2002, J BACTERIOL, V184, P6109, DOI 10.1128/JB.184.22.6109-6114.2002; Garcia-Hernandez R, 2009, J BIOL CHEM, V284, P28720, DOI 10.1074/jbc.M109.015248; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Gerth K, 2003, J BIOTECHNOL, V106, P233, DOI 10.1016/j.jbiotec.2003.07.015; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Inouye S, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P191; Iwanicki A, 2002, BIOCHEM J, V366, P929, DOI 10.1042/BJ20011591; Johnson DL, 2007, J BACTERIOL, V189, P7549, DOI 10.1128/JB.00893-07; Kennelly PJ, 2003, BIOCHEM J, V370, P373, DOI 10.1042/BJ20021547; Kennelly PJ, 2002, FEMS MICROBIOL LETT, V206, P1, DOI 10.1016/S0378-1097(01)00479-7; Kimura Y, 2006, J BACTERIOL, V188, P823, DOI 10.1128/JB.188.2.823-828.2006; Kimura Y, 2009, FEBS LETT, V583, P443, DOI 10.1016/j.febslet.2008.12.044; KOONIN EV, 1994, PROTEIN SCI, V3, P356; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; Li RH, 2005, J BACTERIOL, V187, P5877, DOI 10.1128/JB.187.17.5877-5884.2005; Li RH, 2003, J BACTERIOL, V185, P6780, DOI 10.1128/JB.185.23.6780-6789.2003; LUDWIG W, 1983, ARCH MICROBIOL, V135, P58, DOI 10.1007/BF00419483; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; MECHULAM Y, 1985, J BACTERIOL, V164, P63, DOI 10.1128/JB.164.1.63-69.1985; Mijakovic I, 2005, J MOL MICROB BIOTECH, V9, P189, DOI 10.1159/000089647; Missiakas D, 1997, EMBO J, V16, P1670, DOI 10.1093/emboj/16.7.1670; Mittenhuber G, 2002, J MOL MICROB BIOTECH, V4, P427; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Nariya H, 2002, MOL MICROBIOL, V46, P1353, DOI 10.1046/j.1365-2958.2002.03251.x; Nariya H, 2006, MOL MICROBIOL, V60, P1205, DOI 10.1111/j.1365-2958.2006.05178.x; Page Roderic D M, 2002, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0602s01; Pane-Farre J, 2005, J MOL MICROB BIOTECH, V9, P65, DOI 10.1159/000088837; Perez J, 2008, P NATL ACAD SCI USA, V105, P15950, DOI 10.1073/pnas.0806851105; Reichenbach H., 2005, BERGEYS MANUAL SYSTE, V2, P1059; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schneiker S, 2007, NAT BIOTECHNOL, V25, P1281, DOI 10.1038/nbt1354; Searls T, 2004, J BACTERIOL, V186, P3195, DOI 10.1128/JB.186.10.3195-3201.2004; Shi L, 2004, MICROBIOL-SGM, V150, P2247, DOI 10.1099/mic.0.27057-0; Shi L, 1998, FEMS MICROBIOL REV, V22, P229, DOI 10.1016/S0168-6445(98)00015-1; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shimkets L.J., 2006, PROKARYOTES, P31, DOI [10.1007/0-387-30747-8_3, DOI 10.1007/0-387-30747-8_3]; Singh KD, 2007, J MOL MICROB BIOTECH, V13, P165, DOI 10.1159/000103608; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Treuner-Lange A, 2001, MOL MICROBIOL, V40, P126, DOI 10.1046/j.1365-2958.2001.02362.x; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Wilkes JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-412; Zhang CC, 2005, J MOL MICROB BIOTECH, V9, P154, DOI 10.1159/000089644; Zhang WW, 2004, MICROBIOL-SGM, V150, P4189, DOI 10.1099/mic.0.27480-0	62	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11164	10.1371/journal.pone.0011164	http://dx.doi.org/10.1371/journal.pone.0011164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567509	Green Published, Green Submitted, gold			2022-12-27	WOS:000278886300010
J	Jaeger, PA; Pickford, F; Sun, CH; Lucin, KM; Masliah, E; Wyss-Coray, T				Jaeger, Philipp A.; Pickford, Fiona; Sun, Chung-Huan; Lucin, Kurt M.; Masliah, Eliezer; Wyss-Coray, Tony			Regulation of Amyloid Precursor Protein Processing by the Beclin 1 Complex	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; BETA; AUTOPHAGY; EXPRESSION; FORMS; PATHWAY; TARGET; MTOR; APP	Autophagy is an intracellular degradation pathway that functions in protein and organelle turnover in response to starvation and cellular stress. Autophagy is initiated by the formation of a complex containing Beclin 1 (BECN1) and its binding partner Phosphoinositide-3-kinase, class 3 (PIK3C3). Recently, BECN1 deficiency was shown to enhance the pathology of a mouse model of Alzheimer Disease (AD). However, the mechanism by which BECN1 or autophagy mediate these effects are unknown. Here, we report that the levels of Amyloid precursor protein (APP) and its metabolites can be reduced through autophagy activation, indicating that they are a substrate for autophagy. Furthermore, we find that knockdown of Becn1 in cell culture increases the levels of APP and its metabolites. Accumulation of APP and APP C-terminal fragments (APP-CTF) are accompanied by impaired autophagosomal clearance. Pharmacological inhibition of autophagosomal-lysosomal degradation causes a comparable accumulation of APP and APP-metabolites in autophagosomes. Becn1 reduction in cell culture leads to lower levels of its binding partner Pik3c3 and increased presence of Microtubule-associated protein 1, light chain 3 (LC3). Overexpression of Becn1, on the other hand, reduces cellular APP levels. In line with these observations, we detected less BECN1 and PIK3C3 but more LC3 protein in brains of AD patients. We conclude that BECN1 regulates APP processing and turnover. BECN1 is involved in autophagy initiation and autophagosome clearance. Accordingly, BECN1 deficiency disrupts cellular autophagy and autophagosomal-lysosomal degradation and alters APP metabolism. Together, our findings suggest that autophagy and the BECN1-PIK3C3 complex regulate APP processing and play an important role in AD pathology.	[Jaeger, Philipp A.; Pickford, Fiona; Sun, Chung-Huan; Lucin, Kurt M.; Wyss-Coray, Tony] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA; [Jaeger, Philipp A.] Free Univ Berlin, Inst Chem & Biochem, D-1000 Berlin, Germany; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci & Pathol, San Diego, CA 92103 USA; [Wyss-Coray, Tony] Vet Affairs Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA USA	Stanford University; Free University of Berlin; University of California System; University of California San Diego; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Jaeger, PA (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA.	twc@stanford.edu	Wyss-Coray, Tony/AAF-3380-2019; Jaeger, Philipp/H-8377-2012	Wyss-Coray, Tony/0000-0001-5893-0831; Jaeger, Philipp/0000-0002-3624-0802	Biogen IDEC (TWC); National Institutes of Health (NIH) [AG030144, AG5131, AG18440, AG22074, AG10435, AG02270]; John Douglas French Alzheimer's Foundation; Veterans Administration Geriatric Research, Education, and Clinical Center (GRECC); NATIONAL INSTITUTE ON AGING [R01AG030144, P50AG005131, R37AG018440, P01AG022074, P01AG010435, R01AG018440] Funding Source: NIH RePORTER	Biogen IDEC (TWC)(Biogen); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Douglas French Alzheimer's Foundation; Veterans Administration Geriatric Research, Education, and Clinical Center (GRECC); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Biogen IDEC (TWC), the National Institutes of Health (NIH) (TWC: AG030144, EM: AG5131, AG18440, AG22074, AG10435, and AG02270), The John Douglas French Alzheimer's Foundation (TWC, FP), and the Veterans Administration Geriatric Research, Education, and Clinical Center (GRECC) (TWC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Cabrejo L, 2006, BRAIN, V129, P2966, DOI 10.1093/brain/awl237; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Campion D, 1999, AM J HUM GENET, V65, P664, DOI 10.1086/302553; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chang KA, 2005, J PHARMACOL SCI, V97, P461, DOI 10.1254/jphs.CR0050014; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; DETER RL, 1967, J CELL BIOL, V33, P437, DOI 10.1083/jcb.33.2.437; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; DUNN WA, 1990, J CELL BIOL, V110, P1935, DOI 10.1083/jcb.110.6.1935; Eggert S, 2004, J BIOL CHEM, V279, P18146, DOI 10.1074/jbc.M311601200; Engidawork E, 2001, AMINO ACIDS, V21, P331, DOI 10.1007/s007260170001; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Golde Todd E., 2006, Current Alzheimer Research, V3, P421, DOI 10.2174/156720506779025189; GOODGER Z, 2009, J CELL SCI; Guyant-Marechal L, 2007, NEUROLOGY, V68, P684, DOI 10.1212/01.wnl.0000255938.33739.46; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Hirayama A, 2003, BRAIN DEV-JPN, V25, P180, DOI 10.1016/S0387-7604(02)00209-7; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; HUNG S, 2009, AUTOPHAGY, V5, P441; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; Kametaka S, 1998, J BIOL CHEM, V273, P22284, DOI 10.1074/jbc.273.35.22284; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; KLIONSKY DJ, 2008, AUTOPHAGY, V4, P1; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Masliah E, 1996, J NEUROSCI, V16, P5795; Matsui T, 2007, BRAIN RES, V1161, P116, DOI 10.1016/j.brainres.2007.05.050; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moir RD, 1998, J BIOL CHEM, V273, P5013, DOI 10.1074/jbc.273.9.5013; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; SCHUBERT D, 1993, BRAIN RES, V629, P275, DOI 10.1016/0006-8993(93)91331-L; Schupf N, 2001, NEUROSCI LETT, V301, P199, DOI 10.1016/S0304-3940(01)01657-3; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; SMALL S, 2008, ARCH NEUROL-CHICAGO, P323; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Vergne I, 2010, FEBS LETT, V584, P1313, DOI 10.1016/j.febslet.2010.02.054; Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Walsh DM, 2003, BIOCHEMISTRY-US, V42, P6664, DOI 10.1021/bi027375c; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Xu X, 1999, P NATL ACAD SCI USA, V96, P7547, DOI 10.1073/pnas.96.13.7547; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yen WL, 2010, J CELL BIOL, V188, P101, DOI 10.1083/jcb.200904075; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Yue ZY, 2002, NEURON, V35, P921, DOI 10.1016/S0896-6273(02)00861-9; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zetterberg H, 2010, EXP GERONTOL, V45, P23, DOI 10.1016/j.exger.2009.08.002; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	77	151	165	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11102	10.1371/journal.pone.0011102	http://dx.doi.org/10.1371/journal.pone.0011102			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559548	Green Submitted, Green Published, gold			2022-12-27	WOS:000278775900004
J	Mastrolorenzo, G; Petrone, P; Pappalardo, L; Guarino, FM				Mastrolorenzo, Giuseppe; Petrone, Pierpaolo; Pappalardo, Lucia; Guarino, Fabio M.			Lethal Thermal Impact at Periphery of Pyroclastic Surges: Evidences at Pompeii	PLOS ONE			English	Article							VESUVIUS; ERUPTION; FLOW; DYNAMICS; AD-79; DEATH; BONE	Background: The evaluation of mortality of pyroclastic surges and flows (PDCs) produced by explosive eruptions is a major goal in risk assessment and mitigation, particularly in distal reaches of flows that are often heavily urbanized. Pompeii and the nearby archaeological sites preserve the most complete set of evidence of the 79 AD catastrophic eruption recording its effects on structures and people. Methodology/Principal Findings: Here we investigate the causes of mortality in PDCs at Pompeii and surroundings on the bases of a multidisciplinary volcanological and bio-anthropological study. Field and laboratory study of the eruption products and victims merged with numerical simulations and experiments indicate that heat was the main cause of death of people, heretofore supposed to have died by ash suffocation. Our results show that exposure to at least 250 degrees C hot surges at a distance of 10 kilometres from the vent was sufficient to cause instant death, even if people were sheltered within buildings. Despite the fact that impact force and exposure time to dusty gas declined toward PDCs periphery up to the survival conditions, lethal temperatures were maintained up to the PDCs extreme depositional limits. Conclusions/Significance: This evidence indicates that the risk in flow marginal zones could be underestimated by simply assuming that very thin distal deposits, resulting from PDCs with poor total particle load, correspond to negligible effects. Therefore our findings are essential for hazard plans development and for actions aimed to risk mitigation at Vesuvius and other explosive volcanoes.	[Mastrolorenzo, Giuseppe; Pappalardo, Lucia] Ist Nazl Geofis & Vulcanol, Sez Napoli, Osservatorio Vesuviano, Naples, Italy; [Petrone, Pierpaolo] Univ Naples Federico II, Museo Antropol, Ctr Musei Sci Nat, Naples, Italy; [Guarino, Fabio M.] Univ Naples Federico II, Dipartimento Biol Strutturale & Funz, Naples, Italy	Istituto Nazionale Geofisica e Vulcanologia (INGV); University of Naples Federico II; University of Naples Federico II	Mastrolorenzo, G (corresponding author), Ist Nazl Geofis & Vulcanol, Sez Napoli, Osservatorio Vesuviano, Naples, Italy.	giuseppe.mastrolorenzo@ov.ingv.it	Guarino, Fabio M/ABB-7825-2020	Petrone, Pier Paolo/0000-0002-8897-8171				*BALT MUNS COL COP, 1954, MUNS SOIL COL CHARTS; BAXTER PJ, 1990, B VOLCANOL, V52, P532, DOI 10.1007/BF00301534; Baxter PJ, 1998, NAT HAZARDS, V17, P163, DOI 10.1023/A:1008031004183; Camps Francis E., 1976, GRADWOHL LEGAL MED, V3rd edn, P356; De Natale G, 2006, EARTH-SCI REV, V74, P73, DOI 10.1016/j.earscirev.2005.08.001; DECAROLIS E, 1998, RIV STUDI POMPEIANI, V75, P123; Guarino FM, 2006, J ARCHAEOL SCI, V33, P513, DOI 10.1016/j.jas.2005.09.010; HATCHER PG, 2002, NATURAL HIST ANCIENT, P217; Herrmann NP, 1999, J FORENSIC SCI, V44, P461; HOLDEN JL, 1995, FORENSIC SCI INT, V74, P17, DOI 10.1016/0379-0738(95)01734-Z; Knusel CJ, 2007, OXFORD J ARCHAEOL, V2, P121; Luongo G, 2003, J VOLCANOL GEOTH RES, V126, P169, DOI 10.1016/S0377-0273(03)00147-1; Maiuri A., 1961, NATL GEOGR, V120, P651; Mastrolorenzo G, 2006, P NATL ACAD SCI USA, V103, P4366, DOI 10.1073/pnas.0508697103; Mastrolorenzo G, 2001, NATURE, V410, P769, DOI 10.1038/35071167; MCEWEN AS, 1989, J VOLCANOL GEOTH RES, V37, P205, DOI 10.1016/0377-0273(89)90080-2; MIDDLETON G.V., 1978, SOC EC PAL MIN SHORT; Ongaro TE, 2002, B VOLCANOL, V64, P178, DOI 10.1007/s00445-001-0190-1; Paparazzo E, 2005, BRIT J PHILOS SCI, V56, P363, DOI 10.1093/bjps/axi122; Perla R., 1980, AVALANCHE RELEASE, P397, DOI [DOI 10.1016/B978-0-12-179450-7.50012-7, 10.1016/B978-0-12-179450-7.50012-7]; Rossano S, 1998, J VOLCANOL GEOTH RES, V82, P113, DOI 10.1016/S0377-0273(97)00060-7; Rossano S, 1996, GEOPHYS RES LETT, V23, P3779, DOI 10.1029/96GL03570; SHIPMAN P, 1984, J ARCHAEOL SCI, V11, P307, DOI 10.1016/0305-4403(84)90013-X; SIGURDSSON H, 1985, NATL GEOGR RES, V1, P332; Spence R, 2007, NAT HAZARD EARTH SYS, V7, P219, DOI 10.5194/nhess-7-219-2007; STEFANI G, 2006, ARGENTI POMPEII, P191; Valentine GA, 1987, B VOLCANOL, V49, P616, DOI 10.1007/BF01079967	27	26	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11127	10.1371/journal.pone.0011127	http://dx.doi.org/10.1371/journal.pone.0011127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559555	gold, Green Published, Green Submitted			2022-12-27	WOS:000278775900017
J	Matoba, N; Husk, AS; Barnett, BW; Pickel, MM; Arntzen, CJ; Montefiori, DC; Takahashi, A; Tanno, K; Omura, S; Cao, HY; Mooney, JP; Hanson, CV; Tanaka, H				Matoba, Nobuyuki; Husk, Adam S.; Barnett, Brian W.; Pickel, Michelle M.; Arntzen, Charles J.; Montefiori, David C.; Takahashi, Atsushi; Tanno, Kazunobu; Omura, Satoshi; Cao, Huyen; Mooney, Jason P.; Hanson, Carl V.; Tanaka, Haruo			HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; N-LINKED GLYCOSYLATION; CYANOVIRIN-N; ENVELOPE GLYCOPROTEIN; SYNCYTIUM FORMATION; ANTIBODY 2G12; INFECTION; GP120; MICROBICIDES; TRANSMISSION	The development of a topical microbicide blocking the sexual transmission of HIV-1 is urgently needed to control the global HIV/AIDS pandemic. The actinomycete-derived lectin actinohivin (AH) is highly specific to a cluster of high-mannose-type glycans uniquely found on the viral envelope (Env). Here, we evaluated AH's candidacy toward a microbicide in terms of in vitro anti-HIV-1 activity, potential side effects, and recombinant producibility. Two validated assay systems based on human peripheral blood mononuclear cell (hPBMC) infection with primary isolates and TZM-bl cell infection with Env-pseudotyped viruses were employed to characterize AH's anti-HIV-1 activity. In hPMBCs, AH exhibited nanomolar neutralizing activity against primary viruses with diverse cellular tropisms, but did not cause mitogenicity or cytotoxicity that are often associated with other anti-HIV lectins. In the TZM-bl-based assay, AH showed broad anti-HIV-1 activity against clinically-relevant, mucosally transmitting strains of clades B and C. By contrast, clade A viruses showed strong resistance to AH. Correlation analysis suggested that HIV-19s AH susceptibility is significantly linked to the N-glycans at the Env C2 and V4 regions. For recombinant (r)AH expression, we evaluated a tobacco mosaic virus-based system in Nicotiana benthamiana plants as a means to facilitate molecular engineering and cost-effective mass production. Biochemical analysis and an Env-mediated syncytium formation assay demonstrated high-level expression of functional rAH within six days. Taken together, our study revealed AH's cross-clade anti-HIV-1 activity, apparent lack of side effects common to lectins, and robust producibility using plant biotechnology. These findings justify further efforts to develop rAH toward a candidate HIV-1 microbicide.	[Matoba, Nobuyuki; Husk, Adam S.; Barnett, Brian W.] Owensboro Canc Res Program, Owensboro, KY USA; [Matoba, Nobuyuki] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Matoba, Nobuyuki] Univ Louisville, Sch Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Pickel, Michelle M.; Arntzen, Charles J.] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ USA; [Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Takahashi, Atsushi] Iwaki Meisei Univ, Fac Pharm, Fukushima, Japan; [Takahashi, Atsushi; Tanaka, Haruo] Iwaki Meisei Univ, Coll Sci & Engn, Fukushima, Japan; [Tanno, Kazunobu; Tanaka, Haruo] KIIM Pharmaceut Labs Inc, Fukushima, Japan; [Omura, Satoshi] Kitasato Univ, Kitasato Inst Lifesci, Tokyo, Japan; [Cao, Huyen; Mooney, Jason P.; Hanson, Carl V.] Calif Dept Publ Hlth, Richmond, CA USA	University of Louisville; University of Louisville; Arizona State University; Arizona State University-Tempe; Duke University; Iwaki Meisei University; Iwaki Meisei University; Kitasato University; California Department of Public Health	Matoba, N (corresponding author), Owensboro Canc Res Program, Owensboro, KY USA.	n.matoba@louisville.edu	Mooney, Jason Paul/K-1129-2019	Mooney, Jason Paul/0000-0002-2824-124X; Matoba, Nobuyuki/0000-0001-7231-3004	Owensboro Cancer Research Program startup funds; Telemedicine and Advanced Technology Research Center (TATRC) [W81XWH-09-2-0022]; University of Louisville School of Medicine; National Institutes of Health [AI30034]	Owensboro Cancer Research Program startup funds; Telemedicine and Advanced Technology Research Center (TATRC); University of Louisville School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported in part by Owensboro Cancer Research Program startup funds (as part of a contract that was awarded and administered by the United States Army Medical Research and Materiel Command (USAMRMC) and the Telemedicine and Advanced Technology Research Center (TATRC), under contract number: W81XWH-09-2-0022 and a grant from the University of Louisville School of Medicine (to NM), and a National Institutes of Health Grant AI30034 (to DCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alouf JE, 2003, INT J MED MICROBIOL, V292, P429, DOI 10.1078/1438-4221-00232; Bachrach E, 2005, VIROLOGY, V332, P418, DOI 10.1016/j.virol.2004.11.031; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Balzarini J, 2006, J VIROL, V80, P8411, DOI 10.1128/JVI.00369-06; Botos I, 2002, J BIOL CHEM, V277, P34336, DOI 10.1074/jbc.M205909200; Buffa V, 2009, J GEN VIROL, V90, P234, DOI 10.1099/vir.0.004358-0; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Chiba H, 2004, BIOCHEM BIOPH RES CO, V316, P203, DOI 10.1016/j.bbrc.2004.02.036; Chiba H, 2001, BIOCHEM BIOPH RES CO, V282, P595, DOI 10.1006/bbrc.2001.4495; Chiba H, 2001, J ANTIBIOT, V54, P818, DOI 10.7164/antibiotics.54.818; Cutalo JM, 2004, J AM SOC MASS SPECTR, V15, P1545, DOI 10.1016/j.jasms.2004.07.008; DSOUZA MP, 1995, AIDS, V9, P867, DOI 10.1097/00002030-199508000-00006; Elrefaei M, 2004, J IMMUNOL, V173, P2184, DOI 10.4049/jimmunol.173.3.2184; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Garg Anita B, 2009, Antivir Chem Chemother, V19, P143; Gavrovic-Jankulovic M, 2008, INT J BIOCHEM CELL B, V40, P929, DOI 10.1016/j.biocel.2007.10.033; Grant RM, 2008, SCIENCE, V321, P532, DOI 10.1126/science.1160355; Huskens D, 2008, INT J BIOCHEM CELL B, V40, P2802, DOI 10.1016/j.biocel.2008.05.023; Inokoshi J, 2001, BIOCHEM BIOPH RES CO, V281, P1261, DOI 10.1006/bbrc.2001.4496; *JOINT UN PROGR HI, 2009, AIDS EP UPD; Keller MJ, 2009, SEX TRANSM DIS, V36, pS92, DOI 10.1097/OLQ.0b013e318199417d; Lederman MM, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-116; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Liedtke S, 1997, GLYCOCONJUGATE J, V14, P785, DOI 10.1023/A:1018577619036; Lin G, 2003, J VIROL, V77, P1337, DOI 10.1128/JVI.77.2.1337-1346.2003; Ma JKC, 2005, TRENDS PLANT SCI, V10, P580, DOI 10.1016/j.tplants.2005.10.009; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; Marillonnet S, 2004, P NATL ACAD SCI USA, V101, P6852, DOI 10.1073/pnas.0400149101; Mascola JR, 1996, AIDS RES HUM RETROV, V12, P1319, DOI 10.1089/aid.1996.12.1319; MATOBA N, METHODS MOL IN PRESS; Matoba N, 2009, PLANT BIOTECHNOL J, V7, P129, DOI 10.1111/j.1467-7652.2008.00381.x; McGowan I, 2010, CURR OPIN INFECT DIS, V23, P26, DOI 10.1097/QCO.0b013e328334fe70; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Morris GC, 2010, CURR OPIN INFECT DIS, V23, P57, DOI 10.1097/QCO.0b013e328334de6d; OKEEFE BR, 2009, P NATL ACAD SCI US; Paranjpe S, 2002, AIDS RES HUM RETROV, V18, P1271, DOI 10.1089/088922202320886316; Peters PJ, 2006, J VIROL, V80, P6324, DOI 10.1128/JVI.02328-05; Polonis VR, 2008, VIROLOGY, V375, P315, DOI 10.1016/j.virol.2008.02.007; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Scanlan CN, 2007, NATURE, V446, P1038, DOI 10.1038/nature05818; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122; Shenoy SR, 2002, CHEM BIOL, V9, P1109, DOI 10.1016/S1074-5521(02)00237-5; SWANSON MD, 2010, J BIOL CHEM; Takahashi A, 2005, ARCH BIOCHEM BIOPHYS, V437, P233, DOI 10.1016/j.abb.2005.03.017; Tanaka H, 2009, P NATL ACAD SCI USA, V106, P15633, DOI 10.1073/pnas.0907572106; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Tsai CC, 2003, AIDS RES HUM RETROV, V19, P535, DOI 10.1089/088922203322230897; Tsai CC, 2004, AIDS RES HUM RETROV, V20, P11, DOI 10.1089/088922204322749459; Wang CY, 1999, P NATL ACAD SCI USA, V96, P10367, DOI 10.1073/pnas.96.18.10367; Willey RL, 1996, J VIROL, V70, P6431, DOI 10.1128/JVI.70.9.6431-6436.1996; Yuste E, 2004, J VIROL, V78, P6775, DOI 10.1128/JVI.78.13.6775-6785.2004; Zeitlin L, 2009, P NATL ACAD SCI USA, V106, P6029, DOI 10.1073/pnas.0902239106; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m	58	34	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11143	10.1371/journal.pone.0011143	http://dx.doi.org/10.1371/journal.pone.0011143			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559567	Green Published, gold, Green Submitted			2022-12-27	WOS:000278775900027
J	Jin, G; Kawsar, HI; Hirsch, SA; Zeng, C; Jia, X; Feng, ZM; Ghosh, SK; Zheng, QY; Zhou, AM; McIntyre, TM; Weinberg, A				Jin, Ge; Kawsar, Hameem I.; Hirsch, Stanley A.; Zeng, Chun; Jia, Xun; Feng, Zhimin; Ghosh, Santosh K.; Zheng, Qing Yin; Zhou, Aimin; McIntyre, Thomas M.; Weinberg, Aaron			An Antimicrobial Peptide Regulates Tumor-Associated Macrophage Trafficking via the Chemokine Receptor CCR2, a Model for Tumorigenesis	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; MESSENGER-RNA QUANTIFICATION; ENDOTHELIAL GROWTH-FACTOR; SQUAMOUS-CELL CARCINOMA; HUMAN BETA-DEFENSIN-3; GENE-EXPRESSION; MAST-CELLS; MAMMARY-TUMORS; BETA-DEFENSINS; IMMUNE-SYSTEM	Background: Tumor-associated macrophages (TAMs) constitute a significant part of infiltrating inflammatory cells that are frequently correlated with progression and poor prognosis of a variety of cancers. Tumor cell-produced human beta-defensin-3 (hBD-3) has been associated with TAM trafficking in oral cancer; however, its involvement in tumor-related inflammatory processes remains largely unknown. Methodology: The relationship between hBD-3, monocyte chemoattractant protein-1 (MCP-1), TAMs, and CCR2 was examined using immunofluorescence microscopy in normal and oral carcinoma in situ biopsy specimens. The ability of hBD-3 to chemoattract host macrophages in vivo using a nude mouse model and analysis of hBD-3 on monocytic cell migration in vitro, applying a cross-desensitization strategy of CCR2 and its pharmacological inhibitor (RS102895), respectively, was also carried out. Conclusions/Findings: MCP-1, the most frequently expressed tumor cell-associated chemokine, was not produced by tumor cells nor correlated with the recruitment of macrophages in oral carcinoma in situ lesions. However, hBD-3 was associated with macrophage recruitment in these lesions and hBD-3-expressing tumorigenic cells induced massive tumor infiltration of host macrophages in nude mice. HBD-3 stimulated the expression of tumor-promoting cytokines, including interleukin-1 alpha (IL-1 alpha), IL-6, IL-8, CCL18, and tumor necrosis factor-alpha (TNF-alpha) in macrophages derived from human peripheral blood monocytes. Monocytic cell migration in response to hBD-3 was inhibited by cross-desensitization with MCP-1 and the specific CCR2 inhibitor, RS102895, suggesting that CCR2 mediates monocyte/macrophage migration in response to hBD-3. Collectively, these results indicate that hBD-3 utilizes CCR2 to regulate monocyte/macrophage trafficking and may act as a tumor cell-produced chemoattractant to recruit TAMs. This novel mechanism is the first evidence of an hBD molecule orchestrating an in vivo outcome and demonstrates the importance of the innate immune system in the development of tumors.	[Jin, Ge; Kawsar, Hameem I.; Jia, Xun; Feng, Zhimin; Ghosh, Santosh K.; Weinberg, Aaron] Case Western Reserve Univ, Sch Dent Med, Dept Biol Sci, Cleveland, OH 44106 USA; [Hirsch, Stanley A.] Case Western Reserve Univ, Sch Dent Med, Dept Oral Pathol, Cleveland, OH 44106 USA; [Zeng, Chun; Zhou, Aimin] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Zheng, Qing Yin] Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Dept Otolaryngol Head & Neck Surg, Cleveland, OH 44106 USA; [Jin, Ge; Zheng, Qing Yin] Case Comprehens Canc Ctr, Cleveland, OH USA; [McIntyre, Thomas M.] Case Western Reserve Univ, Cleveland Clin Coll Med, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; University System of Ohio; Cleveland State University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation	Jin, G (corresponding author), Case Western Reserve Univ, Sch Dent Med, Dept Biol Sci, Cleveland, OH 44106 USA.	ge.jin@case.edu	Zheng, Qing/C-1731-2012; Ghosh, Santosh K/I-5461-2019	Ghosh, Santosh K/0000-0001-5669-7853; Weinberg, Aaron/0000-0002-9960-7181	American Heart Association [0535088N]; American Cancer Society [IRG-91-022-15]; NIH/NIDCR [P01DE019089, P01DE019759]; National Institutes of Health [NIH/R01DC007392, NIH/NIDCD R01DC009246]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P01DE019759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE019089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009246, R01DC007392] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a Scientist Development Grant # 0535088N from the American Heart Association (http:www.americanheart.org) (GJ) and Grant # IRG-91-022-15 from the American Cancer Society (wwww.cancer.org) (GJ), NIH/NIDCR P01DE019089 and P01DE019759 (AW), and NIH/R01DC007392 and NIH/NIDCD R01DC009246 (QZ) from the National Institutes of Health (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Aragay AM, 1998, P NATL ACAD SCI USA, V95, P2985, DOI 10.1073/pnas.95.6.2985; Behbahani H, 2007, JAIDS-J ACQ IMM DEF, V45, P9, DOI 10.1097/QAI.0b013e3180415da7; Ben-Baruch A, 2006, CANCER METAST REV, V25, P357, DOI 10.1007/s10555-006-9003-5; BENSCH KW, 1995, FEBS LETT, V368, P331, DOI 10.1016/0014-5793(95)00687-5; BOTTAZZI B, 1990, J IMMUNOL, V144, P2409; Buettner M, 2007, INT J CANCER, V121, P2703, DOI 10.1002/ijc.23018; Burnett GT, 2008, ANTICANCER RES, V28, P2093; BYRNE PV, 1981, J CELL BIOL, V91, P848, DOI 10.1083/jcb.91.3.848; Cantor JP, 2007, INT J CANCER, V120, P24, DOI 10.1002/ijc.22073; Carmi Y, 2009, J IMMUNOL, V183, P4705, DOI 10.4049/jimmunol.0901511; Chao C, 2007, ONCOGENE, V26, P1013, DOI 10.1038/sj.onc.1209862; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Dougherty ST, 1997, CANCER IMMUNOL IMMUN, V44, P165, DOI 10.1007/s002620050369; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Erreni M, 2009, METHOD ENZYMOL, V460, P105, DOI 10.1016/S0076-6879(09)05205-7; Feng Z, 2006, J IMMUNOL, V177, P782, DOI 10.4049/jimmunol.177.2.782; Ferrara G, 2008, SCAND J IMMUNOL, V68, P668, DOI 10.1111/j.1365-3083.2008.02182.x; FU YX, 1990, CANCER RES, V50, P227; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; Fujimoto J, 2000, CANCER RES, V60, P2632; Funderburg N, 2007, P NATL ACAD SCI USA, V104, P18631, DOI 10.1073/PNAS.0702130104; Ghosh SK, 2007, CLIN CHEM, V53, P757, DOI 10.1373/clinchem.2006.081430; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hacker G, 2002, IMMUNOLOGY, V105, P245; Hanada T, 2000, INT J UROL, V7, P263, DOI 10.1046/j.1442-2042.2000.00190.x; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; HIMES RH, 1976, P NATL ACAD SCI USA, V73, P4397, DOI 10.1073/pnas.73.12.4397; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Imada A, 2000, EUR RESPIR J, V15, P1087, DOI 10.1034/j.1399-3003.2000.01517.x; Jimenez-Sainz MC, 2003, MOL PHARMACOL, V64, P773, DOI 10.1124/mol.64.3.773; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kawsar HI, 2010, PEPTIDES, V31, P195, DOI 10.1016/j.peptides.2009.12.008; Kawsar HI, 2009, ORAL ONCOL, V45, P696, DOI 10.1016/j.oraloncology.2008.10.016; Kessler O, 2004, CANCER RES, V64, P1008, DOI 10.1158/0008-5472.CAN-03-3090; Kesting MR, 2009, CANCER INVEST, V27, P575, DOI 10.1080/07357900802620851; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Koga T, 2008, J BIOL CHEM, V283, P12546, DOI 10.1074/jbc.M710518200; Kryczek I, 2006, J EXP MED, V203, P871, DOI 10.1084/jem.20050930; Kurago ZB, 2008, HEAD NECK PATHOL, V2, P1, DOI 10.1007/s12105-007-0038-x; Leek RD, 1996, CANCER RES, V56, P4625; LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1; Lentzsch S, 2003, BLOOD, V101, P3568, DOI 10.1182/blood-2002-08-2383; Lewis JS, 2000, J PATHOL, V192, P150, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH687>3.0.CO;2-G; Li CN, 2002, ONCOL REP, V9, P1219; Li JZ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-241; Lin EY, 2007, CANCER RES, V67, P5064, DOI 10.1158/0008-5472.CAN-07-0912; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Liu SY, 2008, ORAL ONCOL, V44, P277, DOI 10.1016/j.oraloncology.2007.02.007; Malik MT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-61; Mantovani A, 2004, SEMIN CANCER BIOL, V14, P155, DOI 10.1016/j.semcancer.2003.10.001; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Marcus B, 2004, CANCER-AM CANCER SOC, V101, P2779, DOI 10.1002/cncr.20701; Markiewski MM, 2009, CANCER RES, V69, P6367, DOI 10.1158/0008-5472.CAN-09-1918; Markiewski MM, 2009, TRENDS IMMUNOL, V30, P286, DOI 10.1016/j.it.2009.04.002; Mellado M, 1998, J IMMUNOL, V161, P805; Mirzadegan T, 2000, J BIOL CHEM, V275, P25562, DOI 10.1074/jbc.M000692200; Mrowietz U, 1999, BRIT J CANCER, V79, P1025, DOI 10.1038/sj.bjc.6690164; Niwa Y, 2001, CLIN CANCER RES, V7, P285; Overbergh L, 2005, CYTOKINE, V31, P454, DOI 10.1016/j.cyto.2005.07.002; Papageorgiou A, 2004, CANCER RES, V64, P8973, DOI 10.1158/0008-5472.CAN-04-1909; Payne AS, 2002, J INVEST DERMATOL, V118, P915, DOI 10.1046/j.1523-1747.2002.01725.x; Peinnequin Andre, 2004, BMC Immunology, V5, P1, DOI 10.1186/1471-2172-5-3; Peller S, 2009, BLOOD CELL MOL DIS, V43, P74, DOI 10.1016/j.bcmd.2009.01.020; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Ribatti D, 2003, EUR J CLIN INVEST, V33, P420, DOI 10.1046/j.1365-2362.2003.01152.x; Salvesen HB, 1999, INT J CANCER, V84, P539; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Satoh J, 2004, CELL MOL NEUROBIOL, V24, P793, DOI 10.1007/s10571-004-6920-0; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Sciubba J J, 2001, Am J Clin Dermatol, V2, P239, DOI 10.2165/00128071-200102040-00005; Shabo I, 2008, INT J CANCER, V123, P780, DOI 10.1002/ijc.23527; SHAFER WG, 1975, ORAL SURG ORAL MED O, V39, P227, DOI 10.1016/0030-4220(75)90224-8; Shashkin PN, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-13; Shen C, 2008, BIOLOGICALS, V36, P263, DOI 10.1016/j.biologicals.2008.02.002; SICA A, 2008, CANC LETT; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; Soruri A, 2007, EUR J IMMUNOL, V37, P2474, DOI 10.1002/eji.200737292; Steube KG, 1997, LEUKEMIA RES, V21, P327, DOI 10.1016/S0145-2126(96)00129-4; Taylor K, 2008, J BIOL CHEM, V283, P6631, DOI 10.1074/jbc.M709238200; Tjiu JW, 2009, J INVEST DERMATOL, V129, P1016, DOI 10.1038/jid.2008.310; Voronov E, 2007, ADV EXP MED BIOL, V601, P265; Wendt MK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2360; Wu Y, 2008, J IMMUNOL, V181, P6384, DOI 10.4049/jimmunol.181.9.6384; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2007, CURR PHARM DESIGN, V13, P3131, DOI 10.2174/138161207782110453; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zheng XH, 2003, TOXICOLOGY, V187, P39, DOI 10.1016/S0300-483X(03)00025-8; Zhou YH, 1999, J LEUKOCYTE BIOL, V65, P265, DOI 10.1002/jlb.65.2.265; Zucchetto A, 2009, CANCER RES, V69, P4001, DOI 10.1158/0008-5472.CAN-08-4173	101	111	120	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e10993	10.1371/journal.pone.0010993	http://dx.doi.org/10.1371/journal.pone.0010993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544025	Green Submitted, gold, Green Published			2022-12-27	WOS:000278494900010
J	Stander, S; Siepmann, D; Herrgott, I; Sunderkotter, C; Luger, TA				Staender, Sonja; Siepmann, Dorothee; Herrgott, Ilka; Sunderkoetter, Cord; Luger, Thomas A.			Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic Strategy	PLOS ONE			English	Article							SUBSTANCE-P INDUCTION; QUALITY-OF-LIFE; ATOPIC-DERMATITIS; TACHYKININ RECEPTORS; DOUBLE-BLIND; ITCH; NEUROPEPTIDES; SKIN; HISTAMINE; PRURITUS	Background: Chronic pruritus is a global clinical problem with a high impact on the quality of life and lack of specific therapies. It is an excruciating and frequent symptom of e. g. uncurable renal, liver and skin diseases which often does not respond to conventional treatment with e. g. antihistamines. Therefore antipruritic therapies which target physiological mechanisms of pruritus need to be developed. Substance P (SP) is a major mediator of pruritus. As it binds to the neurokinin receptor 1 (NKR1), we evaluated if the application of a NKR1 antagonist would significantly decrease chronic pruritus. Methods and Findings: Twenty hitherto untreatable patients with chronic pruritus (12 female, 8 male; mean age, 66.7 years) were treated with the NKR1 antagonist aprepitant 80 mg for one week. 16 of 20 patients (80%) experienced a considerable reduction of itch intensity, as assessed by the visual analog scale (VAS, range 0 to 10). Considering all patients, the mean value of pruritus intensity was significantly reduced from 8.4 VAS points (SD +/- 1.7) before treatment to 4.9 VAS points (SD +/- 3.2) (p < 0.001, CI 1.913-5.187). Patients with dermatological diseases (e. g. atopic diathesis, prurigo nodularis) had the best profit from the treatment. Side-effects were mild (nausea, vertigo, and drowsiness) and only occurred in three patients. Conclusions: The high response rate in patients with therapy refractory pruritus suggests that the NKR1 antagonist aprepitant may indeed exhibit antipruritic effects and may present a novel, effective treatment strategy based on pathophysiology of chronic pruritus. The results are promising enough to warrant confirming the efficacy of NKR1 antagonists in a randomized, controlled clinical trial.	[Staender, Sonja; Siepmann, Dorothee; Herrgott, Ilka; Sunderkoetter, Cord; Luger, Thomas A.] Univ Munster, Dept Dermatol, Neurodermatol & Competence Ctr Pruritus, D-4400 Munster, Germany	University of Munster	Stander, S (corresponding author), Univ Munster, Dept Dermatol, Neurodermatol & Competence Ctr Pruritus, Von Esmarch Str 56, D-4400 Munster, Germany.	sonja.staender@uni-muenster.de		Stander, Sonja/0000-0003-3612-7786; Sunderkotter, Cord/0000-0002-2929-145X				Almeida TA, 2004, CURR MED CHEM, V11, P2045, DOI 10.2174/0929867043364748; Andoh T, 1998, J PHARMACOL EXP THER, V286, P1140; Chizh BA, 2007, BRIT J ANAESTH, V98, P246, DOI 10.1093/bja/ael344; Dalgard F, 2007, J EUR ACAD DERMATOL, V21, P1215, DOI 10.1111/j.1468-3083.2007.02234.x; Dando TM, 2004, DRUGS, V64, P777, DOI 10.2165/00003495-200464070-00013; DeVane CL, 2001, PHARMACOTHERAPY, V21, P1061, DOI 10.1592/phco.21.13.1061.34612; Duval A, 2009, NEW ENGL J MED, V361, P1415, DOI 10.1056/NEJMc0906670; Furutani K, 1999, ARCH DERMATOL RES, V291, P466, DOI 10.1007/s004030050439; Hesketh PJ, 2003, J CLIN ONCOL, V21, P4112, DOI 10.1200/JCO.2003.01.095; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Jarvikallio A, 2003, ARCH DERMATOL RES, V295, P2, DOI 10.1007/s00403-002-0378-z; Katsuno M, 2003, J DERMATOL SCI, V33, P55, DOI 10.1016/S0923-1811(03)00155-5; Keller M, 2006, BIOL PSYCHIAT, V59, P216, DOI 10.1016/j.biopsych.2005.07.013; Kulka M, 2008, IMMUNOLOGY, V123, P398, DOI 10.1111/j.1365-2567.2007.02705.x; Kumagai H, 2010, NEPHROL DIAL TRANSPL, V25, P1251, DOI 10.1093/ndt/gfp588; Lofgren O, 1999, BURNS, V25, P125, DOI 10.1016/S0305-4179(98)00125-9; Matterne U, 2009, ACTA DERM-VENEREOL, V89, P250, DOI 10.2340/00015555-0641; Mogil JS, 2005, P NATL ACAD SCI USA, V102, P12938, DOI 10.1073/pnas.0503264102; MOLINA FA, 1992, BRIT J DERMATOL, V127, P344, DOI 10.1111/j.1365-2133.1992.tb00452.x; Palframan RT, 1996, BRIT J PHARMACOL, V118, P295, DOI 10.1111/j.1476-5381.1996.tb15402.x; PIERCEY MF, 1981, BRAIN RES, V210, P407, DOI 10.1016/0006-8993(81)90918-5; Pogatzki-Zahn E, 2008, DRUG NEWS PERSPECT, V21, P541, DOI 10.1358/dnp.2008.21.10.1314057; Salomon J, 2008, J EUR ACAD DERMATOL, V22, P223, DOI 10.1111/j.1468-3083.2007.02399.x; Schneider G, 2008, EUR J PAIN, V12, P834, DOI 10.1016/j.ejpain.2007.12.003; Song IS, 2000, EXP DERMATOL, V9, P42, DOI 10.1034/j.1600-0625.2000.009001042.x; Stander S, 2008, EXP DERMATOL, V17, P161, DOI 10.1111/j.1600-0625.2007.00664.x; Stander S, 2007, ACTA DERM-VENEREOL, V87, P291, DOI 10.2340/00015555-0305; Tessari G, 2009, J NEPHROL, V22, P241; Thomsen JS, 2002, BRIT J DERMATOL, V146, P792, DOI 10.1046/j.1365-2133.2002.04722.x; Weisshaar E, 2008, ACTA DERM-VENEREOL, V88, P234, DOI 10.2340/00015555-0432; Weisshaar E, 2009, ACTA DERM-VENEREOL, V89, P339, DOI 10.2340/00015555-0662	31	198	211	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10968	10.1371/journal.pone.0010968	http://dx.doi.org/10.1371/journal.pone.0010968			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532044	Green Published, gold, Green Submitted			2022-12-27	WOS:000278380500013
J	Caesar, S; Karlsson, M; Forsman, A				Caesar, Sofia; Karlsson, Magnus; Forsman, Anders			Diversity and Relatedness Enhance Survival in Colour Polymorphic Grasshoppers	PLOS ONE			English	Article							PYGMY GRASSHOPPERS; GENETIC DIVERSITY; SOCIAL HETEROSIS; FITNESS BENEFITS; KIN RECOGNITION; EVOLUTION; SELECTION; POLYANDRY; PATTERN; CONSEQUENCES	Evolutionary theory predicts that different resource utilization and behaviour by alternative phenotypes may reduce competition and enhance productivity and individual performance in polymorphic, as compared with monomorphic, groups of individuals. However, firm evidence that members of more heterogeneous groups benefit from enhanced survival has been scarce or lacking. Furthermore, benefits associated with phenotypic diversity may be counterbalanced by costs mediated by reduced relatedness, since closely related individuals typically are more similar. Pygmy grasshoppers (Tetrix subulata) are characterized by extensive polymorphism in colour pattern, morphology, behaviour and physiology. We studied experimental groups founded by different numbers of mothers and found that survival was higher in low than in high density, that survival peaked at intermediate colour morph diversity in high density, and that survival was independent of diversity in low density where competition was less intense. We further demonstrate that survival was enhanced by relatedness, as expected if antagonistic and competitive interactions are discriminately directed towards non-siblings. We therefore also performed behavioural observations and staged encounters which confirmed that individuals recognized and responded differently to siblings than to non-siblings. We conclude that negative effects associated with competition are less manifest in diverse groups, that there is conflicting selection for and against genetic diversity occurring simultaneously, and that diversity and relatedness may facilitate the productivity and ecological success of groups of interacting individuals.	[Caesar, Sofia; Karlsson, Magnus; Forsman, Anders] Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden	Linnaeus University	Caesar, S (corresponding author), Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden.	Anders.Forsman@lnu.se	Forsman, Anders/G-8778-2012	Forsman, Anders/0000-0001-9598-7618	Swedish Research Council [621-2007-5337, 217-2007-364]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding: The Swedish Research Council - Grant number 621-2007-5337 http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html. The Swedish Research Council Formas - Grant number 217-2007-364 http://www.formas.se. University of Kalmar; http://www.hik.se.LinnaeusUniversity; http://lnu.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnesjo J, 2006, EVOL ECOL, V20, P235, DOI 10.1007/s10682-006-6178-8; Ahnesjo J, 2003, J EVOLUTION BIOL, V16, P1308, DOI 10.1046/j.1420-9101.2003.00610.x; [Anonymous], 2006, SAS MIXED MODELS; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; BELL G, 1991, EVOLUTION, V45, P1036, DOI 10.1111/j.1558-5646.1991.tb04368.x; Bolnick DI, 2004, EVOLUTION, V58, P608, DOI 10.1111/j.0014-3820.2004.tb01683.x; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Caesar S, 2009, BEHAV ECOL, V20, P354, DOI 10.1093/beheco/arn153; Collett D., 1991, MODELLING BINARY DAT; Collett M, 1998, P NATL ACAD SCI USA, V95, P13052, DOI 10.1073/pnas.95.22.13052; DOBLER R, 2009, BEHAV ECOLOGY; Endler J.A., 1977, Monographs in Population Biology, pi; Ford E.B., 1965, GENETIC POLYMORPHISM; Forsman A, 1999, J EVOLUTION BIOL, V12, P391; Forsman A, 2002, EVOLUTION, V56, P349, DOI 10.1111/j.0014-3820.2002.tb01345.x; Forsman A, 2001, OECOLOGIA, V129, P357, DOI 10.1007/s004420100743; Forsman A, 2008, ECOLOGY, V89, P1201, DOI 10.1890/07-1670.1; Forsman A, 2008, ECOLOGY, V89, P34, DOI 10.1890/07-0572.1; Forsman A, 2007, EVOL ECOL RES, V9, P1305; Forsman A, 2009, CONSERV BIOL, V23, P1535, DOI 10.1111/j.1523-1739.2009.01244.x; Griffiths SW, 2001, P ROY SOC B-BIOL SCI, V268, P1293, DOI 10.1098/rspb.2001.1660; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Karlsson M, 2008, OECOLOGIA, V154, P715, DOI 10.1007/s00442-007-0876-y; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Nabours R. K., 1929, Bibliographia Genetica 's-Gravenhage, V5, P27; Nonacs P, 2008, J EVOLUTION BIOL, V21, P631, DOI 10.1111/j.1420-9101.2007.01489.x; Nonacs P, 2007, J EVOLUTION BIOL, V20, P2253, DOI 10.1111/j.1420-9101.2007.01418.x; Pfennig DW, 1999, BEHAV ECOL, V10, P436, DOI 10.1093/beheco/10.4.436; PFENNIG DW, 1990, EVOLUTION, V44, P785, DOI 10.1111/j.1558-5646.1990.tb03805.x; Protas ME, 2008, ANNU REV CELL DEV BI, V24, P425, DOI 10.1146/annurev.cellbio.24.110707.175302; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; Rueffler C, 2006, TRENDS ECOL EVOL, V21, P238, DOI 10.1016/j.tree.2006.03.003; Santos M, 2008, J EVOLUTION BIOL, V21, P625, DOI 10.1111/j.1420-9101.2007.01484.x; Santos M, 1997, HEREDITY, V78, P302, DOI 10.1038/hdy.1997.45; SAS Institute, 2004, SAS 9 1 3 HELP DOC; Sherman PW, 1997, BEHAV ECOLOGY EVOLUT; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Sinervo B, 2002, HEREDITY, V89, P329, DOI 10.1038/sj.hdy.6800148; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; van Valen L., 1965, AM NAT, V99, P377, DOI DOI 10.1086/282379; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; Zeh JA, 2003, ETHOLOGY, V109, P929, DOI 10.1046/j.1439-0310.2003.00945.x	44	41	42	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10880	10.1371/journal.pone.0010880	http://dx.doi.org/10.1371/journal.pone.0010880			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526364	gold, Green Submitted, Green Published			2022-12-27	WOS:000278222100010
J	Farias, MEM; LaPointe, DA; Atkinson, CT; Czerwonka, C; Shrestha, R; Jarvi, SI				Farias, Margaret E. M.; LaPointe, Dennis A.; Atkinson, Carter T.; Czerwonka, Christopher; Shrestha, Rajesh; Jarvi, Susan I.			Taqman Real-Time PCR Detects Avipoxvirus DNA in Blood of Hawai'i 'Amakihi (Hemignathus virens)	PLOS ONE			English	Article							POX-LIKE LESIONS; RETICULOENDOTHELIOSIS VIRUS; VACCINIA-VIRUS; FOWL POXVIRUS; AVIAN POX; DIAGNOSIS; ASSAY; DIFFERENTIATION; EPIZOOTIOLOGY; INFECTIONS	Background: Avipoxvirus sp. is a significant threat to endemic bird populations on several groups of islands worldwide, including Hawai'i, the Galapagos Islands, and the Canary Islands. Accurate identification and genotyping of Avipoxvirus is critical to the study of this disease and how it interacts with other pathogens, but currently available methods rely on invasive sampling of pox-like lesions and may be especially harmful in smaller birds. Methodology/Principal Findings: Here, we present a nested TaqMan Real-Time PCR for the detection of the Avipoxvirus 4b core protein gene in archived blood samples from Hawaiian birds. The method was successful in amplifying Avipoxvirus DNA from packed blood cells of one of seven Hawaiian honeycreepers with confirmed Avipoxvirus infections and 13 of 28 Hawai'i 'amakihi (Hemignathus virens) with suspected Avipoxvirus infections based on the presence of pox-like lesions. Mixed genotype infections have not previously been documented in Hawai'i but were observed in two individuals in this study. Conclusions/Significance: We anticipate that this method will be applicable to other closely related strains of Avipoxvirus and will become an important and useful tool in global studies of the epidemiology of Avipoxvirus.	[Farias, Margaret E. M.; Czerwonka, Christopher; Shrestha, Rajesh; Jarvi, Susan I.] Univ Hawaii, Coll Pharm, Dept Pharmaceut Sci, Hilo, HI 96720 USA	University of Hawaii System; University Hawaii Hilo	Farias, MEM (corresponding author), Univ Hawaii, Coll Pharm, Dept Pharmaceut Sci, Hilo, HI 96720 USA.	jarvi@hawaii.edu			U.S. Geological Survey; Pacific Island Ecosystems Research Center; U.S. Geological Survey Wildlife; Invasive Species; National Science Foundation [DEB0083944]; NIH/NCRR IDeA Networks of Biomedical Research Excellence (INBRE) [P20RR016467]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016467] Funding Source: NIH RePORTER	U.S. Geological Survey(United States Geological Survey); Pacific Island Ecosystems Research Center; U.S. Geological Survey Wildlife; Invasive Species; National Science Foundation(National Science Foundation (NSF)); NIH/NCRR IDeA Networks of Biomedical Research Excellence (INBRE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for this study was provided by: U.S. Geological Survey, Pacific Island Ecosystems Research Center (biology.usgs.gov/pierc/); U.S. Geological Survey Wildlife (biology.usgs.gov/wter/) and Invasive Species (biology.usgs.gov/invasive/) Programs; National Science Foundation (DEB0083944, www.nsf.gov); NIH/NCRR IDeA Networks of Biomedical Research Excellence (INBRE), P20RR016467 (http://www.ncrr.nih.gov/research_infrastructure/institutional_development_award/idea_networks_of_biomedical_research_excellence/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson CT, 2005, CONDOR, V107, P537, DOI 10.1650/0010-5422(2005)107[0537:POPLAM]2.0.CO;2; Balinsky CA, 2007, J VIROL, V81, P11392, DOI 10.1128/JVI.01093-07; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; Cohen JI, 2007, VACCINE, V25, P4571, DOI 10.1016/j.vaccine.2007.03.044; Gonzalez A, 2008, INT MICROBIOL, V11, P203, DOI 10.2436/20.1501.01.61; Hauck R, 2009, AVIAN DIS, V53, P205, DOI 10.1637/8451-081908-Reg.1; Jarvi SI, 2008, CONSERV GENET, V9, P339, DOI 10.1007/s10592-007-9346-7; Kleindorfer S, 2006, J AVIAN BIOL, V37, P69, DOI 10.1111/j.0908-8857.2006.03503.x; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Lee LH, 1997, J VIROL METHODS, V63, P113, DOI 10.1016/S0166-0934(96)02119-2; Marshall R, 2007, J CLIN MICROBIOL, V45, P747, DOI 10.1128/JCM.01956-06; MINBAY A, 1973, AVIAN DIS, V17, P532, DOI 10.2307/1589151; Saijo M, 2008, JPN J INFECT DIS, V61, P140; Savona MR, 2006, JAMA-J AM MED ASSOC, V295, P1898, DOI 10.1001/jama.295.16.1898; Scaramozzino N, 2007, CLIN CHEM, V53, P606, DOI 10.1373/clinchem.2006.068635; Smith SA, 2002, CRIT REV MICROBIOL, V28, P149, DOI 10.1080/1040-840291046722; Smits JE, 2005, VET PATHOL, V42, P59, DOI 10.1354/vp.42-1-59; Tadese T, 2008, VET MICROBIOL, V127, P39, DOI 10.1016/j.vetmic.2007.08.012; Thiel T, 2005, J WILDLIFE DIS, V41, P342, DOI 10.7589/0090-3558-41.2.342; Trindade GD, 2008, J VIROL METHODS, V152, P63, DOI 10.1016/j.jviromet.2008.05.028; Van Riper C, 2002, AUK, V119, P929, DOI 10.1642/0004-8038(2002)119[0929:EAEOAP]2.0.CO;2; van Riper Charles III, 2007, P131, DOI 10.1002/9780470344668.ch6; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; VARGAS H, 1987, J FIELD ORNITHOL, V58, P101; WARNER RE, 1968, CONDOR, V70, P101, DOI 10.2307/1365954; Watzinger F., 2006, Molecular Aspects of Medicine, V27, P254, DOI 10.1016/j.mam.2005.12.001; Woodworth BL, 2005, P NATL ACAD SCI USA, V102, P1531, DOI 10.1073/pnas.0409454102	27	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10745	10.1371/journal.pone.0010745	http://dx.doi.org/10.1371/journal.pone.0010745			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523726	Green Submitted, Green Published, gold			2022-12-27	WOS:000278221900005
J	Bousbia, S; Papazian, L; La Scola, B; Raoult, D				Bousbia, Sabri; Papazian, Laurent; La Scola, Bernard; Raoult, Didier			Detection of Plant DNA in the Bronchoalveolar Lavage of Patients with Ventilator-Associated Pneumonia	PLOS ONE			English	Article							PULMONARY ASPIRATION; CYSTIC-FIBROSIS; DIAGNOSIS; MORTALITY; POSITION	Background: Hospital-acquired infections such as nosocomial pneumonia are a serious cause of mortality for hospitalized patients, especially for those admitted to intensive care units (ICUs). Despite the number of the studies reported to date, the causative agents of pneumonia are not completely known. Herein, we found by molecular technique that vegetable and tobacco DNA may be detected in the bronchoalveolar lavage from patients with ventilator-associated pneumonia (VAP). Methodology/Principal Findings: In the present study, we studied bronchoalveolar lavage (BAL) from patients admitted to ICUs with ventilator-associated pneumonia. BAL fluids were assessed with molecular tests, culture and blood culture. We successfully identified plant DNA in six patients out of 106 (6%) with ventilator-associated pneumonia. Inhalation was confirmed in four cases and suspected in the other two cases. Inhalation was significantly frequent in patients with plant DNA (four out of six patients) than those without plant DNA (three out of 100 patients) (P < 0.001). Nicotiana tabacum chloroplast DNA was identified in three patients who were smokers (cases 2, 3 and 6). Cucurbita pepo, Morus bombycis and Triticum aestivum DNA were identified in cases 1, 4 and 5 respectively. Twenty-three different bacterial species, two viruses and five fungal species were identified from among these six patients by using molecular and culture techniques. Several of the pathogenic microorganisms identified are reported to be food-borne or tobacco plant-associated pathogens. Conclusions/Significance: Our study shows that plants DNA may be identified in the BAL fluid of pneumonia patients, especially when exploring aspiration pneumonia, but the significance of the presence of plant DNA and its role in the pathogenesis of pneumonia is unknown and remains to be investigated. However, the identification of these plants may be a potential marker of aspiration in patients with pneumonia.	[Bousbia, Sabri; La Scola, Bernard; Raoult, Didier] Fac Med Marseille, CNRS, IRD, UMR 6236 198,Unite Rech Malad Infect & Trop Emerg, F-13385 Marseille, France; [Papazian, Laurent] Hop Sud, Serv Reanimat Med, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Bousbia, S (corresponding author), Fac Med Marseille, CNRS, IRD, UMR 6236 198,Unite Rech Malad Infect & Trop Emerg, F-13385 Marseille, France.	didier.raoult@gmail.com	RAOULT, Didier/A-8434-2008; LA SCOLA, Bernard/P-6477-2016	RAOULT, Didier/0000-0002-0633-5974; LA SCOLA, Bernard/0000-0001-8006-7704	Programme Hospitalier de Recherche Clinique [2006]	Programme Hospitalier de Recherche Clinique	This work was supported by a grant from the Programme Hospitalier de Recherche Clinique 2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Armougom F, 2009, EUR J CLIN MICROBIOL, V28, P1151, DOI 10.1007/s10096-009-0749-x; Artinian V, 2006, CHEST, V129, P960, DOI 10.1378/chest.129.4.960; Bahrani-Mougeot FK, 2007, J CLIN MICROBIOL, V45, P1588, DOI 10.1128/JCM.01963-06; Berger P, 2006, EMERG INFECT DIS, V12, P248; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Bousbia S, 2010, EMERG INFECT DIS, V16, P258, DOI 10.3201/eid1602.090610; CROME L, 1962, J CLIN PATHOL, V15, P21, DOI 10.1136/jcp.15.1.21; Drakulovic MB, 1999, LANCET, V354, P1851, DOI 10.1016/S0140-6736(98)12251-1; Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Heyder Joachim, 2004, Proc Am Thorac Soc, V1, P315, DOI 10.1513/pats.200409-046TA; HICKLING KG, 1988, INTENS CARE MED, V14, P617; Khlif M, 2009, CLIN MICROBIOL INFEC, V15, P656, DOI 10.1111/j.1469-0691.2009.02762.x; La Scola B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008041; MANDELL LA, 2007, B J HOPKINS HOSP S2, V44, pS27; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004; Mukhopadhyay S, 2007, AM J SURG PATHOL, V31, P752, DOI 10.1097/01.pas.0000213418.08009.f9; OROZCOLEVI M, 1995, AM J RESP CRIT CARE, V152, P1387, DOI 10.1164/ajrccm.152.4.7551400; TORRES A, 1992, ANN INTERN MED, V116, P540, DOI 10.7326/0003-4819-116-7-540; VALLES J, 1995, ANN INTERN MED, V122, P179, DOI 10.7326/0003-4819-122-3-199502010-00004; Vincent A, 2009, CRIT CARE MED, V37, P111, DOI 10.1097/CCM.0b013e318192fa8b; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370	24	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11298	10.1371/journal.pone.0011298	http://dx.doi.org/10.1371/journal.pone.0011298			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585574	Green Published, gold, Green Submitted			2022-12-27	WOS:000279135800007
J	Peddinti, D; Memili, E; Burgess, SC				Peddinti, Divyaswetha; Memili, Erdogan; Burgess, Shane C.			Proteomics-Based Systems Biology Modeling of Bovine Germinal Vesicle Stage Oocyte and Cumulus Cell Interaction	PLOS ONE			English	Article							IN-VITRO MATURATION; COMPANION GRANULOSA-CELLS; MESSENGER-RNA EXPRESSION; TANDEM MASS-SPECTROMETRY; PROTEIN EXPRESSION; METABOLIC COOPERATIVITY; EMBRYO DEVELOPMENT; PORCINE OOCYTES; GENE-EXPRESSION; MOUSE OOCYTES	Background: Oocytes are the female gametes which establish the program of life after fertilization. Interactions between oocyte and the surrounding cumulus cells at germinal vesicle (GV) stage are considered essential for proper maturation or 'programming' of oocytes, which is crucial for normal fertilization and embryonic development. However, despite its importance, little is known about the molecular events and pathways involved in this bidirectional communication. Methodology/Principal Findings: We used differential detergent fractionation multidimensional protein identification technology (DDF-Mud PIT) on bovine GV oocyte and cumulus cells and identified 811 and 1247 proteins in GV oocyte and cumulus cells, respectively; 371 proteins were significantly differentially expressed between each cell type. Systems biology modeling, which included Gene Ontology (GO) and canonical genetic pathway analysis, showed that cumulus cells have higher expression of proteins involved in cell communication, generation of precursor metabolites and energy, as well as transport than GV oocytes. Our data also suggests a hypothesis that oocytes may depend on the presence of cumulus cells to generate specific cellular signals to coordinate their growth and maturation. Conclusions/Significance: Systems biology modeling of bovine oocytes and cumulus cells in the context of GO and protein interaction networks identified the signaling pathways associated with the proteins involved in cell-to-cell signaling biological process that may have implications in oocyte competence and maturation. This first comprehensive systems biology modeling of bovine oocytes and cumulus cell proteomes not only provides a foundation for signaling and cell physiology at the GV stage of oocyte development, but are also valuable for comparative studies of other stages of oocyte development at the molecular level.	[Peddinti, Divyaswetha; Burgess, Shane C.] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA; [Memili, Erdogan] Mississippi State Univ, Dept Anim & Dairy Sci, Mississippi State, MS 39762 USA; [Peddinti, Divyaswetha; Memili, Erdogan; Burgess, Shane C.] Mississippi State Univ, Inst Digital Biol, Mississippi State, MS 39762 USA; [Burgess, Shane C.] Mississippi State Univ, Life Sci & Biotechnol Inst, Mississippi State, MS 39762 USA; [Burgess, Shane C.] Mississippi State Univ, Mississippi Agr & Forestry Expt Stn, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University; Mississippi State University; Mississippi State University; Mississippi State University	Peddinti, D (corresponding author), Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA.	dpeddinti@cvm.msstate.edu	Memili, Erdogan/AAY-8726-2020	Memili, Erdogan/0000-0002-8335-5645	Life Sciences and Biology Institute; Mississippi Agricultural and Forestry Experiment Station, Mississippi State University	Life Sciences and Biology Institute; Mississippi Agricultural and Forestry Experiment Station, Mississippi State University	This study was funded by the Life Sciences and Biology Institute and Mississippi Agricultural and Forestry Experiment Station, Mississippi State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2005, THERIOGENOLOGY, V64, P261, DOI 10.1016/j.theriogenology.2004.12.001; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; ASSIDI M, 2008, BIOL REPROD; BETTEGOWDA A, 2008, BIOL REPROD; Bhojwani M, 2006, CLONING STEM CELLS, V8, P259, DOI 10.1089/clo.2006.8.259; BIGGERS JD, 1967, P NATL ACAD SCI USA, V58, P560, DOI 10.1073/pnas.58.2.560; BRIDGES SM, 2007, BMC BIOINFORMATICS, V8; BUCCIONE R, 1990, BIOL REPROD, V43, P543, DOI 10.1095/biolreprod43.4.543; Buza TJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1167; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Coonrod SA, 2002, J REPROD IMMUNOL, V53, P55, DOI 10.1016/S0165-0378(01)00102-4; Cox B, 2005, METHODS, V35, P303, DOI 10.1016/j.ymeth.2004.08.021; Dalbies-Tran R, 2005, MOL REPROD DEV, V71, P414, DOI 10.1002/mrd.20298; deMatos DG, 1997, BIOL REPROD, V57, P1420, DOI 10.1095/biolreprod57.6.1420; DONAHUE RP, 1968, J REPROD FERTIL, V17, P395, DOI 10.1530/jrf.0.0170395; Elias JE, 2004, NAT BIOTECHNOL, V22, P214, DOI 10.1038/nbt930; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Ellederova Z, 2004, BIOL REPROD, V71, P1533, DOI 10.1095/biolreprod.104.030304; EPPIG JJ, 1993, DEV BIOL, V158, P400, DOI 10.1006/dbio.1993.1198; EPPIG JJ, 1991, BIOESSAYS, V13, P569, DOI 10.1002/bies.950131105; Fair T, 2007, THERIOGENOLOGY, V68, pS91, DOI 10.1016/j.theriogenology.2007.04.018; Fatehi AN, 2002, THERIOGENOLOGY, V57, P1347, DOI 10.1016/S0093-691X(01)00717-8; Gerling IC, 2006, MOL CELL PROTEOMICS, V5, P293, DOI 10.1074/mcp.M500197-MCP200; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gilchrist RB, 2004, ANIM REPROD SCI, V82-3, P431, DOI 10.1016/j.anireprosci.2004.05.017; GrazulBilska AT, 1997, BIOL REPROD, V57, P947, DOI 10.1095/biolreprod57.5.947; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hamamah S, 2006, REPROD BIOMED ONLINE, V13, P807, DOI 10.1016/S1472-6483(10)61028-0; Huang Y, 2006, PHYSIOL GENOMICS, V24, P144, DOI 10.1152/physiolgenomics.00258.2005; KIM H, 1991, CELL TISSUE RES, V265, P105, DOI 10.1007/BF00318144; LEESE HJ, 1985, J EXP ZOOL, V234, P231, DOI 10.1002/jez.1402340208; Leyens G, 2004, BIOL REPROD, V71, P1646, DOI 10.1095/biolreprod.104.030155; Lubec G, 2005, PROG NEUROBIOL, V77, P90, DOI 10.1016/j.pneurobio.2005.10.001; Ma MY, 2008, J PROTEOME RES, V7, P4821, DOI 10.1021/pr800392s; MacCoss MJ, 2002, ANAL CHEM, V74, P5593, DOI 10.1021/ac025826t; Martens L, 2005, PROTEOMICS, V5, P3537, DOI 10.1002/pmic.200401303; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; McCarthy FM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-229; McCarthy FM, 2007, NUCLEIC ACIDS RES, V35, pD599, DOI 10.1093/nar/gkl936; McCarthy FM, 2006, PROTEOMICS, V6, P2759, DOI 10.1002/pmic.200500648; Memili E, 2007, REPRODUCTION, V133, P1107, DOI 10.1530/REP-06-0149; Memili E, 1999, BIOL REPROD, V61, P1198, DOI 10.1095/biolreprod61.5.1198; Meng Y, 2007, BBA-PROTEINS PROTEOM, V1774, P1477, DOI 10.1016/j.bbapap.2007.08.026; Monniaux D, 2006, SEMIN REPROD MED, V24, P251, DOI 10.1055/s-2006-948554; Mori T, 2000, BIOL REPROD, V62, P913, DOI 10.1095/biolreprod62.4.913; Nanduri B, 2005, PROTEOMICS, V5, P4852, DOI 10.1002/pmic.200500112; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nie L, 2007, CRIT REV BIOTECHNOL, V27, P63, DOI 10.1080/07388550701334212; Orchard S, 2007, PROTEOMICS, V7, P1006, DOI 10.1002/pmic.200700014; Park GW, 2006, PROTEOMICS, V6, P1121, DOI 10.1002/pmic.200500318; Peddinti D, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-19; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Pennetier S, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-26; Pfeffer PL, 2007, THERIOGENOLOGY, V68, pS84, DOI 10.1016/j.theriogenology.2007.03.016; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; Racedo SE, 2009, REPROD FERT DEVELOP, V21, P738, DOI 10.1071/RD09039; RICHTER JD, 1991, BIOESSAYS, V13, P179, DOI 10.1002/bies.950130406; Sagirkaya H, 2006, REPRODUCTION, V131, P895, DOI 10.1530/rep.1.01021; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Snow AJ, 2008, BIOL REPROD, V79, P337, DOI 10.1095/biolreprod.108.069328; Su YQ, 2008, DEVELOPMENT, V135, P111, DOI 10.1242/dev.009068; Su YQ, 2002, ENDOCRINOLOGY, V143, P2221, DOI 10.1210/en.143.6.2221; Sugiura K, 2005, REPROD FERT DEVELOP, V17, P667, DOI 10.1071/RD05071; Sugiura K, 2005, DEV BIOL, V279, P20, DOI 10.1016/j.ydbio.2004.11.027; Sugiura K, 2007, DEVELOPMENT, V134, P2593, DOI 10.1242/dev.006882; Sutton ML, 2003, REPRODUCTION, V126, P27, DOI 10.1530/rep.0.1260027; Tanghe S, 2002, MOL REPROD DEV, V61, P414, DOI 10.1002/mrd.10102; Thelie A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-125; VESELSKA R, 2001, SCRIPTA MED, V74, P265; Vozzi C, 2001, REPRODUCTION, V122, P619, DOI 10.1530/reprod/122.4.619; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; Wongsrikeao P, 2005, REPROD DOMEST ANIM, V40, P166, DOI 10.1111/j.1439-0531.2005.00576.x; ZHANG L, 1995, MOL REPROD DEV, V40, P338, DOI 10.1002/mrd.1080400310	74	33	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11240	10.1371/journal.pone.0011240	http://dx.doi.org/10.1371/journal.pone.0011240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574525	Green Submitted, Green Published, gold			2022-12-27	WOS:000279058300024
J	Smet, A; Van Nieuwerburgh, F; Vandekerckhove, TTM; Martel, A; Deforce, D; Butaye, P; Haesebrouck, F				Smet, Annemieke; Van Nieuwerburgh, Filip; Vandekerckhove, Tom T. M.; Martel, An; Deforce, Dieter; Butaye, Patrick; Haesebrouck, Freddy			Complete Nucleotide Sequence of CTX-M-15-Plasmids from Clinical Escherichia coli Isolates: Insertional Events of Transposons and Insertion Sequences	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; DNA-SEQUENCE; CTX-M; RESISTANCE; PLASMIDS; DISSEMINATION; SALMONELLA; ENTEROBACTERIACEAE; EMERGENCE; POULTRY	Background: CTX-M-producing Escherichia coli strains are regarded as major global pathogens. Methodology/Principal Findings: The nucleotide sequence of three plasmids (pEC_B24: 73801-bp; pEC_L8: 118525-bp and pEC_L46: 144871-bp) from Escherichia coli isolates obtained from patients with urinary tract infections and one plasmid (pEC_Bactec: 92970-bp) from an Escherichia coli strain isolated from the joint of a horse with arthritis were determined. Plasmid pEC_Bactec belongs to the Incl1 group and carries two resistance genes: bla(TEM-1) and bla(CTX-M-15). It shares more than 90% homology with a previously published bla(CTX-M)-plasmid from E. coli of human origin. Plasmid pEC_B24 belongs to the IncFII group whereas plasmids pEC_L8 and pEC_L46 represent a fusion of two replicons of type FII and FIA. On the pEC_B24 backbone, two resistance genes, blaTEM-1 and blaCTX-M-15, were found. Six resistance genes, blaTEM-1, blaCTX-M-15, bla(OXA-1), aac6'-lb-cr, tetA and catB4, were detected on the pEC_L8 backbone. The same antimicrobial drug resistance genes, with the exception of tetA, were also identified on the pEC_L46 backbone. Genome analysis of all 4 plasmids studied provides evidence of a seemingly frequent transposition event of the bla(CTX-M-15)-ISEcp1 element. This element seems to have a preferred insertion site at the tnpA gene of a bla(TEM)-carrying Tn3-like transposon, the latter itself being inserted by a transposition event. The IS26-composite transposon, which contains the blaOXA-1, aac6'-lb-cr and catB4 genes, was inserted into plasmids pEC_L8 and pEC_L46 by homologous recombination rather than a transposition event. Results obtained for pEC_L46 indicated that IS26 also plays an important role in structural rearrangements of the plasmid backbone and seems to facilitate the mobilisation of fragments from other plasmids. Conclusions: Collectively, these data suggests that IS26 together with ISEcp1 could play a critical role in the evolution of diverse multiresistant plasmids found in clinical Enterobacteriaceae.	[Smet, Annemieke; Martel, An; Butaye, Patrick; Haesebrouck, Freddy] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [Van Nieuwerburgh, Filip; Deforce, Dieter] Univ Ghent, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium; [Van Nieuwerburgh, Filip; Deforce, Dieter] Univ Ghent, NXTGNT Sequencing Facil, B-9000 Ghent, Belgium; [Vandekerckhove, Tom T. M.] Univ Ghent, Dept Mol Biotechnol, Biobix Lab Bioinformat & Computat Genom, B-9000 Ghent, Belgium; [Butaye, Patrick] CODA CERVA VAR, Dept Bacteriol & Immunol, Brussels, Belgium	Ghent University; Ghent University; Ghent University; Ghent University	Smet, A (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium.	Annemieke.Smet@UGent.be	Van Nieuwerburgh, Filip/H-9697-2015; Smet, Annemieke/M-9295-2017; Martel, An/D-3713-2014; Butaye, Patrick/AAJ-8240-2020; Deforce, Dieter LD/J-4725-2013; Haesebrouck, Freddy/M-3857-2014	Van Nieuwerburgh, Filip/0000-0001-8815-5485; Smet, Annemieke/0000-0002-1271-6191; Deforce, Dieter LD/0000-0002-0635-661X; Haesebrouck, Freddy/0000-0002-1709-933X; Butaye, Patrick/0000-0003-0780-6384	Federal Public Service of Health, Food Chain Safety and Environment [RT 06/3 ABRISK]; CODA-CERVA-VAR; Ghent University	Federal Public Service of Health, Food Chain Safety and Environment; CODA-CERVA-VAR; Ghent University(Ghent University)	This work was supported in part by a grant from the Federal Public Service of Health, Food Chain Safety and Environment (Grant number RT 06/3 ABRISK), by the CODA-CERVA-VAR and Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bae IK, 2006, J ANTIMICROB CHEMOTH, V58, P315, DOI 10.1093/jac/dkl252; Bae IK, 2006, J ANTIMICROB CHEMOTH, V58, P1257, DOI 10.1093/jac/dkl397; BELOGUROV AA, 1993, J BACTERIOL, V175, P4843, DOI 10.1128/JB.175.15.4843-4850.1993; BONI IV, 1991, NUCLEIC ACIDS RES, V19, P155, DOI 10.1093/nar/19.1.155; Boyd DA, 2004, ANTIMICROB AGENTS CH, V48, P3758, DOI 10.1128/AAC.48.10.3758-3764.2004; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Bywater RJ, 2005, POULTRY SCI, V84, P644, DOI 10.1093/ps/84.4.644; Bywater RJ, 2004, J VET MED B, V51, P361, DOI 10.1111/j.1439-0450.2004.00791.x; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Chaibi EB, 1999, J ANTIMICROB CHEMOTH, V43, P447, DOI 10.1093/jac/43.4.447; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; Eckert C, 2006, J ANTIMICROB CHEMOTH, V57, P14, DOI 10.1093/jac/dki398; Fernandez AG, 2007, ANTIMICROB AGENTS CH, V51, P4177, DOI 10.1128/AAC.00603-07; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Garcia-Fernandez A, 2008, J ANTIMICROB CHEMOTH, V61, P1229, DOI 10.1093/jac/dkn131; Gootz TD, 2009, ANTIMICROB AGENTS CH, V53, P1998, DOI 10.1128/AAC.01355-08; Gupta V, 2007, INDIAN J MED RES, V126, P417; HEFFRON F, 1979, CELL, V18, P1153, DOI 10.1016/0092-8674(79)90228-9; Hopkins KL, 2006, ANTIMICROB AGENTS CH, V50, P3203, DOI 10.1128/AAC.00149-06; Horish R.E., 2002, CURR TOP MED CHEM, V2, P717; IIDA S, 1984, MOL GEN GENET, V198, P84, DOI 10.1007/BF00328705; Johnson TJ, 2005, ANTIMICROB AGENTS CH, V49, P4681, DOI 10.1128/AAC.49.11.4681-4688.2005; Karim A, 2001, FEMS MICROBIOL LETT, V201, P237, DOI 10.1016/S0378-1097(01)00276-2; Komano T, 2000, MOL MICROBIOL, V35, P1348, DOI 10.1046/j.1365-2958.2000.01769.x; Komarova AV, 2005, J BACTERIOL, V187, P1344, DOI 10.1128/JB.187.4.1344-1349.2005; LEE KY, 1990, J BACTERIOL, V172, P3229, DOI 10.1128/jb.172.6.3229-3236.1990; MIKKONEN M, 1994, FEMS MICROBIOL LETT, V116, P315, DOI 10.1016/0378-1097(94)90053-1; Miriagou V, 2005, ANTIMICROB AGENTS CH, V49, P3541, DOI 10.1128/AAC.49.8.3541-3543.2005; Mushtaq S, 2003, J ANTIMICROB CHEMOTH, V52, P528, DOI 10.1093/jac/dkg353; Naas T, 2001, J BACTERIOL, V183, P235, DOI 10.1128/JB.183.1.235-249.2001; Partridge SR, 2005, ANTIMICROB AGENTS CH, V49, P1267, DOI 10.1128/AAC.49.3.1267-1268.2005; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Perichon B, 2008, ANTIMICROB AGENTS CH, V52, P2581, DOI 10.1128/AAC.01540-07; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Rhodes G, 2000, APPL ENVIRON MICROB, V66, P3883, DOI 10.1128/AEM.66.9.3883-3890.2000; Ruppe E, 2009, EMERG INFECT DIS, V15, P741, DOI 10.3201/eid1505.071299; SCHRAMM E, 1987, J BACTERIOL, V169, P3350, DOI 10.1128/jb.169.7.3350-3357.1987; Shen P, 2008, J ANTIMICROB CHEMOTH, V62, P1252, DOI 10.1093/jac/dkn397; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Sidjabat HE, 2009, ANTIMICROB AGENTS CH, V53, P4733, DOI 10.1128/AAC.00533-09; SMET A, 2010, MICROB DRUG IN PRESS; Smet A, 2008, ANTIMICROB AGENTS CH, V52, P1238, DOI 10.1128/AAC.01285-07; Smet A, 2009, J ANTIMICROB CHEMOTH, V63, P1286, DOI 10.1093/jac/dkp101; Woodford N, 2009, ANTIMICROB AGENTS CH, V53, P4472, DOI 10.1128/AAC.00688-09; Zhu WH, 2009, ANTIMICROB AGENTS CH, V53, P5291, DOI 10.1128/AAC.00032-09	46	88	90	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11202	10.1371/journal.pone.0011202	http://dx.doi.org/10.1371/journal.pone.0011202			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585456	Green Published, gold			2022-12-27	WOS:000278977200007
J	Krankel, N; Armstrong, SP; McArdle, CA; Dayan, C; Madeddu, P				Kraenkel, Nicolle; Armstrong, Stephen Paul; McArdle, Craig Alexander; Dayan, Colin; Madeddu, Paolo			Distinct Kinin-Induced Functions Are Altered in Circulating Cells of Young Type 1 Diabetic Patients	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; NADPH OXIDASE; STEM-CELLS; RECEPTOR; IMPAIRS; MOBILIZATION; RECRUITMENT; MECHANISMS; MELLITUS; STRESS	Aims/Hypothesis: We aimed to understand early alterations in kinin-mediated migration of circulating angio-supportive cells and dysfunction of kinin-sensitive cells in type-1 diabetic (T1D) patients before the onset of cardiovascular disease. Methods: Total mononuclear cells (MNC) were isolated from peripheral blood of 28 T1D patients free from cardiovascular complications except mild background retinopathy (age: 34.8+/-1.6 years, HbA(1C): 7.9+/-0.2%) and 28 age-and sex-matched non-diabetic controls (H). We tested expression of kinin receptors by flow cytometry and migratory capacity of circulating monocytes and progenitor cells towards bradykinin (BK) in transwell migration assays. MNC migrating towards BK (BKmig) were assessed for capacity to support endothelial cell function in a matrigel assay, as well as generation of nitric oxide (NO) and superoxide (O-2(-)*) by using the fluorescent probes diaminofluorescein and dihydroethidium. Results: CD14(hi)CD16(neg), CD14(hi)CD16(pos) and CD14(lo)CD16(pos) monocytes and circulating CD34(pos) progenitor cells did not differ between T1D and H subjects in their kinin receptor expression and migration towards BK. T1D BKmig failed to generate NO upon BK stimulation and supported endothelial cell network formation less efficiently than H BKmig. In contrast, O-2(-)* production was similar between groups. High glucose disturbed BK-induced NO generation by MNC-derived cultured angiogenic cells. Conclusions/Interpretation: Our data point out alterations in kinin-mediated functions of circulating MNC from T1D patients, occurring before manifest macrovascular damage or progressed microvascular disease. Functional defects of MNC recruited to the vessel wall might compromise endothelial maintenance, initially without actively promoting endothelial damage, but rather by lacking supportive contribution to endothelial regeneration and healing.	[Kraenkel, Nicolle; Armstrong, Stephen Paul; McArdle, Craig Alexander; Dayan, Colin] Univ Bristol, Labs Integrated Neurosci & Endocrinol, Bristol, Avon, England	University of Bristol	Krankel, N (corresponding author), Univ Bristol, Labs Integrated Neurosci & Endocrinol, Bristol, Avon, England.	n.kraenkel@gmx.de	McArdle, Craig/AAQ-5660-2021; Dayan, Colin/AAH-6242-2019	McArdle, Craig/0000-0003-4836-5351; Dayan, Colin/0000-0002-6557-3462; Kraenkel, Nicolle/0000-0002-9363-1770	European Foundation for the Study of Diabetes; Juvenile Diabetes Research Foundation; NovoNordisk; Wellcome Trust [083018]; U.K. Biotechnology and Biological Sciences Research Council	European Foundation for the Study of Diabetes; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NovoNordisk(Novo Nordisk); Wellcome Trust(Wellcome TrustEuropean Commission); U.K. Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The study was supported by a grant from the European Foundation for the Study of Diabetes (www.europeandiabetesfoundation.org), co-sponsored by the Juvenile Diabetes Research Foundation and NovoNordisk. N.K. is supported by a Wellcome Trust project grant (# 083018, www.wellcome.ac.uk). S. A. is supported by a Doctoral Training Award of the U.K. Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, and do not participate in intellectual property arising from this research. None of the investigators are employed by the funders. Adherence to the PLoS ONE policies on sharing data and materials is not affected.	Brandes RP, 2008, CURR OPIN LIPIDOL, V19, P513, DOI 10.1097/MOL.0b013e32830c91e3; Busik JV, 2009, J EXP MED, V206, P2897, DOI 10.1084/jem.20090889; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Costa-Neto CM, 2008, INT IMMUNOPHARMACOL, V8, P135, DOI 10.1016/j.intimp.2007.08.003; Csanyi G, 2009, FREE RADICAL BIO MED, V47, P1254, DOI 10.1016/j.freeradbiomed.2009.07.022; Danielisova V, 2008, NEUROCHEM RES, V33, P1057, DOI 10.1007/s11064-007-9550-3; Emanueli C, 2002, CIRCULATION, V105, P360, DOI 10.1161/hc0302.102142; Fadini GP, 2007, DIABETES CARE, V30, P1305, DOI 10.2337/dc06-2305; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; Fujii H, 1997, J BIOL CHEM, V272, P32773, DOI 10.1074/jbc.272.52.32773; Krankel N, 2008, CIRC RES, V103, P1335, DOI 10.1161/CIRCRESAHA.108.179952; Kubo M, 2009, J CELL PHYSIOL, V220, P508, DOI 10.1002/jcp.21803; Larsen BT, 2009, ARTERIOSCL THROM VAS, V29, P739, DOI 10.1161/ATVBAHA.108.169367; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Matsumoto T, 2008, BONE, V43, P434, DOI 10.1016/j.bone.2008.05.001; Oikawa A, 2010, ARTERIOSCL THROM VAS, V30, P498, DOI 10.1161/ATVBAHA.109.200154; Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105; Saederup N, 2008, CIRCULATION, V117, P1642, DOI 10.1161/CIRCULATIONAHA.107.743872; Sambuceti G, 2009, STEM CELLS, V27, P399, DOI 10.1634/stemcells.2008-0800; Seeger FH, 2009, ARTERIOSCL THROM VAS, V29, P1802, DOI 10.1161/ATVBAHA.109.194688; Segal MS, 2006, DIABETES, V55, P102, DOI 10.2337/diabetes.55.1.102; Selemidis S, 2007, CARDIOVASC RES, V75, P349, DOI 10.1016/j.cardiores.2007.03.030; Sessa WC, 2009, J THROMB HAEMOST, V7, P35, DOI 10.1111/j.1538-7836.2009.03424.x; Sorrentino SA, 2007, CIRCULATION, V116, P163, DOI 10.1161/CIRCULATIONAHA.106.684381; Thum T, 2007, DIABETES, V56, P666, DOI 10.2337/db06-0699; Tschope C, 2005, FASEB J, V19, P2057, DOI 10.1096/fj.05-4095fje; Voo S, 2008, EUR HEART J, V29, P241, DOI 10.1093/eurheartj/ehm542; Waltenberger J, 2001, CARDIOVASC RES, V49, P554, DOI 10.1016/S0008-6363(00)00228-5; Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02; Yoder MC, 2009, BBA-REV CANCER, V1796, P50, DOI 10.1016/j.bbcan.2009.04.002; Zemani F, 2008, ARTERIOSCL THROM VAS, V28, P644, DOI 10.1161/ATVBAHA.107.160044	31	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11146	10.1371/journal.pone.0011146	http://dx.doi.org/10.1371/journal.pone.0011146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567501	Green Published, Green Submitted, gold			2022-12-27	WOS:000278886300003
J	Chatterjee, A; Adak, A; Singh, AK; Srivastava, MK; Ghosh, SK; Tiwari, S; Devara, PCS; Raha, S				Chatterjee, Abhijit; Adak, Anandamay; Singh, Ajay K.; Srivastava, Manoj K.; Ghosh, Sanjay K.; Tiwari, Suresh; Devara, Panuganti C. S.; Raha, Sibaji			Aerosol Chemistry over a High Altitude Station at Northeastern Himalayas, India	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; ATMOSPHERIC AEROSOL; SIZE DISTRIBUTIONS; TIBETAN PLATEAU; NEPAL HIMALAYA; DRY DEPOSITION; BOUNDARY-LAYER; PARTICLE-SIZE; WESTERN INDIA; MINERAL DUST	Background: There is an urgent need for an improved understanding of the sources, distributions and properties of atmospheric aerosol in order to control the atmospheric pollution over northeastern Himalayas where rising anthropogenic interferences from rapid urbanization and development is becoming an increasing concern. Methodology/Principal Findings: An extensive aerosol sampling program was conducted in Darjeeling (altitude,2200 meter above sea level (masl), latitude 27 degrees 01'N and longitude 88 degrees 15'E), a high altitude station in northeastern Himalayas, during January-December 2005. Samples were collected using a respirable dust sampler and a fine dust sampler simultaneously. Ion chromatograph was used to analyze the water soluble ionic species of aerosol. The average concentrations of fine and coarse mode aerosol were found to be 29.5 +/- 20.8 mu g m(-3) and 19.6 +/- 11.1 mu g m(-3) respectively. Fine mode aerosol dominated during dry seasons and coarse mode aerosol dominated during monsoon. Nitrate existed as NH4NO3 in fine mode aerosol during winter and as NaNO3 in coarse mode aerosol during monsoon. Gas phase photochemical oxidation of SO2 during premonsoon and aqueous phase oxidation during winter and postmonsoon were the major pathways for the formation of SO42- in the atmosphere. Long range transport of dust aerosol from arid regions of western India was observed during premonsoon. The acidity of fine mode aerosol was higher in dry seasons compared to monsoon whereas the coarse mode acidity was higher in monsoon compared to dry seasons. Biomass burning, vehicular emissions and dust particles were the major types of aerosol from local and continental regions whereas sea salt particles were the major types of aerosol from marine source regions. Conclusions/Significance: The year-long data presented in this paper provide substantial improvements to the heretofore poor knowledge regarding aerosol chemistry over northeastern Himalayas, and should be useful to policy makers in making control strategies.	[Chatterjee, Abhijit; Adak, Anandamay; Raha, Sibaji] Bose Inst, Environm Sci Sect, Kolkata, India; [Singh, Ajay K.; Ghosh, Sanjay K.; Raha, Sibaji] Bose Inst, Ctr Astroparticle Phys & Space Sci, Kolkata, India; [Singh, Ajay K.; Ghosh, Sanjay K.; Raha, Sibaji] Bose Inst, Ctr Astroparticle Phys & Space Sci, Darjeeling, India; [Srivastava, Manoj K.] Banaras Hindu Univ, Dept Geophys, Varanasi 221005, Uttar Pradesh, India; [Ghosh, Sanjay K.; Raha, Sibaji] Bose Inst, Dept Phys, Kolkata, India; [Tiwari, Suresh] Indian Inst Trop Meteorol, New Delhi, India; [Devara, Panuganti C. S.] Indian Inst Trop Meteorol, Pune, Maharashtra, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute; Banaras Hindu University (BHU); Department of Science & Technology (India); Bose Institute; Ministry of Earth Sciences (MoES) - India; Indian Institute of Tropical Meteorology (IITM); Ministry of Earth Sciences (MoES) - India; Indian Institute of Tropical Meteorology (IITM)	Chatterjee, A (corresponding author), Bose Inst, Environm Sci Sect, Kolkata, India.	sibajiraha@bic.boseinst.ernet.in	Singh, Ajay/AAF-4414-2020	Srivastava, Manoj Kumar/0000-0002-1035-8220	Science & Engineering Research Council, Department of Science & Technology, Government of India [IR/S2/PF-01/2003]	Science & Engineering Research Council, Department of Science & Technology, Government of India(Department of Science & Technology (India))	This study was supported through a grant (No. IR/S2/PF-01/2003) of the Science & Engineering Research Council, Department of Science & Technology, Government of India under the IRHPA (Intensification of Research in High Priority Areas) scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHISH A, 2006, NATURE SCI, V4, P53; Carrico CM, 2003, ATMOS ENVIRON, V37, P2811, DOI 10.1016/S1352-2310(03)00197-3; Chatterjee A, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007144; Dasgupta PK, 2007, ATMOS ENVIRON, V41, P4242, DOI 10.1016/j.atmosenv.2006.09.054; DECESARI S, 2009, ATMOS CHEM PHYS DISC, V9, P25522; Duce RA, 1991, GLOBAL BIOGEOCHEM CY, V5, P193, DOI 10.1029/91GB01778; Gajananda K, 2005, ATMOS ENVIRON, V39, P4817, DOI 10.1016/j.atmosenv.2005.01.038; Gautam R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037641; Gautam R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036967; Giuliacci M., 1988, PHYS DYNAMICAL CLIMA; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Kaupp H, 1999, ATMOS ENVIRON, V33, P85, DOI 10.1016/S1352-2310(98)00129-0; Kim HS, 2007, ATMOS ENVIRON, V41, P6762, DOI 10.1016/j.atmosenv.2007.04.060; Kulshrestha MJ, 2003, ATMOS ENVIRON, V37, P3057, DOI 10.1016/S1352-2310(03)00290-5; Kulshrestha UC, 1998, J ATMOS CHEM, V29, P109, DOI 10.1023/A:1005796400044; Kumar A, 2008, ATMOS ENVIRON, V42, P5169, DOI 10.1016/j.atmosenv.2008.03.004; Lau KM, 2006, CLIM DYNAM, V26, P855, DOI 10.1007/s00382-006-0114-2; Lippmann M, 2000, Appl Occup Environ Hyg, V15, P57; MAENHAUT W, 1987, Journal of Trace and Microprobe Techniques, V5, P135; MAYEWSKI PA, 1979, ARCTIC ALPINE RES, V11, P267, DOI 10.2307/1550417; MCINNES LM, 1994, J GEOPHYS RES-ATMOS, V99, P8257, DOI 10.1029/93JD03453; Momin GA, 1999, CURR SCI INDIA, V76, P985; MOZURKEWICH M, 1993, ATMOS ENVIRON A-GEN, V27, P261, DOI 10.1016/0960-1686(93)90356-4; OHTA S, 1990, ATMOS ENVIRON A-GEN, V24, P815, DOI 10.1016/0960-1686(90)90282-R; Pakkanen TA, 1996, ATMOS ENVIRON, V30, P2475, DOI 10.1016/1352-2310(95)00492-0; Pathak RK, 2004, ATMOS ENVIRON, V38, P2965, DOI 10.1016/j.atmosenv.2004.02.044; Ramanathan V, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008124; Rastogi N, 2007, J ATMOS CHEM, V56, P149, DOI 10.1007/s10874-006-9047-5; Rastogi N, 2005, ATMOS ENVIRON, V39, P5541, DOI 10.1016/j.atmosenv.2005.06.011; Rastogi N, 2009, ATMOS ENVIRON, V43, P3481, DOI 10.1016/j.atmosenv.2009.04.030; Rengarajan R, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008150; Safai P.D., 1995, IASTA B, pS1; Seinfeld JH, 1986, ENV POL SUS DEV, V40, P26; Shrestha AB, 1997, ATMOS ENVIRON, V31, P2815, DOI 10.1016/S1352-2310(97)00047-2; Shrestha AB, 2000, ATMOS ENVIRON, V34, P3349, DOI 10.1016/S1352-2310(99)00366-0; *SPSS INC, 2003, ADV STAT MAN SPSS PC; Venkataraman C, 2002, ATMOS ENVIRON, V36, P1979, DOI 10.1016/S1352-2310(02)00167-X; VONSTROCH, 1999, STAT ANAL CLIMATE RE; WAKE CP, 1994, ATMOS ENVIRON, V28, P695, DOI 10.1016/1352-2310(94)90046-9; Wang Y, 2005, ATMOS ENVIRON, V39, P3771, DOI 10.1016/j.atmosenv.2005.03.013; Xiu GL, 2004, ATMOS ENVIRON, V38, P227, DOI 10.1016/j.atmosenv.2003.09.053; ZELENKA MP, 1994, ATMOS ENVIRON, V28, P1425, DOI 10.1016/1352-2310(94)90205-4; Zhuang H, 1999, ATMOS ENVIRON, V33, P843, DOI 10.1016/S1352-2310(98)00305-7	43	57	58	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11122	10.1371/journal.pone.0011122	http://dx.doi.org/10.1371/journal.pone.0011122			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585397	Green Submitted, Green Published, gold			2022-12-27	WOS:000278886100008
J	Gelfand, M; Piro, O; Magnasco, MO; Hudspeth, AJ				Gelfand, Michael; Piro, Oreste; Magnasco, Marcelo O.; Hudspeth, A. J.			Interactions between Hair Cells Shape Spontaneous Otoacoustic Emissions in a Model of the Tokay Gecko's Cochlea	PLOS ONE			English	Article							BASILAR PAPILLA; BOBTAIL LIZARD; ELECTRICAL-STIMULATION; RELAXATION DYNAMICS; EXTERNAL TONES; SUPPRESSION; BUNDLES; SYNCHRONIZATION; AMPLIFICATION; AMPLIFIER	Background: The hearing of tetrapods including humans is enhanced by an active process that amplifies the mechanical inputs associated with sound, sharpens frequency selectivity, and compresses the range of responsiveness. The most striking manifestation of the active process is spontaneous otoacoustic emission, the unprovoked emergence of sound from an ear. Hair cells, the sensory receptors of the inner ear, are known to provide the energy for such emissions; it is unclear, though, how ensembles of such cells collude to power observable emissions. Methodology and Principal Findings: We have measured and modeled spontaneous otoacoustic emissions from the ear of the tokay gecko, a convenient experimental subject that produces robust emissions. Using a van der Pol formulation to represent each cluster of hair cells within a tonotopic array, we have examined the factors that influence the cooperative interaction between oscillators. Conclusions and Significance: A model that includes viscous interactions between adjacent hair cells fails to produce emissions similar to those observed experimentally. In contrast, elastic coupling yields realistic results, especially if the oscillators near the ends of the array are weakened so as to minimize boundary effects. Introducing stochastic irregularity in the strength of oscillators stabilizes peaks in the spectrum of modeled emissions, further increasing the similarity to the responses of actual ears. Finally, and again in agreement with experimental findings, the inclusion of a pure-tone external stimulus repels the spectral peaks of spontaneous emissions. Our results suggest that elastic coupling between oscillators of slightly differing strength explains several properties of the spontaneous otoacoustic emissions in the gecko.	[Gelfand, Michael; Hudspeth, A. J.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Gelfand, Michael; Hudspeth, A. J.] Rockefeller Univ, Lab Sensory Neurosci, New York, NY 10021 USA; [Piro, Oreste] Univ Illes Balears, Dept Fis, Univ Balear Isl UIB, Spanish Natl Res Council CSIC, E-07071 Palma de Mallorca, Spain; [Piro, Oreste] Univ Illes Balears, Inst Cross Disciplinary Phys & Complex Syst IFISC, Univ Balear Isl UIB, Spanish Natl Res Council CSIC, E-07071 Palma de Mallorca, Spain; [Magnasco, Marcelo O.] Rockefeller Univ, Phys Math Lab, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); Rockefeller University	Gelfand, M (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	hudspaj@rockefeller.edu	Piro, Oreste/B-4899-2014	Piro, Oreste/0000-0002-6966-2796; Gelfand, Michael/0000-0002-4816-8756	National Institutes of Health [DC000241, DC007294, GM07739]; Spanish Ministerio de Educacion y Ciencias; Consejo Superior de Investigaciones Cientificas (CSIC); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007294] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministerio de Educacion y Ciencias(Spanish Government); Consejo Superior de Investigaciones Cientificas (CSIC); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This investigation was supported by grants DC000241, DC007294, and GM07739 from the National Institutes of Health, by the Spanish Ministerio de Educacion y Ciencias, and by Consejo Superior de Investigaciones Cientificas (CSIC) project HIELOCRIS. A.J.H. is an Investigator of Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranyosi AJ, 2005, J ACOUST SOC AM, V118, P1585, DOI 10.1121/1.1993147; Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; AUTHIER S, 1995, HEARING RES, V82, P1, DOI 10.1016/0378-5955(94)00138-G; Basak S, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2423254; Bergevin C, 2008, J COMP PHYSIOL A, V194, P665, DOI 10.1007/s00359-008-0338-y; BIALEK W, 1984, PHYS LETT A, V104, P173, DOI 10.1016/0375-9601(84)90371-2; Bozovic D, 2003, P NATL ACAD SCI USA, V100, P958, DOI 10.1073/pnas.0337433100; Chan DK, 2005, BIOPHYS J, V89, P4382, DOI 10.1529/biophysj.105.070474; Chan DK, 2005, NAT NEUROSCI, V8, P149, DOI 10.1038/nn1385; Chiappe ME, 2007, J NEUROSCI, V27, P11978, DOI 10.1523/JNEUROSCI.3679-07.2007; Dallos P, 2006, J PHYSIOL-LONDON, V576, P37, DOI 10.1113/jphysiol.2006.114652; EATOCK RA, 1981, J COMP PHYSIOL, V142, P203, DOI 10.1007/BF00605739; FRISHKOPF LS, 1983, HEARING RES, V12, P393, DOI 10.1016/0378-5955(83)90008-4; HOLTON T, 1983, SCIENCE, V222, P508, DOI 10.1126/science.6623089; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Hudspeth AJ, 2000, P NATL ACAD SCI USA, V97, P11765, DOI 10.1073/pnas.97.22.11765; HUDSPETH AJ, 2008, NEURON IN PRESS; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; Kern A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.128101; KOPPL C, 1994, HEARING RES, V72, P159, DOI 10.1016/0378-5955(94)90215-1; KOPPL C, 1988, HEARING RES, V35, P209, DOI 10.1016/0378-5955(88)90119-0; KOPPL C, 1995, HEARING RES, V82, P14, DOI 10.1016/0378-5955(94)00139-H; KOPPL C, 1993, HEARING RES, V71, P157, DOI 10.1016/0378-5955(93)90031-U; LONG GR, 1991, J ACOUST SOC AM, V89, P1201, DOI 10.1121/1.400651; Manley GA, 2006, HEARING RES, V212, P33, DOI 10.1016/j.heares.2005.10.007; Manley GA, 2001, J NEUROPHYSIOL, V86, P541, DOI 10.1152/jn.2001.86.2.541; Manley GA, 2001, P NATL ACAD SCI USA, V98, P2826, DOI 10.1073/pnas.041604998; Manley GA, 1999, HEARING RES, V131, P107, DOI 10.1016/S0378-5955(99)00021-0; Manley GA, 2000, P NATL ACAD SCI USA, V97, P11736, DOI 10.1073/pnas.97.22.11736; Manley GA, 1996, J ACOUST SOC AM, V99, P1588, DOI 10.1121/1.414680; Manley GA, 1997, J ACOUST SOC AM, V102, P1049, DOI 10.1121/1.419858; Martin P, 2003, J NEUROSCI, V23, P4533; MILLER MR, 1973, Z ZELLFORSCH MIK ANA, V136, P307, DOI 10.1007/BF00307037; MURPHY WJ, 1995, J ACOUST SOC AM, V97, P3711, DOI 10.1121/1.412388; Murphy WJ, 1996, J ACOUST SOC AM, V100, P3979, DOI 10.1121/1.417217; Nadrowski B, 2004, P NATL ACAD SCI USA, V101, P12195, DOI 10.1073/pnas.0403020101; Nobili R, 1998, TRENDS NEUROSCI, V21, P159, DOI 10.1016/S0166-2236(97)01192-2; Probst R, 1990, Adv Otorhinolaryngol, V44, P1; RUGGERO MA, 1984, HEARING RES, V13, P293, DOI 10.1016/0378-5955(84)90083-2; Stewart CE, 2000, P NATL ACAD SCI USA, V97, P454, DOI 10.1073/pnas.97.1.454; TALMADGE CL, 1990, LECT NOTES BIOMATH, V87, P235; VANDIJK P, 1990, J ACOUST SOC AM, V88, P850, DOI 10.1121/1.399734; vanDijk P, 1996, J ACOUST SOC AM, V100, P2220, DOI 10.1121/1.417931; vanHengel PWJ, 1996, J ACOUST SOC AM, V99, P3566, DOI 10.1121/1.414955; Vilfan A, 2008, BIOPHYS J, V95, P4622, DOI 10.1529/biophysj.108.130286; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; WIT HP, 1990, ADV AUDIOL, V7, P110	47	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11116	10.1371/journal.pone.0011116	http://dx.doi.org/10.1371/journal.pone.0011116			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559557	Green Submitted, Green Published, gold			2022-12-27	WOS:000278775900007
J	Touchon, M; Rocha, EPC				Touchon, Marie; Rocha, Eduardo P. C.			The Small, Slow and Specialized CRISPR and Anti-CRISPR of Escherichia and Salmonella	PLOS ONE			English	Article							PROVIDES ACQUIRED-RESISTANCE; STREPTOCOCCUS-THERMOPHILUS; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; BACTERIAL GENOMES; COLI; REPEATS; SEQUENCES; DNA; IDENTIFICATION	Prokaryotes thrive in spite of the vast number and diversity of their viruses. This partly results from the evolution of mechanisms to inactivate or silence the action of exogenous DNA. Among these, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) are unique in providing adaptive immunity against elements with high local resemblance to genomes of previously infecting agents. Here, we analyze the CRISPR loci of 51 complete genomes of Escherichia and Salmonella. CRISPR are in two pairs of loci in Escherichia, one single pair in Salmonella, each pair showing a similar turnover rate, repeat sequence and putative linkage to a common set of cas genes. Yet, phylogeny shows that CRISPR and associated cas genes have different evolutionary histories, the latter being frequently exchanged or lost. In our set, one CRISPR pair seems specialized in plasmids often matching genes coding for the replication, conjugation and antirestriction machinery. Strikingly, this pair also matches the cognate cas genes in which case these genes are absent. The unexpectedly high conservation of this anti-CRISPR suggests selection to counteract the invasion of mobile elements containing functional CRISPR/cas systems. There are few spacers in most CRISPR, which rarely match genomes of known phages. Furthermore, we found that strains divergent less than 250 thousand years ago show virtually identical CRISPR. The lack of congruence between cas, CRISPR and the species phylogeny and the slow pace of CRISPR change make CRISPR poor epidemiological markers in enterobacteria. All these observations are at odds with the expectedly abundant and dynamic repertoire of spacers in an immune system aiming at protecting bacteria from phages. Since we observe purifying selection for the maintenance of CRISPR these results suggest that alternative evolutionary roles for CRISPR remain to be uncovered.	[Touchon, Marie; Rocha, Eduardo P. C.] Inst Pasteur, Dept Genom & Genet, Paris, France; [Touchon, Marie; Rocha, Eduardo P. C.] CNRS, URA2171, Paris, France; [Touchon, Marie; Rocha, Eduardo P. C.] Univ Paris 06, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Touchon, M (corresponding author), Inst Pasteur, Dept Genom & Genet, Paris, France.	marie.touchon@pasteur.fr	Rocha, Eduardo/B-7009-2009; Rocha, Eduardo/A-4727-2008	Rocha, Eduardo/0000-0001-7704-822X; Touchon, marie/0000-0001-7389-447X				Andersson DI, 2009, ANNU REV GENET, V43, P167, DOI 10.1146/annurev-genet-102108-134805; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Balbi KJ, 2009, MOL BIOL EVOL, V26, P345, DOI 10.1093/molbev/msn252; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; DIEZVILLASENOR C, 2010, MICROBIOLOGY; Dobrindt U, 2005, INT J MED MICROBIOL, V295, P357, DOI 10.1016/j.ijmm.2005.07.009; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fouts DE, 2006, NUCLEIC ACIDS RES, V34, P5839, DOI 10.1093/nar/gkl732; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; KRUGER DH, 1983, MICROBIOL REV, V47, P345; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Lerat E, 2004, GENOME RES, V14, P2273, DOI 10.1101/gr.2925604; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; NAKATA A, 1989, J BACTERIOL, V171, P3553, DOI 10.1128/jb.171.6.3553-3556.1989; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Price EP, 2007, APPL ENVIRON MICROB, V73, P3431, DOI 10.1128/AEM.02702-06; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Rocha EPC, 2003, GENOME RES, V13, P1123, DOI 10.1101/gr.966203; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; SAVAGEAU MA, 1983, AM NAT, V122, P732, DOI 10.1086/284168; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shah SA, 2009, BIOCHEM SOC T, V37, P23, DOI 10.1042/BST0370023; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Touchon M, 2007, MOL BIOL EVOL, V24, P969, DOI 10.1093/molbev/msm014; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Vulic M, 1997, P NATL ACAD SCI USA, V94, P9763, DOI 10.1073/pnas.94.18.9763; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Yang F, 2005, NUCLEIC ACIDS RES, V33, P6445, DOI 10.1093/nar/gki954; Zhang J, 2010, J MED MICROBIOL, V59, P285, DOI 10.1099/jmm.0.016949-0; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	54	169	183	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11126	10.1371/journal.pone.0011126	http://dx.doi.org/10.1371/journal.pone.0011126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559554	Green Submitted, Green Published, gold			2022-12-27	WOS:000278775900016
J	Zamborlini, A; Renault, N; Saib, A; Delelis, O				Zamborlini, Alessia; Renault, Noemie; Saib, Ali; Delelis, Olivier			Early Reverse Transcription Is Essential for Productive Foamy Virus Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY; HUMAN MACROPHAGES; HIV-1 INTEGRASE; GAG PROTEIN; TYPE-1 DNA; REPLICATION; EXPRESSION; CLEAVAGE; CIRCLES; GENOME	Background: Although viral RNA constitutes the majority of nucleic acids packaged in virions, a late occurring step of reverse transcription leads to the presence of infectious viral cDNA in foamy virus particles. This peculiarity distinguishes them from the rest of the retroviral family. Principal Findings: To evaluate the respective contribution of these viral nucleic acids in the replication of foamy viruses, their fate was studied by real-time PCR and RT-PCR early after infection, in the presence or in the absence of AZT. We found that an early reverse transcription step, which occurs during the first hours post-entry, is absolutely required for productive infection. Remarkably, sensitivity to AZT can be counteracted by increasing the multiplicity of infection (moi). We also show that 2-LTR circular viral DNA, which appears as soon as four hours post-infection, is transcriptionally competent. Conclusion: Taken together, our data demonstrate that an early reverse transcription process, which takes place soon after viral entry, is indispensable for infectivity of FVs at low moi, when the amount of DNA-containing particles is not sufficient to lead to a productive infection. This study demonstrates a key role of the packaged viral RNA in the foamy virus infection, suggesting that the replication of this virus can be achieved by involving either viral DNA or RNA genome, depending on the condition of infection.	[Zamborlini, Alessia; Renault, Noemie; Saib, Ali] Univ Paris Diderot, CNRS, INSERM, Inst Univ Hematol,UMR7212,U944, Paris, France; [Saib, Ali] Conservatoire Natl Arts & Metiers, Chaire Biol, Paris, France; [Delelis, Olivier] ENS Cachan, CNRS, LBPA, Cachan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Zamborlini, A (corresponding author), Univ Paris Diderot, CNRS, INSERM, Inst Univ Hematol,UMR7212,U944, Paris, France.	delelis@lbpa.ens-cachan.fr	Zamborlini, Alessia/ABE-2256-2021	Zamborlini, Alessia/0000-0002-8902-1996	Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS); F. Lacoste	Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS)(ANRSFrench National Research Agency (ANR)); F. Lacoste	This work is supported by the Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS) and by F. Lacoste. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banda M, 2008, MUTAT RES-GEN TOX EN, V649, P126, DOI 10.1016/j.mrgentox.2007.08.005; Brussel A, 2004, J VIROL, V78, P11263, DOI 10.1128/JVI.78.20.11263-11271.2004; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; DARLIX JL, 1990, J MOL BIOL, V216, P689, DOI 10.1016/0022-2836(90)90392-Y; Delelis O, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-31; Delelis O, 2004, CURR OPIN MICROBIOL, V7, P400, DOI 10.1016/j.mib.2004.06.009; Delelis O, 2003, J VIROL, V77, P8141, DOI 10.1128/JVI.77.14.8141-8146.2003; Delelis Olivier, 2005, Methods Mol Biol, V304, P155; Delelis O, 2008, J BIOL CHEM, V283, P27838, DOI 10.1074/jbc.M803257200; Delelis O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000608; Delelis O, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-114; Flugel RM, 2003, CURR TOP MICROBIOL, V277, P63; Gillim-Ross L, 2005, VIRAL IMMUNOL, V18, P190, DOI 10.1089/vim.2005.18.190; Kelly J, 2008, VIROLOGY, V372, P300, DOI 10.1016/j.virol.2007.11.007; KLOTMAN ME, 1992, P NATL ACAD SCI USA, V89, P1148, DOI 10.1073/pnas.89.3.1148b; Lehmann-Che J, 2005, J VIROL, V79, P9244, DOI 10.1128/JVI.79.14.9244-9253.2005; Lo YT, 2010, J VIROL, V84, P2832, DOI 10.1128/JVI.02435-09; Merkulov GV, 1996, J VIROL, V70, P5548, DOI 10.1128/JVI.70.8.5548-5556.1996; Moebes A, 1997, J VIROL, V71, P7305, DOI 10.1128/JVI.71.10.7305-7311.1997; Pierson TC, 2002, J VIROL, V76, P4138, DOI 10.1128/JVI.76.8.4138-4144.2002; Poon B, 2007, J VIROL, V81, P10515, DOI 10.1128/JVI.00947-07; Rinke CS, 2002, J VIROL, V76, P7560, DOI 10.1128/JVI.76.15.7560-7570.2002; Roy J, 2003, J VIROL, V77, P11324, DOI 10.1128/JVI.77.21.11324-11331.2003; Tobaly-Tapiero J, 2001, J VIROL, V75, P4367, DOI 10.1128/JVI.75.9.4367-4375.2001; Tobaly-Tapiero J, 2008, TRAFFIC, V9, P1717, DOI 10.1111/j.1600-0854.2008.00792.x; Trobridge GD, 1998, HUM GENE THER, V9, P2517, DOI 10.1089/10430349850019355; TRONO D, 1992, J VIROL, V66, P4893, DOI 10.1128/JVI.66.8.4893-4900.1992; Wu YT, 2003, J VIROL, V77, P10376, DOI 10.1128/JVI.77.19.10376-10382.2003; Wu YT, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-61; Yu SF, 1996, SCIENCE, V271, P1579, DOI 10.1126/science.271.5255.1579; Yu SF, 1999, J VIROL, V73, P1565, DOI 10.1128/JVI.73.2.1565-1572.1999; YU SF, 1993, J VIROL, V67, P6618, DOI 10.1128/JVI.67.11.6618-6624.1993	32	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11023	10.1371/journal.pone.0011023	http://dx.doi.org/10.1371/journal.pone.0011023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552014	Green Published, gold, Green Submitted			2022-12-27	WOS:000278662900006
J	Li, AH; Waddell, SJ; Hinds, J; Malloff, CA; Bains, M; Hancock, RE; Lam, WL; Butcher, PD; Stokes, RW				Li, Alice H.; Waddell, Simon J.; Hinds, Jason; Malloff, Chad A.; Bains, Manjeet; Hancock, Robert E.; Lam, Wan L.; Butcher, Philip D.; Stokes, Richard W.			Contrasting Transcriptional Responses of a Virulent and an Attenuated Strain of Mycobacterium tuberculosis Infecting Macrophages	PLOS ONE			English	Article							GENOMIC ANALYSIS; GENE-EXPRESSION; BOVIS BCG; 2-COMPONENT SYSTEM; MURINE MACROPHAGES; ESCHERICHIA-COLI; HYPOXIC RESPONSE; TUBERCLE-BACILLI; INTERFERON-GAMMA; REGULATOR PHOP	Background: H37Rv and H37Ra are well-described laboratory strains of Mycobacterium tuberculosis derived from the same parental strain, H37, that show dramatically different pathogenic phenotypes. Methodology/Principal Findings: In this study, the transcriptomes of the two strains during axenic growth in broth and during intracellular growth within murine bone-marrow macrophages were compared by whole genome expression profiling. We identified and compared adaptations of either strain upon encountering an intracellular environment, and also contrasted the transcriptomes of the two strains while inside macrophages. In the former comparison, both strains induced genes that would facilitate intracellular survival including those involved in mycobactin synthesis and fatty acid metabolism. However, this response was stronger and more extensive for H37Rv than for H37Ra. This was manifested as the differential expression of a greater number of genes and an increased magnitude of expression for these genes in H37Rv. In comparing intracellular transcriptional signatures, fifty genes were found to be differentially expressed between the strains. Of these fifty, twelve were under control of the PhoPR regulon. Further differences between strains included genes whose products were members of the ESAT-6 family of proteins, or were associated with their secretion. Conclusions/Significance: Along with the recent identification of single nucleotide polymorphisms in H37Ra when compared to H37Rv, our demonstration of differential expression of PhoP-regulated and ESX-1 region-related genes during macrophage infection further highlights the significance of these genes in the attenuation of H37Ra.	[Li, Alice H.; Malloff, Chad A.; Lam, Wan L.; Stokes, Richard W.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Stokes, Richard W.] Univ British Columbia, Dept Paediat, Vancouver, BC, Canada; [Bains, Manjeet; Hancock, Robert E.; Stokes, Richard W.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Stokes, Richard W.] British Columbia Childrens Hosp, Div Infect Dis, Vancouver, BC, Canada; [Waddell, Simon J.; Hinds, Jason; Butcher, Philip D.] St Georges Univ London, Div Cellular & Mol Med, Dept Med Microbiol, Ctr Infect, London, England	University of British Columbia; University of British Columbia; University of British Columbia; BC Childrens Hospital; University of British Columbia; St Georges University London	Li, AH (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01605 USA.	rstokes@interchange.ubc.ca	Waddell, Simon J/A-9170-2013; Hancock, Robert E. W./E-1145-2013	Waddell, Simon J/0000-0002-3684-9116; Hancock, Robert E. W./0000-0001-5989-8503; Butcher, Philip/0000-0003-1223-9097; Hinds, Jason/0000-0002-2739-1908	Canadian Bacterial Diseases Network, Networks of Centres of Excellence; British Columbia Lung Association; British Columbia TB Vets Foundation; Child and Family Research Institute; Department of Pathology, University of British Columbia; MRC [G0802079] Funding Source: UKRI; Medical Research Council [G0802079] Funding Source: researchfish	Canadian Bacterial Diseases Network, Networks of Centres of Excellence; British Columbia Lung Association; British Columbia TB Vets Foundation; Child and Family Research Institute; Department of Pathology, University of British Columbia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Canadian Bacterial Diseases Network, Networks of Centres of Excellence, the British Columbia Lung Association, and the British Columbia TB Vets Foundation. R. W. S. is the recipient of a Child and Family Research Institute Investigatorship Award. A. L. was supported by a Hardwick Fellowship from the Department of Pathology, University of British Columbia and a graduate fellowship from the Child and Family Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN P, 1991, INFECT IMMUN, V59, P1905, DOI 10.1128/IAI.59.6.1905-1910.1991; Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Belisle JT, 1998, METH MOL B, V101, P31, DOI 10.1385/0-89603-471-2:31; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Bolhuis A, 1999, J BIOL CHEM, V274, P24585, DOI 10.1074/jbc.274.35.24585; Brandt L, 1996, J IMMUNOL, V157, P3527; Brosch R, 1999, INFECT IMMUN, V67, P5768, DOI 10.1128/IAI.67.11.5768-5774.1999; Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COLLINS FM, 1969, AM REV RESPIR DIS, V100, P631; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; DESSEN A, 1995, SCIENCE, V267, P1638, DOI 10.1126/science.7886450; Dullaghan EM, 2002, MICROBIOL-SGM, V148, P3111, DOI 10.1099/00221287-148-10-3111; DUNN PL, 1995, INFECT IMMUN, V63, P3428, DOI 10.1128/IAI.63.9.3428-3437.1995; Elhay MJ, 1998, INFECT IMMUN, V66, P3454, DOI 10.1128/IAI.66.7.3454-3456.1998; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gao Q, 2004, TUBERCULOSIS, V84, P188, DOI 10.1016/j.tube.2003.12.013; Gonzalo-Asensio J, 2008, J BACTERIOL, V190, P7068, DOI 10.1128/JB.00712-08; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; GOREN MB, 1974, INFECT IMMUN, V9, P142, DOI 10.1128/IAI.9.1.142-149.1974; Hampshire T, 2004, TUBERCULOSIS, V84, P228, DOI 10.1016/j.tube.2003.12.010; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; IMAEDA T, 1985, INT J SYST BACTERIOL, V35, P147, DOI 10.1099/00207713-35-2-147; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Junqueira-Kipnis AP, 2006, IMMUNOLOGY, V119, P224, DOI 10.1111/j.1365-2567.2006.02427.x; KINGER AK, 1993, GENE, V131, P113, DOI 10.1016/0378-1119(93)90678-V; Kurtz S, 2006, INFECT IMMUN, V74, P6855, DOI 10.1128/IAI.01022-06; Lari N, 2001, J MED MICROBIOL, V50, P805, DOI 10.1099/0022-1317-50-9-805; LARSON CL, 1964, AM REV RESPIR DIS, V90, P742; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Li AH, 2008, MICROBIOL-SGM, V154, P2291, DOI 10.1099/mic.0.2008/019661-0; Li AH, 2008, J MICROBIOL METH, V75, P416, DOI 10.1016/j.mimet.2008.07.008; Liu KY, 2003, MICROBIOL-SGM, V149, P1829, DOI 10.1099/mic.0.26234-0; MacGurn JA, 2005, MOL MICROBIOL, V57, P1653, DOI 10.1111/j.1365-2958.2005.04800.x; MADIGAN MT, 1997, BROCK BIOL MICROORGA, P136; Madigan MT, 1997, BROCK BIOL MICROORGA, P473; MANGAN JA, 2002, GENE EXPRESSION HOST, P137; Marrakchi H, 2002, MICROBIOL-SGM, V148, P951, DOI 10.1099/00221287-148-4-951; Menendez MD, 2005, J BACTERIOL, V187, P534, DOI 10.1128/JB.187.2.534-543.2005; MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990; Mostowy S, 2004, TUBERCULOSIS, V84, P197, DOI 10.1016/j.tube.2004.02.002; Mustafa AS, 2006, INFECT IMMUN, V74, P4566, DOI 10.1128/IAI.01660-05; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Nielsen E, 1997, EMBO J, V16, P935, DOI 10.1093/emboj/16.5.935; Parish T, 2007, J BACTERIOL, V189, P3721, DOI 10.1128/JB.01740-06; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Pollock JM, 1997, INFECT IMMUN, V65, P2587, DOI 10.1128/IAI.65.7.2587-2592.1997; Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Ravn P, 1999, J INFECT DIS, V179, P637, DOI 10.1086/314640; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rivera-Marrero CA, 1998, MICROB PATHOGENESIS, V25, P307, DOI 10.1006/mpat.1998.0235; Rodriguez GM, 2006, J BACTERIOL, V188, P424, DOI 10.1128/JB.188.2.424-430.2006; Rodriguez GM, 2003, MOL MICROBIOL, V47, P1485, DOI 10.1046/j.1365-2958.2003.03384.x; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Rooyakkers AWJ, 2005, MICROB PATHOGENESIS, V39, P57, DOI 10.1016/j.micpath.2005.05.001; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sherman DR, 1999, BIOFACTORS, V10, P211, DOI 10.1002/biof.5520100219; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Singh CR, 2006, J IMMUNOL, V177, P3250, DOI 10.4049/jimmunol.177.5.3250; Soto CY, 2002, J CLIN MICROBIOL, V40, P3021, DOI 10.1128/JCM.40.8.3021-3024.2002; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; STEENKEN W, 1946, AM REV TUBERC PULM, V54, P62; STEENKEN W, 1961, AM REV RESPIR DIS, V83, P550; Stokes RW, 2009, FUTURE MICROBIOL, V4, P1317, DOI [10.2217/fmb.09.94, 10.2217/FMB.09.94]; STOKES RW, 1993, J IMMUNOL, V151, P7067; Stokes RW, 1998, J IMMUNOL, V160, P5514; Stokes RW, 1999, CELL IMMUNOL, V197, P1, DOI 10.1006/cimm.1999.1554; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Talaat AM, 2007, J BACTERIOL, V189, P4265, DOI 10.1128/JB.00011-07; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; Teng F, 2002, INFECT IMMUN, V70, P1991, DOI 10.1128/IAI.70.4.1991-1996.2002; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Vandesompele J, 2002, ANAL BIOCHEM, V303, P95, DOI 10.1006/abio.2001.5564; Waddell S. J., 2008, V465, P83, DOI 10.1007/978-1-59745-207-6_6; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Wang S, 2007, BIOCHEMISTRY-US, V46, P14751, DOI 10.1021/bi700970a; Wei J, 2000, J BACTERIOL, V182, P377, DOI 10.1128/JB.182.2.377-384.2000; Xu J, 2007, MOL MICROBIOL, V66, P787, DOI 10.1111/j.1365-2958.2007.05959.x; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375	88	36	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11066	10.1371/journal.pone.0011066	http://dx.doi.org/10.1371/journal.pone.0011066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548782	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000278599600022
J	Moore, AZ; Biggs, ML; Matteini, A; O'Connor, A; McGuire, S; Beamer, BA; Fallin, MD; Fried, LP; Walston, J; Chakravarti, A; Arking, DE				Moore, Ann Z.; Biggs, Mary L.; Matteini, Amy; O'Connor, Ashley; McGuire, Sarah; Beamer, Brock A.; Fallin, M. Danielle; Fried, Linda P.; Walston, Jeremy; Chakravarti, Aravinda; Arking, Dan E.			Polymorphisms in the Mitochondrial DNA Control Region and Frailty in Older Adults	PLOS ONE			English	Article							METABOLIC-RATE; FREE-RADICALS; DISEASES; REPLICATION; PHENOTYPE; LONGEVITY; PARADIGM; VARIANT; CANCER; RISK	Background: Mitochondria contribute to the dynamics of cellular metabolism, the production of reactive oxygen species, and apoptotic pathways. Consequently, mitochondrial function has been hypothesized to influence functional decline and vulnerability to disease in later life. Mitochondrial genetic variation may contribute to altered susceptibility to the frailty syndrome in older adults. Methodology/Principal Findings: To assess potential mitochondrial genetic contributions to the likelihood of frailty, mitochondrial DNA (mtDNA) variation was compared in frail and non-frail older adults. Associations of selected SNPs with a muscle strength phenotype were also explored. Participants were selected from the Cardiovascular Health Study (CHS), a population-based observational study (1989-1990, 1992-1993). At baseline, frailty was identified as the presence of three or more of five indicators (weakness, slowness, shrinking, low physical activity, and exhaustion). mtDNA variation was assessed in a pilot study, including 315 individuals selected as extremes of the frailty phenotype, using an oligonucleotide sequencing microarray based on the Revised Cambridge Reference Sequence. Three mtDNA SNPs were statistically significantly associated with frailty across all pilot participants or in sex-stratified comparisons: mt146, mt204, and mt228. In addition to pilot participants, 4,459 additional men and women with frailty classifications, and an overlapping subset of 4,453 individuals with grip strength measurements, were included in the study population genotyped at mt204 and mt228. In the study population, the mt204 C allele was associated with greater likelihood of frailty (adjusted odds ratio = 2.04, 95% CI = 1.07-3.60, p = 0.020) and lower grip strength (adjusted coefficient = 22.04, 95% CI = 23.33-20.74, p = 0.002). Conclusions: This study supports a role for mitochondrial genetic variation in the frailty syndrome and later life muscle strength, demonstrating the importance of the mitochondrial genome in complex geriatric phenotypes.	[Moore, Ann Z.; Matteini, Amy; Fallin, M. Danielle] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Biggs, Mary L.] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA; [O'Connor, Ashley; McGuire, Sarah; Chakravarti, Aravinda; Arking, Dan E.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Beamer, Brock A.] Univ Maryland, Sch Med, Div Gerontol, Baltimore, MD 21201 USA; [Fried, Linda P.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Walston, Jeremy] Johns Hopkins Univ, Sch Med, Dept Med, Div Geriatr Med & Gerontol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Washington; University of Washington Seattle; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Columbia University; Johns Hopkins University	Moore, AZ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.	arking@jhmi.edu			National Institute on Aging, Claude D. Pepper Older Americans Independence Centers [P30 AG021334]; National Heart, Lung, and Blood Institute [N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, U01 HL080295]; National Institute of Neurological Disorders and Stroke; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC045133, N01HC075150, N01HC055222, N01HC085079, N01HC015103, N01HC035129, N01HC085086] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021334] Funding Source: NIH RePORTER	National Institute on Aging, Claude D. Pepper Older Americans Independence Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institute on Aging, Claude D. Pepper Older Americans Independence Centers, Grant P30 AG021334 and by contract numbers N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, grant number U01 HL080295 from the National Heart, Lung, and Blood Institute, with additional contribution from the National Institute of Neurological Disorders and Stroke. A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, MITOMAP HUM MIT GEN; BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458; Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; Coskun PE, 2003, P NATL ACAD SCI USA, V100, P2174, DOI 10.1073/pnas.0630589100; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Fischel-Ghodsian N, 1998, AM J HUM GENET, V62, P15, DOI 10.1086/301695; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Liu VWS, 2003, HUM MUTAT, V22, P173, DOI 10.1002/humu.10244; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Ruggiero C, 2006, J GERONTOL A-BIOL, V61, P466, DOI 10.1093/gerona/61.5.466; Scheffler IE, 2008, MITOCHONDRIA, 2NDEDITION, P1; TAPPER DP, 1981, J BIOL CHEM, V256, P5109; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521; Zhou SY, 2006, J MOL DIAGN, V8, P476, DOI 10.2353/jmoldx.2006.060008	26	33	35	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11069	10.1371/journal.pone.0011069	http://dx.doi.org/10.1371/journal.pone.0011069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548781	Green Submitted, gold, Green Published			2022-12-27	WOS:000278599600025
J	Cuamba, N; Morgan, JC; Irving, H; Steven, A; Wondji, CS				Cuamba, Nelson; Morgan, John C.; Irving, Helen; Steven, Andrew; Wondji, Charles S.			High Level of Pyrethroid Resistance in an Anopheles funestus Population of the Chokwe District in Mozambique	PLOS ONE			English	Article							AFRICAN MALARIA VECTOR; INSECTICIDE RESISTANCE; CULICIDAE; MOSQUITO; DIPTERA	Background: Although Anopheles funestus is difficult to rear, it is crucial to analyse field populations of this malaria vector in order to successfully characterise mechanisms of insecticide resistance observed in this species in Africa. In this study we carried out a large-scale field collection and rearing of An. funestus from Mozambique in order to analyse its susceptibility status to insecticides and to broadly characterise the main resistance mechanisms involved in natural populations. Methodology/Principal Findings: 3,000 F(1) adults were obtained through larval rearing. WHO susceptibility assays indicated a very high resistance to pyrethroids with no mortality recorded after 1h30min exposure and less than 50% mortality at 3h30min. Resistance to the carbamate, bendiocarb was also noted, with 70% mortality after 1h exposure. In contrast, no DDT resistance was observed, indicating that no kdr-type resistance was involved. The sequencing of the acetylcholinesterase gene indicated the absence of the G119S and F455W mutations associated with carbamate and organophosphate resistance. This could explain the absence of malathion resistance in this population. Both biochemical assays and quantitative PCR implicated up-regulated P450 genes in pyrethroid resistance, with GSTs playing a secondary role. The carbamate resistance observed in this population is probably conferred by the observed altered AChE with esterases also involved. Conclusion/Significance: The high level of pyrethroid resistance in this population despite the cessation of pyrethroid use for IRS in 1999 is a serious concern for resistance management strategies such as rotational use of insecticides. As DDT has now been re-introduced for IRS, susceptibility to DDT needs to be closely monitored to prevent the appearance and spread of resistance to this insecticide.	[Cuamba, Nelson] Natl Inst Hlth, Maputo, Mozambique; [Morgan, John C.; Irving, Helen; Steven, Andrew; Wondji, Charles S.] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Cuamba, N (corresponding author), Natl Inst Hlth, Maputo, Mozambique.	c.s.wondji@liverpool.ac.uk	Wondji, Charles/AAG-1510-2020	Wondji, Charles S./0000-0003-0791-3673	Wellcome Trust; WHO/Gates Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); WHO/Gates Foundation(World Health OrganizationBill & Melinda Gates Foundation)	This work was supported by a Wellcome Trust Research Career Development Fellowship to CSW. NC was supported by a WHO/Gates Foundation Vector Biology and Control project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenya DA, 2008, INSECT MOL BIOL, V17, P19, DOI 10.1111/j.1365-2583.2008.00776.x; [Anonymous], 1968, ANOPHELINAE AFR S SA; Brooke BD, 2001, B ENTOMOL RES, V91, P265, DOI 10.1079/BER2001108; Casimiro S, 2006, J MED ENTOMOL, V43, P267, DOI 10.1603/0022-2585(2006)043[0267:IRIAFD]2.0.CO;2; Casimiro SLR, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-142; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Fontenille D, 2004, COMP IMMUNOL MICROB, V27, P357, DOI 10.1016/j.cimid.2004.03.005; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Nabeshima T, 2004, BIOCHEM BIOPH RES CO, V313, P794, DOI 10.1016/j.bbrc.2003.11.141; Okoye PN, 2008, T ROY SOC TROP MED H, V102, P591, DOI 10.1016/j.trstmh.2008.02.022; Penilla RP, 1998, MED VET ENTOMOL, V12, P217, DOI 10.1046/j.1365-2915.1998.00123.x; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; *WHO, 1998, WHOCDSCPCMAL9812D; Wondji CS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-34; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108	17	95	96	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11010	10.1371/journal.pone.0011010	http://dx.doi.org/10.1371/journal.pone.0011010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544036	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000278494900022
J	Hayakawa, I; Kawasaki, H				Hayakawa, Itaru; Kawasaki, Hiroshi			Rearrangement of Retinogeniculate Projection Patterns after Eye-Specific Segregation in Mice	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; VESICULAR GLUTAMATE TRANSPORTERS; EXPERIENCE-DEPENDENT PLASTICITY; RETINAL GANGLION-CELLS; PRIMARY VISUAL-CORTEX; SUPERIOR COLLICULUS; NEUROTROPHIC FACTOR; MONOCULAR DEPRIVATION; POSTNATAL-DEVELOPMENT; PRENATAL DEVELOPMENT	It has been of interest whether and when the rearrangement of neuronal circuits can be induced after projection patterns are formed during development. Earlier studies using cats reported that the rearrangement of retinogeniculate projections could be induced even after eye-specific segregation has occurred, but detailed and quantitative characterization of this rearrangement has been lacking. Here we delineate the structural changes of retinogeniculate projections in the C57BL/6 mouse in response to monocular enucleation (ME) after eye-specific segregation. When ME was performed after eye-specific segregation, rearrangement of retinogeniculate axons in the dorsal lateral geniculate nucleus (dLGN) was observed within 5 days. Although this rearrangement was observed both along the dorsomedial-ventrolateral and outer-inner axes in the dLGN, it occurred more rapidly along the outer-inner axis. We also examined the critical period for this rearrangement and found that the rearrangement became almost absent by the beginning of the critical period for ocular dominance plasticity in the primary visual cortex. Taken together, our findings serve as a framework for the assessment of phenotypes of genetically altered mouse strains as well as provide insights into the mechanisms underlying the rearrangement of retinogeniculate projections.	[Hayakawa, Itaru; Kawasaki, Hiroshi] Univ Tokyo, Grad Sch Med, Dept Mol & Syst Neurobiol, Tokyo, Japan; [Hayakawa, Itaru; Kawasaki, Hiroshi] Univ Tokyo, Global COE Program, Comprehens Ctr Educ & Res Chem Biol Dis, Tokyo, Japan; [Hayakawa, Itaru; Kawasaki, Hiroshi] Univ Tokyo, 21st Century COE Program, Ctr Integrated Brain Med Sci, Tokyo, Japan; [Kawasaki, Hiroshi] Japan Sci & Technol Agcy, PRESTO, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Hayakawa, I (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol & Syst Neurobiol, Tokyo, Japan.	kawasaki@m.u-tokyo.ac.jp	Kawasaki, Hiroshi/C-4404-2015; KAWASAKI, Hiroshi/L-3736-2015	Kawasaki, Hiroshi/0000-0002-2514-1497; Hayakawa, Itaru/0000-0002-6384-0205	MEXT; Japan Science and Technology Agency (JST); Human Frontier Science Program (HFSP)	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Human Frontier Science Program (HFSP)(Human Frontier Science Program)	This work was supported by the global COE program "Comprehensive Center of Education and Research for Chemical Biology of the Diseases'' from MEXT, the 21st Century COE program "Center for Integrated Brain Medical Sciences'' from MEXT, Grant-in-Aid for Scientific Research on Priority Areas-Elucidation of neural network function in the brain from MEXT, PRESTO from Japan Science and Technology Agency (JST), and Human Frontier Science Program (HFSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; Albright TD, 2000, CELL, V100, pS1; Cafferty WBJ, 2008, TRENDS NEUROSCI, V31, P215, DOI 10.1016/j.tins.2008.02.004; Caleo M, 2000, CURR BIOL, V10, P1155, DOI 10.1016/S0960-9822(00)00713-2; Coleman JE, 2009, NEUROSCIENCE, V161, P561, DOI 10.1016/j.neuroscience.2009.03.045; Conner JM, 1997, J NEUROSCI, V17, P2295; Cramer Karina S., 1995, Current Opinion in Neurobiology, V5, P106, DOI 10.1016/0959-4388(95)80094-8; Cramer KS, 1999, DEV BRAIN RES, V116, P79, DOI 10.1016/S0165-3806(99)00077-2; Cramer KS, 1997, DEV BRAIN RES, V98, P287, DOI 10.1016/S0165-3806(96)00188-5; Demas J, 2003, J NEUROSCI, V23, P2851; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feller MB, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-24; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fujiyama F, 2003, J COMP NEUROL, V465, P234, DOI 10.1002/cne.10848; FUKUDA Y, 1983, J NEUROPHYSIOL, V50, P46, DOI 10.1152/jn.1983.50.1.46; GODEMENT P, 1980, J COMP NEUROL, V190, P611, DOI 10.1002/cne.901900402; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Gordon JA, 1996, J NEUROSCI, V16, P3274; Guido W., 2006, DEV PLASTICITY SENSO, P208; GUILLERY RW, 1972, J COMP NEUROL, V146, P407, DOI 10.1002/cne.901460306; Hahm JO, 1999, J COMP NEUROL, V411, P327, DOI 10.1002/(SICI)1096-9861(19990823)411:2<327::AID-CNE12>3.0.CO;2-#; HAHM JO, 1991, NATURE, V351, P568, DOI 10.1038/351568a0; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; HICKEY TL, 1975, J COMP NEUROL, V161, P359, DOI 10.1002/cne.901610307; Hooks BM, 2007, NEURON, V56, P312, DOI 10.1016/j.neuron.2007.10.003; Huberman AD, 2005, NAT NEUROSCI, V8, P1013, DOI 10.1038/nn1505; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Iwai L, 2009, NEUROSCIENCE, V159, P1326, DOI 10.1016/j.neuroscience.2009.02.010; Jaubert-Miazza L, 2005, VISUAL NEUROSCI, V22, P661, DOI 10.1017/S0952523805225154; JEFFERY G, 1984, DEV BRAIN RES, V13, P81, DOI 10.1016/0165-3806(84)90079-8; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kawasaki H, 2004, J NEUROSCI, V24, P9962, DOI 10.1523/JNEUROSCI.2165-04.2004; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; LACHICA EA, 1990, J COMP NEUROL, V296, P303, DOI 10.1002/cne.902960210; Land PW, 2004, BRAIN RES, V996, P251, DOI 10.1016/j.brainres.2003.10.032; Leamey CA, 2003, J NEUROBIOL, V56, P153, DOI 10.1002/neu.10226; Leamey CA, 2001, J NEUROSCI, V21, P3871, DOI 10.1523/JNEUROSCI.21-11-03871.2001; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; LUND RD, 1973, BRAIN BEHAV EVOLUT, V8, P51, DOI 10.1159/000124347; LUND RD, 1971, SCIENCE, V171, P804, DOI 10.1126/science.171.3973.804; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; Mimura Y, 2002, NEUROREPORT, V13, P1925, DOI 10.1097/00001756-200210280-00019; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; OGAWAMEGURO R, 1992, EXP BRAIN RES, V89, P59; Penn AA, 1999, PEDIATR RES, V45, P447, DOI 10.1203/00006450-199904010-00001; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; REESE BE, 1988, BRAIN RES REV, V13, P119, DOI 10.1016/0165-0173(88)90017-3; ROBSON JA, 1978, SCIENCE, V201, P635, DOI 10.1126/science.675248; ROBSON JA, 1981, J COMP NEUROL, V195, P453, DOI 10.1002/cne.901950306; SHATZ CJ, 1983, J NEUROSCI, V3, P482; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; STRYKER MP, 1983, J NEUROSCI, V3, P1943; SUR M, 1982, NATURE, V300, P183, DOI 10.1038/300183a0; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Toda T, 2008, MOL CELL NEUROSCI, V39, P40, DOI 10.1016/j.mcn.2008.05.014; Toldi J, 1996, PROG NEUROBIOL, V48, P191, DOI 10.1016/0301-0082(95)00038-0; Upton AL, 1999, J NEUROSCI, V19, P7007, DOI 10.1523/JNEUROSCI.19-16-07007.1999; Williams AL, 2001, J COMP NEUROL, V430, P332; Yoshida M, 2009, NEUROSCI RES, V64, P118, DOI 10.1016/j.neures.2009.02.002	64	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11001	10.1371/journal.pone.0011001	http://dx.doi.org/10.1371/journal.pone.0011001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544023	Green Published, gold, Green Submitted			2022-12-27	WOS:000278494900013
J	Lin, GHY; Liu, YQ; Ambagala, T; Kwon, BS; Ohashi, PS; Watts, TH				Lin, Gloria H. Y.; Liu, Yuanqing; Ambagala, Thanuja; Kwon, Byoung S.; Ohashi, Pamela S.; Watts, Tania H.			Evaluating the Cellular Targets of Anti-4-1BB Agonist Antibody during Immunotherapy of a Pre-Established Tumor in Mice	PLOS ONE			English	Article							CD8(+) T-CELLS; SUPERIOR ANTITUMOR IMMUNITY; 4-1BB LIGAND; IN-VIVO; DENDRITIC CELLS; CUTTING EDGE; MONOCLONAL-ANTIBODIES; CANCER-IMMUNOTHERAPY; ENHANCED SURVIVAL; MEMORY CELLS	Background: Manipulation of the immune system represents a promising avenue for cancer therapy. Rational advances in immunotherapy of cancer will require an understanding of the precise correlates of protection. Agonistic antibodies against the tumor necrosis factor receptor family member 4-1BB are emerging as a promising tool in cancer therapy, with evidence that these antibodies expand both T cells as well as innate immune cells. Depletion studies have suggested that several cell types can play a role in these immunotherapeutic regimens, but do not reveal which cells must directly receive the 4-1BB signals for effective therapy. Methodology/Principal Findings: We show that re-activated memory T cells are superior to resting memory T cells in control of an 8-day pre-established E.G7 tumor in mice. We find that ex vivo activation of the memory T cells allows the activated effectors to continue to divide and enter the tumor, regardless of antigen-specificity; however, only antigen-specific reactivated memory T cells show any efficacy in tumor control. When agonistic anti-4-1BB antibody is combined with this optimized adoptive T cell therapy, 80% of mice survive and are fully protected from tumor rechallenge. Using 4-1BB-deficient mice and mixed bone marrow chimeras, we find that it is sufficient to have 4-1BB only on the endogenous host alpha beta T cells or only on the transferred T cells for the effects of anti-4-1BB to be realized. Conversely, although multiple immune cell types express 4-1BB and both T cells and APC expand during anti-4-1BB therapy, 4-1BB on cells other than alpha beta T cells is neither necessary nor sufficient for the effect of anti-4-1BB in this adoptive immunotherapy model. Conclusions/Significance: This study establishes alpha beta T cells rather than innate immune cells as the critical target in anti-4-1BB therapy of a pre-established tumor. The study also demonstrates that ex vivo activation of memory T cells prior to infusion allows antigen-specific tumor control without the need for reactivation of the memory T cells in the tumor.	[Lin, Gloria H. Y.; Liu, Yuanqing; Ambagala, Thanuja; Watts, Tania H.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Kwon, Byoung S.] Natl Canc Ctr, Cell & Immunobiol & R&D Ctr Canc Therapeut, Ilsan, South Korea; [Ohashi, Pamela S.] Princess Margaret Hosp, Campbell Family Canc Res Inst, Toronto, ON M4X 1K9, Canada; [Kwon, Byoung S.] Tulane Univ, Dept Med, New Orleans, LA 70118 USA	University of Toronto; National Cancer Center - Korea (NCC); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Tulane University	Lin, GHY (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	tania.watts@utoronto.ca		Ohashi, Pamela S./0000-0003-2915-9317	Canadian Cancer Society [018119]; National Cancer Center [NCC-0890830-3]; Korean Research Foundation [KRF-2005-084-E00001]; Ontario Graduate scholarship; Canadian Institutes of Health	Canadian Cancer Society(Canadian Cancer Society (CCS)); National Cancer Center; Korean Research Foundation(National Research Foundation of Korea); Ontario Graduate scholarship(Ontario Graduate Scholarship); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This research was supported by grant # 018119 from the Canadian Cancer Society http://www.ncic.cancer.ca (to T. H. W). B.S.K.'s lab is supported by grants from the National Cancer Center, NCC-0890830-3 and Korean Research Foundation, KRF-2005-084-E00001. G.H.Y.L. was supported by an Ontario Graduate scholarship and a Canadian Institutes of Health research studentship. T. H. W. holds the Sanofi Pasteur chair in Human Immunology at the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Bertram EM, 2002, J IMMUNOL, V168, P3777, DOI 10.4049/jimmunol.168.8.3777; BUDHU S, J EXP MED, V207, P223; BUDHU S, J EXP MED, V207, pS221; Bukczynski J, 2004, P NATL ACAD SCI USA, V101, P1291, DOI 10.1073/pnas.0306567101; Carrio R, 2004, J IMMUNOL, V172, P7315, DOI 10.4049/jimmunol.172.12.7315; Cheuk ATC, 2004, CANCER GENE THER, V11, P215, DOI 10.1038/sj.cgt.7700670; Choi BK, 2009, J IMMUNOL, V182, P4107, DOI 10.4049/jimmunol.0800459; DUBROT J, CANC IMMUNOL IMMUNOT; Ehrenstein MR, 2007, J EXP MED, V204, P2249, DOI 10.1084/jem.20071737; Futagawa T, 2002, INT IMMUNOL, V14, P275, DOI 10.1093/intimm/14.3.275; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gorak-Stolinska P, 2001, J LEUKOCYTE BIOL, V70, P756; Hermans IF, 1998, CANCER RES, V58, P3909; Hinrichs CS, 2009, P NATL ACAD SCI USA, V106, P17469, DOI 10.1073/pnas.0907448106; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Houot R, 2009, BLOOD, V114, P3431, DOI 10.1182/blood-2009-05-223958; Hurtado JC, 1997, J IMMUNOL, V158, P2600; Ito F, 2004, CANCER RES, V64, P8411, DOI 10.1158/0008-5472.CAN-04-0590; June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Klebanoff CA, 2009, BLOOD, V114, P1776, DOI 10.1182/blood-2008-12-192419; Kwon BS, 2002, J IMMUNOL, V168, P5483, DOI 10.4049/jimmunol.168.11.5483; Lee HW, 2002, J IMMUNOL, V169, P4882, DOI 10.4049/jimmunol.169.9.4882; Li Q, 2007, INT J BIOL SCI, V3, P455; Lin GHY, 2009, J IMMUNOL, V182, P934, DOI 10.4049/jimmunol.182.2.934; Lynch DH, 2008, IMMUNOL REV, V222, P277, DOI 10.1111/j.1600-065X.2008.00621.x; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Martinet O, 2000, J NATL CANCER I, V92, P931, DOI 10.1093/jnci/92.11.931; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Melero I, 1998, CELL IMMUNOL, V190, P167, DOI 10.1006/cimm.1998.1396; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Miller RE, 2002, J IMMUNOL, V169, P1792, DOI 10.4049/jimmunol.169.4.1792; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Murillo O, 2009, EUR J IMMUNOL, V39, P2424, DOI 10.1002/eji.200838958; Myers L, 2006, INT IMMUNOL, V18, P325, DOI 10.1093/intimm/dxh371; NARAZAKI H, 1941, BLOOD, P115; Niu LG, 2007, J IMMUNOL, V178, P4194, DOI 10.4049/jimmunol.178.7.4194; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; Pan PY, 2004, J IMMUNOL, V172, P4779, DOI 10.4049/jimmunol.172.8.4779; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Pulle G, 2006, J IMMUNOL, V176, P2739, DOI 10.4049/jimmunol.176.5.2739; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Robbins PF, 2004, J IMMUNOL, V173, P7125, DOI 10.4049/jimmunol.173.12.7125; Rolle CE, 2008, CANCER RES, V68, P2984, DOI 10.1158/0008-5472.CAN-07-3040; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schabowsky RH, 2009, VACCINE, V28, P512, DOI 10.1016/j.vaccine.2009.09.127; Sharma RK, 2009, CANCER RES, V69, P4319, DOI 10.1158/0008-5472.CAN-08-3141; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Spaner D, 1998, J IMMUNOL, V160, P2655; Stephan MT, 2007, NAT MED, V13, P1440, DOI 10.1038/nm1676; Takahashi C, 1999, J IMMUNOL, V162, P5037; TAMMANA S, 2009, HUM GENE THER; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Wilcox RA, 2002, J IMMUNOL, V169, P4230, DOI 10.4049/jimmunol.169.8.4230; Wilcox RA, 2002, J IMMUNOL, V168, P4262, DOI 10.4049/jimmunol.168.9.4262; Xu DP, 2004, INT J CANCER, V109, P499, DOI 10.1002/ijc.11696; Zhang H, 2007, J IMMUNOL, V179, P4910, DOI 10.4049/jimmunol.179.7.4910; Zhao YB, 2009, J IMMUNOL, V183, P5563, DOI 10.4049/jimmunol.0900447; Zhu YW, 2007, BLOOD, V109, P4882, DOI 10.1182/blood-2006-10-043463	64	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11003	10.1371/journal.pone.0011003	http://dx.doi.org/10.1371/journal.pone.0011003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20543982	Green Published, Green Submitted, gold			2022-12-27	WOS:000278494900015
J	Miklavc, P; Frick, M; Wittekindt, OH; Haller, T; Dietl, P				Miklavc, Pika; Frick, Manfred; Wittekindt, Oliver H.; Haller, Thomas; Dietl, Paul			Fusion-Activated Ca2+ Entry: An "Active Zone'' of Elevated Ca2+ during the Postfusion Stage of Lamellar Body Exocytosis in Rat Type II Pneumocytes	PLOS ONE			English	Article							MEMBRANE-FUSION; COMPENSATORY ENDOCYTOSIS; NEUROENDOCRINE CELLS; REGULATED EXOCYTOSIS; SURFACTANT RELEASE; PORE EXPANSION; VESICLE FUSION; CALCIUM; MECHANISMS; SECRETION	Background: Ca2+ is essential for vesicle fusion with the plasma membrane in virtually all types of regulated exocytoses. However, in contrast to the well-known effects of a high cytoplasmic Ca2+ concentration ([Ca2+](c)) in the prefusion phase, the occurrence and significance of Ca2+ signals in the postfusion phase have not been described before. Methodology/Principal Findings: We studied isolated rat alveolar type II cells using previously developed imaging techniques. These cells release pulmonary surfactant, a complex of lipids and proteins, from secretory vesicles (lamellar bodies) in an exceptionally slow, Ca2+- and actin-dependent process. Measurements of fusion pore formation by darkfield scattered light intensity decrease or FM 1-43 fluorescence intensity increase were combined with analysis of [Ca2+](c) by ratiometric Fura-2 or Fluo-4 fluorescence measurements. We found that the majority of single lamellar body fusion events were followed by a transient (t(1/2) of decay - 3.2 s) rise of localized [Ca2+](c) originating at the site of lamellar body fusion. [Ca2+](c) increase followed with a delay of similar to 0.2-0.5 s (method-dependent) and in the majority of cases this signal propagated throughout the cell (at similar to 10 mm/s). Removal of Ca2+ from, or addition of Ni2+ to the extracellular solution, strongly inhibited these [Ca2+](c) transients, whereas Ca2+ store depletion with thapsigargin had no effect. Actin-GFP fluorescence around fused LBs increased several seconds after the rise of [Ca2+](c). Both effects were reduced by the non-specific Ca2+ channel blocker SKF96365. Conclusions/Significance: Fusion-activated Ca2+ entry (FACE) is a new mechanism that leads to [Ca2+](c) transients at the site of vesicle fusion. Substantial evidence from this and previous studies indicates that fusion-activated Ca2+ entry enhances localized surfactant release from type II cells, but it may also play a role for compensatory endocytosis and other cellular functions.	[Miklavc, Pika; Frick, Manfred; Wittekindt, Oliver H.; Dietl, Paul] Univ Ulm, Inst Gen Physiol, Ulm, Germany; [Frick, Manfred; Haller, Thomas] Med Univ Innsbruck, Dept Physiol & Med Phys, Innsbruck, Austria	Ulm University; Medical University of Innsbruck	Miklavc, P (corresponding author), Univ Ulm, Inst Gen Physiol, Ulm, Germany.	paul.dietl@uni-ulm.de	Haller, Thomas/H-9036-2015; Frick, Manfred/E-1374-2012	Haller, Thomas/0000-0001-9147-4081; Frick, Manfred/0000-0002-4763-1104	Austrian Science Fund (FWF) [P15742, P15743, P20472]; Deutsche Forschungsgemeinschaft (DFG) [D1402]; Austrian Science Fund (FWF) [P 20472] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The work was supported by the Austrian Science Fund (FWF) grants P15742, P15743, and P20472, and Deutsche Forschungsgemeinschaft (DFG) grant D1402. Pika Miklavc was a research fellow of PulmoNet, a Marie Curie Research Training Network of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; BRECKENRIDGE LJ, 1987, P NATL ACAD SCI USA, V84, P1945, DOI 10.1073/pnas.84.7.1945; BURGOYNE RD, 1993, BIOCHEM J, V293, P305, DOI 10.1042/bj2930305; CECCARELLI B, 1980, J CELL BIOL, V87, P297, DOI 10.1083/jcb.87.1.297; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; Chintagari NR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009228; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Clapham DE, 2007, CELL, V129, P220, DOI 10.1016/j.cell.2007.03.034; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Dietl P, 2005, ANNU REV PHYSIOL, V67, P595, DOI 10.1146/annurev.physiol.67.040403.102553; Dietl P, 2010, CELL PHYSIOL BIOCHEM, V25, P1, DOI 10.1159/000272046; ECKENHOFF RG, 1988, AM J PHYSIOL, V254, pC614, DOI 10.1152/ajpcell.1988.254.5.C614; FINKELSTEIN A, 1986, ANNU REV PHYSIOL, V48, P163, DOI 10.1146/annurev.ph.48.030186.001115; Frick M, 2001, AM J RESP CELL MOL, V25, P306, DOI 10.1165/ajrcmb.25.3.4493; Frick M, 2001, BIOCHEM PHARMACOL, V61, P1161, DOI 10.1016/S0006-2952(01)00582-2; Haller T, 1999, AM J PHYSIOL-LUNG C, V277, pL893, DOI 10.1152/ajplung.1999.277.5.L893; Haller T, 1998, P NATL ACAD SCI USA, V95, P1579, DOI 10.1073/pnas.95.4.1579; Haller T, 2001, J CELL BIOL, V155, P279, DOI 10.1083/jcb.200102106; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Ju YK, 2007, CIRC RES, V100, P1605, DOI 10.1161/CIRCRESAHA.107.152181; Juvin V, 2007, MOL PHARMACOL, V72, P1258, DOI 10.1124/mol.107.037044; Kasai H, 1999, TRENDS NEUROSCI, V22, P88, DOI 10.1016/S0166-2236(98)01293-4; Mair N, 1999, AM J PHYSIOL-LUNG C, V276, pL376, DOI 10.1152/ajplung.1999.276.2.L376; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; Miklavc P, 2009, BIOCHEM J, V424, P7, DOI 10.1042/BJ20091094; Miklavc P, 2009, ANN NY ACAD SCI, V1152, P43, DOI 10.1111/j.1749-6632.2008.03989.x; MONCK JR, 1990, P NATL ACAD SCI USA, V87, P7804, DOI 10.1073/pnas.87.20.7804; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Ochs M, 2010, CELL PHYSIOL BIOCHEM, V25, P27, DOI 10.1159/000272061; Pickett JA, 2006, TRAFFIC, V7, P109, DOI 10.1111/j.1600-0854.2005.00372.x; Scepek S, 1998, EMBO J, V17, P4340, DOI 10.1093/emboj/17.15.4340; Singer W, 2003, BIOPHYS J, V84, P1344, DOI 10.1016/S0006-3495(03)74950-9; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; Smith RM, 2000, J CELL BIOL, V148, P755, DOI 10.1083/jcb.148.4.755; Sokac AM, 2006, MOL BIOL CELL, V17, P1495, DOI 10.1091/mbc.E05-10-0908; Sokac AM, 2003, NAT CELL BIOL, V5, P727, DOI 10.1038/ncb1025; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; Thorn Peter, 2009, Commun Integr Biol, V2, P315; Wadsworth SJ, 2000, J MEMBRANE BIOL, V174, P41, DOI 10.1007/s002320001030; Wang JP, 2005, TOXICOL APPL PHARM, V209, P134, DOI 10.1016/j.taap.2005.04.002; Yu HYE, 2007, NAT CELL BIOL, V9, P149, DOI 10.1038/ncb1527; Zimmerberg J, 1999, ADV DRUG DELIVER REV, V38, P197, DOI 10.1016/S0169-409X(99)00029-0	43	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e10982	10.1371/journal.pone.0010982	http://dx.doi.org/10.1371/journal.pone.0010982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20544027	Green Published, gold, Green Submitted			2022-12-27	WOS:000278494900008
J	Rodriguez, E; Daly, M				Rodriguez, Estefania; Daly, Marymegan			Phylogenetic Relationships among Deep-Sea and Chemosynthetic Sea Anemones: Actinoscyphiidae and Actinostolidae (Actiniaria: Mesomyaria)	PLOS ONE			English	Article							ANTHOZOA-ACTINIARIA; HYDROTHERMAL VENTS; CNIDARIA; EVOLUTION; GENE; BIOGEOGRAPHY; BIOLOGY; MODEL	Sea anemones (Cnidaria, Actiniaria) are present in all marine ecosystems, including chemosynthetic environments. The high level of endemicity of sea anemones in chemosynthetic environments and the taxonomic confusion in many of the groups to which these animals belong makes their systematic relationships obscure. We use five molecular markers to explore the phylogenetic relationships of the superfamily Mesomyaria, which includes most of the species that live in chemosynthetic, deep-sea, and polar sea habitats and to test the monophyly of the recently defined clades Actinostolina and Chemosynthina. We found that sea anemones of chemosynthetic environments derive from at least two different lineages: one lineage including acontiate deep-sea taxa and the other primarily encompassing shallow-water taxa.	[Rodriguez, Estefania] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Daly, Marymegan] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA	American Museum of Natural History (AMNH); University System of Ohio; Ohio State University	Rodriguez, E (corresponding author), Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA.	erodriguez@amnh.org	Rodríguez, Estefanía/AAK-4634-2021; Daly, Marymegan/F-9178-2011	Rodríguez, Estefanía/0000-0002-5590-6606; 	National Science Foundation (NSF) [EF-0531763]; Training Award for New Investigators (TAWNI); American Museum of Natural History	National Science Foundation (NSF)(National Science Foundation (NSF)); Training Award for New Investigators (TAWNI); American Museum of Natural History	This work was supported mainly by National Science Foundation (NSF) EF-0531763 to M. Daly. Through the project, NSF EF-0531763 funds have been available for fieldwork, lab work and salary for E. Rodriguez. Several of the key samples of this study were collected thanks to Kevin Zelnio, who was supported through a Training Award for New Investigators (TAWNI) from the ChEss (Biogeography of Chemosynthetic Ecosystems) project of the Census Marine Life (CoML). Additional support to E. R. was provided by the Lerner Gray Fund for Marine Research from the American Museum of Natural History for fieldwork. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson FE, 2004, MOL PHYLOGENET EVOL, V33, P440, DOI 10.1016/j.ympev.2004.06.015; Apakupakul K, 1999, MOL PHYLOGENET EVOL, V12, P350, DOI 10.1006/mpev.1999.0639; Bachraty C, 2009, DEEP-SEA RES PT I, V56, P1371, DOI 10.1016/j.dsr.2009.01.009; Baco AR, 2003, MAR ECOL PROG SER, V260, P109, DOI 10.3354/meps260109; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Cairns S.D., 1982, Antarctic Research Series, V34, P1; CARLGREN OSKAR, 1949, K SVENSKA VETENSKAPSAKAD HANDL, V1, P1; Chen CA, 2000, MAR BIOTECHNOL, V2, P146; Chen CA, 2002, MOL PHYLOGENET EVOL, V23, P137, DOI 10.1016/S1055-7903(02)00008-8; CHILDRESS JJ, 1992, OCEANOGR MAR BIOL, V30, P337; Daly M, 2008, MOL PHYLOGENET EVOL, V48, P292, DOI 10.1016/j.ympev.2008.02.022; Daly M, 2006, MAR BIOL, V148, P1241, DOI 10.1007/s00227-005-0170-7; Daly M, 2003, ZOOL J LINN SOC-LOND, V139, P419, DOI 10.1046/j.1096-3642.2003.00084.x; Daly M, 2002, EVOLUTION, V56, P502; Daly M, 2007, J NAT HIST, V41, P1, DOI 10.1080/00222930601121775; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; *FAUT, 2009, HEX WORLD; Fautin Daphne Gail, 2009, Bulletin of Zoological Nomenclature, V66, P312; Fisher CR, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.75; Geller JB, 2001, EVOLUTION, V55, P1781; Goloboff P, 2008, CLADISTICS, V24, P91; GUSMAO L, MOL PHYL EV IN PRESS; HURTADO LA, 2002, THESIS RUTGERS U NEW; Jones WJ, 2006, MAR BIOL, V148, P841, DOI 10.1007/s00227-005-0115-1; Kiel S, 2006, SCIENCE, V313, P1429, DOI 10.1126/science.1126286; Little CTS, 2003, TRENDS ECOL EVOL, V18, P582, DOI 10.1016/j.tree.2003.08.009; MANUEL RL, 1981, SYNOPSIS BRIT FAUNA, V18; McArthur AG, 1998, GEOL SOC SPEC PUBL, V148, P271, DOI 10.1144/GSL.SP.1998.148.01.15; NEWMAN WA, 1985, B BIOL SOC WASH, V6, P231; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rodriguez E, 2005, HELGOLAND MAR RES, V59, P301, DOI 10.1007/s10152-005-0005-4; Rodriguez E., 2007, ZOOTAXA, V1668, P131; Rodriguez E, 2008, INVERTEBR SYST, V22, P439, DOI 10.1071/IS07053; SANAMYAN NP, 2007, INVERTEBRATE ZOOLOGY, V4, P83, DOI DOI 10.15298/INVERTZ00L.04.1.07; Sebastian S, 2007, DEEP-SEA RES PT II, V54, P1727, DOI 10.1016/j.dsr2.2007.07.004; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; Song JG, 2003, ACTA PHYS-CHIM SIN, V19, P283, DOI 10.3866/PKU.WHXB20030322; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TUNNICLIFFE V, 1991, OCEANOGR MAR BIOL, V29, P319; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; Vrijenhoek RC, 2009, DEEP-SEA RES PT II, V56, P1713, DOI 10.1016/j.dsr2.2009.05.016; WHEELER WC, 1993, CLADISTICS, V9, P1, DOI 10.1111/j.1096-0031.1993.tb00207.x; Yamaguchi T, 2004, J MAR BIOL ASSOC UK, V84, P111, DOI 10.1017/S0025315404008975h; Zelnio KA, 2009, MAR BIOL RES, V5, P547, DOI 10.1080/17451000902729662; [No title captured]	49	26	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10958	10.1371/journal.pone.0010958	http://dx.doi.org/10.1371/journal.pone.0010958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532040	Green Published, gold, Green Submitted			2022-12-27	WOS:000278380500004
J	Zeng, M; Kikuchi, H; Pino, MS; Chung, DC				Zeng, Min; Kikuchi, Hirotoshi; Pino, Maria S.; Chung, Daniel C.			Hypoxia Activates the K-Ras Proto-Oncogene to Stimulate Angiogenesis and Inhibit Apoptosis in Colon Cancer Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SIGNALING PATHWAYS; UP-REGULATION; EXPRESSION; ERK1/2; AKT; PROLIFERATION; INTERLEUKIN-8; METABOLISM; INDUCTION	The KRAS proto-oncogene plays a key role in the development of many human tumors and is commonly activated by somatic mutation or signaling through specific growth factor receptors. However, the interaction between the micro-environment and K-ras activity has not been defined. Hypoxia invariably develops as tumors outgrow their supply of oxygen. A series of well-orchestrated cellular adaptations occur that stimulate angiogenesis and enhance survival of the tumor in hypoxic conditions. Our previous studies demonstrated that mutant KRAS alleles can interact with hypoxia to induce vascular endothelial growth factor (VEGF) in colon cancer. We sought to determine whether similar hypoxic responses are also present in tumors without a KRAS mutation. Hypoxia consistently increased the levels of activated, GTP-bound K-ras in colon cancer cell lines with a wild-type KRAS gene, and this depended upon the activation of c-Src. Inhibition of c-Src by PP2 treatment or siRNA knockdown blocked the hypoxic activation of K-ras. This activation of K-ras did not depend upon EGFR and resulted in the phosphorylation of Akt and induction of VEGF expression. In addition, activation of K-ras significantly blocked apoptosis in hypoxic conditions. These studies reveal a unique adaptive mechanism in hypoxia that activates K-ras signaling in the absence of a mutant KRAS oncogene.	[Zeng, Min; Kikuchi, Hirotoshi; Pino, Maria S.; Chung, Daniel C.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit,Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Zeng, M (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit,Dept Med, Boston, MA 02115 USA.	dchung@partners.org		Kikuchi, Hirotoshi/0000-0002-1776-1020	National Institutes of Health [CA92594]; Kate J. and Dorothy L. Clapp Fund; NATIONAL CANCER INSTITUTE [R01CA092594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kate J. and Dorothy L. Clapp Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institutes of Health grant CA92594; Kate J. and Dorothy L. Clapp Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berra E, 2000, CANCER METAST REV, V19, P139, DOI 10.1023/A:1026506011458; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Blancher C, 2001, CANCER RES, V61, P7349; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Cho DH, 2007, ONCOGENE, V26, P2809, DOI 10.1038/sj.onc.1210080; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Franovic A, 2007, P NATL ACAD SCI USA, V104, P13092, DOI 10.1073/pnas.0702387104; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Jiang ZJ, 2002, BIOCHEM BIOPH RES CO, V294, P726, DOI 10.1016/S0006-291X(02)00540-5; Lee SM, 2006, CANCER LETT, V242, P231, DOI 10.1016/j.canlet.2005.11.001; Lei H, 2009, J BIOL CHEM, V284, P6329, DOI 10.1074/jbc.M808426200; Mizukami Y, 2005, NAT MED, V11, P992, DOI 10.1038/nm1294; Mizukami Y, 2004, CANCER RES, V64, P1765, DOI 10.1158/0008-5472.CAN-03-3017; Mizukami Y, 2006, J BIOL CHEM, V281, P13957, DOI 10.1074/jbc.M511763200; Pham NA, 2009, INT J CANCER, V124, P280, DOI 10.1002/ijc.23912; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Singh A, 2005, FASEB J, V19, P161, DOI 10.1096/fj.04-2584hyp; Sodhi A, 2001, BIOCHEM BIOPH RES CO, V287, P292, DOI 10.1006/bbrc.2001.5532; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wang Y, 2009, NAT MED, V15, P319, DOI 10.1038/nm.1922; Wu WD, 2002, J BIOL CHEM, V277, P24252, DOI 10.1074/jbc.M200437200; Xu L, 2004, CLIN CANCER RES, V10, P701, DOI 10.1158/1078-0432.CCR-0953-03; Yeh JJ, 2009, MOL CANCER THER, V8, P834, DOI 10.1158/1535-7163.MCT-08-0972; Zhang XB, 2001, CANCER RES, V61, P6050; Zhu YH, 2005, ONCOGENE, V24, P6555, DOI 10.1038/sj.onc.1208800	26	46	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10966	10.1371/journal.pone.0010966	http://dx.doi.org/10.1371/journal.pone.0010966			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532039	gold, Green Submitted, Green Published			2022-12-27	WOS:000278380500011
J	Alkaitis, MS; Solorzano, C; Landry, RP; Piomelli, D; Deleo, JA; Romero-Sandoval, EA				Alkaitis, Matthew S.; Solorzano, Carlos; Landry, Russell P.; Piomelli, Daniele; Deleo, Joyce A.; Romero-Sandoval, E. Alfonso			Evidence for a Role of Endocannabinoids, Astrocytes and p38 Phosphorylation in the Resolution of Postoperative Pain	PLOS ONE			English	Article							CB2 CANNABINOID RECEPTORS; ACTIVATED PROTEIN-KINASE; NEUROPATHIC PAIN; RAT MODEL; MECHANICAL HYPERSENSITIVITY; INFLAMMATORY PAIN; MAP KINASE; CONTRIBUTES; ANANDAMIDE; BRAIN	Background: An alarming portion of patients develop persistent or chronic pain following surgical procedures, but the mechanisms underlying the transition from acute to chronic pain states are not fully understood. In general, endocannabinoids (ECBs) inhibit nociceptive processing by stimulating cannabinoid receptors type 1 (CB(1)) and type 2 (CB(2)). We have previously shown that intrathecal administration of a CB(2) receptor agonist reverses both surgical incision-induced behavioral hypersensitivity and associated over-expression of spinal glial markers. We therefore hypothesized that endocannabinoid signaling promotes the resolution of acute postoperative pain bymodulating pro-inflammatory signaling in spinal cord glial cells. Methodology/Principal Findings: To test this hypothesis, rats receiving paw incision surgery were used as a model of acute postoperative pain that spontaneously resolves. We first characterized the concentration of ECBs and localization of CB(1) and CB(2) receptors in the spinal cord following paw incision. We then administered concomitant CB(1) and CB(2) receptor antagonists/inverse agonists (AM281 and AM630, 1 mg.kg(-1) each, i.p.) during the acute phase of paw incision-induced mechanical allodynia and evaluated the expression of glial cell markers and phosphorylated p38 (a MAPK associated with inflammation) in the lumbar dorsal horn. Dual blockade of CB(1) and CB(2) receptor signaling prevented the resolution of postoperative allodynia and resulted in persistent over-expression of spinal Glial Fibrillary Acidic Protein (GFAP, an astrocytic marker) and phospho-p38 in astrocytes. We provide evidence for the functional significance of these astrocytic changes by demonstrating that intrathecal administration of propentofylline (50 mu g, i.t.) attenuated both persistent behavioral hypersensitivity and over-expression of GFAP and phospho-p38 in antagonist-treated animals. Conclusions/Significance: Our results demonstrate that endocannabinoid signaling via CB(1) and CB(2) receptors is necessary for the resolution of paw incision-induced behavioral hypersensitivity and for the limitation of pro-inflammatory signaling in astrocytes following surgical insult. Our findings suggest that therapeutic strategies designed to enhance endocannabinoid signaling may prevent patients from developing persistent or chronic pain states following surgery.	[Alkaitis, Matthew S.; Landry, Russell P.; Deleo, Joyce A.; Romero-Sandoval, E. Alfonso] Dartmouth Med Sch, Neurosci Ctr Dartmouth, Lebanon, NH USA; [Alkaitis, Matthew S.] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford, England; [Solorzano, Carlos; Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Solorzano, Carlos; Piomelli, Daniele] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Landry, Russell P.; Deleo, Joyce A.; Romero-Sandoval, E. Alfonso] Dartmouth Med Sch, Dept Anesthesiol, Lebanon, NH USA; [Deleo, Joyce A.; Romero-Sandoval, E. Alfonso] Dartmouth Med Sch, Dept Pharmacol & Toxicol, Lebanon, NH USA	Dartmouth College; University of Oxford; University of California System; University of California Irvine; University of California System; University of California Irvine; Dartmouth College; Dartmouth College	Alkaitis, MS (corresponding author), Dartmouth Med Sch, Neurosci Ctr Dartmouth, Lebanon, NH USA.	Edgar.A.Romero-Sandoval@dartmouth.edu			Kaminsky Family Fund; National Institute of Drug Abuse [DA025211, DA11276]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011276, R01DA025211] Funding Source: NIH RePORTER	Kaminsky Family Fund; National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors would like to acknowledge the Kaminsky Family Fund (MA) (http://www.dartmouth.edu/ugar/undergrad/grants/index.html), the Office of Residential Life Class of 1989 Senior Scholars Program (MA) (http://www.dartmouth.edu/orl/life-in-res/spec-pgms/senior.html), American Pain Society 2008 Future Leaders in Pain Research Small Grants (AR-S) (http://www.ampainsoc.org/) and the National Institute of Drug Abuse DA025211 (AR-S) and DA11276 (JAD) (http:// www.nida.nih.gov/) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Astarita G, 2008, J LIPID RES, V49, P48, DOI 10.1194/jlr.M700354-JLR200; Boyle DL, 2006, PLOS MED, V3, P1616, DOI 10.1371/journal.pmed.0030338; Brennan TJ, 1996, PAIN, V64, P493, DOI 10.1016/0304-3959(95)01441-1; Butler RK, 2008, PAIN, V140, P491, DOI 10.1016/j.pain.2008.10.002; Cadas H, 1997, J NEUROSCI, V17, P1226; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cosenza M, 2000, SYNAPSE, V38, P477, DOI 10.1002/1098-2396(20001215)38:4<477::AID-SYN13>3.0.CO;2-Y; Costa B, 2006, BRIT J PHARMACOL, V148, P1022, DOI 10.1038/sj.bjp.0706798; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Fioravanti B, 2008, J NEUROSCI, V28, P11593, DOI 10.1523/JNEUROSCI.3322-08.2008; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Garry EM, 2005, MOL CELL NEUROSCI, V30, P523, DOI 10.1016/j.mcn.2005.08.016; GRECO R, 2009, CEPHALALGIA; Guasti L, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-35; Guindon J, 2007, BRIT J PHARMACOL, V150, P693, DOI 10.1038/sj.bjp.0706990; Guindon J, 2009, CNS NEUROL DISORD-DR, V8, P403, DOI 10.2174/187152709789824660; Gwak YS, 2009, EXP NEUROL, V220, P154, DOI 10.1016/j.expneurol.2009.08.012; Hohmann AG, 2005, NATURE, V435, P1108, DOI 10.1038/nature03658; Hosohata Y, 1997, EUR J PHARMACOL, V321, pR1, DOI 10.1016/S0014-2999(97)00047-2; Ibrahim MM, 2005, P NATL ACAD SCI USA, V102, P3093, DOI 10.1073/pnas.0409888102; Ito N, 2009, ANESTHESIOLOGY, V111, P640, DOI 10.1097/ALN.0b013e3181b05f42; Ji RR, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-33; Jin SX, 2003, J NEUROSCI, V23, P4017; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Khasabova IA, 2008, J NEUROSCI, V28, P11141, DOI 10.1523/JNEUROSCI.2847-08.2008; Kim DS, 2009, PAIN, V143, P114, DOI 10.1016/j.pain.2009.02.006; Kinsey SG, 2009, J PHARMACOL EXP THER, V330, P902, DOI 10.1124/jpet.109.155465; La Rana G, 2006, J PHARMACOL EXP THER, V317, P1365, DOI 10.1124/jpet.105.100792; Lan R, 1999, AAPS PharmSci, V1, pE4; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Racz I, 2008, J NEUROSCI, V28, P12125, DOI 10.1523/JNEUROSCI.3400-08.2008; REGGIO PH, 1995, LIFE SCI, V56, P2025, DOI 10.1016/0024-3205(95)00185-9; Roche M, 2008, IMMUNOLOGY, V125, P263, DOI 10.1111/j.1365-2567.2008.02838.x; Romero-Sandoval A, 2008, BRAIN RES, V1219, P116, DOI 10.1016/j.brainres.2008.05.004; Romero-Sandoval A, 2008, ANESTHESIOLOGY, V108, P722, DOI 10.1097/ALN.0b013e318167af74; Romero-Sandoval A, 2007, ANESTHESIOLOGY, V106, P787, DOI 10.1097/01.anes.0000264765.33673.6c; Ross RA, 1999, BRIT J PHARMACOL, V126, P665, DOI 10.1038/sj.bjp.0702351; SAEZCASSANELLI JL, 2007, J NEUROCHEM; Scott DA, 2004, PAIN, V109, P124, DOI 10.1016/j.pain.2004.01.020; Sheng WS, 2009, J NEUROIMMUNE PHARM, V4, P244, DOI 10.1007/s11481-009-9147-5; Sorkin LS, 2009, NEUROSCIENCE, V162, P462, DOI 10.1016/j.neuroscience.2009.05.008; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Svensson CI, 2010, MOL INTERV, V10, P25, DOI 10.1124/mi.10.1.6; Sweitzer SM, 2001, J PHARMACOL EXP THER, V297, P1210; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Tawfik VL, 2008, NEUROSCIENCE, V152, P1086, DOI 10.1016/j.neuroscience.2008.01.065; Tawfik VL, 2007, BRAIN BEHAV IMMUN, V21, P238, DOI 10.1016/j.bbi.2006.07.001; Tawfik VL, 2006, GLIA, V54, P193, DOI 10.1002/glia.20365; Vignali M, 2009, GLIA, V57, P791, DOI 10.1002/glia.20807; Wen YR, 2009, ANESTHESIOLOGY, V110, P155, DOI 10.1097/ALN.0b013e318190bc16; Wu CR, 2008, ANESTHESIOLOGY, V108, P1100, DOI 10.1097/ALN.0b013e31817302b3; Zhu XY, 2006, PAIN, V125, P43, DOI 10.1016/j.pain.2006.04.027	58	54	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10891	10.1371/journal.pone.0010891	http://dx.doi.org/10.1371/journal.pone.0010891			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531936	gold, Green Published			2022-12-27	WOS:000278222100020
J	Isa, A; Nehlin, JO; Sabir, HJ; Andersen, TE; Gaster, M; Kassem, M; Barington, T				Isa, Adiba; Nehlin, Jan O.; Sabir, Hardee J.; Andersen, Tom E.; Gaster, Michael; Kassem, Moustapha; Barington, Torben			Impaired Cell Surface Expression of HLA-B Antigens on Mesenchymal Stem Cells and Muscle Cell Progenitors	PLOS ONE			English	Article								HLA class-I expression is weak in embryonic stem cells but increases rapidly during lineage progression. It is unknown whether all three classical HLA class-I antigens follow the same developmental program. In the present study, we investigated allele-specific expression of HLA-A, -B, and -C at the mRNA and protein levels on human mesenchymal stem cells from bone marrow and adipose tissue as well as striated muscle satellite cells and lymphocytes. Using multicolour flow cytometry, we found high cell surface expression of HLA-A on all stem cells and PBMC examined. Surprisingly, HLA-B was either undetectable or very weakly expressed on all stem cells protecting them from complement-dependent cytotoxicity (CDC) using relevant human anti-B and anti-Cw sera. IFN gamma stimulation for 48-72 h was required to induce full HLA-B protein expression. Quantitative real-time RT-PCR showed that IFN gamma induced a 9-42 fold increase of all six HLA-A,-B,-C gene transcripts. Interestingly, prior to stimulation, gene transcripts for all but two alleles were present in similar amounts suggesting that post-transcriptional mechanisms regulate the constitutive expression of HLA-A,-B, and -C. Locus-restricted expression of HLA-A, -B and -C challenges our current understanding of the function of these molecules as regulators of CD8(+) T-cell and NK-cell function and should lead to further inquiries into their expression on other cell types.	[Isa, Adiba; Nehlin, Jan O.; Sabir, Hardee J.; Barington, Torben] Univ So Denmark, Odense Univ Hosp, Dept Clin Immunol, Ctr Stem Cell Treatment, Odense, Denmark; [Andersen, Tom E.; Gaster, Michael; Kassem, Moustapha] Univ So Denmark, Odense Univ Hosp, Dept Endocrinol, Clin Mol Endocrinol KMEB, Odense, Denmark; [Andersen, Tom E.; Gaster, Michael; Kassem, Moustapha] Univ So Denmark, Ctr Med Biotechnol, Odense, Denmark; [Kassem, Moustapha] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11461, Saudi Arabia	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; King Saud University	Isa, A (corresponding author), Univ So Denmark, Odense Univ Hosp, Dept Clin Immunol, Ctr Stem Cell Treatment, Odense, Denmark.	aisa@health.sdu.dk	Kassem, Moustapha/J-7688-2013; Barington, Torben/R-6841-2019; Barington, Torben/C-3922-2009; Kassem, Moustapha/O-3819-2019; Nehlin, Jan O./AAR-8721-2020	Kassem, Moustapha/0000-0003-1557-0869; Barington, Torben/0000-0001-6968-148X; Kassem, Moustapha/0000-0003-1557-0869; Nehlin, Jan O./0000-0001-6038-5027	Lundbeck Foundation; Odense University Hospital	Lundbeck Foundation(Lundbeckfonden); Odense University Hospital	This study was supported by the Lundbeck Foundation and by Odense University Hospital. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apps R, 2009, IMMUNOLOGY, V127, P26, DOI 10.1111/j.1365-2567.2008.03019.x; Boulet S, 2008, AIDS, V22, P1487, DOI 10.1097/QAD.0b013e3282ffde7e; Boulet S, 2010, J IMMUNOL, V184, P2057, DOI 10.4049/jimmunol.0902621; Boyton RJ, 2007, CLIN EXP IMMUNOL, V149, P1, DOI 10.1111/j.1365-2249.2007.03424.x; BRODSKY FM, 1979, IMMUNOL REV, V47, P3, DOI 10.1111/j.1600-065X.1979.tb00288.x; Brouwer RE, 2002, HUM IMMUNOL, V63, P200, DOI 10.1016/S0198-8859(01)00381-0; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Browne SK, 2006, J IMMUNOL, V177, P8612, DOI 10.4049/jimmunol.177.12.8612; BUHRING HJ, 2009, ANN NY ACAD SCI, V1176, P134; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; BURNS JS, 2005, CANCER RES, V65, P3135; Cabrera CM, 2007, CELL BIOL INT, V31, P1072, DOI 10.1016/j.cellbi.2007.03.015; Castelli EC, 2009, HUM IMMUNOL, V70, P1020, DOI 10.1016/j.humimm.2009.07.028; CHEN E, 1986, MOL CELL BIOL, V6, P1698, DOI 10.1128/MCB.6.5.1698; CIFUENTESDIAZ C, 1992, MUSCLE NERVE, V15, P295, DOI 10.1002/mus.880150307; Crisan M, 2008, STEM CELLS, V26, P2425, DOI 10.1634/stemcells.2008-0325; DECOOPY P, 2006, DIABETOLOGIA, V49, P1973; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; FLEMING KA, 1981, J CLIN PATHOL, V34, P779, DOI 10.1136/jcp.34.7.779; Gaster M, 2002, DIABETES, V51, P921, DOI 10.2337/diabetes.51.4.921; Gaster M, 2001, APMIS, V109, P735, DOI 10.1034/j.1600-0463.2001.d01-140.x; GASTER M, 2001, APMIS, V109, P744; HAKEM R, 1991, J IMMUNOL, V147, P2384; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Harari A, 2007, P NATL ACAD SCI USA, V104, P16233, DOI 10.1073/pnas.0707570104; Hiraki A, 2004, ANTICANCER RES, V24, P1525; Johnson DR, 2003, J IMMUNOL, V170, P1894, DOI 10.4049/jimmunol.170.4.1894; Jonjic S, 2008, CURR OPIN IMMUNOL, V20, P30, DOI 10.1016/j.coi.2007.11.002; Kaiser BK, 2008, P NATL ACAD SCI USA, V105, P6696, DOI 10.1073/pnas.0802736105; Kawase T, 2007, BLOOD, V110, P1055, DOI 10.1182/blood-2007-02-075911; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kulkarni S, 2008, SEMIN IMMUNOL, V20, P343, DOI 10.1016/j.smim.2008.06.003; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Lewinsohn DA, 2007, PLOS PATHOG, V3, P1240, DOI 10.1371/journal.ppat.0030127; Maeurer MJ, 1996, J CLIN INVEST, V98, P1633, DOI 10.1172/JCI118958; Maeurer MJ, 1996, CLIN CANCER RES, V2, P641; Nasef A, 2008, REGEN MED, V3, P531, DOI 10.2217/17460751.3.4.531; Neumann-Haefelin C, 2006, HEPATOLOGY, V43, P563, DOI 10.1002/hep.21049; Nielsen C, 2004, LUPUS, V13, P510, DOI 10.1191/0961203303lu1052oa; ORTENBLAD N, 2005, BIOCHIM BIOPHYS ACTA, V1741, P214; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Reinders J, 2005, HUM IMMUNOL, V66, P912, DOI 10.1016/j.humimm.2005.06.010; Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI [10.1093/nar/gkg070, 10.1093/nar/GKG070]; Shereck E, 2007, PEDIATR BLOOD CANCER, V49, P615, DOI 10.1002/pbc.21158; Synnergren J, 2007, STEM CELLS, V25, P473, DOI 10.1634/stemcells.2006-0247; UCCELLI A, 2008, NAT REV IMMUNOL; Uchanska-Ziegler B, 2007, RHEUMATOLOGY, V46, P555, DOI 10.1093/rheumatology/kel390; van den Elsen PJ, 1998, IMMUNOGENETICS, V48, P208, DOI 10.1007/s002510050425; WARING JF, 1995, J BIOL CHEM, V270, P12276, DOI 10.1074/jbc.270.20.12276; YAHATA G, 1990, CELL GROWTH DIFFER, V1, P73; Zammit PS, 2008, J CELL SCI, V121, P2975, DOI 10.1242/jcs.019661	53	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10900	10.1371/journal.pone.0010900	http://dx.doi.org/10.1371/journal.pone.0010900			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531935	Green Submitted, gold, Green Published			2022-12-27	WOS:000278222100029
J	Martin, MD; Seth, S; Koutsonanos, DG; Jacob, J; Compans, RW; Skountzou, I				Martin, Maria del P.; Seth, Shaguna; Koutsonanos, Dimitrios G.; Jacob, Joshy; Compans, Richard W.; Skountzou, Ioanna			Adjuvanted Influenza Vaccine Administered Intradermally Elicits Robust Long-Term Immune Responses that Confer Protection from Lethal Challenge	PLOS ONE			English	Article							IMMUNIZATION INDUCES MUCOSAL; ADP-RIBOSYLATING EXOTOXINS; TRANSCUTANEOUS IMMUNIZATION; DENDRITIC CELLS; RETINOIC ACID; ANTIBODY-RESPONSES; CHOLERA-TOXIN; T-CELLS; SKIN; ANTIGEN	Background: The respiratory illnesses caused by influenza virus can be dramatically reduced by vaccination. The current trivalent inactivated influenza vaccine is effective in eliciting systemic virus-specific antibodies sufficient to control viral replication. However, influenza protection generated after parenteral immunization could be improved by the induction of mucosal immune responses. Methodology/Principal Findings: Transcutaneous immunization, a non-invasive vaccine delivery method, was used to investigate the quality, duration and effectiveness of the immune responses induced in the presence of inactivated influenza virus co-administered with retinoic acid or oleic acid. We observed an increased migration of dendritic cells to the draining lymph nodes after dermal vaccination. Here we demonstrate that this route of vaccine delivery in combination with certain immunomodulators can induce potent immune responses that result in long-term protective immunity. Additionally, mice vaccinated with inactivated virus in combination with retinoic acid show an enhanced sIgA antibody response, increased number of antibody secreting cells in the mucosal tissues, and protection from a higher influenza lethal dose. Conclusions/Significance: The present study demonstrates that transdermal administration of inactivated virus in combination with immunomodulators stimulates dendritic cell migration, results in long-lived systemic and mucosal responses that confer effective protective immunity.	[Martin, Maria del P.; Koutsonanos, Dimitrios G.; Jacob, Joshy; Compans, Richard W.; Skountzou, Ioanna] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Seth, Shaguna] MDRNA Inc, Bothell, WA USA	Emory University	Martin, MD (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	rcompan@emory.edu; iskount@emory.edu	Compans, Richard W/I-4087-2013; Skountzou, Ioanna/A-4454-2010	Compans, Richard W/0000-0003-2360-335X; Skountzou, Ioanna/0000-0002-6429-244X	National Institutes of Health [A1074579]; NIH/NIAID [HHSN266200700006C]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health grants A1074579 and by contract HHSN266200700006C from NIH/NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Maria del P. Martin is a trainee supported by contract HHSN266200700006C from NIH/NIAID.	Amorij JP, 2007, VACCINE, V25, P6447, DOI 10.1016/j.vaccine.2007.06.054; Anjuere F, 2003, J IMMUNOL, V170, P1586, DOI 10.4049/jimmunol.170.3.1586; Asahi Y, 2002, J IMMUNOL, V168, P2930, DOI 10.4049/jimmunol.168.6.2930; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Belyakov IM, 2004, J CLIN INVEST, V113, P998, DOI 10.1172/JCI200420261; Berry LJ, 2004, INFECT IMMUN, V72, P1019, DOI 10.1128/IAI.72.2.1019-1028.2004; Bos JD, 2000, EXP DERMATOL, V9, P165, DOI 10.1034/j.1600-0625.2000.009003165.x; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Chen DX, 2001, VACCINE, V19, P2908, DOI 10.1016/S0264-410X(00)00544-2; COMPANS RW, 1974, J VIROL, V14, P1307, DOI 10.1128/JVI.14.5.1307-1309.1974; Deng YP, 1997, J IMMUNOL, V158, P1507; Eksteen B, 2009, GASTROENTEROLOGY, V137, P320, DOI 10.1053/j.gastro.2009.02.046; El-Ghorr AA, 2000, FEMS IMMUNOL MED MIC, V29, P255, DOI 10.1111/j.1574-695X.2000.tb01531.x; Enioutina EY, 2000, VACCINE, V18, P2753, DOI 10.1016/S0264-410X(00)00059-1; Enioutina EY, 2000, VACCINE, V18, P2381, DOI 10.1016/S0264-410X(00)00008-6; Garg S, 2003, NAT IMMUNOL, V4, P907, DOI 10.1038/ni962; GERHARD W, 1991, J VIROL, V65, P364, DOI 10.1128/JVI.65.1.364-372.1991; Glenn GM, 1999, INFECT IMMUN, V67, P1100, DOI 10.1128/IAI.67.3.1100-1106.1999; Gockel CM, 2000, MOL IMMUNOL, V37, P537, DOI 10.1016/S0161-5890(00)00074-2; Guebre-Xabier M, 2003, J VIROL, V77, P5218, DOI 10.1128/JVI.77.9.5218-5225.2003; Guerena-Burgueno F, 2002, INFECT IMMUN, V70, P1874, DOI 10.1128/IAI.70.4.1874-1880.2002; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; HENRI S, 2010, DISENTANGLING COMPLE; Heyman B, 2000, ANNU REV IMMUNOL, V18, P709, DOI 10.1146/annurev.immunol.18.1.709; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kang SM, 2004, J VIROL, V78, P9624, DOI 10.1128/JVI.78.18.9624-9632.2004; Koutsonanos DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004773; Li ZX, 2008, J IMMUNOL, V180, P2504, DOI 10.4049/jimmunol.180.4.2504; Manicassamya S, 2009, SEMIN IMMUNOL, V21, P22, DOI 10.1016/j.smim.2008.07.007; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Moulds JM, 2009, TRANSFUS APHER SCI, V40, P185, DOI 10.1016/j.transci.2009.03.010; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; NOVAK M, 1993, VACCINE, V11, P55, DOI 10.1016/0264-410X(93)90339-Y; Oran AE, 2003, J IMMUNOL, V171, P1999, DOI 10.4049/jimmunol.171.4.1999; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Pulendran B, 2008, J INFECT DIS, V198, P500, DOI 10.1086/590187; ROMANI N, 1985, J EXP MED, V161, P1368, DOI 10.1084/jem.161.6.1368; Ronnelid J, 2008, ADV EXP MED BIOL, V632, P187, DOI 10.1007/978-0-387-78952-1_14; Sallusto F, 1999, J EXP MED, V189, P611, DOI 10.1084/jem.189.4.611; Scharton-Kersten T, 2000, INFECT IMMUN, V68, P5306, DOI 10.1128/IAI.68.9.5306-5313.2000; Sha Z, 2000, J VIROL, V74, P4999, DOI 10.1128/JVI.74.11.4999-5005.2000; Sha ZY, 2005, VIROLOGY, V331, P387, DOI 10.1016/j.virol.2004.10.014; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Skountzou I, 2006, VACCINE, V24, P6110, DOI 10.1016/j.vaccine.2006.05.014; Stingl G, 1989, Curr Probl Dermatol, V18, P22; STREILEIN JW, 1983, J INVEST DERMATOL, V80, pS12, DOI 10.1111/1523-1747.ep12536743; Ueno H, 2010, IMMUNOL REV, V234, P199, DOI 10.1111/j.0105-2896.2009.00884.x; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992	50	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10897	10.1371/journal.pone.0010897	http://dx.doi.org/10.1371/journal.pone.0010897			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531947	gold, Green Published, Green Submitted			2022-12-27	WOS:000278222100026
J	Gigante, B; Bennet, AM; Leander, K; Vikstrom, M; de Faire, U				Gigante, Bruna; Bennet, Anna M.; Leander, Karin; Vikstrom, Max; de Faire, Ulf			The Interaction between Coagulation Factor 2 Receptor and Interleukin 6 Haplotypes Increases the Risk of Myocardial Infarction in Men	PLOS ONE			English	Article							THROMBIN; INFLAMMATION; ATHEROSCLEROSIS; ASSOCIATION; ACTIVATION; EXPRESSION; DISEASE; PREDICT; GENES; ALPHA	The aim of the study was to investigate if the interaction between the coagulation factor 2 receptor (F2R) and the interleukin 6 (IL6) haplotypes modulates the risk of myocardial infarction (MI) in the Stockholm Heart Epidemiology Program (SHEEP). Seven SNPs at the F2R locus and three SNPs at the IL6 locus were genotyped. Haplotypes and haplotype pairs (IL6*F2R) were generated. A logistic regression analysis was performed to analyze the association of the haplotypes and haplotype pairs with the MI risk. Presence of an interaction between the two haplotypes in each haplotype pair was calculated using two different methods: the statistical, on a multiplicative scale, which includes the cross product of the two factors into the logistic regression model; the biological, on an additive scale, which evaluates the relative risk associated with the joint presence of both factors. The ratio between the observed and the predicted effect of the joint exposure, the synergy index (S), indicates the presence of a synergy (S. 1) or of an antagonism (S, 1). None of the haplotypes within the two loci was associated with the risk of MI. Out of 22 different haplotype pairs, the haplotype pair 17 GGG*ADGTCCT was associated with an increased risk of MI with an OR (95%CI) of 1.58 (1.05-2.41) (p = 0.02) in the crude and an OR of 1.72 (1.11-2.67) (p = 0.01) in the adjusted analysis. We observed the presence of an interaction on a multiplicative scale with an OR (95%CI) of 2.24 (1.27-3.95) (p = 0.005) and a slight interactive effect between the two haplotypes on an additive scale with an OR (95%CI) of 1.56 (1.02-2.37) (p = 0.03) and S of 1.66 (0.89-31). In conclusion, our results support the hypothesis that the interaction between these two functionally related genes may influence the risk of MI and suggest new mechanisms involved in the genetic susceptibility to MI.	[Gigante, Bruna; Leander, Karin; Vikstrom, Max; de Faire, Ulf] Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, S-10401 Stockholm, Sweden; [Bennet, Anna M.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Gigante, Bruna; de Faire, Ulf] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Gigante, B (corresponding author), Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, S-10401 Stockholm, Sweden.	bruna.gigante@ki.se	Leander, Karin/C-7261-2017; Gigante, Bruna/I-9252-2012	Leander, Karin/0000-0002-1404-9222; Bennet-Bark, Anna/0000-0003-2704-2625; Gigante, Bruna/0000-0003-4508-7990	Swedish Research Council; Swedish Heart and Lung Foundation; Karolinska Institutet [2008]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Research Council and the Swedish Heart and Lung Foundation (to UdF), Karolinska Institutet grant (KI fonder 2008) (to BG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 2005, EUR J EPIDEMIOL, V20, P563, DOI 10.1007/s10654-005-4410-4; Baessler A, 2007, HUM MOL GENET, V16, P887, DOI 10.1093/hmg/ddm033; Bennet AM, 2003, ATHEROSCLEROSIS, V171, P359, DOI 10.1016/j.atherosclerosis.2003.08.029; Borissoff JI, 2009, CARDIOVASC RES, V82, P392, DOI 10.1093/cvr/cvp066; Chi LQ, 2001, J INTERF CYTOK RES, V21, P231, DOI 10.1089/107999001750169871; Crawford DC, 2005, ANNU REV MED, V56, P303, DOI 10.1146/annurev.med.56.082103.104540; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; de Mutsert R, 2009, KIDNEY INT, V75, P677, DOI 10.1038/ki.2008.645; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Gigante B, 2007, ARTERIOSCL THROM VAS, V27, P1213, DOI 10.1161/ATVBAHA.107.140541; Gigante B, 2009, THROMB HAEMOSTASIS, V101, P943, DOI 10.1160/TH08-09-0612; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Kaplanski G, 1997, J IMMUNOL, V158, P5435; Kranzhofer R, 1996, CIRC RES, V79, P286, DOI 10.1161/01.RES.79.2.286; Lundberg M, 1996, EPIDEMIOLOGY, V7, P655; Marin V, 2001, J IMMUNOL, V167, P3435, DOI 10.4049/jimmunol.167.6.3435; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Noto D, 2007, THROMB HAEMOSTASIS, V98, P1362, DOI 10.1160/TH07-06-0414; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Pickard BS, 2009, MOL PSYCHIATR, V14, P874, DOI 10.1038/mp.2008.24; Reuterwall C, 1999, J INTERN MED, V246, P161, DOI 10.1046/j.1365-2796.1999.00554.x; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V103, P506, DOI 10.1093/oxfordjournals.aje.a112252; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tregouet DA, 2004, ANN HUM GENET, V68, P165, DOI 10.1046/j.1529-8817.2003.00085.x; UTERMANN G, 1989, P NATL ACAD SCI USA, V86, P4171, DOI 10.1073/pnas.86.11.4171; Zhang J, 2008, HUM HERED, V66, P252, DOI 10.1159/000143407	27	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11300	10.1371/journal.pone.0011300	http://dx.doi.org/10.1371/journal.pone.0011300			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585578	Green Published, Green Submitted, gold			2022-12-27	WOS:000279135800009
J	Shin, D; Pierce, MC; Gillenwater, AM; Williams, MD; Richards-Kortum, RR				Shin, Dongsuk; Pierce, Mark C.; Gillenwater, Ann M.; Williams, Michelle D.; Richards-Kortum, Rebecca R.			A Fiber-Optic Fluorescence Microscope Using a Consumer-Grade Digital Camera for In Vivo Cellular Imaging	PLOS ONE			English	Article							REAL-TIME; CONFOCAL MICROSCOPY; PHONES; MICROENDOSCOPY; SYSTEM; TISSUE; CARE	Background: Early detection is an essential component of cancer management. Unfortunately, visual examination can often be unreliable, and many settings lack the financial capital and infrastructure to operate PET, CT, and MRI systems. Moreover, the infrastructure and expense associated with surgical biopsy and microscopy are a challenge to establishing cancer screening/early detection programs in low-resource settings. Improvements in performance and declining costs have led to the availability of optoelectronic components, which can be used to develop low-cost diagnostic imaging devices for use at the point-of-care. Here, we demonstrate a fiber-optic fluorescence microscope using a consumer-grade camera for in vivo cellular imaging. Methods: The fiber-optic fluorescence microscope includes an LED light, an objective lens, a fiber-optic bundle, and a consumer-grade digital camera. The system was used to image an oral cancer cell line labeled with 0.01% proflavine. A human tissue specimen was imaged following surgical resection, enabling dysplastic and cancerous regions to be evaluated. The oral mucosa of a healthy human subject was imaged in vivo, following topical application of 0.01% proflavine. Findings: The fiber-optic microscope resolved individual nuclei in all specimens and tissues imaged. This capability allowed qualitative and quantitative differences between normal and precancerous or cancerous tissues to be identified. The optical efficiency of the system permitted imaging of the human oral mucosa in real time. Conclusion: Our results indicate this device as a useful tool to assist in the identification of early neoplastic changes in epithelial tissues. This portable, inexpensive unit may be particularly appropriate for use at the point-of-care in low-resource settings.	[Shin, Dongsuk; Pierce, Mark C.; Richards-Kortum, Rebecca R.] Rice Univ, Dept Bioengn, Houston, TX 77251 USA; [Gillenwater, Ann M.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Williams, Michelle D.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Rice University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Shin, D (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.	rkortum@rice.edu	Richards-Kortum, Rebecca R/P-4074-2014	Richards-Kortum, Rebecca R/0000-0003-2347-9467; Pierce, Mark/0000-0003-4377-9547; Gillenwater, Ann/0000-0002-0935-0037; Williams, Michelle D./0000-0002-9133-7332	National Institutes of Health (NIH) [RO1 EB007594]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007594] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded through National Institutes of Health (NIH) grant RO1 EB007594. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro L, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-S1-S19; Aslanoglu M, 2006, ANAL SCI, V22, P439, DOI 10.2116/analsci.22.439; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Carlson AL, 2006, LASER SURG MED, V38, P928, DOI 10.1002/lsm.20409; Carlson K, 2005, GYNECOL ONCOL, V99, pS84, DOI 10.1016/j.ygyno.2005.07.049; CHEN Y, 2005, ANN INT C IEEE ENG M, V7, P1442; Collier T, 2002, ACAD RADIOL, V9, P504, DOI 10.1016/S1076-6332(03)80326-4; Collier T, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717899; Dromard T, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2736346; Dubaj V, 2002, J MICROSC-OXFORD, V207, P108, DOI 10.1046/j.1365-2818.2002.01052.x; Ebner C, 2008, J TELEMED TELECARE, V14, P2, DOI 10.1258/jtt.2007.070302; Ghoghawala SY, 2007, EXP EYE RES, V84, P1031, DOI 10.1016/j.exer.2007.01.021; Guillaud M, 2004, CYTOM PART A, V60A, P81, DOI 10.1002/cyto.a.20034; Han B, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2435700; Janssen PA, 2003, PEDIATRICS, V111, P15, DOI 10.1542/peds.111.1.15; Jean F, 2007, OPT EXPRESS, V15, P4008, DOI 10.1364/OE.15.004008; KAUFMAN RH, 1978, AM J OBSTET GYNECOL, V132, P861, DOI 10.1016/0002-9378(78)90713-5; Kurman RJ, 1994, BLAUSTEINS PATHOLOGY; Laemmel E, 2004, J VASC RES, V41, P400, DOI 10.1159/000081209; Lane PM, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3103583; Maisels MJ, 2008, NEW ENGL J MED, V358, P920, DOI 10.1056/NEJMct0708376; MAKINEN JT, 2007, P SPIE, V6585; Martinez AW, 2008, ANAL CHEM, V80, P3699, DOI 10.1021/ac800112r; Massone C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000483; MCCONNELL TP, 2004, NEWBORN INFANT NURS, V4, P211; Moon S, 2009, BIOSENS BIOELECTRON, V24, P3208, DOI 10.1016/j.bios.2009.03.037; Muldoon TJ, 2008, GASTROINTEST ENDOSC, V68, P737, DOI 10.1016/j.gie.2008.05.018; Muldoon TJ, 2007, OPT EXPRESS, V15, P16413, DOI 10.1364/OE.15.016413; PEREZ MA, 2008, IEEE INT S IND EL, P939; Polglase AL, 2005, GASTROINTEST ENDOSC, V62, P686, DOI 10.1016/j.gie.2005.05.021; Roblyer D, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2904658; Rodriguez WR, 2005, PLOS MED, V2, P663, DOI 10.1371/journal.pmed.0020182; Zhong W, 2009, BRIT J CANCER, V101, P2015, DOI 10.1038/sj.bjc.6605436	33	54	56	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11218	10.1371/journal.pone.0011218	http://dx.doi.org/10.1371/journal.pone.0011218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585636	Green Submitted, Green Published, gold			2022-12-27	WOS:000279135400009
J	Drogemuller, C; Becker, D; Kessler, B; Kemter, E; Tetens, J; Jurina, K; Jaderlund, KH; Flagstad, A; Perloski, M; Lindblad-Toh, K; Matiasek, K				Droegemueller, Cord; Becker, Doreen; Kessler, Barbara; Kemter, Elisabeth; Tetens, Jens; Jurina, Konrad; Jaderlund, Karin Hultin; Flagstad, Annette; Perloski, Michele; Lindblad-Toh, Kerstin; Matiasek, Kaspar			A Deletion in the N-Myc Downstream Regulated Gene 1 (NDRG1) Gene in Greyhounds with Polyneuropathy	PLOS ONE			English	Article							MARIE-TOOTH-DISEASE; SENSORY NEUROPATHY; HEREDITARY MOTOR; BORDER-COLLIE; DOGS; COMPLEX	The polyneuropathy of juvenile Greyhound show dogs shows clinical similarities to the genetically heterogeneous Charcot-Marie-Tooth (CMT) disease in humans. The pedigrees containing affected dogs suggest monogenic autosomal recessive inheritance and all affected dogs trace back to a single male. Here, we studied the neuropathology of this disease and identified a candidate causative mutation. Peripheral nerve biopsies from affected dogs were examined using semi-thin histology, nerve fibre teasing and electron microscopy. A severe chronic progressive mixed polyneuropathy was observed. Seven affected and 17 related control dogs were genotyped on the 50k canine SNP chip. This allowed us to localize the causative mutation to a 19.5 Mb interval on chromosome 13 by homozygosity mapping. The NDRG1 gene is located within this interval and NDRG1 mutations have been shown to cause hereditary motor and sensory neuropathy-Lom in humans (CMT4D). Therefore, we considered NDRG1 a positional and functional candidate gene and performed mutation analysis in affected and control Greyhounds. A 10 bp deletion in canine NDRG1 exon 15 (c.1080_1089delTCGCCTGGAC) was perfectly associated with the polyneuropathy phenotype of Greyhound show dogs. The deletion causes a frame shift (p.Arg361SerfsX60) which alters several amino acids before a stop codon is encountered. A reduced level of NDRG1 transcript could be detected by RT-PCR. Western blot analysis demonstrated an absence of NDRG1 protein in peripheral nerve biopsy of an affected Greyhound. We thus have identified a candidate causative mutation for polyneuropathy in Greyhounds and identified the first genetically characterized canine CMT model which offers an opportunity to gain further insights into the pathobiology and therapy of human NDRG1 associated CMT disease. Selection against this mutation can now be used to eliminate polyneuropathy from Greyhound show dogs.	[Droegemueller, Cord; Becker, Doreen] Univ Bern, Fac Vet, Inst Genet, Bern, Switzerland; [Kessler, Barbara; Kemter, Elisabeth] Univ Munich, Gene Ctr, Lab Funct Genome Anal, Chair Mol Anim Breeding & Biotechnol, Munich, Germany; [Tetens, Jens] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany; [Jurina, Konrad] Tierklin Haar, Haar, Germany; [Jaderlund, Karin Hultin] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Jaderlund, Karin Hultin] Norwegian Sch Vet Sci, Dept Compan Anim Clin Sci, Oslo, Norway; [Flagstad, Annette] Univ Copenhagen, Dept Clin Sci, Fac Life Sci, Copenhagen, Denmark; [Perloski, Michele; Lindblad-Toh, Kerstin] Broad Inst Harvard & MIT, Cambridge, MA USA; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Matiasek, Kaspar] Anim Hlth Trust, Neuropathol Lab, Newmarket, Suffolk, England	University of Bern; University of Munich; University of Kiel; Swedish University of Agricultural Sciences; Norwegian University of Life Sciences; University of Copenhagen; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Uppsala University; Animal Health Trust	Drogemuller, C (corresponding author), Univ Bern, Fac Vet, Inst Genet, Bern, Switzerland.	Cord.Droegemueller@itz.unibe.ch	Jäderlund, Karin Hultin/AAL-8211-2020; Tetens, Jens/H-5344-2012; Becker, Doreen/AAF-9108-2020	Becker, Doreen/0000-0003-0425-6284; Tetens, Jens/0000-0001-5352-464X; Drogemuller, Cord/0000-0001-9773-522X; Matiasek, Kaspar/0000-0001-5021-3280; Kemter, Elisabeth/0000-0001-7785-7502	Gesellschaft fur Kynologische Forschung (GKF), Bonn, Germany; Greyhound Club of America; ESF	Gesellschaft fur Kynologische Forschung (GKF), Bonn, Germany; Greyhound Club of America; ESF(European Commission)	This study was financed by research grants of the Gesellschaft fur Kynologische Forschung (GKF), Bonn, Germany, and the Greyhound Club of America to CD. KLT is the recipient of a European Young Investigator Award from the ESF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertorini T, 2004, NEUROLOGIST, V10, P327, DOI 10.1097/01.nrl.0000145596.38640.27; BRAUND KG, 1994, AM J VET RES, V55, P534; BRAUND KG, 1994, VET PATHOL, V31, P316, DOI 10.1177/030098589403100304; Braund KG, 1997, J VET INTERN MED, V11, P243, DOI 10.1111/j.1939-1676.1997.tb00098.x; Coates JR, 2004, VET CLIN N AM-SMALL, V34, P1361, DOI 10.1016/j.cvsm.2004.05.011; DACOSTA RC, 2005, J VET INTERN MED, V19, pA459; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; Gabriel A, 2006, J SMALL ANIM PRACT, V47, P144, DOI 10.1111/j.1748-5827.2006.00058.x; Harkin KR, 2005, JAVMA-J AM VET MED A, V227, P1263, DOI 10.2460/javma.2005.227.1263; HENRICKS PM, 1987, VAN VET J, V28, P165; Horste GMZ, 2006, CURR OPIN NEUROL, V19, P464, DOI 10.1097/01.wco.0000245369.44199.27; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Martyn C, 1997, J NEUROL NEUROSUR PS, V62, P310, DOI 10.1136/jnnp.62.4.310; Muhlemann O, 2008, BBA-GENE REGUL MECH, V1779, P538, DOI 10.1016/j.bbagrm.2008.06.012; Okuda T, 2004, MOL CELL BIOL, V24, P3949, DOI 10.1128/MCB.24.9.3949-3956.2004; Pareyson D, 2009, LANCET NEUROL, V8, P654, DOI 10.1016/S1474-4422(09)70110-3; PATTERSON DF, 1988, J AM VET MED ASSOC, V193, P1131; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schatzberg SJ, 2004, VET CLIN N AM-SMALL, V34, P1497, DOI 10.1016/j.cvsm.2004.06.001; Shelton GD, 2003, MUSCLE NERVE, V27, P471, DOI 10.1002/mus.10350; Vanhaesebrouck AE, 2008, J NEUROL SCI, V275, P100, DOI 10.1016/j.jns.2008.07.031; Vermeersch K, 2005, J SMALL ANIM PRACT, V46, P295, DOI 10.1111/j.1748-5827.2005.tb00324.x; 2010, HOMEPAGE INHERITED P	24	35	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11258	10.1371/journal.pone.0011258	http://dx.doi.org/10.1371/journal.pone.0011258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582309	Green Published, Green Submitted, gold			2022-12-27	WOS:000279058500001
J	Shi, HY; Santander, J; Brenneman, KE; Wanda, SY; Wang, SF; Senechal, P; Sun, W; Roland, KL; Curtiss, R				Shi, Huoying; Santander, Javier; Brenneman, Karen E.; Wanda, Soo-Young; Wang, Shifeng; Senechal, Patti; Sun, Wei; Roland, Kenneth L.; Curtiss, Roy, III			Live Recombinant Salmonella Typhi Vaccines Constructed to Investigate the Role of rpoS in Eliciting Immunity to a Heterologous Antigen	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; SURFACE PROTEIN-A; ESCHERICHIA-COLI; STREPTOCOCCUS-PNEUMONIAE; SIGMA-FACTOR; VI-ANTIGEN; PNEUMOCOCCAL PSPA; REGULATORY SYSTEM; CONJUGATE VACCINE; FOREIGN ANTIGEN	We hypothesized that the immunogenicity of live Salmonella enterica serovar Typhi vaccines expressing heterologous antigens depends, at least in part, on its rpoS status. As part of our project to develop a recombinant attenuated S. Typhi vaccine (RASTyV) to prevent pneumococcal diseases in infants and children, we constructed three RASTyV strains synthesizing the Streptococcus pneumoniae surface protein PspA to test this hypothesis. Each vector strain carried ten engineered mutations designed to optimize safety and immunogenicity. Two S. Typhi vector strains (chi 9639 and chi 9640) were derived from the rpoS mutant strain Ty2 and one (chi 9633) from the RpoS(+) strain ISP1820. In chi 9640, the nonfunctional rpoS gene was replaced with the functional rpoS gene from ISP1820. Plasmid pYA4088, encoding a secreted form of PspA, was moved into the three vector strains. The resulting RASTyV strains were evaluated for safety in vitro and for immunogenicity in mice. All three RASTyV strains were similar to the live attenuated typhoid vaccine Ty21a in their ability to survive in human blood and human monocytes. They were more sensitive to complement and were less able to survive and persist in sewage and surface water than their wild-type counterparts. Adult mice intranasally immunized with any of the RASTyV strains developed immune responses against PspA and Salmonella antigens. The RpoS(+) vaccines induced a balanced Th1/Th2 immune response while the RpoS(-) strain chi 9639(pYA4088) induced a strong Th2 immune response. Immunization with any RASTyV provided protection against S. pneumoniae challenge; the RpoS(+) strain chi 9640(pYA4088) provided significantly greater protection than the ISP1820 derivative, chi 9633(pYA4088). In the pre-clinical setting, these strains exhibited a desirable balance between safety and immunogenicity and are currently being evaluated in a Phase 1 clinical trial to determine which of the three RASTyVs has the optimal safety and immunogenicity profile in human hosts.	[Shi, Huoying] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA; Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Shi, HY (corresponding author), Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA.	rcurtiss@asu.edu	Santander, Javier/AAU-9423-2020		Bill and Melinda Gates Foundation [37863]; CONICYT, Chile; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060557] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); CONICYT, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Bill and Melinda Gates Foundation Grant #37863, and in part by CONICYT, Chile, through Gestion-Propia Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianopoulos K, 1998, J BACTERIOL, V180, P998, DOI 10.1128/JB.180.4.998-1001.1998; Angelakopoulos H, 2000, INFECT IMMUN, V68, P2135, DOI 10.1128/IAI.68.4.2135-2141.2000; Arricau N, 1998, MOL MICROBIOL, V29, P835, DOI 10.1046/j.1365-2958.1998.00976.x; Arulanandam BP, 2001, INFECT IMMUN, V69, P6718, DOI 10.1128/IAI.69.11.6718-6724.2001; Baek CH, 2009, J BACTERIOL, V191, P1278, DOI 10.1128/JB.01142-08; Baker SJ, 1997, MICROB PATHOGENESIS, V22, P165, DOI 10.1006/mpat.1996.0099; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bollen WS, 2008, INFECT IMMUN, V76, P3268, DOI 10.1128/IAI.00244-08; Boron WF, 2003, MED PHYSL CELLULAR M, P1300; Bravo D, 2008, J MED MICROBIOL, V57, P938, DOI 10.1099/jmm.0.47848-0; Briles DE, 1996, VACCINE, V14, P858, DOI 10.1016/0264-410X(96)82948-3; BROOME C, 1996, WHOVRDGEN9602, P28; BUCHMEIER NA, 1995, J CLIN INVEST, V95, P1047, DOI 10.1172/JCI117750; Capozzo AVE, 2004, INFECT IMMUN, V72, P4637, DOI 10.1128/IAI.72.8.4637-4646.2004; CHATFIELD SN, 1992, VACCINE, V10, P53, DOI 10.1016/0264-410X(92)90420-O; CHEN CY, 1995, J BACTERIOL, V177, P5303, DOI 10.1128/jb.177.18.5303-5309.1995; Coligan JE., 1994, CURRENT PROTOCOLS IM; Collinson SK, 1996, J BACTERIOL, V178, P662, DOI 10.1128/jb.178.3.662-667.1996; Coynault C, 1996, MOL MICROBIOL, V22, P149, DOI 10.1111/j.1365-2958.1996.tb02664.x; Coynault C, 1999, MICROB PATHOGENESIS, V26, P299, DOI 10.1006/mpat.1999.0273; Curtiss III R, 2003, International patent, Patent No. [WO 03/096812, 03096812]; Curtiss R, 2002, J CLIN INVEST, V110, P1061, DOI 10.1172/JCI200216941; CURTISS R, 1987, INFECT IMMUN, V55, P3035, DOI 10.1128/IAI.55.12.3035-3043.1987; CURTISS R, 1965, J BACTERIOL, V89, P28, DOI 10.1128/JB.89.1.28-40.1965; Curtiss Roy III, 2007, P297; Curtiss R, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1009, DOI 10.1016/B978-012491543-5/50060-7; Curtiss R, 2009, INFECT IMMUN, V77, P1071, DOI 10.1128/IAI.00693-08; Dagan R, 2003, PEDIATR INFECT DIS J, V22, P532, DOI 10.1097/00006454-200306000-00009; Dozois CM, 2000, INFECT IMMUN, V68, P4145, DOI 10.1128/IAI.68.7.4145-4154.2000; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; ELLNER PD, 1966, J INFECT DIS, V116, P238, DOI 10.1093/infdis/116.2.238; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; FANG FC, 1992, P NATL ACAD SCI USA, V89, P11978, DOI 10.1073/pnas.89.24.11978; FELIX A, 1951, J HYG-CAMBRIDGE, V49, P92, DOI 10.1017/S0022172400015394; FRASER D, 1953, J BIOL CHEM, V205, P291; GALAN JE, 1990, GENE, V94, P29, DOI 10.1016/0378-1119(90)90464-3; GALAN JE, 1989, MICROB PATHOGENESIS, V6, P433, DOI 10.1016/0882-4010(89)90085-5; Galyov EE, 1997, MOL MICROBIOL, V25, P903, DOI 10.1111/j.1365-2958.1997.mmi525.x; GERMANIER R, 1975, J INFECT DIS, V131, P553, DOI 10.1093/infdis/131.5.553; GERMANIER R, 1971, INFECT IMMUN, V4, P663, DOI 10.1128/IAI.4.6.663-673.1971; GULIG PA, 1987, INFECT IMMUN, V55, P2891, DOI 10.1128/IAI.55.12.2891-2901.1987; GUNN BM, 2010, CLIN VACCIN IN PRESS; Hassan JO, 1996, INFECT IMMUN, V64, P938, DOI 10.1128/IAI.64.3.938-944.1996; HENGGEARONIS R, 1992, MOL MICROBIOL, V6, P1877, DOI 10.1111/j.1365-2958.1992.tb01360.x; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; Hindle Z, 2002, INFECT IMMUN, V70, P3457, DOI 10.1128/IAI.70.7.3457-3467.2002; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Hohmann EL, 1996, VACCINE, V14, P19, DOI 10.1016/0264-410X(95)00173-X; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; HONE DM, 1988, INFECT IMMUN, V56, P1326, DOI 10.1128/IAI.56.5.1326-1333.1988; HONE DM, 1991, VACCINE, V9, P810, DOI 10.1016/0264-410X(91)90218-U; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kang HY, 2002, J BACTERIOL, V184, P307, DOI 10.1128/JB.184.1.307-312.2002; Kang HY, 2002, INFECT IMMUN, V70, P1739, DOI 10.1128/IAI.70.4.1739-1749.2002; Kong W, 2008, P NATL ACAD SCI USA, V105, P9361, DOI 10.1073/pnas.0803801105; Konjufca V, 2006, INFECT IMMUN, V74, P6785, DOI 10.1128/IAI.00851-06; KORHONEN TK, 1980, J BACTERIOL, V144, P800, DOI 10.1128/JB.144.2.800-805.1980; Kotton CN, 2004, INFECT IMMUN, V72, P5535, DOI 10.1128/IAI.72.10.5535-5547.2004; KOWARZ L, 1994, J BACTERIOL, V176, P6852, DOI 10.1128/JB.176.22.6852-6860.1994; Ledeboer NA, 2005, J BACTERIOL, V187, P3214, DOI 10.1128/JB.187.9.3214-3226.2005; Li YH, 2008, INFECT IMMUN, V76, P5238, DOI 10.1128/IAI.00720-08; Li YH, 2009, P NATL ACAD SCI USA, V106, P593, DOI 10.1073/pnas.0811697106; Link C, 2006, MICROBES INFECT, V8, P2262, DOI 10.1016/j.micinf.2006.04.013; LOONEY RJ, 1986, J LAB CLIN MED, V108, P506; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; MULVEY MR, 1990, J BACTERIOL, V172, P6713, DOI 10.1128/jb.172.12.6713-6720.1990; NardelliHaefliger D, 1996, INFECT IMMUN, V64, P5219, DOI 10.1128/IAI.64.12.5219-5224.1996; Nayak AR, 1998, INFECT IMMUN, V66, P3744, DOI 10.1128/IAI.66.8.3744-3751.1998; NEILANDS JB, 1994, METHOD ENZYMOL, V235, P352; Nickerson CA, 1997, INFECT IMMUN, V65, P1814, DOI 10.1128/IAI.65.5.1814-1823.1997; Obaro SK, 1996, LANCET, V348, P271, DOI 10.1016/S0140-6736(05)65585-7; OLD DC, 1968, J GEN MICROBIOL, V51, P1; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Pasetti MF, 2003, VACCINE, V21, P401, DOI 10.1016/S0264-410X(02)00472-3; Paton JC, 2003, MED INTELL UNIT, P294; Raffatellu M, 2005, INFECT IMMUN, V73, P3367, DOI 10.1128/IAI.73.6.3367-3374.2005; RIED JL, 1987, GENE, V57, P239, DOI 10.1016/0378-1119(87)90127-2; Roland K, 1999, AVIAN DIS, V43, P429, DOI 10.2307/1592640; Roland KL, 2007, VACCINE, V25, P8574, DOI 10.1016/j.vaccine.2007.09.074; ROMEO T, 1989, J BACTERIOL, V171, P2773, DOI 10.1128/jb.171.5.2773-2782.1989; Ross J, 1996, P NATL ACAD SCI USA, V93, P14314, DOI 10.1073/pnas.93.25.14314; RUBIN FA, 1990, J CLIN MICROBIOL, V28, P825, DOI 10.1128/JCM.28.4.825-827.1990; Sambrook J., 2001, MOL CLONING LAB MANU; Santander J, 2007, INFECT IMMUN, V75, P1382, DOI 10.1128/IAI.00888-06; Santander MJ, 2008, J INFECT DEV COUNTR, V2, P412; Santos RL, 2001, INFECT IMMUN, V69, P4610, DOI 10.1128/IAI.69.7.4610-4617.2001; Schwan WR, 2000, INFECT IMMUN, V68, P1005, DOI 10.1128/IAI.68.3.1005-1013.2000; SEDGWICK JD, 1983, J IMMUNOL METHODS, V57, P301, DOI 10.1016/0022-1759(83)90091-1; SHI H, 2010, CLIN VACCIN IN PRESS; Sizemore DR, 1997, INFECT IMMUN, V65, P309, DOI 10.1128/IAI.65.1.309-312.1997; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; Sun W, 2008, APPL ENVIRON MICROB, V74, P4241, DOI 10.1128/AEM.00940-08; TACKET CO, 1992, INFECT IMMUN, V60, P536, DOI 10.1128/IAI.60.2.536-541.1992; Tacket CO, 2000, INFECT IMMUN, V68, P1196, DOI 10.1128/IAI.68.3.1196-1201.2000; Tacket CO, 1997, INFECT IMMUN, V65, P3381, DOI 10.1128/IAI.65.8.3381-3385.1997; White AP, 2006, J BACTERIOL, V188, P3219, DOI 10.1128/JB.188.9.3219-3227.2006; Winter SE, 2009, MOL MICROBIOL, V74, P175, DOI 10.1111/j.1365-2958.2009.06859.x; WITHOLT B, 1976, ANAL BIOCHEM, V74, P160, DOI 10.1016/0003-2697(76)90320-1; Wu HY, 1997, J INFECT DIS, V175, P839, DOI 10.1086/513980; Xin W, 2008, INFECT IMMUN, V76, P3241, DOI 10.1128/IAI.01623-07; Yamamoto M, 1997, INFECT IMMUN, V65, P640, DOI 10.1128/IAI.65.2.640-644.1997	103	37	38	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11142	10.1371/journal.pone.0011142	http://dx.doi.org/10.1371/journal.pone.0011142			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585446	Green Published, gold, Green Submitted			2022-12-27	WOS:000278977200002
J	Tsai, PS; Garcia-Gil, N; van Haeften, T; Gadella, BM				Tsai, Pei-Shiue; Garcia-Gil, Nuria; van Haeften, Theo; Gadella, Bart M.			How Pig Sperm Prepares to Fertilize: Stable Acrosome Docking to the Plasma Membrane	PLOS ONE			English	Article							DOMAIN PROTEIN MUPP1; MAMMALIAN SPERM; LIPID RAFTS; SCAFFOLDING PROTEIN; SNARE COMPLEXES; VESICLE FUSION; EXOCYTOSIS; SPERMATOZOA; CAPACITATION; SYNTAXIN	Background: Mammalian sperms are activated in the oviduct. This process, which involves extensive sperm surface remodelling, is required for fertilization and can be mimicked under in vitro fertilization conditions (IVF). Methodology/Principal Findings: Here we demonstrate that such treatments caused stable docking and priming of the acrosome membrane to the apical sperm head surface without the emergence of exocytotic membrane fusion. The interacting membranes could be isolated as bilamellar membrane structures after cell disruption. These membrane structures as well as whole capacitated sperm contained stable ternary trans-SNARE complexes that were composed of VAMP 3 and syntaxin 1B from the plasma membrane and SNAP 23 from the acrosomal membrane. This trans-SNARE complex was not observed in control sperm. Conclusions/Significance: We propose that this capacitation driven membrane docking and stability thereof is a preparative step prior to the multipoint membrane fusions characteristic for the acrosome reaction induced by sperm-zona binding. Thus, sperm can be considered a valuable model for studying exocytosis.	[Tsai, Pei-Shiue; Garcia-Gil, Nuria; van Haeften, Theo; Gadella, Bart M.] Univ Utrecht, Fac Vet Med, Grad Sch Anim Hlth, Dept Biochem & Cell Biol, Utrecht, Netherlands; [Tsai, Pei-Shiue; Gadella, Bart M.] Univ Utrecht, Fac Vet Med, Grad Sch Anim Hlth, Dept Farm Anim Hlth, Utrecht, Netherlands	Utrecht University; Utrecht University	Tsai, PS (corresponding author), Univ Utrecht, Fac Vet Med, Grad Sch Anim Hlth, Dept Biochem & Cell Biol, Utrecht, Netherlands.	b.m.gadella@uu.nl	Gadella, B.M./S-8667-2019	TSAI, PEI-SHIUE/0000-0001-8217-6285	University of Utrecht, NL	University of Utrecht, NL	We thank Dr. Ian Brewis (Cardiff University, UK) for critical reading and Prof. Dr. Ben Colenbrander (University of Utrecht, NL) for his support.	Ackermann F, 2008, J CELL PHYSIOL, V214, P757, DOI 10.1002/jcp.21272; Ackermann F, 2009, J CELL SCI, V122, P4547, DOI 10.1242/jcs.058263; Arnoult C, 1996, J CELL BIOL, V134, P637, DOI 10.1083/jcb.134.3.637; BENNETT MK, 1994, ANNU REV BIOCHEM, V63, P63, DOI 10.1146/annurev.bi.63.070194.000431; Bos E S, 1981, J Immunoassay, V2, P187, DOI 10.1080/15321818108056977; Breden TG, 1996, J ANDROL, V17, P443; Breitbart H, 2002, J REPROD IMMUNOL, V53, P151, DOI 10.1016/S0165-0378(01)00085-7; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; Flesch FM, 2000, BBA-REV BIOMEMBRANES, V1469, P197, DOI 10.1016/S0304-4157(00)00018-6; Flesch FM, 1998, BIOL REPROD, V59, P1530, DOI 10.1095/biolreprod59.6.1530; Florman HM, 2008, INT J DEV BIOL, V52, P503, DOI 10.1387/ijdb.082696hf; Gadella BM, 2008, INT J DEV BIOL, V52, P473, DOI 10.1387/ijdb.082583bg; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Harrison RAP, 1996, REPROD FERT DEVELOP, V8, P581, DOI 10.1071/RD9960581; Heydecke D, 2006, J ANDROL, V27, P390, DOI 10.2164/jandrol.05166; Hu C, 2007, EXP CELL RES, V313, P3198, DOI 10.1016/j.yexcr.2007.06.008; JAHN R, 1994, ANNU REV NEUROSCI, V17, P219, DOI 10.1146/annurev.ne.17.030194.001251; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Liu HW, 2000, MOL HUM REPROD, V6, P422, DOI 10.1093/molehr/6.5.422; Lopez CI, 2007, FASEB J, V21, P4121, DOI 10.1096/fj.06-7716com; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; Michaut M, 2000, P NATL ACAD SCI USA, V97, P9996, DOI 10.1073/pnas.180206197; Mollinedo F, 2006, J IMMUNOL, V177, P2831, DOI 10.4049/jimmunol.177.5.2831; Ramalho-Santos J, 2000, DEV BIOL, V223, P54, DOI 10.1006/dbio.2000.9745; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; Roggero CM, 2007, J BIOL CHEM, V282, P26335, DOI 10.1074/jbc.M700854200; Salaun C, 2005, J BIOL CHEM, V280, P1236, DOI 10.1074/jbc.M410674200; Schulz JR, 1998, J BIOL CHEM, V273, P24355, DOI 10.1074/jbc.273.38.24355; SOUCEK DA, 1984, BIOL REPROD, V31, P687, DOI 10.1095/biolreprod31.4.687; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; SUSI FR, 1971, AM J ANAT, V130, P251, DOI 10.1002/aja.1001300302; Tiwari N, 2009, Inflamm Res, V58 Suppl 1, P13, DOI 10.1007/s00011-009-0645-y; Tomes CN, 2002, DEV BIOL, V243, P326, DOI 10.1006/dbio.2002.0567; Tsai PS, 2007, MOL MEMBR BIOL, V24, P313, DOI 10.1080/09687860701228692; van Gestel RA, 2005, MOL HUM REPROD, V11, P583, DOI 10.1093/molehr/gah200; van Gestel RA, 2007, MOL HUM REPROD, V13, P445, DOI 10.1093/molehr/gam030; Verhage M, 2007, CURR OPIN CELL BIOL, V19, P402, DOI 10.1016/j.ceb.2007.05.002; Verhage M, 2009, P NATL ACAD SCI USA, V106, P19745, DOI 10.1073/pnas.0911425106; Vrljic M, 2010, NAT STRUCT MOL BIOL, V17, P325, DOI 10.1038/nsmb.1764; Wit H, 2010, BIOCHEM SOC T, V38, P192; Yanagimachi R., 1994, Zygote, V2, P371; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649; Yang CM, 2001, MOL CELL BIOL, V21, P1573, DOI 10.1128/MCB.21.5.1573-1580.2001; ZANETTI N, 2009, BIOL REPROD; Zhao L, 2007, DEV BIOL, V309, P236, DOI 10.1016/j.ydbio.2007.07.009	49	60	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11204	10.1371/journal.pone.0011204	http://dx.doi.org/10.1371/journal.pone.0011204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585455	Green Published, Green Submitted, gold			2022-12-27	WOS:000278977200009
J	Scherzer-Attali, R; Pellarin, R; Convertino, M; Frydman-Marom, A; Egoz-Matia, N; Peled, S; Levy-Sakin, M; Shalev, DE; Caflisch, A; Gazit, E; Segal, D				Scherzer-Attali, Roni; Pellarin, Riccardo; Convertino, Marino; Frydman-Marom, Anat; Egoz-Matia, Nirit; Peled, Sivan; Levy-Sakin, Michal; Shalev, Deborah E.; Caflisch, Amedeo; Gazit, Ehud; Segal, Daniel			Complete Phenotypic Recovery of an Alzheimer's Disease Model by a Quinone-Tryptophan Hybrid Aggregation Inhibitor	PLOS ONE			English	Article							AMYLOID FIBRIL FORMATION; ORBITAL ELECTRONEGATIVITY METHOD; MODIFIED PARTIAL EQUALIZATION; A-BETA; STRUCTURAL-CHARACTERIZATION; DROSOPHILA MODEL; BINDING MODES; PEPTIDE; POLYPEPTIDE; FRAGMENT	The rational design of amyloid oligomer inhibitors is yet an unmet drug development need. Previous studies have identified the role of tryptophan in amyloid recognition, association and inhibition. Furthermore, tryptophan was ranked as the residue with highest amyloidogenic propensity. Other studies have demonstrated that quinones, specifically anthraquinones, can serve as aggregation inhibitors probably due to the dipole interaction of the quinonic ring with aromatic recognition sites within the amyloidogenic proteins. Here, using in vitro, in vivo and in silico tools we describe the synthesis and functional characterization of a rationally designed inhibitor of the Alzheimer's disease-associated beta-amyloid. This compound, 1,4-naphthoquinon-2-yl-L-tryptophan (NQTrp), combines the recognition capacities of both quinone and tryptophan moieties and completely inhibited A beta oligomerization and fibrillization, as well as the cytotoxic effect of A beta oligomers towards cultured neuronal cell line. Furthermore, when fed to transgenic Alzheimer's disease Drosophila model it prolonged their life span and completely abolished their defective locomotion. Analysis of the brains of these flies showed a significant reduction in oligomeric species of A beta while immuno-staining of the 3(rd) instar larval brains showed a significant reduction in A beta accumulation. Computational studies, as well as NMR and CD spectroscopy provide mechanistic insight into the activity of the compound which is most likely mediated by clamping of the aromatic recognition interface in the central segment of A beta. Our results demonstrate that interfering with the aromatic core of amyloidogenic peptides is a promising approach for inhibiting various pathogenic species associated with amyloidogenic diseases. The compound NQTrp can serve as a lead for developing a new class of disease modifying drugs for Alzheimer's disease.	[Scherzer-Attali, Roni; Frydman-Marom, Anat; Egoz-Matia, Nirit; Peled, Sivan; Levy-Sakin, Michal; Gazit, Ehud; Segal, Daniel] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Pellarin, Riccardo; Convertino, Marino; Caflisch, Amedeo] Univ Zurich, Dept Biochem, Zurich, Switzerland; [Shalev, Deborah E.] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, Jerusalem, Israel	Tel Aviv University; University of Zurich; Hebrew University of Jerusalem	Scherzer-Attali, R (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	vpr@tauex.tau.ac.il; dsegal@post.tau.ac.il	Gazit, Ehud/M-8026-2019; Gazit, Ehud/AHE-9332-2022; Caflisch, Amedeo/I-3459-2012; Shalev, Deborah E/AAY-2873-2021; Gazit, Ehud/C-3715-2011	Gazit, Ehud/0000-0001-5764-1720; Gazit, Ehud/0000-0001-5764-1720; Segal, Daniel/0000-0002-6777-505X	German-Israeli Project Cooperation (DIP); Swiss National Competence Center in Research (NCCR) on Neural Plasticity and Repair and the Swiss National Science Foundation	German-Israeli Project Cooperation (DIP); Swiss National Competence Center in Research (NCCR) on Neural Plasticity and Repair and the Swiss National Science Foundation(Swiss National Science Foundation (SNSF))	The authors acknowledge the funding by the German-Israeli Project Cooperation (DIP) to UG and the Swiss National Competence Center in Research (NCCR) on Neural Plasticity and Repair and the Swiss National Science Foundation, to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUE WP, 1976, J CHEM PHYS, V64, P2229, DOI 10.1063/1.432450; Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200; Balbach JJ, 2000, BIOCHEMISTRY-US, V39, P13748, DOI 10.1021/bi0011330; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bastianetto S, 2008, MINI-REV MED CHEM, V8, P429, DOI 10.2174/138955708784223512; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cecchini M, 2006, J MOL BIOL, V357, P1306, DOI 10.1016/j.jmb.2006.01.009; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cohen T, 2006, BIOCHEMISTRY-US, V45, P4727, DOI 10.1021/bi051525c; Colombo G, 2005, PROTEINS, V59, P519, DOI 10.1002/prot.20426; Convertino M, 2009, PROTEIN SCI, V18, P792, DOI 10.1002/pro.87; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Ferrara P, 2002, PROTEINS, V46, P24, DOI 10.1002/prot.10001; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fraser PE, 2000, BBA-MOL BASIS DIS, V1502, P1, DOI 10.1016/S0925-4439(00)00028-4; FREW T, 1995, ANTI-CANCER DRUG DES, V10, P347; Frydman-Marom A, 2009, ANGEW CHEM INT EDIT, V48, P1981, DOI 10.1002/anie.200802123; GANETZKY B, 1978, EXP GERONTOL, V13, P189, DOI 10.1016/0531-5565(78)90012-8; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Gazit E, 2004, DRUG FUTURE, V29, P613, DOI 10.1358/dof.2004.029.06.853453; Gazit E, 2002, BIOINFORMATICS, V18, P880, DOI 10.1093/bioinformatics/18.6.880; GAZIT E, 2005, DRUG DES REV, V2, P115; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HONIG B, 1993, J PHYS CHEM-US, V97, P1101, DOI 10.1021/j100108a002; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Inouye H, 2006, BIOPHYS J, V90, P1774, DOI 10.1529/biophysj.105.070136; Jarvet J, 2000, J AM CHEM SOC, V122, P4261, DOI 10.1021/ja991167z; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lieu VH, 2007, BIOTECHNOL PROGR, V23, P698, DOI 10.1021/bp060353n; MacDougall C, 2004, J ANTIMICROB CHEMOTH, V53, P899, DOI 10.1093/jac/dkh244; Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102; MANN DMA, 1989, NEUROBIOL AGING, V10, P397, DOI 10.1016/0197-4580(89)90073-0; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; NO KT, 1990, J PHYS CHEM-US, V94, P4740, DOI 10.1021/j100374a067; NO KT, 1990, J PHYS CHEM-US, V94, P4732, DOI 10.1021/j100374a066; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; PEARLMEN DA, 1995, COMP PHYS, V91, P6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pickhardt M, 2005, J BIOL CHEM, V280, P3628, DOI 10.1074/jbc.M410984200; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Porat Y, 2004, BIOCHEMISTRY-US, V43, P14454, DOI 10.1021/bi048582a; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387; Riviere C, 2007, BIOORGAN MED CHEM, V15, P1160, DOI 10.1016/j.bmc.2006.09.069; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; ShresthaDawadi PB, 1996, SYNTHESIS-STUTTGART, P1468; Tartaglia GG, 2004, PROTEIN SCI, V13, P1939, DOI 10.1110/ps.04663504; TERRY RD, 1994, PROG BRAIN RES, V101, P383; Tomiyama T, 1997, BIOCHEM J, V322, P859, DOI 10.1042/bj3220859; van Leuven F, 2000, PROG NEUROBIOL, V61, P305, DOI 10.1016/S0301-0082(99)00055-6; Wagner R, 1996, J MAGN RESON SER A, V123, P119, DOI 10.1006/jmra.1996.0222; Wu C, 2005, BIOPHYS J, V88, P2897, DOI 10.1529/biophysj.104.055574; Wu C, 2007, J AM CHEM SOC, V129, P1225, DOI 10.1021/ja0662772; Wu C, 2009, J MOL BIOL, V394, P627, DOI 10.1016/j.jmb.2009.09.056; Wuthrich K, 1986, NMR PROTEINS NUCL AC; XURONG Q, 2002, BIOCHEM BIOPH RES CO, V297, P1011; Zanuy D, 2004, STRUCTURE, V12, P439, DOI 10.1016/j.str.2004.02.002	65	116	117	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11101	10.1371/journal.pone.0011101	http://dx.doi.org/10.1371/journal.pone.0011101			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559435	Green Published, Green Submitted, gold			2022-12-27	WOS:000278741100015
J	Wilson, K; Das, M; Wahl, KJ; Colton, RJ; Hickman, J				Wilson, Kerry; Das, Mainak; Wahl, Kathryn J.; Colton, Richard J.; Hickman, James			Measurement of Contractile Stress Generated by Cultured Rat Muscle on Silicon Cantilevers for Toxin Detection and Muscle Performance Enhancement	PLOS ONE			English	Article							SKELETAL-MUSCLE; DEFINED SYSTEM; IN-VITRO; FILMS; INTEGRATION; DEVICES; DIFFERENTIATION; MICROSTRUCTURES; FABRICATION; IMPROVEMENT	Background: To date, biological components have been incorporated into MEMS devices to create cell-based sensors and assays, motors and actuators, and pumps. Bio-MEMS technologies present a unique opportunity to study fundamental biological processes at a level unrealized with previous methods. The capability to miniaturize analytical systems enables researchers to perform multiple experiments in parallel and with a high degree of control over experimental variables for high-content screening applications. Methodology/Principal Findings: We have demonstrated a biological microelectromechanical system (BioMEMS) based on silicon cantilevers and an AFM detection system for studying the physiology and kinetics of myotubes derived from embryonic rat skeletal muscle. It was shown that it is possible to interrogate and observe muscle behavior in real time, as well as selectively stimulate the contraction of myotubes with the device. Stress generation of the tissue was estimated using a modification of Stoney's equation. Calculated stress values were in excellent agreement with previously published results for cultured myotubes, but not adult skeletal muscle. Other parameters such as time to peak tension (TPT), the time to half relaxation (KRT) were compared to the literature. It was observed that the myotubes grown on the BioMEMS device, while generating stress magnitudes comparable to those previously published, exhibited slower TPT and KRT values. However, growth in an enhanced media increased these values. From these data it was concluded that the myotubes cultured on the cantilevers were of an embryonic phenotype. The system was also shown to be responsive to the application of a toxin, veratridine. Conclusions/Significance: The device demonstrated here will provide a useful foundation for studying various aspects of muscle physiology and behavior in a controlled high-throughput manner as well as be useful for biosensor and drug discovery applications.	[Wilson, Kerry; Das, Mainak; Hickman, James] Univ Cent Florida, NanoSci Technol Ctr, Orlando, FL 32816 USA; [Wahl, Kathryn J.] USN, Res Lab, Mol Interfaces & Tribol Sect, Washington, DC 20375 USA; [Colton, Richard J.] USN, Res Lab, Div Chem, Washington, DC 20375 USA	State University System of Florida; University of Central Florida; United States Department of Defense; United States Navy; Naval Research Laboratory; United States Department of Defense; United States Navy; Naval Research Laboratory	Wilson, K (corresponding author), UCL, London Ctr Nanotechnol, London, England.	jhickman@mail.ucf.edu	Wahl, Kathryn J/A-6494-2012	Wahl, Kathryn/0000-0001-8163-6964	Office of Naval Research; NIH [5RO1-NS050452]; DARPA [F30602-02-2-0541]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050452] Funding Source: NIH RePORTER	Office of Naval Research(Office of Naval Research); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to acknowledge the MEMS Exchange for fabrication of the cantilevers. Finally, the authors also acknowledge the support of the Office of Naval Research for this project.; The authors acknowledge funding support from NIH grant 5RO1-NS050452 and DARPA F30602-02-2-0541. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER S, 1989, J APPL PHYS, V65, P164, DOI 10.1063/1.342563; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bousse L, 1996, SENSOR ACTUAT B-CHEM, V34, P270, DOI 10.1016/S0925-4005(96)01906-5; Brewer GJ, 2008, J NEUROSCI METH, V170, P181, DOI 10.1016/j.jneumeth.2008.01.009; Butt HJ, 1996, J COLLOID INTERF SCI, V180, P251, DOI 10.1006/jcis.1996.0297; CLOSE R, 1964, J PHYSIOL-LONDON, V173, P74, DOI 10.1113/jphysiol.1964.sp007444; Das M, 2007, NEUROSCIENCE, V146, P481, DOI 10.1016/j.neuroscience.2007.01.068; DAS M, 2010, BIOMATERIAL IN PRESS; Das M, 2007, NAT PROTOC, V2, P1795, DOI 10.1038/nprot.2007.229; Das M, 2006, BIOMATERIALS, V27, P4374, DOI 10.1016/j.biomaterials.2006.03.046; Das M, 2009, BIOMATERIALS, V30, P5392, DOI 10.1016/j.biomaterials.2009.05.081; Dennis RG, 2000, IN VITRO CELL DEV-AN, V36, P327; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Glass DJ, 2007, J CLIN INVEST, V117, P2388, DOI 10.1172/JCI33379; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170, DOI 10.1113/jphysiol.1966.sp007909; Klein Claude A., 2000, J APPL PHYS, V88; LEE WE, 1995, CERAMIC FILMS COATIN; MEYER G, 1988, APPL PHYS LETT, V53, P1045, DOI 10.1063/1.100061; Mohan DK, 2006, BIOSENS BIOELECTRON, V21, P1804, DOI 10.1016/j.bios.2005.09.008; Moulard G, 1998, J VAC SCI TECHNOL A, V16, P736, DOI 10.1116/1.581053; Muller P, 2004, SURF SCI REP, V54, P157, DOI 10.1016/j.surfrep.2004.05.001; Pancrazio JJ, 1999, ANN BIOMED ENG, V27, P697, DOI 10.1114/1.225; Peterson CA, 1999, J VAC SCI TECHNOL A, V17, P2753, DOI 10.1116/1.581941; Ravenscroft MS, 1998, J AM CHEM SOC, V120, P12169, DOI 10.1021/ja973669n; SADER JE, 1995, REV SCI INSTRUM, V66, P3789, DOI 10.1063/1.1145439; SANDER D, 1995, REV SCI INSTRUM, V66, P4734, DOI 10.1063/1.1145316; Sin A, 2004, BIOTECHNOL PROGR, V20, P338, DOI 10.1021/bp034077d; Sivaraman A, 2005, CURR DRUG METAB, V6, P569, DOI 10.2174/138920005774832632; Spetzler D, 2007, LAB CHIP, V7, P1633, DOI 10.1039/b711066a; Stoney GG, 1909, P R SOC LOND A-CONTA, V82, P172, DOI 10.1098/rspa.1909.0021; Tanaka Y, 2007, LAB CHIP, V7, P207, DOI 10.1039/b612082b; Wheeler AR, 2003, ANAL CHEM, V75, P3581, DOI 10.1021/ac0340758; Wilson K, 2007, LAB CHIP, V7, P920, DOI 10.1039/b617939h; Xi JZ, 2005, NAT MATER, V4, P180, DOI 10.1038/nmat1308	34	58	70	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11042	10.1371/journal.pone.0011042	http://dx.doi.org/10.1371/journal.pone.0011042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548775	gold, Green Submitted, Green Published			2022-12-27	WOS:000278599600005
J	McElroy, SL; Byrne, JA; Chavez, SL; Behr, B; Hsueh, AJ; Westphal, LM; Pera, RAR				McElroy, Sohyun L.; Byrne, James A.; Chavez, Shawn L.; Behr, Barry; Hsueh, Aaron J.; Westphal, Lynn M.; Pera, Renee A. Reijo			Parthenogenic Blastocysts Derived from Cumulus-Free In Vitro Matured Human Oocytes	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; MESSENGER-RNA; GROWTH-FACTOR; EMBRYO DEVELOPMENT; DEVELOPMENTAL COMPETENCE; MEIOTIC MATURATION; EXPRESSION; FERTILIZATION; PROMOTES; STIMULATION	Background: Approximately 20% of oocytes are classified as immature and discarded following intracytoplasmic sperm injection (ICSI) procedures. These oocytes are obtained from gonadotropin-stimulated patients, and are routinely removed from the cumulus cells which normally would mature the oocytes. Given the ready access to these human oocytes, they represent a potential resource for both clinical and basic science application. However culture conditions for the maturation of cumulus-free oocytes have not been optimized. We aimed to improve maturation conditions for cumulus-free oocytes via culture with ovarian paracrine/autocrine factors identified by single cell analysis. Methodology/Principal Finding: Immature human oocytes were matured in vitro via supplementation with ovarian paracrine/autocrine factors that were selected based on expression of ligands in the cumulus cells and their corresponding receptors in oocytes. Matured oocytes were artificially activated to assess developmental competence. Gene expression profiles of parthenotes were compared to IVF/ICSI embryos at morula and blastocyst stages. Following incubation in medium supplemented with ovarian factors (BDNF, IGF-I, estradiol, GDNF, FGF2 and leptin), a greater percentage of oocytes demonstrated nuclear maturation and subsequently, underwent parthenogenesis relative to control. Similarly, cytoplasmic maturation was also improved as indicated by development to blastocyst stage. Parthenogenic blastocysts exhibited mRNA expression profiles similar to those of blastocysts obtained after IVF/ICSI with the exception for MKLP2 and PEG1. Conclusions/Significance: Human cumulus-free oocytes from hormone-stimulated cycles are capable of developing to blastocysts when cultured with ovarian factor supplementation. Our improved IVM culture conditions may be used for obtaining mature oocytes for clinical purposes and/or for derivation of embryonic stem cells following parthenogenesis or nuclear transfer.	[McElroy, Sohyun L.; Byrne, James A.; Chavez, Shawn L.; Pera, Renee A. Reijo] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Ctr Human Embryon Stem Cell Res & Educ, Palo Alto, CA 94304 USA; [McElroy, Sohyun L.; Byrne, James A.; Chavez, Shawn L.; Behr, Barry; Hsueh, Aaron J.; Westphal, Lynn M.; Pera, Renee A. Reijo] Stanford Univ, Dept Obstet & Gynecol, Palo Alto, CA 94304 USA; [Behr, Barry; Westphal, Lynn M.] Stanford Hosp & Clin, Div Reprod Endocrinol & Infertil, Palo Alto, CA USA	Stanford University; Stanford University; Stanford University	McElroy, SL (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Ctr Human Embryon Stem Cell Res & Educ, Palo Alto, CA 94304 USA.	reneer@stanford.edu	Chavez, Shawn L./ABF-6125-2021	Chavez, Shawn L./0000-0002-8285-0222; Byrne, James/0000-0002-2232-292X; Reijo Pera, Renee/0000-0002-6487-1329	California Institute for Regenerative Medicine [CIRM TG2-01159, CIRM RC1-00137]; Stanford University	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Stanford University(Stanford University)	This work was supported by a postdoctoral fellowship to SLM from the California Institute for Regenerative Medicine (CIRM TG2-01159), a comprehensive research grant to RARP (CIRM RC1-00137) and matching funds from Stanford University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 2010, FERTIL STERIL, V93, P1394, DOI 10.1016/j.fertnstert.2009.04.007; BACHVAROVA R, 1985, DEV BIOL, V108, P325, DOI 10.1016/0012-1606(85)90036-3; Ben-Haroush A, 2005, FERTIL STERIL, V84, P1257, DOI 10.1016/j.fertnstert.2005.05.018; Ben-Shlomo I, 2007, MOL ENDOCRINOL, V21, P2009, DOI 10.1210/me.2007-0087; Boelhauve M, 2005, BIOL REPROD, V73, P737, DOI 10.1095/biolreprod.105.041103; Brevini IAL, 2008, CELL PROLIFERAT, V41, P20, DOI 10.1111/j.1365-2184.2008.00485.x; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Chian R C, 2002, Reprod Biomed Online, V5, P125; Chung Y, 2008, CELL STEM CELL, V2, P113, DOI 10.1016/j.stem.2007.12.013; Cibelli JB, 2006, METHOD ENZYMOL, V418, P117, DOI 10.1016/S0076-6879(06)18008-8; da Silva SJM, 2005, REPRODUCTION, V129, P423, DOI 10.1530/rep.1.00471; Dobson AT, 2004, HUM MOL GENET, V13, P1461, DOI 10.1093/hmg/ddh157; EDWARDS RG, 1969, NATURE, V221, P632, DOI 10.1038/221632a0; Fauser B, 1998, HUM REPROD, V13, P71; Friden B, 2005, HUM REPROD, V20, P2556, DOI 10.1093/humrep/dei109; Fuchimoto D, 2001, BIOL REPROD, V65, P986, DOI 10.1095/biolreprod65.4.986; GEBER S, 1995, HUM REPROD, V10, P1492, DOI 10.1093/HUMREP/10.6.1492; Geens M, 2009, HUM REPROD, V24, P2709, DOI 10.1093/humrep/dep262; Geuns E, 2007, EUR J HUM GENET, V15, P352, DOI 10.1038/sj.ejhg.5201759; Gomez E, 2009, REPRODUCTION, V137, P285, DOI 10.1530/REP-08-0220; Heindryckx B, 2007, HUM REPROD, V22, P1982, DOI 10.1093/humrep/dem106; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HILLIER SG, 1980, J CLIN ENDOCR METAB, V50, P640, DOI 10.1210/jcem-50-4-640; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Kawamura K, 2005, P NATL ACAD SCI USA, V102, P9206, DOI 10.1073/pnas.0502442102; Kawamura K, 2008, DEV BIOL, V315, P189, DOI 10.1016/j.ydbio.2007.12.029; Kawamura K, 2009, ENDOCRINOLOGY, V150, P3774, DOI 10.1210/en.2009-0213; Kimura N, 2007, Soc Reprod Fertil Suppl, V63, P327; Lee SH, 2004, BIOL REPROD, V71, P919, DOI 10.1095/biolreprod.103.026138; Leo CP, 2000, ENDOCRINOLOGY, V141, P3052, DOI 10.1210/en.141.9.3052; Linher KJ, 2007, ENDOCRINOLOGY, V148, P4292, DOI 10.1210/en.2007-0021; Liu JH, 2008, GENOMICS, V91, P121, DOI 10.1016/j.ygeno.2007.10.005; Liu JY, 2003, FERTIL STERIL, V80, P447, DOI 10.1016/S0015-0282(03)00665-4; Magnani L, 2008, REPROD FERT DEVELOP, V20, P818, DOI 10.1071/RD08072; McElroy SL, 2008, REPROD BIOMED ONLINE, V16, P684, DOI 10.1016/S1472-6483(10)60483-X; McNatty K P, 2007, Soc Reprod Fertil Suppl, V64, P55; Moncayo HE, 1998, HUM REPROD, V13, P3310, DOI 10.1093/humrep/13.12.3310; Patsoula E, 2001, REPRODUCTION, V121, P455, DOI 10.1530/rep.0.1210455; Reeka N, 1998, HUM REPROD, V13, P2199, DOI 10.1093/humrep/13.8.2199; Rougier N, 2001, MOL REPROD DEV, V59, P468, DOI 10.1002/mrd.1054; Shu YM, 2007, FERTIL STERIL, V87, P1022, DOI 10.1016/j.fertnstert.2006.08.110; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; TESARIK J, 1995, J CLIN ENDOCR METAB, V80, P1438, DOI 10.1210/jc.80.4.1438; Trounson A, 1998, HUM REPROD, V13, P52, DOI 10.1093/humrep/13.suppl_3.52; Wasielak M, 2007, J REPROD DEVELOP, V53, P419, DOI 10.1262/jrd.18076; Wolgemuth DJ, 2002, RECENT PROG HORM RES, V57, P75, DOI 10.1210/rp.57.1.75; Zimmermann BG, 2008, PRENATAL DIAG, V28, P1087, DOI 10.1002/pd.2150	47	27	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10979	10.1371/journal.pone.0010979	http://dx.doi.org/10.1371/journal.pone.0010979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539753	Green Submitted, Green Published, gold			2022-12-27	WOS:000278465900004
J	Springer, DJ; Ren, P; Raina, R; Dong, YM; Behr, MJ; McEwen, BF; Bowser, SS; Samsonoff, WA; Chaturvedi, S; Chaturvedi, V				Springer, Deborah J.; Ren, Ping; Raina, Ramesh; Dong, Yimin; Behr, Melissa J.; McEwen, Bruce F.; Bowser, Samuel S.; Samsonoff, William A.; Chaturvedi, Sudha; Chaturvedi, Vishnu			Extracellular Fibrils of Pathogenic Yeast Cryptococcus gattii Are Important for Ecological Niche, Murine Virulence and Human Neutrophil Interactions	PLOS ONE			English	Article							DISEASE RESISTANCE; SALICYLIC-ACID; ACETYLSALICYLIC-ACID; DISTINCT ROLES; IN-VITRO; NEOFORMANS; ARABIDOPSIS; GENE; CAPSULE; PLANTS	Cryptococcus gattii, an emerging fungal pathogen of humans and animals, is found on a variety of trees in tropical and temperate regions. The ecological niche and virulence of this yeast remain poorly defined. We used Arabidopsis thaliana plants and plant-derived substrates to model C. gattii in its natural habitat. Yeast cells readily colonized scratch-wounded plant leaves and formed distinctive extracellular fibrils (40-100 nm diameter x500-3000 nm length). Extracellular fibrils were observed on live plants and plant-derived substrates by scanning electron microscopy (SEM) and by high voltage-EM (HVEM). Only encapsulated yeast cells formed extracellular fibrils as a capsule-deficient C. gattii mutant completely lacked fibrils. Cells deficient in environmental sensing only formed disorganized extracellular fibrils as apparent from experiments with a C. gattii STE12 alpha mutant. C. gattii cells with extracellular fibrils were more virulent in murine model of pulmonary and systemic cryptococcosis than cells lacking fibrils. C. gattii cells with extracellular fibrils were also significantly more resistant to killing by human polymorphonuclear neutrophils (PMN) in vitro even though these PMN produced elaborate neutrophil extracellular traps (NETs). These observations suggest that extracellular fibril formation could be a structural adaptation of C. gattii for cell-to-cell, cell-to-substrate and/or cell-to-phagocyte communications. Such ecological adaptation of C. gattii could play roles in enhanced virulence in mammalian hosts at least initially via inhibition of host PMN- mediated killing.	[Springer, Deborah J.; Ren, Ping; Dong, Yimin; Behr, Melissa J.; McEwen, Bruce F.; Bowser, Samuel S.; Samsonoff, William A.; Chaturvedi, Sudha; Chaturvedi, Vishnu] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Springer, Deborah J.; McEwen, Bruce F.; Chaturvedi, Sudha; Chaturvedi, Vishnu] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA; [Raina, Ramesh] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Syracuse University	Springer, DJ (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	vishnu@wadsworth.org		Ren, Ping/0000-0002-4022-6667; Chaturvedi, Vishnu/0000-0002-3922-9676	National Institutes of Health (NIH) [AI-53732, AI-48462, P41-RR01219]; Wadsworth Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048462, R03AI053732] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wadsworth Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Partial financial support came from the National Institutes of Health (NIH) (AI-53732, AI-48462) and NIH biotechnology grant (P41-RR01219) and Clinical Laboratory Reference System funds from the Wadsworth Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nazhan S, 2004, ORAL SURG ORAL MED O, V97, P393, DOI 10.1016/j.tripleo.2003.08.004; Bohman S, 2004, PLANT J, V37, P9, DOI 10.1046/j.1365-313X.2003.01927.x; Brandl MT, 2006, ANNU REV PHYTOPATHOL, V44, P367, DOI 10.1146/annurev.phyto.44.070505.143359; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Casadevall A, 2003, CURR OPIN MICROBIOL, V6, P332, DOI 10.1016/S1369-5274(03)00082-1; CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912; Chaturvedi S, 2005, MYCOPATHOLOGIA, V160, P207, DOI 10.1007/s11046-005-0162-7; Chaturvedi V, 1996, J IMMUNOL, V156, P3836; Chaturvedi V, 2002, INFECT IMMUN, V70, P5225, DOI 10.1128/IAI.70.9.5225-5235.2002; Chen XW, 2006, MOL PLANT PATHOL, V7, P391, DOI 10.1111/j.1364-3703.2006.00349.x; Clark ME, 2007, ENVIRON MICROBIOL, V9, P2844, DOI 10.1111/j.1462-2920.2007.01398.x; De Hoog GS, 2009, ATLAS CLIN FUNGI, V3rd, DOI DOI 10.4103/idoj.IDOJ_146_19; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; DONG ZM, 1995, INFECT IMMUN, V63, P2632, DOI 10.1128/IAI.63.7.2632-2644.1995; Dworkin M, 1999, BIOESSAYS, V21, P590, DOI 10.1002/(SICI)1521-1878(199907)21:7<590::AID-BIES7>3.0.CO;2-E; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Fonseca A, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P263, DOI 10.1007/3-540-30985-3_13; Frases S, 2009, P NATL ACAD SCI USA, V106, P1228, DOI 10.1073/pnas.0808995106; Fullner KJ, 1998, J BACTERIOL, V180, P430, DOI 10.1128/JB.180.2.430-434.1998; Gao L, 2009, MOL BIOL CELL, V20, P2540, DOI 10.1091/mbc.E09-03-0194; Garcia-Rivera J, 2004, EUKARYOT CELL, V3, P385, DOI 10.1128/EC.3.2.385-392.2004; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Hu GG, 2006, CURR GENET, V49, P341, DOI 10.1007/s00294-005-0054-x; Huerfano Sandra, 2001, Revista Iberoamericana de Micologia, V18, P131; Inacio J, 2005, FEMS YEAST RES, V5, P1167, DOI 10.1016/j.femsyr.2005.05.007; Jarrell KF, 2009, PILI AND FLAGELLA: CURRENT RESEARCH AND FUTURE TRENDS, P215; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kwon-Chung Kyung J., 2002, Taxon, V51, P804, DOI 10.2307/1555045; Machado CML, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-13; Machesky L, 2008, EMBO REP, V9, P139, DOI 10.1038/sj.embor.7401162; Mithofer A, 2005, PLANT PHYSIOL, V137, P1160, DOI 10.1104/pp.104.054460; Mylonakis E, 2007, PLOS PATHOG, V3, P859, DOI 10.1371/journal.ppat.0030101; Narasipura SD, 2005, MOL MICROBIOL, V55, P1782, DOI 10.1111/j.1365-2958.2005.04503.x; Narasipura SD, 2003, MOL MICROBIOL, V47, P1681, DOI 10.1046/j.1365-2958.2003.03393.x; Narusaka Y, 2004, PLANT MOL BIOL, V55, P327, DOI 10.1007/s11103-004-0685-1; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nicola AM, 2009, EUKARYOT CELL, V8, P1373, DOI 10.1128/EC.00044-09; Nielsen K, 2007, EUKARYOT CELL, V6, P949, DOI 10.1128/EC.00097-07; Okabayashi K, 2007, MYCOPATHOLOGIA, V163, P1, DOI 10.1007/s11046-006-0083-0; Panepinto J, 2009, MOL MICROBIOL, V71, P1165, DOI 10.1111/j.1365-2958.2008.06588.x; Polizzi G, 2006, PLANT DIS, V90, P114, DOI 10.1094/PD-90-0114B; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Reese AJ, 2003, MOL MICROBIOL, V50, P1401, DOI 10.1046/j.1365-2958.2003.03780.x; Reese AJ, 2007, MOL MICROBIOL, V63, P1385, DOI 10.1111/j.1365-2958.2006.05551.x; Ren P, 2006, EUKARYOT CELL, V5, P1065, DOI 10.1128/EC.00009-06; RIEDER CL, 1985, J ELECTRON MICR TECH, V2, P11, DOI 10.1002/jemt.1060020103; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Roetschi A, 2001, PLANT J, V28, P293, DOI 10.1046/j.1365-313X.2001.01148.x; Rokusek D, 2005, J BIOMED MATER RES A, V75A, P588, DOI 10.1002/jbm.a.30459; Saarimaa C, 2006, J BACTERIOL, V188, P7016, DOI 10.1128/JB.00608-06; Sebolai OM, 2008, CAN J MICROBIOL, V54, P91, DOI [10.1139/W07-114, 10.1139/w07-114]; Sebolai OM, 2008, CAN J MICROBIOL, V54, P111, DOI 10.1139/w07-116; Sebolai OM, 2007, CAN J MICROBIOL, V53, P809, DOI 10.1139/W07-045; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Springer DJ, 2010, EMERG INFECT DIS, V16, P14, DOI 10.3201/eid1601.090369; STAIB F, 1981, ZBL BAKT-INT J MED M, V248, P575; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Urban CF, 2006, CELL MICROBIOL, V8, P1687, DOI 10.1111/j.1462-5822.2006.00792.x; van Baarlen P, 2007, DRUG DISCOV TODAY, V12, P167, DOI 10.1016/j.drudis.2006.12.007; Vardy L, 2000, EMBO J, V19, P6098, DOI 10.1093/emboj/19.22.6098; Varon M, 2000, J BACTERIOL, V182, P3877, DOI 10.1128/JB.182.13.3877-3880.2000; Walker JR, 2007, MOL MICROBIOL, V63, P629, DOI 10.1111/j.1365-2958.2006.05494.x; Wartha F, 2007, CELL MICROBIOL, V9, P1162, DOI 10.1111/j.1462-5822.2006.00857.x; Wright LC, 2002, FEMS MICROBIOL LETT, V209, P175, DOI 10.1111/j.1574-6968.2002.tb11128.x; Xue CY, 2007, CELL HOST MICROBE, V1, P263, DOI 10.1016/j.chom.2007.05.005; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	68	44	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10978	10.1371/journal.pone.0010978	http://dx.doi.org/10.1371/journal.pone.0010978			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20539754	Green Published, Green Submitted, gold			2022-12-27	WOS:000278465900003
J	Fristedt, R; Granath, P; Vener, AV				Fristedt, Rikard; Granath, Pontus; Vener, Alexander V.			A Protein Phosphorylation Threshold for Functional Stacking of Plant Photosynthetic Membranes	PLOS ONE			English	Article							HARVESTING-COMPLEX-II; PHOTOSYSTEM-II; STATE TRANSITIONS; ISOLATED-CHLOROPLASTS; THYLAKOID MEMBRANES; ELECTRON-TRANSPORT; SUBSTRATE LEVEL; KINASE STT7; LIGHT; PHOSPHOPROTEIN	Phosphorylation of photosystem II (PSII) proteins affects macroscopic structure of thylakoid photosynthetic membranes in chloroplasts of the model plant Arabidopsis. In this study, light-scattering spectroscopy revealed that stacking of thylakoids isolated from wild type Arabidopsis and the mutant lacking STN7 protein kinase was highly influenced by cation (Mg++) concentrations. The stacking of thylakoids from the stn8 and stn7stn8 mutants, deficient in STN8 kinase and consequently in light-dependent phosphorylation of PSII, was increased even in the absence of Mg++. Additional PSII protein phosphorylation in wild type plants exposed to high light enhanced Mg++-dependence of thylakoid stacking. Protein phosphorylation in the plant leaves was analyzed during day, night and prolonged darkness using three independent techniques: immunoblotting with anti-phosphothreonine antibodies; Diamond ProQ phosphoprotein staining; and quantitative mass spectrometry of peptides released from the thylakoid membranes by trypsin. All assays revealed dark/night-induced increase in phosphorylation of the 43 kDa chlorophyll-binding protein CP43, which compensated for decrease in phosphorylation of the other PSII proteins in wild type and stn7, but not in the stn8 and stn7stn8 mutants. Quantitative mass spectrometry determined that every PSII in wild type and stn7 contained on average 2.5 +/- 0.1 or 1.4 +/- 0.1 phosphoryl groups during day or night, correspondingly, while less than every second PSII had a phosphoryl group in stn8 and stn7stn8. It is postulated that functional cation-dependent stacking of plant thylakoid membranes requires at least one phosphoryl group per PSII, and increased phosphorylation of PSII in plants exposed to high light enhances stacking dynamics of the photosynthetic membranes.	[Fristedt, Rikard; Granath, Pontus; Vener, Alexander V.] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University	Fristedt, R (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	alexander.vener@liu.se			Swedish Research Council; Swedish Research Council for Environment, Agriculture and Spatial Planning	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agriculture and Spatial Planning(Swedish Research Council Formas)	This work was supported by grants from the Swedish Research Council and from the Swedish Research Council for Environment, Agriculture and Spatial Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsson PA, 2004, PHYSIOL PLANTARUM, V121, P334, DOI 10.1111/j.0031-9317.2004.00315.x; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Aro EM, 2004, METH MOL B, V274, P271; Aro EM, 2003, ANTIOXID REDOX SIGN, V5, P55, DOI 10.1089/152308603321223540; Baena-Gonzalez E, 1999, PLANTA, V208, P196, DOI 10.1007/s004250050550; Barber J, 2006, BIOCHEM SOC T, V34, P619, DOI 10.1042/BST0340619; BARBER J, 1982, ANNU REV PLANT PHYS, V33, P261, DOI 10.1146/annurev.pp.33.060182.001401; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Chow WS, 2005, PHOTOCH PHOTOBIO SCI, V4, P1081, DOI 10.1039/b507310n; CHOW WS, 1980, ARCH BIOCHEM BIOPHYS, V201, P347, DOI 10.1016/0003-9861(80)90520-2; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Fristedt R, 2009, BIOCHEMISTRY-US, V48, P499, DOI 10.1021/bi8016334; Fristedt R, 2009, PLANT CELL, V21, P3950, DOI 10.1105/tpc.109.069435; Hansson M, 2007, J BIOL CHEM, V282, P16214, DOI 10.1074/jbc.M605833200; IZAWA S, 1966, PLANT PHYSIOL, V41, P544, DOI 10.1104/pp.41.3.544; IZAWA S, 1966, PLANT PHYSIOL, V41, P533, DOI 10.1104/pp.41.3.533; Kargul J, 2005, FEBS J, V272, P4797, DOI 10.1111/j.1742-4658.2005.04894.x; Kargul J, 2008, FEBS J, V275, P1056, DOI 10.1111/j.1742-4658.2008.06262.x; Khatoon M, 2009, J BIOL CHEM, V284, P25343, DOI 10.1074/jbc.M109.007740; Kirchhoff H, 2008, TRENDS PLANT SCI, V13, P201, DOI 10.1016/j.tplants.2008.03.001; Kirchhoff H, 2008, BIOCHEMISTRY-US, V47, P431, DOI 10.1021/bi7017877; Koivuniemi A, 1995, BIOCHEMISTRY-US, V34, P16022, DOI 10.1021/bi00049a016; Lemeille S, 2009, PLOS BIOL, V7, P664, DOI 10.1371/journal.pbio.1000045; Mullineaux CW, 2005, TRENDS PLANT SCI, V10, P521, DOI 10.1016/j.tplants.2005.09.001; Mustardy L, 2003, TRENDS PLANT SCI, V8, P117, DOI 10.1016/S1360-1385(03)00015-3; Noren H, 2004, PHYSIOL PLANTARUM, V121, P343, DOI 10.1111/j.0031-9317.2004.00350.x; Rintamaki E, 1997, J BIOL CHEM, V272, P30476, DOI 10.1074/jbc.272.48.30476; Rochaix JD, 2007, FEBS LETT, V581, P2768, DOI 10.1016/j.febslet.2007.04.038; Shapiguzov A, 2010, P NATL ACAD SCI USA, V107, P4782, DOI 10.1073/pnas.0913810107; Spetea C, 1999, P NATL ACAD SCI USA, V96, P6547, DOI 10.1073/pnas.96.11.6547; Steen H, 2005, P NATL ACAD SCI USA, V102, P3948, DOI 10.1073/pnas.0409536102; Tikkanen M, 2008, BBA-BIOENERGETICS, V1777, P1432, DOI 10.1016/j.bbabio.2008.08.004; Tikkanen M, 2006, PLANT MOL BIOL, V62, P779, DOI 10.1007/s11103-006-9044-8; Turkina MV, 2006, MOL CELL PROTEOMICS, V5, P1412, DOI 10.1074/mcp.M600066-MCP200; Vainonen JP, 2005, J BIOL CHEM, V280, P33679, DOI 10.1074/jbc.M505729200; Vainonen JP, 2008, FEBS J, V275, P1767, DOI 10.1111/j.1742-4658.2008.06335.x; Vener AV, 2007, BBA-BIOENERGETICS, V1767, P449, DOI 10.1016/j.bbabio.2006.11.007; Vener AV, 2001, J BIOL CHEM, V276, P6959, DOI 10.1074/jbc.M009394200; Vener AV, 1998, CURR OPIN PLANT BIOL, V1, P217, DOI 10.1016/S1369-5266(98)80107-6; Vener AV, 1997, P NATL ACAD SCI USA, V94, P1585, DOI 10.1073/pnas.94.4.1585; Vener AV, 2005, IUBMB LIFE, V57, P433, DOI 10.1080/15216540500138360; Vener AV, 1999, BIOCHEMISTRY-US, V38, P14955, DOI 10.1021/bi990971v; Vink M, 2000, PHOTOSYNTH RES, V64, P209, DOI 10.1023/A:1006455926748; Zer H, 1999, P NATL ACAD SCI USA, V96, P8277, DOI 10.1073/pnas.96.14.8277	45	59	59	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2010	5	6							e10963	10.1371/journal.pone.0010963	http://dx.doi.org/10.1371/journal.pone.0010963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605XA	20532038	gold, Green Published, Green Submitted			2022-12-27	WOS:000278380500009
J	Chilov, D; Sinjushina, N; Saarimaki-Vire, J; Taketo, MM; Partanen, J				Chilov, Dmitri; Sinjushina, Natalia; Saarimaki-Vire, Jonna; Taketo, Makoto M.; Partanen, Juha			beta-Catenin Regulates Intercellular Signalling Networks and Cell-Type Specific Transcription in the Developing Mouse Midbrain-Rhombomere 1 Region	PLOS ONE			English	Article							INT-1 PROTOONCOGENE; ISTHMIC ORGANIZER; IN-VIVO; WNT; EXPRESSION; GENE; FGF8; HINDBRAIN; BRAIN; DIFFERENTIATION	beta-catenin is a multifunctional protein involved in both signalling by secreted factors of Wnt family and regulation of the cellular architecture. We show that beta-catenin stabilization in mouse midbrain-rhombomere1 region leads to robust up-regulation of several Wnt signalling target genes, including Fgf8. Suggestive of direct transcriptional regulation of the Fgf8 gene, beta-catenin stabilization resulted in Fgf8 up-regulation also in other tissues, specifically in the ventral limb ectoderm. Interestingly, stabilization of beta-catenin rapidly caused down-regulation of the expression of Wnt1 itself, suggesting a negative feedback loop. The changes in signal molecule expression were concomitant with deregulation of anterior-posterior and dorso-ventral patterning. The transcriptional regulatory functions of beta-catenin were confirmed by beta-catenin loss-of-function experiments. Temporally controlled inactivation of beta-catenin revealed a cell-autonomous role for beta-catenin in the maintenance of cell-type specific gene expression in the progenitors of midbrain dopaminergic neurons. These results highlight the role of beta-catenin in establishment of neuroectodermal signalling centers, promoting region-specific gene expression and regulation of cell fate determination.	[Chilov, Dmitri; Sinjushina, Natalia; Saarimaki-Vire, Jonna; Partanen, Juha] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Partanen, Juha] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan	University of Helsinki; University of Helsinki; Kyoto University	Chilov, D (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	Juha.M.Partanen@Helsinki.Fi		chilov, dmitri/0000-0002-2279-0854; Saarimaki-Vire, Jonna/0000-0002-8865-7060; Partanen, Juha/0000-0001-8850-4825	Academy of Finland; Biocentrum Helsinki; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Biocentrum Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This study was supported by funding from the Academy of Finland, Biocentrum Helsinki, and Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 1997, DEVELOPMENT, V124, P3639; Alexandre P, 2006, DEVELOPMENT, V133, P2905, DOI 10.1242/dev.02460; Alvarez-Medina R, 2008, DEVELOPMENT, V135, P237, DOI 10.1242/dev.012054; Andersson E, 2006, DEVELOPMENT, V133, P507, DOI 10.1242/dev.02224; Andersson ER, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003517; Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Brault V, 2001, DEVELOPMENT, V128, P1253; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chi CL, 2003, DEVELOPMENT, V130, P2633, DOI 10.1242/dev.00487; CHILOV D, BETACATENIN MA UNPUB; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hermanson E, 2003, EXP CELL RES, V288, P324, DOI 10.1016/S0014-4827(03)00216-7; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Joksimovic M, 2009, NAT NEUROSCI, V12, P125, DOI 10.1038/nn.2243; Jukkola T, 2004, GENE EXPR PATTERNS, V4, P755, DOI 10.1016/j.modgep.2004.03.006; Jukkola T, 2006, DEV BIOL, V297, P141, DOI 10.1016/j.ydbio.2006.05.002; Kimmel RA, 2000, GENE DEV, V14, P1377; Machon O, 2007, DEV BIOL, V311, P223, DOI 10.1016/j.ydbio.2007.08.038; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Matsunaga E, 2002, DEVELOPMENT, V129, P5269; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Nordstrom U, 2002, NAT NEUROSCI, V5, P525, DOI 10.1038/nn854; Olander S, 2006, MECH DEVELOP, V123, P166, DOI 10.1016/j.mod.2005.11.001; Panhuysen M, 2004, MOL CELL NEUROSCI, V26, P101, DOI 10.1016/j.mcn.2004.01.011; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; Prakash N, 2004, CELL TISSUE RES, V318, P5, DOI 10.1007/s00441-004-0955-x; Tang MZ, 2009, DEVELOPMENT, V136, P2027, DOI 10.1242/dev.034330; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Wassarman KM, 1997, DEVELOPMENT, V124, P2923; Wilkinson D. G., 1990, POSTIMPLANTATION MAM, P155; Wilson SI, 2001, NATURE, V411, P325, DOI 10.1038/35077115; Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006; Ye WL, 2001, NAT NEUROSCI, V4, P1175, DOI 10.1038/nn761; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4	39	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10881	10.1371/journal.pone.0010881	http://dx.doi.org/10.1371/journal.pone.0010881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532162	Green Submitted, Green Published, gold			2022-12-27	WOS:000278318700002
J	Yan, XH; Lin, XM; Wang, QF; Zhang, YC; Chen, YM; Song, SJ; Jiang, TZ				Yan, Xiaohe; Lin, Xiaoming; Wang, Qifeng; Zhang, Yuanchao; Chen, Yingming; Song, Shaojie; Jiang, Tianzi			Dorsal Visual Pathway Changes in Patients with Comitant Extropia	PLOS ONE			English	Article							DISCORDANT BINOCULAR VISION; MAGNETIC-RESONANCE; HORIZONTAL CONNECTIONS; STRABISMIC CATS; WATER DIFFUSION; WHITE-MATTER; HUMAN BRAIN; CORTEX V1; NEURONS; MONKEY	Background: Strabismus is a disorder in which the eyes are misaligned. Persistent strabismus can lead to stereopsis impairment. The effect of strabismus on human brain is not unclear. The present study is to investigate whether the brain white structures of comitant exotropia patients are impaired using combined T1-weighted imaging and diffusion tensor imaging (DTI). Principal Findings: Thirteen patients with comitant strabismus and twelve controls underwent magnetic resonance imaging (MRI) with acquisition of T1-weighted and diffusion tensor images. T1-weighted images were used to analyze the change in volume of white matter using optimized voxel-based morphology (VBM) and diffusion tensor images were used to detect the change in white matter fibers using voxel-based analysis of DTI in comitant extropia patients. VBM analysis showed that in adult strabismus, white matter volumes were smaller in the right middle occipital gyrus, right occipital lobe/cuneus, right supramarginal gyrus, right cingulate gyrus, right frontal lobe/sub-gyral, right inferior temporal gyrus, left parahippocampa gyrus, left cingulate gyrus, left occipital lobe/cuneus, left middle frontal gyrus, left inferior parietal lobule, and left postcentral gyrus, while no brain region with greater white matter volume was found. Voxel-based analysis of DTI showed lower fractional anisotropy (FA) values in the right middle occipital gyrus and right supramarginal gyrus in strabismus patients, while brain region with increased FA value was found in the right inferior frontal gyrus. Conclusion: By combining VBM and voxel-based analysis of DTI results, the study suggests that the dorsal visual pathway was abnormal or impaired in patients with comitant exotropia.	[Yan, Xiaohe; Lin, Xiaoming; Song, Shaojie] Sun Yat Sen Univ, ZhongShan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Qifeng; Zhang, Yuanchao; Jiang, Tianzi] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China; [Chen, Yingming] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Chinese Academy of Sciences; Institute of Automation, CAS; Sun Yat Sen University	Yan, XH (corresponding author), Sun Yat Sen Univ, ZhongShan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	linxiaom@mail.sysu.edu.cn	Jiang, Tianzi/I-4256-2012	Jiang, Tianzi/0000-0001-9531-291X; lin, xiao ming/0000-0001-7161-1085	Research Foundation of Science and Technology Plan Project, Guangdong, People's Republic of China [2007B031505002, 2008B060600031]	Research Foundation of Science and Technology Plan Project, Guangdong, People's Republic of China	These studies were supported by grants 2007B031505002 and 2008B060600031 from the Research Foundation of Science and Technology Plan Project, Guangdong, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Linera J, 2008, EUR J RADIOL, V67, P415, DOI 10.1016/j.ejrad.2008.02.045; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; BAKER FH, 1974, BRAIN RES, V66, P185, DOI 10.1016/0006-8993(74)90140-1; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BLAKEMORE C, 1976, B SCHWEIZ AKAD MED, V32, P13; Busatto Geraldo F, 2008, Expert Rev Neurother, V8, P1691, DOI 10.1586/14737175.8.11.1691; Chan ST, 2004, NEUROIMAGE, V22, P986, DOI 10.1016/j.neuroimage.2004.02.021; Cheng H, 1995, J NEUROPHYSIOL, V74, P2558, DOI 10.1152/jn.1995.74.6.2558; CHEW E, 1994, ARCH OPHTHALMOL-CHIC, V112, P1349, DOI 10.1001/archopht.1994.01090220099030; CHINO YM, 1994, P NATL ACAD SCI USA, V91, P6938, DOI 10.1073/pnas.91.15.6938; CRAWFORD MLJ, 1979, INVEST OPHTH VIS SCI, V18, P496; CRAWFORD MLJ, 1983, INVEST OPHTH VIS SCI, V24, P491; CRAWFORD MLJ, 1984, INVEST OPHTH VIS SCI, V25, P779; Engelmann R, 2002, VISUAL NEUROSCI, V19, P39, DOI 10.1017/S0952523801191042; Fortin A, 2002, NEUROREPORT, V13, P895, DOI 10.1097/00001756-200205070-00032; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Govindan M, 2005, OPHTHALMOLOGY, V112, P104, DOI 10.1016/j.ophtha.2004.07.033; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Kumagami T, 2000, INVEST OPHTH VIS SCI, V41, P948; Kwee IL, 1999, NEUROLOGY, V53, P1599, DOI 10.1212/WNL.53.7.1599; LOWEL S, 1992, SCIENCE, V255, P209, DOI 10.1126/science.1372754; McKee SP, 2003, J VISION, V3, P380, DOI 10.1167/3.5.5; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Mori T, 2002, INVEST OPHTH VIS SCI, V43, P1262; Nishida Y, 2001, NEUROREPORT, V12, P2259, DOI 10.1097/00001756-200107200-00043; Robaei D, 2006, OPHTHALMOLOGY, V113, P1146, DOI 10.1016/j.ophtha.2006.02.019; Scarabino T, 2003, EUR J RADIOL, V48, P154, DOI 10.1016/j.ejrad.2003.08.008; Schmidt KF, 2008, NEUROSCIENCE, V152, P128, DOI 10.1016/j.neuroscience.2007.08.038; Schmidt KE, 1997, J NEUROSCI, V17, P5480; SENGPIEL F, 1994, J NEUROSCI, V14, P6855; Sengpiel F, 2006, CEREB CORTEX, V16, P1750, DOI 10.1093/cercor/bhj110; Shu N, 2009, HUM BRAIN MAPP, V30, P220, DOI 10.1002/hbm.20507; SINGER W, 1980, EXP BRAIN RES, V40, P294, DOI 10.1007/BF00237794; Tootell RBH, 1998, TRENDS COGN SCI, V2, P174, DOI 10.1016/S1364-6613(98)01171-1; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; Zhang B, 2005, P NATL ACAD SCI USA, V102, P9026, DOI 10.1073/pnas.0500280102	38	43	48	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2010	5	6							e10931	10.1371/journal.pone.0010931	http://dx.doi.org/10.1371/journal.pone.0010931			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AD	20532166	Green Published, gold, Green Submitted			2022-12-27	WOS:000278318700005
J	Bruining, H; de Sonneville, L; Swaab, H; de Jonge, M; Kas, M; van Engeland, H; Vorstman, J				Bruining, Hilgo; de Sonneville, Leo; Swaab, Hanna; de Jonge, Maretha; Kas, Martien; van Engeland, Herman; Vorstman, Jacob			Dissecting the Clinical Heterogeneity of Autism Spectrum Disorders through Defined Genotypes	PLOS ONE			English	Article							DIAGNOSTIC OBSERVATION SCHEDULE; KLINEFELTER-SYNDROME; RETT-SYNDROME; CHILDREN; INTERVIEW; ADOLESCENTS; MUTATIONS; GENETICS; SAMPLE; MECP2	Background: The etiology of autism spectrum disorders (ASD) is largely determined by different genetic factors of variable impact. This genetic heterogeneity could be a factor to explain the clinical heterogeneity of autism spectrum disorders. Here, a first attempt is made to assess whether genetically more homogeneous ASD groups are associated with decreased phenotypic heterogeneity with respect to their autistic symptom profile. Methodology: The autistic phenotypes of ASD subjects with 22q11 deletion syndrome (22q11DS) and ASD subjects with Klinefelter Syndrome (KS) were statistically compared to the symptom profile of a large (genetically) heterogeneous ASD sample. Autism diagnostic interview-revised (ADI-R) variables were entered in different statistical analyses to assess differences in symptom homogeneity and the feasibility of discrimination of group-specific ASD-symptom profiles. Principal Findings: The results showed substantially higher symptom homogeneity in both the genetic disorder ASD groups in comparison to the heterogeneous ASD sample. In addition, a robust discrimination between 22q11-ASD and KS-ASD and idiopathic ASD phenotypes was feasible on the basis of a reduced number of autistic scales and symptoms. The lack of overlap in discriminating subscales and symptoms between KS-ASD and 22q11DS-ASD suggests that their autistic symptom profiles cluster around different points in the total diagnostic space of profiles present in the general ASD population. Conclusion: The findings of the current study indicate that the clinical heterogeneity of ASDs may be reduced when subgroups based on a specific genotype are extracted from the idiopathic ASD population. The current strategy involving the widely used ADI-R offers a relatively straightforward possibility for assessing genotype-phenotype ASD relationships. Reverse phenotype strategies are becoming more feasible, given the accumulating evidence for the existence of genetic variants of large effect in a substantial proportion of the ASD population.	[Bruining, Hilgo; Swaab, Hanna; de Jonge, Maretha; van Engeland, Herman; Vorstman, Jacob] Univ Med Ctr Utrecht, Dept Children & Adolescent Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [de Sonneville, Leo; Swaab, Hanna] Leiden Univ, Dept Clin Child & Adolescent Studies, Leiden, Netherlands; [Kas, Martien] Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center	Bruining, H (corresponding author), Univ Med Ctr Utrecht, Dept Children & Adolescent Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	h.bruining@Umcutrecht.nl	Kas, Martien J./G-8269-2018; Swaab, Hanna/AAD-2555-2019; De Jonge, Maretha V/F-4942-2013	Kas, Martien J./0000-0002-4471-8618; de Sonneville, Leo/0000-0003-0133-4953				Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Abramsky L, 1997, PRENATAL DIAG, V17, P363, DOI 10.1002/(SICI)1097-0223(199704)17:4<363::AID-PD79>3.0.CO;2-O; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Antshel KM, 2007, J AUTISM DEV DISORD, V37, P1776, DOI 10.1007/s10803-006-0308-6; Beaudet AL, 2007, NAT MED, V13, P534, DOI 10.1038/nm0507-534; Bojesen A, 2003, J CLIN ENDOCR METAB, V88, P622, DOI 10.1210/jc.2002-021491; Bruining H, 2009, PEDIATRICS, V123, pE865, DOI 10.1542/peds.2008-1954; Brune CW, 2006, AM J PSYCHIAT, V163, P2148, DOI 10.1176/appi.ajp.163.12.2148; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; de Bildt A, 2004, J AUTISM DEV DISORD, V34, P129, DOI 10.1023/B:JADD.0000022604.22374.5f; duMontcel ST, 1996, J MED GENET, V33, P719, DOI 10.1136/jmg.33.8.719; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Ghidoni BB, 2007, CHILD ADOL PSYCH CL, V16, P723, DOI 10.1016/j.chc.2007.03.004; Kates WR, 2007, AM J MED GENET A, V143A, P2642, DOI 10.1002/ajmg.a.32012; Konstantareas MM, 1999, J AUTISM DEV DISORD, V29, P275, DOI 10.1023/A:1022155201662; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Mullen E. M, 1995, MULLEN SCALES EARLY; Nomura Y, 2005, J CHILD NEUROL, V20, P764, DOI 10.1177/08830738050200091201; Raven J. C., 1995, COLORED PROGR MATRIC; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; SNIJDERS JT, 2009, SON R 2 5 7 NIET VER; Trappe R, 2001, AM J HUM GENET, V68, P1093, DOI 10.1086/320109; Vorstman JAS, 2006, J AM ACAD CHILD PSY, V45, P1104, DOI 10.1097/01.chi.0000228131.56956.c1; Wassink TH, 2007, J AUTISM DEV DISORD, V37, P703, DOI 10.1007/s10803-006-0196-9; Wechsler D., 2014, WECHSLER PRESCHOOL P; WECHSLER D, 2002, WISC 3; Wechsler D., 1997, WECHSLER ADULT INTEL	33	71	71	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10887	10.1371/journal.pone.0010887	http://dx.doi.org/10.1371/journal.pone.0010887			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526357	Green Published, gold, Green Submitted			2022-12-27	WOS:000278222100016
J	Chittenden, CM; Melnychuk, MC; Welch, DW; McKinley, RS				Chittenden, Cedar M.; Melnychuk, Michael C.; Welch, David W.; McKinley, R. Scott			An Investigation into the Poor Survival of an Endangered Coho Salmon Population	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; EN-ROUTE MORTALITY; SOCKEYE-SALMON; BRITISH-COLUMBIA; FRASER-RIVER; MARINE SURVIVAL; STOCK IDENTIFICATION; THOMPSON RIVER; CLIMATE-CHANGE; FRESH-WATER	To investigate reasons for the decline of an endangered population of coho salmon (O. kisutch), 190 smolts were acoustically tagged during three consecutive years and their movements and survival were estimated using the Pacific Ocean Shelf Tracking project (POST) array. Median travel times of the Thompson River coho salmon smolts to the lower Fraser River sub-array were 16, 12 and 10 days during 2004, 2005 and 2006, respectively. Few smolts were recorded on marine arrays. Freshwater survival rates of the tagged smolts during their downstream migration were 0.0-5.6% (0.0-9.0% s.e.) in 2004, 7.0% (6.2% s.e.) in 2005, and 50.9% (18.6% s.e.) in 2006. Overall smolt-to-adult return rates exhibited a similar pattern, which suggests that low freshwater survival rates of out-migrating smolts may be a primary reason for the poor conservation status of this endangered coho salmon population.	[Chittenden, Cedar M.] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway; [Chittenden, Cedar M.; McKinley, R. Scott] Univ British Columbia, Ctr Aquaculture & Environm Res, W Vancouver, BC, Canada; [Melnychuk, Michael C.] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada; [Melnychuk, Michael C.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Welch, David W.] Kintama Res Corp, Nanaimo, BC, Canada	UiT The Arctic University of Tromso; University of British Columbia; University of British Columbia; University of British Columbia	Chittenden, CM (corresponding author), Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway.	Cedar.M.Chittenden@uit.no	Melnychuk, Michael/A-4680-2013	Melnychuk, Michael/0000-0002-6088-7657	Census of Marine Life; Gordon and Betty Moore Foundation; Pacific Salmon Foundation	Census of Marine Life; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Pacific Salmon Foundation	Funding for this work was provided by Census of Marine Life, the Gordon and Betty Moore Foundation, and the Pacific Salmon Foundation. The Pacific Ocean Shelf Tracking project (POST) acoustic receiver arrays were designed and deployed by Kintama Research Corp. None of these organizations were directly involved in the study design, analysis, or writing of the paper, nor the decision to submit the manuscript for publication. This work is a contribution to the Census of Marine Life.	Beacham TD, 2001, T AM FISH SOC, V130, P1116, DOI 10.1577/1548-8659(2001)130&lt;1116:EAAOMA&gt;2.0.CO;2; Beamish RJ, 2008, T AM FISH SOC, V137, P503, DOI 10.1577/T07-080.1; Beamish RJ, 1997, CAN J FISH AQUAT SCI, V54, P543, DOI 10.1139/cjfas-54-3-543; Beamish RJ, 2000, FISH OCEANOGR, V9, P114; Beamish RJ, 2004, PROG OCEANOGR, V60, P355, DOI 10.1016/j.pocean.2004.02.009; Beamish RJ, 1999, CAN J FISH AQUAT SCI, V56, P506, DOI 10.1139/cjfas-56-3-506; Bradford MJ, 1999, T AM FISH SOC, V128, P840, DOI 10.1577/1548-8659(1999)128<0840:TASTIT>2.0.CO;2; Bradford MJ, 2000, CAN J FISH AQUAT SCI, V57, P13, DOI 10.1139/cjfas-57-1-13; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 1987, AM FISHERIES SOC MON; Chittenden CM, 2008, J FISH BIOL, V72, P614, DOI 10.1111/j.1095-8649.2007.01729.x; Chittenden CM, 2009, T AM FISH SOC, V138, P1220, DOI 10.1577/T09-037.1; Chittenden C, 2009, ENVIRON BIOL FISH, V84, P129, DOI 10.1007/s10641-008-9396-9; Cooke SJ, 2004, FISHERIES, V29, P22, DOI 10.1577/1548-8446(2004)29[22:AMTAHE]2.0.CO;2; CORMACK RM, 1964, BIOMETRIKA, V51, P429, DOI 10.1093/biomet/51.3-4.429; Coronado C, 1998, CAN J FISH AQUAT SCI, V55, P2067, DOI 10.1139/cjfas-55-9-2067; *COSEWIC, 2002, ASS STAT REP COH SAL; Crossin GT, 2008, CAN J ZOOL, V86, P127, DOI 10.1139/Z07-122; Crossin GT, 2007, MAR BIOL, V152, P905, DOI 10.1007/s00227-007-0741-x; *DFO, 2006, 2006 MAR SURV FOR SO; *ENV CAN, 2001, STAT WAT QUAL S THOM; *ENV CAN, 2008, ARCH HYDR DAT; GISLASON G, 1996, EC VALUE SALMON CHIN; Groot C., 1991, PACIFIC SALMON LIFE; Hare SR, 1999, FISHERIES, V24, P6, DOI 10.1577/1548-8446(1999)024<0006:IPR>2.0.CO;2; Hobday AJ, 2001, CAN J FISH AQUAT SCI, V58, P2021, DOI 10.1139/cjfas-58-10-2021; Hockersmith EE, 2003, N AM J FISH MANAGE, V23, P404, DOI 10.1577/1548-8675(2003)023<0404:COMRAS>2.0.CO;2; Irvine JR, 2005, FISHERIES, V30, P11, DOI 10.1577/1548-8446(2005)30[11:CSARA]2.0.CO;2; IRVINE JR, 2000, P C BIOL MAN SPEC HA, V2, P595; IRVINE JR, 1999, 9928 CSAS; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Koslow JA, 2002, FISH OCEANOGR, V11, P65, DOI 10.1046/j.1365-2419.2002.00187.x; Laake J., 2022, MARK, P109; Lacroix GL, 2008, CAN J FISH AQUAT SCI, V65, P2063, DOI 10.1139/F08-119; Lawson PW, 2004, CAN J FISH AQUAT SCI, V61, P360, DOI 10.1139/F04-003; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; McPhail J.D., 1986, P615; MELNYCHUK M, 2009, MORTALITY MIGRATING; Melnychuk MC, 2007, HYDROBIOLOGIA, V582, P55, DOI 10.1007/s10750-006-0541-1; Morrison J, 2002, J HYDROL, V263, P230, DOI 10.1016/S0022-1694(02)00065-3; Noakes Donald J., 2000, North Pacific Anadromous Fish Commission Bulletin, V2, P155; Pearcy W. G., 1992, OCEAN ECOLOGY N PACI; PERRY EA, 1995, AM FISH S S, V15, P152; PITRE KR, 1993, P 1992 COH WORKSH NA, P140; ROOD KM, 1995, CAN MAN REPT FISH AQ, V2297; ROUTLEDGE R, 1999, COAST WIDE COHO; SEBER GAF, 1965, BIOMETRIKA, V52, P249; Shaklee JB, 1999, FISH RES, V43, P45, DOI 10.1016/S0165-7836(99)00066-1; Skalski JR, 2001, CAN J FISH AQUAT SCI, V58, P1987, DOI 10.1139/cjfas-58-10-1987; Small MP, 1998, MOL ECOL, V7, P141, DOI 10.1046/j.1365-294x.1998.00324.x; Small MP, 1998, FISH B-NOAA, V96, P843; SWAIN DP, 1991, CAN J FISH AQUAT SCI, V48, P1783, DOI 10.1139/f91-210; TAYLOR EB, 1986, PROG FISH CULT, V48, P171, DOI 10.1577/1548-8640(1986)48<171:DIMBWA>2.0.CO;2; Walters C, 1998, CAN J FISH AQUAT SCI, V55, P2533, DOI 10.1139/cjfas-55-12-2533; Ward BR, 2000, CAN J FISH AQUAT SCI, V57, P298, DOI 10.1139/cjfas-57-2-298; Welch DW, 2007, HYDROBIOLOGIA, V582, P289, DOI 10.1007/s10750-006-0553-x; Welch DW, 2008, PLOS BIOL, V6, P2101, DOI 10.1371/journal.pbio.0060265; Welch DW, 2009, CAN J FISH AQUAT SCI, V66, P736, DOI 10.1139/F09-032; Welch DW, 2000, FISH OCEANOGR, V9, P17; Welch DW, 2004, DEEP-SEA RES PT II, V51, P897, DOI 10.1016/j.dsr2.2004.05.010; Welch DW, 2002, OCEANOL ACTA, V25, P243, DOI 10.1016/S0399-1784(02)01206-9; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Young JL, 2006, CAN J FISH AQUAT SCI, V63, P1067, DOI 10.1139/F06-014; Zabel RW, 2004, ECOLOGY, V85, P795, DOI 10.1890/02-0719	64	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10869	10.1371/journal.pone.0010869	http://dx.doi.org/10.1371/journal.pone.0010869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526367	Green Published, gold			2022-12-27	WOS:000278222100005
J	McNulty, S; Bornmann, W; Schriewer, J; Werner, C; Smith, SK; Olson, VA; Damon, IK; Buller, M; Heuser, J; Kalman, D				McNulty, Shannon; Bornmann, William; Schriewer, Jill; Werner, Chas; Smith, Scott K.; Olson, Victoria A.; Damon, Inger K.; Buller, Mark; Heuser, John; Kalman, Daniel			Multiple Phosphatidylinositol 3-Kinases Regulate Vaccinia Virus Morphogenesis	PLOS ONE			English	Article							INTRACELLULAR MATURE VIRIONS; STRAIN L CELLS; ENDOPLASMIC-RETICULUM; INTERMEDIATE COMPARTMENT; ENVELOPE GLYCOPROTEIN; EXTRACELLULAR VIRUS; P85-ALPHA SUBUNIT; TYROSINE KINASES; PROGENY VACCINIA; RAB5 EFFECTORS	Poxvirus morphogenesis is a complex process that involves the successive wrapping of the virus in host cell membranes. We screened by plaque assay a focused library of kinase inhibitors for those that caused a reduction in viral growth and identified several compounds that selectively inhibit phosphatidylinositol 3-kinase (PI3K). Previous studies demonstrated that PI3Ks mediate poxviral entry. Using growth curves and electron microscopy in conjunction with inhibitors, we show that that PI3Ks additionally regulate morphogenesis at two distinct steps: immature to mature virion (IMV) transition, and IMV envelopment to form intracellular enveloped virions (IEV). Cells derived from animals lacking the p85 regulatory subunit of Type I PI3Ks (p85 alpha(-/-)beta(-/-)) presented phenotypes similar to those observed with PI3K inhibitors. In addition, VV appear to redundantly use PI3Ks, as PI3K inhibitors further reduce plaque size and number in p85 alpha(-/-)beta(-/-) cells. Together, these data provide evidence for a novel regulatory mechanism for virion morphogenesis involving phosphatidylinositol dynamics and may represent a new therapeutic target to contain poxviruses.	[McNulty, Shannon] Emory Univ, Sch Med, Microbiol & Mol Genet Grad Program, Atlanta, GA 30322 USA; [Bornmann, William] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA; [Schriewer, Jill; Buller, Mark] St Louis Univ, Hlth Sci Ctr, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA; [Smith, Scott K.; Olson, Victoria A.; Damon, Inger K.] Ctr Dis Control & Prevent, Poxvirus Team,Natl Ctr Zoonot Viral & Enter Dis, Poxvirus & Rabies Branch, Div Viral & Rickettsial Dis, Atlanta, GA USA; [Heuser, John] Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA; [Kalman, Daniel] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Saint Louis University; Centers for Disease Control & Prevention - USA; Washington University (WUSTL); Emory University	McNulty, S (corresponding author), Emory Univ, Sch Med, Microbiol & Mol Genet Grad Program, Atlanta, GA 30322 USA.	dkalman@emory.edu			National Institutes of Health [R56A105896101A2, R01A107246201A2]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health R56A105896101A2 and R01A107246201A2 to DK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG JA, 1973, J GEN VIROL, V21, P533, DOI 10.1099/0022-1317-21-3-533; Assarsson E, 2008, P NATL ACAD SCI USA, V105, P2140, DOI 10.1073/pnas.0711573105; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Betakova T, 1999, J VIROL, V73, P3534, DOI 10.1128/JVI.73.5.3534-3543.1999; BLASCO R, 1993, J VIROL, V67, P3319, DOI 10.1128/JVI.67.6.3319-3325.1993; BLASCO R, 1991, J VIROL, V65, P5910, DOI 10.1128/JVI.65.11.5910-5920.1991; Blouch RE, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-91; Bommarius B, 2007, MOL MICROBIOL, V63, P1748, DOI 10.1111/j.1365-2958.2007.05626.x; Brachmann SA, 2005, MOL CELL BIOL, V25, P2593, DOI 10.1128/MCB.25.7.2593-2606.2005; Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855; Byrd CM, 2006, REV MED VIROL, V16, P187, DOI 10.1002/rmv.499; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Carter GC, 2005, J GEN VIROL, V86, P1279, DOI 10.1099/vir.0.80831-0; Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; CHANG A, 1976, J GEN VIROL, V32, P275, DOI 10.1099/0022-1317-32-2-275; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Cheng KKF, 2009, J PAIN SYMPTOM MANAG, V37, P44, DOI 10.1016/j.jpainsymman.2007.12.019; Cluett EB, 1997, MOL BIOL CELL, V8, P2233, DOI 10.1091/mbc.8.11.2233; Cluett EB, 1996, J CELL SCI, V109, P2121; Condit RC, 2002, BBA-GENE STRUCT EXPR, V1577, P325, DOI 10.1016/S0167-4781(02)00461-X; Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; DALES S, 1965, AM J MED, V38, P699, DOI 10.1016/0002-9343(65)90191-9; DALES S, 1963, J CELL BIOL, V18, P51, DOI 10.1083/jcb.18.1.51; DALES S, 1968, VIROLOGY, V35, P564, DOI 10.1016/0042-6822(68)90286-9; Earley AK, 2008, J VIROL, V82, P2161, DOI 10.1128/JVI.01971-07; ENGELSTAD M, 1993, VIROLOGY, V194, P627, DOI 10.1006/viro.1993.1302; ERICSSON M, 1995, J VIROL, V69, P7072, DOI 10.1128/JVI.69.11.7072-7086.1995; Franke TF, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe29; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Geada MM, 2001, J GEN VIROL, V82, P2747, DOI 10.1099/0022-1317-82-11-2747; Gur I, 2008, INT J STD AIDS, V19, P503, DOI 10.1258/ijsa.2008.008186; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hayakawa M, 2006, BIOORGAN MED CHEM, V14, P6847, DOI 10.1016/j.bmc.2006.06.046; Herrera E, 1998, J VIROL, V72, P294, DOI 10.1128/JVI.72.1.294-302.1998; Heuser J, 2005, J CELL BIOL, V169, P269, DOI 10.1083/jcb.200412169; HILLER G, 1981, J VIROL, V39, P903, DOI 10.1128/JVI.39.3.903-913.1981; Hirsch E, 2007, J ENDOCRINOL, V194, P243, DOI 10.1677/JOE-07-0097; Hollinshead M, 1999, J VIROL, V73, P1503, DOI 10.1128/JVI.73.2.1503-1517.1999; HOLOWCZAK JA, 1972, VIROLOGY, V50, P216, DOI 10.1016/0042-6822(72)90362-5; Hu NJ, 2009, VACCINE, V27, P2994, DOI 10.1016/j.vaccine.2009.02.103; Huang RH, 2008, P NATL ACAD SCI USA, V105, P482, DOI 10.1073/pnas.0710079105; Husain M, 2002, J VIROL, V76, P7777, DOI 10.1128/JVI.76.15.7777-7789.2002; Husain M, 2001, J VIROL, V75, P7528, DOI 10.1128/JVI.75.16.7528-7542.2001; Ichihashi Y, 1996, VIROLOGY, V217, P478, DOI 10.1006/viro.1996.0142; Jezek Z, 1988, HUMAN MONKEYPOX; Jiang BH, 2008, BBA-PROTEINS PROTEOM, V1784, P150, DOI 10.1016/j.bbapap.2007.09.008; JOKLIK WK, 1964, J MOL BIOL, V8, P277, DOI 10.1016/S0022-2836(64)80137-6; KAJIOKA R, 1964, VIROLOGY, V24, P295, DOI 10.1016/0042-6822(64)90167-9; Knight ZA, 2007, BIOCHEM SOC T, V35, P245, DOI 10.1042/BST0350245; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; KrijnseLocker J, 1996, J BIOL CHEM, V271, P14950, DOI 10.1074/jbc.271.25.14950; Law M, 2006, P NATL ACAD SCI USA, V103, P5989, DOI 10.1073/pnas.0601025103; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Mallardo M, 2002, J VIROL, V76, P5167, DOI 10.1128/JVI.76.10.5167-5183.2002; Mallo GV, 2008, J CELL BIOL, V182, P741, DOI 10.1083/jcb.200804131; Martinez O, 1998, BBA-MOL CELL RES, V1404, P101, DOI 10.1016/S0167-4889(98)00050-0; Mauvais-Jarvis F, 2002, J CLIN INVEST, V109, P141, DOI 10.1172/JCI200213305; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; MOSS B, 1969, NATURE, V224, P1280, DOI 10.1038/2241280a0; PAYNE LG, 1979, J VIROL, V32, P614, DOI 10.1128/JVI.32.2.614-622.1979; Pedersen K, 2000, J VIROL, V74, P3525, DOI 10.1128/JVI.74.8.3525-3536.2000; Ploubidou A, 2000, EMBO J, V19, P3932, DOI 10.1093/emboj/19.15.3932; POWIS G, 1994, CANCER RES, V54, P2419; Punjabi A, 2005, J VIROL, V79, P2171, DOI 10.1128/JVI.79.4.2171-2190.2005; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Reeves PM, 2005, NAT MED, V11, P731, DOI 10.1038/nm1265; Rimoin AW, 2007, EMERG INFECT DIS, V13, P934, DOI 10.3201/eid1306.061540; Risco C, 2002, J VIROL, V76, P1839, DOI 10.1128/JVI.76.4.1839-1855.2002; Rodriguez JR, 1997, J VIROL, V71, P1821; Roper RL, 1999, J VIROL, V73, P1108, DOI 10.1128/JVI.73.2.1108-1117.1999; RUECKLE TJ, 2005, AZOLIDINOLONEVINYL F; Saeed MF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000141; Sanderson CM, 2000, J GEN VIROL, V81, P47, DOI 10.1099/0022-1317-81-1-47; SCHMELZ M, 1994, J VIROL, V68, P130, DOI 10.1128/JVI.68.1.130-147.1994; Scott CC, 2002, J BIOL CHEM, V277, P12770, DOI 10.1074/jbc.M110399200; Senkevich TG, 2000, P NATL ACAD SCI USA, V97, P12068, DOI 10.1073/pnas.210397997; Senkevich TG, 2002, P NATL ACAD SCI USA, V99, P6667, DOI 10.1073/pnas.062163799; Senkevich TG, 2002, VIROLOGY, V300, P296, DOI 10.1006/viro.2002.1608; Senkevich TG, 2000, VIROLOGY, V278, P244, DOI 10.1006/viro.2000.0656; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; Soares JAP, 2009, J VIROL, V83, P6883, DOI 10.1128/JVI.00245-09; SODEIK B, 1993, J CELL BIOL, V121, P521, DOI 10.1083/jcb.121.3.521; Stein RC, 2000, MOL MED TODAY, V6, P347, DOI 10.1016/S1357-4310(00)01770-6; Stenmark H, 2001, SEMIN CELL DEV BIOL, V12, P193, DOI 10.1006/scdb.2000.0236; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; Swimm A, 2004, MOL BIOL CELL, V15, P3520, DOI 10.1091/mbc.E04-02-0093; Szajner P, 2005, J CELL BIOL, V170, P971, DOI 10.1083/jcb.200504026; TOOZE J, 1993, EUR J CELL BIOL, V60, P163; Townsley AC, 2006, J VIROL, V80, P8899, DOI 10.1128/JVI.01053-06; Ueki K, 2002, MOL CELL BIOL, V22, P965, DOI 10.1128/MCB.22.3.965-977.2002; Unger B, 2004, J VIROL, V78, P8885, DOI 10.1128/JVI.78.16.8885-8901.2004; Vanderplasschen A, 1998, J GEN VIROL, V79, P877, DOI 10.1099/0022-1317-79-4-877; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Ward BM, 2005, J VIROL, V79, P4755, DOI 10.1128/JVI.79.8.4755-4763.2005; Ward BM, 2000, J VIROL, V74, P3771, DOI 10.1128/JVI.74.8.3771-3780.2000; Ward BM, 2001, J VIROL, V75, P11651, DOI 10.1128/JVI.75.23.11651-11663.2001; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; White CL, 2000, J VIROL, V74, P9175, DOI 10.1128/JVI.74.19.9175-9183.2000; WOLFFE EJ, 1993, J VIROL, V67, P4732, DOI 10.1128/JVI.67.8.4732-4741.1993; WOSCHOLSKI R, 1994, FEBS LETT, V342, P109, DOI 10.1016/0014-5793(94)80482-6; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379; Yuan H, 2007, CHEM BIOL, V14, P321, DOI 10.1016/j.chembiol.2007.02.007; ZABOROWSKA I, 2009, J VIROL	108	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10884	10.1371/journal.pone.0010884	http://dx.doi.org/10.1371/journal.pone.0010884			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526370	Green Submitted, gold, Green Published			2022-12-27	WOS:000278222100013
J	Lepp, D; Roxas, B; Parreira, VR; Marri, PR; Rosey, EL; Gong, J; Songer, JG; Vedantam, G; Prescott, JF				Lepp, Dion; Roxas, Bryan; Parreira, Valeria R.; Marri, Pradeep R.; Rosey, Everett L.; Gong, Joshua; Songer, J. Glenn; Vedantam, Gayatri; Prescott, John F.			Identification of Novel Pathogenicity Loci in Clostridium perfringens Strains That Cause Avian Necrotic Enteritis	PLOS ONE			English	Article							ENTEROTOXIN GENE CPE; BROILER-CHICKENS; GENOME SEQUENCE; ENCODING PLASMIDS; VIBRIO-CHOLERAE; ALPHA-TOXIN; BETA2 TOXIN; VIRULENCE; IMMUNIZATION; EXPRESSION	Type A Clostridium perfringens causes poultry necrotic enteritis (NE), an enteric disease of considerable economic importance, yet can also exist as a member of the normal intestinal microbiota. A recently discovered pore-forming toxin, NetB, is associated with pathogenesis in most, but not all, NE isolates. This finding suggested that NE-causing strains may possess other virulence gene(s) not present in commensal type A isolates. We used high-throughput sequencing (HTS) technologies to generate draft genome sequences of seven unrelated C. perfringens poultry NE isolates and one isolate from a healthy bird, and identified additional novel NE-associated genes by comparison with nine publicly available reference genomes. Thirty-one open reading frames (ORFs) were unique to all NE strains and formed the basis for three highly conserved NE-associated loci that we designated NELoc-1 (42 kb), NELoc-2 (11.2 kb) and NELoc-3 (5.6 kb). The largest locus, NELoc-1, consisted of netB and 36 additional genes, including those predicted to encode two leukocidins, an internalin-like protein and a ricin-domain protein. Pulsed-field gel electrophoresis (PFGE) and Southern blotting revealed that the NE strains each carried 2 to 5 large plasmids, and that NELoc-1 and -3 were localized on distinct plasmids of sizes similar to 85 and similar to 70 kb, respectively. Sequencing of the regions flanking these loci revealed similarity to previously characterized conjugative plasmids of C. perfringens. These results provide significant insight into the pathogenetic basis of poultry NE and are the first to demonstrate that netB resides in a large, plasmid-encoded locus. Our findings strongly suggest that poultry NE is caused by several novel virulence factors, whose genes are clustered on discrete pathogenicity loci, some of which are plasmid-borne.	[Lepp, Dion; Parreira, Valeria R.; Prescott, John F.] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Lepp, Dion; Gong, Joshua] Agr & Agri Food Canada, Guelph Food Res Ctr, Guelph, ON, Canada; [Roxas, Bryan; Songer, J. Glenn; Vedantam, Gayatri] Univ Arizona, Dept Vet Sci & Microbiol, Tucson, AZ USA; [Marri, Pradeep R.] Univ Arizona, Inst BIO5, Tucson, AZ USA; [Rosey, Everett L.] Pfizer Anim Hlth, Vet Med Res & Dev, Kalamazoo, MI USA; [Vedantam, Gayatri] So Arizona VA Healthcare Syst, Tucson, AZ USA	University of Guelph; Agriculture & Agri Food Canada; University of Arizona; University of Arizona; Pfizer; US Department of Veterans Affairs; Veterans Health Administration (VHA); Southern Arizona Veterans Affairs Health Care System	Lepp, D (corresponding author), Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada.	prescott@uoguelph.ca			Agriculture and Agri-Food Canada (AAFC) [F.1208.FC]; Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA); Poultry Industry Council (PIC); United States Department of Agriculture (USDA) [2007-35204-18362]; Pfizer Animal Health	Agriculture and Agri-Food Canada (AAFC)(Agriculture & Agri Food Canada); Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA); Poultry Industry Council (PIC); United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Pfizer Animal Health	Funding: This work was funded by Agriculture and Agri-Food Canada (AAFC) A-base Fund (WBSE# F.1208.FC) (JG and DL), the Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA) and the Poultry Industry Council (PIC) (JFP, VRP and DL), United States Department of Agriculture (USDA) grant no. 2007-35204-18362 and Pfizer Animal Health (JGS). Apart from the input provided by ELR in the conception of the research and review of the manuscript, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arndt JW, 2005, J MOL BIOL, V346, P1083, DOI 10.1016/j.jmb.2004.12.039; ARTHUR M, 1993, J BACTERIOL, V175, P117, DOI 10.1128/JB.175.1.117-127.1993; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bannam TL, 2006, J BACTERIOL, V188, P4942, DOI 10.1128/JB.00298-06; Barbara AJ, 2008, VET MICROBIOL, V126, P377, DOI 10.1016/j.vetmic.2007.07.019; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bhowmick R, 2008, INFECT IMMUN, V76, P4968, DOI 10.1128/IAI.01615-07; Bierne H, 2007, MICROBES INFECT, V9, P1156, DOI 10.1016/j.micinf.2007.05.003; Brouillette E, 2005, ANTIMICROB AGENTS CH, V49, P3109, DOI 10.1128/AAC.49.8.3109-3113.2005; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; Carpusca I, 2006, MOL MICROBIOL, V62, P621, DOI 10.1111/j.1365-2958.2006.05401.x; Cheung JK, 2004, J BACTERIOL, V186, P3321, DOI 10.1128/JB.186.11.3321-3330.2004; CHEUNG JK, 2009, 6 CLOSTPATH INT C RO; Cooper KK, 2009, VET MICROBIOL, V133, P92, DOI 10.1016/j.vetmic.2008.06.001; Cooper KK, 2009, ANAEROBE, V15, P55, DOI 10.1016/j.anaerobe.2009.01.006; COOPER KK, 2009, VET MICROBI IN PRESS; CORNILLOT E, 1995, MOL MICROBIOL, V15, P639, DOI 10.1111/j.1365-2958.1995.tb02373.x; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Fisher DJ, 2005, MOL MICROBIOL, V56, P747, DOI 10.1111/j.1365-2958.2005.04573.x; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gibert M, 1997, GENE, V203, P65, DOI 10.1016/S0378-1119(97)00493-9; Gusils C, 2003, CAN J MICROBIOL, V49, P472, DOI [10.1139/w03-055, 10.1139/W03-055]; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Jiang YF, 2009, AVIAN DIS, V53, P409, DOI 10.1637/8656-021109-Reg.1; Jolles P., 1999, CHITIN CHITINASES; JONAS K, 2009, ENV MICROBIOLOGY, V9999; Kaneko J, 2004, BIOSCI BIOTECH BIOCH, V68, P981, DOI 10.1271/bbb.68.981; Karaolis DKR, 2005, ANTIMICROB AGENTS CH, V49, P1029, DOI 10.1128/AAC.49.3.1029-1038.2005; Keyburn AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040026; Keyburn AL, 2006, INFECT IMMUN, V74, P6496, DOI 10.1128/IAI.00806-06; Keyburn AL, 2010, VET RES, V41, DOI 10.1051/vetres/2009069; Khambualai O, 2009, BRIT POULTRY SCI, V50, P592, DOI 10.1080/00071660903247182; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kulkarni RR, 2008, VACCINE, V26, P4194, DOI 10.1016/j.vaccine.2008.05.079; Kulkarni RR, 2007, CLIN VACCINE IMMUNOL, V14, P1070, DOI 10.1128/CVI.00162-07; Kulkarni RR, 2006, CLIN VACCINE IMMUNOL, V13, P1358, DOI 10.1128/CVI.00292-06; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Li JH, 2007, INFECT IMMUN, V75, P1811, DOI 10.1128/IAI.01981-06; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Manasherob R, 2006, MICROBIOL-SGM, V152, P2651, DOI 10.1099/mic.0.28981-0; Manich M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003764; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Miyamoto K, 2006, J BACTERIOL, V188, P1585, DOI 10.1128/JB.188.4.1585-1598.2006; Miyamoto K, 2004, J CLIN MICROBIOL, V42, P1552, DOI 10.1128/JCM.42.4.1552-1558.2004; Miyamoto K, 2008, J BACTERIOL, V190, P7178, DOI 10.1128/JB.00939-08; Morimoto K, 1997, J BACTERIOL, V179, P7306, DOI 10.1128/jb.179.23.7306-7314.1997; Morimoto K, 1999, APPL MICROBIOL BIOT, V51, P340, DOI 10.1007/s002530051400; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Nakamura T, 2008, J MOL BIOL, V376, P854, DOI 10.1016/j.jmb.2007.12.031; OHTANI K, ANAEROBE IN PRESS; Olkowski AA, 2008, RES VET SCI, V85, P543, DOI 10.1016/j.rvsc.2008.02.007; QUINLAN AR, 2010, BIOINFORMATICS; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sayeed S, 2007, INFECT IMMUN, V75, P2391, DOI 10.1128/IAI.02014-06; Sayeed S, 2010, INFECT IMMUN, V78, P495, DOI 10.1128/IAI.00838-09; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schmidt M, 2004, MICROBIOL-SGM, V150, P3253, DOI 10.1099/mic.0.27197-0; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Thompson DR, 2006, VET MICROBIOL, V113, P25, DOI 10.1016/j.vetmic.2005.10.015; Van Immerseel F, 2009, TRENDS MICROBIOL, V17, P32, DOI 10.1016/j.tim.2008.09.005; Xu Z, 2009, NUCLEIC ACIDS RES, V37, pW174, DOI 10.1093/nar/gkp278; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; 2009, ALPHA TOXIN ACCUMULA	78	81	84	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10795	10.1371/journal.pone.0010795	http://dx.doi.org/10.1371/journal.pone.0010795			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20532244	gold, Green Published, Green Submitted			2022-12-27	WOS:000278034600019
J	Nitta, M; Kozono, D; Kennedy, R; Stommel, J; Ng, K; Zinn, PO; Kushwaha, D; Kesari, S; Furnari, F; Hoadley, KA; Chin, L; DePinho, RA; Cavenne, WK; D'Andrea, A; Chen, CC				Nitta, Masayuki; Kozono, David; Kennedy, Richard; Stommel, Jayne; Ng, Kimberly; Zinn, Pascal O.; Kushwaha, Deepa; Kesari, Santosh; Furnari, Frank; Hoadley, Katherine A.; Chin, Lynda; DePinho, Ronald A.; Cavenee, Webster K.; D'Andrea, Alan; Chen, Clark C.			Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; DNA-DAMAGE RESPONSE; INTEGRATED GENOMIC ANALYSIS; REACTIVE OXYGEN; HUMAN CANCERS; REPAIR; CELLS; INSTABILITY; MODULATION; ACTIVATION	Despite the critical role of Epidermal Growth Factor Receptor (EGFR) in glioblastoma pathogenesis [1,2], EGFR targeted therapies have achieved limited clinical efficacy [3]. Here we propose an alternate therapeutic strategy based on the conceptual framework of non-oncogene addiction [4,5]. A directed RNAi screen revealed that glioblastoma cells overexpressing EGFRvIII [6], an oncogenic variant of EGFR, become hyper-dependent on a variety of DNA repair genes. Among these, there was an enrichment of Base Excision Repair (BER) genes required for the repair of Reactive Oxygen Species (ROS)-induced DNA damage, including poly-ADP ribose polymerase 1 (PARP1). Subsequent studies revealed that EGFRvIII overexpression in glioblastoma cells caused increased levels of ROS, DNA strand break accumulation, and genome instability. In a panel of primary glioblastoma lines, sensitivity to PARP1 inhibition correlated with the levels of EGFR activation and oxidative stress. Gene expression analysis indicated that reduced expression of BER genes in glioblastomas with high EGFR expression correlated with improved patient survival. These observations suggest that oxidative stress secondary to EGFR hyperactivation necessitates increased cellular reliance on PARP1 mediated BER, and offer critical insights into clinical trial design.	[Nitta, Masayuki; Kozono, David; Ng, Kimberly; Zinn, Pascal O.; Kushwaha, Deepa; D'Andrea, Alan; Chen, Clark C.] Dana-Farber Canc Inst, Dept Radiat Oncol, Boston, MA USA; [Kozono, David] Harvard Radiat Oncol Program, Boston, MA USA; [Kennedy, Richard] Almac Diagnost, Craigavon, North Ireland; [Stommel, Jayne; Chin, Lynda; DePinho, Ronald A.] Dana-Farber Canc Inst, Belfer Inst Appl Canc Sci, Dept Med Oncol, Boston, MA USA; [Kesari, Santosh] Univ Calif San Diego, Dept Neurol, Moores UCSD Canc Ctr, La Jolla, CA USA; [Furnari, Frank; Cavenee, Webster K.] Ludwig Inst Canc Res, La Jolla, CA USA; [Hoadley, Katherine A.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Chen, Clark C.] Beth Israel Deaconess Med Ctr, Div Neurosurg, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Beth Israel Deaconess Medical Center	Nitta, M (corresponding author), Dana-Farber Canc Inst, Dept Radiat Oncol, Boston, MA USA.	clark_chen@dfci.harvard.edu	Chen, Clark C/C-8714-2013; Stommel, Jayne M/M-3439-2017; Kesari, Santosh/E-8461-2013	Chen, Clark C/0000-0001-6258-9277; Furnari, Frank/0000-0003-1909-4361; Hoadley, Katherine/0000-0002-1216-477X; DePinho, Ronald/0000-0002-5625-577X	Burroughs Wellcome Fund [CAMS 1006775.01]; National Brain Tumor Foundation; ABC2 Foundation	Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Brain Tumor Foundation; ABC2 Foundation	CCC was supported by an award from the Burroughs Wellcome Fund (CAMS 1006775.01), National Brain Tumor Foundation, and ABC2 Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chen CC, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-24; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; DENKO NC, 1994, P NATL ACAD SCI USA, V91, P5124, DOI 10.1073/pnas.91.11.5124; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Haince JF, 2005, TRENDS MOL MED, V11, P456, DOI 10.1016/j.molmed.2005.08.003; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hazra TK, 2007, DNA REPAIR, V6, P470, DOI 10.1016/j.dnarep.2006.10.011; Helbock HJ, 1999, METHOD ENZYMOL, V300, P156; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kim HW, 2003, CARCINOGENESIS, V24, P235, DOI 10.1093/carcin/24.2.235; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Mukherjee B, 2009, CANCER RES, V69, P4252, DOI 10.1158/0008-5472.CAN-08-4853; Nagane M, 1998, P NATL ACAD SCI USA, V95, P5724, DOI 10.1073/pnas.95.10.5724; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rassool FV, 2007, CANCER RES, V67, P8762, DOI 10.1158/0008-5472.CAN-06-4807; Sallmyr A, 2008, CANCER LETT, V270, P1, DOI 10.1016/j.canlet.2008.03.036; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Tudek B, 2007, MOL ASPECTS MED, V28, P258, DOI 10.1016/j.mam.2007.05.003; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Yoon JH, 2003, NUCLEIC ACIDS RES, V31, P5399, DOI 10.1093/nar/gkg730	33	51	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2010	5	5							e10767	10.1371/journal.pone.0010767	http://dx.doi.org/10.1371/journal.pone.0010767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601CC	20532243	Green Published, gold, Green Submitted			2022-12-27	WOS:000278034600002
J	Romano, CM; de Carvalho-Mello, IMVG; Jamal, LF; de Melo, FL; Iamarino, A; Motoki, M; Pinho, JRR; Holmes, EC; Zanotto, PMD				Romano, Camila Malta; Guedes de Carvalho-Mello, Isabel M. V.; Jamal, Leda F.; de Melo, Fernando Lucas; Iamarino, Atila; Motoki, Marco; Rebello Pinho, Joao Renato; Holmes, Edward C.; de Andrade Zanotto, Paolo Marinho		VGDN Consortium	Social Networks Shape the Transmission Dynamics of Hepatitis C Virus	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; RISK-FACTOR; INFECTION; SEQUENCES; HISTORY; SEROPREVALENCE; EVOLUTION; VIREMIA; MODELS	Hepatitis C virus (HCV) infects 170 million people worldwide, and is a major public health problem in Brazil, where over 1% of the population may be infected and where multiple viral genotypes co-circulate. Chronically infected individuals are both the source of transmission to others and are at risk for HCV-related diseases, such as liver cancer and cirrhosis. Before the adoption of anti-HCV control measures in blood banks, this virus was mainly transmitted via blood transfusion. Today, needle sharing among injecting drug users is the most common form of HCV transmission. Of particular importance is that HCV prevalence is growing in non-risk groups. Since there is no vaccine against HCV, it is important to determine the factors that control viral transmission in order to develop more efficient control measures. However, despite the health costs associated with HCV, the factors that determine the spread of virus at the epidemiological scale are often poorly understood. Here, we sequenced partial NS5b gene sequences sampled from blood samples collected from 591 patients in Sao Paulo state, Brazil. We show that different viral genotypes entered Sao Paulo at different times, grew at different rates, and are associated with different age groups and risk behaviors. In particular, subtype 1b is older and grew more slowly than subtypes 1a and 3a, and is associated with multiple age classes. In contrast, subtypes 1a and 3b are associated with younger people infected more recently, possibly with higher rates of sexual transmission. The transmission dynamics of HCV in Sao Paulo therefore vary by subtype and are determined by a combination of age, risk exposure and underlying social network. We conclude that social factors may play a key role in determining the rate and pattern of HCV spread, and should influence future intervention policies.	[Romano, Camila Malta; de Melo, Fernando Lucas; Iamarino, Atila; Motoki, Marco; de Andrade Zanotto, Paolo Marinho] Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Lab Mol Evolut & Bioinformat,ICBII, Sao Paulo, Brazil; [Guedes de Carvalho-Mello, Isabel M. V.] Butantan Inst, Viral Immunol Lab, Sao Paulo, Brazil; [Guedes de Carvalho-Mello, Isabel M. V.; Rebello Pinho, Joao Renato] Univ Sao Paulo, Sch Med, Lab Trop Gastroenterol & Hepatol, Dept Gastroenterol,Inst Trop Med, Sao Paulo, Brazil; [Jamal, Leda F.] Ctr Dis Control, Training & Reference Ctr DST AIDS, Sao Paulo, Brazil; [Holmes, Edward C.] Penn State Univ, Dept Biol, Mueller Lab, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Holmes, Edward C.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Universidade de Sao Paulo; Instituto Butantan; Universidade de Sao Paulo; Coordenadoria de Controle de Doencas da Secretaria de Estado; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Romano, CM (corresponding author), Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Lab Mol Evolut & Bioinformat,ICBII, Sao Paulo, Brazil.	pzanotto@usp.br	Romano, Camila/ABC-2883-2020; Botosso, Viviane/I-5591-2014; Romano, Camila M/C-8185-2013; de A. Zanotto, Paolo M./B-9286-2019; Holmes, Edward/GVR-9499-2022; Pinho, Joao R. R./G-2850-2012; Melo, Fernando Lucas/U-6535-2017; Holmes, Edward/Y-2789-2019; de carvalho-Mello, Isabel Maria V G/D-3641-2012; Richtzenhain, Leonardo J/U-1026-2017	Romano, Camila/0000-0003-4550-1987; Botosso, Viviane/0000-0002-7876-3687; de A. Zanotto, Paolo M./0000-0002-8167-0625; Pinho, Joao R. R./0000-0003-3999-0489; Melo, Fernando Lucas/0000-0002-9591-0239; Holmes, Edward/0000-0001-9596-3552; de carvalho-Mello, Isabel Maria V G/0000-0002-4448-1972; Richtzenhain, Leonardo J/0000-0002-1419-3515; Iamarino, Atila/0000-0003-3904-0248; Rezende, Rosamar/0000-0003-3895-0864; Durigon, Edison/0000-0003-4898-6553	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [00/04205-6]; Conselho Nacional de Pesquisa (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This project was made possible by the Viral Genetic Diversity (VGDN) program funded by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (www.fapesp.br) project number 00/04205-6 and by the Conselho Nacional de Pesquisa (CNPq) (www.cnpq.br), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceijas C, 2007, INT J DRUG POLICY, V18, P352, DOI 10.1016/j.drugpo.2007.04.004; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; ANDERSON RM, 1992, FRAMEWORK POPULATION, P665; Andrade AFB, 2006, MEM I OSWALDO CRUZ, V101, P673, DOI 10.1590/S0074-02762006000600016; [Anonymous], 2006, THESIS U TEXAS AUSTI; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Brown KA, 2005, CURR OPIN GASTROEN, V21, P331, DOI 10.1097/01.mog.0000159830.36793.2b; Chevaliez S, 2007, WORLD J GASTROENTERO, V13, P2461, DOI 10.3748/wjg.v13.i17.2461; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Pardini MI, 2008, PLOS BIOL, V6, P428, DOI 10.1371/journal.pbio.0060057; de Oliveira T, 2006, NATURE, V444, P836, DOI 10.1038/444836a; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dubois F, 1997, HEPATOLOGY, V25, P1490, DOI 10.1002/hep.510250630; Friedman SR, 2001, J URBAN HEALTH, V78, P411, DOI 10.1093/jurban/78.3.411; Grassly NC, 2008, NAT REV MICROBIOL, V6, P477, DOI 10.1038/nrmicro1845; Karmochkine M, 2006, J VIRAL HEPATITIS, V13, P775, DOI 10.1111/j.1365-2893.2006.00742.x; Kiss IZ, 2005, P ROY SOC B-BIOL SCI, V272, P1407, DOI 10.1098/rspb.2005.3092; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Lopes Carmen L R, 2009, Rev. Saúde Pública, V43, P43, DOI 10.1590/S0034-89102009000800008; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; Martinez A, 2008, LIVER INT, V28, P757, DOI 10.1111/j.1478-3231.2008.01765.x; Mathei C, 2008, J VIRAL HEPATITIS, V15, P399, DOI 10.1111/j.1365-2893.2007.00950.x; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; MILLER LH, 1956, J AM STAT ASSOC, V51, P111, DOI 10.2307/2280807; Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448; Nakano T, 2006, J GEN VIROL, V87, P73, DOI 10.1099/vir.0.81360-0; Nakano T, 2004, J INFECT DIS, V190, P1098, DOI 10.1086/422606; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Olsson GE, 2002, EMERG INFECT DIS, V8, P924, DOI 10.3201/eid0809.020037; PAWLOTSKY JM, 1995, J INFECT DIS, V171, P1607, DOI 10.1093/infdis/171.6.1607; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Pybus Oliver G, 2005, Infect Genet Evol, V5, P131, DOI 10.1016/j.meegid.2004.08.001; Rambaut A, 2000, BIOINFORMATICS, V16, P395, DOI 10.1093/bioinformatics/16.4.395; Shannon K, 2010, ARCH PEDIAT ADOL MED, V164, P61, DOI 10.1001/archpediatrics.2009.241; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; SHERLOCK S, 1993, LANCET, V342, P1127, DOI 10.1016/0140-6736(93)92117-C; SILINI E, 1995, J HEPATOL, V22, P691, DOI 10.1016/0168-8278(95)80225-8; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Simmonds P, 1996, J GEN VIROL, V77, P3013, DOI 10.1099/0022-1317-77-12-3013; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trepo C, 1999, J HEPATOL, V31, P80, DOI 10.1016/S0168-8278(99)80379-1; Villano SA, 1999, HEPATOLOGY, V29, P908, DOI 10.1002/hep.510290311; Reiche EMV, 2008, INT J MOL MED, V21, P387	46	36	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11170	10.1371/journal.pone.0011170	http://dx.doi.org/10.1371/journal.pone.0011170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585651	Green Published, gold, Green Submitted			2022-12-27	WOS:000279135400004
J	Priest, JR; Bereknyei, S; Hooper, K; Braddock, CH				Priest, James R.; Bereknyei, Sylvia; Hooper, Kambria; Braddock, Clarence H., III			Relationships of the Location and Content of Rounds to Specialty, Institution, Patient-Census, and Team Size	PLOS ONE			English	Article							BEDSIDE; MORTALITY; CARE; SATISFACTION; PHYSICIANS; HOSPITALS; RESIDENTS	Objective: Existing observational data describing rounds in teaching hospitals are 15 years old, predate duty-hour regulations, are limited to one institution, and do not include pediatrics. We sought to evaluate the effect of medical specialty, institution, patient-census, and team participants upon time at the bedside and education occurring on rounds. Methods and Participants: Between December of 2007 and October of 2008 we performed 51 observations at Lucile Packard Children's Hospital, Seattle Children's Hospital, Stanford University Hospital, and the University of Washington Medical Center of 35 attending physicians. We recorded minutes spent on rounds in three location and seven activity categories, members of the care team, and patient-census. Results: Results presented are means. Pediatric rounds had more participants (8.2 vs. 4.1 physicians, p<.001; 11.9 vs. 2.4 non-physicians, p<.001) who spent more minutes in hallways (96.9 min vs. 35.2 min, p<.001), fewer minutes at the bedside (14.6 vs. 38.2 min, p=.01) than internal medicine rounds. Multivariate regression modeling revealed that minutes at the bedside per patient was negatively associated with pediatrics (-2.77 adjusted bedside minutes; 95% CI -4.61 to -0.93; p<.001) but positively associated with the number of non-physician participants (0.12 adjusted bedside minutes per non physician participant; 95% CI 0.07 to 0.17; p=<.001). Education minutes on rounds was positively associated with the presence of an attending physician (2.70 adjusted education minutes; 95% CI 1.27 to 4.12; p<.001) and with one institution (1.39 adjusted education minutes; 95% CI 0.26 to 2.53; p=.02). Conclusions: Pediatricians spent less time at the bedside on rounds than internal medicine physicians due to reasons other than patient-census or the number of participants in rounds. Compared to historical data, internal medicine rounds were spent more at the bedside engaged in patient care and communication, and less upon educational activities.	[Priest, James R.] Seattle Childrens Hosp, Seattle, WA USA; [Priest, James R.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Bereknyei, Sylvia; Hooper, Kambria; Braddock, Clarence H., III] Stanford Univ, Sch Med, Dept Gen Internal Med, Stanford, CA 94305 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; Stanford University	Priest, JR (corresponding author), Seattle Childrens Hosp, Seattle, WA USA.	James.Priest@seattlechildrens.org	Merrell, Sylvia Bereknyei/AAB-2813-2019	Merrell, Sylvia Bereknyei/0000-0002-5525-0379				*ACCR COUNC GRAD M, 2009, ED; *ACCR COUNC GRAD M, 2007, ED; Alpert JS, 2009, AM J MED, V122, P203, DOI 10.1016/j.amjmed.2008.10.024; *AM MED ASS, 2009, FREIDA ONL RES FELL; Anderson RC, 2001, AM J MED, V110, P419, DOI 10.1016/S0002-9343(01)00621-0; Ashar B, 2007, J GEN INTERN MED, V22, P1393, DOI 10.1007/s11606-007-0285-2; Bergeson SC, 2006, JAMA-J AM MED ASSOC, V296, P2848, DOI 10.1001/jama.296.23.2848; BRAZLETO.TB, 1969, PEDIATRICS, V43, P469; ELLIOT DL, 1993, MED EDUC, V27, P503, DOI 10.1111/j.1365-2923.1993.tb00311.x; Friedberg MW, 2009, AM J MANAG CARE, V15, P137; Goldenberg J, 2008, MT SINAI J MED, V75, P430, DOI 10.1002/msj.20075; Hauer KE, 2004, ARCH INTERN MED, V164, P1866, DOI 10.1001/archinte.164.17.1866; HAWKINS C, 1968, BRIT MED J, V1, P702, DOI 10.1136/bmj.1.5593.702-a; HOLM S, 1979, SCAND J STAT, V6, P65; Horwitz LI, 2006, J GEN INTERN MED, V21, P961, DOI 10.1007/BF02743145; Lehmann LS, 1997, NEW ENGL J MED, V336, P1150, DOI 10.1056/NEJM199704173361606; Mathis BR, 2006, ACAD MED, V81, P68, DOI 10.1097/00001888-200601000-00018; MAZZAFERRI EL, 1986, ARCH INTERN MED, V146, P1912, DOI 10.1001/archinte.146.10.1912; Miller GE, 1954, J MED EDUC, V29, P28; MILLER M, 1992, J GEN INTERN MED, V7, P646, DOI 10.1007/BF02599208; Morelock JA, 2003, AM J MED, V115, P163, DOI 10.1016/S0002-9343(03)00332-2; Muething SE, 2007, PEDIATRICS, V119, P829, DOI 10.1542/peds.2006-2528; R Development Core Team, 2007, R LANG ENV STAT COMP; Rosen P, 2009, PEDIATRICS, V123, pE603, DOI 10.1542/peds.2008-2238; Shetty KD, 2007, ANN INTERN MED, V147, P73, DOI 10.7326/0003-4819-147-2-200707170-00161; Sisterhen LL, 2007, TEACH LEARN MED, V19, P319, DOI 10.1080/10401330701366812; Steinert A, 2006, CYTOTHERAPY, V8, P28; Verghese A, 2008, NEW ENGL J MED, V359, P2748, DOI 10.1056/NEJMp0807461; Vidyarthi AR, 2006, ACAD MED, V81, P76, DOI 10.1097/00001888-200601000-00019; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; WEINHOLTZ D, 1986, EVAL HEALTH PROF, V9, P75, DOI 10.1177/016327878600900106; WIENER SL, 1974, J MED EDUC, V49, P351; WIENER SL, 1973, ANN INTERN MED, V79, P606, DOI 10.7326/0003-4819-79-4-606_2; Williams KN, 2008, ACAD MED, V83, P257, DOI 10.1097/ACM.0b013e3181637f3e; Zwarentein M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000072.pub2; 1968, BR MED J, V1, P591	37	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11246	10.1371/journal.pone.0011246	http://dx.doi.org/10.1371/journal.pone.0011246			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574534	Green Published, Green Submitted, gold			2022-12-27	WOS:000279058300029
J	Vala, IS; Martins, LR; Imaizumi, N; Nunes, RJ; Rino, J; Kuonen, F; Carvalho, LM; Ruegg, C; Grillo, IM; Barata, JT; Mareel, M; Santos, SCR				Vala, Ines Sofia; Martins, Leila R.; Imaizumi, Natsuko; Nunes, Raquel J.; Rino, Jose; Kuonen, Francois; Carvalho, Lara M.; Rueegg, Curzio; Grillo, Isabel Monteiro; Barata, Joao Taborda; Mareel, Marc; Rosa Santos, Susana Constantino			Low Doses of Ionizing Radiation Promote Tumor Growth and Metastasis by Enhancing Angiogenesis	PLOS ONE			English	Article							SURVIVAL; THERAPY; RADIOTHERAPY; RECURRENCE; APOPTOSIS; VEGFR-2; CELLS	Radiotherapy is a widely used treatment option in cancer. However, recent evidence suggests that doses of ionizing radiation (IR) delivered inside the tumor target volume, during fractionated radiotherapy, can promote tumor invasion and metastasis. Furthermore, the tissues that surround the tumor area are also exposed to low doses of IR that are lower than those delivered inside the tumor mass, because external radiotherapy is delivered to the tumor through multiple radiation beams, in order to prevent damage of organs at risk. The biological effects of these low doses of IR on the healthy tissue surrounding the tumor area, and in particular on the vasculature remain largely to be determined. We found that doses of IR lower or equal to 0.8 Gy enhance endothelial cell migration without impinging on cell proliferation or survival. Moreover, we show that low-dose IR induces a rapid phosphorylation of several endothelial cell proteins, including the Vascular Endothelial Growth Factor (VEGF) Receptor-2 and induces VEGF production in hypoxia mimicking conditions. By activating the VEGF Receptor-2, low-dose IR enhances endothelial cell migration and prevents endothelial cell death promoted by an anti-angiogenic drug, bevacizumab. In addition, we observed that low-dose IR accelerates embryonic angiogenic sprouting during zebrafish development and promotes adult angiogenesis during zebrafish fin regeneration and in the murine Matrigel assay. Using murine experimental models of leukemia and orthotopic breast cancer, we show that low-dose IR promotes tumor growth and metastasis and that these effects were prevented by the administration of a VEGF receptor-tyrosine kinase inhibitor immediately before IR exposure. These findings demonstrate a new mechanism to the understanding of the potential pro-metastatic effect of IR and may provide a new rationale basis to the improvement of current radiotherapy protocols.	[Vala, Ines Sofia; Nunes, Raquel J.; Rosa Santos, Susana Constantino] Univ Lisbon, Fac Med, Inst Mol Med, Angiogenesis Unit, P-1699 Lisbon, Portugal; [Martins, Leila R.; Barata, Joao Taborda] Univ Lisbon, Fac Med, Inst Mol Med, Canc Biol Unit, P-1699 Lisbon, Portugal; [Imaizumi, Natsuko; Kuonen, Francois; Rueegg, Curzio] Univ Lausanne, Fac Biol & Med, Div Expt Oncol, Ctr Pluridisciplinaire Oncol, CH-1066 Epalinges, Switzerland; [Imaizumi, Natsuko; Kuonen, Francois; Rueegg, Curzio] EPFL, NCCR Mol Oncol ISREC, Epalinges, Switzerland; [Rino, Jose] Univ Lisbon, Fac Med, Inst Mol Med, Bioimaging Unit, P-1699 Lisbon, Portugal; [Carvalho, Lara M.] Univ Lisbon, Fac Med, Inst Mol Med, Zebrafish Unit, P-1699 Lisbon, Portugal; [Grillo, Isabel Monteiro] Hosp Santa Maria, Serv Radioterapia, Lisbon, Portugal; [Mareel, Marc] Univ Ghent, Dept Radiotherapy, B-9000 Ghent, Belgium	Universidade de Lisboa; Universidade de Lisboa; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria; Ghent University	Vala, IS (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, Angiogenesis Unit, P-1699 Lisbon, Portugal.	sconstantino@fm.ul.pt	Barata, João T./D-9181-2015; Rino, José/I-2990-2013; Santos, Susana/AAM-8902-2021	Barata, João T./0000-0002-4826-8976; Rino, José/0000-0002-0637-4527; monteiro grillo, isabel/0000-0002-2481-5576; Martins, Leila/0000-0002-5887-4734; Kuonen, Francois/0000-0001-6137-7483; Constantino Rosa Santos, Susana/0000-0002-5711-1292; Batista Vala Silva de Oliveira, Ines Sofia/0000-0003-0497-6804	Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/27541/2006, SFRH/BD/41415/2007, SFRH/BPD/43482/2008, PPCDT/SAU-OBS/58913, PTDC/SAU-OBD/69974]; National Centre for Competence in Research (NCCR); Swiss National Science Foundation; TUMIC FP7; Children with Leukaemia Charity, U.K.	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); National Centre for Competence in Research (NCCR)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); TUMIC FP7; Children with Leukaemia Charity, U.K.	I. S. V., L. R. M. and R.J.N. were supported by Fundacao para a Ciencia e Tecnologia (FCT) fellowships (SFRH/BD/27541/2006 and SFRH/BD/41415/2007, SFRH/BPD/43482/2008 respectively). Work in C. R. lab was supported by grants from the Molecular Oncology Program of the National Centre for Competence in Research (NCCR), the Swiss National Science Foundation and TUMIC FP7. Work in J.T.B. lab was supported by FCT (PPCDT/SAU-OBS/58913 and PTDC/SAU-OBD/69974) and by Children with Leukaemia Charity, U.K. (IVIS Lumina support). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2005, CLIN CANCER RES, V11, P6270, DOI 10.1158/1078-0432.CCR-04-1223; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Barcellos-Hoff MH, 2005, NAT REV CANCER, V5, P867, DOI 10.1038/nrc1735; Bayliss PE, 2006, NAT CHEM BIOL, V2, P265, DOI 10.1038/nchembio778; Constantino S, 2001, ONCOGENE, V20, P2080, DOI 10.1038/sj.onc.1204308; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; Gorski DH, 1999, CANCER RES, V59, P3374; Lee CG, 2000, CANCER RES, V60, P5565; Madani I, 2008, B CANCER, V95, P292, DOI 10.1684/bdc.2008.0598; Mauceri HJ, 1998, NATURE, V394, P287, DOI 10.1038/28412; McBride WH, 2004, RADIAT RES, V162, P1, DOI 10.1667/RR3196; Nozue M, 2001, ONCOL REP, V8, P1247; OBRIEN CJ, 1986, AM J SURG, V152, P456, DOI 10.1016/0002-9610(86)90324-7; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; PASSANITI A, 1992, LAB INVEST, V67, P519; Santos SCR, 2007, EXP CELL RES, V313, P1561, DOI 10.1016/j.yexcr.2007.02.020; SUIT HD, 1992, INT J RADIAT ONCOL, V23, P653, DOI 10.1016/0360-3016(92)90025-D; Sung HK, 2006, BIOCHEM BIOPH RES CO, V345, P545, DOI 10.1016/j.bbrc.2006.04.121; Teicher BA, 1994, RADIAT ONCOL INVEST, V2, P269, DOI DOI 10.1002/ROI.2970020604; Vicini FA, 2003, CANCER, V97, P910, DOI 10.1002/cncr.11143; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Zoula S, 2003, BRIT J CANCER, V88, P1439, DOI 10.1038/sj.bjc.6600837	27	136	136	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11222	10.1371/journal.pone.0011222	http://dx.doi.org/10.1371/journal.pone.0011222			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574535	Green Submitted, Green Published, gold			2022-12-27	WOS:000279058300014
J	Faure, A; Richard, JM; Berridge, KC				Faure, Alexis; Richard, Jocelyn M.; Berridge, Kent C.			Desire and Dread from the Nucleus Accumbens: Cortical Glutamate and Subcortical GABA Differentially Generate Motivation and Hedonic Impact in the Rat	PLOS ONE			English	Article							VENTRAL PALLIDUM; MESOLIMBIC DOPAMINE; DEFENSIVE BEHAVIOR; INCENTIVE SALIENCE; NEURONS; REWARD; SHELL; RECEPTORS; ACTIVATION; MODULATION	Background: GABAergic signals to the nucleus accumbens (NAc) shell arise from predominantly subcortical sources whereas glutamatergic signals arise mainly from cortical-related sources. Here we contrasted GABAergic and glutamatergic generation of hedonics versus motivation processes, as a proxy for comparing subcortical and cortical controls of emotion. Local disruptions of either signals in medial shell of NAc generate intense motivated behaviors corresponding to desire and/or dread, along a rostrocaudal gradient. GABA or glutamate disruptions in rostral shell generate appetitive motivation whereas disruptions in caudal shell elicit fearful motivation. However, GABA and glutamate signals in NAc differ in important ways, despite the similarity of their rostrocaudal motivation gradients. Methodology/Principal Findings: Microinjections of a GABA(A) agonist (muscimol), or of a glutamate AMPA antagonist (DNQX) in medial shell of rats were assessed for generation of hedonic "liking'' or "disliking'' by measuring orofacial affective reactions to sucrose-quinine taste. Motivation generation was independently assessed measuring effects on eating versus natural defensive behaviors. For GABAergic microinjections, we found that the desire-dread motivation gradient was mirrored by an equivalent hedonic gradient that amplified affective taste "liking'' (at rostral sites) versus "disliking'' (at caudal sites). However, manipulation of glutamatergic signals completely failed to alter pleasure-displeasure reactions to sensory hedonic impact, despite producing a strong rostrocaudal gradient of motivation. Conclusions/Significance: We conclude that the nucleus accumbens contains two functional affective keyboards for amino-acid signals: a motivation-generating keyboard and a hedonic-generating keyboard. Corticolimbic glutamate signals and subcortical GABA signals equivalently engage the motivation keyboard to generate desire and-or dread. Only subcortical GABA signals additionally engage the hedonic keyboard to amplify affective "liking'' and "disliking'' reactions. We thus suggest that top-down cortical glutamate signals powerfully regulate motivation components, but are relatively unable to penetrate core hedonic components of emotion. That may carry implications of limits to therapeutic regulation of pathological emotions.	[Faure, Alexis; Richard, Jocelyn M.; Berridge, Kent C.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Faure, A (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	afaure@umich.edu	Carroll, Joseph/D-1158-2011; Richard, Jocelyn/G-1980-2011; Richard, Jocelyn/I-4327-2019; Berridge, Kent C/C-1525-2009	Carroll, Joseph/0000-0003-2656-1378; Richard, Jocelyn/0000-0001-5750-0418; Berridge, Kent C/0000-0002-6031-2626; FAURE, alexis/0000-0002-2033-3879	NIH [DA015188, MH63649]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015188] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Research described here was supported by grants from the NIH (DA015188, and MH63649). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldo BA, 2005, BEHAV NEUROSCI, V119, P1195, DOI 10.1037/0735-7044.119.5.1195; Barch DM, 2005, SCHIZOPHRENIA BULL, V31, P875, DOI 10.1093/schbul/sbi040; Barrett LF, 2006, CURR DIR PSYCHOL SCI, V15, P79, DOI 10.1111/j.0963-7214.2006.00411.x; Barrett LF, 2007, ANNU REV PSYCHOL, V58, P373, DOI 10.1146/annurev.psych.58.110405.085709; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Behrends JC, 2002, PFLUG ARCH EUR J PHY, V443, P707, DOI 10.1007/s00424-001-0740-6; Belujon P, 2008, J NEUROSCI, V28, P9797, DOI 10.1523/JNEUROSCI.2200-08.2008; Berridge KC, 2000, NEUROSCI BIOBEHAV R, V24, P173, DOI 10.1016/S0149-7634(99)00072-X; Berridge KC, 2008, PSYCHOPHARMACOLOGY, V199, P457, DOI 10.1007/s00213-008-1099-6; Berthoud HR, 2008, ANNU REV PSYCHOL, V59, P55, DOI 10.1146/annurev.psych.59.103006.093551; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Chen Q, 1998, NEUROSCIENCE, V83, P749, DOI 10.1016/S0306-4522(97)00452-1; CHURCHILL L, 1994, J COMP NEUROL, V345, P579, DOI 10.1002/cne.903450408; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; CROMWELL HC, 1993, BRAIN RES, V624, P1, DOI 10.1016/0006-8993(93)90053-P; Damasio A. R., 2004, FEELINGS EMOTIONS, P49, DOI DOI 10.1017/CBO9780511806582.004; Davidson RJ, 2004, PHILOS T R SOC B, V359, P1395, DOI 10.1098/rstb.2004.1510; Faure A, 2008, J NEUROSCI, V28, P7184, DOI 10.1523/JNEUROSCI.4961-07.2008; Gable P, 2008, PSYCHOPHYSIOLOGY, V45, P275, DOI 10.1111/j.1469-8986.2007.00627.x; Goetz T, 2007, PROG BRAIN RES, V160, P21, DOI 10.1016/S0079-6123(06)60003-4; Groenewegen HJ, 1999, PSYCHOBIOLOGY, V27, P149; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Jeun SH, 2009, KOREAN J PHYSIOL PHA, V13, P209, DOI 10.4196/kjpp.2009.13.3.209; JOHNSON LR, 1994, BASAL GANGLIA, V4, P109; Kalivas PW, 2004, CURR OPIN PHARMACOL, V4, P23, DOI 10.1016/j.coph.2003.11.002; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; KALIVAS PW, 2009, NAT REV NEUROSCI; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kiyatkin EA, 1999, BRAIN RES, V822, P88, DOI 10.1016/S0006-8993(99)01093-8; Koos T, 2004, J NEUROSCI, V24, P7916, DOI 10.1523/JNEUROSCI.2163-04.2004; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; KRINGELBACH ML, 2009, PLEASURE CTR; Kringelbach ML, 2010, PLEASURES BRAIN, P202; Mahler SV, 2007, NEUROPSYCHOPHARMACOL, V32, P2267, DOI 10.1038/sj.npp.1301376; Mahler SV, 2009, J NEUROSCI, V29, P6500, DOI 10.1523/JNEUROSCI.3875-08.2009; MEREDITH GE, 1990, BRAIN RES, V513, P329, DOI 10.1016/0006-8993(90)90476-R; MEREDITH GE, 1993, PROG BRAIN RES, V99, P3; Meredith GE, 1999, ANN NY ACAD SCI, V877, P140, DOI 10.1111/j.1749-6632.1999.tb09266.x; Meredith GE, 2008, BRAIN STRUCT FUNCT, V213, P17, DOI 10.1007/s00429-008-0175-3; Moore H, 2001, BIOL PSYCHIAT, V49, p10S; O'Donnell P, 1999, PSYCHOBIOLOGY, V27, P187; Owings D. H., 1998, ANIMAL VOCAL COMMUNI; Paxinos G., 1996, RAT BRAIN STEREOTAXI; PAXINOS G, 2007, RAT BRAIN COORDINATE; Pecina S, 2005, J NEUROSCI, V25, P11777, DOI 10.1523/JNEUROSCI.2329-05.2005; Pecina S, 1997, PHARMACOL BIOCHEM BE, V58, P801, DOI 10.1016/S0091-3057(97)00044-0; PENNARTZ CMA, 1994, PROG NEUROBIOL, V42, P719, DOI 10.1016/0301-0082(94)90025-6; Posner MI, 2007, COGN AFFECT BEHAV NE, V7, P391, DOI 10.3758/CABN.7.4.391; Reynolds SM, 2008, NAT NEUROSCI, V11, P423, DOI 10.1038/nn2061; Reynolds SM, 2003, EUR J NEUROSCI, V17, P2187, DOI 10.1046/j.1460-9568.2003.02642.x; Reynolds SM, 2002, J NEUROSCI, V22, P7308; Reynolds SM, 2001, J NEUROSCI, V21, P3261, DOI 10.1523/JNEUROSCI.21-09-03261.2001; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Salomons TV, 2007, J COGNITIVE NEUROSCI, V19, P993, DOI 10.1162/jocn.2007.19.6.993; Schoepp DD, 2001, J PHARMACOL EXP THER, V299, P12; SESACK SR, 1992, J COMP NEUROL, V320, P145, DOI 10.1002/cne.903200202; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Shimura T, 2006, EUR J NEUROSCI, V23, P1596, DOI 10.1111/j.1460-9568.2006.04689.x; Smith K.S., 2010, PLEASURES BRAIN, P27; Smith KS, 2005, J NEUROSCI, V25, P8637, DOI 10.1523/JNEUROSCI.1902-05.2005; Smith KS, 2007, J NEUROSCI, V27, P1594, DOI 10.1523/JNEUROSCI.4205-06.2007; Smith KS, 2009, BEHAV BRAIN RES, V196, P155, DOI 10.1016/j.bbr.2008.09.038; Spooren W, 2003, BEHAV PHARMACOL, V14, P257, DOI 10.1097/01.fbp.0000081783.35927.8f; Stratford TR, 1999, J NEUROSCI, V19, P11040, DOI 10.1523/JNEUROSCI.19-24-11040.1999; Stratford TR, 1998, BEHAV BRAIN RES, V93, P43, DOI 10.1016/S0166-4328(97)00140-X; SUN N, 1993, J COMP NEUROL, V330, P381, DOI 10.1002/cne.903300308; Suwabe T, 2008, J NEUROPHYSIOL, V99, P1267, DOI 10.1152/jn.01115.2007; Swanson LW, 2005, J COMP NEUROL, V493, P122, DOI 10.1002/cne.20733; Taylor SF, 2005, NEUROPSYCHOPHARMACOL, V30, P984, DOI 10.1038/sj.npp.1300679; Tecuapetla F, 2010, J NEUROSCI, V30, P7105, DOI 10.1523/JNEUROSCI.0265-10.2010; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; WILKIE DM, 1979, J EXP ANAL BEHAV, V31, P299, DOI 10.1901/jeab.1979.31-299; Wolf JA, 2005, J NEUROSCI, V25, P9080, DOI 10.1523/JNEUROSCI.2220-05.2005; Wyvell CL, 2000, J NEUROSCI, V20, P8122; Zahm DS, 2006, NEUROSCI BIOBEHAV R, V30, P148, DOI 10.1016/j.neubiorev.2005.06.003; Zhang M, 2003, BEHAV NEUROSCI, V117, P202, DOI 10.1037/0735-7044.117.2.202	76	80	80	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11223	10.1371/journal.pone.0011223	http://dx.doi.org/10.1371/journal.pone.0011223			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585461	Green Submitted, Green Published, gold			2022-12-27	WOS:000278977200018
J	Conteh, L; Sicuri, E; Manzi, F; Hutton, G; Obonyo, B; Tediosi, F; Biao, P; Masika, P; Matovu, F; Otieno, P; Gosling, RD; Hamel, M; Odhiambo, FO; Grobusch, MP; Kremsner, PG; Chandramohan, D; Aponte, JJ; Egan, A; Schellenberg, D; Macete, E; Slutsker, L; Newman, RD; Alonso, P; Menendez, C; Tanner, M				Conteh, Lesong; Sicuri, Elisa; Manzi, Fatuma; Hutton, Guy; Obonyo, Benson; Tediosi, Fabrizio; Biao, Prosper; Masika, Paul; Matovu, Fred; Otieno, Peter; Gosling, Roly D.; Hamel, Mary; Odhiambo, Frank O.; Grobusch, Martin P.; Kremsner, Peter G.; Chandramohan, Daniel; Aponte, John J.; Egan, Andrea; Schellenberg, David; Macete, Eusebio; Slutsker, Laurence; Newman, Robert D.; Alonso, Pedro; Menendez, Clara; Tanner, Marcel			The Cost-Effectiveness of Intermittent Preventive Treatment for Malaria in Infants in Sub-Saharan Africa	PLOS ONE			English	Article							MILLENNIUM DEVELOPMENT GOALS; ROUTINE VACCINATIONS; TANZANIAN INFANTS; EXPANDED PROGRAM; DELIVERY-SYSTEM; VECTOR CONTROL; ANEMIA CONTROL; DOUBLE-BLIND; HEALTH; IPTI	Background: Intermittent preventive treatment in infants (IPTi) has been shown to decrease clinical malaria by approximately 30% in the first year of life and is a promising malaria control strategy for Sub-Saharan Africa which can be delivered alongside the Expanded Programme on Immunisation (EPI). To date, there have been limited data on the cost-effectiveness of this strategy using sulfadoxine pyrimethamine (SP) and no published data on cost-effectiveness using other antimalarials. Methods: We analysed data from 5 countries in sub-Saharan Africa using a total of 5 different IPTi drug regimens; SP, mefloquine (MQ), 3 days of chlorproguanil-dapsone (CD), SP plus 3 days of artesunate (SP-AS3) and 3 days of amodiaquine-artesunate (AQ3-AS3). The cost per malaria episode averted and cost per Disability-Adjusted Life-Year (DALY) averted were modeled using both trial specific protective efficacy (PE) for all IPTi drugs and a pooled PE for IPTi with SP, malaria incidence, an estimated malaria case fatality rate of 1.57%, IPTi delivery costs and country specific provider and household malaria treatment costs. Findings: In sites where IPTi had a significant effect on reducing malaria, the cost per episode averted for IPTi-SP was very low, USD 1.36-4.03 based on trial specific data and USD 0.68-2.27 based on the pooled analysis. For IPTi using alternative antimalarials, the lowest cost per case averted was for AQ3-AS3 in western Kenya (USD 4.62) and the highest was for MQ in Korowge, Tanzania (USD 18.56). Where efficacious, based only on intervention costs, IPTi was shown to be cost effective in all the sites and highly cost-effective in all but one of the sites, ranging from USD 2.90 (Ifakara, Tanzania with SP) to USD 39.63 (Korogwe, Tanzania with MQ) per DALY averted. In addition, IPTi reduced health system costs and showed significant savings to households from malaria cases averted. A threshold analysis showed that there is room for the IPTi-efficacy to fall and still remain highly cost effective in all sites where IPTi had a statistically significant effect on clinical malaria. Conclusions: IPTi delivered alongside the EPI is a highly cost effective intervention against clinical malaria with a range of drugs in a range of malaria transmission settings. Where IPTi did not have a statistically significant impact on malaria, generally in low transmission sites, it was not cost effective.	[Conteh, Lesong; Hutton, Guy; Tediosi, Fabrizio; Tanner, Marcel] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Sicuri, Elisa; Aponte, John J.; Egan, Andrea; Alonso, Pedro; Menendez, Clara] Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin, Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain; [Sicuri, Elisa; Alonso, Pedro; Menendez, Clara] CIBERESP, Barcelona, Spain; [Manzi, Fatuma] IHI, Dar Es Salaam, Tanzania; [Obonyo, Benson; Otieno, Peter; Hamel, Mary; Odhiambo, Frank O.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Tediosi, Fabrizio] Univ Boconni, Milan, Italy; [Masika, Paul] Natl Inst Med Res, Tanga, Tanzania; [Matovu, Fred] Makerere Univ, Fac Econ & Management, Kampala, Uganda; [Conteh, Lesong; Gosling, Roly D.; Chandramohan, Daniel; Schellenberg, David; Slutsker, Laurence; Newman, Robert D.] London Sch Hyg & Trop Med, London WC1, England; [Hamel, Mary] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis, Atlanta, GA USA; [Grobusch, Martin P.] Albert Schweitzer Hosp, Resp Med Unit, Lambarene, Gabon; [Grobusch, Martin P.; Kremsner, Peter G.] Univ Witwatersrand, Sch Med, Fac Hlth Sci, Div Infect Dis, Johannesburg, South Africa; [Grobusch, Martin P.; Kremsner, Peter G.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Macete, Eusebio; Alonso, Pedro; Menendez, Clara] Manhica Hlth Res Ctr, Manhica, Mozambique	University of Basel; Swiss Tropical & Public Health Institute; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Kenya Medical Research Institute; Makerere University; University of London; London School of Hygiene & Tropical Medicine; Centers for Disease Control & Prevention - USA; University of Witwatersrand; Eberhard Karls University of Tubingen; Centro de Investigacao em Saude de Manhica	Conteh, L (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	lesong.conteh@lshtm.ac.uk	Sicuri, Elisa/L-8012-2014; Tediosi, Fabrizio/ABC-7880-2020; Conteh, Lesong/ABE-9550-2020; Menéndez, Clara/Q-3446-2016; Tediosi, Fabrizio/AAD-4805-2022; Alonso, Pedro L/AAZ-3645-2020; Agyemang, Samuel/H-8377-2014	Sicuri, Elisa/0000-0002-2499-2732; Conteh, Lesong/0000-0002-0719-3672; Menéndez, Clara/0000-0002-2641-6907; Tediosi, Fabrizio/0000-0001-8671-9400; Alonso, Pedro L/0000-0003-3292-3443; Schellenberg, David/0000-0001-8222-0186; MATOVU, FRED/0000-0003-1562-2374	Bill and Melinda Gates Global Health Foundation [38479]	Bill and Melinda Gates Global Health Foundation	The work was funded by the Bill and Melinda Gates Global Health Foundation, Grant Number 38479. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; ANAND S, 1997, J HLTH EC, V6; [Anonymous], 2008, WORLD MAL REP 2008; [Anonymous], 1996, GLOBAL BURDEN DIS CO; APONTE JJ, 2009, POOLED ANAL 6 IPTI T; Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Barbieri M, 2005, VALUE HEALTH, V8, P10, DOI 10.1111/j.1524-4733.2005.03070.x; Bognar G, 2008, ECON PHILOS, V24, P167, DOI 10.1017/S026626710800179X; Briggs A, 1998, HEALTH ECON, V7, P723, DOI 10.1002/(SICI)1099-1050(199812)7:8<723::AID-HEC392>3.3.CO;2-F; Briggs AH, 1997, HEALTH ECON, V6, P327, DOI 10.1002/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W; Brooker S, 2008, HEALTH POLICY PLANN, V23, P24, DOI 10.1093/heapol/czm041; Chandramohan D, 2005, BMJ-BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; Chandramohan D, 2007, TROP MED INT HEALTH, V12, P743, DOI 10.1111/j.1365-3156.2007.01844.x; Conteh L, 2004, TROP MED INT HEALTH, V9, P125, DOI 10.1046/j.1365-3156.2003.01150.x; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Egan A, 2005, TROP MED INT HEALTH, V10, P815, DOI 10.1111/j.1365-3156.2005.01474.x; Gosling RD, 2009, LANCET, V374, P1521, DOI 10.1016/S0140-6736(09)60997-1; Grobusch MP, 2007, CURR OPIN INFECT DIS, V20, P613, DOI 10.1097/QCO.0b013e3282f1ae3b; Grobusch MP, 2007, J INFECT DIS, V196, P1595, DOI 10.1086/522160; Hutton G, 2005, HEALTH POLICY PLANN, V20, P252, DOI 10.1093/heapol/czi025; Hutton Guy, 2004, Appl Health Econ Health Policy, V3, P161, DOI 10.2165/00148365-200403030-00007; Hutton G, 2009, B WORLD HEALTH ORGAN, V87, P123, DOI 10.2471/BLT.08.051961; Jha P, 2002, SCIENCE, V295, P2036, DOI 10.1126/science.295.5562.2036; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; *JOINT WHO RBM UNI, 2004, SOUR PRIC SEL PROD P; Kobbe R, 2007, CLIN INFECT DIS, V45, pS16, DOI 10.1086/518575; Kolaczinski J, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-37; Kruger C, 2004, LANCET, V363, P2000, DOI 10.1016/S0140-6736(04)16424-6; Kweku M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004000; Lord J, 1999, HEALTH ECON, V8, P323, DOI 10.1002/(SICI)1099-1050(199906)8:4<323::AID-HEC431>3.0.CO;2-0; Macete E, 2006, J INFECT DIS, V194, P276, DOI 10.1086/505431; Manzi F, 2009, T ROY SOC TROP MED H, V103, P79, DOI 10.1016/j.trstmh.2008.08.014; Manzi F, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-165; Mbonye AK, 2008, T ROY SOC TROP MED H, V102, P685, DOI 10.1016/j.trstmh.2008.04.016; Menendez C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-132; Mockenhaupt FP, 2007, ANTIMICROB AGENTS CH, V51, P3273, DOI 10.1128/AAC.00513-07; Morel CM, 2005, BMJ-BRIT MED J, V331, P1299, DOI 10.1136/bmj.38639.702384.AE; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Mushi AK, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-191; Odhiambo FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010016; Phillips M, 1996, PHARMACOECONOMICS, V10, P225, DOI 10.2165/00019053-199610030-00004; Pool R, 2006, TROP MED INT HEALTH, V11, P1670, DOI 10.1111/j.1365-3156.2006.01725.x; Pool R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-213; Ross A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002661; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; Sachs JD, 2001, MACR HLTH INV HLTH E; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Sculpher MJ, 2004, HEALTH TECHNOL ASSES, V8, P1; Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000; Smith T, 2008, PARASITOLOGY, V135, P1507, DOI 10.1017/S0031182008000371; TAN-TORRES TE, 2003, MAKING CHOICES HLTH; TANTORRES, 2005, BMJ, V331; Temperley M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-196; WHO, 1996, INV HLTH RES DEV; *WHO, 2008, LIF TABL WHO MEMB ST; *WORLD BANK, 1993, WORLD DEV REP; Yeung S, 2004, AM J TROP MED HYG, V71, P179, DOI 10.4269/ajtmh.2004.71.179; Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258; 2007, INT DRUG PRICE INDIC	59	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e10313	10.1371/journal.pone.0010313	http://dx.doi.org/10.1371/journal.pone.0010313			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	610YF	20559558	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000278775900001
J	Lund, JP; Sadeghi, S; Athanassiadis, T; Salas, NC; Auclair, F; Thivierge, B; Arsenault, I; Rompre, P; Westberg, KG; Kolta, A				Lund, James P.; Sadeghi, Somayeh; Athanassiadis, Tuija; Salas, Nadia Caram; Auclair, Francois; Thivierge, Benoit; Arsenault, Isabel; Rompre, Pierre; Westberg, Karl-Gunnar; Kolta, Arlette			Assessment of the Potential Role of Muscle Spindle Mechanoreceptor Afferents in Chronic Muscle Pain in the Rat Masseter Muscle	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; METABOTROPIC GLUTAMATE RECEPTORS; PRIMARY SENSORY NEURONS; MESENCEPHALIC-V NEURONS; C-FOS; MECHANICAL ALLODYNIA; TRIGEMINAL NEURONS; NEUROPATHIC PAIN; JAW-MUSCLE; GROUP-I	Background: The phenotype of large diameter sensory afferent neurons changes in several models of neuropathic pain. We asked if similar changes also occur in "functional'' pain syndromes. Methodology/Principal Findings: Acidic saline (AS, pH 4.0) injections into the masseter muscle were used to induce persistent myalgia. Controls received saline at pH 7.2. Nocifensive responses of Experimental rats to applications of Von Frey Filaments to the masseters were above control levels 1-38 days post-injection. This effect was bilateral. Expression of c-Fos in the Trigeminal Mesencephalic Nucleus (NVmes), which contains the somata of masseter muscle spindle afferents (MSA), was above baseline levels 1 and 4 days after AS. The resting membrane potentials of neurons exposed to AS (n = 167) were hyperpolarized when compared to their control counterparts (n = 141), as were their thresholds for firing, high frequency membrane oscillations (HFMO), bursting, inward and outward rectification. The amplitude of HFMO was increased and spontaneous ectopic firing occurred in 10% of acid-exposed neurons, but never in Controls. These changes appeared within the same time frame as the observed nocifensive behaviour. Ectopic action potentials can travel centrally, but also antidromically to the peripheral terminals of MSA where they could cause neurotransmitter release and activation of adjacent fibre terminals. Using immunohistochemistry, we confirmed that annulospiral endings of masseter MSA express the glutamate vesicular transporter VGLUT1, indicating that they can release glutamate. Many capsules also contained fine fibers that were labelled by markers associated with nociceptors (calcitonin gene-related peptide, Substance P, P2X3 receptors and TRPV1 receptors) and that expressed the metabotropic glutamate receptor, mGluR5. Antagonists of glutamatergic receptors given together with the 2(nd) injection of AS prevented the hypersensitivity observed bilaterally but were ineffective if given contralaterally. Conclusions/Significance: Low pH leads to changes in several electrical properties of MSA, including initiation of ectopic action potentials which could propagate centrally but could also invade the peripheral endings causing glutamate release and activation of nearby nociceptors within the spindle capsule. This peripheral drive could contribute both to the transition to, and maintenance of, persistent muscle pain as seen in some "functional'' pain syndromes.	[Lund, James P.; Auclair, Francois; Arsenault, Isabel; Kolta, Arlette] Univ Montreal, Dept Physiol, Grp Rech Syst Nerveux Cent Fonds Rech Sante Quebe, Montreal, PQ H3C 3J7, Canada; [Thivierge, Benoit; Rompre, Pierre; Kolta, Arlette] Univ Montreal, Dept Stomatol, Montreal, PQ, Canada; [Lund, James P.; Sadeghi, Somayeh; Salas, Nadia Caram; Kolta, Arlette] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Athanassiadis, Tuija; Westberg, Karl-Gunnar] Umea Univ, Physiol Sect, Dept Integrat Med Biol, Umea, Sweden	Universite de Montreal; Universite de Montreal; McGill University; Umea University		arlette.kolta@umontreal.ca	Caram-Salas, Nadia L/F-1977-2019; Salas, Nadia Lizeth Caram/AAG-4767-2020	Salas, Nadia Lizeth Caram/0000-0002-1894-9498; Auclair, Francois/0000-0001-7617-4056	Canadian Institute of Health Research [15176]; Fonds de la Recherche en Sante du Quebec [5249]; Louise and Alan Edwards Foundation [217171]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Louise and Alan Edwards Foundation	Canadian Institute of Health Research, grant number 15176, Fonds de la Recherche en Sante du Quebec, grant number 5249, and The Louise and Alan Edwards Foundation, grant number 217171. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKOEV GN, 1988, MECHANORECEPTORS THE, P198; Ambalavanar R, 2007, NEUROSCIENCE, V149, P650, DOI 10.1016/j.neuroscience.2007.07.058; Ambalavanar R, 2005, PAIN, V117, P280, DOI 10.1016/j.pain.2005.06.029; Ambalavanar R, 2003, J COMP NEUROL, V460, P167, DOI 10.1002/cne.10655; Amir R, 2005, J NEUROSCI, V25, P2576, DOI 10.1523/JNEUROSCI.4118-04.2005; Amir R, 1999, J NEUROSCI, V19, P8589; Amir R, 2002, J NEUROSCI, V22, P1187, DOI 10.1523/JNEUROSCI.22-03-01187.2002; Amir R, 1997, J PHYSIOL-LONDON, V501, P183, DOI 10.1111/j.1469-7793.1997.183bo.x; Barbe MF, 2006, BRAIN BEHAV IMMUN, V20, P423, DOI 10.1016/j.bbi.2006.03.001; Barden JA, 2000, NEUROSCI LETT, V287, P183, DOI 10.1016/S0304-3940(00)01150-2; Barlas P, 2000, PAIN, V87, P221, DOI 10.1016/S0304-3959(00)00287-6; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Bewick GS, 2005, J PHYSIOL-LONDON, V562, P381, DOI 10.1113/jphysiol.2004.074799; Bhave G, 2001, NAT NEUROSCI, V4, P417, DOI 10.1038/86075; Bombardi C, 2006, TISSUE CELL, V38, P121, DOI 10.1016/j.tice.2005.12.003; Boucher TJ, 2000, SCIENCE, V290, P124, DOI 10.1126/science.290.5489.124; Carlton S M, 2001, Curr Opin Pharmacol, V1, P52, DOI 10.1016/S1471-4892(01)00002-9; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chizh BA, 2001, PHARMACOL REV, V53, P553; Connor M, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-31; Cook SP, 1997, NATURE, V387, P505, DOI 10.1038/387505a0; Corbin KB, 1940, J NEUROPHYSIOL, V3, P423, DOI 10.1152/jn.1940.3.5.423; DECAMILLI P, 1988, J NEUROSCI, V8, P1625; DelNegro CA, 1997, J NEUROPHYSIOL, V77, P537; Devor M, 2005, WALL MELZACKS TXB PA, P905; Devor M, 2009, EXP BRAIN RES, V196, P115, DOI 10.1007/s00221-009-1724-6; Dogrul A, 2000, NEUROSCI LETT, V292, P115, DOI 10.1016/S0304-3940(00)01458-0; Dong XD, 2006, NEUROSCIENCE, V141, P939, DOI 10.1016/j.neuroscience.2006.04.024; Dong XD, 2007, NEUROSCIENCE, V146, P822, DOI 10.1016/j.neuroscience.2007.01.051; DORAN JF, 1983, J NEUROCHEM, V40, P1542, DOI 10.1111/j.1471-4159.1983.tb08124.x; DRAISCI G, 1989, MOL BRAIN RES, V6, P31, DOI 10.1016/0169-328X(89)90025-9; Fields RD, 1997, J NEUROSCI, V17, P7252; Gerke MB, 2001, BRAIN RES, V911, P101, DOI 10.1016/S0006-8993(01)02750-0; Gossard JP, 1999, BRAIN RES, V825, P132, DOI 10.1016/S0006-8993(99)01236-6; GRACELY RH, 1992, PAIN, V51, P175, DOI 10.1016/0304-3959(92)90259-E; Guo A, 1999, EUR J NEUROSCI, V11, P946, DOI 10.1046/j.1460-9568.1999.00503.x; HOHEISEL U, 1994, ANAT EMBRYOL, V189, P41; HOOD VL, 1988, AM J PHYSIOL, V255, P479; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Issberner U, 1996, NEUROSCI LETT, V208, P191, DOI 10.1016/0304-3940(96)12576-3; Jin YH, 2009, J PHARMACOL SCI, V109, P233, DOI 10.1254/jphs.08262FP; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kellgren JH, 1938, CLIN SCI, V3, P175; Khakh BS, 1998, J PHYSIOL-LONDON, V510, P695, DOI 10.1111/j.1469-7793.1998.00695.x; Kim YS, 2008, J COMP NEUROL, V506, P627, DOI 10.1002/cne.21544; Kitagawa J, 2006, EUR J NEUROSCI, V24, P1976, DOI 10.1111/j.1460-9568.2006.05065.x; Klis SFL, 2000, NEUROREPORT, V11, P623, DOI 10.1097/00001756-200002280-00037; KOPIN IJ, 1972, PHARMACOL REV, V24, P245; KRUGER L, 1989, J COMP NEUROL, V280, P291, DOI 10.1002/cne.902800210; Lawson SN, 2002, J PHYSIOL-LONDON, V540, P989, DOI 10.1113/jphysiol.2001.013086; Lee HJ, 2006, BRAIN RES BULL, V70, P378, DOI 10.1016/j.brainresbull.2005.09.021; Lee J, 2007, NEUROSCI LETT, V421, P91, DOI 10.1016/j.neulet.2007.05.031; Leffler A, 2006, NEUROSCIENCE, V139, P699, DOI 10.1016/j.neuroscience.2005.12.020; LEVITT M, 1965, J PHARMACOL EXP THER, V148, P1; Liu CN, 2000, PAIN, V85, P503, DOI 10.1016/S0304-3959(00)00251-7; LUO PF, 1995, J COMP NEUROL, V358, P63, DOI 10.1002/cne.903580104; Matthews PBC, 1972, MAMMALIAN MUSCLE REC, P630; Mayer E.A., 2009, FUNCTIONAL PAIN SYND; MCCARTHY PW, 1990, NEUROSCIENCE, V34, P623, DOI 10.1016/0306-4522(90)90169-5; Molliver DC, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-35; Munoz A, 1999, J COMP NEUROL, V409, P549; NORDIN M, 1984, PAIN, V20, P231, DOI 10.1016/0304-3959(84)90013-7; Pang YW, 2006, J COMP NEUROL, V498, P129, DOI 10.1002/cne.21047; Pare M, 2001, J NEUROSCI, V21, P7236, DOI 10.1523/JNEUROSCI.21-18-07236.2001; Pedroarena CM, 1999, J NEUROPHYSIOL, V82, P1465, DOI 10.1152/jn.1999.82.3.1465; PUIL E, 1988, NEUROSCIENCE, V24, P635, DOI 10.1016/0306-4522(88)90357-0; Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7; Ren K, 1999, PHYSIOL BEHAV, V67, P711, DOI 10.1016/S0031-9384(99)00136-5; Ro JY, 2007, EUR J PAIN, V11, P398, DOI 10.1016/j.ejpain.2006.05.008; Rosendal L, 2004, PAIN, V112, P324, DOI 10.1016/j.pain.2004.09.017; RUSSELL LC, 1988, SOMATOSENS MOT RES, V6, P163, DOI 10.3109/08990228809144672; SANTINI M, 1971, BRAIN RES, V33, P289, DOI 10.1016/0006-8993(71)90104-1; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Sluka KA, 2002, J PHARMACOL EXP THER, V302, P1146, DOI 10.1124/jpet.102.033167; Sluka KA, 2001, MUSCLE NERVE, V24, P37, DOI 10.1002/1097-4598(200101)24:1<37::AID-MUS4>3.0.CO;2-8; Sohn MK, 2000, MUSCLE NERVE, V23, P1219, DOI 10.1002/1097-4598(200008)23:8<1219::AID-MUS10>3.0.CO;2-A; Staikopoulos V, 2007, NEUROSCIENCE, V144, P208, DOI 10.1016/j.neuroscience.2006.09.035; Stohler CS, 1992, BIOL MECH TOOTH MOVE, P503; Sukhotinsky I, 2004, EUR J PAIN, V8, P135, DOI 10.1016/S1090-3801(03)00086-7; Svensson P, 1998, J OROFAC PAIN, V12, P7; Svensson P, 2003, PAIN, V101, P221, DOI 10.1016/S0304-3959(02)00079-9; SZENTAGOTHAI J, 1948, J NEUROPHYSIOL, V11, P445, DOI 10.1152/jn.1948.11.5.445; Taguchi T, 2005, J PHYSIOL-LONDON, V564, P259, DOI 10.1113/jphysiol.2004.079483; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Tanaka S, 2003, J NEUROPHYSIOL, V89, P1288, DOI 10.1152/jn.00850.2002; Tegeder I, 2002, INFLAMM RES, V51, P393, DOI 10.1007/PL00000320; THOMPSON RJ, 1983, BRAIN RES, V278, P224, DOI 10.1016/0006-8993(83)90241-X; Tsuboi Y, 2004, PAIN, V111, P323, DOI 10.1016/j.pain.2004.07.014; Turman JE, 2001, DEV NEUROSCI-BASEL, V23, P41, DOI 10.1159/000048695; Verdier D, 2004, J NEUROPHYSIOL, V92, P2444, DOI 10.1152/jn.00279.2004; Walker R E, 2001, Semin Musculoskelet Radiol, V5, P5; WALL PD, 1983, PAIN, V17, P321, DOI 10.1016/0304-3959(83)90164-1; Weerakkody NS, 2001, J PAIN, V2, P209, DOI 10.1054/jpai.2001.22496; Westberg KG, 1997, PAIN, V73, P295, DOI 10.1016/S0304-3959(97)00103-6; Willis WD, 1999, EXP BRAIN RES, V124, P395, DOI 10.1007/s002210050637; WILSON POG, 1988, BRIT J EXP PATHOL, V69, P91; Winarakwong L, 2004, ARCH HISTOL CYTOL, V67, P227, DOI 10.1679/aohc.67.227; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Wu NP, 2001, J NEUROSCI, V21, P3729, DOI 10.1523/JNEUROSCI.21-11-03729.2001; Wu SX, 2004, BRAIN RES, V1011, P247, DOI 10.1016/brainres.2004.03.047; XIE YK, 1995, J NEUROPHYSIOL, V73, P1811, DOI 10.1152/jn.1995.73.5.1811; Zhu CZ, 2005, PAIN, V114, P195, DOI 10.1016/j.pain.2004.12.016	102	35	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11131	10.1371/journal.pone.0011131	http://dx.doi.org/10.1371/journal.pone.0011131			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559566	Green Published, Green Submitted, gold			2022-12-27	WOS:000278775900020
J	Rehle, TM; Hallett, TB; Shisana, O; Pillay-van Wyk, V; Zuma, K; Carrara, H; Jooste, S				Rehle, Thomas M.; Hallett, Timothy B.; Shisana, Olive; Pillay-van Wyk, Victoria; Zuma, Khangelani; Carrara, Henri; Jooste, Sean			A Decline in New HIV Infections in South Africa: Estimating HIV Incidence from Three National HIV Surveys in 2002, 2005 and 2008	PLOS ONE			English	Article							PREVALENCE; INCOME	Background: Three national HIV household surveys were conducted in South Africa, in 2002, 2005 and 2008. A novelty of the 2008 survey was the addition of serological testing to ascertain antiretroviral treatment (ART) use. Methods and Principal Findings: We used a validated mathematical method to estimate the rate of new HIV infections (HIV incidence) in South Africa using nationally representative HIV prevalence data collected in 2002, 2005 and 2008. The observed HIV prevalence levels in 2008 were adjusted for the effect of antiretroviral treatment on survival. The estimated "excess'' HIV prevalence due to ART in 2008 was highest among women 25 years and older and among men 30 years and older. In the period 2002-2005, the HIV incidence rate among men and women aged 15-49 years was estimated to be 2.0 new infections each year per 100 susceptible individuals (/100pyar) (uncertainty range: 1.2-3.0/100pyar). The highest incidence rate was among 15-24 year-old women, at 5.5/100pyar (4.5-6.5). In the period 2005-2008, incidence among men and women aged 15-49 was estimated to be 1.3/100 (0.6-2.5/100pyar), although the change from 2002-2005 was not statistically significant. However, the incidence rate among young women aged 15-24 declined by 60% in the same period, to 2.2/100pyar, and this change was statistically significant. There is evidence from the surveys of significant increases in condom use and awareness of HIV status, especially among youth. Conclusions: Our analysis demonstrates how serial measures of HIV prevalence obtained in population-based surveys can be used to estimate national HIV incidence rates. We also show the need to determine the impact of ART on observed HIV prevalence levels. The estimation of HIV incidence and ART exposure is crucial to disentangle the concurrent impact of prevention and treatment programs on HIV prevalence.	[Rehle, Thomas M.; Shisana, Olive; Pillay-van Wyk, Victoria; Zuma, Khangelani; Carrara, Henri; Jooste, Sean] Human Sci Res Council, Cape Town, South Africa; [Hallett, Timothy B.] Univ London Imperial Coll Sci Technol & Med, London, England	Human Sciences Research Council-South Africa; Imperial College London	Rehle, TM (corresponding author), Human Sci Res Council, Cape Town, South Africa.	TRehle@hsrc.ac.za	Hallett, Timothy/A-2390-2011; Pillay-van Wyk, Victoria/D-3567-2018	Pillay-van Wyk, Victoria/0000-0001-8772-7197; Hallett, Timothy/0000-0002-9681-0424; Zuma, Khangelani/0000-0003-4492-5083	Nelson Mandela Foundation; Nelson Mandela Children's Fund; Swiss Agency for Development and Cooperation; United States Centers for Disease Control and Prevention (CDC) [CDC-RFA-PS06-614]; United Nations Children's Fund; Wellcome Trust	Nelson Mandela Foundation; Nelson Mandela Children's Fund; Swiss Agency for Development and Cooperation; United States Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United Nations Children's Fund; Wellcome Trust(Wellcome TrustEuropean Commission)	The 2002 survey was funded by the Nelson Mandela Foundation and the Nelson Mandela Children's Fund, with additional financial support from the Swiss Agency for Development and Cooperation. The 2005 survey was commissioned by the Nelson Mandela Foundation, with additional financial support from the Swiss Agency for Development and Cooperation and the United States Centers for Disease Control and Prevention (CDC). The 2008 survey was funded by the CDC through Funding Opportunity Announcement Number CDC-RFA-PS06-614 of the President's Emergency Plan for AIDS Relief (PEPFAR), with additional financial support from the United Nations Children's Fund. TBH thanks the Wellcome Trust for funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; Boerma JT, 2003, LANCET, V362, P1929, DOI 10.1016/S0140-6736(03)14967-7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; *DEP HLTH S AFR, 2007, NAT STRAT PLAN HIV A; Department of Health (South Africa), 2009, NAT ANT SENT HIV SYP; DODD P, 2009, AIDS IN PRESS; Egger M, 2007, 14 C RETR OPP INF LO; Gouws E, 2008, SEX TRANSM INFECT, V84, pI17, DOI 10.1136/sti.2008.030452; GRANICH RM, 2008, LANCET; Gregson S, 2002, SEX TRANSM DIS, V29, P568, DOI 10.1097/00007435-200210000-00002; Hallett TB, 2007, SEX TRANSM INFECT, V83, pI50, DOI 10.1136/sti.2006.023606; Hallett T, 2009, AIDS, V23, P131, DOI 10.1097/QAD.0b013e3283177f59; Hallett TB, 2008, PLOS MED, V5, P611, DOI 10.1371/journal.pmed.0050080; Hallett TB, 2009, EPIDEMICS-NETH, V1, P108, DOI 10.1016/j.epidem.2009.03.001; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Kirkwood BR, 2003, ESSENTIAL MED STAT; Koal T, 2005, RAPID COMMUN MASS SP, V19, P2995, DOI 10.1002/rcm.2158; Lewis JJC, 2004, AIDS, V18, pS35, DOI 10.1097/00002030-200406002-00005; MARSH KA, 2009, SEX TRANSM INF UNPUB; Marston M, 2008, SEX TRANSM INFECT, V84, pI71, DOI 10.1136/sti.2008.030353; Michelo C, 2008, TROP MED INT HEALTH, V13, P171, DOI 10.1111/j.1365-3156.2007.01987.x; Mishra V, 2008, SEX TRANSM INFECT, V84, pI63, DOI 10.1136/sti.2008.030411; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; REHLE T, 2007, 3 S AFR AIDS C JUN 5; Rehle T, 2007, SAMJ S AFR MED J, V97, P194; Shisana O, 2009, S AFRICAN NATL PREVA; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; Stover J, 2008, SEX TRANSM INFECT, V84, pI24, DOI 10.1136/sti.2008.029868; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; *UNAIDS, 2005, EV HIV DECL ZIMB COM; Zaba B, 2000, AIDS, V14, P1633, DOI 10.1097/00002030-200007280-00020; Zwahlen M, 2008, SEX TRANSM INFECT, V84, pI31, DOI 10.1136/sti.2008.029793	32	108	112	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11094	10.1371/journal.pone.0011094	http://dx.doi.org/10.1371/journal.pone.0011094			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559425	Green Submitted, Green Published, gold			2022-12-27	WOS:000278741100010
J	Imaizumi, N; Monnier, Y; Hegi, M; Mirimanoff, RO; Ruegg, C				Imaizumi, Natsuko; Monnier, Yan; Hegi, Monika; Mirimanoff, Rene-Olivier; Rueegg, Curzio			Radiotherapy Suppresses Angiogenesis in Mice through TGF-beta RI/ALK5-Dependent Inhibition of Endothelial Cell Sprouting	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; IONIZING-RADIATION; DEPENDENT KINASE; GENE-EXPRESSION; MAMMARY-GLAND; CYCLE ARREST; MOUSE SKIN; CANCER; METASTASIS	Background: Radiotherapy is widely used to treat cancer. While rapidly dividing cancer cells are naturally considered the main target of radiotherapy, emerging evidence indicates that radiotherapy also affects endothelial cell functions, and possibly also their angiogenic capacity. In spite of its clinical relevance, such putative anti-angiogenic effect of radiotherapy has not been thoroughly characterized. We have investigated the effect of ionizing radiation on angiogenesis using in vivo, ex vivo and in vitro experimental models in combination with genetic and pharmacological interventions. Principal Findings: Here we show that high doses ionizing radiation locally suppressed VEGF-and FGF-2-induced Matrigel plug angiogenesis in mice in vivo and prevented endothelial cell sprouting from mouse aortic rings following in vivo or ex vivo irradiation. Quiescent human endothelial cells exposed to ionizing radiation in vitro resisted apoptosis, demonstrated reduced sprouting, migration and proliferation capacities, showed enhanced adhesion to matrix proteins, and underwent premature senescence. Irradiation induced the expression of P53 and P21 proteins in endothelial cells, but p53 or p21 deficiency and P21 silencing did not prevent radiation-induced inhibition of sprouting or proliferation. Radiation induced Smad-2 phosphorylation in skin in vivo and in endothelial cells in vitro. Inhibition of the TGF-beta type I receptor ALK5 rescued deficient endothelial cell sprouting and migration but not proliferation in vitro and restored defective Matrigel plug angiogenesis in irradiated mice in vivo. ALK5 inhibition, however, did not rescue deficient proliferation. Notch signaling, known to hinder angiogenesis, was activated by radiation but its inhibition, alone or in combination with ALK5 inhibition, did not rescue suppressed proliferation. Conclusions: These results demonstrate that irradiation of quiescent endothelial cells suppresses subsequent angiogenesis and that ALK5 is a critical mediator of this suppression. These results extend our understanding of radiotherapy-induced endothelial dysfunctions, relevant to both therapeutic and unwanted effects of radiotherapy.	[Imaizumi, Natsuko; Monnier, Yan; Rueegg, Curzio] CHUV, CePO, Div Expt Oncol, Epalinges, Switzerland; [Imaizumi, Natsuko; Monnier, Yan; Hegi, Monika; Mirimanoff, Rene-Olivier; Rueegg, Curzio] Univ Lausanne, CH-1066 Epalinges, Switzerland; [Imaizumi, Natsuko; Monnier, Yan; Hegi, Monika; Rueegg, Curzio] ISREC EPFL, NCCR Mol Oncol, Epalinges, Switzerland; [Hegi, Monika] CHU Vaudois, Ctr Univ Romand Neurochirurg, Lab Brain Tumor Biol & Genet, Lausanne, Switzerland; [Mirimanoff, Rene-Olivier] CHU Vaudois, Dept Radiooncol, Lausanne, Switzerland; [Rueegg, Curzio] Univ Fribourg, Fac Sci, Dept Med, CH-1700 Fribourg, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Fribourg	Imaizumi, N (corresponding author), Diagnoplex SA, Lausanne, Switzerland.	curzio.ruegg@unifr.ch	Hegi, Monika/O-4796-2015	Hegi, Monika/0000-0003-0855-6495	National Center of Competence in Research (NCCR); Swiss National Science Foundation; Oncosuisse [CCRP-OCS-01812-12-2005]; MEDIC foundation	National Center of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Oncosuisse; MEDIC foundation	This work was funded by the Molecular Oncology Program of the National Center of Competence in Research (NCCR) of ISREC-EPFL, a research instrument of the Swiss National Science Foundation, a Collaborative Research Grant from Oncosuisse (CCRP-OCS-01812-12-2005), and the MEDIC foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Natsuko Imaizumi was not employed by Diagnoplex SA at the time the work was performed, and Diagnoplex did not contribute financially, scientifically or in any other way to this study.	Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Akhtar Nasim, 2002, Angiogenesis, V5, P75, DOI 10.1023/A:1021507031486; Allan DS, 2009, INT J RADIAT ONCOL, V75, P220, DOI 10.1016/j.ijrobp.2009.04.033; Arocho A, 2006, DIAGN MOL PATHOL, V15, P56, DOI 10.1097/00019606-200603000-00009; Balasubramaniam P, 1992, J Postgrad Med, V38, P8; Barcellos-Hoff MH, 2006, MUTAT RES-FUND MOL M, V597, P32, DOI 10.1016/j.mrfmmm.2005.09.008; Barcellos-Hoff MH, 2005, NAT REV CANCER, V5, P867, DOI 10.1038/nrc1735; BARCELLOSHOFF MH, 1994, J CLIN INVEST, V93, P892, DOI 10.1172/JCI117045; BARCELLOSHOFF MH, 1993, CANCER RES, V53, P3880; BARTON M, 1995, INT J RADIAT ONCOL, V31, P371, DOI 10.1016/0360-3016(94)E0126-5; Bernier J, 2004, NAT REV CANCER, V4, P737, DOI 10.1038/nrc1451; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Blacher Silvia, 2001, Angiogenesis, V4, P133, DOI 10.1023/A:1012251229631; Brown JM, 2008, INT J RADIAT ONCOL, V71, P324, DOI 10.1016/j.ijrobp.2008.02.003; Burdelya LG, 2006, CANCER RES, V66, P9356, DOI 10.1158/0008-5472.CAN-06-1223; Castanares C, 2007, J CELL SCI, V120, P1256, DOI 10.1242/jcs.03419; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Davis TA, 2008, INT J RADIAT BIOL, V84, P713, DOI 10.1080/09553000802317778; Dormand Emma-Louise, 2005, Int Wound J, V2, P112, DOI 10.1111/j.1742-4801.2005.00079.x; Dorresteijn LDA, 2005, EUR J CANCER, V41, P1026, DOI 10.1016/j.ejca.2005.01.020; Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; Fajardo LF, 2005, ACTA ONCOL, V44, P13, DOI 10.1080/02841860510007440; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Hlushchuk R, 2008, AM J PATHOL, V173, P1173, DOI 10.2353/ajpath.2008.071131; Igrashi K, 2007, EXP CELL RES, V313, P3326, DOI 10.1016/j.yexcr.2007.06.001; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kim IY, 2005, J BIOCHEM MOL BIOL, V38, P1; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Kuo LJ, 2008, IN VIVO, V22, P305; Lahn M, 2005, EXPERT OPIN INV DRUG, V14, P629, DOI 10.1517/13543784.14.6.629; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Leong KG, 2002, MOL CELL BIOL, V22, P2830, DOI 10.1128/MCB.22.8.2830-2841.2002; Liu ZJ, 2006, FASEB J, V20, P1009, DOI 10.1096/fj.05-4880fje; Lyng FM, 2006, INT J RADIAT BIOL, V82, P393, DOI 10.1080/09553000600803904; Mallet C, 2006, STEM CELLS, V24, P2120, DOI 10.1634/stemcells.2005-0494; Martin M, 1997, ONCOGENE, V15, P981, DOI 10.1038/sj.onc.1201433; Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045; Monnier Y, 2008, CANCER RES, V68, P7323, DOI 10.1158/0008-5472.CAN-08-0841; Munoz-Chapuli R, 2004, CELL MOL LIFE SCI, V61, P2224, DOI 10.1007/s00018-004-4070-7; NICOSIA RF, 1990, LAB INVEST, V63, P115; Niimi H, 2007, J CELL BIOL, V176, P695, DOI 10.1083/jcb.200612129; Noseda M, 2004, MOL CELL BIOL, V24, P8813, DOI 10.1128/MCB.24.20.8813-8822.2004; Oh CW, 2001, RADIAT RES, V156, P232, DOI 10.1667/0033-7587(2001)156[0232:IOASLP]2.0.CO;2; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Park CC, 2000, MOL MED TODAY, V6, P324, DOI 10.1016/S1357-4310(00)01756-1; PASSANITI A, 1992, LAB INVEST, V67, P519; Qu JF, 2004, J RADIAT RES, V45, P341, DOI 10.1269/jrr.45.341; RANDALL K, 1995, INT J RADIAT BIOL, V68, P301, DOI 10.1080/09553009514551231; Randall K, 1996, INT J RADIAT BIOL, V70, P351, DOI 10.1080/095530096145085; Rofstad EK, 2005, CANCER RES, V65, P2387, DOI 10.1158/0008-5472.CAN-04-3039; Rosen EM, 1999, CANCER INVEST, V17, P56; Ruegg C, 1998, NAT MED, V4, P408, DOI 10.1038/nm0498-408; Scharpfenecker M, 2009, INT J RADIAT ONCOL, V73, P506, DOI 10.1016/j.ijrobp.2008.09.052; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Spyridopoulos I, 2002, BASIC RES CARDIOL, V97, P117, DOI 10.1007/s003950200001; SUIT HD, 1992, INT J RADIAT ONCOL, V23, P653, DOI 10.1016/0360-3016(92)90025-D; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Tetik O, 2008, VASCULAR, V16, P239, DOI 10.2310/6670.2008.00013; Vicini FA, 2003, CANCER, V97, P910, DOI 10.1002/cncr.11143; VIKRAM B, 1984, HEAD NECK SURG, V6, P730, DOI 10.1002/hed.2890060305; WORTHINGTON RE, 1987, EXP HEMATOL, V15, P85; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069	70	56	57	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11084	10.1371/journal.pone.0011084	http://dx.doi.org/10.1371/journal.pone.0011084			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552031	Green Published, Green Submitted, gold			2022-12-27	WOS:000278662900022
J	Ogonuki, N; Mori, M; Shinmen, A; Inoue, K; Mochida, K; Ohta, A; Ogura, A				Ogonuki, Narumi; Mori, Manami; Shinmen, Akie; Inoue, Kimiko; Mochida, Keiji; Ohta, Akihiko; Ogura, Atsuo			The Effect on Intracytoplasmic Sperm Injection Outcome of Genotype, Male Germ Cell Stage and Freeze-Thawing in Mice	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; FULL-TERM DEVELOPMENT; ROUND SPERMATIDS; MOUSE OOCYTES; FUNCTIONAL ASSESSMENT; EFFICIENT PRODUCTION; NORMAL YOUNG; MICROINSEMINATION; EMBRYOS; ACTIVATION	Background: Intracytoplasmic sperm injection (ICSI) has been widely used to study the mechanisms of mammalian fertilization and to rescue male-factor infertility in humans and animals. However, very few systematic analyses have been conducted to define factors affecting the efficiency of ICSI. In this study, we undertook a large-scale series of ICSI experiments in mice to define the factors that might affect outcomes. Methodology/Principal Findings: We used a 5 x 3 x 2 factorial design with the following factors: mouse genotype (ICR, C57BL/6, DBA/2, C3H/He, and 129/Sv strains), type of male germ cells (epididymal sperm, elongated or round spermatids), and their freeze-thawing treatment. The efficiencies (parameters) of each developmental step were analyzed by three-way ANOVA (significance level P < 0.01). The type of male germ cells affected all the four parameters observed: oocyte survival after injection, cleavage of oocytes, implantation, and birth of offspring. Genotype affected the oocyte survival, cleavage and birth rates, whereas freeze-thawing had no effects on any of the parameters. There were significant genotype/cell type interactions for oocyte survival and cleavage, indicating that they were determined by a combination of strain and germ cell maturity. Multiple comparisons revealed that spermatozoa and elongated spermatids gave better implantation and birth rates than did round spermatids, while spermatozoa and elongated spermatozoa were indistinguishable in their ability to support embryonic development. The best overall efficiency (birth rate per oocytes injected) was obtained with frozen-thawed DBA/2 strain elongated spermatids (23.2 +/- 4.2%). Conclusions/Significance: The present study provides the first comprehensive information on ICSI using the mouse as a model and will contribute to the efficient use of materials, time, and efforts in biomedical research and clinics involving ICSI.	[Ogonuki, Narumi; Mori, Manami; Shinmen, Akie; Inoue, Kimiko; Mochida, Keiji; Ogura, Atsuo] RIKEN BioResouce Ctr, Tsukuba, Ibaraki, Japan; [Mori, Manami; Ohta, Akihiko] Meiji Univ, Sch Agr, Dept Life Sci, Kawasaki, Kanagawa, Japan; [Inoue, Kimiko; Ogura, Atsuo] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Ogura, Atsuo] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 113, Japan	RIKEN; Meiji University; University of Tsukuba; University of Tokyo	Ogonuki, N (corresponding author), RIKEN BioResouce Ctr, Tsukuba, Ibaraki, Japan.	ogura@rtc.riken.go.jp	Ogura, Atsuo/J-3916-2014	Ogura, Atsuo/0000-0003-0447-1988	Ministry of Education, Culture, Sports, Science and Technology [20062012, 20500383]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank funding support from the Ministry of Education, Culture, Sports, Science and Technology (20062012 and 20500383). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hasani S, 1999, HUM REPROD, V14, P97, DOI 10.1093/humrep/14.suppl_1.97; Byers SL, 2006, THERIOGENOLOGY, V65, P1716, DOI 10.1016/j.theriogenology.2005.09.016; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Eisener-Dorman AF, 2009, BRAIN BEHAV IMMUN, V23, P318, DOI 10.1016/j.bbi.2008.09.001; Endoh K, 2007, J REPROD DEVELOP, V53, P1199, DOI 10.1262/jrd.19058; Glaser S, 2005, NAT GENET, V37, P1187, DOI 10.1038/ng1668; HANSEN FD, 1988, IN VIVO, V2, P339; Hirabayashi M, 2002, MOL REPROD DEV, V62, P295, DOI 10.1002/mrd.10127; Hirabayashi M, 2009, MOL REPROD DEV, V76, P573, DOI 10.1002/mrd.20984; Ibanez E, 2005, REPRODUCTION, V129, P27, DOI 10.1530/rep.1.00452; Kai M, 2004, BIOL REPROD, V70, P1213, DOI 10.1095/biolreprod.103.024802; Kanatsu-Shinohara M, 2007, ANN NY ACAD SCI, V1120, P59, DOI 10.1196/annals.1411.001; Kaneda H, 2007, EXP ANIM TOKYO, V56, P385, DOI 10.1538/expanim.56.385; Kawai Y, 2006, J REPROD DEVELOP, V52, P561, DOI 10.1262/jrd.18023; Kawase Y, 2001, MOL REPROD DEV, V60, P74, DOI 10.1002/mrd.1063; KIMURA Y, 1995, DEVELOPMENT, V121, P2397; KIMURA Y, 1995, BIOL REPROD, V53, P855, DOI 10.1095/biolreprod53.4.855; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Kimura Y, 1998, BIOL REPROD, V58, P1407, DOI 10.1095/biolreprod58.6.1407; Kishigami S, 2006, DEV BIOL, V289, P195, DOI 10.1016/j.ydbio.2005.10.026; Miki H, 2004, BIOL REPROD, V71, P2022, DOI 10.1095/biolreprod.104.031542; Miki H, 2004, J REPROD DEVELOP, V50, P131, DOI 10.1262/jrd.50.131; Miki H, 2009, GENESIS, V47, P155, DOI 10.1002/dvg.20451; Navara CS, 1995, CURR TOP DEV BIOL, V31, P321; Ogonuki N, 2005, MOL REPROD DEV, V72, P411, DOI 10.1002/mrd.20363; Ogonuki N, 2003, BIOL REPROD, V68, P1821, DOI 10.1095/biolreprod.102.011726; Ogonuki N, 2006, P NATL ACAD SCI USA, V103, P13098, DOI 10.1073/pnas.0605755103; Ogonuki N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004943; Ogura A, 1998, P NATL ACAD SCI USA, V95, P5611, DOI 10.1073/pnas.95.10.5611; Ogura A, 1996, J ASSIST REPROD GEN, V13, P431, DOI 10.1007/BF02066177; OGURA A, 1993, BIOL REPROD, V48, P219, DOI 10.1095/biolreprod48.2.219; Ogura A, 2005, INT REV CYTOL, V246, P189, DOI 10.1016/S0074-7696(05)46005-2; OGURA A, 1994, P NATL ACAD SCI USA, V91, P7460, DOI 10.1073/pnas.91.16.7460; Ohta H, 2009, HUM REPROD, V24, P775, DOI 10.1093/humrep/den456; Ohta H, 2009, BIOL REPROD, V80, P511, DOI 10.1095/biolreprod.108.073270; Shinmen A, 2007, MOL REPROD DEV, V74, P1081, DOI 10.1002/mrd.20612; SPEAROW JL, 1988, J REPROD FERTIL, V82, P787, DOI 10.1530/jrf.0.0820787; Suzuki O, 1996, REPROD FERT DEVELOP, V8, P975, DOI 10.1071/RD9960975; Szczygiel MA, 2002, BIOL REPROD, V67, P1278, DOI 10.1095/biolreprod67.4.1278; Tachibana M, 2009, MOL REPROD DEV, V76, P270, DOI 10.1002/mrd.20951; Tanemura K, 1997, LAB ANIM SCI, V47, P203; UEHARA T, 1976, BIOL REPROD, V15, P467, DOI 10.1095/biolreprod15.4.467; UEHARA T, 1977, BIOL REPROD, V16, P315, DOI 10.1095/biolreprod16.3.315; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Ward WS, 2010, MOL HUM REPROD, V16, P30, DOI 10.1093/molehr/gap080; Yanagimachi R, 2005, REPROD BIOMED ONLINE, V10, P247, DOI 10.1016/S1472-6483(10)60947-9	46	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11062	10.1371/journal.pone.0011062	http://dx.doi.org/10.1371/journal.pone.0011062			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552034	Green Published, Green Submitted, gold			2022-12-27	WOS:000278662900009
J	Ombetta, JE; Thelier, N; Dong, CZ; Plocki, S; Tsagris, L; Rannou, F; Massicot, F; Djimde, A; El-Hayek, E; Shi, YM; Heymans, F; Gresh, N; Chauvet, C				Ombetta, Jean-Edouard; Thelier, Natacha; Dong, Chang Zhi; Plocki, Stephanie; Tsagris, Lydia; Rannou, Francois; Massicot, France; Djimde, Atime; El-Hayek, Elissar; Shi, Yiming; Heymans, Francoise; Gresh, Nohad; Chauvet, Caroline			Design of Group IIA Secreted/Synovial Phospholipase A(2) Inhibitors: An Oxadiazolone Derivative Suppresses Chondrocyte Prostaglandin E-2 Secretion	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; POLARIZABLE MOLECULAR-MECHANICS; RHEUMATOID-ARTHRITIS; SELECTIVE INHIBITOR; NITRIC-OXIDE; OSTEOARTHRITIS; 4,5-DIHYDRO-3-(4-TETRADECYLOXYBENZYL)-1,2,4-4H-OXADIAZOL-5-ONE; CYCLOOXYGENASE-2; QUANTITIES; EXPRESSION	Group IIA secreted/synovial phospholipase A(2) (GIIAPLA(2)) is an enzyme involved in the synthesis of eicosanoids such as prostaglandin E-2 (PGE(2)), the main eicosanoid contributing to pain and inflammation in rheumatic diseases. We designed, by molecular modeling, 7 novel analogs of 3-{4-[5(indol-1-yl)pentoxy]benzyl}-4H-1,2,4-oxadiazol-5-one, denoted C1, an inhibitor of the GIIAPLA(2) enzyme. We report the results of molecular dynamics studies of the complexes between these derivatives and GIIAPLA(2), along with their chemical synthesis and results from PLA(2) inhibition tests. Modeling predicted some derivatives to display greater GIIAPLA(2) affinities than did C1, and such predictions were confirmed by in vitro PLA(2) enzymatic tests. Compound C8, endowed with the most favorable energy balance, was shown experimentally to be the strongest GIIAPLA(2) inhibitor. Moreover, it displayed an anti-inflammatory activity on rabbit articular chondrocytes, as shown by its capacity to inhibit IL-1 beta-stimulated PGE(2) secretion in these cells. Interestingly, it did not modify the COX-1 to COX-2 ratio. C8 is therefore a potential candidate for anti-inflammatory therapy in joints.	[Ombetta, Jean-Edouard] Univ Tours, Fac Pharm, Chim Organ Lab, Tours, France; [Thelier, Natacha; Tsagris, Lydia; Rannou, Francois; El-Hayek, Elissar; Chauvet, Caroline] Univ Paris 05, UFR Biomed St Peres, INSERM,UMR S 747, Lab Pharmacol Toxicol & Signalisat Cellulaire, Paris, France; [Dong, Chang Zhi; Plocki, Stephanie; Djimde, Atime; Shi, Yiming; Heymans, Francoise] Univ Paris Diderot, CNRS, UMR7086, Equipe Pharmacochim,ITODYS, Paris, France; [Rannou, Francois] Hop Cochin, AP HP, Serv Reeducat, F-75674 Paris, France; [Massicot, France] Univ Paris 05, Fac Pharm, EA4463, Lab Chim Toxicol Analyt & Cellulaire, Paris, France; [Gresh, Nohad] Univ Paris 05, UFR Biomed St Peres, CNRS, Lab Chim & Biochim Pharmacol & Toxicol,UMR8601, Paris, France	Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite	Ombetta, JE (corresponding author), Univ Tours, Fac Pharm, Chim Organ Lab, Tours, France.	caroline.chauvet@parisdescartes.fr	Shi, Yi-Ming/S-2780-2019	Shi, Yi-Ming/0000-0001-6933-4971; Dong, Changzhi/0000-0001-7927-6306	INSERM; University Paris Descartes; Arthritis Foundation Courtin; Paris Centre University (Paris Descartes and Paris Diderot); Ligue Nationale Contre le Cancer; Assistance Publique-Hopitaux de Paris	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Paris Descartes; Arthritis Foundation Courtin; Paris Centre University (Paris Descartes and Paris Diderot); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Assistance Publique-Hopitaux de Paris	Funding: This study was supported in part by INSERM, University Paris Descartes, Arthritis Foundation Courtin and a program of Paris Centre University (Paris Descartes and Paris Diderot). The authors thank the computer center CINES-Montpellier for computer time and technical support. The authors also thank the Ligue Nationale Contre le Cancer for support. NT was supported by Assistance Publique-Hopitaux de Paris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AR, 1997, J CLIN INVEST, V99, P1231, DOI 10.1172/JCI119280; Assogba L, 2005, EUR J MED CHEM, V40, P850, DOI 10.1016/j.ejmech.2005.03.027; BOMALASKI JS, 1991, J IMMUNOL, V146, P3904; Boukli L, 2008, BIOORGAN MED CHEM, V16, P1242, DOI 10.1016/j.bmc.2007.10.077; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradley JD, 2005, J RHEUMATOL, V32, P417; CAREY MC, 1983, ANNU REV PHYSIOL, V45, P651, DOI 10.1146/annurev.ph.45.030183.003251; Chen YF, 2008, HEALTH TECHNOL ASSES, V12, P1, DOI 10.3310/hta12110; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; DEHAEN W, 1991, J ORG CHEM, V56, P896, DOI 10.1021/jo00002a083; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Dong CZ, 2005, BIOORGAN MED CHEM, V13, P1989, DOI 10.1016/j.bmc.2005.01.016; Dong CZ, 2002, BIOCHEM J, V365, P505, DOI 10.1042/BJ20011648; Evans CH, 1996, METHOD ENZYMOL, V269, P75; Fernandes JC, 2002, BIORHEOLOGY, V39, P237; Francois M, 2004, J BIOL CHEM, V279, P28411, DOI 10.1074/jbc.M312708200; FRASER H, 2009, VARESPLADIB A 002 SE; GOETZL EJ, 1995, FASEB J, V9, P1051, DOI 10.1096/fasebj.9.11.7649404; Gresh N, 2007, J CHEM THEORY COMPUT, V3, P1960, DOI 10.1021/ct700134r; HARA S, 1989, J BIOCHEM-TOKYO, V105, P395, DOI 10.1093/oxfordjournals.jbchem.a122675; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; LANGLET J, 1988, J PHYS CHEM-US, V92, P1617, DOI 10.1021/j100317a048; Lin MKS, 1996, J RHEUMATOL, V23, P1162; Martel-Pelletier J, 2003, SEMIN ARTHRITIS RHEU, V33, P155, DOI 10.1016/S0049-0172(03)00134-3; McCoy JM, 2002, J CLIN INVEST, V110, P651, DOI 10.1172/JCI200215528; Murakami M, 2004, PROG LIPID RES, V43, P3, DOI 10.1016/S0163-7827(03)00037-7; MURAKAMI M, 1990, FEBS LETT, V268, P113, DOI 10.1016/0014-5793(90)80986-S; Nevalainen TJ, 2000, BBA-MOL CELL BIOL L, V1488, P83, DOI 10.1016/S1388-1981(00)00112-8; Plocki S, 2005, EUR J ORG CHEM, V2005, P2747, DOI 10.1002/ejoc.200400541; RADVANYI F, 1989, ANAL BIOCHEM, V177, P103, DOI 10.1016/0003-2697(89)90022-5; REKKER RF, 1979, EUR J MED CHEM, V14, P479; Roux C, 2007, J COMPUT CHEM, V28, P938, DOI 10.1002/jcc.20586; SAKURAI H, 1995, J CLIN INVEST, V96, P2357, DOI 10.1172/JCI118292; SEILHAMER JJ, 1989, J BIOCHEM, V106, P38, DOI 10.1093/oxfordjournals.jbchem.a122815; Solomon DH, 2006, ARTHRITIS RHEUM-US, V54, P1378, DOI 10.1002/art.21887; Touaibia M, 2007, J MED CHEM, V50, P1618, DOI 10.1021/jm060082n; Zeiher BG, 2005, CRIT CARE MED, V33, P1741, DOI 10.1097/01.CCM.0000171540.54520.69	37	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2010	5	6							e10914	10.1371/journal.pone.0010914	http://dx.doi.org/10.1371/journal.pone.0010914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QF	20531958	Green Published, gold, Green Submitted			2022-12-27	WOS:000278222400009
J	Bopp, SER; Ramachandran, V; Henson, K; Luzader, A; Lindstrom, M; Spooner, M; Steffy, BM; Suzuki, O; Janse, C; Waters, AP; Zhou, YY; Wiltshire, T; Winzeler, EA				Bopp, Selina E. R.; Ramachandran, Vandana; Henson, Kerstin; Luzader, Angelina; Lindstrom, Merle; Spooner, Muriel; Steffy, Brian M.; Suzuki, Oscar; Janse, Chris; Waters, Andrew P.; Zhou, Yingyao; Wiltshire, Tim; Winzeler, Elizabeth A.			Genome Wide Analysis of Inbred Mouse Lines Identifies a Locus Containing Ppar-gamma as Contributing to Enhanced Malaria Survival	PLOS ONE			English	Article							PYRUVATE-KINASE DEFICIENCY; CEREBRAL MALARIA; PLASMODIUM-BERGHEI; SUSCEPTIBILITY LOCUS; GENETIC-CONTROL; PARASITE SEQUESTRATION; POPULATION-STRUCTURE; NATURAL-SELECTION; MURINE MALARIA; MICE	The genetic background of a patient determines in part if a person develops a mild form of malaria and recovers, or develops a severe form and dies. We have used a mouse model to detect genes involved in the resistance or susceptibility to Plasmodium berghei malaria infection. To this end we first characterized 32 different mouse strains infected with P. berghei and identified survival as the best trait to discriminate between the strains. We found a locus on chromosome 6 by linking the survival phenotypes of the mouse strains to their genetic variations using genome wide analyses such as haplotype associated mapping and the efficient mixed-model for association. This new locus involved in malaria resistance contains only two genes and confirms the importance of Ppar-gamma in malaria infection.	[Bopp, Selina E. R.; Ramachandran, Vandana; Henson, Kerstin; Winzeler, Elizabeth A.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Ramachandran, Vandana] Inst Med Biol, Singapore, Singapore; [Henson, Kerstin; Luzader, Angelina; Lindstrom, Merle; Spooner, Muriel; Zhou, Yingyao; Winzeler, Elizabeth A.] Novartis Fdn, Genom Inst, La Jolla, CA USA; [Steffy, Brian M.; Suzuki, Oscar; Wiltshire, Tim] Univ N Carolina, Sch Pharm, Dept Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA; [Janse, Chris] Leiden Univ, Med Ctr, Leiden, Netherlands; [Waters, Andrew P.] Univ Glasgow, Glasgow Biomed Res Ctr, Glasgow, Lanark, Scotland	Scripps Research Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Novartis; University of North Carolina; University of North Carolina Chapel Hill; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Glasgow	Bopp, SER (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	selina@scripps.edu	Waters, Andy P/C-9377-2009; Winzeler, Elizabeth/AAP-6752-2020	Waters, Andy P/0000-0001-8900-2982; Winzeler, Elizabeth/0000-0002-4049-2113; Bopp, Selina/0000-0002-9412-9766; Janse, Chris J/0000-0002-6410-6205	W.M. Keck Foundation	W.M. Keck Foundation(W.M. Keck Foundation)	EAW was supported by the W.M. Keck Foundation (www.wmkeck.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Ayi K, 2008, NEW ENGL J MED, V358, P1805, DOI 10.1056/NEJMoa072464; Bagot S, 2002, P NATL ACAD SCI USA, V99, P9919, DOI 10.1073/pnas.152215199; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; BERGHOUT J, 2009, GENES IMMUN; Boggild AK, 2009, CLIN INFECT DIS, V49, P841, DOI 10.1086/605431; Bogue MA, 2004, GENETICA, V122, P71, DOI 10.1007/s10709-004-1438-4; Burt RA, 2002, INFECT IMMUN, V70, P4750, DOI 10.1128/IAI.70.8.4750-4753.2002; Burt RA, 1999, IMMUNOGENETICS, V50, P278, DOI 10.1007/s002510050603; Campino S, 2005, GENES IMMUN, V6, P416, DOI 10.1038/sj.gene.6364219; CORDEIRO RSB, 1983, ANN TROP MED PARASIT, V77, P455, DOI 10.1080/00034983.1983.11811739; CURFS JHAJ, 1989, CLIN EXP IMMUNOL, V75, P136; Elased KM, 2001, MOL GENET METAB, V73, P248, DOI 10.1006/mgme.2001.3186; ELING WMC, 1980, INFECT IMMUN, V30, P635; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; Foote SJ, 1997, NAT GENET, V17, P380, DOI 10.1038/ng1297-380; Fortin A, 1997, NAT GENET, V17, P382, DOI 10.1038/ng1297-382; Fortin A, 2001, P NATL ACAD SCI USA, V98, P10793, DOI 10.1073/pnas.191288998; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Frodsham AJ, 2004, HUM MOL GENET, V13, pR187, DOI 10.1093/hmg/ddh225; Goncalves LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001874; Hearn J, 2000, INFECT IMMUN, V68, P5364, DOI 10.1128/IAI.68.9.5364-5376.2000; Hermsen C, 1997, PARASITOLOGY, V114, P7, DOI 10.1017/S0031182096008293; Hernandez-Valladares M, 2004, MAMM GENOME, V15, P390, DOI 10.1007/s00335-004-3042-4; Hernandez-Valladares M, 2004, IMMUNOGENETICS, V56, P115, DOI 10.1007/s00251-004-0667-0; JACOBS RL, 1967, T ROY SOC TROP MED H, V61, P273, DOI 10.1016/0035-9203(67)90170-8; Jeninga EH, 2009, TRENDS ENDOCRIN MET, V20, P380, DOI 10.1016/j.tem.2009.04.005; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; KAUL DK, 1994, AM J TROP MED HYG, V50, P512, DOI 10.4269/ajtmh.1994.50.512; Kort WJ, 1998, LAB ANIM-UK, V32, P260, DOI 10.1258/002367798780559329; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; McClelland S, 2009, PPAR RES, V2009, DOI 10.1155/2009/193413; McClurg P, 2007, GENETICS, V176, P675, DOI 10.1534/genetics.106.066241; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; MILLER LH, 1969, AM J TROP MED HYG, V18, P860, DOI 10.4269/ajtmh.1969.18.860; MILLER LH, 1971, AM J TROP MED HYG, V20, P816, DOI 10.4269/ajtmh.1971.20.816; Min-Oo G, 2003, NAT GENET, V35, P357, DOI 10.1038/ng1260; Min-Oo G, 2007, J EXP MED, V204, P511, DOI 10.1084/jem.20061252; Nagayasu E, 2002, INFECT IMMUN, V70, P512, DOI 10.1128/IAI.70.2.512-516.2002; Ohno T, 2004, IMMUNOGENETICS, V56, P675, DOI 10.1007/s00251-004-0739-1; Ohno T, 2001, IMMUNOGENETICS, V53, P736, DOI 10.1007/s00251-001-0390-z; Pletcher MT, 2004, PLOS BIOL, V2, P2159, DOI 10.1371/journal.pbio.0020393; Robert V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-81; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Serghides L, 2009, J INFECT DIS, V199, P1536, DOI 10.1086/598222; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; STUNNENBERG HG, 1993, BIOESSAYS, V15, P309, DOI 10.1002/bies.950150504; Watanabe T, 2008, HEPATOL RES, V38, P441, DOI 10.1111/j.1872-034X.2007.00313.x; Wilairatana Polrat, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P203; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087	55	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10903	10.1371/journal.pone.0010903	http://dx.doi.org/10.1371/journal.pone.0010903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531941	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000278222100032
J	Titov, N; Andrews, G; Kemp, A; Robinson, E				Titov, Nickolai; Andrews, Gavin; Kemp, Alice; Robinson, Emma			Characteristics of Adults with Anxiety or Depression Treated at an Internet Clinic: Comparison with a National Survey and an Outpatient Clinic	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIORAL THERAPY; MENTAL-HEALTH-SURVEY; SOCIAL PHOBIA; PANIC DISORDER; SELF-HELP; DSM-IV; VALIDATION; QUESTIONNAIRE; REPLICATION	Background: There is concern that people seeking treatment over the Internet for anxiety or depressive disorders may not resemble the general population or have less severe disorders than patients attending outpatient clinics or cases identified in community surveys. Thus the response to treatment in Internet based trials might not generalize. Methodology: We reviewed the characteristics of applicants to an Australian Internet-based treatment clinic for anxiety and depression, and compared this sample with people from a national epidemiological survey and a sample of patients at a specialist outpatient anxiety and depression clinic. Participants included 774 volunteers to an Internet clinic, 454 patients at a specialist anxiety disorders outpatient clinic, and 627 cases identified in a national epidemiological survey. Main measures included demographic characteristics, and severity of symptoms as measured by the Kessler 10-Item scale (K-10), the 12-item World Health Organisation Disability Assessment Schedule second edition (WHODAS-II), the Penn State Worry Questionnaire (PSWQ), the Body Sensations Questionnaire (BSQ), the Automatic Cognitions Questionnaire (ACQ), the Social Interaction Anxiety Scale (SIAS) and the Social Phobia Scale (SPS). Principal Findings: The severity of symptoms of participants attending the two clinics was similar, and both clinic samples were more severe than cases in the epidemiological survey. The Internet clinic and national samples were older and comprised more females than those attending the outpatient clinic. The Internet clinic sample were more likely to be married than the other samples. The Internet clinic and outpatient clinic samples had higher levels of educational qualifications than the national sample, but employment status was similar across groups. Conclusions: The Internet clinic sample have disorders as severe as those attending an outpatient clinic, but with demographic characteristics more consistent with the national sample. These data indicate that the benefits of Internet treatment could apply to the wider population.	[Titov, Nickolai; Andrews, Gavin; Kemp, Alice] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Robinson, Emma] St Vincents Hosp, Sydney, NSW 2010, Australia	University of New South Wales Sydney; St Vincents Hospital Sydney	Titov, N (corresponding author), Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia.	nickt@unsw.edu.au	Andrews, Gavin/J-6537-2012	Andrews, Gavin/0000-0002-4315-2173; Titov, Nickolai/0000-0002-7268-729X	Clinical Research Unit for Anxiety and Depression (CRUfAD); University of New South Wales; St Vincent's Hospital, Sydney, Australia	Clinical Research Unit for Anxiety and Depression (CRUfAD); University of New South Wales; St Vincent's Hospital, Sydney, Australia	This study was investigator initiated. It was funded by departmental funds from the Clinical Research Unit for Anxiety and Depression (CRUfAD), University of New South Wales and St Vincent's Hospital, Sydney, Australia. CRUfAD is a not-for-profit entity (www.crufad.org and www.virtualclinic.org.au) that has existed for 30 years and regularly conducts studies such as this. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andersson G, 2005, BRIT J PSYCHIAT, V187, P456, DOI 10.1192/bjp.187.5.456; Andersson G, 2006, J CONSULT CLIN PSYCH, V74, P677, DOI 10.1037/0022-006X.74.4.677; Andrews G, 2001, BRIT J PSYCHIAT, V178, P145, DOI 10.1192/bjp.178.2.145; Australian Bureau of Statistics [ABS], 2008, NAT SURV MENT HLTH W; Carlbring P, 2005, BEHAV RES THER, V43, P1321, DOI 10.1016/j.brat.2004.10.002; Carlbring P, 2007, BRIT J PSYCHIAT, V190, P123, DOI 10.1192/bjp.bp.105.020107; CHAMBLESS DL, 1984, J CONSULT CLIN PSYCH, V52, P1090, DOI 10.1037/0022-006X.52.6.1090; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kiropoulos LA, 2008, J ANXIETY DISORD, V22, P1273, DOI 10.1016/j.janxdis.2008.01.008; Klein B, 2006, J BEHAV THER EXP PSY, V37, P213, DOI 10.1016/j.jbtep.2005.07.001; MARKS I, 2007, HANDS ON HELP COMPUT, P223; Marks I, 2009, ANNU REV CLIN PSYCHO, V5, P121, DOI 10.1146/annurev.clinpsy.032408.153538; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Perini S, 2009, AUST NZ J PSYCHIAT, V43, P571, DOI 10.1080/00048670902873722; ROBINSON E, 2010, PLOS ONE IN PRESS; *RTI INT, 2008, SUDAAN WIND REL 10 0; Shandley K, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1033; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; *SPSS INC, 2008, SPSS 17 WIND REL 17; TITOV N, 2010, PLOS ONE IN PRESS; Titov N, 2008, AUST NZ J PSYCHIAT, V42, P595, DOI 10.1080/00048670802119820; Titov N, 2008, AUST NZ J PSYCHIAT, V42, P585, DOI 10.1080/00048670802119762; Titov N, 2007, AUST NZ J PSYCHIAT, V41, P95, DOI 10.1080/00048670601109873; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P920, DOI 10.1080/00048670903179228; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P905, DOI 10.1080/00048670903179269; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P913, DOI 10.1080/00048670903179160; Titov N, 2008, AUST NZ J PSYCHIAT, V42, P1030, DOI 10.1080/00048670802512107; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P36, DOI 10.1080/00048670802534424; Wells JE, 2006, AUST NZ J PSYCHIAT, V40, P835, DOI 10.1111/j.1440-1614.2006.01902.x; WHO, WHO DIS ASS SCHED; [No title captured]	35	68	68	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10885	10.1371/journal.pone.0010885	http://dx.doi.org/10.1371/journal.pone.0010885			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	603QC	20526371	Green Published, gold			2022-12-27	WOS:000278222100014
J	Buchy, P; Vong, S; Chu, S; Garcia, JM; Tran, TH; Vo, MH; Channa, M; Do, QH; Nguyen, VVC; Simmons, C; Farrar, JJ; Peiris, M; de Jong, MD				Buchy, Philippe; Vong, Sirenda; Chu, Simon; Garcia, Jean-Michel; Tran Tinh Hien; Vo Minh Hien; Channa, Mey; Do Quang Ha; Nguyen Van Vinh Chau; Simmons, Cameron; Farrar, Jeremy J.; Peiris, Malik; de Jong, Menno D.			Kinetics of Neutralizing Antibodies in Patients Naturally Infected by H5N1 Virus	PLOS ONE			English	Article							INFLUENZA-A H5N1; POULTRY WORKERS; LOW-FREQUENCY; TRANSMISSION; THAILAND	Background: Little is known about the kinetics of anti-H5 neutralizing antibodies in naturally H5N1-infected patients with severe clinical illness or asymptomatic infection. Methods: Using H5N1 microneutralisation (MN) and H5-pseudotype particle-based microneutralisation assays (H5pp) we analyzed sera sequentially obtained from 11 severely ill patients diagnosed by RT-PCR (follow-up range 1-139 weeks of disease onset) and 31 asymptomatically infected individuals detected in a sero-epidemiological study after exposure to H5N1 virus (follow-up range: 1-2 month -11 months after exposure). Results: Of 44 sera from 11 patients with H5N1 disease, 70% tested positive by MN (antibody titre >= 80) after 2 weeks and 100% were positive by 3 weeks after disease onset. The geometric mean MN titers in severely ill patients were 540 at 1-2 months and 173 at 10-12 months and thus were higher than the titers from asymptomatic individuals (149 at 1-2 months, 62.2 at 10-12 months). Fractional polynomial regression analysis demonstrated that in all severely ill patients, positive titers persisted beyond 2 years of disease onset, while 10 of 23 sera collected 10-11 months after exposure in asymptomatically infected individuals tested negative. Conclusions: Our results indicate that people with asymptomatic H5N1 infection have lower H5N1 antibody titres compared to those with severe illness and that in many asymptomatically infected patients the antibody titer decreased to levels below the threshold of positivity within one year. These data are essential for the design and interpretation of sero-epidemiological studies.	[Buchy, Philippe; Vong, Sirenda; Chu, Simon; Channa, Mey] Inst Pasteur Cambodia, Phnom Penh, Cambodia; [Garcia, Jean-Michel; Peiris, Malik] HKU Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Tran Tinh Hien; Vo Minh Hien] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Tran Tinh Hien; Vo Minh Hien; Do Quang Ha; Nguyen Van Vinh Chau; Simmons, Cameron; Farrar, Jeremy J.; de Jong, Menno D.] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Peiris, Malik] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [de Jong, Menno D.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; University of Hong Kong; University of Oxford; University of Hong Kong; University of Amsterdam; Academic Medical Center Amsterdam	Buchy, P (corresponding author), Inst Pasteur Cambodia, Phnom Penh, Cambodia.	pbuchy@pasteur-kh.org	Garcia, Jean-Michel/J-7166-2013; Simmons, Cameron P/ABA-3896-2021; Farrar, Jeremy J./HGA-7610-2022; Chu, Simon/AAJ-7802-2020	Garcia, Jean-Michel/0000-0002-6005-9982; Simmons, Cameron P/0000-0002-9039-7392; Chu, Simon/0000-0003-4658-215X; BUCHY, Philippe/0000-0003-1372-3008; Farrar, Jeremy/0000-0002-2700-623X	AFD; Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services; University Grants Committee, Hong Kong [AoE/M-12/06]; Wellcome Trust, UK	AFD; Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services; University Grants Committee, Hong Kong; Wellcome Trust, UK(Wellcome Trust)	This work was supported by a grant from the AFD (French Agency for Development, SISEA project, RESPARI program, http://www.pasteurinternational.org/ip/easysite/pasteur-international-en/scientific-activities/projects/all-our-projects/sisea), by the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, by the Area of Excellence Scheme of the University Grants Committee, Hong Kong (Grant AoE/M-12/06), and by the Wellcome Trust, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; Buchy P, 2007, J CLIN VIROL, V39, P164, DOI 10.1016/j.jcv.2007.04.010; Buchy P, 2009, EMERG INFECT DIS, V15, P1641, DOI 10.3201/eid1510.090115; Cavailler P, 2010, J CLIN VIROL, V48, P123, DOI 10.1016/j.jcv.2010.02.021; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dejpichai R, 2009, EMERG INFECT DIS, V15, P756, DOI 10.3201/eid1505.080316; FOX JP, 1982, AM J EPIDEMIOL, V116, P212, DOI 10.1093/oxfordjournals.aje.a113407; Garcia JM, 2010, J CLIN VIROL, V47, P29, DOI 10.1016/j.jcv.2009.10.009; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Hinjoy S, 2008, EMERG INFECT DIS, V14, P499, DOI 10.3201/eid1403.070662; Kitphati R, 2009, CLIN VACCINE IMMUNOL, V16, P978, DOI 10.1128/CVI.00062-09; Nefkens I, 2007, J CLIN VIROL, V39, P27, DOI 10.1016/j.jcv.2007.02.005; Ortiz JR, 2007, J INFECT DIS, V196, P1685, DOI 10.1086/522158; REED LJ, 1938, AM J HYG, V27; Stephenson I, 2009, EMERG INFECT DIS, V15, P1250, DOI 10.3201/eid1508.081754; Takano R, 2009, ARCH VIROL, V154, P677, DOI 10.1007/s00705-009-0353-5; Vincent AL, 2008, ADV VIRUS RES, V72, P127, DOI 10.1016/S0065-3527(08)00403-X; Vong S, 2006, EMERG INFECT DIS, V12, P1542, DOI 10.3201/eid1210.060424; Vong S, 2009, J INFECT DIS, V199, P1744, DOI 10.1086/599208; *WHO, REC LAB PROC DET AV; World Health Organization, CUM NUMB CONF HUM CA	26	58	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10864	10.1371/journal.pone.0010864	http://dx.doi.org/10.1371/journal.pone.0010864			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20532246	Green Published, gold			2022-12-27	WOS:000278221900014
J	Carlin, S; Khan, N; Ku, T; Longo, VA; Larson, SM; Smith-Jones, PM				Carlin, Sean; Khan, Nahida; Ku, Thomas; Longo, Valerie A.; Larson, Steve M.; Smith-Jones, Peter M.			Molecular Targeting of Carbonic Anhydrase IX in Mice with Hypoxic HT29 Colorectal Tumor Xenografts	PLOS ONE			English	Article							RADIOLABELED MONOCLONAL-ANTIBODIES; RENAL-CELL CARCINOMA; IN-VITRO; MODELING ANALYSIS; INTRINSIC MARKER; POOR-PROGNOSIS; SOLID TUMORS; LUNG-CANCER; NECK-CANCER; NUDE-MICE	Background: Carbonic anhydrase IX (CAIX) is a membrane spanning protein involved in the enzymatic regulation of tumor acid-base balance. CAIX has been shown to be elevated in a number of hypoxic tumor types. The purpose of this study was to determine the efficiency of intact and IgG fragments of cG250 to target CAIX in vivo in a hypoxic tumor model. Methodology/Principal Findings: Conventional biodistribution studies were performed with In-111-DO3A-cG250, In-111-DO3A-F(ab')(2)-cG250 and In-111-DO3A-Fab-cG250. Additional ex vivo analysis of the tumor was performed with markers for tumor hypoxia, blood perfusion and endogenous CAIX expression. All four data sets were digitally correlated to determine the optimal agent for determining hypoxia in a HT29 colon cancer xenograft. The HT29 human colorectal tumor xenografts show strong CAIX expression in hypoxic areas of poor blood perfusion. The intact IgG had an initial high focal uptake at the periphery of these hypoxic regions and penetration into the areas of highest CAIX expression over the 7-day study period. The lower molecular weight antibody fragments had a faster uptake into areas of high CAIX expression, but had a much lower absolute uptake at the optimal imaging times. Conclusions/Significance: For the clinical detection of hypoxia induced CAIX using cG250 antibody based agents, imaging with the intact IgG at 7 days post injection would allow for the most sensitive and accurate detection of CAIX.	[Carlin, Sean; Khan, Nahida; Ku, Thomas; Longo, Valerie A.; Larson, Steve M.; Smith-Jones, Peter M.] Mem Sloan Kettering Canc Serv, Dept Radiol, New York, NY 10021 USA; [Carlin, Sean] Mem Sloan Kettering Canc Serv, Dept Med Phys, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Carlin, S (corresponding author), Mem Sloan Kettering Canc Serv, Dept Radiol, New York, NY 10021 USA.	smithjop@mskcc.org		Carlin, Sean/0000-0002-5401-0648	National Institutes of Health [P01 CA033049, P01 CA115675, P50 CA086438]; Byrne Foundation; Geoffrey Beene Cancer Research Foundation; NATIONAL CANCER INSTITUTE [P01CA033049, P01CA115675, P50CA086438] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Byrne Foundation; Geoffrey Beene Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health grants P01 CA033049, P01 CA115675 and P50 CA086438. In addition Dr Carlin was funded in part by generous grants from the Byrne Foundation and the Geoffrey Beene Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUCHEGGER F, 1983, J EXP MED, V158, P413, DOI 10.1084/jem.158.2.413; Bui MHT, 2003, CLIN CANCER RES, V9, P802; Chia SK, 2001, J CLIN ONCOL, V19, P3660, DOI 10.1200/JCO.2001.19.16.3660; Chrastina A, 2003, INT J CANCER, V105, P873, DOI 10.1002/ijc.11142; Colcher D, 1998, Q J NUCL MED, V42, P225; Divgi CR, 2007, LANCET ONCOL, V8, P304, DOI 10.1016/S1470-2045(07)70044-X; Driessen A, 2006, ANN SURG, V243, P334, DOI 10.1097/01.sla.0000201452.09591.f3; DVORAK HF, 1988, AM J PATHOL, V133, P95; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; FUJIMORI K, 1989, CANCER RES, V49, P5656; Giatromanolaki A, 2001, CANCER RES, V61, P7992; Grabmaier K, 2004, ONCOGENE, V23, P5624, DOI 10.1038/sj.onc.1207764; He FQ, 2008, CANCER RES, V68, P8597, DOI 10.1158/0008-5472.CAN-08-0677; Hussain SA, 2004, ONCOL REP, V11, P1005; Javela S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-1; JUWEID M, 1992, CANCER RES, V52, P5144; Kivela AJ, 2005, WORLD J GASTROENTERO, V11, P155, DOI 10.3748/wjg.v11.i2.155; Korkeila E, 2009, BRIT J CANCER, V100, P874, DOI 10.1038/sj.bjc.6604949; Koukourakis MI, 2001, CLIN CANCER RES, V7, P3399; Koukourakis MI, 2006, J CLIN ONCOL, V24, P727, DOI 10.1200/JCO.2005.02.7474; LAWRENTSCHUK N, 2009, UROL ONCOL; Li XF, 2007, CANCER RES, V67, P7646, DOI 10.1158/0008-5472.CAN-06-4353; LINDMO T, 1984, J IMMUNOL METHODS, V72, P77, DOI 10.1016/0022-1759(84)90435-6; Loncaster JA, 2001, CANCER RES, V61, P6394; Pantuck AJ, 2003, CLIN CANCER RES, V9, P4641; Pastorekova S, 1997, GASTROENTEROLOGY, V112, P398, DOI 10.1053/gast.1997.v112.pm9024293; Potter C, 2004, CELL CYCLE, V3, P164; Saarnio J, 2001, J HEPATOL, V35, P643, DOI 10.1016/S0168-8278(01)00193-3; Said HM, 2007, RADIOTHER ONCOL, V83, P398, DOI 10.1016/j.radonc.2007.05.003; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Smith-Jones PM, 2000, CANCER RES, V60, P5237; Smith-Jones PM, 2004, METHOD ENZYMOL, V386, P262; Swinson DEB, 2003, J CLIN ONCOL, V21, P473, DOI 10.1200/JCO.2003.11.132; Wouters A, 2007, ONCOLOGIST, V12, P690, DOI 10.1634/theoncologist.12-6-690; Wykoff CC, 2000, CANCER RES, V60, P7075; YOKOTA T, 1992, CANCER RES, V52, P3402	37	49	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2010	5	5							e10857	10.1371/journal.pone.0010857	http://dx.doi.org/10.1371/journal.pone.0010857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QA	20523727	Green Submitted, Green Published, gold			2022-12-27	WOS:000278221900009
J	De Luca, M; Klimentidis, YC; Casazza, K; Chambers, MM; Cho, R; Harbison, ST; Jumbo-Lucioni, P; Zhang, SY; Leips, J; Fernandez, JR				De Luca, Maria; Klimentidis, Yann C.; Casazza, Krista; Chambers, Michelle Moses; Cho, Ruth; Harbison, Susan T.; Jumbo-Lucioni, Patricia; Zhang, Shaoyan; Leips, Jeff; Fernandez, Jose R.			A Conserved Role for Syndecan Family Members in the Regulation of Whole-Body Energy Metabolism	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; INSULIN-LIKE PEPTIDES; HEPARAN-SULFATE PROTEOGLYCAN; GENE DISRUPTION PROJECT; DROSOPHILA-MELANOGASTER; LIFE-SPAN; SKELETAL-MUSCLE; SUSCEPTIBILITY LOCUS; AFFECTING LONGEVITY; STRESS RESISTANCE	Syndecans are a family of type-I transmembrane proteins that are involved in cell-matrix adhesion, migration, neuronal development, and inflammation. Previous quantitative genetic studies pinpointed Drosophila Syndecan (dSdc) as a positional candidate gene affecting variation in fat storage between two Drosophila melanogaster strains. Here, we first used quantitative complementation tests with dSdc mutants to confirm that natural variation in this gene affects variability in Drosophila fat storage. Next, we examined the effects of a viable dSdc mutant on Drosophila whole-body energy metabolism and associated traits. We observed that young flies homozygous for the dSdc mutation had reduced fat storage and slept longer than homozygous wild-type flies. They also displayed significantly reduced metabolic rate, lower expression of spargel (the Drosophila homologue of PGC-1), and reduced mitochondrial respiration. Compared to control flies, dSdc mutants had lower expression of brain insulin-like peptides, were less fecund, more sensitive to starvation, and had reduced life span. Finally, we tested for association between single nucleotide polymorphisms (SNPs) in the human SDC4 gene and variation in body composition, metabolism, glucose homeostasis, and sleep traits in a cohort of healthy early pubertal children. We found that SNP rs4599 was significantly associated with resting energy expenditure (P = 0.001 after Bonferroni correction) and nominally associated with fasting glucose levels (P = 0.01) and sleep duration (P = 0.044). On average, children homozygous for the minor allele had lower levels of glucose, higher resting energy expenditure, and slept shorter than children homozygous for the common allele. We also observed that SNP rs1981429 was nominally associated with lean tissue mass (P = 0.035) and intra-abdominal fat (P = 0.049), and SNP rs2267871 with insulin sensitivity (P = 0.037). Collectively, our results in Drosophila and humans argue that syndecan family members play a key role in the regulation of body metabolism.	[De Luca, Maria; Casazza, Krista; Chambers, Michelle Moses; Jumbo-Lucioni, Patricia; Zhang, Shaoyan; Fernandez, Jose R.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [De Luca, Maria; Fernandez, Jose R.] Univ Alabama Birmingham, Nutr & Obes Res Ctr, Birmingham, AL 35294 USA; [De Luca, Maria; Fernandez, Jose R.] Univ Alabama Birmingham, Diabet Res Training Ctr, Birmingham, AL 35294 USA; [Klimentidis, Yann C.] Univ Alabama Birmingham, Sect Stat Genet, Dept Biostat, Birmingham, AL 35294 USA; [Cho, Ruth; Leips, Jeff] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA; [Harbison, Susan T.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University System of Maryland; University of Maryland Baltimore County; University of North Carolina; North Carolina State University	De Luca, M (corresponding author), Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA.	mdeluca2@uab.edu	Leips, Jeff/AAK-6676-2021; Klimentidis, Yann/B-2348-2015; Harbison, Susan T/P-2577-2016	Klimentidis, Yann/0000-0002-6065-4044; Harbison, Susan T/0000-0001-7233-0947; Leips, Jeff/0000-0001-8999-6630; De Luca, Maria/0000-0001-6345-7508; Jumbo-Lucioni, Patricia/0000-0003-0266-5498	U.S. National Institutes of Health [P30-DK56336, P60-DK0797626, R01HL80812, R01DK084219, R01DK067426]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067426, R01DK084219, P30DK056336] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health Grants P30-DK56336 (Nutrition Obesity Research Center), P60-DK0797626 (Diabetes Research and Training Center's Bioanalytical Redox Biology Core), R01HL80812 (to MD and JL), R01DK084219 (to MD and JL), and R01DK067426 (to JF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bauer JH, 2007, P NATL ACAD SCI USA, V104, P13355, DOI 10.1073/pnas.0706121104; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; Bisht B, 2007, DIABETOLOGIA, V50, P1058, DOI 10.1007/s00125-007-0591-6; Bray MS, 2007, OBES REV, V8, P169, DOI 10.1111/j.1467-789X.2006.00277.x; Bray MS, 2009, OBES REV, V10, P6, DOI 10.1111/j.1467-789X.2009.00684.x; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Broughton S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003721; Buch S, 2008, CELL METAB, V7, P321, DOI 10.1016/j.cmet.2008.02.012; Carskadon MA, 2002, SLEEP, V25, P606, DOI 10.1093/sleep/25.6.606; CASAZZA K, 2009, OBESITY  SILVER SPRI, V17, P1313; Chen LG, 2004, J BIOL CHEM, V279, P15715, DOI 10.1074/jbc.C300430200; CHO I, 2010, DNA CELL BIOL   0522; Cirelli C, 2005, J NEUROCHEM, V94, P1411, DOI 10.1111/j.1471-4159.2005.03291.x; CLARK AG, 1988, GENETICS, V119, P595; Comuzzie AG, 1998, SCIENCE, V280, P1374, DOI 10.1126/science.280.5368.1374; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Couchman JR, 2001, INT REV CYTOL, V207, P113; Cox D. R., 1984, ANAL SURVIVAL DATA; De Luca M, 2005, OBES RES, V13, P1596, DOI 10.1038/oby.2005.196; De Luca M, 2003, NAT GENET, V34, P429, DOI 10.1038/ng1218; De Luca M, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-52; DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09; Divers J, 2007, GENETICS, V176, P1823, DOI 10.1534/genetics.107.075408; Drysdale RA, 2005, NUCLEIC ACIDS RES, V33, pD390, DOI 10.1093/nar/gki046; Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130; Fernandez JR, 2003, OBES RES, V11, P904, DOI 10.1038/oby.2003.124; FLEGAL KM, 2010, JAMA-J AM MED ASSOC, V235, P1999; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P2198, DOI 10.1073/pnas.96.5.2198; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; HANIS CL, 1986, TEXAS AM J PHYS ANTH, V70, P433; Harbison ST, 2008, GENETICS, V178, P2341, DOI 10.1534/genetics.107.081232; Harbison ST, 2009, NAT GENET, V41, P371, DOI 10.1038/ng.330; Hendricks JC, 2001, NAT NEUROSCI, V4, P1108, DOI 10.1038/nn743; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Hunter GR, 2000, AM J CLIN NUTR, V71, P500; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Ji LN, 1997, DIABETES, V46, P876, DOI 10.2337/diabetes.46.5.876; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; KOJIMA T, 1993, BIOCHEM BIOPH RES CO, V190, P814, DOI 10.1006/bbrc.1993.1122; Kolset SO, 1999, CELL MOL LIFE SCI, V56, P857, DOI 10.1007/s000180050031; Korner J, 2009, AM J MED, V122, pS12, DOI 10.1016/j.amjmed.2009.01.003; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Leips J, 2006, GENETICS, V172, P1595, DOI 10.1534/genetics.105.048520; Leopold P, 2007, NATURE, V450, P186, DOI 10.1038/nature06286; MATTHEWS DR, 1990, DIABETIC MED, V7, P246, DOI 10.1111/j.1464-5491.1990.tb01379.x; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Nuzhdin SV, 1997, P NATL ACAD SCI USA, V94, P9734, DOI 10.1073/pnas.94.18.9734; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; PACINI G, 1986, COMPUT METH PROG BIO, V23, P113, DOI 10.1016/0169-2607(86)90106-9; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Pasyukova EG, 2000, GENETICS, V156, P1129; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Rostand KS, 1997, INFECT IMMUN, V65, P1; Roy JLP, 2006, AM J HUM BIOL, V18, P454, DOI 10.1002/ajhb.20509; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Silventoinen K, 2010, INT J OBESITY, V34, P29, DOI 10.1038/ijo.2009.177; Spradling AC, 1999, GENETICS, V153, P135; SPRING J, 1994, P NATL ACAD SCI USA, V91, P3334, DOI 10.1073/pnas.91.8.3334; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505; Ten S, 2008, J PEDIATR ENDOCR MET, V21, P359; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; Tiefenbock SK, 2010, EMBO J, V29, P171, DOI 10.1038/emboj.2009.330; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Van Voorhies WA, 2004, J APPL PHYSIOL, V97, P1915, DOI 10.1152/japplphysiol.00505.2004; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Weinsier RL, 2000, AM J CLIN NUTR, V71, P1138; Weinsier RL, 2002, AM J CLIN NUTR, V75, P499, DOI 10.1093/ajcn/75.3.499; Wilcox-Adelman SA, 2002, J BIOL CHEM, V277, P32970, DOI 10.1074/jbc.M201283200; Woods A, 2001, J CLIN INVEST, V107, P935, DOI 10.1172/JCI12802; Zepelin H, 1994, PRINCIPLES PRACTICE, P69; Zhang H, 2009, P NATL ACAD SCI USA, V106, P19617, DOI 10.1073/pnas.0905083106; Zouali H, 1997, HUM MOL GENET, V6, P1401, DOI 10.1093/hmg/6.9.1401; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	91	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11286	10.1371/journal.pone.0011286	http://dx.doi.org/10.1371/journal.pone.0011286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585652	Green Published, Green Submitted, gold			2022-12-27	WOS:000279135400028
J	Tang, SY; Xiao, YN; Yang, YP; Zhou, YC; Wu, JH; Ma, ZE				Tang, Sanyi; Xiao, Yanni; Yang, Youping; Zhou, Yicang; Wu, Jianhong; Ma, Zhien			Community-Based Measures for Mitigating the 2009 H1N1 Pandemic in China	PLOS ONE			English	Article							INFLUENZA; INTERVENTIONS; MODELS; VIRUS	Since the emergence of influenza A/H1N1 pandemic virus in March-April 2009, very stringent interventions including Fengxiao were implemented to prevent importation of infected cases and decelerate the disease spread in mainland China. The extent to which these measures have been effective remains elusive. We sought to investigate the effectiveness of Fengxiao that may inform policy decisions on improving community-based interventions for management of on-going outbreaks in China, in particular during the Spring Festival in mid-February 2010 when nationwide traveling will be substantially increased. We obtained data on initial laboratory-confirmed cases of H1N1 in the province of Shaanxi and used Markov-chain Monte-Carlo (MCMC) simulations to estimate the reproduction number. Given the estimates for the exposed and infectious periods of the novel H1N1 virus, we estimated a mean reproduction number of 1.68 (95% CI 1.45-1.92) and other A/H1N1 epidemiological parameters. Our results based on a spatially stratified population dynamical model show that the early implementation of Fengxiao can delay the epidemic peak significantly and prevent the disease spread to the general population but may also, if not implemented appropriately, cause more severe outbreak within universities/ colleges, while late implementation of Fengxiao can achieve nothing more than no implementation. Strengthening local control strategies (quarantine and hygiene precaution) is much more effective in mitigating outbreaks and inhibiting the successive waves than implementing Fengxiao. Either strong mobility or high transport-related transmission rate during the Spring Festival holiday will not reverse the ongoing outbreak, but both will result in a large new wave. The findings suggest that Fengxiao and travel precautions should not be relaxed unless strict measures of quarantine, isolation, and hygiene precaution practices are put in place. Integration and prompt implementation of these interventions can significantly reduce the overall attack rate of pandemic outbreaks.	[Tang, Sanyi] Shaanxi Normal Univ, Coll Math & Informat Sci, Xian, Peoples R China; [Xiao, Yanni; Yang, Youping; Zhou, Yicang; Ma, Zhien] Xi An Jiao Tong Univ, Dept Appl Math, Xian 710049, Peoples R China; [Wu, Jianhong] York Univ, Ctr Dis Modeling, Toronto, ON M3J 2R7, Canada	Shaanxi Normal University; Xi'an Jiaotong University; York University - Canada	Tang, SY (corresponding author), Shaanxi Normal Univ, Coll Math & Informat Sci, Xian, Peoples R China.	zhma@mail.xjtu.edu.cn	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	National Natural Science Foundation of China (NSFC) [10871122, 10701062]; Program for New Century Excellent Talents in University [NCET-08-0430]; Mathematics of Information Technology and Complex Systems (MITACS); Communications Research Centre Canada; Natural Sciences and Engineering Research Council of Canada (NSERC); GEOmatics for Informed DEcisions (GEOIDE); Communications Research Centre Canada-International Development Research Centre (CRC-IDRC)	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Mathematics of Information Technology and Complex Systems (MITACS); Communications Research Centre Canada; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); GEOmatics for Informed DEcisions (GEOIDE); Communications Research Centre Canada-International Development Research Centre (CRC-IDRC)	This work was partially supported by the National Natural Science Foundation of China (NSFC), 10871122 (ST) and 10701062 (YX), and by the Program for New Century Excellent Talents in University (NCET-08-0430, YX). This work was also partially supported by Mathematics of Information Technology and Complex Systems (MITACS), Communications Research Centre Canada, Natural Sciences and Engineering Research Council of Canada (NSERC), and GEOmatics for Informed DEcisions (GEOIDE) (JWU) and by the Canada-China collaboration on disease modeling, as well as funded by the Communications Research Centre Canada-International Development Research Centre (CRC-IDRC) International Research Chair Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Day T, 2006, AM J EPIDEMIOL, V163, P479, DOI 10.1093/aje/kwj056; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559; LEVIN SA, 1974, AM NAT, V108, P207, DOI 10.1086/282900; NISHIURA H, 2009, NZ MED J, V122; PEREZTRALLERO E, 2009, EURO SURVEILL, V14; TUITE AR, 2009, CMAJ, DOI DOI 10.1503/CMAJ091807; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Wallinga J, 2010, P NATL ACAD SCI USA, V107, P923, DOI 10.1073/pnas.0908491107; Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; 2010, NATIONWIDE TRAVEL SP; 2009, REPORT POLICY; 2009, FENGXIAO STRATEGY	21	58	61	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e10911	10.1371/journal.pone.0010911	http://dx.doi.org/10.1371/journal.pone.0010911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585565	Green Published, Green Submitted, gold			2022-12-27	WOS:000278977200001
J	Mehla, R; Bivalkar-Mehla, S; Zhang, RN; Handy, I; Albrecht, H; Giri, S; Nagarkatti, P; Nagarkatti, M; Chauhan, A				Mehla, Rajeev; Bivalkar-Mehla, Shalmali; Zhang, Ruonan; Handy, Indhira; Albrecht, Helmut; Giri, Shailendra; Nagarkatti, Prakash; Nagarkatti, Mitzi; Chauhan, Ashok			Bryostatin Modulates Latent HIV-1 Infection via PKC and AMPK Signaling but Inhibits Acute Infection in a Receptor Independent Manner	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; KINASE-C-ZETA; T-CELLS; IN-VIVO; VALPROIC ACID; UP-REGULATION; VIRAL LOAD; EXPRESSION; RESERVOIR	HIV's ability to establish long-lived latent infection is mainly due to transcriptional silencing in resting memory T lymphocytes and other non dividing cells including monocytes. Despite an undetectable viral load in patients treated with potent antiretrovirals, current therapy is unable to purge the virus from these latent reservoirs. In order to broaden the inhibitory range and effectiveness of current antiretrovirals, the potential of bryostatin was investigated as an HIV inhibitor and latent activator. Bryostatin revealed antiviral activity against R5- and X4-tropic viruses in receptor independent and partly via transient decrease in CD4/CXCR4 expression. Further, bryostatin at low nanomolar concentrations robustly reactivated latent viral infection in monocytic and lymphocytic cells via activation of Protein Kinase C (PKC) -alpha and -delta, because PKC inhibitors rottlerin and GF109203X abrogated the bryostatin effect. Bryostatin specifically modulated novel PKC (nPKC) involving stress induced AMP Kinase (AMPK) inasmuch as an inhibitor of AMPK, compound C partially ablated the viral reactivation effect. Above all, bryostatin was non-toxic in vitro and was unable to provoke T-cell activation. The dual role of bryostatin on HIV life cycle may be a beneficial adjunct to the treatment of HIV especially by purging latent virus from different cellular reservoirs such as brain and lymphoid organs.	[Mehla, Rajeev; Bivalkar-Mehla, Shalmali; Zhang, Ruonan; Handy, Indhira; Nagarkatti, Prakash; Nagarkatti, Mitzi; Chauhan, Ashok] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Albrecht, Helmut] Univ S Carolina, Sch Med, Dept Med, Columbia, SC 29208 USA; [Giri, Shailendra] Mayo Clin, Dept Expt Pathol, Rochester, MN USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Mayo Clinic	Mehla, R (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	Ashok.Chauhan@uscmed.sc.edu	Albrecht, Helmut/D-5319-2011	Nagarkatti, Prakash/0000-0003-2663-0759	National Institutes of Health [RO1 NS 050064, PO1AT003961]; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported with federal funds from National Institutes of Health grant RO1 NS 050064 (AC) and PO1AT003961 (PN and MN).	Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; ASIEDU C, 1995, CANCER RES, V55, P3716; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Banda N K, 1999, Biol Blood Marrow Transplant, V5, P162, DOI 10.1053/bbmt.1999.v5.pm10392962; Bedoya LM, 2009, BIOCHEM PHARMACOL, V77, P965, DOI 10.1016/j.bcp.2008.11.025; BOTO WMO, 1991, CELL REGUL, V2, P95, DOI 10.1091/mbc.2.2.95; Brown A, 2006, J LEUKOCYTE BIOL, V80, P1127, DOI 10.1189/jlb.0206126; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chauhan A, 2003, J BIOL CHEM, V278, P13512, DOI 10.1074/jbc.M209381200; Chauhan A, 2007, FASEB J, V21, P777, DOI 10.1096/fj.06-7054com; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Das SR, 2005, INDIAN J MED RES, V121, P315; Davidson SK, 2001, APPL ENVIRON MICROB, V67, P4531, DOI 10.1128/AEM.67.10.4531-4537.2001; Do Y, 2004, CANCER RES, V64, P6756, DOI 10.1158/0008-5472.CAN-03-4002; Duvic M, 2007, BLOOD, V109, P31, DOI 10.1182/blood-2006-06-025999; Edelstein LC, 2009, AIDS RES HUM RETROV, V25, P883, DOI 10.1089/aid.2008.0294; ESA AH, 1990, INT J IMMUNOPHARMACO, V12, P481, DOI 10.1016/0192-0561(90)90110-9; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Folgueira L, 1996, J VIROL, V70, P223, DOI 10.1128/JVI.70.1.223-231.1996; Geeraert L, 2008, ANNU REV MED, V59, P487, DOI 10.1146/annurev.med.59.062806.123001; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; He X, 2008, CANCER RES, V68, P8678, DOI 10.1158/0008-5472.CAN-08-0294; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; Jones J, 2005, VIROLOGY, V331, P106, DOI 10.1016/j.virol.2004.10.013; Kulkosky J, 2001, BLOOD, V98, P3006, DOI 10.1182/blood.V98.10.3006; Kutsch O, 2002, J VIROL, V76, P8776, DOI 10.1128/JVI.76.17.8776-8786.2002; Lambotte O, 2000, J ACQ IMMUN DEF SYND, V23, P114; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Lewinski MK, 2005, ADV GENET, V55, P147, DOI 10.1016/S0065-2660(05)55005-3; LINT CV, 1996, EMBO J, V15, P1112; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; MANN DL, 1990, J IMMUNOL, V144, P2152; Margolis David M., 2006, Infectious Disorders - Drug Targets, V6, P369, DOI 10.2174/187152606779025824; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Martelli AM, 2003, HISTOL HISTOPATHOL, V18, P1301, DOI 10.14670/HH-18.1301; MATTHES E, 1990, ANTIVIR RES, V13, P273, DOI 10.1016/0166-3542(90)90012-V; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Nekhai S, 2002, BIOCHEM J, V364, P649, DOI 10.1042/BJ20011191; Nelson TJ, 2009, TRENDS BIOCHEM SCI, V34, P136, DOI 10.1016/j.tibs.2008.11.006; Nishino Y, 2004, CARDIOVASC RES, V61, P610, DOI 10.1016/j.cardiores.2003.10.022; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; PETTIT GR, 1984, J AM CHEM SOC, V106, P6768, DOI 10.1021/ja00334a050; Pierson T, 2000, J VIROL, V74, P7824, DOI 10.1128/JVI.74.17.7824-7833.2000; REUSE S, 2009, PLOS, V4, P1; Sagot-Lerolle N, 2008, AIDS, V22, P1125, DOI 10.1097/QAD.0b013e3282fd6ddc; SAJAN MP, 2009, AM J PHYSIOL-ENDOC M, DOI DOI 10.1152/AJPENDO.00392; Scripture-Adams DD, 2002, J VIROL, V76, P13077, DOI 10.1128/JVI.76.24.13077-13082.2002; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Smith L, 2000, J BIOL CHEM, V275, P40620, DOI 10.1074/jbc.M908517199; STANLEY SK, 1992, J IMMUNOL, V149, P689; Steel A, 2006, AIDS, V20, P1681, DOI 10.1097/01.aids.0000238421.36313.fa; Sundstrom JB, 2007, BLOOD, V109, P5293, DOI 10.1182/blood-2006-11-058438; THEOPHILUS SV, 2008, VIROLOGY, V381, P1; Thiebot H, 2001, J VIROL, V75, P11594, DOI 10.1128/JVI.75.23.11594-11602.2001; Wang FX, 2005, J CLIN INVEST, V115, P128, DOI 10.1172/JCI200522574; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Wolf D, 2008, VIROLOGY, V370, P45, DOI 10.1016/j.virol.2007.08.015; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yang HC, 2009, J CLIN INVEST, V119, P3473, DOI 10.1172/JCI39199; Zhu TF, 2002, J VIROL, V76, P707, DOI 10.1128/JVI.76.2.707-716.2002	69	174	180	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11160	10.1371/journal.pone.0011160	http://dx.doi.org/10.1371/journal.pone.0011160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585398	Green Published, Green Submitted, gold			2022-12-27	WOS:000278886100021
J	von Kraus, LM; Sacktor, TC; Francis, JT				von Kraus, Lee Michael; Sacktor, Todd Charlton; Francis, Joseph Thachil			Erasing Sensorimotor Memories via PKM zeta Inhibition	PLOS ONE			English	Article							PROTEIN-KINASE-C; MOTOR CORTEX; MOVEMENT REPRESENTATIONS; SKILL; RAT; CONSOLIDATION; REORGANIZATION; SYNAPTOGENESIS; MAINTENANCE; EXPRESSION	Sensorimotor cortex has a role in procedural learning. Previous studies suggested that this learning is subserved by long-term potentiation (LTP), which is in turn maintained by the persistently active kinase, protein kinase Mzeta (PKM zeta). Whereas the role of PKMf in animal models of declarative knowledge is established, its effect on procedural knowledge is not well understood. Here we show that PKMf inhibition, via injection of zeta inhibitory peptide (ZIP) into the rat sensorimotor cortex, disrupts sensorimotor memories for a skilled reaching task even after several weeks of training. The rate of relearning the task after the memory disruption by ZIP was indistinguishable from the rate of initial learning, suggesting no significant savings after the memory loss. These results indicate a shared molecular mechanism of storage for declarative and procedural forms of memory.	[von Kraus, Lee Michael] SUNY Hlth Sci Ctr, Grad Program Neural & Behav Sci, Brooklyn, NY 11203 USA; [Sacktor, Todd Charlton; Francis, Joseph Thachil] SUNY Hlth Sci Ctr, Robert Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA; [Sacktor, Todd Charlton; Francis, Joseph Thachil] SUNY Hlth Sci Ctr, Dept Physiol, Brooklyn, NY 11203 USA; [Sacktor, Todd Charlton; Francis, Joseph Thachil] SUNY Hlth Sci Ctr, Dept Pharmacol, Brooklyn, NY 11203 USA; [Sacktor, Todd Charlton] SUNY Hlth Sci Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Francis, Joseph Thachil] SUNY Hlth Sci Ctr, Grad Program Biomed Engn, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	von Kraus, LM (corresponding author), SUNY Hlth Sci Ctr, Grad Program Neural & Behav Sci, Brooklyn, NY 11203 USA.	Joe.francis@downstate.edu	Francis, Joseph T/I-4984-2012		New York State Spinal Cord Injury Research Board [C022048, C023682]; National Academies Keck Futures Initiative [N66001-10-C-2008]; Downstate Medical Center; NIH [R01 MH53576, MH57068]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057068, R37MH057068, R01MH053576] Funding Source: NIH RePORTER	New York State Spinal Cord Injury Research Board; National Academies Keck Futures Initiative; Downstate Medical Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the New York State Spinal Cord Injury Research Board (www.health.state.ny.us) Grants C022048, C023682, National Academies Keck Futures Initiative (www.keckfutures.org) Grant NAKFI SP09, DARPA (www.darpa.mil) Contract #N66001-10-C-2008, Downstate Medical Center (www.downstate.edu) Dean's Initiative Research Grant (J.T.F.), and NIH (www.nih.gov) R01 MH53576 and MH57068 (T.C.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Byl NN, 1997, PHYS THER, V77, P269, DOI 10.1093/ptj/77.3.269; Caithness G, 2004, J NEUROSCI, V24, P8662, DOI 10.1523/JNEUROSCI.2214-04.2004; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Crary JF, 2006, J NEUROPATH EXP NEUR, V65, P319, DOI 10.1097/01.jnen.0000218442.07664.04; Criscimagna-Hemminger SE, 2008, J NEUROSCI, V28, P9610, DOI 10.1523/JNEUROSCI.3071-08.2008; Kleim JA, 2003, NEURON, V40, P167, DOI 10.1016/S0896-6273(03)00592-0; Kleim JA, 2002, NEUROBIOL LEARN MEM, V77, P63, DOI 10.1006/nlme.2000.4004; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; Kleim JA, 1996, J NEUROSCI, V16, P4529; Lenz FA, 1999, J NEUROPHYSIOL, V82, P3204, DOI 10.1152/jn.1999.82.6.3204; Monfils MH, 2004, CEREB CORTEX, V14, P586, DOI 10.1093/cercor/bhh020; Naik MU, 2000, J COMP NEUROL, V426, P243, DOI 10.1002/1096-9861(20001016)426:2<243::AID-CNE6>3.0.CO;2-8; Oster H, 2004, MOL BRAIN RES, V127, P79, DOI 10.1016/j.molbrainres.2004.05.009; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PETERSON GM, 1932, COMP PSYCHOL MONOGRA, V9; Remple MS, 2001, BEHAV BRAIN RES, V123, P133, DOI 10.1016/S0166-4328(01)00199-1; Rioult-Pedotti MS, 2007, J NEUROPHYSIOL, V98, P3688, DOI 10.1152/jn.00164.2007; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; SHAO CY, 2009, SOC NEUR ANN M CHIC; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; Wang Y, 1998, BRAIN RES, V781, P137, DOI 10.1016/S0006-8993(97)01223-7; WHISHAW IQ, 1989, BEHAV BRAIN RES, V32, P11, DOI 10.1016/S0166-4328(89)80067-1; WHISHAW IQ, 1986, BRAIN, V109, P805, DOI 10.1093/brain/109.5.805	29	37	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11125	10.1371/journal.pone.0011125	http://dx.doi.org/10.1371/journal.pone.0011125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559553	Green Published, Green Submitted, gold			2022-12-27	WOS:000278775900015
J	Ryan, GJ; Hoff, DR; Driver, ER; Voskuil, MI; Gonzalez-Juarrero, M; Basaraba, RJ; Crick, DC; Spencer, JS; Lenaerts, AJ				Ryan, Gavin J.; Hoff, Donald R.; Driver, Emily R.; Voskuil, Martin I.; Gonzalez-Juarrero, Mercedes; Basaraba, Randall J.; Crick, Dean C.; Spencer, John S.; Lenaerts, Anne J.			Multiple M. tuberculosis Phenotypes in Mouse and Guinea Pig Lung Tissue Revealed by a Dual-Staining Approach	PLOS ONE			English	Article							MYCOBACTERIAL ACID-FASTNESS; DORMANT TUBERCLE-BACILLI; INTERFERON-GAMMA; ALPHA-CRYSTALLIN; GENE-EXPRESSION; IN-VITRO; NONREPLICATING PERSISTENCE; LATENT TUBERCULOSIS; STATIONARY-PHASE; BOVIS BCG	A unique hallmark of tuberculosis is the granulomatous lesions formed in the lung. Granulomas can be heterogeneous in nature and can develop a necrotic, hypoxic core which is surrounded by an acellular, fibrotic rim. Studying bacilli in this in vivo microenvironment is problematic as Mycobacterium tuberculosis can change its phenotype and also become acid-fast negative. Under in vitro models of differing environments, M. tuberculosis alters its metabolism, transcriptional profile and rate of replication. In this study, we investigated whether these phenotypic adaptations of M. tuberculosis are unique for certain environmental conditions and if they could therefore be used as differential markers. Bacilli were studied using fluorescent acid-fast auramine-rhodamine targeting the mycolic acid containing cell wall, and immunofluorescence targeting bacterial proteins using an anti-M. tuberculosis whole cell lysate polyclonal antibody. These techniques were combined and simultaneously applied to M. tuberculosis in vitro culture samples and to lung sections of M. tuberculosis infected mice and guinea pigs. Two phenotypically different subpopulations of M. tuberculosis were found in stationary culture whilst three subpopulations were found in hypoxic culture and in lung sections. Bacilli were either exclusively acid-fast positive, exclusively immunofluorescent positive or acid-fast and immunofluorescent positive. These results suggest that M. tuberculosis exists as multiple populations in most conditions, even within seemingly a single microenvironment. This is relevant information for approaches that study bacillary characteristics in pooled samples (using lipidomics and proteomics) as well as in M. tuberculosis drug development.	[Ryan, Gavin J.; Hoff, Donald R.; Driver, Emily R.; Gonzalez-Juarrero, Mercedes; Basaraba, Randall J.; Crick, Dean C.; Spencer, John S.; Lenaerts, Anne J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Voskuil, Martin I.] Univ Colorado, Sch Med, Denver, CO USA	Colorado State University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Ryan, GJ (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	lenaerts@colostate.edu	Crick, Dean/H-8251-2017; Lenaerts, Anne/F-1353-2017; Spencer, John S/G-6968-2017	Crick, Dean/0000-0001-9281-7058; Spencer, John S/0000-0002-8051-3038; gonzalez-juarrero, mercedes/0000-0002-4045-2365	National Institutes of Health (NIH) [RO-1 AI061505, NO1 AI-95385]; NIH, at CSU [NO1 AI-95385]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095385, R01AI061505] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, at CSU(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by the National Institutes of Health (NIH) grant RO-1 AI061505 and the NIH Contract NO1 AI-95385 at CSU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amand ALS, 2005, J CLIN MICROBIOL, V43, P5369, DOI 10.1128/JCM.43.10.5369-5371.2005; Basaraba RJ, 2008, TUBERCULOSIS, V88, pS35, DOI 10.1016/S1472-9792(08)70035-0; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Brandt L, 2004, INFECT IMMUN, V72, P6622, DOI 10.1128/IAI.72.11.6622-6632.2004; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cunningham AF, 1998, J BACTERIOL, V180, P801, DOI 10.1128/JB.180.4.801-808.1998; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; DELONG EF, 1989, SCIENCE, V243, P1360, DOI 10.1126/science.2466341; Desjardin LE, 2001, J BACTERIOL, V183, P5311, DOI 10.1128/JB.183.18.5311-5316.2001; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Dick T, 2001, J ANTIMICROB CHEMOTH, V47, P117, DOI 10.1093/jac/47.1.117; Fenhalls G, 2002, INFECT IMMUN, V70, P6330, DOI 10.1128/IAI.70.11.6330-6338.2002; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; GOREN MB, 1978, AM REV RESPIR DIS, V118, P151; Hanscheid T, 2007, LANCET INFECT DIS, V7, P236, DOI 10.1016/S1473-3099(07)70058-0; HARADA K, 1976, STAIN TECHNOL, V51, P255, DOI 10.3109/10520297609116714; Hoff DR, 2008, ANTIMICROB AGENTS CH, V52, P4137, DOI 10.1128/AAC.00196-08; Johnson CM, 2005, ANTIMICROB AGENTS CH, V49, P4335, DOI 10.1128/AAC.49.10.4335-4338.2005; Kelly BP, 1996, ANTIMICROB AGENTS CH, V40, P2809, DOI 10.1128/AAC.40.12.2809; KOJIMA K, 1989, AM J CLIN PATHOL, V92, P57, DOI 10.1093/ajcp/92.1.57; Kraft SL, 2004, INFECT IMMUN, V72, P5963, DOI 10.1128/IAI.72.10.5963-5971.2004; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lenaerts AJ, 2005, ANTIMICROB AGENTS CH, V49, P2294, DOI 10.1128/AAC.49.6.2294-2301.2005; Lenaerts AJ, 2008, TRENDS MICROBIOL, V16, P48, DOI 10.1016/j.tim.2007.12.002; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; McMurray DN, 2003, TUBERCULOSIS, V83, P131, DOI 10.1016/S1472-9792(02)00079-3; Murugasu-Oei B, 2000, J ANTIMICROB CHEMOTH, V46, P917, DOI 10.1093/jac/46.6.917; ORTALOMAGNE A, 1995, MICROBIOL-UK, V141, P1609, DOI 10.1099/13500872-141-7-1609; OSTER G, 1951, CR HEBD ACAD SCI, V232, P1708; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Pearl JE, 2001, CELL IMMUNOL, V211, P43, DOI 10.1006/cimm.2001.1819; Purohit MR, 2007, DIAGN PATHOL, V2, DOI 10.1186/1746-1596-2-36; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; RICHARDS OSCAR W., 1941, SCIENCE, V93, P190, DOI 10.1126/science.93.2408.190; Saunders BM, 2000, IMMUNOL CELL BIOL, V78, P334, DOI 10.1046/j.1440-1711.2000.00933.x; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Shapiro HM, 2008, J MICROBIOL METH, V74, P119, DOI 10.1016/j.mimet.2008.04.005; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; SMITH DW, 1991, TUBERCLE, V72, P223, DOI 10.1016/0041-3879(91)90013-I; Turner OC, 2003, GRANULOMATOUS INFECTIONS AND INFLAMMATIONS: CELLULAR AND MOLECULAR MECHANISMS, P65; Ulrichs T, 2005, J PATHOL, V205, P633, DOI 10.1002/path.1728; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Voskuil MI, 2004, TUBERCULOSIS, V84, P138, DOI 10.1016/j.tube.2003.12.008; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; *WHO, 2009, WHO REP 2009 GLOB TU; Yuan Y, 1998, MOL MICROBIOL, V29, P1449, DOI 10.1046/j.1365-2958.1998.01026.x; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291	58	59	60	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11108	10.1371/journal.pone.0011108	http://dx.doi.org/10.1371/journal.pone.0011108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559431	Green Published, gold, Green Submitted			2022-12-27	WOS:000278741100021
J	Todeschini, AL; Teysset, L; Delmarre, V; Ronsseray, S				Todeschini, Anne-Laure; Teysset, Laure; Delmarre, Valerie; Ronsseray, Stephane			The Epigenetic Trans-Silencing Effect in Drosophila Involves Maternally-Transmitted Small RNAs Whose Production Depends on the piRNA Pathway and HP1	PLOS ONE			English	Article							SMALL INTERFERING RNA; TELOMERIC P-ELEMENTS; DISTINCT CHROMATIN DOMAINS; HYBRID DYSGENESIS; CYTOTYPE REGULATION; SUBTELOMERIC HETEROCHROMATIN; ENDOGENOUS RETROVIRUS; TRANSPOSABLE ELEMENTS; TISSUE-SPECIFICITY; MELANOGASTER	Background: The study of P transposable element repression in Drosophila melanogaster led to the discovery of the Trans-Silencing Effect (TSE), a homology-dependent repression mechanism by which a P-transgene inserted in subtelomeric heterochromatin (Telomeric Associated Sequences, "TAS'') has the capacity to repress in trans, in the female germline, a homologous P-lacZ transgene located in euchromatin. Phenotypic and genetic analysis have shown that TSE exhibits variegation in ovaries, displays a maternal effect as well as epigenetic transmission through meiosis and involves heterochromatin (including HP1) and RNA silencing. Principal Findings: Here, we show that mutations in squash and zucchini, which are involved in the piwi-interacting RNA (piRNA) silencing pathway, strongly affect TSE. In addition, we carried out a molecular analysis of TSE and show that silencing is correlated to the accumulation of lacZ small RNAs in ovaries. Finally, we show that the production of these small RNAs is sensitive to mutations affecting squash and zucchini, as well as to the dose of HP1. Conclusions and Significance: Thus, our results indicate that the TSE represents a bona fide piRNA-based repression. In addition, the sensitivity of TSE to HP1 dose suggests that in Drosophila, as previously shown in Schizosaccharomyces pombe, a RNA silencing pathway can depend on heterochromatin components.	[Todeschini, Anne-Laure; Teysset, Laure; Delmarre, Valerie; Ronsseray, Stephane] Univ Paris 06, CNRS, Lab Biol Dev, UMR7622, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Todeschini, AL (corresponding author), Univ Paris Diderot, CNRS, Inst Jacques Monod, UMR7592, Paris, France.	stephane.ronsseray@snv.jussieu.fr	Ronsseray, Stephane/AAD-6378-2021	Teysset, Laure/0000-0002-7413-1850	Centre National de la Recherche Scientifique (Laboratoire de Biologie du Developpement - Unite Mixte de Recherche, Institut Jacques Monod - Unite Mixte de Recherche ) [7622, 7592]; Universite Pierre & Marie Curie - Paris; Universite Paris-Diderot - Paris; Action Concertee Incitative - Biologie Moleculaire et Structurale programme; Association pour la Recherche sur le Cancer; Fondation pour la Recherche Medicale	Centre National de la Recherche Scientifique (Laboratoire de Biologie du Developpement - Unite Mixte de Recherche, Institut Jacques Monod - Unite Mixte de Recherche )(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre & Marie Curie - Paris; Universite Paris-Diderot - Paris; Action Concertee Incitative - Biologie Moleculaire et Structurale programme; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Centre National de la Recherche Scientifique (Laboratoire de Biologie du Developpement - Unite Mixte de Recherche 7622 and Institut Jacques Monod - Unite Mixte de Recherche 7592), Universite Pierre & Marie Curie - Paris 6, Universite Paris-Diderot - Paris 7, Action Concertee Incitative - Biologie Moleculaire et Structurale programme and the Association pour la Recherche sur le Cancer. A. L. T. was supported by a post-doctoral fellowship from the Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyeva EN, 2005, J CELL SCI, V118, P5465, DOI 10.1242/jcs.02654; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; Biessmann H, 2005, GENETICS, V171, P1767, DOI 10.1534/genetics.105.048827; Blumenstiel JP, 2005, P NATL ACAD SCI USA, V102, P15965, DOI 10.1073/pnas.0508192102; Brasset E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-25; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; BUCHETON A, 1984, CELL, V38, P153, DOI 10.1016/0092-8674(84)90536-1; Chalvet F, 1999, EMBO J, V18, P2659, DOI 10.1093/emboj/18.9.2659; Chambeyron S, 2008, P NATL ACAD SCI USA, V105, P14964, DOI 10.1073/pnas.0805943105; COEN D, 1994, GENETICA, V93, P61, DOI 10.1007/BF01435240; Cryderman DE, 1999, EMBO J, V18, P3724, DOI 10.1093/emboj/18.13.3724; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Desset S, 2003, GENETICS, V164, P501; Desset S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001526; Dramard X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000304; EISSENBERG JC, 1992, GENETICS, V131, P345; ENGELS WR, 1979, GENET RES, V33, P219, DOI 10.1017/S001667230001836X; ENGELS WR, 1979, P NATL ACAD SCI USA, V76, P4011, DOI 10.1073/pnas.76.8.4011; ENGELS WR, 1989, P ELEMENTS DROSOPHIL, P437; FAGEGALTIER D, 2009, P NATL ACAD SCI US; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Frydrychova RC, 2008, GENETICS, V180, P121, DOI 10.1534/genetics.108.090647; Girard A, 2008, TRENDS CELL BIOL, V18, P136, DOI 10.1016/j.tcb.2008.01.004; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Haley KJ, 2005, GENETICS, V171, P583, DOI 10.1534/genetics.102.001594; Jensen S, 1999, NAT GENET, V21, P209, DOI 10.1038/5997; Josse T, 2007, PLOS GENET, V3, P1633, DOI 10.1371/journal.pgen.0030158; Josse T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003249; KARPEN GH, 1992, GENETICS, V132, P737; KIDWELL MG, 1977, GENETICS, V86, P813; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Klenov MS, 2007, NUCLEIC ACIDS RES, V35, P5430, DOI 10.1093/nar/gkm576; LASKI FA, 1986, CELL, V44, P7, DOI 10.1016/0092-8674(86)90480-0; LEMAITRE B, 1993, GENETICS, V135, P149; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Marin L, 2000, GENETICS, V155, P1841; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; PELISSON A, 1994, EMBO J, V13, P4401, DOI 10.1002/j.1460-2075.1994.tb06760.x; Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06; PICARD G, 1978, GENET RES, V32, P275, DOI 10.1017/S0016672300018772; Reiss D, 2004, MOL GENET GENOMICS, V272, P336, DOI 10.1007/s00438-004-1061-1; Rio Donald C., 2002, P484; Roche SE, 1998, GENETICS, V149, P1839; Ronsseray S, 1996, GENETICS, V143, P1663; RONSSERAY S, 1993, MOL GEN GENET, V241, P115, DOI 10.1007/BF00280208; RONSSERAY S, 1991, GENETICS, V129, P501; Ronsseray S, 2003, GENETICA, V117, P327, DOI 10.1023/A:1022929121828; Ronsseray S, 2001, GENETICS, V159, P1631; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Savitsky M, 2006, GENE DEV, V20, P345, DOI 10.1101/gad.370206; SCHUPBACH T, 1991, GENETICS, V129, P1119; Simmons MJ, 2007, GENETICS, V176, P1945, DOI 10.1534/genetics.106.066746; Simmons MJ, 2004, GENETICS, V166, P243, DOI 10.1534/genetics.166.1.243; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Stuart JR, 2002, GENETICS, V162, P1641; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Tushir JS, 2009, CELL, V139, P634, DOI 10.1016/j.cell.2009.10.021; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Vastenhouw NL, 2003, CURR BIOL, V13, P1311, DOI 10.1016/s0960-9822(03)00539-6; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	73	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11032	10.1371/journal.pone.0011032	http://dx.doi.org/10.1371/journal.pone.0011032			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559422	Green Published, gold, Green Submitted			2022-12-27	WOS:000278741100002
J	Wang, W; Xu, RH; Li, JM				Wang, Wei; Xu, Ruihuan; Li, Jinming			Production of Native Bispecific Antibodies in Rabbits	PLOS ONE			English	Article							SEX-HORMONES; HUMAN IGG4; IMMUNOGLOBULIN G4; DIGOXIN; SPECIFICITY; FRAGMENTS; DIGESTION; AFFINITY; PEPSIN	Background: A natural bispecific antibody, which can be produced by exchanging Fab arms of two IgG4 molecules, was first described in allergic patients receiving therapeutic injections with two distinct allergens. However, no information has been published on the production of natural bispecific antibody in animals. Even more important, establishment of an animal model is a useful approach to investigate and characterize the naturally occurring antibody. Methodology/Principal Findings: We demonstrated that a natural bispecific antibody can also be generated in New Zealand white rabbits by immunization with synthesized conjugates. These antibodies showed bispecificity to the components that were simultaneously used to immunize the animals. We observed a trend in our test animals that female rabbits exhibited stronger bispecific antibody responses than males. The bispecific antibody was monomeric and primarily belonged to immunoglobulin (Ig) G. Moreover, bispecific antibodies were demonstrated by mixing 2 purified monospecific antibodies in vivo and in vitro. Conclusions/Significance: Our results extend the context of natural bispecific antibodies on the basis of bispecific IgG4, and may provide insights into the exploration of native bispecific antibodies in immunological diseases.	[Wang, Wei; Xu, Ruihuan] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing 100037, Peoples R China; [Wang, Wei; Xu, Ruihuan; Li, Jinming] Beijing Hosp, Natl Ctr Clin Labs, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Hospital	Wang, W (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing 100037, Peoples R China.	ljm63hn@yahoo.com.cn						Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; AALBERSE RC, 1983, J IMMUNOL, V130, P722; Aalberse RC, 1999, INT ARCH ALLERGY IMM, V118, P187, DOI 10.1159/000024062; Ball WJ, 1999, J IMMUNOL, V163, P2291; Bilbo SD, 2001, AM J PHYSIOL-REG I, V280, pR207, DOI 10.1152/ajpregu.2001.280.1.R207; Boushaba R, 2003, BIOTECHNOL PROGR, V19, P1176, DOI 10.1021/bp034037+; BUTLER VP, 1967, P NATL ACAD SCI USA, V57, P71, DOI 10.1073/pnas.57.1.71; BUTLER VP, 1982, METHOD ENZYMOL, V84, P558; Da Silva JAP, 1999, ANN NY ACAD SCI, V876, P102; Esteves PJ, 2006, INT J IMMUNOGENET, V33, P171, DOI 10.1111/j.1744-313X.2006.00588.x; FAHEY JL, 1965, J AMER MED ASSOC, V194, P71, DOI 10.1001/jama.194.1.71; FEIGEN GA, 1978, INT ARCH ALLER A IMM, V57, P385, DOI 10.1159/000232130; Harlow E., 1988, ANTIBODIES LAB MANUA; Jones RGA, 2003, J IMMUNOL METHODS, V275, P239, DOI 10.1016/S0022-1759(03)00005-X; KILLION JJ, 1983, CLIN CHEM, V29, P1982; Kindt TJ, 2006, KUBY IMMUNOLOGY; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; MARGNI RA, 1988, ANNU REV IMMUNOL, V6, P535, DOI 10.1146/annurev.iy.06.040188.002535; Margni RA, 1998, IMMUNOL REV, V163, P77, DOI 10.1111/j.1600-065X.1998.tb01189.x; OKARMA TB, 1972, MOL PHARMACOL, V8, P476; PODESTA A, 1993, J STEROID BIOCHEM, V46, P847, DOI 10.1016/0960-0760(93)90328-T; Rispens T, 2009, J IMMUNOL, V182, P4275, DOI 10.4049/jimmunol.0804338; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; Smirnov MB, 1997, BIOCHEMISTRY-MOSCOW+, V62, P41; SMITH TW, 1970, BIOCHEMISTRY-US, V9, P331, DOI 10.1021/bi00804a020; VanGriensven M, 1997, CLIN EXP IMMUNOL, V107, P254, DOI 10.1111/j.1365-2249.1997.261-ce1141.x; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yamamoto T, 2001, ALLERGY, V56, P525, DOI 10.1034/j.1398-9995.2001.056006525.x; Zhang SF, 2009, VACCINE, V27, P2108, DOI 10.1016/j.vaccine.2009.01.126	29	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e10879	10.1371/journal.pone.0010879	http://dx.doi.org/10.1371/journal.pone.0010879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559427	Green Submitted, Green Published, gold			2022-12-27	WOS:000278741100001
J	Kravets, A; Qin, H; Ahmad, A; Bethlendy, G; Gao, QS; Rustchenko, E				Kravets, Anatoliy; Qin, Hong; Ahmad, Ausaf; Bethlendy, Gabor; Gao, Qinshan; Rustchenko, Elena			Widespread Occurrence of Dosage Compensation in Candida albicans	PLOS ONE			English	Article							ANEUPLOIDY; MECHANISM; MUTANTS; STRAINS	The important human pathogen Candida albicans possesses an unusual form of gene regulation, in which the copy number of an entire specific chromosome or a large portion of a specific chromosome changes in response to a specific adverse environment, thus, insuring survival. In the absence of the adverse environment, the altered portion of the genome can be restored to its normal condition. One major question is how C. albicans copes with gene imbalance arising by transitory aneuploid states. Here, we compared transcriptomes from cells with either two copies or one copy of chromosome 5 (Ch5) in, respectively, a diploid strain 3153A and its representative derivative Sor55. Statistical analyses revealed that at least 40% of transcripts from the monosomic Ch5 are fully compensated to a disomic level, thus, indicating the existence of a genome-wide mechanism maintaining cellular homeostasis. Only approximately 15% of transcripts were diminished twofold in accordance with what would be expected for Ch5 monosomy. Another minor portion of approximately 6% of transcripts, unexpectedly, increased up to twofold and higher than the disomic level, demonstrating indirect control by monosomy. Array comparative genome hybridization revealed that only few out of approximately 500 genes on the monosomic Ch5b were duplicated, thus, not causing a global up regulation. Dosage compensation was confirmed with several representative genes from another monosomic Ch5a in the mutant Sor60. We suggest that C. albicans's unusual regulation of gene expression by the loss and gain of entire chromosomes is coupled with widespread compensation of gene dosage at the transcriptional level.	[Kravets, Anatoliy; Ahmad, Ausaf; Rustchenko, Elena] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Qin, Hong] Spelman Coll, Dept Biol, Atlanta, GA 30314 USA; [Bethlendy, Gabor] Roche Diagnost Corp, Indianapolis, IN USA; [Gao, Qinshan] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA	University of Rochester; Spelman College; Roche Holding; Icahn School of Medicine at Mount Sinai	Kravets, A (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA.	elena_bulgac@urmc.rochester.edu	Ahmad, Ausaf/T-3014-2019; Ahmad, Ausaf/AAR-6733-2020	Ahmad, Ausaf/0000-0002-5029-9536	National Institutes of Health [AI29433]; Pfizer Global Pharmaceuticals, Pfizer Inc.; University of Rochester;  [P30 AG18254]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG018254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Global Pharmaceuticals, Pfizer Inc.(Pfizer); University of Rochester; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grant AI29433 and Pfizer Global Pharmaceuticals, Pfizer Inc. to Fred Sherman, as well as partially supported by P30 AG18254 to Hong Qin. The authors are grateful to the University of Rochester funds that enabled this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2008, YEAST, V25, P433, DOI 10.1002/yea.1597; Arnold AP, 2008, ANNU REV GENOM HUM G, V9, P109, DOI 10.1146/annurev.genom.9.081307.164220; Bell O, 2008, MOL CELL BIOL, V28, P3401, DOI 10.1128/MCB.00006-08; Birchler JA, 2001, DEV BIOL, V234, P275, DOI 10.1006/dbio.2001.0262; Dementyeva EV, 2009, BIOESSAYS, V31, P21, DOI 10.1002/bies.080149; Ding Yongzeng, 2007, J Biomol Tech, V18, P321; Epstein C.J, 1986, CONSEQUENCES CHROMOS; Graves Jennifer A Marshall, 2007, J Biol, V6, P1; Greenberg JR, 2005, YEAST, V22, P957, DOI 10.1002/yea.1282; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Itoh Yuichiro, 2007, Journal of Biology, V6, pUnpaginated, DOI 10.1186/jbiol53; Janbon G, 1998, P NATL ACAD SCI USA, V95, P5150, DOI 10.1073/pnas.95.9.5150; Kabir MA, 2005, GENE, V345, P279, DOI 10.1016/j.gene.2004.11.029; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; Lage JM, 2003, GENOME RES, V13, P294, DOI 10.1101/gr.377203; LIM WK, 2007, BIOINFORMATICS; Makarevitch I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-7; Melamed E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r202; Patalano S, 2009, DEVELOPMENT, V136, P689, DOI 10.1242/dev.027656; Perepnikhatka V, 1999, J BACTERIOL, V181, P4041, DOI 10.1128/JB.181.13.4041-4049.1999; Phillips JL, 2001, CANCER RES, V61, P8143; Platzer P, 2002, CANCER RES, V62, P1134; RUSTCHENKO E, 2003, RECENT RES DEV BACTE, P91; Rustchenko E, 2007, FEMS YEAST RES, V7, P2, DOI 10.1111/j.1567-1364.2006.00150.x; RUSTCHENKO EP, 1993, J BACTERIOL, V175, P7189, DOI 10.1128/JB.175.22.7189-7199.1993; Rustchfnko Elena, 2008, P197; Serazin-Leroy V, 1998, MOL CELL PROBE, V12, P283, DOI 10.1006/mcpr.1998.0182; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210	29	13	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e10856	10.1371/journal.pone.0010856	http://dx.doi.org/10.1371/journal.pone.0010856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552010	Green Published, gold, Green Submitted			2022-12-27	WOS:000278662900001
J	Savy, M; Hennig, BJ; Doherty, CP; Fulford, AJ; Bailey, R; Holland, MJ; Sirugo, G; Rockett, KA; Kwiatkowski, DP; Prentice, AM; Cox, SE				Savy, Mathilde; Hennig, Branwen J.; Doherty, Conor P.; Fulford, Anthony J.; Bailey, Robin; Holland, Martin J.; Sirugo, Giorgio; Rockett, Kirk A.; Kwiatkowski, Dominic P.; Prentice, Andrew M.; Cox, Sharon E.			Haptoglobin and Sickle Cell Polymorphisms and Risk of Active Trachoma in Gambian Children	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; HEMOGLOBIN SCAVENGER RECEPTOR; GENETIC SUSCEPTIBILITY; CHLAMYDIA-PNEUMONIAE; INFECTIOUS-DISEASES; ENDEMIC POPULATION; SCARRING TRACHOMA; IRON RESTRICTION; SEX-DIFFERENCES; 2-2 PHENOTYPE	Background: Susceptibility and resistance to trachoma, the leading infectious cause of blindness, have been associated with a range of host genetic factors. In vitro studies of the causative organism, Chlamydia trachomatis, demonstrate that iron availability regulates its growth, suggesting that host genes involved in regulating iron status and/or availability may modulate the risk of trachoma. The objective was to investigate whether haptoglobin (Hp) haplotypes constructed from the functional polymorphism (Hp1/Hp2) plus the functional promoter SNPs-61A-C (rs5471) and-101C-G (rs5470), or sickle cell trait (HbAS, rs334) were associated with risk of active trachoma when stratified by age and sex, in rural Gambian children. Methodology and Principal Findings: In two cross sectional surveys of children aged 6-78 months (n = 836), the prevalence of the clinical signs of active trachoma was 21.4%. Within boys, haplotype E (-101G, -61A, Hp1), containing the variant allele of the -101C-G promoter SNP, was associated with a two-fold increased risk of active trachoma (OR = 2.0 [1.17-3.44]). Within girls, an opposite association was non-significant (OR = 0.58 [0.32-1.04]; P = 0.07) and the interaction by sex was statistically significant (P = 0.001). There was no association between trachoma and HbAS. Conclusions: These data indicate that genetic variation in Hp may affect susceptibility to active trachoma differentially by sex in The Gambia.	[Savy, Mathilde; Hennig, Branwen J.; Fulford, Anthony J.; Prentice, Andrew M.; Cox, Sharon E.] London Sch Hyg & Trop Med, MRC Int Nutr Grp, London WC1, England; [Doherty, Conor P.; Bailey, Robin; Holland, Martin J.; Sirugo, Giorgio] MRC Labs, Fajara, Gambia; [Bailey, Robin; Holland, Martin J.] London Sch Hyg & Trop Med, Dept Infect Trop Dis, London WC1, England; [Sirugo, Giorgio] San Pietro Hosp, Dept Med Genet, Rome, Italy; [Rockett, Kirk A.; Kwiatkowski, Dominic P.] Wellcome Trust Ctr Human Genet, Oxford, England; [Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Malaria Programme, Hinxton, England	University of London; London School of Hygiene & Tropical Medicine; MRC Laboratory Molecular Biology; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute	Savy, M (corresponding author), London Sch Hyg & Trop Med, MRC Int Nutr Grp, London WC1, England.	Sharon.Cox@lshtm.ac.uk	Hennig, Branwen/M-6444-2014; Prentice, Andrew/AAG-1961-2019; Cox, Sharon E/ABA-7986-2020; Sirugo, Giorgio/N-9056-2019; Holland, Martin J/K-6502-2012; Sirugo, Giorgio/L-1628-2016	Cox, Sharon E/0000-0002-9908-2936; Holland, Martin J/0000-0002-5828-6318; Kwiatkowski, Dominic/0000-0002-5023-0176; Savy, Mathilde/0000-0003-0562-9601; Hennig, Branwen J./0000-0003-4127-8386	Medical Research Council, UK; MRC [MC_U123292699, G19/9, MC_U123292700] Funding Source: UKRI; Medical Research Council [G19/9, G0600718B, MC_U123292699, MC_U123292700] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou A, 2007, BRIT J OPHTHALMOL, V91, P13, DOI 10.1136/bjo.2006.099507; Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; Al-Younes HM, 2001, CELL MICROBIOL, V3, P427, DOI 10.1046/j.1462-5822.2001.00125.x; Allen SJ, 1997, P NATL ACAD SCI USA, V94, P14736, DOI 10.1073/pnas.94.26.14736; Arredouani M, 2003, IMMUNOLOGY, V108, P144, DOI 10.1046/j.1365-2567.2003.01569.x; Asleh R, 2003, CIRC RES, V92, P1193, DOI 10.1161/01.RES.0000076889.23082.F1; Atik B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003600; Atkinson SH, 2006, PLOS MED, V3, P652, DOI 10.1371/journal.pmed.0030172; Atkinson SH, 2007, CLIN INFECT DIS, V44, P802, DOI 10.1086/511868; Cabrera G, 2005, J INFECT DIS, V191, P1631, DOI 10.1086/429832; CLAYTON D, SNPHAP PROGRAM ESTIM; Clementi M, 2006, REPROD TOXICOL, V21, P345, DOI 10.1016/j.reprotox.2005.08.006; Conway DJ, 1997, INFECT IMMUN, V65, P1003, DOI 10.1128/IAI.65.3.1003-1006.1997; Conway DJ, 1996, J INFECT DIS, V174, P643, DOI 10.1093/infdis/174.3.643; Courtright P, 2004, EMERG INFECT DIS, V10, P2012, DOI 10.3201/eid1011.040353; COX SE, 2008, TROP MED INT HLTH; Cox SE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000362; Delanghe JR, 2007, CLIN CHEM, V53, P1397, DOI 10.1373/clinchem.2007.088658; Delanghe JR, 1998, AIDS, V12, P1027, DOI 10.1097/00002030-199809000-00009; Elagib AA, 1998, T ROY SOC TROP MED H, V92, P309, DOI 10.1016/S0035-9203(98)91025-2; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Freidank HM, 2001, J MED MICROBIOL, V50, P223, DOI 10.1099/0022-1317-50-3-223; Friis T, 2003, JAIDS-J ACQ IMM DEF, V33, P74, DOI 10.1097/00126334-200305010-00011; Gambhir M, 2007, LANCET INFECT DIS, V7, P420, DOI 10.1016/S1473-3099(07)70137-8; GRANT DJ, 1993, AM J HUM GENET, V52, P974; GUETTA J, 2006, ATHEROSCLEROSIS; Harding-Esch EM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000573; Hill AVS, 2006, ANNU REV GENET, V40, P469, DOI 10.1146/annurev.genet.40.110405.090546; *INT TRACH IN, 2006, ANN REP 2006; Jallow M, 2009, NAT GENET; Kasvosve I, 2002, CLIN CHEM LAB MED, V40, P810, DOI 10.1515/CCLM.2002.140; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Koch W, 2003, CLIN CHEM, V49, P1937, DOI 10.1373/clinchem.2003.022442; Koch W, 2002, CLIN CHEM, V48, P1377; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Langlois M, 1997, EUR J CLIN CHEM CLIN, V35, P199; Langlois MR, 2000, CLIN CHEM, V46, P1619; Larue RW, 2007, INFECT IMMUN, V75, P2374, DOI 10.1128/IAI.01465-06; Mabey DCW, 2003, LANCET, V362, P223, DOI 10.1016/S0140-6736(03)13914-1; Melamed-Frank M, 2001, BLOOD, V98, P3693, DOI 10.1182/blood.V98.13.3693; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Minang JT, 2004, ACTA TROP, V90, P107, DOI 10.1016/j.actatropica.2003.10.016; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; Mozzato-Chamay N, 2000, J INFECT DIS, V182, P1545, DOI 10.1086/315891; Mustafa S, 2004, DIABETES CARE, V27, P2103, DOI 10.2337/diacare.27.9.2103; Natividad A, 2007, GENES IMMUN, V8, P288, DOI 10.1038/sj.gene.6364384; Natividad A, 2005, GENES IMMUN, V6, P332, DOI 10.1038/sj.gene.6364182; Natividad A, 2008, HUM MOL GENET, V17, P323, DOI 10.1093/hmg/ddm310; Natividad A, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-138; Okazaki T, 1997, CLIN CHEM, V43, P2012; Quaye IK, 2006, J ATHEROSCLER THROMB, V13, P90, DOI 10.5551/jat.13.90; Quaye IKE, 2000, HUM HERED, V50, P382, DOI 10.1159/000022944; Quaye IK, 2008, T ROY SOC TROP MED H, V102, P735, DOI 10.1016/j.trstmh.2008.04.010; Raulston JE, 1997, INFECT IMMUN, V65, P4539, DOI 10.1128/IAI.65.11.4539-4547.1997; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; SINGH IP, 1986, HUM HERED, V36, P31, DOI 10.1159/000153596; Sirugo G, 2004, NAT GENET, V36, P785, DOI 10.1038/ng0804-785; Slepenkin A, 2007, INFECT IMMUN, V75, P3478, DOI 10.1128/IAI.00023-07; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; Teye K, 2003, CLIN GENET, V64, P439, DOI 10.1034/j.1399-0004.2003.00149.x; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; vanOoij C, 1997, INFECT IMMUN, V65, P758, DOI 10.1128/IAI.65.2.758-766.1997; WARD M, 1990, SCAND J INFECT DIS, P137; West S K, 2001, Ophthalmic Epidemiol, V8, P137, DOI 10.1076/opep.8.2.137.4158; Wieringa FT, 2007, BRIT J NUTR, V98, P1070, DOI 10.1017/S0007114507756945; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744	67	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11075	10.1371/journal.pone.0011075	http://dx.doi.org/10.1371/journal.pone.0011075			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20552021	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000278662900015
J	Meier, P; Brilakis, ES; Corti, R; Knapp, G; Shishehbor, MH; Gurm, HS				Meier, Pascal; Brilakis, Emmanouil S.; Corti, Roberto; Knapp, Guido; Shishehbor, Mehdi H.; Gurm, Hitinder S.			Drug-Eluting versus Bare-Metal Stent for Treatment of Saphenous Vein Grafts: A Meta-Analysis	PLOS ONE			English	Article							ACCELERATED ATHEROSCLEROSIS; BYPASS GRAFTS; FOLLOW-UP; LONG; OUTCOMES; INTERVENTION; IMPLANTATION; EFFICACY; AORTOCORONARY; IMMEDIATE	Background: Saphenous vein grafts develop an aggressive atherosclerotic process and the efficacy of drug eluting stents (DES) in treating saphenous vein graft (SVG) lesions has not been convincingly demonstrated. The aim of this study was to review and analyze the current literature for controlled studies comparing DES versus bare metal stents (BMS) for treatment of SVG stenoses. Methodology/Principal Findings: We searched several scientific databases and conference proceedings up to March 15, 2010 for controlled studies comparing target vessel revascularization (TVR) between DES and BMS. Summary odds ratios (OR) for the primary endpoint TVR and secondary endpoints infarction, stent thrombosis and death were calculated using random-effect models. A total of 29 studies (3 randomized controlled trials RCT) involving 7549 (202 in RCT) patients were included. The need for target vessel revascularization in the DES group tended to be lower compared to BMS for the 3 RCT (OR 0.50 [0.24-1.00]; p = 0.051) and for observational studies (0.62 [0.49-0.79]; p < 0.001). There was no significant difference in the risk for myocardial infarction in the RCT (OR 1.25 [0.22-6.99]; p = 0.250) but a lower risk for DES based on the observational studies 0.68 [0.49-0.95]; p = 0.023. The risk for stent thrombosis was found to be non-different in the RCT (OR 0.78 [0.03-21.73], p = 0.885) while it was in favor of DES in the observational studies (0.58 [0.38-0.84]; p < 0.001). The mortality was not significantly different between DES and BMS in the RCT's (OR 2.22 [0.17-29.50]; p = 0.546) while the observation studies showed a decreased mortality in the DES group (0.69 [0.55-0.85]; p < 0.001). Conclusion: DES may decrease TVR rate in treatment of SVG stenoses. No differences in reinfarction rate, stent thrombosis or mortality was found between the DES and BMS groups in the RCT's while the observational data showed lower risk for myocardial infarction, stent thrombosis and death in the DES group. This may be a result of patient selection bias in the observational studies or represent a true finding that was not the detected in the RCT analysis due to limited statistical power.	[Meier, Pascal; Gurm, Hitinder S.] Univ Michigan, Med Ctr, Ann Arbor, MI 48109 USA; [Meier, Pascal; Gurm, Hitinder S.] Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Brilakis, Emmanouil S.] Vet Affairs N Texas Healthcare Syst, Div Cardiovasc Dis, Dallas, TX USA; [Corti, Roberto] Univ Zurich Hosp, Dept Cardiol, CH-8091 Zurich, Switzerland; [Knapp, Guido] TU Dortmund Univ, Dept Stat, Dortmund, Germany; [Shishehbor, Mehdi H.] Cleveland Clin Fdn, Cleveland, OH 44195 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Zurich; University Zurich Hospital; Dortmund University of Technology; Cleveland Clinic Foundation	Meier, P (corresponding author), Univ Michigan, Med Ctr, Ann Arbor, MI 48109 USA.	hgurm@med.umich.edu	Brilakis, Emmanouil/B-5282-2009	Meier, Pascal/0000-0001-8909-2180; Brilakis, Emmanouil/0000-0001-9416-9701; Gurm, Hitinder/0000-0002-1646-0218	Swiss National Foundation	Swiss National Foundation(Swiss National Science Foundation (SNSF))	Pascal Meier has been supported by a research fellowship grant by the Swiss National Foundation to perform this study. The foundation had no role in the study design, data collection and analysis nor in the decision to publish or in the preparation of the manuscript.	Applegate RJ, 2008, CATHETER CARDIO INTE, V72, P7, DOI 10.1002/ccd.21566; Assali Abid, 2008, EuroIntervention, V4, P108, DOI 10.4244/EIJV4I1A18; Bansal D, 2008, CATHETER CARDIO INTE, V71, P58, DOI 10.1002/ccd.21413; Brilakis ES, 2009, J AM COLL CARDIOL, V53, P919, DOI 10.1016/j.jacc.2008.11.029; BRILAKIS ES, 2010, AM COLL CARD ACC SCI; Brodie BR, 2009, JACC-CARDIOVASC INTE, V2, P1105, DOI 10.1016/j.jcin.2009.08.020; BRODY WR, 1972, J THORAC CARDIOV SUR, V64, P847; Brouwers Melissa C, 2005, BMC Med Res Methodol, V5, P8, DOI 10.1186/1471-2288-5-8; BULKLEY BH, 1977, CIRCULATION, V55, P163, DOI 10.1161/01.CIR.55.1.163; Chu WW, 2006, AM J CARDIOL, V97, P34, DOI 10.1016/j.amjcard.2005.08.018; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ellis Stephen G, 2007, J Invasive Cardiol, V19, P404; Ge L, 2005, J AM COLL CARDIOL, V45, P989, DOI 10.1016/j.jacc.2004.11.060; Gioia G, 2008, CATHETER CARDIO INTE, V72, P13, DOI 10.1002/ccd.21599; Gualano SK, 2010, CLIN CARDIOL, V33, P111, DOI 10.1002/clc.20717; Gurm HS, 2008, AM HEART J, V155, P630, DOI 10.1016/j.ahj.2007.11.021; Hartung J., 2008, STAT METAANALYSIS AP; Hoffmann R, 2007, HEART, V93, P331, DOI 10.1136/hrt.2006.094722; Jeger RV, 2009, CARDIOLOGY, V112, P49, DOI 10.1159/000137699; JINCHENG G, 2008, J CLIN REHABILITATIV, V12, P6971; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kaplan Sahin, 2008, Acute Card Care, V10, P88, DOI 10.1080/17482940701885400; Latib A, 2008, EUR HEART J, V29, P455; Lee MS, 2005, CATHETER CARDIO INTE, V66, P507, DOI 10.1002/ccd.20498; LICHTENWALTER C, 2010, AM COLL CARD ACC SCI; Lichtenwalter C, 2009, JACC-CARDIOVASC INTE, V2, P855, DOI 10.1016/j.jcin.2009.06.014; Lozano I, 2009, REV ESP CARDIOL, V62, P39, DOI 10.1016/S0300-8932(09)70019-3; MAY HT, 2008, J AM COLL CARDIOL SA, V51; Meier P, 2007, J AM COLL CARDIOL, V49, P15, DOI 10.1016/j.jacc.2006.08.043; Meier P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c467; Meier P, 2010, J INVASIVE CARDIOL, V22, P33; MILLER JJ, 1978, AM STAT, V32, P138, DOI 10.2307/2682942; Minutello Robert M, 2007, J Interv Cardiol, V20, P458, DOI 10.1111/j.1540-8183.2007.00301.x; MOORE PA, 2007, TRANSC CARD THER TCT; Okabe T, 2008, AM J CARDIOL, V102, P530, DOI 10.1016/j.amjcard.2008.04.041; R Core Team, 2020, R LANG ENV STAT COMP; Ramana RK, 2008, CATHETER CARDIO INTE, V71, P886, DOI 10.1002/ccd.21552; Ribichin F, 2008, CLIN SCI, V114, P211, DOI 10.1042/CS20070243; Rodes-Cabau J, 2009, CIRCULATION, V120, P1978, DOI 10.1161/CIRCULATIONAHA.109.874057; Safian RD, 2002, PROG CARDIOVASC DIS, V44, P437, DOI 10.1053/pcad.2002.123471; Sankey SS, 1996, COMMUN STAT SIMULAT, V25, P1031, DOI 10.1080/03610919608813357; Shishehbor MH, 2009, AM HEART J, V158, P637, DOI 10.1016/j.ahj.2009.08.003; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; van Twisk Piet-Hein, 2008, EuroIntervention, V4, P311, DOI 10.4244/EIJV4I3A57; Vermeersch P, 2007, J AM COLL CARDIOL, V50, P261, DOI 10.1016/j.jacc.2007.05.010; Vermeersch P, 2006, J AM COLL CARDIOL, V48, P2423, DOI 10.1016/j.jacc.2006.09.021; Vignali L, 2008, AM J CARDIOL, V101, P947, DOI 10.1016/j.amjcard.2007.11.055; Voudris V, 2006, EUR HEART J, V27, P925; WILSON BH, 2007, AM COLL CARD ACC I2; Wilson CT, 2007, HEALTH AFFAIR, V26, P162, DOI 10.1377/hlthaff.26.1.162; Wohrle J, 2007, CLIN RES CARDIOL, V96, P70, DOI 10.1007/s00392-006-0460-1	51	36	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11040	10.1371/journal.pone.0011040	http://dx.doi.org/10.1371/journal.pone.0011040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20548794	Green Published, gold			2022-12-27	WOS:000278599600003
J	Zhang, SF; Wei, JN; Guo, XJ; Liu, TX; Kang, L				Zhang, Sufang; Wei, Jianing; Guo, Xiaojiao; Liu, Tong-Xian; Kang, Le			Functional Synchronization of Biological Rhythms in a Tritrophic System	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; PLANT VOLATILES; SOCIAL SYNCHRONIZATION; EMERGENCE RHYTHM; PARASITIC WASP; BEAN-PLANTS; LIGHT; CLOCK; HOST; EMISSIONS	In a tritrophic system formed by a plant, an herbivore and a natural enemy, each component has its own biological rhythm. However, the rhythm correlations among the three levels and the underlying mechanisms in any tritrophic system are largely unknown. Here, we report that the rhythms exhibited bidirectional correlations in a model tritrophic system involving a lima bean, a pea leafminer and a parasitoid. From the bottom-up perspective, the rhythm was initiated from herbivore feeding, which triggered the rhythms of volatile emissions; then the rhythmic pattern of parasitoid activities was affected, and these rhythms were synchronized by a light switch signal. Increased volatile concentration can enhance the intensity of parasitoid locomotion and oviposition only under light. From the top-down perspective, naive and oviposition-experienced parasitoids were able to utilize the different volatile rhythm information from the damaged plant to locate host leafminers respectively. Our results indicated that the three interacting organisms in this system can achieve rhythmic functional synchronization under a natural light-dark photoperiod, but not under constant light or darkness. These findings provide new insight into the rhythm synchronization of three key players that contribute to the utilization of light and chemical signals, and our results may be used as potential approaches for manipulating natural enemies.	[Zhang, Sufang; Wei, Jianing; Guo, Xiaojiao; Kang, Le] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Zhang, Sufang] Univ Sci & Technol China, Coll Life Sci, Hefei 230026, Peoples R China; [Liu, Tong-Xian] NW A&F Univ, Key Lab Appl Entomol, Yangling, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Northwest A&F University - China	Zhang, SF (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	lkang@ioz.ac.cn	Wei, Jianing/L-7575-2019; Kang, Le/ABD-1116-2022	Wei, Jianing/0000-0002-8517-2164; Kang, Le/0000-0003-4262-2329	National Basic Research Program of China (973 Program) [2006CB102006, 2006CB102002X]; Chinese Academy of Sciences [KSCX2-YW-N-006]; National Nature Science Foundation of China [30670356, 30621003]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was supported by the National Basic Research Program of China (973 Program) (No. 2006CB102006 and 2006CB102002X), the Chinese Academy of Sciences (Project No: KSCX2-YW-N-006), and the National Nature Science Foundation of China (30670356 and 30621003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEMAND R, 1994, PHYSIOL ENTOMOL, V19, P1, DOI 10.1111/j.1365-3032.1994.tb01067.x; Arimura G, 2005, BBA-MOL CELL BIOL L, V1734, P91, DOI 10.1016/j.bbalip.2005.03.001; Arimura GI, 2008, PLANT PHYSIOL, V146, P965, DOI 10.1104/pp.107.111088; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; CROWLEY M, 1980, BEHAV ECOL SOCIOBIOL, V7, P99, DOI 10.1007/BF00299514; Davidson AJ, 2003, CURR OPIN NEUROBIOL, V13, P765, DOI 10.1016/j.conb.2003.10.011; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; EDMONDS SC, 1977, PHYSIOL BEHAV, V18, P915, DOI 10.1016/0031-9384(77)90201-3; ENGELMAN.W, 1966, EXPERIENTIA, V22, P606, DOI 10.1007/BF01895281; Fantinou AA, 1998, BIOCONTROL, V43, P141, DOI 10.1023/A:1009984318289; Goldbeter A, 2008, CURR BIOL, V18, pR751, DOI 10.1016/j.cub.2008.06.044; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Halle S, 1995, J BIOL RHYTHM, V10, P211, DOI 10.1177/074873049501000304; Holopainen JK, 2004, TRENDS PLANT SCI, V9, P529, DOI 10.1016/j.tplants.2004.09.006; Kang L, 2009, ANNU REV ENTOMOL, V54, P127, DOI 10.1146/annurev.ento.54.110807.090507; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Levine JD, 2002, SCIENCE, V298, P2010, DOI 10.1126/science.1076008; LEWIS WJ, 1988, NATURE, V331, P257, DOI 10.1038/331257a0; LEWIS WJ, 1990, NATURE, V348, P635, DOI 10.1038/348635a0; LOUGHRIN JH, 1994, P NATL ACAD SCI USA, V91, P11836, DOI 10.1073/pnas.91.25.11836; Maeda T, 2000, EXP APPL ACAROL, V24, P415, DOI 10.1023/A:1006449108245; MARTINHEIL, 2008, NEW PHYTOL, V178, P41; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Pyza E, 2001, J INSECT PHYSIOL, V47, P897, DOI 10.1016/S0022-1910(01)00062-2; Shiojiri K, 2006, PLOS BIOL, V4, P1044, DOI 10.1371/journal.pbio.0040164; Turlings TCJ, 1998, PLANTA, V207, P146, DOI 10.1007/s004250050466; VINSON SB, 1976, ANNU REV ENTOMOL, V21, P109, DOI 10.1146/annurev.en.21.010176.000545; Wei JN, 2006, CHEM SENSES, V31, P467, DOI 10.1093/chemse/bjj051; Wei JN, 2006, PLANTA, V224, P279, DOI 10.1007/s00425-005-0212-x; Wei JN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000852	32	12	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2010	5	6							e11064	10.1371/journal.pone.0011064	http://dx.doi.org/10.1371/journal.pone.0011064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608QA	20552008	Green Published, gold, Green Submitted			2022-12-27	WOS:000278599600020
J	McNulty, SN; Foster, JM; Mitreva, M; Hotopp, JCD; Martin, J; Fischer, K; Wu, B; Davis, PJ; Kumar, S; Brattig, NW; Slatko, BE; Weil, GJ; Fischer, PU				McNulty, Samantha N.; Foster, Jeremy M.; Mitreva, Makedonka; Hotopp, Julie C. Dunning; Martin, John; Fischer, Kerstin; Wu, Bo; Davis, Paul J.; Kumar, Sanjay; Brattig, Norbert W.; Slatko, Barton E.; Weil, Gary J.; Fischer, Peter U.			Endosymbiont DNA in Endobacteria-Free Filarial Nematodes Indicates Ancient Horizontal Genetic Transfer	PLOS ONE			English	Article							INTRACELLULAR BACTERIA; INTERFERING RNAS; BRUGIA-MALAYI; MOUSE OOCYTES; WOLBACHIA; EVOLUTION; TRANSCRIPTION; PSEUDOGENES; EUKARYOTES; EXPRESSION	Background: Wolbachia are among the most abundant symbiotic microbes on earth; they are present in about 66% of all insect species, some spiders, mites and crustaceans, and most filarial nematode species. Infected filarial nematodes, including many pathogens of medical and veterinary importance, depend on Wolbachia for proper development and survival. The mechanisms behind this interdependence are not understood. Interestingly, a minority of filarial species examined to date are naturally Wolbachia-free. Methodology/Principal Findings: We used 454 pyrosequencing to survey the genomes of two distantly related Wolbachia-free filarial species, Acanthocheilonema viteae and Onchocerca flexuosa. This screen identified 49 Wolbachia-like DNA sequences in A. viteae and 114 in O. flexuosa. qRT-PCR reactions detected expression of 30 Wolbachia-like sequences in A. viteae and 56 in O. flexuosa. Approximately half of these appear to be transcribed from pseudogenes. In situ hybridization showed that two of these pseudogene transcripts were specifically expressed in developing embryos and testes of both species. Conclusions/Significance: These results strongly suggest that the last common ancestor of extant filarial nematodes was infected with Wolbachia and that this former endosymbiont contributed to their genome evolution. Horizontally transferred Wolbachia DNA may explain the ability of some filarial species to live and reproduce without the endosymbiont while other species cannot.	[McNulty, Samantha N.; Fischer, Kerstin; Weil, Gary J.; Fischer, Peter U.] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA; [Foster, Jeremy M.; Wu, Bo; Davis, Paul J.; Kumar, Sanjay; Slatko, Barton E.] New England Biolabs Inc, Ipswich, MA USA; [Mitreva, Makedonka; Martin, John] Washington Univ, Sch Med, Dept Genet, Genome Ctr, St Louis, MO 63110 USA; [Hotopp, Julie C. Dunning] Univ Maryland, Dept Microbiol & Immunol, Inst Genome Sci, Baltimore, MD 21201 USA; [Brattig, Norbert W.] Bernhard Nocht Inst Trop Med, Hamburg, Germany	Washington University (WUSTL); New England Biolabs; Washington University (WUSTL); University System of Maryland; University of Maryland Baltimore; Bernhard Nocht Institut fur Tropenmedizin	McNulty, SN (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA.	snpiper@artsci.wustl.edu	Fischer, Peter/A-2746-2008; Dunning Hotopp, Julie/E-7762-2010; Kumar, Sanjay/AAO-2593-2021	Dunning Hotopp, Julie/0000-0003-3862-986X; Fischer, Peter/0000-0003-4558-3417; Mitreva, Makedonka/0000-0001-9572-3436	University of Maryland School of Medicine; Barnes Jewish Hospital Foundation; New England Biolabs; NSF [EF-0826732]; NIH [T32-AI007172]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007172] Funding Source: NIH RePORTER; Emerging Frontiers [0826732] Funding Source: National Science Foundation	University of Maryland School of Medicine; Barnes Jewish Hospital Foundation; New England Biolabs; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Sequencing studies were funded by the University of Maryland School of Medicine internal funds, The Barnes Jewish Hospital Foundation, New England Biolabs, NSF Grant EF-0826732 to JCDH and NIH T32-AI007172 for SNM. JF, BW, PJD, SK and BS are employees of New England Biolabs; this funder is therefore considered by PLoS ONE to have played a role in study design, data collection and analysis; however the authors confirm that the funder did not play a direct role in the study.	ASH LR, 1970, J PARASITOL, V56, P969, DOI 10.2307/3277515; Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591; Baranov PV, 2001, NUCLEIC ACIDS RES, V29, P264, DOI 10.1093/nar/29.1.264; Bird DM, 2003, INT J PARASITOL, V33, P1269, DOI 10.1016/S0020-7519(03)00160-7; Brindley PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000538; Casiraghi M, 2004, INT J PARASITOL, V34, P191, DOI 10.1016/j.ijpara.2003.10.004; Fenn K, 2006, PLOS PATHOG, V2, P887, DOI 10.1371/journal.ppat.0020094; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Harrison PM, 2002, J MOL BIOL, V318, P1155, DOI 10.1016/S0022-2836(02)00109-2; Hoerauf A, 1999, J CLIN INVEST, V103, P11, DOI 10.1172/JCI4768; Hoerauf A, 2003, MED MICROBIOL IMMUN, V192, P211, DOI 10.1007/s00430-002-0174-6; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Juhas M, 2008, CELL MICROBIOL, V10, P2377, DOI 10.1111/j.1462-5822.2008.01187.x; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; KOZEK WJ, 1977, J PARASITOL, V63, P992, DOI 10.2307/3279832; Lucius R., 1995, Applied Parasitology, V36, P22; McGarry Helen F., 2003, Filaria Journal, V2, pUnpaginated, DOI 10.1186/1475-2883-2-9; Mitreva Makedonka, 2009, V532, P517, DOI [10.1007/978-1-60327-853-9_30, 10.1007/978-1-60327-853-9-30]; NIKOH N, 2007, GENOME RES; Noutsos C, 2007, TRENDS GENET, V23, P597, DOI 10.1016/j.tig.2007.08.016; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Pichon S, 2009, BIOCHEM BIOPH RES CO, V385, P557, DOI 10.1016/j.bbrc.2009.05.118; PLENGEBONIG A, 1995, PARASITOL RES, V81, P66, DOI 10.1007/BF00932419; PODLAHA O, 2009, TRENDS GENET; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Sasidharan R, 2008, NATURE, V453, P729, DOI 10.1038/453729a; Scott AL, 2009, PARASITOL INT, V58, P6, DOI 10.1016/j.parint.2008.09.003; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Whitaker JW, 2009, BIOCHEM SOC T, V37, P792, DOI 10.1042/BST0370792; Williams DL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-397; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307	35	84	86	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2010	5	6							e11029	10.1371/journal.pone.0011029	http://dx.doi.org/10.1371/journal.pone.0011029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608BX	20543958	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000278557600008
J	Titov, N; Andrews, G; Davies, M; McIntyre, K; Robinson, E; Solley, K				Titov, Nickolai; Andrews, Gavin; Davies, Matthew; McIntyre, Karen; Robinson, Emma; Solley, Karen			Internet Treatment for Depression: A Randomized Controlled Trial Comparing Clinician vs. Technician Assistance	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; SOCIAL PHOBIA; SELF-HELP; PANIC DISORDER; COST-EFFECTIVENESS; COMPUTER; SEVERITY; OUTCOMES; PROGRAM; IV	Background: Internet-based cognitive behavioural therapy (iCBT) for depression is effective when guided by a clinician, less so if unguided. Question: Would guidance from a technician be as effective as guidance from a clinician? Method: Randomized controlled non-inferiority trial comparing three groups: Clinician-assisted vs. technician-assisted vs. delayed treatment. Community-based volunteers applied to the VirtualClinic (www.virtualclinic.org.au) research program, and 141 participants with major depressive disorder were randomized. Participants in the clinician-and technician-assisted groups received access to an iCBT program for depression comprising 6 online lessons, weekly homework assignments, and weekly supportive contact over a treatment period of 8 weeks. Participants in the clinician-assisted group also received access to a moderated online discussion forum. The main outcome measures were the Beck Depression Inventory (BDI-II) and the Patient Health Questionnaire-9 Item (PHQ-9). Completion rates were high, and at post-treatment, both treatment groups reduced scores on the BDI-II (p<0.001) and PHQ-9 (p<0.001) compared to the delayed treatment group but did not differ from each other. Within group effect sizes on the BDI-II were 1.27 and 1.20 for the clinician-and technician-assisted groups respectively, and on the PHQ-9, were 1.54 and 1.60 respectively. At 4-month follow-up participants in the technician group had made further improvements and had significantly lower scores on the PHQ-9 than those in the clinician group. A total of approximately 60 minutes of clinician or technician time was required per participant during the 8-week treatment program. Conclusions: Both clinician-and technician-assisted treatment resulted in large effect sizes and clinically significant improvements comparable to those associated with face-to-face treatment, while a delayed treatment control group did not improve. These results provide support for large scale trials to determine the clinical effectiveness and acceptability of technician-assisted iCBT programs for depression. This form of treatment has potential to increase the capacity of existing mental health services.	[Titov, Nickolai; Andrews, Gavin; Solley, Karen] Univ New S Wales, Sch Psychiat, St Vincents Hosp, Clin Res Unit Anxiety & Depress, Sydney, NSW, Australia	St Vincents Hospital Sydney; University of New South Wales Sydney	Titov, N (corresponding author), Univ New S Wales, Sch Psychiat, St Vincents Hosp, Clin Res Unit Anxiety & Depress, Sydney, NSW, Australia.	nickt@unsw.edu.au	Andrews, Gavin/J-6537-2012	Andrews, Gavin/0000-0002-4315-2173; Titov, Nickolai/0000-0002-7268-729X				American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andersson G, 2005, BRIT J PSYCHIAT, V187, P456, DOI 10.1192/bjp.187.5.456; Andersson G, 2006, J CONSULT CLIN PSYCH, V74, P677, DOI 10.1037/0022-006X.74.4.677; Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Andrews G, 2004, BRIT J PSYCHIAT, V184, P526, DOI 10.1192/bjp.184.6.526; Andrews G, 2001, BRIT J PSYCHIAT, V178, P145, DOI 10.1192/bjp.178.2.145; Andrews G, 2007, LANCET, V370, P808, DOI 10.1016/S0140-6736(07)61393-2; Australian Bureau of Statistics [ABS], 2008, NAT SURV MENT HLTH W; Beck AT, 1996, BDI 2 BECK DEPRESSIO; BORKOVEC TD, 1972, J BEHAV THER EXP PSY, V3, P257, DOI 10.1016/0005-7916(72)90045-6; Carlbring P, 2005, BEHAV RES THER, V43, P1321, DOI 10.1016/j.brat.2004.10.002; Carlbring P, 2007, BRIT J PSYCHIAT, V190, P123, DOI 10.1192/bjp.bp.105.020107; Carlbring P, 2007, COMPUT HUM BEHAV, V23, P1421, DOI 10.1016/j.chb.2005.05.002; Clarke G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.2.e16; Cuijpers Pim, 2009, Cognitive Behaviour Therapy, V38, P66, DOI 10.1080/16506070802694776; Devilly GJ, 2000, J BEHAV THER EXP PSY, V31, P73, DOI 10.1016/S0005-7916(00)00012-4; Garb HN, 2007, PSYCHOL ASSESSMENT, V19, P4, DOI 10.1037/1040-3590.19.1.4; Haby MM, 2006, AUST NZ J PSYCHIAT, V40, P9, DOI 10.1080/j.1440-1614.2006.01736.x; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Julious SA, 2004, STAT MED, V23, P1921, DOI 10.1002/sim.1783; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kiropoulos LA, 2008, J ANXIETY DISORD, V22, P1273, DOI 10.1016/j.janxdis.2008.01.008; Klein B, 2006, J BEHAV THER EXP PSY, V37, P213, DOI 10.1016/j.jbtep.2005.07.001; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Marks I, 2007, HANDS ON HELP COMPUT; Marks IM, 2004, PSYCHOL MED, V34, P9, DOI 10.1017/S003329170300878X; Marks I, 2009, ANNU REV CLIN PSYCHO, V5, P121, DOI 10.1146/annurev.clinpsy.032408.153538; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Perini S, 2009, AUST NZ J PSYCHIAT, V43, P571, DOI 10.1080/00048670902873722; Richards DA, 2009, BRIT J CLIN PSYCHOL, V48, P377, DOI 10.1348/014466509X405178; Shandley K, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1033; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sheehan DV., 1983, ANXIETY DIS; Titov N, 2008, AUST NZ J PSYCHIAT, V42, P595, DOI 10.1080/00048670802119820; Titov N, 2008, AUST NZ J PSYCHIAT, V42, P585, DOI 10.1080/00048670802119762; Titov N, 2007, AUST NZ J PSYCHIAT, V41, P95, DOI 10.1080/00048670601109873; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P920, DOI 10.1080/00048670903179228; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P905, DOI 10.1080/00048670903179269; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P913, DOI 10.1080/00048670903179160; Vernmark K, 2010, BEHAV RES THER, V48, P368, DOI 10.1016/j.brat.2010.01.005; Vickers AJ, 2005, PSYCHOSOM MED, V67, P652, DOI 10.1097/01.psy.0000172624.52957.a8; Vickers Andrew J, 2005, BMC Med Res Methodol, V5, P35, DOI 10.1186/1471-2288-5-35; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	48	223	228	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e10939	10.1371/journal.pone.0010939	http://dx.doi.org/10.1371/journal.pone.0010939			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	607IR	20544030	Green Published, gold, Green Submitted			2022-12-27	WOS:000278494900002
J	Chambers, R; Takimoto, T				Chambers, Raychel; Takimoto, Toru			Trafficking of Sendai Virus Nucleocapsids Is Mediated by Intracellular Vesicles	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; PLASMA-MEMBRANE TRANSPORT; CANINE KIDNEY-CELLS; DYNEIN LIGHT-CHAIN; MATRIX PROTEIN; MARBURG-VIRUS; RAB PROTEINS; LIVING CELLS; P-PROTEIN; BASOLATERAL TRANSPORT	Background: Paramyxoviruses are assembled at the plasma membrane budding sites after synthesis of all the structural components in the cytoplasm. Although viral ribonuclocapsid (vRNP) is an essential component of infectious virions, the process of vRNP translocation to assembly sites is poorly understood. Methodology/Principal Findings: To analyze real-time trafficking of vRNPs in live infected cells, we created a recombinant Sendai virus (SeV), rSeVLeGFP, which expresses L protein fused to enhanced green fluorescent protein (eGFP). The rSeVLeGFP showed similar growth kinetics compared to wt SeV, and newly synthesized LeGFP could be detected as early as 8 h postinfection. The majority of LeGFP co-localized with other components of vRNPs, NP and P proteins, suggesting the fluorescent signals of LeGFP represent the locations of vRNPs. Analysis of LeGFP movement using time-lapse digital video microscopy revealed directional and saltatory movement of LeGFP along microtubules. Treatment of the cells with nocodazole restricted vRNP movement and reduced progeny virion production without affecting viral protein synthesis, suggesting the role of microtubules in vRNP trafficking and virus assembly. Further study with an electron microscope showed close association of vRNPs with intracellular vesicles present in infected cells. In addition, the vRNPs co-localized with Rab11a protein, which is known to regulate the recycling endocytosis pathway and Golgi-to-plasma membrane trafficking. Simultaneous movement between LeGFP and Rab11a was also observed in infected cells, which constitutively express mRFP-tagged Rab11a. Involvement of recycling endosomes in vRNP translocation was also suggested by the fact that vRNPs move concomitantly with recycling transferrin labeled with Alexa 594. Conclusions/Significance: Collectively, our results strongly suggest a previously unrecognized involvement of the intracellular vesicular trafficking pathway in vRNP translocation and provide new insights into the transport of viral structural components to the assembly sites of enveloped viruses.	[Chambers, Raychel; Takimoto, Toru] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA	University of Rochester	Chambers, R (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	toru_takimoto@urmc.rochester.edu		Tripp, Ralph/0000-0002-2924-9956	National Institute of Allergy and Infectious Disease [AI055940]; NIH [T32 AI007362]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055940, T32AI007362, R01AI081779] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant AI055940 from the National Institute of Allergy and Infectious Disease. RC was supported by NIH training grant T32 AI007362. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; Ang AL, 2004, J CELL BIOL, V167, P531, DOI 10.1083/jcb.200408165; Bousse T, 2002, J VIROL, V76, P8244, DOI 10.1128/JVI.76.16.8244-8251.2002; Brignati MJ, 2003, J VIROL, V77, P4888, DOI 10.1128/JVI.77.8.4888-4898.2003; Brock SC, 2003, P NATL ACAD SCI USA, V100, P15143, DOI 10.1073/pnas.2434327100; Casanova JE, 1999, MOL BIOL CELL, V10, P47, DOI 10.1091/mbc.10.1.47; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; Coronel EC, 2001, J VIROL, V75, P1117, DOI 10.1128/JVI.75.3.1117-1123.2001; CURRAN J, 1995, J VIROL, V69, P849, DOI 10.1128/JVI.69.2.849-855.1995; Das SC, 2006, J VIROL, V80, P6368, DOI 10.1128/JVI.00211-06; Dohner K, 2005, TRENDS MICROBIOL, V13, P320, DOI 10.1016/j.tim.2005.05.010; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Greber UF, 2006, CELL, V124, P741, DOI 10.1016/j.cell.2006.02.018; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hales CM, 2002, J BIOL CHEM, V277, P50415, DOI 10.1074/jbc.M209270200; Hammer JA, 2002, CURR OPIN CELL BIOL, V14, P69, DOI 10.1016/S0955-0674(01)00296-4; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; HOMANN HE, 1991, J VIROL, V65, P1304, DOI 10.1128/JVI.65.3.1304-1309.1991; HORIKAMI SM, 1992, J VIROL, V66, P4901, DOI 10.1128/JVI.66.8.4901-4908.1992; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; IKONEN E, 1995, CELL, V81, P571, DOI 10.1016/0092-8674(95)90078-0; Jacob Y, 2000, J VIROL, V74, P10217, DOI 10.1128/JVI.74.21.10217-10222.2000; Jing J, 2009, HISTOL HISTOPATHOL, V24, P1171, DOI 10.14670/HH-24.1171; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Kato A, 2002, J VIROL, V76, P7114, DOI 10.1128/JVI.76.14.7114-7124.2002; KINSELLA BT, 1992, J BIOL CHEM, V267, P3940; Kolesnikova L, 2004, J VIROL, V78, P12277, DOI 10.1128/JVI.78.22.12277-12287.2004; Kolesnikova L, 2004, J VIROL, V78, P2382, DOI 10.1128/JVI.78.5.2382-2393.2004; Kolesnikova L, 2002, J VIROL, V76, P1825, DOI 10.1128/JVI.76.4.1825-1838.2002; Lahaye X, 2009, J VIROL, V83, P7948, DOI 10.1128/JVI.00554-09; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Lamb R.A., 2006, FIELDS VIROLOGY, P1449; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Meyers JM, 2002, J BIOL CHEM, V277, P49003, DOI 10.1074/jbc.M205728200; Ogawa-Goto K, 2003, J VIROL, V77, P8541, DOI 10.1128/JVI.77.15.8541-8547.2003; Peranen J, 1996, J CELL BIOL, V135, P153, DOI 10.1083/jcb.135.1.153; Poisson N, 2001, J GEN VIROL, V82, P2691, DOI 10.1099/0022-1317-82-11-2691; Prekeris R, 2001, J BIOL CHEM, V276, P38966, DOI 10.1074/jbc.M106133200; Prekeris R, 2000, MOL CELL, V6, P1437, DOI 10.1016/S1097-2765(00)00140-4; Raux H, 2000, J VIROL, V74, P10212, DOI 10.1128/JVI.74.21.10212-10216.2000; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Roland JT, 2007, MOL BIOL CELL, V18, P2828, DOI 10.1091/mbc.E07-02-0169; Rowe RK, 2008, VIROLOGY, V382, P239, DOI 10.1016/j.virol.2008.09.021; SANDERSON CM, 1993, J VIROL, V67, P651, DOI 10.1128/JVI.67.2.651-663.1993; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Schonteich E, 2008, J CELL SCI, V121, P3824, DOI 10.1242/jcs.032441; Seisenberger G, 2001, SCIENCE, V294, P1929, DOI 10.1126/science.1064103; Sodeik B, 2000, TRENDS MICROBIOL, V8, P465, DOI 10.1016/S0966-842X(00)01824-2; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Suikkanen S, 2003, J VIROL, V77, P10270, DOI 10.1128/JVI.77.19.10270-10279.2003; TAKAHASHI T, 1992, GENET ANAL-BIOMOL E, V9, P91, DOI 10.1016/1050-3862(92)90004-O; Takimoto T, 2004, J VIROL, V78, P6043, DOI 10.1128/JVI.78.11.6043-6047.2004; Takimoto T, 2004, VIRUS RES, V106, P133, DOI 10.1016/j.virusres.2004.08.010; Tang Y, 1999, J VIROL, V73, P10508, DOI 10.1128/JVI.73.12.10508-10513.1999; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Utley TJ, 2008, P NATL ACAD SCI USA, V105, P10209, DOI 10.1073/pnas.0712144105; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhan X, 2008, VACCINE, V26, P3480, DOI 10.1016/j.vaccine.2008.04.022	61	52	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2010	5	6							e10994	10.1371/journal.pone.0010994	http://dx.doi.org/10.1371/journal.pone.0010994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	606YU	20543880	Green Published, gold, Green Submitted			2022-12-27	WOS:000278465900011
J	Concepcion, F; Chen, J				Concepcion, Francis; Chen, Jeannie			Q344ter Mutation Causes Mislocalization of Rhodopsin Molecules That Are Catalytically Active: A Mouse Model of Q344ter-Induced Retinal Degeneration	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; LIGHT-INDUCED DAMAGE; 2 APOPTOTIC PATHWAYS; PHOTORECEPTOR APOPTOSIS; MONOCLONAL-ANTIBODIES; BOVINE RHODOPSIN; TRANSGENIC MICE; CELL-DEATH; PROTEIN; TRANSPORT	Q344ter is a naturally occurring rhodopsin mutation in humans that causes autosomal dominant retinal degeneration through mechanisms that are not fully understood, but are thought to involve an early termination that removed the trafficking signal, QVAPA, leading to its mislocalization in the rod photoreceptor cell. To better understand the disease mechanism(s), transgenic mice that express Q344ter were generated and crossed with rhodopsin knockout mice. Dark-reared Q344ter(rho+/-) mice exhibited retinal degeneration, demonstrating that rhodopsin mislocalization caused photoreceptor cell death. This degeneration is exacerbated by light-exposure and is correlated with the activation of transducin as well as other G-protein signaling pathways. We observed numerous sub-micrometer sized vesicles in the interphotoreceptor space of Q344ter(rho+/-) and Q344ter(rho-/-) retinas, similar to that seen in another rhodopsin mutant, P347S. Whereas light microscopy failed to reveal outer segment structures in Q344ter(rho-/-) rods, shortened and disorganized rod outer segment structures were visible using electron microscopy. Thus, some Q344ter molecules trafficked to the outer segment and formed disc structures, albeit inefficiently, in the absence of full length wildtype rhodopsin. These findings helped to establish the in vivo role of the QVAPA domain as well as the pathways leading to Q344ter-induced retinal degeneration.	[Concepcion, Francis] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Ophthalmol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Concepcion, F (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA.	jeannie@usc.edu			National Institutes of Health [EY12155]; Vision Core Grant; NATIONAL EYE INSTITUTE [R01EY012155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vision Core Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported the National Institutes of Health (EY12155) to JC and by a Vision Core Grant to Doheny Eye Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; Alfinito PD, 2002, P NATL ACAD SCI USA, V99, P5655, DOI 10.1073/pnas.072557799; Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; Berson EL, 2002, INVEST OPHTH VIS SCI, V43, P3027; BLANKS JC, 1992, EXP EYE RES, V54, P637, DOI 10.1016/0014-4835(92)90019-O; Brill E, 2007, INVEST OPHTH VIS SCI, V48, P5445, DOI 10.1167/iovs.06-1402; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Chen J, 1999, INVEST OPHTH VIS SCI, V40, P2978; Chen JY, 2006, J NEUROSCI, V26, P11929, DOI 10.1523/JNEUROSCI.3212-06.2006; Concepcion F, 2002, VISION RES, V42, P417, DOI 10.1016/S0042-6989(01)00195-X; Danciger M, 2000, MAMM GENOME, V11, P422, DOI 10.1007/s003350010081; Deretic D, 2005, P NATL ACAD SCI USA, V102, P3301, DOI 10.1073/pnas.0500095102; Deretic D, 1998, P NATL ACAD SCI USA, V95, P10620, DOI 10.1073/pnas.95.18.10620; Deretic D, 1996, J BIOL CHEM, V271, P2279, DOI 10.1074/jbc.271.4.2279; Gregory-Evans K, 1998, TRENDS GENET, V14, P103, DOI 10.1016/S0168-9525(98)01402-4; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Hagstrom SA, 1999, INVEST OPHTH VIS SCI, V40, P2795; Hagstrom SA, 2001, INVEST OPHTH VIS SCI, V42, P1955; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Hao WS, 2002, NAT GENET, V32, P254, DOI 10.1038/ng984; HECKENLIVELY JR, 1995, P NATL ACAD SCI USA, V92, P11100, DOI 10.1073/pnas.92.24.11100; HODGES RS, 1988, J BIOL CHEM, V263, P11768; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Jozwick C, 2006, EXP EYE RES, V83, P1074, DOI 10.1016/j.exer.2006.05.012; KANAHO Y, 1984, J BIOL CHEM, V259, P7378; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; KUHN H, 1987, J RECEPTOR RES, V7, P283, DOI 10.3109/10799898709054990; LAIRD DW, 1988, INVEST OPHTH VIS SCI, V29, P419; Lee ES, 2007, INVEST OPHTH VIS SCI, V48, P2868, DOI 10.1167/iovs.06-0035; Lee ES, 2006, INVEST OPHTH VIS SCI, V47, P2150, DOI 10.1167/iovs.05-0919; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Li TS, 1996, P NATL ACAD SCI USA, V93, P14176, DOI 10.1073/pnas.93.24.14176; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Mendez A, 2000, METHOD ENZYMOL, V316, P167; Metaye T, 2005, CELL SIGNAL, V17, P917, DOI 10.1016/j.cellsig.2005.01.002; Naash MI, 1996, J NEUROSCI, V16, P7853; Noell W K, 1966, Invest Ophthalmol, V5, P450; NOELL WK, 1980, VISION RES, V20, P1163, DOI 10.1016/0042-6989(80)90055-3; Oguni N, 1996, HISTOCHEM CELL BIOL, V106, P235; Oh KT, 2003, AM J OPHTHALMOL, V136, P306, DOI 10.1016/S0002-9394(03)00206-X; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Organisciak DT, 2003, INVEST OPHTH VIS SCI, V44, P486, DOI 10.1167/iovs.02-0708; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; Rivolta C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/hmg/11.10.1219; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; Roca A, 2004, NEUROSCIENCE, V129, P779, DOI 10.1016/j.neuroscience.2004.08.021; Shi G, 2004, REC ADV HUM BIOL, V10, P93; Sim-Selley LJ, 2002, METHOD ENZYMOL, V344, P42; Sohocki MM, 2001, HUM MUTAT, V17, P42, DOI 10.1002/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO;2-K; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; SUNG CH, 1993, J BIOL CHEM, V268, P26645; SUNG CH, 1994, J NEUROSCI, V14, P5818; Tam BM, 2006, J NEUROSCI, V26, P203, DOI 10.1523/JNEUROSCI.3849-05.2006; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Taylor MR, 2000, METHOD ENZYMOL, V316, P536; Terakita A, 2002, J BIOL CHEM, V277, P40, DOI 10.1074/jbc.M104960200; Vaughan DK, 2003, INVEST OPHTH VIS SCI, V44, P848, DOI 10.1167/iovs.02-0709; Wang DY, 2005, CLIN CHIM ACTA, V351, P5, DOI 10.1016/j.cccn.2004.08.004; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; White DA, 2007, INVEST OPHTH VIS SCI, V48, P1942, DOI 10.1167/iovs.06-1131; ZACK DJ, 1991, NEURON, V6, P187, DOI 10.1016/0896-6273(91)90355-4; Zhang X, 2003, J NEUROSCI, V23, P1287, DOI 10.1523/JNEUROSCI.23-04-01287.2003	69	49	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2010	5	6							e10904	10.1371/journal.pone.0010904	http://dx.doi.org/10.1371/journal.pone.0010904			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604NC	20532191	Green Submitted, Green Published, gold			2022-12-27	WOS:000278284700003
J	Siontis, GCM; Patsopoulos, NA; Vlahos, AP; Ioannidis, JPA				Siontis, George C. M.; Patsopoulos, Nikolaos A.; Vlahos, Antonios P.; Ioannidis, John P. A.			Selection and Presentation of Imaging Figures in the Medical Literature	PLOS ONE			English	Article							DIAGNOSTIC-ACCURACY; REPORTING GUIDELINES; QUALITY	Background: Images are important for conveying information, but there is no empirical evidence on whether imaging figures are properly selected and presented in the published medical literature. We therefore evaluated the selection and presentation of radiological imaging figures in major medical journals. Methodology/Principal Findings: We analyzed articles published in 2005 in 12 major general and specialty medical journals that had radiological imaging figures. For each figure, we recorded information on selection, study population, provision of quantitative measurements, color scales and contrast use. Overall, 417 images from 212 articles were analyzed. Any comment/hint on image selection was made in 44 (11%) images (range 0-50% across the 12 journals) and another 37 (9%) (range 0-60%) showed both a normal and abnormal appearance. In 108 images (26%) (range 0-43%) it was unclear whether the image came from the presented study population. Eighty-three images (20%) (range 0-60%) had any quantitative or ordered categorical value on a measure of interest. Information on the distribution of the measure of interest in the study population was given in 59 cases. For 43 images (range 0-40%), a quantitative measurement was provided for the depicted case and the distribution of values in the study population was also available; in those 43 cases there was no over-representation of extreme than average cases (p = 0.37). Significance: The selection and presentation of images in the medical literature is often insufficiently documented; quantitative data are sparse and difficult to place in context.	[Siontis, George C. M.; Patsopoulos, Nikolaos A.; Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin Trials & Evidence Based Med Unit, GR-45110 Ioannina, Greece; [Vlahos, Antonios P.] Univ Ioannina, Sch Med, Dept Pediat, GR-45110 Ioannina, Greece; [Ioannidis, John P. A.] Fdn Res & Technol Hellas, Biomed Res Inst, Ioannina, Greece; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Dept Med, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; [Ioannidis, John P. A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	University of Ioannina; University of Ioannina; Foundation for Research & Technology - Hellas (FORTH); Tufts University; Harvard University; Harvard T.H. Chan School of Public Health	Siontis, GCM (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin Trials & Evidence Based Med Unit, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Ioannidis, John P. A./G-9836-2011	Patsopoulos, Nikolaos/0000-0003-3757-8941				Altman DG, 2008, LANCET, V371, P1149, DOI 10.1016/S0140-6736(08)60505-X; Bossuyt PMM, 2009, J CLIN EPIDEMIOL, V62, P355, DOI 10.1016/j.jclinepi.2008.11.002; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Couzin J, 2006, SCIENCE, V314, P1866, DOI 10.1126/science.314.5807.1866; Douglas PS, 2006, J AM COLL CARDIOL, V48, P2152, DOI 10.1016/j.jacc.2006.04.107; Hermoye L, 2005, RADIOLOGY, V234, P171, DOI 10.1148/radiol.2341031801; Knottnerus JA, 2003, J CLIN EPIDEMIOL, V56, P1118, DOI 10.1016/S0895-4356(03)00206-3; Lawler A, 2001, SCIENCE, V292, P1044, DOI 10.1126/science.292.5519.1044; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Pearson H, 2005, NATURE, V434, P952, DOI 10.1038/434952a; Schriger DL, 2006, ANN EMERG MED, V48, P750, DOI 10.1016/j.annemergmed.2006.06.017; Smidt N, 2005, RADIOLOGY, V235, P347, DOI 10.1148/radiol.2352040507; Smidt N, 2006, NEUROLOGY, V67, P792, DOI 10.1212/01.wnl.0000238386.41398.30; Smidt Nynke, 2006, BMC Med Res Methodol, V6, P12, DOI 10.1186/1471-2288-6-12; Tack D, 2005, RADIOLOGY, V236, P318, DOI 10.1148/radiol.2361040190; Whiting Penny F, 2006, BMC Med Res Methodol, V6, P9, DOI 10.1186/1471-2288-6-9; 2010, THOMSON J CITATION R	18	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10888	10.1371/journal.pone.0010888	http://dx.doi.org/10.1371/journal.pone.0010888			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20526360	Green Published, Green Submitted, gold			2022-12-27	WOS:000278222100017
J	Tonge, PD; Olariu, V; Coca, D; Kadirkamanathan, V; Burrell, KE; Billings, SA; Andrews, PW				Tonge, Peter D.; Olariu, Victor; Coca, Daniel; Kadirkamanathan, Visakan; Burrell, Kelly E.; Billings, Stephen A.; Andrews, Peter W.			Prepatterning in the Stem Cell Compartment	PLOS ONE			English	Article							NEURONAL DIFFERENTIATION; TERATOCARCINOMA CELLS; INFORMATION CRITERION; LINEAGE-COMMITMENT; NEURAL PRECURSORS; PROGENITOR CELLS; MODEL SELECTION; GLOBO-SERIES; IN-VITRO; PLURIPOTENCY	The mechanism by which an apparently uniform population of cells can generate a heterogeneous population of differentiated derivatives is a fundamental aspect of pluripotent and multipotent stem cell behaviour. One possibility is that the environment and the differentiation cues to which the cells are exposed are not uniform. An alternative, but not mutually exclusive possibility is that the observed heterogeneity arises from the stem cells themselves through the existence of different interconvertible substates that pre-exist before the cells commit to differentiate. We have tested this hypothesis in the case of apparently homogeneous pluripotent human embryonal carcinoma (EC) stem cells, which do not follow a uniform pattern of differentiation when exposed to retinoic acid. Instead, they produce differentiated progeny that include both neuronal and non-neural phenotypes. Our results suggest that pluripotent NTERA2 stem cells oscillate between functionally distinct substates that are primed to select distinct lineages when differentiation is induced.	[Tonge, Peter D.; Burrell, Kelly E.; Andrews, Peter W.] Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England; [Olariu, Victor; Coca, Daniel; Kadirkamanathan, Visakan; Billings, Stephen A.] Univ Sheffield, Dept Automat Control & Syst Engn, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield	Tonge, PD (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	p.w.andrews@sheffield.ac.uk		Andrews, Peter/0000-0001-7215-4410; Kadirkamanathan, Visakan/0000-0002-4243-2501	Medical Research Council; Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council; European Research Council; European Union [LSHG-CT-2006-018739]; EPSRC [EP/G042209/1, EP/H00453X/1] Funding Source: UKRI; MRC [G0802627, G0700785] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H00453X/1, EP/G042209/1] Funding Source: researchfish; Medical Research Council [G0802627, G0700785] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors gratefully acknowledge that this work was supported by funding from the Medical Research Council (www.mrc.ac.uk), the Engineering and Physical Sciences Research Council (www.epsrc.ac.uk), Biotechnology and Biological Sciences Research Council (www.bbscr.ac.uk), European Research Council (erc.europa.eu) and the ESTOOLS consortium (www.estools.eu), under the Sixth Research Framework Programme of the European Union contract LSHG-CT-2006-018739. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akaike H., 1971, P 2 INT S INF THEOR, P267, DOI DOI 10.2307/2334537; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bauwens CL, 2008, STEM CELLS, V26, P2300, DOI 10.1634/stemcells.2008-0183; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Bozdogan H, 2000, J MATH PSYCHOL, V44, P62, DOI 10.1006/jmps.1999.1277; BURNHAM KP, 1999, MODEL SELECTION MULT; Burridge PW, 2007, STEM CELLS, V25, P929, DOI 10.1634/stemcells.2006-0598; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chickarmane V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000268; Crawford TQ, 2007, DEV DYNAM, V236, P886, DOI 10.1002/dvdy.21083; Delassus S, 1999, BLOOD, V94, P1495, DOI 10.1182/blood.V94.5.1495.417a08_1495_1503; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Erceg S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002122; FENDERSON BA, 1987, DEV BIOL, V122, P21, DOI 10.1016/0012-1606(87)90328-9; Forster MR, 2000, J MATH PSYCHOL, V44, P205, DOI 10.1006/jmps.1999.1284; Gan Q, 2007, STEM CELLS, V25, P2, DOI 10.1634/stemcells.2006-0383; GOKHALE DV, 1978, COMMUNICATIONS STAT, V10, P987; Guenechea G, 2001, NAT IMMUNOL, V2, P75, DOI 10.1038/83199; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; HUEBNER K, 1981, P NATL ACAD SCI-BIOL, V78, P5071, DOI 10.1073/pnas.78.8.5071; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; KOHLER G, 1975, NATURE, V256, P497; KULLBACK DVG, 1978, INFORM CONTINGENCY T; Laslett AL, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-12; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; MARTIN GR, 1975, P NATL ACAD SCI USA, V72, P1441, DOI 10.1073/pnas.72.4.1441; Ng ES, 2005, BLOOD, V106, P1601, DOI 10.1182/blood-2005-03-0987; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; WAN JKS, 2008, NUCL ACIDS RES, V6; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	45	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2010	5	5							e10901	10.1371/journal.pone.0010901	http://dx.doi.org/10.1371/journal.pone.0010901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	603QC	20531938	Green Accepted, gold, Green Published			2022-12-27	WOS:000278222100030
J	Zhang, Q; Yang, RY; Tang, JJ; Yang, HS; Hu, SJ; Chen, X				Zhang, Qian; Yang, Ruyi; Tang, Jianjun; Yang, Haishui; Hu, Shuijin; Chen, Xin			Positive Feedback between Mycorrhizal Fungi and Plants Influences Plant Invasion Success and Resistance to Invasion	PLOS ONE			English	Article							SOLIDAGO-CANADENSIS L.; SOIL BIOTA; COMMUNITY STRUCTURE; GROWTH; GRASS; NITROGEN; COLONIZATION; COEXISTENCE; SERPENTINE; DIVERSITY	Negative or positive feedback between arbuscular mycorrhizal fungi (AMF) and host plants can contribute to plant species interactions, but how this feedback affects plant invasion or resistance to invasion is not well known. Here we tested how alterations in AMF community induced by an invasive plant species generate feedback to the invasive plant itself and affect subsequent interactions between the invasive species and its native neighbors. We first examined the effects of the invasive forb Solidago canadensis L. on AMF communities comprising five different AMF species. We then examined the effects of the altered AMF community on mutualisms formed with the native legume forb species Kummerowia striata (Thunb.) Schindl. and on the interaction between the invasive and native plants. The host preferences of the five AMF were also assessed to test whether the AMF form preferred mutualistic relations with the invasive and/or the native species. We found that S. canadensis altered AMF spore composition by increasing one AMF species (Glomus geosporum) while reducing Glomus mosseae, which is the dominant species in the field. The host preference test showed that S. canadensis had promoted the abundance of AMF species (G. geosporum) that most promoted its own growth. As a consequence, the altered AMF community enhanced the competitiveness of invasive S. canadensis at the expense of K. striata. Our results demonstrate that the invasive S. canadensis alters soil AMF community composition because of fungal-host preference. This change in the composition of the AMF community generates positive feedback to the invasive S. canadensis itself and decreases AM associations with native K. striata, thereby making the native K. striata less dominant.	[Zhang, Qian; Yang, Ruyi; Tang, Jianjun; Yang, Haishui; Chen, Xin] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Ruyi] Anhui Normal Univ, Coll Environm Sci, Wuhu, Peoples R China; [Hu, Shuijin] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA	Zhejiang University; Anhui Normal University; University of North Carolina; North Carolina State University	Chen, X (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	chen-tang@zju.edu.cn	Schlyter, Fredrik/F-8567-2015	Schlyter, Fredrik/0000-0002-1244-0308; Hu, Shuijin/0000-0002-3225-5126; Yang, Haishui/0000-0001-7255-9653	Zhejiang Provincial Natural Science Foundation of China [Z5090089]; Research Fund for the Doctoral Program of Higher Education of China (RFDP) [20070335079]; Natural Science Foundation of China (NSFC) [3073020, 30870405]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Research Fund for the Doctoral Program of Higher Education of China (RFDP)(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the Zhejiang Provincial Natural Science Foundation of China (No. Z5090089), the Research Fund for the Doctoral Program of Higher Education of China (RFDP, No. 20070335079), and the Natural Science Foundation of China (NSFC, No. 3073020 and 30870405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batten KM, 2006, BIOL INVASIONS, V8, P217, DOI 10.1007/s10530-004-3856-8; Bever JD, 2009, ECOL LETT, V12, P13, DOI 10.1111/j.1461-0248.2008.01254.x; Bever JD, 2002, PLANT SOIL, V244, P281, DOI 10.1023/A:1020221609080; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Bever JD, 1996, J ECOL, V84, P71, DOI 10.2307/2261701; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Bever JD, 2002, P ROY SOC B-BIOL SCI, V269, P2595, DOI 10.1098/rspb.2002.2162; Bray SR, 2003, ECOL APPL, V13, P565, DOI 10.1890/1051-0761(2003)013[0565:MDAGPA]2.0.CO;2; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P1007, DOI 10.2136/sssaj1993.03615995005700040021x; Callaway RM, 2008, ECOLOGY, V89, P1043, DOI 10.1890/07-0370.1; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Carey EV, 2004, PLANT ECOL, V172, P133, DOI 10.1023/B:VEGE.0000026031.14086.f1; Chen X, 2005, APPL SOIL ECOL, V28, P259, DOI 10.1016/j.apsoil.2004.07.009; Chen X, 2004, AGR ECOSYST ENVIRON, V102, P377, DOI 10.1016/j.agee.2003.08.006; Cornejo P, 2004, FEMS MICROBIOL LETT, V241, P265, DOI 10.1016/j.femsle.2004.10.030; Eom AH, 2000, OECOLOGIA, V122, P435, DOI 10.1007/s004420050050; Fransen B, 2001, ECOLOGY, V82, P2534, DOI 10.1890/0012-9658(2001)082[2534:SNHACB]2.0.CO;2; GERDEMANN J. W., 1963, TRANS BRIT MYCOL SOC, V46, P235; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hausmann NT, 2009, NEW PHYTOL, V183, P1188, DOI 10.1111/j.1469-8137.2009.02882.x; Hawkes CV, 2006, PLANT SOIL, V281, P369, DOI 10.1007/s11104-005-4826-3; Hu S, 2001, NATURE, V409, P188, DOI 10.1038/35051576; Jansa J, 2008, NEW PHYTOL, V177, P779, DOI 10.1111/j.1469-8137.2007.02294.x; Kiers ET, 2006, ECOLOGY, V87, P1627, DOI 10.1890/0012-9658(2006)87[1627:MSITAM]2.0.CO;2; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Kowalchuk GA, 2002, MOL ECOL, V11, P571, DOI 10.1046/j.0962-1083.2001.01457.x; Liang ZB, 2008, SOIL BIOL BIOCHEM, V40, P956, DOI 10.1016/j.soilbio.2007.11.016; Lu JZ, 2007, ACTA PHYTOTAXON SIN, V45, P670, DOI 10.1360/aps06200; Marler MJ, 1999, ECOLOGY, V80, P1180, DOI 10.1890/0012-9658(1999)080[1180:MIECEO]2.0.CO;2; Moora M, 2004, FUNCT ECOL, V18, P554, DOI 10.1111/j.0269-8463.2004.00876.x; Mummey DL, 2006, PLANT SOIL, V288, P81, DOI 10.1007/s11104-006-9091-6; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Olsen S. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P403; PLENCHETTE C, 1983, PLANT SOIL, V70, P199, DOI 10.1007/BF02374780; Reinhart KO, 2006, NEW PHYTOL, V170, P445, DOI 10.1111/j.1469-8137.2006.01715.x; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Schechter SP, 2008, MOL ECOL, V17, P3198, DOI 10.1111/j.1365-294X.2008.03828.x; SCHEUBLIN TR, 2007, J ECOL, V85, P2682; Seifert EK, 2009, ECOLOGY, V90, P1055, DOI 10.1890/08-0419.1; SEMPLE JC, 2006, FLORA N AM MAGNOLI 2; SEMPLE JC, 2006, FLORA N AM MAGNOLI 7; SIMON L, 1992, APPL ENVIRON MICROB, V58, P291, DOI 10.1128/AEM.58.1.291-295.1992; Stampe ED, 2003, OIKOS, V100, P362, DOI 10.1034/j.1600-0706.2003.12006.x; Stinson KA, 2006, PLOS BIOL, V4, P727, DOI 10.1371/journal.pbio.0040140; Sykorova Z, 2007, APPL ENVIRON MICROB, V73, P5426, DOI 10.1128/AEM.00987-07; Tanaka Y, 2005, PLANT CELL ENVIRON, V28, P1247, DOI 10.1111/j.1365-3040.2005.01360.x; Tang J.J., 2009, B SCI TECHNOLOGY, V25, P233; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van der Heijden MGA, 2003, NEW PHYTOL, V157, P569, DOI 10.1046/j.1469-8137.2003.00688.x; van der Putten WH, 2007, ECOLOGY, V88, P978, DOI 10.1890/06-1051; Vandenkoornhuyse P, 2003, MOL ECOL, V12, P3085, DOI 10.1046/j.1365-294X.2003.01967.x; Vogelsang KM, 2009, ECOLOGY, V90, P399, DOI 10.1890/07-2144.1; Weber E, 2001, CONSERV BIOL, V15, P122, DOI 10.1046/j.1523-1739.2001.99424.x; Yang RY, 2007, ALLELOPATHY J, V19, P241; ZANBINKI CA, 2002, FUNCT ECOL, V16, P758; Zhang Q, 2007, ALLELOPATHY J, V20, P71; Zhang SS, 2009, APPL SOIL ECOL, V41, P215, DOI 10.1016/j.apsoil.2008.11.002	60	126	144	8	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12380	10.1371/journal.pone.0012380	http://dx.doi.org/10.1371/journal.pone.0012380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20548795	Green Submitted, gold, Green Published			2022-12-27	WOS:000281154300014
J	Jensen, MA; Fukushima, M; Davis, RW				Jensen, Michael A.; Fukushima, Marilyn; Davis, Ronald W.			DMSO and Betaine Greatly Improve Amplification of GC-Rich Constructs in De Novo Synthesis	PLOS ONE			English	Article							FACTOR-II RECEPTOR; ESCHERICHIA-COLI; PCR-AMPLIFICATION; DNA AMPLIFICATION; REPEAT SEQUENCES; GENE SYNTHESIS; GENOME; CANCER; EXPRESSION; GROWTH	In Synthetic Biology, de novo synthesis of GC-rich constructs poses a major challenge because of secondary structure formation and mispriming. While there are many web-based tools for codon optimizing difficult regions, no method currently exists that allows for potentially phenotypically important sequence conservation. Therefore, to overcome these limitations in researching GC-rich genes and their non-coding elements, we explored the use of DMSO and betaine in two conventional methods of assembly and amplification. For this study, we compared the polymerase (PCA) and ligase-based (LCR) methods for construction of two GC-rich gene fragments implicated in tumorigenesis, IGF2R and BRAF. Though we found no benefit in employing either DMSO or betaine during the assembly steps, both additives greatly improved target product specificity and yield during PCR amplification. Of the methods tested, LCR assembly proved far superior to PCA, generating a much more stable template to amplify from. We further report that DMSO and betaine are highly compatible with all other reaction components of gene synthesis and do not require any additional protocol modifications. Furthermore, we believe either additive will allow for the production of a wide variety of GC-rich gene constructs without the need for expensive and time-consuming sample extraction and purification prior to downstream application.	[Jensen, Michael A.; Fukushima, Marilyn; Davis, Ronald W.] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA	Stanford University	Jensen, MA (corresponding author), Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA.	m.a.jensen@stanford.edu	; Kjaer, Andreas/E-8932-2015	Bjorkling, Fredrik/0000-0001-7018-8334; Kjaer, Andreas/0000-0002-2706-5547; Erichsen, Kamille Dumong/0000-0002-8814-7220	National Institutes of Health [P01-HG000205]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Institutes of Health [P01-HG000205]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au LC, 1998, BIOCHEM BIOPH RES CO, V248, P200, DOI 10.1006/bbrc.1998.8929; BACHMANN B, 1990, NUCLEIC ACIDS RES, V18, P1309, DOI 10.1093/nar/18.5.1309; BARANY F, 1991, P NATL ACAD SCI USA, V88, P189, DOI 10.1073/pnas.88.1.189; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; BRODY RS, 1986, J BIOL CHEM, V261, P7136; CHOU Q, 1992, NUCLEIC ACIDS RES, V20, P4371, DOI 10.1093/nar/20.16.4371; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; D'Souza GGM, 2007, PHARM RES-DORDR, V24, P228, DOI 10.1007/s11095-006-9150-y; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Drouin R, 2005, BIOCHEM CELL BIOL, V83, P147, DOI 10.1139/O04-134; FRACKMAN S, 1998, BETAINE DMSO ENHANCI; Frey UH, 2008, NAT PROTOC, V3, P1312, DOI 10.1038/nprot.2008.112; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Hakkaart GAJ, 2006, EMBO REP, V7, P341, DOI 10.1038/sj.embor.7400601; Hapgood JP, 2001, CELL BIOL INT, V25, P17, DOI 10.1006/cbir.2000.0674; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Jayaraj S, 2005, NUCLEIC ACIDS RES, V33, P3011, DOI 10.1093/nar/gki614; KHORANA HG, 1979, SCIENCE, V203, P614, DOI 10.1126/science.366749; Kotsinas A, 2008, CANCER LETT, V259, P177, DOI 10.1016/j.canlet.2007.10.013; Marcuello E, 2004, INT J CANCER, V112, P733, DOI 10.1002/ijc.20487; MCCONLOGUE L, 1988, NUCLEIC ACIDS RES, V16, P9869, DOI 10.1093/nar/16.20.9869; McDowell DG, 1998, NUCLEIC ACIDS RES, V26, P3340, DOI 10.1093/nar/26.14.3340; Meyer Peter, 2003, J Carcinog, V2, P7, DOI 10.1186/1477-3163-2-7; MORGAN DO, 1987, NATURE, V329, P301, DOI 10.1038/329301a0; PANZER S, 1995, STEM CELLS, V13, P146, DOI 10.1002/stem.5530130206; REES WA, 1993, BIOCHEMISTRY-US, V32, P137, DOI 10.1021/bi00052a019; Richardson SM, 2006, GENOME RES, V16, P550, DOI 10.1101/gr.4431306; Rouillard JM, 2004, NUCLEIC ACIDS RES, V32, pW176, DOI 10.1093/nar/gkh401; Sahdev S, 2007, MOL CELL PROBE, V21, P303, DOI 10.1016/j.mcp.2007.03.004; Sanli G, 2001, J MOL MICROB BIOTECH, V3, P123; SARKAR G, 1990, NUCLEIC ACIDS RES, V18, P7465, DOI 10.1093/nar/18.24.7465; Simonsson T, 2001, BIOL CHEM, V382, P621, DOI 10.1515/BC.2001.073; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Spiess AN, 2004, CLIN CHEM, V50, P1256, DOI 10.1373/clinchem.2004.031336; Stahler P, 2006, J BIOTECHNOL, V124, P206, DOI 10.1016/j.jbiotec.2005.12.011; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; VARADARAJ K, 1994, GENE, V140, P1, DOI 10.1016/0378-1119(94)90723-4; WEISSMAN SM, 2000, Patent No. 6114150; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266; Zavras AI, 2003, CANCER RES, V63, P296; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	107	120	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11024	10.1371/journal.pone.0011024	http://dx.doi.org/10.1371/journal.pone.0011024			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20885974	Green Published, Green Submitted, gold			2022-12-27	WOS:000278662900007
J	Barott, K; Smith, J; Dinsdale, E; Hatay, M; Sandin, S; Rohwer, F				Barott, Katie; Smith, Jennifer; Dinsdale, Elizabeth; Hatay, Mark; Sandin, Stuart; Rohwer, Forest			Hyperspectral and Physiological Analyses of Coral-Algal Interactions	PLOS ONE			English	Article							CLIMATE-CHANGE; REEF COMMUNITY; MASS MORTALITY; ORGANIC-CARBON; PHASE-SHIFTS; COMPETITION; FLUORESCENCE; REFLECTANCE; DEGRADATION; MACROALGAE	Space limitation leads to competition between benthic, sessile organisms on coral reefs. As a primary example, reef-building corals are in direct contact with each other and many different species and functional groups of algae. Here we characterize interactions between three coral genera and three algal functional groups using a combination of hyperspectral imaging and oxygen microprofiling. We also performed in situ interaction transects to quantify the relative occurrence of these interaction on coral reefs. These studies were conducted in the Southern Line Islands, home to some of the most remote and near-pristine reefs in the world. Our goal was to determine if different types of coral-coral and coral-algal interactions were characterized by unique fine-scale physiological signatures. This is the first report using hyperspectral imaging for characterization of marine benthic organisms at the micron scale and proved to be a valuable tool for discriminating among different photosynthetic organisms. Consistent patterns emerged in physiology across different types of competitive interactions. In cases where corals were in direct contact with turf or macroalgae, there was a zone of hypoxia and altered pigmentation on the coral. In contrast, interaction zones between corals and crustose coralline algae (CCA) were not hypoxic and the coral tissue was consistent across the colony. Our results suggest that at least two main characteristic coral interaction phenotypes exist: 1) hypoxia and coral tissue disruption, seen with interactions between corals and fleshy turf and/or some species of macroalgae, and 2) no hypoxia or tissue disruption, seen with interactions between corals and some species of CCA. Hyperspectral imaging in combination with oxygen profiling provided useful information on competitive interactions between benthic reef organisms, and demonstrated that some turf and fleshy macroalgae can be a constant source of stress for corals, while CCA are not.	[Barott, Katie; Dinsdale, Elizabeth; Hatay, Mark; Rohwer, Forest] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Smith, Jennifer; Sandin, Stuart] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	California State University System; San Diego State University; University of California System; University of California San Diego; Scripps Institution of Oceanography	Barott, K (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	katiebarott@gmail.com	Rohwer, Forest/AAC-5315-2019	dinsdale, elizabeth/0000-0002-2177-203X; Obura, David/0000-0003-2256-6649; Barott, Katie/0000-0001-7371-4870; Rohwer, Forest/0000-0003-1548-5429	San Diego State University; Gordon and Betty Moore Foundation; Canadian Institute for Advanced Research; National Geographic Society; National Science Foundation	San Diego State University; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF))	Funding for this work was provided by San Diego State University, the Gordon and Betty Moore Foundation, and the Canadian Institute for Advanced Research. The Southern Line Islands expedition was organized and sponsored by the National Geographic Society. KB was supported by a National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey WH, 1998, J PHYCOL, V34, P393, DOI 10.1046/j.1529-8817.1998.340393.x; Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; BENAYAHU Y, 1981, B MAR SCI, V31, P514; Bou-Abdallah F, 2006, BBA-GEN SUBJECTS, V1760, P1690, DOI 10.1016/j.bbagen.2006.08.014; Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001; CARPENTER RC, 1988, P NATL ACAD SCI USA, V85, P511, DOI 10.1073/pnas.85.2.511; CHORNESKY EA, 1983, BIOL BULL, V165, P569, DOI 10.2307/1541466; CHORNESKY EA, 1989, ECOLOGY, V70, P843, DOI 10.2307/1941353; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Gross EM, 2003, CRIT REV PLANT SCI, V22, P313, DOI 10.1080/713610859; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hattery D, 2002, 31ST APPLIED IMAGERY PATTERN RECOGNITION WORKSHOP, PROCEEDINGS, P124; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hochberg EJ, 2004, CORAL REEFS, V23, P84, DOI 10.1007/s00338-003-0350-1; Hochberg EJ, 2000, CORAL REEFS, V19, P164, DOI 10.1007/s003380000087; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; JORDAN CF, 1969, ECOLOGY, V50, P663, DOI 10.2307/1936256; KAUFMAN YJ, 1992, IEEE T GEOSCI REMOTE, V30, P261, DOI 10.1109/36.134076; KAWAGUTI S, 1944, PHYSL REEF CORALS, V6; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Kuntz NM, 2005, MAR ECOL PROG SER, V294, P173, DOI 10.3354/meps294173; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; LOGAN A, 1984, CORAL REEFS, V3, P131, DOI 10.1007/BF00301957; MAZEL CH, 1995, MAR ECOL PROG SER, V120, P185, DOI 10.3354/meps120185; Mazel CH, 1997, OPT ENG, V36, P2612, DOI 10.1117/1.601486; Mazel CH, 1997, P SOC PHOTO-OPT INS, V2963, P240, DOI 10.1117/12.266450; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; Miller MW, 1998, OCEANOGR MAR BIOL<D>, V36, P65; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; Mumby PJ, 2004, MAR POLLUT BULL, V48, P219, DOI 10.1016/j.marpolbul.2003.10.031; Myers MR, 1999, CORAL REEFS, V18, P179, DOI 10.1007/s003380050177; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Ostrander GK, 2000, P NATL ACAD SCI USA, V97, P5297, DOI 10.1073/pnas.090104897; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pinter PJ, 2003, PHOTOGRAMM ENG REM S, V69, P647, DOI 10.14358/PERS.69.6.647; Rouse Jr. J.W., 1974, MONITORING VERNAL AD; Sabins FF, 1999, ORE GEOL REV, V14, P157, DOI 10.1016/S0169-1368(99)00007-4; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; SALIH A, 1997, P AUSTR COR REEF SOC, P217; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; SCHLICHTER D, 1994, OECOLOGIA, V99, P124, DOI 10.1007/BF00317092; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Tanner JE, 1997, J EXP MAR BIOL ECOL, V214, P19, DOI 10.1016/S0022-0981(97)00024-5; Thenkabail PS, 2000, REMOTE SENS ENVIRON, V71, P158, DOI 10.1016/S0034-4257(99)00067-X; Vermeij MJA, 2009, OECOLOGIA, V159, P325, DOI 10.1007/s00442-008-1223-7; VOGEL A, 2007, J BIOMED OPT, V12; WELLINGTON GM, 1980, OECOLOGIA, V47, P340, DOI 10.1007/BF00398527; Wilkinson C., 2004, STATUS CORAL REEFS W; Zawada DG, 2003, LIMNOL OCEANOGR, V48, P412, DOI 10.4319/lo.2003.48.1_part_2.0412	57	103	106	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2009	4	11							e8043	10.1371/journal.pone.0008043	http://dx.doi.org/10.1371/journal.pone.0008043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MN	19956632	gold, Green Submitted, Green Published			2022-12-27	WOS:000272828100006
J	Cox, MJ; Allgaier, M; Taylor, B; Baek, MS; Huang, YJ; Daly, RA; Karaoz, U; Andersen, GL; Brown, R; Fujimura, KE; Wu, B; Tran, D; Koff, J; Kleinhenz, ME; Nielson, D; Brodie, EL; Lynch, SV				Cox, Michael J.; Allgaier, Martin; Taylor, Byron; Baek, Marshall S.; Huang, Yvonne J.; Daly, Rebecca A.; Karaoz, Ulas; Andersen, Gary L.; Brown, Ronald; Fujimura, Kei E.; Wu, Brian; Tran, Diem; Koff, Jonathan; Kleinhenz, Mary Ellen; Nielson, Dennis; Brodie, Eoin L.; Lynch, Susan V.			Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients	PLOS ONE			English	Article							POPULATION-DYNAMICS; BACTERIAL DIVERSITY; LUNG-INFECTIONS; SPUTUM; EXACERBATIONS; PRODUCTIVITY; COMMUNITIES; PHYLOGENIES; ACTIVATION; SUCCESSION	Bacterial communities in the airways of cystic fibrosis (CF) patients are, as in other ecological niches, influenced by autogenic and allogenic factors. However, our understanding of microbial colonization in younger versus older CF airways and the association with pulmonary function is rudimentary at best. Using a phylogenetic microarray, we examine the airway microbiota in age stratified CF patients ranging from neonates (9 months) to adults (72 years). From a cohort of clinically stable patients, we demonstrate that older CF patients who exhibit poorer pulmonary function possess more uneven, phylogenetically-clustered airway communities, compared to younger patients. Using longitudinal samples collected form a subset of these patients a pattern of initial bacterial community diversification was observed in younger patients compared with a progressive loss of diversity over time in older patients. We describe in detail the distinct bacterial community profiles associated with young and old CF patients with a particular focus on the differences between respective "early'' and "late'' colonizing organisms. Finally we assess the influence of Cystic Fibrosis Transmembrane Regulator (CFTR) mutation on bacterial abundance and identify genotype-specific communities involving members of the Pseudomonadaceae, Xanthomonadaceae, Moraxellaceae and Enterobacteriaceae amongst others. Data presented here provides insights into the CF airway microbiota, including initial diversification events in younger patients and establishment of specialized communities of pathogens associated with poor pulmonary function in older patient populations.	[Cox, Michael J.; Huang, Yvonne J.; Fujimura, Kei E.; Wu, Brian; Koff, Jonathan; Kleinhenz, Mary Ellen; Nielson, Dennis; Lynch, Susan V.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Allgaier, Martin; Taylor, Byron; Baek, Marshall S.; Brown, Ronald] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Daly, Rebecca A.; Karaoz, Ulas; Andersen, Gary L.; Brodie, Eoin L.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Ecol, Berkeley, CA 94720 USA; [Daly, Rebecca A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Huang, Yvonne J.; Koff, Jonathan; Kleinhenz, Mary Ellen] Univ Calif San Francisco, Adult Cyst Fibrosis Program, San Francisco, CA 94143 USA; [Wu, Brian; Tran, Diem; Nielson, Dennis] Univ Calif San Francisco, Pediat Cyst Fibrosis Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cox, MJ (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	susan.lynch@ucsf.edu	Lynch, Susan V/B-6272-2009; Karaoz, Ulas/J-7093-2014; Andersen, Gary/G-2792-2015; Cox, Michael/A-6959-2010; Brodie, Eoin L/A-7853-2008; Huang, Yvonne/A-7360-2015	Karaoz, Ulas/0000-0002-8238-6757; Andersen, Gary/0000-0002-1618-9827; Brodie, Eoin L/0000-0002-8453-8435; Cox, Michael/0000-0002-4002-1506; Nielson, Dennis/0000-0003-0275-8942; Huang, Yvonne/0000-0002-7497-6597; Daly, Rebecca/0000-0003-2223-7458	NIH/NIAID [AI075410]; CFRI; NIH/NHLBI [HL-073856]; STAR [FP-916933]; U.S. Environmental Protection Agency; US Department of Energy by the University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080074] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CFRI; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); STAR; U.S. Environmental Protection Agency(United States Environmental Protection Agency); US Department of Energy by the University of California, Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SVL, ELB, UK and GLA are supported by NIH/NIAID award AI075410 http://www.nih.gov/. MJC is supported by an Elizabeth Nash, CFRI research fellowship http://www.elizabethnashfoundation.org. DN is partly funded by NIH/NHLBI award HL-073856. RAD was supported under a STAR Research Assistance Agreement No. FP-916933 awarded by the U.S. Environmental Protection Agency. This publication has not been formally reviewed by the EPA http://www.epa.gov/. The views expressed in this publication are solely those of the group of authors and the EPA does not endorse any products or commercial services mentioned in this publication. Part of this work was performed under the auspices of the US Department of Energy by the University of California, Lawrence Berkeley National Laboratory, under Contract DE-AC02-05CH11231 http://www.lbl.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadori A, 2009, RESP MED, V103, P407, DOI 10.1016/j.rmed.2008.09.024; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Armougom F, 2009, EUR J CLIN MICROBIOL, V28, P1151, DOI 10.1007/s10096-009-0749-x; Atkinson TP, 2008, FEMS MICROBIOL REV, V32, P956, DOI 10.1111/j.1574-6976.2008.00129.x; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Bowman C M, 2002, J Cyst Fibros, V1, P194, DOI 10.1016/S1569-1993(02)00003-6; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; Bruzzese E, 2007, CLIN NUTR, V26, P322, DOI 10.1016/j.clnu.2007.01.004; Coenye T, 2002, J CLIN MICROBIOL, V40, P2062, DOI 10.1128/JCM.40.6.2062-2069.2002; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Flanagan JL, 2007, J CLIN MICROBIOL, V45, P1954, DOI 10.1128/JCM.02187-06; Gao-sheng Zhang, 2007, Journal of Zhejiang University-Science B, V8, P540, DOI 10.1631/jzus.2007.B0540; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; HAHN DL, 2002, FRONT BIOSCI, V7, P66; HAMADY M, 2009, ISME J IN PRESS; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hogardt M, 2008, JPN J INFECT DIS, V61, P77; HOIBY N, 1988, CHEST, V94, pS97, DOI 10.1378/chest.94.2_Supplement.97S; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Jackson CR, 2003, OIKOS, V101, P444, DOI 10.1034/j.1600-0706.2003.12254.x; Jahn HU, 2000, J INFECT DIS, V182, P1678, DOI 10.1086/317608; KEMBEL SW, 2008, PICANTE TOOLS INTEGR; Kerem B, 1996, EUR J HUM GENET, V4, P65; Kolak M, 2003, INT J MED MICROBIOL, V293, P309, DOI 10.1078/1438-4221-00265; Kumar PS, 2003, J DENT RES, V82, P338, DOI 10.1177/154405910308200503; Kumar PS, 2006, J CLIN MICROBIOL, V44, P3665, DOI 10.1128/JCM.00317-06; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; LAWLEY TD, 2009, INFECT IMMUN; Lawley TD, 2008, INFECT IMMUN, V76, P403, DOI 10.1128/IAI.01189-07; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; LEY R, 2006, NATURE, V444, P1023; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Marcante S, 2009, ANN BOT-LONDON, V103, P1129, DOI 10.1093/aob/mcp047; Martinez-Medina M, 2006, INFLAMM BOWEL DIS, V12, P1136, DOI 10.1097/01.mib.0000235828.09305.0c; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Meyer EH, 2006, P NATL ACAD SCI USA, V103, P2782, DOI 10.1073/pnas.0510282103; Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Pollard K.S., 2014, MULTTEST RESAMPLING; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; QIN J, NATURE, V464, P59; RAZVI S, 2009, CHEST; ROBERTS RC, 1983, INFECT IMMUN, V40, P553, DOI 10.1128/IAI.40.2.553-562.1983; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Rogers GB, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-49; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; Saiman Lisa, 2004, Paediatr Respir Rev, V5 Suppl A, pS367, DOI 10.1016/S1526-0542(04)90065-6; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Shen Y E, 1991, J Hyg Epidemiol Microbiol Immunol, V35, P309; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Song YL, 2006, AM J PHYSIOL-CELL PH, V290, pC741, DOI 10.1152/ajpcell.00379.2005; Souza Helena A. P. H. M., 2006, J. Pediatr. (Rio J.), V82, P377, DOI [10.1590/S0021-75572006000600012, 10.2223/JPED.1527]; STECHER B, PLOS PATHOG, V6; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Team RDC, 2019, R LANG ENV STAT COMP; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Wardle DA, 2003, SCIENCE, V300, P972, DOI 10.1126/science.1082709; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2006, ECOLOGY, V87, pS1, DOI 10.1890/0012-9658(2006)87[1:IPICE]2.0.CO;2; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Widdicombe JH, 2001, PFLUG ARCH EUR J PHY, V443, pS8; Zabner J, 1998, MOL CELL, V2, P397, DOI 10.1016/S1097-2765(00)80284-1	74	383	395	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11044	10.1371/journal.pone.0011044	http://dx.doi.org/10.1371/journal.pone.0011044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585638	Green Published, Green Submitted, gold			2022-12-27	WOS:000279135400003
J	Li, YH; Lu, WY; King, TD; Liu, CC; Bijur, GN; Bu, GJ				Li, Yonghe; Lu, Wenyan; King, Taj D.; Liu, Chia-Chen; Bijur, Gautam N.; Bu, Guojun			Dkk1 Stabilizes Wnt Co-Receptor LRP6: Implication for Wnt Ligand-Induced LRP6 Down-Regulation	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-6; KREMEN PROTEINS; WINGLESS; INTERNALIZATION; DICKKOPF-1; MECHANISM; ENDOCYTOSIS; ACTIVATION; INDUCTION; PATHWAYS	Background: The low density lipoprotein receptor-related protein-6 (LRP6) is an essential co-receptor for canonical Wnt signaling. Dickkopf 1 (Dkk1), a major secreted Wnt signaling antagonist, binds to LRP6 with high affinity and prevents the Frizzled-Wnt-LRP6 complex formation in response to Wnts. Previous studies have demonstrated that Dkk1 promotes LRP6 internalization and degradation when it forms a ternary complex with the cell surface receptor Kremen. Methodology/Principal Findings: In the present study, we found that transfected Dkk1 induces LRP6 accumulation while inhibiting Wnt/LRP6 signaling. Treatment with Dkk1-conditioned medium or recombinant Dkk1 protein stabilized LRP6 with a prolonged half-life and induces LRP6 accumulation both at the cell surface and in endosomes. We also demonstrated that Kremen2 co-expression abrogated the effect of Dkk1 on LRP6 accumulation, indicating that the effect of Kremen2 is dominant over Dkk1 regulation of LRP6. Furthermore, we found that Wnt3A treatment induces LRP6 down-regulation, an effect paralleled with a Wnt/LRP6 signaling decay, and that Dkk1 treatment blocked Wnt3A-induced LRP6 down-regulation. Finally, we found that LRP6 turnover was blocked by an inhibitor of caveolae-mediated endocytosis. Conclusions/Significance: Our results reveal a novel role for Dkk1 in preventing Wnt ligand-induced LRP6 down-regulation and contribute significantly to our understanding of Dkk1 function in Wnt/LRP6 signaling.	[Li, Yonghe; Lu, Wenyan; King, Taj D.] So Res Inst, Drug Discovery Div, Dept Biochem & Mol Biol, Birmingham, AL 35255 USA; [Li, Yonghe; Liu, Chia-Chen; Bu, Guojun] Washington Univ, St Louis Childrens Hosp, Dept Pediat, Sch Med, St Louis, MO 63110 USA; [Bu, Guojun] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Bijur, Gautam N.] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA	St. Louis Children's Hospital; Washington University (WUSTL); Washington University (WUSTL); University of Alabama System; University of Alabama Birmingham	Li, YH (corresponding author), So Res Inst, Drug Discovery Div, Dept Biochem & Mol Biol, Birmingham, AL 35255 USA.	y.li@sri.org; bu@wustl.edu		Du, Hanjian/0000-0002-2353-8802	National Institutes of Health [CA124531, AG031784, AG027924]; NATIONAL CANCER INSTITUTE [R01CA124531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG027924, R01AG027924, R01AG031784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: This work was supported in part by grants from the National Institutes of Health CA124531 (to Y.L.), and AG031784 and AG027924 (to G. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bafico A, 1998, ONCOGENE, V16, P2819, DOI 10.1038/sj.onc.1201797; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Davidson G, 2002, DEVELOPMENT, V129, P5587, DOI 10.1242/dev.00154; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Ellwanger K, 2008, MOL CELL BIOL, V28, P4875, DOI 10.1128/MCB.00222-08; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Hassler C, 2007, DEVELOPMENT, V134, P4255, DOI 10.1242/dev.005942; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Khan Z, 2007, MOL CELL BIOL, V27, P7291, DOI 10.1128/MCB.00773-07; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Li YH, 2005, J CELL SCI, V118, P5305, DOI 10.1242/jcs.02651; Li YH, 2004, ONCOGENE, V23, P9129, DOI 10.1038/sj.onc.1208123; Li Yonghe, 2005, Future Oncol, V1, P673, DOI 10.2217/14796694.1.5.673; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; Marois E, 2006, DEVELOPMENT, V133, P307, DOI 10.1242/dev.02197; Mi KH, 2005, J CELL BIOCHEM, V95, P328, DOI 10.1002/jcb.20400; Monaghan AP, 1999, MECH DEVELOP, V87, P45, DOI 10.1016/S0925-4773(99)00138-0; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Obermoeller LM, 1997, J BIOL CHEM, V272, P10761; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Rives AF, 2006, DEV BIOL, V293, P268, DOI 10.1016/j.ydbio.2006.02.006; Sakane H, 2010, J CELL SCI, V123, P360, DOI 10.1242/jcs.058008; Schulze J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010309; Semenov MV, 2008, J BIOL CHEM, V283, P21427, DOI 10.1074/jbc.M800014200; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003	40	93	97	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2010	5	6							e11014	10.1371/journal.pone.0011014	http://dx.doi.org/10.1371/journal.pone.0011014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	607IR	20543981	Green Published, gold, Green Submitted			2022-12-27	WOS:000278494900026
J	Cox, MJ; Huang, YJ; Fujimura, KE; Liu, JT; McKean, M; Boushey, HA; Segal, MR; Brodie, EL; Cabana, MD; Lynch, SV				Cox, Michael J.; Huang, Yvonne J.; Fujimura, Kei E.; Liu, Jane T.; McKean, Michelle; Boushey, Homer A.; Segal, Mark R.; Brodie, Eoin L.; Cabana, Michael D.; Lynch, Susan V.			Lactobacillus casei Abundance Is Associated with Profound Shifts in the Infant Gut Microbiome	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; IRRITABLE-BOWEL-SYNDROME; INTESTINAL MICROBIOTA; BACTERIAL DIVERSITY; PROBIOTIC BACTERIA; COMMUNITY ECOLOGY; ASTHMA PREVENTION; IMMUNE FUNCTION; ATOPIC DISEASE; CLONE LIBRARY	Colonization of the infant gut by microorganisms over the first year of life is crucial for development of a balanced immune response. Early alterations in the gastrointestinal microbiota of neonates has been linked with subsequent development of asthma and atopy in older children. Here we describe high-resolution culture-independent analysis of stool samples from 6-month old infants fed daily supplements of Lactobacillus casei subsp. Rhamnosus (LGG) or placebo in a double-blind, randomized Trial of Infant Probiotic Supplementation (TIPS). Bacterial community composition was examined using a high-density microarray, the 16S rRNA PhyloChip, and the microbial assemblages of infants with either high or low LGG abundance were compared. Communities with high abundance of LGG exhibited promotion of phylogenetically clustered taxa including a number of other known probiotic species, and were significantly more even in their distribution of community members. Ecologically, these aspects are characteristic of communities that are more resistant to perturbation and outgrowth of pathogens. PhyloChip analysis also permitted identification of taxa negatively correlated with LGG abundance that have previously been associated with atopy, as well as those positively correlated that may prove useful alternative targets for investigation as alternative probiotic species. From these findings we hypothesize that a key mechanism for the protective effect of LGG supplementation on subsequent development of allergic disease is through promotion of a stable, even, and functionally redundant infant gastrointestinal community.	[Cox, Michael J.; Fujimura, Kei E.; Lynch, Susan V.] Univ Calif San Francisco, Div Gastroenterol, San Francisco, CA 94143 USA; [Huang, Yvonne J.; Liu, Jane T.; Boushey, Homer A.; Cabana, Michael D.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [McKean, Michelle; Cabana, Michael D.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Segal, Mark R.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Brodie, Eoin L.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Dept Ecol, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Cox, MJ (corresponding author), Univ Calif San Francisco, Div Gastroenterol, San Francisco, CA 94143 USA.	susan.lynch@ucsf.edu	Lynch, Susan V/B-6272-2009; Karaoz, Ulas/J-7093-2014; Andersen, Gary/G-2792-2015; Cox, Michael/A-6959-2010; Brodie, Eoin L/A-7853-2008; Huang, Yvonne/A-7360-2015	Karaoz, Ulas/0000-0002-8238-6757; Andersen, Gary/0000-0002-1618-9827; Brodie, Eoin L/0000-0002-8453-8435; Cox, Michael/0000-0002-4002-1506; Nielson, Dennis/0000-0003-0275-8942; Huang, Yvonne/0000-0002-7497-6597; Daly, Rebecca/0000-0003-2223-7458	National Institutes of Health (NIH) [HL080074, HL074207]; Tobacco-Related Disease Research Program; National Institutes of Health/National Center for Research Resources (NIH/NCRR) [UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080074] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-Related Disease Research Program(University of California System); National Institutes of Health/National Center for Research Resources (NIH/NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SVL is supported by an American Lung Association Award (http://www.lungusa.org/), MDC and and HAB are supported by a National Institutes of Health (NIH) award (http://www.nih.gov/), HL080074 to MDC and HL074207 to HAB and ELB, and YLH by a Tobacco-Related Disease Research Program award (http://www.trdrp.org/). Part of this work was performed at Lawrence Berkeley National Laboratory under the auspices of the University of California under contract number DOE DE-AC02-05CH11231. This study was also supported in part by National Institutes of Health/National Center for Research Resources (NIH/NCRR) University of California San Francisco Clinical and Translational Science (UCSF-CTSI) Grant Number UL1 RR024131. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baken KA, 2006, INT J FOOD MICROBIOL, V112, P8, DOI 10.1016/j.ijfoodmicro.2006.06.009; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Barbara G, 2008, J CLIN GASTROENTEROL, V42, pS214, DOI 10.1097/MCG.0b013e31817da129; Barrett JS, 2008, WORLD J GASTROENTERO, V14, P5020, DOI 10.3748/wjg.14.5020; Bell SG, 2007, NEONATAL NETW, V26, P57, DOI 10.1891/0730-0832.26.1.57; Betsi GL, 2008, AM J CLIN DERMATOL, V9, P93, DOI 10.2165/00128071-200809020-00002; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Corr SC, 2009, ADV FOOD NUTR RES, V56, P1, DOI 10.1016/S1043-4526(08)00601-3; DeAngelis KM, 2009, ISME J, V3, P168, DOI 10.1038/ismej.2008.103; Delcenserie V, 2008, CURR ISSUES MOL BIOL, V10, P37; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edwards CA, 1996, BIOL ECOLOGY EARTHWO, DOI DOI 10.1016/S0167-8809(97)88859-7; Flanagan JL, 2007, J CLIN MICROBIOL, V45, P1954, DOI 10.1128/JCM.02187-06; Forsythe P, 2007, AM J RESP CRIT CARE, V175, P561, DOI 10.1164/rccm.200606-821OC; Galdeano CM, 2007, CLIN VACCINE IMMUNOL, V14, P485, DOI 10.1128/CVI.00406-06; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Ghadimi D, 2008, IMMUNOBIOLOGY, V213, P677, DOI 10.1016/j.imbio.2008.02.001; Gill H, 2008, ADV EXP MED BIOL, V606, P423, DOI 10.1007/978-0-387-74087-4_17; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hrncir T, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-65; Kalliomaki M., 2002, Current Drug Targets - Infectious Disorders, V2, P193; Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; KEMBEL SW, 2008, PICANTE TOOLS INTEGR; Kumar PS, 2006, J CLIN MICROBIOL, V44, P3665, DOI 10.1128/JCM.00317-06; KUVAEVA IB, 1984, NAHRUNG, V28, P689; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lawley TD, 2008, INFECT IMMUN, V76, P403, DOI 10.1128/IAI.01189-07; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; LEY R, 2006, NATURE, V444, P1023; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Liu AH, 2007, PAEDIATR PERINAT EP, V21, P2, DOI 10.1111/j.1365-3016.2007.00878.x; Maassen CBM, 2000, VACCINE, V18, P2613, DOI 10.1016/S0264-410X(99)00378-3; Nova E, 2007, BRIT J NUTR, V98, pS90, DOI 10.1017/S0007114507832983; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Park CW, 2008, J MED FOOD, V11, P405, DOI 10.1089/jmf.2007.0144; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Pollard K.S., 2014, MULTTEST RESAMPLING; Prescott SL, 1998, J IMMUNOL, V160, P4730; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rakoff-Nahoum S, 2008, MUCOSAL IMMUNOL, V1, pS10, DOI 10.1038/mi.2008.49; Sagaram US, 2009, APPL ENVIRON MICROB, V75, P1566, DOI 10.1128/AEM.02404-08; Sakamoto M, 2004, J MED MICROBIOL, V53, P563, DOI 10.1099/jmm.0.45576-0; Samanta M, 2009, J TROP PEDIATRICS, V55, P128, DOI 10.1093/tropej/fmn091; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Sepp E, 1997, ACTA PAEDIATR, V86, P956, DOI 10.1111/j.1651-2227.1997.tb15178.x; Shawkey MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004522; Staley JT, 2005, FEMS MICROBIOL LETT, V243, P9, DOI 10.1016/j.femsle.2004.11.034; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; SUNAGAWA S, 2009, ISME J; Team RDC, 2019, R LANG ENV STAT COMP; Teske A, 2002, APPL ENVIRON MICROB, V68, P1994, DOI 10.1128/AEM.68.4.1994-2007.2002; THOMSEN SF, 2009, AM J RESP CRIT CARE; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Verhulst SL, 2008, J ASTHMA, V45, P828, DOI 10.1080/02770900802339734; Versalovic J, 2007, HEPATOLOGY, V46, P618, DOI 10.1002/hep.21916; Webb CO, 2006, ECOLOGY, V87, pS1, DOI 10.1890/0012-9658(2006)87[1:IPICE]2.0.CO;2; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; WILLIAMS E, 2008, ALIMENT PHARM THER; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Yergeau E, 2009, ISME J, V3, P340, DOI 10.1038/ismej.2008.111; Yoo Jennifer, 2007, Proc Am Thorac Soc, V4, P277, DOI 10.1513/pats.200702-033AW	73	383	395	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8745	10.1371/journal.pone.0008745	http://dx.doi.org/10.1371/journal.pone.0008745			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20585638	Green Published, gold, Green Submitted			2022-12-27	WOS:000273715000006
